<SEC-DOCUMENT>0000950170-22-003655.txt : 20220315
<SEC-HEADER>0000950170-22-003655.hdr.sgml : 20220315
<ACCEPTANCE-DATETIME>20220315074238
ACCESSION NUMBER:		0000950170-22-003655
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		111
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220315
DATE AS OF CHANGE:		20220315

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Frequency Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001703647
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				472324450
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39062
		FILM NUMBER:		22739139

	BUSINESS ADDRESS:	
		STREET 1:		75 HAYDEN AVENUE
		STREET 2:		SUITE 300
		CITY:			LEXINGTON
		STATE:			MA
		ZIP:			02421
		BUSINESS PHONE:		781-315-4600

	MAIL ADDRESS:	
		STREET 1:		75 HAYDEN AVENUE
		STREET 2:		SUITE 300
		CITY:			LEXINGTON
		STATE:			MA
		ZIP:			02421
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>freq-20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2022-03-14T18:34:37.6883+00:00 --><!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:freq="http://frequencytx.com/20211231" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>10-K</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body>
  <div style="display:none;"><ix:header><ix:hidden><ix:nonFraction id="F_f3fea894-401b-42b7-a411-98f6c2335c88" name="us-gaap:ProceedsFromStockPlans" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_6cc8354e-b09a-486a-a3bb-72248169c646" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_61d0d67c-f4cd-4d4b-8d9e-d7034d0a2bef" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_32214a13-ed73-4cf7-9633-40ed5fcef2f1" name="dei:CurrentFiscalYearEndDate" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa">--12-31</ix:nonNumeric><ix:nonNumeric id="F_a1ba2582-5a42-4603-807e-439544ec19e9" name="dei:AmendmentFlag" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonFraction id="F_ddc3cbc9-ebdc-4197-a73d-3719f2462855" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_7f4715db-25ee-4490-aad3-011a331de8ce" name="dei:EntityIncorporationDateOfIncorporation" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" format="ixt:datemonthdayyearen">Nov. 30, 2014</ix:nonNumeric><ix:nonFraction id="F_137eb426-abf4-4990-891b-091eb5ac7e50" name="us-gaap:InterestPaidNet" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_ed329d69-2529-48fa-9178-d9e728957db7" name="freq:LeaseExpirationYear1" contextRef="C_815714a9-1c63-462b-be7a-be127a4674d0">2025-02</ix:nonNumeric><ix:nonNumeric id="F_33a1a1f8-0cd6-4834-b151-886edae55ebb" name="dei:EntityCentralIndexKey" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa">0001703647</ix:nonNumeric><ix:nonFraction id="F_1798d1a5-8d3c-4e74-b507-c3d76c7abeb0" name="freq:PrepaidRentAndDepositsCurrent" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_119e31d0-176a-42b1-86b8-f27ae33f50c7" name="dei:DocumentFiscalPeriodFocus" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa">FY</ix:nonNumeric><ix:nonFraction id="F_6fbc1e93-2815-4047-9fa0-937dffc4cfe1" name="us-gaap:PaidInKindInterest" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_ded4314f-4db0-4f7e-8996-c64ecbefa332" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" unitRef="U_pure" decimals="2" scale="-2" format="ixt:zerodash">&#x2014;</ix:nonFraction><ix:nonFraction id="F_ac776299-523f-419b-b2ba-1e3e866cfec3" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" unitRef="U_pure" decimals="2" scale="-2" format="ixt:zerodash">&#x2014;</ix:nonFraction><ix:nonFraction id="F_61d18edd-8162-4f61-97f0-1bcc5dfcfd2d" name="us-gaap:GainLossOnDispositionOfAssets1" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonFraction id="F_cdd6ec79-42ae-4060-abec-f2ff3f16e689" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" unitRef="U_USD" xsi:nil="true"></ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="freq-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_9a6459ef-90a2-45d3-bb28-8c54d3edc4d6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis">us-gaap:ShareDistributionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_10cead94-19bf-43da-bf2a-3aa91fbb188c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">freq:UnvestedRestrictedCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_06abad24-e21e-42ba-b771-10d1643ab3f6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:CaliforniaInstituteForBiomedicalResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1d3c986e-4a0f-4b46-957f-19f2213ac557"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">freq:LongTermMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fb927f4e-76df-424a-920e-b43ae68e4b30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">freq:PrepaymentOccursOnOrPriorToFirstAnniversaryOfClosingDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">freq:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-11</xbrli:startDate><xbrli:endDate>2020-12-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_549428fd-e30a-428e-9b6b-925a65a7eaa2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_86cb445a-0d20-403b-b211-6cec00f8b29a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a2aa7323-25ff-4251-80f3-998eec4375b1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f16d2dd7-db5e-4985-9658-6e9c9f5382ec"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_90c637f8-8aac-4313-bec9-a8d318734b7f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">freq:TwoThousandAndNineteenIncentiveAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f970257d-5f8c-4f69-a8af-6c7b98ed7be9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f02c82d0-ac2f-4ce8-8c28-dace93e62425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201912Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0342be7e-519c-43c8-ab77-ca720271c910"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:AREMARegionNo20LLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LeasesTerminationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-11</xbrli:startDate><xbrli:endDate>2020-12-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_419cd7aa-c2d9-47e1-b2f2-d57d5c727db3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9b494e1f-e9d7-4e68-8c4e-6503e6471f18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">freq:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d31917a1-75da-46d6-8ef7-52754985fa8f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_dcccf903-dd0c-4b08-adcc-14b5fde28ebb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">freq:TwoThousandAndNineteenIncentiveAwardPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_63fbb0a1-d118-421f-b0be-baa522b2c4c1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">freq:TwoThousandAndFourteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_49bd1a34-70e0-4358-af75-4f83449a848f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis">us-gaap:ShareDistributionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-10</xbrli:startDate><xbrli:endDate>2021-12-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_815714a9-1c63-462b-be7a-be127a4674d0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bbfcdb78-4741-401f-8112-443fb777bdf1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ff34e46d-05f9-400b-970a-b5976aa47ab4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">freq:PatentLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-12-01</xbrli:startDate><xbrli:endDate>2016-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fa37d2a6-9437-44d8-82ac-ad9b23ac3a6b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0d93812e-8c05-49cd-9223-e00467bcba4d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_dfc08580-a6c7-489e-9745-b9dfdc59a70d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e4d444fc-edc2-40cf-ab70-0c120e61141a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_36f8045c-3f63-4117-a53e-1768fa09baac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f6fd7cfb-c8de-4aa0-bb14-1baec943103c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">freq:WoburnMassachusettsFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9ee00bb1-b451-49aa-8278-506702da2a88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:HaydenLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">freq:LexingtonLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-07</xbrli:startDate><xbrli:endDate>2020-01-07</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f955b24a-1210-4587-a090-44353cb3e0a3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">freq:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-11</xbrli:startDate><xbrli:endDate>2020-12-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_37c7af32-e4c8-439d-8648-1ffe795bcb36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fd9346ee-0123-48e4-a5e9-177e9e88d4c9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9a711a28-f230-4980-b126-e2e78357768d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:CambridgeEnterpriseLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5acfbb01-3b1d-498b-b247-28b787110380"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b7c53ec7-6b2a-4521-bec1-3cfbee53835a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">freq:PrepaymentOccursAfterFirstAnniversaryOfClosingDateAndOnOrPriorToSecondAnniversaryOfClosingDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">freq:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-11</xbrli:startDate><xbrli:endDate>2020-12-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e8ed63ae-2752-4e17-8e6b-1b8e47c58699"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_639ebc28-c88b-4d67-a3ae-091fbf1f8c30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:CambridgeEnterpriseLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f92ea8d8-789c-4c65-915c-479148f6a96f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8f05e1d9-5717-4801-93c4-ba371f31a50e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_88431303-989b-46e7-871d-38ecd5178aee"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d5705e72-9931-4ce1-ae42-4f74ee48fe5f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_242a50fc-c372-4fff-a068-1d46d8ada8fc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3518f4db-a6ab-442b-9131-2ac71642f3dc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">freq:TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5f444349-7223-41bf-bdbf-3c460376bd0e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:CaliforniaInstituteForBiomedicalResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-01</xbrli:startDate><xbrli:endDate>2018-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_635de625-e8b1-4d5c-9ee3-b354458b428c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">freq:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0f0e0f6b-efeb-4ef1-b44a-ccadd9a887cd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">freq:PrepaymentOccursAfterSecondAnniversaryOfClosingDateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">freq:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-11</xbrli:startDate><xbrli:endDate>2020-12-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7a257f5b-ab22-4c07-8bef-38a92a6dc698"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LicenseAndCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:AstellasPharmaLimitedLiabilityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3b0f514e-4e02-4094-a8b5-6f2ea6aca5d4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsEyeAndEarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_be99fc1c-8083-4f95-90f4-0e839dbb422d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_394b00a6-d93c-4bb0-9bba-bc11145aea27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_51d717fb-7e75-44ae-bee6-68ee19956485"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bd09e8d5-eab7-4713-8061-e03dbe21d25f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">freq:UnvestedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_78fdf8df-07e6-446d-b5a9-2f520f345e58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:CaliforniaInstituteForBiomedicalResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">freq:PatentLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-01</xbrli:startDate><xbrli:endDate>2018-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_17ed3f9d-c233-4f9d-80c1-fd64ea247cb7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_76fdd776-fb2d-4e7e-946f-9baef372cfc0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fe2774ae-4979-4575-894a-1f57dedae7e9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_768ee818-71ae-4ce4-8037-4961cf5029cc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_45970929-9cc5-4976-bf18-cee30c4707f1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">freq:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c51b15b1-1d54-4248-ae05-78c643fea245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">freq:TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_81e252a8-16c5-427e-a03f-1106ff94238b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0c30c3e8-0228-45a8-9bfc-3207d2e201fc"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_be7fbd4c-1845-482f-953d-2642af2fb06e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2f466342-40f3-44b7-934b-9ce9617ba401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsEyeAndEarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_746daa8a-e230-4375-9cc8-fcf4f87699a6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_58f5a961-03f6-4320-a30e-9ed5284f4e0a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LoanAndSecurityAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_46cac2fb-9412-44da-9032-89c8b384ae1e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsEyeAndEarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f644c8ed-481c-4510-a475-3d938a78a2e1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LicenseAndCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">freq:Phase3ClinicalTrailMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:AstellasPharmaLimitedLiabilityCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_50db1a66-c934-4741-b3a2-b2969bdf7bf1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7f631c9f-2ca8-42db-859b-91805fd36959"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-12-31</xbrli:startDate><xbrli:endDate>2014-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c1ca8ce4-5cf1-421c-b2f3-843fbb4b6877"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cc3ef655-c17e-488c-8981-986ec4c9084c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_afc37fa6-10a6-4cfc-b132-46416981a53b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_55a858d8-b30a-41c7-bb81-5e2b9474ff72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5d611fcf-f5e9-4ee1-96e1-00b7bbb48319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3a7f3500-4681-4b89-b3ee-9823efb5714a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ecc116a0-70fc-4e40-92ed-6d00d8ab497a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7d7f8a9d-9d6d-47a1-b8ea-fd4b0fa83331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3d40bafe-0686-48fd-af67-9a140619ba32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_36d6826a-c031-4794-9b6c-6a3f3d257de7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LicenseAndCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:AstellasPharmaLimitedLiabilityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2ca9c59f-69d7-4fec-9a05-50e04ddc9998"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7186f7f7-8d1b-4a52-9633-5bf6e27f4982"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">freq:TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_314d3398-4d13-4f53-b054-20b54a955ba4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">freq:TwoThousandAndFourteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2014-11-13</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1136a968-0349-44e0-8596-79d8ce8e10d1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_7b227e56-bafa-4e07-a541-a4c468281188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsEyeAndEarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_742c5792-c6e5-48a5-b310-178c83269552"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">freq:UnvestedRestrictedCommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_27210ea1-a4d8-4337-a254-d92c29bebf12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LicenseAndCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">freq:Phase3ClinicalTrailMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:AstellasPharmaLimitedLiabilityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_54ac7307-3cc3-42f9-b337-69f60c51b471"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e07d7cda-060f-41bc-aed2-892bed256b7c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_23b528ed-dd66-4d9c-8b20-60a086d86ba5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">freq:LabEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ab8f2bc9-2386-4491-8d49-6ec657154d28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_83f34b69-48ab-4eeb-affa-ce666d46960a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b9d233e8-2d05-48fa-b3db-72146492d1a0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:CaliforniaInstituteForBiomedicalResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-01</xbrli:startDate><xbrli:endDate>2018-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_48cf3447-6d32-4520-8654-49cad8c660d5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a6c92f46-0d7d-45d4-8e0d-11c1797e8585"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsEyeAndEarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ac62a1b7-c43f-4181-a7f5-94b13f47cb97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">freq:TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_602a4133-255d-4026-bf0c-6e87837e587b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LicenseAndCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:AstellasPharmaLimitedLiabilityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b4e6b702-2e18-4b8d-b021-d0ca35b2f1ec"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_fcb1bda2-b216-4764-a4c2-09a3d13f32ac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LeasesTerminationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b4192ab1-1392-4775-850f-0b32e8099e98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6ed16120-fd10-493e-aced-7ba0d3024b61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f6dcc9b6-8e32-4d98-bffb-d9bddefb3adf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">freq:TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a8197e94-f689-4588-95d8-113863133fd1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5cd63438-4bcf-47ba-83d5-992899a88d69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_389d9cd1-a5f9-4537-a214-aae7847e6a94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LoanAndSecurityAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">freq:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-11</xbrli:startDate><xbrli:endDate>2020-12-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e6d90f27-4552-437d-96bb-a911e3141b0e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cf3edb08-0022-48b3-8d33-0b7ecf23a4eb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e468091a-59de-4c2e-9cae-c71034b0d9a8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LicenseAndCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">freq:Phase2bClinicalTrialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:AstellasPharmaLimitedLiabilityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_96ab2203-ccc4-4423-a539-b0358bf75478"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6b618c84-e67f-47f3-a70b-580a46e694b4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e8bc2828-4017-4ef6-bfea-d1f31df30f70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">freq:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_49c37535-f895-4807-a0bd-aba968e19e1d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_774fe501-efdb-4b83-b9f8-19875ffb2b41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:CaliforniaInstituteForBiomedicalResearchMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5b1c30df-3436-4ba5-a445-bc2cba68d121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8464360a-28a5-4526-89c7-192cc0292849"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9c459f52-c125-4fea-a2f0-f75d77c58396"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">freq:OutstandingStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_875116db-7306-464c-bdd4-f7030d1b80b3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201815Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1ffc57b1-4997-466a-89cb-19ba9650731e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:HaydenLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">freq:LexingtonLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-07</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_962eb6f1-dfe5-4536-a514-2f4945f570af"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">freq:ResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-06-01</xbrli:startDate><xbrli:endDate>2018-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_51ed66a1-ea9a-4086-b613-ef93bdcffe77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_becb1019-1881-4f79-9f76-55c0d3336ef7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a03b4b17-c9bb-4e37-9fb7-544f7db43dca"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a3c46bd6-df2a-4676-94dc-776e2b2317ad"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">freq:LexingtonMassachusettsFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_659cc924-ac55-436f-91ee-94a2aaf8f068"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:CambridgeEnterpriseLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0699cfb2-3e40-4b40-9c53-76a5fb6da6fe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_50ecffe0-e791-47f3-a7b0-8430f4d7aedb"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2c72469d-cb8e-4588-8128-2bea9727b19f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">freq:LexingtonMassachusettsFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d4edc7de-0885-4db2-96f1-84fc825e4ca5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LicenseAndCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:AstellasPharmaLimitedLiabilityCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">freq:Phase2bClinicalTrialMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8547fe2d-e68e-4291-9f90-da18d274d639"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_02bfcdf4-c4aa-45c7-8d3c-0e389bcfa619"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">freq:OutstandingStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5d72a168-259a-44dd-9d7b-8058d6b3899a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LicenseAndCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:AstellasPharmaLimitedLiabilityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f8a74942-bd20-4ca8-bf18-3a482101a0a2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_14a91b0e-22cb-42cd-8677-a4630683bcaf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6cb0fef5-08a6-44b1-8683-04aaee45ba50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-12-01</xbrli:startDate><xbrli:endDate>2016-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_011eaa78-a982-439b-9cbe-570f4099f0e2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">freq:UnvestedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_b285e24e-c01a-491d-bc76-fbdb9109846f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3248f726-ed7b-4ffd-ae3b-b39e2f79d1c2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-12-01</xbrli:startDate><xbrli:endDate>2016-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_aef0c60c-efa8-489b-aeea-79457818c6d2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_ad952da4-5b38-4e64-a1f0-d990bf170c57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-20</xbrli:startDate><xbrli:endDate>2019-09-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0a19bf2f-1258-4062-91ef-67f93a769e1f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_31fe05e6-676e-4a62-ac60-318d537f9748"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_961e7065-ef44-44fe-a970-97b4c237d73a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7b7e8741-8d9b-4c87-a41b-14d39da56ae6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_cdbc9d91-abb1-471d-8577-f5ca0f7f45b1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f8e0e336-1655-4b45-be69-22f29e76c3ee"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c58972d9-4eff-40b9-999f-af1bc8c7e65c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsEyeAndEarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_81406c60-6425-4fce-9724-dd646af7f352"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LicenseAndCollaborationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:AstellasPharmaLimitedLiabilityCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-01</xbrli:startDate><xbrli:endDate>2019-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6ad987ee-9ba1-42bf-b041-260c412a34d4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8f8e9273-079c-4fb5-a1f5-9391aab3c140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2d3ea299-2712-49d7-9a62-f5bd2236cb7b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_514ddae0-918c-4159-afcf-c75cb08a52fd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">freq:TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5bbe5741-fe10-4417-b986-c463fe4c347d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">freq:PatentLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:CambridgeEnterpriseLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_227c25ee-a3e6-4434-8f48-824b730e370e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsEyeAndEarMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">freq:NonExclusivePatentLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2ae98e31-ab5c-4c24-810c-110edeacf851"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001703647</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:CambridgeEnterpriseLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_UnitedStatesOfAmericaDollarsShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U_sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_Term"><xbrli:measure>freq:Term</xbrli:measure></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="border-top:2.250pt double;padding-top:1.0pt;text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:Times New Roman;">UNITED STATES</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:Times New Roman;">SECURITIES AND EXCHANGE COMMISSION</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Washington, D.C. 20549</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"> </span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.000pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:Times New Roman;">FORM </span><span style="font-size:16.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_34694310-e3ef-4f6d-b7e7-7078eeafeaa6" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:DocumentType"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:Times New Roman;">10-K</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:16.0pt;font-family:Times New Roman;"> </span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.000pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(Mark One)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"> </span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:4.759%;"></td>
    <td style="width:95.241%;"></td>
   </tr>
   <tr style="height:11.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.010in;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:11.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_da80ec0a-1e97-4251-9a4a-03e51e1ed971" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.010in;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:2.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;"> </span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">For the fiscal year ended </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bd8c29e2-6b1a-4a65-aee9-ad7058f9c930" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">December 31, </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b999d91f-8055-4f3f-8877-006248bfbeff" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:DocumentFiscalYearFocus"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">2021</span></ix:nonNumeric></span><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"></span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">OR</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"> </span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:4.759%;"></td>
    <td style="width:95.241%;"></td>
   </tr>
   <tr style="height:11.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.010in;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:3.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:11.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_412a52c4-84be-4053-8791-dd688a8fbb42" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.010in;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:2.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM                      TO</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">                     </span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Commission File Number </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_02a5de0d-57fb-45a5-b332-f19dede06e66" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:EntityFileNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">001-39062</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.000pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:21.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2c9e28dc-e8fd-479f-9153-43aa5e579e16" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:EntityRegistrantName"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:21.0pt;font-family:Times New Roman;">FREQUENCY THERAPEUTICS, INC.</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:21.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(Exact name of Registrant as specified in its Charter)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"> </span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.000pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:3.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.0%;"></td>
    <td style="width:50.0%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4473d060-4c14-491d-a62e-1cb08f46337f" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9165bf65-ae86-4f2b-93b5-6091d9e552c7" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:EntityTaxIdentificationNumber"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">47-2324450</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(State or other jurisdiction of</span></p><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">incorporation or organization)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(I.R.S. Employer</span></p><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Identification No.)</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:3.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_86e39c85-33e3-4bfe-ac9b-e965c07f6448" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:EntityAddressAddressLine1"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">75 Hayden Avenue</span></ix:nonNumeric></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">, </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_69759c77-adee-4789-91e3-16781914cb65" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:EntityAddressAddressLine2"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Suite 300</span></ix:nonNumeric></span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0203d912-8c98-41d6-a060-4bd8ebf72e33" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:EntityAddressCityOrTown"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Lexington</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">, </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d99899ba-f14e-4c7d-a3b8-37af30012e89" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:EntityAddressStateOrProvince"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">MA</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_99ddbbea-32e4-4803-a719-08716d56bafb" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:EntityAddressPostalZipCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">02421</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(Address of principal executive offices)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Registrant&#x2019;s telephone number, including area code: </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7d6567da-90da-4628-adde-17d6d38d01b4" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:CityAreaCode"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">781</span></ix:nonNumeric></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">) </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f1142072-5aec-49eb-ad2a-2372aa4ae482" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:LocalPhoneNumber"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">315-4600</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.000pt solid;margin-right:40.0%;text-align:center;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Securities registered pursuant to Section 12(b) of the Act:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:41.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:16.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:41.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Title of each class</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Trading</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Symbol(s)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1b002cf5-9c9b-4291-a682-0a83168c4cad" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:Security12bTitle"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Common Stock, $0.001 par value per share</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4f52ccb1-27dc-4182-9078-209d9c523f28" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:TradingSymbol"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">FREQ</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e83c50ce-80db-4df3-9131-25d06f996279" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">The Nasdaq Global Select Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Securities registered pursuant to Section 12(g) of the Act: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">None</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. </span><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_caebea74-f7c4-41f5-8d0b-ea3ffd159c47" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:EntityWellKnownSeasonedIssuer"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> &#9746; No &#9744;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.  Yes &#9744; </span><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_75809f84-3387-4f73-8e1e-a693c357d7a6" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:EntityVoluntaryFilers"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">No</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> &#9746;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  </span><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b33828f9-23fb-43cb-ba0b-0253f53ebf0f" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:EntityCurrentReportingStatus"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> &#9746; No &#9744;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).  </span><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_29d43dab-b4c3-42d0-93f2-a35f4af34154" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:EntityInteractiveDataCurrent"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> &#9746; No &#9744;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#x201c;large accelerated filer,&#x201d; &#x201c;accelerated filer,&#x201d; &#x201c;smaller reporting company,&#x201d; and &#x201c;emerging growth company&#x201d; in Rule 12b-2 of the Exchange Act.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:20.007%;"></td>
    <td style="width:1.002%;"></td>
    <td style="width:54.976%;"></td>
    <td style="width:1.002%;"></td>
    <td style="width:20.007%;"></td>
    <td style="width:1.002%;"></td>
    <td style="width:2.004%;"></td>
   </tr>
   <tr style="height:10.8pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Large accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#9744;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#9744;</span></p></td>
   </tr>
   <tr style="height:2.15pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_54259686-1622-4cf1-8279-f49f68449d7d" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Non-accelerated filer</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#9746;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Smaller reporting company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_29bd0b4b-8fbc-411b-a614-425adb32cfc2" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:2.15pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:2.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Emerging growth company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f63c7a9b-55f4-4d99-b10d-026bec705527" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:0.9450000000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d00d34c4-1950-4c2b-8da4-19bc41180098" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes </span><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_32e8dd93-852b-4d61-9c6e-60e66af4fbe7" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">No &#9746;</span></p>
  <p style="text-indent:4.173%;font-size:10.0pt;margin-top:2.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#x2019;s assessment of the effectiveness of its internal control over financial reporting under </span><span><span style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Section 404(b) of the Sarbanes-Oxley Act</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> (</span><span><span style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">15 U.S.C. 7262(b)</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">) by the registered public accounting firm that prepared or issued its audit report. </span><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_87105965-c592-41cc-ab84-8a5d91f89346" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">The aggregate market value of common stock held by non-affiliates of the registrant based on the closing price of the registrant&#x2019;s common stock as reported on the Nasdaq Global Select Market on June 30, 2021, was</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> $</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_88f02971-dd37-459a-aad1-8acaa0a88b69" contextRef="C_f8e0e336-1655-4b45-be69-22f29e76c3ee" name="dei:EntityPublicFloat" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">306.0</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> million.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> The number of shares of Registrant&#x2019;s Common Stock outstanding as of March 8, 2022 was </span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bc9f6923-214c-417a-9183-9b9575698d9c" contextRef="C_88431303-989b-46e7-871d-38ecd5178aee" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">34,976,409</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">DOCUMENTS INCORPORATED BY REFERENCE</span></p>
  <div><ix:nonNumeric id="F_ce3fea7a-a805-4798-9b99-4110d6a57b07" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:DocumentsIncorporatedByReferenceTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Portions of the Proxy Statement for the registrant&#x2019;s 2022 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K.</span></p></ix:nonNumeric></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Auditor Firm ID: </span><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ada15885-8667-45b2-a10d-ebe69814c2f1" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:AuditorFirmId"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">49</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">                                                              Auditor Name: </span><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5e39d4ea-f941-4676-95f4-18bddb177e7a" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:AuditorName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">RSM US LLP</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">                                      Auditor Location: </span><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f3489c08-a3ee-466b-8496-3200f9e5e581" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="dei:AuditorLocation"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Boston, Massachusetts, USA</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.250pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Table of Contents</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:10.0%;"></td>
    <td style="width:82.996%;"></td>
    <td style="width:7.004%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Page</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#bbbbbb"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Forward-Looking Statements</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#cccccccc"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Risk Factors Summary</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#part_i"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">PART I</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 1.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1_business"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Business</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 1A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1a_risk_factors"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Risk Factors</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 1B.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1b_unresolved_staff_comments"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Unresolved Staff Comments</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">88</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 2.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_2_properties"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Properties</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">88</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 3.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_3_legal_proceedings"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Legal Proceedings</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">88</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 4.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_4_mine_safety_disclosures"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Mine Safety Disclosures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">89</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#part_ii"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">PART II</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 5.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_5_market_for_registrants_common_equ"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Market for Registrant&#x2019;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">93</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 7.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_7_managements_discussion_analysis_f"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">95</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 7A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_7a_quantitative_qualitative_disclos"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">111</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 8.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_8_financial_statements_supplementar"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Financial Statements and Supplementary Data</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">111</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 9.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9_changes_in_disagreements_with_acc"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">111</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 9A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9a_controls_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Controls and Procedures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">111</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 9B.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9b_or_information"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Other Information</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">112</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 9C.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9c"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">112</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#part_iii"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">PART III</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 10.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_10_directors_executive_ficers_corpo"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Directors, Executive Officers and Corporate Governance</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">113</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 11.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_11_executive_compensation"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Executive Compensation</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">113</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 12.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_12_security_ownership_certain_benef"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">113</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 13.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_13_certain_relationships_related_tr"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">113</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 14.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_14_principal_accounting_fees_servic"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Principal Accounting Fees and Services</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">113</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#part_iv"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">PART IV</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 15.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_15_exhibits_financial_statement_sch"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Exhibits, Financial Statement Schedules</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">114</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 16</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_16_form_10k_summary"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Form 10-K Summary</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">116</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">i</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="bbbbbb"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">FORWARD-LOO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">KING STATEMENTS</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This Annual Report on Form 10-K, or Annual Report, contains forward-looking statements. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this Annual Report, including statements regarding our future results of operations and financial position, business strategy, product candidates, clinical development plans and expectations, prospective products, product approvals, research and development costs, timing and likelihood of success, and plans and objectives of management for future operations and results, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In some cases, you can identify forward-looking statements by terms such as &#x201c;may,&#x201d; &#x201c;will,&#x201d; &#x201c;should,&#x201d; &#x201c;expect,&#x201d; &#x201c;plan,&#x201d; &#x201c;anticipate,&#x201d; &#x201c;could,&#x201d; &#x201c;intend,&#x201d; &#x201c;target,&#x201d; &#x201c;project,&#x201d; &#x201c;contemplate,&#x201d; &#x201c;believe,&#x201d; &#x201c;estimate,&#x201d; &#x201c;predict,&#x201d; &#x201c;potential&#x201d; or &#x201c;continue&#x201d; or the negative of these terms or other similar expressions. The forward-looking statements in this Annual Report are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. These forward-looking statements speak only as of the date of this Annual Report and are subject to a number of important factors that could cause actual results to differ materially from those in the forward-looking statements, including the risks, uncertainties and assumptions described under the sections in this Annual Report titled &#x201c;Risk Factors&#x201d; and &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations.&#x201d; These forward-looking statements are subject to numerous risks, including, without limitation, the following:</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the initiation, timing, progress and results of our preclinical and clinical trials and research and development of programs, including our Phase 2b clinical trial of FX-322 (FX-322-208), extension trials of FX-322-111 and FX-322-112, and any future clinical trials for our product candidates;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the continued impact of the novel coronavirus, COVID-19, on our ongoing and planned clinical trials, our research and development activities and our business and financial markets;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to continue to develop our progenitor cell activation, or PCA, platform and identify additional product candidates;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to successfully complete clinical trials of any product candidate and obtain regulatory approval for it;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the timing or likelihood of regulatory filings and approvals;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the commercialization, marketing and manufacture of any product candidate, if approved;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the pricing and reimbursement of any product candidate, if approved;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the rate and degree of market acceptance and clinical utility of any products for which we receive regulatory approval;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the implementation of our strategic plans for our business, product candidates, and technology;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the scope of protection we are able to establish and maintain for intellectual property rights covering our product candidates, PCA platform, and technology;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">estimates of our expenses, future revenues, capital requirements, and our need for additional financing;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to maintain and establish collaborations, including our License and Collaboration Agreement with Astellas Pharma Inc.;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to protect our network from cybersecurity threats; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our financial performance and the sufficiency of our financial resources; and</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">developments relating to our competitors and our industry, including the impact of government regulation.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified and some of which are beyond our control, you should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur, and actual results could differ materially from those projected in the forward-looking statements. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for management to predict all risk factors and uncertainties. As a result of these factors, we cannot assure you that the forward-looking statements in this Annual Report will prove to be accurate. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances, or otherwise.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">You should read this Annual Report and the documents that we reference in this Annual Report completely and with the understanding that our actual future results may be materially different from what we expect. We qualify that all of our forward-looking statements by these cautionary statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="cccccccc"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">RISK FACTO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">RS SUMMARY</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our business is subject to numerous risks and uncertainties, including those described in Part I Item 1A. &#x201c;Risk Factors&#x201d; in this Annual Report on Form 10-K. You should carefully consider these risks and uncertainties when investing in our common stock. The principal risks and uncertainties affecting our business include the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are heavily dependent on the success of FX-322, our lead product candidate for the treatment of hearing loss, which is still under clinical development. If FX-322 does not receive regulatory approval or is not successfully commercialized, our business will be materially adversely harmed; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We utilize our PCA platform to develop product candidates that are designed to activate progenitor cells, which is a new approach to therapeutic intervention and, as a result, successful development, approval, and commercialization of our product candidates, including FX-322, is uncertain; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Clinical trials are expensive, time consuming, and difficult to design and implement, and involve an uncertain outcome. The results of preclinical studies and early clinical trials are not always predictive of future results. Our Phase 2a results (FX-322-202), for example, showed that four weekly injections in subjects with mild to moderately severe SNHL did not demonstrate improvements in hearing measures versus placebo, a finding we believe is due to an uncontrolled bias and the limitation to a single baseline measure. Any product candidate that we advance into clinical trials may not achieve favorable results in later clinical trials, if any, or receive marketing approval; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The regulatory approval processes of the FDA and comparable foreign regulatory authorities are lengthy, time consuming, and inherently unpredictable, and if we are ultimately unable to obtain regulatory approval for FX-322 or our other product candidates, our business will be substantially harmed; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may not be successful in our efforts to identify additional product candidates. Due to our limited resources and access to capital, we must prioritize development of certain product candidates, the choice of which may prove to be wrong and adversely affect our business; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we fail to comply with our obligations in our intellectual property licenses and funding arrangements with third parties, or otherwise experience disruptions to our business relationships with our licensors, we could lose intellectual property rights that are important to our business; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We will require additional capital to fund our operations, and if we fail to obtain necessary financing, we may not be able to complete the development and commercialization of FX-322 and additional product candidates;  </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We face significant competition from biotechnology, pharmaceutical, and medical device companies and our operating results will suffer if we fail to compete effectively; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we are unable to establish sales and marketing capabilities either on our own or in collaboration with third parties, we may not be successful in commercializing any product candidate we develop, if approved; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The COVID-19 pandemic has caused and could continue to cause disruptions to our business, including our preclinical studies, clinical trials and operations and could adversely impact our financial condition and results of operations; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may be impacted by general economic, political, and geopolitical conditions such as recessions, interest rates, fuel prices, and acts of war or terrorism, including the recent hostilities between Russia and Ukraine; and</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are currently subject to securities class action litigation and could be subject to similar or other litigation in the future.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="part_i"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PAR</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">T I</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_1_business"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 1. B</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">usiness.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Overview</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person&#x2019;s innate regenerative potential to restore function. Our focus is on advancing our lead product candidate, FX-322, through clinical studies with the goal of developing and commercializing a medicine to help millions of people with the most common form of hearing loss while continuing to broaden the potential of our regenerative approach in other applications. We believe we are a leading company using mitotic regeneration for cochlear sensory hair cell regeneration and that FX-322 has the potential to meaningfully improve overall hearing function and enhance quality of life for people with this condition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our proprietary approach, called Progenitor Cell Activation, or PCA, uses small molecules to activate progenitor cells within the body to create functional tissue. These progenitor cells, which are closely related to stem cells, are already resident in the targeted location in the body and programmed to develop and differentiate into specific cell types within an organ. We believe this approach provides us the opportunity to pursue multiple proposed indications and develop potential treatments for an array of degenerative diseases throughout the body.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our hearing program is for a condition called sensorineural hearing loss, or SNHL, which is the most prevalent type of hearing loss, typically caused by permanent loss of sensory hair cells in the cochlea within the ear. Cochlear sensory hair cells can be lost by noise exposure, as a result of aging, certain viral infections or exposure to ototoxic drugs. FX-322 aims to treat the underlying cause of SNHL by regenerating hair cells through the activation of progenitor cells already present in the cochlea. Since 2019, we have completed five studies, all with the aim of understanding the safety of FX-322 as well as severities and etiologies that FX-322 might treat and the appropriate dose regime. In October 2021, we commenced dosing of a Phase 2b clinical trial of FX-322 (FX-322-208). </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We continue to advance work related to SNHL. In November 2021, we introduced our new SNHL investigational therapeutic program, FX-345, designed to achieve broader exposure through the cochlea. Refer to </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our hearing program</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> below for detailed information on completed and ongoing studies as well as our hearing pipeline.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In July 2019, we entered into a license and collaboration agreement, or the Astellas Agreement, with Astellas Pharma Inc., or Astellas, under which we granted them rights to develop and commercialize FX-322 outside of the United States. As consideration for the licensed rights under the Astellas Agreement, Astellas paid us an upfront payment of $80.0 million in July 2019 and has agreed to pay potential development milestone payments of up to $230.0 million.  If the Astellas licensed products are successfully commercialized, we would be eligible for up to $315.0 million in potential commercial milestone payments plus tiered royalties on any future product sales ranging from low- to mid-teen percentages. Refer to </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">License and collaboration agreements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> below for detailed information on this agreement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe our PCA approach can impact a wide range of degenerative diseases. To that end, in addition to our lead program in hearing, we are working to rapidly advance discovery efforts using our PCA approach to potentially remyelinate nerves in patients with multiple sclerosis, or MS. MS induces demyelination, stripping axons of the myelin sheaths that support nerve signal conduction and axonal survival. Prior to initiating our internal discovery program against a novel target, we licensed intellectual property from Scripps and Cambridge Enterprise on approaches to promote remyelination of nerve fibers. We continue to engage in sponsoring clinical research to validate this initial approach at Cambridge University. In November 2021, we introduced FREQ-162, an internally discovered preclinical stage compound that has been shown to induce substantially more remyelination than published comparator approaches based on </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> models. Our efforts are focused on advancing Frequency compounds in preclinical safety studies to enable the initiation of clinical trials in 2023.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Refer to </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our multiple sclerosis (MS) program </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">below for detailed information on our internal program and ongoing sponsored research.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Impact of COVID-19</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our offices are located in states that have lifted many COVID-19 restrictions. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of the date of the filing of this Annual Report, the majority of our non-laboratory based employees continue to work from home two to three days per week, while our laboratory personnel have largely resumed a full in-person schedule in our Lexington, MA facility. </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have also taken steps consistent with the updated industry guidance for conducting clinical trials from the U.S. Food and Drug Administration, or FDA.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The COVID-19 pandemic, and actions taken to mitigate it, have had and are expected to continue to have an impact on the economies and financial markets of many countries, including the geographical area in which we operate, which could adversely impact our ability to raise additional capital when needed or on acceptable terms, if at all. In addition, COVID-19 may cause disruptions in our business or operations, as well as the business and operations of our clinical manufacturing organizations, or CMOs, clinical research organizations, or CROs, and other third parties with whom we conduct business. The COVID-19 pandemic may also adversely impact our clinical trials, which could impede, delay, limit or prevent the clinical development of our product candidates and ultimately lead to the delay or denial of regulatory approval of our product candidates, which would materially adversely affect our business and operations, including our ability to generate revenue.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Our product pipeline</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The table at Exhibit 1 summarizes our PCA therapeutic candidate pipeline and discovery research programs:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 1:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_0.jpg" alt="img88009329_0.jpg" style="width:672px;height:603px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Our team and history</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our company was founded in 2014 with the goal of creating medicines based on breakthrough research focused on activating the body&#x2019;s regenerative potential. In their groundbreaking research, Professors Robert S. Langer at the Massachusetts Institute of Technology and Jeffrey Karp at Harvard Medical School, decoded the natural signals between cells that make the intestine one of the most regenerative organs in the body through the continuous activation of progenitor cells. Recognizing that similar progenitor cells were present but inactive in other organs, they discovered how to adapt these natural signals using small molecules to temporarily activate progenitor cells in other organs, including the cochlea, and create a localized healing response.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our leadership team includes experienced biotech executives David L. Lucchino, our Chief Executive Officer and co-founder, Christopher R. Loose, our Chief Scientific Officer and co-founder, Peter P. Pfreundschuh, our Chief Financial Officer, Carl P. LeBel, our Chief Development Officer, Quentin McCubbin, our Chief Manufacturing Officer, Susan Stewart, our Chief Regulatory Officer, and Wendy S. Arnold, our Chief People Officer. We have also assembled a world-class team of leaders in regenerative biology, otology, drug development, and drug delivery. Our Clinical Advisory Board is comprised of leaders in hearing science and technology who shape how the community thinks about hearing function and restoration. Our Regenerative Medicine Advisory Board members are at the forefront of scientific discovery on the activation of progenitor cells and their potential application to therapeutic interventions in diseases of multiple tissues and organs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Our strategy</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We intend to create and commercialize therapeutics to potentially transform the lives of individuals by repairing or reversing damage done to cells, tissue, and organs. To do so, we are implementing the following strategies:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Advance development of a single dose regimen of FX-322 for the treatment of SNHL</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. We believe our lead product candidate has the potential to improve hearing function for the millions of people affected by SNHL who currently have no therapeutic options. We now have three independent, single-dose studies in individuals with mild to severe SNHL that showed a hearing signal with FX-322 and with statistically significant improvements in speech perception. The results from our Phase 2a study (FX-322-202) demonstrated that four weekly injections in subjects with mild to moderately severe SNHL did not demonstrate improvements in hearing measures versus placebo, a finding we believe is due to an uncontrolled bias and the limitation to a single baseline measure. Therefore, we are advancing further development of FX-322 as a single dose regimen in our Phase 2b clinical trial (FX-322-208) which commenced in October 2021.  </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Establish our position as a global leader in the field of hearing function. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We plan to continue to grow our discovery organization and add experts in the field of otology to drive the optimization of our PCA approach for the treatment of hearing loss. We also plan to expand our presence in the field of hearing restoration and to work closely with the broader community of advocates, physicians, and payors to bring new treatments to patients globally. </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expand the opportunities of our PCA platform beyond hearing.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> We believe our PCA platform has the potential to address a wide range of clinical applications. We will continue to invest in research and development to enhance our PCA platform with the goal of delivering new therapeutics in additional indications. We identified MS as a disease where PCA has the potential to produce a restorative effect by stimulation of oligodendrocyte precursor cells, or OPCs, to myelinate axons. We established an internal research program using PCA to drive remyelination as a potential therapy for MS and, as a result of that program, have now introduced FREQ-162, a preclinical stage compound that has been shown to induce substantially more remyelination than published comparator approaches based on</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> in vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> models. Our efforts are focused on advancing a candidate in preclinical safety studies in preparation for the initiation of clinical development. We have also obtained worldwide licenses for intellectual property from Scripps and Cambridge, on approaches to promote remyelination of nerve fibers.  </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Continue to build strategic collaborative relationships</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Given the broad potential opportunity of our PCA platform, we believe entering into strategic research, development, and commercial collaborations in select therapeutic areas may provide an attractive avenue to facilitate the capital-efficient development of our PCA platform and product pipeline. We believe these strategic collaborations could potentially provide significant funding to advance our product candidates while allowing us to benefit from the development and therapeutic area expertise of our collaborators. We may collaborate with large pharmaceutical companies, biotechnology </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;visibility:hidden;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;"></span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">companies, and academic institutions to maximize the potential of our PCA platform to create new therapies for patients.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Our approach: Progenitor cell activation within the body</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are pioneering a new class of small molecule therapeutics designed to activate progenitor cells already present within the body to create healthy functional tissues and organs. We developed our PCA platform to identify combinations of small molecules that selectively activate progenitor cells to regenerate tissues. Our current therapeutic focus is SNHL and MS. We believe that our preclinical and clinical studies in SNHL and our preclinical studies in MS have validated the potential of our PCA platform to provide a new approach to regenerative medicine.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Exhibit 2 below illustrates the application of our PCA platform to activate progenitor cells and create healthy functioning target cells. Our small molecules are designed to activate key genes in a progenitor cell, which enable the cell to go through asymmetric division, leaving behind a copy of the progenitor cell as well as creating a functional cell, such as a hair cell. This asymmetric division process is a common mechanism used during the natural development and repair of tissues.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 2:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_1.jpg" alt="img88009329_1.jpg" style="width:660px;height:375px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:5.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:5.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Relationship between stem cells and progenitor cells</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All cells in the human body arise from a single unspecialized, or undifferentiated, cell type called a pluripotent stem cell. Two of the key characteristics of pluripotent stem cells are their ability to renew themselves through cell division and the ability to differentiate into any cell type. Progenitor cells have similar self-renewal properties as pluripotent stem cells. However, progenitor cells are programmed to develop and differentiate into specific cell types within an organ. This process can be visualized using Waddington&#x2019;s epigenetic landscape, which depicts a pluripotent stem cell as a ball rolling down a hill as development progresses as seen in Exhibit 3 below. As the ball commits to specific valleys, the cell becomes more specialized and increasingly commits to a tissue-specific fate, such as a progenitor cell. The progenitor cells are programmed to create specific cell types, and, in some cases, allow mature tissue and organs to repair and renew. However, researchers have discovered that many organs throughout the human body that do not spontaneously regenerate do contain inactive progenitor cells that, if stimulated, are potentially available to drive regeneration.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Over the course of several decades, multiple attempts have been made to harness the regenerative potential of stem cells. More recently, the 2012 Nobel Prize in Physiology or Medicine was awarded to Dr. Shinya Yamanaka for discovering how to create induced pluripotent stem cells by adding four genetic factors to a fully differentiated cell, as illustrated by the solid black arrow in Exhibit 3 below. However, the Yamanaka factors cannot be applied </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">it has proven challenging to manufacture pluripotent or other human stem cells outside of the body and to control their differentiation to produce a particular cell type. Further, delivering and properly integrating these cells back into the body adds substantial complexity. Using another approach, some investigators have tried to force progenitor cells within the body to directly convert into other cell types through a process called trans-differentiation, as illustrated by the dotted black arrow in the graphic below. However, trans-differentiation may deplete progenitor cells, which reduces the target cell population for future treatments.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe that our PCA approach, illustrated in Exhibit 3 below, bypasses the challenges presented by stem cell therapies by utilizing small molecule therapeutics to temporarily reactivate progenitor cells that are already located at the tissue target site within the body and are pre-programmed to make specific cell types. Our combinations of small molecules are designed to induce a progenitor cell to temporarily enter an active state, where it then divides asymmetrically, replacing itself (blue arrows) and regenerating a desired cell type (orange arrow). Asymmetric division occurs when organs naturally regenerate, so progenitor cells are thought to be maintained for future use.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 3:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_2.jpg" alt="img88009329_2.jpg" style="width:672px;height:301px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:5.0pt;font-family:Times New Roman;">=</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Key attributes of our PCA platform</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our discoveries in regenerative medicine allow us to activate the innate and under-utilized capabilities of progenitor cells. We believe our PCA platform represents a transformative step in the evolution of regenerative medicine by providing the following key advantages compared to other regenerative approaches:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Harnesses innate biology</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. We overcome the major challenge of delivering and integrating cells into the proper location within tissue. Our small molecule therapeutic candidates activate the body&#x2019;s own progenitor cells at the desired location in targeted tissues. </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Ease of manufacturing</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. We eliminate the need to remove and grow live cells </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">ex vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, which can be costly and complex to manufacture, difficult to control quality, and may pose potential safety risks. In contrast, our small molecule therapeutic candidates will be produced using standard manufacturing methods. </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">No change to genome</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Instead of altering genes, our small molecules are designed to temporarily activate the innate genes that play a central role in the development of organs and tissues. This small molecule approach could create a disease-modifying or restorative effect without changing the body&#x2019;s genetic code. In addition, we believe we avoid the risk of acquiring immune reactivity to our therapeutics, which is commonly associated with genetically modifying cells. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our therapeutic discovery process</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We utilize a proprietary process to identify small molecule combinations for activating progenitor cells.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Discovery in the right context</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Traditional drug screening uses immortalized cell lines that are convenient for use in a laboratory but may not reflect the complex biology of tissue-specific cell types in the body. In our discovery process, we develop primary progenitor cell assays that are designed to maintain these cells in their natural state in order to increase the likelihood of successful drug discovery and translation into an effective tissue-specific therapeutic. </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.0829166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Decoding and controlling activation pathways for progenitor cells</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. We use our accumulated insights into           progenitor cell signaling and aging to identify biological pathways that may activate a specific progenitor cell. We then select and apply combinations of small molecules from our proprietary toolbox of compounds to modulate the chosen biological pathways and achieve PCA.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By assessing our small molecule combinations in a highly relevant context, we and our collaborators have applied this discovery process to identify compounds that activate progenitor cells in numerous tissues.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Our hearing program</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Impact and prevalence of hearing loss</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">According to the WHO, over 1.5 billion people suffer from some degree of hearing loss worldwide, and, according to the NIH, approximately 90% of people with hearing loss have SNHL. Based on our estimates, we believe that approximately 41 million adults in the United States are aware of their SNHL. The WHO also estimates that 1.1 billion children and adults ages 12 to 35 years old are at risk for hearing loss from recreational noise exposure. In middle- and high-income countries, the WHO estimates that nearly 50% of people aged 12 to 35 listen to personal audio devices at unsafe sound levels. Moreover, damage from noise exposure in early childhood can render the ears more susceptible to the effects of aging. Noise exposure is difficult to avoid in modern society. Noise at restaurants, for example, routinely climbs into the high 70-decibel, or dB, range, equivalent to a canister vacuum cleaner, and sometimes to the mid-80 dB, as loud as a nearby diesel truck.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">After a person first complains of hearing loss, which is most often to their primary care physician, individuals with SNHL are managed by audiologists and otolaryngologists, who are trained as ear, nose, and throat specialists, or ENTs. In the United States, there are about 13,000 audiologists and about 12,500 ENTs. Developing a therapeutic to potentially modify an underlying cause of SNHL may provide a critically important treatment option for this group of health-care providers and their patients.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There are also further direct and indirect impacts on individuals suffering from SNHL. Hearing loss profoundly affects an individual&#x2019;s ability to participate in the social interactions of daily life, which can lead to feelings of loneliness, isolation, and frustration. Untreated hearing loss is associated with a 50% increased risk of dementia and a 40% increased risk of depression. Adults with hearing loss also have higher unemployment rates than non-hearing-impaired adults, and a relationship between hearing loss and diminished employment and advancement opportunities has been reported. According to a 2020 study in the medical journal </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The Lancet</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, hearing loss is the largest potentially modifiable risk factor for developing dementia.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Biology and measurement of hearing</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We hear sounds when sound waves enter the inner ear and generate movement of the fluid in the cochlea, a portion of the inner ear that looks like a snail shell. This fluid movement causes hair cells within the cochlea to bend and in turn generate electrical signals that are transmitted to the brain via the auditory nerve. The cochlea is arranged so that hair cells at the base detect high frequencies and hair cells at the apex detect low frequencies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Humans are born with about 15,000 hair cells in the cochlea of each ear. Hair cells are commonly lost due to noise exposure in work settings, travel or leisure activities, as a result of aging or certain viral infections or exposure to ototoxic drugs. Lost hair cells do not spontaneously regenerate. Over time, hearing loss can accumulate with greater prevalence at high frequencies. The left panel of Exhibit 4 below shows a picture of the inside of a healthy cochlea, with one row of inner hair cells, or IHCs, and three rows of outer hair cells, or OHCs. OHCs amplify or dampen sound volume and tune the cochlea to detect specific frequencies. IHCs convert sound waves into nerve impulses that are sent to the auditory nerve. Functional hair cells allow the auditory system to focus on a sound and filter it appropriately throughout the cochlea. The right panel in Exhibit 4, adapted from Ryan AF PNAS 2000, shows a cochlea after noise damage, with both IHCs and OHCs missing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 4:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Healthy and Noise-Damaged Cochlea</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_3.jpg" alt="img88009329_3.jpg" style="width:612px;height:175px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The two primary components for hearing testing are intelligibility, or the ability to understand spoken words which is referred to as speech perception, and the audibility or loudness of sound. While amplifying devices such as hearing aids can make sounds louder, they have limited ability to improve speech clarity, particularly in noisy environments. Intelligibility is particularly important to understand speech in social settings such as in meetings or at restaurants, where filtering sound is critical for communication.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Speech perception is typically measured by playing a list of words that are repeated back by the person being tested and scoring based on the number of words that the person gets correct. The two validated testing methods of speech perception that are most widely used by audiologists are: word recognition, or WR, where subjects are asked to identify monosyllabic words delivered at a loud, but conversational volume level, and words-in-noise, or WIN, where subjects are asked to identify monosyllabic words in the presence of background, multi-talker noise.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Audibility is determined by measuring hearing function at different levels of loudness and pitch or frequency. Subjects are most often tested using pure tone audiometry, in which a tone is played at a particular frequency and subjects are asked to indicate whether they can hear the tone at varying levels of loudness. Loudness is recorded in dB HL. Frequency is recorded in Hertz, or Hz, and is generally measured in the range of 250 to 8000 Hz. According to the WHO, normal hearing is defined as the ability to hear sounds at a loudness value of less than 26 dB HL, which is the average of loudness values measured at a range of low, middle, and high frequencies, such as 500, 1000, 2000, and 4000 Hz. The larger the loudness value needed for a subject to hear sounds the greater the decline in hearing function, or more severe hearing loss. Exhibit 5 below depicts the severity of hearing loss across a range of frequencies based on the American Speech-Language-Hearing Association scale.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 5:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_4.jpg" alt="img88009329_4.jpg" style="width:631px;height:326px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:5.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:5.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Limitations of current treatment options</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Current treatment options for hearing loss have significant limitations and none are disease modifying. The only available treatments for hearing loss are hearing aids, or in extreme cases, cochlear implants. No drug therapies have been approved by the FDA or, to our knowledge, by other regulatory bodies, for the treatment of SNHL.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Hearing aids</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Hearing aids help many people cope with mild-to-moderate hearing loss and are used or have been tried by more than 10 million people in the United States. According to the National Institute on Deafness and Other Communication Disorders, only one in four adults who could benefit from hearing aids has ever used them. Limitations of hearing aids include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Poor sound quality</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Hearing aids amplify sounds, allowing people to perceive sounds that would otherwise be too soft for them to hear, but do not address the loss of hair cells, which determine sound quality and speech perception, particularly in noisy environments. </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Challenges in social settings</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The wide range of frequencies and sharp tuning provided by hair cells enables the auditory system to accurately recognize and distinguish different sounds, allowing the brain to focus on a single sound source. Hearing aids on the other hand typically amplify all sounds and do not enable this important sound-processing capability. As a result, interactions in social settings, which require distinguishing one speaker among many sound sources, are significantly impaired. </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Difficulties with background noise</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. People with hearing loss may become more sensitive to background noise, and many people with hearing aids turn them off in noisy environments. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stigma associated with wearing a visible device</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Some people refuse to wear hearing aids, or do not wear them regularly, as they do not want to be stigmatized or identified as having a physical handicap. </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Need for maintenance</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Hearing aids must be replaced, on average, every four to six years, need regular battery replacement, and can require repair due to damage during use. Medicare and most private insurance plans do not pay for hearing aids, and most people must pay for these devices out of pocket. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cochlear Implants</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">People with severe or profound hearing loss who have not been helped by hearing aids may be candidates for a cochlear implant. Of the roughly one million people in the United States who qualify, only about 100,000 people have cochlear implants. Cochlear implants comprise an external microphone, sound processor and transmitter system, which receive sounds from the environment, and an implanted receiver and electrode system that directly stimulates the auditory nerve. Cochlear implants do not mimic natural hearing, and people with cochlear implants need to learn to interpret the low-resolution electric signal produced by the device as sound. Cochlear implants also require an invasive, costly surgical procedure.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our lead product candidate: FX-322</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Using our PCA platform, we are developing our lead product candidate, FX-322, for the treatment of SNHL. FX-322 is designed to treat the underlying cause of SNHL by regenerating hair cells through activation of progenitor cells already present in the cochlea. We believe that FX-322 has the potential to meaningfully improve overall hearing function and significantly enhance quality of life for people with hearing loss.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Mechanism of Action</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By studying the most regenerative organ in the body, the intestine, we discovered that signaling for proliferation and differentiation among stem cells could be replicated with small molecules. Specifically, activating the Wnt pathway, which is fundamental for cell growth, using a glycogen synthase kinase 3, or GSK3, inhibitor and inhibiting histone deacetylase, or HDAC, caused intestinal stem cells expressing the protein Lgr5 to proliferate. The inner ear contains progenitor cells with the Lgr5 protein that do not regenerate on their own. On the hypothesis, depicted in Exhibit 6 below, that these progenitor cells lacked the signals required for regeneration, we applied a GSK3 inhibitor and HDAC inhibitor to these cells and found that they proliferated and regenerated lost hair cells. Based on this discovery, we created FX-322, which is a proprietary combination of an FDA-approved HDAC inhibitor, sodium valproate, and a new chemical entity that inhibits GSK3.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 6:</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_5.jpg" alt="img88009329_5.jpg" style="width:570px;height:263px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Administration</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">FX-322 is our proprietary thermoreversible polymer formulation that is administered through the eardrum, or intratympanically, into the middle ear in a procedure that takes approximately 10 to 15 minutes. The intratympanic</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">administration procedure is generally well-tolerated and is routinely performed by ENTs as an office-based procedure. FX-322, which is liquid at room temperature, gels at body temperature inside the middle ear, allowing the active ingredients to diffuse into the inner ear and reach the cochlea. Similar thermoreversible polymer formulations have been used in FDA-approved products for other indications in the ear. Exhibit 7 below shows delivery of FX-322 via intratympanic injection.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 7:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_6.jpg" alt="img88009329_6.jpg" style="width:672px;height:286px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">FX-322 preclinical studies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prior to commencing clinical trials, we tested FX-322 in multiple preclinical studies, including in human cells </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">ex vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and functional hearing tests in mice </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> testing of isolated human inner ear progenitor cells with the compounds comprising FX-322, we observed the formation of new progenitor cells and their subsequent conversion into hair cells. We also observed translation across species in our </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> studies of the inner ear progenitor cells from rhesus macaques in which a similar expansion of cell numbers were observed as in the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> studies of human cells</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Exhibit 8 below summarizes these outcomes.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 8:</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_7.jpg" alt="img88009329_7.jpg" style="width:570px;height:332px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We also conducted </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">ex vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> testing in intact cochlea isolated from mice. To cause hair cell loss, we exposed the cochlea for 16 hours to an aminoglycoside antibiotic that is toxic to hair cells. We then treated the cochlea for 72 hours with the compounds comprising the active agents in FX-322. Aminoglycoside treatment (left panel of Exhibit 9 below) killed more than 80% of the hair cells in the cochlea (shown in green). By contrast, cochlea treated with the compounds in FX-322 (right panel of Exhibit 9) regenerated hair cells to a near native level, as shown graphically in the right panel.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 9:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_8.jpg" alt="img88009329_8.jpg" style="width:596px;height:247px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_9.jpg" alt="img88009329_9.jpg" style="width:191px;height:204px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We also tested FX-322 in a mouse model of severe noise-induced hearing loss. Following noise exposure, 47 mice were treated with FX-322 and 37 were treated with placebo. Hearing function was measured using auditory brainstem response, or ABR, in which the signal generated by the auditory nerve upon sensing sound is detected by electrodes on the scalp. We performed ABR testing after 24 hours, and measured hearing recovery after 30 days. Exhibit 10 below shows the percentage of mice treated with FX-322 (shown in orange) or with placebo (shown in blue) that achieved a hearing recovery of at least 10 dB at 20000 Hz, a mid-range frequency for mice. The improvement observed in the placebo-treated mice was due to recovery of temporary effects not related to hair cell death, which is typical following acute hearing loss.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 10:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Hearing Recovery in Mice Treated with FX-322</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_10.jpg" alt="img88009329_10.jpg" style="width:287px;height:185px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have also conducted pharmacokinetic tests in multiple species in which we observed that FX-322 administration achieved therapeutic levels of the active pharmaceutical ingredients in the cochlea.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Exhibit 11 below illustrates the cellular regeneration identified in the</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> in vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> hearing loss model.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 11:</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_11.jpg" alt="img88009329_11.jpg" style="width:570px;height:286px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">FX-322 completed clinical trials</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Phase 1/2 clinical trial</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We conducted a Phase 1/2 clinical trial of FX-322 (FX-322-201) in which we enrolled 23 adult subjects aged 33 to 64 with an established diagnosis of mild to moderately severe stable SNHL, defined as the average pure tone value of 26 to 70</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">dB at the 500, 1000, 2000 and 4000 Hz frequencies, who had no change of 10 dB or more at any frequency for more than six months prior to the study. Fourteen subjects had mild SNHL and nine subjects had moderate to moderately severe SNHL. Of the nine moderate to moderately severe subjects, six were randomized to FX-322 and three to placebo. In this trial, 15 subjects were treated with a single injection of FX-322 and eight subjects received placebo. Each subject had a documented medical history consistent with either noise-induced hearing loss, or NIHL, typically from noise exposure at work, or sudden SNHL, or SSNHL, which is characterized as a loss of 30 dB at three adjacent frequencies occurring over a 72-hour period. Hearing function, specifically speech perception, was assessed using WR and WIN. Hearing loudness was also measured using pure tone audiometry. Subjects were randomized to a single injection of FX-322 or placebo administered at one of two different dose volumes (0.05 mL and 0.2 mL) to assess the safety of FX-322 administration and systemic exposure to FX-322. Follow-up visits occurred at 15, 30, 60, and 90 days after injection. The objectives of the trial were to assess the systemic safety of FX-322, the plasma pharmacokinetic profile to determine the systemic exposure to FX-322, and the effect of FX-322 on measures of ear health and hearing function.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">FX-322 was observed to be well-tolerated in this trial. No serious adverse events were observed, and all treatment-related adverse events were mild, procedure-related, and generally resolved within minutes after dosing. We also observed limited concentrations of the FX-322 components in systemic circulation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to the prospective analysis, we conducted a prospective statistical analysis where we tested whether the Day 90 WR value for each subject fell outside of the 95% confidence interval compared to their baseline WR value. A confidence interval, or CI, is a range of values in which, statistically, there is a specified level of confidence where the result lies. In this subject-by-subject analysis, we observed statistically significant and clinically meaningful increases in WR in four of fifteen subject treated with FX-322 at Day 90. All four of these subject were among the six FX-322 subjects that had moderate to moderately severe SNHL (as shown in Exhibit 12 below).We also observed improvements for the two remaining FX-322 subjects in the study that had moderate to moderately severe SNHL in the range of 30-50% from their baseline score, but these improvements were not statistically significant.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In June 2020, we shared preliminary findings from a follow-up study we conducted that assessed durability of the WR improvements beyond 90 days at a single follow-up visit from 407 to 639 days post</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;">&#xf02d;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">FX-322 administration in five of the subjects that showed a response in the Phase 1/2 trial (FX-322-201) (the 6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">th</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> subject was unable to participate in the follow-up study). The mean percentage of words correct in the treated ear was 38.4% at baseline, 69.6% at day 90, and 54.8% at follow-up. Three of five subjects showed statistically significant improvements in WR at the follow-up visit compared to baseline, as illustrated in Exhibit 12 below. We believe that the results suggest that a single dose of FX-322 can result in durable improvements in speech perception and support further investigation of the efficacy of FX-322.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There was no apparent association between WR improvements and whether the subjects had stable NIHL, or stable SSNHL, and similar results were obtained with both dose volumes. This is consistent with published work showing drug delivery to the cochlea depends more on the concentration of the drug than the volume of injection. There were no clinically meaningful WR improvements observed in the placebo group.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 12:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_12.jpg" alt="img88009329_12.jpg" style="width:672px;height:319px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:5.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:5.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We also performed a </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">post hoc</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> analysis on WR and WIN data for the Phase 1/2 study (FX-322-201). The analysis showed a statistically significant improvement in WR by all FX-322-treated subjects versus all placebo subjects (p=0.010). A p value is the probability that the difference between two data sets was due to chance. The smaller the p value, the more likely the differences are not due to chance alone. In general, if the p value is less than or equal to 0.05, the outcome is statistically significant. The data in the figures below are presented as adjusted mean relative percent change from baseline. FX-322 treated subjects saw improvements in WR as early as 15 days after treatment that were sustained over 90 days.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As shown in Exhibit 13 below for WIN, the adjusted mean relative percent change from baseline was assessed at 15, 30, 60, and 90 days after injection, and a trend in improvement was seen in FX-322-treated subjects versus placebo. Also,</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">there were non-statistically significant trends in improved WIN scores at Day 90 in the four FX-322, treated subjects that had statistically significant and clinically meaningful improvements in WR in the prospective statistical analysis.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 13:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_13.jpg" alt="img88009329_13.jpg" style="width:637px;height:291px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.507%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The same WR data was published in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Otology and Neurotology </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">in February 2021, as shown in Exhibit 14 below. In compliance with the publication&#x2019;s policy, the data was presented with standard error, resulting in a slightly different adjusted mean and p value. Despite the change, the results shown in Exhibit 14 were consistent with those in Exhibit 13 above.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 14:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_14.jpg" alt="img88009329_14.jpg" style="width:316px;height:314px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.507%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As shown in Exhibit 15 below, published in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Otology and Neurotology </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">in February 2021, speech recognition in a noisy background also improved over time for FX-322-treated subjects versus placebo subjects. Performance was quantified as the signal-to-noise ratio, or SNR, consistent with 50% correct WR, with lower SNR values indicating better speech perception in background noise. Analyses showed a significant improvement in average SNR from baseline to Day 90 in FX-322-treated subjects versus placebo subjects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 15:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_15.jpg" alt="img88009329_15.jpg" style="width:566px;height:295px;" />&#160;</p>
  <p style="text-indent:5.507%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We also assessed audiometric changes from 250 Hz to 8000 Hz for all subjects. Since drug enters closest to the high frequency region, the greatest drug exposure is expected to occur in the high frequency region. While no statistical differences were observed at any frequency when comparing pooled treatment groups, four of the moderate to moderately severe FX-322 subjects showed a 10 dB threshold improvement at 8000 Hz at Day 90.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Phase 2a clinical trial</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Based on our analysis of the data from our Phase 1/2 clinical trial, we initiated a randomized, double-blind, placebo-controlled, single- and repeat-dose Phase 2a clinical trial of FX-322 (FX-322-202) in the fourth quarter of 2019. In September 2020, we completed enrollment of 95 </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">subjects </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">aged 18-65 across sixteen sites in the Phase 2a clinical trial. As in the Phase 1/2 clinical trial, </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">subjects </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">were required to have a documented medical history consistent with either stable NIHL or stable SSNHL, meaning that a </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">subject's </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">hearing deficit has remained consistent over a defined period of time based on a </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">subject's </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">audiograms. All subjects in the clinical trial had meaningful WR deficits including </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">subjects </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">who were considered to have &#x201c;mild&#x201d; hearing loss.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To explore how a single dose compares to multiple doses of FX-322, we randomized </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">subjects </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">to one of four groups, each of which received four injections, once per week at weekly intervals starting at the initial visit. Group 1 received one injection of FX-322 and three injections of placebo. Group two received two injections of FX-322 and two injections of placebo. Group three received four injections of FX-322. Group four received four injections of placebo. </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">subjects </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">had follow-up visits two weeks after dosing and then monthly for seven months. The efficacy endpoints of this trial were WR, WIN, and pure tone audiometry in the range of 250 to 8000 Hz. The exploratory efficacy endpoints were the TFI, the HHIA, and pure tone audiometry in the range of 9000 to 16000 Hz.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">June 2021, we announced final results from the Phase 2a clinical trial (FX-322-202). Consistent with the topline, day-90 interim data, the end-of-study results (as of day 210) showed that four weekly injections of FX-322 did not demonstrate improvements in any hearing measures versus placebo, a finding we believe is due to an uncontrolled bias and the limitation to a single baseline measure. We also observed an unexpected increase in WR scores in the placebo group that did not occur in previous FX-322 trials and exceeded well-established published standards, potentially suggesting bias due to trial design. Given this lack of reliability of baseline WR scores of the placebo group, we were unable to evaluate hearing improvements in WR scores for FX-322 dosing regimens versus placebo. The study results showed a favorable safety and tolerability profile for FX-322 in the Phase 2a clinical trial.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> N</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">o treatment-related serious adverse events were observed in the study.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Phase 1b clinical trials</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2021, </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we announced data from a Phase 1b clinical trial of FX-322 designed to evaluate the impact of injection conditions on tolerability (FX-322-111). The data showed hearing improvement from a single injection of FX-322. In the multi-center, randomized study, subjects with mild to severe SNHL (n=33) were injected in one ear with FX-322 with the untreated ear as the control. Hearing function was tested over the course of 90 days following dosing. Thirty-two subjects completed the 90-day clinical assessment period and, at day 90 following dosing, 34% of these subjects achieved a 10% or greater absolute improvement in WR scores in the treated ear, which was clinically meaningful and statistically significant compared to the untreated ear (p &lt;0.05). This included a subset of subjects that more than doubled their WR scores. Twenty-five subjects were subsequently evaluated during the 8 to 12 months following FX-322 dosing and nine subjects, including the five initial responders at day 90, had shown statistically significant hearing improvements when evaluated during this time period. Of the five subjects that showed a statistically significant response and doubled their WR scores at day 90, four of these returned for evaluation and had scores that remained above their baseline WR measures, though were below the threshold for statistical significance. In this trial, FX-322 showed a favorable safety profile and was well tolerated.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In May 2021, we announced data from a Phase 1b clinical trial of FX-322 in presbycusis (age-related hearing loss) (FX-322-112). The double-blind, placebo-controlled, randomized, multicenter safety study enrolled 30 individuals aged 66-85 with age-related hearing loss. Study participants were randomized 4:1 to receive either FX-322 or placebo in one ear. Validated hearing measures, as well as safety, otologic and audiologic assessments were also evaluated in the study. By design, the study recruited subjects with no medical history of noise-induced or SSNHL, etiologies where FX-322 associated hearing benefits were observed in prior studies, as we continue to separately evaluate subjects with specific forms of hearing loss to better refine cohorts for future studies. While the treatment effect was not significant compared to placebo, results from the study showed a favorable safety and tolerability profile with no reported treatment-related serious adverse events.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2021 we announced data from a Phase 1b clinical trial of FX-322 in subjects aged 18-65 with severe SNHL (FX-322-113). The trial enrolled 31 subjects with Severe SNHL, defined as a pure tone average deficit between 71-90 dB. Many subjects with this clinical profile typically would be candidates for cochlear implants. The primary objectives of the study were to assess the local and systemic safety of a single dose of FX-322 and evaluate hearing responses in a more severe adult cohort. Study participants were randomized 4:1 to receive either FX-322 or placebo in one ear. Validated measures of hearing including WR, sentences in noise, and pure tone audiometry were utilized in the study. Safety, otologic and audiologic assessments were conducted at days 30 and 90 following administration of FX-322 or placebo. To gain a more comprehensive understanding of the potential impact of FX-322 in this population, we evaluated hearing using multiple tests of speech perception in both quiet and noisy backgrounds, including the Bamford-Kowal-Bench Sentence-in-Noise exam, or BKB-SIN. In this study, BKB-SIN test improvements were observed in four subjects, all of whom exceeded the 95 percent critical difference of 3.1dB SNR, with two subjects showing a 6dB response. A single placebo subject had a 3.6dB change. In the study, subjects did not show substantial changes in speech perception measures in quiet, the safety profile in the study was favorable and there were no treatment-related serious adverse events reported.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Human PK exposure</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In May 2020, we announced top-line data from an exploratory clinical study in Germany that we believe demonstrated that FX-322 effectively reached the cochlea at levels predicted, based on computer models, to be therapeutically active. Top-line results from the exploratory study showed measurable concentrations of FX-322 in every sample analyzed and that anatomical factors did not prevent FX-322 from reaching the cochlea. The study results were based on analyzing samples of cochlear fluid, known as perilymph, taken intraoperatively from patients undergoing cochlear implant surgery. A total of seven patients received a single intratympanic injection of FX-322, enabling researchers to directly measure the level of FX-322 in perilymph, which is not otherwise feasible in inner-ear studies because accessing the cochlea involves an invasive surgical procedure. Study patients were followed for approximately 30 days after the procedure and no serious treatment related adverse events were observed. The study results were included in the article accepted for publication in the journal </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Otology and Neurotology</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and were published in February 2021.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">FX-322 clinical results</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since 2019, we have completed five studies, as depicted in Exhibit 16 below and described in detail in the </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">FX-322 completed clinical trials </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">section above, all with the aim of understanding the safety of FX-322 as well as severities and etiologies that FX-322 might treat and the appropriate dose regime.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 16:</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_16.jpg" alt="img88009329_16.jpg" style="width:672px;height:367px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0925;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Based on the data from these studies, we have demonstrated a pharmacokinetic, pharmacodynamic relationship for FX-322, where we have observed that therapeutic concentrations of FX-322 in the cochlea were associated with statistically significant improvements in hearing function as measured by improved speech perception in </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">subjects </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">with SNHL. Further, we observed that these improvements in speech perception were sustained in some subjects for almost two years, which we believe suggests a potential disease-modifying benefit. Furthermore, we have uncovered that some </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">subjects </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">may respond at different times -- important learnings to the overall program.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0925;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0925;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Exhibit 17 below, shows data from our Phase 1/2 clinical trial (FX-322-201) and one of our Phase 1b clinical trials (FX-322-111), two independent, single-dose studies in </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">subjects </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">with mild to severe SNHL that showed a hearing signal with FX-322 and statistically significant improvements in speech perception.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 17:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_17.jpg" alt="img88009329_17.jpg" style="width:634px;height:375px;" /><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">        </span>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The scale of the overall FX-322 clinical program has enabled us to pool the data from these two trials and a third single-dose trial, our Phase 1b clinical trial (FX-322-112), and conduct a post-hoc analysis to look for patterns in the data and give us important insight into the characteristics of responders. Exhibit 18 below shows our pooled data analysis where we evaluated how many subjects showed at least a 10% absolute change from baseline in speech perception. In this graph, the y-axis is the change in the numbers of words correct from a 50-word test. We observed that the changes in FX-322-treated subjects exceeded the threshold for meaningful improvements, while a fraction of placebo-treated subjects or untreated ears, land above the threshold. Several FX-322 responders showed at least 10-word improvements or 20% absolute word increase, while some had a 40% absolute word increase.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0925;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Another way that we looked at the pooled data was by using the responder definition of the number of subjects that exceed the 95% confidence intervals from well-established historical standards. Looking at the data in this way, as illustrated in Exhibit 18, we observed that 14% of FX-322- treated subjects exceeded the threshold for improved speech perception and that placebo-treated subjects and untreated ears are consistent with the historical literature standards, Thornton &amp; Raffin (1978) and modified by Carney &amp; Schlauch (2007), as referenced in Exhibit 18 below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0925;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0925;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">22</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0925;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0925;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 18:</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0925;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_18.jpg" alt="img88009329_18.jpg" style="width:570px;height:316px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Using the same responder definition, we also evaluated the multi-injection Phase 2a clinical trial (FX-322-202) study and compared it to the three single-dose trials. Exhibit 19 below shows results from comparing the proportion of placebo-treated patients and untreated ears in the Phase 2a clinical trial (FX-322-202) against the three single-dose Phase 1b clinical trials. Based on our analysis, we observed that 15% of placebo-treated or untreated ears exceeded the 95% confidence intervals in the Phase 2a clinical trial compared to 2.1% in the three Phase 1b clinical trials. In the Phase 2a clinical trial, we collected a single baseline measurement compared to the three Phase 1b clinical trials where we collected baseline measurements. We believe that as a result, baseline speech perception scores in the Phase 2a clinical trial were not consistent with previous scores from many of the subjects in this trial.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 19:</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_19.jpg" alt="img88009329_19.jpg" style="width:570px;height:311px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0925;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0925;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0925;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0925;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0925;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Ongoing clinical trials</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0925;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0925;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our large clinical database has enabled us to pool data and better understand responder profiles and we have captured important learnings from all of our trials that have been incorporated into our Phase 2b study (FX-322-208), which commenced dosing i</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">n October 2021 in subjects with SNHL.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> In Exhibit 20 below, the orange circle indicates the focus that we have for this trial with respect to the subject populations. Our pooled data strategy has led us to focus on SSNHL and noise-induced hearing loss subjects in the high mild to low severe range.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0925;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0925;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 20:</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0925;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_20.jpg" alt="img88009329_20.jpg" style="width:570px;height:313px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Phase 2b study (FX-322-208) is a randomized, placebo-controlled, multi-center study designed to evaluate the impact of a single administration of FX-322 on speech perception in approximately 124 subjects with either noise-induced or sudden SNHL (study design shown in Exhibit 21 below). The study&#x2019;s primary endpoint is speech perception, a measure of sound clarity and understanding speech. In a Type-C meeting with the FDA, the FDA agreed that speech perception is an acceptable primary efficacy endpoint. The Phase 2b study&#x2019;s inclusion criteria are designed to enroll subjects with the same hearing loss severities and etiologies as those subjects in which statistically significant improvements in speech perception were observed in prior FX-322 clinical studies.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> For the study, we have assumed 5% of placebo subjects would show an improvement. Therefore, our treatment effect is targeted to be 20%. Thusly, we need a sample size of 112 subjects at 80% power to detect this 20% difference at a significance level of 0.05. and is the reason what we will be recruiting 124 subjects into the study as we account for potential subject attrition.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 21:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_21.jpg" alt="img88009329_21.jpg" style="width:539px;height:289px;" />&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have also employed several new design elements which are designed to mitigate bias, such as a lead-in phase with multiple visits to establish a sound baseline measure based on consistent test results. We believe other design elements, such as masking of both subjects and sites will further mitigate potential bias and a level of audiology surveillance is built into the study, such that all test sessions are recorded. Finally, the lead-in phase is used to disqualify subjects with poor test consistency. We believe that the Phase 2b trial is optimally designed to evaluate the effect of FX-322 in speech perception.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0925;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0925;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, we are continuing to gather data via extension trials of our Phase 1b clinical trials, FX-322-111 and FX-322-112.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our hearing pipeline: FX-345</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In November 2021, we introduced our new SNHL investigational therapeutic program, FX-345. As illustrated in Exhibit 22 below, we believe this program </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">may offer some advantages over FX-322 as we look to expand the opportunity to treat different types of SNHL. Specifically, FX-345 </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">was designed to achieve broader exposure </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">through a large portion of the cochlea, which could have a greater treatment impact or be used to treat a broader patient population than FX-322</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Further, FX-345 may provide greater flexibility in dose selection and formulation, which could enable us to evaluate a range of different dose levels.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 22:</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_22.jpg" alt="img88009329_22.jpg" style="width:570px;height:296px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have used cochlear pharmacokinetic measures and human modeling data in a preclinical setting to assess FX-345. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In Exhibit 23 below, we see human modeling data for FX-322 and FX-345 showing drug distribution levels across time and the location of the cochlea. Specifically, one axis is the position within the cochlea from the base to the apex. The second axis is the time from injection from left to right. The height of the surface is the concentration relative to the target level for the GSK-3 inhibitor (GSK3i). Based on this modeling, FX-345 achieved greater exposure through a larger portion of the cochlea for longer time.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 23:</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_23.jpg" alt="img88009329_23.jpg" style="width:623px;height:278px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We anticipate filing an investigational new drug application with the FDA for FX-345 in the second half of 2022. This will be our first step in exploring the impact of broad and sustained cochlear coverage on a range of hearing loss populations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Our multiple sclerosis (MS) program</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe our PCA approach can impact a wide range of degenerative diseases, including MS. MS induces demyelination, stripping axons of the myelin sheaths that support nerve signal conduction and axonal survival. Our program focuses on inducing remyelination by activating oligodendrocyte progenitor cells, or OPCs, in the central nervous system to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">generate new oligodendrocytes and regenerate myelin, potentially repairing the damage caused by MS. In November 2021, we introduced FREQ-162, a preclinical stage compound that induced substantially more remyelination than published comparator approaches based on </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vivo </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">models. Our efforts are focused on advancing Frequency compounds in preclinical safety studies to enable the initiation of clinical trials in 2023.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The potential for pharmacologic therapy to induce remyelination in MS has been supported by multiple clinical trials. Clinical trials testing clemastine, histamine receptor 3 inverse agonists, anti-LINGO antibodies, and bexarotene have shown modest improvements in biomarkers, electrophysiological or MRI measures. Prior to initiating our internal discovery program against a novel target, we licensed intellectual property from Scripps and Cambridge Enterprise on approaches to promote remyelination of nerve fibers. We continue to engage in sponsoring clinical research to validate this initial approach at Cambridge University.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">       </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">However, in order to maximize the benefit to individuals with MS, we believe it is likely that significantly more effective remyelinating agents will be necessary. To create such a therapeutic, we established an independent internal research program to explore the biology underlying remyelination and develop novel chemical entities, or NCEs. We have identified a novel target that drives remyelination and, to the best our knowledge, is only being pursued by us. Our internal discovery efforts have yielded a number of NCEs that have shown encouraging activity to induce remyelination, including FREQ-162. We compared FREQ-162 to three known compounds, thyroid hormone, anti-LINGO antibody, and clemastine, in standard</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> in vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> models. Based on these models, FREQ-162 induced significantly more oligodendrocyte differentiation and remyelination </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> than the published comparator compounds as illustrated in Exhibit 24 below. FREQ-162 was shown to be effective even in aged animals and drove remyelination in both white and gray matter, which are critical in motor, sensory and cognitive aspects of MS. Our research efforts are focused on optimizing this compound and advancing a candidate into clinical trials in 2023.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 24:</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img88009329_24.jpg" alt="img88009329_24.jpg" style="width:672px;height:264px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Overview of multiple sclerosis</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The symptoms of MS include numbness or tingling, weakness, dizziness and vertigo, spasticity, vision problems, sexual problems, bladder or bowel problems, pain, cognitive changes, emotional changes, and depression. Initially, most individuals experience a relapsing-remitting experience course of disease, with periods of new or relapsing symptoms followed by recovery and periods of remission. Early in the disease course, the individuals are partially able to remyelinate the demyelinated nerves. As the disease progresses the ability of the body to remyelinate axons significantly decreases leading to progressive and irreversible neurological deficits. According to the National Multiple Sclerosis Society, nearly one million people in the United States are living with MS.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The FDA has approved a number of</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">disease-modifying therapies for MS that reduce the immune system attack on myelin, which may reduce the number of relapses, delay progression of disability, and limit new disease activity. However, none of these products directly drive the remyelination of the nerve fibers. There are no FDA approved remyelinating therapies for MS and we believe this remains the largest unmet medical need in individuals with MS. Our program aims to induce OPCs to differentiate into oligodendrocytes and replace the myelin lost to multiple sclerosis.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">27</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Leveraging our PCA platform for future applications</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to our hearing and MS programs, we believe our PCA platform has the potential to address a wide range of clinical applications. In directing our internal research, research collaborations, and in-licensing efforts, we intend to target areas of high unmet medical need for which the underlying disease process involves loss or degeneration of key cells that could be reversed using PCA. We believe the PCA platform could further be applied to diseases of the muscle, gastrointestinal tract, skin, and bone. We intend to continue to identify areas with high unmet need where our PCA platform and novel approach to regenerative medicine could lead to potentially disease-modifying therapeutics that create healthy functional tissues and improve peoples&#x2019; lives.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Manufacturing</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our product candidates consist of small chemical compounds to stimulate cell and tissue regeneration </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. As a result, we can rely on the well-established and available manufacturing and drug-delivery technologies developed over decades by the pharmaceutical industry. We source our active pharmaceutical ingredients from contract manufacturers with a track record of FDA-compliant GMP manufacturing. After rigorous internal and external quality control testing, we release these materials to additional contract manufacturers for formulation and packaging into final drug product for use in clinical testing. We expect to use a similar hybrid of internal and contract resources for commercialization of our products, at least until our operations reach a scale sufficient to justify investment in internal manufacturing capacity.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Commercialization</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We intend to directly market and commercialize our lead product candidate, FX-322 for the treatment of SNHL, if approved in the United States, by developing our own sales and marketing force, targeting ENTs and audiologists. Under the Astellas Agreement, Astellas has the right to market and commercialize FX-322 for the treatment of SNHL, and any other products containing both a GSK-3 inhibitor and an HDAC inhibitor if approved, outside of the United States. For any other product candidates that are not part of the Astellas Agreement, we intend to establish marketing and commercialization strategies for each on a case by case basis.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Intellectual property</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We strive to protect and enhance the proprietary technology, inventions, and improvements that are commercially important to the development of our business, including by seeking, maintaining, and defending patent rights, whether developed internally or licensed from third parties. We also rely on trade secrets, confidential information and know-how, continuing technological innovation, and in-licensing opportunities to develop, strengthen, and maintain our proprietary position in our field.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our future commercial success depends, in part, on our ability to: obtain and maintain patent and other proprietary protection for commercially important technology, inventions, and know-how related to our business; defend and enforce our intellectual property rights, in particular our patent rights; preserve the confidentiality of our trade secrets; and operate without infringing, misappropriating, or violating the valid and enforceable patents and proprietary rights of third parties. Our ability to stop third parties from making, using, selling, offering to sell, or importing products identical or similar to ours may depend on the extent to which we have rights under valid and enforceable patents or trade secrets that cover these activities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0445833333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The patent positions of biotechnology and pharmaceutical companies like ours are generally uncertain and can involve complex legal, scientific, and factual issues. We cannot predict whether the patent applications we are currently pursuing will issue as patents in any particular jurisdiction or whether the claims of any issued patents will provide sufficient proprietary protection from competitors. We also cannot ensure that patents will issue with respect to any patent applications that we or our licensors may file in the future, nor can we ensure that any of our owned or licensed patents or future patents will be commercially useful in protecting our product candidates and methods of manufacturing the same. In addition, the coverage claimed in a patent application may be significantly reduced before a patent is issued, and its scope can be reinterpreted and even challenged after issuance. As a result, we cannot guarantee that any of our products will be protected or remain protectable by enforceable patents. Moreover, any patents that we hold may be challenged, circumvented, or invalidated by third parties. See &#x201c;Risk factors&#x2014;Risks related to our intellectual property&#x201d; for a more comprehensive description of risks related to our intellectual property.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In an effort to secure our intellectual property positions we generally file patent applications directed to our programs.  As of March 1, 2022, we owned, licensed, or have an option to license 37 patent families. These patent families include 29 U.S. patents, 101 ex-U.S. patents, 26 pending U.S. utility patent applications, 109 pending ex-U.S. utility applications, and 1 U.S. provisional patent application.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">28</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The intellectual property portfolio for our lead programs as of March 1, 2022, are summarized below. Prosecution is a lengthy process, during which the scope of the claims initially submitted for examination by the U.S. Patent and Trademark Office may be significantly narrowed before issuance, if issued at all. We expect this may be the case with respect to some of our pending patent applications referred to below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Hearing loss</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The patent portfolio for our Hearing Loss program is based upon our owned and in-licensed patent families that include patents and patent applications directed generally to compositions of matter, pharmaceutical compositions, and methods of using the same to treat hearing loss; and specifically directed to compositions of matter of our lead product FX-322, pharmaceutical compositions of FX-322 and methods of using the same to treat hearing loss. The in-licensed patents and patent applications are subject to license agreements with Massachusetts Institute of Technology and Massachusetts Eye and Ear Infirmary described herein. As of March 1, 2022, we have rights to, through ownership and in-licensing, 32 patent families, including 26 U.S. patents, 86 ex-U.S. patents, 22 pending U.S. utility patent applications, and 107 pending ex-U.S. patent applications related to treating hearing loss, generally and related to FX-322. While we believe that the specific and generic claims contained in our issued U.S. patents provide protection for the composition of matter and the method of using FX-322 to treat hearing loss and/or diseases associated with the absence or lack of certain tissue cells, third parties may nevertheless challenge such claims in our patents. If any such claims are invalidated or rendered unenforceable for any reason, we will lose valuable intellectual property rights, and our ability to prevent others from competing with us would be impaired. Any U.S. or ex-U.S. patents that may issue from pending applications that we control, if any, for our hearing program, including our lead product FX-322, are projected to have a statutory expiration date in between 2035 and 2040, excluding any additional term for patent term adjustments or patent term extensions, if applicable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Multiple sclerosis program</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We plan to use a similar intellectual property strategy when building protection with respect to other programs. Within our MS program, we own intellectual property directed to the treatment of MS and we advise on an exclusively in-licensed portfolio of intellectual property directed to the treatment of MS from The Scripps Research Institute and Cambridge Enterprise. As of March 1, 2022, no development candidate has been designated, but the intellectual property portfolio for our MS research program currently includes 4 patent families including 3 U.S. patents, 15 ex-U.S. patents, 3 pending U.S. utility patent applications, 9 ex-U.S. patent applications, and 1</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> U.S. provisional patent application</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. While we believe that the specific and generic claims, contained in our U.S. and ex-U.S. patents provide protection for the claimed pharmaceutical compositions and methods of use third parties may nevertheless challenge such claims. If any such claims are invalidated or rendered unenforceable for any reason, we will lose valuable intellectual property rights, and our ability to prevent others from competing with us would be impaired. Any U.S. or ex-U.S. patents that may issue from pending applications that we own or exclusively in-licensed, if any, for our MS program are projected to have a statutory expiration date between 2032 and 2042, excluding any additional term for patent term adjustments or patent term extensions. The term of individual patents depends upon the legal term of the patents in the countries in which they are obtained. In most countries in which we file, the patent term is 20 years from the earliest date of filing a non-provisional patent application.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the United States, the term of a patent covering an FDA-approved drug may, in certain cases, be eligible for a patent term extension under the Hatch-Waxman Act as compensation for the loss of patent term during the FDA regulatory review process. The period of extension may be up to five years, but the remaining term of a patent cannot be extended beyond a total of 14 years from the date of product approval. Only one patent among those eligible for an extension and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended. Similar provisions are available in Europe and in certain other jurisdictions to extend the term of a patent that covers an approved drug. It is possible that issued U.S. patents covering the use of products from our intellectual property may be entitled to patent term extensions. If our use of drug candidates or the drug candidate itself receive FDA approval, we intend to apply for patent term extensions, if available, to extend the term of patents that cover the approved use or drug candidate. We also intend to seek patent term extensions in any jurisdictions where available, however, there is no guarantee that the applicable authorities, including the FDA, will agree with our assessment of whether such extensions should be granted, and, even if granted, the length of such extensions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">29</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to patent protection, we rely upon trade secrets, confidential information and know-how, and continuing technological innovation to develop and maintain our competitive position. However, trade secrets and confidential information and know-how are difficult to protect. We seek to protect our proprietary information, in part, using confidentiality agreements with any collaborators, scientific advisors, employees, and consultants; and invention assignment agreements with our employees. We also have agreements requiring assignment of inventions with selected consultants, scientific advisors, and collaborators. These agreements may not provide meaningful protection. These agreements may also be breached, and we may not have an adequate remedy for any such breach. In addition, our trade secrets and/or confidential information and know-how may become known or be independently developed by a third party, or misused by any collaborator to whom we disclose such information. Despite any measures taken to protect our intellectual property, unauthorized parties may attempt to copy aspects of our products or obtain or use information that we regard as proprietary. Although we take steps to protect our proprietary information, third parties may independently develop the same or similar proprietary information or may otherwise gain access to our proprietary information. As a result, we may be unable to meaningfully protect our trade secrets and proprietary information.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our commercial success will also depend in part on not infringing upon the proprietary rights of third parties. It is uncertain whether the issuance of any third-party patent would require us to alter our development or commercial strategies, or our drugs or processes, obtain licenses, or cease certain activities. Our breach of any license agreements or failure to obtain a license to proprietary rights that we may require to develop or commercialize our future drugs may have an adverse impact on us. If third parties have prepared and filed patent applications prior to March 16, 2013, in the United States that also claim technology to which we have rights, we may have to participate in interference proceedings in the United States Patent and Trademark Office, or USPTO, to determine priority of inventions. See &#x201c;Risk factors&#x2014;Risks related to our intellectual property&#x201d; for a more comprehensive description of risks related to our intellectual property.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">License and collaboration agreements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Astellas Pharma Inc.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In July 2019, we entered into the Astellas Agreement with Astellas, under which we granted Astellas an exclusive, royalty-bearing, sub-licensable, nontransferable license to certain patent rights to research, develop, manufacture, have manufactured, use, seek and secure regulatory approval for, commercialize, offer for sale, sell, have sold and import, and otherwise exploit licensed products containing both a GSK-3 inhibitor and an HDAC inhibitor, or the Astellas licensed products, including our product candidate FX-322, outside of the United States. We also granted Astellas a right of first negotiation and a right of last refusal if we enter into any negotiation or agreement of any kind (other than an acquisition of all of our stock or assets) with any third party under which such third party would obtain the right to develop, manufacture, or commercialize Astellas licensed products in the United States.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We and Astellas have agreed to jointly develop the Astellas licensed products, including potentially carrying out joint studies. Each party has agreed to use commercially reasonable efforts to carry out development activities assigned to it under an agreed-upon development plan. Astellas has agreed to use commercially reasonable efforts to obtain regulatory approval for at least one Astellas licensed product in SNHL and in age-related hearing loss, in each case, in one major Asian country and one major European country. We have agreed to use commercially reasonable efforts to obtain regulatory approval for at least one Astellas licensed product in the United States. Astellas has the sole right to commercialize the Astellas licensed products outside of the United States, and we have the sole right to commercialize the Astellas licensed products in the United States. Astellas has agreed to use commercially reasonable efforts to commercialize Astellas licensed products in a major Asian country and a major European country following receipt of regulatory approval in such countries.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As consideration for the licensed rights under the Astellas agreement, Astellas paid us an upfront payment of $80.0 million in July 2019 and has agreed to pay potential development milestone payments up to $230.0 million. Specifically, we would receive development milestone payments of $65.0 million and $25.0 million upon the first dosing of a subject in a Phase 2b clinical trial for SNHL in Europe and Asia, respectively, and $100.0 million and $40.0 million upon the first dosing of a subject in a Phase 3 clinical trial for SNHL in Europe and Asia, respectively.  If the Astellas licensed products are successfully commercialized, we would be eligible for up to $315.0 million in potential commercial milestone payments and also tiered royalties at rates ranging from low- to mid-teen percentages.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Astellas Agreement remains in effect until the expiration of all royalty obligations. Royalties are paid on a licensed product-by-licensed product and country-by-country basis until the latest of (i) the expiration of the last valid claim in the licensed patent rights with respect to such Astellas licensed product in such country or (ii) a set number of years from the first commercial sale of such Astellas licensed product in such country. Astellas may terminate the Astellas Agreement at will upon 60 days&#x2019; written notice. Each party has the right to terminate the Astellas Agreement due to the other party&#x2019;s material breach if such breach remains uncured for 90 days (or 45 days in the case of nonpayment) or if the other party becomes bankrupt.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Massachusetts Institute of Technology</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2016, we entered into an Exclusive Patent License Agreement, or the MIT License, with the Massachusetts Institute of Technology, or MIT, under which we received an exclusive, worldwide, royalty-bearing license to certain patent rights to develop, make, have made, use, sell, offer to sell, lease, and import products, or the MIT licensed products, and to develop and perform processes, or the MIT licensed processes, which incorporate the licensed technology for the treatment of disease, including, but not limited to, the prevention and remediation of hearing loss. We also have the right to grant sublicenses under the MIT License. MIT and Brigham and Women&#x2019;s Hospital retain the right on behalf of themselves and all other nonprofit research institutions to practice the licensed patent rights for nonclinical research, teaching, and educational purposes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are required to use diligent efforts to develop and commercialize the MIT licensed products or processes and to make such products or processes reasonably available to the public. We are also subject to certain development obligations with regards to a first MIT licensed product. We have satisfied certain obligations related to preclinical and clinical studies and the filing of an IND for a first MIT licensed product with our development activities related to FX-322. Our future development obligations are: (i) to commence a Phase III clinical trial for such Product within five years of the IND filing for such product, (ii) to file a New Drug Application or equivalent with the FDA or comparable European regulatory agency for such Product within nine years of the IND filing for such Product, and (iii) to make a first commercial sale of such Product within 11 years of the IND filing for such Product. We also have certain development obligations with regards to a second MIT licensed product. If we fail to meet our development obligations, other than those relating to a second MIT licensed product, MIT may terminate the MIT License. In the event that we have failed to fulfill our development timeline obligation with respect to a second MIT licensed product and fail to cure such breach within 90 days of written notice by MIT, MIT may restrict the licensed field to the prevention and remediation of hearing loss in humans and animals. We do not have the right to control prosecution of the in-licensed patent applications, and our rights to enforce the in-licensed patents are subject to certain limitations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon entering the MIT License, we paid a $50 thousand license fee payment and issued to MIT shares of our common stock equal to 5% of our then-outstanding capital stock. We are required to pay certain annual license maintenance fees ranging from $30 thousand to $0.1 million per year prior to first commercial sale of a MIT licensed product and an annual license maintenance fee of $0.2 million every year afterwards, which may be credited to running royalties during the same calendar year, if any. We are also required to make potential milestone payments in an aggregate amount of up to $2.9 million on each MIT licensed product or process. In addition, we agreed to pay a low single-digit royalty on the MIT licensed products and processes and a 20% royalty on sub-license revenues.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The MIT License will remain in effect until the expiration or abandonment of all licensed issued patents and filed patent applications, unless terminated earlier. We have the right to terminate for any reason upon three months&#x2019; prior written notice. MIT has the right to terminate immediately if we cease to carry on any business related to the MIT License. MIT may also terminate the MIT License for our material breach if such breach remains uncured for 90 days (or 30 days in the case of nonpayment). MIT may also terminate the MIT License if we or our affiliates commence any action against MIT to declare or render any claim of the licensed patent rights invalid, unpatentable, unenforceable, or not infringed, or if our sub-licensee commences such actions and we do not terminate such sub-license within 30 days after MIT&#x2019;s demand. MIT has the right to increase all payments due by us, instead of terminating the MIT License in the case of a patent challenge.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In May 2019, we entered into an amendment with MIT, updating the diligence milestones for a second Licensed Product.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2022, we entered into an amendment with MIT, removing a patent and certain patent applications from the MIT License Agreement which were unrelated to our hearing and MS programs and which we were not utilizing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Massachusetts Eye and Ear (Formerly Massachusetts Eye and Ear Infirmary)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In February 2019, we entered into an Non-Exclusive Patent License Agreement, or the MEE License, with the Massachusetts Eye and Ear, or MEE, under which we received a non-exclusive, non-sub-licensable, worldwide, royalty-bearing license to certain patent rights to develop, make, have made, use, sell, offer to sell, lease and import products and to develop and perform processes that incorporate the licensed technology for the treatment or prevention of hearing loss, or the MEE licensed products.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are obligated to use diligent efforts to develop and commercialize the MEE licensed products. We met one of our milestone timeline obligations by dosing a first subject in a Phase II trial by December 31, 2020. We are still subject to a milestone timeline obligation to dose a first subject in a Phase III trial by December 31, 2024. We do not control the filing, prosecution, enforcement, and defense of any licensed patent rights.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon entering the MEE License, we made a $20 thousand license fee payment. We are obligated to pay certain annual license maintenance fees between $5 thousand and $7.5 thousand per each MEE patent family case number included in the licensed MEE patent rights prior to first commercial sale of an MEE licensed product. We are also obligated to pay a minimum annual royalty payment of $15 thousand per each MEE patent family case number included in the licensed MEE patent rights after first commercial sale of an MEE licensed product. We are also obligated to make milestone payments up to $350 thousand on each product or process that incorporates the licensed patent rights. In addition, we have agreed to pay a low single-digit royalty on products and processes that incorporate the licensed patent rights.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The MEE License remains in effect until all issued patents and filed patent applications within the licensed patent rights have expired or been abandoned, unless terminated earlier. We have the right to terminate the MEE License at will by 30 business days&#x2019; advance written notice to MEE. MEE has the right to terminate the MEE License (i) if we fail to make any payment due within 30 business days after MEE notifies us of such failure, (ii) if we fail to maintain required insurance, (iii) upon 45 business days&#x2019; written notice if we become insolvent, or (iv) for any other default by us that is not cured within 60 business days of receipt of written notice. MEE also has the right to terminate if we or our affiliates challenge the validity of the licensed patent rights.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The Scripps Research Institute (California Institute for Biomedical Research)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In September 2018, we entered into a license agreement, or the CALIBR License, with the California Institute for Biomedical Research, or CALIBR, a division of Scripps, under which we received an exclusive, worldwide, royalty-bearing license to certain patent rights to make, have made, use, sell, offer to sell, and import products, or the CALIBR licensed products, which incorporate licensed technology for the treatment of MS. We also have the right to grant sublicenses under the CALIBR License. CALIBR reserves the right to use for itself and the right to grant nonexclusive licenses to other nonprofit or academic institutions for any internal research and educational purposes.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have agreed to use commercially reasonable efforts to develop, manufacture, and sell at least one CALIBR licensed product. We are also subject to certain milestone timeline obligations, which may be extended in certain circumstances as set forth in the CALIBR License. In October 2021, we entered into an amendment with CALIBR which updated the milestone obligations to: (i) initiate a Phase II clinical trial (or equivalent) for a CALIBR licensed product by December 31, 2023 and (ii) initiate a Phase III clinical trial (or equivalent) for a CALIBR licensed product by December 31, 2025. We do not have the right to control prosecution of the in-licensed patent applications, and our rights to enforce the in-licensed patents are subject to certain limitations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon entering the CALIBR license, we made a $1.0 million license fee payment, and are required to make milestone payments in an aggregate amount of up to $26.0 million for each category of CALIBR licensed products. Category 1 is any CALIBR licensed products containing a compound that modulates any muscarinic receptor, and Category 2 is any CALIBR licensed products not included in Category 1 that could differentiate oligodendrocyte precursor cells from </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> studies and/or are active in animal models relevant to MS. We are also required to pay a mid-single-digit royalty on CALIBR licensed products and a royalty on sub-license revenues ranging from a low-teen percentage to 50%.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The CALIBR License continues in effect until expiration of all our obligations to pay royalties. Royalties are payable by us on a country-by-country and licensed-product-by-licensed product basis upon the later of (i) the expiration or abandonment of all valid claims of the licensed patent rights in such country and (ii) 10 years from the first commercial sale of each CALIBR licensed product in such country. We may terminate the CALIBR License at will upon 30 days&#x2019; prior written notice. We may also elect to terminate our license to one or more licensed patents in any or all jurisdictions by giving 90 days&#x2019; prior written notice to CALIBR. CALIBR may terminate the CALIBR License for our material breach if such breach remains uncured for 30 days. CALIBR has the right to terminate or reduce the license to a non-exclusive license if we fail to use diligent efforts to develop and commercially exploit CALIBR licensed products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The Scripps Research Institute</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In September 2018, we entered into a Research Funding and Option Agreement, or the Scripps option agreement, with Scripps (CALIBR is a division of Scripps), under which we provided funding to Scripps to pursue certain MS research activities on selected targets. In the same agreement, we were granted an exclusive option to acquire an exclusive, sublicensable, worldwide license under certain intellectual property arising from the MS research activities on the selected targets. The Scripps option agreement, including the MS research activities and the exclusive option, terminated on December 31, 2021. The CALIBR License remains active.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cambridge Enterprise Limited</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2019, we entered into an Exclusive Patent License Agreement, or the Cambridge License, with Cambridge, under which we received an exclusive, worldwide, royalty-bearing license to certain patent rights to make, have made, use, sell, offer to sell, and import products, or the Cambridge licensed products, which incorporate licensed technology for the treatment of demyelinating diseases. We also have the right to grant sublicenses under the Cambridge License. Cambridge reserves the right to use for itself (as well as for the inventors and the funder) to grant nonexclusive licenses to other academic institutions for any academic publication, research and teaching and clinical patient care.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have agreed to use diligent and good faith efforts to develop and commercially exploit at least one Cambridge licensed product. Upon entering into the Cambridge License, we made a $50.0 thousand license fee payment. We are obligated to pay an annual license fee of $50.0 thousand. We are also obligated to make milestone payments up to $10.5 million on each Cambridge licensed product. In addition, we have agreed to pay a low single-digit royalty on products that incorporate the licensed patent rights, subject to offset in certain circumstances.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Cambridge License continues in effect on a country-by-country basis until the expiration or revocation, without right of further appeal, of all licensed issued patents and filed patent applications, unless terminated earlier. We have the right to terminate for any reason upon 90 days&#x2019; prior written notice. Each party has the right to terminate immediately if the other party ceases to carry on its business. Either party may also terminate the Cambridge License for material breach if such breach remains uncured for 30 days. Cambridge may also terminate the Cambridge License if we fail to diligently develop and commercially exploit at least one Cambridge licensed product or we or our affiliates or sub-licensees commence any action against Cambridge to declare or render any claim of the licensed patent rights invalid, unpatentable, unenforceable, or not infringed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Competition</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As a clinical-stage biotechnology company, we face competition from a wide array of companies in the pharmaceutical, biotechnology, and medical device industries. These include both small companies and large companies with much greater financial and technical resources and far longer operating histories than our own. We also compete with the intellectual property, technology, and product development efforts of academic, governmental, and private research institutions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our competitors may have significantly greater financial resources, established presence in the market, expertise in research and development, manufacturing, preclinical and clinical testing, obtaining regulatory approvals and reimbursement, and marketing approved products than we do. These competitors also compete with us in recruiting and retaining qualified scientific, sales, marketing, and management personnel, establishing clinical trial sites and subject registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The key competitive factors affecting the success of any product candidates that we develop, if approved, are likely to be their efficacy, safety, convenience, price, and the availability of reimbursement from government and other third-party payors. Our commercial opportunity for any of our product candidates could be reduced or eliminated if our competitors develop and commercialize products that are more effective, have fewer or less severe side effects, are more convenient, or are less expensive than any products that we may develop. Our competitors also may obtain FDA or other regulatory approval for their products more rapidly than we may obtain approval for ours and may commercialize products more quickly than we are able to.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are aware of the following treatment options in the areas that we are initially targeting:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Hearing loss</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There are dozens of hearing aid brands, although most of these devices are manufactured by only a few leading companies. We anticipate the hearing aid landscape in the United States will change as the FDA implements regulations for over-the-counter hearing aids, which will be sold directly to consumers with mild to moderate perceived hearing loss. There are three manufacturers of cochlear implants that market in the United States. We are also aware of multiple companies developing therapeutics to treat various forms of SNHL currently in clinical trials, such as Audion Therapeutics, which will initiate a Phase 2 study of its notch inhibitor, LY3056480, in 2022. Pipeline Therapeutics completed a Phase 1/2 study of its</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">33</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">gamma secretase inhibitor, PIPE-505, in 2021; the data from this study has not been shared to date. In 2020 Otonomy, Inc. disclosed top level data from a Phase 1/2 study of OTO-413, a sustained-exposure formulation of brain-derived neurotrophic factor, in subjects with a condition described as speech-in-noise impairment. In 2021 Otonomy initiated an extension of this Phase 1/2 study, which is estimated to complete in 2022. In addition, Sensorion, a clinical stage company, is conducting a Phase 2 study of SENS-401 to treat sudden SNHL. There are also multiple programs in early-stage or preclinical development by pharmaceutical and biotechnology companies. There are also several companies targeting genetic forms of hearing loss with gene therapy treatments, as well as otoprotective therapies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Multiple sclerosis</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There are multiple therapeutic options for treating the symptoms of MS, as well as the underlying disease. However, all approved therapies are directed at blocking demyelination, and, to our knowledge, there are no approved therapies which promote remyelination. We are aware of numerous efforts to identify drugs or biologics that can stimulate oligodendrocyte regeneration and myelin repair in the central nervous system. These include companies such as Clene Pharma, which has an ongoing Phase 2 trial of CNM-Au8, a gold nanocrystal suspension, and Pipeline Therapeutics, which completed a Phase 1 trial for PIPE-307, a selective M1 receptor antagonist to treat multiple sclerosis and other demyelinating disorders. Pipeline Therapeutics has not announced results from this trial to date. Convelo Therapeutics is in preclinical development for potential remyelinating compounds that inhibit enzymes in the brain involved in the production of cholesterol. Idorsia Pharma completed two Phase 1 studies in 2019 and 2020 for ACT-1004-1239, a small molecule CXCR7 inhibitor involved in OPC differentiation.  This is an active research area with a number of entities researching compounds, antibodies, and proteins which may enhance remyelination.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Government regulation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The FDA and comparable regulatory authorities in state and local jurisdictions and in other countries impose substantial and burdensome requirements upon companies involved in the clinical development, manufacture, marketing, and distribution of drugs, such as those we are developing. These agencies and other federal, state, and local entities regulate, among other things, the research and development, testing, manufacture, quality control, safety, effectiveness, labeling, storage, record keeping, approval, advertising and promotion, distribution, post-approval monitoring and reporting, sampling, and export and import of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">U.S. drug development process</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the United States, the FDA regulates drugs under the Federal Food, Drug, and Cosmetic Act, or FDCA, and its implementing regulations. The process of obtaining regulatory approvals and the subsequent compliance with appropriate federal, state, local, and foreign statutes and regulations requires the expenditure of substantial time and financial resources. Failure to comply with the applicable U.S. requirements at any time during the product development process, approval process, or after approval, may subject an applicant to a variety of administrative or judicial sanctions, such as the FDA&#x2019;s refusal to approve pending NDAs, withdrawal of an approval, imposition of a clinical hold, issuance of warning letters, product recalls, product seizures, total or partial suspension of production or distribution, injunctions, fines, refusals of government contracts, restitution, disgorgement, or civil or criminal penalties.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The process required by the FDA before a drug may be marketed in the United States generally involves the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">completion of preclinical laboratory tests and formulation studies, as well as animal safety studies, in compliance with the FDA&#x2019;s good laboratory practice, or GLP, regulations, as appropriate; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">submission to the FDA of an IND which must become effective before human clinical trials may begin; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">approval by an independent institutional review board, or IRB, at each clinical site before each trial may be initiated; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">performance of adequate and well-controlled human clinical trials in accordance with good clinical practice, or GCP, requirements to establish the safety and efficacy of the proposed drug product for each indication; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">submission to the FDA of an NDA; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">endorsement by an FDA advisory committee, if applicable; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">satisfactory completion of an FDA inspection of the clinical site(s), and related services involved in the conduct of the clinical studies to assess compliance with good clinical practices, or GCP;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">34</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">satisfactory completion of an FDA inspection of the manufacturing facility or facilities at which the product is produced to assess compliance with current good manufacturing practice, or cGMP, requirements, and to assure that the facilities, methods, and controls are adequate to preserve the drug&#x2019;s identity, strength, quality, and purity; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">FDA review and approval of the NDA prior to commercial marketing or sale of the drug in the United States; and </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">compliance with any post-approval requirements, including the potential requirement to implement a Risk Evaluation and Mitigation Strategy, or REMS, or to conduct a post-approval study or studies. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Preclinical studies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Preclinical studies include laboratory evaluation of product chemistry, toxicity, and formulation, as well as animal studies to assess potential safety and efficacy. An IND sponsor must submit the results of the preclinical tests, together with manufacturing information, analytical data, and any available clinical data or literature, among other things, to the FDA as part of an IND. Some preclinical testing may continue even after the IND is submitted. An IND automatically becomes effective 30 days after receipt by the FDA, unless before that time the FDA raises concerns or questions related to the submission including to one or more proposed clinical trials and places the clinical trial on a partial or full clinical hold. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before the clinical trial can begin. Clinical holds also may be imposed by the FDA at any time before or during clinical trials due to safety concerns about on-going or proposed clinical trials or noncompliance with specific FDA requirements, and the trials may not begin or continue until the FDA notifies the sponsor that the hold has been lifted. As a result, submission of an IND may not result in the FDA allowing clinical trials to commence.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Clinical trials</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Clinical trials involve the administration of the investigational new drug to human subjects under the supervision of qualified investigators in accordance with GCP requirements, which include the requirement that all research subjects provide their informed consent for their participation in any clinical trial. Clinical trials are conducted under protocols detailing, among other things, the objectives of the trial, the parameters to be used in monitoring safety, and the effectiveness criteria to be evaluated. A protocol for each clinical trial and any subsequent protocol amendments must be submitted to the FDA as part of the IND. In addition, an IRB at each institution participating in the clinical trial must review and approve the plan for any clinical trial before it commences at that institution. Information about certain clinical trials must be submitted within specific time frames to the National Institutes of Health, or NIH, for public dissemination on their www.clinicaltrials.gov website.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Human clinical trials are typically conducted in three sequential phases, which may overlap or be combined:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.035;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Phase 1: The drug is initially introduced into healthy human subjects or patients with the target disease or condition and tested for safety, dosage tolerance, absorption, metabolism, distribution, excretion, and, if possible, to gain an early indication of its effectiveness. </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.035;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Phase 2: The drug is administered to a limited patient population to identify possible adverse effects and safety risks, to preliminarily evaluate the efficacy of the product for specific targeted diseases, and to determine dosage tolerance and optimal dosage. </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.035;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Phase 3: The drug is administered to an expanded patient population, generally at geographically dispersed clinical trial sites, in well-controlled clinical trials to generate enough data to statistically evaluate the efficacy and safety of the product for approval, to establish the overall risk-benefit profile of the product, and to provide adequate information for the labeling of the product. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The FDA or the sponsor may suspend a clinical trial at any time on various grounds, including a finding that the research subjects or patients are being exposed to an unreasonable health risk. Similarly, an IRB can suspend or terminate approval of a clinical trial at its institution if the clinical trial is not being conducted in accordance with the IRB&#x2019;s requirements or if the drug has been associated with unexpected serious harm to patients. In addition, some clinical trials are overseen by an independent group of qualified experts organized by the sponsor, known as a data safety monitoring board or committee. Depending on its charter, this group may determine whether a trial may move forward at designated check points based on access to certain data from the trial.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Concurrent with clinical trials, companies usually complete additional animal studies, and must also develop additional information about the chemistry and physical characteristics of the drug and finalize a process for manufacturing the product in commercial quantities in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the product candidate, and, among other things, the manufacturer must develop methods for testing the identity, strength, quality, and purity of the final drug. In addition, appropriate packaging must be selected and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">35</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">tested, and stability studies must be conducted to demonstrate that the product candidate does not undergo unacceptable deterioration over its shelf life.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Progress reports detailing the results of the clinical trials must be submitted at least annually to the FDA, and more frequently if serious adverse events occur. Phase 1, Phase 2, and Phase 3 clinical trials may not be completed successfully within any specified period, or at all. There are also requirements governing the registration of, reporting of ongoing clinical trials and completed trial results to public registries.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Marketing approval</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Assuming successful completion of the required clinical testing, the results of the preclinical and clinical studies, together with detailed information relating to the product&#x2019;s chemistry, manufacture, controls, and proposed labeling, among other things, are submitted to the FDA as part of an NDA requesting approval to market the product for one or more indications. In most cases, the submission of an NDA is subject to a substantial application user fee. Under the Prescription Drug User Fee Act, or PDUFA, guidelines that are currently in effect, the FDA has a goal of ten months from the date of &#x201c;filing&#x201d; of a standard NDA for a new molecular entity to review and act on the submission. This review typically takes 12 months from the date the NDA is submitted to the FDA because the FDA has approximately two months to make a &#x201c;filing&#x201d; decision. Specifically, the FDA conducts a preliminary review of all NDAs within the first 60 days after submission, before accepting them for filing, to determine whether they are sufficiently complete to permit substantive review. The FDA may request additional information rather than accept an NDA for filing. In this event, the application must be resubmitted with the additional information. The resubmitted application is also subject to review before the FDA accepts it for filing.  Once the submission is accepted for filing, the FDA begins an in-depth substantive review. The FDA reviews an NDA to determine, among other things, whether the submitted information supports that the drug is safe and effective and whether the facility in which it is manufactured, processed, packaged, or held meets standards designed to assure the product&#x2019;s continued safety, quality, and purity.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The FDA also may require submission of a REMS plan to ensure that for certain medications with serious safety concerns the benefits of the drug outweigh its risks. The REMS plan could include medication guides, physician communication plans, assessment plans, and/or elements to assure safe use, such as restricted distribution methods, patient registries, or other risk minimization tools.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The FDA may refer an application for a novel drug to an advisory committee. An advisory committee is a panel of independent experts, including clinicians and other scientific experts, that reviews, evaluates, and provides a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Before approving an NDA, the FDA typically will inspect the facility or facilities where the product is manufactured. The FDA will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving an NDA, the FDA may inspect one or more clinical trial sites to assure compliance with GCP requirements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">After evaluating the NDA and all related information, including the advisory committee recommendation, if any, and inspection reports regarding the manufacturing facilities and clinical trial sites, the FDA may issue an approval letter, or, in some cases, a Complete Response Letter, or CRL. A CRL generally contains a statement of specific conditions that must be met in order to secure final approval of the NDA and may require additional clinical or preclinical testing in order for the FDA to reconsider the application for approval. Even with submission of this additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval. If and when those conditions have been met to the FDA&#x2019;s satisfaction, the FDA will typically issue an approval letter. An approval letter authorizes commercial marketing of the drug with specific prescribing information for specific indications.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Even if the FDA approves a product, it may limit the approved indications for use of the product, require that contraindications, warnings, or precautions be included in the product labeling, require that post-approval studies, including Phase 4 clinical trials, be conducted to further assess a drug&#x2019;s safety after approval, require testing and surveillance programs to monitor the product after commercialization, or impose other conditions, including distribution and use restrictions or other risk management mechanisms under a REMS, which can materially affect the potential market and profitability of the product. The FDA may prevent or limit further marketing of a product based on the results of post-marketing studies or surveillance programs. After approval, some types of changes to the approved product, such as adding new indications, manufacturing changes, and additional labeling claims, are subject to further testing requirements and FDA review and approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Pediatric Research Equity Act, or PREA, requires a sponsor to conduct pediatric clinical trials for most drugs, for a new active ingredient, new indication, new dosage form, new dosing regimen, or new route of administration. Under PREA, original NDAs and supplements must contain a pediatric assessment unless the sponsor has received a deferral or waiver, or</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">36</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0589583333333332;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the indication sought is for an orphan condition. The required assessment must evaluate the safety and effectiveness of the product for the claimed indications in all relevant pediatric subpopulations and support dosing and administration for each pediatric subpopulation for which the product is safe and effective. The sponsor or the FDA may request a deferral of pediatric clinical trials for some or all of the pediatric subpopulations. A deferral may be granted for several reasons, including a finding that the drug is ready for approval for use in adults before pediatric clinical trials are complete or that additional safety or effectiveness data needs to be collected before the pediatric clinical trials begin. The FDA must send a noncompliance letter to any sponsor that fails to submit the required assessment, keep a deferral current, or fails to submit a request for approval of a pediatric formulation. In some situations, the requirement for studies in pediatric populations can be waived if there is no relevant use.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">FDA-expedited development and review programs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The FDA has various programs, including orphan drug designation, rare pediatric disease designation, fast track designation, accelerated approval priority review, and breakthrough therapy designation, which are intended to expedite or simplify the process for the development and the FDA review of drugs that are intended for the treatment of serious or life-threatening diseases or conditions and demonstrate the potential to address unmet medical needs. The purpose of these programs is to provide important new drugs to patients earlier than under standard FDA review procedures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To be eligible for a fast track designation, the FDA must determine, based on the request of a sponsor, that a product is intended to treat a serious or life-threatening disease or condition, demonstrates the potential to address an unmet medical need, and is actively developing the drug for the disease. The FDA will determine that a product will fill an unmet medical need if it will provide a therapy where none exists or provide a therapy that may be potentially superior to existing therapy based on efficacy or safety factors. The FDA may review sections of the NDA for a fast track product on a rolling basis before the complete application is submitted, if the sponsor provides a schedule for the submission of the sections of the NDA, the FDA agrees to accept sections of the NDA and determines that the schedule is acceptable, and the sponsor pays any required user fees upon submission of the first section of the NDA.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The FDA may give a priority review designation to drugs that offer major advances in treatment or provide a treatment where no adequate therapy exists. A priority review means that the goal for the FDA to review an application is six months, rather than the standard review of 10 months under current PDUFA guidelines. Under the new PDUFA agreement, these six- and 10-month review periods are measured from the &#x201c;filing&#x201d; date rather than the receipt date for NDAs for new molecular entities, which typically adds approximately two months to the timeline for review and decision from the date of submission. Most products that are eligible for fast track designation are also likely to be considered appropriate to receive a priority review, and, if relevant, accelerated approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, products studied for their safety and effectiveness in treating serious or life-threatening illnesses and that provide meaningful therapeutic benefit over existing treatments may be eligible for accelerated approval and may be approved on the basis of adequate and well-controlled clinical trials establishing that the drug product has an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit, or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality, that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments. As a condition of approval, the FDA may require a sponsor of a drug receiving accelerated approval to perform post-marketing studies to verify and describe the predicted effect on irreversible morbidity or mortality or other clinical endpoint, and the drug may be subject to accelerated withdrawal procedures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, under the provisions of the Food and Drug Administration Safety and Innovation Act, or FDASIA, passed in July 2012, a sponsor can request designation of a product candidate as a &#x201c;breakthrough therapy.&#x201d; A breakthrough therapy is defined as a drug that is intended, alone or in combination with one or more other drugs, to treat a serious or life-threatening disease or condition, and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. Drugs designated as breakthrough therapies are also eligible for priority review and accelerated approval. The FDA must take certain actions, such as holding timely meetings and providing advice, intended to expedite the development and review of an application for approval of a breakthrough therapy. The designation includes all the benefits of a fast track designation. The breakthrough therapy designation is a distinct status from both accelerated approval and priority review, which can also be granted to the same drug if relevant criteria are met.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Even if a product qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for qualification or decide that the time period for FDA review or approval will not be shortened. Furthermore, fast track designation, priority review, and breakthrough therapy designation do not change the standards for</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">37</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">approval but may expedite the development or approval process. We may explore some of these opportunities for our product candidates as appropriate.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Post-approval requirements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Drugs manufactured or distributed pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating to recordkeeping, periodic reporting, product sampling and distribution, advertising and promotion, and reporting of adverse experiences with the product. After approval, most changes to the approved product, such as adding new indications or other labeling claims, are subject to prior FDA review and approval. There also are continuing, annual user fee requirements for any marketed products and the establishments at which such products are manufactured, as well as new application fees for supplemental applications with clinical data.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The FDA may impose a number of post-approval requirements as a condition of approval of an NDA. For example, the FDA may require post-marketing testing, including Phase 4 clinical trials, and surveillance to further assess and monitor the product&#x2019;s safety and effectiveness after commercialization.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, drug manufacturers and other entities involved in the manufacture and distribution of approved drugs are required to register their establishments with the FDA and state and local agencies and are subject to periodic unannounced inspections by government agencies for compliance with cGMP and other requirements. Changes to the manufacturing process are strictly regulated and often require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP requirements and impose reporting and documentation requirements upon the sponsor and any third-party manufacturers that the sponsor may decide to use. Accordingly, manufacturers must continue to expend time, money, and effort in the area of production and quality control to maintain cGMP compliance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Once an approval is granted, the FDA may withdraw the approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in mandatory revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical trials to assess new safety risks; or imposition of distribution or other restrictions under a REMS program. Other potential consequences include, among other things:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the market or product recalls; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">safety alerts, Dear Healthcare Provider letters, press releases, or other communications containing warning or other safety information about the product; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">fines, warning letters, or holds on post-approval clinical trials; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">refusal of the FDA to approve pending NDAs or supplements to approved NDAs, or suspension or revocation of product approvals; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">product seizure or detention, or refusal to permit the import or export of products; or </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">injunctions or the imposition of civil or criminal penalties. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The FDA strictly regulates marketing, labeling, advertising, and promotion of products that are placed on the market. Drugs may be promoted only for the approved indications and in accordance with the provisions of the approved label. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of off-label uses, and a company that is found to have improperly promoted off-label uses may be subject to significant liability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, the distribution of prescription pharmaceutical products is subject to the Prescription Drug Marketing Act, or PDMA, which regulates the distribution of drugs and drug samples at the federal level and sets minimum standards for the registration and regulation of drug distributors by the states. Both the PDMA and state laws limit the distribution of prescription pharmaceutical product samples and impose requirements to ensure accountability in distribution.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Marketing exclusivity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Market exclusivity provisions under the FDCA can delay the submission or the approval of certain marketing applications. The FDCA provides a five-year period of non-patent marketing exclusivity within the United States to the first applicant to obtain approval of an NDA for a new chemical entity. A drug is a new chemical entity if the FDA has not</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">38</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">previously approved any other new drug containing the same active moiety, which is the molecule or ion responsible for the action of the drug substance. During the exclusivity period, the FDA may not approve or even accept for review an abbreviated new drug application, or ANDA, or an NDA submitted under Section 505(b)(2), or 505(b)(2) NDA, submitted by another company for another drug based on the same active moiety, regardless of whether the drug is intended for the same indication as the original innovative drug or for another indication, where the applicant does not own or have a legal right of reference to all the data required for approval. However, an application may be submitted after four years if it contains a certification of patent invalidity or non-infringement to one of the patents listed with the FDA by the innovator NDA holder.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The FDCA alternatively provides three to five years of marketing exclusivity for an NDA, or supplement to an existing NDA, if new clinical investigations, other than bioavailability studies, that were conducted or sponsored by the applicant are deemed by the FDA to be essential to the approval of the application. This three-year exclusivity covers only the modification for which the drug received approval based on the new clinical investigations and does not prohibit the FDA from approving ANDAs or 505(b)(2) NDAs for drugs containing the active agent for the original indication or condition of use. Five-year and three-year exclusivity will not delay the submission or approval of a full NDA. However, an applicant submitting a full NDA would be required to conduct or obtain a right of reference to all of the preclinical studies and adequate and well-controlled clinical trials necessary to demonstrate safety and effectiveness.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pediatric exclusivity is another type of marketing exclusivity available in the United States. Pediatric exclusivity provides for an additional six months of marketing exclusivity attached to another period of exclusivity and extends patent life of a related patent if a sponsor conducts clinical trials in children in response to a written request from the FDA. The issuance of a written request does not require the sponsor to undertake the described clinical trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Other healthcare laws and compliance requirements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pharmaceutical companies are subject to additional healthcare regulation and enforcement by the federal government and by authorities in the state, local, and foreign jurisdictions in which they conduct their business. Such laws include, without limitation, U.S. federal and state anti-kickback, fraud and abuse, false claims, consumer fraud, pricing reporting, and transparency laws and regulations, as well as similar foreign laws in the jurisdictions outside the U.S. State laws may require pharmaceutical companies to comply with the pharmaceutical industry&#x2019;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government, as well as require the registration of pharmaceutical sales representatives and the reporting of pricing information and marketing expenditures. Violations of such laws, or any other governmental regulations that apply, may result in penalties, including, without limitation, civil and criminal penalties, damages, fines, additional reporting and oversight obligations, the curtailment or restructuring of operations, exclusion from participation in governmental healthcare programs, and individual imprisonment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Coverage and reimbursement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Sales of any pharmaceutical product depend, in part, on the extent to which such product will be covered by third-party payors, such as federal, state, and foreign government healthcare programs, commercial insurance and managed healthcare organizations, and the level of reimbursement for such product by third-party payors. Significant uncertainty exists as to the coverage and reimbursement status of any newly approved product. Decisions regarding the extent of coverage and amount of reimbursement to be provided are made on a plan-by-plan basis. One third-party payor&#x2019;s decision to cover a product does not ensure that other payors will also provide coverage for the product. As a result, the coverage determination process can require manufactures to provide scientific and clinical support for the use of a product to each payor separately, and can be a time-consuming process, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance. For products administered under the supervision of a physician, obtaining coverage and adequate reimbursement may be particularly difficult because of the higher prices often associated with such drugs. Additionally, separate reimbursement for the product itself or the treatment or procedure in which the product is used may not be available, which may impact physician utilization.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, third-party payors are increasingly reducing reimbursements for pharmaceutical products and services. The U.S. government and state legislatures have continued implementing cost-containment programs, including price controls, restrictions on coverage and reimbursement, and requirements for substitution of generic products. Third-party payors are more and more challenging the prices charged, examining the medical necessity, and reviewing the cost effectiveness of pharmaceutical products, in addition to questioning their safety and efficacy. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit sales of any product. Decreases in third-party reimbursement for any product or a decision by a third-party payor not to cover a product could reduce physician usage and patient demand for the product.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">39</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In international markets, reimbursement and healthcare payment systems vary significantly by country, and many countries have instituted price ceilings on specific products and therapies. For example, the European Union provides options for its member states to restrict the range of medicinal products for which their national health insurance systems provide reimbursement and to control the prices of medicinal products for human use. A member state may approve a specific price for the medicinal product, or it may instead adopt a system of direct or indirect controls on the profitability of the company placing the medicinal product on the market. Pharmaceutical products may face competition from lower-priced products in foreign countries that have placed price controls on pharmaceutical products and may also compete with imported foreign products. Furthermore, there is no assurance that a product will be considered medically reasonable and necessary for a specific indication, will be considered cost-effective by third-party payors, that an adequate level of reimbursement will be established even if coverage is available, or that the third-party payors&#x2019; reimbursement policies will not adversely affect the ability of manufacturers to sell products profitably.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Healthcare reform</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the United States and certain foreign jurisdictions, there have been, and we expect there will continue to be, a number of legislative and regulatory changes to the healthcare system that could affect the pharmaceutical industry. In March 2010, the Affordable Care Act (ACA) was signed into law, which substantially changed the way healthcare is financed by both governmental and private insurers in the United States. The ACA contains a number of provisions of particular import to the pharmaceutical industry, including those governing enrollment in federal healthcare programs, reimbursement adjustments, and fraud and abuse changes. Additionally, the ACA increases the minimum level of Medicaid rebates payable by manufacturers of brand name drugs from 15.1% to 23.1%; requires collection of rebates for drugs paid by Medicaid managed care organizations; imposes a nondeductible annual fee on pharmaceutical manufacturers or importers who sell &#x201c;branded prescription drugs&#x201d; to specified federal government programs; implements a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted, or injected; expands of eligibility criteria for Medicaid programs; creates a new Patient-Centered Outcomes Research Institute to oversee; identify priorities in, and conducts comparative clinical effectiveness research, along with funding for such research; and establishes a Center for Medicare Innovation at CMS to test innovative payment and service delivery models to lower Medicare and Medicaid spending, potentially including prescription drug spending.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since its enactment, there have been judicial, executive and Congressional challenges to certain aspects of the ACA. On June 17, 2021, the U.S. Supreme Court dismissed the most recent judicial challenge to the ACA brought by several states without specifically ruling on the constitutionality of the ACA. Prior to the Supreme Court&#x2019;s decision, President Biden issued an executive order initiating a special enrollment period from February 15, 2021 through August 15, 2021 for purposes of obtaining health insurance coverage through the ACA marketplace.  The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legislative changes have been proposed and adopted since the ACA was enacted, including aggregate reductions of Medicare payments to providers of 2% per fiscal year, which was temporarily suspended from May 1, 2020 through March 31, 2022, and reduced payments to several types of Medicare providers. Moreover, there has recently been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products, which has resulted in several Congressional inquiries, and proposed and enacted legislation designed, among other things, to bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drug products. Individual states in the United States have also become increasingly active in implementing regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access, and marketing cost disclosure and transparency measures, and, in some cases, mechanisms to encourage importation from other countries and bulk purchasing. Furthermore, there has been increased interest by third-party payors and governmental authorities in reference-pricing systems and publication of discounts and list prices.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Foreign regulation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to regulations in the United States, we will be subject to a variety of foreign regulations governing clinical trials and commercial sales and distribution of our products. Whether or not we obtain FDA approval for a product, we must obtain approval by the comparable regulatory authorities of foreign countries before we can commence clinical trials in those countries, if relevant, and market application approval by foreign countries or economic areas, such as the European Union, or EU, before we may market products in those countries or areas. The approval process and requirements governing the conduct of clinical trials, product licensing, pricing, and reimbursement vary greatly from place to place, and the time may be longer or shorter than that required for FDA approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">40</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the European Economic Area, or EEA, which is comprised of the Member States of the European Union plus Norway, Iceland and Liechtenstein, medicinal products can only be commercialized after obtaining a Marketing Authorization, or MA. There are two types of MAs:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Community MAs&#x2014;These are issued by the European Commission through the Centralized Procedure, based on the opinion of the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, and are valid throughout the entire territory of the EEA. The Centralized Procedure is mandatory for certain types of products, such as biotechnology medicinal products, orphan medicinal products, and medicinal products indicated for the treatment of AIDS, cancer, neurodegenerative disorders, diabetes, auto-immune, and viral diseases. The Centralized Procedure is optional for products containing a new active substance not yet authorized in the EEA; for products that constitute a significant therapeutic, scientific or technical innovation; or for products that are in the interest of public health in the EU. </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">National MAs&#x2014;These are issued by the competent authorities of the Member States of the EEA and only cover their respective territory and are available for products not falling within the mandatory scope of the Centralized Procedure. Where a product has already been authorized for marketing in a Member State of the EEA, this National MA can be recognized in another Member State through the Mutual Recognition Procedure. If the product has not received a National MA in any Member State at the time of application, it can be approved simultaneously in various Member States through the Decentralized Procedure. Under the Decentralized Procedure, an identical dossier is submitted to the competent authorities of each of the Member States in which the MA is sought, one of which is selected by the applicant as the Reference Member State. The competent authority of the Reference Member State prepares a draft assessment report, a draft summary of the product characteristics, or SmPC, and a draft of the labeling and package leaflet, which are sent to the other Member States (referred to as the Member States Concerned) for their approval. If the Member States Concerned raise no objections, based on a potential serious risk to public health, to the assessment, SmPC, labeling or packaging proposed by the Reference Member State, the product is subsequently granted a National MA in all the Member States, i.e., in the Reference Member State and the Member States Concerned. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the above described procedures, before granting the MA, the EMA or the competent authorities of the Member States of the EEA assess the risk-benefit balance of the product on the basis of scientific criteria concerning its quality, safety, and efficacy.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As in the United States, it may be possible in foreign countries to obtain a period of market and/or data exclusivity that would have the effect of postponing the entry into the marketplace of a competitor&#x2019;s generic product. For example, if any of our products receive marketing approval in the EEA, we expect they will benefit from eight years of data exclusivity and 10 years of marketing exclusivity. An additional noncumulative one-year period of marketing exclusivity is possible if during the data exclusivity period (the first eight years of the 10-year marketing exclusivity period) we obtain an authorization for one or more new therapeutic indications that are deemed to bring a significant clinical benefit compared to existing therapies. The data exclusivity period begins on the date of the product&#x2019;s first marketing authorization in the EEA and prevents generics from relying on the marketing authorization holder&#x2019;s pharmacological, toxicological, and clinical data for a period of eight years. After eight years, a generic product application may be submitted, and generic companies may rely on the marketing authorization holder&#x2019;s data. However, a generic cannot launch until two years later (or a total of 10 years after the first marketing authorization in the EU of the innovator product), or three years later (or a total of 11 years after the first marketing authorization in the EU of the innovator product) if the marketing authorization holder obtains marketing authorization for a new indication with significant clinical benefit within the eight-year data exclusivity period. In Japan, our products may be eligible for eight years of data exclusivity. There can be no assurance that we will qualify for such regulatory exclusivity, or that such exclusivity will prevent competitors from seeking approval solely on the basis of their own studies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">When conducting clinical trials in the EU, we must adhere to the provisions of the European Union Clinical Trials Directive (Directive 2001/20/EC) and the laws and regulations of the EU Member States implementing them. These provisions require, among other things, that the prior authorization of an Ethics Committee and the competent Member State authority is obtained before commencing the clinical trial. In April 2014, the EU passed the Clinical Trials Regulation (Regulation 536/2014), which will replace the current Clinical Trials Directive. To ensure that the rules for clinical trials are identical throughout the European Union, the EU Clinical Trials Regulation was passed as a regulation that is directly applicable in all EU member states. All clinical trials performed in the European Union are required to be conducted in accordance with the Clinical Trials Directive until the Clinical Trials Regulation becomes applicable. According to the current plans of the EMA, the Clinical Trials Regulation is expected to become applicable sometime in 2020.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Data privacy and security laws</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Numerous state, federal and foreign laws, including consumer protection laws and regulations, govern the collection, dissemination, use, access to, confidentiality and security of personal information, including health-related information. In the United States, numerous federal and state laws and regulations, including data breach notification laws, health information privacy and security laws, including the Health Insurance Portability and Accountability Act of 1996, as amended, or HIPAA, and federal and state consumer protection laws and regulations (e.g., Section 5 of the FTC Act), that govern the collection, use, disclosure, and protection of health-related and other personal information could apply to our operations or the operations of our partners. In addition, certain state and non-U.S. laws, such as the California Consumer Privacy Act, or the CCPA, the California Privacy Rights Act, or the CPRA, and the European Union General Data Protection Regulation, or the GDPR, govern the privacy and security of personal information, including health-related information in certain circumstances, some of which are more stringent than HIPAA and many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts. Failure to comply with these laws, where applicable, can result in the imposition of significant civil and/or criminal penalties and private litigation.  Privacy and security laws, regulations, and other obligations are constantly evolving, may conflict with each other to complicate compliance efforts, and can result in investigations, proceedings, or actions that lead to significant civil and/or criminal penalties and restrictions on data processing.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Environmental, Social, and Governance Initiatives</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Corporate sustainability and environmental responsibility</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">understand the importance of reducing our environmental impact. We are proud to be headquartered in a LEED certified building, a globally recognized symbol of sustainability achievement and leadership. We continue to promote sustainability within our office by limiting single-use plastic and implementing compost and recycling programs. Our current hybrid work model allows employees to work remotely for a portion of the week, decreasing the emissions associated with employees commuting to the office.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Diversity &amp; Inclusion</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">committed to creating and maintaining a workplace free from discrimination or harassment on the basis of color, race, sex, national origin, ethnicity, religion, age, disability, sexual orientation, gender identification or expression, or any other status protected by applicable law. Our management team and employees are expected to exhibit and promote honest, ethical and respectful conduct in the workplace. All of our employees must adhere to a code of conduct that sets standards for appropriate behavior and are required to attend training upon hire and at our request to help prevent, identify, report and stop any type of discrimination and harassment. Ongoing acknowledgement of our anti-harassment policy is required on an annual basis. Our recruitment, hiring, development, training, compensation and advancement at our company is based on qualifications, performance, skills and experience without regard to gender, race and ethnicity. Our Diversity, Equity &amp; Inclusion (DEI) Committee is an employee-led group that works to raise awareness for DEI initiatives and identify ways we can continue to promote inclusion within our corporate culture. Although we are a smaller reporting company, our Board of Directors meets the requirements under NASDAQ's Board Diversity Rule for accelerated and large-accelerated filers with two diverse directors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Employees and Human Capital Resources</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 8, 2022</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, we had 74 employees, including 72 full-time employees. Women represent approximately 50% of our employees, with approximately 29% holding senior management level/leadership roles. Thirty-eight percent of our employees have an M.D. or a Ph.D. From time to time, we also retain independent contractors to support our organization.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">42</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">None of our employees are represented by a labor union or covered by collective bargaining agreements, and we believe our relationship with our employees is good.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We strive to provide pay, comprehensive benefits and services that help meet the varying needs of our employees. Our total rewards package includes competitive pay; comprehensive healthcare benefits package for employees, with family member healthcare benefits covered at 90%; a health savings account with company contribution; unlimited paid time off and paid holidays; family medical leave; and flexible work schedules. In addition, we offer every full-time employee, both exempt and non-exempt, the benefit of equity ownership in the company through stock option grants, restricted stock units, and our employee stock purchase plan. We also sponsor a 401(k) plan with a 5% match.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We focus on attracting, retaining, and cultivating talented individuals. We emphasize employee development and training by providing access to a wide range of online and instructor led development and continual learning programs. Employees are encouraged to attend scientific, clinical and technological meetings and conferences and have access to broad resources they need to be successful.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Safety</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The safety, health and wellness of our employees is a top priority. In response to COVID-19, we have implemented a safety protocols including a flexible work schedule, requirements for the wearing of masks, increased cleaning procedures and readily available hand sanitizer. These protocols are designed to comply with health and safety standards as required by federal, state and local government agencies, taking into consideration guidelines of the Centers for Disease Control and Prevention and other public health authorities. In addition, we have provided work-at-home arrangements for employees who are able to do so.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Our Corporate Information</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We were incorporated under the laws of the state of Delaware in November 2014. Our principal executive offices are located at 75 Hayden Avenue, Suite 300, Lexington, Massachusetts 02421 and our telephone number is (781) 315-4600. Our corporate website address is </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">www.frequencytx.com</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The information contained in, or accessible through, our website is not incorporated by reference into this Annual Report and you should not consider information on our website to be a part of this Annual Report. We have included our website address in this Annual Report solely as an inactive textual reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Where you can find more information</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are subject to the information requirements of the Securities Exchange Act of 1934, as amended. The SEC maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically, such as ourselves, with the SEC at </span><span><span style="background-color:rgba(0,0,0,0);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">http://www.sec.gov</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">43</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_1a_risk_factors"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 1A. Ri</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">sk Factors.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our future operating results could differ materially from the results described in this Annual Report on Form 10-K due to the risks and uncertainties described below. You should consider carefully the following information about risks below in evaluating our business. If any of the following risks actually occur, our business, financial conditions, results of operations and future growth prospects would likely be materially and adversely affected. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business operations. In these circumstances, the market price of our common stock would likely decline. In addition, we cannot assure investors that our assumptions and expectations will prove to be correct. Important factors could cause our actual results to differ materially from those indicated or implied by forward-looking statements. See &#x201c;Forward Looking Statements&#x201d; for a discussion of some of the forward-looking statements that are qualified by these risk factors. Factors that could cause or contribute to such differences include those factors discussed below.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks related to our financial position and need for additional capital</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We have incurred significant losses since inception and anticipate that we will continue to incur losses for the foreseeable future. We are not currently profitable, and we may never achieve or sustain profitability. If we are unable to achieve or sustain profitability, the market value of our common stock will likely decline.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are a clinical-stage biotechnology company with a limited operating history. As a result, we are not profitable and have incurred significant losses since our formation. We had net losses of $84.7 million and $26.5 million for the years ended December 31, 2021 and 2020, respectively. As of December 31, 2021, we had an accumulated deficit of $180.1 million. Investment in biopharmaceutical product development is highly speculative because it entails substantial upfront capital expenditures and significant risk that any potential product candidate will fail to gain regulatory approval and become commercially viable. We have not commercialized any products and have never generated revenue from the commercialization of any product. To date, we have devoted most of our financial resources to licensing technologies and research and development, including our preclinical platform development activities and clinical trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect to incur significant additional operating losses for the next several years, at least, as we advance FX-322 and our other product candidates through clinical development, complete clinical trials, seek regulatory approval and commercialize FX-322 or our other product candidates, if approved. The costs of advancing product candidates into each clinical phase tend to increase substantially over the duration of the clinical development process. Therefore, the total costs to advance any product candidate to marketing approval in even a single jurisdiction are substantial. Because of the numerous risks and uncertainties associated with pharmaceutical product development, we are unable to accurately predict the timing or amount of increased expenses or when, or if, we will be able to begin generating revenue from the commercialization of any product candidates or achieve or maintain profitability. Our expenses will also increase substantially if and as we:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">continue to conduct our Phase 2b trial of FX-322 (FX-322-208) and extension trials of FX-322-111 and FX-322-112 and commence additional clinical studies relating to our product candidates; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">continue to develop and commence clinical trials of FX-345 and our remyelination program;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">expand our development programs based on our progenitor cell activation, or PCA, platform; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">continue to develop our PCA platform;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">seek regulatory approvals for FX-322 and our other product candidates; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">expand the target indications and patient population for FX-322; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">secure a commercial manufacturing source and supply chain capacity sufficient to produce commercial quantities of any product candidate for which we obtain regulatory approval; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">establish a sales, marketing and distribution infrastructure to commercialize FX-322 for the treatment of SNHL, if approved, and for any of our other product candidates for which we may obtain marketing approval; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">maintain, expand, and protect our intellectual property portfolio; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">hire additional clinical, scientific, and commercial personnel; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">add operational, financial, and management personnel, including personnel to support our product development and planned future commercialization efforts, as well as to support operations as a public company; and </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">acquire or in-license other product candidates or technologies. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furthermore, our ability to successfully develop, commercialize and license any product candidates and generate product revenue is subject to substantial additional risks and uncertainties, as described under &#x201c;&#x2014;Risks related to development, clinical testing, manufacturing, and regulatory approval&#x201d; and &#x201c;&#x2014;Risks related to commercialization.&#x201d; As a result, we expect to continue to incur net losses and negative cash flows for the foreseeable future. These net losses and negative cash flows have had, and will continue to have, an adverse effect on our stockholders&#x2019; equity and working capital. The amount of our future net losses will depend, in part, on the rate of future growth of our expenses and our ability to generate revenues. If we are unable to develop and commercialize one or more product candidates, either alone or through collaborations, or if revenues from any product that receives marketing approval are insufficient, we will not achieve profitability. Even if we successfully commercialize FX-322 or our other product candidates, we may continue to incur substantial research and development and other expenses to identify and develop other product candidates. Even if we do achieve profitability, we may not be able to sustain profitability or meet outside expectations for our profitability. If we are unable to achieve or sustain profitability or to meet outside expectations for our profitability, the value of our common stock will be materially adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We will require additional capital to fund our operations, and if we fail to obtain necessary financing, we may not be able to complete the development and commercialization of FX-322 or our additional product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect to spend substantial amounts to complete the development of, seek regulatory approvals for and, if approved, commercialize FX-322 and our other product candidates. These expenditures include and will include, as the case may be, costs related to the Phase 2b trial of FX-322 (FX-322-208), extension trials of FX-322-111 and FX-322-112, and any additional trials we conduct to support the development of FX-322 and our other product candidates. In addition, we are obligated to make milestone and royalty payments in connection with the sale of resulting products and licensing revenues under our license agreements with Massachusetts Institute of Technology, or MIT, Massachusetts Eye and Ear, or MEE, the Scripps Research Institute, or Scripps, and Cambridge Enterprise Limited (the technology transfer arm of the University of Cambridge), or Cambridge. We also expect to spend substantial amounts to identify and develop new product candidates based on our PCA platform.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We will require additional capital to enable us to develop additional product candidates based on our PCA platform, which we may acquire through equity offerings, debt financings, marketing and distribution arrangements and other collaborations, strategic alliances and licensing arrangements or other sources. Adequate additional financing may not be available to us on acceptable terms, or at all. Our failure to raise capital as and when needed would have a negative effect on our financial condition and our ability to pursue our business strategy. In addition, attempting to secure additional financing may divert the time and attention of our management from day-to-day activities and harm our development efforts.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Based upon our current operating plan, we believe that our existing cash, cash equivalents, and marketable securities of $142.4 million will enable us to fund our operating expenses and capital expenditure requirements through the end of 2023. This estimate and our expectation regarding the sufficiency of our current financial resources to advance the clinical development of FX-322 and our other product candidates are based on assumptions that may prove to be wrong, and we could use our available capital resources sooner than we currently expect, or our clinical trials, including our Phase 2b trial of FX-322 (FX-322-208), or extension trials of FX-322-111 and FX-322-112, and other clinical trials of FX-322 or our other product candidates, may be more expensive, time consuming or difficult to design or implement than we currently anticipate. Changing circumstances, including any unanticipated expenses, could cause us to consume capital significantly faster than we currently anticipate, and we may need to spend more than currently expected because of circumstances beyond our control. Because the length of time and scope of activities associated with successful development of FX-322 or any product candidate we may develop is highly uncertain, we are unable to estimate the actual funds we will require for development and any marketing and commercialization activities. Our future funding requirements, both near and long-term, will depend on many factors, including, but not limited to:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the initiation, progress, timing, costs and results of our clinical trials through all phases of development, including the Phase 2b trial of FX-322 (FX-322-208), extension trials of FX-322-111 and FX-322-112, any other clinical trials of FX-322, the development of FX-345 and our remyelination program, and the development of </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">45</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;visibility:hidden;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;"></span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any of our other product candidates including any unforeseen costs we may incur as a result of clinical trials due to the COVID-19 global pandemic or other causes;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the outcome, timing and cost of meeting regulatory requirements established by the U.S. Food and Drug Administration, or the FDA, and other comparable foreign regulatory authorities, including any additional clinical trials required by the FDA or other comparable foreign regulatory authorities; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the willingness of the FDA and other comparable foreign regulatory authorities to accept our clinical trial designs, as well as data from our completed and planned clinical trials and preclinical studies, as the basis for review and approval of FX-322 or our other product candidates; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the cost of filing, prosecuting, defending, and enforcing our patent claims and other intellectual property rights; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the cost of defending potential intellectual property disputes, including patent infringement actions brought by third parties against us; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the effect of competing technological and market developments; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the cost and timing of completion of commercial-scale manufacturing activities; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the costs of operating as a public company; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the cost of making royalty, milestone or other payments under current and any future in-license agreements; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the extent to which we in-license or acquire other product candidates or technologies; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the cost of establishing sales, marketing and distribution capabilities for our product candidates, if approved; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to maintain our collaboration with Astellas Pharma Inc., or Astellas, including achievement of the development milestones and to establish new collaborations; and </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the initiation, progress, and timing of our commercialization of FX-322, if approved, or our other product candidates. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Depending on our business performance, the economic climate and market conditions, we may be unable to raise additional funds through any sources. Market volatility resulting from the COVID-19 global pandemic could also adversely impact our ability to access capital as and when needed. If we are unable to raise additional capital in sufficient amounts or on terms acceptable to us, we may have to significantly delay, scale back or discontinue the development or commercialization of FX-322 or our other product candidates, or potentially discontinue operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We have a limited operating history and no history of commercializing pharmaceutical products, which may make it difficult to evaluate the prospects for our future viability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We were established and began operations in 2014. Our operations to date have been limited to financing and staffing our company, licensing technologies, developing our PCA platform, developing and conducting preclinical and clinical studies of FX-322 for the treatment of SNHL, and developing a pipeline of preclinical and research programs, including FX-345 and our remyelination program. We have not yet demonstrated the ability to successfully complete a large-scale, pivotal clinical trial, obtain marketing approval, manufacture a commercial-scale product, or arrange for a third party to do so on our behalf, or conduct sales and marketing activities necessary for successful product commercialization. Consequently, predictions about our future success or viability may not be as accurate as they could be if we had a longer operating history or a history of successfully developing and commercializing pharmaceutical products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, as a business with a limited operating history, we may encounter unforeseen expenses, difficulties, complications, delays and other known and unknown challenges. Our Phase 2a results (FX-322-202), for example, showed that four weekly injections in subjects with mild to moderately severe SNHL did not demonstrate improvements in hearing measures versus placebo, a finding we believe is due to an uncontrolled bias and the limitation to a single baseline measure. We will eventually need to transition from a company with a research focus to a company capable of supporting commercial activities. We may not be successful in such a transition and, as a result, our business may be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As we continue to build our business, we expect our financial condition and operating results may fluctuate significantly from quarter to quarter and year to year due to a variety of factors, many of which are beyond our control. Accordingly, the results of any quarterly or annual period are not necessarily indicative of future operating performance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2410416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">46</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2410416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our ability to use our net operating loss carryforwards to offset future taxable income, or tax credit carryforward to offset future income tax liabilities, may be subject to certain limitations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2410416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021, we had net operating loss carryforwards, or NOLs, of $149.1 million for federal income tax purposes and $83.5 million for state income tax purposes, which may be available to offset our future taxable income, if any. Our NOLs expire in various amounts through 2037, provided that federal NOLs generated in taxable years beginning after December 31, 2017 will not be subject to expiration. As of December 31, 2021, we also had federal and state research and development and other tax credit carryforwards of approximately $5.2 million and $2.1 million, respectively, available to reduce future tax liabilities. Our tax credit carryforwards expire at various dates through 2041. These NOLs and tax credit carryforwards could expire unused, to the extent subject to expiration, and be unavailable to offset future income tax liabilities. In addition, in general, under Sections 382 and 383 of the U.S. Internal Revenue Code of 1986, as amended, or the Code, a corporation that undergoes an &#x201c;ownership change&#x201d; is subject to limitations on its ability to use its pre-change NOLs and tax credit carryforwards to offset future taxable income. For these purposes, an ownership change generally occurs where the aggregate stock ownership of one or more stockholders or groups of stockholders who owns at least 5% of a corporation&#x2019;s stock increases its ownership by more than 50 percentage points over its lowest ownership percentage within a specified testing period. We believe we have experienced an ownership change in 2017 and 2019 and may experience ownership changes in the future as a result of future transactions in our stock, some of which may be outside our control. If we undergo additional ownership changes, our ability to use our NOLs and tax credit carryforwards could be further limited. As a result of the changes in ownership in 2017 and 2019, $0.01 million and $0.04 million of NOL carryforwards are limited under Section 382. For these reasons, we may not be able to use a material portion of our NOLs or tax credit carryforwards, even if we attain profitability. We have recorded a full valuation allowance related to our NOLs and other deferred tax assets due to the uncertainty of the ultimate realization of the future tax benefits of such assets. Furthermore, NOLs generated in periods beginning after December 31, 2017 may be carried forward indefinitely but may only be used to offset 80% of our taxable income in years beginning after December 31, 2021, which may require us to pay federal income taxes in future years despite generating federal NOLs in prior years.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks related to development, clinical testing, manufacturing, and regulatory approval</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We are heavily dependent on the success of FX-322, our lead product candidate, which is still under clinical development, and if FX-322 does not receive regulatory approval or is not successfully commercialized, our business will be materially adversely harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To date, we have invested a significant portion of our efforts and financial resources in the development of FX-322 for the treatment of SNHL. Our future success is substantially dependent on our ability to successfully complete clinical development for, obtain regulatory approval for, and successfully commercialize FX-322, which may never occur. We a currently have no products that are approved for commercial sale and may never be able to develop a marketable product. We expect that a substantial portion of our efforts and expenditures over the next few years will continue to be devoted to FX-322, which will require additional clinical development, management of clinical and manufacturing activities, regulatory approval, establishing commercial scale manufacturing, and significant sales, marketing, and distribution efforts before we can generate any revenues from any commercial sales. We cannot be certain that we will be able to successfully complete any of these activities or that, even if it receives regulatory approval, FX-322 will be as effective as anticipated at treating SNHL. Our Phase 2a results (FX-322-202), for example, showed that four weekly injections in subjects with mild to moderately severe SNHL did not demonstrate improvements in hearing measures versus placebo, a finding we believe is due to an uncontrolled bias and the limitation to a single baseline measure, and our Phase 1b study of FX-322 in presbycusis (FX-322-112) did not show any significant treatment effects compared to placebo.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The research, testing, manufacturing, labeling, approval, sale, packaging, marketing, and distribution of drug products are subject to extensive regulation by the FDA and comparable regulatory authorities in other countries. We are not permitted to market FX-322 in the United States until we receive approval of a New Drug Application, or NDA, from the FDA, or in any foreign countries until our collaborator, Astellas, receives the requisite approval from such countries. We have not submitted an NDA to the FDA and Astellas has not submitted comparable applications to other regulatory authorities for FX-322. We or Astellas may not be in a position to do so for several years, if ever. If we or Astellas are unable to obtain the necessary regulatory approval for FX-322 in a country, including as a result of the COVID-19 pandemic, we or Astellas will not be able to commercialize FX-322 for the treatment of SNHL in that country. As a result, our financial position will be materially adversely affected, and we may not be able to generate sufficient revenue to continue our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">47</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We utilize our PCA platform to develop product candidates that are designed to activate progenitor cells, which is a new approach to therapeutic intervention and, as a result, successful development, approval, and commercialization of our product candidates, including FX-322 and FX-345 is uncertain.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We utilize our PCA platform to develop product candidates, including FX-322 and FX-345, for the treatment of SNHL. Our PCA platform is designed to identify pathways to activate progenitor cells already present in the body to treat conditions or diseases through cellular regeneration. We have not, nor to our knowledge has any other company, received regulatory approval utilizing this mechanism of cellular regeneration. Given the novelty of our approach, we could encounter a longer than expected regulatory review process, increased development costs, or unexpected delays in, or even prevention of, the regulatory approval and commercialization of our product candidates, and we cannot be certain that our approach will lead to the development of any approvable or marketable products. For example, the FDA-approved treatment options available for people with SNHL are hearing aids and cochlear implants. Unlike FX-322, which is a therapeutic that targets the underlying biology of SNHL, these treatment options are medical devices that are designed to target the symptoms of SNHL. As a result, these treatment options are not directly comparable to FX-322, and FDA requirements for marketing authorization of these treatment options may not be relevant for FX-322. While we are developing what we believe are appropriate measurements of efficacy for FX-322, we cannot be certain that the FDA will agree with our measurements or that they will be sufficient for approval. If we were to encounter any of the foregoing, our business and financial prospects could be materially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Clinical trials are expensive, time consuming, and difficult to design and implement, and involve an uncertain outcome. The results of preclinical studies and early clinical trials are not always predictive of future results. Any product candidate that we advance into clinical trials may not achieve favorable results in later clinical trials, if any, or receive marketing approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Failure can occur at any time during the clinical trial process. The results of preclinical studies and completed clinical trials are not necessarily predictive of future results, and any product candidates we develop may not be further developed or may have additional unfavorable results in later studies or trials. Clinical trial failure may result from a multitude of factors, including, but not limited to, flaws in study design, dose selection, placebo effect, subject enrollment criteria, selection of subjects based on subject misrepresentations, and failure to demonstrate favorable safety or efficacy traits. As such, failure in clinical trials can occur at any stage of testing. Several companies in the pharmaceutical industry have suffered setbacks in the advancement of their drug candidates into later-stage clinical trials due to lack of efficacy or adverse safety profiles, notwithstanding favorable results in earlier preclinical studies or clinical trials. Our Phase 2a results (FX-322-202), for example, showed that four weekly injections in subjects with mild to moderately severe SNHL did not demonstrate improvements in hearing measures versus placebo, a finding we believe is due to an uncontrolled bias and the limitation to a single baseline measure. Based upon negative or inconclusive results or a need for additional information, we may decide, or regulatory authorities may require us, to conduct additional clinical trials or preclinical studies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may experience delays in initiating and completing any clinical trials that we intend to conduct, and we do not know whether our clinical trials will begin on time, need to be redesigned, enroll subjects on time, or be completed on schedule, or at all. For example, a number of clinical trial sites for our completed Phase 2a clinical trial of FX-322 (FX-322-202) temporarily halted subject enrollment during the first and second quarter of 2020 in response to the COVID-19 pandemic. Enrollment in other ongoing or planned clinical trials could be adversely affected by the pandemic. Clinical trials can be delayed for a variety of reasons, including delays related to:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the FDA or comparable foreign regulatory authorities disagreeing as to the design or implementation of our clinical studies;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">obtaining regulatory approval to commence a trial; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">reaching an agreement on acceptable terms with prospective contract research organizations, or CROs, and clinical trial sites, the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">obtaining Institutional Review Board, or IRB, approval at each site within the United States, or Independent Ethics Committee, or IEC, approval at sites outside the United States; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">business interruptions resulting from the COVID-19 pandemic;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">recruiting suitable subjects to participate in a trial in a timely manner and in sufficient numbers; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">having subjects complete a trial or return for post-treatment follow-up; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">48</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">imposition of a clinical hold by regulatory authorities, including as a result of unforeseen safety issues or side effects or failure of trial sites or investigators to adhere to regulatory requirements or follow trial protocols; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">clinical sites deviating from the trial protocol or dropping out of a trial; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">addressing subject safety concerns that arise during a trial; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adding a sufficient number of clinical trial sites; or </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">manufacturing sufficient quantities of a product candidate for use in clinical trials. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We could also encounter delays if a clinical trial is suspended or terminated by us, the IRBs or IECs of the institutions in which such trials are being conducted, the FDA or other regulatory authorities, or recommended for termination by a Data and Safety Monitoring Board, or DSMB, for such trial. Such authorities may impose a suspension or termination or recommend an alteration due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical trial operations or trial site by the FDA or other regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from using a drug, changes in governmental regulations or administrative actions, or lack of adequate funding to continue the clinical trial.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furthermore, we rely on CROs and clinical trial sites to ensure the proper and timely conduct of our clinical trials and, while we have agreements governing their committed activities, we have limited influence over their actual performance, as described in the section titled &#x201c;&#x2014;Risks related to our dependence on third parties.&#x201d;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our lead product candidate, FX-322, is still in development and will require the successful completion of FX-322-208 and at least one, and possibly more, Phase 3 trials before we are prepared to submit an NDA for regulatory approval by the FDA. In addition, we have been advised by the FDA that, while the nonclinical studies conducted by us to date suggest a pharmacodynamic interaction between the two active components of FX-322, the FDA has indicated that the results of such nonclinical studies do not preclude the need for a human study and that inclusion of a factorial study in humans in future trials of FX-322 to thoroughly assess the effects attributable to each component drug of FX-322 in the combination so as to satisfy the FDA&#x2019;s &#34;combination rule&#34;. The design and conduct of a factorial study in humans, including the development of each active component to administer in such study, may cause additional delays in the development of FX-322. We cannot predict with any certainty if or when we might complete the development of FX-322 and submit an NDA for regulatory approval by the FDA of FX-322 or whether any such NDA will be approved by the FDA.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we experience delays in the commencement or completion of any clinical trials, or if we terminate a clinical trial prior to completion, the commercial prospects of any product candidate we develop could be harmed, and our ability to generate revenues may be delayed. In addition, any delays in our clinical trials could increase our costs, slow the development and approval process and jeopardize our ability to commence product sales and generate revenues. Any of these occurrences may materially harm our business, financial condition, and results of operations. In addition, many of the factors that may cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Principal investigators for our clinical trials may serve as scientific advisors or consultants to us from time to time and receive compensation in connection with such services. Under certain circumstances, we may be required to report some of these relationships to the FDA. The FDA may conclude that a financial relationship between us and a principal investigator has created a conflict of interest or otherwise affected interpretation of a clinical trial. The FDA may therefore question the integrity of the data generated at the applicable clinical trial site, and the utility of the clinical trial itself may be jeopardized. This could result in a delay in approval, or rejection, of our marketing applications by the FDA and may ultimately lead to the denial of marketing approval of a product candidate.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The regulatory approval processes of the FDA and comparable foreign regulatory authorities are lengthy, time- consuming, and inherently unpredictable, and if we are ultimately unable to obtain regulatory approval for FX-322, FX-345, or any of our other product candidates, our business will be substantially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The time required to obtain approval by the FDA and comparable foreign regulatory authorities is unpredictable but typically takes many years following the commencement of clinical trials and depends upon numerous factors, including the substantial discretion of the regulatory authorities. In addition, approval policies, regulations, or the type and amount of clinical data necessary to gain approval may change during a product candidate&#x2019;s clinical development and may vary among jurisdictions. The approval process may also be delayed by changes in government regulation, the impact of the COVID-19</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">49</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">pandemic, future legislation or administrative action. We have not obtained regulatory approval for any product candidate and it is possible that we will never obtain regulatory approval for any product candidate. We are not permitted to market any of our product candidates in the United States until we receive approval of an NDA from the FDA.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prior to obtaining approval to commercialize a product candidate in the United States or abroad, we must demonstrate with substantial evidence from well-controlled clinical trials, and to the satisfaction of the FDA or comparable foreign regulatory authority, that such product candidates are safe and effective for their intended uses. In addition, data obtained from preclinical trials and clinical trials are susceptible to varying interpretations, and regulatory authorities may not interpret our data as favorably as we do, which may further delay, limit, or prevent development efforts, clinical trials, or marketing approval. Furthermore, as more competing drug candidates within a class of drugs proceed through clinical development to regulatory review and approval, the amount and type of clinical data that may be required by regulatory authorities may increase or change. Even if we believe the preclinical or clinical data for our product candidates are promising, such data may not be sufficient to support approval by the FDA and other comparable regulatory authorities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The FDA or any foreign regulatory authority can delay, limit, or deny approval of FX-322, FX-345, or any of our other product candidates that we develop or require us to conduct additional preclinical or clinical testing or abandon a program for many reasons, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the FDA or comparable foreign regulatory authorities may disagree with the design or implementation of our clinical trials; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may be unable to demonstrate to the satisfaction of the FDA or comparable foreign regulatory authorities that a product candidate is safe and effective for its proposed indication; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">serious and unexpected drug-related side effects experienced by participants in our clinical trials or by individuals using drugs similar to our product candidates, or other products containing an active ingredient in our product candidates; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">negative or ambiguous results from our clinical trials or results that may not meet the level of statistical significance required by the FDA or comparable foreign regulatory authorities for approval; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may be unable to demonstrate that a product candidate&#x2019;s clinical and other benefits outweigh its safety risks; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the FDA or comparable foreign regulatory authorities may disagree with our interpretation of data from preclinical studies or clinical trials; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the data collected from clinical trials of our product candidates may not be acceptable or sufficient to support the submission of an NDA or other submission or to obtain regulatory approval in the United States or elsewhere, and we may be required to conduct additional clinical trials; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the FDA&#x2019;s or the applicable foreign regulatory authority&#x2019;s disagreement regarding the formulation, the labeling, and/or the specifications of our product candidates; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the FDA or comparable foreign regulatory authorities may fail to approve or find deficiencies with the manufacturing processes or facilities of third-party manufacturers with which we contract for clinical and commercial supplies;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the approval policies or regulations of the FDA or comparable foreign regulatory authorities may significantly change in a manner rendering our clinical data insufficient for approval; and</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">significant regulatory GxP non-compliance or data integrity findings from FDA Bioresearch Monitoring inspections or pre-approval inspections inclusive of clinical investigator sites, contracted partners and their company&#x2019;s quality management system and execution thereof. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Of the large number of drugs in development, only a small percentage successfully complete the regulatory approval processes and are commercialized. This lengthy approval process, as well as the unpredictability of future clinical trial results, may result in our failing to obtain regulatory approval to market our product candidates, which would significantly harm our business, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, the FDA or the applicable foreign regulatory authority also may approve a product candidate for a more limited indication or patient population than we originally requested, and the FDA or applicable foreign regulatory authority may approve a product candidate with a label that does not include the labeling claims necessary or desirable for the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">successful commercialization of that product candidate. Any of the foregoing circumstances could materially harm the commercial prospects for our product candidates and our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Enrollment and retention of individuals in clinical trials is an expensive and time-consuming process and could be made more difficult or rendered impossible by multiple factors outside our control.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The timely completion of clinical trials in accordance with their protocols depends, among other things, on our ability to enroll a sufficient number of subjects who remain in the study until its conclusion. We may encounter delays in enrolling, or be unable to enroll, a sufficient number of subjects to complete any of our clinical trials, and even once enrolled, we may be unable to retain a sufficient number of subjects to complete any of our trials.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Subject enrollment and retention in clinical trials depends on many factors, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the extent of the ongoing COVID-19 pandemic, see </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The COVID-19 pandemic could adversely impact our business, including our preclinical studies, clinical trials and operations;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the subject eligibility criteria defined in the protocol, such as the requirement to establish stable hearing loss in our Phase 2b clinical trial;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the size of the subject population required for analysis of the trial&#x2019;s primary endpoints; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the nature of the trial protocol, trial design, side effects or other results that may arise in development; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the existing body of safety and efficacy data with respect to the product candidate; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the proximity of subjects to clinical sites; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to recruit clinical trial investigators with the appropriate competencies, motivation and experience; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">clinicians&#x2019; and subjects&#x2019; perceptions as to the potential advantages of the product candidate being studied in relation to other available therapies, including any new drugs or medical devices that may be approved for the indications we are investigating; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">competing clinical trials being conducted by other companies or institutions; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to obtain and maintain subject consents; and</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the risk that subjects enrolled in clinical trials will drop out of the trials before completion.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, our clinical trials will compete with other clinical trials for product candidates and medical devices that are in the same therapeutic areas as our product candidates, and this competition will reduce the number and types of subjects available to us, because some people who might have opted to enroll in our trials may instead opt to enroll in a trial being conducted by one of our competitors. Furthermore, any negative results we may report in clinical trials of any product candidate may make it difficult or impossible to recruit and retain people in other clinical trials of that same product candidate. Delays or failures in planned subject enrollment or retention may result in increased costs or program delays, which could have a harmful effect on our ability to develop a product candidate or could render further development impossible.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Results of preclinical studies, clinical trials, or analyses may not be indicative of results that may be obtained in later trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The results of preclinical studies, clinical trials, or analyses of the results from such trials, including our prospective and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">post hoc</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> analyses of the data from the Phase 1/2 trial of FX-322 for the treatment of SNHL (FX-322-201), may not be predictive of the results of later clinical trials. Product candidates in later clinical trials may fail to show the desired safety and efficacy traits despite having progressed through preclinical studies and prior clinical trials or having shown promising results based on analyses of data from earlier trials. A number of companies in the pharmaceutical industry have suffered significant setbacks in advanced clinical trials due to lack of efficacy or adverse safety profiles, notwithstanding earlier promising results. Our Phase 2a results (FX-322-202), for example, showed that four weekly injections in subjects with mild to moderately severe SNHL did not demonstrate improvements in hearing measures versus placebo, a finding we believe is due to an uncontrolled bias and the limitation to a single baseline measure. In addition, conclusions based on promising data from analyses of clinical results, such as the prospective and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">post hoc</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> analysis of data from our Phase 1/2 clinical trial of FX-322 for the treatment of SNHL (FX-322-201), may be shown to be incorrect in subsequent clinical trials that have pre-specified end points or may not be considered adequate by regulatory authorities. Even if we complete later clinical trials as</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">51</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">planned, we cannot be certain that their results will support the safety and efficacy requirements sufficient to obtain regulatory approval, and, as a result, our clinical development plans may be materially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Interim and preliminary &#x201c;top-line&#x201d; data from our clinical trials that we announce or publish from time to time may change as more subject data become available and are subject to audit and verification procedures that could result in material changes in the final data.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, we may publicly disclose interim, top-line or preliminary data from our clinical trials, which is based on a preliminary analysis of then-available data, and the results and related findings and conclusions are subject to change following a more comprehensive review of the data related to the particular study or trial. We also make assumptions, estimations, calculations and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully and carefully evaluate all data. As a result, the top-line or preliminary results that we report may differ from future results of the same studies, or different conclusions or considerations may qualify such results, once additional data have been received and fully evaluated. Top-line or preliminary data also remain subject to audit and verification procedures that may result in the final data being materially different from the top-line or preliminary data we previously published. As a result, top-line and preliminary data should be viewed with caution until the final data are available.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, we may also disclose interim data from our preclinical studies and clinical trials. Interim data from clinical trials that we may complete are subject to the risk that one or more of the clinical outcomes may materially change as subject enrollment continues and more subject data become available. Adverse differences between interim data and final data could significantly harm our business prospects. Further, disclosure of interim data by us or by our competitors could result in volatility in the price of our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, others, including regulatory agencies, may not accept or agree with our assumptions, estimates, calculations, conclusions or analyses or may interpret or weigh the importance of data differently, which could impact the value of the particular program, the approvability or commercialization of the particular product candidate or product and our company in general. In addition, the information we choose to publicly disclose regarding a particular study or clinical trial is based on what is typically extensive information, and you or others may not agree with what we determine is material or otherwise appropriate information to include in our disclosure.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If the interim, top-line or preliminary data that we report differ from actual results, or if others, including regulatory authorities, disagree with the conclusions reached, our ability to obtain approval for, and commercialize, our product candidates may be harmed, which could harm our business, operating results, prospects or financial condition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Any of our product candidates or component of a product candidate that we develop or the administration thereof, may cause serious adverse events or undesirable side effects, which may halt their clinical development, delay or prevent marketing approval, or, if approved, require them to be taken off the market, include safety warnings, or otherwise limit their sales.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Serious adverse events or undesirable side effects caused by our product candidates or component of a product candidate we develop could cause us or regulatory authorities to interrupt, delay, or halt clinical trials and could result in a more restrictive label or the delay or denial of regulatory approval by the FDA or other comparable foreign regulatory authorities. Results of any clinical trial we conduct could reveal a high and unacceptable severity and prevalence of side effects. In our clinical studies to date, subjects treated with FX-322 have experienced adverse events that include ear discomfort and ear pain that are considered to be associated with the intratympanic injection procedure.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If unacceptable side effects arise in the development of any product candidate, we, the FDA, or the IRBs or IECs at the institutions in which our studies are conducted, or the DSMB, if constituted for our clinical trials, could recommend a suspension or termination of our clinical trials, or the FDA or comparable foreign regulatory authorities could order us to cease further development of or deny approval of a product candidate for any or all targeted indications. In addition, drug-related side effects could affect subject recruitment or the ability of enrolled subjects to complete a trial or result in potential product liability claims. These side effects also may not be appropriately recognized or managed by the treating medical staff. We may have to train medical personnel regarding the proper administration protocol for our product candidates and to understand the side effect profiles for our clinical trials and upon any commercialization of any of our product candidates. Inadequate training in recognizing or managing the potential side effects of our product candidates could result in subject injury or death. Any of these occurrences may harm our business, financial condition, and prospects significantly.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">52</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, if FX-322, FX-345, or any of our other product candidates we develop receives marketing approval, and we or others later identify undesirable side effects caused by such products, a number of potentially significant negative consequences could result, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">regulatory authorities may suspend, withdraw, or limit approvals of such product, or seek an injunction against its manufacture or distribution; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">regulatory authorities may require us to recall a product or we may decide to initiate a voluntary recall of a product;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">regulatory authorities may require additional warnings on the label, such as a &#x201c;black box&#x201d; warning or contraindication;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">additional restrictions may be imposed on the marketing of the product or the manufacturing processes for the product or any component thereof; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may be required to implement a Risk Evaluation and Mitigation Strategy, or REMS, or create a medication guide outlining the risks of such side effects for distribution to subjects; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may be required to conduct post-market studies or agree to post marketing commitments; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we could be sued and held liable for harm caused to subjects; </span></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the product may become less competitive; and </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our reputation may suffer. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any of these events could prevent us from achieving or maintaining market acceptance of a product candidate, if approved, and could significantly harm our business, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Disruptions at the FDA and other government agencies caused by funding shortages, changes in the federal administration or global health concerns could hinder their ability to hire and retain key leadership and other personnel, or otherwise prevent new products and services from being developed or commercialized in a timely manner, which could negatively impact our business.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, ability to hire and retain key personnel and accept the payment of user fees, and statutory, regulatory, and policy changes. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of other government agencies that fund research and development activities is subject to the political process, which is inherently fluid and unpredictable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Disruptions at the FDA and other agencies may also slow the time necessary for new drugs to be reviewed or approved by necessary government agencies, which would adversely affect our business. For example, over the last several years, including for 35 days beginning on December 22, 2018, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA, have had to furlough critical employees and stop critical activities. If a prolonged government shutdown occurs, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Separately, in response to the COVID-19 pandemic, on March 10, 2020 the FDA announced its intention to postpone most inspections of foreign manufacturing facilities and on March 18, 2020, the FDA temporarily postponed routine surveillance inspections of domestic manufacturing facilities. Subsequently, in July 2020 the FDA resumed certain on-site inspections of domestic manufacturing facilities subject to a risk-based prioritization system. The FDA utilized this risk-based assessment system to identify when and where it was safest to conduct prioritized domestic inspections. Additionally, on April 15, 2021, the FDA issued a guidance document in which the FDA described its plans to conduct voluntary remote interactive evaluations of certain drug manufacturing facilities and clinical research sites, among other facilities. According to the guidance, the FDA may request such remote interactive evaluations where the FDA determines that remote evaluation would be appropriate based on mission needs and travel limitations. In May 2021, the FDA outlined a detailed plan to move toward a more consistent state of inspectional operations, and in July 2021, the FDA resumed standard inspectional operations of domestic facilities and was continuing to maintain this level of operation as of September 2021. More recently, the FDA has continued to monitor and implement changes to its inspectional activities to ensure the safety of its employees and those of the firms it regulates as it adapts to the evolving COVID-19 pandemic. Regulatory authorities outside the United States may adopt similar restrictions or other policy measures in response to the COVID-19 pandemic or issue guidance materially affecting the conduct of clinical trials. If a prolonged government shutdown occurs, or if global health concerns</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">53</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">continue to prevent the FDA or other regulatory authorities from conducting their regular inspections, reviews, or other regulatory activities, it could significantly impact the ability of the FDA to timely review and process our regulatory submissions, which could have a material adverse effect on our business. Further, in our operations as a public company, future government shutdowns or delays could impact our ability to access the public markets and obtain necessary capital in order to properly capitalize and continue our operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may not be successful in our efforts to identify additional product candidates. Due to our limited resources and access to capital, we must prioritize development of certain product candidates, the choice of which may prove to be wrong and adversely affect our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Although we intend to explore additional product candidates based on our PCA platform, we may fail to identify viable new product candidates for clinical development for several reasons. If we fail to identify additional potential product candidates, our business could be materially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research programs to develop additional product candidates based on our PCA platform require substantial technical, financial, and human resources whether or not they are ultimately successful. Our research programs may initially show promise in identifying potential indications or product candidates, yet fail to yield results for clinical development for several reasons, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1020833333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the research methodology used may not be successful in identifying potential indications or product candidates; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1020833333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">potential product candidates may, after further study, be shown to have harmful or unexpected adverse effects or other characteristics that indicate they are unlikely to be effective drugs; or </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1020833333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">it may take greater human and financial resources than we possess to identify additional therapeutic opportunities for our product candidates or to develop suitable potential product candidates through internal research programs, thereby limiting our ability to develop, diversify, and expand our product portfolio. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Because we have limited financial and human resources, we intend to initially focus on research programs and product candidates for a limited set of indications. As a result, we may forego or delay pursuit of opportunities with other product candidates or for other indications that could have greater commercial potential or a greater likelihood of success. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accordingly, there can be no assurance that we will ever be able to identify additional therapeutic opportunities for our product candidates or to develop suitable potential product candidates through internal research programs, which could materially adversely affect our future growth and prospects. For example, we may encounter delays in the process of selecting a product candidate for the treatment of MS and we may not achieve the timeline we currently anticipate for submitting an IND or comparable foreign equivalent. We may focus our efforts and resources on potential product candidates or other potential programs that ultimately prove to be unsuccessful.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The market opportunities for FX-322, if approved, may be smaller than we anticipate and, as a result, our commercial opportunity may be limited.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect to initially seek approval of FX-322 for the treatment of SNHL. Our projections of the number of eligible patients are based on our beliefs and estimates. These estimates have been derived from a variety of sources, including scientific literature, patient foundations, and market research, and may prove to be incorrect. Further, new sources may reveal a change in the estimated number of eligible patients, and the number of patients may turn out to be lower than expected. Additionally, the potentially addressable patient population for our current programs or future product candidates may be limited. Our Phase 1b study of FX-322 in presbycusis (FX-322-212), for example, did not show any significant treatment effects. Even if we obtain FDA approval for FX-322, it may be approved for a target population that is more limited than what we currently anticipate. Even if we obtain significant market share for any product candidate, if approved, if the potential target populations are smaller, we may never achieve profitability without obtaining marketing approval for additional indications.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We have never obtained marketing approval for a product candidate and we may be unable to obtain, or may be delayed in obtaining, marketing approval for any product candidate.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have never obtained marketing approval for a product candidate. It is possible that the FDA may refuse to accept for substantive review any NDAs that we submit for our product candidates or may conclude after review of our data that our</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">54</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">applications are insufficient to obtain marketing approval of our product candidates. We believe our approach of activating progenitor cells to treat conditions or diseases through cellular regeneration is novel and, as a result, the process for, and the outcome of, FDA approval is especially uncertain. If the FDA does not accept or approve our NDAs for our product candidates, it may require that we conduct additional clinical, preclinical, or manufacturing validation studies and submit that data before it will reconsider our applications. Depending on the extent of these or any other FDA-required studies, approval of any NDA that we submit may be delayed or may require us to expend more resources than we have available. It is also possible that additional studies, if performed and completed, may not be considered sufficient by the FDA to approve our NDAs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any delay in obtaining, or an inability to obtain, marketing approvals would prevent us from commercializing our product candidates, generating revenues, and achieving and sustaining profitability. If any of these outcomes occur, we may be forced to abandon our development efforts for our product candidates, which could significantly harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Even if we obtain FDA approval for a product candidate in the United States, we or our collaborators may never obtain approval for or commercialize the product candidate in any other jurisdiction, which would limit our ability to realize its full market potential.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In order to market any product in a particular jurisdiction, we or our collaborators must establish and comply with numerous and varying regulatory requirements regarding safety and efficacy on a country-by-country basis. Approval by the FDA in the United States does not ensure approval by comparable regulatory authorities in other countries or jurisdictions. However, the failure to obtain approval in one jurisdiction may negatively impact our or our collaborators&#x2019; ability to obtain approval elsewhere. In addition, clinical trials conducted in one country may not be accepted by regulatory authorities in other countries, and regulatory approval in one country does not guarantee regulatory approval in any other country.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Approval processes vary among countries and can involve additional product testing and validation and additional administrative review periods. Seeking foreign regulatory approval could result in difficulties and increased costs for us and require additional preclinical studies or clinical trials which could be costly and time- consuming. Regulatory requirements can vary widely from country to country and could delay or prevent the introduction of our products in those countries. We do not have any product candidates approved for sale in any jurisdiction, including in international markets, and we do not have experience in obtaining regulatory approval in international markets. If we or our collaborators fail to comply with regulatory requirements in international markets or to obtain and maintain required approvals, or if regulatory approvals in international markets are delayed, our target market will be reduced and we will be unable to realize the full market potential of any product we develop.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Even if we obtain regulatory approval for any product candidate, we will still face extensive and ongoing regulatory requirements and obligations, which may result in significant additional expense, and any product candidates, if approved, may face future development and regulatory difficulties.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any product candidate for which we obtain marketing approval, along with the manufacturing processes, post-approval clinical data, labeling, packaging, distribution, adverse event reporting, storage, recordkeeping, export, import, and advertising and promotional activities for such product, among other things, will be subject to extensive and ongoing requirements of and review by the FDA and other regulatory authorities. These requirements include submissions of safety and other post-marketing information and reports, establishment registration and drug listing requirements, continued compliance with current Good Manufacturing Practice, or cGMP, requirements relating to manufacturing, quality control, quality assurance, and corresponding maintenance of records and documents, requirements regarding the distribution of samples to physicians and recordkeeping and Good Clinical Practice, or GCP, and requirements for any clinical trials that we conduct post-approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Even if marketing approval of a product candidate is granted, the approval may be subject to limitations on the indicated uses for which the product candidate may be marketed or to the conditions of approval, including a requirement to implement a REMS. If a product candidate receives marketing approval, the accompanying label may limit the approved indicated use of the product, which could limit sales of the product. The FDA may also require costly post-marketing studies or clinical trials and surveillance to monitor the safety or efficacy of a product. The FDA closely regulates the post-approval marketing and promotion of drugs to ensure drugs are marketed only for the approved indications and in accordance with the provisions of the approved labeling. The FDA imposes stringent restrictions on manufacturers&#x2019; communications regarding off-label use, and if we market our products for uses beyond their approved indications, we may be subject to enforcement action for off-label marketing. Violations of the Federal Food, Drug, and Cosmetic Act, or FDCA, relating to the promotion</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">55</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">of prescription drugs, may lead to FDA enforcement actions and investigations alleging violations of federal and state healthcare fraud and abuse laws, as well as state consumer protection laws.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, later discovery of previously unknown adverse events or other problems with our products, manufacturers, or manufacturing processes or failure to comply with regulatory requirements, may yield various results, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">restrictions on manufacturing such products; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">restrictions on the labeling or marketing of products; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">restrictions on product distribution or use; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">requirements to conduct post-marketing studies or clinical trials; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">warning letters or untitled letters; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">refusal to approve pending applications or supplements to approved applications that we submit; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">recalls or market withdrawals of products; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">fines, restitution, or disgorgement of profits or revenues; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">suspension or withdrawal of marketing approvals; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">refusal to permit the import or export of our products; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">product seizure; or </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">injunctions, consent decrees, or the imposition of civil or criminal penalties. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, the FDA&#x2019;s policies may change, and additional government regulations may be enacted that could prevent, limit, or delay regulatory approval of a product candidate. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained, which would adversely affect our business, prospects, and ability to achieve or sustain profitability.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We also cannot predict the likelihood, nature, or extent of government regulation that may arise from future legislation or administrative or executive action, either in the United States or abroad. The policies of the FDA and of other comparable regulatory authorities may change and additional government regulations may be enacted that could prevent, limit, or delay regulatory approval of a product candidate. If we are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may be subject to enforcement action, and we may not achieve or sustain profitability, which would adversely affect our business, prospects, financial condition, and results of operations. Furthermore, noncompliance by us or any collaborator with regulatory requirements, including safety monitoring or pharmacovigilance, may also result in significant financial penalties, which would adversely affect our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We received Fast Track designation by the FDA for FX-322 and may seek Fast Track designation by the FDA for any future product candidates, but we might not receive such a designation. However, such designation may not lead to a faster development or regulatory review or approval process.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In October 2019, FX-322 received Fast Track designation by the FDA. If a drug is intended for the treatment of a serious condition and nonclinical or clinical data demonstrate the potential to address an unmet medical need for this condition, a drug sponsor may qualify for FDA Fast Track designation. Fast Track designation provides increased opportunities for sponsor meetings with the FDA during preclinical and clinical development, in addition to the potential for rolling review and priority review once a marketing application is filed. The FDA has broad discretion whether to grant Fast Track designation, and we may not receive such a designation for all of the product candidates for which we may request it. Moreover, even if we receive Fast Track designation, Fast Track designation does not ensure that we will receive marketing approval or that approval will be granted within any particular time frame. We may not experience a faster development or regulatory review or approval process with Fast Track designation compared to conventional FDA procedures. In addition, the FDA may withdraw Fast Track designation if it believes that the designation is no longer supported by data from our clinical development program. Fast Track designation alone does not guarantee qualification for the FDA&#x2019;s priority review procedures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">56</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may seek a Breakthrough Therapy designation for FX-322 and our other product candidates, but we might not receive such designation, and even if we do, such designation may not lead to a faster development or regulatory review or approval process.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may seek a Breakthrough Therapy designation for FX-322 if results from our ongoing clinical trial support such designation and we may seek a Breakthrough Therapy designation for other product candidates we may develop. A Breakthrough Therapy is defined as a drug that is intended, alone or in combination with one or more other drugs, to treat a serious condition, and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. For drugs that have been designated as breakthrough therapies, interaction and communication between the FDA and the sponsor of the trial can help to identify the most efficient path for clinical development while minimizing the number of patients placed in ineffective control regimens. Drugs designated as breakthrough therapies by the FDA may also be eligible for priority review if supported by clinical data at the time the NDA is submitted to the FDA.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Designation as a Breakthrough Therapy is within the discretion of the FDA. Accordingly, even if we believe that a product candidate meets the criteria for designation as a Breakthrough Therapy, the FDA may disagree and instead determine not to make such a designation. Even if we receive Breakthrough Therapy designation, the receipt of such designation may not result in a faster development or regulatory review or approval process compared to drugs considered for approval under conventional FDA procedures and does not assure ultimate approval by the FDA. In addition, even if a product candidate qualifies as a Breakthrough Therapy, the FDA may later decide that it no longer meets the conditions for qualification or decide that the time period for FDA review or approval will not be shortened.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Potential product liability lawsuits against us could cause us to incur substantial liabilities and limit commercialization of any products that we may develop.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The use of any product candidate we may develop in clinical trials and the sale of any products for which we obtain marketing approval exposes us to the risk of product liability claims. Product liability claims might be brought against us by patients, healthcare providers, pharmaceutical companies or others selling or otherwise coming into contact with our products. On occasion, large judgments have been awarded in class action lawsuits based on drugs that had unanticipated adverse effects. If we cannot successfully defend against product liability claims, we could incur substantial liability and costs. In addition, regardless of merit or eventual outcome, product liability claims may result in:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">impairment of our business reputation and significant negative media attention; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">withdrawal of participants from our clinical trials; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">significant costs to defend the litigation; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">distraction of management&#x2019;s attention from our primary business; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">substantial monetary awards to patients or other claimants; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">inability to commercialize a product candidate; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">product recalls, withdrawals or labeling, marketing or promotional restrictions; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">decreased market demand for any product; and </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">loss of revenue. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The product liability insurance we currently carry, and any additional product liability insurance coverage we acquire in the future, may not be sufficient to reimburse us for any expenses or losses we may suffer. Moreover, insurance coverage is becoming increasingly expensive and, in the future, we may not be able to maintain insurance coverage at a reasonable cost or in sufficient amounts to protect us against losses due to liability. If we obtain marketing approval for any product candidate, we intend to acquire insurance coverage to include the sale of commercial products; however, we may be unable to obtain product liability insurance on commercially reasonable terms or in adequate amounts. A successful product liability claim, or series of claims, brought against us could cause our share price to decline and, if judgments exceed our insurance coverage, could adversely affect our results of operation and business, including preventing or limiting the commercialization of any product candidates we develop.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">57</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.2410416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.2410416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The COVID-19 pandemic has caused and could continue to cause disruptions to our business, including our preclinical studies, clinical trials and operations and could adversely impact our financial condition and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Calibri;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.2410416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2020, the World Health organization designated the outbreak of the novel strain of coronavirus, known as COVID-19, as a global pandemic. This virus and its variants have and continue to spread globally and governments and businesses around the world have taken unprecedented actions to mitigate the spread of COVID-19, including, but not limited to, shelter-in-place orders, business closures, quarantines, border closures, significant restrictions on travel, social distancing practices as well as restrictions that prohibit many employees from going to work. Massachusetts, the primary business location of our company, closed all non-essential business for a period of time in response to the pandemic, but has since May 2021, lifted all restrictions related to the pandemic. The pandemic, and government measures taken in response, have had a significant impact, both direct and indirect, on business and commerce, as worker shortages have occurred; supply chains have been disrupted; facilities and production have been suspended; and demand for certain goods and services, such as medical services and supplies, has spiked, while demand for other goods and services, such as travel, has fallen.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In light of recent developments relating to the COVID-19 pandemic, the focus of healthcare providers and hospitals has been on fighting the virus and vaccinating the public and we have been required to take steps consistent with the FDA&#x2019;s updated industry guidance for conducting clinical trials issued on March 18, 2020. The majority of our employees have continued to work from home two to three days per week, while our laboratory employees have largely resumed a full in-person schedule in our Lexington, MA facility. We have also taken steps consistent with the FDA&#x2019;s updated industry guidance for conducting clinical trials.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If COVID-19 or its variants again spread in the United States and worldwide, and measures to mitigate the ongoing effects of the pandemic, such as stay home orders and/or advisories persist or are reintroduced, we may continue to experience disruptions and other effects on our business that could severely impact our business, operations, preclinical studies and clinical trials, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays, difficulties or postponement in enrolling and retaining subjects in our clinical trials;</span></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays, difficulties or postponement in clinical site initiation, including difficulties in recruiting clinical site investigators and clinical site staff;</span></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">diversion of healthcare resources away from the conduct of clinical trials, including the diversion of ENT practices and academic centers serving as our clinical trial sites and staff supporting the conduct of our clinical trials;</span></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">interruption of key clinical trial activities, such as clinical trial site monitoring, due to limitations on travel imposed or recommended by federal or state governments, employers and others or interruption of clinical trial subject visits and study procedures, which may impact the integrity of subject data and clinical study endpoints; </span></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">interruption or delays in the operations of the FDA or other regulatory authorities, which may impact review and approval timelines;</span></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">interruption of, or delays in receiving, supplies of our product candidates from our contract manufacturing organizations due to staffing shortages, production slowdowns or stoppages and disruptions in delivery systems; </span></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">interruptions in planned trials due to restricted or limited operations at our laboratory facility; </span></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">continual changes to operating requirements and related expenses, limitations in employee resources that would otherwise be focused on the conduct of our preclinical studies and clinical trials, including because of sickness of employees or their families or the desire of employees to avoid contact with large groups of people and resulting losses of productivity and employee work culture; </span></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">risk that participants enrolled in our clinical trials will acquire COVID-19 while the clinical trial is ongoing, which could impact the results of the clinical trial, including by increasing the number of observed adverse events;</span></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">refusal of the FDA, or other government agencies, to accept data from clinical trials in these affected geographies;</span></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">interruption or delayed to our sourced discovery and clinical activities;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">58</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">inability to obtain additional financing or access the financial markets, and</span></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">if any of the CMOs involved in the manufacture and supply of FX-322 or FX-345 experience a delay or disruption due to COVID-19, we may not have sufficient quantities of our products for our planned activities and may not be able to transition to a new CMO in a timely or cost-effective manner, or at all, which would negatively impact our ability to develop and potentially commercialize FX-322 and FX-345.</span></div></div>
  <p style="margin-left:3.333%;text-indent:-4.92%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The global outbreak of COVID-19 continues to rapidly evolve and continues to have indeterminable adverse effects on general commercial activity and the world economy. We previously experienced an impact from COVID-19 in our completed Phase 2a clinical trial (FX-322-202), as a number of clinical trial sites temporarily halted enrollment. Due to the uncertain nature of the effects of the outbreak, particularly in the United States, enrollment, participation and retention in our ongoing and planned trials may be reduced, and for a number of the clinical sites, halted for an unknown period of time. Any reduction in enrollment, participation and retention and any halts may delay our ongoing and planned clinical trials and our development plans for FX-322 and our other product candidates, which could have an adverse impact on our business and results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The extent to which COVID-19 may continue </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">to impact our business, preclinical studies, clinical trials (including the completion and timing of our extension trials of FX-322-111 and FX-322-112 and our Phase 2b clinical trial of FX-322 (FX-322-208)) and operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, such as the ongoing and ultimate geographic spread of the disease, duration of the outbreak,  including future waves of infection, new variant strains of the underlying virus, travel restrictions and social distancing in the United States and other countries, business closures or business disruptions, adoption and effectiveness of vaccines and other actions taken in the United States and other countries to contain, treat and mitigate the spread of COVID-19. In addition, if we or any of the third parties with whom we engage were to experience shutdowns or additional business disruptions, our ability to conduct our business in the manner and on the timelines presently planned could be materially and negatively impacted, which could have a material adverse effect on our business and our financial results. The COVID-19 pandemic has resulted in a widespread health crisis that has adversely affected the economies and financial markets worldwide, resulting in an economic downturn that could continue to significantly impact our business, financial condition and results of operations. To the extent the COVID-19 pandemic adversely affects our business, financial condition and results of operations, it may also have the effect of heightening many of the other risks described in this &#x201c;Risk Factors&#x201d; section.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks related to commercialization</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We face significant competition from biotechnology, pharmaceutical, and medical device companies, and our operating results will suffer if we fail to compete effectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The biotechnology, pharmaceutical, and medical device industries are highly competitive and subject to significant and rapid technological change. Our success is highly dependent on our ability to acquire, develop, and obtain marketing approval for new products on a cost-effective basis and to market them successfully. If a product candidate we develop is approved, we will face intense competition from a variety of businesses, including large, fully integrated pharmaceutical companies, specialty pharmaceutical companies, and early-stage companies, particularly if the early-stage company has a collaborative arrangement with a large and established company. We are aware of several companies developing products to treat SNHL through the regeneration of hair cells or through other mechanisms, and we also anticipate that new companies will enter the SNHL market in the future. If we successfully develop and, if approved, commercialize FX-322 or FX-345 for the treatment of SNHL, it may compete, or potentially be used in conjunction, with currently marketed devices, including the hearing aids and cochlear implants currently available and the next generation of improved hearing aids and cochlear implants, and any new therapies that may become available in the future. Furthermore, changes in the regulatory landscape may increase competition from hearing aids. The FDA Reauthorization Act of 2017 directed the FDA to, by regulation, categorize certain hearing aids as over-the-counter, or OTC, hearing aids, which would permit such OTC hearing aids to be available to consumers without first requiring a visit to a medical professional. The FDA has proposed regulations to create this new category of OTC devices. When the FDA finalizes these proposed regulations, obtaining hearing aids may become less expensive and more convenient. We are also aware of several companies developing programs with research and development efforts to treat MS through the regeneration of myelin. If we successfully develop and, if approved, commercialize our remyelination program for the treatment of MS, it may compete, or potentially be used in conjunction with, currently marketed therapeutics and any new therapeutics that may become available in the future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">59</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Competition could render any product candidate we develop obsolete, less competitive, or uneconomical. Our competitors may, among other things:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">have significantly greater name recognition and financial, manufacturing, marketing, product development, technical, and human resources than we do, with mergers and acquisitions in the biotechnology, pharmaceutical, and medical device industries resulting in even more resources being concentrated in our competitors; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">more effectively recruit and retain qualified scientific and management personnel; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">more effectively establish clinical trial sites and subject registration; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">develop and commercialize products that are safer, more effective, less expensive, more convenient, or easier to administer, or have fewer or less severe side effects; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">obtain quicker regulatory approval; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">better protect their patents and intellectual property or acquire technologies that are complementary to, or necessary for, our programs; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">implement more effective approaches to sales, marketing, pricing, coverage, and reimbursement; or </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">form more advantageous strategic alliances or collaborations. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we are not able to effectively compete for any of the foregoing reasons, our business will be materially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The successful commercialization of any product candidate we develop will depend in part on the extent to which governmental authorities and health insurers establish adequate coverage, reimbursement levels, and pricing policies. Failure to obtain or maintain coverage and adequate reimbursement for our product candidates, if approved, could limit our or our collaborators&#x2019; ability to market those products and decrease our or our collaborators&#x2019; ability to generate revenue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The availability and adequacy of coverage and reimbursement by governmental healthcare programs such as Medicare and Medicaid, private health insurers, and other third-party payors are essential for most patients to be able to afford prescription medications. Our ability to achieve acceptable levels of coverage and reimbursement for products or procedures using our products by governmental authorities, private health insurers and other organizations will influence our ability to successfully commercialize any product candidates we develop. Obtaining adequate coverage and reimbursement for any product candidate we develop that is administered under the supervision of a physician, which is what we anticipate for FX-322, may be particularly difficult because of the higher prices associated with such products. In addition, we believe that FX-322 and FX-345 are novel approaches to treating hearing loss and, as a result, availability of coverage and reimbursement by payors is highly uncertain, particularly because the cost of existing treatments for SNHL, such as hearing aids, are generally not reimbursed by payors. A decision by a third-party payor not to cover or separately reimburse for our products or procedures using our products could reduce physician utilization of our products once approved. Assuming we obtain coverage for our product candidates or procedures using our products by a third-party payor, the resulting reimbursement payment rates may not be adequate or may require co-payments that patients find unacceptably high. We cannot be sure that coverage and reimbursement in the United States or elsewhere will be available for any product we commercialize, and any reimbursement that may become available may be decreased or eliminated in the future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Third-party payors increasingly are challenging prices charged for pharmaceutical products and services, and the current presidential administration and Congress have introduced several proposals related to drug pricing. Many third-party payors may refuse to provide coverage and reimbursement for particular drugs or biologics when an equivalent generic drug, biosimilar, or a less expensive therapy is available. Although there are currently no FDA approved drugs for the treatment of SNHL, it is possible that a third-party payor may consider FX-322 or FX-345 as substitutable and only offer to reimburse patients for the less expensive product. Even if we show improved efficacy, pricing of existing drugs and medical devices, such as hearing aids, may limit the amount we will be able to charge for any product we commercialize. Payors may deny or revoke the reimbursement status of a given product or establish prices for new or existing marketed products at levels that are too low to enable us to realize a satisfactory return on our investment in our product candidates. If reimbursement is not available or is available only at limited levels, we may not be able to successfully commercialize our product candidates and may not be able to obtain a satisfactory financial return on our product candidates. Additionally, our ability to obtain a satisfactory financial return depends on what, if any, proposals related to drug pricing may be implemented and, if implemented, when they might take effect.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">60</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There is significant uncertainty related to the insurance coverage and reimbursement of newly approved products. In the United States, third-party payors, including private and governmental payors, such as the Medicare and Medicaid programs, play an important role in determining the extent to which new drugs and biologics will be covered. The Medicare and Medicaid programs increasingly are used as models in the United States for how private payors and other governmental payors develop their coverage and reimbursement policies for drugs and biologics. Some third-party payors may require pre-approval of coverage for new or innovative devices or drug therapies before they will reimburse healthcare providers who use such therapies. It is difficult to predict at this time what third-party payors will decide with respect to the coverage and reimbursement for our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">No uniform policy for coverage and reimbursement for products exists among third-party payors in the United States. Therefore, coverage and reimbursement for products can differ significantly from payor to payor, and one third-party payor&#x2019;s decision to cover a product does not ensure that other payors will also provide similar coverage. Additionally, the process for determining whether a third-party payor will provide coverage for a product is typically separate from the process for setting the price of such product or establishing the reimbursement rate that the payor will pay for the product once coverage is approved. As a result, the determination of coverage and reimbursement is often a time-consuming and costly process that will require us to provide scientific and clinical support for the use of our product candidates to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance. Furthermore, rules and regulations regarding reimbursement change frequently, in some cases at short notice, and we believe that changes in these rules and regulations are likely.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, increasing efforts by governmental and third-party payors in the United States to cap or reduce healthcare costs may cause such organizations to limit both coverage and the level of reimbursement for newly approved products and, as a result, they may not cover or provide adequate payment for any product we commercialize. We expect to experience pricing pressures in connection with the sale of our product candidates due to the trend toward managed health care, the increasing influence of health maintenance organizations, and additional legislative, administrative, or regulatory changes. The downward pressure on healthcare costs in general, particularly prescription drugs and biologics and surgical procedures and other treatments, has become intense. As a result, increasingly high barriers are being erected to the entry of new products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We or our collaborators may also be subject to extensive governmental price controls and other market regulations outside of the United States, and we believe the increasing emphasis on cost-containment initiatives in other countries have and will continue to put pressure on the pricing and usage of medical products. In many countries, the prices of medical products are subject to varying price control mechanisms as part of national health systems. Other countries allow companies to fix their own prices for medical products but monitor and control company profits. Additional foreign price controls or other changes in pricing regulation could restrict the amount that we or our collaborators are able to charge for products we or our collaborators commercialize. Accordingly, in markets outside the United States, the reimbursement for products we or our collaborators commercialize may be reduced compared with the United States and may be insufficient to generate commercially reasonable revenue and profits.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Even if a product candidate we develop receives marketing approval, it may fail to achieve market acceptance by physicians, patients, third-party payors, or others in the medical community necessary for commercial success.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If a product candidate we develop receives marketing approval, it may nonetheless fail to gain sufficient market acceptance by physicians, patients, third-party payors, and others in the medical community. If it does not achieve an adequate level of acceptance, we may not generate significant product revenues or become profitable. The degree of market acceptance of our product candidates, if approved, will depend on several factors, including, but not limited to:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the efficacy and potential advantages compared to alternative treatments; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">effectiveness of sales and marketing efforts; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the cost of treatment in relation to alternative treatments, including any similar generic treatments; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to offer our products for sale at competitive prices; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the convenience and ease of administration compared to alternative treatments; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the willingness of the target patient population to try new therapies and of physicians to prescribe these therapies; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the strength of marketing and distribution support; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the availability of third-party coverage and adequate reimbursement; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">61</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the prevalence and severity of any side effects; and </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any restrictions on the use of our product together with other medications. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Because we expect sales of our product candidates, if approved, to generate substantially all our revenues for the foreseeable future, the failure of our product candidates to find market acceptance would harm our business and could require us to seek additional financing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we are unable to establish sales and marketing capabilities either on our own or in collaboration with third parties, we may not be successful in commercializing any product candidate we develop, if approved.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In order to market and successfully commercialize any product candidate we develop, if approved, we must build our sales and marketing capabilities or enter into collaborations with third parties for these services. We currently have no sales, marketing or distribution capabilities and as a company have no experience in marketing products. We intend to directly market and commercialize FX-322 for the treatment of SNHL, if approved, in the United States by developing our own sales and marketing force, targeting ear, nose, and throat doctors and audiologists. There are significant expenses and risks involved with establishing our own sales and marketing capabilities, including our ability to hire, train, retain, and appropriately incentivize a sufficient number of qualified individuals, generate sufficient sales leads and provide our sales and marketing team with adequate access to physicians who may prescribe our product, effectively manage a geographically dispersed sales and marketing team, and other unforeseen costs and expenses. Any failure or delay in the development of a product candidate that affects the expected timing of commercialization of the product candidate or results in the failure of the product candidate to be commercialized could result in us having prematurely or unnecessarily incurred costly commercialization expenses. Our investment would be lost if we are unable to retain or reposition our sales and marketing personnel.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may also enter into collaborations for the sales and marketing of our product candidates, if approved. To the extent that we depend on collaborators for sales and marketing activities, any revenues we receive will depend upon the success of those collaborators&#x2019; sales and marketing teams and the collaborators&#x2019; prioritization of our product and compliance with applicable regulatory requirements, and there can be no assurance that the collaborators&#x2019; efforts will be successful. For example, under the License and Collaboration Agreement with Astellas, or the Astellas Agreement, we will depend on Astellas to sell and market FX-322 for the treatment of SNHL, if approved, outside of the United States, and we can have no assurance that it will be successful in its efforts or devote sufficient resources to the sale and marketing of FX-322.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we are unable to build our own sales and marketing team or enter into a collaboration for the commercialization of product candidates we develop, if approved, we may be forced to delay the commercialization of our product candidates or reduce the scope of our sales or marketing activities, which would have an adverse effect on our business, operating results and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">A variety of risks associated with operating internationally could materially adversely affect our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our business strategy includes potentially expanding internationally if any of our product candidates receive regulatory approval. Doing business internationally involves several risks, including, but not limited to:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">multiple, conflicting, and changing laws and regulations, such as data privacy and security laws and regulations, tax laws, export and import restrictions, economic sanctions laws and regulations, employment laws, regulatory requirements, and other governmental approvals, permits, and licenses; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">failure by us to obtain and maintain regulatory approvals for the use of our products in various countries; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">additional potentially relevant third-party patent rights; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">complexities and difficulties in obtaining protection and enforcing our intellectual property; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">difficulties in staffing and managing foreign operations; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">complexities associated with managing multiple payor reimbursement regimes, government payors, or patient self-pay systems; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">limits in our ability to penetrate international markets; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">62</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">financial risks, such as longer payment cycles, difficulty collecting accounts receivable, the impact of local and regional financial crises on demand and payment for our products, and exposure to foreign currency exchange rate fluctuations; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">natural disasters, political and economic instability, including wars, terrorism and political unrest, outbreak of disease, boycotts, curtailment of trade, and other business restrictions; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">certain expenses, including, among others, expenses for travel, translation, and insurance; and </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">regulatory and compliance risks that relate to maintaining accurate information and control over sales and activities that may fall within the purview of the U.S. Foreign Corrupt Practices Act of 1977, as amended, or the FCPA, its books and records provisions, or its anti-bribery provisions, as well as other applicable laws and regulations prohibiting bribery and corruption. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any of these factors could significantly harm any future international expansion and operations and, consequently, our results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks related to our dependence on third parties</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The Astellas Agreement is important to our business. If we or Astellas fail to adequately perform under the Astellas Agreement, or if we or Astellas terminate the Astellas Agreement, the development and commercialization of FX-322 for SNHL outside the United States would be materially delayed and our business would be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the Astellas Agreement, Astellas is responsible for the development and commercialization of FX-322 outside of the United States and we are responsible for development and commercialization in the United States. We and Astellas are jointly responsible for conducting global clinical studies and coordinating commercial launch activities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have received an upfront payment from Astellas of $80.0 million, and we may also receive development milestone payments up to $230.0 million. If the Astellas licensed products are successfully commercialized, we would be eligible for up to $315.0 million in potential commercial milestone payments plus tiered royalties at rates ranging from low- to mid-teen percentages.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Termination of the Astellas Agreement could cause significant delays in our development and commercialization efforts for FX-322 for the treatment of SNHL outside of the United States. If the Astellas Agreement is terminated, we would need to expand our internal capabilities or enter into another agreement to compensate for the loss in funding and clinical development support from Astellas. Any suitable alternative agreement would take considerable time to negotiate and could also be on less favorable terms to us. Whether or not we identify another suitable collaborator, we may need to seek additional financing to continue the development of FX-322, or we may be forced to discontinue development of FX-322, either of which could have a material adverse effect on our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We intend to continue to collaborate with third parties for the development and commercialization of our product candidates. We may not succeed in establishing and maintaining collaborations, which may significantly limit our ability to successfully develop and commercialize our other product candidates, if at all.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have entered into the Astellas Agreement for the development and commercialization of FX-322 for the treatment of SNHL outside the United States and may seek collaborations for the development and commercialization of other product candidates. The process of establishing and maintaining collaborative relationships is difficult, time-consuming, and involves significant uncertainty, such as:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a collaborator may shift its priorities and resources away from our product candidates due to a change in business strategies, or a merger, acquisition, sale, or downsizing; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a collaborator may seek to renegotiate or terminate its relationships with us due to unsatisfactory clinical results, manufacturing issues, a change in business strategy, a change of control or other reasons; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a collaborator may cease development in therapeutic areas which are the subject of our collaboration; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a collaborator may not devote sufficient capital or resources towards our product candidates, or may fail to comply with applicable regulatory requirements; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a collaborator may change the success criteria for a product candidate, thereby delaying or ceasing development of such candidate; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">63</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a significant delay in initiation of certain development activities by a collaborator will also delay payment of milestones tied to such activities, thereby impacting our ability to fund our own activities; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a collaborator could develop a product that competes, either directly or indirectly, with our product candidate; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a collaborator with commercialization obligations may not commit sufficient financial resources or personnel to the marketing, distribution, or sale of a product; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a collaborator with manufacturing responsibilities may encounter regulatory, resource, or quality issues and be unable to meet demand requirements; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a collaborator may terminate a strategic alliance; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a dispute may arise between us and a collaborator concerning the research, development, or commercialization of a product candidate resulting in a delay in milestones or royalty payments or termination of the relationship and possibly resulting in costly litigation or arbitration, which may divert management&#x2019;s attention and resources; and </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a collaborator may use our products or technology in such a way as to invite litigation from a third party. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If any collaborator fails to fulfill its responsibilities in a timely manner, or at all, our research, clinical development, manufacturing, or commercialization efforts related to that collaboration could be delayed or terminated, or it may be necessary for us to assume responsibility for expenses or activities that would otherwise have been the responsibility of our collaborator. If we are unable to establish and maintain collaborations on acceptable terms or to successfully transition away from terminated collaborations, we may have to delay or discontinue further development of one or more of our product candidates, undertake development and commercialization activities at our own expense, or find alternative sources of capital, which would have a material adverse impact on our clinical development plans and business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our employees and independent contractors, including principal investigators, CROs, consultants, vendors, and any third parties we may engage in connection with development and commercialization may engage in misconduct or other improper activities, including noncompliance with regulatory standards and requirements, which could have a material adverse effect on our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our employees and independent contractors, including principal investigators, CROs, consultants, vendors, and any third parties we may engage in connection with development and commercialization of our product candidates, could engage in misconduct, including intentional, reckless, or negligent conduct or unauthorized activities that violate applicable laws, rules, and regulations including: the laws and regulations of the FDA or other similar regulatory requirements of other authorities, including those laws that require the reporting of true, complete, and accurate information to such authorities; manufacturing standards; data privacy, security, fraud and abuse, and other healthcare laws and regulations; or laws that require the reporting of true, complete, and accurate financial information and data. Specifically, sales, marketing, and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing, and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs, and other business arrangements. Activities subject to these or other laws could also involve the improper use or misrepresentation of information obtained in the course of clinical trials, creation of fraudulent data in preclinical studies or clinical trials, or illegal misappropriation of drug product, which could result in regulatory sanctions and cause serious harm to our reputation. It is not always possible to identify and deter misconduct by employees and other third parties, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with such laws or regulations. Additionally, we are subject to the risk that a person or government agency could allege such fraud or other misconduct, even if none occurred. If any such actions are instituted against us or them and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business and results of operations, including the imposition of significant civil, criminal, and administrative penalties, damages, monetary fines, possible exclusion from participation in Medicare, Medicaid, other U.S. federal healthcare programs or healthcare programs in other jurisdictions, individual imprisonment, other sanctions, contractual damages, reputational harm, diminished profits and future earnings, and curtailment of our operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We currently rely on third-party contract manufacturing organizations, or CMOs, for the production of clinical supply of FX-322 and intend to rely on CMOs for the production of commercial supply of FX-322, if approved, and for clinical and commercial supply of our future product candidates, as well as to supply raw materials necessary to produce our product</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">64</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">candidates. Our dependence on CMOs may impair the development of our product candidates and may impair their commercialization, which would adversely impact our business and financial position.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We do not own facilities for manufacturing FX-322 or any product candidate. Instead, we rely on and expect to continue to rely on CMOs for the supply of cGMP grade clinical trial materials of FX-322 and any product candidates we develop and, in future, for commercial quantities. Reliance on CMOs may expose us to more risk than if we were to manufacture our product candidates ourselves. If any CMO we engage is unable to provide sufficient supply of any product candidate we develop, we may be unable to arrange for an alternative supply or to do so on commercially reasonable terms or in a timely manner, which could delay any clinical trials, the commercial launch of our product candidates, if approved, or, regarding any commercial supply, result in a shortage in supply that could negatively impact our revenues. For example, we are substantially dependent on the CMO that supplies us with the proprietary glycogen synthase kinase 3, or GSK3, inhibitor that is a key component of FX-322 and the CMO that lyophilizes FX-322 into a powder. While there are other CMOs who are able to supply the GSK3 inhibitor or lyophilize FX-322, manufacture of the GSK3 inhibitor and the lyophilization process require proprietary knowledge or specialized capabilities that only a limited number of CMOs have. As a result, transitioning to a new CMO for either the supply of the GSK3 inhibitor or to conduct the lyophilization process would be particularly time consuming and costly. We have just begun to engage other CMOs as back-up for the manufacture and supply of FX-322. As a result, if any of the CMOs involved in the manufacture and supply of FX-322 experience a delay or disruption, or if we fail to obtain the appropriate approvals to manufacture and supply FX-322 outside the US (e.g., as a result of a failure to obtain a waiver under the Bayh-Dole Act), we may not have sufficient quantities of FX-322 for our planned activities and may not be able to transition to a new CMO in a timely or cost-effective manner, or at all, which would negatively impact our ability to develop and potentially commercialize FX-322.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The facilities used to manufacture our product candidates must be inspected by the FDA and comparable foreign regulatory authorities. While we provide oversight of manufacturing activities, we do not and will not control the execution of manufacturing activities by, and are or will be dependent on, our CMOs for compliance with cGMP requirements for the manufacture of our product candidates. As a result, we are subject to the risk that our product candidates may have manufacturing defects that we have limited ability to prevent. If a CMO cannot successfully manufacture material that conforms to our specifications and the regulatory requirements, we will not be able to secure or maintain regulatory approval for the use of our product candidates in clinical trials, or for commercial distribution of our product candidates, if approved. While we have engaged independent auditors to assess the compliance with the protocol that we co-developed with our CMOs regarding the manufacturing process for FX-322, in general, we have limited control over the ability of our CMOs to maintain adequate quality control, quality assurance, and qualified personnel, and we were not involved in developing our CMOs&#x2019; policies and procedures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If the FDA or comparable foreign regulatory authority finds deficiencies with or does not approve these facilities for the manufacture of our product candidates or if it withdraws any such approval or finds deficiencies in the future, we may need to find alternative manufacturing facilities, which would delay our development program and significantly impact our ability to develop, obtain regulatory approval for, or commercialize our product candidates, if approved. In addition, any failure to achieve and maintain compliance with laws, regulations, and standards related to manufacturing could subject us to risks, including the risk that we may have to suspend the manufacture of our product candidates, that obtained approvals could be revoked, and that the FDA or another governmental regulatory authority may take enforcement actions, including untitled letters, warning letters, seizures, injunctions, or product recalls. Furthermore, CMOs may breach existing agreements they have with us because of factors beyond our control. They may also terminate or refuse to renew their agreement at a time that is costly or otherwise inconvenient for us. If we were unable to find an adequate CMO or another acceptable solution in time, our clinical trials could be delayed, or our commercial activities could be harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We contract for the supply of the active pharmaceutical ingredient, or API, and other raw material necessary to produce FX-322 and we may contract in the future for the supply of API and other raw material for any of our other product candidates we develop. Supplies of API or other raw material could be interrupted from time to time and we cannot be certain that alternative supplies could be obtained within a reasonable time frame, at an acceptable cost, or at all. The extent to which the COVID-19 pandemic impacts our ability to procure sufficient supplies for the development of our products and product candidates will depend on the severity and duration of the spread of the virus, and the actions undertaken to mitigate the spread of COVID-19 or treat its effects and may cause delays. In addition, a disruption in the supply of API or other raw material could delay the commercial launch of our product candidates, if approved, or result in a shortage in supply, which would impair our ability to generate revenues. Growth in the costs and expenses of API or other raw material may also impair our ability to cost-effectively manufacture our product candidates. In addition, there may be a limited number of suppliers for API or other raw material that we may use to manufacture our product candidates, and we cannot be certain that we will be able to engage such suppliers in a timely manner or at all. If we are unable to do so, clinical development of our product candidates, commercialization for any approved product, or our business could be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">65</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Finding new CMOs or third-party suppliers involves additional cost and requires our management&#x2019;s time and focus. In addition, there is typically a transition period when a new CMO commences work. Although we have not, and do not intend to, begin a clinical trial unless we believe we have on hand, or will be able to obtain, a sufficient supply of our product candidates to complete the clinical trial, any significant delay in the supply of our product candidates or the raw materials needed to produce our product candidates, could considerably delay conducting our clinical trials and potential regulatory approval of our product candidates.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As part of their manufacture of our product candidates, our CMOs and third-party suppliers are expected to comply with and respect the proprietary rights of others. If a CMO or third-party supplier fails to acquire the proper licenses or otherwise infringes the proprietary rights of others in the course of providing services to us, we may have to find alternative CMOs or third-party suppliers or defend against claims of infringement, either of which would significantly impact our ability to develop, obtain regulatory approval for, or commercialize our product candidates, if approved.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We intend to rely on third parties to conduct, supervise, and monitor our clinical trials. If those third parties do not successfully carry out their contractual duties, or if they perform in an unsatisfactory manner, it may harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We rely, and will continue to rely, on CROs, CRO-contracted vendors, and clinical trial sites to ensure the proper and timely conduct of our clinical trials, including our Phase 2b trial of FX-322 (FX-322-208), extension trials of FX-322-111 and FX-322-112, any future clinical trials of FX-322 for the treatment of SNHL, and any future clinical trials of our other product candidates. Our reliance on CROs for clinical development activities limits our control over these activities and we were not involved in developing our CRO&#x2019;s policies and procedures, but we remain responsible for ensuring that each of our trials is conducted in accordance with the applicable protocol and legal, regulatory, and scientific standards.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We and our CROs will be required to comply with the Good Laboratory Practice requirements for our preclinical studies and GCP requirements for our clinical trials, which are regulations and guidelines enforced by the FDA and are also required by comparable foreign regulatory authorities. Regulatory authorities enforce GCP requirements through periodic inspections of trial sponsors, principal investigators, and clinical trial sites. If we or our CROs fail to comply with GCP requirements, the clinical data generated in our clinical trials may be deemed unreliable and the FDA or comparable foreign regulatory authorities may require us to perform additional clinical trials before approving our marketing applications. We cannot assure you that upon inspection by a given regulatory authority, such regulatory authority will determine that any of our clinical trials comply with GCP requirements. In addition, our clinical trials must be conducted with product produced under cGMP requirements. Accordingly, if our CROs fail to comply with these requirements, we may be required to repeat clinical trials, which would delay the regulatory approval process.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our CROs are not our employees, and we do not control whether they devote sufficient time and resources to our clinical trials. Our CROs may also have relationships with other commercial entities, including our competitors, for whom they may also be conducting clinical trials, or other drug development activities, which could harm our competitive position. We face the risk of potential unauthorized disclosure or misappropriation of our intellectual property by CROs, which may reduce our trade secret protection and allow our potential competitors to access and exploit our proprietary technology. If our CROs do not successfully carry out their contractual duties or obligations, or fail to meet expected deadlines, or if the quality or accuracy of the clinical data they obtain is compromised due to the failure to adhere to our clinical protocols or regulatory requirements or for any other reason, our clinical trials may be extended, delayed or terminated, and we may not be able to obtain regulatory approval for, or successfully commercialize, any product candidate that we develop. As a result, our financial results and the commercial prospects for any product candidate that we develop would be harmed, our costs could increase, and our ability to generate revenue could be delayed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If our relationship with any CROs terminates, we may not be able to enter into arrangements with alternative CROs or do so on commercially reasonable terms. Switching or adding additional CROs involves substantial cost and requires management&#x2019;s time and focus. In addition, there is a natural transition period when a new CRO commences work. As a result, delays occur, which can materially impact our ability to meet our desired clinical development timelines. While the COVID-19 pandemic and government measures taken in response have had a significant impact on our CROs and their ability to conduct clinical trials, there is potential they will face disruption in the future, which may affect our ability to initiate and complete our clinical trials. Though we intend to carefully manage our relationships with our CROs, there can be no assurance that we will not encounter challenges or delays in the future or that these delays or challenges will not have an adverse impact on our business, financial condition, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">66</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks related to healthcare laws and other legal compliance matters</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Enacted and future healthcare legislation may increase the difficulty and cost for us to obtain marketing approval of and commercialize our product candidates, if approved, and may affect the prices we may set.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the United States and other jurisdictions, there have been, and we expect there will continue to be, a number of legislative and regulatory changes, and additional proposed changes, to the healthcare system that could affect our future results of operations. In particular, there have been and continue to be a number of initiatives at the U.S. federal and state levels that seek to reduce healthcare costs and improve the quality of health care. For example, in March 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or collectively the ACA, was enacted, which substantially changed the way healthcare is financed by both governmental and private insurers. Among the provisions of the ACA, those of greatest importance to the biotechnology and pharmaceutical industries include the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">an annual, non-deductible fee payable by any entity that manufactures or imports certain branded prescription drugs and biologic agents; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">an increase in the statutory minimum rebates a manufacturer must pay under the Medicaid Drug Rebate Program; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs and biologics that are inhaled, infused, instilled, implanted, or injected; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative clinical effectiveness research, along with funding for such research; and </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">establishment of a Center for Medicare Innovation at the Centers for Medicare &amp; Medicaid Services, or CMS, to test innovative payment and service delivery models to lower Medicare and Medicaid spending, potentially including prescription drug spending. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since its enactment, there have been judicial challenges to certain aspects of the ACA. On June 17, 2021, the U.S. Supreme Court dismissed the most recent judicial challenge to the ACA brought by several states without specifically ruling on the constitutionality of the ACA. Prior to the Supreme Court&#x2019;s decision, President Biden issued an executive order initiating a special enrollment period from February 15, 2021 through August 15, 2021 for purposes of obtaining health insurance coverage through the ACA marketplace.  The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare. It is unclear how healthcare reform measures enacted by Congress or implemented by the Biden administration, if any, will impact our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">   </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, other legislative changes have been proposed and adopted since the ACA was enacted. In August 2011, the Budget Control Act of 2011, among other things, included aggregate reductions of Medicare payments to providers of 2% per fiscal year, which went into effect on April 1, 2013 and, due to subsequent legislative amendments, will remain in effect through 2030, with the exception of a temporary suspension from May 1, 2020 through March 31, 2022, unless additional Congressional action is taken. On January 2, 2013, President Obama signed into law the American Taxpayer Relief Act of 2012 which, among other things, reduced Medicare payments to several providers, including hospitals, and an increase in the statute of limitations period for the government to recover overpayments to providers from three to five years. Further, in March 2021, the American Rescue Plan Act of 2021 was signed into law, which, among other things, eliminated the statutory cap on drug manufacturers&#x2019; Medicaid Drug Rebate Program rebate liability, effective January 1, 2024. Under current law enacted as part of the ACA, drug manufacturers&#x2019; Medicaid Drug Rebate Program rebate liability is capped at 100% of the average manufacturer price for a covered outpatient drug. These new laws may result in additional reductions in Medicare and other healthcare funding and otherwise affect the prices we may obtain.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, there has been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices. Specifically, there have been administration efforts, Congressional inquiries and proposed federal and state legislation designed to bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient assistance programs and reform government program reimbursement methodologies for drugs. Moreover, payment methodologies may be subject to changes in healthcare legislation and regulatory initiatives. We expect that additional U.S. federal healthcare reform measures will be implemented in the future, any of which could limit the amounts that the U.S. federal government will pay for healthcare products and services, which could result in reduced demand for our product candidates or additional pricing pressures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">67</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Individual states in the United States have also become increasingly active in passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, measures designed to encourage importation from other countries and bulk purchasing. Legally mandated price controls on payment amounts by third-party payors or other restrictions could harm our business, results of operations, financial condition, and prospects. In addition, regional healthcare authorities and individual hospitals are increasingly using bidding procedures to determine what pharmaceutical products and which suppliers will be included in their prescription drug and other healthcare programs. Furthermore, there has been increased interest by third-party payors and governmental authorities in reference pricing systems and publication of discounts and list prices. These reforms could reduce the ultimate demand for our product candidates or put pressure on our product pricing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In markets outside of the United States, reimbursement and healthcare payment systems vary significantly by country, and many countries have instituted price ceilings on specific products and therapies. We cannot predict the likelihood, nature, or extent of government regulation that may arise from future legislation or administrative action in the United States or any other jurisdiction. If we or any third parties we may engage are slow or unable to adapt to changes in existing requirements or the adoption of new requirements or policies, or if we or such third parties are not able to maintain regulatory compliance, our product candidates may lose any regulatory approval that may have been obtained and we may not achieve or sustain profitability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our business operations and current and future relationships with contractors, investigators, healthcare professionals, consultants, third-party payors, patient organizations, customers, and others will be subject to applicable healthcare regulatory laws, which could expose us to penalties.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our business operations and current and future arrangements with contractors, investigators, healthcare professionals, consultants, third-party payors, patient organizations, and customers may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations. These laws may constrain the business or financial arrangements and relationships through which we conduct our operations, including how we research, market, sell, and distribute our product candidates, if approved. Such laws include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.491405046981553%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the U.S. federal Anti-Kickback Statute, which prohibits, among other things, persons or entities from knowingly and willfully soliciting, offering, receiving, or providing any remuneration (including any kickback, bribe, or certain rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward, or in return for, either the referral of an individual for, or the purchase, lease, order, or recommendation of, any good, facility, item or service for which payment may be made, in whole or in part, under U.S. federal and state healthcare programs such as Medicare and Medicaid. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. The U.S. federal Anti-Kickback Statute has been interpreted to apply to arrangements between pharmaceutical manufacturers on the one hand and prescribers, purchasers and formulary managers on the other hand; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1020833333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the U.S. federal false claims, including the civil False Claims Act, or FCA, which, among other things, impose criminal and civil penalties, including through civil whistleblower or </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">qui tam</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> actions, against individuals or entities for knowingly presenting, or causing to be presented, to the U.S. federal government claims for payment or approval that are false or fraudulent, knowingly making, using or causing to be made or used a false record or statement material to a false or fraudulent claim, or from knowingly making a false statement to avoid, decrease or conceal an obligation to pay money to the U.S. federal government. In addition, the government may assert that a claim including items and services resulting from a violation of the U.S. federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the FCA. A claim includes &#x201c;any request or demand&#x201d; for money or property presented to the federal government. In addition, pharmaceutical manufacturers can be held liable under the FCA even when they do not submit claims directly to government payors if they are deemed to &#x201c;cause&#x201d; the submission of false or fraudulent claims; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1020833333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the U.S. federal Health Insurance Portability and Accountability Act of 1996, or HIPAA, which imposes criminal and civil liability for, among other things, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program or obtain, by means of false or fraudulent pretenses, representations, or promises, any of the money or property owned by, or under the custody or control of, any healthcare benefit program, regardless of the payor (e.g., public or private) and knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false statement, in connection with the delivery of, or payment for, healthcare benefits, items or services. Similar to the U.S. federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation: </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">68</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1020833333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the FDCA, which prohibits, among other things, the adulteration or misbranding of drugs, biologics, and medical devices; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1020833333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">federal consumer protection and unfair competition laws, which broadly regulate marketplace activities and activities that potentially harm consumers; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1020833333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">federal price reporting laws, which require manufacturers to calculate and report complex pricing metrics to government programs, where such reported prices may be used in the calculation of reimbursement and/or discounts on approved products; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1020833333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the U.S. federal legislation commonly referred to as the Physician Payments Sunshine Act, enacted as part of the ACA, and its implementing regulations, which requires certain manufacturers of drugs, devices, biologics, and medical supplies that are reimbursable under Medicare, Medicaid, or the Children&#x2019;s Health Insurance Program to report annually to the government information related to certain payments and other transfers of value to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), certain non-physician practitioners (physician assistants, nurse practitioners, clinical nurse specialists, certified nurse anesthetists, anesthesiology assistants and certified nurse midwives) and teaching hospitals, as well as ownership and investment interests held by such physicians and their immediate family members;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.2410416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">analogous U.S. state laws and regulations, including: state anti-kickback and false claims laws, which may apply to our business practices, including but not limited to, research, distribution, sales, and marketing arrangements and claims involving healthcare items or services reimbursed by any third-party payor, including private insurers; state laws that require pharmaceutical companies to comply with the pharmaceutical industry&#x2019;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the U.S. federal government, or otherwise restrict payments that may be made to healthcare providers and other potential referral sources; and state laws and regulations that require drug manufacturers to file reports relating to pricing and marketing information, which requires tracking gifts and other remuneration and items of value provided to healthcare professionals and entities; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.2410416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">similar healthcare laws and regulations in the European Union, or EU, and other jurisdictions, including reporting requirements detailing interactions with and payments to healthcare providers; and </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">laws and regulations prohibiting bribery and corruption such as the FCPA, which, among other things, prohibits U.S. companies and their employees and agents from authorizing, promising, offering, or providing, directly or indirectly, corrupt or improper payments or anything else of value to foreign government officials, employees of public international organizations or foreign government-owned or affiliated entities, candidates for foreign public office, and foreign political parties or officials thereof. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Because of the breadth of these laws and the narrowness of the statutory exceptions and regulatory safe harbors available under such laws, it is possible that some of our business activities, including our consulting agreements and other relationships with healthcare providers, some of whom receive stock or stock options as compensation for their services, could be subject to challenge under one or more of such laws. Ensuring that our current and future internal operations and business arrangements with third parties comply with applicable healthcare laws and regulations will involve substantial costs. It is possible that governmental authorities will conclude that our business practices do not comply with current or future statutes, regulations, agency guidance, or case law involving applicable fraud and abuse or other healthcare laws and regulations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If our operations are found to be in violation of any of the laws described above or any other governmental laws and regulations that may apply to us, we may be subject to actions including the imposition of civil, criminal, and administrative penalties, damages, disgorgement, monetary fines, possible exclusion from participation in Medicare, Medicaid, and other federal healthcare programs, individual imprisonment, contractual damages, reputational harm, diminished profits and future earnings, additional reporting requirements, or oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of noncompliance with these laws, and curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations. If any of the physicians or other providers or entities with whom we expect to do business are found to not be in compliance with applicable laws, they may be subject to criminal, civil or administrative sanctions, including exclusions from government-funded healthcare programs and imprisonment, which could affect our ability to operate our business. Further, defending against any such actions can be costly, time consuming, and may require significant personnel resources. Therefore, even if we are successful in defending against any such actions that may be brought against us, our business may be impaired.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">69</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.2410416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Actual or perceived failures to comply with applicable data protection, privacy and security laws, regulations, standards and other requirements could adversely affect our business, results of operations, and financial condition.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:18.0pt;line-height:1.2410416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The global data protection landscape is rapidly evolving, and we are or may become subject to numerous state, federal and foreign laws, requirements and regulations governing the collection, use, disclosure, retention, and security of personal data, such as information that we may collect in connection with clinical trials in the U.S. and abroad. Implementation standards and enforcement practices are likely to remain uncertain for the foreseeable future, and we cannot yet determine the impact future laws, regulations, standards, or perception of their requirements may have on our business. This evolution may create uncertainty in our business, affect our ability to operate in certain jurisdictions or to collect, store, transfer use and share personal information, necessitate the acceptance of more onerous obligations in our contracts, result in liability or impose additional costs on us. The cost of compliance with these laws, regulations and standards is high and is likely to increase in the future. Any failure or perceived failure by us to comply with federal, state or foreign laws or regulation, our internal policies and procedures or our contracts governing our processing of personal information could result in negative publicity, government investigations and enforcement actions, claims by third parties and damage to our reputation, any of which could have a material adverse effect on our operations, financial performance and business.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As our operations and business grow, we may become subject to or affected by new or additional data protection laws and regulations and face increased scrutiny or attention from regulatory authorities. In the U.S., HIPAA imposes, among other things, certain standards relating to the privacy, security, transmission and breach reporting of individually identifiable health information. We may obtain health information from third parties (including research institutions from which we obtain clinical trial data) that are subject to privacy and security requirements under HIPAA. Depending on the facts and circumstances, we could be subject to significant penalties if we violate HIPAA. Certain states have also adopted comparable privacy and security laws and regulations, some of which may be more stringent than HIPAA. Such laws and regulations will be subject to interpretation by various courts and other governmental authorities, thus creating potentially complex compliance issues for us and our future customers and strategic partners.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, we may also be or become subject to other state laws governing the privacy, processing and protection of personal information For example, the CCPA went into effect on January 1, 2020. The CCPA creates individual privacy rights for California consumers and increases the privacy and security obligations of entities handling certain personal information. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation. The CCPA may increase our compliance costs and potential liability, and many similar laws have been proposed at the federal level and in other states. Further, the CPRA recently passed in California. The CPRA significantly amends the CCPA and will impose additional data protection obligations on covered businesses, including additional consumer rights processes, limitations on data uses, new audit requirements for higher risk data, and opt outs for certain uses of sensitive data. It will also create a new California data protection agency authorized to issue substantive regulations and could result in increased privacy and information security enforcement. The majority of the provisions will go into effect on January 1, 2023, and additional compliance investment and potential business process changes may be required. Similar laws have passed in Virginia and Colorado, and have been proposed in other states and at the federal level, reflecting a trend toward more stringent privacy legislation in the United States. The enactment of such laws could have potentially conflicting requirements that would make compliance challenging. In the event that we are subject to or affected by HIPAA, the CCPA, the CPRA  or other domestic privacy and data protection laws, any liability from failure to comply with the requirements of these laws could adversely affect our financial condition.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2410416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, the General Data Protection Regulation applies to companies established in the EEA, as well as to companies that are not established in the EEA and which collect and use personal data in relation to (i) offering goods or services to, or (ii) monitoring the behavior of, individuals located in the EEA. If we conduct clinical trial programs in the EEA (whether the trials are conducted directly by us or through a clinical vendor or collaborator), or enter into research collaborations involving the monitoring of individuals in the EEA, or market our products to individuals in the EEA, we will be subject to the GDPR. The GDPR puts in place stringent operational requirements for processors and controllers of personal data, including, for example, high standards for obtaining consent from individuals to process their personal data (or reliance on another appropriate legal basis), the provision of robust and detailed disclosures to individuals about how personal data is collected and processed (in a concise, intelligible and easily accessible form), a comprehensive individual data rights regime (including access, erasure, objection, restriction, rectification and portability), maintaining a record of data processing, data export restrictions governing transfers of data from the EEA, short timelines for data breach notifications to be given to data protection regulators or supervisory authorities (and in certain cases, affected individuals) of significant data breaches, and limitations on retention of information. The GDPR also imposes stringent requirements pertaining to health data and other special categories of personal data, as well as a definition of pseudonymized (i.e., key-coded) data. Further, the GDPR</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">70</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2410416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">provides that EEA member states may establish their own laws and regulations limiting the processing of genetic, biometric, or health data, which could limit our ability to collect, use, and share such data and/or could cause our costs to increase. In addition, there are certain obligations if we contract third-party processors in connection with the processing of personal data. If our or our collaborators&#x2019; or service providers&#x2019; privacy or data security measures fail to comply with the GDPR requirements, we may be subject to litigation, regulatory investigations, enforcement notices requiring us to change the way we use personal data, or fines of up to 20 million Euros or up to 4% of our total worldwide annual revenue of the preceding financial year, whichever is higher, as well as compensation claims by affected individuals, including class-action type litigation, negative publicity, reputational harm and a potential loss of business and goodwill. Among other requirements, the GDPR regulates transfers of personal data subject to the GDPR to third countries that have not been found to provide adequate protection to such personal data, including the United States, in July 2020, the Court of Justice of the EU, or the CJEU, limited how organizations could lawfully transfer personal data from the EU/EEA to the United States by invalidating the Privacy Shield for purposes of international transfers and imposing further restrictions on the use of standard contractual clauses (SCCs). The European Commission issued revised SCCs on June 4, 2021 to account for the decision of the CJEU and recommendations made by the European Data Protection Board. The revised SCCs must be used for relevant new data transfers from September 27, 2021; existing standard contractual clauses arrangements must be migrated to the revised clauses by December 27, 2022. The new SCCs apply only to the transfer of personal data outside of the EEA and not the UK; the UK&#x2019;s Information Commissioner&#x2019;s Office launched a public consultation on its draft revised data transfers mechanisms in August 2021. There is some uncertainty around whether the revised clauses can be used for all types of data transfers, particularly whether they can be relied on for data transfers to non-EEA entities subject to the GDPR. As supervisory authorities issue further guidance on personal data export mechanisms, including circumstances where the SCCs cannot be used, and/or start taking enforcement action, we could suffer additional costs, complaints and/or regulatory investigations or fines, and/or if we are otherwise unable to transfer personal data between and among countries and regions in which we operate, it could affect the manner in which we provide our services, the geographical location or segregation of our relevant systems and operations, and could adversely affect our financial results.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2410416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, from January 1, 2021, companies have to comply with the GDPR and also the United Kingdom GDPR, or the UK GDPR, which, together with the amended UK Data Protection Act 2018, retains the GDPR in UK national law. The UK GDPR mirrors the fines under the GDPR, i.e., fines up to the greater of &#x20ac;20 million (&#163;17.5 million) or 4% of global turnover. The relationship between the United Kingdom and the European Union in relation to certain aspects of data protection law remains unclear, and it is unclear how United Kingdom data protection laws and regulations will develop in the medium to longer term, and how data transfers to and from the United Kingdom will be regulated in the long term. The European Commission has adopted an adequacy decision in favor of the United Kingdom, enabling data transfers from EU member states to the United Kingdom without additional safeguards.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2410416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Although we work to comply with applicable laws, regulations and standards, our contractual obligations and other legal obligations, these requirements are evolving and may be modified, interpreted and applied in an inconsistent manner from one jurisdiction to another, and may conflict with one another or other legal obligations with which we must comply. Any failure or perceived failure by us or our employees, representatives, contractors, consultants, collaborators, or other third parties to comply with such requirements or adequately address privacy and security concerns, even if unfounded, could result in additional cost and liability to us, damage our reputation, and adversely affect our business and results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We are subject to environmental, health and safety laws and regulations, and we may become exposed to liability and substantial expenses in connection with environmental compliance or remediation activities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our operations, including our development, testing and manufacturing activities, are subject to numerous environmental, health and safety laws and regulations. These laws and regulations govern, among other things, the controlled use, handling, release, and disposal of and the maintenance of a registry for, hazardous materials and biological materials, such as chemical solvents, human cells, carcinogenic compounds, mutagenic compounds, and compounds that have a toxic effect on reproduction, laboratory procedures and exposure to blood-borne pathogens. If we fail to comply with such laws and regulations, we could be subject to fines or other sanctions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As with other companies engaged in activities similar to ours, we face a risk of environmental liability inherent in our current and historical activities, including liability relating to releases of or exposure to hazardous or biological materials. Environmental, health and safety laws and regulations are becoming more stringent. We may be required to incur substantial expenses in connection with future environmental compliance or remediation activities, in which case, the production efforts of our third-party manufacturers or our development efforts may be interrupted or delayed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">71</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks related to our intellectual property</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we are unable to obtain, maintain, enforce and protect patent protection for our technology and product candidates or if the scope of the patent protection obtained is not sufficiently broad, our competitors could develop and commercialize technology and products similar or identical to ours, and our ability to successfully develop and commercialize our technology and product candidates may be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our success depends in large part on our ability to obtain and maintain protection of the intellectual property we may own solely and jointly with others, or may license from others, particularly patents, in the United States and other countries with respect to any proprietary technology and product candidates we develop. We seek to protect our proprietary position by filing patent applications in the United States and abroad related to our technologies and product candidates that are important to our business and by in-licensing intellectual property related to such technologies and product candidates. If we are unable to obtain or maintain patent protection with respect to any proprietary technology or product candidate, our business, financial condition, results of operations and prospects could be materially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The patent prosecution process is expensive, time-consuming, and complex, and we may not be able to file, prosecute, maintain, defend, or license all necessary or desirable patent applications at a reasonable cost or in a timely manner. It is also possible that we will fail to identify patentable aspects of our research and development output before it is too late to obtain patent protection. Moreover, in some circumstances, we do not have the right to control the preparation, filing, and prosecution of patent applications, or to maintain, enforce, and defend the patents, covering technology that we license from third parties. Therefore, these in-licensed patents, and applications may not be prepared, filed, prosecuted, maintained, defended, and enforced in a manner consistent with the best interests of our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The patent position of pharmaceutical and biotechnology companies generally is highly uncertain, involves complex legal and factual questions and has in recent years been the subject of much litigation. In addition, the scope of patent protection outside of the United States is uncertain and laws of foreign countries may not protect our rights to the same extent as the laws of the United States or vice versa. For example, European patent law restricts the patentability of methods of treatment of the human body more than U.S. law does. With respect to both owned and in-licensed patent rights, we cannot predict whether the patent applications we and our licensors are currently pursuing will issue as patents in any particular jurisdiction or whether the claims of any issued patents will provide sufficient protection from competitors. Further, we may not be aware of all third-party intellectual property rights potentially relating to our product candidates. In addition, publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18 months after filing, or in some cases not published at all. Therefore, neither we nor our licensors can know with certainty whether either we or our licensors were the first to make the inventions claimed in the patents and patent applications we own or in-license now or in the future, or that either we or our licensors were the first to file for patent protection of such inventions. As a result, the issuance, scope, validity, enforceability, and commercial value of our owned and in-licensed patent rights are uncertain. Moreover, our owned and in-licensed pending and future patent applications may not result in patents being issued that protect our technology and product candidates, in whole or in part, or that effectively prevent others from commercializing competitive technologies and products. Changes in either the patent laws or interpretation of the patent laws in the United States and other countries may diminish the value of our patents and our ability to obtain, protect, maintain, defend, and enforce our patent rights, narrow the scope of our patent protection and, more generally, could affect the value or narrow the scope of our patent rights.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, we or our licensors may be subject to a third-party pre-issuance submission of prior art to the United States Patent and Trademark Office, or USPTO, or become involved in opposition, derivation, revocation, reexamination, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">inter partes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> review, post-grant review, or interference proceedings challenging our patent rights or the patent rights of others. An adverse determination in any such submission, proceeding or litigation could reduce the scope of, or invalidate, our patent rights, allow third parties to commercialize our technology or product candidates and compete directly with us, without payment to us, or result in our inability to manufacture or commercialize drugs without infringing third-party patent rights. If the breadth or strength of protection provided by our patents and patent applications is threatened, regardless of the outcome, it could dissuade companies from collaborating with us to license, develop or commercialize current or future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, the coverage claimed in a patent application can be significantly reduced before the patent is issued, and its scope can be reinterpreted after issuance. Even if our owned and in-licensed patent applications issue as patents, they may not issue in a form that will provide us with any meaningful protection, prevent competitors from competing with us, or otherwise provide us with any competitive advantage. The issuance of a patent is not conclusive as to its inventorship, scope, validity, or enforceability, and our owned and in-licensed patents may be challenged in the courts or patent offices in the United States and abroad. Such challenges may result in loss of exclusivity or freedom to operate or in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, which could limit our ability to stop others from using or</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">72</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">commercializing similar or identical technology and products, or limit the duration of the patent protection of our technology and product candidates. Such proceedings also may result in substantial cost and require significant time from our management and employees, even if the eventual outcome is favorable to us. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. Furthermore, our competitors may be able to circumvent our owned or in-licensed patents by developing similar or alternative technologies or products in a non-infringing manner. As a result, our owned and in-licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing technology and products similar or identical to any of our technology and product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Patent terms may be inadequate to protect our competitive position on our product candidates for an adequate amount of time.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">expiration of a patent is generally 20 years from its earliest United States non-provisional filing date. Various extensions may be available, but the life of a patent, and the protection it affords, is limited. Even if patents covering our product candidates are obtained, once the patent life has expired, we may be open to competition from competitive products, including generics or biosimilars. Given the amount of time required for the development, testing, and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we are unable to obtain licenses from third parties on commercially reasonable terms or fail to comply with our obligations under such agreements, our business could be harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">It may be necessary for us to use the patented or proprietary technology of third parties to commercialize our products, in which case we would be required to obtain a license from these third parties. If we are unable to license such technology, or if we are forced to license such technology on unfavorable terms, our business could be materially harmed. If we are unable to obtain a necessary license, we may be unable to develop or commercialize the affected product candidates, which could materially harm our business and the third parties owning such intellectual property rights could seek either an injunction prohibiting our sales or an obligation on our part to pay royalties and/or other forms of compensation. Even if we are able to obtain a license, it may be non-exclusive, thereby giving our competitors access to the same technologies licensed to us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we are unable to obtain rights to required third-party intellectual property rights or maintain the existing intellectual property rights we have, we may be required to expend significant time and resources to redesign our technology, product candidates, or the methods for manufacturing them or to develop or license replacement technology, all of which may not be feasible on a technical or commercial basis. If we are unable to do so, we may be unable to develop or commercialize the affected technology and product candidates, which could significantly harm our business, financial condition, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, if we fail to comply with our obligations under license agreements, our counterparties may have the right to terminate these agreements, in which event we might not be able to develop, manufacture or market, or may be forced to cease developing, manufacturing or marketing, any product that is covered by these agreements or may face other penalties under such agreements. Such an occurrence could materially adversely affect the value of the product candidate being developed under any such agreement. Termination of these agreements or reduction or elimination of our rights under these agreements, or restrictions on our ability to freely assign or sublicense our rights under such agreements when it is in the interest of our business to do so, may result in our having to negotiate new or reinstated agreements with less favorable terms, cause us to lose our rights under these agreements, including our rights to important intellectual property or technology, or impede, or delay or prohibit the further development or commercialization of, one or more product candidates that rely on such agreements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we do not obtain patent term extension in the United States under the Hatch-Waxman Act and in foreign countries under similar legislation, thereby potentially extending the term of our marketing exclusivity for any product candidates we may develop, our business may be materially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the United States, the patent term of a patent that covers an FDA-approved drug may be eligible for limited patent term extension, which permits patent term restoration as compensation for the patent term lost during the FDA regulatory review process. The Drug Price Competition and Patent Term Restoration Act of 1984, also known as the Hatch-Waxman</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">73</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Act, permits a patent term extension of up to five years beyond the expiration of the patent. The length of the patent term extension is related to the length of time the drug is under regulatory review. Patent extension cannot extend the remaining term of a patent beyond a total of 14 years from the date of product approval. In addition, only one patent applicable to an approved drug may be extended, and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended. Similar provisions may be available in Europe and certain other non-United States jurisdictions to extend the term of a patent that covers an approved drug. While, in the future, if and when our product candidates receive FDA approval, we expect to apply for patent term extensions on patents covering those product candidates, there is no guarantee that the applicable authorities will agree with our assessment of whether such extensions should be granted, and even if granted, the length of such extensions. We may not be granted patent term extension either in the United States or in any foreign country because of, for example, failing to exercise due diligence during the testing phase or regulatory review process, failing to apply within applicable deadlines, failing to apply prior to expiration of relevant patents, or otherwise failing to satisfy applicable requirements. Moreover, the term of extension, as well as the scope of patent protection during any such extension, afforded by the governmental authority could be less than we request. If we are unable to obtain any patent term extension or the term of any such extension is less than we request, our competitors may obtain approval of competing products following the expiration of our patent rights, and our business, financial condition, results of operations, and prospects could be materially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">It is possible that we will not obtain patent term extension under the Hatch-Waxman Act for a United States patent covering any of our product candidates that we may identify even where that patent is eligible for patent term extension, or if we obtain such an extension, it may be for a shorter period than we had sought. Further, for our licensed patents, we may not have the right to control prosecution, including filing with the USPTO, of a petition for patent term extension under the Hatch-Waxman Act. Thus, if one of our licensed patents is eligible for patent term extension under the Hatch-Waxman Act, we may not be able to control whether a petition to obtain a patent term extension is filed, or obtained, from the USPTO.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Also, there are detailed rules and requirements regarding the patents that may be submitted to the FDA for listing in the Approved Drug Products with Therapeutic Equivalence Evaluations, or the Orange Book. We may be unable to obtain patents covering our product candidates that contain one or more claims that satisfy the requirements for listing in the Orange Book. Even if we submit a patent for listing in the Orange Book, the FDA may decline to list the patent, or a manufacturer of generic drugs may challenge the listing. If one of our product candidates is approved and a patent covering that product candidate is not listed in the Orange Book, a manufacturer of generic drugs would not have to provide advance notice to us of any abbreviated new drug application filed with the FDA to obtain permission to sell a generic version of such product candidate.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Although we or our licensors are not currently involved in any litigation, we may become involved in lawsuits to protect or enforce our patent or other intellectual property rights, which could be expensive, time-consuming and unsuccessful.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Competitors and other third parties may infringe, misappropriate or otherwise violate our or our licensors&#x2019; issued patents or other intellectual property. As a result, we or our licensors may need to file infringement, misappropriation or other intellectual property related claims, which can be expensive and time-consuming. Any claims we assert against perceived infringers could provoke such parties to assert counterclaims against us alleging that we infringe, misappropriate, or otherwise violate their intellectual property. In addition, in a patent infringement proceeding, such parties could counterclaim that the patents we or our licensors have asserted are invalid or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are commonplace. Grounds for a validity challenge could be an alleged failure to meet any of several statutory requirements, including lack of novelty, obviousness, or non-enablement. Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO or made a misleading statement during prosecution. Third parties may institute such claims before administrative bodies in the United States or abroad, even outside the context of litigation. Such mechanisms include re-examination, post-grant review, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">inter partes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> review, interference proceedings, derivation proceedings, and equivalent proceedings in foreign jurisdictions (e.g., opposition proceedings). The outcome following legal assertions of invalidity and unenforceability is unpredictable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">An adverse result in any such proceeding could put one or more of our owned or in-licensed patents at risk of being invalidated or interpreted narrowly and could put any of our owned or in-licensed patent applications at risk of not yielding an issued patent. A court may also refuse to stop the third party from using the technology at issue in a proceeding on the grounds that our owned or in-licensed patents do not cover such technology. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information or trade secrets could be compromised by disclosure during this type of litigation. Any of the foregoing could</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">74</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">allow such third parties to develop and commercialize competing technologies and products and have a material adverse impact on our business, financial condition, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Interference or derivation proceedings provoked by third parties or brought by us or declared by the USPTO may be necessary to determine the priority of inventions with respect to our patents or patent applications. An unfavorable outcome could require us to cease using the related technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does not offer us a license on commercially reasonable terms or at all, or if a non-exclusive license is offered and our competitors gain access to the same technology. Our defense of litigation or interference or derivation proceedings may fail and, even if successful, may result in substantial costs, and distract our management and other employees. In addition, the uncertainties associated with litigation could have a material adverse effect on our ability to raise the funds necessary to continue our clinical trials, continue our research programs, license necessary technology from third parties, or enter into development partnerships that would help us bring our product candidates to market.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. There could also be public announcements of the results of hearings, motions, or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Third parties may initiate legal proceedings alleging that we are infringing, misappropriating or otherwise violating their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on the success of our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our commercial success depends upon our ability and the ability of our collaborators to develop, manufacture, market and sell our product candidates and use our proprietary technologies without infringing, misappropriating or otherwise violating the intellectual property and proprietary rights of third parties. There is considerable patent and other intellectual property litigation in the pharmaceutical and biotechnology industries. We may become party to, or threatened with, adversarial proceedings or litigation regarding intellectual property rights with respect to our technology and product candidates, including interference proceedings, post grant review, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">inter partes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> review, and derivation proceedings before the USPTO and similar proceedings in foreign jurisdictions such as oppositions before the European Patent Office. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are pursuing development candidates. As the biotechnology and pharmaceutical industries expand and more patents are issued, the risk increases that our technologies or product candidates that we may identify may be subject to claims of infringement of the patent rights of third parties.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The legal threshold for initiating litigation or contested proceedings is low, so that even lawsuits or proceedings with a low probability of success might be initiated and require significant resources to defend. Litigation and contested proceedings can also be expensive and time-consuming, and our adversaries in these proceedings may have the ability to dedicate substantially greater resources to prosecuting these legal actions than we can. The risks of being involved in such litigation and proceedings may increase if and as our product candidates near commercialization and as we gain the greater visibility associated with being a public company. Third parties may assert infringement claims against us based on existing patents or patents that may be granted in the future, regardless of merit. We may not be aware of all such intellectual property rights potentially relating to our technology and product candidates and their uses, or we may incorrectly conclude that third party intellectual property is invalid or that our activities and product candidates do not infringe such intellectual property. Thus, we do not know with certainty that our technology and product candidates, or our development and commercialization thereof, do not and will not infringe, misappropriate or otherwise violate any third party&#x2019;s intellectual property.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Third parties may assert that we are employing their proprietary technology without authorization. There may be third-party patents or patent applications with claims to materials, formulations, methods of manufacture or methods for treatment related to the discovery, use or manufacture of the product candidates that we may identify or related to our technologies. Because patent applications can take many years to issue, there may be currently pending patent applications which may later result in issued patents that the product candidates that we may develop may be found to infringe. In addition, third parties may obtain patents in the future and claim that use of our technologies infringes upon these patents. Moreover, as noted above, there may be existing patents that we are not aware of or that we have incorrectly concluded are invalid or not infringed by our activities. If any third-party patents were held by a court of competent jurisdiction to cover, for example, the manufacturing process of the product candidates that we may develop, any molecules formed during the manufacturing</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">75</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">process or any final product itself, the holders of any such patents may be able to block our ability to commercialize such product candidate unless we obtained a license under the applicable patents, or until such patents expire.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Parties making claims against us may obtain injunctive or other equitable relief, which could effectively block our ability to further develop and commercialize the product candidates that we may identify. Defense of these claims, regardless of their merit, would involve substantial litigation expense and would be a substantial diversion of employee resources from our business. In the event of a successful claim of infringement against us, we may have to pay substantial damages, including treble damages and attorneys&#x2019; fees for willful infringement, pay royalties, redesign our infringing products, or obtain one or more licenses from third parties, which may be impossible or require substantial time and monetary expenditure.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may choose to take a license or, if we are found to infringe, misappropriate or otherwise violate a third party&#x2019;s intellectual property rights, we could also be required to obtain a license from such third party to continue developing, manufacturing and marketing our technology and product candidates. However, we may not be able to obtain any required license on commercially reasonable terms or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors and other third parties access to the same technologies licensed to us and could require us to make substantial licensing and royalty payments. We could be forced, including by court order, to cease developing, manufacturing and commercializing the infringing technology or product. In addition, we could be found liable for significant monetary damages, including treble damages and attorneys&#x2019; fees, if we are found to have willfully infringed a patent or other intellectual property right and could be forced to indemnify our customers or collaborators. A finding of infringement could prevent us from commercializing our product candidates or force us to cease some of our business operations, which could materially harm our business. In addition, we may be forced to redesign our product candidates, seek new regulatory approvals, and indemnify third parties pursuant to contractual agreements. Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar material adverse effect on our business, financial condition, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Intellectual property litigation or other legal proceedings relating to intellectual property could cause us to spend substantial resources and distract our personnel from their normal responsibilities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Even if resolved in our favor, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses and could distract our technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments, and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. Such litigation or proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing, or distribution activities. We may not have sufficient financial or other resources to conduct such litigation or proceedings adequately. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial resources and may also have an advantage in such proceedings due to their more mature and developed intellectual property portfolios. Uncertainties resulting from the initiation and continuation of intellectual property litigation or other proceedings could compromise our ability to compete in the marketplace.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Obtaining and maintaining patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for noncompliance with these requirements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Periodic maintenance, renewal and annuity fees and various other government fees on any issued patent and pending patent application must be paid to the USPTO and foreign patent agencies in several stages or annually over the lifetime of our owned and in-licensed patents and patent applications. The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. In certain circumstances, we rely on our licensing partners to pay these fees to, or comply with the procedural and documentary rules of, the relevant patent agency. With respect to our patents, we rely on an annuity service, outside firms, and outside counsel to remind us of the due dates and to make payment after we instruct them to do so. While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance events that could result in abandonment or lapse of a patent or patent application include failure to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and submit formal documents. In such an event, potential competitors might be able to enter the market with similar or identical products or technology. If we or our licensors fail to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">76</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">maintain the patents and patent applications covering our product candidates, it would have a material adverse effect on our business, financial condition, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we fail to comply with our obligations in our intellectual property licenses and funding arrangements with third parties, or otherwise experience disruptions to our business relationships with our licensors, we could lose intellectual property rights that are important to our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are party to license and funding agreements that impose, and we may enter into additional licensing and funding arrangements with third parties that may impose, diligence, development, and commercialization timelines, milestone payment, royalty, insurance and other obligations on us. Under our existing licensing and funding agreements, we are obligated to pay royalties on net product sales of product candidates or related technologies to the extent they are covered by the agreements. If we fail to comply with such obligations under current or future license and funding agreements, our counterparties may have the right to terminate these agreements or require us to grant them certain rights. Such an occurrence could materially adversely affect the value of any product candidate being developed under any such agreement. Termination of these agreements or reduction or elimination of our rights under these agreements may result in our having to negotiate new or reinstated agreements with less favorable terms, or cause us to lose our rights under these agreements, including our rights to important intellectual property or technology, which would have a material adverse effect on our business, financial condition, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Disputes may arise regarding intellectual property subject to a licensing agreement, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the scope of rights granted under the license agreement and other interpretation related issues; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the extent to which our technology and processes infringe on intellectual property of the licensor that is not subject to the licensing agreement; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the sublicensing of patent and other rights under our collaborative development relationships; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our diligence obligations under the license agreement and what activities satisfy those diligence obligations; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the inventorship and ownership of inventions and know-how resulting from the joint creation or use of intellectual property by our licensors and us and our partners; and </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the priority of invention of patented technology. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, the agreements under which we currently license intellectual property or technology from third parties are complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, or increase what we believe to be our financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business, financial condition, results of operations, and prospects. Moreover, if disputes over intellectual property that we have licensed prevent or impair our ability to maintain our current licensing arrangements on commercially acceptable terms, we may be unable to successfully develop and commercialize the affected technology and product candidates, which could have a material adverse effect on our business, financial conditions, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our current or future licensors may have relied on third-party consultants or collaborators or on funds from third parties such that our licensors are not the sole and exclusive owners of the patents and patent applications we in-license. If other third parties have ownership rights to patents and/or patent applications we in-license, they may be able to license such patents to our competitors, and our competitors could market competing products and technology. This could have a material adverse effect on our competitive position, business, financial conditions, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In spite of our best efforts, our licensors might conclude that we have materially breached our license agreements and might therefore terminate the license agreements, thereby removing our ability to develop and commercialize product candidates and technology covered by these license agreements. If these in-licenses are terminated, or if the underlying intellectual property fails to provide the intended exclusivity, competitors would have the freedom to seek regulatory approval of, and to market, products and technologies identical to ours. This could have a material adverse effect on our competitive position, business, financial conditions, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">77</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may be subject to claims challenging the inventorship or ownership of our patents and other intellectual property.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We or our licensors may be subject to claims that former employees, collaborators or other third parties have an interest in our owned or in-licensed patents, trade secrets, or other intellectual property as an inventor or co-inventor. For example, we or our licensors may have inventorship disputes arise from conflicting obligations of employees, consultants or others who are involved in developing our product candidates. Litigation may be necessary to defend against these and other claims challenging inventorship or our or our licensors&#x2019; ownership of our owned or in-licensed patents, trade secrets, or other intellectual property. If we or our licensors fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of, or right to use, intellectual property that is important to our product candidates. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to seeking patents for some of our technology and product candidates, we also rely on trade secrets and confidentiality agreements to protect our unpatented know-how, technology, and other proprietary information, to maintain our competitive position. We seek to protect our trade secrets and other proprietary technology, in part, by entering into non-disclosure and confidentiality agreements with parties who have access to them, such as our employees, corporate collaborators, outside scientific collaborators, CROs, contract manufacturers, consultants, advisors, and other third parties. We also enter into confidentiality and invention or patent assignment agreements with our employees and consultants. We cannot guarantee that we have entered into such agreements with each party that may have or has had access to our trade secrets or proprietary technology. Despite these efforts, any of these parties may breach the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Detecting the disclosure or misappropriation of a trade secret and enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive, and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside of the United States are less willing or unwilling to protect trade secrets. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent them, or those to whom they communicate it, from using that technology or information to compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor or other third party, our competitive position would be materially and adversely harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our registered and unregistered trademarks or trade names may be challenged, infringed, circumvented, or declared generic or determined to be infringing on other marks. We may not be able to protect our rights to these trademarks and trade names, which we need to build name recognition among potential collaborators or customers in our markets of interest. At times, competitors may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other registered trade names or trademarks that incorporate variations of our unregistered trade names or trademarks. Over the long term, if we are unable to successfully register our trade names and trademarks and establish name recognition based on our trade names and trademarks, then we may not be able to compete effectively, and our business may be adversely affected. Our efforts to enforce or protect our proprietary rights related to trade names and trademarks may be ineffective and could result in substantial costs and diversion of resources and could adversely impact our financial condition or results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Intellectual property rights do not necessarily address all potential threats.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations and may not adequately protect our business or permit us to maintain our competitive advantage. For example:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we, or our license partners or current or future collaborators, might not have been the first to file patent applications covering certain of our or their inventions; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing our owned or in-licensed intellectual property rights; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">it is possible that our owned and in-licensed pending patent applications or those we may own or in-license in the future will not lead to issued patents; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">78</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">issued patents that we hold rights to may be held invalid or unenforceable, including as a result of legal challenges by our competitors; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our competitors might conduct research and development activities in countries where we do not have patent rights and then use the information learned from such activities to develop competitive products for sale in our major commercial markets; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we cannot ensure that any of our pending patent applications, if issued, or those of our licensors, will include claims having a scope sufficient to protect our product candidates; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we cannot ensure that any patents issued to us or our licensors will provide a basis for an exclusive market for our commercially viable product candidates or will provide us with any competitive advantages; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we cannot ensure that our commercial activities or product candidates will not infringe upon the patents of others; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we cannot ensure that we will be able to successfully commercialize our product candidates on a substantial scale, if approved, before the relevant patents that we own, or license expire; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may not develop additional proprietary technologies that are patentable; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the patents of others may harm our business; and </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may choose not to file a patent in order to maintain certain trade secrets or know-how, and a third party may subsequently file a patent covering such intellectual property. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Should any of these events occur, they could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks related to our employees, managing our growth and our operations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our future success depends on our ability to retain our key personnel and to attract, retain and motivate qualified personnel.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are highly dependent on the expertise of David L. Lucchino, our President and Chief Executive Officer, as well as the other principal members of our management, scientific, and clinical teams. Although we have employment agreements, offer letters or consulting agreements with our executive officers, these agreements do not prevent them from terminating their services at any time.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we lose one or more of our executive officers or key employees, our ability to implement our business strategy successfully could be seriously harmed. Furthermore, replacing executive officers and key employees may be difficult and may take an extended period because of the limited number of individuals in our industry with the breadth of skills and experience required to develop, gain regulatory approval of and commercialize product candidates successfully. Competition to hire from this limited pool is intense, and we may be unable to hire, train, retain or motivate these additional key personnel on acceptable terms given the competition among numerous biotechnology and pharmaceutical companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel from universities and research institutions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in formulating our research and development and commercialization strategy. Our consultants and advisors may be engaged by other companies or organizations and may have commitments that limit their availability. If we are unable to continue to attract and retain highly qualified personnel, our ability to develop and commercialize our product candidates will be limited.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We expect to expand our development, regulatory, and sales and marketing capabilities, and as a result, we may encounter difficulties in managing our growth, which could disrupt our operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Notwithstanding COVID-19, we have continued to identify key talent for critical roles, particularly in the areas of clinical development, regulatory affairs, quality and sales and marketing. To manage our anticipated future growth, we must continue to implement and improve our managerial, operational and financial systems, expand our facilities or acquire new facilities, and continue to recruit and train additional qualified personnel. Due to our limited financial resources and the limited experience of our management team in managing a company with such anticipated growth, as well as the competition within the region, we may not be able to effectively manage the expansion of our operations or recruit and train additional</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">79</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">qualified personnel. The expansion of our operations may lead to significant costs and may divert our management and business development resources. Any inability to manage growth could delay the execution of our business plans or disrupt our operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may engage in transactions that could disrupt our business, cause dilution to our shareholders or reduce our financial resources.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the future, we may enter into transactions to acquire or in-license rights to product candidates, products or technologies, or to acquire other businesses. If we do identify suitable candidates, we may not be able to enter into such transactions on favorable terms, or at all. Any such acquisitions or in-licenses may not strengthen our competitive position, and these transactions may be viewed negatively by analysts, investors, customers, or other third parties with whom we have relationships. We may decide to incur debt in connection with an acquisition, or in-license or issue our common stock or other equity securities as consideration for the acquisition, which would reduce the percentage ownership of our existing stockholders. We could incur losses resulting from undiscovered liabilities of the acquired business that are not covered by the indemnification we may obtain from the sellers of the acquired business. In addition, we may not be able to successfully integrate the acquired personnel, technologies, and operations into our existing business in an effective, timely, and nondisruptive manner. Such transactions may also divert management attention from day-to-day responsibilities, increase our expenses, and reduce our cash available for operations and other uses. We cannot predict the number, timing or size of future acquisitions or in-licenses or the effect that any such transactions might have on our operating results.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.2410416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our business and operations would suffer in the event of security breaches or system failures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.2410416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the ordinary course of our business, we and third parties with which we have relationships will continue to collect and store sensitive data, including clinical trial data, proprietary business information, personal data and personally identifiable information of our clinical trial subjects and employees, in data centers and on networks. The secure processing, maintenance and transmission of this information is critical to our operations. Despite the implementation of security measures, our computer systems, as well as those of our CROs and other contractors and consultants, are vulnerable to damage from computer viruses, unauthorized access, malfeasance, natural and manmade disasters (including hurricanes), terrorism, war, and telecommunication, electrical failures or other disruptions. Attacks upon information technology systems are increasing in their frequency, levels of persistence, sophistication and intensity, and are being conducted by sophisticated and organized groups and individuals with a wide range of motives and expertise.  For instance, companies have experienced an increase in phishing and social engineering attacks from third parties in connection with COVID-19 global pandemic, and the recent hostilities between Russia and Ukraine may result in increased attacks that could either directly or indirectly impact us. Furthermore, because the techniques used to obtain unauthorized access to, or to sabotage, systems change frequently and often are not recognized until launched against a target, we may be unable to anticipate these techniques or implement adequate preventative measures. We may also experience security breaches that may remain undetected for an extended period. A number of proposed and enacted federal, state and international laws and regulations obligate companies to notify individuals of security breaches involving particular personally identifiable information, which could result from breaches experienced by us or by third parties, including collaborators, vendors, contractors, or other organizations with which we have formed strategic relationships. While we do not believe that our network has experienced any such system failure, accident, or security breach to date, if such an event were to occur and cause interruptions in our operations, it could result in delays and/or material disruptions of our research and development programs. For example, the loss of preclinical or clinical trial data from completed, ongoing, or planned trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. Likewise, we currently rely on third parties for the manufacture of our product candidates and to conduct clinical trials, and similar events relating to their computer systems could also have a material adverse effect on our business. Any such access, disclosure, notifications, follow-up actions related to such a security breach or other loss of information could result in legal claims or proceedings, liability under data protection laws, and significant costs, including regulatory penalties, fines, and legal expenses, and such an event could disrupt our operations, cause us to incur remediation costs, damage our reputation, and cause a loss of confidence in us and our or such third parties&#x2019; ability to conduct clinical trials, which could adversely affect our reputation and delay the clinical development of our product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">80</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks related to our common stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The market price of our common stock has been volatile and fluctuated and may in future fluctuate substantially, which could result in substantial losses for our stockholders.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The market price of our common stock has been highly volatile and subject to wide fluctuations in response to various factors, some of which are beyond our control. In addition to the factors discussed in this section titled &#x201c;Risk factors&#x201d; and elsewhere in this Annual Report on Form 10-K, these factors include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any delay in the enrollment or </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ultimate completion of the Phase 2b trial of FX-322 (FX-322-208), extension trials of FX-322-111 and FX-322-112 and any futures clinical trials of FX-322 for the treatment of SNHL; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the results </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the Phase 2b trial of FX-322 (FX-322-208), extension trials of FX-322-111 and FX-322-112 or any future clinical trials of FX-322 for the treatment of SNHL or clinical trials of our competitors for the same or similar indication. For example, the price of our common stock decreased significantly following the announcement of our Phase 2a (FX-322-202) interim results, showing that four weekly injections in subjects with mild to moderately severe SNHL did not demonstrate improvements in hearing measures versus placebo, a finding we believe is due to an uncontrolled bias and the limitation to a single baseline measure; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to develop FX-345, our remyelination program, or any additional product candidates based on our PCA platform; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any delay in submitting a regulatory filing and any adverse development or perceived adverse development with respect to the regulatory review of such filing; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">failure to successfully develop and commercialize FX-322 or FX-345 for the treatment of SNHL or any future product candidates; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">inability to obtain additional funding; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">regulatory or legal developments in the United States and other countries applicable to our PCA platform or any product candidate: </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adverse regulatory decisions; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes in the structure of healthcare payment systems; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adverse developments concerning our CMOs or CROs; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">inability to obtain adequate product supply for our other product candidates, or the inability to do so at acceptable prices; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">introduction of new products, services or technologies by our competitors; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to effectively manage our growth; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">failure to meet or exceed financial projections we provide to the public; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">failure to meet or exceed the estimates and projections of the investment community; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes in the market valuations of companies similar to us; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">market conditions in the biotechnology and pharmaceutical sectors, and the issuance of new or changed securities analysts&#x2019; reports or recommendations; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">announcements of significant acquisitions, strategic collaborations, joint ventures or capital commitments by us or our competitors; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the termination of a collaboration agreement, licensing agreement or other strategic arrangement, or the inability to establish additional collaboration arrangements that we need on favorable terms, or at all; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">significant lawsuits and their outcomes, including patent or shareholder litigation, and disputes or other developments relating to our proprietary rights, including patents, litigation matters, and our ability to obtain patent protection for our product candidates and PCA platform; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">additions or departures of key scientific or management personnel; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">sales of our common stock by us or our shareholders in the future; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">81</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">trading volume of our common stock; and </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">general economic, industry and market conditions, including the effects of recession or slow economic growth in the U.S. and abroad, interest rates, fuel prices, international currency fluctuations, corruption, political instability, acts of war, including the hostilities between Russia and Ukraine, acts of terrorism, and the ongoing COVID-19 pandemic or other public health crises. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, the trading prices for common stock of biopharmaceutical companies have been highly volatile as a result of the COVID-19 pandemic. The ongoing COVID-19 pandemic continues to rapidly evolve. The extent to which the outbreak may impact our business and clinical trials will depend on future developments, which are highly uncertain and cannot be predicted with confidence.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our directors, executive officers and shareholders affiliated with our directors and executive officers own a significant percentage of our common stock and, if they choose to act together, will be able to exert significant influence over matters subject to shareholder approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our directors, executive officers, and shareholders affiliated with our directors and executive officers exert significant influence on us. As of March 8, 2022, these holders beneficially owned approximately 17.2% of the voting power of our outstanding common stock. As a result, these holders, acting together, have significant influence over all matters that require approval of our stockholders, including the election of directors, amendments of our organizational documents, or approval of any merger, sale of assets, or other major corporate transactions. The interests of these holders may not always coincide with our corporate interests or the interests of other shareholders, and they may act in a manner with which our shareholders may not agree or that may not be in the best interests of our other shareholders.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Because we do not anticipate paying any cash dividends on our common stock in the foreseeable future, capital appreciation, if any, will be the sole source of gain for our stockholders.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have never declared or paid any cash dividends on our common stock. We currently anticipate that we will retain future earnings for the development, operation and expansion of our business and do not anticipate declaring or paying any cash dividends for the foreseeable future. In addition, our loan and security agreement with Silicon Valley Bank currently prohibits us from paying dividends on our equity securities, and any future debt agreements may likewise preclude us from paying dividends. As a result, capital appreciation, if any, of our common stock will be the sole source of gain on an investment in our common stock for the foreseeable future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We will continue to incur increased costs as a result of operating as a public company, and our management will continue to devote substantial time to compliance initiatives and corporate governance practices.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As a public company, and particularly after we no longer qualify as an emerging growth company, we will continue to  incur significant legal, accounting and other expenses. The Sarbanes-Oxley Act of 2002, or SOX, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the listing requirements of The Nasdaq Stock Market LLC, and other applicable securities rules and regulations impose various requirements on U.S. reporting public companies, including the establishment and maintenance of effective disclosure and financial controls and corporate governance practices. Our management and other personnel will need to devote a substantial amount of time to these compliance initiatives. Moreover, these rules and regulations will increase our legal and financial compliance costs and will make some activities more time consuming and costly. For example, these rules and regulations may make it more expensive for us to obtain director and officer liability insurance, which in turn could make it more difficult for us to attract and retain qualified senior management personnel or members for our board of directors. In addition, these rules and regulations are often subject to varying interpretations, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to Section 404 of SOX, or Section 404, we are required to furnish a report by our senior management on our internal control over financial reporting, and our independent registered public accounting firm is required to provide an attestation report on our internal control over financial reporting. However, while we remain an emerging growth company, our independent registered public accounting firm will not be required to provide the attestation report. To ensure compliance with Section 404, we continue to engage in a process to document and evaluate our internal control over financial reporting, which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants, and adopt a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">82</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">functioning as documented, and implement a continuous reporting and improvement process for internal control over financial reporting. Despite our efforts, there is a risk that we will not be able to conclude, within the prescribed timeframe or at all, that our internal control over financial reporting is effective as required by Section 404. If we identify one or more material weaknesses, it could result in an adverse reaction on the price of our common stock in the market due to a loss of confidence in the reliability of our financial statements. Furthermore, if we are unable to conclude that our internal control over financial reporting is effective, our investors may lose confidence in the accuracy and completeness of our financial reports and the market price of our common stock could decline.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We are an &#x201c;emerging growth company&#x201d; and a &#x201c;smaller reporting company&#x201d; and the reduced disclosure requirements applicable to emerging growth companies and smaller reporting companies may make our common stock less attractive to investors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are an &#x201c;emerging growth company,&#x201d; as defined in the JOBS Act, and a &#x201c;smaller reporting company&#x201d; as defined under the rules promulgated under the Securities Act. As an emerging growth company and a smaller reporting company we may follow reduced disclosure requirements and do not have to make all the disclosures that public companies that are not emerging growth companies or smaller reporting companies do. We will remain an emerging growth company until the earlier of (a) the last day of the fiscal year in which we have total annual gross revenues of $1.07 billion or more; (b) the last day of the fiscal year following the fifth anniversary of the date of the completion of our initial public offering; (c) the date on which we have issued more than $1 billion in nonconvertible debt during the previous three years; or (d) the date on which we are deemed to be a large accelerated filer under the rules of the Securities and Exchange Commission, or SEC, which means the market value of our voting and non-voting common stock that is held by non-affiliates exceeds $700 million as of the last business day of our second fiscal quarter. For so long as we remain an emerging growth company, we are permitted and intend to rely on exemptions from certain disclosure requirements that are applicable to other public companies that are not emerging growth companies. These exemptions include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">not being required to comply with the auditor attestation requirements of Section 404;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">an exemption from compliance with the requirement of the Public Company Accounting Oversight Board regarding the communication of critical audit matters in the auditor&#x2019;s report on the financial statements; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">progressively adding to the number of years of audited financial statements required to be included in our periodic reports; and </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">exemptions from the requirements of holding a nonbinding advisory vote on executive compensation, stockholder approval of any golden parachute payments not previously approved and having to disclose the ratio of the compensation of our chief executive officer to the median compensation of our employees. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected to use the extended transition period for complying with new or revised accounting standards; and as a result of this election, our financial statements may not be comparable to companies that comply with public company effective dates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are also a smaller reporting company, and we will remain a smaller reporting company until the fiscal year following the determination that our voting and non-voting common stock held by non-affiliates is more than $250 million measured on the last business day of our second fiscal quarter, or our annual revenues are more than $100 million during the most recently completed fiscal year and our voting and non-voting common stock held by non-affiliates is more than $700 million measured on the last business day of our second fiscal quarter. Similar to emerging growth companies, smaller reporting companies are able to provide simplified executive compensation disclosure, are exempt from the auditor attestation requirements of Section 404, and have certain other reduced disclosure obligations, including, among other things, being required to provide only two years of audited financial statements and not being required to provide selected financial data, supplemental financial information or risk factors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may choose to take advantage of some, but not all, of the available exemptions for emerging growth companies and smaller reporting companies. We cannot predict whether investors will find our common stock less attractive if we rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our shares price may be more volatile.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">83</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Provisions in our restated certificate of incorporation and our amended and restated bylaws or Delaware law may discourage, delay or prevent a merger, acquisition or other change in control of our company that our shareholders may consider favorable, including transactions in which our shareholders might otherwise receive a premium for their shares.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our restated certificate of incorporation and our amended and restated bylaws include certain anti-takeover provisions, including those establishing:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a classified board of directors with three-year staggered terms, which may delay the ability of stockholders to change the membership of a majority of our board of directors; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no cumulative voting in the election of directors, which limits the ability of minority stockholders to elect director candidates; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the exclusive right of our board of directors to elect a director to fill a vacancy created by the expansion of the board of directors or the resignation, death or removal of a director, which prevents shareholders from filling vacancies on our board of directors; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the ability of our board of directors to authorize the issuance of shares of preferred stock and to determine the terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the ability of our board of directors to alter our bylaws without obtaining stockholder approval; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the required approval of the holders of at least two-thirds of the shares entitled to vote at an election of directors to adopt, amend or repeal our bylaws or repeal the provisions of our restated certificate of incorporation regarding the election and removal of directors: </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual or special meeting of our stockholders; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the requirement that a special meeting of stockholders may be called only by the chairman of the board of directors, the chief executive officer, the president, or the board of directors, which may delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors: and </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">advance notice procedures that stockholders must comply with in order to nominate candidates to our board of directors or to propose matters to be acted upon at a shareholders&#x2019; meeting, which may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer&#x2019;s own slate of directors or otherwise attempting to obtain control of us. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These provisions could also limit the price that investors might be willing to pay in the future for shares of our common stock, thereby depressing the market price of our common stock. In addition, because our board of directors is responsible for appointing the members of our management team, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the General Corporation Law of the State of Delaware, which prohibits a person who owns in excess of 15% of our outstanding voting stock from merging or combining with us for a period of three years after the date of the transaction in which the person acquired in excess of 15% of our outstanding voting stock, unless the merger or combination is approved in a prescribed manner.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our restated certificate of incorporation and amended and restated bylaws designates specific courts as the exclusive forum for certain litigation that may be initiated by our stockholders, which could limit our stockholders&#x2019; ability to obtain a favorable judicial forum for disputes with us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our restated certificate of incorporation specifies that, unless we consent in writing to the selection of an alternative forum to the fullest extent permitted by law, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for (1) any derivative action or proceeding brought on our behalf, (2) any action asserting a claim for breach of a fiduciary duty owed by any of our directors, officers, or other employees to us or our stockholders, (3) any action asserting a claim arising pursuant to any provision of the General Corporation Law of the State of Delaware, our restated certificate of incorporation, or our amended and restated bylaws, (4) any action to interpret, apply, enforce, or determine the validity of our restated certificate of incorporation or our amended and restated bylaws, or (5) any action asserting a claim governed by the internal affairs doctrine. Under our restated certificate of incorporation, this exclusive forum provision will not apply to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">84</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">claims which are vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery of the State of Delaware, or for which the Court of Chancery of the State of Delaware does not have subject matter jurisdiction. In addition, our amended and restated bylaws specifies that unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of America shall, to the fullest extent permitted by law, be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended. These exclusive forum provisions may limit a stockholder&#x2019;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers, or other employees, which may discourage such lawsuits against us and our directors, officers and other employees. For example, stockholders who do bring a claim in the Court of Chancery could face additional litigation costs in pursuing any such claim, particularly if they do not reside in or near the State of Delaware. The Court of Chancery may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments or results may be more favorable to us than to our stockholders. The enforceability of similar choice of forum provisions in other companies&#x2019; certificates of incorporation has been challenged in legal proceedings, and it is possible that, in connection with any applicable action brought against us, a court could find the choice of forum provisions contained in our amended and restated certificate of incorporation to be inapplicable or unenforceable in such action. If a court were to find the choice of forum provisions contained in our amended and restated certificate of incorporation or amended and restated bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could adversely affect our business, financial condition, or results of operations.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">General Risk Factors</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Raising additional capital may cause dilution to our stockholders, restrict our operations or require us to relinquish rights to our technologies or product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Until such time, if ever, as we can generate substantial revenues, we may finance our cash needs through a combination of equity offerings, debt financings, marketing and distribution arrangements and other collaborations, strategic alliances and licensing arrangements or other sources. We do not currently have any committed external source of funds. In addition, we may seek additional capital due to favorable market conditions or strategic considerations, even if we believe that we have sufficient funds for our current or future operating plans.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To the extent that we raise additional capital through the sale of equity or convertible debt securities, our existing stockholders&#x2019; ownership interests will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of our common stockholders. In addition, debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise additional funds through collaborations, strategic alliances or marketing, distribution or licensing arrangements with third parties, we may be required to relinquish valuable rights to our technologies, intellectual property, future revenue streams or product candidates or grant licenses on terms that may not be favorable to us. Furthermore, any capital raising efforts may divert our management from their day-to-day activities, which may adversely affect our ability to advance research programs, product development activities or product candidates. If we are unable to raise additional funds when needed, we may be required to delay, limit, reduce or terminate product candidate development or future commercialization efforts.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Changes to patent laws in the United States and other jurisdictions could diminish the value of patents in general, thereby impairing our ability to protect our products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Changes in either the patent laws or interpretation of patent laws in the United States, including patent reform legislation such as the Leahy-Smith America Invents Act, or the Leahy-Smith Act, could increase the uncertainties and costs surrounding the prosecution of our owned and in-licensed patent applications and the maintenance, enforcement, or defense of our owned and in-licensed issued patents. The Leahy-Smith Act includes a number of significant changes to United States patent law. These changes include provisions that affect the way patent applications are prosecuted, redefine prior art, provide more efficient and cost-effective avenues for competitors to challenge the validity of patents, and enable third-party submission of prior art to the USPTO during patent prosecution, and additional procedures to attack the validity of a patent at USPTO-administered post-grant proceedings, including post-grant review, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">inter partes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> review, and derivation proceedings. Assuming that other requirements for patentability are met, prior to March 2013, in the United States, the first to invent the claimed invention was entitled to the patent, while outside the United States, the first to file a patent application was entitled to the patent. After March 2013, under the Leahy-Smith Act, the United States transitioned to a first-to-file system in which, assuming that the other statutory requirements for patentability are met, the first inventor to file a patent application will be entitled to the patent on an invention regardless of whether a third party was the first to invent the claimed invention. As such, the Leahy-Smith Act and its implementation could increase the uncertainties and costs surrounding the prosecution of</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">85</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, the patent positions of companies in the development and commercialization of biologics and pharmaceuticals are particularly uncertain. Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. This combination of events has created uncertainty with respect to the validity and enforceability of patents once obtained. Depending on future actions by the U.S. Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that could have a material adverse effect on our patent rights and our ability to protect, defend and enforce our patent rights in the future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may not be able to protect our intellectual property and proprietary rights throughout the world.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Filing, prosecuting, and defending patents on product candidates in all countries throughout the world would be prohibitively expensive. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States, and even where such protection is nominally available, judicial and governmental enforcement of such intellectual property rights may be lacking. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we have patent protection or licenses, but enforcement is not as strong as that in the United States. These products may compete with our products, and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets, and other intellectual property protection, particularly those relating to biotechnology products, which could make it difficult for us to stop the infringement of our patents or marketing of competing products in violation of our intellectual property and proprietary rights generally. In addition, certain jurisdictions do not protect, to the same extent or at all, inventions that constitute new methods of treatment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Proceedings to enforce our intellectual property and proprietary rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly, could put our patent applications at risk of not issuing, and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce our intellectual property and proprietary rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Many countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In addition, many countries limit the enforceability of patents against government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of such patent. If we or any of our licensors are forced to grant a license to third parties with respect to any patents relevant to our business, our competitive position may be impaired, and our business, financial condition, results of operations, and prospects may be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may be subject to claims by third parties asserting that our employees, consultants or contractors have wrongfully used or disclosed confidential information of third parties, or we have wrongfully used or disclosed alleged trade secrets of their current or former employers, or claims asserting we have misappropriated their intellectual property, or claiming ownership of what we regard as our own intellectual property.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Many of our employees, consultants and contractors were previously employed at universities or other pharmaceutical or biotechnology companies, including our competitors or potential competitors. Although we try to ensure that our employees, consultants, and contractors do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that these individuals or we have used or disclosed intellectual property, including trade secrets or other proprietary information, of any such individual&#x2019;s current or former employer. Litigation may be necessary to defend against these claims.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">86</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, while it is our policy to require our employees, consultants and contractors who may be involved in the development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who in fact develops intellectual property that we regard as our own. Our intellectual property assignment agreements with them may not be self-executing or may be breached, and we may be forced to bring claims against third parties, or defend claims they may bring against us, to determine the ownership of what we regard as our intellectual property. Such claims could have a material adverse effect on our business, financial conditions, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we fail in prosecuting or defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel, which could have a material adverse effect on our competitive business position and prospects. Such intellectual property rights could be awarded to a third party, and we could be required to obtain a license from such third party to commercialize our technology or products, which license may not be available on commercially reasonable terms, or at all, or such license may be non-exclusive. Even if we are successful in prosecuting or defending against such claims, litigation could result in substantial costs and be a distraction to our management and employees.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We are currently subject to securities class action litigation and could be subject to similar or other litigation in the future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the past, securities class action litigation has often been brought against companies following a decline in the market price of their securities. This risk is especially relevant for us because biotechnology and pharmaceutical companies have experienced significant share price volatility in recent years. For example, the price of our common stock decreased significantly following the announcement of our Phase 2a (FX-322-202) interim results. Following that announcement, on June 3, 2021, and June 22, 2021, purported stockholders of our company filed putative class action lawsuits in the U.S. District Court for the District of Massachusetts against the Company entitled </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Evans v. Frequency Therapeutics, Inc. et al.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Hingston v. Frequency Therapeutics, Inc. et al.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively. The lawsuits allege violations of Section 10(b), 20(a) and Rule 10b5 of the Securities Exchange Act of 1934, as amended, due to allegedly false and misleading statements and omissions about our Phase 2a clinical trial (FX-322-202) for our product candidate FX-322 in our public disclosures between November 16, 2020 and March 22, 2021. The lawsuits seek, among other things, damages in connection with our allegedly artificially inflated stock price between November 16, 2020, and March 22, 2021 as a result of those allegedly false and misleading statements and omissions, as well as interest, attorneys&#x2019; fees and costs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, on June 24, 2021, two purported stockholders of our company filed a lawsuit in the Court of Chancery of the State of Delaware against (i) us, (ii) our Chief Executive Officer, President, and Director, David Lucchino, (iii) Computershare Inc., and (iv) Computershare Trust Company, N.A., entitled </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The Gregory J. Parseghian Revocable Trust</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">et al.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> v. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Frequency Therapeutics, Inc., et al. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The lawsuit asserts causes of action against us of conversion and, in the alternative, unjust enrichment, and against Mr. Lucchino for breach of the fiduciary duty of loyalty, based on allegations that actions were taken to prevent the purported stockholders from selling their shares in the Company. The lawsuit seeks monetary damages, as well as interest, attorneys&#x2019; fees and costs, against all defendants.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We can make no assurances as to the time or resources that will need to be devoted to these lawsuits or their final outcomes, or the impact, if any, of these lawsuits or any proceedings on our business, financial condition, results of operations and cash flows. While we are vigorously defending against all claims asserted, these lawsuits could result in substantial costs to us and a diversion of our management&#x2019;s attention and resources, which could harm our business. In addition, the uncertainty of the pending lawsuits or potential filing of additional lawsuits could lead to more volatility and a reduction in our stock price.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If securities or industry analysts issue an adverse or misleading opinion regarding our common stock, our stock price and trading volume could decline.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The trading market for our common stock is influenced by the research and reports that industry or securities analysts publish about us or our business. If any of the analysts who cover us issue an adverse or misleading opinion regarding us, our business model, our intellectual property or our stock performance, or if our clinical studies and operating results fail to meet the expectations of analysts, our stock price would likely decline. If one or more of these analysts cease coverage of us or fail to publish reports on us regularly, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to decline.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">87</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Sales of a substantial number of shares of our common stock, or the perception that substantial sales might occur, could cause the price of our common stock to fall.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Sales of a substantial number of shares of our common stock, or the perception that these sales might occur, could depress the market price of our common stock and could impair our ability to raise capital through the sale of additional equity securities. The shares of common stock that were sold in the initial public offering of our common stock are freely transferable without restrictions or further registration under the Securities Act of 1933, as amended, or the Securities Act, except for any shares acquired by our affiliates, as defined in Rule 144 under the Securities Act. The remaining shares of our common stock that are outstanding are either unrestricted or restricted as a result of securities laws. In addition, there are shares of common stock that are either subject to outstanding options or reserved for future issuance under our existing equity incentive plans and may become eligible for future sale subject to vesting, and Rule 144 and Rule 701 under the Securities Act. If these additional shares of common stock are sold, or if it is perceived that they will be sold, in the public market, the trading price of our common stock could decline.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The increasing focus on environmental sustainability and social initiatives could increase our costs, harm our reputation and adversely impact our financial results.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There has been increasing public focus by investors, customers environmental activists, the media and governmental and nongovernmental organizations on a variety of environmental, social and other sustainability matters. We may experience pressure to make commitments relating to sustainability matters that affect us, including the design and implementation of specific risk mitigation strategic initiatives relating to sustainability. If we are not effective in addressing environmental, social and other sustainability matters affecting our business, or setting and meeting relevant sustainability goals, our reputation and financial results may suffer. We may experience increased costs in order to execute upon our sustainability goals and measure achievement of those goals, which could have an adverse impact on our business and financial condition.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, this emphasis on environmental, social and other sustainability matters has resulted and may result in the adoption of new laws and regulations, including new reporting requirements. If we fail to comply with new laws, regulations or reporting requirements, our reputation and business could be adversely impacted.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Financial volatility or geopolitical instability outside of the U.S. may adversely impact the U.S.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We could be adversely affected by general conditions in the global economy and in the global financial markets. Global credit and financial markets have experienced volatility and disruptions in the past several years, including severely diminished liquidity and credit availability, declines in consumer confidence, declines in economic growth, increase in unemployment rates and uncertainty about economic stability. Our business and stock price may be adversely affected by any such economic downturn, volatile business environment or large-scale unpredictable or unstable market conditions, including the recent hostilities between Russia and Ukraine which could have a lasting impact on regional and global economies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_1b_unresolved_staff_comments"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 1B. Unresolve</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">d Staff Comments.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">None</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_2_properties"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 2. Pro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">perties.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our principal office is located at 75 Hayden Avenue, Lexington, Massachusetts 02421, where we lease approximately 61,307 square feet of office and laboratory space. The lease term commenced on December 11, 2020 and expires on May 31, 2031.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_3_legal_proceedings"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 3. Legal </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Proceedings.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On June 3, 2021 and June 22, 2021, purported stockholders of our company filed putative class action lawsuits in the U.S. District Court for the District of Massachusetts against us entitled Evans v. Frequency Therapeutics, Inc. et al. and Hingston v. Frequency Therapeutics, Inc. et al., respectively. The lawsuits allege violations of Section 10(b), 20(a) and Rule 10b5 of the Securities Exchange Act of 1934, as amended, due to allegedly false and misleading statements and omissions about our Phase 2a clinical trial (FX-322-202) for our product candidate FX-322 in our public disclosures between November 16, 2020 and March 22, 2021. The lawsuits seek, among other things, damages in connection with our allegedly artificially inflated stock price between November 16, 2020, and March 22, 2021 as a result of those allegedly false and misleading statements and omissions, as well as interest, attorneys&#x2019; fees and costs. We can make no assurances as to the time or</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">88</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">resources that will need to be devoted to these lawsuits or their final outcomes, or the impact, if any, of these lawsuits or any proceedings on our business, financial condition, results of operations and cash flows. We are vigorously defending against all claims asserted in both lawsuits.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On June 24, 2021, two purported stockholders of our company filed a lawsuit in the Court of Chancery of the State of Delaware against (i) us, (ii) our Chief Executive Officer, President, and Director, David Lucchino, (iii) Computershare Inc., and (iv) Computershare Trust Company, N.A., entitled The Gregory J. Parseghian Revocable Trust, et al. v. Frequency Therapeutics, Inc., et al. The lawsuit asserts causes of action against us of conversion and, in the alternative, unjust enrichment, and against Mr. Lucchino for breach of the fiduciary duty of loyalty, based on allegations that actions were taken to prevent the purported stockholders from selling their shares in the Company. The lawsuit seeks monetary damages, as well as interest, attorneys&#x2019; fees and costs, against all defendants. This matter is at the very early stages of the legal process, and as a result, we are not able to estimate a range of possible loss. We are vigorously defending against all claims asserted and have filed a motion to dismiss the complaint, which remains pending.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_4_mine_safety_disclosures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 4. Mine Saf</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ety Disclosures.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Not applicable</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Management</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Executive officers and directors</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table sets forth information regarding our executive officers and directors as of the date of this Annual Report on Form 10-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:25.149%;"></td>
    <td style="width:1.948%;"></td>
    <td style="width:1.521%;"></td>
    <td style="width:5.298%;"></td>
    <td style="width:1.183%;"></td>
    <td style="width:2.376%;"></td>
    <td style="width:62.525%;"></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="border-top:0.750pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Name</span></p></td>
    <td style="border-top:0.750pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span>&#160;</p></td>
    <td colspan="2" style="border-top:0.750pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Age</span></p></td>
    <td style="border-top:0.750pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="border-top:0.750pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">    </span>&#160;</p></td>
    <td style="border-top:0.750pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Position</span></p></td>
   </tr>
   <tr style="height:3.6pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Executive Officers</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">    </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:3.6pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">David L. Lucchino</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">53</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">    </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">President, Chief Executive Officer, Director, and Co-Founder</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Christopher R. Loose, Ph.D.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">    </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Chief Scientific Officer and Co-Founder</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Peter P. Pfreundschuh</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">53</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">    </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Chief Financial Officer</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Carl P. LeBel, Ph.D.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">63</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">    </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Chief Development Officer</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Quentin McCubbin</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">52</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Chief Manufacturing Officer</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Wendy S. Arnold</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">    </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Chief People Officer</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Non-Employee Directors</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">    </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:3.6pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Marc A. Cohen</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">58</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">    </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Chairman and Director</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Timothy J. Barberich</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">74</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">    </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cynthia L. Feldmann</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">69</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Michael Huang</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">48</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">    </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Robert S. Langer, Sc.D.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">73</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">    </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.1pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Joel S. Marcus</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">74</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">    </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Executive officers</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">David L. Lucchino</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> has served as our President and Chief Executive Officer and a member of our board of directors since November 2014 and was a co-founder of our company with Dr. Robert S. Langer and Dr. Christopher R. Loose. From December 2014 until June 2016, Mr. Lucchino served as the President and Chief Executive Officer of Entrega Bio, a</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">89</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">PureTech Health-founded biotechnology company focused on oral drug delivery technology. Prior to that, Mr. Lucchino co-founded Semprus BioSciences, or Semprus, a biotechnology company, and served as its President and Chief Executive Officer from June 2007 to June 2012. Mr. Lucchino oversaw the development of the company&#x2019;s lead medical product, which received FDA clearance in 2012. Semprus was acquired by Teleflex, Inc., or Teleflex, in June 2012. Prior to Semprus, Mr. Lucchino worked at the investment firm Polaris Partners. Mr. Lucchino is the immediate past chairman of the board of directors of MassBio, a non-profit organization that represents and provides services and support for the biotechnology industry in Massachusetts. He is a member of the College of Fellows of the American Institute for Medical and Biological Engineering and was appointed by Governor Charlie Baker as a member of the Commonwealth&#x2019;s Economic Planning Council. Mr. Lucchino also serves as a trustee of Mt. Auburn Hospital, a Harvard Medical School facility, a trustee of the Multiple Myeloma Research Foundation, and a member of the Board of Advisors of Life Science Cares. Mr. Lucchino holds an MBA from the Massachusetts Institute of Technology&#x2019;s, or MIT&#x2019;s, Sloan School of Management, an M.S. from the Newhouse School of Journalism at Syracuse University, and a B.A. in Philosophy and Religious Studies from Denison University. We believe Mr. Lucchino&#x2019;s extensive management experience in the biotechnology and pharmaceutical industry qualifies him to serve on our board of directors.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Christopher R. Loose, Ph.D.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> co-founded our company and has served as our Chief Scientific Officer since January 2016. Prior to our company, Dr. Loose co-founded Semprus with Mr. Lucchino and Dr. Langer and served as its Chief Technology Officer from June 2007 until its acquisition by Teleflex in June 2012. At Semprus, he led the technology team in the development through regulatory clearance of medical products designed to reduce infection and clotting. Prior to Semprus, Dr. Loose worked as a chemical engineer at Merck Research Labs. In 2011, Dr. Loose was awarded the inaugural Peter Strauss Entrepreneurial Award from the Hertz Foundation. Since 2014, Dr. Loose has served as an Associate Professor Adjunct of Urology at the Yale School of Medicine. Dr. Loose is also the Executive Director of Yale University&#x2019;s Center for Biomedical and Interventional Technology. Dr. Loose holds a Ph.D. in Chemical Engineering from MIT and a BSE in Chemical Engineering summa cum laude from Princeton University.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Peter P. Pfreundschuh</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> has served as our Chief Financial Officer since December 2020. He joined our company from UroGen Pharma Ltd., a commercial-stage biopharma company, where he served as Chief Financial Officer, Chief Compliance Officer and Corporate Secretary from August 2018 to October 2020. He brings to our company more than 30 years of finance, business development, commercial and public company leadership experience in the life sciences and medical device industries. Prior to joining UroGen, Mr. Pfreundschuh was the Chief Financial Officer of Sucampo Pharmaceuticals Inc. from March 2017 to February 2018, where he co-led the sale of the company to Mallinckrodt, was EVP and Chief Financial Officer of Immunomedics Inc. from September 2013 to September 2016, and was chief financial officer of the heart pump maker, CircuLite Inc. Mr. Pfreundschuh also has held senior roles across finance, commercial operations and business development within the pharmaceutical industry at AstraZeneca Pharmaceuticals and Johnson &amp; Johnson. He started his career as an auditor at Ernst &amp; Young, LLP. Mr. Pfreundschuh is a Certified Public Accountant and holds an MBA in finance from Rider University. He has completed master&#x2019;s coursework in strategic marketing from Northwestern University&#x2019;s Kellogg School of Management and received his B.S. in accounting from Rutgers University. Mr. Pfreundschuh is currently on the boards of Speratus Therapeutics Inc. and GitBasic.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Carl P. LeBel, Ph.D.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> has served as our Chief Development Officer since March 2018. In 2017, Dr. LeBel founded LeBel Consulting, LLC, a biopharmaceutical consulting company. Prior to joining our company, from February 2009 until November 2016, Dr. LeBel served as the Chief Scientific Officer of Otonomy, Inc., or Otonomy, a biopharmaceutical company where he was responsible for all research and development activities. From 2008 to 2009, he served as the President and Chief Executive Officer of Akesis Pharmaceuticals, Inc., or Akesis, a virtual metabolic disorders company. Prior to Akesis, Dr. LeBel served as an Executive Director in a variety of research and development management positions for Amgen, Inc., or Amgen, a biopharmaceutical company. Before joining Amgen, Dr. LeBel served as a Research Scientist at Alkermes, Inc. Dr. LeBel is a scientific fellow of the American Academy of Otolaryngology and a full member of the American Association for the Advancement of Science and the Society of Toxicology. Dr. LeBel is a co-inventor on numerous patents in the field of drug delivery for otology-related disorders. He was a National Institute of Environmental Health Sciences post-doctoral fellow in Molecular Neurotoxicology at the University of California Irvine. Dr. LeBel holds a Ph.D. in Biomedical Sciences and Toxicology from Northeastern University and a B.S. in Chemistry from the University of Detroit.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Quentin McCubbin, Ph.D. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">has served as our Chief Manufacturing Officer since January 2021. He joined our company from Cerevel Therapeutics, Inc., or Cerevel, a clinical-stage biotechnology company, where he served as Head of Technical Operations for two years. Prior to Cerevel, he spent 19 years at Takeda/Millennium Pharmaceuticals in a variety of roles including six years as Vice President of Pharmaceutical Sciences and Global Head of Process Chemistry. He began his career as a chemist, completing a post-doctoral fellowship at Imperial College in London. He earned his B.S. and Ph.D. in Chemistry from Monash University in Australia.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Wendy S. Arnold </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">has served as our Chief People Officer since February 2020. Ms. Arnold previously served as Senior Vice President, Human Resources at Kaleido Biosciences, Inc., or Kaleido, a healthcare company, where she helped to establish the HR infrastructure, compensation, performance and development programs. Prior to Kaleido, she was the head of the HR business partnership function at Moderna, a biotechnology company, where she helped to lead the HR organization during a period of significant growth, including implementing talent development and engagement initiatives. Prior to that, she was at Celgene Avilomics Research (formerly Avila Therapeutics), where she was responsible for building and developing the HR infrastructure for the company&#x2019;s early research and development division. She also held senior HR positions at Inotek Pharmaceuticals and Amylin Pharmaceuticals. Ms. Arnold received her B.S. from Colorado State University.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Non-Employee Directors</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Marc A. Cohen</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> has served as a member of our board of directors and as Chairman since June 2020 and Executive Chairman from September 2016 to June 2020. Since 2012, Mr. Cohen has served as the Chief Executive Officer of Bublup, Inc., an online knowledge-sharing platform, as well as CoBro Ventures, Inc., an investment management company. Mr. Cohen has also been Executive Chairman of C4 Therapeutics since 2015 and Mana Therapeutics since 2018. Mr. Cohen holds an M.S. in Electrical Engineering from Stanford University and a B.S. in Engineering Science from Harvard University. We believe Mr. Cohen&#x2019;s extensive entrepreneurial experience in the life sciences industry qualifies him to serve on our board of directors.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Timothy J. Barberich</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> has served as a member of our board of directors since September 2016. Mr. Barberich has served on the board of directors of Verastem, Inc. since 2014, and TScan Therapeutics, Inc. since 2019. Mr. Barberich previously served as a director for GI Dynamics, Inc. from 2011 to 2021, Tokai Pharmaceuticals, Inc. from 2009 to 2017, for HeartWare International, Inc. from 2008 to 2016, for Inotek Pharmaceuticals Corporation from 2016 to 2017, and for Neurovance, Inc. from 2010 to 2016. Mr. Barberich is co-founder, and served as the CEO and Chairman of Sepracor Inc. from 1984 to 2009. He holds a B.S. in Chemistry from Kings College. We believe Mr. Barberich&#x2019;s extensive experience in the life sciences industry qualifies him to serve on our board of directors.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cynthia L. Feldmann </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">has served as a member of our board of directors since September 2020 and is the Chair of our Audit Committee. Ms. Feldmann has served as a director of UFPT since June 2017. She chairs the UFPT Audit Committee and serves on the Nominating &amp; Governance Committee. Since 2005, Ms. Feldmann has served on the board of directors of STERIS PLC, or STERIS, a ~$23 billion provider of infection prevention, decontamination, and health science technologies, products and services. She is the Chair of STERIS&#x2019; Nominating &amp; Governance Committee, serves on and was previously Chair of the Audit Committee, and previously served on the Compliance Committee. Ms. Feldmann also served from 2003 to January 2018 on the board of directors of Hanger Inc., or Hanger, a ~$670 million provider of orthotic and prosthetic services and products, and the largest orthotic and prosthetic managed care network in the U.S. Ms. Feldmann served on the Audit Committee, including as Chair of the Audit Committee, the Compensation Committee and the Quality and Technology Committee of Hanger. Ms. Feldmann currently serves on the board of directors and is a member and previous Chair of the Finance Committee of Falmouth Academy, an academically rigorous, co&#x2010;ed college preparatory day school for grades 7 to 12. She was the President and Founder of Jetty Lane Associates, a consulting firm, from 2005 until 2012. Previously, Ms. Feldmann served as Business Development Officer at Palmer &amp; Dodge LLP, a Boston based law firm, with a specialty in serving life sciences companies. From 1994 to 2002, she was a Partner at KPMG LLP, holding various leadership roles in the firm&#x2019;s Medical Technology and Health Care &amp; Life Sciences industry groups. Ms. Feldmann is a retired CPA and holds a B.S. in accounting, and holds a Masters Professional Director Certification from the American College of Corporate Directors. We believe Ms. Feldmann's extensive expertise in auditing and accounting, particularly her experience in the life sciences industry, qualifies her to serve on our board of directors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Michael Huang</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> has served as a member of our board of directors since October 2018. Since 2021, Mr. Huang has served as a member of the board of directors of Windgap Medical, Inc. Mr. Huang has served as a member of the board of directors of Viracta Therapeutics since 2019. Mr. Huang serves as Managing Partner at Taiwania Capital Management Corporation, a venture capital firm. From 2014 to 2017, Mr. Huang served as Chief Executive Officer of NeuroVive Pharmaceutical Asia, Inc., a biopharmaceutical company. Mr. Huang holds an MBA from Rice University, a M.A. in Chemistry from the University of Texas, Arlington, and a B.S. from the University of Texas, Austin. We believe Mr. Huang's extensive investment experience in the life sciences industry qualifies him to serve on our board of directors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Robert S. Langer, Sc.D.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, has served as a member of our board of directors since September 2016. Dr. Langer has served as a David H. Koch Institute Professor at the Massachusetts Institute of Technology since 2005. Dr. Langer currently serves on the board of directors of Rubius Therapeutics, Inc., Moderna, Inc., and Puretech Health plc, and previously served</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">91</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">on the board of directors of Momenta Pharmaceuticals, Inc., Kala Pharmaceuticals, Inc., Fibrocell Science, Inc. and Millipore Corp. Dr. Langer holds a Sc.D. in Chemical Engineering from MIT and a B.S. in Chemical Engineering from Cornell University. We believe Dr. Langer&#x2019;s pioneering academic work, extensive medical and scientific knowledge, and experience serving on public company boards of directors qualify him to serve on our board of directors.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Joel S. Marcus, J.D., CPA</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> has served on our board of directors since December 2018. Mr. Marcus is Executive Chairman and Founder of Alexandria Real Estate Equities, Inc., or Alexandria, the urban office REIT that pioneered life science real estate from a specialty niche to a mainstream asset class and today is the preeminent and longest-tenured owner, operator, and developer uniquely focused on collaborative life science, agtech, and technology campuses in AAA innovation cluster locations. Since co-founding the company in 1994 as a garage startup with $19 million in Series A capital and a mission to advance human health, he has led the remarkable growth of Alexandria into an S&amp;P 500 company that as of December 31, 2021 has a total market capitalization of ~$44 billion, and a total equity capitalization of ~$35 million that ranks it in the top 10% among all publicly traded U.S. REITs. Alexandria, which celebrates its 25th anniversary as a New York Stock Exchange listed company in May 2022, had a total shareholder return exceeding 2,500% as of December 31, 2021. Mr. Marcus also founded and continues to lead Alexandria Venture Investments, Alexandria's strategic venture capital platform. Since its inception in 1996, Alexandria Venture Investments has strategically invested in disruptive life science, agrifoodtech, climate change, and technology companies advancing transformative new modalities and platforms to meaningfully improve human health. With nearly $2 billion in carrying value, Alexandria Venture Investments has been recognized by Silicon Valley Bank as the #1 most active corporate investor in biopharma by new deal volume for five consecutive years and by AgFunder as one of the five most active U.S. agtech investors in 2020. Mr. Marcus also currently serves on the boards of directors of Applied Therapeutics, Inc., Intra-Cellular Therapies, Inc., and MeiraGTx Holdings plc, publicly traded biopharmaceutical companies. He earned his undergraduate and Juris Doctor degrees from the University of California, Los Angeles. We believe that Mr. Marcus&#x2019; extensive experience in the life sciences industry and as a chief executive officer and attorney qualifies him to serve on our board of directors.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">92</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="part_ii"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PAR</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">T II</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_5_market_for_registrants_common_equ"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 5. Market for Registrant&#x2019;s Common Equity, Related Stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">holder Matters and Issuer Purchases of Equity Securities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Market Information</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our common stock is traded under the symbol &#x201c;FREQ&#x201d; on the Nasdaq Global Select Market.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On March 8, 2022, there were approximately 78 registered holders of record of our common stock. The actual number of stockholders is greater than this number of record holders, and includes stockholders who are beneficial owners, but whose shares are held in street name by brokers and other nominees. The number of holders of record also does not include stockholders whose shares may be held in trust by other entities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Dividend Policy</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have never declared or paid any dividends on our capital stock. We currently intend to retain all available funds and any future earnings, if any, to fund the development and expansion of our business and we do not anticipate paying any cash dividends in the foreseeable future. Any future determination to pay dividends will be made at the discretion of our board of directors and will require approval from Silicon Valley Bank under the terms of our loan and security agreement. Investors should not purchase our common stock with the expectation of receiving cash dividends.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Equity Compensation Plan Information</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table provides information on our equity compensation plans as of December 31, 2021.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:11.5pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:35.712%;"></td>
    <td style="width:1.401%;"></td>
    <td style="width:19.113%;"></td>
    <td style="width:2.077%;"></td>
    <td style="width:1.401%;"></td>
    <td style="width:18.925%;"></td>
    <td style="width:1.58%;"></td>
    <td style="width:18.925%;"></td>
    <td style="width:0.865%;"></td>
   </tr>
   <tr style="height:7.9pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.08333333333333333in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Number of Securities</span></p></td>
   </tr>
   <tr style="height:7.9pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.09722222222222222in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Remaining Available for Future</span></p></td>
   </tr>
   <tr style="height:7.9pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Number of Securities to be</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.09722222222222222in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Issuance Under Equity</span></p></td>
   </tr>
   <tr style="height:7.9pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Issued Upon Exercise of</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.2361111111111111in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Weighted-Average Exercise</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.08333333333333333in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Compensation Plans</span></p></td>
   </tr>
   <tr style="height:7.9pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Outstanding Options,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.2361111111111111in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Price of Outstanding Options,</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.08333333333333333in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(excludes securities</span></p></td>
   </tr>
   <tr style="height:8.65pt;">
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Plan Category</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Warrants and Rights</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.2361111111111111in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Warrants and Rights</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.08333333333333333in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">reflected in first column) </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">(1)</span></p></td>
   </tr>
   <tr style="height:10.8pt;">
    <td style="border-top:1.000pt solid;background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Equity compensation plans approved by</span></p></td>
    <td style="border-top:1.000pt solid rgba(207,240,252,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="border-top:1.000pt solid;background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="border-top:1.000pt solid rgba(207,240,252,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="border-top:1.000pt solid;background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="border-top:1.000pt solid;background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="border-top:1.000pt solid rgba(207,240,252,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="border-top:1.000pt solid;background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="border-top:1.000pt solid rgba(207,240,252,1);background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:11.5pt;">
    <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:7.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:7.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">security holders </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:Times New Roman;">(2)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;6,830,037</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:Times New Roman;">(3)</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#160;14.72</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:Times New Roman;">(4)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,508,651</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.5pt;font-family:Times New Roman;">(5)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.8pt;">
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Equity compensation plans not approved by</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:11.5pt;">
    <td colspan="2" style="background-color:rgba(0,0,0,0);text-indent:7.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:7.0pt;text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">security holders</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.125in;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.08333333333333333in;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
   </tr>
   <tr style="height:11.5pt;">
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Total</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">                                                                                                </span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:1.000pt solid;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">6,830,037</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:1.000pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:1.000pt solid;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">14.72</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:1.000pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:1.000pt solid;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">2,508,651</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:1.000pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:9.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:11.2pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to the terms of the 2019 Incentive Award Plan, or the 2019 Plan, the number of shares of common stock available for issuance under the 2019 Plan automatically increases on each January 1 until and including January 1, 2029, by an amount equal to the lesser of: (a) 4% of the shares of common stock outstanding on the final day of the immediately preceding calendar year and (b) such smaller number of shares as is determined by our board of directors. Pursuant to the terms of the 2019 Employee Stock Purchase Plan, or the 2019 ESPP, the number of shares of common stock available for issuance under the 2019 ESPP automatically increases on each January 1 until and including January 1, 2029, by an amount equal to the lesser of: (a) 1% of the shares of common stock outstanding on the final day of the immediately preceding calendar year and (b) such smaller number of shares as is determined by our board of directors.</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Consists of the 2014 Stock Incentive Plan, or the 2014 Plan, the 2019 Plan, and the 2019 ESPP.</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(3)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Includes 2,931,005 outstanding options to purchase shares of common stock under the 2014 Plan and 3,899,032 outstanding options to purchase stock under the 2019 Plan.</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(4)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021, the weighted-average exercise price of outstanding options under the 2014 Plan was $2.99 and the weighted-average exercise price per share of outstanding options under the 2019 Plan was $23.54.</span></div></div>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(5)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021, a total of 2,508,651 shares of common stock were available for issuance, consisting of (a) 956,021 shares of common stock available for future issuance under the 2019 ESPP, none of which shares were subject to outstanding purchase rights under the 2019 ESPP and (b) 1,552,630 shares of common stock available for future issuance under the 2019 Plan.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">93</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Recent Sales of Unregistered Equity Securities</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">During the period covered by this Annual Report on Form 10-K, we did not issue any securities which were unregistered under the Securities Act and required to be disclosed herein.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Use of Proceeds</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In October 2019, we issued and sold 6,325,000 shares of our common stock in our IPO at a public offering price of $14.00 per share.  The offer and sale of all the shares in the IPO were registered under the Securities Act pursuant to a registration statement on Form S-1 (File No. 333-233652), as amended, which was declared effective by the SEC on October 2, 2019.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The $79.7 million in net proceeds we received from the IPO have been invested in cash and cash equivalents. There has been no material change in the expected use of the net proceeds from our IPO as described in our final prospectus, dated October 2, 2019, filed with the SEC pursuant to Rule 424(b) relating to our registration statement on Form S-1 on October 4, 2019.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">94</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_7_managements_discussion_analysis_f"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 7. Management&#x2019;s Discussion and Analysis of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Financial Condition and Results of Operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">You should read the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and the related notes and other financial information included elsewhere in this Annual Report on Form 10-K. Some of the information contained in this discussion and analysis contains forward-looking statements that involve risks and uncertainties. You should review the section titled &#x201c;Risk factors&#x201d; in this Annual Report on Form 10-K for a discussion of important factors that could cause actual results to differ materially from the results described below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Overview</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person&#x2019;s innate regenerative potential to restore function. Our focus is on advancing our lead product candidate, FX-322, through clinical studies with the goal of developing and commercializing a medicine to help millions of people with the most common form of hearing loss while continuing to broaden the potential of our regenerative approach in other applications. We believe we are a leading company using mitotic regeneration for cochlear sensory hair cell regeneration and that FX-322 has the potential to meaningfully improve overall hearing function and enhance quality of life for people with this condition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our initial therapeutic focus is sensorineural hearing loss, or SNHL, which is the most prevalent type of hearing loss. We are developing FX-322 to treat a major underlying cause of SNHL, which is the loss of hair cells. FX-322 is designed to regenerate hair cells through the activation of progenitor cells already present in the ear. In our Phase 1/2 clinical trial (FX-322-201) evaluating FX-322 in 23 subjects with stable SNHL, we observed a statistically significant and clinically meaningful improvement in key measures of hearing loss, including word recognition, or WR, and clarity of sounds, and FX-322 was observed to be well-tolerated.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2021, we announced topline, day-90 interim data from the Phase 2a clinical trial (FX-322-202), and in June 2021, we announced final results from the Phase 2a clinical trial (FX-322-202). The goals of the FX-322-202 trial were to further establish the hearing signal observed in the Phase 1/2 clinical trial(FX-322-201), evaluate the impact of multiple doses and provide insights on endpoints and patient population for further studies. Both day-90 interim data and the end-of-study results (as of day 210) showed that four weekly injections of FX-322 did not demonstrate improvements in any hearing measures versus placebo, a finding we believe is due to an uncontrolled bias and the limitation to a single baseline measure. We also observed an unexpected increase in WR scores in the placebo group that did not occur in previous FX-322 trials and exceeded well-established published standards, potentially suggesting bias due to trial design. Given this lack of reliability of baseline WR scores of the placebo group, we were unable to evaluate hearing improvements in WR scores for FX-322 dosing regimens versus placebo. Both the interim data and end-of-study results showed a favorable safety and tolerability profile for FX-322.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2021, we also announced data from a Phase 1b clinical trial of FX-322 that was designed to evaluate the impact of injection conditions on tolerability (FX-322-111). The data showed hearing improvement from a single injection of FX-322. In the multi-center, randomized study, subjects with mild to severe SNHL (n=33) were injected in one ear with FX-322 with the untreated ear as the control. Hearing function was tested over the course of 90 days following dosing. Thirty-two subjects completed the 90-day clinical assessment period and, at day 90 following dosing, 34% of these subjects achieved a 10% or greater absolute improvement in WR scores in the treated ear, which was clinically meaningful and statistically significant compared to the untreated ear (p &lt;0.05). This included a subset of subjects that more than doubled their WR scores. Twenty-five subjects were subsequently evaluated during the 8 to 12 months following FX-322 dosing and, as of September 22, 2021, nine subjects, including the five initial responders at day 90, had shown statistically significant hearing improvements when evaluated during this time period. Of the five subjects that showed a statistically significant response and doubled their WR scores at day 90, four of these returned for evaluation and had scores that remained above their baseline word recognition measures, though were below the threshold for statistical significance. In this trial, FX-322 showed a favorable safety profile and was well tolerated.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In May 2021, we announced data from a Phase 1b clinical trial of FX-322 in presbycusis (age-related hearing loss) (FX-322-112). The double-blind, placebo-controlled, randomized, multicenter safety study enrolled 30 individuals aged 66-85 with age-related hearing loss. Study participants were randomized 4:1 to receive either FX-322 or placebo in one ear. Validated hearing measures, as well as safety, otologic and audiologic assessments were also evaluated in the study. By design, the study recruited subjects with no medical history of noise-induced or sudden sensorineural hearing loss (SSNHL), etiologies where FX-322 associated hearing benefits were observed in prior studies, as we continue to separately evaluate subjects with specific forms of hearing loss to better refine cohorts for future studies. While the treatment effect was not</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">95</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">significant compared to placebo, results from the study showed a favorable safety and tolerability profile with no reported treatment-related serious adverse events.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2021 we announced data from a Phase 1b clinical trial of FX-322 in subjects aged 18-65 with severe SNHL (FX-322-113). The trial enrolled 31 subjects with Severe SNHL, defined as a pure tone average deficit between 71-90 dB. Many subjects with this clinical profile typically would be candidates for cochlear implants. The primary objectives of the study were to assess the local and systemic safety of a single dose of FX-322 and evaluate hearing responses in a more severe adult cohort. Study participants were randomized 4:1 to receive either FX-322 or placebo in one ear. Validated measures of hearing including WR, sentences in noise, and pure tone audiometry were utilized in the study. Safety, otologic and audiologic assessments were conducted at days 30 and 90 following administration of FX-322 or placebo. To gain a more comprehensive understanding of the potential impact of FX-322 in this population, we evaluated hearing using multiple tests of speech perception in both quiet and noisy backgrounds, including the Bamford-Kowal-Bench Sentence-in-Noise exam, or BKB-SIN. In this study, BKB-SIN test improvements were observed in four subjects, all of whom exceeded the 95 percent critical difference of 3.1dB SNR, with two subjects showing a 6dB response. A single placebo subject had a 3.6dB change. In the study, subjects did not show substantial changes in speech perception measures in quiet, the safety profile in the study was favorable and there were no treatment-related serious adverse events reported.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In October 2021, we commenced dosing of a Phase 2b clinical trial of FX-322 (FX-322-208) in subjects with SNHL. FX-322-208 is a randomized, placebo-controlled, multi-center study designed to evaluate the impact of a single administration of FX-322 on speech perception in approximately 124 subjects with either noise-induced or sudden SNHL, the same hearing loss severities and etiologies as those subject in which statistically significant improvements in speech perception were observed in prior FX-322 clinical trials. The study&#x2019;s primary endpoint is speech perception, a measure of sound clarity and understanding speech. In a Type-C meeting with the U.S. Food and Drug Administration, or the FDA, the FDA agreed that speech perception is an acceptable primary efficacy endpoint.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In November 2021, we introduced our new SNHL investigational therapeutic program, FX-345. This program </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">may offer some advantages as we look to expand the opportunity to treat different types of sensory neural hearing loss. Specifically, FX-345 </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">was designed to achieve broader exposure </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">through a large portion of the cochlea to assess if FX-345 could have an even bigger patient impact or help a broader population than FX-322</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Additionally, d</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">eeper delivery into the cochlea using FX-345 may extend the reach of our approach. Further, FX-345 has greater flexibility and dose selection and formulation, enabling us to evaluate a range of different dose levels. </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cochlear pharmacokinetic measures and human modeling data in a preclinical setting show</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> FX-345 achieves greater exposure through a larger portion of the cochlea for longer time. </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We anticipate filing an IND for FX-345 in the second half of 2022.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe our PCA approach can impact a wide range of degenerative diseases. To that end, in addition to our lead program in hearing, we are working to rapidly advance discovery efforts using our PCA approach to potentially remyelinate nerves in individuals with multiple sclerosis, or MS. MS induces demyelination, stripping axons of the myelin sheaths that support nerve signal conduction and axonal survival. Prior to initiating our internal discovery program against a novel target, we licensed intellectual property from Scripps and Cambridge Enterprise on approaches to promote remyelination of nerve fibers. We continue to engage in sponsoring clinical research to validate this initial approach at Cambridge University. In November 2021, we introduced FREQ-162, an internally discovered preclinical stage compound that has been shown to induce substantially more remyelination than published comparator approaches based on </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> models. Our efforts are focused on advancing Frequency compounds in preclinical safety studies to enable the initiation of clinical trials in 2023.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since our formation in 2014, we have devoted substantially all our resources to developing our PCA platform, conducting research and development activities, including product candidate development, recruiting skilled personnel, establishing our intellectual property portfolio, and providing general and administrative support for these operations. We have financed our operations primarily through proceeds from the sale of convertible notes, convertible preferred stock, the common stock and the Astellas Agreement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since our formation, we have incurred significant operating losses and have not generated any revenue from the sale of products. Our ability to generate any product revenue or product revenue sufficient to achieve profitability will depend on the successful development and eventual commercialization of one or more of our product candidates. Our net losses were $84.7 million and $26.5 million for the years ended December 31, 2021 and 2020, respectively. As of December 31, 2021, we had an accumulated deficit of $180.1 million. During the periods presented, we do not have any off balance sheet arrangements as  defined under SEC rules.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect our operating expenses to increase substantially in connection with the expansion of our product development programs around FX-322, FX-345, FREQ-162 and any future programs. In addition, we expect to continue to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">96</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">incur significant additional costs associated with operating as a public company. We will not generate revenue from product sales unless and until we successfully complete clinical development, obtain regulatory approval for, and successfully commercialize our product candidates, or until our collaborators do so, which could result in milestone payments or royalties to us. If we obtain regulatory approval for any of our product candidates, we expect to incur significant expenses related to developing our commercialization capability to support product sales, marketing and distribution.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As a result of these anticipated expenditures, we will need additional financing to support our continuing operations. Until such time as we can generate significant revenue from product sales, if ever, we expect to finance our cash needs through a combination of public or private equity or debt financings and other sources, which may include current and new collaborations with third parties. Adequate additional financing may not be available to us on acceptable terms, or at all. Our inability to raise capital as and when needed would have a negative impact on our financial condition and our ability to pursue our business strategy. We cannot be sure that we will ever generate sufficient revenue to achieve profitability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Because of the numerous risks and uncertainties associated with the development of therapeutics, we are unable to predict the timing or amount of increased expenses or when or if we will be able to achieve or maintain profitability. Even if we can generate revenue from product sales, we may not become profitable. If we fail to become profitable or are unable to sustain profitability on a continuing basis, then we may be required to raise additional capital on terms that are unfavorable to us or we may be unable to continue our operations at planned levels and be forced to reduce or terminate our operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our offices are located in states that have lifted many COVID-19 restrictions. As of the date of the filing of this Annual Report, the majority of our non-laboratory based employees continue to work from home two to three days per week, while our laboratory personnel have largely resumed a full in-person schedule in our Lexington, MA facility. We have also taken steps consistent with the FDA&#x2019;s updated industry guidance for conducting clinical trials. The continuing COVID-19 pandemic, and actions taken to mitigate it, have had and are expected to continue to have an impact on the economies and financial markets of many countries, including the geographical area in which we operate, which could adversely impact our ability to raise additional capital when needed or on acceptable terms, if at all. In addition, COVID-19 may cause disruptions in our business or operations, as well as the business and operations of our CMOs, CROs and other third parties with whom we conduct business. The COVID-19 pandemic may also adversely impact our clinical trials, which could impede, delay, limit or prevent the clinical development of our product candidates and ultimately lead to the delay or denial of regulatory approval of our product candidates, which would materially adversely affect our business and operations, including our ability to generate revenue.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">License and collaboration agreements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Astellas Pharma Inc.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In July 2019, we entered into the Astellas Agreement with Astellas, under which we granted Astellas an exclusive, royalty-bearing, sub-licensable, nontransferable license to certain patent rights to research, develop, manufacture, have manufactured, use, seek, and secure regulatory approval for, commercialize, offer for sale, sell, have sold and import, and otherwise exploit licensed products containing both a GSK-3 inhibitor and an HDAC inhibitor, or the Astellas licensed products, including our product candidate FX-322, outside of the United States. We and Astellas have agreed to jointly develop the Astellas licensed products, including carrying out joint studies. Each party has agreed to use commercially reasonable efforts to carry out development activities assigned to it under an agreed-upon development plan. Astellas has agreed to use commercially reasonable efforts to obtain regulatory approval for at least one Astellas licensed product in SNHL and in age-related hearing loss, in each case in one major Asian country and one major European country. We have agreed to use commercially reasonable efforts to obtain regulatory approval for at least one Astellas licensed product in the United States. Astellas has the sole right to commercialize the Astellas licensed products outside of the United States and we have the sole right to commercialize the Astellas licensed products in the United States. Astellas has agreed to use commercially reasonable efforts to commercialize Astellas licensed products in a major Asian country and a major European country following receipt of regulatory approval in such countries.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As a consideration for the licensed rights under the Astellas Agreement, Astellas paid us an upfront payment of $80.0 million in July 2019 and has agreed to pay potential development milestones up to $230.0 million. Specifically, we would receive development milestone payments of $65.0 million and $25.0 million upon the first dosing of a subject in Phase 2b clinical trial for SNHL in Europe and Asia, respectively and $100.0 million and $40.0 million upon the first dosing of a subject in a Phase 3 clinical for SNHL in Europe and Asia, respectively. If the Astellas Licensed Products are successfully commercialized, we would be eligible for up to $315.0 million in potential commercial milestone payments and tiered royalties at rates ranging from low to mid-teen percentages. The parties shall share equally, on a 50/50 basis, all out-of-pocket costs and joint study costs for all the joint activities conducted pursuant to the development plans or the joint manufacturing plan. Pursuant to our Exclusive Patent License Agreement, or the MIT License, with the Massachusetts Institute of Technology, or MIT, we are required to pay MIT a royalty on sublicense revenues. A royalty of $16.0 million</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">97</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">related to the $80.0 million upfront payment received from Astellas was expensed in the quarter ended September 30, 2019 and paid in November 2019. The $80.0 million upfront payment received from Astellas in July 2019 was recorded as deferred revenue and recognized as revenue, using the input method, over the period from execution of the agreement through June 30, 2021, when the Phase 2a clinical trials were completed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Massachusetts Institute of Technology</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2016, we entered into the MIT License, with MIT under which we received an exclusive, worldwide, royalty-bearing license to certain patent rights to develop, make, have made, use, sell, offer to sell, lease, and import products, or the MIT licensed products, and to develop and perform processes, or the MIT licensed processes, which incorporate the licensed technology for the treatment of disease, including but not limited to the prevention and remediation of hearing loss. We are required to use diligent efforts to develop and commercialize the MIT licensed products or processes, and to make such products or processes reasonably available to the public. We are also subject to certain development obligations with regards to a first MIT licensed product. We have satisfied certain obligations related to preclinical studies and the filing of an IND for a first MIT licensed product with our development activities related to FX-322. Our future development obligations are: (i) to commence a Phase III clinical trial for such product within five years of the IND filing for such product, (ii) to file a New Drug Application, or NDA, or equivalent with the FDA or comparable European regulatory agency for such product within nine years of the IND filing for such product, and (iii) to make a first commercial sale of such product within 11 years of the IND filing for such product. We also have certain development obligations with regards to a second MIT licensed product.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon entering into the MIT License, we paid a $50 thousand license fee payment and issued shares of our common stock equal to 5% of our then-outstanding capital stock to MIT. We are required to pay certain annual license maintenance fees ranging from $30 thousand to $0.1 million per year prior to first commercial sale of a MIT licensed product and an annual license maintenance fee of $0.2 million every year afterwards, which may be credited to running royalties during the same calendar year, if any. We are also required to make potential milestone payments in an aggregate amount of up to $2.9 million on each MIT licensed product or process. In addition, we agreed to pay a low single-digit royalty on the MIT licensed products and processes and a low-twenties royalty on sub-license revenues.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2022, we entered into an amendment with MIT, removing a patent and certain patent applications from the MIT License Agreement which were unrelated to our hearing and MS programs and which we were not utilizing.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Massachusetts Eye and Ear (Formerly Massachusetts Eye and Ear Infirmary)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In February 2019, we entered into an Non-Exclusive Patent License Agreement, or the MEE License, with the Massachusetts Eye and Ear, or MEE, under which we received a non-exclusive, non-sub-licensable, worldwide, royalty-bearing license to certain patent rights to develop, make, have made, use, sell, offer to sell, lease, and import products, and to develop and perform processes that incorporate the licensed technology for the treatment or prevention of hearing loss, or the MEE licensed products. We are obligated to use diligent efforts to develop and commercialize the MEE licensed products. We met one of our milestone timeline obligations by dosing a first subject in a Phase II trial by December 31, 2020. We are still subject to a milestone timeline obligation to dose a first subject in a Phase III trial by December 31, 2024.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon entering into the MEE License, we made a $20 thousand license fee payment. We are obligated to pay certain annual license maintenance fees between $5 thousand and $7.5 thousand per each MEE patent family case number included in the licensed MEE patent rights prior to first commercial sale of an MEE licensed product. We are also obligated to pay a minimum annual royalty payment of $15 thousand per each MEE patent family case number included in the licensed MEE patent rights after first commercial sale of an MEE licensed product. We are also obligated to make milestone payments up to $350 thousand on each product or process that incorporates the licensed patent rights. In addition, we have agreed to pay a low single-digit royalty on products and processes that incorporate the licensed patent rights.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The Scripps Research Institute (California Institute for Biomedical Research)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In September 2018, we entered into a license agreement, or the CALIBR License, with the California Institute for Biomedical Research, or CALIBR, a division of Scripps, under which we received an exclusive, worldwide, royalty-bearing license to certain patent rights to make, have made, use, sell, offer to sell, and import products, or the CALIBR licensed products, which incorporate licensed technology for the treatment of MS. We have agreed to use commercially reasonable efforts to develop, manufacture, and sell at least one CALIBR licensed product. We are also subject to certain milestone timeline obligations, which may be extended in certain circumstances as described in the CALIBR License. In October 2021, we entered into an amendment with CALIBR which updated the milestone obligations to: (i) initiate a Phase II clinical trial</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">98</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(or equivalent) for a CALIBR licensed product by December 31, 2023 and (ii) initiate a Phase III clinical trial (or equivalent) for a CALIBR licensed product by December 31, 2025.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon entering into the CALIBR License, we made a $1.0 million license fee payment, and are required to make milestone payments in an aggregate amount of up to $26.0 million for each category of CALIBR licensed products. Category 1 is any CALIBR licensed products containing a compound that modulates any muscarinic receptor, and Category 2 is any CALIBR licensed products not included in Category 1 that could differentiate oligodendrocyte precursor cells from </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> studies and/or are active in animal models relevant to MS. We are also required to pay a mid-single-digit royalty on CALIBR licensed products and a royalty on sub-license revenues ranging from a low-teen percentage to 50%.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The Scripps Research Institute</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In September 2018, we entered into a Research Funding and Option Agreement, or the Scripps option agreement, with Scripps (CALIBR is a division of Scripps), under which we provided funding to Scripps to pursue certain MS research activities on selected targets. In the same agreement, we were granted an exclusive option to acquire an exclusive, sublicensable, worldwide license under certain intellectual property arising from the MS research activities on the selected targets. The Scripps option agreement, including the MS research activities and the exclusive option, terminated on December 31, 2021. The CALIBR License remains active.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cambridge Enterprise Limited</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2019, we entered into an Exclusive Patent License Agreement, or the Cambridge License, with Cambridge, under which we received an exclusive, worldwide, royalty-bearing license to certain patent rights to make, have made, use, sell, offer to sell, and import products, or the Cambridge licensed products, which incorporate licensed technology for the treatment of demyelinating diseases. We also have the right to grant sublicenses under the Cambridge License. Cambridge reserves the right to use for itself (as well as the investors and the funder) and the right to grant nonexclusive licenses to other academic institutions for any academic publication, research and teaching and clinical patient care.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have agreed to use diligent and good faith efforts to develop and commercially exploit at least one Cambridge licensed product. Upon entering into the Cambridge License, we made a $50 thousand license fee payment. We are obligated to pay an annual license fee of $50 thousand. We are also obligated to make milestone payments up to $10.5 million on each Cambridge licensed product. In addition, we have agreed to pay a low single-digit royalty on products that incorporate the licensed patent rights, subject to offset in certain circumstances.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Cambridge License continues in effect on a country-by-country basis until the expiration or revocation, without right of further appeal, of all licensed issued patents and filed patent applications, unless terminated earlier. We have the right to terminate for any reason upon 90 days&#x2019; prior written notice. Each party has the right to terminate immediately if the other party ceases to carry on its business. Either party may also terminate the Cambridge License for material breach if such breach remains uncured for 30 days. Cambridge may also terminate the Cambridge License if we fail to diligently develop and commercially exploit at least one Cambridge licensed product or we or our affiliates or sub-licensees commence any action against Cambridge to declare or render any claim of the licensed patent rights invalid, unpatentable, unenforceable, or not infringed.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Components of our results of operations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Revenue</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To date, we have not generated any revenue from product sales and do not expect to generate any revenue from product sales in the foreseeable future. In July 2019, we entered into the Astellas Agreement and received an upfront license fee payment of $80.0 million. In the year ended December 31, 2021, we recognized $14.1 million of the $80.0 million upfront fee as revenue. In the years ended December 31, 2020, we recognized $37.0 million of the $80.0 million upfront fee as revenue.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and development expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development expenses consist primarily of costs incurred for our research activities. These research and development activities are largely focused on hearing restoration, specifically our lead product candidate FX-322 and new</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">99</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">investigational therapeutic program FX-345, and MS, specifically early-stage research related to our novel target FREQ-162. These expenses include the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">salaries, benefits and other related costs, including stock-based compensation expense, for personnel engaged in research and development functions; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">expenses incurred under agreements with third parties, including contract research organizations, or CROs, and other third parties that conduct preclinical research and development activities and clinical trials on our behalf; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">costs to manufacture our clinical trial material for use in our preclinical studies and clinical trials; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">costs of outside consultants, including their fees and related travel expenses; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">costs of laboratory supplies and acquiring, developing and manufacturing preclinical study and clinical trial materials; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">option and license payments made to third parties, including MIT, Scripps, MEEI and Cambridge, for intellectual property used in research and development activities; and </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">facility-related expenses, which include direct depreciation costs and expenses for rent and maintenance of facilities and other operating costs if specifically, identifiable to research activities. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expense research and development costs as incurred.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We track external research and development costs, including the cost of services, outsourced research and development, clinical trials, contract manufacturing, laboratory equipment and maintenance, and certain other development costs, by product candidate when the costs are specifically identifiable to a product candidate. Internal and external costs associated with infrastructure resources, other research and development costs, facility-related costs, and depreciation and amortization that are not identifiable to a specific product candidate are included in the platform development, early-stage research, and unallocated expenses category.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect that our research and development expenses will continue to increase substantially for the foreseeable future as we conduct our Phase 2b trial of FX-322 (FX-322-208) and extension trials of FX-322-111 and FX-322-112, continue ongoing activities related to FX-345 and FREQ-162, initiate additional clinical trials, and continue to discover and develop additional product candidates. We have in the past and may in the future need to engage additional third parties and CROs earlier than we might normally do so in response to limitations on these CROs services as a result of the COVID-19 pandemic to advance these activities. Product candidates in later stages of clinical development generally have higher development costs than those in earlier stages of clinical development, primarily due to increased scale, duration and the higher costs associated with later stage clinical trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We cannot determine with certainty the duration and costs of future clinical trials of FX-322 or any other product candidate we may develop or if, when, or to what extent we will generate revenue from the commercialization and sale of any product candidate for which we obtain marketing approval. The duration, costs, and timing of clinical trials and development of FX-322 and any other product candidate we may develop will depend on a variety of factors, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the scope, rate of progress, expense and results of clinical trials of FX-322, as well as of any future clinical trials of other product candidates and other research and development activities that we may conduct; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the actual probability of success for our product candidates, including their safety and efficacy, early clinical data, competition, manufacturing capability, and commercial viability; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">significant and changing government regulation and regulatory guidance; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the timing and receipt of any marketing approvals; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the progress of the development efforts of parties with whom we may enter into collaboration agreements; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to secure manufacturing supply through relationships with third parties; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the commercialization of our product candidates, if and when approved; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the expense of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; and</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1260416666666666;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the impact of COVID-19 on our Phase 2b clinical trial of FX-322 (FX-322-208) and extension trials of FX-322-111 and FX-322-112.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A change in the outcome of any of these variables with respect to the development of a product candidate could mean a significant change in the costs and timing associated with the development of that product candidate.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">General and administrative expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1260416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative expenses consist primarily of salaries and other related costs, including stock-based compensation, for personnel in our executive, finance, business development, and administrative functions. General and administrative expenses also include legal fees relating to intellectual property and corporate matters; professional fees for accounting, auditing, tax and consulting services; insurance costs; travel expenses; and facility-related expenses, which include direct depreciation costs and expenses for rent and maintenance of facilities, and other operating costs that are not specifically attributable to research and development activities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect that our general and administrative expenses will increase in the future as we increase our personnel headcount to support our business. In addition, we expect to continue to incur increased expenses associated with being a public company, including costs of accounting, audit, legal, regulatory, and tax-related services associated with maintaining compliance with the requirements of The Nasdaq Stock Market LLC and the SEC; director and officer insurance costs; and investor and public relations costs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Interest income</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Interest income consists of interest earned on cash equivalents and marketable securities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Interest expense</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Interest expense consists of interest paid on our term loan.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Realized (loss) gain on investments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Realized (loss) gain on investments represents the loss or gain realized on our marketable securities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Foreign exchange gain (loss)</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Foreign exchange gain (loss) represents the gain or loss recorded as a result of remeasuring the financial statements of our foreign subsidiaries.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Other expense, net</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other expense, net consists of amortization expense and accretion income on investments.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income taxes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since our inception in 2014, we have generated cumulative federal and state net operating loss and research and development credit carryforwards for which we have not recorded any net tax benefit due to uncertainty around utilizing these tax attributes within the respective carryforward periods.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021, we had federal net operating loss carryforwards of approximately $149.1 million and Massachusetts state operating loss carryforwards of approximately $83.5 million which may be available to offset future taxable income. The U.S. federal net operating loss carryforwards include $22.4 million available to reduce future taxable income through 2037 and approximately $126.7 million which do not expire and are available to reduce future taxable income indefinitely. The state net operating loss carryforwards are available to offset future taxable income through 2041. As of December 31, 2021, we also had federal and Massachusetts research and development tax credit carryforwards of $5.2 million and $2.1 million, respectively, which are available to offset federal and state tax liabilities through 2041 and 2036, respectively. Realization of future tax benefits is dependent on many factors, including our ability to generate taxable income within the net operating loss carryforward period. Net operating loss and tax credit carryforwards may become subject to an annual limitation in the event of certain cumulative changes in the ownership interest of significant shareholders over a three-year period in excess of 50%, as provided under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, respectively, as well as similar state provisions. These ownership changes may limit the number of carryforwards that can be</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">utilized annually to offset future taxable income. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by more than 50% over a three-year period. We have completed several financings and have conducted a study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception and have determined that an ownership change did occur in March 2017. Accordingly, utilization of $12.4 million of the U.S. net operating loss carryforwards which were incurred prior to March 2017 (pre-ownership change) is limited under Section 382. After the Section 382 limitations, we may utilize approximately $10.8 million of our pre-ownership change net operating loss carryforwards based upon an annual usage of approximately $1.6 million for each of the next five years after the ownership change and approximately $0.2 million for each of the 15 years thereafter. The remaining pre-ownership change net operating losses of approximately $1.6 million were written off due to expiration under limitation. The limitation has been determined by first multiplying the value of our stock at the time of the ownership change by the applicable long-term tax-exempt rate. These carryforwards may be subject to further annual limitations under Section 382 in the event of future changes in ownership.  Additionally, we have determined an ownership changed occurred in October of 2019 as a result of the IPO.  Accordingly, utilization of approximately $46.1 million of the U.S. net operating loss carryforwards incurred prior to October 2019 is also limited under Section 382.  We have determined we will be able to utilize the entire $46.1 million of our pre-ownership change net operating loss carryforwards based upon the limitations calculated from the October 2019 ownership change. These carryforwards may be subject to further annual limitations under Section 382 in the event of future changes in ownership.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0254166666666664;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0254166666666664;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Results of operations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0254166666666664;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0254166666666664;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Comparison of years ended December 31, 2021 and 2020</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0254166666666664;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0254166666666664;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes our results of operations for the years ended December 31, 2021 and 2020:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.0254166666666664;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:81.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:54.401%;"></td>
    <td style="width:1.707%;"></td>
    <td style="width:1.768%;"></td>
    <td style="width:18.146%;"></td>
    <td style="width:1.179%;"></td>
    <td style="width:1.707%;"></td>
    <td style="width:1.768%;"></td>
    <td style="width:18.146%;"></td>
    <td style="width:1.179%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Years ended December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Revenue</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,068</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">36,984</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating expenses:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">60,923</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">37,415</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">37,176</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">27,119</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total operating expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">98,099</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">64,534</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Loss from operations</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(84,031</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(27,550</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Interest income</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">397</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">994</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Interest expense</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(764</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Realized (loss) gain on investments</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(23</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">84</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Foreign exchange gain (loss)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(4</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other expense, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(266</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Loss before income taxes</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(84,671</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(26,476</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Income taxes</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(15</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(35</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(84,686</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(26,511</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.0254166666666664;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Revenue</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0254166666666664;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0254166666666664;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Revenue was $14.1 million for the year ended December 31, 2021 compared to $37.0 million for the year ended December 31, 2020. In July 2019, we entered into the Astellas Agreement and received an upfront license fee payment of $80.0 million. In accordance with ASC 606, we recognized the $80.0 million as revenue over the period that research and development services and the Phase 2a clinical study for FX-322 were provided using the input method. These research and development services concluded in June 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">102</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0254166666666664;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0254166666666664;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and development expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0254166666666664;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:53.449%;"></td>
    <td style="width:1.382%;"></td>
    <td style="width:1.272%;"></td>
    <td style="width:12.197%;"></td>
    <td style="width:0.636%;"></td>
    <td style="width:1.382%;"></td>
    <td style="width:1.272%;"></td>
    <td style="width:12.197%;"></td>
    <td style="width:0.636%;"></td>
    <td style="width:1.382%;"></td>
    <td style="width:1.272%;"></td>
    <td style="width:12.058%;"></td>
    <td style="width:0.865%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Years ended December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Increase</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(Decrease)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Direct research and development expenses by therapeutic area and product candidate:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">FX-322</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,334</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9,392</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">942</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">FX-345</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,471</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,867</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,604</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Multiple Sclerosis/FREQ-162</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,627</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,534</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,093</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Platform development, early-stage research and <br />&#160;&#160;&#160;unallocated expenses:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Employee-related</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25,557</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17,140</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,417</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Laboratory supplies</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">716</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">228</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">488</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outsourced research and development</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,305</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">597</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,708</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Facility-related</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,898</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,392</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,506</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Depreciation and amortization</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,599</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">759</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">840</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other research and development</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,416</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,506</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(90</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Platform development, early-stage research and unallocated<br />&#160;&#160;&#160;expenses total</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">38,491</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21,622</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16,869</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total research and development expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">60,923</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">37,415</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23,508</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.0014583333333331;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.0014583333333331;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The $10.3 million of costs related to FX-322 incurred for the year ended December 31, 2021 consisted primarily of $8.4 million of clinical costs associated with ongoing trials, including FX-322-208 which is new in 2021, and $1.9 million of drug development and manufacturing costs. The $9.4 million of costs related to FX-322 incurred for the year ended December 31, 2020 consisted primarily of $6.7 million of clinical costs associated with the Phase 2a and other related clinical trials of FX-322 and $2.7 million related to drug development and manufacturing. The overall increase from the year ended December 31, 2020 is due primarily to the clinical trial activity in the year ended December 31, 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.0014583333333331;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.0014583333333331;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The $5.5 million of costs related to FX-345 incurred for the year ended December 31, 2021 consisted of drug development and manufacturing costs, including $3.1 million related to preclinical safety. The $1.9 million of costs related to FX-345 for the year ended December 31, 2020 consisted primarily of $1.5 million of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> testing. The overall increase from the year ended December 31, 2020 is due primarily to our efforts to advance our new SNHL investigational therapeutic program, FX-345.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.0014583333333331;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.0014583333333331;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The $6.6 million of costs related to MS incurred for the year ended December 31, 2021 consisted of drug development and manufacturing, including $3.0 million in preclinical safety, $1.6 million in outsourced chemistry, and $0.9 million in </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> testing. Similarly, the $4.5 million of costs related to MS incurred for the year ended December 31, 2020 consisted of drug development and manufacturing, including $1.2 million in both preclinical safety and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vivo</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> testing. The overall increase from the year ended December 31, 2020 is due primarily to our focus on the advancement of our novel target, FREQ-162.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.0014583333333331;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.0014583333333331;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The $38.5 million of platform development, early-stage research and unallocated expenses incurred for the year ended December 31, 2021 consisted primarily of $25.6 million of employee-related costs, including $9.6 million of stock-based compensation expense, $6.9 million in facility-related costs, and $2.3 million of outsourced research and development expense. This increase of $15.0 million from the year ended December 31, 2020 is primarily attributable to an increase of $8.4 million in employee-related expenses associated with increased headcount to support pre-clinical and clinical development across hearing and MS programs, a $4.3 million increase in rent, including utilities and maintenance, or CAM, charges related to our new office space, and a $0.8 million increase in depreciation related to equipment purchases for our new office space.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">General and administrative expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The $37.2 million of general and administrative expenses for the year ended December 31, 2021 consisted primarily of $21.1 million of employee-related costs, including $12.1 million in stock-based compensation expense, $7.6 million of professional services expense, $1.7 million in rent, including utilities and CAM charges, and $1.2 million in depreciation expense. General and administrative expenses increased $10.1 million from December 31, 2020 due to an increase of $8.2 million in employee-related costs as we increase our general and administrative headcount to manage our growth and the impact of being a public company, and increases of $1.0 million and $0.8 million in rent, including utilities and CAM charges, and depreciation expense, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">103</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Interest income</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Interest income was $0.4 million for the year ended December 31, 2021 compared to $1.0 million for the year ended December 31, 2020, due to changes in interest rates from the previous year.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Interest expense</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Interest expense was $0.8 million for the year ended December 31, 2021. There was no interest expense for the year ended December 31, 2020. This increase is due to interest expense on our term loan which commenced in December 2020.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Realized (loss) gain on investments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Realized loss on investments was $23 thousand for the year ended December 31, 2021 compared to a gain of $84 thousand for the year ended December 31, 2020 due to changes in the composition of investments year over year.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Foreign exchange gain (loss)</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Foreign exchange gain was $16 thousand for the year ended December 31, 2021 compared to a loss of $4 thousand for the year ended December 31, 2020. The increase of $20 thousand was due to differences in foreign exchange remeasurement of the financial statements of our foreign subsidiaries.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Other expense, net</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other expense, net was $0.3 million for the year ended December 31, 2021. This expense represents amortization expense on investments, partially offset by accretion income on investments. There was no comparable expense for the year ended December 31, 2020.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income taxes</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Income tax expense, which represents taxes on interest income earned by our subsidiary, Frequency Therapeutics Securities Corporation, a Massachusetts Securities Corporation, was $15 thousand for the year ended December 31, 2021.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Liquidity and capital resources</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since our inception, we have incurred significant operating losses. We expect to continue to incur significant expenses and operating losses for the foreseeable future as we advance the preclinical and clinical development of our product candidates. We expect that our research and development and general and administrative costs will continue to increase, in connection with conducting preclinical studies and clinical trials for our product candidates, contracting with contract manufacturing organizations, or CMOs, to support preclinical studies and clinical trials, expanding our intellectual property portfolio, and providing general and administrative support for our operations particularly as we continue to operate as a public company. As a result, we will need additional capital to fund our operations, which we may obtain from additional equity or debt financings, collaborations, licensing arrangements or other sources.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We do not currently have any approved products and have never generated any revenue from product sales. We have financed our operations primarily through proceeds from private and public securities financings, the upfront payment under the Astellas Agreement, and our term loan. To date, we have raised approximately $378.2 million, including from grants and option exercises. Our cash, cash equivalents and marketable securities totaled $142.4 million as of December 31, 2021. As of December 31, 2021, we had $0.8 million of current debt and $14.2 million of non-current debt related to the Term Loan.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">104</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2020, we entered into a Loan and Security Agreement with a commercial bank for a Term Loan with a principal balance of $15 million. We will make monthly interest only payments through November 30, 2022. The principal balance and interest will be repaid in equal monthly installments after the interest only period and continue through May 1, 2024. Advances under the Loan Agreement will bear an interest rate equal to the greater of either (i) 1.50% plus the Prime Rate (as reported in</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> The Wall Street Journal</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, subject to an interest rate floor of zero) or (ii) 4.75%.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2021, we entered into an Equity Distribution Agreement with Oppenheimer &amp; Co. Inc., or Oppenheimer, to sell shares of our common stock, having aggregate gross sales proceeds of up to $125.0 million, from time to time, through an &#x201c;at the market&#x201d; equity offering program under which Oppenheimer acts as sales agent, or the ATM program. As of December 31, 2021, we have not sold any shares of common stock under the ATM program.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cash flows</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes our sources and uses of cash for the periods presented:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:80.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:60.86%;"></td>
    <td style="width:1.368%;"></td>
    <td style="width:1.815%;"></td>
    <td style="width:15.343%;"></td>
    <td style="width:1.206%;"></td>
    <td style="width:1.368%;"></td>
    <td style="width:1.815%;"></td>
    <td style="width:15.019%;"></td>
    <td style="width:1.206%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended <br />December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash used in operating activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(76,059</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(45,188</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash (used in) provided by investing activities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(66,126</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,402</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash provided by financing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,358</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">56,688</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net (decrease) increase in cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(140,827</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21,902</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cash flows for the year ended December 31, 2021</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Operating activities</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash used in operating activities for the year ended December 31, 2021 was $76.1 million, consisting of a net loss of $84.7 million as we incurred expenses associated with our FX-322 program, platform development and early-stage research, and general and administrative expenses. In addition, we had non-cash charges of $26.0 million for depreciation, stock-based compensation expense, non-cash lease expense, non-cash interest expense and loss on disposal of assets. Net cash used in operating activities was also impacted by a net $17.3 million decrease in operating assets and liabilities, including a decrease of $14.1 million in deferred revenues from the upfront payment under the Astellas Agreement, a $2.3 million decrease in accounts payable, a decrease in accrued expenses of $0.8 million, and a $0.2 million increase in prepaid expenses and other assets.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Investing activities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash used in investing activities for the year ended December 31, 2021 was $66.1 million, which was attributable to $92.4 million of purchases of marketable securities and $2.9 million of purchases of property and equipment, partially offset by $29.2 million in redemptions of marketable securities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Financing activities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash provided by financing activities for the year ended December 31, 2021 was $1.4 million, primarily attributable to $1.3 million in proceeds from the exercise of stock options and $60 thousand in proceeds from the Employee Stock Purchase Plan.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cash flows for the year ended December 31, 2020</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Operating activities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash used in operating activities for the year ended December 31, 2020 was $45.2 million, consisting of a net loss of $26.5 million as we incurred expenses associated with our FX-322 program, platform development and early-stage research, and general and administrative expenses. In addition, we had non-cash charges of $11.6 million for depreciation, stock-based compensation expense, and non-cash lease expense. Net cash used in operating activities was also impacted by a net $30.2 million decrease in operating assets and liabilities, including a decrease of $37.0 million in deferred revenues from the upfront payment under the Astellas Agreement, and increases in accounts payable, accrued expenses and prepaid expense and other current assets of $4.3 million, $3.1 million, and $0.6 million, respectively.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">105</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Investing activities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash provided by investing activities for the year ended December 31, 2020 was $10.4 million, which was attributable to $43.4 million of redemptions of available for sale securities, partially offset by $26.3 million of available for sale securities and $6.7 million of purchases of property and equipment, $2.6 million of which is related to the buildout of our new Lexington office.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Financing activities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash provided by financing activities for the year ended December 31, 2020 was $56.7 million, primarily attributable to $40.1 million in net proceeds from the July 2020 Private Placement, $15.0 million in proceeds from the Term Loan, and $1.5 million in proceeds from the exercise of stock options.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Funding requirements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our operating expenses increased substantially in the years ended December 31, 2021 and 2020 and are expected to increase substantially in the future in connection with our ongoing activities, particularly as we advance FX-322 through clinical trials and as we research and develop additional product candidates, including FX-345 and FREQ-162, conduct preclinical activities, studies for INDs, and initiation of human clinical trials. In addition, we expect to incur additional general and administrative costs to build the infrastructure necessary to manage the growth of our research and development efforts and requirements of operating as a public company.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Specifically, our costs and expenses will increase as we:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">advance the clinical development of FX-322; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">pursue the preclinical and clinical development of other product candidates using our PCA platform, including FX-345 and FREQ-162; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">in-license or acquire the rights to other products, product candidates or technologies; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">maintain, expand, and protect our intellectual property portfolio; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">hire additional personnel in research, manufacturing, and regulatory and clinical development, as well as management personnel; and </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1020833333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">expand our operational, financial, investor relations, and management systems and increase personnel, including personnel to support our operations as a public company. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe that our existing cash, cash equivalents, and marketable securities, will enable us to fund our operating expenses and capital expenditure requirements through the end of 2023. We have based this estimate on assumptions that may prove to be incorrect, and we could utilize our available capital resources sooner than we expect.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Because of the numerous risks and uncertainties associated with the research, development, and commercialization of therapeutics, it is difficult to estimate with certainty the amount of our working capital requirements. Our future funding requirements will depend on many factors, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1020833333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the progress, costs, and results of our clinical development and clinical trials for FX-322; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1020833333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the progress, costs, and results of our additional research and preclinical development programs, including FX-345 and FREQ-162; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1020833333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the outcome, timing and cost of meeting regulatory requirements established by the FDA and comparable foreign regulatory authorities, if applicable, for our product candidates; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1020833333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">business and operations interruptions resulting from the COVID-19 global pandemic;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1020833333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the costs and timing of internal process development, manufacturing activities, and clinical trial management associated with FX-322 and other product candidates, including FX-345 and FREQ-162, we advance through preclinical and clinical development; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1020833333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to establish and maintain strategic collaborations, licensing or other agreements and the financial terms of such agreements; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">106</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1020833333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the scope, progress, results, and costs of any product candidates that we may derive from our PCA platform or any other product candidates we may develop alone or with collaborators; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1020833333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the extent to which we in-license or acquire rights to other products, product candidates, or technologies; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1020833333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">additions or departures of key scientific or management personnel; </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1020833333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the costs and timing of preparing, filing, and prosecuting patent applications, maintaining and protecting our intellectual property rights, and defending against any intellectual property-related claims; and </span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.1020833333333333;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the costs and timing of future commercialization activities, including product manufacturing, marketing, sales, and distribution for any product candidates for which we or our collaborators obtain marketing approval. </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Until such time as we can generate significant revenue from product sales, if ever, we expect to finance our cash needs through a combination of public or private equity or debt financings and other sources, which may include current and new collaborations with third parties. To the extent that we raise additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a common stockholder. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise additional funds through other sources, such as collaboration agreements, strategic alliances, licensing arrangements or marketing and distribution arrangements, we may have to relinquish valuable rights to our technologies, future revenue streams, product development, and research programs or product candidates, or grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds when needed, we may be required to delay, limit, reduce, or terminate our product development or future commercialization efforts or grant rights to develop and market products or product candidates that we would otherwise prefer to develop and market ourselves.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Contractual obligations and commitments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following is a summary of our contractual obligations and commitments as of December 31, 2021:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:30.88%;"></td>
    <td style="width:1.273%;"></td>
    <td style="width:10.582%;"></td>
    <td style="width:0.627%;"></td>
    <td style="width:2.069%;"></td>
    <td style="width:1.273%;"></td>
    <td style="width:10.552%;"></td>
    <td style="width:0.627%;"></td>
    <td style="width:1.502%;"></td>
    <td style="width:1.273%;"></td>
    <td style="width:10.582%;"></td>
    <td style="width:0.627%;"></td>
    <td style="width:1.87%;"></td>
    <td style="width:1.273%;"></td>
    <td style="width:10.582%;"></td>
    <td style="width:0.627%;"></td>
    <td style="width:1.303%;"></td>
    <td style="width:1.273%;"></td>
    <td style="width:10.582%;"></td>
    <td style="width:0.627%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="18" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Payments due by period (in thousands)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Total</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Less than 1 year</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">1-3 years</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">4-6 years</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">More than 6 years</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating lease obligations (1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44,471</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,161</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13,241</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,469</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12,600</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Represents future minimum lease payments under our operating leases for office and laboratory space at our Lexington, Massachusetts and Farmington, Connecticut facilities (see Note 14 of notes to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K for additional information on these lease agreements). </span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have not included future milestone payments under our collaboration and license agreements in the table above since the payment obligations under these agreements are contingent upon future events, such as the achievement of specified product development milestones or generating product sales, and we are unable to estimate the timing or likelihood of achieving these milestones or generating future product sales. We are also required to spend certain minimum amounts on research and development of licensed products or processes under the MIT License, which are not included in the table above. See &#x201c;&#x2014;License and collaboration agreements&#x201d; for more information regarding our payment obligations under these agreements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We also enter into contracts in the normal course of business with CROs, CMOs, universities, and other third parties for preclinical research studies, clinical trials and testing and manufacturing services. These contracts generally do not contain minimum purchase commitments and are cancelable by us upon prior written notice although, purchase orders for clinical materials are generally non-cancelable. Payments due upon cancellation consist only of payments for services provided or expenses incurred, including noncancelable obligations of our service providers, up to the date of cancellation or upon completion of a manufacturing run. These payments are not included in the table above as the amount and timing of such payments are not known or are not material.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Critical accounting policies and use of estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our management&#x2019;s discussion and analysis of financial condition and results of operations is based on our audited consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of our consolidated financial statements and related disclosures requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenue, costs and expenses, and the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">107</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">disclosure of contingent assets and liabilities in our consolidated financial statements. We base our estimates on historical experience, known trends and events, and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">While our significant accounting policies are described in more detail in the notes to our consolidated financial statements included elsewhere in this Annual Report on Form 10-K, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Revenue recognition</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We account for contracts with customers in accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;), Topic 606, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Revenue from Contracts with Customers</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#x201c;ASC 606&#x201d;), including all amendments thereto. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as collaborative arrangements and leases. Our disclosure in the accompanying consolidated financial statements reflects the Company&#x2019;s accounting policies in compliance with this standard.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under ASC 606, an entity recognizes revenue when or as its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To recognize revenue for arrangements that an entity determines are within the scope of ASC 606, the entity performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price, including variable consideration, if any; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies its performance obligations. We only apply the five-step model to contracts when it is probable that the entity will collect substantially all of the consideration to which it will be entitled in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606, we assess the goods or services promised within each contract and identifies as a performance obligation each promise to transfer to the customer either (a) a good or service (or bundle of goods and services) that is distinct, or (b) a series of distinct goods and services that are substantially the same and have been the same pattern of transfer to the customer.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We assess whether each promised good or service is distinct for the purpose of identifying the performance obligations in the contract. This assessment involves subjective determinations and requires management to make judgments about the individual promised goods or services and whether such are separable from the other aspects of the contractual relationship. Promised goods and services are considered distinct provided that: (i) the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (that is, the good or service is capable of being distinct) and (ii) the entity&#x2019;s promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (that is, the promise to transfer the good or service is distinct within the context of the contract). In assessing whether a promised good or service is distinct, we consider factors such as the research, manufacturing and commercialization capabilities of the collaboration partner (the &#x201c;customer&#x201d; in this type of arrangement) and the availability of the associated expertise in the general marketplace. We also consider the intended benefit of the contract in assessing whether a promised good or service is separately identifiable from other promises in the contract. If a promised good or service is not distinct, an entity is required to combine that good or service with other promised goods or services until it identifies a bundle of goods or services that is distinct. For each arrangement that results in revenues, we identify all performance obligations, which may include, for example, a license to IP and know-how, research and development activities, and/or manufacturing services.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to any upfront payment, if the consideration promised in a contract includes a variable amount, we estimate the amount of consideration to which it will be entitled in exchange for transferring the promised goods or services to a customer. We determine the amount of variable consideration by using the expected value method or the most likely amount method. We include the estimated variable consideration in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, we re-evaluate the estimated variable consideration included in the transaction price and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis in the period of adjustment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If an arrangement includes development and regulatory milestone payments, we evaluate whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. There is considerable judgment involved in determining whether it is probable that a significant revenue reversal would not occur. If it is probable that a significant revenue reversal will not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within our control or of the licensee such as regulatory</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">108</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">approvals, are generally not considered probable of being achieved until those approvals are received. At the end of each subsequent reporting period, we re-evaluate the probability of achievement of all milestones subject to constraint and, if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For contracts that include sales-based royalties (including milestone payments based on the level of sales) promised in the exchange for licenses of intellectual property, and the license is deemed to be the predominant item to which the royalties relate, we recognize royalty revenue and sales-based milestone payments at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied. In determining the transaction price, we adjust the promised amount of consideration for the effects of the time value of money if the timing of payments provides the Company or the Company&#x2019;s customer with a significant benefit of financing the transfer of goods and services. We do not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be one year or less. We assess each of its revenue generating arrangements in order to determine whether a significant financing component exists. We recognize as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) each performance obligation is satisfied, either at a point in time or over time.  For performance obligations satisfied over time, we measure progress toward completion of its performance obligations using an input method based on our efforts and inputs to satisfy its performance obligations relative to total expected inputs to the satisfaction of that performance obligation.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Amounts received from a customer prior to revenue recognition are recorded as deferred revenue. Amounts received from a customer that are expected to be recognized as revenue within the 12 months following the balance sheet date are classified as a current liability in the consolidated balance sheets.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our only revenue recognized since inception is related to the Astellas Agreement. At commencement of the Astellas Agreement, we estimated the performance obligation, the completion of the Phase 2a clinical trial of (FX-322-202), would be satisfied by June 30, 2021. As such, we recognized revenue over time as we satisfied this performance obligation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accrued research and development expenses</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As part of the process of preparing our consolidated financial statements, we are required to estimate our accrued research and development expenses. This process involves reviewing open contracts and purchase orders, communicating with our personnel to identify services that have been performed on our behalf, and estimating the level of service performed and the associated costs incurred for the services when we have not yet been invoiced or otherwise notified of the actual costs. Most of our service providers invoice us in arrears for services performed, on a pre-determined schedule or when contractual milestones are met; however, some require advance payments. We make estimates of our accrued expenses as of each balance sheet date in our consolidated financial statements based on facts and circumstances known to us at that time. Examples of estimated accrued research and development expenses include fees paid to the following:</span></p>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">CROs and other third parties in connection with performing research and development activities and conducting preclinical studies and clinical trials on our behalf;</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vendors in connection with preclinical development activities; and</span></div></div>
  <div style="margin-left:4.537%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.752626672113803%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">CMOs and other vendors in connection with product manufacturing and development and distribution of preclinical supplies.</span></div></div>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We base our expenses related to preclinical studies on our estimates of the services received and efforts expended pursuant to quotes and contracts with CROs that conduct and manage preclinical studies and clinical trials and CMOs that manufacture product for our research and development activities on our behalf. The financial terms of these agreements are subject to negotiation, vary from contract to contract, and may result in uneven payment flows. There may be instances in which payments made to our vendors will exceed the level of services provided and result in a prepayment of the expense. In accruing fees, we estimate the time period over which services will be performed and the level of effort to be expended in each period. If the actual timing of the performance of services or the level of effort varies from our estimate, we adjust the accrual or amount of prepaid expense accordingly. Although we do not expect our estimates to be materially different from amounts actually incurred, our understanding of the status and timing of services performed relative to the actual status and timing of services performed may vary and may cause us to report amounts that are too high or too low in any particular period. To date, we have not made any material adjustments to our prior estimates of accrued research and development expenses.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">109</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Leases</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company elected to early adopt ASC 842, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Leases</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, as of January 1, 2020 and elected the transition method under ASU 2016-02 whereby the Company records a right-to-use asset and a lease liability on the consolidated balance sheet for all leases with terms longer than 12 months. The Company also elected to apply the package of practical expedients intended to ease transition. Accordingly, the Company has only applied ASC 842 to leases existing at January 1, 2020. The Company determines if an arrangement is, or contains, a lease at inception. Operating leases are included in operating lease right-of-issue (&#x201c;ROU&#x201d;) assets, other current liabilities, and operating lease liabilities on the consolidated balance sheets.</span></p>
  <p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments to be made over the lease term. The ROU asset also includes any lease payments made at or before the lease commencement date and excludes lease incentives received. As the Company&#x2019;s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Operating lease expense is recognized on a straight-line basis over the lease term. The Company has elected to not apply the recognition requirements of ASC 842 for short-term leases, which is defined as a lease that, at the lease commencement date, has a lease term of 12 months or less and does not include an option to purchase the underlying asset that the Company is reasonably certain to exercise.</span></p>
  <p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For real estate lease agreements entered into or modified after the adoption of ASC 842 that include lease and non-lease components, the Company has elected to account for the lease and non-lease components, such as common area maintenance charges, as a single lease component.</span></p>
  <p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since the adoption of ASC 842 in 2020, we have entered into one new lease resulting in right of use assets and lease liabilities balances of $31.4 million and $30.6 million, respectively, at December 31, 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-based compensation</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We measure stock options and other stock-based awards granted to our employees, directors, consultants, advisors based on the fair value on the date of the grant, awards, net of actual forfeitures, over the requisite service period, which is generally the vesting period of the respective award. For stock-based awards granted to non-employees, compensation expense is recognized over the period during which services are rendered by such non-employees until completed.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We estimate the fair value of each stock option grant on the date of grant using the Black-Scholes option-pricing model, which uses as inputs the fair value of our common stock and assumptions we make for the volatility of our common stock, the expected term of our stock options, the risk-free interest rate for a period that approximates the expected term of our stock options, and our expected dividend yield.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Recent accounting pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A description of recent accounting pronouncements that may potentially impact our financial position, results of operations, or cash flows is disclosed below:</span></p>
  <p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Financial Instruments - Credit Losses</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (Topic 326): Measurement of Credit Losses on Financial Instruments. The FASB has subsequently issued amendments to ASU 2016-13, which have the same effective date and transition date. These standards require that credit losses be reported using an expected losses model rather than the incurred losses model that was previously used, and establishes additional disclosures related to credit risks. For available-for-sale debt securities with unrealized losses, this standard now requires allowances to be recorded instead of reducing the amortized cost of the investment. These standards limit the amount of credit losses to be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. This standard will become effective for the Company on January 1, 2023. The Company is still evaluating the impact of this standard on its consolidated financial statements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">   </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There are no other recent accounting pronouncements that we believe will have a material impact on our consolidated financial statements.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">110</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:1.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_7a_quantitative_qualitative_disclos"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 7A. Quantitative and Qualitati</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ve Disclosures About Market Risk.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are exposed to market risks in the ordinary course of our business. These risks primarily include interest rate sensitivities. Our interest-earning assets consist of cash, cash equivalents and marketable securities, which are denominated in U.S. dollars. We had cash, cash equivalents and marketable securities of $142.4 million, or 77% of our total assets, at December 31, 2021. Interest income earned on these assets was $0.4 million for the year ended December 31, 2021. Our interest income is sensitive to changes in the general level of interest rates, primarily U.S. interest rates. Such interest-earning instruments carry a degree of interest rate risk however, if a change by 10% in interest rates were to have immediately occurred on December 31, 2021, such change would not have had a material impact on our financial position or results of operations. We had $0.8 million of current debt and $14.2 million non-current debt outstanding as of December 31, 2021.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_8_financial_statements_supplementar"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 8. Financial Statement</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">s and Supplementary Data.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our consolidated financial statements, together with the reports of our independent registered public accounting firms, appear at pages F-1 through F-30 of this Annual Report on Form 10-K for the year ended December 31, 2021. An index of those financial statements is found in Item 15 of Part IV of this Annual Report on Form 10-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9_changes_in_disagreements_with_acc"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 9. Changes in and Disagreements with Accou</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ntants on Accounting and Financial Disclosure.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">None</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9a_controls_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 9A. Controls </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">and Procedures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Evaluation of Disclosure Controls and Procedures</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We maintain &#x201c;disclosure controls and procedures,&#x201d; as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission&#x2019;s rules and forms and (2) accumulated and communicated to our management, including our principal executive and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their control objectives.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer (our principal executive officer and principal financial officer, respectively), evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2021. Based on the evaluation of our disclosure controls and procedures as of December 31, 2021, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">111</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Management&#x2019;s Annual Report on Internal Control Over Financial Reporting</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with policies or procedures may deteriorate. Our internal control over financial reporting is a process designed under the supervision of our principal executive officer and principal financial officer to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our financial statements for external reporting purposes in accordance with U.S. generally accepted accounting principles.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our management, with the participation of Chief Executive Officer and Chief Financial Officer (our principal executive officer and principal financial officer, respectively), conducted an evaluation of the effectiveness of our internal control over financial reporting based on the criteria set forth in &#x201c;Internal Control &#x2013;Integrated Framework (2013)&#x201d; issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, management concluded that our internal control over financial reporting was effective as of December 31, 2021.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Changes in Internal Control over Financial Reporting</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There was no change in our internal control over financial reporting that occurred during the period covered by this Annual Report on Form 10-K that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9b_or_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 9B. Other</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> Information.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">None</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9c"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Not applicable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">112</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="part_iii"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PART </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">III</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_10_directors_executive_ficers_corpo"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 10. Directors, Executive Off</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">icers and Corporate Governance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The information required by this Item 10 will be included in our Definitive Proxy Statement to be filed with the SEC with respect to our 2022 Annual Meeting of Stockholders and is incorporated herein by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_11_executive_compensation"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 11. Executiv</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">e Compensation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The information required by this Item 11 will be included in our Definitive Proxy Statement to be filed with the SEC with respect to our 2022 Annual Meeting of Stockholders and is incorporated herein by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_12_security_ownership_certain_benef"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 12. Security Ownership of Certain Beneficial Own</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ers and Management and Related Stockholder Matters.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The information required by this Item 12 will be included in our Definitive Proxy Statement to be filed with the SEC with respect to our 2022 Annual Meeting of Stockholders and is incorporated herein by reference.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_13_certain_relationships_related_tr"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 13. Certain Relationships and Related</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> Transactions, and Director Independence.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The information required by this Item 13 will be included in our Definitive Proxy Statement to be filed with the SEC with respect to our 2022 Annual Meeting of Stockholders and is incorporated herein by reference.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_14_principal_accounting_fees_servic"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 14. Principal Accoun</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ting Fees and Services.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The information required by this Item 14 will be included in our Definitive Proxy Statement to be filed with the SEC with respect to our 2022 Annual Meeting of Stockholders and is incorporated herein by reference.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">113</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="part_iv"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PART</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> IV</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_15_exhibits_financial_statement_sch"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 15. Exhibits, Financi</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">al Statement Schedules.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(1) Financial Statements</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following documents are included on pages F-1 through F-30 attached hereto and are filed as part of this Annual Report on Form 10-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:91.332%;"></td>
    <td style="width:0.149%;"></td>
    <td style="width:8.519%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#opinion"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Report of an Independent Registered Public Accounting Firm (PCAOB ID: 49)</span></a></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Consolidated financial statements As of December 31, 2021 and 2020</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Consolidated balance sheets</span></a></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_statements_operations"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Consolidated statements of operations</span></a></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_statements_comprehensive_lo"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Consolidated statements of comprehensive loss</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_statement_convertible_prefe"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Consolidated statements of stockholders&#x2019; equity</span></a></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_statements_cash_flows"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Consolidated statements of cash flows</span></a></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#notes_to_consolidated_financial_statemen"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Notes to consolidated financial statements</span></a></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:8.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(2) Financial Statement Schedules:</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All financial statement schedules have been omitted because they are not applicable, not required or the information required is shown in the Consolidated Financial Statements or the Notes thereto set forth below beginning on page F-1.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(3) Exhibits.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following is a list of exhibits filed as part of this Annual Report on Form 10-K.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:9.63%;"></td>
    <td style="width:1.004%;"></td>
    <td style="width:37.547%;"></td>
    <td style="width:0.845%;"></td>
    <td style="width:8.597%;"></td>
    <td style="width:0.964%;"></td>
    <td style="width:11.479%;"></td>
    <td style="width:1.67%;"></td>
    <td style="width:8.786%;"></td>
    <td style="width:0.964%;"></td>
    <td style="width:9.024%;"></td>
    <td style="width:1.381%;"></td>
    <td style="width:8.11%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.750pt solid rgba(255,255,255,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.750pt solid rgba(255,255,255,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.750pt solid rgba(255,255,255,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.750pt solid rgba(255,255,255,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td colspan="9" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Incorporated by Reference</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Exhibit</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Number</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.750pt solid rgba(255,255,255,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Exhibit Description</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.750pt solid rgba(255,255,255,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Form</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.750pt solid rgba(255,255,255,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">File No.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.750pt solid rgba(255,255,255,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Exhibit</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.750pt solid rgba(255,255,255,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Filing</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Date</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.750pt solid rgba(255,255,255,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Filed/</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Furnished</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Herewith</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;3.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001703647/000119312519263787/d796545dex31.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Restated Certificate of Incorporation of Frequency</span></a><a href="https://www.sec.gov/Archives/edgar/data/0001703647/000119312519263787/d796545dex31.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;"> Therapeutics, Inc.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39062</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10/7/19</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;3.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001703647/000119312519263787/d796545dex32.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Amended and Restated Bylaws of Frequency</span></a><a href="https://www.sec.gov/Archives/edgar/data/0001703647/000119312519263787/d796545dex32.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;"> Therapeutics, Inc.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39062</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9/25/20</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;4.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001703647/000119312519251257/d72917dex41.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Form of Specimen Common Stock Certificate</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">S-1/A</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-233652</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9/23/19</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;4.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001703647/000119312519239976/d72917dex42.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Second Amended and Restated Investors&#x2019;</span></a><a href="https://www.sec.gov/Archives/edgar/data/0001703647/000119312519239976/d72917dex42.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;"> Rights Agreement, dated as of July 17, 2019</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-233652</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9/6/19</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;4.3</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1703647/000156459020012977/freq-ex43_875.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Description of Frequency Therapeutics, Inc. Securities</span></a><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39062</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.3</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3/26/20</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.1#</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1703647/000119312519239976/d72917dex101.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">2014 Stock Incentive Plan, as amended and form of option agreements thereunder</span></a><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-233652</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9/6/19</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.2#</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001703647/000119312519251257/d72917dex102.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">2019 Incentive Award Plan and form of option</span></a><a href="https://www.sec.gov/Archives/edgar/data/0001703647/000119312519251257/d72917dex102.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;"> agreements thereunder</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">S-1/A</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-233652</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9/23/19</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.3#</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001703647/000119312519251257/d72917dex103.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Non-Employee Director Compensation Program</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">S-1/A</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-233652</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.3</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9/23/19</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.4</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001703647/000119312519251257/d72917dex105.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Form of Indemnification Agreement for Directors</span></a><a href="https://www.sec.gov/Archives/edgar/data/0001703647/000119312519251257/d72917dex105.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;"> and Officers</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">S-1/A</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-233652</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.5</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9/23/19</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">114</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:9.63%;"></td>
    <td style="width:1.004%;"></td>
    <td style="width:37.547%;"></td>
    <td style="width:0.845%;"></td>
    <td style="width:8.597%;"></td>
    <td style="width:0.964%;"></td>
    <td style="width:11.479%;"></td>
    <td style="width:1.67%;"></td>
    <td style="width:8.786%;"></td>
    <td style="width:0.964%;"></td>
    <td style="width:9.024%;"></td>
    <td style="width:1.381%;"></td>
    <td style="width:8.11%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.6</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001703647/000119312519251257/d72917dex107.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Second Amended and Restated Executive</span></a><a href="https://www.sec.gov/Archives/edgar/data/0001703647/000119312519251257/d72917dex107.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;"> Employment Agreement, dated as of September</span></a><a href="https://www.sec.gov/Archives/edgar/data/0001703647/000119312519251257/d72917dex107.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;"> 20, 2019, between David L. Lucchino and</span></a><a href="https://www.sec.gov/Archives/edgar/data/0001703647/000119312519251257/d72917dex107.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;"> Frequency Therapeutics, Inc.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">S-1/A</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-233652</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.7</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9/23/19</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.7&#134;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="freq-ex10_7.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Exclusive Patent License Agreement, dated as of December 13, 2016, as amended, between Massachusetts Institute of Technology and Frequency Therapeutics, Inc.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;*</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.8&#134;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1703647/000119312519239976/d72917dex1011.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Non-Exclusive Patent License Agreement, dated as of February 7, 2019, between Massachusetts Eye and Ear Infirmary and Frequency Therapeutics, Inc.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-233652</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.11</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9/6/19</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.9&#134;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001703647/000119312519239976/d72917dex1012.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">License and Collaboration Agreement, dated as of</span></a><a href="https://www.sec.gov/Archives/edgar/data/0001703647/000119312519239976/d72917dex1012.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;"> July 16, 2019, between Astellas Pharma, Inc. and</span></a><a href="https://www.sec.gov/Archives/edgar/data/0001703647/000119312519239976/d72917dex1012.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;"> Frequency Therapeutics, Inc.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-233652</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.12</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9/6/19</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.10#</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1703647/000119312519251257/d72917dex1013.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">2019 Employee Stock Purchase Plan</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">S-1/A</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">333-233652</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.13</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9/23/19</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.11</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1703647/000156459020012977/freq-ex1013_758.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Indenture of Lease, effective as of January 7, 2020 between HCP/KING 75 Hayden LLC and Frequency Therapeutics, Inc.</span><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></a><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39062</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.13</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3/26/20</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.12</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1703647/000119312520196443/d12381dex101.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Securities Purchase Agreement, dated July 17, 2020, by and among Frequency Therapeutics, Inc. and the Investors named therein.</span><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></a><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39062</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7/21/20</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.13</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1703647/000119312520196443/d12381dex102.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Registration Rights Agreement, dated July 17, 2020, by and among Frequency Therapeutics, Inc. and the Investors named therein.</span><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></a><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39062</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7/21/20</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.14#</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1703647/000119312520307216/d32382dex101.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Employment Agreement, effective December 1, 2020, by and between Frequency Therapeutics, Inc. and Peter P. Pfreundschuh.</span><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></a><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39062</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12/1/20</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.15</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1703647/000119312520318153/d61497dex101.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Loan and Security Agreement, dated December 11, 2020, by and between Frequency Therapeutics, Inc. and Silicon Valley Bank.</span></a><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39062</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12/15/20</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.16#</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1703647/000156459021016117/freq-ex1016_1057.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Employment Agreement, effective February 3, 2020, by and between Frequency Therapeutics, Inc. and Wendy S. Arnold.</span></a><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">001-39062</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.16</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3/26/21</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="freq-ex21_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Subsidiaries of Frequency Therapeutics, Inc.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">*</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="freq-ex23_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Consent of RSM US, LLP, Independent Registered Public Accounting Firm</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">*</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="freq-ex31_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">*</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">115</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:9.63%;"></td>
    <td style="width:1.004%;"></td>
    <td style="width:37.547%;"></td>
    <td style="width:0.845%;"></td>
    <td style="width:8.597%;"></td>
    <td style="width:0.964%;"></td>
    <td style="width:11.479%;"></td>
    <td style="width:1.67%;"></td>
    <td style="width:8.786%;"></td>
    <td style="width:0.964%;"></td>
    <td style="width:9.024%;"></td>
    <td style="width:1.381%;"></td>
    <td style="width:8.11%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="freq-ex31_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">*</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="freq-ex32_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">**</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="freq-ex32_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">**</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.INS</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Instance Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">***</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.SCH</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Schema Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">***</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.CAL</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">***</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.DEF</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Extension Definition Linkbase Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">***</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.LAB</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Label Linkbase Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">***</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101.PRE</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">***</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">104</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The cover page for the Company's Annual Report on Form 10-K has been formatted in Inline XBRL and contained in Exhibit 101.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.500pt solid;margin-right:86.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">* Filed herewith</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">** Furnished herewith</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">*** Submitted electronically herewith</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#134; Portions of this exhibit have been omitted pursuant to Item 601 of Regulation S-K promulgated under the Securities Act because the information is not material and would be competitively harmful if publicly disclosed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"># A management contract or compensatory plan or arrangement required to be filed as an exhibit pursuant to Item 15(a)(3) of Form 10&#x2011;K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_16_form_10k_summary"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 16. Form</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> 10-K Summary</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">116</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="signatures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">SIGNAT</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">URES</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:60.437%;"></td>
    <td style="width:1.322%;"></td>
    <td style="width:3.728%;"></td>
    <td style="width:34.513%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">FREQUENCY THERAPEUTICS, INC.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: March 15, 2022</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ David L. Lucchino</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">David L. Lucchino</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">President, Chief Executive Officer and Director (Principal Executive Officer)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">POWER OF ATTORNEY</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each person whose individual signature appears below hereby authorizes and appoints David L. Lucchino and Peter P. Pfreundschuh, and each of them, with full power of substitution and resubstitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act in his or her name, place and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file any and all amendments to this annual report on Form 10-K and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his substitute or substitutes may lawfully do or cause to be done by virtue thereof.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:32.996%;"></td>
    <td style="width:1.002%;"></td>
    <td style="width:40.0%;"></td>
    <td style="width:1.002%;"></td>
    <td style="width:25.0%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Name</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(255,255,255,0.01);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Title</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(255,255,255,0.01);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Date</span></p></td>
   </tr>
   <tr style="height:4.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:4.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:4.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ David L. Lucchino</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(255,255,255,0.01);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(255,255,255,0.01);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">President, Chief Executive Officer and Director (Principal Executive Officer)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 15, 2022</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">David L. Lucchino</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Peter P. Pfreundschuh</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(255,255,255,0.01);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(255,255,255,0.01);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Chief Financial Officer (Principal Financial and Accounting Officer)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 15, 2022</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Peter P. Pfreundschuh</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Chairman and Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 15, 2022</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Marc A. Cohen</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Cynthia L. Feldmann</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 15, 2022</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="border-top:0.250pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Cynthia L. Feldmann</span></p></td>
    <td style="border-top:0.250pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="border-top:0.250pt solid rgba(255,255,255,0.01);background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Timothy J. Barberich</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(255,255,255,0.01);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(255,255,255,0.01);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 15, 2022</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Timothy J. Barberich</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Michael Huang</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(255,255,255,0.01);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(255,255,255,0.01);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 15, 2022</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Michael Huang</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Robert S. Langer</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(255,255,255,0.01);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(255,255,255,0.01);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 15, 2022</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Robert S. Langer, Sc.D.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Joel S. Marcus</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(255,255,255,0.01);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(255,255,255,0.01);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 15, 2022</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Joel S. Marcus</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">117</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:92.996%;"></td>
    <td style="width:7.004%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#opinion"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Report of an Independent Registered Public Accounting Firm (PCAOB ID: 49)</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Consolidated financial statements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Consolidated balance sheets</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_statements_operations"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Consolidated statements of operations</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_statements_comprehensive_lo"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Consolidated statements of comprehensive loss</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_statement_convertible_prefe"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Consolidated statements of stockholder&#x2019;s equity</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_statements_cash_flows"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Consolidated statements of cash flows</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#notes_to_consolidated_financial_statemen"><span style="background-color:rgba(0,0,0,0);color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Notes to consolidated financial statements</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="opinion"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Report of Independent Registered Public Accounting Firm</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To the Stockholders and the Board of Directors of Frequency Therapeutics, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Opinion on the Financial Statements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have audited the accompanying consolidated balance sheets of Frequency Therapeutics, Inc. and its subsidiaries (the Company) as of December 31, 2021 and 2020, the related consolidated statements of operations, comprehensive loss, stockholders&#x2019; equity and cash flows for the years then ended, and the related notes to the consolidated financial statements (collectively, the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Basis for Opinion</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These financial statements are the responsibility of the Company&#x2019;s management. Our responsibility is to express an opinion on the Company&#x2019;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#x2019;s internal control over financial reporting. Accordingly, we express no such opinion.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have served as the Company's auditor since 2017.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ RSM US LLP</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Boston, Massachusetts</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 15, 2022</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Frequency Therapeutics, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="consolidated_balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Consolidated </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Balance Sheets</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(in thousands, except share and per share amounts)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.594%;"></td>
    <td style="width:1.6%;"></td>
    <td style="width:1.282%;"></td>
    <td style="width:12.961%;"></td>
    <td style="width:0.865%;"></td>
    <td style="width:1.6%;"></td>
    <td style="width:1.282%;"></td>
    <td style="width:12.951%;"></td>
    <td style="width:0.865%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Current assets:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1e3eba26-e433-4357-8f67-e13f822bc60d" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">79,635</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_eefc3185-5aad-4109-9a2e-f411665b788f" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">220,341</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Short-term marketable securities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_167eb624-46ab-4408-931c-fa44b1c18e63" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">51,072</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prepaid expenses and other current assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_48f948ba-317a-4bf1-9cbd-3532ebb5d1db" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,041</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_273aedde-264b-4617-af1a-df72d03260b1" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,723</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total current assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_53a1193c-6a28-41aa-8e57-33452b12045f" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">134,748</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4207fbc5-be6f-4b02-9099-5f8965acdee2" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">225,064</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Long-term marketable securities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c7723c6b-346f-4782-adab-2b02c9404c3c" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,719</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment, net</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cb7de139-5416-4cd5-bc8a-4490ae2aae0f" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,522</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4ef0167e-a9a3-4b8c-b79e-739368a33254" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,287</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Right of use assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3f6fdf0e-1b74-43e5-aa35-e43f9d70b36d" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">31,350</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a9aeb045-139b-4906-abaf-4e0212c9023b" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,551</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Restricted cash</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0df1fa63-d016-49e0-82ee-6176250611f7" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,699</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b682162e-bcad-4c50-b52c-470298684b09" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,820</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Long-term assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_704ccc40-6470-421e-b335-38ff6447df31" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="freq:LongTermAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">320</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dddf0a0b-8ca0-4e4c-b1fc-2e6ecc7ae004" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">185,358</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7d2f3720-a78a-46c4-929f-9030ee68b865" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">264,722</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Liabilities and Stockholders&#x2019; Equity</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Current liabilities:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accounts payable</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_84580d76-05fe-4df1-a04a-3cb94cd80c37" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,748</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b82d290f-4075-4e73-9555-7b0e5ae09552" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,506</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_26d9a6e2-6379-4d1e-aa28-cbade91b3711" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,101</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4b5ed6fc-b10b-409e-8418-1fd34b5f567b" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,663</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deferred revenue</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4083149c-053c-4dac-ac56-c96ee6727153" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:ContractWithCustomerLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,068</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Lease liabilities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_018b2019-d823-4627-8231-bd78dc4297c1" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,747</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e271a781-c984-4e13-b19e-a17c0f7dff1d" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">397</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Term loan, current portion</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1220c7ce-ee53-4d89-a03f-c9acdd5a2c99" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:LongTermDebtCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">833</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total current liabilities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d76896e2-f983-4ef4-aebc-22607d8f66bb" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,429</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aa6251f5-c121-46b7-84ee-e1c593002259" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">26,634</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Lease liabilities, net of current portion</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6bd794fc-dfd2-4178-84ba-0edac4fad090" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">28,851</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7513d05e-af23-4846-a07a-dc59b1118380" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,597</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Term loan, net of current portion</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4bff210a-96db-450f-96b0-76b80e685b28" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:LongTermLoansFromBank" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,167</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e5547b22-0b6d-4d2b-8cef-f97ed00643de" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:LongTermLoansFromBank" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,000</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Long-term liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_210d0120-fb8e-44c3-ab8a-9cb5855df9d6" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:OtherLiabilitiesNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">87</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total liabilities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_44a83cf1-e58b-497b-be11-c8bd7a7efe55" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">54,534</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1106d006-df4f-4f59-b540-4a7a1c852191" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">72,231</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stockholders&#x2019; equity:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Preferred stock, $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_df184f34-5461-48c8-87fa-915d169476ef" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3"><ix:nonFraction id="F_871556b5-2a58-4ef0-be9d-8e15724c46e8" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3">0.001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;par value; </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9a74ddb2-b2d3-40da-86a5-3a9cff836a2c" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_d4bd91a9-5709-4ea9-9d04-316faf2bf39b" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;shares authorized, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ff48505c-7981-4c54-9eae-371401553aea" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_47af5c86-5172-44d2-af6d-8d54d53038fb" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_34fc4922-5497-4057-a9f3-1b45bd58f3f1" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen"><ix:nonFraction id="F_cbcad50c-40ba-46de-9f8e-38135b3896cc" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;shares issued<br />&#160;&#160;&#160;or  outstanding at December 31, 2021 and December 31, 2020, respectively</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f474cfc4-3ec7-45ee-b540-c88a72257dfe" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:PreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6d557ced-ed45-4c9f-a8a2-4621826939f4" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:PreferredStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Common stock, $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f0b3fed8-7fa1-4dd7-ad63-19177eb4961e" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3"><ix:nonFraction id="F_a7223039-5bc5-422a-b7bb-d76a2909c7c9" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="3">0.001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;par value; </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e2a0ff64-a95a-4a1f-bd75-7ee46b86e0cb" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_8ccabd4e-b9bc-456c-a8a4-781f23477474" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">200,000,000</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;shares authorized, <br />&#160;&#160;&#160;</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1f50127c-be02-4cd1-b15f-07b06affb27d" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_7e2be2ad-5d06-4cab-a431-1a732a94acc8" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">34,611,213</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d77f327c-5362-4466-a4fa-001c5b797213" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal"><ix:nonFraction id="F_c874784b-dcee-4009-a708-cbd41356fa22" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">33,964,000</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;shares issued and outstanding at December 31, 2021<br />&#160;&#160;&#160;and December 31, 2020, respectively</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dc8496a4-6057-4bca-be86-1c96275f9d78" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">35</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3175bd70-da9c-40af-bd03-da0184b84482" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">34</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additional paid-in capital</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1896e835-cbda-43aa-bfd7-5b246abb9607" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:AdditionalPaidInCapital" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">310,936</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_57744e5d-1fcc-4e5a-afc2-d9b0f7d3410f" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:AdditionalPaidInCapital" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">287,829</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accumulated other comprehensive (loss) income</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ef0fab7e-e492-43d1-943f-a49f8d0f9227" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">62</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_921eda9c-8f7c-4860-b7b2-8b9a2943e995" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accumulated deficit</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_86cf5ff7-648d-4752-936e-6ef297e14348" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">180,085</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a588a213-633f-4197-abeb-a557f0ba8a43" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">95,399</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total stockholders&#x2019; equity</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_562a6550-4f85-4cde-951e-ec9b71d960b5" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">130,824</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c4b99ef1-17dc-4d51-bc54-3c568a307e77" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">192,491</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total liabilities and stockholders&#x2019; equity</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9355b33f-8555-4eec-a6c2-14dd4c28c523" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">185,358</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7eb4f440-e260-44b2-a8f7-6cb3017186ab" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">264,722</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">See accompanying notes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Frequency Therapeutics, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="consolidated_statements_operations"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Consolidated Statem</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ents of Operations</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(in thousands, except share and per share amounts)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.488%;"></td>
    <td style="width:1.481%;"></td>
    <td style="width:1.282%;"></td>
    <td style="width:13.129%;"></td>
    <td style="width:0.865%;"></td>
    <td style="width:1.481%;"></td>
    <td style="width:1.282%;"></td>
    <td style="width:13.129%;"></td>
    <td style="width:0.865%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended <br />December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Revenue</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_83ea6ecb-0552-4275-a2fc-a382c936ccf2" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,068</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_327c92ac-9144-4ea0-9f3c-f73946b74b0c" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">36,984</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating expenses:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_39889f52-4bea-475d-b7bc-5971b0d70802" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">60,923</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0fb69c88-8650-4505-9d8b-d18b3ccfef56" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">37,415</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a4e2c6e6-9a32-49bc-b2e2-bd095a60293e" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">37,176</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_10d0d2ca-fd46-4239-ab98-349a2f870eea" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27,119</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total operating expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_679fb530-b1c3-4fec-914f-9b135e7fb94b" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">98,099</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bf216791-5b63-481c-8038-b2f4db5eebfd" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">64,534</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Loss from operations</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_94450e47-c64c-450e-8497-b7d993c10c6f" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">84,031</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_37d9a9de-4d15-4d0e-a666-629a9765d7ee" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">27,550</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Interest income</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5b338fd3-70f2-4247-bc7f-a28820ddc9ef" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">397</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_54312493-bfd4-4d00-912a-d0c416445e24" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">994</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Interest expense</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ee66cf8c-68ef-4a34-8908-be4ca3111086" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">764</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_691fe35f-50bb-4361-942a-d2b26c67a875" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:InterestExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Realized (loss) gain on investments</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2c0f47c9-e6f1-414b-825a-5956f8c18b79" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:RealizedInvestmentGainsLosses" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">23</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_75fbf065-8c56-4b0a-acde-1dff6b86297b" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:RealizedInvestmentGainsLosses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">84</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Foreign exchange gain (loss)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d0b56caf-6f6c-40be-bddb-2997ce96c352" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1dd16e5e-324d-4e31-8a82-bd8ac0f5b121" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">4</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other expense, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b9c0b0c3-c8fb-4b84-90be-c6083933261d" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:OtherNonoperatingExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">266</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ee38de9d-7074-4680-b579-3e34e1f2471a" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:OtherNonoperatingExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Loss before income taxes</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5a61a5c6-3808-4fa4-901d-3584a228c941" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">84,671</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5e938cee-8b0d-4984-a85c-f565053b7d66" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">26,476</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Income taxes</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6288649c-448c-4a0e-8ba1-ffcba82f22e0" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_229cc83a-1f8e-41c8-9bd5-da220814fcf7" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">35</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_19921682-e35d-49b4-9369-ce879df2ce96" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">84,686</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2d68f7a3-03ff-493a-8399-c2e5aff1d81e" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">26,511</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss per share-basic and diluted</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c9f05a2d-d222-4bc0-b7aa-f49082dda8f5" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-">2.47</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_efb47cc0-c88c-4cb8-93a8-c89d654e4a72" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-">0.82</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average shares of common stock outstanding-basic and diluted</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_56074ad0-2060-400f-a085-3da86a7b6126" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">34,351,274</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bba8e658-5225-418e-8931-3eabaee41ae2" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">32,253,227</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">See accompanying notes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Frequency Therapeutics, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="consolidated_statements_comprehensive_lo"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Consolidated Statements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> of Comprehensive Loss</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(in thousands, except share and per share amounts)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.938%;"></td>
    <td style="width:1.412%;"></td>
    <td style="width:1.282%;"></td>
    <td style="width:12.853%;"></td>
    <td style="width:0.964%;"></td>
    <td style="width:1.412%;"></td>
    <td style="width:1.282%;"></td>
    <td style="width:12.893%;"></td>
    <td style="width:0.964%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended <br />December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c31e8564-93f0-4bc8-bc24-3e6549728f8a" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">84,686</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_93293f10-9878-4467-aa90-b0c15261fa6a" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">26,511</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other comprehensive loss:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unrealized loss on marketable securities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6cce7e55-6a19-440f-bd79-ea87a433cac3" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">89</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4b29617a-5cae-422f-a57e-ada3edf8bafc" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">27</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total comprehensive loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2d91f2ce-1335-4d9f-87d6-24024f808aab" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">89</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cd95b9b0-3f4f-42c3-b98f-4c40f4afb49b" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">27</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Comprehensive loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c65abb1c-b9f9-460e-acec-136d5c34ce7e" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">84,775</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7606b8c2-19fc-4efb-9fdf-5f59347f484c" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:ComprehensiveIncomeNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">26,538</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">See accompanying notes.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Frequency Therapeutics, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="consolidated_statement_convertible_prefe"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Consolidated Stateme</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">nt of Stockholder&#x2019;s Equity</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(in thousands, except share and per share amounts)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:26.797%;"></td>
    <td style="width:1.3%;"></td>
    <td style="width:0.32%;"></td>
    <td style="width:11.82%;"></td>
    <td style="width:0.417%;"></td>
    <td style="width:0.744%;"></td>
    <td style="width:0.64%;"></td>
    <td style="width:9.025%;"></td>
    <td style="width:0.32%;"></td>
    <td style="width:0.744%;"></td>
    <td style="width:0.64%;"></td>
    <td style="width:9.025%;"></td>
    <td style="width:0.32%;"></td>
    <td style="width:0.744%;"></td>
    <td style="width:0.64%;"></td>
    <td style="width:14.643%;"></td>
    <td style="width:0.417%;"></td>
    <td style="width:0.744%;"></td>
    <td style="width:0.64%;"></td>
    <td style="width:8.921%;"></td>
    <td style="width:0.417%;"></td>
    <td style="width:0.744%;"></td>
    <td style="width:0.64%;"></td>
    <td style="width:8.921%;"></td>
    <td style="width:0.417%;"></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">Common<br />shares<br />issued</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">Common<br />par<br />value</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">Additi-<br />onal<br />paid-in<br />capital</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">Accumulated<br />other<br />comprehensive income (loss)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">Accumu-<br />lated<br />deficit</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">Total<br />stock-<br />holders&#x2019;<br />equity</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">Balance, December 31, 2019</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b75d8c47-6958-45b7-a6ce-facdfe0084dd" contextRef="C_b4e6b702-2e18-4b8d-b021-d0ca35b2f1ec" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">30,844,507</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4740eb31-eabb-498f-a8be-e6bd2f3b1ac2" contextRef="C_b4e6b702-2e18-4b8d-b021-d0ca35b2f1ec" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">31</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_709ac7e2-9aee-4806-b60f-502568b30bfc" contextRef="C_0699cfb2-3e40-4b40-9c53-76a5fb6da6fe" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">236,161</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b0da2f5f-81a2-4ea4-b204-5d2c4904f9e0" contextRef="C_394b00a6-d93c-4bb0-9bba-bc11145aea27" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">54</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">(</span><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5f7984d9-05de-4243-b234-9fa9e7594a10" contextRef="C_55a858d8-b30a-41c7-bb81-5e2b9474ff72" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">68,888</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bfe68604-fd0b-4766-8fd1-550ec68b3fff" contextRef="C_fa37d2a6-9437-44d8-82ac-ad9b23ac3a6b" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">167,358</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">Stock-based compensation expense</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5f9b2658-373c-45fa-9b40-171da2f84e34" contextRef="C_dfc08580-a6c7-489e-9745-b9dfdc59a70d" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,983</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9ab8701a-f02c-46df-b8db-d2772a2862a8" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,983</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">Issuance of common stock upon exercise of stock options</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_89de2c2d-3a0a-4193-a541-6b5c0912d5ca" contextRef="C_e8ed63ae-2752-4e17-8e6b-1b8e47c58699" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">769,385</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_750a8da9-6c9c-4375-9d3f-5da2eed9c480" contextRef="C_e8ed63ae-2752-4e17-8e6b-1b8e47c58699" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_803ac913-905b-4377-83bc-cca6715c2b8c" contextRef="C_dfc08580-a6c7-489e-9745-b9dfdc59a70d" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,544</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8b1f48ed-6c53-4be9-90a9-715710681361" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,545</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">Issuance of common stock in Private Placement, net</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d7de0bfe-f1ba-455e-b749-ac284d83474c" contextRef="C_e8ed63ae-2752-4e17-8e6b-1b8e47c58699" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,350,108</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5ac4b365-f929-4d98-8d8c-b34221d4289a" contextRef="C_e8ed63ae-2752-4e17-8e6b-1b8e47c58699" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_69af13d2-acb0-4975-b6b7-64c03a8f7ab2" contextRef="C_dfc08580-a6c7-489e-9745-b9dfdc59a70d" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">40,141</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d4720e1b-17f4-420f-a016-cc524394d262" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">40,143</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">Other comprehensive loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">(</span><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fb33c142-4d0f-4e10-9ae5-850bc908433c" contextRef="C_2d3ea299-2712-49d7-9a62-f5bd2236cb7b" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">27</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">(</span><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_09fc89dc-72bf-426e-80d2-26a50f3be1be" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">27</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">(</span><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8db57257-e330-46e7-9695-87f92d4c07c7" contextRef="C_51ed66a1-ea9a-4086-b613-ef93bdcffe77" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">26,511</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">(</span><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_448de5d0-ec46-4e2b-9d73-7817b3ba6f83" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">26,511</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">Balance, December 31, 2020</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c79e0501-e273-4832-ba7b-60ae69f2a026" contextRef="C_3a7f3500-4681-4b89-b3ee-9823efb5714a" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">33,964,000</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b6b02661-24ed-40fd-b880-9f05a0e4c546" contextRef="C_3a7f3500-4681-4b89-b3ee-9823efb5714a" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">34</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_85857d8c-4c73-4b72-a4ad-661b554d13e8" contextRef="C_83f34b69-48ab-4eeb-affa-ce666d46960a" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">287,829</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_58fba303-b7b8-4096-a77d-942e4e2b2792" contextRef="C_8f8e9273-079c-4fb5-a1f5-9391aab3c140" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">(</span><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7c7a4a73-8cac-4e60-b79c-f515f0c7e641" contextRef="C_48cf3447-6d32-4520-8654-49cad8c660d5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">95,399</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_41c1956f-4a99-47e0-9619-98127f412db1" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">192,491</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">Stock-based compensation expense</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c0f63721-5be7-4a62-9e68-979ee0690bf9" contextRef="C_a2aa7323-25ff-4251-80f3-998eec4375b1" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,750</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a17e2d24-229a-4797-98c5-453675cad5e6" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,750</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">Purchase under Employee Stock Purchase Plan</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4aecada3-8e1c-4c03-8a6f-d65166376e8d" contextRef="C_96ab2203-ccc4-4423-a539-b0358bf75478" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,064</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3b02b6b1-576c-4256-afe7-d48ec9c38f84" contextRef="C_a2aa7323-25ff-4251-80f3-998eec4375b1" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">60</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2ad0ce0a-898e-4388-b01f-b5bf82cff15d" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">60</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">Issuance of common stock upon exercise of stock options</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_586598bc-93c1-47a3-8a7f-cdb3138f5748" contextRef="C_96ab2203-ccc4-4423-a539-b0358bf75478" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">642,314</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_22bac9d4-2279-425d-bb05-e9bc559996d8" contextRef="C_96ab2203-ccc4-4423-a539-b0358bf75478" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_96a9af97-86a0-4691-ad96-743c31fe9341" contextRef="C_a2aa7323-25ff-4251-80f3-998eec4375b1" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,297</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aaf562e9-21cb-4243-bfcb-5c58e40f517e" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,298</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">Forfeiture of restricted stock</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">(</span><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6d21e075-a15a-45d3-b633-181533de9ccf" contextRef="C_96ab2203-ccc4-4423-a539-b0358bf75478" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,165</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">Other comprehensive loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">(</span><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1bf1053d-c030-496a-ba96-90a465d08358" contextRef="C_242a50fc-c372-4fff-a068-1d46d8ada8fc" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">89</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">(</span><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_410b2633-d519-43b0-bc4a-128baf05682d" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">89</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">(</span><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f67ab4b1-a28c-4aac-a20a-04e005a84d29" contextRef="C_3d40bafe-0686-48fd-af67-9a140619ba32" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">84,686</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">(</span><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_494686bd-7cd3-4194-a681-2e04e227a9a5" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">84,686</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">Balance, December 31, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c711c393-1664-4933-9b84-2e5d47ce66d1" contextRef="C_36f8045c-3f63-4117-a53e-1768fa09baac" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">34,611,213</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a65229ee-5217-415b-9ec7-259c86913ea6" contextRef="C_36f8045c-3f63-4117-a53e-1768fa09baac" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">35</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_20da4d6c-1bd7-49a3-8b99-91ae76879d8e" contextRef="C_f8a74942-bd20-4ca8-bf18-3a482101a0a2" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">310,936</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">(</span><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e224c467-9e63-4d72-a082-489a39699c4e" contextRef="C_6ed16120-fd10-493e-aced-7ba0d3024b61" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">62</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">(</span><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a90ead00-2bc2-4fed-a14d-9af983fc2f61" contextRef="C_b285e24e-c01a-491d-bc76-fbdb9109846f" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">180,085</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6414c939-3bd4-41e9-af24-5d1f52aaedc4" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">130,824</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:4.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">See accompanying notes</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Frequency Therapeutics, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="consolidated_statements_cash_flows"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Consolidated Statem</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ents of Cash Flows</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(in thousands)</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:70.073%;"></td>
    <td style="width:1.56%;"></td>
    <td style="width:1.282%;"></td>
    <td style="width:12.603%;"></td>
    <td style="width:0.865%;"></td>
    <td style="width:1.56%;"></td>
    <td style="width:1.282%;"></td>
    <td style="width:9.91%;"></td>
    <td style="width:0.865%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended <br />December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cash flows from operating activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4f13b4ae-c90a-4108-8b56-3ab8de0e680f" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">84,686</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4ce215c8-0ef1-46e0-8438-7ef7cbc5e340" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">26,511</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Adjustments to reconcile net loss to net cash used in operating<br />&#160;&#160;&#160;activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock-based compensation</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dbe7b631-1297-4aae-ba95-0f67b3ab7296" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,750</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4333ef35-3911-4296-bc4e-e46677afb11e" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,983</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Depreciation expense</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_79fd5bc8-068c-4dcc-a916-97ac19068f86" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,775</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1022b323-7d5b-4f0d-bcff-e3696f22e3a5" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,146</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Non-cash lease expense</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2da490f4-2e13-43a3-a87a-c9b599b44e1e" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="freq:NonCashLeaseExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,066</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_75425ed6-ffc7-4c38-941b-cf55c559aefd" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="freq:NonCashLeaseExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">434</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Non-cash interest expense</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7dba5c6d-270e-4d39-a389-2d37173cd828" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:PaidInKindInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">347</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_6fbc1e93-2815-4047-9fa0-937dffc4cfe1;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Loss on disposal of assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e8449907-ba4c-48c2-87d4-e7c37acb723e" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:GainLossOnDispositionOfAssets1" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">16</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_61d18edd-8162-4f61-97f0-1bcc5dfcfd2d;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Changes in operating assets and liabilities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prepaid expenses and other assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b1095c27-1f45-4301-8947-a629179ae08e" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">173</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c362b962-4ed1-42d6-b0db-91bfa32bd2a6" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">626</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accounts payable</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_81e68175-a1d1-47f5-a4ff-d9f49b9f17e0" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">2,292</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7f94d3d7-829f-403c-8db6-07a8d3c99331" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:IncreaseDecreaseInAccountsPayable" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,287</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deferred revenue</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8c4ec800-864a-4da3-a740-6f2fd4518a33" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">14,068</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_732da880-5cf4-4a68-aecb-5924268d2dbf" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">36,984</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fbb9d3e7-19fc-4d35-8179-099ebf616135" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">794</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b80e24ee-e849-4cfd-a78e-2f5199c2cc68" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,083</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash used in operating activities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d745e238-71c9-4ee0-8db0-a483315be4d5" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">76,059</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2972117d-d933-4651-a6a1-280cffd5f47a" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">45,188</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cash flows from investing activities:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Purchases of property and equipment</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c06e51f2-2e12-4ef5-bc98-d8bb5d2c4307" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,914</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_499e02ca-6812-456d-907b-8a4515b9fe15" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,671</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Purchase of marketable securities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_69f100e9-5403-4ecc-a5f4-67c9f99fd41b" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">92,445</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0039700a-0bd5-4689-872a-08333fdf86a7" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:PaymentsToAcquireMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">26,345</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Redemption of marketable securities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f556539c-2c4b-4b13-b422-04c374156251" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">29,233</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cd829ada-a4cd-43fe-ae87-746d21c87b0a" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">43,418</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash (used in) provided by investing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cf33dd61-c348-4613-a122-ddf934fb14f4" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">66,126</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_103045c1-f062-4427-91b7-9907a55ca99c" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,402</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cash flows from financing activities:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Proceeds from issuance of common stock</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c6cbc8cb-5d89-447a-a20f-dca347293516" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,298</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3d5863fc-ba88-435f-9aed-85116aedc0cb" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,545</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Proceeds from Employee Stock Purchase Plan</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4ab724ae-5578-4689-883a-8ad91e51fda9" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ProceedsFromStockPlans" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">60</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_f3fea894-401b-42b7-a411-98f6c2335c88;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Proceeds from Private Placement, net of issuance costs</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_ddc3cbc9-ebdc-4197-a73d-3719f2462855;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_91f45205-6b6e-4d7f-baba-a2ac832b87b3" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">40,143</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Proceeds from Term Loan</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_6cc8354e-b09a-486a-a3bb-72248169c646;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_74ab7261-4523-41e6-852d-00760e410fc3" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,000</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash provided by financing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_616abc50-3120-4548-af04-e478f9e55b24" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,358</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_114d8698-10df-45f7-8d13-7385a0289a99" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">56,688</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Net (decrease) increase in cash, cash equivalents, and restricted cash</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_76d91013-68aa-44f4-85a9-928060300c65" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">140,827</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1f28bfb3-4095-4838-94fa-39b698984635" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,902</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash, cash equivalents, and restricted cash at<br />&#160;&#160;&#160;beginning of period</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c3959906-9cc0-4d70-9656-041b1814d5f2" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">222,161</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6fca6aac-e328-46c4-bec1-1feb5aa2787a" contextRef="C_fa37d2a6-9437-44d8-82ac-ad9b23ac3a6b" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">200,259</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash, cash equivalents, and restricted cash at end of period</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bab4b962-9ddd-4d2d-84d5-f95c1bcdf871" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">81,334</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7e553283-5ca1-44ab-86ba-4cbb44710878" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">222,161</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Supplemental disclosures:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash paid for interest</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ebab044f-2c5f-4cb5-b4e9-12985636f7ad" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:InterestPaidNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">703</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_137eb426-abf4-4990-891b-091eb5ac7e50;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Right-of-use assets in exchange for lease liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_cdd6ec79-42ae-4060-abec-f2ff3f16e689;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5ddbae01-fa65-402d-a944-51a5065fe6e7" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">31,335</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Purchases of property and equipment included in accounts payable and<br />&#160;&#160;&#160;accrued expenses</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_61d0d67c-f4cd-4d4b-8d9e-d7034d0a2bef;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3f0bbf7d-eab4-43e0-8f91-14235fd613f2" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,145</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">See accompanying notes</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:1.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Frequency Therapeutics, Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="notes_to_consolidated_financial_statemen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Notes to Consolidated </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Financial Statements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">(Amounts in thousands, except share and per share amounts)</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_879dfe11-82a7-4d86-9f78-5ec742e5c3cd" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">1. Organization</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Frequency Therapeutics, Inc., together with its wholly owned subsidiaries, Frequency Therapeutics, PTY, LTD, Frequency Therapeutics Securities Corporation and Frequency Therapeutics Japan KK (Frequency Japan) (the Company), headquartered in Lexington, Massachusetts, was incorporated in </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_7f4715db-25ee-4490-aad3-011a331de8ce;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">November 2014</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> as a Delaware corporation. Frequency Japan was closed down in February 2021. The Company is a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person&#x2019;s innate regenerative potential to restore function.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Liquidity and capital resources</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has funded its operations primarily with proceeds from the sale of its capital stock, convertible notes and amounts received under a collaboration agreement. The Company has incurred recurring losses since its inception. In addition, as of December 31, 2021, the Company had an accumulated deficit of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_90c910bd-df0b-4caf-9e3b-7d18e27557ae" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">180,085</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company expects to continue to generate operating losses for the foreseeable future. The future viability of the Company is dependent on its ability to raise additional capital to finance its operations. The Company&#x2019;s inability to raise capital as and when needed could have a negative impact on its financial condition and ability to pursue its business strategies. There can be no assurances that additional funding will be available on terms acceptable to the Company, or at all. The Company believes that existing resources will be sufficient to fund planned operations for at least 12 months from the date the financial statements were available to be issued.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div><ix:nonNumeric id="F_55ce9377-3192-43f0-8c1d-9bd47ec7e104" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2. Summary of significant accounting policies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c5738b27-9d26-4c5c-916d-808d9705bd95" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" escape="true" continuedAt="F_c5738b27-9d26-4c5c-916d-808d9705bd95_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Basis of presentation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_c5738b27-9d26-4c5c-916d-808d9705bd95_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying consolidated financial statements have been prepared in accordance with accounting standards set by the Financial Accounting Standards Board (FASB). The FASB sets generally accepted accounting principles (GAAP) that the Company follows to ensure its financial condition, results of operations, and cash flows are consistently reported. References to GAAP issued by the FASB in these notes to the consolidated financial statements are to the FASB </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accounting Standards</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Codification (ASC).</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b2a09fae-49a7-4549-840d-4d5c2769cd59" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ConsolidationPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Principles of consolidation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The consolidated financial statements include the accounts of Frequency Therapeutics, Inc. and its wholly owned subsidiaries Frequency Therapeutics Securities Corporation, Frequency Therapeutics PTY, LTD and Frequency Japan through the date of its dissolution. All intercompany transactions and balances have been eliminated.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1c22d6ff-7af2-4c09-9254-e83ee612d449" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:UseOfEstimates" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of the Company&#x2019;s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of expenses during the reporting period. On an ongoing basis, the Company&#x2019;s management evaluates its estimates, which include but are not limited to management&#x2019;s judgments of accrued expenses, revenue recognition, fair value of common stock, valuation of share-based awards, present value of lease liabilities and income taxes. Actual results could differ from those estimates.</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1d64f18e-2f23-40f3-b6ed-2d1ba6011556" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" escape="true" continuedAt="F_1d64f18e-2f23-40f3-b6ed-2d1ba6011556_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Comprehensive loss</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Components </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">of comprehensive income or loss, including net income or loss, are reported in the financial statements in the period in which they are recognized. Other comprehensive income or loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Net income (loss) and other comprehensive income (loss) are reported net of any related tax effect to arrive at comprehensive income (loss). Comprehensive loss includes net loss as well as other changes in stockholders&#x2019; equity that result from transactions and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_1d64f18e-2f23-40f3-b6ed-2d1ba6011556_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">economic </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">events other than those with stockholders which for the years ended December 31, 2021 and 2020 consist of unrealized loss on marketable securities. </span></ix:continuation></span><span style="font-size:10.0pt;font-family:Times New Roman;"></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ceeaf197-5d8f-47d8-a70e-f97126849e32" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" escape="true" continuedAt="F_ceeaf197-5d8f-47d8-a70e-f97126849e32_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Segment information</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><ix:continuation id="F_ceeaf197-5d8f-47d8-a70e-f97126849e32_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision-maker in deciding how to allocate resources and assess performance. The Company and the Company&#x2019;s chief operating decision-maker, the Company&#x2019;s chief executive officer, views the Company&#x2019;s operations and manages its business as a single operating segment, which is in the business of discovering and developing small molecule drugs that activate progenitor cells within the body to create healthy tissue.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e8e14f63-63c0-42ae-b1f3-0748a354df58" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" escape="true" continuedAt="F_e8e14f63-63c0-42ae-b1f3-0748a354df58_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Foreign currency</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:12.0pt;font-family:Times New Roman;"><ix:continuation id="F_e8e14f63-63c0-42ae-b1f3-0748a354df58_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All periods presented are reported in US dollars. The functional currency for entities outside the United States is the US dollar. Realized and unrealized gains and losses from foreign currency transactions are reflected in the consolidated statements of operations as other expense.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> During the years ended December 31, 2021 and 2020 the Company recorded $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1ab6662d-0251-4796-a86d-a390b4c7882a" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">of foreign currency exchange gains and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a5fdc91a-0ba6-47b5-9d06-f062d9f211fe" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of foreign currency exchange losses, respectively.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_09d9cf7d-ade2-4b14-afab-a5c7a83aed8f" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" escape="true" continuedAt="F_09d9cf7d-ade2-4b14-afab-a5c7a83aed8f_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cash and cash equivalents</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><ix:continuation id="F_09d9cf7d-ade2-4b14-afab-a5c7a83aed8f_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company considers all highly liquid investments with an original maturity of six months or less at acquisition to be cash equivalents which are stated at fair market value. Cash and cash equivalents at December 31, 2021 and 2020 consists entirely of cash and money market funds.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9b817321-5a62-4f1f-8e87-8731cd9907f7" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Restricted cash</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2a2e8dae-c922-4d27-8b1a-79e05699a21e" contextRef="C_a3c46bd6-df2a-4676-94dc-776e2b2317ad" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,700</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of restricted cash as of December 31, 2021 which represents a security deposit on the Company's Lexington, Massachusetts facility. The $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c30f7e57-c6d3-4fe3-914f-f7e0ca9b51fc" contextRef="C_2c72469d-cb8e-4588-8128-2bea9727b19f" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,800</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of restricted cash at December 31, 2020 represented the security deposit on the Lexington, Massachusetts facility as well as a $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c87d5918-c100-4b26-90cd-a5ef7852db17" contextRef="C_f6fd7cfb-c8de-4aa0-bb14-1baec943103c" name="us-gaap:RestrictedCashNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">100</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> security deposit on the Company's previous Woburn, Massachusetts facility.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4bfea9d9-31fd-4b38-883a-c1077a1817cf" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:MarketableSecuritiesPolicy" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Marketable securities</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Marketable securities represent holdings of available-for-sale marketable debt securities in accordance with the Company&#x2019;s investment policy. Short-term marketable securities mature within one year from the balance sheet date while long-term marketable securities mature after one year. Investments in marketable securities are recorded at fair value, with any unrealized gains and losses reported within accumulated other comprehensive income as a separate component of stockholders&#x2019; equity until realized or until a determination is made that an other-than-temporary decline in market value has occurred. The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization and accretion are reflected as a component of other expense. Interest on securities sold is determined based on the specific identification method and reflected as interest income. Any realized gains or losses on the sale of investment are reflected as realized (loss) gain on investments.</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b7bd2b34-aafb-474d-ab29-56565d138875" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ConcentrationRiskCreditRisk" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Concentration of credit risk and off-balance sheet risk</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instrument that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents and marketable securities. The Company maintains its cash, cash equivalents, and restricted cash at several accredited financial institutions, in amounts that exceed federally insured limits. Marketable securities consist of short term and long term investments. Management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which its money market accounts are maintained.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has no significant off-balance sheet arrangements such as foreign exchange contracts, option contracts, or other foreign hedging arrangements.</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_93105077-3051-4eec-802f-f32222a1a409" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="freq:SignificantSuppliersPolicyTextBlock" escape="true" continuedAt="F_93105077-3051-4eec-802f-f32222a1a409_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Significant suppliers</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><ix:continuation id="F_93105077-3051-4eec-802f-f32222a1a409_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is dependent on third-party manufacturers to supply products for research and development activities of its programs, including preclinical and clinical testing. In particular, the Company relies and expects to continue to rely on a single manufacturer of its product candidates for use in clinical trials. The Company would be adversely affected by a significant interruption in the supply of product for use in clinical programs.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_25127b2b-bacb-4cb1-a93d-e6e3aff811ab" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" escape="true" continuedAt="F_25127b2b-bacb-4cb1-a93d-e6e3aff811ab_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Fair value measurements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Fair value is defined as the price that would be received upon sale of an asset or paid to transfer a liability between market participants at measurement dates. ASC Topic 820, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Fair Value Measurement</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (ASC 820), establishes a three-level valuation hierarchy for instruments measured at fair value. The hierarchy is based on the transparency of inputs to the valuation of an asset or liability as of the measurement date. The hierarchy defines three levels of valuation inputs, of which the first two are considered observable and the last is considered unobservable:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:4.533%;text-indent:-10.836%;padding-left:9.333%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 1	Quoted prices in active markets for identical assets or liabilities.</span></p><p style="margin-left:4.533%;text-indent:-10.836%;padding-left:9.333%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 2	Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable,     such as quoted market prices, interest rates and yield curves.</span></p><p style="margin-left:4.533%;text-indent:-10.836%;padding-left:9.333%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 3	Unobservable inputs developed using estimates or assumptions developed by the Company, which reflect those that a market participant would use in pricing the asset or liability.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&#x2019;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><ix:continuation id="F_25127b2b-bacb-4cb1-a93d-e6e3aff811ab_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The carrying values of other current assets, accounts payable, and accrued expenses approximate their fair values due to the short-term nature of these assets and liabilities. The fair value of the Company&#x2019;s Term Loan is </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a397f2a1-bd45-40ee-b2d8-3a3ef82493b6" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="freq:FairValueOfTermLoan" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t materially different from the carrying value as presented.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:12.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8caa6183-0e0a-4a27-8ef3-deb6eb6ce494" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Property and equipment, net</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:12.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e5e26dcf-0e10-47dd-a656-2cbf235dadf6" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="freq:PropertyAndEquipmentTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment consist of lab equipment, computer equipment, furniture and office equipment and leasehold improvements recorded at cost. These amounts are depreciated using the straight-line method over the estimated useful lives of the assets as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:71.997%;"></td>
          <td style="width:1.002%;"></td>
          <td style="width:27.001%;"></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.175in;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.175in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Estimated useful life</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Lab equipment</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6d6025f8-bedd-435a-87a6-9ffcb6cc2353" contextRef="C_23b528ed-dd66-4d9c-8b20-60a086d86ba5" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3 years</span></ix:nonNumeric></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Software</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fbbb4bc0-8ff1-4ada-96e9-ca7a72798ee1" contextRef="C_a03b4b17-c9bb-4e37-9fb7-544f7db43dca" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3 years</span></ix:nonNumeric></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furniture and office equipment</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8a91b05f-b8f4-4fa3-98d2-27913e0bdf6b" contextRef="C_635de625-e8b1-4d5c-9ee3-b354458b428c" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3 years</span></ix:nonNumeric></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Leasehold improvements</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e0491f57-db49-4bd3-825c-ec4e04ed77d2" contextRef="C_549428fd-e30a-428e-9b6b-925a65a7eaa2" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives" continuedAt="F_e0491f57-db49-4bd3-825c-ec4e04ed77d2_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Shorter of the estimated useful</span></ix:nonNumeric></span></p><div><ix:continuation id="F_e0491f57-db49-4bd3-825c-ec4e04ed77d2_1"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">life or lease term</span></p></ix:continuation></div></td>
         </tr>
        </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon retirement or sale, the cost of the assets disposed of and the related accumulated depreciation are eliminated from the balance sheet and related gains or losses are reflected in the consolidated statements of operations.</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d6723ade-4c43-4a7b-b310-9339d21d83f9" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Impairment of long-lived assets</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company continually evaluates long-lived assets for potential impairment when events or changes in circumstances indicate the carrying value of the assets may not be recoverable. Recoverability is measured by comparing the book values of the assets to the expected future net undiscounted cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the book values of the assets exceed their fair value. The Company did </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_73bb0ed6-8c8f-4793-95d8-23269853fbeb" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_779a8ddd-dacc-4720-96a4-7a2ec4062e9e" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t recognize any impairment losses for the years ended December 31, 2021 and 2020.</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e4228fdb-77d5-442f-b4b9-5a07ad2891db" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ResearchAndDevelopmentExpensePolicy" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and development costs and accruals</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">and development expenses include salaries and benefits, materials and supplies, preclinical and clinical trial expenses, stock-based compensation expense, depreciation of equipment, contract services and other outside expenses. The Company has entered into various research and development-related contracts with research institutions, contract research organizations, contract manufacturers and other companies. These agreements are generally cancelable, and related payments are recorded as research and development expenses as incurred. Costs of certain development activities, such as manufacturing, pre-clinical and clinical trial expenses, are recognized based on an evaluation of the progress to completion of specific tasks. Payments for these activities are based on the terms of the individual arrangements, which may differ from the pattern of costs incurred, and are reflected in the consolidated financial statements as prepaid or accrued research and development costs. Nonrefundable advance payments for goods or services to be received in the future for use in research and development activities are deferred and capitalized. The capitalized amounts are expensed as the related goods are delivered or the services are performed. Costs incurred in obtaining technology licenses are charged to research and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">development </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">expense as acquired in-process research and development if the technology licensed has not reached technological feasibility and has no alternative future use.</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e601af30-08b6-4c9c-ad99-d449fdd59da4" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:LesseeLeasesPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Leases</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company elected to early adopt ASC 842, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Leases</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (ASC 842) as of January 1, 2020 and elected the transition method under ASU 2016-02 whereby the Company records a right-to-use asset and a lease liability on the consolidated balance sheet for all leases with terms longer than 12 months. The Company also elected to apply the package of practical expedients intended to ease transition. Accordingly, the Company has only applied ASC 842 to leases existing at January 1, 2020. The Company determines if an arrangement is, or contains, a lease at inception. Operating leases are included in operating lease right-of-issue (&#x201c;ROU&#x201d;) assets, other current liabilities, and operating lease liabilities on the consolidated balance sheets.</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments to be made over the lease term. The ROU asset also includes any lease payments made at or before the lease commencement date and excludes lease incentives received. As the Company&#x2019;s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Operating lease expense is recognized on a straight-line basis over the lease term. The Company has elected to not apply the recognition requirements of ASC 842 for short-term leases, which is defined as a lease that, at the lease commencement date, has a lease term of 12 months or less and does </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3a660ac7-14e1-4b73-83d8-81d48270006a" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="freq:IncreaseDecreaseInOperatingLeaseRightOfUseAssets" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t include an option to purchase the underlying asset that the Company is reasonably certain to exercise.</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For real estate lease agreements entered into or modified after the adoption of ASC 842 that include lease and non-lease components, the Company has elected to account for the lease and non-lease components, such as common area maintenance charges, as a single lease component.</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3bc568f3-9c94-4adc-93cc-dda70df81ee7" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:CollaborativeArrangementAccountingPolicy" escape="true" continuedAt="F_3bc568f3-9c94-4adc-93cc-dda70df81ee7_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Collaborative arrangements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company analyzes its collaborative arrangements to assess whether they are within the scope of ASC 808, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Collaborative Arrangements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#x201c;ASC 808&#x201d;) to determine whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards dependent on the commercial success of such activities. This assessment is performed throughout the life of the arrangement based on changes in the responsibilities of all parties in the arrangement. For collaboration arrangements within the scope of ASC 808 that contain multiple elements, the Company first determines which elements of the collaboration are deemed to be within the scope of ASC 808 and those that are more reflective of a vendor-customer relationship (e.g., a licensing arrangement) where the contracted party has obtained goods or services that are an output of the Company&#x2019;s ordinary activities in exchange for a consideration and therefore within the scope of ASC 606, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Revenue from Contracts with Customers</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#x201c;ASC 606&#x201d;). For those elements of the arrangement that are accounted for pursuant to ASC 606, including those to which ASC 606 is applied by analogy, the Company applies the five-step model described in the Company&#x2019;s revenue recognition policy. For elements of collaborative arrangements that are accounted for pursuant to ASC 808, an appropriate and rational recognition method is determined and applied consistently. Reimbursements from the counterparty that are the result of a collaborative relationship with the counterparty, instead of a customer relationship, such as co-development or clinical activities, are recorded as a reduction to research and development expense as the services are performed. Similarly, amounts that are owed to a collaboration partner related to the co-development clinical activities are recognized as research and development expense.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company enters into out-licensing agreements that are within the scope of ASC 606. The terms of such out-license agreements include licenses to functional intellectual property (IP), given the functionality of the intellectual property is not expected to change substantially as a result of the licensor&#x2019;s ongoing activities. Such arrangements typically include payment of one or more of the following: non-refundable up-front license fees; reimbursement of certain costs; development and regulatory milestone payments and milestone payments based on the level of sales; and royalties on net sales of licensed products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company considers the economic and regulatory characteristics of the licensed IP, research, development, manufacturing and commercialization capabilities of the licensee and the availability of the associated expertise in the general marketplace to determine if it has standalone value at the inception of the licensing arrangement, which would make the license distinct. In addition, the Company considers whether the licensee can benefit from a promise for its intended purpose without the receipt of any additional good or services promised in the contract, whether the value of the license is dependent on the remaining goods and services, whether there are other vendors that could provide the remaining promise, and whether the license is separately identifiable from the remaining good and services. For licenses that are combined with</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">other goods and services, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of progress and related revenue recognition. The measure of progress, and thereby periods over which revenue should be recognized, are subject to estimates by management and may change over the course of the research and development and licensing agreement. Such a change could have a material impact on the amount of revenue the Company records in future periods.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Revenue is allocated to the licensed IP on a relative standalone selling price basis and, for functional IP, is recognized at a point when the licensed IP is made available for the customer&#x2019;s use and benefit, which generally occurs at the inception of the arrangement. However, in cases, where the functionality of the IP is expected to substantively change as a result of activities of the Company that do not transfer additional promised goods or services, or in cases, where there is an expectation that the Company will undertake activities to change the standalone functionality of the IP and the customer is contractually or practically required to use the latest version of the IP, revenue for the license to functional IP is recognized over time.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Development and regulatory milestone fees, which are a type of variable consideration, are recognized as revenue to the extent that it is probable that a significant reversal will not occur. The Company recognizes royalty revenue and sales-based milestones at the later of (i) when the related sales occur, or (ii) when the performance obligation to which the royalty has been allocated has been satisfied.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><ix:continuation id="F_3bc568f3-9c94-4adc-93cc-dda70df81ee7_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has entered into a collaboration arrangement with Astellas Pharma Inc. (&#x201c;Astellas&#x201d;), as further described in Note 13 of notes to consolidated financial statements.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3549af38-8f93-4d21-8c40-8e9cc82e0bd0" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:RevenueRecognitionPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Revenue recognition</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company accounts for contracts with customers in accordance with ASC 606, including all amendments thereto. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as collaborative arrangements and leases. The Company&#x2019;s disclosure within the below sections or elsewhere within these consolidated financial statements reflects the Company&#x2019;s accounting policies in compliance with this new standard.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under ASC 606, an entity recognizes revenue when or as its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To recognize revenue for arrangements that an entity determines are within the scope of ASC 606, the entity performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price, including variable consideration, if any; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies its performance obligations. The Company only applies the five-step model to contracts when it is probable that the entity will collect substantially all of the consideration to which it will be entitled in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and identifies as a performance obligation each promise to transfer to the customer either (a) a good or service (or bundle of goods and services) that is distinct, or (b) a series of distinct goods and services that are substantially the same and have been the same pattern of transfer to the customer.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company assesses whether each promised good or service is distinct for the purpose of identifying the performance obligations in the contract. This assessment involves subjective determinations and requires management to make judgments about the individual promised goods or services and whether such are separable from the other aspects of the contractual relationship. Promised goods and services are considered distinct provided that: (i) the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (that is, the good or service is capable of being distinct) and (ii) the entity&#x2019;s promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (that is, the promise to transfer the good or service is distinct within the context of the contract). In assessing whether a promised good or service is distinct, the Company considers factors such as the research, manufacturing and commercialization capabilities of the collaboration partner (the &#x201c;customer&#x201d; in this type of arrangement) and the availability of the associated expertise in the general marketplace. The Company also considers the intended benefit of the contract in assessing whether a promised good or service is separately identifiable from other promises in the contract. If a promised good or service is not distinct, an entity is required to combine that good or service with other promised goods or services until it identifies a bundle of goods or services that is distinct. For each arrangement that results in revenues, the Company identifies all performance obligations, which may include, for example, a license to IP and know-how, research and development activities, and/or manufacturing services.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to any upfront payment, if the consideration promised in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the promised goods</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">or services to a customer. The Company determines the amount of variable consideration by using the expected value method or the most likely amount method. The Company includes the estimated variable consideration in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, the Company re-evaluates the estimated variable consideration included in the transaction price and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis in the period of adjustment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If an arrangement includes development and regulatory milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. There is considerable judgment involved in determining whether it is probable that a significant revenue reversal would not occur. If it is probable that a significant revenue reversal will not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or of the licensee such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of all milestones subject to constraint and, if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For contracts that include sales-based royalties (including milestone payments based on the level of sales) promised in the exchange for licenses of intellectual property, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes royalty revenue and sales-based milestone payments at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied. In determining the transaction price, the Company adjusts the promised amount of consideration for the effects of the time value of money if the timing of payments provides the Company or the Company&#x2019;s customer with a significant benefit of financing the transfer of goods and services. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be one year or less. The Company assesses each of its revenue generating arrangements in order to determine whether a significant financing component exists. The Company recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) each performance obligation is satisfied, either at a point in time or over time.  For performance obligations satisfied over time, the Company measures progress toward completion of its performance obligations using an input method based on the Company&#x2019;s efforts and inputs to satisfy its performance obligations relative to total expected inputs to the satisfaction of that performance obligation.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Amounts received from a customer prior to revenue recognition are recorded as deferred revenue. Amounts received from a customer that are expected to be recognized as revenue within the 12 months following the balance sheet date are classified as a current liability in the accompanying consolidated balance sheets.</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8d9a7528-ca0d-4276-b978-f7398473cadb" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="freq:PatentCostsPolicyTextBlock" escape="true" continuedAt="F_8d9a7528-ca0d-4276-b978-f7398473cadb_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Patent costs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><ix:continuation id="F_8d9a7528-ca0d-4276-b978-f7398473cadb_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company expenses patent application and related legal costs as incurred and classifies such costs as general and administrative expenses in the accompanying consolidated statements of operations.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_71f32c21-dd43-4e3d-9a2e-12137693857d" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" escape="true" continuedAt="F_71f32c21-dd43-4e3d-9a2e-12137693857d_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-based compensation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company accounts for its stock-based compensation in accordance with ASC Topic 718, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Compensation&#x2014;Stock Compensation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (ASC 718). ASC 718 requires all share-based payments to employees and directors to be recognized as expense in the consolidated statements of operations and comprehensive loss based on their grant date fair values. The Company adopted FASB Accounting Standards Update (ASU) 2016-09 which identifies areas for simplification of several areas of share-based payment transactions. The Company treats non-employee grants in a manner consistent with employee grants. The Company estimates the fair value of options granted using the Black-Scholes option pricing model for stock option grants to both employees and non-employees. The Company believes the fair value of the stock options granted to non-employees is more reliably determinable than the fair value of the services provided.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Black-Scholes option pricing model requires inputs based on certain subjective assumptions, including (a) the expected stock price volatility, (b) the expected term of the award, (c) the risk-free interest rate and (d) expected dividends. Due to the lack of sufficient company-specific historical and implied volatility data, the Company has based its computation of expected volatility on the historical volatility of a representative group of public companies with similar characteristics to the Company, including stage of product development and life science industry focus. The historical volatility is calculated based on a period of time commensurate with the expected term assumption. The Company uses the simplified method as prescribed by the SEC Staff Accounting Bulletin No. 107, Share-Based Payment, to calculate the expected term for options granted to employees as it does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The expected term is applied to the stock option grant group as a whole, as the Company does not expect substantially different exercise or post-vesting termination behavior among its employee population. For options granted to non-employees, the Company utilizes the contractual term of the share-based payment as the basis for the expected term assumption. The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected term of the stock options. The expected dividend yield is assumed to be zero as the Company has never paid dividends and has no current plans to pay any dividends on its common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><ix:continuation id="F_71f32c21-dd43-4e3d-9a2e-12137693857d_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company expenses the fair value of its share-based compensation awards to employees and non-employees on a straight-line basis over the requisite service period, which is generally the vesting period.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span>&#160;</p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4437dfe4-760f-4f80-93be-9278ced720f4" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:IncomeTaxPolicyTextBlock" escape="true" continuedAt="F_4437dfe4-760f-4f80-93be-9278ced720f4_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income taxes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_4437dfe4-760f-4f80-93be-9278ced720f4_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company accounts for income taxes using the asset and liability method in accordance with ASC Topic 740, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income Taxes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (ASC 740) which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the Company&#x2019;s tax returns. Deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. At December 31, 2021 and 2020, the Company has concluded that a full valuation allowance is necessary for its deferred tax assets (see Note 11).</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fe2aa8cf-90c0-4eaf-9054-0995ba08ab1e" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:EarningsPerSharePolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Net loss per share</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed using the weighted-average number of shares of common stock outstanding during the period and, if dilutive, the weighted-average number of potential shares of common stock. Diluted net loss per share is the same as basic net loss per share for the years ended December 31, 2021 and 2020 since all potential shares of common stock instruments are anti-dilutive as a result of the loss for such periods.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#x2019;s convertible preferred stock contractually entitled the holders of such shares to participate in dividends but did not contractually require the holders of such shares to participate in losses of the Company. Accordingly, in periods in which the Company reported a net loss, such losses are not allocated to such participating securities. In periods where the Company reported a net loss attributable to common stockholders, diluted net loss per share is the same as basic net loss per share, since dilutive shares of common stock are not assumed to have been issued if their effect is anti-dilutive. The Company reported a net loss attributable to common stockholders for the years ended December 31, 2021 and 2020.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_32066afe-84dc-452b-a4ac-991d742556df" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Basic and diluted net loss per share attributable to common stockholders was calculated as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:52.878%;"></td>
          <td style="width:1.378%;"></td>
          <td style="width:2.061%;"></td>
          <td style="width:18.687%;"></td>
          <td style="width:1.378%;"></td>
          <td style="width:1.492%;"></td>
          <td style="width:2.061%;"></td>
          <td style="width:18.687%;"></td>
          <td style="width:1.378%;"></td>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended <br />December 31,</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Numerator:</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d6bd4af6-575d-4b72-a649-4cf64d40ddaf" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">84,686</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_79bc56b1-f418-45f6-a07c-b6a3a2ad200b" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">26,511</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Denominator:</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average shares of common stock<br />&#160;&#160;&#160;outstanding-basic and diluted</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c71bb297-2ed4-44eb-82ca-0637f38143f5" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">34,351,274</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_17360805-d85a-4b85-97ab-d905a5c8eb9b" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">32,253,227</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss per share-basic and diluted</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a8d97944-2969-4a2c-9872-b3ad84a2a7ae" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-">2.47</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ff4ab991-7438-41c4-a134-72b98514bcaf" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-">0.82</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
         </tr>
        </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14</span></p>
         <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_eacee7a9-9da8-494b-903b-934160be5b29" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company excluded the following potential shares of common stock from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:55.109%;"></td>
          <td style="width:1.478%;"></td>
          <td style="width:0.853%;"></td>
          <td style="width:19.199%;"></td>
          <td style="width:0.853%;"></td>
          <td style="width:1.606%;"></td>
          <td style="width:0.853%;"></td>
          <td style="width:19.199%;"></td>
          <td style="width:0.853%;"></td>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended <br />December 31,</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested restricted common stock</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b3af5ba7-e034-4892-9afe-1061a8a555c6" contextRef="C_742c5792-c6e5-48a5-b310-178c83269552" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b9357404-4657-4e54-b765-f3b0f964b6eb" contextRef="C_10cead94-19bf-43da-bf2a-3aa91fbb188c" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">3,093</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested restricted stock units</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d6f11405-5014-4c03-84f7-24a5bf675bdd" contextRef="C_011eaa78-a982-439b-9cbe-570f4099f0e2" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">626,300</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8537fc2d-8dea-44cb-ba12-d22c553e61d6" contextRef="C_bd09e8d5-eab7-4713-8061-e03dbe21d25f" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding stock options</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5cde1764-3ce6-45a0-b647-4be4c93a4e7a" contextRef="C_02bfcdf4-c4aa-45c7-8d3c-0e389bcfa619" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">6,830,037</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3e4c028b-7ca3-4d6a-ae06-1ca9c229d944" contextRef="C_9c459f52-c125-4fea-a2f0-f75d77c58396" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">6,816,798</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_901a071f-732b-421e-9076-4f9a0c2daeb1" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">7,456,337</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f15a3341-ba36-40f9-94c6-580a29c97883" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">6,819,891</ix:nonFraction></span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
        </table></ix:nonNumeric></div></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2f437cac-bd18-496a-af2f-94cf46a74f07" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recently adopted accounting pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In August 2018, the FASB issued ASU No. 2018-15,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> Intangibles - Goodwill and Other - Internal-Use Software</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract. This standard addresses the accounting for implementation costs incurred by a customer in a cloud computing arrangement that is a service contract and also adds certain disclosure requirements related to implementation costs incurred for internal-use software and cloud computing arrangements. The amendment aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The Company adopted this standard on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9fe14f18-8e6f-4693-a5f1-e05784e091b2" contextRef="C_875116db-7306-464c-bdd4-f7030d1b80b3" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2021</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, using a prospective approach. The adoption of this new standard did not have a material </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fb059a0c-c5a7-42d2-b75e-078d9f289487" contextRef="C_875116db-7306-464c-bdd4-f7030d1b80b3" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" format="ixt:booleanfalse"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">impact</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> on the consolidated financial statements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2019, the FASB issued ASU 2019-12 amending accounting guidance that simplifies the accounting for income taxes, as part of its initiative to reduce complexity in the accounting standards. The amendments eliminate certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The amendments also clarify and simplify other aspects of the accounting for income taxes. The Company adopted this standard on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f8b12a90-5efb-4478-942a-e67ba22fab9f" contextRef="C_f02c82d0-ac2f-4ce8-8c28-dace93e62425" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2021</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and it did not have a material </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7023f076-c663-46b9-85a6-5fc0d21364b6" contextRef="C_f02c82d0-ac2f-4ce8-8c28-dace93e62425" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" format="ixt:booleanfalse"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">impact</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> on the consolidated financial statements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recently issued accounting pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. The Company is an &#x201c;emerging growth company&#x201d; as defined in the Jumpstart Our Business Startups Act of 2012, as amended (Jobs Act). The Jobs Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. Thus, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company elected to avail itself of this extended transition period and, as a result, we will not be required to adopt new or revised accounting standards on the relevant dates on which adoption of such standards is required for other public companies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Financial Instruments - Credit Losses</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (Topic 326): Measurement of Credit Losses on Financial Instruments. The FASB has subsequently issued amendments to ASU 2016-13, which have the same effective date and transition date. These standards require that credit losses be reported using an expected losses model rather than the incurred losses model that was previously used, and establishes additional disclosures related to credit risks. For available-for-sale debt securities with unrealized losses, this standard now requires allowances to be recorded instead of reducing the amortized cost of the investment. These standards limit the amount of credit losses to be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. This standard will become effective for the Company on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_24787a3a-bcd7-450c-92d7-779afde38f4b" contextRef="C_bbfcdb78-4741-401f-8112-443fb777bdf1" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2023</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company is still evaluating the </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0521c36a-c143-48a6-a163-07f44b291199" contextRef="C_bbfcdb78-4741-401f-8112-443fb777bdf1" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" format="ixt:booleantrue"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">impact</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of this standard on its consolidated financial statements.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">3. </span><span><ix:nonNumeric id="F_c818ed8c-466f-4fe2-aec7-784eea969991" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:FairValueDisclosuresTextBlock" escape="true" continuedAt="F_c818ed8c-466f-4fe2-aec7-784eea969991_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Fair value measurements </span></ix:nonNumeric></span><span style=""></span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_c818ed8c-466f-4fe2-aec7-784eea969991_1"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:12.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_daa370cd-ba07-4256-9731-796b173d6a0f" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#x2019;s financial assets measures at fair value on a recurring basis by level within the fair value hierarchy at December 31, 2021 and 2020 are summarized as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:41.9%;"></td>
        <td style="width:1.302%;"></td>
        <td style="width:12.95%;"></td>
        <td style="width:1.302%;"></td>
        <td style="width:1.272%;"></td>
        <td style="width:11.409%;"></td>
        <td style="width:0.636%;"></td>
        <td style="width:1.302%;"></td>
        <td style="width:1.272%;"></td>
        <td style="width:11.201%;"></td>
        <td style="width:0.865%;"></td>
        <td style="width:1.302%;"></td>
        <td style="width:1.272%;"></td>
        <td style="width:11.379%;"></td>
        <td style="width:0.636%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Fair Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Amortization</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Unrealized</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Fair Market</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Hierarchy</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Cost</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(Loss)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1d4b84c3-529f-4b7b-8179-ca151d5cf9c7" contextRef="C_be7fbd4c-1845-482f-953d-2642af2fb06e" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">48,160</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dcc3beb8-2546-45c0-8972-c57084eaf3a6" contextRef="C_be7fbd4c-1845-482f-953d-2642af2fb06e" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">48,160</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Short-term marketable securities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_06bf02a1-dea0-44b0-bb97-4f5947ad54ce" contextRef="C_e8bc2828-4017-4ef6-bfea-d1f31df30f70" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">51,116</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e285aa02-8a27-4a41-bd0d-6baf17cfaef8" contextRef="C_e8bc2828-4017-4ef6-bfea-d1f31df30f70" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">44</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4dfc28e4-b3c5-4b59-9d54-701f114002b1" contextRef="C_e8bc2828-4017-4ef6-bfea-d1f31df30f70" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">51,072</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Long-term marketable securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1b7f9880-9667-436e-aee3-71ea58005b13" contextRef="C_1d3c986e-4a0f-4b46-957f-19f2213ac557" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,764</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e179669c-26ac-489e-bce2-7ac5488588e7" contextRef="C_1d3c986e-4a0f-4b46-957f-19f2213ac557" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">45</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7221de22-c102-4b35-8997-ed0985ddf552" contextRef="C_1d3c986e-4a0f-4b46-957f-19f2213ac557" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,719</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">    </span>&#160;</p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6d38a4d9-6d80-42be-a414-9a7117e106b5" contextRef="C_cc3ef655-c17e-488c-8981-986ec4c9084c" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">111,040</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a19f7f80-4204-4509-b97b-0f8902fc8752" contextRef="C_cc3ef655-c17e-488c-8981-986ec4c9084c" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">89</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_eff28684-83f3-4270-a391-b7172c18f5ac" contextRef="C_cc3ef655-c17e-488c-8981-986ec4c9084c" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">110,951</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:41.894%;"></td>
        <td style="width:1.302%;"></td>
        <td style="width:12.971%;"></td>
        <td style="width:1.302%;"></td>
        <td style="width:1.272%;"></td>
        <td style="width:11.42%;"></td>
        <td style="width:0.636%;"></td>
        <td style="width:1.302%;"></td>
        <td style="width:1.272%;"></td>
        <td style="width:11.391%;"></td>
        <td style="width:0.636%;"></td>
        <td style="width:1.302%;"></td>
        <td style="width:1.272%;"></td>
        <td style="width:11.391%;"></td>
        <td style="width:0.636%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Fair Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Amortization</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Unrealized</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Fair Market</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Hierarchy</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Cost</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Gain</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_06bf308a-6fe1-4d08-b5ec-df6b2d9d36dc" contextRef="C_961e7065-ef44-44fe-a970-97b4c237d73a" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">214,522</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_88d61607-3d6a-43d7-b109-11ca017ac249" contextRef="C_961e7065-ef44-44fe-a970-97b4c237d73a" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_16e79f2d-7a23-455d-a73b-4166fe7556b2" contextRef="C_961e7065-ef44-44fe-a970-97b4c237d73a" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">214,549</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">     </span>&#160;</p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_93d197de-bcee-4302-8eba-b4016873c0aa" contextRef="C_5d611fcf-f5e9-4ee1-96e1-00b7bbb48319" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">214,522</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4a7f7e82-2a60-4618-ac2c-59afea4e4cf8" contextRef="C_5d611fcf-f5e9-4ee1-96e1-00b7bbb48319" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0de9cbf3-4f70-43fa-81d6-2f2e21b078ec" contextRef="C_5d611fcf-f5e9-4ee1-96e1-00b7bbb48319" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">214,549</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:continuation></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_685730f8-0499-4312-90bf-a909fcca4808" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="freq:PrepaidExpensesAndOtherCurrentAssetsTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">4. Prepaid expenses and other current assets</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0307d8ce-18a4-466a-ad4c-355e9b1a3f9c" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="freq:SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prepaid expenses and other current assets consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.816%;"></td>
        <td style="width:1.481%;"></td>
        <td style="width:1.282%;"></td>
        <td style="width:13.192%;"></td>
        <td style="width:0.636%;"></td>
        <td style="width:1.481%;"></td>
        <td style="width:1.282%;"></td>
        <td style="width:13.192%;"></td>
        <td style="width:0.636%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Rent and deposits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_94e73d67-f7e2-4ede-b849-4a8f1eeedceb" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="freq:PrepaidRentAndDepositsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">470</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_1798d1a5-8d3c-4e74-b507-c3d76c7abeb0;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development expenses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_df309547-352c-450c-97ff-144133a19791" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="freq:PrepaidResearchAndDevelopmentExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">858</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_74fdbd2f-c996-400c-b5fb-9396f042dd0e" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="freq:PrepaidResearchAndDevelopmentExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,729</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accounts receivable</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9f5621ff-29d8-4c76-8996-0b85ef285055" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="freq:PrepaidAccountsReceivableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">144</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4b9dcef3-d7f0-43cd-89aa-daee83fde9ab" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="freq:PrepaidAccountsReceivableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">340</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Insurance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0e5a7eec-feaa-4ea5-a933-86784415e2a6" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:PrepaidInsurance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,384</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0eba5832-503c-4563-aa8e-98977c94c16c" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:PrepaidInsurance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,552</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_359197e7-5e3a-425c-87f9-4f3437e41d33" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:OtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">185</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cfeebf4a-f1fc-49eb-b956-874ef9f9b546" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:OtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">102</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1930dfe1-84e9-47ea-ac05-b2e7b8cae1a1" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,041</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_416da0d9-366c-4655-a1a4-730dd2724e99" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,723</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_258e19f1-3a08-4f82-ba5c-5616ec750602" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">5. Property and equipment</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5fb5310d-6508-461c-aa93-c921f40e2289" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:PropertyPlantAndEquipmentTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment include the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.446%;"></td>
        <td style="width:1.879%;"></td>
        <td style="width:1.282%;"></td>
        <td style="width:17.642%;"></td>
        <td style="width:0.964%;"></td>
        <td style="width:1.879%;"></td>
        <td style="width:1.282%;"></td>
        <td style="width:17.662%;"></td>
        <td style="width:0.964%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Lab equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8b1d148d-4710-4146-9efd-b0139b0ece09" contextRef="C_49c37535-f895-4807-a0bd-aba968e19e1d" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,177</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_adcf2610-9341-4df6-9798-0f56eece367f" contextRef="C_6b618c84-e67f-47f3-a70b-580a46e694b4" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,166</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furniture and office equipment</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fd7c55a9-2ee4-4e80-96f8-0492510481cb" contextRef="C_0a19bf2f-1258-4062-91ef-67f93a769e1f" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,238</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bf25cce6-6dbe-490a-abd7-5d1a00342238" contextRef="C_f16d2dd7-db5e-4985-9658-6e9c9f5382ec" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">283</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Software</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2ad2c2dc-6251-47d0-8c07-0305fd6ac1d7" contextRef="C_d31917a1-75da-46d6-8ef7-52754985fa8f" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">291</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cf1992ab-ec19-43a9-9478-d286ecc22b5b" contextRef="C_2ca9c59f-69d7-4fec-9a05-50e04ddc9998" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">291</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Leasehold improvements</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_80f74aed-584f-4049-853a-ec1b844259a6" contextRef="C_f970257d-5f8c-4f69-a8af-6c7b98ed7be9" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2919d6ca-cc21-4753-b22a-ff3e1b3c59fa" contextRef="C_14a91b0e-22cb-42cd-8677-a4630683bcaf" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,419</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Construction in progress</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_17f7892e-0818-4675-9a41-d63845526b71" contextRef="C_76fdd776-fb2d-4e7e-946f-9baef372cfc0" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_68fb1196-8474-4074-9614-3a4db58d9733" contextRef="C_b4192ab1-1392-4775-850f-0b32e8099e98" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,340</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bfb3334e-9395-4d6c-8d9c-0e5574bc9111" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,706</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8757d297-d7b8-4aac-8598-08786227a1d1" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,499</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accumulated depreciation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a2b1c67b-5179-4044-9ef6-7cf91ebe4023" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,184</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_663e12e6-b2ea-4884-8c4a-26d15ca2118b" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,212</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment, net</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_14003389-128b-48ec-a25d-f2f3aeef23c1" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,522</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_af0ce29e-3e3f-4782-a1c8-c05726c4b3ec" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,287</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company recognized </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dafb35c5-1fba-49fc-89ae-737273112b20" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,775</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6ffb14e6-1463-4822-986c-b2d15d680bc2" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,146</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of depreciation expense for the years ended December 31, 2021 and 2020, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3c04b666-780d-4054-8bab-21c3bc4c6c72" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">6. Accrued expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_69f34471-d29b-4d66-9e54-d141b757d1ef" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses consist of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.2%;"></td>
        <td style="width:1.392%;"></td>
        <td style="width:1.282%;"></td>
        <td style="width:12.742%;"></td>
        <td style="width:0.964%;"></td>
        <td style="width:1.411%;"></td>
        <td style="width:1.282%;"></td>
        <td style="width:12.762%;"></td>
        <td style="width:0.964%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Payroll and employee related expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_194cbf5c-5f26-4d94-a83c-82255ce1254b" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,375</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7b06532f-0c33-45f2-9cb3-e52998b1a7e0" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,062</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Professional fees</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1c7a9cf0-bab6-49e8-80a3-19e539c163f2" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">767</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_eb0f28f0-4c18-4314-a498-a0f0091554e9" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">647</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Third-party research and development expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_579b6617-d361-4b5d-888b-45c53b5bfe5e" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="freq:AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">840</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3b8e7b6b-05c3-40db-b8dc-c413f3967ee3" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="freq:AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">874</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_53de23a6-e374-4c04-b4c0-5632a57a6f1e" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="freq:AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">119</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_84fba69b-7e4a-4a02-98d7-bc03f5097fa1" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="freq:AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">80</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5679035a-7b31-47dc-b186-d6925efd1cd4" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,101</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1c661f46-f336-41ab-a63b-4d726d043371" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,663</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9e4a1bb7-5f77-4bd7-a921-b361b3e52383" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:DebtDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">7.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> Debt</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On December 11, 2020, the Company entered into a Loan and Security Agreement (the &#x201c;Loan Agreement&#x201d;) with a commercial bank for a Term Loan with a principal balance of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_15d9d055-7745-411a-b84a-83046d35271a" contextRef="C_45970929-9cc5-4976-bf18-cee30c4707f1" name="us-gaap:DebtInstrumentFaceAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,000</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e107107e-50c4-4885-aadb-6ed9dedb724c" contextRef="C_9b494e1f-e9d7-4e68-8c4e-6503e6471f18" name="us-gaap:DebtInstrumentPaymentTerms"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company will make monthly interest only payments through </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_00b4091b-1582-440a-a094-ca15b3a1fd27" contextRef="C_389d9cd1-a5f9-4537-a214-aae7847e6a94" name="freq:DebtInstrumentInterestOnlyPaymentMaturityDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">November 30, 2022</span></ix:nonNumeric></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The principal balance and interest will be repaid in equal </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_62641037-9e3b-4230-b39f-ce32fc7c7da6" contextRef="C_9b494e1f-e9d7-4e68-8c4e-6503e6471f18" name="us-gaap:DebtInstrumentFrequencyOfPeriodicPayment"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">monthly</span></ix:nonNumeric></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> installments after the interest only period and continue through </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c80e5e65-22a2-4f1e-a640-ab8c6c908a6c" contextRef="C_389d9cd1-a5f9-4537-a214-aae7847e6a94" name="us-gaap:DebtInstrumentMaturityDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">May 1, 2024</span></ix:nonNumeric></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (the &#x201c;Loan Maturity Date&#x201d;)</span></ix:nonNumeric></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Advances under the Loan Agreement will bear an interest rate equal to the greater of either (i) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b77b9d46-289e-4b60-ad9c-d1b4a14f9f13" contextRef="C_f955b24a-1210-4587-a090-44353cb3e0a3" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">1.50</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% plus the Prime Rate (as reported in</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> The Wall Street Journal</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, subject to an interest rate floor of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1ab2a623-151f-4461-b766-d3a1b826b2fa" contextRef="C_45970929-9cc5-4976-bf18-cee30c4707f1" name="freq:DebtInstrumentFloorInterestRatePercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt-sec:numwordsen">zero</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) or (ii) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b27d447d-8c21-4711-90e1-1de9fc72f1a7" contextRef="C_9b494e1f-e9d7-4e68-8c4e-6503e6471f18" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">4.75</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%. The interest rate at December 31, 2021 was </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_56ffe904-606c-4331-bb8a-3fd71128beba" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" unitRef="U_pure" scale="-2" decimals="4" format="ixt:numdotdecimal">4.75</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Interest related to the Loan Agreement was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7786c2b1-01bb-4cfa-b1d1-a9861899d47a" contextRef="C_58f5a961-03f6-4320-a30e-9ed5284f4e0a" name="us-gaap:InterestExpenseDebt" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">764</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for the year ended December 31, 2021 and immaterial for the year ended December 31, 2020.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company may prepay the advance made under the Loan Agreement in whole, at any time subject to a prepayment premium equal to: (a) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2910024c-7886-48c5-a21e-cffc007b8962" contextRef="C_fb927f4e-76df-424a-920e-b43ae68e4b30" name="freq:DebtInstrumentPrepaymentPremiumPercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">2.0</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the then-outstanding principal amount of the advance, if such prepayment occurs on or prior to the first anniversary of the Closing Date; (b) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1bc2e1a7-e1ad-4901-8adc-b080e81a9cc8" contextRef="C_b7c53ec7-6b2a-4521-bec1-3cfbee53835a" name="freq:DebtInstrumentPrepaymentPremiumPercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">1.0</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the then-outstanding principal amount of the advance, if such prepayment occurs after the first anniversary of the Closing Date and on or prior to the second anniversary of the Closing Date; and (c) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_85c274b7-6ff4-492a-aed3-a758d1457c75" contextRef="C_0f0e0f6b-efeb-4ef1-b44a-ccadd9a887cd" name="freq:DebtInstrumentPrepaymentPremiumPercentage" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.0</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the then-outstanding principal amount of the advance, if such prepayment occurs after the second anniversary of the Closing Date. The prepayment premium is waived if the Term Loan is refinanced by the bank (in its sole and absolute discretion) on or prior to the Loan Maturity Date.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company will pay a final payment of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b5e03086-c81f-43e8-9168-939b3c88af10" contextRef="C_45970929-9cc5-4976-bf18-cee30c4707f1" name="us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">150</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, which will occur on the earliest of: (i) the Loan Maturity Date; (ii) the date that the Company prepays all of the outstanding principal in full; (iii) the date the loan payments are accelerated due to an event of default; or (iv) the termination of the Loan Agreement. The Company is recording the final payment as interest expense over the term of the loan. The Term Loan is secured by substantially all of the Company&#x2019;s assets, excluding intellectual property.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9f41010c-2bdc-4dab-b042-2d628342cb1f" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">8. Stockholders&#x2019; equity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Preferred stock</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">   </span>&#160;</p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">    </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has authorized </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_76668500-4d0f-4fa5-9508-a83501db6c7b" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3adf5ed7-883b-4409-b2f3-27347a1589ce" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.001</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> par value preferred stock of which </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_faee29d2-6cf9-44fb-a0ce-9e87b76ccb4f" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_9a55a0d8-9a10-47f5-800e-201e60233a22" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares were issued or outstanding as of December 31, 2021.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Common stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has authorized </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bb8e766a-957a-4d59-a54d-46cf89a774c0" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">200,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4fda8906-be7f-44fa-87ea-8a1a2cc3b141" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.001</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> par value common stock of which </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3858c27e-145c-4d98-af38-31bc679a2508" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_272da50e-1487-4315-8c2c-3d5e477c645f" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">34,611,213</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> were issued and outstanding as of December 31, 2021. Common shares are voting, and dividends may be paid when, as and if declared by the Board of Directors.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e978e1e7-392b-4bb1-ab90-2dca8b9b7b7d" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="freq:ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has reserved the following shares of common stock for future issuance as of December 31, 2021 and 2020:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.146%;"></td>
        <td style="width:1.779%;"></td>
        <td style="width:1.004%;"></td>
        <td style="width:11.33%;"></td>
        <td style="width:1.004%;"></td>
        <td style="width:1.779%;"></td>
        <td style="width:1.004%;"></td>
        <td style="width:15.951%;"></td>
        <td style="width:1.004%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock options outstanding</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fb908091-36e1-4b87-9a5e-e56ac12efd1c" contextRef="C_fd9346ee-0123-48e4-a5e9-177e9e88d4c9" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">6,830,037</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d3cacbe4-0f91-40e7-b95c-82e3a8409ebe" contextRef="C_afc37fa6-10a6-4cfc-b132-46416981a53b" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">6,816,798</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Shares available for future grant under stock option plan</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f650b28d-a836-4cde-afeb-9ad59c9c7686" contextRef="C_81e252a8-16c5-427e-a03f-1106ff94238b" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,552,630</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0fd28d4b-18bc-4911-bcbe-82c62103da76" contextRef="C_5cd63438-4bcf-47ba-83d5-992899a88d69" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,475,923</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_90d9ee00-68d9-4c1c-b32f-d5e83faf1715" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">8,382,667</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_31f603c9-2317-4771-a21a-73b240b344a8" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">8,292,721</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Equity Offerings</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In July 2020, the Company completed a private placement of common stock to new and existing investors, or the Private Placement. In the Private Placement, the Company issued and sold </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c3e48338-3574-4da8-b07f-32c9edb379aa" contextRef="C_ecc116a0-70fc-4e40-92ed-6d00d8ab497a" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,350,108</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock at a purchase price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_45bf129b-7dcb-469f-8ad8-c8c2da8688c8" contextRef="C_8464360a-28a5-4526-89c7-192cc0292849" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">18.00</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share. The Company received approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_600347d2-92e3-4873-ab44-893aaa6794e9" contextRef="C_ecc116a0-70fc-4e40-92ed-6d00d8ab497a" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">40,100</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> in net proceeds, after deducting placement agent fees and other offering expenses. In connection with the Private Placement, the Company entered into a Registration Rights Agreement, or the Registration Rights Agreement, with the investors purchasing shares in the Private Placement. Pursuant to the Registration Rights Agreement, the Company filed a registration statement with the Securities and Exchange Commission, or the SEC, which was declared effective on September 3, 2020, registering the resale of the shares sold in the Private Placement.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On December 10, 2021, the Company entered into an Equity Distribution Agreement (the &#34;Sales Agreement&#34;) with Oppenheimer &amp; Co. Inc. (the &#34;Sales Agent&#34;) to sell shares of the Company&#x2019;s common stock, par value $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ea989a9e-37ad-4024-b47a-ea0ef6f40206" contextRef="C_9a6459ef-90a2-45d3-bb28-8c54d3edc4d6" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.001</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share, with aggregate gross sales proceeds of up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0a886165-3e9e-4d07-ac40-08ff33b60548" contextRef="C_49bd1a34-70e0-4358-af75-4f83449a848f" name="us-gaap:ProceedsFromIssuanceOfCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">125,000</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, from time to time, through an &#x201c;at the market&#x201d; equity offering program. Subject to the terms and conditions of the Sales Agreement, the Sales Agent may sell the shares by methods deemed to be an &#x201c;at the market offering&#x201d; as defined in Rule 415 promulgated under the Securities Act of 1933, as amended, including sales made through The Nasdaq Global Select Market, on any other existing trading market for the Common Stock, to or through a market maker, or, if expressly authorized by the Company, in privately negotiated transactions. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company or Sales Agent may terminate the Sales Agreement upon notice to the other party and subject to other conditions. </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company will pay the Sales Agent a commission equal to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_abdf2643-a6b1-4ab2-ac03-7d3288532ad9" contextRef="C_9a6459ef-90a2-45d3-bb28-8c54d3edc4d6" name="freq:SalesAgentCommission" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">3.0</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the gross proceeds of any Common Stock sold through the Sales Agent under the Sales Agreement and has provided the Sales Agent with customary indemnification rights.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Issuance costs incurred related to the Sales Agreement are classified as long-term assets on the balance sheet at December 31, 2021.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_85330db7-1fac-42ee-8e4e-84dc49258c61" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">9. Stock-based compensation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On November 13, 2014, the Company adopted the 2014 Stock Incentive Plan (2014 Plan). All of the Company&#x2019;s employees, officers, directors, and consultants are eligible to be granted options to purchase common shares and restricted stock under the terms of the 2014 Plan. The Company reserved an aggregate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d104d08b-b321-450e-8fc0-df7896003914" contextRef="C_314d3398-4d13-4f53-b054-20b54a955ba4" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">8,550,415</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock for issuance under the 2014 Plan. As of December 31, 2021, there were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_43592d85-54f1-4438-af11-09794a83c695" contextRef="C_63fbb0a1-d118-421f-b0be-baa522b2c4c1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock available for future grants under the 2014 Plan.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On September 17, 2019, the Company&#x2019;s board of directors and on September 19, 2019, its stockholders approved and adopted the 2019 Incentive Award Plan (&#x201c;the &#x201c;2019 Plan&#x201d;).  Under the 2019 Plan, the Company may grant stock options, stock appreciation rights, restricted stock, restricted stock units, and other stock and cash-based awards to individuals who are then employees, officers, directors or consultants of the Company, and employees and consultants of the Company&#x2019;s subsidiaries.  A total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ce4baf70-b81e-4e88-a1f9-5b1f5d6599f9" contextRef="C_90c637f8-8aac-4313-bec9-a8d318734b7f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,100,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock were approved to be initially reserved for issuance under the 2019 plan.  The number of shares under the 2014 Plan subject to outstanding awards as of the effective date of the 2019 Plan that are subsequently canceled, forfeited or repurchased by the Company will be added to the shares reserved under the 2019 Plan. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_405ebd4f-259f-461e-ab74-3fb293123717" contextRef="C_dcccf903-dd0c-4b08-adcc-14b5fde28ebb" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> In addition, the number of shares of common stock available for issuance under the 2019 Plan will be automatically increased on the first day of each calendar year during the </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3621efec-9eb5-4972-8b23-0270acaceaf2" contextRef="C_dcccf903-dd0c-4b08-adcc-14b5fde28ebb" name="freq:PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ten-year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> term of the 2019 Plan, beginning with January 1, 2020 and ending with January 1, 2029, by the amount equal to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_587c887f-a4d7-4c32-a559-e0475b42be82" contextRef="C_dcccf903-dd0c-4b08-adcc-14b5fde28ebb" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the outstanding number of shares of the Company&#x2019;s common stock on December 31, of the preceding calendar year or such lesser amount as determined by the Company&#x2019;s board of directors.</span></ix:nonNumeric></span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All stock option grants are non-statutory stock options except option grants to employees (including officers and directors) intended to qualify as incentive stock options under the Internal Revenue Code of 1986, as amended. Incentive stock options may not be granted at less than the fair market value of the Company&#x2019;s common stock on the date of grant, as determined in good faith by the Board of Directors at its sole discretion. Nonqualified stock options may be granted at an exercise price established by the Board of Directors at its sole discretion (which has not been less than fair market value on the date of grant) and the vesting periods may vary. Vesting periods are generally</span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dccde3cf-4e02-4e64-9156-ac4d325e5c5c" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> four years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and are determined by the Board of Directors. Stock options become exercisable as they vest. Options granted under the 2014 Plan and the 2019 Plan expire no more than </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9656526c-fc42-4af0-8c09-69610e096ad5" contextRef="C_7b7e8741-8d9b-4c87-a41b-14d39da56ae6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ten years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> from the date of grant.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock options</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f080ccb9-1f5c-4ce4-a7cc-21bc59f2f3af" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A summary of the stock option activity under the 2014 Plan and the 2019 Plan are as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:42.779%;"></td>
        <td style="width:0.736%;"></td>
        <td style="width:0.507%;"></td>
        <td style="width:12.355%;"></td>
        <td style="width:0.686%;"></td>
        <td style="width:0.736%;"></td>
        <td style="width:1.044%;"></td>
        <td style="width:12.056%;"></td>
        <td style="width:0.507%;"></td>
        <td style="width:0.736%;"></td>
        <td style="width:0.517%;"></td>
        <td style="width:12.494%;"></td>
        <td style="width:0.507%;"></td>
        <td style="width:0.736%;"></td>
        <td style="width:1.044%;"></td>
        <td style="width:12.056%;"></td>
        <td style="width:0.507%;"></td>
       </tr>
       <tr style="height:7.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Number of<br />shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Weighted<br />average<br />exercise price</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Weighted<br />average<br />remaining<br />contractual<br />term (in years)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Aggregate<br />intrinsic value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Outstanding as of December 31, 2019</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e2c86059-7628-4735-a8a2-435ad0afa40f" contextRef="C_f6dcc9b6-8e32-4d98-bffb-d9bddefb3adf" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">5,968,672</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_46279e32-f426-4c54-b0ea-6f561df1a660" contextRef="C_f6dcc9b6-8e32-4d98-bffb-d9bddefb3adf" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">5.21</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_27c0f8b4-76a5-4a08-b675-17e884dcddad" contextRef="C_514ddae0-918c-4159-afcf-c75cb08a52fd" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">9.08</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_43f102f0-31bc-47b9-811f-5d1b98ab1933" contextRef="C_f6dcc9b6-8e32-4d98-bffb-d9bddefb3adf" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">73,561</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_74533906-b4c8-43f2-bccc-c3608df51369" contextRef="C_c51b15b1-1d54-4248-ae05-78c643fea245" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,645,859</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b871d9ec-c75c-41fd-9605-a8ca910cf345" contextRef="C_c51b15b1-1d54-4248-ae05-78c643fea245" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">24.22</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5f41bb57-062e-4313-86d5-8353969df64a" contextRef="C_c51b15b1-1d54-4248-ae05-78c643fea245" name="freq:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">9.30</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7b5efab6-bd06-4708-893c-3694ec82658b" contextRef="C_c51b15b1-1d54-4248-ae05-78c643fea245" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">769,385</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b911d04c-6582-40a7-91cd-5d608f50be84" contextRef="C_c51b15b1-1d54-4248-ae05-78c643fea245" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">1.99</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2d82ed4d-f4d6-4a91-a2e0-40ba289b39ad" contextRef="C_c51b15b1-1d54-4248-ae05-78c643fea245" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,667</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Forfeited</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0ea446bd-ab7d-4eba-9bd6-5a0138874fdf" contextRef="C_c51b15b1-1d54-4248-ae05-78c643fea245" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">28,348</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_186ebe2f-4e7a-4a60-96a6-79558ccf7d52" contextRef="C_c51b15b1-1d54-4248-ae05-78c643fea245" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">16.38</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Outstanding as of December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a5c46280-2dd1-4298-aefe-c0c477c1ecb0" contextRef="C_ac62a1b7-c43f-4181-a7f5-94b13f47cb97" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">6,816,798</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_04384858-fcd2-4013-a424-f1a9e30daecc" contextRef="C_ac62a1b7-c43f-4181-a7f5-94b13f47cb97" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">10.11</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d9804df3-c8d7-4ee1-8f70-0d16e7d41ad5" contextRef="C_c51b15b1-1d54-4248-ae05-78c643fea245" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">8.45</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_64321f4e-f350-4f64-8ee0-03bf3eaf3f47" contextRef="C_ac62a1b7-c43f-4181-a7f5-94b13f47cb97" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">171,415</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1e9cd947-ac66-4a64-a6d9-e9cf208ed9ef" contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,357,426</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b8aea6da-b621-4e49-899c-b94c1a3fbf27" contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">32.76</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_883895a9-ccfb-4534-9473-c391c63ea9ac" contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc" name="freq:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">8.07</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4142b3f3-91ce-4c19-b718-2bf8e6d91dc5" contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">642,314</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_71206924-7475-4f2e-a26a-72ccd9181726" contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">2.02</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_436e736d-38cc-42fc-87bb-c5549b7fe5d0" contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,652</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Forfeited</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9d92991d-99d3-4f72-b7b0-6fab86ac31fe" contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">701,873</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e07e81f5-1262-47a1-9b38-dfd79b4dbb3c" contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">16.48</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Outstanding as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4087028c-6c22-4f3f-a51d-fc4e24a55fe3" contextRef="C_7186f7f7-8d1b-4a52-9633-5bf6e27f4982" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">6,830,037</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_06e8e78e-b05b-4277-9141-8dccd53b2d83" contextRef="C_7186f7f7-8d1b-4a52-9633-5bf6e27f4982" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">14.72</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_369f3565-ec49-47f0-a1ae-d4316eacfb3c" contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">7.76</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0611f6ff-b6de-443c-8346-fc1c97d940a9" contextRef="C_7186f7f7-8d1b-4a52-9633-5bf6e27f4982" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,987</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Options exercisable as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8129b7cd-ab2d-4702-aa82-0629773914d6" contextRef="C_7186f7f7-8d1b-4a52-9633-5bf6e27f4982" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">3,993,231</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_836c6027-4713-4650-90c2-1fefe63efd18" contextRef="C_7186f7f7-8d1b-4a52-9633-5bf6e27f4982" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">9.77</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_970fb8a0-286d-4112-be0d-1d1ed39e76ea" contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">7.34</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8c0d196a-84f2-492c-83a3-2f05bd1f1b63" contextRef="C_7186f7f7-8d1b-4a52-9633-5bf6e27f4982" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,275</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Options unvested as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2e8157d4-7944-474c-97ef-834b6ac3d054" contextRef="C_7186f7f7-8d1b-4a52-9633-5bf6e27f4982" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">2,836,806</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2b6e0dc9-c3b5-48c7-bf18-994add77f32d" contextRef="C_7186f7f7-8d1b-4a52-9633-5bf6e27f4982" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">21.70</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5894de8c-9906-49c1-9d3d-3c6095da9eeb" contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">8.36</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3827d1ed-d0e1-41c4-afe3-0380b99e6528" contextRef="C_7186f7f7-8d1b-4a52-9633-5bf6e27f4982" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">712</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock option valuation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a2011dc4-36f5-426e-b3c7-e28881f0816a" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The assumptions that the Company used to determine the grant-date fair value of stock options granted to</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">employees and directors were as follows, presented on a weighted average basis:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:53.724%;"></td>
        <td style="width:1.364%;"></td>
        <td style="width:0.981%;"></td>
        <td style="width:17.268%;"></td>
        <td style="width:3.525%;"></td>
        <td style="width:1.364%;"></td>
        <td style="width:0.981%;"></td>
        <td style="width:17.268%;"></td>
        <td style="width:3.525%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Risk-free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_75edfd77-747d-4ac4-9547-b667e39577c2" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2b101da4-2a01-483c-a5fa-d2494cea398b" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">1.1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected term (in years)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_adec2ebd-5d63-4270-9f99-90d610437315" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.0</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a4f81be7-a85b-45d7-a967-1826401d0340" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.0</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected volatility</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ef79f5c2-ee05-4122-947c-52c8c4dbb107" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">79.8</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dfc20fb2-84c6-41cb-b7e5-36d909a7f02e" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">79.1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected dividend yield</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3baaa1df-36e9-4332-850e-515053d81f74" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8867c12a-cacf-4844-8397-762b60918cf3" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The weighted-average grant date fair value of options granted to employees during the years ended December 31, 2021 and 2020 was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_18054162-8706-4c92-8cc1-4d590205b4ee" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">22.39</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5a4ff6b9-4ee1-4c6f-9bbe-d4c42178164a" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">16.41</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The total grant date fair value of options vested during the years ended December 31, 2021 and 2020 was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_70eceb40-fe86-419d-a86b-ed911fb329a4" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,304</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c44939bd-e566-4ee3-b786-11e3ca70d942" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,907</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Restricted common stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company issued common stock to founders, employees and advisors which was subject to vesting over four years. If any of these individuals ceased to be employed or to provide services to the Company prior to vesting, the Company had the right to repurchase any unvested Common Stock at the price paid by the holder.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_60e8e26e-edc8-471a-b3ec-f56d6301d0c8" contextRef="C_0d93812e-8c05-49cd-9223-e00467bcba4d" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A summary of the status of restricted common stock as of December 31, 2021 and 2020 is presented below:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.673%;"></td>
        <td style="width:1.491%;"></td>
        <td style="width:0.646%;"></td>
        <td style="width:13.627%;"></td>
        <td style="width:0.865%;"></td>
        <td style="width:1.491%;"></td>
        <td style="width:1.282%;"></td>
        <td style="width:13.289%;"></td>
        <td style="width:0.636%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Number of<br />shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Weighted<br />average fair<br />value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested, December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cb2506a2-b1c4-4327-91b0-1e9f14aa7f57" contextRef="C_8f05e1d9-5717-4801-93c4-ba371f31a50e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">3,093</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0dc738a9-8660-42e9-8ccd-1328aa56f70b" contextRef="C_8f05e1d9-5717-4801-93c4-ba371f31a50e" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">1.75</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Awarded</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vested</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1ce77e84-342d-4299-9040-2ff2ac8f9854" contextRef="C_0d93812e-8c05-49cd-9223-e00467bcba4d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">928</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_85124594-ba25-43fc-962f-097aed96a63b" contextRef="C_0d93812e-8c05-49cd-9223-e00467bcba4d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">1.75</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Forfeited</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0d5632a5-c938-489d-a17f-0d568640eb8b" contextRef="C_0d93812e-8c05-49cd-9223-e00467bcba4d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">2,165</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5b162889-7a70-4d24-90f6-2c2a4df81c71" contextRef="C_0d93812e-8c05-49cd-9223-e00467bcba4d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">1.75</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested, December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3700433c-f07f-4c67-9d5a-44c24552cab4" contextRef="C_768ee818-71ae-4ce4-8037-4961cf5029cc" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="0" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_024dd129-07c9-4868-b7a0-059131d360c8" contextRef="C_768ee818-71ae-4ce4-8037-4961cf5029cc" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="0" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The total value of restricted stock awards that vested during the years ended December 31, 2021 and 2020, based on estimated fair values of the stock underlying the restricted stock awards was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_17f09a27-0ba5-475a-ab48-eb563166b4ca" contextRef="C_0d93812e-8c05-49cd-9223-e00467bcba4d" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ccc3711b-bc3a-4e20-a3c5-daa575215656" contextRef="C_54ac7307-3cc3-42f9-b337-69f60c51b471" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">20</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Restricted stock units</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In April 2021, the Company issued restricted stock units to employees which will </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ace26adf-e53f-4a1a-9b39-bc858f01c0f2" contextRef="C_fe2774ae-4979-4575-894a-1f57dedae7e9" name="freq:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">vest in equal installments in the first quarter of 2022 and the third quarter of 2022.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></ix:nonNumeric></span><span style="font-size:10.0pt;font-family:Times New Roman;"></span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ab685c8a-6e6a-4ac5-9707-7f02b3e0aca9" contextRef="C_fe2774ae-4979-4575-894a-1f57dedae7e9" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A summary of the status of restricted stock units as of December 31, 2021 and 2020 is presented below:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.547%;"></td>
        <td style="width:1.481%;"></td>
        <td style="width:0.636%;"></td>
        <td style="width:13.799%;"></td>
        <td style="width:0.865%;"></td>
        <td style="width:1.481%;"></td>
        <td style="width:1.282%;"></td>
        <td style="width:13.272%;"></td>
        <td style="width:0.636%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Number of<br />shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Weighted<br />average fair<br />value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested, December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f7e7b588-3695-4afb-bd9a-1ad25691b16e" contextRef="C_746daa8a-e230-4375-9cc8-fcf4f87699a6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="0" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_801e9250-28bc-4761-91a2-e64ba139e832" contextRef="C_746daa8a-e230-4375-9cc8-fcf4f87699a6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="0" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Awarded</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0d82136e-bbab-4ff7-9b66-82555fa10128" contextRef="C_fe2774ae-4979-4575-894a-1f57dedae7e9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">800,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2bed57b9-6d9a-4720-b3ee-a77ad4d44100" contextRef="C_fe2774ae-4979-4575-894a-1f57dedae7e9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">9.54</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vested</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Forfeited</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b1335636-a98b-4ae9-868f-a15f000649cb" contextRef="C_fe2774ae-4979-4575-894a-1f57dedae7e9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">173,700</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f1f46e82-8a42-4827-a0f5-09932bf25c36" contextRef="C_fe2774ae-4979-4575-894a-1f57dedae7e9" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">9.54</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested, December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1e028910-e709-40e4-a2fe-903b645c1789" contextRef="C_0c30c3e8-0228-45a8-9bfc-3207d2e201fc" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">626,300</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b3f17e65-c739-44da-9a64-4bdc07f68e37" contextRef="C_0c30c3e8-0228-45a8-9bfc-3207d2e201fc" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">9.54</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-based compensation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock-based compensation expense of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_304c1225-a0d8-448e-b824-d4f1cc40b6ff" contextRef="C_51d717fb-7e75-44ae-bee6-68ee19956485" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,750</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1bfa78ef-a224-408e-a9b9-fe409226c7c3" contextRef="C_e6d90f27-4552-437d-96bb-a911e3141b0e" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">9,983</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for the years ended December 31, 2021 and 2020 respectively, is included in research and development and general and administrative expenses in the Company&#x2019;s consolidated statements of operations and comprehensive loss.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021 and 2020, total unrecognized stock-based compensation expense relating to unvested stock options, restricted stock awards, and restricted stock units was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e803b3e9-d0e5-47a8-a306-b15e687074ac" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">39,112</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_48311898-f1a4-4663-a849-a68745f9547d" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">31,006</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively. This amount is expected to be recognized over a weighted-average period of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a70e3e04-13d2-4552-8646-695d4356e231" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.49 </span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">years and </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fd8604c8-348f-4e26-911f-a6ec98db4b73" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.08</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> years, respectively.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:12.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a04af75b-8633-4afa-a6e1-097c82c9eedf" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="freq:EmployeeStockPurchasePlanDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">10. Employee stock purchase plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On September 20, 2019, the Company&#x2019;s board of directors and stockholders approved and adopted the 2019 Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;) which became effective on the date of the Company&#x2019;s initial public offering of shares of its common stock. The ESPP permits participants to purchase common stock through payroll deductions of up to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_daddb8a7-10ab-41ce-a289-ab406d19d21f" contextRef="C_ad952da4-5b38-4e64-a1f0-d990bf170c57" name="freq:PercentageOfEligibleEmployeeCompensation" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">15</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of their eligible compensation.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The number of shares of common stock available for issuance under the ESPP will be automatically increased on the first day of each calendar year during the first </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b5241f0b-4529-4c4f-8e77-d330e220d0e9" contextRef="C_ad952da4-5b38-4e64-a1f0-d990bf170c57" name="freq:PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance" format="ixt-sec:durwordsen"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ten years</span></ix:nonNumeric></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of the term of the ESPP, beginning with January 1, 2020 and ending with January 1, 2029, by an amount equal to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_75c40b25-49b4-43a8-a94e-1ce642a2449e" contextRef="C_ad952da4-5b38-4e64-a1f0-d990bf170c57" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">1</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the outstanding number of shares of the Company&#x2019;s common stock on December 31 of the preceding calendar year or such lesser amount as determined by the Company&#x2019;s board of directors. The Company&#x2019;s first offering period of 2021 concluded on June 30, 2021 with the purchase of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3c4bc4e2-5647-42da-b40a-2cac5c928107" contextRef="C_1136a968-0349-44e0-8596-79d8ce8e10d1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,064</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares in July 2021 related to this offering period. A</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">s of December 31, 2021, a</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b779d928-f9c8-4458-8a9e-9c4bbe97c892" contextRef="C_f92ea8d8-789c-4c65-915c-479148f6a96f" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">956,021</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares remain for future offering periods.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company's second offering period of 2021 concluded on December 31, 2021 with the purchase of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0c3f2ab4-e6bc-4eca-93f5-24bcc165abfa" contextRef="C_419cd7aa-c2d9-47e1-b2f2-d57d5c727db3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">31,832</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares in January 2022 related to this offering.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6e6b5cdf-7324-4fe3-bbf7-0eda9195dbf9" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">11.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> Income taxes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since inception in 2014, the Company has generated cumulative federal and state net operating loss and research and development credit carryforwards for which we have </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fb6860c6-26e5-4041-b257-1d100ccd406c" contextRef="C_7f631c9f-2ca8-42db-859b-91805fd36959" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" decimals="0" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t recorded any net tax benefit due to uncertainty around utilizing these tax attributes within the respective carryforward periods.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021, the Company had federal net operating loss carryforwards of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f2830edb-8010-46c6-808d-cdca502d9944" contextRef="C_6ad987ee-9ba1-42bf-b041-260c412a34d4" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">149,071</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and Massachusetts state operating loss carryforwards of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fd8bfb9c-176c-4b1b-b0d2-7de91e19c586" contextRef="C_cf3edb08-0022-48b3-8d33-0b7ecf23a4eb" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">83,467</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> which may be available to offset future taxable income. The U.S. federal net operating loss carryforwards include $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_80c5406b-5db5-4788-9837-eef9bce87cbb" contextRef="C_5acfbb01-3b1d-498b-b247-28b787110380" name="freq:NetOperatingLossCarryforwardsExpirationWithLimitation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22,399</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> available to reduce future taxable income through </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_37deb3ac-0585-461d-b5f0-eb8a9aba507b" contextRef="C_17ed3f9d-c233-4f9d-80c1-fd64ea247cb7" name="freq:OperatingLossCarryforwardsExpirationYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2037</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1c6a466a-38de-4640-9fdc-28b6d16c586b" contextRef="C_5acfbb01-3b1d-498b-b247-28b787110380" name="freq:NetOperatingLossCarryforwardsExpirationWithoutLimitation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">126,672</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> which do not expire and are available to reduce future taxable income indefinitely. The state net operating loss carryforwards are available to offset future taxable income through </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bf8bd597-711b-414d-ba26-53a02d983cde" contextRef="C_50db1a66-c934-4741-b3a2-b2969bdf7bf1" name="freq:OperatingLossCarryforwardsExpirationYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2041</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. As of December 31, 2021, the Company also had federal and Massachusetts research and development tax credit carryforwards of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5b3b8be2-50a3-46c3-80ce-a467af8ec261" contextRef="C_e4d444fc-edc2-40cf-ab70-0c120e61141a" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,241</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c837ec00-7641-4881-8881-218b7fba343f" contextRef="C_7d7f8a9d-9d6d-47a1-b8ea-fd4b0fa83331" name="us-gaap:TaxCreditCarryforwardAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,071</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, which are available to offset federal and state tax liabilities through </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ce368509-bd71-414f-a77b-1d28260ea6b1" contextRef="C_17ed3f9d-c233-4f9d-80c1-fd64ea247cb7" name="freq:TaxCreditCarryforwardExpirationYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2041</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7cd1fd74-1f0c-4ef9-86ff-5188b3a17d56" contextRef="C_cdbc9d91-abb1-471d-8577-f5ca0f7f45b1" name="freq:TaxCreditCarryforwardExpirationYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2036</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Realization of future tax benefits is dependent on many factors, including the Company&#x2019;s ability to generate taxable income within the net operating loss carryforward period. Net operating loss and tax credit carryforwards may become subject to an annual limitation in the event of certain cumulative changes in the ownership interest of significant shareholders over a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ea3b96b4-5fbc-4060-82d4-c67ae3222205" contextRef="C_50ecffe0-e791-47f3-a7b0-8430f4d7aedb" name="freq:PeriodOfCumulativeChangeInOwnership" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">three-year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> period in excess of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_deea5bcd-c188-4a8b-960b-0a73d55b4865" contextRef="C_ab8f2bc9-2386-4491-8d49-6ec657154d28" name="freq:CumulativeChangeInOwnershipPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">50</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%, as provided under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, respectively, as well as similar state provisions. These ownership changes may limit the number of carryforwards that can be utilized annually to offset future taxable income. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by more than 50% over a three-year period. The Company has completed several financings and has conducted a study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception and has determined that an ownership change did occur in March 2017. Accordingly, utilization of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7e4888e2-a41c-428a-a8ad-ffdeed55cd91" contextRef="C_31fe05e6-676e-4a62-ac60-318d537f9748" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,400</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the U.S. net operating</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">loss </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">carryforwards which were incurred prior to March 2017 (pre-ownership change) is limited under Section 382. After the Section 382 limitations, the Company may utilize approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a25457c4-45cd-4120-a092-4fd3c9c82466" contextRef="C_37c7af32-e4c8-439d-8648-1ffe795bcb36" name="freq:OperatingLossCarryforwardsUsageAfterOwnershipChange" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,800</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of its pre-ownership change net operating loss carryforwards based upon an annual usage of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4c579672-c7ab-446f-9cbd-259bef2dcdb4" contextRef="C_37c7af32-e4c8-439d-8648-1ffe795bcb36" name="freq:OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,600</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for each of the next five years after the ownership change and approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_84e6955c-683e-437b-aa98-e29d96e1a9eb" contextRef="C_37c7af32-e4c8-439d-8648-1ffe795bcb36" name="freq:OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">180</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for each of the 15 years thereafter. The remaining pre-ownership change net operating losses of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f820b6a4-e9f8-48bf-a1c9-469a60325800" contextRef="C_37c7af32-e4c8-439d-8648-1ffe795bcb36" name="freq:RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,600</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> were written off due to expiration under limitation. The limitation has been determined by first multiplying the value of our stock at the time of the ownership change by the applicable long-term tax-exempt rate. These carryforwards may be subject to further annual limitations under Section 382 in the event of future changes in ownership.  Additionally, the Company has determined an ownership changed occurred in October of 2019 as a result of the IPO.  Accordingly, utilization of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_28b65280-c211-4db0-aaf3-c74e95b16f74" contextRef="C_86cb445a-0d20-403b-b211-6cec00f8b29a" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">46,123</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of the U.S. net operating loss carryforwards incurred prior to October 2019 is also limited under Section 382. The Company has determined it will be able to utilize the entire $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_09e04eb7-ed0d-4fa2-aae1-04d2240f6096" contextRef="C_86cb445a-0d20-403b-b211-6cec00f8b29a" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">46,123</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of its pre-ownership change net operating loss carryforwards based upon the limitations calculated from the October 2019 ownership change. These carryforwards may be subject to further annual limitations under Section 382 in the event of future changes in ownership.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ASC 740 requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of the evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. After consideration of all the evidence, both positive and negative, the Company has recorded a valuation allowance against its deferred tax assets at December 31, 2021 and 2020 because the Company&#x2019;s management has determined that it is more likely than not that the Company will </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d2f0a9e6-ffd3-4f03-a2d7-a00ae47f4b7b" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_4b294199-6dfc-49ba-91d3-74ee7a5a9479" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t recognize the benefits of its federal and state deferred tax assets primarily due to its cumulative loss position and, as a result, a valuation allowance of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e43941c7-712d-4e22-b443-0fd809122279" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50,931</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_13e9dcd6-f6e0-41ac-bcef-35532011514e" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">26,995</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> as of December 31, 2021 and 2020 has been established.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a1aca3e4-51d3-421e-8e81-3a60db500128" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_5656eeb1-efa9-4b82-a6e4-debcdbca9e50" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> unrecognized tax benefits. The Company has not, as yet, conducted a study of its research and development credit carryforwards. Such a study may result in an adjustment to the Company&#x2019;s research and development credit carryforwards; however, until a study is completed, and any adjustment is known, no amounts are being presented as an uncertain tax position. A full valuation allowance has been provided against the Company&#x2019;s research and development credits and, if an adjustment were required, this adjustment would be offset by an adjustment to the valuation allowance. Thus, there would be no impact to the consolidated balance sheet or consolidated statements of operations if an adjustment were required. The Company has elected to recognize interest and penalties related to income tax matters as a component of income tax expense, of which </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bf4a5c5c-4731-48b2-ab5a-65f4832c1f14" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_77a187cc-7643-4cf2-9ed5-b20911f568d9" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> interest or penalties were recorded for the years ended December 31, 2021 and 2020.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company files income tax returns in the U.S. and Massachusetts. The statute of limitations for assessment by the Internal Revenue Service and Massachusetts tax authorities remains open for all years since 2014. To the extent the Company has tax attribute carryforwards, the tax years in which the attribute was generated may still be adjusted upon examination by the Internal Revenue Service or state authorities to the extent utilized in a future period. No federal or state tax audits are currently in process.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_375181b1-1526-486e-94f6-1bc667e8e4c0" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A reconciliation of the Company&#x2019;s pre-tax income for the years ended December 31, 2021 and 2020 is as follows:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.763%;"></td>
        <td style="width:0.845%;"></td>
        <td style="width:2.048%;"></td>
        <td style="width:12.245%;"></td>
        <td style="width:1.461%;"></td>
        <td style="width:0.865%;"></td>
        <td style="width:2.048%;"></td>
        <td style="width:12.265%;"></td>
        <td style="width:1.461%;"></td>
       </tr>
       <tr style="height:10.8pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.95pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Domestic</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_50cac8d8-d2d2-4add-a180-f8feca431565" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">84,624</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_99f5d9c4-2669-4216-921b-1f116b3f1893" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">25,744</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:12.95pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Foreign</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4a14d562-0849-48b5-b53b-23d17275aaed" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">47</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fe32d24f-5e46-4a15-a188-a9e720da2040" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">732</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:13.7pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_107179ad-c5f9-4e5b-b138-cd968c5e1d2c" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">84,671</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_34a1b62e-d0b9-49c9-a47d-0625457dc0d8" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:IncomeLossFromEquityMethodInvestments" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">26,476</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_370a0a04-66cb-4b6c-b5d0-85d23241e0e1" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#x2019;s provision at December 31, 2021 and 2020 consist of the following:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.121%;"></td>
        <td style="width:1.123%;"></td>
        <td style="width:2.067%;"></td>
        <td style="width:12.514%;"></td>
        <td style="width:0.706%;"></td>
        <td style="width:1.163%;"></td>
        <td style="width:2.067%;"></td>
        <td style="width:12.534%;"></td>
        <td style="width:0.706%;"></td>
       </tr>
       <tr style="height:10.1pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.25pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Current:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.25pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;&#160;&#160;&#160;Federal</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4119a4f9-4841-472f-a849-eea3a48451cc" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:CurrentFederalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8bcc4802-24f3-44ef-93db-c54f3b823739" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:CurrentFederalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">35</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.95pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;&#160;&#160;&#160;State</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ae68fa38-e11c-4409-9088-6f8eded2f1f8" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7c6bd208-e287-44a4-b3c2-366a8bb3dfd4" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.95pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;&#160;&#160;&#160;Foreign</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_da111924-068d-491d-a50d-97b50ef8295d" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:CurrentForeignTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9ece8b18-10bf-426e-970d-7427ad844140" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:CurrentForeignTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.25pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total current</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_37112a2f-e627-4da4-b0fc-10d8ff1fc950" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:CurrentIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_71d7968a-6cec-48e9-a39b-61c8452693ac" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:CurrentIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">35</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.25pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deferred:</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.95pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;&#160;&#160;&#160;Federal</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7e2d329b-6592-4892-a3c0-b3542b492754" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0b366ec2-5129-42c9-94e4-4f658a1bd6da" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.25pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;&#160;&#160;&#160;State</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_82a94f29-bd6f-4279-b6af-2cdc9487a9d2" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_36edb460-8a86-4c5e-bc70-fe4ee92188bb" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.95pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;&#160;&#160;&#160;Foreign</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aa03377e-bdcf-4a8f-841e-552e03ee222c" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cbc3008d-efa7-4416-a97e-755326fbbac3" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.25pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total Deferred</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1ff4afcb-67f9-4250-9f08-eff621586c75" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cb8b5761-fe9b-4e08-9c33-da609cc74ebf" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:DeferredIncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">-</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.25pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total provision (benefit)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c9a359a2-51a0-480e-986b-89340cb61e3f" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_91aae879-e33c-49de-a6bc-95b86bcfdf61" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:IncomeTaxExpenseBenefit" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">35</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_526bfe60-50da-458b-8c6f-65638fc2c10e" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A reconciliation of the U.S. federal statutory income tax rate to the Company&#x2019;s effective income tax rate for the years ended December 31, 2021 and 2020 is as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:62.7%;"></td>
        <td style="width:1.859%;"></td>
        <td style="width:0.636%;"></td>
        <td style="width:14.355%;"></td>
        <td style="width:2.137%;"></td>
        <td style="width:1.859%;"></td>
        <td style="width:0.636%;"></td>
        <td style="width:13.679%;"></td>
        <td style="width:2.137%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S federal statutory income tax rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e0ad9f91-486a-4cad-b1e0-5d684ba2bd16" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">21.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8d6aac62-4e01-4db2-96fa-0f52c450973b" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">21.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Permanent differences</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_ac776299-523f-419b-b2ba-1e3e866cfec3;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d1dc60ba-b771-4ba6-8c8c-34b53084b552" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">State income taxes, net of federal benefit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b908801f-71c9-48cf-921d-3dc28ea84316" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">2.7</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_97ec4e50-d6a3-4422-a89a-23c95097416e" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">3.0</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development tax credits</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_07910f01-fd29-4752-aedf-03db657dc777" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">3.6</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f0fc5011-8f51-408b-b7e2-21224505f6e4" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">11.2</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock compensation deductions</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b9289ea3-25e5-49bc-a494-93565e8e15d7" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">1.6</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b7f19879-ec21-43ae-89e7-01b5f28d1e93" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">5.1</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other items</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_70f825bf-6a08-4da8-8926-ed63c0ebc5c1" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">0.7</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_86978056-f6db-486d-8251-7f843621f79d" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.6</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Change in deferred tax asset valuation allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e04e6202-926e-43bc-8def-6116038097a3" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">28.2</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aee4767f-ec46-4d76-9f6b-91e416ccacb3" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">40.7</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Effective income tax rate</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_ded4314f-4db0-4f7e-8996-c64ecbefa332;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_09defff9-d432-46af-8443-a9a7de484f45" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#x2019;s deferred tax assets at December 31, 2021 and 2020 consist of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:62.662%;"></td>
        <td style="width:1.038%;"></td>
        <td style="width:2.119%;"></td>
        <td style="width:14.105%;"></td>
        <td style="width:1.408%;"></td>
        <td style="width:1.038%;"></td>
        <td style="width:2.119%;"></td>
        <td style="width:14.105%;"></td>
        <td style="width:1.408%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fb9db2cc-84b3-4fcc-a903-21a444fe132c" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">36,590</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bbfa134a-9dad-48ed-b3ba-3714d6bdbfa8" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,885</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development tax credits</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_295b8816-50e8-4a1a-885b-aa7dfbe61ad7" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,026</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_03c4f229-ec2b-41d8-9237-fd8eedfcdfd3" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,992</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Intangibles</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9d5eb8ca-3748-4c24-90b0-8421b437bef7" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">392</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_83430884-febe-4b1b-9197-d30e6a259f9d" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">360</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock compensation</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_69c9ea0d-e8a1-477e-b987-84a55e1612ac" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,554</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d8ced774-031e-4e64-8564-dccd711cae38" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">850</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_47a6265c-bab3-4450-be4d-467bb1b76db3" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">107</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deferred revenue</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c2291dac-805f-4017-8cc2-061bd070ed9a" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:DeferredTaxAssetsDeferredIncome" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,606</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bdd005dc-b8a4-4569-89fe-6be98a9d5dec" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:DeferredTaxAssetsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">176</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7e8a5577-eb67-4eca-898c-2d297bd45273" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:DeferredTaxAssetsOther" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">142</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Fixed assets</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5d22bece-d58a-49ee-b026-eb0858a94957" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="freq:DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">265</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cc23a1f9-3fd2-4107-85bd-f527c9d7bf11" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="freq:DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">56</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Lease liability</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ed73ca8e-7c1b-4942-ae6c-3264ae0b0da2" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="freq:DeferredTaxAssetsLeasingArrangements" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,269</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f2cda2dd-a43c-4b76-b150-a8c5aabd7aa5" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="freq:DeferredTaxAssetsLeasingArrangements" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,285</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Right of use asset</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_64f36dbb-6825-434b-b13d-43ade6cf6736" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="freq:DeferredTaxAssetsRightOfUseAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,448</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e657739f-3afc-4e61-ad04-0bf0954faa02" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="freq:DeferredTaxAssetsRightOfUseAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,181</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total deferred tax asset</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_352f7def-3c8a-45f0-8f2e-67972c1c3e56" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50,931</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6455aae3-21fb-4dd4-896d-1c62bbc83b06" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">26,995</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cd333216-8329-4a97-9ab8-62c40f07ef8a" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50,931</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e361af5a-8f11-4290-a2c7-05fb7f6adae8" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">26,995</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f03ee966-0a7b-45bc-91e9-46f9c92f6144" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e844dabb-c68a-4e67-9de7-92b44aa1bd14" contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dd75d70e-bcd1-4f30-9fe6-0e64a96a5315" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="freq:ResearchAndLicenseAgreementsDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">12. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Research and license agreements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Massachusetts Institute of Technology</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_15b9f7b7-e649-4996-a133-b39661f23b13" contextRef="C_ff34e46d-05f9-400b-970a-b5976aa47ab4" name="freq:LicenseAgreementEnteredDate" format="ixt:datemonthyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 2016</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the Company entered into an exclusive patent license agreement (MIT License Agreement), with the Massachusetts Institute of Technology, (MIT), under which the Company received an exclusive, worldwide, royalty-bearing license to certain patent rights to develop, make, have made, use, sell, offer to sell, lease and import products (Licensed Products) and to develop and perform processes (Licensed Processes) which incorporate the licensed technology for the treatment of disease, including but not limited to the prevention and remediation of hearing loss. The Company also has the right to grant sublicenses of its rights under the MIT License Agreement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Company is required to use diligent efforts to develop and commercialize the Licensed Products or Processes, and to make such products or processes reasonably available to the public and to spend certain minimum amounts on research</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">22</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">development of Licensed Products and/or Processes each year until the first commercial sale of a Licensed Product and/or a first commercial performance of a Licensed Process. The Company is also subject to certain development obligations with regards to a first Licensed Product. The Company has satisfied certain obligations related to preclinical studies and the filing of an IND for a first Licensed Product with its development activities related to FX-322. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_71073a87-b1dd-44ed-afc5-745afb4f297e" contextRef="C_becb1019-1881-4f79-9f76-55c0d3336ef7" name="freq:DescriptionOfFutureDevelopmentObligations"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#x2019;s future development obligations are: (i) to commence a Phase III clinical trial for such Product within five years of the IND filing for such product, (ii) to file a New Drug Application or equivalent with the FDA or comparable European regulatory agency for such Product within nine years of the IND filing for such Product, and (iii) to make a first commercial sale of such Product within 11 years of the IND filing for such Product.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The Company also has certain development obligations for a second Licensed Product. In the event that the Company has failed to fulfill the development timeline obligation with respect to a second Licensed Product and fails to cure such breach within ninety (90) days of written notice by MIT, MIT may restrict the licensed field to the prevention and remediation of hearing loss in humans and animals. The Company does not have the right to control prosecution of the in-licensed patent applications, and its rights to enforce the in-licensed patents are subject to certain limitations.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon entering into the MIT License Agreement, the Company paid a $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1bb447cf-5e05-4256-976a-fe2fcac9078b" contextRef="C_d5705e72-9931-4ce1-ae42-4f74ee48fe5f" name="freq:LicenseFeePayment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> license fee payment and issued to MIT shares of our common stock equal to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3c639aa7-3542-4481-b2df-760b9257d62c" contextRef="C_3248f726-ed7b-4ffd-ae3b-b39e2f79d1c2" name="freq:PercentageOfSharesOfCommonStockIssued" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of total then-outstanding capital stock. The Company is required to pay certain annual license maintenance fees which may be credited to running royalties during the same calendar year, if any, and to make potential milestone payments up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7315a657-a702-40c3-a2d0-097bc00597ae" contextRef="C_6cb0fef5-08a6-44b1-8683-04aaee45ba50" name="freq:MilestonePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,900</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> on each Licensed Product or Licensed Process. In addition, The Company is required to pay a low single-digit royalty on Licensed Products and Licensed Processes and a low-twenties royalty on sublicense revenues.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The MIT License Agreement will remain in effect until the expiration or abandonment of all issued patents and filed patent applications licensed thereunder remain in effect, unless terminated earlier. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b8d78c6f-c4fc-4a88-91c6-0b3b08113c69" contextRef="C_becb1019-1881-4f79-9f76-55c0d3336ef7" name="freq:DescriptionOfConditionsToTerminateLicenseAgreement"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has the right to terminate for any reason upon a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_84b5634e-70d9-4ee8-93fd-dcf3f4a83d0c" contextRef="C_3248f726-ed7b-4ffd-ae3b-b39e2f79d1c2" name="freq:RightToTerminateAgreementUponPriorWrittenNotice" format="ixt-sec:durmonth"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-month prior written notice. MIT shall have the right to terminate if the Company ceases to carry on any business related to the MIT License Agreement. MIT may terminate the MIT License Agreement for the Company&#x2019;s material breach uncured within ninety (</span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4ceb3e6a-dd25-4c16-a977-50ee3e041c1a" contextRef="C_3248f726-ed7b-4ffd-ae3b-b39e2f79d1c2" name="freq:RightToTerminateAgreementIfBreachRemainsUncured" format="ixt-sec:durday"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) days (or thirty (</span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_eb4084c8-59a0-4842-badd-c05317ae6e62" contextRef="C_3248f726-ed7b-4ffd-ae3b-b39e2f79d1c2" name="freq:RightToTerminateAgreementIncaseOfNonpayment" format="ixt-sec:durday"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) days in the case of nonpayment). MIT may also terminate the MIT License Agreement if the Company or our affiliates commence any action against MIT to declare or render any claim of the licensed patent rights invalid, unpatentable, unenforceable, or non-infringed (a patent challenge), or if our sublicensee commences such actions and the Company does not terminate such sublicense within thirty (30) days after MIT&#x2019;s demand. MIT has the right to increase all payments due, instead of terminating the MIT License Agreement in the case of a patent challenge. </span></ix:nonNumeric></span><span style="font-size:10.0pt;font-family:Times New Roman;"></span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In May 2019, the Company entered into an amendment with MIT, updating the diligence milestones for a second Licensed Product.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2022, the Company entered into an amendment with MIT, removing a patent and certain patent applications from the MIT License Agreement which were unrelated to the Company&#x2019;s hearing and MS programs and which were not being utilized by the Company.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The patents in-licensed by the Company from MIT pursuant to the MIT License claim inventions created by, among others, Dr. Langer, one of the Company&#x2019;s directors. Pursuant to MIT&#x2019;s policy on the ownership, distribution and commercial development of MIT technology, or the MIT Policy, inventors of intellectual property invented at MIT, including the inventors of patents licensed to the Company under the MIT License, are entitled to a portion of the net royalty income derived by MIT from such inventions, but not amounts received by MIT from the sale of common stock previously issued by the Company to MIT pursuant to the MIT License. Accordingly, pursuant to the MIT Policy, Dr. Langer is entitled to receive a portion of the amounts the Company pays to MIT under the MIT License, including the Astellas Royalty Payment and future milestone payments or royalties, if any, that the Company may receive pursuant to the Astellas Agreement. Accordingly, Dr. Langer has received $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f84e7f25-0f43-49ab-80d9-936de098e075" contextRef="C_8547fe2d-e68e-4291-9f90-da18d274d639" name="us-gaap:PaymentForManagementFee" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a4e844f8-f598-41b4-bd15-586e536f979d" contextRef="C_e07d7cda-060f-41bc-aed2-892bed256b7c" name="us-gaap:PaymentForManagementFee" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,980</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> from MIT under the MIT Policy during the years ended December 31, 2021 and 2020, respectively. Refer to Note 17 for all related party disclosures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The Scripps Research Institute (California Institute for Biomedical Research)</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_954bf8c3-7fd9-4308-aea4-2dd1957bb283" contextRef="C_78fdf8df-07e6-446d-b5a9-2f520f345e58" name="freq:LicenseAgreementEnteredDate" format="ixt:datemonthyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">September 2018</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the Company entered into a license agreement, (CALIBR License Agreement), with the California Institute for Biomedical Research, (CALIBR), under which the Company received an exclusive, worldwide, royalty-bearing license to certain patent rights to make, have made, use, sell, offer to sell, and import products (CALIBR Licensed Products) which incorporate the licensed technology for the treatment of multiple sclerosis. The Company also have the right to grant sublicenses of our rights under the CALIBR License Agreement. CALIBR reserves the right to use for itself and the right to grant non-exclusive licenses to other nonprofit or academic institutions, for any internal research and educational purposes.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is required to use commercially reasonable efforts to develop, manufacture, and sell at least one CALIBR Licensed Product. The Company is also subject to certain milestone timeline obligations, which may be extended in certain circumstances as set forth in the CALIBR License Agreement. In October 2021, the Company entered into an amendment with CALIBR which updated the milestone obligations to: (i) initiate a Phase II clinical trial (or equivalent) for a CALIBR Licensed Product by December 31, 2023 and (ii) initiate a Phase III clinical trial (or equivalent) for a CALIBR Licensed Product by December 31, 2025. EW do not have the right to control prosecution of the in-licensed patent applications , and our rights to enforce the in-licensed patents are subject to certain limitations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon entering into the CALIBR License Agreement, the Company made a $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_74daccbe-e076-46e6-9c85-e0eda142644a" contextRef="C_06abad24-e21e-42ba-b771-10d1643ab3f6" name="freq:LicenseFeePayment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> license fee payment and are required to make milestone payments up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_52cfa723-ac96-46ab-873b-c46c196c2583" contextRef="C_b9d233e8-2d05-48fa-b3db-72146492d1a0" name="freq:MilestonePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">26,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for each Category of CALIBR Licensed Products (Category 1 is any CALIBR Licensed Products containing a compound that modulates any muscarinic receptor and Category 2 is any CALIBR Licensed Products not included in Category 1 that could differentiate oligodendrocyte precursor cells from </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> studies and/or are active in animal models relevant to MS. The Company is also required to pay a middle single-digit royalty on CALIBR Licensed Products and a royalty on sublicense revenues ranging from low-teen percentage to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_605696d5-36d1-43b0-9962-f2321ec1d50a" contextRef="C_5f444349-7223-41bf-bdbf-3c460376bd0e" name="freq:PercentageOfRoyaltyOnSublicenseRevenue" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">50</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The CALIBR License Agreement shall continue in effect until expiration of all Company obligations to pay royalties. Royalties shall be payable on a country-by-country and CALIBR Licensed Product-by-CALIBR Licensed Product basis upon the later of (1) the expiration or abandonment of all valid claims of the licensed patent rights in such country and (2) ten years from the first commercial sale of each CALIBR Licensed Product. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0ea1f81c-39de-4c09-87f2-160d4d316171" contextRef="C_774fe501-efdb-4b83-b9f8-19875ffb2b41" name="freq:DescriptionOfConditionsToTerminateLicenseAgreement"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company may terminate the CALIBR License Agreement at will upon a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0bc47b99-5359-4138-a548-190fc5ab9297" contextRef="C_5f444349-7223-41bf-bdbf-3c460376bd0e" name="freq:RightToTerminateAgreementUponPriorWrittenNotice" format="ixt-sec:durday"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-day prior written notice. The Company may also elect to terminate its license to one or more licensed patents in any or all jurisdictions by giving ninety (</span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_46c12aef-3e2d-44eb-9402-f9ab3caa0e43" contextRef="C_5f444349-7223-41bf-bdbf-3c460376bd0e" name="freq:RightToTerminateLicensedPatentsUponPriorWrittenNotice" format="ixt-sec:durday"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) days&#x2019; prior written notice to CALIBR. CALIBR may terminate the CALIBR License Agreement for material breach uncured within thirty (</span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8ee451cb-1e4c-4e82-90b7-3444e6b3f863" contextRef="C_5f444349-7223-41bf-bdbf-3c460376bd0e" name="freq:RightToTerminateAgreementIfBreachRemainsUncured" format="ixt-sec:durday"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) days. CALIBR has the right to terminate or reduce the license to a non-exclusive license if the Company fails to use diligent efforts to develop and commercially exploit CALIBR Licensed Products. </span></ix:nonNumeric></span><span style="font-size:10.0pt;font-family:Times New Roman;"></span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The Scripps Research Institute</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In September 2018, the Company entered into a Research Funding and Option Agreement, or the Scripps option agreement, with Scripps (CALIBR is a division of Scripps), under which the Company provided funding to Scripps to pursue certain MS research activities on selected targets. In the same agreement, the Company was granted an exclusive option to acquire an exclusive, sublicensable, worldwide license under certain intellectual property arising from the MS research activities on the selected targets. The Scripps option agreement, including the MS research activities and the exclusive option, terminated on December 31, 2021. The CALIBR License remains active.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Massachusetts Eye and Ear (Formerly Massachusetts Eye and Ear Infirmary)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_865f20b2-54ef-4182-9702-58dc91c7440d" contextRef="C_227c25ee-a3e6-4434-8f48-824b730e370e" name="freq:LicenseAgreementEnteredDate" format="ixt:datemonthyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">February 2019</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the Company entered into an Non-Exclusive Patent License Agreement (MEE License Agreement) with the Massachusetts Eye and Ear (MEE) under which it received a non-exclusive, non-sublicensable, worldwide, royalty-bearing license to certain patent rights to develop, make, have made, use, sell, offer to sell, lease and import products and to develop and perform processes which incorporate the licensed technology for the treatment or prevention of hearing loss (MEE licensed products).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is obligated to use diligent efforts to develop and commercialize the MEE licensed products. The Company met one of its milestone timeline obligations by dosing a first subject in a Phase II trial by December 31, 2020. The Company is still subject to a milestone timeline obligation to dose a first subject in a Phase III trial by December 31, 2024. The Company does not control the filing, prosecution, enforcement, and defense of any licensed patent rights.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon entering the MEE License, the Company made a $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_55e50018-c773-4be3-890d-383cfbfe683d" contextRef="C_a6c92f46-0d7d-45d4-8e0d-11c1797e8585" name="freq:LicenseFeePayment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">20</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> license fee payment. The Company is obligated to pay certain annual license maintenance fees between $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e04db82d-b579-4eba-9169-0d86530cc3e7" contextRef="C_46cac2fb-9412-44da-9032-89c8b384ae1e" name="freq:AnnualLicenseFeePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="0">5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_87f75518-c76c-4c93-8825-d28b3f1b337a" contextRef="C_7b227e56-bafa-4e07-a541-a4c468281188" name="freq:AnnualLicenseFeePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="1">7.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per each MEE patent family case number included in the licensed MEE patent rights prior to first commercial sale of an MEE licensed product. The Company is also obligated to pay a minimum annual royalty payment of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0f98cb15-1310-4f63-99fb-cbc139bb5c12" contextRef="C_46cac2fb-9412-44da-9032-89c8b384ae1e" name="freq:RoyaltyExpensePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="0">15</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per each MEE patent family case number included in the licensed MEE patent rights after first commercial sale of an MEE licensed product. The Company is also obligated to make milestone payments up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5e4681a9-b0e4-4e85-beb8-e0dfb9b0ddd8" contextRef="C_3b0f514e-4e02-4094-a8b5-6f2ea6aca5d4" name="freq:MilestonePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">350</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> on each product or process that incorporates the licensed patent rights. In addition, the Company has agreed to pay a low single-digit royalty on products and processes that incorporate the licensed patent rights.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The MEE License Agreement shall remain in effect until all issued patents and filed patent applications within the licensed patent rights have expired or been abandoned, unless terminated earlier. </span><span style="font-size:12.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d4e45847-8cb6-4c29-b299-9e48306e23d2" contextRef="C_c58972d9-4eff-40b9-999f-af1bc8c7e65c" name="freq:DescriptionOfConditionsToTerminateLicenseAgreement" continuedAt="F_d4e45847-8cb6-4c29-b299-9e48306e23d2_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has the right to terminate the MEE License Agreement at will by giving thirty (</span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_25194614-695b-4733-8293-7978381fdda8" contextRef="C_2f466342-40f3-44b7-934b-9ce9617ba401" name="freq:RightToTerminateAgreementUponPriorWrittenNotice" format="ixt-sec:durday"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) business days advance written notice to MEE. MEE has the right to terminate the MEE License Agreement if the Company fails to make any payment due within thirty (</span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d2ed6d57-a3b3-468b-bd43-81d311b95e15" contextRef="C_2f466342-40f3-44b7-934b-9ce9617ba401" name="freq:RightToTerminateAgreementIncaseOfNonpayment" format="ixt-sec:durday"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">business days after </span></ix:nonNumeric></span><span style=""></span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_d4e45847-8cb6-4c29-b299-9e48306e23d2_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">MEE </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">notifies the Company of such failure. MEE shall have the right to terminate if the Company fails to maintain the required insurance. MEE shall also have the right to terminate the MEE License Agreement upon forty-five (</span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4f91d6a8-5351-4f47-baba-31c56f472bd2" contextRef="C_2f466342-40f3-44b7-934b-9ce9617ba401" name="freq:RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent" format="ixt-sec:durday"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">45</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) business days written notice if the Company becomes insolvent. MEE has the right to terminate for any other default not cured within sixty (</span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0bddc65d-f08c-47dc-96a4-50a982998c63" contextRef="C_2f466342-40f3-44b7-934b-9ce9617ba401" name="freq:RightToTerminateAgreementIfBreachRemainsUncured" format="ixt-sec:durday"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">60</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) business days written notice. MEE also has the right to terminate if the Company or its affiliates challenge the validity of the licensed patent rights.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></ix:continuation></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cambridge Enterprise Limited</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d2b38462-b7e0-497f-ab0b-68ae01045d75" contextRef="C_5bbe5741-fe10-4417-b986-c463fe4c347d" name="freq:LicenseAgreementEnteredDate" format="ixt:datemonthyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 2019</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, we entered into an Exclusive Patent License Agreement ( the &#x201c;Cambridge License&#x201d;) with Cambridge Enterprise Limited (the technology transfer arm of the University of Cambridge)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(&#x201c;Cambridge&#x201d;) under which we received an exclusive worldwide royalty-bearing license to certain patent rights to make, have made, sell, offer to sell and import products, or the (the &#x201c;Cambridge License Product&#x201d;) which incorporate licensed technology for the treatment of demyelinating diseases. We also have the right to grant sublicenses under the Cambridge License. Cambridge reserves the right to use for itself (as well as for the inventors and the funder) to grant nonexclusive licenses to other academic institutions for any academic publication, research and teaching and clinical patient care.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has agreed to use diligent and good faith efforts to develop and commercially exploit at least one Cambridge Licensed Product.  Upon entering into the Cambridge License, the Company made a $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e6fc5587-de4e-4a07-9560-5cedb40d3bd3" contextRef="C_659cc924-ac55-436f-91ee-94a2aaf8f068" name="freq:LicenseFeePayment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> license fee payment.  The Company is obligated to pay an annual license fee of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_548d458f-dfbf-4e5e-8f3a-72ed8afef12f" contextRef="C_2ae98e31-ab5c-4c24-810c-110edeacf851" name="freq:AnnualLicenseFee" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company is also obligated to make milestone payments up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6beb44b4-5d37-49ef-9602-3aada312f326" contextRef="C_9a711a28-f230-4980-b126-e2e78357768d" name="freq:MilestonePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,500</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> on each Cambridge License Product.  In addition, the Company has agreed to pay a low single-digit royalty on products that incorporate the licensed patent rights, subject to offset in certain circumstances.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Cambridge License continues in effect on a country-by-country basis until the expiration or revocation, without right of further appeal, of all licensed issued patents and filed patent applications, unless terminated earlier.  </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_33a96e7b-9b8e-4f9d-8dae-495c1c4ea5ac" contextRef="C_639ebc28-c88b-4d67-a3ae-091fbf1f8c30" name="freq:DescriptionOfConditionsToTerminateLicenseAgreement"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have the right to terminate for any reason upon </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_404ee546-9cac-46a8-83c8-db1680be8c75" contextRef="C_2ae98e31-ab5c-4c24-810c-110edeacf851" name="freq:RightToTerminateAgreementUponPriorWrittenNotice" format="ixt-sec:durday"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90 </span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">days&#x2019; prior to written notice.  Each party has the right to terminate immediately if the other party ceases to carry on its business.  Either party may also terminate the Cambridge License for material breach if such breach remains uncured for </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b219720b-1866-418a-aae2-bc3b637bac9e" contextRef="C_2ae98e31-ab5c-4c24-810c-110edeacf851" name="freq:RightToTerminateAgreementIfBreachRemainsUncured" format="ixt-sec:durday"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> days.  Cambridge may also terminate the Cambridge License if we fail to diligently develop and commercially exploit at least one Cambridge Licensed Product or we or our affiliates or sub-licenses commence any action against Cambridge to declare or render any claim of the licensed patent rights invalid, unpatentable, unenforceable, or not infringed.</span></ix:nonNumeric></span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Department of Defense</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In June 2018, the Company received a grant (the Grant) from the Department of Defense (DoD) under which the Company is receiving funding to further the Company&#x2019;s research and development of a therapeutic drug to treat hearing loss. The Company received funding of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c3b05cd7-c117-4c35-b9a9-7a042044c07e" contextRef="C_962eb6f1-dfe5-4536-a514-2f4945f570af" name="freq:AmountOfFundingReceivedAsGrant" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,596</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> over </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cab74745-5e22-4ef9-9c85-011cbf49b9c5" contextRef="C_962eb6f1-dfe5-4536-a514-2f4945f570af" name="freq:GrantTermPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">two years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> from the date of the Grant. The Company has determined that the DoD is not considered a customer under ASC 606, therefore funding received from the DoD under the Grant is recorded as a reduction of research and development expenses. The Company has recorded $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_890c8b32-860c-482d-917a-f6f80044cd64" contextRef="C_aef0c60c-efa8-489b-aeea-79457818c6d2" name="freq:IncreaseDecreaseInResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">323</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> as a reduction in research and development expenses for the year ended December 31, 2020. No funding was received in 2021.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:12.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_50e7bd4b-2c26-4079-a7aa-0f66ac2852d1" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">13.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> Collaboration agreement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In July 2019, the Company entered into a License and Collaboration Agreement with Astellas (the &#x201c;Astellas Agreement&#x201d;), under which the Company granted Astellas an exclusive, royalty-bearing, sub-licensable, nontransferable license to certain patent rights to research, develop, manufacture, have manufactured, use, seek and secure regulatory approval for, commercialize, offer for sale, sell, have sold and import, and otherwise exploit licensed products containing both a GSK-3 inhibitor and an HDAC inhibitor, (the &#x201c;Astellas Licensed Products&#x201d;), including the product candidate FX-322, outside of the United States. The Company also granted Astellas a right of first negotiation and a right of last refusal if it entered into any negotiation or agreement of any kind (other than an acquisition of all of the stock or assets of the Company) with any third party under which such third party would obtain the right to develop, manufacture, or commercialize Astellas Licensed Products in the United States.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These parties have agreed to use commercially reasonable efforts to carry out development activities assigned to it under an agreed-upon development plan. Astellas has agreed to use commercially reasonable efforts to obtain regulatory approval for at least one Astellas Licensed Product in sensorineural hearing loss and in age-related hearing loss, in each case, in one major Asian country and one major European country. The Company has agreed to use commercially reasonable efforts to obtain regulatory approval for at least one Astellas Licensed Product in the United States. Astellas has the sole right to commercialize the Astellas Licensed Products outside of the United States, and the Company has the sole right to commercialize the Astellas Licensed Products in the United States. Astellas has agreed to use commercially reasonable</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">efforts to commercialize Astellas Licensed Products in a major Asian country and a major European country following receipt of regulatory approval in such countries.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The collaboration is governed by a joint steering committee (&#x201c;JSC&#x201d;) established under the Astellas Agreement and shall be comprised of three representatives each from the Company and Astellas. The JSC shall oversee and coordinate the overall conduct of the development, manufacture and commercialization of the Astellas Licensed Products. All decisions of JSC shall be taken through a unanimous vote with each party&#x2019;s representatives collectively having one vote. Both the parties shall be responsible for carrying out the development and manufacturing activities in their defined territory in accordance with the plan as reviewed and approved in the JSC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">   </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As consideration for the licensed rights under the Astellas Agreement, Astellas paid the Company an upfront payment of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8c085539-d6a6-40c7-aa98-b7cce08f666d" contextRef="C_81406c60-6425-4fce-9724-dd646af7f352" name="us-gaap:ProceedsFromCollaborators" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">80,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> in July 2019 and has agreed to pay potential development milestone payments up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a33f62cd-921f-4ffa-824f-02002a2e2a46" contextRef="C_5d72a168-259a-44dd-9d7b-8058d6b3899a" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">230,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and commercialization milestones of up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_155359ea-0f82-400d-8461-22a7e77b99c0" contextRef="C_5d72a168-259a-44dd-9d7b-8058d6b3899a" name="freq:ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">315,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Specifically, the Company would receive development milestone payments of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9d3b8ac6-f9d8-403b-b18f-4e6b25a11b27" contextRef="C_d4edc7de-0885-4db2-96f1-84fc825e4ca5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">65,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1b9f7d54-8260-452f-9a9e-390e480fcfde" contextRef="C_e468091a-59de-4c2e-9cae-c71034b0d9a8" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">25,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> upon the first dosing of a subject in a Phase 2b clinical trial for SNHL in Europe and Asia, respectively and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_90fa7659-83c3-4a52-97ee-1d235a257202" contextRef="C_f644c8ed-481c-4510-a475-3d938a78a2e1" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">100,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_25eadf7f-9b4c-427a-8865-5c1590a1a0cc" contextRef="C_27210ea1-a4d8-4337-a254-d92c29bebf12" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">40,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> upon the first dosing of a subject in a Phase 3 clinical trial for SNHL in Europe and Asia, respectively. If the Astellas Licensed Products are successfully commercialized, the Company would be eligible for up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_124ee2f3-7489-41f8-9197-e6c1ff482274" contextRef="C_5d72a168-259a-44dd-9d7b-8058d6b3899a" name="freq:RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">315,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> in potential commercial milestone payments and also tiered royalties at rates ranging from low- to mid-teen percentages. The parties shall share equally, on a 50/50 basis, all out-of-pocket costs and joint study costs for all the joint activities conducted pursuant to the development plans or the joint manufacturing plan.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Astellas Agreement remains in effect until the expiration of all royalty obligations. Royalties are paid on a licensed product-by-licensed product and country-by-country basis until the latest of (i) the expiration of the last valid claim in the licensed patent rights with respect to such Astellas Licensed Product in such country or (ii) a set number of years from the first commercial sale of such Astellas Licensed Product in such country. Astellas may terminate the Astellas Agreement at will upon </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_65b0d9db-1534-4b1b-aa72-290bb59bfc3f" contextRef="C_81406c60-6425-4fce-9724-dd646af7f352" name="freq:AgreementTerminationNoticePeriod" format="ixt-sec:durday"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">60</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> days&#x2019; written notice. Each party has the right to terminate the Astellas Agreement due to the other party&#x2019;s material breach if such breach remains uncured for </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_157ebaa6-aacc-4ba2-b552-409dedca78ba" contextRef="C_81406c60-6425-4fce-9724-dd646af7f352" name="freq:RightToTerminateAgreementIfBreachRemainsUncured" format="ixt-sec:durday"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> days (or </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_48ef3fbf-3639-4ab6-a145-94aed14104e0" contextRef="C_81406c60-6425-4fce-9724-dd646af7f352" name="freq:RightToTerminateAgreementIncaseOfNonpayment" format="ixt-sec:durday"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">45</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> days in the case of nonpayment) or if the other party becomes bankrupt.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Astellas Agreement is a collaborative agreement that is within the scope of ASC 808. The Company analyzed the joint research and development activities to assess whether they fall within the scope of ASC 808, and will reassess this throughout the life of the arrangement based on changes in the roles and responsibilities of the parties. Based on the terms of the arrangement as outlined above, both parties are deemed to be active participants in the collaboration. Both parties are performing research and development activities in their defined territory and will be performing joint clinical studies in accordance with the development plan and the study protocol approved by the JSC. Additionally, Astellas and the Company are exposed to significant risks and rewards dependent on the commercial success of any product candidates that may result from the collaboration. As such, the collaboration arrangement is deemed to be within the scope of ASC 808.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The arrangement consists of two components; the license of IP and the research and development activities, including committee participation, to support the co-development and research plan. Under the provisions of ASC 808, the Company has determined that it will apply the guidance in ASC 606 to recognize the revenue related to the license since that component of the arrangement is more reflective of a vendor-customer relationship. The Company determined that the license and the related research and development services associated with the Phase 2a clinical study were not distinct from one another, as the license has limited value to Astellas without the performance of the research and development activities and the Phase 2a study is essential to the use of the license. As such, the Company determined that these activities should be accounted for as a single combined performance obligation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Revenue associated with this single performance obligation was recognized as the research and development work was performed, using an input method on the basis of research and development costs incurred to date relative to total research and development costs expected to be incurred. The transfer of control occurred over this time period and, in management&#x2019;s judgment, is the best measure of progress towards satisfying the performance obligation. The Company determined that the period of performance of the research and development services began upon the signing of the Astellas Agreement and continued until the completion of the Phase 2a clinical trial of FX-322 (FX-322-202). The transaction price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aef02f0f-e64a-40f6-a92f-ab2e2f5ef218" contextRef="C_7a257f5b-ab22-4c07-8bef-38a92a6dc698" name="freq:RevenueRecognitionTransactionPrice" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">80,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> was allocated to the single combined performance obligation and recognized over such period. The completion date of the Phase 2a clinical trial (FX-322-202) and the total research and development costs incurred in performing the trial was June 30, 2021. As such, the Company recognized the $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_438ae4a3-be18-4765-930a-b19fe2b4b340" contextRef="C_602a4133-255d-4026-bf0c-6e87837e587b" name="freq:UpfrontFeeRecognizedAsRevenue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">80,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> upfront fee as revenue over the period from July 2019 until June 30, 2021, the completion date of the Phase 2a clinical trial (FX-322-202), using the input method.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aa47cc81-d2f7-4172-bd7c-e2a22940ca88" contextRef="C_7a257f5b-ab22-4c07-8bef-38a92a6dc698" name="freq:UpfrontFeeRecognizedAsRevenue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">80,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> upfront </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">payment received from Astellas in July 2019 was initially recorded as deferred revenue and was recognized as revenue according to the policy described above. As of June 30, 2021, the Company completed its performance</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">obligation </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">with respect to the upfront payment and, accordingly, recognized all remaining revenue related to the Astellas Agreement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The potential development and regulatory milestone payments are fully constrained until the Company can conclude that achievement of the milestone is probable and that it is probable that recognition of revenue related to the milestone will not result in a significant reversal in the amount of cumulative revenue recognized when the uncertainty associated with the variable consideration is ultimately resolved and as such these have been excluded from the transaction price. As part of its evaluation of the constraint, the Company considers numerous factors, including the fact that achievement of the milestones is outside the control of the Company and contingent upon the future success of clinical trials, the licensee&#x2019;s efforts, and the receipt of regulatory approval. Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as these amounts have been determined to relate predominantly to the license granted to Astellas and therefore are recognized at the later of when the performance obligation is satisfied, or the related sales of licensed products occur. The Company re-evaluates the transaction price, including its estimated variable consideration included in the transaction price and all constrained amounts, at each reporting period and as uncertain events are resolved or other changes in circumstances occur, and, if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Astellas Agreement contains joint research and development activities that are not within the scope of ASC 606. The Company will recognize research and development expense related to the joint study costs for all the joint activities in future periods and reimbursements received from Astellas will be recognized as an offset to research and development expense on the consolidated statements of operations during the development period. In the year ended December 31, 2021 and 2020, the Company invoiced Astellas $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ee3086ba-da65-420a-9926-4538b12387dd" contextRef="C_7a257f5b-ab22-4c07-8bef-38a92a6dc698" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">885</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_65020f0a-de41-40ff-8ae4-065129c194d3" contextRef="C_36d6826a-c031-4794-9b6c-6a3f3d257de7" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,046</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for joint costs.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:12.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6c2bfdd3-2b05-47a8-86e0-92e7b8f97588" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:LesseeOperatingLeasesTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">14. Leases</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In 2016, the Company entered into a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ee19634b-c63c-48dc-a928-09d1020663a7" contextRef="C_c1ca8ce4-5cf1-421c-b2f3-843fbb4b6877" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">five-year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> operating lease for the Company&#x2019;s primary office and laboratory space in Woburn, Massachusetts. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_17e9e704-8a77-4947-8982-8a0e7b4879f7" contextRef="C_815714a9-1c63-462b-be7a-be127a4674d0" name="us-gaap:LesseeOperatingLeaseOptionToExtend"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_58b58484-0cb6-401c-9b57-c4a37abaf9fe" contextRef="C_815714a9-1c63-462b-be7a-be127a4674d0" name="freq:OperatingLeaseAgreementAmendedDate" format="ixt:datemonthyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">November 2019</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, this lease was amended to add additional laboratory and office space as well as extend the termination date for all spaces to </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_ed329d69-2529-48fa-9178-d9e728957db7;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">February 2025</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The lease and amendment do not contain any material residual value guarantees or material restrictive covenants.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;">  </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On December 11, 2020, the Company entered into an Agreement for Termination of Lease and Voluntary Surrender of Premises (the &#x201c;Lease Termination Agreement&#x201d;) with ARE-MA Region No. 20, LLC (the &#x201c;Landlord&#x201d;). The Lease Termination Agreement provides that the Lease Agreement, dated as of August 14, 2016, by and between the Company and Landlord (as the same may have been amended, the &#x201c;Lease&#x201d;) will terminate on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9d84a3c7-6f43-49ce-b024-4e4e4fe355d4" contextRef="C_0342be7e-519c-43c8-ab77-ca720271c910" name="us-gaap:LeaseExpirationDate1" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 31, 2021</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, unless the Company elects to extend the term of the Lease. The Company exercised the option to extend the lease until May 31, 2021.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As consideration for the Landlord&#x2019;s agreement to enter into the Lease Termination Agreement and accelerate the expiration date of the term of the Lease, the Company has agreed to pay to Landlord a fee of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_93149a81-7ee7-4150-807b-a195c994e351" contextRef="C_fcb1bda2-b216-4764-a4c2-09a3d13f32ac" name="freq:OperatingLeaseTerminationFee" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">200</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On January 7, 2020 the Company entered into an indenture of lease (the &#x201c;Lexington Lease&#x201d;) with HCP/KING 75 Hayden LLC, for the lease of approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aad6aab7-d2ba-46c1-bb7f-d5e3200cbf28" contextRef="C_1ffc57b1-4997-466a-89cb-19ba9650731e" name="us-gaap:NetRentableArea" unitRef="U_sqft" decimals="INF" format="ixt:numdotdecimal">61,307</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> square feet of rentable area in Lexington, Massachusetts or (the &#x201c;Lexington Premises&#x201d;).  The Lexington Lease commenced on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1328e47b-3323-43d7-8174-15e0dc40283b" contextRef="C_9ee00bb1-b451-49aa-8278-506702da2a88" name="freq:OperatingLeaseCommencementDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 11, 2020</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the second quarter of 2021, the Company began using the Lexington Premises as its principal executive offices and laboratory for research and development. The term of the Lexington Lease is expected to end on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bc2599dc-3d2a-40c2-9bc6-b62b3a784af9" contextRef="C_9ee00bb1-b451-49aa-8278-506702da2a88" name="us-gaap:LeaseExpirationDate1" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">May 31, 2031</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company also has the option to extend the Initial Term for </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_727c4c5b-9d29-4fc9-92e5-d971ca412152" contextRef="C_1ffc57b1-4997-466a-89cb-19ba9650731e" name="freq:OperatingLeaseNumberOfAdditionalExtensionTerms" unitRef="U_Term" decimals="INF" format="ixt-sec:numwordsen">two</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> additional terms of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_38c69f58-422b-4ae2-92aa-70d7144cfd77" contextRef="C_9ee00bb1-b451-49aa-8278-506702da2a88" name="freq:OperatingLeasesAdditionalExtensionTerm" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">five years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> each.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company continues to lease a small office space in Connecticut.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company's rent expense for the years ended December 31, 2021 and 2020 was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_972493fd-024c-4439-bb5b-ccc0404a111c" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:OperatingLeaseExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,960</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_33d1264b-942d-4f03-8eca-c78a9e6b6f1f" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:OperatingLeaseExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">835</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_dbcd4ac2-4582-47ac-98ff-957c6ab7532a" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:LeaseCostTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:77.097%;"></td>
        <td style="width:1.67%;"></td>
        <td style="width:0.805%;"></td>
        <td style="width:18.28%;"></td>
        <td style="width:2.147%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Other information</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average remaining operating lease term</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_07f7a25e-4ed7-4cf8-ad11-1e707e4debd1" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.4</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;years</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average discount rate</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3d56b245-ff5d-4daa-99e8-89c9500d2ade" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">8.5</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">27</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_29e1cfd5-5e4a-4773-8a0f-b3de8119e54a" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" escape="true"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The table below reconciles the undiscounted cash flows to the operating lease liability recorded on the consolidated balance sheet as of December 31, 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:77.452%;"></td>
        <td style="width:1.833%;"></td>
        <td style="width:1.278%;"></td>
        <td style="width:18.457%;"></td>
        <td style="width:0.981%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aa55cd31-cd0b-41a5-91f2-fdfb5931e320" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,159</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2023</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_34506e36-d1ef-4d5e-b230-ac8d70b587d5" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,284</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2024</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6fd3234a-e4ed-4f49-89bf-1a07eb39ec05" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,412</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2025</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cdd9d9f2-9db1-4318-8685-03af2f144225" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,545</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2026</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8b42b399-02a7-460d-bec4-e2bc3977a0ce" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,681</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Thereafter</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d3c4e0e3-a35c-4f78-b072-89dd6a3dd747" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22,389</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total minimum lease payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c30c208a-c367-46ba-9d08-23ed2c65c677" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">44,470</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Less: amount of lease payments representing interest</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c3da70f0-5e06-48df-905e-ca8f51393a6a" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">13,872</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Present value of future lease payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_901978b5-0dbd-44a6-9a55-7c00cd7ada18" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,598</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Less: current lease liabilities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_77980166-c385-4c32-878f-37715f399622" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,747</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Noncurrent lease liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_11d43c29-a984-40b6-830e-377f4c8cae19" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">28,851</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:11.0pt;font-family:Calibri;"><ix:nonNumeric id="F_7e55cd27-7764-4384-af11-23dce3259310" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Future aggregate minimum payments under the noncancelable operating leases and short term leases, including the Lexington, MA lease and Connecticut lease, which is not subject to ASC 842, as of December 31, 2021 are as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:76.935%;"></td>
        <td style="width:1.653%;"></td>
        <td style="width:2.133%;"></td>
        <td style="width:17.956%;"></td>
        <td style="width:0.248%;"></td>
        <td style="width:1.075%;"></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7521c5e1-bc37-4db8-93ae-97403eca8ba5" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,161</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2023</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fa349bf4-6cb3-46fa-aa9d-793fcf71f90f" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,284</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2024</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c64dc124-f048-465f-a3f0-3fd584910a9d" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,412</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2025</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bc78f261-6427-4ddc-9b1d-044386e45ab6" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,545</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2026</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_975db203-3f43-426d-944f-523061ac63ae" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,681</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2027 and beyond</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ee776326-d9a1-46b7-9714-9fada7ea4dcb" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">22,388</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total minimum lease payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_80b45493-3793-40b4-b2f9-cd89ab880607" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">44,471</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:12.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_838118b8-1964-435a-b937-1e2a3485c802" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">15. Commitments and contingencies</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Contract commitments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has contracted with a research institution to provide research for a therapeutic drug to treat multiple sclerosis. In September 2020, the Company extended the term of this contract through December 2021. As consideration for this extension, the Company committed to total payments of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_edf089d5-fa8c-42a8-befb-3b031e952480" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:LongTermPurchaseCommitmentAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">600</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> through December 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">   </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company enters into contracts in the normal course of business with CROs, CMOs, universities, and other third parties for preclinical research studies, clinical trials and testing and manufacturing services. These contracts generally do not contain minimum purchase commitments and are cancelable by us upon prior written notice although, purchase orders for clinical materials are generally non-cancelable. Payments due upon cancellation consist only of payments for services provided or expenses incurred, including non-cancelable obligations of our service providers, up to the date of cancellation or upon the completion of a manufacturing run.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Guarantees</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has identified the guarantees described below as disclosable, in accordance with ASC 460, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Guarantees</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As permitted under Delaware law, the Company indemnifies its officers and directors for certain events or occurrences while the officer or director is, or was, serving at the Company&#x2019;s request in such capacity. The maximum potential amount of future payments the Company could be required to make is unlimited; however, the Company has directors&#x2019; and officers&#x2019; insurance coverage that should limit its exposure and enable it to recover a portion of any future amounts paid.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is a party to a number of agreements entered into in the ordinary course of business that contain typical provisions that obligate the Company to indemnify the other parties to such agreements upon the occurrence of certain events. Such indemnification obligations are usually in effect from the date of execution of the applicable agreement for a period equal to the applicable statute of limitations. The aggregate maximum potential future liability of the Company under such indemnification provisions is uncertain.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">28</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company leases office space in Lexington, Massachusetts under a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_badd76a0-b8ea-44dc-9b85-cfff1f573f06" contextRef="C_a3c46bd6-df2a-4676-94dc-776e2b2317ad" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ten-year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> noncancelable lease. The $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_969d0d86-a089-48cb-98dd-b8110057412e" contextRef="C_a3c46bd6-df2a-4676-94dc-776e2b2317ad" name="us-gaap:RestrictedCash" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,700</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> security deposit for this lease is classified as restricted cash as of December 31, 2021. The Company exited the Woburn, Massachusetts facility in the second quarter of 2021. The Company has standard indemnification arrangements under these leases that require it to indemnify the landlord against all costs, expenses, fines, suits, claims, demands, liabilities, and actions directly resulting from any breach, violation, or nonperformance of any covenant or condition of the lease.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021 and 2020, the Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b87d49b6-4a53-4e7e-b5ec-fe9df38d94aa" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:LossContingencyLossInPeriod" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen"><ix:nonFraction id="F_6971040c-b6a8-42a5-94ee-269c3252ce03" contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2" name="us-gaap:LossContingencyLossInPeriod" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t experienced any losses related to these indemnification obligations, and no material claims with respect thereto were outstanding. The Company does not expect significant claims related to these indemnification obligations and, consequently, concluded that the fair value of these obligations is negligible, and no related reserves have been established.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Legal Contingencies</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company accrues a liability for legal contingencies when it believes that it is both probable that a liability has been incurred and that the Company can reasonably estimate the amount of the loss. The Company reviews these accruals and adjusts them to reflect ongoing negotiations, settlements, rulings, advice of legal counsel and other relevant information. To the extent new information is obtained and the views on the probable outcomes of claims, suits, assessments, investigations or legal proceedings change, changes in the Company&#x2019;s accrued liabilities would be recorded in the period in which such determination is made.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, in accordance with the relevant authoritative guidance, for any matters in which the likelihood of material loss is at least reasonably possible, the Company will provide disclosure of the possible loss or range of loss. If a reasonable estimate cannot be made, however, the Company will provide disclosure to that effect. The Company expenses legal costs as they are incurred.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On June 3, 2021 and June 22, 2021, purported stockholders of the Company filed putative class action lawsuits in the U.S. District Court for the District of Massachusetts against the Company entitled Evans v. Frequency Therapeutics, Inc. et al. and Hingston v. Frequency Therapeutics, Inc. et al., respectively. The lawsuits allege violations of Section 10(b), 20(a) and Rule 10b5 of the Securities Exchange Act of 1934, as amended, due to allegedly false and misleading statements and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">omissions about the Company&#x2019;s Phase 2a clinical trial (FX-322-202) for its product candidate FX-322 in the Company&#x2019;s public disclosures between November 16, 2020 and March 22, 2021. The lawsuits seek, among other things, damages in connection with the Company&#x2019;s allegedly artificially inflated stock price between November 16, 2020 and March 22, 2021 as a result of those allegedly false and misleading statements and omissions, as well as interest, attorneys&#x2019; fees and costs. These matters are at the very early stages of the legal process, and as a result, the Company is not able to estimate a range of possible loss. The Company is vigorously defending against all claims asserted in both lawsuits. The Company has not yet filed a responsive pleading. Since an estimate of the possible loss or range of loss cannot be made at this time, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5a779dfa-84ef-4d2e-a8ee-ccce03c749eb" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:LossContingencyAccrualAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> accruals have been recorded as of December 31, 2021.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On June 24, 2021, two purported stockholders of the Company filed a lawsuit in the Court of Chancery of the State of Delaware against (i) the Company, (ii) the Company&#x2019;s Chief Executive Officer, President, and Director, David Lucchino, (iii) Computershare Inc., and (iv) Computershare Trust Company, N.A., entitled The Gregory J. Parseghian Revocable Trust, et al. v. Frequency Therapeutics, Inc., et al. The lawsuit asserts causes of action against the Company of conversion and, in the alternative, unjust enrichment, and against Mr. Lucchino for breach of the fiduciary duty of loyalty, based on allegations that actions were taken to prevent the purported stockholders from selling their shares in the Company. The lawsuit seeks monetary damages, as well as interest, attorneys&#x2019; fees and costs, against all defendants. This matter is at the very early stages of the legal process, and as a result, the Company is not able to estimate a range of possible loss. We are vigorously defending against all claims asserted and have filed a motion to dismiss the complaint, which remains pending. Since an estimate of the possible loss or range of loss cannot be made at this time, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2e3dd689-a8d8-442c-95ff-6c6d4c25e8a6" contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8" name="us-gaap:LossContingencyAccrualAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> accruals have been recorded as of December 31, 2021.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4354211f-12ed-464c-baa7-120f99c68ebc" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">16. Employee benefit plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Employees of the Company are eligible to participate in the Company&#x2019;s 401(k) retirement plan (the &#x201c;401(k) Plan&#x201d;). Participants may contribute up to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_847e574b-fded-4c2b-a8c2-45487791c009" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">90</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of their annual compensation to the 401(k) Plan, subject to statutory limitations. Under the 401(k) Plan Safe Harbor Match, the Company matches </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_eacd65c2-e78c-44d6-8876-9bda84e85b72" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">100</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the first </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a421a269-c5d2-44f5-9a15-640152de9d26" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of employee contributions and vests </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4f5b1b4a-8b67-4ede-9077-32b4afc91619" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">100</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% at time of match. For the years ended December 31, 2021 and 2020, the Company made matching contributions of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ff06427d-7f5d-408a-96ef-77affaf44412" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">723</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_365ac2f5-d231-4d30-9b05-01434e2c83ca" contextRef="C_5b1c30df-3436-4ba5-a445-bc2cba68d121" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">400</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">29</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_425149d0-b925-47e8-994a-312aca55af1a" contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">17. Related party transactions</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As disclosed in Note 12, the Company entered into the MIT License Agreement in December 2016. The patents in-licensed by the Company from MIT pursuant to the MIT License Agreement claim inventions created by, among others, Dr. Langer, one of the Company&#x2019;s directors. Accordingly, Dr. Langer has received $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d778b1ca-28f2-4105-9806-adc9d508fe66" contextRef="C_be99fc1c-8083-4f95-90f4-0e839dbb422d" name="us-gaap:PaymentForManagementFee" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3753d73e-1ac8-4a1a-a461-b638d40c1da4" contextRef="C_a8197e94-f689-4588-95d8-113863133fd1" name="us-gaap:PaymentForManagementFee" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,980</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> from MIT under the MIT Policy during the years ended December 31, 2021 and 2020, respectively.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company's lease for its Woburn, Massachusetts facility, terminated in May 2021 as disclosed in Note 14, was with an entity affiliated with one of the Company's directors and shareholders.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>2
<FILENAME>freq-ex10_7.htm
<DESCRIPTION>EX-10.7
<TEXT>
<html>
 <head>
  <title>EX-10.7</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.2410416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">	                      Exhibit 10.7</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.2410416666666666;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">TABLE OF CONTENTS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:3.191%;"></td>
    <td style="width:2.12%;"></td>
    <td style="width:85.043%;"></td>
    <td style="width:1.146%;"></td>
    <td style="width:2.163%;"></td>
    <td style="width:5.193%;"></td>
    <td style="width:1.146%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;border-bottom:1.000pt solid rgba(0,0,0,1);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Page</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;border-bottom:1.000pt solid rgba(255,255,255,0.01);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">DEFINITIONS</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">GRANT OF RIGHTS</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">COMPANY DILIGENCE OBLIGATIONS</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ROYALTIES AND PAYMENT TERMS</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">REPORTS AND RECORDS</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">PATENT PROSECUTION</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">INFRINGEMENT AND PATENT CHALLENGE</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">22</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">INDEMNIFICATION AND INSURANCE</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">REPRESENTATIONS AND WARRANTIES</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">CHANGE OF CONTROL</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">GENERAL COMPLIANCE WITH LAWS</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">TERMINATION</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">27</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">DISPUTE RESOLUTION</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">29</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">CONFIDENTIAL INFORMATION</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">MISCELLANEOUS</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">APPENDIX A</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">35</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">APPENDIX B</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">36</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">APPENDIX C</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">37</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">EXHIBIT A</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">43</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">EXHIBIT B</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">EXHIBIT C</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">45</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">EXHIBIT D</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">46</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">i</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">MASSACHUSETTS INSTITUTE OF TECHNOLOGY</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">EXCLUSIVE PATENT LICENSE AGREEMENT</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This Agreement, effective as of the date set forth above the signatures of the parties below (the &#x201c;EFFECTIVE DATE&#x201d;), is between the Massachusetts Institute of Technology (&#x201c;M.I.T.&#x201d;), a Massachusetts corporation, with a principal office at 77 Massachusetts Avenue, Cambridge, MA 02139-4307 and Frequency Therapeutics Inc., a Delaware corporation, with a principal place of business at 300 Technology Square, 8th Floor, Cambridge, MA 02139 (&#x201c;COMPANY&#x201d;).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">RECITALS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">WHEREAS, M.I.T. and Brigham and Women&#x2019;s Hospital (hereinafter &#x201c;BWH&#x201d;) jointly own certain PATENT RIGHTS (as later defined herein) relating to [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] by Jeffrey M. Karp, Robert S. Langer, [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], and [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] by [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], Jeffrey M. Karp, Robert S. Langer and [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], and have signed a [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], that appoints M.I.T. as the exclusive agent for licensing such PATENT RIGHTS;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">WHEREAS, M.I.T. and BWH jointly own certain PATENT RIGHTS relating to [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] by Jeffrey M. Karp, Robert S. Langer and [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]; and have signed a [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], that appoints M.I.T. as the exclusive agent for licensing such PATENT RIGHTS;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">WHEREAS, Robert S. Langer, an inventor of the PATENT RIGHTS and current employee of M.I.T., has or will shortly acquire equity in COMPANY, the Conflict Avoidance Statement of Robert S. Langer is attached as Exhibit A hereto;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">WHEREAS, Robert S. Langer, an inventor of the PATENT RIGHTS, has or will shortly acquire equity in COMPANY not resulting from this Agreement, the Inventor/Author Acknowledgment of No Financial Interest in M.I.T.&#x2019;s institutional equity share of Robert S. Langer is attached as Exhibit B hereto;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">WHEREAS, [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], an inventor of the PATENT RIGHTS and current employee of M.I.T., has or will shortly acquire equity in COMPANY, the Conflict Avoidance Statement of [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] is attached as Exhibit C hereto;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">WHEREAS, [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], an inventor of the PATENT RIGHTS, has or will shortly acquire equity in COMPANY not resulting from this Agreement, the Inventor/Author Acknowledgment of No Financial Interest in M.I.T.&#x2019;s institutional equity share of [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] is attached as Exhibit D hereto;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">WHEREAS, M.I.T.&#x2019;s Vice President for Research has approved that Robert S. Langer and [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], inventors of the PATENT RIGHTS, now hold or shall shortly acquire equity in COMPANY and that M.I.T. is accepting equity as partial consideration for the rights and licenses granted under this Agreement;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">WHEREAS, M.I.T. desires to have the PATENT RIGHTS developed and commercialized to benefit the public and is willing to grant a license thereunder;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">WHEREAS, COMPANY has represented to M.I.T., to induce M.I.T. to enter into this Agreement, that COMPANY shall commit itself to a thorough, vigorous and diligent program of exploiting the PATENT RIGHTS so that public utilization shall result therefrom; and</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">WHEREAS, COMPANY desires to obtain a license under the PATENT RIGHTS upon the terms and conditions hereinafter set forth.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">NOW, THEREFORE, M.I.T. and COMPANY hereby agree as follows:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">DEFINITIONS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.1 &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">AFFILIATE</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean any legal entity (including, but not limited to, a corporation, partnership, or limited liability company) that is controlled by COMPANY. For the purposes of this definition, the term &#x201c;control&#x201d; means (i) beneficial ownership of at least fifty percent (50%) of the voting securities of a corporation or other business organization with voting securities or (ii) a fifty percent (50%) or greater interest in the net assets or profits of a partnership or other business organization without voting securities.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.2 &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">COMBINATION PRODUCT</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean a product or process which contains or uses (i) a component that is a LICENSED PRODUCT or LICENSED PROCESS, and (ii) one or more essential functional components (&#x201c;OTHER COMPONENT&#x201d;) that are or which could be sold or used separately and which perform a useful function independent of the LICENSED PRODUCT or LICENSED PROCESS.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.3 &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">CONFIDENTIAL INFORMATION</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean any confidential or proprietary information furnished by COMPANY (the &#x201c;Disclosing Party&#x201d;) to M.I.T. (the &#x201c;Receiving Party&#x201d;) in connection with this Agreement, including reports, records, and other information, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> that such information is specifically designated as confidential as follows: CONFIDENTIAL INFORMATION that is disclosed in writing shall be marked with a legend indicating its confidential status (such as &#x201c;Confidential&#x201d; or &#x201c;Proprietary&#x201d;). CONFIDENTIAL INFORMATION that is disclosed orally or visually shall be identified as confidential at the time of disclosure and documented in a written notice prepared by the Disclosing Party and delivered to the Receiving Party within [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) days of the date of disclosure; and such notice shall summarize the CONFIDENTIAL INFORMATION disclosed and reference the time and place of disclosure.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.4 &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">COVERED</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean, with respect to a given product, process, method or service, that a claim of the PATENT RIGHTS would (absent a license thereunder or ownership thereof) be infringed by the making, using, selling, offering for sale, importation or other exploitation of such product, process, method or service. With respect to a claim of a pending patent application, &#x201c;infringed&#x201d; refers to activity that would infringe or be covered by a claim of the PATENT RIGHTS if it were contained in an issued patent.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.5 &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">DEVELOPMENT CANDIDATE</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean a pre-clinical LICENSED PRODUCT that possesses desirable properties of a therapeutic agent for the treatment of a clinical condition based on in vitro and/or animal proof-of-concept studies.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.6 &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">EXCLUSIVE PERIOD</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean the period of time set forth in Section 2.2.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.7 &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">FIELD</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean treatment and/or prevention of disease or other conditions in humans and animals. For the avoidance of doubt, the FIELD shall specifically include the prevention and remediation of hearing loss.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.8 &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">LICENSED PROCESS</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean any process that, in whole or in part:</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(i) is COVERED by one or more VALID CLAIMS of the PATENT RIGHTS; or</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(ii) which uses a LICENSED PRODUCT.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.9 &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">LICENSED PRODUCT</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean any product that, in whole or in part:</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(i) is COVERED by one or more VALID CLAIMS of the PATENT RIGHTS; or</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(ii) is manufactured by using a LICENSED PROCESS or that, when used, practices a LICENSED PROCESS.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.10 &#x201c;NET SALES&#x201d; shall mean the gross amount billed by COMPANY and its AFFILIATES and SUBLICENSEES for LICENSED PRODUCTS and LICENSED PROCESSES, less the following:</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(i) customary trade, quantity, or cash discounts to the extent actually allowed and taken;</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(ii) amounts repaid or credited by reason of rejection or return;</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(iii) to the extent separately stated on purchase orders, invoices, or other documents of sale, any taxes or other governmental charges levied on the production, sale, transportation, delivery, or use of a LICENSED PRODUCT or LICENSED PROCESS which is paid by or on behalf of COMPANY;</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(iv) outbound transportation costs if separately stated on the invoice; and</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">4</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(v) amounts written off by reason of uncollectible bad debt, but not to exceed [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] percent ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]%) of the gross amount billed by COMPANY and its AFFILIATES and SUBLICENSEES for LICENSED PRODUCTS and LICENSED PROCESSES in a given REPORTING PERIOD.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For the avoidance of doubt, transfers of a LICENSED PRODUCT or LICENSED PROCESS between any of COMPANY, an AFFILIATE or a SUBLICENSEE (e.g., in a manufacturing or supply arrangement) shall not be included in NET SALES hereunder unless such transfer or sale is a final purchase by COMPANY, AFFILIATE or SUBLICENSEE, without the intent to further sell, transfer or distribute to a third party and </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> that COMPANY shall pay M.I.T. running royalties on NET SALES of the transfer or sale of such LICENSED PRODUCT or LICENSED PROCESS to the end user.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">No deductions shall be made for commissions paid to individuals whether they be with independent sales agencies or regularly employed by COMPANY and on its payroll, or for cost of collections. NET SALES shall occur on the date of billing for a LICENSED PRODUCT or LICENSED PROCESS. If a LICENSED PRODUCT or LICENSED PROCESS is distributed in a country at a discounted price that is substantially lower than the customary price charged by COMPANY (taking into account customary pricing charged by COMPANY for sales to a governmental entity), or distributed for non-monetary consideration (whether or not at a discount), NET SALES shall be calculated based on the non-discounted price of the LICENSED PRODUCT or LICENSED PROCESS, as applicable, charged to an independent third party during the same REPORTING PERIOD in such country or, in the absence of such sales, on the fair market value of the LICENSED PRODUCT or LICENSED PROCESS, as applicable, as determined in good faith based on pricing in comparable markets. NET SALES shall not include sales or transfers of reasonable amounts of LICENSED PRODUCTS without consideration for use in clinical trials or compassionate, named patient, indigent patient or similar uses. Non-monetary consideration shall </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">not</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> be accepted by COMPANY, any AFFILIATE, or any SUBLICENSEE for any LICENSED PRODUCTS or LICENSED PROCESSES without the prior written consent of M.I.T.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the event that a LICENSED PRODUCT or LICENSED PROCESS is sold as a COMBINATION PRODUCT, NET SALES, for the purposes of determining royalty payments on the COMBINATION PRODUCT, shall mean the gross amount billed for the COMBINATION PRODUCT less the deductions set forth in clauses (i) - (v) above, multiplied by a proration factor that is determined as follows:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:8.997%;"></td>
    <td style="width:3.996%;"></td>
    <td style="width:87.007%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If all components of the COMBINATION PRODUCT were sold separately during the same or immediately preceding REPORTING PERIOD, the proration factor shall be determined by the formula [A / (A+B)], where A is the average gross sales price of all LICENSED PRODUCT or LICENSED PROCESS components (as applicable) during such period when sold separately from the OTHER COMPONENT(S), and B is the average gross sales price of the OTHER COMPONENT(S) during such period when sold separately from the LICENSED PRODUCT or LICENSED PROCESS components (as applicable); or</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">5</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:8.077%;"></td>
    <td style="width:4.038%;"></td>
    <td style="width:87.885%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If all components of the COMBINATION PRODUCT were not sold or provided separately during the same or immediately preceding REPORTING PERIOD, the proration factor shall be determined by M.I.T. and COMPANY in good faith negotiations, taking into account, without limitation, the relative value contributed by each component.</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.11 &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">PATENT CHALLENGE</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean a challenge to the validity, patentability, enforceability and/or non-infringement of any of the PATENT RIGHTS (as defined below) or otherwise opposing any of the PATENT RIGHTS.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.12 &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">PATENT RIGHTS</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean:</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a) the United States and international patents listed on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Appendix A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">:</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b) the United States and international patent applications and/or provisional applications listed on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Appendix A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and the resulting patents;</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(c) any patent applications resulting from the provisional applications listed on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Appendix A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and any divisional, continuations, continuation-in-part applications, and continued prosecution applications (and their relevant international equivalents) of the patent applications listed on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Appendix A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and of such patent applications that result from the provisional applications listed on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Appendix A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, to the extent the claims are directed to subject matter specifically described in the patent applications listed on </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Appendix A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and the resulting patents;</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(d) any patents resulting from reissues, reexaminations, or extensions (and their relevant international equivalents) of the patents described in (a), (b), and (c) above; and</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(e) international (non-United States) patent applications and provisional applications filed after the EFFECTIVE DATE and the relevant international equivalents to divisional, continuations, continuation-in-part applications and continued prosecution applications of the patent applications to the extent the claims are directed to subject matter specifically described in the patents or patent applications referred to in (a), (b), (c), and (d) above, and the resulting patents.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.13 &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">PHASE 2 CLINICAL TRIAL</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean a human clinical trial of a LICENSED PRODUCT, the principal purpose of which is the preliminary determination of efficacy and/or preliminary establishment of appropriate dose ranges for efficacy and safety in the target patient population and that would satisfy the requirements under 21 C.F.R. &#167; 312.21(b) for the United States, as amended from time to time, or the corresponding regulations for a comparable filing with a comparable regulatory authority in a country other than the United States.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">6</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.14 &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">PHASE 3 CLINICAL TRIAL</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean a human clinical trial of a LICENSED PRODUCT that is prospectively designed to be a pivotal trial for obtaining regulatory approval or to otherwise establish safety and efficacy in patients with the disease or condition being studied for purposes of filing an application for marketing authorization with the FDA that would satisfy the requirements under 21 C.F.R. &#167; 312.21(c), as amended from time to time, or the corresponding regulations for a comparable filing with a comparable regulatory authority in a country other than the United States.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.15 &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">REPORTING PERIOD</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall begin on the first day of each calendar quarter and end on the last day of such calendar quarter.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.16 &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">RESEARCH SUPPORT PAYMENTS</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean payments to COMPANY or an AFFILIATE from a SUBLICENSEE for the purpose of funding the costs of bona fide research and development of LICENSED PRODUCTS and LICENSED PROCESSES by COMPANY under a written research and development plan, and only to the extent COMPANY can reasonably demonstrate that such payments are or were spent on such research and development activities for the LICENSED PRODUCTS and LICENSED PROCESSES covered by the agreement to such SUBLICENSEE, and that are expressly intended only to fund or pay for (i) the purchase or use of equipment, supplies, products or services, or (ii) the use of employees and/or consultants, to achieve a bona fide research and/or development goal for the commercialization of LICENSED PRODUCTS or LICENSED PROCESSES, as indicated in a written agreement between COMPANY and SUBLICENSEE, and shall exclude any funding in excess of COMPANY&#x2019;S cost of performing such research and development activities.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.17 &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">SUBLICENSE INCOME</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean any payments that COMPANY or an AFFILIATE receives from a SUBLICENSEE in consideration of the sublicense of the rights granted COMPANY and AFFILIATES under Section 2.1, including without limitation license fees, milestone and bonus payments (net of any amount due to M.I.T. under Section 4. l(c) for the identical milestone event), option payments, license maintenance fees, and other payments, but specifically excluding (i) royalties on NET SALES of LICENSED PRODUCTS and LICENSED PROCESSES by SUBLICENSEES payable under Section 4.1(d), (ii) RESEARCH SUPPORT PAYMENTS, and (iii) payments for equity or debt securities of COMPANY or its AFFILIATE at fair market value (excluding amounts in excess of the fair market value of such securities).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.18 &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">SUBLICENSEE</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean any person or entity that has been granted a sublicense of the rights granted COMPANY under Section 2.1. For clarity, a sublicense shall include, without limitation (i) any right granted, license given or agreement entered into by COMPANY to or with another person or entity, under or with respect to or permitting any use of the PATENT RIGHTS or otherwise granting rights to such person or entity under the rights</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">7</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">granted COMPANY under Section 2.1, (ii) any option or other right granted by COMPANY to any other person or entity to negotiate for or receive any of the rights described under clause (i), or (iii) any standstill or similar obligation undertaken by COMPANY toward another person or entity not to grant any of the rights described in clause (i) or (ii) to any third party, in each case regardless of whether such grant of rights, license given or agreement entered into is referred to or is described as a sublicense.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.19 &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">TERM</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean the term of this Agreement, which shall commence on the EFFECTIVE DATE and shall remain in effect until the expiration or abandonment of all issued patents and filed patent applications within the PATENT RIGHTS, unless earlier terminated in accordance with the provisions of this Agreement,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.20 &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">TERRITORY</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean worldwide.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.21 &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">VALID CLAIM</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean (a) a claim of an issued and unexpired patent within the PATENT RIGHTS, which claim has not been revoked or found to be unpatentable, invalid or unenforceable by an unreversed and unappealable decision of a court or other government agency of competent jurisdiction; or (b) a claim set forth in an application within the PATENT RIGHTS that has been filed in good faith and that has not been abandoned or finally rejected in a decision that is unappealable or unappealed within the time allowed for appeal nor which has been pending for more than [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) years after the date of first substantive examination of such patent application, as evidenced by the receipt of an office action on the merits from the United States Patent and Trademark Office (or an equivalent examination report form a foreign patent office); </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, that in the event such claim subsequently issues in an issued patent, then such claim shall be a VALID CLAIM hereunder, and COMPANY shall pay to M.I.T. any amounts that would otherwise have been due under such VALID CLAIM. Notwithstanding the foregoing, (i) the [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) year pendency period set forth in clause (b) above shall only apply if, after [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) years of prosecution on the merits of a given application, COMPANY notifies M.I.T. in writing that it does not believe that M.I.T. should continue to prosecute such application and M.I.T. continues to do so at its discretion, and (ii) if the prosecution of a given application is interrupted and/or delayed by a patent office and/or due to a PATENT CHALLENGE and/or a patent office proceeding such as an interference, appeal or opposition, then the pendency of such PATENT CHALLENGE and/or proceeding(s) shall not be included in the [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) year time period set forth above. The invalidity of a particular claim in one or more countries shall not invalidate such claim in the remaining countries of the TERRITORY.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">GRANT OF RIGHTS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.1 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">License Grants</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Subject to the terms of this Agreement, including without limitation Section 2.5, M.I.T. hereby grants to COMPANY and its AFFILIATES for the TERM a royalty-bearing exclusive license, with the right to sublicense as set forth in Section 2.3 below, under the PATENT RIGHTS to develop, make, have made, use, sell, offer to sell, lease and import LICENSED PRODUCTS in the FIELD in the TERRITORY and to develop and perform LICENSED PROCESSES in the FIELD in the TERRITORY.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">8</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.2 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Exclusivity</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In order to establish an exclusive period for COMPANY, M.I.T. agrees that, subject to the terms of this Agreement, including without limitation Sections 2.3(b) and 2.5, it shall not grant any other license under the PATENT RIGHTS (i) to make, have made, use, sell, offer to sell, lease and/or import LICENSED PRODUCTS in the FIELD in the TERRITORY or (ii) to perform LICENSED PROCESSES in the FIELD in the TERRITORY, during the TERM (&#x201c;EXCLUSIVE PERIOD&#x201d;), unless sooner terminated as provided in this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.3 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Sublicenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a) COMPANY shall have the right to grant sublicenses of its rights under Section 2.1 only during the EXCLUSIVE PERIOD; SUBLICENSEES shall not have the right to grant further sublicenses except as expressly provided below. Such sublicenses may extend past the expiration date of the EXCLUSIVE PERIOD, but any exclusivity of such sublicense shall expire upon the expiration of the EXCLUSIVE PERIOD. COMPANY will incorporate terms and conditions into its sublicense agreements sufficient to enable COMPANY to comply with this Agreement. COMPANY and SUBLICENSEES will also include provisions in all sublicenses to provide that in the event that SUBLICENSEE brings a PATENT CHALLENGE against M.I.T. or assists another party in bringing a PATENT CHALLENGE against M.I.T. (except as required under a court order or subpoena) then COMPANY may terminate the sublicense. COMPANY will promptly furnish M.I.T. with a fully signed copy of each sublicense agreement and any amendments thereto, which may be reasonably redacted to preserve any confidential information of the parties thereto, except that terms directly relevant to COMPANY&#x2019;S and AFFILIATE&#x2019;S obligations under this Agreement (including financial provisions) may not be redacted. Notwithstanding the foregoing, COMPANY shall not be required to provide M.I.T. will copies of sublicenses granted by COMPANY to third party service providers performing contract research services on behalf of and at the direction of COMPANY, but will do so upon request by M.I.T.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Non-monetary consideration shall not be accepted by COMPANY for any sublicense of the PATENT RIGHTS hereunder without the prior written consent of M.I.T. COMPANY shall not structure sublicensing arrangements for the PATENT RIGHTS, either alone or in connection with other assets (e.g., technology and/or intellectual property rights) owned or controlled by COMPANY and/or an AFFILIATE in a single transaction or series of related transactions, in order to minimize or avoid payments to MIT for SUBLICENSE INCOME sharing under this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">9</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Notwithstanding the foregoing, in any sublicense agreement with a SUBLICENSEE, COMPANY may grant to such SUBLICENSEE the right to grant further sublicenses of the PATENT RIGHTS sublicensed by COMPANY to SUBLICENSEE (&#x201c;SUBLICENSEE SUBLICENSED RIGHTS&#x201d;) through a single tier solely to bona fide third party collaborators and third party contractors performing research services on behalf of and at the direction of SUBLICENSEE for SUBLICENSEE&#x2019;S subsequent use (and with no right to grant further sublicenses) (each, a &#x201c;Service Provider&#x201d;) or (ii) in connection with a license to a third party commercialization partner for the right to develop and/or commercialize a product owned and/or controlled by SUBLICENSEE (each, a &#x201c;Commercialization Partner&#x201d;), but not otherwise for use, sale or any other commercial activity by such Service Providers or Commercialization Partners directly, on the following terms and conditions:</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(i) Each Service Provider and Commercialization Partner that has been granted a sublicense of the SUBLICENSEE SUBLICENSED RIGHTS, a &#x201c;SUBLICENSEE SUBLICENSED PARTY,&#x201d; shall be considered a &#x201c;SUBLICENSEE&#x201d; for the purposes of this Agreement;</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(ii) Any consideration that COMPANY or an AFFILIATE receives from a SUBLICENSEE in consideration of the sublicense of the licenses and rights granted COMPANY and AFFILIATES under Section 2.1, including without limitation in connection with the sublicense of such rights to a SUBLICENSEE SUBLICENSED PARTY, shall be considered SUBLICENSE INCOME hereunder;</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(iii) Any agreement pursuant to which a SUBLICENSEE grants a sublicense of the SUBLICENSEE SUBLICENSED RIGHTS (a &#x201c;SUBLICENSEE SUBLICENSE AGREEMENT&#x201d;) shall satisfy the requirements of this Section 2.3(a); notwithstanding and without limiting the foregoing, any SUBLICENSEE SUBLICENSE AGREEMENT shall include terms that are sufficient to enable COMPANY to comply with this Agreement; and</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(iv) COMPANY shall, and ensures that SUBLICENSEE shall (I) furnish M.I.T. with a fully signed copy of any SUBLICENSEE SUBLICENSE AGREEMENT, and any amendments thereto, promptly after it is executed, which may be redacted as set forth in this Section 2.3, and (II) deliver to M.I.T. reports containing the information described in Article 5 with respect to any SUBLICENSEE SUBLICENSED PARTY.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Sublicense Survival</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event of termination of this Agreement by M.I.T., except pursuant to Section 12.4(b), M.I.T. agrees that, after the effective date of termination of this Agreement, and as soon as practicable after receiving a written request from a SUBLICENSEE, M.I.T. will negotiate in good faith a license with such SUBLICENSEE (the &#x201c;NEW LICENSE AGREEMENT&#x201d;), </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> that:</font></p>
  <p style="margin-left:9.08%;text-indent:4.986%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(1) SUBLICENSEE shall notify M.I.T. in writing of its request for a license agreement under the PATENT RIGHTS in accordance with this Section 2.3(b) within [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) days of the effective date of termination of this Agreement;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">10</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(2) M.I.T. shall not be obligated to grant to any such SUBLICENSEE any rights under the PATENT RIGHTS that are broader than the rights previously granted by COMPANY to SUBLICENSEE, or inconsistent with the rights granted to COMPANY under this Agreement;</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(3) SUBLICENSEE is not in material breach under the sublicense agreement with COMPANY, or in default of any relevant provisions of this Agreement, at the date of termination of this Agreement;</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(4) Unless otherwise agreed to in writing by M.I.T. and the SUBLICENSEE, under the NEW LICENSE AGREEMENT SUBLICENSEE shall be obligated to pay M.I.T. (i) a commercially reasonable license issue fee, and (ii) all of the payments M.I.T. would have been entitled to receive from COMPANY under Article 4 of this Agreement, including without limitation license maintenance fees (Section 4.1(b)), running royalties (Section 4.1(d)) and milestone payments (Section 4.1(c)) specified in this Agreement, as well as sharing of SUBLICENSE INCOME (Section 4.1(e)) and reimbursement of future PATENT EXPENSES (Sections 4.1(a) and 6.3), in each case as if the sublicense agreement between COMPANY and SUBLICENSEE and this Agreement were both still in full effect. For example, for a given milestone event achieved under Section 4.1(c) of this Agreement, the NEW LICENSE AGREEMENT shall require payment of the applicable amounts due under both Sections 4.1(c) and 4.1(e), with respect to consideration that would otherwise have been SUBLICENSE INCOME, of this Agreement, as if the sublicense agreement between COMPANY and SUBLICENSEE was still in full effect. Notwithstanding the foregoing, in the event that the provisions of the sublicense agreement between COMPANY and SUBLICENSEE are amended at any time after the effective date of such agreement such that any consideration that would have otherwise been due to M.I.T. under this Agreement is impacted, this Section 2.3(b)(4) shall not apply and M.I.T. and SUBLICENSEE shall negotiate in good faith consideration for the grant of rights under the NEW LICENSE AGREEMENT; and</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(5) The NEW LICENSE AGREEMENT shall include substantially similar terms and conditions of the following provisions of this Agreement:</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Subject to Sections 2.3(b)(2) above, Section 2.1 (License Grants);</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Section 2.3(a) (Sublicenses);</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Section 2.4 (U.S. Manufacturing);</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Section 2.5 (Retained Rights);</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Section 3.1 (Diligence Requirements);</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Section 4.1(f) (Consequences of a PATENT CHALLENGE);</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Article 5 (Reports and Records);</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Section 6.1 (Responsibility for PATENT RIGHTS);</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Section 6.3 (Payment of Expenses), </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> that responsibility for payment of PATENT EXPENSES shall be equitably apportioned among all SUBLICENSEES of the PATENT RIGHTS that enter into a NEW LICENSE AGREEMENT with M.I.T.;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">11</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Article 7 (Infringement);</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Article 8 (Indemnification and Insurance);</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Article 9 (Representations or Warranties);</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Article 11 (General Compliance with Laws);</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Section 12.2 (Cessation of Business; Insolvency);</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Section 12.3 (Termination for Default);</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Section 12.4 (Termination as a Consequence of a PATENT CHALLENGE);</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Article 13 (Dispute Resolution);</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Section 15.1 (Notice); and</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Section 15.2 (Governing Law and Jurisdiction).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.4 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">U.S. Manufacturing</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. During the EXCLUSIVE PERIOD, COMPANY agrees to comply with the requirements of 35 U.S.C. &#167;204 &#x201c;Preference for United States Industry,&#x201d; as amended, or any successor statutes or regulations.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.5 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Retained Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Research and Educational Use</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. M.I.T. and BWH retain the right on behalf of themselves and all other non-profit research institutions to practice under the PATENT RIGHTS for non-clinical research, teaching and educational purposes, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, that in no event shall any PATENT RIGHTS that are exclusively licensed hereunder be used by M.I.T. or BWH for the production or manufacture of products for sale in the FIELD.</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Federal Government</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. COMPANY acknowledges that the U.S. federal government retains a royalty-free, non-exclusive, non-transferable license to practice any government-funded invention claimed in any PATENT RIGHTS as set forth in 35 U.S.C. &#167;&#167; 201-211, and the regulations promulgated thereunder, as amended, or any successor statutes or regulations.</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(c) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Sponsor Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The invention underlying the PATENT RIGHTS for [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] (the &#x201c;Invention&#x201d;) was based on research supported by The Leona M. and Harry B. Helmsley Charitable Trust. COMPANY acknowledges that The Leona M. and Harry B. Helmsley Charitable Trust and Harvard Medical School have been granted an irrevocable, royalty-free, non-transferrable, non-exclusive, non-commercial license to use the Invention for non-commercial, academic and/or research purposes.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.6 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">No Additional Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Nothing in this Agreement shall be construed to confer any rights upon COMPANY by implication, estoppel, or otherwise as to any technology or patent rights of M.I.T. or any other entity other than the PATENT RIGHTS, regardless of whether such technology or patent rights shall be dominant or subordinate to any PATENT RIGHTS.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">12</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">COMPANY DILIGENCE OBLIGATIONS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.1 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Diligence Requirements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. COMPANY will use diligent efforts, or will cause its AFFILIATES or SUBLICENSEES to use diligent efforts, to develop LICENSED PRODUCTS or LICENSED PROCESSES and to introduce LICENSED PRODUCTS or LICENSED PROCESSES into the commercial market; thereafter, COMPANY or its AFFILIATES or SUBLICENSEES will make LICENSED PRODUCTS or LICENSED PROCESSES reasonably available to the public. Specifically, COMPANY or AFFILIATE will fulfill the following obligations:</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a) Within [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) months after the EFFECTIVE DATE, COMPANY will furnish M.I.T. with a written research and development plan describing the major tasks to be achieved in order to bring to market a LICENSED PRODUCT or a LICENSED PROCESS, specifying the number of staff and other resources, to be devoted to such commercialization effort.</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b) Within [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) days after the end of each calendar year, COMPANY will furnish M.I.T. with a written report (consistent with Section 5.1(a)) on the progress of its efforts during the immediately preceding calendar year to develop and commercialize LICENSED PRODUCTS or LICENSED PROCESSES. Such report will include a description, but not the sequence, of the DEVELOPMENT CANDIDATE(S) being developed by COMPANY, and its AFFILIATES and SUBLICENSEES. The report will also contain a discussion of intended efforts and sales projections for the year in which the report is submitted.</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(c) COMPANY (and/or an AFFILIATE OR SUBLICENSEE) shall expend at least the amounts set forth below on research and development of LICENSED PRODUCTS and/or LICENSED PROCESSES in each calendar year (pro-rated for partial years) beginning in 2016 and ending with the first commercial sale of a LICENSED PRODUCT and/or a first commercial performance of a LICENSED PROCESS,</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:72.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:88.604%;"></td>
    <td style="width:1.336%;"></td>
    <td style="width:1.692%;"></td>
    <td style="width:8.369%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2016</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***]</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2017</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***]</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2018</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***]</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2019 and every year thereafter</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(d) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Fundraising</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(i) COMPANY shall have received at least [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] Dollars ($[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) by January 31, 2017 from the sale of equity securities or securities convertible into equity for its own account; and</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">13</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(ii) In the aggregate, COMPANY shall receive at least [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] dollars ($[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) by the one (1) year anniversary of the EFFECTIVE DATE from the sale of equity securities for its own account.</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(e) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">First LICENSED PRODUCT</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(1) Within one (1) year of the EFFECTIVE DATE, COMPANY shall advance a DEVELOPMENT CANDIDATE for a first LICENSED PRODUCT to Absorption, Distribution, Metabolism and Excretion (&#x201c;ADME&#x201d;) and toxicology studies in support of an Investigational New Drug application (&#x201c;IND&#x201d;) (or equivalent) for human studies.</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(2) Within two (2) years of the EFFECTIVE DATE, COMPANY shall file an IND for a first LICENSED PRODUCT.</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(3) COMPANY shall commence dosing of individuals in a PHASE 2 CLINICAL TRIAL for a first LICENSED PRODUCT within two (2) years of IND filing for such LICENSED PRODUCT in accordance with subsection (e)(2) above.</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(4) COMPANY shall commence dosing of individuals in a PHASE 3 CLINICAL TRIAL for a first LICENSED PRODUCT within five (5) years of IND filing for such LICENSED PRODUCT in accordance with subsection (e)(2) above.</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(5) COMPANY shall file a New Drug Application (or equivalent) with the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) or comparable European regulatory agency for a first LICENSED PRODUCT within nine (9) years of IND filing for such LICENSED PRODUCT in accordance with subsection (e)(2) above.</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(6) COMPANY shall make a FIRST COMMERCIAL SALE of a first LICENSED PRODUCT within eleven (11) years of IND filing for such LICENSED PRODUCT in accordance with subsection (e)(2) above.</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(f) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Second LICENSED PRODUCT</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Prior to [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], COMPANY shall provide M.I.T. with a development plan with mutually acceptable diligence milestones, such diligence milestones to be added by amendment to this Agreement, for a second LICENSED PRODUCT as set forth below:</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(1) On or before a reasonable deadline to be determined by the parties by [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], COMPANY shall advance a DEVELOPMENT CANDIDATE for a second LICENSED PRODUCT to ADME and toxicology studies in support of an IND (or equivalent) for human studies.</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(2) On or before a reasonable deadline to be determined by the parties by [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], COMPANY shall file an IND for a second LICENSED PRODUCT.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">14</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(3) On or before a reasonable deadline to be determined by the parties by [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], COMPANY shall commence dosing of individuals in a PHASE 2 CLINICAL TRIAL for a second LICENSED PRODUCT.</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(4) On or before a reasonable deadline to be determined by the parties by [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], COMPANY shall commence dosing of individuals in a PHASE 3 CLINICAL TRIAL for a second LICENSED PRODUCT.</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(5) On or before a reasonable deadline to be determined by the parties by [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], COMPANY shall file a New Drug Application (or equivalent) with the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) or comparable European regulatory agency for a second LICENSED PRODUCT.</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(6) On or before a reasonable deadline to be determined by the parties by [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]. COMPANY shall make a FIRST COMMERCIAL SALE of a second LICENSED PRODUCT.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the event that M.I.T. determines that COMPANY (or an AFFILIATE) has failed to fulfill any of its obligations under Section 3.1, other than under Section 3.1(f), then M.I.T. may treat such failure as a material breach of the Agreement in accordance with Section 12.3(b), and M.I.T. shall have the ability to terminate this Agreement. In the event of any breach under Section 3.1(f) that has not been cured within ninety (90) days of written notice of such failure, M.I.T. may, by written notice to COMPANY, restrict the definition of FIELD hereunder to the prevention and remediation of hearing loss in humans and animals, and this Agreement shall be deemed amended to such effect. For clarity, M.I.T. may not terminate the Agreement for failure by COMPANY (or an AFFILIATE) to fulfill any of its obligations under Section 3.1(f).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.2 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Changes to Diligence Requirements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event that COMPANY anticipates that a failure to meet an obligation set forth in Section 3.1(e) or 3.1(f) will occur, COMPANY will promptly notify M.I.T. in writing, and representatives of each party will meet to review the reasons for anticipated failure. In addition to the foregoing, if COMPANY provides written notice and reasonably demonstrates to M.I.T. that the anticipated failure to meet any one of the diligence obligations set forth in Section 3.1(e) or 3.1(f) is due to (i) an action, inaction, delay or ruling by the FDA or any comparable regulatory agency, or (ii) the existence of material technical difficulties (e.g., negative toxicological or pharmacological test results or an adverse clinical event with respect to LICENSED PRODUCTS and/or LICENSED PROCESSES) that COMPANY could not reasonably have predicted and/or avoided (each of (i) and (ii), a &#x201c;DEVELOPMENT ISSUE&#x201d;), then the parties shall meet to review the cause and nature of the DEVELOPMENT ISSUE as well as COMPANY&#x2019;S proposed plan and timeline to address same, and the parties shall reasonably amend the relevant aspects of the diligence schedule to account for such DEVELOPMENT ISSUE.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">15</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">COMPANY and M.I.T. will enter into a written amendment to this Agreement with respect to any mutually agreed upon change(s) to the relevant obligation(s) in accordance with this Section 3.2.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">ROYALTIES AND PAYMENT TERMS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.1 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Consideration for Grant of Rights</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">License Issue Fee and Patent Cost Reimbursement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. COMPANY will pay to M.I.T. [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] a license issue fee of fifty thousand dollars ($50,000), and, in accordance with Section 6.3, will reimburse M.I.T. for its actual expenses incurred as of the EFFECTIVE DATE in connection with obtaining the PATENT RIGHTS. These payments are nonrefundable.</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">License Maintenance Fees</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. COMPANY will pay to M.I.T. the following license maintenance fees on the dates set forth below:</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:84.667%;"></td>
    <td style="width:2.276%;"></td>
    <td style="width:2.276%;"></td>
    <td style="width:10.279%;"></td>
    <td style="width:0.502%;"></td>
   </tr>
   <tr style="height:10.8pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:11.5pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1,2017</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30,000</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.8pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each January 1 for 2018 and 2019</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50,000</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:11.5pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each January 1 for 2020 and 2021</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">75,000</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:21.6pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2022 and each January 1 thereafter until first commercial sale of a LICENSED PRODUCT</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100,000</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:21.6pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each January 1 of every year after first commercial sale of a LICENSED PRODUCT</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">200,000</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This annual license maintenance fee is nonrefundable; however, the annual license maintenance fee may be credited to running royalties subsequently due on NET SALES earned during the same calendar year, if any. License maintenance fees paid in excess of running royalties due in such calendar year will not be creditable to amounts due for future years.</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(c) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Milestone Payments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. COMPANY will pay to M.IT. the amounts set forth below upon the achievement by COMPANY or any of its AFFILIATES or SUBLICENSEES of certain milestone events as described below. Payments will be due in respect of the achievement of the milestone events in the tables below for each LICENSED PRODUCT and/or LICENSED PROCESS, and will only be payable once for each LICENSED PRODUCT and/or LICENSED PROCESS.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">16</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="border-spacing:0;table-layout:fixed;width:68.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:83.974%;"></td>
    <td style="width:0.52%;"></td>
    <td style="width:0.599%;"></td>
    <td style="width:0.236%;"></td>
    <td style="width:14.151%;"></td>
    <td style="width:0.52%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.000pt solid rgba(0,0,0,1);text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Milestone Event</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;border-bottom:1.000pt solid rgba(0,0,0,1);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Payment</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;border-bottom:1.000pt solid rgba(255,255,255,0.01);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$[***]</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The milestone events set forth in Section 4.1(c) above are intended to be successive. In the event that [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], the milestone payment for [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] and the milestone payment for [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] both shall be due [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]. In addition and notwithstanding the foregoing, if any milestone is reached without achieving a preceding milestone, then the amount that would have been payable on achievement of the preceding milestone will be payable upon the achievement of the next successive milestone.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">COMPANY will notify M.I.T. within [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) days of the achievement of any of the above milestones by COMPANY or any of its AFFILIATES or SUBLICENSEES, such notice to specifically identify the payment obligation and request an invoice for same. COMPANY will make such non-creditable, non-refundable milestone payments within [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) days after receipt of an invoice from M.I.T. for same.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(d) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Running Royalties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(i) COMPANY shall pay to M.I.T. a running royalty of [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] percent ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]%) of NET SALES. Running royalties shall be payable for each REPORTING PERIOD during the TERM and shall be due to M.I.T. within [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) days of the end of each REPORTING PERIOD.</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(ii) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Royalty Offset</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. If COMPANY or an AFFILIATE or SUBLICENSEE is required to pay royalties to one or more third parties in order to obtain a license or similar right necessary to practice the PATENT RIGHTS or to make, use or sell a LICENSED PRODUCT or LICENSED PROCESS, COMPANY and its AFFILIATES and SUBLICENSEES shall be entitled to deduct up to [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] percent ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]%) of the royalties actually paid by COMPANY (and its AFFILIATES and SUBLICENSEES, as applicable) to such third party(ies) from the running royalties owed to M.I.T. under this Agreement in the same REPORTING PERIOD; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, that in no event will the royalties due to M.I.T. under Section 4.1(d)(1), when aggregated with any other offsets and credits allowed under this Agreement, be less than [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] percent ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]%) of NET SALES in any REPORTING PERIOD.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(e) S</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">haring of SUBLICENSE INCOME</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. COMPANY will pay M.I.T. a total of twenty percent (20%) of all SUBLICENSE INCOME received by COMPANY or AFFILIATES. COMPANY shall notify M.I.T. within [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) days of the receipt of SUBLICENSE INCOME from a SUBLICENSEE, such notice to specifically identify the payment obligation and request an invoice for same. COMPANY shall make such non-creditable, non-refundable SUBLICENSE INCOME payments within [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) days after receipt of an invoice from M.I.T. for same.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">17</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(f) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Consequences of a PATENT CHALLENGE</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event that (i) COMPANY or any of its AFFILIATES brings a PATENT CHALLENGE against M.I.T., or (ii) COMPANY or any of its AFFILIATES assists another party in bringing a PATENT CHALLENGE against M.I.T. (except as required under a court order or subpoena), and (iii) M.I.T. does not choose to exercise its rights to terminate this Agreement pursuant to Section 12.4, then all payments due under Article 4 shall [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] for the remainder of the TERM. In the event that such a PATENT CHALLENGE is successful, COMPANY will have no right to recoup any payments paid during the period of challenge. In the event that a PATENT CHALLENGE is unsuccessful, COMPANY shall reimburse M.I.T. for all reasonable legal fees and expenses incurred in its defense against the PATENT CHALLENGE.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(g) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">No Multiple Royalties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. If the manufacture, use, lease, or sale of any LICENSED PRODUCT or the performance of any LICENSED PROCESS is covered by more than one of the PATENT RIGHTS, multiple royalties shall not be due.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(h) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Equity</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(i) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Initial Grant</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. COMPANY shall issue a total of six hundred and nineteen thousand two hundred and ten (619,210) shares of Common Stock of COMPANY, $.001 par value per share, (the &#x201c;Shares&#x201d;). COMPANY shall issue a certain percentage of the Shares in the name of M.I.T., the Brigham and Women&#x2019;s Hospital and Omega Cambridge SPV L.P. (&#x201c;Omega&#x201d;), collectively the &#x201c;Shareholders,&#x201d; in the amounts as M.I.T. shall direct. The aforementioned percentages shall be determined by M.I.T. Such issuances shall be recorded on the Stock Transfer Ledger of COMPANY on the EFFECTIVE DATE and the Shares shall be delivered to the Shareholders within thirty (30) days of the EFFECTIVE DATE.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">COMPANY represents to M.I.T. that, as of the EFFECTIVE DATE, the aggregate number of Shares equals Five Percent (5%) of the COMPANY&#x2019;S issued and outstanding Common Stock calculated on a &#x201c;Fully Diluted Basis,&#x201d; For purposes of this Section 4.1(h), &#x201c;Fully Diluted Basis&#x201d; shall mean the total number of issued and outstanding shares of the COMPANY&#x2019;S Common Stock calculated to include conversion of all issued and outstanding securities convertible into Common Stock, the exercise of all outstanding options and warrants to purchase shares of Common Stock, whether or not then exercisable, the conversion or exercise of all rights to purchase or acquire Common Stock, whether or not then convertible or exercisable, and shall assume the issuance or grant of all securities reserved for issuance pursuant to any COMPANY stock or stock option plan in effect on the date of the calculation.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">18</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(ii) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Anti-Dilution Protection Through Funding Threshold</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. COMPANY from time to time shall issue additional shares of Common Stock to the Shareholders, pro rata in accordance with their respective ownership of the Shares, as may be necessary to ensure that the Shares (together with any and all shares issued pursuant to this Section 4.1 (h)(ii)) continue to represent in the aggregate at least Five Percent (5%) of the COMPANY&#x2019;S issued and outstanding Common Stock calculated on a Fully Diluted Basis, as calculated after giving effect to the anti-dilutive issuance. Such issuances shall continue until and including the point upon which a total of [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] Dollars ($[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) in cash in exchange for COMPANY&#x2019;S capital stock (the &#x201c;Funding Threshold&#x201d;) shall be received by COMPANY. Thereafter, no additional shares shall be due to the Shareholders pursuant to this section. For the avoidance of doubt, it is agreed that if COMPANY raises capital in a single financing of more than $[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], anti-dilution issuances will be calculated only on the first $[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] of the financing, even if COMPANY simultaneously raises additional financing.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(iii) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Participation in Private Equity Offerings After Funding Threshold</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. After the date of the Funding Threshold, each of the Shareholders shall have the right to purchase additional shares of COMPANY&#x2019;S capital stock in any private offering by the COMPANY of such capital stock in exchange for cash, to maintain its pro rata ownership as calculated immediately prior to such offering on a Fully Diluted Basis, pursuant to the terms and conditions at least as favorable as those granted to the other offerees. All rights granted to the Shareholders pursuant to this Section 4. l(h)(iii) shall terminate immediately prior to a firm commitment underwritten public offering of the COMPANY&#x2019;S common stock resulting in gross proceeds to the COMPANY of at least $[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]. The Shareholders may together elect to share their Participation Rights between them in such proportion as they see fit so that if they both so direct either may take over all or some of the other&#x2019;s Participation Rights.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(iv) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Anti-Dilution Protection After Funding Threshold</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The provisions of Annex 4.1(h)(iv) (attached hereto as Appendix C) are incorporated herein by reference. All rights granted to the Shareholders pursuant to this Section 4.1 (h)(iv) shall terminate immediately prior to a firm commitment underwritten public offering of the COMPANY&#x2019;S common stock resulting in gross proceeds to the COMPANY of at least $[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">].</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(v) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Miscellaneous</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(A) The Shares, and all other shares of Common Stock and other securities of the COMPANY that may be issued to the Shareholders pursuant to this Section 4.1(h), shall be duly authorized, validly issued, fully paid and nonassessable.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(B) COMPANY acknowledges that it has been informed that, pursuant to separate agreement between M.I.T. and Omega, Omega may hereafter become obligated to transfer to M.I.T. any and all of its Shares, COMPANY agrees that M.I.T. shall be deemed to be the sole Shareholder for all purposes of this Section 4.1(h) upon receipt of written notice from M.I.T, to that effect.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">19</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.2 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Payments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Method of Payment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. All payments under this Agreement should be made payable to &#x201c;Massachusetts Institute of Technology&#x201d; and sent to the address identified in Section 15.1. Each payment should reference this Agreement and identify the obligation under this Agreement that the payment satisfies.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Payments in U.S. Dollars</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. All payments due under this Agreement shall be payable in United States dollars. Conversion of foreign currency to U.S. dollars shall be made at the conversion rate existing in the United States (as reported by the Federal Reserve Bank of St. Louis) on the last working day of the calendar quarter of the applicable REPORTING PERIOD. Such payments shall be without deduction of exchange, collection, or other charges, and, specifically, without deduction of withholding or similar taxes or other government imposed fees or taxes, except as permitted in the definition of NET SALES.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(c) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Late Payments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Any payments by COMPANY that are not paid on or before the date such payments are due under this Agreement shall bear interest, to the extent permitted by law, at [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] percentage points above the Prime Rate of interest as reported by the Federal Reserve Bank of St. Louis on the last business day of the calendar quarterly reporting period to which such royalty payments relate.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">REPORTS AND RECORDS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.1 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Reports</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Progress Reports</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. COMPANY shall deliver progress reports to M.I.T. annually, within [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) days of the end of each calendar year, containing information concerning the immediately preceding calendar year, specifically including the following information:</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(i) the progress of its efforts to develop and commercialize LICENSED PRODUCTS or LICENSED PROCESSES, in accordance with Section 3.1;</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(ii) the number of new sublicenses entered into for the PATENT RIGHTS, LICENSED PRODUCTS and/or LICENSED PROCESSES for the applicable calendar year and an updated list of all sublicenses and amendments thereto entered into for the PATENT RIGHTS, LICENSED PRODUCTS and/or LICENSED PROCESSES over the lifetime of the Agreement;</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(iii) a summary of the milestones achieved pursuant to Section 4.1(c) and the associated payment amounts due to M.I.T.; and</font></p>
  <p style="margin-left:9.08%;text-indent:4.986%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(iv) COMPANY&#x2019;S current Certificates of Insurance, in accordance with Section 8.2.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">20</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If no amounts are due to M.I.T. for the applicable calendar year, the report shall so state.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Royalty Reports</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In addition to Section 5.1(a) above, COMPANY shall report to M.I.T. the date of first commercial sale of a LICENSED PRODUCT and the date of first commercial performance of a LICENSED PROCESS in each country within [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) days of such occurrence. After the earlier of (i) the execution of a sublicense agreement with a SUBLICENSEE and (ii) the first commercial sale of a LICENSED PRODUCT or first commercial performance of a LICENSED PROCESS in any country, COMPANY shall deliver running royalty reports to M.I.T. within [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) days of the end of each REPORTING PERIOD, containing information concerning the immediately preceding REPORTING PERIOD. Each report delivered by COMPANY to M.I.T. shall contain at least the following information for the immediately preceding REPORTING PERIOD:</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(i) the number of LICENSED PRODUCTS sold, leased or distributed by COMPANY, its AFFILIATES and SUBLICENSEES to independent third parties in each country, and, if applicable, the number of LICENSED PRODUCTS used by COMPANY, its AFFILIATES and SUBLICENSEES in the provision of services in each country;</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(ii) a description of LICENSED PROCESSES performed by COMPANY, its AFFILIATES and SUBLICENSEES in each country as may be pertinent to a royalty accounting hereunder;</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(iii) the gross price per unit charged by COMPANY, its AFFILIATES and SUBLICENSEES for each LICENSED PRODUCT and, if applicable, the gross price charged for each LICENSED PRODUCT used to provide services in each country; and the gross price charged for each LICENSED PROCESS performed by COMPANY, its AFFILIATES and SUBLICENSEES in each country;</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(iv) calculation of NET SALES for the applicable REPORTING PERIOD in each country, including a listing of applicable deductions;</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(v) total royalty payable on NET SALES in U.S. dollars, together with the exchange rates used for conversion; COMPANY shall use reasonable efforts to identify royalties payable hereunder on account of sales of LICENSED PRODUCTS and/or LICENSED PROCESSES to BWH; and</font></p>
  <p style="margin-left:13.613%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(vi) the total amount of SUBLICENSE INCOME received by COMPANY from each SUBLICENSEE and the amount due to M.I.T. from such SUBLICENSE INCOME, including an itemized breakdown of the sources of income comprising the SUBLICENSE INCOME.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If no amounts are due to M.I.T. for any REPORTING PERIOD, the report shall so state.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">21</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.2 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Financial Statements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. On or before the [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] day following the close of COMPANY&#x2019;S fiscal year, COMPANY shall provide M.I.T. with COMPANY&#x2019;S financial statements for the preceding fiscal year including, at a minimum, a balance sheet and an income statement, certified by COMPANY&#x2019;S treasurer or chief financial officer or by an independent auditor.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.3 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Records</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. COMPANY will maintain, and will cause its AFFILIATES and SUBLICENSEES to maintain, complete and accurate records relating to the rights and obligations under this Agreement and any amounts payable to M.I.T. in relation to this Agreement, which records will contain sufficient information to permit M.I.T. to confirm the accuracy of any reports delivered to M.I.T. and compliance in other respects with this Agreement. COMPANY and its AFFILIATES and SUBLICENSEES will retain such records for at least [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) years following the end of the REPORTING PERIOD to which they pertain. An independent auditor appointed by M.I.T. and reasonably acceptable to COMPANY (or, in the case of any audit of a SUBLICENSEE&#x2019;S records, reasonably acceptable to SUBLICENSEE), will have the right, [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] and on reasonable prior written notice, to inspect such records during normal business hours to verify any reports and payments made or compliance in other respects under this Agreement. In the event that any audit performed under this Section reveals an underpayment in excess of the lesser of (i) [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] percent ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]%) for the audited period or any REPORTING PERIOD or (ii) [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] dollars ($[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]), COMPANY shall bear the full cost of such audit and shall remit any amounts due to M.I.T. within [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) days of receiving notice thereof from M.I.T.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">PATENT PROSECUTION</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.1 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Responsibility for PATENT RIGHTS</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. M.I.T. shall prepare, file, prosecute, and maintain all of the PATENT RIGHTS. COMPANY shall have reasonable opportunities to advise M.I.T. and shall cooperate with M.I.T. in such filing, prosecution and maintenance. M.I.T. shall instruct its patent counsel to copy COMPANY on all patent prosecution documents relating to the PATENT RIGHTS. M.I.T. shall provide COMPANY a reasonable opportunity, if time permits, to review and comment on such materials. M.I.T. shall consider in good faith any comments received from COMPANY relating to prosecution and maintenance of the PATENT RIGHTS.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.2 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">International (non-United States) Filings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Appendix B is a list of countries in which patent applications corresponding to the United States patent applications listed in </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Appendix A</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shall be filed, prosecuted, and maintained. Appendix B may be amended by mutual agreement of COMPANY and M.I.T.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.3 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Payment of Expenses</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Payment of all fees and costs, including attorneys&#x2019; fees, relating to the filing, prosecution and maintenance of the PATENT RIGHTS incurred by M.I.T. and/or BWH (including without limitation interferences, reissues and any type of review or correction of the PATENT RIGHTS initiated by or on behalf of M.I.T) shall be the responsibility of COMPANY, whether such amounts were incurred before or after the EFFECTIVE DATE. As of December 13, 2016, M.I.T. has incurred approximately $[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] for such patent-related fees and costs.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">22</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">COMPANY will reimburse all amounts due pursuant to this Section within [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) days of invoicing; late payments will accrue interest pursuant to Section 4.2(c). In all instances, M.I.T. shall pay the fees prescribed for large entities to the United States Patent and Trademark Office.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">INFRINGEMENT AND PATENT CHALLENGE</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.1 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Notification of Infringement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Each party agrees to provide written notice to the other party promptly after becoming aware of any infringement of the PATENT RIGHTS in the FIELD.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.2 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Right to Prosecute Infringements</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">COMPANY Right to Prosecute</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. So long as COMPANY remains the exclusive licensee of the PATENT RIGHTS in the FIELD in the TERRITORY, COMPANY, to the extent permitted by law, shall have the right, under its own control and [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], to prosecute any third party infringement of the PATENT RIGHTS in the FIELD in the TERRITORY, subject to Sections 7.4 and 7.5. If required by law, M.I.T. shall permit any action under this Section to be brought in its name, including being joined as a party-plaintiff, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> that [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">].</font></p>
  <p style="margin-left:9.08%;text-indent:4.986%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prior to commencing any such action, COMPANY will consult with M.I.T. and will consider the views of M.I.T. regarding the advisability of the proposed action and its effect on the public interest. COMPANY will not enter into any settlement, consent judgment, or other voluntary final disposition of any infringement action under this Section without the prior written consent of M.I.T. (subject to concurrence of BWH, as applicable).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:1.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">M.I.T. Right to Prosecute</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event that COMPANY is unsuccessful in persuading the alleged infringer to desist or fails to have initiated an infringement action within a reasonable time after COMPANY first becomes aware of the basis for such action, M.I.T. shall have the right, at its sole discretion, to prosecute such infringement under its sole control and [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], and [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.3 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Third Party Patent Challenges</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a) In the event of a PATENT CHALLENGE by a third party, other than as set forth in Section 7.3(b) below, M.I.T. shall notify COMPANY of the PATENT CHALLENGE, and COMPANY may request that M.I.T. defend the PATENT RIGHTS [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]; in such event [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]. If COMPANY does not so request and agree, M.I.T. shall have the right, but not the obligation, to defend the PATENT RIGHTS. In the event that M.I.T. defends the PATENT RIGHTS, M.I.T. shall have the right to immediately terminate this Agreement with respect to the PATENT RIGHT(S) that are the subject of the PATENT CHALLENGE.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">23</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b) In the event that a PATENT CHALLENGE is brought by a third party defendant in a suit brought by COMPANY against an alleged infringer, COMPANY shall have the first right to defend the PATENT RIGHTS [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], subject to Sections 7.4 and 7.5, and shall [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]. If COMPANY does not exercise this right, M.I.T. may take over the sole defense of the action at its sole discretion and [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], and if so, (i) M.I.T. shall have the right to immediately terminate this Agreement with respect to the PATENT RIGHT(S) that are the subject of the PATENT CHALLENGE and (ii) [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.4 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Offsets</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. COMPANY may offset a total of [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] percent ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]%) of any expenses incurred under Sections 7.2 and 7.3 against any payments due to M.I.T. under Article 4, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> that in no event shall such payments under Article 4, when aggregated with any other offsets and credits allowed under this Agreement, be reduced by more than [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] percent ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]%) in any REPORTING PERIOD.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.5 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Recovery</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Any recovery obtained in an action brought by COMPANY under Sections 7.2 or 7.3 shall be distributed as follows: [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.6 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Cooperation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Each party agrees to cooperate in any action under this Article which is controlled by the other party, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> that [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.7 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Right to Sublicense</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. So long as COMPANY remains the exclusive licensee of the PATENT RIGHTS in the FIELD in the TERRITORY, COMPANY shall have the sole right to sublicense any alleged infringer in the FIELD in the TERRITORY for future use of the PATENT RIGHTS in accordance with the terms and conditions of this Agreement relating to sublicenses. Any fees or other revenues to COMPANY pursuant to such sublicense shall be subject to the provisions of Section 4.1(e).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">INDEMNIFICATION AND INSURANCE</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.1 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Indemnification</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Indemnity</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. COMPANY shall indemnify, defend, and hold harmless M.I.T., BWH and their affiliates, trustees, officers, faculty, students, employees, and agents and their respective successors, heirs and assigns (the &#x201c;Indemnitees&#x201d;), against any liability, damage, loss, or expense (including reasonable attorneys&#x2019; fees and expenses) (collectively, &#x201c;Losses&#x201d;) incurred by or imposed upon any of the Indemnitees in connection with any claims, suits, investigations, actions, demands or judgments, (i) arising out of any theory of product liability (including without limitation actions in the form of tort, warranty, or strict liability) concerning any product, process, or service that is made, used, sold, imported, or performed pursuant to any right or license granted under this Agreement or (ii) arising out of or related to the exercise of</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">24</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any rights granted to COMPANY and AFFILIATES under this Agreement or a material breach of this Agreement by COMPANY and/or AFFILIATES; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, that COMPANY shall have no obligation pursuant to the foregoing with respect to any Losses to the extent that they result from the gross negligence or willful misconduct of any Indemnitee.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Procedures</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Indemnitees agree to provide COMPANY with prompt written notice of any claim, suit, action, demand, or judgment for which indemnification is sought under this Agreement. COMPANY agrees, at its own expense, to provide attorneys reasonably acceptable to M.I.T. to defend against any such claim. The Indemnitees shall cooperate fully with COMPANY in such defense and will permit COMPANY to conduct and control such defense and the disposition of such claim, suit, or action (including all decisions relative to litigation, appeal, and settlement); </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, that any Indemnitee shall have the right to retain its own counsel, [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], if representation of such Indemnitee by the counsel retained by COMPANY would be inappropriate because of actual or potential differences in the interests of such Indemnitee and any other party represented by such counsel and COMPANY does not choose to retain new counsel to defend against such claim. COMPANY agrees to keep M.I.T. (and BWH, as applicable) informed of the progress in the defense and disposition of such claim and to consult with M.I.T. (and BWH, as applicable) with regard to any proposed settlement. Notwithstanding anything to the contrary in this Agreement, COMPANY shall not enter into any settlement, consent judgment, or other voluntary final disposition of any claim that has a material adverse effect on the rights of any Indemnitee(s) hereunder or admits any wrongdoing or fault by any Indemnitee(s) or imposes on any Indemnitee(s) any payment or other liability, without the prior written consent of such Indemnitee(s).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.2 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Insurance</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. COMPANY shall obtain and carry in full force and effect commercial general liability insurance, including products/completed operations coverage and errors and omissions liability insurance which shall protect COMPANY and Indemnitees with respect to events covered by Section 8.1(a) above. Such insurance (i) shall be issued by an insurer licensed to practice in the Commonwealth of Massachusetts or an insurer pre-approved by M.I.T., such approval not to be unreasonably withheld, (ii) shall list M.I.T. and BWH as additional insureds thereunder, for the commercial general liability policy only, and (iii) shall require [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) days written notice to be given to M.I.T. prior to any cancellation or material change thereof. The limits of the commercial general liability insurance shall not be less than [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] Dollars ($[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) per occurrence with an annual aggregate of [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] Dollars ($[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) for bodily injury including death, property damage, and products/completed operations coverage. The limits of the errors and omissions liability insurance shall not be less than [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] Dollars ($[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) per claim and in the aggregate. COMPANY shall provide M.I.T. with Certificates of Insurance evidencing ongoing compliance with this Section. COMPANY shall continue to maintain such insurance after the expiration or termination of this Agreement during any period in which COMPANY or any AFFILIATE or SUBLICENSEE continues (i) to make, use, or sell a product that was a LICENSED PRODUCT under this Agreement or (ii) to perform a service that was a LICENSED PROCESS under this Agreement, and thereafter for a period of [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) years, if the coverage is under a claims-made policy.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">25</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If COMPANY desires to self-insure all or part of the limits described above, such self-insurance program must be acceptable to M.I.T., BWH, and the Risk Management Foundation of the Harvard Medical Institutions, Inc.. The minimum amounts of insurance coverage required under this Section 8.2 shall not be construed to create a limit of COMPANY&#x2019;S liability with respect to its indemnification under Section 8.1 of this Agreement. If there is a cancellation, non-renewal, or material change in insurance, and COMPANY does not obtain replacement insurance providing comparable coverage prior to the expiration of the [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) day notice period described above, M.I.T. shall have the right to terminate this Agreement effective at the end of such [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) day period without notice or any additional waiting periods.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If there is a cancellation, non-renewal, or material change in insurance, and COMPANY does not obtain replacement insurance providing comparable coverage prior to the expiration of the [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) day notice period described above, M.I.T. shall have the right to terminate this Agreement effective at the end of such [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) day period without notice or any additional waiting periods. For clarity, this termination clause applies to any material changes in the following terms: (i) commercial general liability insurance in amounts not less than $[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] per incident and $[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] annual aggregate; (ii) the naming of Indemnitees as additional insureds; and (iii) product liability coverage and broad form contractual liability coverage for COMPANY&#x2019;S indemnification under Section 8.1 of this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">REPRESENTATIONS AND WARRANTIES</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.1 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Representations and Warranties</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The M.I.T. Technology Licensing Office represents and warrants that, as of the EFFECTIVE DATE, subject to Section 2.5, to its knowledge and without due inquiry: (a) it has the authority to grant the licenses provided for herein to COMPANY, (b) it has not given any notice to any third party asserting infringement of the PATENT RIGHTS, and (c) it has not granted to any third party any rights under the PATENT RIGHTS that would conflict with the rights granted to COMPANY under this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">M.I.T.&#x2019;s total liability under the representations and warranties of this Agreement shall not exceed the amounts received by M.I.T. from COMPANY under Sections 4.1 and 6.3 of this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">EXCEPT AS OTHERWISE EXPRESSLY SET FORTH IN THIS AGREEMENT, M.I.T. AND BWH MAKE NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE PATENT RIGHTS AND HEREBY DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS OF M.I.T., BWH OR THIRD PARTIES, VALIDITY, ENFORCEABILITY AND SCOPE OF PATENT RIGHTS, WHETHER ISSUED OR PENDING, AND THE ABSENCE OF LATENT OR OTHER DEFECTS, WHETHER OR NOT DISCOVERABLE.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">26</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">IN NO EVENT SHALL M.I.T., BWH OR THEIR TRUSTEES, DIRECTORS, OFFICERS, EMPLOYEES AND AFFILIATES BE LIABLE FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES OF ANY KIND, INCLUDING ECONOMIC DAMAGES OR INJURY TO PROPERTY AND LOST PROFITS, REGARDLESS OF WHETHER M.I.T. OR BWH SHALL BE ADVISED, SHALL HAVE OTHER REASON TO KNOW, OR IN FACT SHALL KNOW OF THE POSSIBILITY OF THE FOREGOING.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">CHANGE OF CONTROL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This Agreement is personal to COMPANY and no rights or obligations may be assigned or transferred by COMPANY without the prior written consent of M.I.T. Notwithstanding the foregoing, COMPANY may assign its rights and obligations under this Agreement to (a) an AFFILIATE or (b) to a successor in connection with the merger, consolidation, reorganization or sale of all or substantially all of its assets or that portion of its business to which this Agreement relates; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, that (i) COMPANY shall provide M.I.T. with written notice of any such assignment within [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) days of any such assignment, such notice to include the assignee&#x2019;s contact information, (ii)this Agreement shall immediately terminate if the proposed assignee fails to agree in writing to M.I.T. to be bound by the terms and conditions of this Agreement on or before the effective date of such assignment, and (iii) COMPANY and its AFFILIATES are not in default of any of their obligations under this Agreement (including without limitation payment of any amounts due under this Agreement and/or diligence obligations) at the time of such proposed assignment. Any purported assignment in contravention of this Article 10 shall be null and void and of no effect. No assignment of this Agreement shall act as a novation or release of COMPANY and its AFFILIATES from responsibility for the performance of any obligations accrued prior to such assignment.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">GENERAL COMPLIANCE WITH LAWS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11.1 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Compliance with Laws</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. COMPANY will use reasonable commercial efforts to comply with all commercially material local, state, federal, and international laws and regulations relating to the development, manufacture, use, and sale of LICENSED PRODUCTS and LICENSED PROCESSES.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11.2 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Export Control</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. COMPANY and its AFFILIATES and SUBLICENSEES will comply with all United States laws and regulations controlling the export of certain commodities and technical data, including without limitation all Export Administration Regulations of the United States Department of Commerce. Among other things, these laws and regulations prohibit or require a license for the export of certain types of commodities and technical data to specified countries. COMPANY hereby gives written assurance that it will comply with, and will cause its AFFILIATES and SUBLICENSEES to comply with, all United States export control laws and regulations, that it bears sole responsibility for any violation of such laws and regulations by itself or its AFFILIATES or SUBLICENSEES, and that it will indemnify, defend and hold M.I.T. and BWH harmless (in accordance with Section 8.1) for the consequences of any such violation.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">27</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11.3 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Non-Use of M.I.T, and COMPANY Name</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. COMPANY and its AFFILIATES and SUBLICENSEES will not use the name of &#x201c;Massachusetts Institute of Technology,&#x201d; &#x201c;Lincoln Laboratory,&#x201d; &#x201c;Brigham and Women&#x2019;s Hospital,&#x201d; or any variation, adaptation, or abbreviation thereof, or of any of its trustees, officers, faculty, students, employees, or agents, or any trademark owned by M.I.T. or BWH, or any terms of this Agreement in any promotional material or other public announcement or disclosure without the prior written consent of M.I.T, and/or BWH, as applicable, which consent M.I.T. and/or BWH may withhold in its sole discretion. The foregoing notwithstanding, without the consent of M.I.T., COMPANY may make factual statements during the TERM (i) that it is licensed by M.I.T. under the PATENT RIGHTS, and (ii) identifying the inventors of the PATENT RIGHTS and their affiliation with M.I.T., </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, that such statements may not be used in marketing, promotion, or advertising. In addition, COMPANY may comply with disclosure requirements of all applicable laws relating to its business, including, without limitation, United States and state securities laws.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">M.I.T. shall not use the name of COMPANY or its AFFILIATES or SUBLICENSEES in any promotional material or other public announcement or disclosure without the prior written consent of COMPANY or its AFFILIATES or SUBLICENSEES (as applicable).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11.4 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Marking of LICENSED PRODUCTS</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. To the extent commercially feasible and consistent with prevailing business practices, COMPANY will mark, and will cause its AFFILIATES and SUBLICENSEES to mark, all LICENSED PRODUCTS that are manufactured or sold under this Agreement with the number of each issued patent under the PATENT RIGHTS that applies to such LICENSED PRODUCT.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">TERMINATION</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12.1 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Voluntary Termination by COMPANY</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. COMPANY shall have the right to terminate this Agreement, for any reason, (i) upon at least three (3) months prior written notice to M.I.T., such notice to state the date at least three (3) months in the future upon which termination is to be effective, and (ii) upon payment of all amounts due to M.I.T. through such termination effective date.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12.2 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Cessation of Business</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. If COMPANY ceases to carry on its business related to this Agreement, M.I.T. shall have the right to terminate this Agreement immediately upon written notice to COMPANY.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12.3 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Termination for Default</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">28</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Nonpayment</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event COMPANY fails to pay any amounts due and payable to M.I.T. hereunder, and fails to make such payments within thirty (30) days after receiving written notice of such failure, M.I.T. may terminate this Agreement immediately upon written notice to COMPANY.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Material Breach</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event COMPANY commits a material breach of its obligations under this Agreement, except for breach as described in Section 12.3(a), and fails to cure that breach within ninety (90) days after receiving written notice thereof, M.I.T. may terminate this Agreement immediately upon written notice to COMPANY.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12.4 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Termination as a Consequence of PATENT CHALLENGE</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">By COMPANY</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. If COMPANY or any of its AFFILIATES brings a PATENT CHALLENGE against M.I.T., or assists others in bringing a PATENT CHALLENGE against M.I.T. (except as required under a court order or subpoena), then M.I.T. may immediately terminate this Agreement.</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">By SUBLICENSEE</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. If a SUBLICENSEE brings a PATENT CHALLENGE or assists another party in bringing a PATENT CHALLENGE (except as required under a court order or subpoena), then M.I.T. may send a written demand to COMPANY to terminate such sublicense. If COMPANY fails to so terminate such sublicense within thirty (30) days after M.I.T.&#x2019;s demand, M.I.T. may immediately terminate this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12.5 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Disputes regarding Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. If COMPANY disputes any termination by M.I.T. under this Section 12, it must notify M.I.T. of the nature of such dispute and the proposed manner in which to resolve the dispute within [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) days of receipt of notification of breach or notification of termination by M.I.T., whichever is sooner. If the parties do not resolve such dispute within [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) days of such notification, then COMPANY will be required to initiate the dispute resolution procedures outlined in Section 13.3(a) immediately. If it does not do so, COMPANY shall be considered to have waived its rights to dispute the termination.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12.6 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Effect of Termination</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Survival</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The following provisions shall survive the expiration or termination of this Agreement:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:13.397%;"></td>
    <td style="width:2.062%;"></td>
    <td style="width:1.036%;"></td>
    <td style="width:83.504%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Article 1 (&#x201c;Definitions&#x201d;);</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:13.397%;"></td>
    <td style="width:2.062%;"></td>
    <td style="width:1.036%;"></td>
    <td style="width:83.504%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Article 8 (&#x201c;Indemnification and Insurance&#x201d;);</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:13.397%;"></td>
    <td style="width:2.062%;"></td>
    <td style="width:1.036%;"></td>
    <td style="width:83.504%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Article 9 (&#x201c;Representations or Warranties&#x201d;);</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:13.26%;"></td>
    <td style="width:3.056%;"></td>
    <td style="width:1.015%;"></td>
    <td style="width:82.669%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Article 13 (&#x201c;Dispute Resolution&#x201d;);</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:13.138%;"></td>
    <td style="width:3.044%;"></td>
    <td style="width:2.019%;"></td>
    <td style="width:81.799%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Article 14 (&#x201c;Confidential Information&#x201d;)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:13.26%;"></td>
    <td style="width:3.056%;"></td>
    <td style="width:1.015%;"></td>
    <td style="width:82.669%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Section 15 (&#x201c;Miscellaneous&#x201d;);</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:13.259%;"></td>
    <td style="width:2.041%;"></td>
    <td style="width:2.041%;"></td>
    <td style="width:82.66%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Section 4.1(h) (&#x201c;Consideration for Grant of Rights,&#x201d; &#x201c;Equity&#x201d;)</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">29</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:13.259%;"></td>
    <td style="width:3.056%;"></td>
    <td style="width:2.041%;"></td>
    <td style="width:81.645%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Section 5.2 (&#x201c;Content of Reports and Payments&#x201d;);</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:14.284%;"></td>
    <td style="width:2.041%;"></td>
    <td style="width:1.015%;"></td>
    <td style="width:82.66%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Section 5.3 (&#x201c;Records&#x201d;);</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:13.259%;"></td>
    <td style="width:2.041%;"></td>
    <td style="width:2.041%;"></td>
    <td style="width:82.66%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Section 11.1 (&#x201c;Compliance With Laws&#x201d;);</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:13.259%;"></td>
    <td style="width:2.041%;"></td>
    <td style="width:2.041%;"></td>
    <td style="width:82.66%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Section 11.2 (&#x201c;Export Control&#x201d;);</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:13.26%;"></td>
    <td style="width:3.056%;"></td>
    <td style="width:1.015%;"></td>
    <td style="width:82.669%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Section 12.5 (&#x201c;Disputes regarding Termination&#x201d;); and</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:13.138%;"></td>
    <td style="width:3.044%;"></td>
    <td style="width:2.019%;"></td>
    <td style="width:81.799%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#149;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Section 12.6 (&#x201c;Effect of Termination&#x201d;).</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Pre-termination Obligations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In no event shall termination of this Agreement release COMPANY, AFFILIATES, or SUBLICENSEES from the obligation to pay any amounts that became due on or before the effective date of termination.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">DISPUTE RESOLUTION</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13.1 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Mandatory Procedures</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The parties agree that any dispute arising out of or relating to this Agreement will be resolved solely by means of the procedures set forth in this Article, and that such procedures constitute legally binding obligations that are an essential provision of this Agreement. If either party fails to observe the procedures of this Article, as may be modified by their written agreement, the other party may bring an action for specific performance of these procedures in any court of competent jurisdiction.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13.2 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Equitable Remedies</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Although the procedures specified in this Article are the sole and exclusive procedures for the resolution of disputes arising out of or relating to this Agreement, either party may seek a preliminary injunction or other provisional equitable relief if, in its reasonable judgment, such action is necessary to avoid irreparable harm to itself or to preserve its rights under this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13.3 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Dispute Resolution Procedures</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Mediation</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event of any dispute arising out of or relating to this Agreement, either party may initiate mediation upon written notice to the other party (&#x201c;Notice Date&#x201d;) pursuant to Section 15.1, whereupon both parties will be obligated to engage in a mediation proceeding. Unless the parties agree otherwise, the mediation will commence within [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) days of the Notice Date. The mediation will be conducted by a single mediator in Boston, Massachusetts. The party requesting mediation will designate two (2) or more nominees for mediator in its notice. The other party may accept one of the nominees or may designate its own nominees by notice addressed to the American Arbitration Association (AAA) and copied to the requesting party. If within, [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) days following the request for mediation, the parties have not selected a mutually acceptable mediator, a mediator shall be appointed by the AAA according to the Commercial Mediation Rules or otherwise as the parties agree. The mediator shall attempt to facilitate a negotiated settlement of the dispute, but shall have no authority to impose any settlement terms on the parties. [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]. If neither party initiates mediation, the parties shall not be obliged to engage in a mediation proceeding, and either party may pursue any other remedies legally available to resolve the dispute.</font></p>
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">30</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:4.533%;text-indent:4.749%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Trial Without Jury</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. If the dispute is not resolved by mediation within [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) days after commencement of mediation, each party shall have the right to pursue any other remedies legally available to resolve the dispute, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, that, unless otherwise agreed, the parties expressly waive any right to a jury trial in any legal proceeding under this Article.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13.4 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Performance to Continue</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Each party will continue to perform its undisputed obligations under this Agreement pending final resolution of any dispute arising out of or relating to this Agreement; </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">however</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, that a party may suspend performance of its undisputed obligations during any period in which the other party fails or refuses to perform its undisputed obligations. Nothing in this Article is intended to relieve COMPANY from its obligation to make undisputed payments pursuant to Articles 4 and 6 of this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13.5 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Statute of Limitations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The parties agree that all applicable statutes of limitation and time-based defenses (including, but not limited to, estoppel and laches) shall be tolled while the procedures set forth in Sections 13.3(a) are pending. The parties shall cooperate in taking any actions necessary to achieve this result.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">CONFIDENTIAL INFORMATION</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14.1 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Obligations</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. For a period of [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">] ([</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]) years after disclosure, the Receiving Party shall (i) maintain such CONFIDENTIAL INFORMATION in confidence, except that the Receiving Party may disclose or permit the disclosure of any CONFIDENTIAL INFORMATION to its directors, officers, employees, consultants, and advisors, as well as co-owners of the PATENT RIGHTS and/or sponsors of the PATENT RIGHTS, who are obligated to maintain the confidential nature of such CONFIDENTIAL INFORMATION and who need to know such CONFIDENTIAL INFORMATION for the purposes of this Agreement, and (ii) use such CONFIDENTIAL INFORMATION solely for the purposes of this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14.2 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Exceptions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The obligations of the Receiving Party under Section 14.1 above shall not apply to the extent that certain Confidential Information (i) was in the public domain prior to the time of its disclosure under this Agreement; (ii) entered the public domain after the time of its disclosure under this Agreement through means other than an unauthorized disclosure resulting from an act or omission by the Receiving Party; (iii) was independently developed or discovered by the Receiving Party without use of the Confidential Information; (iv) is or was disclosed to the Receiving Party at any time, whether prior to or after the time of its disclosure under this Agreement, by a third party having no fiduciary relationship with the Disclosing Party and having no obligation of confidentiality with respect to such Confidential Information; or (v) is required to be disclosed to comply with applicable laws or regulations, or with a court or administrative order, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> that the Disclosing Party receives reasonable prior written notice of such disclosure, and that information disclosed pursuant to clause (v) will only be exempt from the obligation of non-disclosure and non-use for the purpose of such disclosure required by law, regulation or court or administrative order, and not for any other purpose, and shall only be disclosed to the extent required.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">31</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14.3 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Ownership and Return</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Receiving Party acknowledges that the Disclosing Party (or any third party entrusting its own information to the Disclosing Party) claims ownership of its CONFIDENTIAL INFORMATION in the possession of the Receiving Party. Upon the expiration or termination of this Agreement, and at the request of the Disclosing Party, the Receiving Party shall destroy or return to the Disclosing Party all originals, copies and summaries of documents, materials, and other tangible manifestations of CONFIDENTIAL INFORMATION in the possession or control of the Receiving Party, except that the Receiving Party may retain one copy of the CONFIDENTIAL INFORMATION in the possession of its legal counsel solely for the purpose of monitoring its obligations under this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15. </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">MISCELLANEOUS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15.1 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Notice</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Any notices required or permitted under this Agreement shall be in writing, shall specifically refer to this Agreement, and shall be sent by hand, recognized national overnight courier, confirmed facsimile transmission, confirmed electronic mail, or registered or certified mail, postage prepaid, return receipt requested, to the following addresses or facsimile numbers of the parties:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:14.145%;"></td>
    <td style="width:1.015%;"></td>
    <td style="width:84.84%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If to M.I.T.:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Massachusetts Institute of Technology</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Technology Licensing Office, Room</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">NE18-501</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">255 Main Street</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cambridge, MA 02142</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Attention: Director</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Tel: [***]</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Fax: [***]</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Email: [***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If, to M.I.T., notices regarding financial matters, including invoices:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:14.304%;"></td>
    <td style="width:1.156%;"></td>
    <td style="width:84.54%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Contact Name:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial Coordinator</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Massachusetts Institute of Technology</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Technology Licensing Office</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">255 Main Street, Room NE</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18-501</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cambridge, MA 02142</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If to COMPANY:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Frequency Therapeutics Inc.</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">300 Technology Square, 8th Floor</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cambridge, MA 02139</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Tel: [***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">32</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If, to COMPANY, notices regarding financial matters, including invoices:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:14.145%;"></td>
    <td style="width:1.015%;"></td>
    <td style="width:84.84%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Contact Name: [***]</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Department: Accounting</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Address: 300 Technology Square, 8th Floor, Cambridge, MA 02139</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Tel: [***]</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Email: [***]</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All notices under this Agreement shall be deemed effective upon receipt. A party may change its contact information immediately upon written notice to the other party in the manner provided in this Section.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15.2 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Governing Law/Jurisdiction</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. This Agreement and all disputes arising out of or related to this Agreement, or the performance, enforcement, breach or termination hereof, and any remedies relating thereto, shall be construed, governed, interpreted and applied in accordance with the laws of the Commonwealth of Massachusetts, U.S.A., without regard to conflict of laws principles, except that questions affecting the construction and effect of any patent shall be determined by the law of the country in which the patent shall have been granted. The state and federal courts having jurisdiction over Cambridge, MA, USA, provide the exclusive forum for any PATENT CHALLENGE and/or any court action between the parties relating to this Agreement. COMPANY submits to the jurisdiction of such courts and waives any claim that such court lacks jurisdiction over COMPANY or its AFFILIATES or constitutes an inconvenient or improper forum.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15.3 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Force Majeure</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Neither party will be responsible for delays resulting from causes beyond the reasonable control of such party, including without limitation fire, explosion, flood, war, strike, or riot, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> that the nonperforming party uses commercially reasonable efforts to avoid or remove such causes of nonperformance and continues performance under this Agreement with reasonable dispatch whenever such causes are removed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15.4 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Amendment and Waiver</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. This Agreement may be amended, supplemented, or otherwise modified only by means of a written instrument signed by both parties. Any waiver of any rights or failure to act in a specific instance shall relate only to such instance and shall not be construed as an agreement to waive any rights or fail to act in any other instance, whether or not similar.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15.5 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Severability</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event that any provision of this Agreement shall be held invalid or unenforceable for any reason, such invalidity or unenforceability shall not affect any other provision of this Agreement, and the parties shall negotiate in good faith to modify the Agreement to preserve (to the extent possible) their original intent. If the parties fail to reach a modified agreement within thirty (30) days after the relevant provision is held invalid or unenforceable, then the dispute shall be resolved in accordance with the procedures set forth in Article 13. While the dispute is pending resolution, this Agreement shall be construed as if such provision were deleted by agreement of the parties.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">33</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15.6 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Binding Effect</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. This Agreement shall be binding upon and inure to the benefit of the parties and their respective permitted successors and assigns.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15.7 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Headings</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. All headings are for convenience only and shall not affect the meaning of any provision of this Agreement.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15.8 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Entire Agreement</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. This Agreement constitutes the entire agreement between the parties with respect to its subject matter and supersedes all prior agreements or understandings between the parties relating to its subject matter.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">{Signature Page Follows}</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">34</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by their duly authorized representatives.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">The EFFECTIVE DATE of this Agreement is December 13, 2016.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:5.706%;"></td>
    <td style="width:1.135%;"></td>
    <td style="width:40.306%;"></td>
    <td style="width:1.135%;"></td>
    <td style="width:3.458%;"></td>
    <td style="width:1.135%;"></td>
    <td style="width:5.706%;"></td>
    <td style="width:1.135%;"></td>
    <td style="width:40.285%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">MASSACHUSETTS INSTITUTE OF TECHNOLOGY</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">FREQUENCY THERAPEUTICS, INC.</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Lesley Millar-Nicholson</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ David Lucchino</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Name</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Lesley Millar-Nicholson</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Name</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">David Lucchino</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director,</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">CEO</font></p></td>
   </tr>
   <tr>
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">MASSACHUSETTS INSTITUTE OF TECHNOLOGY</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Maria T. Zuber</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Name</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Maria T. Zuber</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vice President for Research</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">E.A. Griswold Professor of Geophysics</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">35</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">APPENDIX A</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">List of Patent Applications and Patents</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">36</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">APPENDIX B</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">List of Countries (excluding United States) for which</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">PATENT RIGHTS Applications Will Be Filed, Prosecuted and Maintained</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">37</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">APPENDIX C</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Annex 4.1(h)(iv)</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Anti-Dilution Protection After Funding Threshold</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:3.045%;"></td>
    <td style="width:96.955%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Adjustments for Certain Dilutive Issuances</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:3.056%;"></td>
    <td style="width:4.081%;"></td>
    <td style="width:92.863%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Definitions</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. For purposes of this Section 1, the following definitions shall apply:</font></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(i) &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Additional Shares of Common Stock</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean all shares of Common Stock issued (or, pursuant to Section 1(b) below, deemed to be issued) by the COMPANY after the Threshold Date, other than (1) the following shares of Common Stock and (2) shares of Common Stock deemed issued pursuant to the following Options and Convertible Securities (clauses (1) and (2), collectively, &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Exempted Securities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;):</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(A) shares of Common Stock issued pursuant to the terms of this Section l;</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(B) shares of Common Stock, Options or Convertible Securities issued by reason of a dividend, stock split, split-up or other distribution on all then outstanding shares of Common Stock; or</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(C) shares of Common Stock or Convertible Securities actually issued upon the exercise of Options or shares of Common Stock actually issued upon the conversion or exchange of Convertible Securities, in each case </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">provided</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> such issuance is pursuant to the terms of such Option or Convertible Security.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(ii) &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Convertible Securities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean any evidences of indebtedness, shares or other securities directly or indirectly convertible into or exchangeable for Common Stock, but excluding Options.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:3.045%;"></td>
    <td style="width:96.955%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:Times New Roman;position:relative;">1</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Draft Note</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">: The provisions of this Annex are intended to provide customary broad-based weighted-average anti-dilution protection and are based on the anti-dilution provisions contained in the model legal documents published by the National Venture Capital Association (NVCA). The principal component in this Annex that is not contained in the NVCA model is Section 1(d) of this Annex, which provides for the issuance of additional common stock to give effect to anti-dilution adjustments (unlike the NVCA form, which is premised solely on an adjustment of the conversion ratio of convertible preferred stock).</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">38</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(iii) &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Options</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean rights, options or warrants to subscribe for, purchase or otherwise acquire Common Stock or Convertible Securities.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(iv) &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Share Price</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean the Threshold Share Price, subject to adjustment following the Threshold Date as provided in this Section 1.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(v) &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Threshold Date</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean the date of the Funding Threshold.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(vi) &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Threshold Share Price</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean the fair market value per share of the Common Stock as of the Threshold Date, as determined in good faith by the Board of Directors of the COMPANY by the reasonable application of a reasonable valuation method in accordance with the provisions of Treasury Regulation &#167; 1.409A-l(b)(iv)(B), subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Common Stock occurring after the Threshold Date. On or as soon as reasonably practicable following the Threshold Date, the COMPANY shall give written notice to each Shareholder of the Threshold Share Price as determined in accordance with the foregoing, together with reasonable supporting details. Upon the reasonable request of a Shareholder, the COMPANY shall afford such Shareholder a reasonable opportunity to consult with management of the COMPANY in connection with the determination of the Threshold Share Price, whether prior to or after such determination has been made.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(vii) &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Threshold Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean, with respect to each Shareholder, the number of shares of Common Stock held by such Shareholder as of the Threshold Date, subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Common Stock occurring after the Threshold Date.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:3.044%;"></td>
    <td style="width:5.062%;"></td>
    <td style="width:91.894%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Deemed Issue of Additional Shares of Common Stock</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p></td>
   </tr>
  </table>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(i) If the COMPANY at any time or from time to time after the Threshold Date shall issue any Options or Convertible Securities (excluding Options or Convertible Securities which are themselves Exempted Securities) or shall fix a record date for the determination of holders of any class of securities entitled to receive any such Options or Convertible Securities, then the maximum number of shares of Common Stock (as set forth in the instrument relating thereto, assuming the satisfaction of any conditions to exercisability, convertibility or exchangeability but without regard to any provision contained therein for a subsequent adjustment of such number) issuable upon the exercise of such Options or, in the case of Convertible Securities and Options therefor, the conversion or exchange of such Convertible Securities, shall be deemed to be Additional Shares of Common Stock issued as of the time of such issue or, in case such a record date shall have been fixed, as of the close of business on such record date.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">39</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(ii) If the terms of any Option or Convertible Security, the issuance of which resulted in an adjustment to the Share Price pursuant to the terms of Section 1(c) below are revised as a result of an amendment to such terms or any other adjustment pursuant to the provisions of such Option or Convertible Security to provide for either (1) any increase or decrease in the number of shares of Common Stock issuable upon the exercise, conversion and/or exchange of any such Option or Convertible Security or (2) any increase or decrease in the consideration payable to the COMPANY upon such exercise, conversion or exchange, then, effective upon such increase or decrease becoming effective, the Share Price computed upon the original issue of such Option or Convertible Security (or upon the occurrence of a record date with respect thereto) shall be readjusted to such Share Price as would have obtained had such revised terms been in effect upon the original date of issuance of such Option or Convertible Security. Notwithstanding the foregoing, no readjustment pursuant to this clause (ii) shall have the effect of increasing the Share Price to an amount which exceeds the lower of (A) the Share Price in effect immediately prior to the original adjustment made as a result of the issuance of such Option or Convertible Security, or (B) the Share Price that would have resulted from any issuances of Additional Shares of Common Stock (other than deemed issuances of Additional Shares of Common Stock as a result of the issuance of such Option or Convertible Security) between the original adjustment date and such readjustment date.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(iii) If the terms of any Option or Convertible Security (excluding Options or Convertible Securities which are themselves Exempted Securities), the issuance of which did not result in an adjustment to the Share Price pursuant to the terms of Section 1(c) (either because the consideration per share (determined pursuant to Section 1(e)) of the Additional Shares of Common Stock subject thereto was equal to or greater than the Share Price then in effect, or because such Option or Convertible Security was issued on or before the Threshold Date), are revised after the Threshold Date as a result of an amendment to such terms or any other adjustment pursuant to the provisions of such Option or Convertible Security to provide for either (1) any increase in the number of shares of Common Stock issuable upon the exercise, conversion or exchange of any such Option or Convertible Security or (2) any decrease in the consideration payable to the COMPANY upon such exercise, conversion or exchange, then such Option or Convertible Security, as so amended or adjusted, and the Additional Shares of Common Stock subject thereto (determined in the manner provided in Section 1 (b)(i)) shall be deemed to have been issued effective upon such increase or decrease becoming effective.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(iv) Upon the expiration or termination of any unexercised Option or unconverted or unexchanged Convertible Security (or portion thereof) which resulted (either upon its original issuance or upon a revision of its terms) in an adjustment to the Share Price pursuant to the terms of Section 1(c), the Share Price shall be readjusted to such Share Price as would have been obtained had such Option or Convertible Security (or portion thereof) never been issued.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(v) If the number of shares of Common Stock issuable upon the exercise, conversion and/or exchange of any Option or Convertible Security, or the consideration payable to the COMP ANY upon such exercise, conversion and/or exchange, is calculable at the time such Option or Convertible Security is issued or amended but is subject to adjustment based</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">40</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">upon subsequent events, any adjustment to the Share Price provided for in this Section 1(b) shall be effected at the time of such issuance or amendment based on such number of shares or amount of consideration without regard to any provisions for subsequent adjustments (and any subsequent adjustments shall be treated as provided in clauses (ii) and (iii) of this Section 1 (b)). If the number of shares of Common Stock issuable upon the exercise, conversion and/or exchange of any Option or Convertible Security, or the consideration payable to the COMPANY upon such exercise, conversion and/or exchange, cannot be calculated at all at the time such Option or Convertible Security is issued or amended, any adjustment to the Share Price that would result under the terms of this Section 1(b) at the time of such issuance or amendment shall instead be effected at the time such number of shares and/or amount of consideration is first calculable (even if subject to subsequent adjustments), assuming for purposes of calculating such adjustment to the Share Price that such issuance or amendment took place at the time such calculation can first be made.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(c) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Adjustment of Share Price Upon Issuance of Additional Shares of Common Stock</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event the COMPANY shall at any time after the Threshold Date issue Additional Shares of Common Stock (including Additional Shares of Common Stock deemed to be issued pursuant to Section 1(b)), without consideration or for a consideration per share less than the Share Price in effect immediately prior to such issue, then the Share Price shall be reduced, concurrently with such issue of Additional Shares of Common Stock, to a price (calculated to the nearest one- hundredth of a cent) determined in accordance with the following formula;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">P</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:bottom;font-size:6.7pt;font-family:Times New Roman;">2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> = P</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:bottom;font-size:6.7pt;font-family:Times New Roman;">1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">*(A + B) &divide; (A + C).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For purposes of the foregoing formula, the following definitions shall apply:</font></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(i) &#x201c;P</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:bottom;font-size:6.7pt;font-family:Times New Roman;">2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean the Share Price in effect immediately after such issue of Additional Shares of Common Stock;</font></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(ii) &#x201c;P</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:bottom;font-size:6.7pt;font-family:Times New Roman;">1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean the Share Price in effect immediately prior to such issue of Additional Shares of Common Stock;</font></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(iii) &#x201c;A&#x201d; shall mean the number of shares of Common Stock outstanding immediately prior to such issue of Additional Shares of Common Stock (treating for this purpose as outstanding all shares of Common Stock issuable upon exercise of Options outstanding immediately prior to such issue or upon conversion or exchange of Convertible Securities outstanding (assuming exercise of any outstanding Options therefor) immediately prior to such issue);</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(iv) &#x201c;B&#x201d; shall mean the number of shares of Common Stock that would have been issued if such Additional Shares of Common Stock had been issued at a price per share equal to P</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:bottom;font-size:6.7pt;font-family:Times New Roman;">1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (determined by dividing the aggregate consideration received by the COMPANY in respect of such issue by P</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:bottom;font-size:6.7pt;font-family:Times New Roman;">1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">); and</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">41</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(v) &#x201c;C&#x201d; shall mean the number of such Additional Shares of Common Stock issued in such transaction.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(d) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Issuance of Anti-Dilution Shares Upon Adjustment of Share Price</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event of any adjustment of the Share Price pursuant to this Section 1, then the COMPANY shall issue to each Shareholder, concurrently with such adjustment of the Share Price, a number of shares of Common Stock, rounded up to the nearest whole number of shares (any such shares issued pursuant to this Section 1(d), &#x201c;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Anti-Dilution Shares</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;) determined in accordance with the following formula (it being understood, for avoidance of doubt, that no such issuance shall be required unless the following formula results in a positive number):</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">S</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:bottom;font-size:6.7pt;font-family:Times New Roman;">3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> = S</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:bottom;font-size:6.7pt;font-family:Times New Roman;">1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> * (TSP &divide; SP) &#x2013; S</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:bottom;font-size:6.7pt;font-family:Times New Roman;">1 </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">- S</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:bottom;font-size:6.7pt;font-family:Times New Roman;">2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For purposes of the foregoing formula, the following definitions shall apply:</font></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(i) &#x201c;S</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:bottom;font-size:6.7pt;font-family:Times New Roman;">3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean the number of new Anti-Dilution Shares to be issued to such Shareholder;</font></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(ii) &#x201c;S</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:bottom;font-size:6.7pt;font-family:Times New Roman;">1</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean the Threshold Shares of such Shareholder;</font></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(iii) &#x201c;S</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:bottom;font-size:6.7pt;font-family:Times New Roman;">2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d; shall mean the aggregate number of Anti-Dilution Shares, if any, issued to such Shareholder as determined immediately prior to such issue of new Anti-Dilution Shares (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Common Stock);</font></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(iv) &#x201c;TSP&#x201d; shall mean the Threshold Share Price; and</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(v) &#x201c;SP&#x201d; shall mean the Share Price then in effect (after giving effect to the adjustment thereto giving rise to this calculation under Section 1(d)).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(e) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Determination of Consideration</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. For purposes of this Section 1, the consideration received by the COMPANY for the issue of any Additional Shares of Common Stock shall be computed as follows:</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(i) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cash and Property</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Such consideration shall:</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(A) insofar as it consists of cash, be computed at the aggregate amount of cash received by the COMPANY, excluding amounts paid or payable for accrued interest;</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(B) insofar as it consists of property other than cash, be computed at the fair market value thereof at the time of such issue, as determined in good faith by the Board of Directors of the COMPANY; and</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">42</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(C) in the event Additional Shares of Common Stock are issued together with other shares or securities or other assets of the COMPANY for consideration which covers both, be the proportion of such consideration so received, computed as provided in (A) and (B) above, as determined in good faith by the Board of Directors of the COMPANY.</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(ii) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Options and Convertible Securities</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The consideration per share received by the COMPANY for Additional Shares of Common Stock deemed to have been issued pursuant to Section 1(b), relating to Options and Convertible Securities, shall be determined by dividing:</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(A) the total amount, if any, received or receivable by the COMPANY as consideration for the issue of such Options or Convertible Securities, plus the minimum aggregate amount of additional consideration (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such consideration) payable to the COMPANY upon the exercise of such Options or the conversion or exchange of such Convertible Securities, or in the case of Options for Convertible Securities, the exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities, </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">by</font></p>
  <p style="margin-left:9.08%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(B) the maximum number of shares of Common Stock (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such number) issuable upon the exercise of such Options or the conversion or exchange of such Convertible Securities, or in the case of Options for Convertible Securities, the exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(f) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Certificate as to Adjustments</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Upon the occurrence of each adjustment or readjustment of the Share Price pursuant to this Section 1, the COMPANY at its expense shall, as promptly as reasonably practicable, compute such adjustment or readjustment in accordance with the terms hereof and furnish to each Shareholder a certificate setting forth (i) such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based and (ii) the number of Anti-Dilution Shares issued or to be issued to such Shareholder as a result of such adjustment or readjustment. The COMPANY shall, as promptly as reasonably practicable after the written request at any time of any Shareholder, furnish or cause to be furnished to such holder a certificate setting forth the Share Price and the Threshold Share Price then in effect.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">43</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">EXHIBIT A</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">CONFLICT AVOIDANCE STATEMENT</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">44</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">EXHIBIT B</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">INVENTOR/AUTHOR ACKNOWLEDGMENT</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">OF NO FINANCIAL INTEREST IN MIT&#x2019;S EQUITY</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Form Version 7/14/2010</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">45</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">EXHIBIT C</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">CONFLICT AVOIDANCE STATEMENT</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">46</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">EXHIBIT D</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">INVENTOR/AUTHOR ACKNOWLEDGMENT</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">OF NO FINANCIAL INTEREST IN MIT&#x2019;S EQUITY</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Form Version 7/14/2010</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">47</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Massachusetts Institute of Technology</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">and</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Frequency Therapeutics Inc.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">FIRST AMENDMENT</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This FIRST AMENDMENT, effective as of May 10, 2019, is made by and between the Massachusetts Institute of Technology, a nonprofit research institution having a principal address at 77 Massachusetts Avenue, Cambridge, MA 02139 (&#x201c;MIT&#x201d;) and Frequency Therapeutics Inc., a Delaware corporation, with a principal place of business at 300 Technology Square, 8th Floor, Cambridge, MA 02139 (&#x201c;COMPANY&#x201d;) (each individually a &#x201c;Party&#x201d; and collectively the &#x201c;Parties&#x201d;) and amends that certain Exclusive Patent License between the Parties with an Effective Date of December 13, 2016, (the &#x201c;LICENSE AGREEMENT&#x201d;) (MIT No. 4914538). Capitalized terms used herein without definition shall have the meaning given such terms in the LICENSE AGREEMENT.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">WHEREAS, pursuant to Section 3.1(f) of the LICENSE AGREEMENT, COMPANY is obligated to provide a development plan with mutually acceptable diligence milestones for a second LICENSED PRODUCT;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">WHEREAS, COMPANY has provided the diligence milestones for a second LICENSED PRODUCT to MIT;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">NOW, THEREFORE, the Parties agree to amend the LICENSE AGREEMENT as follows:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1. Section 3.1(f) of the LICENSE AGREEMENT is hereby deleted in its entirety and replaced with the following:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;3.1 (f) </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Second LICENSED PRODUCT</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:12.115%;"></td>
    <td style="width:5.064%;"></td>
    <td style="width:82.821%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(1)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On or before [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], COMPANY shall advance a DEVELOPMENT CANDIDATE for a second LICENSED PRODUCT to ADME and toxicology studies in support of an IND (or equivalent) for human studies.</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:12.115%;"></td>
    <td style="width:5.064%;"></td>
    <td style="width:82.821%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(2)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On or before [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], COMPANY shall file an IND for a second LICENSED PRODUCT.</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:13.141%;"></td>
    <td style="width:4.038%;"></td>
    <td style="width:82.821%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(3)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On or before [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], COMPANY shall commence dosing of individuals in a PHASE 2 CLINICAL TRIAL for a second LICENSED PRODUCT.</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">48</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:13.141%;"></td>
    <td style="width:4.038%;"></td>
    <td style="width:82.821%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(4)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On or before [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], COMPANY shall commence dosing of individuals in a PHASE 3 CLINICAL TRIAL for a second LICENSED PRODUCT.</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:12.115%;"></td>
    <td style="width:5.064%;"></td>
    <td style="width:82.821%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(5)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On or before [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], COMPANY shall file a New Drug Application (or equivalent) with the FDA or comparable European regulatory agency for a second LICENSED PRODUCT.</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:12.115%;"></td>
    <td style="width:5.064%;"></td>
    <td style="width:82.821%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(6)</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On or before [</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">***</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">], COMPANY shall make a FIRST COMMERCIAL SALE of a second LICENSED PRODUCT.</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2. Except as specifically amended herein, the terms and conditions of the LICENSE AGREEMENT shall remain in full force and effect.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">IN WITNESS WHEREOF, the parties have caused this FIRST AMENDMENT to be executed by their duly authorized representatives as of </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">May 10,2019</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6.016%;"></td>
    <td style="width:0.653%;"></td>
    <td style="width:41.548%;"></td>
    <td style="width:0.161%;"></td>
    <td style="width:3.736%;"></td>
    <td style="width:0.161%;"></td>
    <td style="width:6.016%;"></td>
    <td style="width:0.161%;"></td>
    <td style="width:41.548%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">MASSACHUSETTS INSTITUTE OF TECHNOLOGY</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">COMPANY</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Lauren C. Foster</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Chris Loose</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Name:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Lauren C. Foster</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Name:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Chris Loose</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Associate Director, MIT TLO</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title:</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Chief Scientific Officer</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">49</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Massachusetts Institute of Technology</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">and</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Frequency Therapeutics Inc.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">SECOND AMENDMENT</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">	This SECOND AMENDMENT, effective as of February 15, 2022, is made by and between the Massachusetts Institute of Technology, a nonprofit research institution having a principal address at 77 Massachusetts Avenue, Cambridge, MA 02139 (&#x201c;M.I.T.&#x201d;) and Frequency Therapeutics Inc, a Delaware corporation  having a principal address at 300 Technology Square, 8th Floor, Cambridge, MA 02139 (&#x201c;COMPANY&#x201d;) (each individually a &#x201c;Party&#x201d; and collectively the &#x201c;Parties&#x201d;) and amends that certain., Exclusive Patent License Agreement between the Parties dated as of December 13, 2016, as amended by the FIRST AMENDMENT, dated as of May 10, 2019 (the &#x201c;LICENSE AGREEMENT&#x201d;) (M.I.T. No. 4914538). Capitalized terms used herein without definition shall have the meaning given such terms in the LICENSE AGREEMENT.</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">	</font>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">WHEREAS, COMPANY notified M.I.T., in a letter dated [***] of its desire to discontinue support of all patents and patent applications associated with M.I.T. Case No. [***]);</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">	</font>&#160;</p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">WHEREAS, the M.I.T. [***] Patents will be removed from the LICENSE AGREEMENT;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">NOW, THEREFORE, the Parties agree to amend the LICENSE AGREEMENT as follows:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The M.I.T. [***] Patents shall be removed from the definition of PATENT RIGHTS and Appendix A of the LICENSE AGREEMENT and the rights granted to COMPANY and its AFFILIATES shall be terminated effective April 18, 2022.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon removal of the M.I.T. [***] Patents from the PATENT RIGHTS as set forth in Section 1 above, COMPANY acknowledges and agrees that it and its AFFILIATES do not have any rights to practice under any intellectual property, including both United States and international patents and patent applications, associated with M.I.T. Case No. [***].</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Appendix A of the LICENSE AGREEMENT is hereby deleted in its entirety and replaced with an updated Appendix A attached hereto and set forth below the signatures of the Parties.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Except as specifically amended herein, the terms and conditions of the LICENSE AGREEMENT shall remain in full force and effect.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">IN WITNESS WHEREOF, the parties have caused this SECOND AMENDMENT to be executed by their duly authorized representatives</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">MASSACHUSETTS INSTITUTE OF		FREQUENCY THERAPEUTICS INC.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">TECHNOLOGY						</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">	/s/ Lesley Millar-Nicholson		</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">	By:</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">	/s/ Peter Pfreundschuh			</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Name:	Lesley Millar-Nicholson			Name: 	Peter Pfreundschuh</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Title: Director, TLO					Title: Chief Financial Officer</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">	 </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">50</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Appendix A</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(34,29,34,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">I.	United States Patents and Applications</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***]</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">51</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>freq-ex21_1.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html>
 <head>
  <title>EX-21.1</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Calibri;">		Exhibit 21.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:24.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Subsidiaries of Frequency Therapeutics, Inc.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:76.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:49.002%;"></td>
    <td style="width:5.004%;"></td>
    <td style="width:45.994%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:1.000pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Legal Name of Subsidiary</font></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:1.000pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">  </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:1.000pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:1.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Jurisdiction of Organization</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Frequency Therapeutics Pty Ltd</font></p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </font>&#160;</p></td>
    <td style="background-color:rgba(204,238,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Australia</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Frequency Therapeutics Securities Corporation</font></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </font>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Massachusetts</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.2410416666666666;font-family:Times New Roman;margin-bottom:8.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>freq-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html>
 <head>
  <title>EX-23.1</title>
 </head>
 <body>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">Exhibit 23.1</font></p>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Arial;">&#160;</font></p>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Arial;">&#160;</font></p>
  <p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">Consent of Independent Registered Public Accounting Firm</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Arial;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Arial;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">We consent to the incorporation by reference in the Registration Statement (No. 333-248474) on Form S-1, the Registration Statement (No. 333-234128) on Form S-8, and the Registration Statement on Form S-3 (No. 333-250099) of Frequency Therapeutics, Inc. of our report dated March 15, 2022, relating to the consolidated financial statements of Frequency Therapeutics, Inc. and Subsidiaries, appearing in this Annual Report on Form 10-K of Frequency Therapeutics, Inc. for the year ended December 31, 2021.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Arial;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">/s/ RSM US LLP</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Arial;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Boston, Massachusetts</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">March 15, 2022</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>freq-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31.1</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">Exhibit 31.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">CERTIFICATIONS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">I, David L. Lucchino, certify that:</font></p>
  <div style="display:flex;margin-top:12.0pt;line-height:1.0829166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.537%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">I have reviewed this Annual Report on Form 10-K of Frequency Therapeutics, Inc.;</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.0829166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.537%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.0829166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.537%;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.0829166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.537%;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting</font><font style="background-color:rgba(255,255,255,1);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:Arial;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">(as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:12.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:12.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:12.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.7521786492374725%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:12.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.7521786492374725%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.0829166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.537%;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:12.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:12.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:5.0pt;font-family:Arial;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:44.904%;"></td>
    <td style="width:8.002%;"></td>
    <td style="width:5.256%;"></td>
    <td style="width:41.838%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Date: March 15, 2022</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">/s/ David L. Lucchino</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">David L. Lucchino</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">President and Chief Executive Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">(Principal Executive Officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>freq-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31.2</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">Exhibit 31.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">CERTIFICATIONS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">I, Peter Pfreundschuh, certify that:</font></p>
  <div style="display:flex;margin-top:12.0pt;line-height:1.0829166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.537%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">I have reviewed this Annual Report on Form 10-K of Frequency Therapeutics, Inc.;</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.0829166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.537%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.0829166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.537%;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.0829166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.537%;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting</font><font style="background-color:rgba(255,255,255,1);color:rgba(51,51,51,1);white-space:pre-wrap;font-weight:normal;font-size:9.5pt;font-family:Arial;"> </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">(as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:12.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:12.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:12.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.7521786492374725%;">(c)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:12.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.7521786492374725%;">(d)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></div></div>
  <div style="display:flex;margin-top:12.0pt;line-height:1.0829166666666667;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.537%;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:12.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.7521786492374725%;">(a)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:12.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.7521786492374725%;">(b)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:5.0pt;font-family:Arial;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:44.904%;"></td>
    <td style="width:8.002%;"></td>
    <td style="width:5.256%;"></td>
    <td style="width:41.838%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Date: March 15, 2022</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">/s/ Peter Pfreundschuh</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">Peter Pfreundschuh</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">Chief Financial Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">(Principal Financial Officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>freq-ex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html>
 <head>
  <title>EX-32.1</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">Exhibit 32.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">In connection with the Annual Report of Frequency Therapeutics, Inc. (the &#x201c;Company&#x201d;) on Form 10-K for the period ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), I, David L. Lucchino, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:</font></p>
  <div style="margin-left:4.528%;display:flex;margin-top:12.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.7521786492374725%;">(1)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</font></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:12.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.7521786492374725%;">(2)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Arial;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:44.971%;"></td>
    <td style="width:8.996%;"></td>
    <td style="width:4.096%;"></td>
    <td style="width:41.936%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Date: March 15, 2022</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">/s/ David L. Lucchino</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">David L. Lucchino</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">President and Chief Executive Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;font-style:italic;">(principal executive officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Arial;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>freq-ex32_2.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html>
 <head>
  <title>EX-32.2</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">Exhibit 32.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">In connection with the Annual Report of Frequency Therapeutics, Inc. (the &#x201c;Company&#x201d;) on Form 10-K for the period ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), I, Peter Pfreundschuh, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to &#167; 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:</font></p>
  <div style="margin-left:4.528%;display:flex;margin-top:12.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.7521786492374725%;">(1)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and</font></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:12.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;display:inline-flex;font-size:10.0pt;font-family:Arial;justify-content:flex-start;min-width:4.7521786492374725%;">(2)</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div></div>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Arial;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:44.971%;"></td>
    <td style="width:8.996%;"></td>
    <td style="width:4.096%;"></td>
    <td style="width:41.936%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Date: March 15, 2022</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">/s/ Peter Pfreundschuh</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">Peter Pfreundschuh</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">Chief Financial Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;font-style:italic;">(principal financial officer and principal accounting officer)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Arial;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>img88009329_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0.!(4# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]_P/7_\ A;VE?] V]_-/\:/^%O:5_P! V]_-/\:\@HH^I4>P?VKB>_X'K_\
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M[_@>O_\ "WM*_P"@;>_FG^-'_"WM*_Z!M[^:?XUY!11]2H]@_M7$]_P/7_\
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ME:0^V3FJU%$::B[H)UY3CROO?] HHHJS$**** "BBB@ HHHH **** "BBB@
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M^3_C7K5%'URMW#^R\+_+^+/)?^%/WO\ T%[?_OR?\:/^%/WO_07M_P#OR?\
M&O6J*/KE;N']EX7^7\6>2_\ "G[W_H+V_P#WY/\ C1_PI^]_Z"]O_P!^3_C7
MK5%'URMW#^R\+_+^+/)?^%/WO_07M_\ OR?\:/\ A3][_P!!>W_[\G_&O6J*
M/KE;N']EX7^7\6>2_P#"G[W_ *"]O_WY/^-'_"G[W_H+V_\ WY/^->M44?7*
MW</[+PO\OXL\E_X4_>_]!>W_ ._)_P :/^%/WO\ T%[?_OR?\:]:HH^N5NX?
MV7A?Y?Q9Y+_PI^]_Z"]O_P!^3_C1_P *?O?^@O;_ /?D_P"->M44?7*W</[+
MPO\ +^+/)?\ A3][_P!!>W_[\G_&C_A3][_T%[?_ +\G_&O6J*/KE;N']EX7
M^7\6>2_\*?O?^@O;_P#?D_XT?\*?O?\ H+V__?D_XUZU11]<K=P_LO"_R_BS
MR7_A3][_ -!>W_[\G_&C_A3][_T%[?\ [\G_ !KUJBCZY6[A_9>%_E_%GDO_
M  I^]_Z"]O\ ]^3_ (T?\*?O?^@O;_\ ?D_XUZU11]<K=P_LO"_R_BSR7_A3
M][_T%[?_ +\G_&C_ (4_>_\ 07M_^_)_QKUJBCZY6[A_9>%_E_%GDO\ PI^]
M_P"@O;_]^3_C1_PI^]_Z"]O_ -^3_C7K5%'URMW#^R\+_+^+/)?^%/WO_07M
M_P#OR?\ &C_A3][_ -!>W_[\G_&O6J*/KE;N']EX7^7\6>2_\*?O?^@O;_\
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MU"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/B%97D=G<3:9J-G97DODP7<Z)Y;/D@ [6)&2".153PGK&DF!+./Q9)J=U-;
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MK:^UZ_TB*.4364<<CNP&U@XR,<Y_,5@Z/XTTBWT2RLW2XCU**%(6TU(&,X8
M*0%QT]^F.]9MOKVEZ)\3?$<FJ7L5FLUO;>7YQQNPIS^5.RO85W8ZV\\1VMEK
M\.CR13-/+:R70=0-H5.HZYS^%4]&\;:5KGAJ[URT$WE6BNTT+ "1=HSC&<<C
MIS7/:E>VVI?$/3+RRF6>VET2Z*2)R&^;%<U;Z==Z5\-;3Q#I<)<3Z;):ZE;K
MQYD9W!9/]Y"?RJ7HK_UN_P#(NRNOZ['I=EXMLKZ[T:WC@N%;5;1KN$L%PB@
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MH'Z5R%UXBTGQ+XJ:SU74K>ST[3;T+#9L<27<ZGAF]$!Z#N>M'VD@Z'IE%%%
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M4444 %%%% !1110 4444 1P@A6R,?.Q_6I*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MPJW4M-;FB::N@HHHI#.,\0_$6T\/:S+ILMA/,\:J2Z,H!R,]ZR_^%OZ?_P!
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MX6_I_P#T"KK_ +[6C_A;^G_] JZ_[[6O(Z*/J5'L']J8GO\ @CUS_A;^G_\
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M*BU?_H(V/_C_ /A1]:H_S!_9^)_D//:*]"_X5%J__01L?_'_ /"C_A46K_\
M01L?_'_\*/K5'^8/[/Q/\AY[17H7_"HM7_Z"-C_X_P#X4?\ "HM7_P"@C8_^
M/_X4?6J/\P?V?B?Y#SVBO0O^%1:O_P!!&Q_\?_PH_P"%1:O_ -!&Q_\ '_\
M"CZU1_F#^S\3_(>>T5Z%_P *BU?_ *"-C_X__A1_PJ+5_P#H(V/_ (__ (4?
M6J/\P?V?B?Y#SVBO0O\ A46K_P#01L?_ !__  H_X5%J_P#T$;'_ ,?_ ,*/
MK5'^8/[/Q/\ (>?#J*NZS_R'=0_Z^9?_ $(UVH^$6KY_Y"-C_P"/_P"%3W_P
MJU6[U&ZN4O[,+-,\@!W9 ))]*7UFE?XBU@,3RM<AYK17H7_"HM7_ .@C8_\
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M (4?\*BU?_H(V/\ X_\ X4?6J/\ ,']GXG^0\]HKT+_A46K_ /01L?\ Q_\
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M_P */^%1:O\ ]!&Q_P#'_P#"G]:H_P Q']GXG^0\]HKT+_A46K_]!&Q_\?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJVEM<>>8YH&:5?FW;00P&/?&:2Z7&^MCM?$_]LC3T;2-0L=/"L3<75VF[RT
MZJ.F?K6;\/M=U/7M%N)]2:.;RKEX8+N./RUN4'\87\Z/'GA;4?%.G6=G87T%
MM%%-YLT<Z%DEQ]T$#J,]JTO#-CK6GV+P:S=V5P58" 6<'E(B8Z8H74'T-NBB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BH;F[MK*$S
M75Q%!$.KRN%4?B:=#/#<PK-!*DL3#*O&P93]"* )*",]:** "BHH[JWFFEAB
MGB>6$@2HK@LF>F1V_&I: "BBJ]Q?6=H\:7-U!"\IVQK)(%+GT&>M %BBBB@
MHJ&XN[:U,8N+B*'S6"1^8X7>QZ 9ZGVJ:@ HHJ%[NVBN8K:2XB2>4$QQ,X#/
MCK@=30!-1145Q<P6D#3W,T<,*_>DD8*H^I- $M%(K!E#*001D$=Z6@ HHHH
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M "2< =2: %HJ&VNK>]@$]K/%/"V<21.&4_B*FH **** "BBB@ HHHH ****
M"BDR"2,C([4;EW;<C/IF@!:*** "BDW DC(R.U)YB;MN]<^F: '4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMBUC$,7ES.N$'\)P>1SWK7FT>QFT1M'\HQV)B\GRXF*83&, CD4/9@MT>?\
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MD\FM"D 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !17F'Q!T?4KGQ+!?W6F7NKZ!';;3:V=P8WBDR<OM!RW%8>JZK+<V_@E_#<4
MMY:1W9$!OK@^:TXSF*0]@!WH6H,]KHKE;?Q1>-XN?0KFRBC:/2UO9&60G$A.
M"GT]ZQ+;XD7U]H^D?8M'2?6-4>98;?SML:K&<%F8B@#T6BO'="\2ZEX?7Q-J
ML^GHP&M*M_%YI;[.C#!*D=<&N_T;Q+)K7B?5;&V@C;3K!47[4&)+RL,E0.F
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MDT:W2[V2M%;O=<-(5^=6(Z #!![YH:L[ M4>KT5PE_XXUC^T=1@T?0$O8-)
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MO_\ P)?_ !H_L^7\P?VU#^1GTG17S9_;NL?]!:__ / E_P#&C^W=8_Z"U_\
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M HHHH **** "BBB@ HHHH ZWX;_\CE!_UQD_]!KV:O&?AO\ \CE!_P!<9/\
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M_@:&<?9M,6RUA8)Q91CR)G)!$P/^SR??-"U_KS!GO%%>8^)M<O["RT;2]/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK6KC5WU'_0[B .(H;<$;65@0 ..:S=3O;U+3Q?I/]DZ@=2U;4Q'YHMV,:PY
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MI,-Q;:19P7<WG7$<*+)(<_,P R>:N4,2V"BBB@84444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** *6IZQINC6XN-3OH+2(G
M:9PH)]LU"?$.CC3XM0_M.U^QRR"-)A("K.>BY]?:N2\>:(VI^(-)N[*_TO\
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MN[<RVK6,H>.*$'&W Z$X!R:U/B#XF\1Z+K$4>G3+;:<D EEFCMUN'#9/WU+
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M:TM6+0Q\_(3R><YY[\\T]?!?AQ-(FTH:3!]@FD\UX>2-_J.>/PQ6]10!R_\
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M >@KT'2-%T_0;+['IEL+>WWE]@8GYCU/)-7Z* "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **Y7Q=XU3PI/:QM
M8-<_:%9LB79MP1['UKF_^%Q1?] 1_P#P)'_Q-;PPU6:YHK0Y*F.P].3A.5FO
M4].HKS'_ (7%%_T!'_\  D?_ !-'_"XHO^@(_P#X$C_XFJ^J5OY?R(_M+"_S
M_@_\CTZBO,?^%Q1?] 1__ D?_$T?\+BB_P"@(_\ X$C_ .)H^J5OY?R#^TL+
M_/\ @_\ (].HKS'_ (7%%_T!'_\  D?_ !-'_"XHO^@(_P#X$C_XFCZI6_E_
M(/[2PO\ /^#_ ,CTZBO,?^%Q1?\ 0$?_ ,"1_P#$T?\ "XHO^@(__@2/_B:/
MJE;^7\@_M+"_S_@_\CTZBO,?^%Q1?] 1_P#P)'_Q-'_"XHO^@(__ ($C_P")
MH^J5OY?R#^TL+_/^#_R/3J*\Q_X7%%_T!'_\"1_\31_PN*+_ * C_P#@2/\
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M^0?VEA?Y_P '_D>G45YC_P +BB_Z C_^!(_^)IT?Q?BDE1/[%<;F"Y^TCO\
M\!H^J5OY?R#^TL+_ #_@_P#(],HKS6Y^+D5O=30?V,[>6[)G[0.<'']VH_\
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M?*!W)Y/-:<C#2M))6.YNA;1<*OSRR8'ZDURW@*YN5?4K6YTO4+4S74MVLEQ
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M1J\FD75]"-,2V,<,>Z2"08YVGIGI^=)8:'=:MX?\2PWEG)93SWC7$"R#&U@
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M[?B>0_\ "H=2_P"@G:?]\-1_PJ'4O^@G:?\ ?#5Z]11]=K=P_LO#=OQ/(?\
MA4.I?]!.T_[X:C_A4.I?]!.T_P"^&KUZBCZ[6[A_9>&[?B>0_P#"H=2_Z"=I
M_P!\-1_PJ'4O^@G:?]\-7KU%'UVMW#^R\-V_$\A_X5#J7_03M/\ OAJ/^%0Z
ME_T$[3_OAJ]>HH^NUNX?V7ANWXGD/_"H=2_Z"=I_WPU'_"H=2_Z"=I_WPU>O
M44?7:W</[+PW;\3R'_A4.I?]!.T_[X:C_A4.I?\ 03M/^^&KUZBCZ[6[A_9>
M&[?B>:^'/AK?Z+K]KJ,M_;2)"6)15;)RI']:]!^S-_>%6:*QJ595'>1UT,/3
MH1Y::T*WV9O[PH^S-_>%6:*S-BM]F;^\*/LS?WA5FB@"M]F;^\*/LS?WA5FB
M@"M]F;^\*/LS?WA5FB@"M]F;^\*/LS?WA5FB@"M]F;^\*/LS?WA5FB@"M]F;
M^\*/LS?WA5FB@"M]F;^\*/LS?WA5FB@"M]F;^\*46S8(W#FK%% %;[,W]X4?
M9F_O"K-% %;[,W]X4?9F_O"K-% %;[,W]X4?9F_O"K-% %;[,W]X4?9F_O"K
M-% %;[,W]X4?9F_O"K-% %;[,W]X4?9F_O"K-% %;[,W]X4?9F_O"K-% %;[
M,W]X4?9F_O"K-% %;[,W]X4?9F_O"K-% #(D,:X)SSFL+QCX?F\2Z&+"">.%
MQ,LFZ0$C SZ?6N@HJHR<6I(BI"-2+A+9GD/_  J'4O\ H)VG_?#4?\*AU+_H
M)VG_ 'PU>O45T?7:W<X?[+PW;\3S_P (?#^]\.:\NH3WMO,@B9-J*0><>M>@
M445C4J2J/FD==&A"C'DAL%%%%9FP4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%<+\2M8U?2;33OL,UQ:6,TY6]O;>'S7A3'
M&![^OM7.:MXJO-/^&]U<Z?XEN-8E>Y6.&]AMPC6PR"1+Z9Y&2.XH6H6/7:*Y
M=_&D%MX<M-5GTG6,SL8UMA:$S9&>2N< '&02:8OQ#T$^'?[9+W"Q^?\ 9OLY
MB/G>;_<V>M#T ZNBN2L?B'H]W:ZE/<0WVG_V:BO<QWL&QU#?=P,G)/I[T[3O
M'^F:@MXIM-1M9[:V:Z^SW5OY;RQ ?>0$\B@#JZ*Y?4O$!U#X;WNNZ;Y]LSV4
MDL)D4+(A ."1R,Y%>?>%O%6JOK.A16WB:?6GOD;^T+22(?Z( N<[@.,'^5'6
MP=+GM-%>7>#?B3"FEV=KK9U&6>:Z> WS09A#%SM0OZXQT%=+J7Q!TO2=8:PO
M+/4XT601/=FU/D*QZ?-GIR.0* .LHKE=4\?Z5I>N-I'V74;NX0*9C:6YD6+=
MTW<Y_(&DUCX@:3HVHRV3V^H7+VZAKJ2UMS(EL",@R'MQ0!U=%9U[=7=QH;76
MA?9KBXEC#VQF8B-LXP21SC!S6'\/=9U36M$NY=8FCENH+V6 M&@5<+@8'MUH
MZV#I<ZVBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 C,J*68@*!DDG@4R&XAN4WP31RIG&Y&##]*Y;XAZ+J&O^'D
MLM-DC,RSK*UL\FP7*+U3/XBN#_M.STSP9XBN_#NE'1-5MWCM+ZW>9R(\DKF+
M!QNR>#[4K[CML>TT5P.FZQXBTBX\+^']1%E->7?F&=P7=A"B@@Y8Y+DYR>E5
MS\1-0>.Z%K96]Q//JS:=I:9*JX4#+NV3Q],4^MA(]#,T0F$)E02D;@FX;B/7
M%/KQYM6\16^O^)M>N(-.DU31-/B@VP[VA.YM[8R0<[?Y5V^D^);S7?$OV:QC
M@.EV]I')=3E26,SC<J*<XX!!/!H0/0ZJHYIXK>,R32I&@_B=@!^9K@-7\<:Z
M#K%[HVGV#Z5HTACN9+N5A),R_>" <#&>_6L;Q)_:?C7QIHFG);V,FF_8TU#[
M-<LX&QP WF;?XAD[0/QH6M@>AZV"& (((/((I:XC5]<U72O$=EX9\-V%@R)I
M[3L+AF58E'RKR.W'3'/J.M8NG_$/Q+<V^@:A/I6GI8:E=BS8+(QE=\D%U'0+
MP>N3Q0M=@VW/2WO+6,R![F%3$ 9 7 V ],^E2;U";]PV8SNSQCUKQS7KM-:L
M=;6&RMH9-2UZ'2UFB#;YT0@DL22#T[ 5H>(_&6LW.@:[-I-G81Z%9;[%IIY&
M\V5ON'RP.."1UZTKZ7_K^M4.VMOZ_K1GJ4<L<T:R1.KHW(93D'\:?7FOBS^U
M/#GPNTG3M(D2":006C,K,L@+ ?<*]#N_3-7GU[Q1:R:?X;MK;3;CQ ;4SW$T
MDC_9XXPVU3_>9C_.J>[1*>B9WE%<GH'B^74_!]_J]Y;QP7%@TT<RHV8V:,<E
M3Z&N;L_'7C&9M!5](TMFUF%V@1974@@9#MUVK@@XY/TZ4NMAGJ%%>;V?Q"U=
M]*,,VFVLFMOJ;:; L4A6!W R6).2 /UIQ^(>I:1!K-KKFGVLFIZ>85C%D[>5
M,TOW1EN1[T >AO-%&Z(\J*\APBLP!8^WK3Z\DO-8U>+QM:WGB>WL5.B:=/?^
M78LS8W@*JMN_B^G%:/AGXD7VJZ[;6E]%IIM[R%Y4%F[M);[1NQ+N&.1Z4 >E
M45YQIGC?Q#<>&YO$5]!I%KIBK+Y)D=U:9]V(QCG Z^I)Z 5GZ9\2=9U72/$.
M(]-^T6%I]HCN(EE2,#."K!P&W8R1V)H'8]7ILDB11M)(ZHBC+,QP /K7E%CX
MLU_PGX*TH:JUI<7NI./L4EQ+(=J$;B\S')XR.%J/5_&5WX@^'.M6MPEK]M^T
MQ6 EM"QAF\PCE=W/3/6AKHA+I<]<1UD0.C!E89# Y!%+7G<GC"\\/_VWHQM;
M=Y]-6V@TN)%8&?S%P@;GGD<XQT-;7B;7M9\.^#XK];.&ZU'*+,$1_*B)^\^!
MEBHH=MP78ZJBO,[GXDWUIX=TR9QI,FH:C,\<4R2O]F5$QEVXW#DXV]:6R^(N
MIW%E83R06.W^UET^\FB#F-E895XR2"/QS0*YZ717FNH_$B_L[2:^2VM/LMU>
MFTTMI=RAPOWY9&R?EST %0I\2]3_ .$7U*X^SV$^IVMW%;1/;[V@G,AXVYPW
M3- SU"BO-];\=:_H4]MIM[#HUOJ=WNF5I))#!!".!O(&6<D-TXK>\.^,!JW@
MR;7+U8+9K<R)*2Y$1*?Q GG:>*.EP\CJJ*\N\-_%*[O]7NH-2BL6M(K22Z,E
MFLH,009PV\#=GU%6+;QOXGDU'09KC3=-ATW69<01>8[7"QXSO8_=Z<T >DT5
MY3;?%>[N]6@DAM]/.F378ME@WN;O:6P),8VX[XZUVD7B^";Q"VCC2-85ED9#
M=/:8M_E!R=Y/3CK0!T5%>:6OQ UXZ!>>);JPL!HMO)*L>QG\V?#;8P!R ,]2
M?P%)HOQ'OKN:_@U%=-=4T^2]CEL'=A'M'W'W?Q>XXI7T';4])BFBG0O#*DB@
MD91@1D=N*?7C%GXMN?!?@G0[2SDTT7=S UY<"Z$K,-[%A\L8XR#U)'2KVL>)
M/$WB+_A#QH_V>TEU &Z,1ED7+1YR'*_\LB.W4U5M;"/6:*\LUSXGZCI^IWMK
M:Q:7C3=J7*W#N'N),?,(@.F#G[U:]_XUU:\U%[/P]8V9^RV<=Y>S7[LJQJZ[
M@@"\YQWI=+@=Q'/#*',<J.$)5BK [2.H/I2Q31SQB2&1)(VZ,C @_B*\RT"Z
M;2O@QJ>LR86>]6YNB1_>D8@?TJ'PMXCU?PM'INAZM86<>GII+7B&W9C*BJ,D
MOGC)/8>O6C;</0]6HKS#P_\ $Z]U+6[&*\BTU;*_W[4MY',UM@%@921MQ@=N
ME)H_Q.OM1\96NE^7IT]G=3-&AMO-WH "0Y9@%8<=J+:V"_4]0)P,GI3(9HKB
M,20RI(AX#(P(_,5YU#XSU^_TS6M6-EIJZ)8R7*>8Y?S)E0$*  <?>QDY'7@5
M5L-?URP32="\.Z5I$+'2?[0N4DWK'"6)/'S$_@<]>HHN!ZE17G-E\0-7U;2-
M#AT[3;5];U1)7VRN5@B1&(+GO@XX%;/@_P 3:CK&EZK<:M%9HVGW$D!DM2VQ
M]@RQ&[G%'<#JHYHIM_E2H^QMK;6!VGT/O3Z\C\):YJ=GHEA8Z-:6\^L:Y-<Z
M@7NF*Q1Q[\;FQR3QT%:4_P 0]:B\*7-V-+MSJ-I?FRN73>]O'@<R?+\Q7M1_
M7]?,#TJBO.M2\=:W9>#-.U:*UTZ>6ZF*27,)DDMHD'1V &X9Z8[5M2^*+JU^
M',WB.=;)[E+=I5%NY>%SG"X/!P>./PH>E_(%K;S.KHKSW3O&GB"UUZPL?$EI
MIEO#>V3W2O;R-F$*N29-W0?R]35'PY\2]2UGQ7%I30Z;+#<K(8S;^:#'M4D%
MF< ,#CJM 'IY( ))  ZDTV*:*>,20R)(AZ,C @_B*\F\.Z[XCC\-^)_$6K26
MEQIS"<I&TDC?O%^4*@)P(B<].:63QQ/X>M+#0M)L]'L98+&.YG%R9%B5G&[R
MXP,G//4F@#UNBO.F\=:YJL^@VV@:?9?:=1L7NYTO"P6( X'([9![<\=*Q=8\
M6^)/$'@?2'LQ;V=YJ&HFR=H9'4LP;Y2A!R%.#GFC^OQL']?J>OT5YUXF\8^(
M_#(TJTFMM,2::'=<WDWF_9@X.-@(R0<=VKOK29YK6%YO+69HU9UC?<H)'8]Q
M[T 3T5YAXQ^)UWH&NS6EA_9D\-N5$B/YK2LW=<J-JD>YK0UCQKK<EUJ<6@V5
MBL.DP+->W%^[  E=VQ0O4X[TKZ7#K8[^BO+K[XFZBEOI5O#!IMKJ%U9+>3O>
MNXAC#$[5&WDD@9]JEU+XD:JGA;1=5L].MX3>EUN)[D2-! 5..=@SACG!I@>F
M45RFL^)+O3OAS-KK+;_;/LP91 _F1[V("D'N.0:XCPVSZ#K4]SKMA?IK,>F2
MWZW#Z@95N% YW(.%YZ#M1LW<.A[%17BWA?[5<^)M#U'Q)97S76JLTUI>KJ!V
M\#<$\I>%3&.M>@:MXYM](U.6Q;0]>NFBQF6UL3)&V1GAL\T =317*ZOXJ@'@
M:XU<K>Z:TR-% MQ!MF$ARJ_)GKGI7%^"-/O--\:);3I>6&H1:<9[J"XO#,+Y
MFX#9Z+@_CS1UL'0]>HKR#P?I9LO'<-OXDTF>+7)5EO8KI;XR(_S'.4!P.O'T
MKU^CI<.M@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@#"\0^$M+\2M!)>BXCG@R(I[>9HW0'J 151/A]X?3
MP]<Z*+>7[/<N))I3*3*[CHQ;UKJ** .1N?ASH5W:V$,KWY:QW".87;^80QRP
M9NN#^%*WPX\/GP_!HP2Y6"WG:>&59B)4<]2&%=;10!P=YX9E\,:/>6'A?2)-
M0?5F9;A[J[&(<KMW'=RPY/'6NA\)^'(/"WAVVTR$[W0;II.\DAZG^@]@*VZ*
M .4O?ASX=O\ 5Y=1G@GS,XDFMUG9897_ +S(.":U[?0+*V\07&M1B3[7- EN
M06^147D!1VK4HH QW\-6,FL7VJ%I_M5[:BUD(?A4_P!D8X/O5:'P9I4$.B0I
MY_EZ,Q:U4R<%B,9;CDUT-% ',VO@31[1-.2,W)%A=O>1;I,[I7ZEN.?:J5Y\
M+_#E[?3W3K>)YTPG:&.X(CWYR3MZ<UV=% &1XA\.:?XFTU;'4%E$:2"6-H7*
M,C#H01]369?_  ]T/4+>RCE-ZDEG'Y4=Q'=.)63.2K-G)&:ZJB@#&;POI?\
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M/<7#/*4_NAL\#Z5U5% '/:!X+TCP[=27=J+F>[D789[J8RN$_N@GH*Z&BB@
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MQ8\.EWFJ6\(AD=4G"I;H$RQY_D!VKH+SP TMOHALM;N;&]TJW^S)<Q1J2Z$
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MDJB'9D/O&,YSQBH-8\(6FI3Z,]LZ6*:9>_:UCAA&USU(XQC)YS1'2WK_ %^
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MINCW5CK6IWTVJW%U#>,IBMI,[+?&<A>3U^@H6W]>0WN:]%%% !1110 4444
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M0 4444 %%%% !2C[K?A24H^ZWX4 )1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% %JV_U9^M<;\5O^1/3_KZ3^35V5M_JS]:XWXK?\B>G_7T
MG\FK;#_Q8^IRXW_=Y^AXI@>E&!Z58L;47M]#;&XAMQ(VWS9VVHON3V%:&LZ"
MND0Q2#5]-OO,8KMLY]Y7CJ>.!7NN23LSY%4Y2BY+9&[\+!_Q60_Z]I/Z5[=7
MB/PL_P"1R'_7M)_2O;J\C'?Q?D?291_N_P V%%%%<9Z@4444 %%%% !1110
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M_O\ X?\ !/E[RW_N-^5'EO\ W&_*OJ&BC^T/[OX_\ /[%_O_ (?\$^7O+?\
MN-^5'EO_ '&_*OJ&BC^T/[OX_P# #^Q?[_X?\$^>O!J,/&.E$JP_?CM[&O=<
M5H45R8BO[:2=K'HX/"?5H.-[W,^BM"BL#L,^BM"B@#/HK0HH SZ*T** ,^BM
M"B@#/HK0HH SZ*T** ,^BM"B@#/IP^ZWX5>HH SZ*T** ,^BM"B@#/HK0HH
MSZ*T** ,^BM"B@#/HK0HH SZ*T** ,^BM"B@#/HK0HH AMO]6?K7'?%4$^$$
M !/^E)T^C5V]%73GR34NQE7I^UIN%[7/E[RW_N-^5'EO_<;\J^H:*[_[0_N_
MC_P#Q_[%_O\ X?\ !/$OA:K#QD,J1_HTG4?2O;:**XZ];VLN:UCT\)AOJ]/D
MO<****Q.H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BL?Q)XCL_#&E_;KQ97#2+%%%$N7D<]%%9MKXU,FDZI>WFA:G8/IT)
MG>*YC"[UP3A6S@GB@#JJ*IZ3J*:MH]GJ,:-&EU"DP1CRH89P?SJYUIM6T **
M,@]#1FD 45'-*(;>28C<$4L0.^!FN#TSXJ6MZ;.:YT34;.PO)A!%>R!6B+DX
M )!]:%KH'2YZ!16-H/B&'7SJ B@DA^Q7;VK;R#N*]QCM6SF@ HHSBC.* "BH
MKFYAL[66YN)!'#$I=W;HJCDFL?PWXNTOQ6+MM+:9X[60(SR1[0V1D%<\X^N*
M -VBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI=O]K5M'@M9+?S(D>/"CIYJLN#GMS2_X'ZA_7Y'I]]XAT?3=-CU&\U*VALY
M#',T@VOG^[CK^%<MXA^).F:;<Z&UEJ-C+9WLV;B4DMLA'!88/!SQS^58O_"$
M:UIFG^&KNVL+?49M+$PETVXN%*_O"3E7("Y&?2K^N:!K>H:5H6H0>'=/CO\
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M)M0-<LLW?^I'FCYN<?ASZXKD-*\!:A87GA&*\@BO+?3TN&N6+ I&SG*J >2
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MT:]DO;;3M3M;F\M8V=HD?)&!^OX5D>#O'VG:_IMA%>ZA8QZS<(6>UC;&#N(
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MN=&MY=:M(K34&!\Z&)MRJ<G&#D]L=Z8C1HHHI#"BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;4?\+?U#_H%VO_?;4?4JW8/[4PW\WX,]<HKRNU^*U_.ERQTVV'DPF08=N3N
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M +/7J=>6?!W_ %FL?2'_ -GKU.O%QG\9_P!=#ZG+/]UC\_S84445S'>%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5=2L_P"T=+N[
M+?Y?VB%XM^,[=RD9QWZU:HIIV=Q-)JS/+_\ A3J?]!QO_ 7_ .SH_P"%.I_T
M'&_\!?\ [.O4**Z/K=;^;\CB_LW"_P GXO\ S/+_ /A3J?\ 0<;_ ,!?_LZ/
M^%.I_P!!QO\ P%_^SKU"BCZW6_F_(/[-PO\ )^+_ ,SR_P#X4ZG_ $'&_P#
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MMUOYOR#^S<+_ "?B_P#,\VM_A,MNEPO]M,WG1&/_ (]L8Y!S][VJ#_A3J?\
M0<;_ ,!?_LZ]0HH^MUN_Y!_9V%_E_%_YGE__  IU/^@XW_@+_P#9T?\ "G4_
MZ#C?^ O_ -G7J%%'UNM_-^0?V;A?Y/Q?^9Y?_P *=3_H.-_X"_\ V='_  IU
M/^@XW_@+_P#9UZA11];K?S?D']FX7^3\7_F>7_\ "G4_Z#C?^ O_ -G1_P *
M=3_H.-_X"_\ V=>H44?6ZW\WY!_9N%_D_%_YGE__  IU/^@XW_@+_P#9T?\
M"G4_Z#C?^ O_ -G7J%%'UNM_-^0?V;A?Y/Q?^9Y?_P *=3_H.-_X"_\ V='_
M  IU/^@XW_@+_P#9UZA11];K?S?D']FX7^3\7_F>7_\ "G4_Z#C?^ O_ -G1
M_P *=3_H.-_X"_\ V=>H44?6ZW\WY!_9N%_D_%_YGE__  IU/^@XW_@+_P#9
MT?\ "G4_Z#C?^ O_ -G7J%%'UNM_-^0?V;A?Y/Q?^9Y?_P *=3_H.-_X"_\
MV='_  IU/^@XW_@+_P#9UZA11];K?S?D']FX7^3\7_F>7_\ "G4_Z#C?^ O_
M -G70^%/ P\,3W,HU$W/GH%P8=FW!S_>-=?14SQ-6:Y9/0NG@</3DIPC9KS9
M7^R_[?Z4?9?]O]*L45@=97^R_P"W^E'V7_;_ $JQ10!7^R_[?Z4?9?\ ;_2K
M%% %?[+_ +?Z4?9?]O\ 2K%% %?[+_M_I1]E_P!O]*L44 5_LO\ M_I1]E_V
M_P!*L44 5_LO^W^E'V7_ &_TJQ10!7^R_P"W^E'V7_;_ $JQ10!7^R_[?Z4?
M9?\ ;_2K%% $'V;C&_\ 2D^R_P"W^E6** *_V7_;_2C[+_M_I5BB@"O]E_V_
MTH^R_P"W^E6** *_V7_;_2C[+_M_I5BB@"O]E_V_TH^R_P"W^E6** *_V7_;
M_2C[+_M_I5BB@"O]E_V_TH^R_P"W^E6** *_V7_;_2C[+_M_I5BB@"O]E_V_
MTH^R_P"W^E6** *_V7_;_2E-MD#Y^GM4]% %?[+_ +?Z4?9?]O\ 2K%% %?[
M+_M_I1]E_P!O]*L44 5_LO\ M_I1]E_V_P!*L44 5_LO^W^E'V7_ &_TJQ10
M!7^R_P"W^E'V7_;_ $JQ10!7^R_[?Z4?9?\ ;_2K%% %?[+_ +?Z4?9?]O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **Y?QZS)X?0JQ4_:%Y!QV->;>=-_SVD_[[->9BLQ6'J<G
M+?YGL8+*7BJ7M.>WR_X)[C17AWG3?\]I/^^S1YTW_/:3_OLUS?VTOY/Q_P"
M=?\ J^_^?GX?\$]QHKP[SIO^>TG_ 'V:/.F_Y[2?]]FC^VE_)^/_   _U??_
M #\_#_@GN-%>'>=-_P ]I/\ OLT>=-_SVD_[[-']M+^3\?\ @!_J^_\ GY^'
M_!/<:*\.\Z;_ )[2?]]FCSIO^>TG_?9H_MI?R?C_ , /]7W_ ,_/P_X)[C17
MAWG3?\]I/^^S1YTW_/:3_OLT?VTOY/Q_X ?ZOO\ Y^?A_P $]QHKP[SIO^>T
MG_?9H\Z;_GM)_P!]FC^VE_)^/_ #_5]_\_/P_P"">XT5X=YTW_/:3_OLT>=-
M_P ]I/\ OLT?VTOY/Q_X ?ZOO_GY^'_!/<:*\.\Z;_GM)_WV:/.F_P">TG_?
M9H_MI?R?C_P _P!7W_S\_#_@GN-%>'>=-_SVD_[[-'G3?\]I/^^S1_;2_D_'
M_@!_J^_^?GX?\$]QHKP[SIO^>TG_ 'V:/.F_Y[2?]]FC^VE_)^/_   _U??_
M #\_#_@GN-%>'>=-_P ]I/\ OLT>=-_SVD_[[-']M+^3\?\ @!_J^_\ GY^'
M_!/<:*\.\Z;_ )[2?]]FCSIO^>TG_?9H_MI?R?C_ , /]7W_ ,_/P_X)[C17
MAWG3?\]I/^^S1YTW_/:3_OLT?VTOY/Q_X ?ZOO\ Y^?A_P $]QHKP[SIO^>T
MG_?9H\Z;_GM)_P!]FC^VE_)^/_ #_5]_\_/P_P"">XT5X=YTW_/:3_OLT>=-
M_P ]I/\ OLT?VTOY/Q_X ?ZOO_GY^'_!/<:*\.\Z;_GM)_WV:/.F_P">TG_?
M9H_MI?R?C_P _P!7W_S\_#_@GN-%>'>=-_SVD_[[-'G3?\]I/^^S1_;2_D_'
M_@!_J^_^?GX?\$]QHKP[SIO^>TG_ 'V:/.F_Y[2?]]FC^VE_)^/_   _U??_
M #\_#_@GN-%>'>=-_P ]I/\ OLT>=-_SVD_[[-']M+^3\?\ @!_J^_\ GY^'
M_!/<:*\.\Z;_ )[2?]]FCSIO^>TG_?9H_MI?R?C_ , /]7W_ ,_/P_X)[C17
MAWG3?\]I/^^S1YTW_/:3_OLT?VTOY/Q_X ?ZOO\ Y^?A_P $]QHKP[SIO^>T
MG_?9H\Z;_GM)_P!]FC^VE_)^/_ #_5]_\_/P_P"">XT5X=YTW_/:3_OLT>=-
M_P ]I/\ OLT?VTOY/Q_X ?ZOO_GY^'_!/<:*\.\Z;_GM)_WV:/.F_P">TG_?
M9H_MI?R?C_P _P!7W_S\_#_@GN-%>'>=-_SVD_[[-'G3?\]I/^^S1_;2_D_'
M_@!_J^_^?GX?\$]QHKP[SIO^>TG_ 'V:/.F_Y[2?]]FC^VE_)^/_   _U??_
M #\_#_@GN-%>'>=-_P ]I/\ OLT>=-_SVD_[[-']M+^3\?\ @!_J^_\ GY^'
M_!/<:*\.\Z;_ )[2?]]FCSIO^>TG_?9H_MI?R?C_ , /]7W_ ,_/P_X)[C17
MAWG3?\]I/^^S1YTW_/:3_OLT?VTOY/Q_X ?ZOO\ Y^?A_P $]QHKP[SIO^>T
MG_?9H\Z;_GM)_P!]FC^VE_)^/_ #_5]_\_/P_P"">XT5X=YTW_/:3_OLT>=-
M_P ]I/\ OLT?VTOY/Q_X ?ZOO_GY^'_!/<:*\.\Z;_GM)_WV:/.F_P">TG_?
M9H_MI?R?C_P _P!7W_S\_#_@GN-%>'>=-_SVD_[[-'G3?\]I/^^S1_;2_D_'
M_@!_J^_^?GX?\$]QHKP[SIO^>TG_ 'V:/.F_Y[2?]]FC^VE_)^/_   _U??_
M #\_#_@GN-%>'>=-_P ]I/\ OLT>=-_SVD_[[-']M+^3\?\ @!_J^_\ GY^'
M_!/<:*\.\Z;_ )[2?]]FCSIO^>TG_?9H_MI?R?C_ , /]7W_ ,_/P_X)[C17
MAWG3?\]I/^^S1YTW_/:3_OLT?VTOY/Q_X ?ZOO\ Y^?A_P $]QHKP[SIO^>T
MG_?9H\Z;_GM)_P!]FC^VE_)^/_ #_5]_\_/P_P"">XT5X=YTW_/:3_OLT>=-
M_P ]I/\ OLT?VTOY/Q_X ?ZOO_GY^'_!/<:*\.\Z;_GM)_WV:/.F_P">TG_?
M9H_MI?R?C_P _P!7W_S\_#_@GN-%>'>=-_SVD_[[-'G3?\]I/^^S1_;2_D_'
M_@!_J^_^?GX?\$]QHKP[SIO^>TG_ 'V:/.F_Y[2?]]FC^VE_)^/_   _U??_
M #\_#_@GN-%>'>=-_P ]I/\ OLT>=-_SVD_[[-']M+^3\?\ @!_J^_\ GY^'
M_!/<:*\.\Z;_ )[2?]]FCSIO^>TG_?9H_MI?R?C_ , /]7W_ ,_/P_X)[C17
MAWG3?\]I/^^S1YTW_/:3_OLT?VTOY/Q_X ?ZOO\ Y^?A_P $]QHKP[SIO^>T
MG_?9H\Z;_GM)_P!]FC^VE_)^/_ #_5]_\_/P_P"">XT5X=YTW_/:3_OLT>=-
M_P ]I/\ OLT?VTOY/Q_X ?ZOO_GY^'_!/<:*\.\Z;_GM)_WV:/.F_P">TG_?
M9H_MI?R?C_P _P!7W_S\_#_@GN-%>'>=-_SVD_[[-'G3?\]I/^^S1_;2_D_'
M_@!_J^_^?GX?\$]QHKP[SIO^>TG_ 'V:/.F_Y[2?]]FC^VE_)^/_   _U??_
M #\_#_@GN-%>'>=-_P ]I/\ OLT>=-_SVD_[[-']M+^3\?\ @!_J^_\ GY^'
M_!/<:*\.\Z;_ )[2?]]FCSIO^>TG_?9H_MI?R?C_ , /]7W_ ,_/P_X)[C17
MAWG3?\]I/^^S1YTW_/:3_OLT?VTOY/Q_X ?ZOO\ Y^?A_P $]QHKP[SIO^>T
MG_?9H\Z;_GM)_P!]FC^VE_)^/_ #_5]_\_/P_P"">XT5X=YTW_/:3_OLT>=-
M_P ]I/\ OLT?VTOY/Q_X ?ZOO_GY^'_!/<:*\.\Z;_GM)_WV:/.F_P">TG_?
M9H_MI?R?C_P _P!7W_S\_#_@GN-%>'>=-_SVD_[[-'G3?\]I/^^S1_;2_D_'
M_@!_J^_^?GX?\$]QHKP[SIO^>TG_ 'V:/.F_Y[2?]]FC^VE_)^/_   _U??_
M #\_#_@GN-%>'>=-_P ]I/\ OLT>=-_SVD_[[-']M+^3\?\ @!_J^_\ GY^'
M_!/<:*\.\Z;_ )[2?]]FCSIO^>TG_?9H_MI?R?C_ , /]7W_ ,_/P_X)[C17
MAWG3?\]I/^^S1YTW_/:3_OLT?VTOY/Q_X ?ZOO\ Y^?A_P $]QHKP[SIO^>T
MG_?9H\Z;_GM)_P!]FC^VE_)^/_ #_5]_\_/P_P"">XT5X=YTW_/:3_OLT>=-
M_P ]I/\ OLT?VTOY/Q_X ?ZOO_GY^'_!/<:*\.\Z;_GM)_WV:/.F_P">TG_?
M9H_MI?R?C_P _P!7W_S\_#_@GN-%>'>=-_SVD_[[-'G3?\]I/^^S1_;2_D_'
M_@!_J^_^?GX?\$]QHKP[SIO^>TG_ 'V:/.F_Y[2?]]FC^VE_)^/_   _U??_
M #\_#_@GN-%>'>=-_P ]I/\ OLTHFFR/WTG_ 'V:/[97\GX_\ /]7W_S\_#_
M ()[A14-I_QYP?\ 7-?Y5-7MIW5SYUJSL%%%%,04444 %%%% !1110!RWC[_
M )%Y/^OA?Y&O-*]+\??\B\G_ %\+_(UYI7S.;?[Q\D?8Y)_NOS8445U_@^WL
M)-+U*34(HVB#(FYE!*YXX/;K7%0HNM/D3L>AB:ZH4W4:OM^+L<A17?Z)X9M]
M*U-VU$1R^9(8K56 (<8SNQ]*YNZT225]7NHGC2*SF(9"""03QBM9X.I"*;W=
M].UC"GF%*I-Q6RMKWOH8E%:]EI$AM+/4V>,P/=+%Y9SGK^6*ZI=%L+CQ7J D
M6U$:0X6W(P0<#Y\#C%.G@JDXI[7?Z7N%;'TZ3:WLG^#2M^)Y]172Z3I[Q7FH
M0V[Z?>!+8L7<%E _V>/O57@\+S2Z;;W\E[:003#@RL1@^G2H^JU&DTK_ /#V
M-/KE)-J3MM^*OL85%=;H>AOI_BN"VO8X9HWB9T;&Y'&.HS6;%H,UZ;J[,UO:
M6B3,@DF; )ST&*3PM2RTUUT[6M_F)8VES-7TLG?O>_\ D8E%7]5TBXTF6-9F
MCD25=T<L9RKCVKIM%M4?PTDNEVEI=:AO_?K. Q SV!_"G2PTIS<'HU]X5L7"
MG351:INWE\WT.*HK:U"TN]1UQ+5-+2SN7 !A08!]6^E%WX=:SAED.HV,K0D>
M9$DGS#_&I^KS;=EHNI:Q-/W5)V;Z;_D8M%=?XBT5[[Q'#:6$$48^SJ[$ *JC
M)R3BLF\\.3VMB]Y#=6UW#&VV0P-G8?>JJ86I!RTNEU]"*6-I3C%MV;Z>IC45
MO7OA:;3[?SKB^LT!CWHI8[GXZ 8ZTZ/PG=%81/>6EM/,,I!*Y#G]*7U6M>W*
M/Z[0MS<VAS]%:]KX=OKC4+BS?RX6MEW2O(?E4>M6;+26M=<T](;FPO3,QVC<
M63H?O#&:4</4=KJR;M^-ARQ5)7L[NU_PON<_16]_8-S?WFH3M):VL$$I61R2
M$!]!QG%9NHV']GW B^TP7 *A@\+;A4SHS@N9K0J&(IS?*GJ4Z***R-PHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M):2>8(H0K<$8(-7[N\T'6;V#4[J]FMIE"^9 (]V2/0]JY"BH^MRYI-I.[O\
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MH_X0W7?^?1?^_B_XUZM16']D4.[_  _R.G^WL3V7X_YGE/\ PANN_P#/HO\
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M4?V10[O\/\@_M[$]E^/^9Y3_ ,(;KO\ SZ+_ -_%_P :/^$-UW_GT7_OXO\
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M\:/^$-UW_GT7_OXO^->K44?V10[O\/\ (/[>Q/9?C_F>4_\ "&Z[_P ^B_\
M?Q?\:/\ A#==_P"?1?\ OXO^->K44?V10[O\/\@_M[$]E^/^9Y3_ ,(;KO\
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ML3V7X_YGE/\ PANN_P#/HO\ W\7_ !H_X0W7?^?1?^_B_P"->K44?V10[O\
M#_(/[>Q/9?C_ )GE/_"&Z[_SZ+_W\7_&C_A#==_Y]%_[^+_C7JU%']D4.[_#
M_(/[>Q/9?C_F>4_\(;KO_/HO_?Q?\:/^$-UW_GT7_OXO^->K44?V10[O\/\
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M+_W\7_&C_A#==_Y]%_[^+_C7JU%']D4.[_#_ "#^WL3V7X_YGE/_  ANN_\
M/HO_ '\7_&C_ (0W7?\ GT7_ +^+_C7JU%']D4.[_#_(/[>Q/9?C_F>4_P#"
M&Z[_ ,^B_P#?Q?\ &C_A#==_Y]%_[^+_ (UZM11_9%#N_P /\@_M[$]E^/\
MF>4_\(;KO_/HO_?Q?\:/^$-UW_GT7_OXO^->K44?V10[O\/\@_M[$]E^/^9Y
M3_PANN_\^B_]_%_QH_X0W7?^?1?^_B_XUZM11_9%#N_P_P @_M[$]E^/^9Y3
M_P (;KO_ #Z+_P!_%_QH_P"$-UW_ )]%_P"_B_XUZM11_9%#N_P_R#^WL3V7
MX_YGE/\ PANN_P#/HO\ W\7_ !H_X0W7?^?1?^_B_P"->K44?V10[O\ #_(/
M[>Q/9?C_ )GE/_"&Z[_SZ+_W\7_&C_A#==_Y]%_[^+_C7JU%']D4.[_#_(/[
M>Q/9?C_F>4_\(;KO_/HO_?Q?\:/^$-UW_GT7_OXO^->K44?V10[O\/\ (/[>
MQ/9?C_F>4_\ "&Z[_P ^B_\ ?Q?\:/\ A#==_P"?1?\ OXO^->K44?V10[O\
M/\@_M[$]E^/^9Y3_ ,(;KO\ SZ+_ -_%_P :/^$-UW_GT7_OXO\ C7JU%']D
M4.[_  _R#^WL3V7X_P"9Y3_PANN_\^B_]_%_QH'@W7,_\>B_]_%_QKU:BC^R
M*'=_A_D']O8GLOQ_S([=#';1(PPRH ?KBI***]1*RL>*W=W"BBBF(**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **3<-VW/.,XI: "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***3<-VW/.,XH 6BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDW ,%SR>@I: "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***0L 0">3TH 6BBB@
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M@?G6[7E>J>"AX=M--N!//J%T-6MPLSJ2T4"Y"I]!GDUZI1T#J%%%% !1110
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M.(V7_5L?52,?3%5H-*U!]$6_ALY9QIWB*:ZEMMOS2Q[CRH/4CJ*GM_75#?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH CVG[06QQLQG\:DHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ J,J?/#8XVD9J2B@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@"-E)F1L< '/Z5)110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !4;J3+&0.!G/Y5)10 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110!'(I,D9 X#<_D:DHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ J-U)EB(' )S^5244 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ;^?];=>QW]%%%8G2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHH\M/[HH HT5>\M/[HH\M/[HH HT5>\M/[HH\M/[HH HT5>\M/[HH\M/[HH
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MXM)=*U*^FT[4K0Z>F^:&YMS&^#TQG@T =11573;Z/4]+M;^$,L5S"LR!NH#
M$9_.K5#5M "BBB@ HHSQ7!VOQ6TF=4FDT[4X+)YO)^V/!^Y#YQ@L#1Y!YG>4
M4@8, 000>AI: "BBN97QI;S)?&UTS4+IK*\^QRI!%O;=_>P/X?>@#IJ*,UGO
MJC+KJ:9]@O"K1>;]K$7[D=?E+?WN.E &A112$@ GTH 6BLKP]K]MXDTUKZTC
MD2,2O%B0 '*G!K5H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXWCGV@X^ZS.Q#$>H KW:BGUN+I8XKX6Q21>$9%EC=&^W3G#J0<;_ 'KM:**
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
9HH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>img88009329_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_1.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" -K!@,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR4GH_P S:\9^,[C0+V&TL4@>4KOD\T$X';H172:%<WMYH]O<WZQI/*N\K&I
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M16EU+>1PHT4@5?*4CC&>Y-<[;^/M5E\2QV#06?E-<B$L$;=MW8Z[NM>D@ =
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MX2"E"<6>)Z#XQU+PU!):)#')$6+>7*""I[]*HZ]J&IZQ<)J.H1E%D&V+"X7
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M^PIX 4    = *"H8$, 0>H-82=VV=,(\L4NQX?&)?%OC$;\D7$V6_P!E!_\
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MHH4L/.5/DE(ATW_D&6O_ %R7^5>0>-]+;1O$SS092.<^=&5XP>^/QKVD  8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% ";1Z"EHHH **** "BBB@ HHHH **** "BBB@ HHHH 1E5Q
MAE!'H10JJHPH 'H*6B@ HHHH **** "BBB@ HHHH **** "BBB@ QFF>3$&W
M>6F[UQS3Z* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0@'J!2T4 %%%%
M !1110 4444 %%%% !1110 4A /44M% !C'2BBB@ HHHH **** "D  Z 4M%
M !1110 F >H%+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%-+J.] #J*C\
MU<X'6D\[G[IQ185T2T4P2J33@P/0T#N+1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !112%@O6@!:*;O7/6ER#T- "T444 %%%% !1110 4
M4$@=:891VYH"X^BHMTC=!BEQ)CKS0*Y)146Z0'IFE$P[@BG8+HDHIH=3WIU(
M84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%-,BCO3/,9N%% KDI.*;O7UIGEL?O&G>6OI3#47>OK1O7
MUH\M?2D\E/2D&H[<#WI<BH_)4=.*3R3G.XTPNR6D+ =34.'W[0U/$0[G- 78
M&4=AFDW2-T&*D"@=!2T!9D7E,>K4X1*.O-/HI7"R$V@=J7 ]***!C2BGJ*:8
M1V)%244"LB+8Z]#FCS&'WEJ6BF%A@D4]Z?G-,,:MVJ,J58 -U[4!=HGI-P'>
MH_*)ZL:40KWR: U'&11WI#*N,\TOEKZ4NT#M2#4C$V>@-!E;LE2X%%,+,AWR
M?W*<)?[PQ4E(0#U% 68@=3T-.IAB4].#3=KKT.: NR6BHO-(^\N*>'4]Z070
MZBBB@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 45F:;K<&IW=Y;11R*UJVURV,'K
MT_*M.@ HHI"0!DT +13?,4]Q2[E]10%Q:*HW6K6EG>6]I,Y$MP<1@#.:AUN\
MU*SMXGTRT6YD9P'#=A^= &I138RS1J77:Q'(]#3J "CI2$@#)J/+2'C@4";%
M:3/"T+'W;DTY5"CBG4!;N,,2'M33".Q(J6BBX61$8V[-1B0'CD5+11<+$7F.
M#RM*)AG&#4E)@'M3"S&B5#WI-[-PH_&E,:D<#!IJ-M.TT"UZB^5GEC3PJCH*
M6BD.P4444#"D(!ZBEHH 88U--\HC[K5+11<5D1?O%/J*/-(^\M2T8!IA89YB
MT4NQ?044:!J.HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **0D#K3?-7.,
M\T!<?14?G#.,&D,I[+FG85T2T5#YDA_@IVY_3]*+!<DI"P'4U$&=Z<(AW.:
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M%1"4@X84\.K=#2"Z'4444#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MGCC4EF% F[;BR-A<=S2HNU?>J0NQ),!T'O5Y3N4&FU8F,E)Z"T444BPHHHH
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M?_?VO2Z* /,CX:\16WS1H_'_ #SF_P#KTT7WB;2_OFZ51_?7<*]/I"H/4 T
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M9VD_2BS#GCW)B<#)J-07;)Z57-V'8!E91]*M(Z,,*PHLT)24A]%%%(L****
M"BBB@ HHHH **** "F2$!>1FGGBHA^\?V% F-CMX_O%1DU, !T%+11<$D@HH
MHH&%%%% !1110 4444 %-<@*<TZHG^=PHZ"@3&Q0)G?M&34^,4#@447!)(**
M**!A1110 4444 %%%% !1137;:I- %=[>.6;E>!UJ=(DC&%4"B)<#)ZFGTVR
M5%;A1112*"BBB@ HHHH **** "BBB@ IK(K#D"G44 5)K9@,Q.5]JB2"XDQN
M?:/:KDIX"CO3U&% JN9V,^1-D*VJ?Q$L?<U*L:+T44ZBE<M12"BBBD,****
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MCU/K5>.W>VSY9W#WJ9;A2<,-IIOR$GUEN344@(/0TM2:!1110 4444 %%%%
M!11D>M(64=2* %IK.J#).*B>X!.V/YC2+"SG=(?PIV[D\W1 9'E.$&!W-*EK
M&O)4%O4U,  , 8I:+@H]6,$2#HHI=B_W13J*15A-H]!1@>E+10 F!Z48'I2T
M4 &!Z4A4$8(I:* (&MP#F,E32>;)&<2+D>HJQ00#UIW)Y>PQ)4?H:?4+VZMR
M/E/M4$DLMO\ [8].]%K["<FMR[15-+R1NL#"G_:7_P">3468^=%FBJWVE_\
MGBU'VB3_ )XM19ASHLT57\^3_GD:/.F[146#F18I&.T$GM4'F7!_Y9BH9UNW
M&!@ T)"<[+1$L(\R0R'\*LU4AE>)=LJ8 [BK"R(_1A0P@U8?1112+"BBB@ H
MHHH **** "BBB@ J.7H!ZU)41^:;'84T)DBC"@4M%%(84444 %%%% !1110
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MAN33:Z(B+:U:-RBL6X\3:;93RP7=U%%+%C>I/(STK42YC?&#U&:5F7S(FHI
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M:0"7X07#",,R3N0<9(&_FO2E6Q:Y:Y\B,3NNQI-GS%?3/I3H8;&"V-M##%'
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M9!G/.:D$:J.%%--(34I*VQ7CNF;[T3"G_:E[JWY5/BDP#VI70[2[D0N4/K7
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MN\\8:K>Y2)A"I[1CG\ZKVNA:MJLF]DDP>KR&O1+30=-L\>5;)D=R,UHA0HP
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M !1110 A4-U&:A:V4\J=IJ>BG<32>Y59IX><;Q2)?HQ(*L".M6CTJ"W"MO.
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M^O7,6>DZKXFN3<3NPC)YEDZ?@*T_#OA$RE;S4E.#RL1[^YKN8XTC0*BA5'0
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MLQFXM"(+Y.>.,F@#LP<TV2-94*. RD8((ZUS7AW79)I#INH?)=Q\ M_%744
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M"BBB@ HHHH **** "BBB@ HHHH **** "FM&C=5!IU% %*.!%N6&P8JX% &
M*@D!%RA'3%6*;9$%:X4444BS*\1ZLFB:'<WK$;U7;&/5CTKS+P'I#:UKLFI7
M0+QP-O)/\3FK_P 4M4::^MM+C.5C'F.!W8\#]*[/PCI*Z3X>MH",2./,D]V-
M=J_=4+]9'CS_ -JQO*_AA^9O@ "EHHKB/8$-96N:S%I%F9&.96X1/4UH7$R6
M\3RR,%11DDUP2Y\0:G+?W619PGY5/>NC#TE-\TME_5CAQV*=&/+#XGM_F06V
MGSZO,VHZG(5A)R ?XO\ ZU:3W:I&(;11'$...IJE>WKW3[1Q$O"J*IR72VR%
M1S(>WI7I<KEO]Q\Q.LHWM\WW+LDBH"SM@>IK.GU2-3B-2S>M9]Q<R2MEF)JN
M.?\ &M8TUU..==O8OG59R#C ^@I%U&YR6+<?2J6.1SUJ0;5XR,>]4U%;D)SE
ML:$6I2KC> WOTJ]!<Q7'W3AO0UA CL13@Q4AE.".]3RQDKHM5)Q?O'303O!)
MO0X]O6EU&W+A=6T_*7$7,BKW%9UG>"9-K$!EZ^]:MA.8I@K_ ''X85A*+B[G
M;1J7LOZ1U&CZFFJ:?'<*>2,,/0UI#I7%:!(=+\27&G$XAF&^/VKM!TKS:]-0
MGIL]CZK!UW6I)O=:,0C->5_$G03:W<>KVZX24[9<=F['\:]5K-U_34U71;FT
M8 ET.WV;M10J>SFF+&X=5Z+CUZ>IC>"]>DUC0HT8YN8/W<A]?0_E73)  =S'
M+5Y!X U%]+\4&SE)59R8R#_>'2O9:K$P]G4:6QGE];V]%2ENM&%%%%<YWA11
M10 4444 %%-:14')J$S._$:_B:=A.21.S!1R<5"TY;B-<^]"P$G,C9-8OB;Q
M59^%HX#-"\SS$X1" 0!U-5&+D[+5F<Y\D7*3LD:ILS*VZ9B?:I5M(EZ+26-Y
M%J%C#=P',<J!E_&IRZJ<%@#[FDVT[,<8P:YEU(Q;Q#^ 4OD1_P!P4_<N<;AD
M]LT%@HR2 />EJ79#/)C_ +@H\B+^X*?N7.-PS]: RD9!!'L:-0LAGV>+^X*3
M[/%_=%2!E;H0?H:-RYQN&?3-%V%D1&UB(QMJ"6R1<.@Y':K@92,@@CV- 96Z
M,#]#0FT2X19' RE/E&,=14M5I086\P$!>]3HZNFX$$>M#[CB^C'45EV7B"PO
M]3O-/A=O/M#B3<,#\#WK3W+G&X9],T.+6X1G&6J8M%8>NWNLV\UB-)MHIXY)
M<3EV VK^=;><+EB!3<;),2FG)Q["T4@8,,@@CVI:DL**BFF$<4C @LJDXS7+
M:9XEU/6?"U[?V=I$;R*5HXX\\'&/7ZU48.2NC.=6,&HO=W_ ZZBJ.DW%W/I=
MM)J,:17CIF2-3P#5TD*,D@#WI-6=BHRYDF+16)'>:RWBJ2V:UB_LH1@K,&&X
MMCZUM%U4X+ 'W--QM849J5_(6BL7Q%=ZQ:PV[:/;1SNTH$@=@,+^=;(/R@M@
M''-)QTN-33DX]A:CECWC(X84\,K?=(/T-&Y<XW#/IFD-I-$44I/R/PPJ:H9%
M$@W(P+#T-+%+N^4\,*;$G;1DM%%%(H**** "BBB@ HHHH *8T2-U44^B@" V
M^.48BFYGCZ@,*LT4[D\JZ$ N5'WP5J59%;HPH9%;J :C:V4_=)7Z4:![R)J*
MKE)D^ZP8>]'V@H#YB$8HL'-W+%%0K=0L<;P#[U)YB?WA19C33'44WS$_O"D,
MT8ZN*5@NA]0/&4;>GXBG&XB'\8I/M,7]ZFKB;B^H^.02#CKWI]49IE1@\8.>
MXJ2*^BDX)VGT--Q9*FMF6J*0,&Z'-+4F@4444 %(0#U%+10!"UNIY4[34;/<
M0_PAU_6K5%.Y+CV*:7WF<*AW>AIY:X8< "GR0!CO7AJ(I<_*_#"GIT)L[VDQ
MGDRMC<^/I3OLRYRS$U,3@$^E<BWQ)T%6*G[5D''^J'^-.,92^%"DX0^)G5&V
MB(P5%1_90G,1*FHM(U:VUK3TO;3?Y+D@;Q@\'%7JEW3LRDHR5T5Q-)'Q(N1Z
MBI4F1QP:>0#UJ)[=&Y'!]J-!VDMB6BJVR:/[IW#TI1<$<.A%%@YNY8HIBRHW
M1A3\TBKW"BD) ZFHVGC7OD^U FTMR6BJYG=ON)^-)LG?[S;?:G87-V)VD5!E
MB!5-;J+[4?F[5-]E4@[R3FC[%#_=%-6)?.]B=6##(/%+5?[,5'R.11F=#TW"
ME8KF:W18HJN+G ^="*D$\9XW8/O19@I)DE%-WK_>%%(H8;>,_P ---JO\+$5
M/13NR>5%?R9E^[+^=&Z=>JAJL447#E[$'VC'#(13UGC;^+'UJ3 IC1(W511H
M%F.# ]"*,CUJ%K5<?*Q4^U5)(9XV'[WY?6FDF)R:Z&@75>I J-KE <#)-,CM
MAM^=BV?6IUC51P!2T'[S(3+*_P!U, ]S0(96'SO^56**+AR]R$6R#DC-2!%7
MH *=12N-)(****!B%0>HJ-K>-L\8^E2T4":3*YMV7E'/TI-TZ8R-PJS13N+E
M[$ N0/O*14BRHW1A3BJGJ*B:V0YP,$^E&@>\B;-%5_)D4_(_X4"29<!ES[BB
MP<W=%BBJQO8U.&R#[TX7<7=A19ASQ[G)^/[O;;6UH#]]B[#V'2M3PC9_9-!A
M.,-*3(?Q_P#K5RGC*<76OI&IR%55_.O0[2(06<,0&-B ?I2*)Z*3-+F@#E/&
M-Z_DP:; ?WMRW('I5>:)-+TN/3XC\Y&Z0BF[A?\ CB9VY2U3 _"J]S*9[B21
MNYH PKN<6T#.>O0#WK(+%SN8Y)ZU;U659;LJ!\L?'XU3!!H @E'SXS_]:HB>
M<]!VJ27[Y /+5&?[W;^E #HHI)YA'%]X]3_=%;=OI<$(!8;W[EJIZ0\4-NTL
MC?,QR?:M,W"$Q+&0S2MA: )%MU886($>RU2O-.MW4YQ%)V/2NS1GL(%\N.*4
M8 *E>23V'Z5@:G"FV629"MRN6<.,$>P]J .2\QEW128++W]15K3IS%=(O8\5
M3N(7CNHW9O\ 6#.WTS4D3;70XYSUH [>UE*F-P3D$'FM"?\ <>-;&=>!<18/
M\O\ "LJU.8%K6O/F\0Z&.X0D_I0!V5% Z44 <9X^LPUM;W8'*,4)]C5WP1=F
M?1O*)YB;;^%7/%<'G^'KH8Y0!Q^!KF_ ,^VZN8"?O*"* .^HHHH **** "BB
MB@!" >HJ)K=#RORGVJ:BBXFD]RMMFCZ'</>G"X .'4K27U]!IUG)=W+%88QE
MB!G%<^?'OAUAS<L?^V9JU%RV1G*48:.5CIE=6'!%.KD6\;^',Y6[=?\ @!I!
MX^T5#_Q]LP_W#3]E+L3]8@MVCKZ*Y5?B#H)^]<./^ &G_P#"P/#W_/T__?LT
M>RGV*]O3_F1T]4-:U'^R-(GOMF\0@$KGJ,@5C_\ "?\ A[_GZ?\ []FLGQ-X
MRT74?#MY:6UPS32( H*$9Y%.-*7,KHF=>"B[25SL-*U6TUBR2ZM) Z-U'=3Z
M&KM>":#K]WH%\+BV;*'B2(GAQ7M&B:Y9Z[8K<VK\]'0_>0^AJJU%P=UL3A\0
MJJL]S3HHR/6DW#U%8'2+133(@ZL/SIIGC'5J+"NB2BH?M*8R,FF?:2P^5#FG
M9BYXBW!(DC/O5BLV4W4F,)C!S4L=Q.I_>1G'J*;CH0IJ[+M%0BYC/7(^M5]6
MO%M=&O;E6&8X'8?4 XI6=[%N:2;/(ESXC^(HS\T;W)_[X7_ZPKVA4V@ = *\
ME^&%MY_B*XN6&?*A.#[L?_K&O7:Z\8[34%T1YF4QO3E5>\FPI,TM-:N,]4Y3
MQC?.X@TR GS)SE@/2J-RBV.GQV4?\(R_N:()/MOB6_O7Y6 ;5SVQ4,SF1F9^
M<\FO5IQY8J';7YGRF+JNI.4^^B]$95Q/Y(&/O'I5!B3ECR33YV$D[-V' J-N
MAKLBK'BSE=D)]Z;NPO/ IW?Z5!/RZ1YX8\_2L,;B5A</*L^B.K+L&\;BH4%]
MIDL$4MT<H=D7][N:N+IEN/O N?4FIHWB15C4@8'%;.B6*WP>=R-BG"C'6OS*
MKBL7F%;WI?Y'ZW0P6%R^C:G"R7WOYG//ID&,IE#Z@U3\Q[>7R9B&!^ZXKN-0
MT^*6(EH@L:$C<@XS7%ZM;X#8./*.,CO75AZ^)RZLI<UUVZ&&*P6%S.A*$XZ]
M'U3'PR^5("#QFNB@D+*#G.*YA#F,$CJ :Z#3FWP+GTK]'DU**DNI^3TTX3<'
MT-'4&\O5-(OEZEMC'_/XUWB_=%<#J7-AIOK]I&*[U/N#Z5YN*VC\SZG*W\?R
M?X"FD8<4M!-<9ZQXIXPMFT7QK)<0?*&=9T_F?US7L>GW"W>GP3J<AT!KS?XJ
MVP\^PN@.H9#_ #KJ/!-W-<^%K4J =@V9/M7;7]^C"?R/(P;]EBJM+IN=315?
M%R>ZBCRYSUDQ7'8]7F\BQ2%@.I%0"!\\R$TCV@?[SM^=%D%Y=A[W,2\;@3Z"
MF[Y93\HVCUJ*VMXXY&4KDCH35VF[(E7EN0K;C.7.XU*  .!2T5-RTDM@)P,F
MO+UU72-:\9ZA=ZI=PI:6\;6]NLA^]G@M_/\ .O0M7M[JZTFYM[*18[B5"BNW
M1<]ZQM#\%:7IVDPV]Y9V]S<@9DE9,[B?K6]*48IN6^QR8F%2I*,8+1:N^VFR
M_4R/AUJT>R^T,3K*;5RUNX/#(3_3^M<^8T_M"\;Q6VK1S^:?+DBSY:K^%=A<
M^#S;^);/5=%,%HL:E)H@N P]L57G\/\ BYEFMTUZ"2VDR#YL(+ 'T.*V52',
MY)[G(Z-505.2ORO2VJMZ-K8R]:CCT_2]&\0:3>RW4%G($ED9B2Z$]_Y?C6AX
MAO?^$AUO1]&LY"8G NKAE/\ !V%3?9M$\.>&)O#]_J$>YX6=M_!;/<#ZU3^&
M.CO#93ZM/N9Y_P!W"6ZB-?\ /Z4[JSGVV\[_ -7#EESJDM.9+F7:V_WK0J7N
MFRZO\3+JP^V3P6PMU:01-@L !Q5.ZT:ZT[QG#X?LM4NX[*\0.^7R0!G(!_"N
MUM_#]Q%XVN=;,L9@EA$809W \?X4V\\.W%SXVL];66,001%&0YW$\_XU,:R5
ME?2WXE3PK:E*VO-^&ASD]@_A'QCI$=C=W#VUZQ22.5]WX_K3-3L)M7^)TM@+
MR:" VP:3RVP2HQQ^>*ZC7O#]QJNN:1?12QHEE(6=6SENG2DB\/W$?CB77#+'
MY#V_E!.=V>/\*(U592;UL_\ @#GAI7<(KW>:+^74XN^T6ZTOQC;:%8ZI=QV=
M]&&?+Y(&3D _A5Z[T]_"'BW1Q87EP]O>2>7+'*Y8')QG]:Z74?#T]WXRL-:6
M:-8;:+8R'[Q//3\ZC\1Z-)JNL:3=Q31JME,)'4YRPR#Q^5.-:[BF^FI,\+RJ
M;BM4UR_AM^)RVNZE_:_C&ZL+^>]CT^T  BM5)+MZG%.T.9[/Q"VG6KW\FCW<
M15A<(08CCL36[J_AF\N-:_MG1+O['>,NV3<N5?ZBK6D:'K:W4MQK&JBXWKM$
M4:;5'O1[2"IV\MO,3HU76;L[WNGY=M_PL<CX=\,:?=>,-8MGEG\NTD!B(E()
MY[GO5GQ#9W6I_$F+3[>\EMDDMP'9#SMQSBM6Z\&ZI;Z[/J&C:E' MSCS5D7/
MY5>_X1B[/C&+6C<1^6L'ELN#N)QC-/VJ<E+FZ?C82PTE!TU"WO7^5_T1B^*+
M+^QE\,V,$\KHEX!N=N6RP/-2:D+KQ/XWET1[R6VL+2(.ZQ-@R'C_ !K8\1>&
M[O6+K398KA%%I.)6#YY (Z5!K7A6^N=6CUC2KT6E^J[68C*N/>IA4C97>NOW
MLNI1FI248^[[NG=+=%O1?"KZ'JCS6VIW#V3)C[-*=WS>N:G\8:K-HWAF[O+?
M_7 !4/\ =).,U2T;2->M]3?4-6U1KERFP0QC:GY5K:G:1ZOIL]C=Q'RI5VG'
M4>A%8R?OIR=SIIJU*2A%QWM<X^S\&&Y\/KJ<FJWG]H2P^;Y@D^4$C.,>E9FA
M%X_A5K)#'>)V^8'O\M:D7ASQ)!:'2H]<"Z=@J,Q_.%],U8T[PM/9^#+_ $-K
MJ(S7$A97P< ''7\JZ7-6=Y7U5OO.&-)\T;0::3OYNWJ9>H0W,/@K0->MG<S6
M01I,'[R'U_SWK3\2ZG_;\VC:/8R'_3"L\Q4](Q_DUT.G:4D/A:+1[ITDQ!Y3
MD=#Q6-X/\&R:!?SW=W=)<.4$<&"?D7\?PJ/:0NV^C;7S_JYK["JE&,=I)*7E
M;_-:$-J6C^*EQ K-Y:62A5SQ]T5S9BB^WWC>*FU:*X\T[)8L^6J]L8KNX] G
M7QM/KGG1^3) (@G\0.!S^E9=SH7BPK-;KK]O);2Y!\V$%@#Z<40J+37HA5*,
MK/1_$WT:V72Z,WQ/) GA;0_[/O9+B#[4H$S-EF^M7?$4UWK/BZR\.1W4EK:F
M'S9FC.&?VHN_!V/#VGZ7:72LUM<>?([@_,<Y.*O^(?#TNK7-KJ.GSM::C;C"
M2 <$>AI\T$UKU?\ P&)TZK3TZ1T7E>Z,35]/E\#ZCIMYIU[</;SS"&6"5]P.
M>XIFJ6,VL?$V2R%Y-;P-;*TGEM@D8'%:47A/6=2U2VO=?U%+D6QW111KM7/K
M6BGANZ'C236FGC\EH1'LYW9P!1[1+=W=GK^0.C.5U&+46UI^9S_V63PCXYTR
MUL[R>2SO01)'*^['6N\N)8U.Y6^8>E86K^%Y]0\2:7J4<R"*T)WJV<GZ5T@M
MXA_ *QJ34E%O?J=5"E*$IQ2M&^GW$,-]$X )P>^:LK(CCY6!J,VL+=4%-^R1
MC[N166AU+G6Y8HJOY4RYVOGZT>9,N-R9^E*P^;NBQ14 ND_B!'UJ59$;HPHL
M-23'4444AA1110 4444 %%%% !2$ ]12T4 5I;**4'Y<'U%010(C['SGM6A3
M)(Q(O/7UJE)[&;@MTAHMXQT'ZT?9XSU%,21HSL?\#5BD[C2B^A$+>,?PBG"*
M,=%%/HI7*LANQ1V%,>WB?J@J6B@+(K_9MO\ JV(]J-\T?WEW#UJQ13N+E[$*
MW"'@\'WJ4,#T--:)''*BHC;D<HQ!HT#WD6**K[YD^\-PIRW*$X.0?>BP<R)J
M*0,&Z$&EI%!3)(@X]#ZTD\T=M!)/*VV.-2S'T K!_P"$Y\/?]!!?^^351C)[
M(B4HK23-DR-&C+)Z<&OGJ;_7R?[Q_G7M,OC7P[)&RF_4Y']TUXK(0TKD="Q(
MKLPT6KW1YV,DGRV=SV7X=_\ (GV_^_)_Z$:ZJO/?!?BC1]+\-PVMY=B.97<E
M2#W8FN@_X3GP]_T$%_[Y-<]2$G-Z'91JP5.*;6QT5%4=,U>RUB!YK&82QHVU
MB!C!QG^M7JR::T9NFFKH*0J#U%+12&1-;QMVQ]*@DMIER8I3]#5RBG=DN"9G
MQ;V8K<,<U<6&->0!2O&L@P1467@Z\I3O<E+EW+& **:CJXR#3JDT"BBB@ HH
MHH 0@'J*888S_"*DHH%9,@^RQ^]%3T4[L7*NP4444B@HHHH **** "F2IOC(
M[]J?10#5R&W?='@]14U5O]5<?[+59ILF.U@HHHI%!1110 4444 %%%% !111
M0 4444 %%%% $<D*2=0*IQ6L?G,I'?-:%5VPEVI_O"J39G.*T9YQJRB3QL8P
M/E\^-<?E7IPZ"O,[_P"7QX2?^?I/YBO31TJ30**** .&TKCQ#K.?O8./SJE)
M,L?7K6F$^R>.+F,\+<Q9%95Y;OYS8Z@D$4 <JTHEED(ZDFF)UISP-#<RAN"&
M--Z-^- $4HVDD]3P*C(W'9ZC%6GC$@&3TIAB_>;LT ,TPA(G20_-G)S_ "K0
MM;.3?]IB;8RG*!AQ5"6$E_,C.''Y&K$>JW,0VO%N]\4 =QI]_%(89+MD#1'(
M7)Y/:H==U2VN0S$*QQ@N1T'H*XYM8G882+'X54F>XN#F:3"^F: %GF^U7K2C
M[B=*6W4R3(@[D"HU*C"J,"M#2T#WX*X.W)'N: .GLHR52/');%:T(^U>-XU'
M*VL&#]:@TJ/=>HQZ1@L?PJWX1C^TWFI:BW_+238I]A_D4 =91110!2U9!)I-
MXA[PO_(UP'@IROB!5[,C5Z%J) TZZ)[0O_(UYUX._P"1BB_W6H ]/HHHH **
M** "BBB@ HHHH P/&O\ R*.H?[@_F*\-KW+QK_R*.H?[@_F*\-KOPOP,\O'?
M&O0****ZCA"BBB@ HHHH *OZ3J]WHUXMQ:R%3_$O9AZ&J%%)I/1C3:=T>X>'
MM8M/$-D)H92LR_ZR(GE3_A6V+<=V)KQGP7INK7>LQS:<[0I$?WDQ'R@>GO\
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M?T%;^AW8L@8'D C/3(Z5RL9NK0D(=Z=JF_M*;'_'N<U^=?4<=A:ND&?JBS+
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M,.<AR/I7*:;\1(-4N((+?3+EI'DV/MY6,9QDG%7-2\;06FI/I]C8W&H7,?\
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MW6!&<X-.VA',^:Z1HT57$[K_ *Q#]13UGC;OCZTK,M23):*0$'H:6D4%%%%
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M_P#GR@_[]BM/K:[&/U!_S'SU@^E&#Z5]"'1]./\ RY0?]\"F?V)IV<BTA'_
M!3^MKL+ZA+N?/V#Z48/I7OYT2S&=MO#^*"L/Q;IT4'A:_=;: $(,,J $<BG'
M$INUB)8.44VV>.5T/A?PK=>(;G/,=FA_>2D=?8>]2>%_"=QK<RW$Z.EBI^9L
M<O["O7K1;;3[6.V@@\J)!A544ZU;ETCN+#X?F?-/8DT[3K;2[*.TM(Q'$@Z#
MO[FK51"YB/\ %^=.$J'HPK@=]V>JFK60^BD# ]Q2YI%!11D>M(74=Q0 M%1F
M>->K"FFZC'J?PIV8N9$U9'BF W'A;4HP.?(9OR&?Z5H&X.?EC)J*=9;B&2$H
M-DBE3GT(Q51TDF9U+2BX]SSCX4S@7M_ >K(KC\#C^M>IUXOX*F;2/' MI.-Y
M>W;ZYX_45[.*WQB_>W[G!E,KX?EZIM"TTTZC%<IZAQVKQ_9?%UI,.!.FUOK5
M&X39/(GH36GXM(CU#2Y.XEJE?C%[)[G->I2=XQ?E^I\OCXI59)=_S1RTHVS.
MOH348%27A(OI%[9IA.!DUW+8\"2LP) ZTG<>E1$F1O:I@,"F(3()P*C<\_>Q
M0G^L-2;1GD4 0]?4^] ZX')J0H"<9X]J< %Z4[@2V%OYMTN1\J\GWKJ+ !9F
ME;[L:EC6+I:?+(_OBM*\E-MH-PX^]*1&*Y:NKL=V&5ES?,V?!D9:RN+MOO3R
MEJZ<=*RO#UO]FT2U3&#LR?QK5' KRJTN:HV?982')1C'R%I#2TC5D=!YU\5)
MP+*QA!^\[-CZ"M7X<QB+PPCM@;V)KD?B;>>?X@AM%.1!&,CW;G_"O0/"VFBV
M\/6D;YSL!(]Z[:GNX>,7UU/(P[<\=4FNBL;+7*#@<_2F^9,_W5V^YJ58T7H!
M3ZX[H]6S>[*X@9N7<FI%A1.BU)11<%%(****104444 17,9EM9HUZNC*/Q%>
M<>"?$NF^'M)NM.U64VUU#,Q\ME.6^E>F53FTK3[B<3S64$DH_C:,$_G6M.:2
M<9+1G/6I2E*,X.S5]_,\Y\)W-C=:=XIN+]76SED#. /F .?UJG)K,>A6"-H'
MB:6Y"D!+&6(MQZ=*]6BL+2#S?)MHD\TYDVH!N^OK4,>C:9%-YT=A;+(#G>(P
M#6WUB/,VUIIIZ(Y?J51045)75]=;ZN_1G$ZM-)<>._"TTR>7*\.YT_ND@Y%3
M:2BM\6=78J"5@&">W"UV\EE:S7,=Q);QO-']R1E!9?H:$LK6.Z>Z2WC6X<8:
M0*-Q'N:CVRM:W1K[V:/"2<N9O[2?W*QQ&N+CXI:05&&,#9([\-5#2M5@\)>*
M]6&KQ2(EXX>*X"9!'/'ZUZ,]E;2727+P1M.@PLA4;E'L:Y/6[7Q-'J<CV26%
MW9R8V13KRE53J*24'VM^-S.O0E"3JQWYK[7Z6V,)-:MM<^)^FW-G$ZPK&4$C
MKM\S //]*],G_P"/>3_=/\JY#0?#>J/KPUO6V@66./RX((/NH*[,@$$$9!J*
M[CI&/1&N#C-*4I]7?MT70XCX8HHT2^<*-S7CY/KP*S]!GDL=>\8SVT6^2)G=
M(P.I!->@VUI;6:%+:".%&.XJBX!/K2165K!-+-%;QI)*<R,J@%OKZT.LG*3M
MNO\ ((X5QA"-_A=_S_S/*Y-<?4?#4\][XD=;F1&4V,<0Z_W<8K4M(I)_@RR1
MJ6;RF.!Z!S7<_P!C:9YK2_8+;S&SN;RQDU9AM8+:W$$$*1PCHBK@#\*J5>+5
MHKJF13P<U*\Y7T:Z]>NK.0\,:YIUYX0CT^"X5KN"Q(DBP05PN#5'PEIB:Q\-
MIK)ADR-)M]FSQ7;P:786S.T%G!&T@PY5 -P]ZEMK6WLXO*MH4ACSG:BX%3*J
MO>Y>K3+AAI>YSM/E37WV_P CRG2+JZ\3W6D>'[E&V:<Y:Y)_B"G"C^E7_%\4
MNF>-[74I;B:UM)(O+6YC3=Y9]*]%AL+.WN))X;:*.:3[[J@!;ZFI)X(;F(QS
MQ)(AZJXR*MXA<Z:6FOX[F:P+]FXREKI9^FQYU:)INM>([ #Q'<7]Q ?,C(AP
M!Z@G%>CO_JV^AJO:Z;96))M;2&$GJ8T S5EAE"!W%959J5DMD=.'HNFFY;OU
M_5L\M\"^)=*T8:C;ZA)]G9[AG64J2&'ID5;T*4:SXSUG6;*)EL/(,>\K@.VW
M'],UL^$_"YLM.NX-7LX)"]RTB!@'&#7516T$$/DPQ)''C&Q5P*VJU8*4G'=J
MWD<N'P]5P@INR3O:VN[.+^%\2#P[.X4!VN&!;')K.\.ZI:>%=?UFTUHFWDGF
M\R.=E)#KSWKT2VL[:RC,=K!'"A.=J+@9IEUI]G? "ZM8IL=/,0'%0ZR<Y-K1
MFD<)*-."B]8_<>?V)_X2?QKJ6H:8K)9_8V@\[;@.Y7 -,\*^)-/\-:7-I&L1
M2V]U#(Q/[LG?7H\-O#;1>5;Q)$@Z*BX%<5=VGC*.Y?$&EWJ[B8Y9%PRC\JN-
M2,[QZ:=>QE.A.E:HM97=[*ZU\K^1E^!KQ+KQAK=PD31)*N51A@@9[BM'X7Q(
M-.U"4*-YN2"V.<5>\-^'I=(^V7VIW$<NH7C;GV?=4>@K<L&LK-&C@ACA!.3L
M7 )]:=6HG=1[)?<+#49+EE/2SD_O.*G\0W5SXBU*UOM;_L>&V;$2"/F0>N<5
M#X"D$NI^(G69YE8$B1EP7Z\D5W\UEIE]()9[6WF<=&= 2*FAL;.!Y'AMH4:7
M[Y50"WUJ'6CR.*6ZL:K"S=53<KI._7_.QR'PQ11X8F.T9:=\GUJ+X<1HMSKS
M!0#]KVYQVYKM[:SMK.(Q6T$<,9.=J+@9I+>RMK0R&WMXXC(=S[% W'U-*59-
MS?<JGA7!4U?X;_B<'H?V>/Q=XM%P,6^&,@ _AYS6+_:5CHVGR2Z!XGF0*=R6
M,L1;)].E>K1V5K%/+-';Q+++_K'"C+?7UJ#^Q=,\[SO[/MO,SG=Y8S35>-]5
MT7X$2P<VK1:O=OKU?DT-T*[N+_0[.ZNH_+GEC#.N,8-:%   P.E%<\FFVT=T
M$XQ2;N%%%%(H**** "BBB@ I&4,"".#2T4 5AF!\'E#^E6 01D4,H88-0*QA
M?8WW3T-/<CX?0L4444BPHHHH **** "D*@]0*6B@")K=#R!@TSR9$^X_'I5B
MBG=D\J*PDF3 9<^XIZW*'KD?6IJ:T:MU44706:V8!U;H13J@-LO.TD4TK.F<
M'(HL@NUNBS15<3LO#H?J*D6>-NC?G19@I)DE%("#T-+2*"D(!&"*6B@"M+$R
M*S1GL>*^>Y@?/DX_B/\ .OHVJ$FCZ>_/V2 'UV"MZ-;V=[HY,1A_:6LS$^'?
M_(H6_P#OO_Z$:ZJJ,#1V2"$(J(.@48%7%=6&5(-9S=Y-F]*RBH]AU%%%0:!1
M@'M110!&T$;=5J,VY&2CD&K%%.[)<4RJQN8^@#"F_;'+!?+(/O5RFLBMVYIW
M743B^C(=L[CE@![4HME_B)-.^9/<4]7#4KL%%=0$:KT44AB1CDJ*?12*LB V
MR8XR/I2>1(N-CU8HIW8N1%;,Z$Y&X4OVDJ!O0BK%(0#U%%PY7T9%]I3WHJ3R
MT_NBBC0+2(3#(IRC_@:3S9D^\F1[59HHN'+V*?\ :" X8$'TIXNBX^1"?K2W
M,2E0X494YJ6,@H" *>A*YKV;(?W[X_A% MBWWW)JS12N5R+J1+ B]L_6I H'
M0"EHI#22V"BBB@88!J-H4;^'GUJ2B@3297-NR_<<B@/.F-P#"K%%.XN7L0"Y
M7^($5*KJW0@T,BMU J(VRYRI*_2C0/>1/158K/'T.X5$;YT.)$*T<M]A.:6Y
M>HJHEX7R%0DT_?.^,*!]:+,.=/8L4A91U(%0"&5CEI/PI1;+C!)/UHLAW?8<
MUQ&O\5-^TY/RJ33UAC7HHIX '04:!:1!YDS' 3 ]:@D@N9,Y? /:K]%%["<+
M[LX_Q9IDSZ-YH.X0-N_ \&G^!;X3:=):,?GA;('^R?\ Z^:ZFXA6XMI87&5D
M4J?QKS/2IW\/>)S%*2J!C$_T/0_RH;N5&/*K(]0HIJ$,H(Z&G4AG+^.%SH@(
M[2 _SJG>-YMC8S?WHA_*MOQ1:FYT"X4#)4;A^%<]IS?;?#$)'+VQ*L/:@#F_
M$<),<,P&0I(-9*-N0&NMN85N('B;HPKEY8FAE:-Q@J<4 5EA^?+<BIJ*,T 0
MW"Y Q3E.U!GTI&F!'R<GTIGG'^YS0!+EF['%+@],X'M0C9 SC/I3B<4 "("Z
MCU.*ZR !D1$.<86N>L8#(XE8?*/N^]=5H=MONE9ONK\Y^@H 6_07'BW3K0<B
M)5R/U_I7=@8KB_#B?VCXFO=1/,<9*H?T_E7:T %!HJO>726=I+/(<)&I8T <
M+X[OA-J$5FIXA7+?4_\ UOYUT'A>S-IHD088>0[R*X2$OK&NAY<GS9-S?2O3
MX9H$V(IPJ* *:3)E)+0O#@44Q94?[K T^D4%%%% !1110 4444 %%%% !111
M0 4444 %5M0L8=2LI+2X!,4F-P!Z@'/]*LT4)V$U=69'#!%;PI#"BI&@PJJ,
M "GE0>H%+10,88HSU44W[/'V&/I4M%%Q<J(/LJ@Y!/YU6DA<R;8YF_PJW-*%
M&T?>/2B*,(,G[QZU2;(<4W9$*V;Y^:9C4@M4SDD_G4]%*[*Y(D0MXP<[<T\(
MHZ**=12N.R0F!2T44#/&?&ML^B^-?MD8VB1EG4CUSS^HKUNPNDO+"&YC.5E0
M,#]:Y7XDZ*=0T-;Z)<S6AW' Y*'K_C5/X::W]HTV32Y6_>6YW1Y[H?\  UVU
M/WM",NL=#R*/^SXV5-[3U1Z#12=J7-<1ZYR'CD%$L9NR257U#FX#C^) :V/%
MUF;O1)"HRT1WBL&WD^W:-!..7B&Q_P *]*@[THOMH?.9C!JO+S2?W'/ZG"R7
M0D X:JS+N6MZY@$\)7OU!K#=6C8JPP17=!W5CY^M"TKC%4**=1368J.*LR&J
MI#DTX[CTJ/<2<@XI58@Y)S]* ) O')I< 49XJ:VA,KY884?K28TKLT; A(53
M&">:LZRI:WT^S7[TLF[%+8VQEG48_P#U5:L8QJOB[>HS!:# /;(_^O7+*23Y
MNVIZN&IN5H=VE_F=K!$(X(T'15 J7% Z45XY]BE96$J.>1(86E<X5 23[5(3
MBN.^(6N#3M!-M&V)[H[ !U"]S5TX.<E%&=>JJ5-S?0\[C\SQ+XT,A!(GGW?1
M0>/TQ7N4,8A@2,# 50*\R^&.D%YY=3D7Y1\J$UZC6^+FG/E6R.+*Z3C1]I+>
M3N%%%%<IZ04444 %%%% !1110 449Q3&E11RPH"X^BH#<KG"@FF^9,X^5<?6
MG9D\ZZ%FF-*B]6%1>3(V=[TY;9 03R:- O)[(:;I?X035>5[B9<"/ [&KP15
MZ**=3ND)Q;W91C:\& 0IJ8R3C^ &K%%*X*-NI )G RR$4"Y!ZJPJ>DP#VHNA
MV?<A%U'G!.*?YT9_B%.,:'JHIC6\;?PT:![Q('4]"*6H#;*1@$BD^SL!A7-&
M@7EV+%%5O+G7H^:0R7"KR@/THL'-W1:HK/:^D0?-$:>EQ/+P$QGO3Y6+VD7H
M7::75>I J$12L?F? ]*46RXPQ)^M*R'=]$*US&#C.33?M#'.U#^-2B)%Z**?
M1H%I=RN?M#^BB@6['.YR<U8HHN'*NI"+:/'(S]:#:Q'^$5-11=ARKL5_LD0'
M Q]*0V[#[KD59HHNPY(E8"=#U!%+Y\BC+QG\*L447#E?1D(N4X!X-/$J-T84
MIC1NJBHS;)DD<9HT#WB:BJY@=1\CD49G0\@$46#F?5%BBJ_VD@?.A%.%S'W;
M'UHLPYD344P2QGHXH,L8ZN*0[H?14)N8^QS]*07(;[JFG9BYD3T56\^0GB,B
M@M<'HH%%@YT6:;(@=<&H0LY'+8-)Y,QZRXHL*]^@Z*0JWEOU[5/5![%VY\UL
M^M*B741X.X>]-I,E2DM&B]15?SW7[Z&GK<1MWP?>E9E\R):*0,#T(I:10444
M4 %%%% !1110 4444 (0#U%,:%&_AYJ2B@3296>U;'[N1E-0L]Y#U 8>M7Z"
M,C!JE+N2X=M"HK7$BY!6G".<CEJ5HVB.Y.GI4L<HD'H?2AOL)+HR$P2GK(:4
M6YQRY-6**5V5R(K-91O]XDTW["$_U3LM6Z*.9B]G'L5AY\8[,*=]HP?G4BIZ
M0J#U -%Q\K6S&K*C=&%/J)K=#R!@^U,,,B_<?\#1H%VMT6**KB65,!TS[BG+
M<H>O'UHLPYD344@93T(-+2*"HVC[KP:DHH"Q&'*G#4\$$9%! (YJ)_W?(/X4
MQ;$U%0)=Q-P6 /O4P8'H0:5@33V%HHHH&%%%% !1110 C#<I![U#;-C<AZ@U
M/59OW=R#V:FB9:-,LT444B@HHHH **** "BBB@ HHHH **** "HIXP\1R*EH
M(R,4":NK$-M@Q @8J:J]O\LCIGO5BF]Q0V"BBBD4%%%% !1110 5Q/CG1RRI
MJ<*\J-LH'IV-=M4<\,=S \,JAD<8(- '.^$-9%_IXMI6_P!(@&/]Y>QKIJ\M
MO+>Z\*:\'B)*@[D/9E]#7HFEZG#JEFMQ"PP>J]U/I0!;D021LC#*L,$>U<%:
M9\/>(9K&X/\ HMQPI/3V_P *] K%\0Z(FL6A"X6=.4;^E &!>VK6DY7'R'E3
M[5A:G MQ]P 2K_%_2MW3=0%PITG5 8[J/A';O574=+GMIB2N5/0CH: ..(EB
MDV2I@^M,D=U;('%=2EH'/[U 1Z&J]SI$)YB5@3Z&@#F"5)S@J?:C/^W6XVC
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M\-=#X<TC^R]/4/S/)\TA]_2J>A>'&MI?MU^?,NVY /(6NF KBKUE;DC\SZ'
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M9BSLQ^9VZ"@ 1+[Q)JN3EW<\GLHKTK2-+ATJS6&,#=CYF]33-'T:WTBU6.,
MR8^9^YK3H **** "BBB@ HHHH **** "BBB@!DCB-"U,@0@;VZFFM^^FVC[J
M]:L4]D2M7<****104444 %%%% !1110 4449 H **8TJ+U85&;E>=H+4[,3D
MD3T57,DK?=3 ]:3RIGSNDQ]*+"YNR+!=1U(J-KF,=#GZ4T6R\%B214BQ(O11
M1H'O$+7#D?)&34,GVN4CY0%J_@"BG>PG!O=E51<@8.VE_P!)]%JS12N/E\SS
MGQOX.FO0^J640\]1F6-?XQZCWJAX,\;&S9-,U1B(P=L<K=4]C7JO45P'C'P&
MM^7U#2U"7/5XAP']Q[UUTJT9Q]G5VZ,\O$X2I2G]8P^_5=SO(W62,.I!4\@@
M]:<:\;\.^,K_ ,.3_8=0222W4X*-]Z/Z5ZIIFLV.KVXFLYUD4]1GD?45E5H2
MI^AU87&TZZLM)=B>[LX+V$Q3QJZ'L17,S^&;W3W,ND7)V]?*<\5UPIV*FG6E
M#;8NOA:5;XEKWZG!RZI?6_R:CI3''5E%1?VYIAY:SF4_2N_**WWE!^M0-96S
MG+01GZJ*W6)AUC]S.">5R^S/[T<*=?L%_P!58R,?<4#6M1N3LLM.*YZ?+7=+
M8VJGY;>,?\!%3)&BCY5 ^@I_6H+:/WL2RN?VI_<CB8/#FK:FP?4;@PI_<4\U
MT^F:+9Z8F+>(!N[GDFM+%%85*\YZ/1=CNH8*C1=XJ[[L0#%+0>E4K[4[33;=
MI[N=8D'=CU^E8I-Z(ZG)15V66;:"2>!7G?C3QPL8?3=+DS(1MEF7^'V%9/B?
MQ[<ZH6LM,W16Y."X^\_^%3>$O LMY(E[J*E8ARJ'J?K7;"C&DN>K\D>16Q53
M%2]CAMNLB+P3X0DU*X74+U"(%.Y0W\1KUM$6- B !0, "FPPQV\2Q1(%11@
M5)7-5JNI*[/0PV&AAX<D0HHHK,Z HHHH **** "BBB@".89B84L/^J6DF8")
MLD=*9;2+Y*_,*?0F_O$]%%%(H**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ IDJ;XR*<64=2*@ENXXQUS35Q-JVHZW;='@]14U9B7NR5CL.TU;CO
M(Y.^/K3<61&I%Z7+%%-#J>A!IU2:!1110 4444 %%%% !1110 4444 %%%%
M!1110 5P7C/Q&K$Z;9MG'^MD'\A6]XMU*ZT[26-K$Q:3Y6D'_+,>M>5$EF+,
M22>237E9CBG#]U'YGNY1@8U/W\]ELA*L6=[/87*W%M(4D7N.]5Z*\5-IW1](
MTI*S/5/#OBBWUB,12XBNP.4)X;W%=#7AD<CQ2+)&Q5U.00<$5Z%X:\8I=!+/
M46"S=%E/1OK[U[>$QZG[E7?N?-9AE3IWJ4=5V['8T4=:*]0\,**** "BBB@
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M'S-M^E210JB+QVJ6AM= C%VU9"MLH^\2WUJ01JO113J*5RTD@HHHI#"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@!"H(Y%4[BV41LP49J[4-R1Y8![FFG
MJ1-)K4KP6:A%+ $U<5%4  "A!A /:G4-W'&*BM HHHI%!1110 4444 %%%%
M!1110 4444 %%%% !1110 4THK=0#3J* *LUJ&&5)'TJFRSK((E<X/?%:U5N
MMY]!5J1E."Z$<-HQYD=B*LK!&O\ "*DHJ6VRU!(0 #H*6BBD4%%%% !1110
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M3MZX/2E1TD7*,&'J#FKIT8P:Y>UON(K8BI534EN[_,=1116QS!1110 4444
M%0RQ<[TX:IJ*!-7(XI=_!X:I*AEBR=Z_>IT4@<8/##M3$GT9)1112*"BBB@
MHHHH C29'Z''UJ2HG@1^V#[5'MFB^Z=PIV1-VMRS14*W"DX;Y3[U*"".#2L-
M-/86BBB@84444 %%%% !1110!7F^29' ]C5BH;E<QY].:DC;=&I]J;V)6[0Z
MBBBD4%%%% !1110 4444 %%%% !1110 56?Y;Q/<59JO/Q-&??%-$RV+%%%%
M(H**** "BBB@ HHHH **** "BBB@ HHHH **** &N<(321#"?6DE/ 'K3P,
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MMG.;>UMN)9%'S$U8'AB\LYXI;'59N&'F+,<@BJ4<X\,^)[QKQ66TO&WI*!D
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M6,L/&4N9M^G0Z*>+G3CRQ2OWZD<L$4\?ERQJZ?W6&14=O8VEH2;>WBB)Z[%
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ME1^*?%<FG7+V%HJF0+^\=NV1V_"NGL;*'3[2.V@7"(,#WKDO%?A6ZOK\W]D
MY< .A.#D#&17IUJ=>EA%"ENMSQ\/5P]?'2J5M(O:_?S)/ VLI-;_ -F,FUXP
M64_WAGFNRKC_  CX:N=,N'O+P!9"NU$!SCU)KL*WP*J*@E46OZ'-F3I/$R=)
MW7ZA115&XUG3K6;R9KN-)/[I-=4I1BKR=CBC"4W:*N7J*:CK(@=&#*>01WIU
M42%%%% !1110 4449Q0!7A_U\E6*K0,/.DY[U9ILF&P4444B@HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **0D#J:C:X1>^?I0)M+<E) ZU65E-TQR,@
M5#+-,[?(AQZFH5AG1RX()/:K43*4]=$:M%5(YG1?WB$5.L\;=&J;&BDF244
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M\JVR[&2Q":GNC#-<!#"RC*GLR:BBBO2/("BBB@ HHHH **** "BBB@ HHHH
MC/\ K*DJ(G]^![5+0)!1110,**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ J(',Q%2U'&<NWM0)DE%%% PHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@".7[F/6GJ,*![5'*>5'K4M NH4444#"BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** &2G$9I4^X*;,< ?6GC[HIBZBT
M444AA1110 4444 %%%% !1110 5%<3I:V\D\APB*234M<GXWU Q6<=FC8:4[
MF^@K'$5E1I.H^AOAJ+K58TUU.8_?^(M>YS^\;_OE:]+M+6.TMHX8@ B# %<S
MX+TT16CWKK\\G"^PKK5Z5QY;1<8>UG\4M3LS.NI5/90^&.@'K3)95BC9V. !
MFGFL/59VN+A;.(]3\V*]"<E%79P4J?/*Q7;S=7NR<E85/7VJR]Q';IY-NH '
M!/K2SE;2!;>+CCYB.]4B0HRQXKR:U9IVZG<ESI=NB+._Y=Q-5)KT*"$Y/K5>
M6=I,]E'057)S7#4K/9'3"BMV/DFDE/S,<>E1Y_*CI36D5%+,0 .I-<[;>K.E
M)+1$B#O3^:S)-;M(R0K,_P#NBFC7K8GYED7W(J/:P74OV%1Z\IM1SO&>N1Z5
M>BF68 CK6+!=0W*[HI WMFITE\MP1733JM>ARU*5^FIMPRF)\CIW%17:FSN8
M[R'[C'YA3(G$@R*MA!<6<L)Y.,BO2HSZ'%)<LKOYFG%()8U<=",TVXMTN8'A
MD *.""#5'192]IL8\H<5JXKTU[T=3BG%TYM+H>5WUM-H.LD(2-C;D/J*])TV
M]34+"*X0_>'/L:P?&6F_:; 72+^\A//NM4/!&H%9);)VX(W)FO*P_P#LN*='
M[,M4>OB?]KPBK_:CHSN****]@\4**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@"*:%95(QS5);60N5#D**T2< FF1#@D]S5)M
M(B4$V1QVJJ/F))J188UZ**DHI78U%(, 4444B@HHHH **** "BBB@!C0H_4<
MU%Y#I_JW/T-6**=R7%,K^9*GWER/44Y;F,_>.WZU-4<D*2+@@4:!9K9AY\7]
M\4PW48^[EOI4"64;,3G@=JMI$B# 44]!)R9%YLK_ '4P/>CRIG^^^/858HI7
M'R]R%;9!UY^M2JBJ. !2T4KC22V"BBB@84444 %%%% !1110 48'I110!#)"
MA!)%$$:K&"!4DGW#21?ZL4[Z$V5Q]%%%(H**** "BBB@ HHHH **** "BBB@
M HHHH **** .(\8^&[BZN/[0LT,C$8D0=>.XKCH=*OYYA%':3%R<8*$5[12
M '( KS*^5TZM3GO:^Y[&&SFK0I*FXWML87AC1CHUDT<A!FD.YR/Y5E^(=:L$
MU[31YV?LTI,NT9VUU;!BT@4X8J<'WKQJ]@FM[V6.=6$H8YSWJ,?4^K4HTZ:T
M_P M2\KI+&5YU:LM?\]/P/:+>XBNH%F@</&PR&'>I*YOP3;W$&@CSP0&<L@/
M85TE>C1FZE.,VK7/*Q%-4JLH1=TF,FB2>%XI!E'!4CVKS/5O!VH6ERQM8C/
M3E2O4#WKT^BLL3A*>(24NAO@\=5PC;AL^AYMH?@V]N+I);Z,PP*<E6ZM7I"J
M%4*!@ 8%+13PV%AAXV@3C,;4Q4E*?3H%%%%=)R!1110 4444 %%%% !1110
M4444 0_\O'X5-47_ "W_  J6FQ(****0PHHHH **** "BBB@ HHHH **** "
MBBB@ HHHH ****  ]*BA'WC[U(W"FF0C"4Q/<DHHHI#"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** (CS.!Z5+4:9+DU)38D%%%%(84444
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M+N0#\HJ[=OLB]STK/&!7BUI:V/0HQTN(W2HZD;D5'U_&N=G0B&XN$MH&E<\
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M*0IP?>LV:)G-^((&\Z&?!VC@_6JH4RC:HR#W]*ZF:V2XA,4@R#6!/I=Y:.3
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M+C.VH38N>6D8GUII+J1*3Z(O#I2U4CAGB'#[A3O.E7[Z?E2L/G[HLT5 +E.
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M_<2BS$Y(L]*C:9%ZFHO*E<_.Y'TIZVZ+VS]:- O)[(:;@M]Q2:39-)]YL"K
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MG''TJ:BG<3296-LP'R2$4N)UQ@@U8HHN+D70K&>5,[HR0/2HFOO]D@^F*O5
MZJ9E&!331+4NC(DFGE'$>!ZFI! ['YW./058HI7[#4>Y$L"+VS]:D  Z"EHI
M%));!1110,**** "BBB@ HHHH **** "BBB@ HHHH BG^Y4@Z"F3#,=/7[HI
MBZBT444AA1110 4444 %%%% 'S)<_P#'U-_OM_.HJEN?^/J;_?;^=15]"MCX
M5[A1113$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%% !1110 4444 %(>!2TUSA": &Q<@FI*9$/W8I]#$M@HHHH&%%%% !1110
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M2_<QZT^HY><"A">PY!A *=0.E% PHHHH **** "BBB@ HHHH **** "BBB@
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MQ1WKRV'4=5TMM@EFC _A?I6K!XVO$P)H8Y/<<&M(YK2VJ)Q9C/**V]-J2.^
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MJY117J)6T1Y3;;NPHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% "
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M@!K*+E)M:ZIG145.FE+2ZDNVWWO\2OXQ&FZAXEDLM.M)8]0>[,<LC-E78G'
M[<UI7&@>&]%G33KRTO[NXP/-GB4[4)]*S_$:6%EKH\0:?JL%T[W8G$"CYEYS
MS707NJ6VN2K?67BH:<CJ/,MY5Y4]\47:A%*]NN^X[0=6HY)7OIMMKYV_4XGQ
M7X?_ .$>U588Y#);S()87(YVGL?>M+P-H.G:X-3_ +0R%@B#*X.-O7)K(\37
MIN]595U*6_@B&V.608/O^M=1\,O)\K7/M!(A^S#?C^[SFM9N2H-MZG-2C3EC
M%%+W;[?(CL-.\':Y=G2K-;N"Y((BG<Y#D>U1>%O"=G>WFM6>J95[,%?,!P$(
MSD_I5G2-.\.>']2&L/KL=S'%EH8$7YR>V:CT#7K:=O%%U=SQP/>0N8U8XR2#
M@"LY.5I<C=K?B;PC3YH>U2O=[6VMU^93AT+1O$'B*"PT1YDM8XRUS-)U(!ZC
M]*N6]EX*U#4?[(@6[CF9O+CNBW#-]*PO!VN1:#K@GN%)MIHS#+CJ >_Z5T%G
MI'AK3=875VU^*6VC?S8X%7Y\]0#533B[-NUM/4SHN,X\T8QO?6_1>7]7*>E^
M"4&L:G'JLYCLM-&Z5TZN.HQ^%7]%T_P9X@U9+.WANH)!DJ';B4#^51Z=XQM+
MS6M9748G73]27:2HR8P!@$_A6CX0TGP[8^)(I+/4WOK@AO*14P$&.2QJ)2FD
MW.][=/Q-:<*3DE22:N[WWM?2WR[&#I/A2UO]:U9KAI(].T^1MP099L$X _*K
M\?AS0M?M[F+2[6]L;R&,NGG@[9 *31/$=KIVOZ[974[0V][,^VX3K&V3@U->
M7)L;*YG/C0SOL/DQPIR3Z&B3J7WZ*P0A12>B>KOMWTW:MIV*>@^'M$E\'7&J
MZL)5:"X*L4/) Q\N/QI)=$T#7/#E]?Z(D]O<62[WCE;.Y?\ ]50V^I6O_"LK
MRT>Y3[6]WO\ +)^8CCG%)X0U"TM/#_B&*XN(XY)K8K&K'!8[3P*J7/[TKNZ?
M^1$'2O"FTK-.[Z]1MII5F?AW+J<HD,J72J0'."N1GCI73ZS=^'T\#Z3)/83O
M:/D01J^&0X/4US4&H6B_"ZXL3<1BZ:Y#"+/S$9'.*O0RZ5XA\$Z?IL^J16-Q
M9,=PE&=PYZ4JB;;;O92_"Q5&48I1C:[AY;W,[1= TJ#P^VO:X\IMV?9#!'U<
MU-=:#HFM:!=:IH'G0RVG,UO*<\>HJ33+W2M6\+GP[J-Z+62WF+V]P1\K=>OY
MU(;K2/"?AN_LK/4$U"_O@$9HQA57_)-.3E=[WOIVL3"%/E5TN6VKZW_K8DM/
M#_ANW\(:=K.JF52^=ZQG)D.3@5PMX8&O)C:AA;ESY8;J%SQ74ZU?VDWP^T2T
MCN(VN(G8R1@\KUZUQ];4D[R;?5G+B91Y81BELF_6QVUMH.BZ+H%KJFO^=-+=
MC,-O$<<>YJE>Z7HFJWVGP^'YI1+=OL>"4?ZOWS6H+O2/%GARPLKS4%T^^L5V
M*T@RKC_(%9TITCPMJNF76FWS7US ^Z<J,(1[?@36<6^9W;OKZ>1O.,.1<J7+
M9:];]?.YLS:%X7L+T:5/::C-*"$>[13M5O\ "I/#&AOX?^))LB^^/R&>-_[R
MGI5J\O[;5+K[=9^+A9V[_,UO(OS+Z@5D^'=:@7Q^]S=ZH9K9(VCCN)_ER.U9
M+G<7?L[[G1)4HU(M)?$K-6V^^_WD_A?_ )!GC#_<;_V:JND>'-*@\+0ZS?VU
MU?-,Y416_P# />CP[J5E;Z?XH2:YC1KA&$08_?\ O=*;X<2./2XWM/%@T^<D
MF6"5?E'TJFI*_3;\B(N#44TG\7;OYG/:_P#V1]IC_LF"YA7;^\2?J#[5D5V7
MCO4].OA8PVTT=U=0IB>YC3:'-<;712;<-3@Q,5&JTFOD%%%%:G.%%%% !7O?
M@#_D2]/_ -UOYFO!*][\ ?\ (EZ?_NM_,UQ8[^&O4]?)_P",_3]4=+1117E'
MT@4444 %%%% #6C1NH%0FW(Y1B*L44[B<4ROOFC^\NX>U--['TZ'WJU52>W!
M!.T&FK/<B2DEH(;Y5.#S]*>))91E5P#W-1P6H"@[1FKBC: *';H**D]R$6^>
M78DU*L:KT%.HI7-%%(****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "H_P#EK4E1G_6BFA,DHHHI#"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH ***:75>] #JCED$8I-[MT&!080WW^:9+
M;>Q3DF:0_+FE$T@/W35L0(.E.$2CM571')+N11SMM^934GFC'(J3 I,#TJ2T
MF-$JGO2^8OK1L7TI/*7.<4:#U';AZTN149B![FD\H@<-2"[):*B"./XLT#S!
MUIA<EHJ+S'!^[1YO."*+!=$M%,\U>]+O7UI!=#J*:TBKU--\Y: NB2BH_.3U
MYI/,)^Z*+!=$M%1?O**87):***0PHHHH ***:YPI- #%^:4GTJ6HXAA<^M24
M"04444#"BBB@ HHHH **** "BBB@ HHHH **** (I/F=5J6HD^:0GTJ6FQ+N
M%%%%(84444 %%%% !1110 4444 %%%% !1110 444A(% "TR4@)S39)E1<BJ
M;RO)T!Q32N1*:6A?C&$%.JE%.00K BK@8'H:&K#C)-"T444B@HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** /F2Y_X^IO]]OYU%6GXAL'TWQ!?6KC
M&R9MONI.0?RK,KZ"+NDT?#SBXR:844451 4444 %%%% !1110 4444 %%%%
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MO;?]]&C_ (53K7_/>V_[Z-'UBE_,'U'$_P C.#HKO/\ A5.M?\][;_OHT?\
M"J=:_P">]M_WT:/K%+^8/J.)_D9P=%=Y_P *IUK_ )[VW_?1H_X53K7_ #WM
MO^^C1]8I?S!]1Q/\C.#HKO/^%4ZU_P ][;_OHT?\*IUK_GO;?]]&CZQ2_F#Z
MCB?Y&<'17>?\*IUK_GO;?]]&C_A5.M?\][;_ +Z-'UBE_,'U'$_R,X.BN\_X
M53K7_/>V_P"^C1_PJG6O^>]M_P!]&CZQ2_F#ZCB?Y&<'17>?\*IUK_GO;?\
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M&X_>*:DZ5!+*JLO--"EL3T5&)5-2=:0[W"BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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@B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>img88009329_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_2.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" *T!@8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"D5U;.U@<'!QVI:J6/WKG_KJ: +=%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%%% !115"]U2.ROK*U:-F:Z<HK \+CUI.2CN5&$INT2_1113)"BBB@ HHHH
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MO;)N8#W]*I1^-8X9DCU72[[35<X669,IGW/:H?A_ DNEW&J28>[N[AS(YZ@
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M** "JEC]ZY_ZZFK=5+'[US_UU- %NBBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M44 %%%% !52Q^]<_]=35NJEC]ZY_ZZF@"W1110 4444 %%%% !1110 4444
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MIR7\U8****LS"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "JEC]ZY_ZZFK=5+'[US_ -=30!;HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ JI8_>N?\ KJ:MU4L?O7/_ %U- %NBBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "JEC]ZY_ZZFK=5+'[US_UU- %NBBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "JEC]ZY_ZZFK=5+'[US_UU- %NBBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "JEC]ZY_ZZFK=5+'[US_ -=30!;HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ JI8_>N?\ KJ:MU4L?O7/_ %U- %NBBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***#0 4444 %%%%
M !1110 54L?O7/\ UU-6ZJ6/WKG_ *ZF@"W1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M#10: "BBB@ HHHH **** "JEC]ZY_P"NIJW52Q^]<_\ 74T 6Z*** "BBB@
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M"Y62T. KR<'//>@"FC36VML$_<R%#+)"#N2X.. I/0C'ZUKV&I07ZN$8":/
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M.ASTJ2%(40K $"ACD)TSWJ!YSYLQB<2"%#NA0?,6ZCGZ5+ D40VHBQE_G*@
M')ZDT 3T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %(6 ZD"C-4Y$'V>1K_RY$C<R+M4_*!T_$4 /
MN'%J#-';-*[LJMY8&2,XR?89I=JJMP;?:TQ.2&;C=CC/IVILAN&N(3!)%Y(_
MUJL/F([8JMYOVFW>/!L+N<MMS@N=O\7OQB@!DBM+?9B<)J"1(74EC'M)Y]L]
M:B6#YC+'&RQN&5[&3&'"DC*CH,G!JW=/$(/(OW5!,PC1U)!8X'<=#G-5/GM[
MF*UG5BQC*6]]C<<D$D'TZ=>] %II9FDD:U>-VC15:U8XVGKU'?%8,5SL\V>&
M-[NUBDS+8S#,ENP[KGJ/\BM&>U^THJ3W'DW*C=%>0G ?  RW;OT-,F0?:P]Z
MBVDZ$^3>(1B3L WN<YP?2@"DTJFT-Q)=O<:>\WF^<C$2QG<-J$=QR:G"ZA#?
MGS1%;W C98I$/[B0DC[P_O4YTCBUDI&PM+HJ,[EQ#=G'IZ@_C3"6,LT=M&%F
M21I);.?D3GCE">G([4 ;=IJ<%Q<36N\"XA;:Z'@GC.1ZBKU<A]F,MG(TKS)Y
M19WFR?M$#'D*,?>'-:=KJLEMY<=XZ20+"&:]SM4MG !'8XQ0!N44U'61 Z,&
M4C((.013J "BBB@ HHHH **** "BBB@ HHIDDJ1(6=@J@9))H ?3))8XEW2.
MJ+G&6..:S9]2FD(%FB&*2/?'<L<J6S]W'4G%4+.5KT!92NRXD$JI<_,RMU*;
M/X>!D&@#0N-3)M)I(04V>8"T@^Z5[XZD9]*K7+R!EO&E2'B-&9R65U;J G8D
MX&:FMXECCE!AV2N)',?F;I,$]0>P/^% LF-M&T+K!*T"B1I5WR< 8S[CF@"N
M;0K<L4189OM.8FN6W[EXW;!VXJS' JV5XA,L6V1V2:<AMIQ]Y<]AVJ=9ENIH
MV2 /%Y6^.Y(& QXP >:9!;'[1(TUPT\_E!)(SQ&??;TYH JV9BDL]/GWR:@X
M;8LZ\=3RQ'I5R]G6"W\RXNEMU24$LO<9X!^M5G62:S6UFE6REPS-%;-EBG/3
MN/PJ2W6.589UME\F2,>9)<#$G'W<@T 3&W5(XX/*-Q"[EG:5L[>XZ]>:$@D=
M[F&YN%=9#F-4&UD3TR*2>W@NHHK.\D\QV/F#;E<X.>WIQ5K&V8?<"E<#^\30
M B^<L^T*OD!.#D[MW^&*GJO$OV.U FN"X7K)(0._>K Y% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4&B@T %%%% !1110 4444 %5+'[US_UU-6ZJ
M6/WKG_KJ: +=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %(S*BEF("CDDGI2%P&VY&<9Q56&Z2]:YA>WD41-L;S$^5
MQCJ/44 2F21ID"(&@9<F0-W[<5&5BDO@ZW!\R)2IB5^.<<D?A3B,1Q?9Y(TB
M0_,,9&T=AZ5F++%=37,<UK)93R(P^T+CYD!X(<?RH N7$D'E6\6I+%ODDP@Y
M*[AR.:JZBS6]JQN]\T<C,//A0!K=".OX>M3S79M(UDD0W%L2BHT0+MSW/M[B
MF2/<6B0?8;=+FRP%,:-\RC/W@3U'M0 UU6(1_:WV01&-89Q(=TA]&QVZ56U)
MX9IHK+4(WB\PYAO(20 Y)P,]C@?2G2[],MKRZLMU["&+&USN(?/.#_2GV\WE
MPQ2V>V?3V 'E]#"!G+>I^E %"XMKL74+3S1VMQ$/W5\@!2;/&UQZTL/GSZBQ
MEB6QNEXGC(#)=H 0-IZ5;L42* R6$XN[$KN\EVW-& .BY[D]C5.?-K&5N?,U
M*R9M[;@#+:D\C([C^5 "6R1V46V&V"*Q-Q+9S,"\&,_,@[]*FL-8>PMX!>S2
M7=O, 8[M8_NY/1_3ZU!>[4%N+U7NX%(,>HP !XC_ +>.U3-/'&P222)C/R]T
MD68749^1N2%..] '3!@0.0:6N:BO+BU#2)%&MS<2AOL[2Y5D'RY0].F#BMFP
MU&WU&$R6[DA6*L"""I]"#0!<HHHH **** "BBB@ HHHH ***:SJBEF("CJ2>
M!0 ZF22I$A>1U11U+' %5GO#)&K6ICD5BR[RW"D _GR,<5BSR13,UU=%A\BQ
M,&RT;Y_C1.3D-@9- &J^I&5&^RA-Z3^4WGDH#SSCCGVJK(ES/%-YH*LAF\MI
M "V.V$'##&>OM5:RMIK34V2:'S72(9NG?<9@HZ!<\-DU=B(6U\U\VT)B=RTS
MGS8RQR?8 4 48G\B%YRD5HCK&_GW');& 1L_A_\ KUIPZ?!%(\\($B7#^;(9
M6+ <<;1VHMLM)'"86FBCA!2[D()<GMZ^])<[[91?!9KEU3R_(A.%;)ZXH ;:
M>5'?7"12W$S3KYX=R6B Z *?Z5'>@+I\'V^[9'67=_HH*[R,G8 ,GI_*KKSI
M;K)))(BPQQ[B@'S+^51VMO%9Q(+5(TLRK2%F8Y#'G//XT  ,KQ,UM'%"9561
M6D')8]=R^O2HK_R;JWCO((6O)+=]T:12;<MG!]CCWIC^7&8Y65[Z_MX"\;*-
MNX-Z?P]JN&4KY$@DBCB/#*W4D] "#C.: )ONR\;!E<D?Q&H+9K2^=;V--SIN
MC#LI!'/(YI!.MP8+FWMQ(&)1I&^0HO?KSU%3F7S+9Y+4QRM@[/F^4GZB@">B
MFQEB@W@!L<@= :=0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !3)-Y \L@'(SD9X[TX]*@CMT%S)<*[EG 4C=E
M1CT%  UNANTN26WJA0#)Q@D'I^%">=]ID#M&8=HV #Y@>^:=Y;"X,AE;9MQY
M?& ?6J%DK17;SW-N8[JX8J3&2R;5^Z3Z<&@"!;9;YGOIG0/%)E9+1R2R+R%;
MU^E3DO)%=PW[1O$5RC1@B0*P].H(]:AT\.S.BI";:29I5FM&P, C ;U)YS01
M&;AKF1<3,C'[1",,D8.0"#SZ]J '8$=D;?;]NM$#))DY=0%Z8_B/Y=:1Y?LM
MD[6B&Y@15C%HHPR#O[DX/2GRVI>YAG?)F#/Y4D0P$4KQO&>:IFX$TS2S#9'&
MI$6H0,"IX&[(['(Q^% #+*-(;3[/"?M5BP)>VF'[R%/0+U//K4D<T]C'))YC
M:E:$Y,04&6(DC"X] /7FJ]PRATU&65+:4 (E_$=T<PYX8#MQW[U*DH\N-I)4
MTV\FD.)44;+@C@$^H.<XSF@"22"VFLWABVWEDI(:-3ND20MU!SQC)JK=0J]K
M%;W+?;K-"4^V1'][ P[G'7ZU.DPBN"+@I87\KG:R?ZNX SMS^?3K2(]Q$_G2
M,+*Z\PKY(8>5<MC(V^A/K0!6E>X58!<2M>6L;AH[^V/S1L/[ZCJ/6GL[/:7)
M>2V:&4@_;%0-'.>0$=>V..:@0>7,7LW&EZF_+6<Q_=2D^GJ3ZBD_?VMPTD42
MV.HS$;K:=O\ 1YO4J?6@!;34;K2A.X5GA!11;'A%)P/W;]",<XKK+:Z@NHM\
M,J2*"5)4YP1U%<O<PP/I9L_LJI*'S]DN"1&SDY.QOIG&*2W1K)%:WANHU2$(
MR=)%9WR6)/RD#% '7T5D6>KEWVSJ-CM)Y;J".%[$'G/TJT=4L]N1,K'<5"C[
MQ8=0!US0!=HS6)=7>J+!+,L:0CR\QH4,C;@#D''X5F#Q7<6%_#;ZA&CQLH,D
ML:LIBSC[P- '745'#-%<0K+#(LD;#*LIR#3V8*,DB@!:0D 9)K,O=92W7;;0
MO=S,,JD8^7'J6Z 52NIY[J.5MP=""$C0[4,;+RS'^+'^SZT 7YM41ITMK4B1
MW++Y@Y2-@.C?X55@GGEF*7"K,D9619W7'7@A5ZC'/)I3#Y%O',\<7[C9([F/
M"]#N9 .<X]:B@A:,S3F=H?-+AYY3F1E RI7T YXQ0 ):M(CH\SVTDCX8C!D.
M&^4C' !&1TJ98X(Y6O[J**UD?,3[CEF&<+D^]3-(&9'MPN9H>+T@'ITR._<T
M".&2[AN@IE9X"IG!^0 <]/K0 EKYTL/EV\)MH5B,:22#,@8' X/48YJ5&@#I
M<1+YTTJ^49E''RYZ^@SFJK74UQ/;26D9F:,A9)'RD95NK+ZGBI)H8G:))I9)
MU></"(EP$(&>2.WUH :US%=V)@O%6642JDL=J2VPYR,_UJ:9Y)GGM7NHH&E&
M(&B;]Y@=3S5:VN'F98[EX;:Z8N7MXF#-(HXZ]0:@L8C;6\2Q0K9VJQG)G.Z9
M')P/4<T :0E+PRLR_9Y4;R4EF4?-TP?H2>E5Y;"*^N;F.X>:53&J-$X*Q$CG
M(ITB-"\NRWGNV>5-XE;"C_:7/''MWI]S/B:=6O0BIL/EQ+F1<GOUX/TH F"3
M):1;Y8X3%S)L7(V@=!GI21-$72,AW:*,,L\B\'/'7UIL-K)!J<TL:I]GG7>[
M%CNWC &!T P*DDMHWM&M[N7S4E8CYL+G)R!Q0!)&/,B\FX*2R!1OPN%/X5/P
M.*KQ-<"[DC:)!;JJ^6X;DGOD?E4OE@S>;N;.W;C/'Y4 24444 %%%% !1110
M 4444 %%%% !1110 4444 %!HH- !1110 4444 %%%% !52Q^]<_]=35NJEC
M]ZY_ZZF@"W1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %(:6H;J62"V>2*%IG49$:D M^= !"R3J)0A!&5!=<'K_ /6HBN(I
MU9HW#!6*GV(ZU(C$H&(VDC)![54O5AN8A9S0O)#<@JQ3H!C/)[4 1!5?2)A%
M9J@8/^XE.P'DYR1TSUS[TZ-,6MK#'M@14!9 N]=H'*Y_'K4&'%O=QVDT5ZJ(
M(EM2P&T@8*EN?UI88HH1+;*SQ$PJ3'*"\4:XQ@=!^M $5HWV11;10"RC$S^6
M&^=91@G((^Z.<T@<&\)WO:3?NR\N<PR\'Y5S_P#6-2H2C3%R+>V5UC FP8V3
M&/EYXSG]*'EV(1&J(^#';VL[!48H>"N/;% %>]:6:XB1[AK"XB(V3*-T<I8'
M*X/7IWJ!)F;5I1-&NG7H 5)R=R7" ]!G S^M5[:5S;7=K'!*9"/GL;]L*0<Y
M"-WR35F:,S6,26UNE[&9#YUM=-EEYP=I/3;S0!)Y:+?PS%TTZ_ERTD((99P.
M "?UXYI\!:2Z#RPBPO,DN@(*W( P/FQTY^M5);X) RI$=1LHP(VAV?OXF'&<
M'J/>EDD_T22)435-. "&%1^]B((&#SS^G2@!T:@WDKV3);WQ3-Q9,OR3$=QG
M'_?0JG9D&YE^R[=.NR3YVFSX,<Q]0??U%7&&^U6V@?[=;I^ZDF20?:(3GC&/
M3CWXJM=(;@!+F*/5;*%C_I<1Q- ?3 ZD>HH ;;-#/92VL$!@<.6FL)B0Q/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M.3:S;CLO+/F"3_?';/O^=5IM$TSS/M,:06,Q<* Q!@N3CGOWSUJLFCZ3!/\
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M #@4 :-%4/[$TW_GSB_*KL<:11K'&H5%&% ["@!U%%% !1110 4444 %%%%
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MGKT^]]#0!,+=KRQ6Z@D#EXP3>VGRR;L]TZ'CK^-.E6:?3//#F6='V)=6(^<
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M#:K$C.?J?K0 Q"\<L-J984<HZHS-NE91T;W]320@EI%8376YQ%-Y@VHN%Y8
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MI16'>>+=(LIM.C>=I%U#)ADA0NF "<DCZ=LUN4 %%%% !1110 4444 %%%%
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MA$G$Y9E:"+Y"O;)[5':0A4L#(CD1[L/<M^\5N@'OD9H GD=EL9=JF_W2E2G
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MY"/XFZF@#(7PSI@O)"VF6!MRHV 0#<#WR?RJI<Z#H;)<1SZ;:B'>%1K>++C
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M_P!^A52R\.:*S7&=+M#B4X_="M^JEC]ZY_ZZF@"M_P (UHG_ $"K3_OT*/\
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M!()]QC%27:QQS?8KV5\_9S*(X8\*>H?J>0>N.V*JV][82VD<EY&DJ2/Y<+K
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MZ\-U'M5F]2&REMWNI6MKXA5&H*@V2-_=;'K[U'*\TTL=M<YT[47;,=S" 4G
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M3PWX5IW<+130V<L$4)<#_0IVW12>\<G\)]LBHGLH[NY6.WN,3Q]+.^&UP/\
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M?84 3KK>K*,+J=Z!Z"X?_&@ZWJK$$ZG>G'(S<-Q^M4:* +_]NZO_ -!6^_\
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MH[_6GV;217$]Q80"'4B,W6GR']W,O=D_SWK-M)S;)<0I;/+9'_C]TZ08,/\
MM)ZC-6;FVBM8H+J.[DETSK;72<O:OV5O5?:@"W:W M+:2[T6'[1IKG_3+%Q\
MT![X'T[>U5[B*VBT_P#T<?:_#DS$LP^_:MW([XZ4R">\>X^T6YCM]8X9HT(\
MJ]3U';-6<_NY=4T9"UL21J&FN/\ OK />@"E?1!8X+>YF+6BC-EJJ=4/97QV
MSQ5#R74^1/ WGR89HU?B<?\ /2,] W\ZV98X[;3?MFEK]JT"<YNK1ADQ^I'<
M5458EMD2YE,V@Y_T:Z3[]LQ/&>_7C\J (F8H\LBR0[9P(RTP^68_W)!_ _'7
MVJQ\LUD+'9-=6\0S+:L<3VI'=#_$M-N;!F,D4TD0NIQ^ZN'_ -5>KVSZ-TYJ
M*";9=JM])<0RV\>!,%_>6YSC!_OI[T 79'AN(87OY9)K6+'V?4[7(>/_ &9
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MO*#]XCL>XR<GM7CU%%'6X=+$MM_Q\Q_[PK[QLY4:".,,"ZQJ6'<9'%?!UO\
M\?$?^\*^[M+NK>\T^&:W=73:%W#U'6@"Y1110 4444 %%%% !1110 4&B@T
M%%%% !1110 4444 %5+'[US_ -=35NJEC]ZY_P"NIH MT444 %%%% !1110
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MI9--FYM;E#\UJQ['V[$5HQ/<7T[RV!2TUNU'[Y,?+=K_ 'AZYQG\:/K5;O\
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MQFZT2=ML<S<F'/13[>]4'\0Z%(O]A:IJ]G<6K)NAO_/4!3V!.>&'KWXI-/\
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MD!<]:6'9F66*T*JLS-(UQD'@?>4'M^59<7B+P^EPI?6K"9G5@&\^/RXAQ\N
M?7\>*K:YXIT9-#N;B/6+":ZAMY5XN H.5.<+GGH,4 8_P6/VKPEJ5ZX!:\U*
M:4YYSD+7H5H)?L@$\D4K\_-$,*1V%>6_"W5=$TGP#8R7&H6PNEDD;R3<*I&Y
ML<@GT /-=\OBG0!*X.O:;Y>  @G4$'OSGZ4 :UBACLXT,*PX'^K1LA?QJQ6)
M#XF\-P1+%'K.GJB\ ?:5_P :D_X2OP]_T&]/_P# A?\ &@#7Q44\*7$1CD&5
M/7!Q_*LS_A*_#W_0;T__ ,"%_P :A3Q7HB22M+KFFF/(\L).I(&.<\\\T :0
M =S-=0I&87/EN7SQZ^U13P[(G>&U#LD@EC59-N]CU)JC)XM\-R2FUDU6R963
M<295*8SC!.<9]JAN/$_A^Y8V@UC3Q" #(6F7:RGLI##!XH NL4O3+((9HR[?
M9F;S-A _O#\3@&HY7G'DE-T7#0A'C$@7')9B#QD#'7O6+<Z[IG]HR-:^(=-0
MAEE4&4[2<;<$YVXP.W/>HF\3Z+9(R2:EI\KRWC2[A=(PCST<@$'% &[#MN+:
M$J@2W0^9;""8AI<9.-I _*J8C69%2?R3<2;YECE7R'1">F5XSFLRW\5Z'';[
M+?6H-SS-NN9ID A)_B0-U4_UJM<:_H7V/;I>MVHG:7-P\EPJ%NN2 ^00>N![
M4 07VG.+QA> 6SR'*"4 +]-Z\<?[0K,-A+IT_EW"*LV=P7JDJ^Q'&?H:EN/$
M^FK,]Y!JMJ-SD-LF5!(!W,;D@_ABHO\ A(])^U)<_P!J6T<<Q^9(95*Y]X6Y
MQ]#B@"5)(I7=HI#%&>4WY(#?[,G53[$8ISSLQ\N:'%VG61%W,Z^I7[KC'<55
MU#4M*6Y+0ZMI^)%PA@F!5#[H3N4\?3VJHNNZ9DRW%[8ET^615D!23_:X.,_0
M@^U '11)%OB:5U2%_N*[$Q%O16'S1GV-;.FZA>6TK0RWXC)'RPZ@N0!_LR X
M-<.VOZ=;*9(=5@;9@,GGJ>.W7[P]B,BM>PUS1(+QW36K*W,J[LK*LT![X9#S
M'0!Z#!<W;C+K9*I_B28GZ=J26Z2,;KB]CX@/F0PC))_O#O[5QC>+-$0[[BVT
MBZ/]^SNHV'XC.:V+'Q;H<D4TD4FG6;A1Y?FW$8+$]C@\4 :]@$,"?9;5V58!
MY4]Q]YN?NG/S4ZY,A8B:YSF(.MM!PS,IRV#U(/ Q5-O$FA.Z,_B2Q4(^[:MP
M@!&,;3SS4$?BCPS9+%':7]DZF4J2)U^3/).2>GTH U5^T71=XK<6CR1J1.Z@
MMGNI7VI&:WBFNI(%-W>1X9H0^2#C QGA>*SYM?\ #]S&T=SX@L"GFAT$=RJ$
M8Z D'FFQ^,-'G5G@U/3H&6;:_GS+\ZCN,'\J ->=3EIKJ8):^3M>(]B>^?TI
M;B.:>":VB8VR>6!'<*<D>O'M_6LF?Q/X;MS-<QZG933.%#(MROS#Z$XJ4^)?
M#[W!<^(+ QF/:8?M";?KU_"@#7*?,DT*Q,[8#.>I7ZBGS7*0&,.3F1PBX!/)
MK"M?%>CFW99M6TJ&0$A%2Y4J!V[BK$?BO0=H$FMZ<7 &XB=0"?;F@#;%%8R^
M+?#K#*ZYIQ'J+E/\:=_PE?A[_H-Z?_X$+_C0!KT5D?\ "5^'O^@WI_\ X$+_
M (T?\)7X>_Z#>G_^!"_XT :]%9'_  E?A[_H-Z?_ .!"_P"-'_"5^'O^@WI_
M_@0O^- &O0:R/^$K\/?]!O3_ /P(7_&D_P"$K\/?]!O3_P#P(7_&@#8HK'_X
M2OP]_P!!O3__  (7_&E_X2OP]_T&]/\ _ A?\: ->BLC_A*_#W_0;T__ ,"%
M_P :/^$K\/?]!O3_ /P(7_&@#7HK(_X2OP]_T&]/_P# A?\ &C_A*_#W_0;T
M_P#\"%_QH UZJ6/WKG_KJ:I_\)7X>_Z#>G_^!"_XU4L_%.@*UQG6K 9E)&;A
M?\: .BHK(_X2OP]_T&]/_P# A?\ &C_A*_#W_0;T_P#\"%_QH UZ*R/^$K\/
M?]!O3_\ P(7_ !H_X2OP]_T&]/\ _ A?\: ->BLC_A*_#W_0;T__ ,"%_P :
M/^$K\/?]!O3_ /P(7_&@#7HK(_X2OP]_T&]/_P# A?\ &C_A*_#W_0;T_P#\
M"%_QH UZ*R/^$K\/?]!O3_\ P(7_ !H_X2OP]_T&]/\ _ A?\: ->BLC_A*_
M#W_0;T__ ,"%_P :/^$K\/?]!O3_ /P(7_&@#7HK(_X2OP]_T&]/_P# A?\
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M+>_AO/WF=SW"R./<#<#CZ44)QJI-;,G$*5*+[HZB"YB<R3OTBDP6D/ &T#*
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MQ7R710!]>1:MIVOV#:9JNHV=OJMF<Q3"=?F..&!S^=4TUFWN;HW[7UK#KUD
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M73?@1*PXR#CCN:LG9('.1*5 D0R#Y%XXP<4 ,D+722),?(@F7RU&=LF[GO\
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M M]>TYN><>:!W!H ;#+>7ER6C18-<T[(<'@72=*E:,:H!KVB!8=0B&+JU/\
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MG']S'X]:K">2"81275TXCS=&0VXP4_N9]?UJ1K&VDOW$=JK02V[!Y$EP.3G
M4>O7-):V,,;0O']JM99L,8]Y8 +_  GJ!0!GWL$<MG$BPVUP)7^TRY_<,1GA
MOJ/>N9BTK5;N^G9I'LTNG,Z)N.UMI[L.G'0]Z[*:<7<MW%#>6\RX&^VN8\*B
M@_-S4!LEF"HHEM)[B/RMUL_F1QJO*\=.1_.@#FF6*Y>*"ZB<737!5)S^[94]
M0_1JS+BU97=["9Y-XV2)Y>R3'NIX;ZBMN[L+JVMKR6V$=S!(5W-;?/NP,?,G
M;W(K+6>.YLC#)M:%&/EPW#95?99.JGV- &;!(983 8PK#E%9L;3WPW\)]CQ5
MV&=8D?"*.020NW#CU_N-[]#27$$K0^?&9)"ORMD8E0>C#^-?>JZ326J) \*R
MP-GRY(VY&>H4_P#LIH L2G9*'C0,F=RL/D:-L=O[I_0U8DCM[^[\VX(2<#"S
M@;59L<!P/N-[]*S(IO*E\O+$#*AE&"JD?=(/;K\I_"K5HY61<R,N!MWKA@%]
M"/XD]>XH UK9Y!-\_FQ70&&,3K%(1]#\LGUK:MYM2MXFFECNVC977;/.B8&,
M@C ZUCP0M#&UI.EH4+;HK>[;,; ]XI/3VKHXA)'9QM):65NQ.3NE\S9P1E1C
MDX XH CT_4)K@) \-LJD(I9KX/D#T &<UI2RRR2!?ML:;<OL@3<S*#Z_I7.3
MV1^T0WWFWK,H)4PV"@#GT-:!O$O=B!]3V[=CQQV^P$]R3CCUZT :T,"686+S
M%P9/W;S-O<D\D<]*AMYE#@99XY6=TEG.&5^FU5(ST%*9C:6LDEP$M%? #9WN
MS=/Q. *=%.!#)("T$3$2+)/R6SRP"GD=* &F7,=M,^QF$3L)95Q*#C^%*2WG
M+2-+&@W31AU60E7D*\$;3]T=.?>EAVLA6!V!^_%<3#>6#<L%[]*+$IY$<\0:
MV$DS;EN$^=\D\<GC/6@";SVC-M,]F!-,-LK(0?* !/+>F:</W90AC/)*S>7*
M4!" \XR.W2H4ADM;17\@H$=\VT!W"3<W4Y^N?SJT4>W9I(@\F\JOEY 5!T)%
M $GGB'R8IG7S9/E&!@,0,G%3U5B9X72!S)*6#,92O YZ'\_TIZLT*QI*YDD8
MXW*N 3U_"@">B@44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 444UR51BJ[B!P/6@!20HY( K.N)UABO[B82VRQIM
M\[.<@#.X#V)J:>XB*>7<PMM,1D<%"R@#&03TSSTJK'<6=ZTTMEJ49D<)N <.
M% /]WMG.* )+F[?3[7SIHFN(8U7+QC+^[$?X5QOCCP\GB?X<ZO#H!8RWYCDV
MLQPQ256(P>AX/Y5JZA=W2:DT$UG=68:97CN[0&19,<#?_A4-_,+JW6XO,SK&
M2!J&F-@PC/=>?ZT ?&S*R.48%64X(/4&DKZ.\5?##1-78ZD988H3C??6B-))
M*3W= P /7)K"O?@1;"P6_P!)UG^T8>K(D&& ]@'/Y4 >'45[+/\ !FPDT@ZC
MINL/<>4<7%NUOM:+_P ?]:DE^"=G-HJZKI>KO=(O^N@^SX:/U_CH \6HKW2'
MX$Z;J6BO?:7KKS2HI/D_9L'</X3\_!K/MO@O;7^D3W-MJ;_;;8_OK-K<AL>H
M^;- 'C=%>VVOP/L]3\/OJ%AJ[O=1YWVOD<Y'4??].1Q19_ ^SU31)+JQUAC>
MQ?ZRT:WP01V^_P#TH \2HKV2W^"]MJ&CR75EJ;O>VYQ/9FWPP'J/GR:D3X)V
MM]I OM,U5KB:/_7VI@PR>N/GYH \7HKV_3?@OX=U. '_ (2@VLXX:*:W"D'\
M9.:DE^!NA1_(GBS[3,2 L5M:;V8GZ24 >&45[_%^SS:;0UUK9M\L%"?9]S<]
M,X? IX_9ZL/.B3^VI9%F8[)(K4LH4#.6._B@#Y]HKZ-_X9MT_P#Z#\G_ ("_
M_;*K2_LYP+<>7%JS-'L)\QH,#=Z8WY_&@#Y[HKW]_P!G> &XVZU&=@'E9B(W
M-W!^?BJT_P"S^T:AHKW[0HAWGRTYW_W1\_/UH \)HKVI_@KIT$PAOM4O;*39
MO+-9;D QGJ'I;KX&)%'YUCJD>I0#!)MT)?'^[NH YCX-?9_^$QN/M-A<7J?8
MWQ'!G(.Y.>.W^-?36D+/]G7['I2:;'O'F"8?.ZXZC'?ZUY7X%\$:9X5UMKZW
M\1SV=\T)B:*YM-BC)!()+$'ITKTE(HY3))J?BB.:%UP8H9%C7\P<T ;$1$21
MP1R&[F0.K7#8;RVZ_-CI]/:O.?A5.=6U#Q;X@6'S7N+\&%2V.!NP,_1A797F
MIQQ^&=0OK*$6]K##*S-)'M,N%.&7GU[FN;^#^GW%IX#M&@*1FXG:>8R(3E3P
M-O3L.M 'H,BS*TL\+^8Y4*L+-A ?7.,TIGMVNEM7>,W 7S!'U('3-0I<0-;2
MS6C11HLI\UY%*C@_,>W..]3/&LZ":WD178*1*JALKG.,^A_K0 V.]C^V?8I'
M4W.TR;5!QMS@5(L$HOGF-PQB*!5AVC"GN<U&S275N'MG\EM^"TD>3M!Y&#ZX
MXJ>WG2YA66/=M.<;E(/!QT- $M%%% !2'Z4M% %.X69IC'NE\J9"F4P/+.#\
MV>OH*IS65Q;JT=M>76^2,(C, ZQE1G)]2>E:TG^J;EAP>5Z_A5#*%;.Y*W9(
M.T+@Y^88RX_SB@"I(US]IM9?M2QM<;1'%+;9*8&7&0>"<?I3;*WB:-I[>"V8
M3"19);9RAQGC ]<]:67SH!?$2:@H699 X029!QE4 YQ3A<"5R\4EM(5F,:)(
MAB9/[P!/4]^E %<32O*TGSP2[5F9+U 4C095E5AT)XK/DW6[1VL;"-)\8M+G
M,L#Y[+)V-7H2EFJ03RRVRB-PJ7;"2)\G@L_],BJ=W/%8&X2.-[1)V#)<*OF6
MQP.^/N@]Z ,*[L$COFMXH6MIF7,5LS;MQ]8I1_(BLXS74,/G,B/"K".9'X&<
M])$['_:%7VE#3&$QPVZ.#B/?OM93VVOGY#[YJ,S>9$L<V\+"1F0#_28?K_ST
M3W]* (G@2>W=[3>_E?,UN,&6 >H/\:>U8\)9[B0 ;E?)4KA3QZ#^E:-[:>3,
M+A/GW#Y)8FPL@_O(!T;U7ZU8$:2,"R6Z23)M5Y/]5<?4_P $GXT 9-K=L%(W
M%W!&0>F!^OX]16]:Z@U]:E[R&[%Q 1B\M.)0O;<O\0]ZJ,L<R-"RM Z +EX^
M 1T#GL?1AU[U6@E<2_9Y0L6#P9 5P?7</N_4<4 =UILGVBV1[A;V:)=Q,U\1
M$ASC@KW'IQ4&O37$,JV\3A,Q A(-/\T=3_$3C\*GT5$^P(EQ]F 5BRO/<BX.
MXXY!X&,5IW5M%>V\N(QDGRP+H-MR#Q\N1GK0!Q5OJ6HV$VQB\;-R/^)8-P]P
M :Z>&_M]2%I')8W5Y)D9>6W*(AQ]X@\?SKG?$&D1(Y-I!=-(%!5+>R(1?^!=
M:IV!?>J27EY/MX:V6Y,+K_P%NOX&@#N)-WG06MPIN;AD;,40*Q*I/!;Z<#^E
M674I.T@W3R,B(]L'&Q03RV#^/Y5E6%Y>-'@68TNPBY9YSN>3U _QYK1LF66V
MB6 .+5XROFRL5ESG@<B@!82D-]#;W+&:[P[1ND1543/3T]J>CN3-9&Z#WBJ9
M%D:+A 2=O'M]://C^Q.'>X@2!MI=QAGV]QZ@_K4Y_P!)RL@C:UEC&%((8D^O
MX4 )$\DN8B75X2NZ39@2<9./:FF:>;[6D$'DRQG:DDR_*_'48Y(I@:5A'._F
MP>5O_P!&4@^8!P/\:6)Q*GF7+,J70 6WF &WCD>Y- %DJP =4C,V "3QQWYQ
M4]4XQYD2P7/EI+]X1QO_  @\>_I4L0WL)CYBDKC8W;\* )Z*!THH *#10: "
MBBB@ HHHH **** "JEC]ZY_ZZFK=5+'[US_UU- %NBBB@ HHHH **** "BBB
M@ HHHH **** "JES=;6>WC95G\LNID4[/Q-3OYGF+M*[.=P/7VQ67?:G-96J
MO=:=))&Q99/)^?:O8D=\T %R\7VFWED@S'%$T@NXS\L9QC@=\Y--2YNA+##&
MD5_:.!NEW@. >[+T(JO;W5E>@C3;G[)>R0;8X91C8 ?[GX?E63=07-N\MYJ<
M30R($!O[)R2X!QROIZT ;<-OITNK-=65YY=Q&#$\"OA21V*_X5 ]\;A9--\0
M6:P)(,"<-^Z?TP3T-9>HSPRSQW=Q#'+ W,>IV8.^(]BPYJ677/LUK%'?1#4M
M*D7#7JC/)]5'3% #9Q<^&(!L']HZ$XPRG#-&#Z'N*IQW,_AR0:AIQ:]T.?DQ
MJ<^3G^56/+N-!M3?Z5+_ &AH\@^>V)SL!_NUG"X70YDUC3%,^DW>1/;=?*)Z
M@^E &M?::FIJOB70)F%YC<4'1\<$$=C6<MQ)?N=;TU!#K-KQ=6A'^L'0G'6I
M?F\/2)KNDEI])N>9;<'_ %>>_P"%7-6L_M20^)]!)-T &9%Z2+WR/6@!DL2:
M]:1ZYI!$.L08\R)3U(ZJ14=RB^*=/6\M1]FUVS^_&.&R.V.OTJHTKICQ5I./
M.)Q>68YQZGCGWJ]J*^=%!XKT09N /WT(YW#N#CN* *ZW$OB&U2YMC]G\06'W
MD(P7 ZC%*\TFH1+K^E)Y>JVWRW=MC[P[\=:=?0'4;>'Q-HAVWZ &>!#G/J".
MN?Z5!YKL/^$FT1<W/2]M,9^O'6@"S<6YU18_$&@2*FH*,SP _>]01Z_SJ"UC
M_M.X?4M(E^PZNG_'Q:R<*_KQZ4^&)@Q\0^'&621QFYLCS]1ZTMQJ6A:[)&+^
MSN[2_! !1"&SZ9Q_.@"S>W^J7=LEGJ%M#:2._)5\_*.I]A_A5FW5))X+@RB:
MRA.5EE;RXX\<?*/XOJ>*KZ?')-<O.!$;=1Y*R7+9 4=_<GC]:UT^S6DCWLLD
MMPI1E:8#*QX8#:JCW^O2N'"?O)2KO[6B]%_GN=-?W$J2Z;^K%,*JPN%VI<F3
MR5DO!G<,_P (&.O;Z5K0PM%)*QF=]YR%;&$]A4%JES&ZPR$20)&-LS'YW;OD
M8P*N'BNXYBG>3+&-XN?+$)#2JJ[B5],=16+(8_-AD>35G)NB4PA ''T^Y6R8
MYENI6:XA120P"I\VT=<DGGZUEO([6GFC7L*SF57$(^X#@KCN,]Z *5Y-9Q-;
M ZKJEN"C2#*D\9/+9'&*EBEU&>$_8]2T_5(-N/+E7#'V)!JU]JFNA+]EU73K
MA)' 5)%SA>Z\'FL'4=-_TEY;K1638ZB.?3G.6SWQ[4 02K'97HE:WN=#N@0"
M\2^9 _U]JU;6ZURY<FV.C7:]IE.#^(!JK:W%TD9.G:TETH.&L]0 5_I6?/)8
M><SW^BWNF3_\];3.#^E %W0X(H-4U32;R7R[=)/,\K=A9 XQM/KVQ4_BE&N?
M#(NK>'RK>T97C#J5<$-MZ'MBL>RO;>V\5QRV"37L;VN$60?.[#/KWR*ZC6(;
MBY\/W4U])Y$SVKJ+97!3(R1[EN*ZI.U6,^]F>3"/-A:M+^5R2_-&G97#7^GP
MW,!$3.$+,R9W# )Q_+-21>7>1-/:.8F>0;W*8+;3@C!^F,UA>$@;KP_IEP;B
M16@5U$"L 'P2.>YXK7>XFET^*\EBN+9HWWM @#,PS@ ^W>L*D>6;CV/0P\_:
M48S[I/\  MQW)ENI[?RI%$87]X1\K9]/I3+(S1.]K(LK)$!MN)&!,A/7IZ5)
M/%'.8]Q.]&\Q5#8R1Z^HJ$I-<VD,L\;13QGS##%)P2,X4GN*@V+$5I##<33H
MN))L;SGK@8%3U!:RRRVT<D\/DR,,M'NSM/IFI@P)(!''6@!:*** $Z55FM@\
MQ)2-HY%VS!R3D8XP.E6ZCE :-D(4[@1M;H?:@#,N-+M&S#%#%&9TVL5?:V%^
M[C'8<4BV1:6&9@ZSNR^>8ISM4J.!SU!Z&K+GR8K66:*WCD!"G>^ F1R%/>J5
MQ:B1;N.*"V<^<LH5)BK%N.6]#Q0!8A#,(4DEE7>9 8YT!+#/0GT'\JS7M"F^
MX6,1C8)'GL&RTC*<;=O.1BK*L\$LKR27-LTMQ@>9^\0@#/']T&H+BZBBC$R1
MK+'L<+-8\O&&(_AY_.@#/<)?2I):[_/X$MQ:_NYD/^W&>HK*OO+DE,K2QN#\
MCW=O'@C_ *[1\\>]:=_*EY;NT2PWR.%+&!O+NDP."1W(^@K$DNY)WBFDFDE,
M1(,\*;;B(>CK_$* *4UG<0",^:%D4YA ;*N/6-O_ &6I#<6UT7C=X[:Z8?,"
MN(ISZ,O\#>]6 65Y(=L.R8!Q QS%<>I0_P #>WK52\B0Q1RQ/*X7*$RK\\1_
MNR>H]#0!G>7.MY+F*2-1_K(W!; ]_4>]%O'/$A;RF49#!SV]#[?7IZUJ!@MK
M&7641Q-L\Q3F2U_^*0_XU++&Y+PO#$8V'F1M _7U://ZI0 FF7T\%I-;S+;R
MVCM_JIU.S/?YOX#^E=-IK):V?F):V5M&7Z6[&X?<0<8QT-<1AK><;9&,)^X\
M9QQW&#W_ -DUV>AZG:?8O*6Z/S[OW<%J8W<X_'GZ4 6-;BD:!'*2SH8F=O-N
M3$4Z?P@>]<BT\=I*C1[E#G!*W4B@#T)*UZ8ZLT,NY3$,85TY?!'7V.?Y5SFN
M:*\\*@QK(RQE/M%S=;>AX.!QDT 2:5JDRVD:0Q6$<9?+.]]OP,\^^:T8P'DC
M-H5O_P!^S&>1P1!P.!CVX&*X&UA@TNZ"7443L,?O& GB_-<$?K75K?FZA#W.
MKV,%BF#Y5F?G?';GD?0"@#8,"F>/&)[U%?R[ITRL9]#CIUZ58RT+K)"@F$T@
M,S^9A4 &"1^72J]K<.]LMRZ+8P^86,; $R*>A/H234SI%;P7$4T,,=C@!0#]
M[=UR/J: )26ANU\N%G28EI)=_"8  X_#M4-LJR1"*+$EC(K'S6D)8L3T^G6E
MA+M%;3RE[-4)7R"00V>%!_3I4DZ*Y(NS&T0E4Q  Y![9_&@!X^TB[VXB%KY?
M!R=^[_"F6BJNG*J7,C@ @32?>[\U%(1'(;J:'?<Q@JD<+$DH3Z5.6:"8F61Y
M%F<*B!.$X[_XF@":)@(HQY@?( #9'S5+4 0%P9%0;&_=X[<?SZU/0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !56]
MO[?3XTDN9-BO((U."?F/0<5:JAK!6/3GF-F;PQ$.L(&22#U'TH Y23QCK"_;
MG&E1&.SEV2_.<J,D#O[>E)=:KHMV?LNM:9+8RRHLK.HZ^ARO/YT^[L+E9?%(
M\IUCN($F1CT8@'(S^=(RP7FN:?-A3]LTME(8'KC% &M!<7=UJ27&EZE:7.FX
M5)(.I0#J01SGZUC>=87%]/)ILKZ3J@DP8IU*QS>@(/'/YUR=C'=6LFGW-C*\
M4TRN-P/!=2>/QXZUK2Z]'K6FQP:[ 8BY/D7L2X 8<9([CZ4 6D\RPUAY90-+
MU&0$;'&ZUN#[>F>.]-L9YK"^N;FQC^RZ@#F;3G.4F&.L?\^]1K?RV]O'8Z]B
M]TF4[8KF,9*@=&5A_(\TVZ2%/+@NYVDTP\6&I+RT9_NL1S@=,'TH OL5U G7
MO#PQ?+Q>61_C'?([_P">]4[2[FT^4ZYHT1:SD_X_K3_GBW?CTZX-9EM=:GIF
MJ2W< "WB#,L87Y98_P"][],\>N?6MR>X"1C7-&B#V-PNW4K8<[?7CMU/(H F
MF:/0[F'Q!HY,NE71 N8E'"^X';O]#]:M:S9L9(O%>BREW50TD8Z2(.O3OCK]
M*S]-FM]%N/L,LBW&@ZGGRY3T0G@@^AZ9_.K.GW4OA+5_[*N\'2KERT$QY"Y[
M9_+/YT 1-=I:O%XJTF'=;RC9?6X/W3ZX]?\ />K&H0_9)D\6Z)^^CD&;B'LR
MG@GZ^OTINI0?\(MK'VR*$OHUX-MS&.55CWQ^OYBDMI_^$9OT(D63PY?',;_>
M$9(_E0 S5UDMIH/%>AX=)%'VF->A'?(_G3A9_:I?^$B\,3 W#<W%J>C$\D?Y
M_"F$W'@[4GFV^=H5V^<+\WEY_P _B*>='O+.X_M;PG<1RPS\O 2,8Z]__P!8
MH =+<IJC'^TO"%RUP/XD0C/X\58A%Y#;O9V-A;:=(Z;E@1LSE<XSNZ+WZYI9
MM2UHD?VE<VVEQ ',<.))9/7'7%8=CXXT=M0M-*LKYI-0FN-L,<;-,OS?\]GZ
M=>RGC- '6V,MK9[\;Y+0Q#S+N7&!MXVLW4G.>U:5M&]M'#%"%D@9B<C"B-.H
M  Z]A6=JJWZVNIQ:>/(N7@!@N;A@81)T5=ISCGV[US6G^%?'DE_;7>K>,E9(
MY%=[:V@"HX!SMR .#0!Z$[A4+'. ,\#-9MVX,NGOLO)3OW Q# ^[U<<<<]*L
M7L$UQ 4BNC;@HRLP&3R, @]L'FO-X?"GC:T8&T\<W ;?@17:)(60'[PR3QB@
M#JY(D00>7X<E?SYS+*"P^1LXW'GT)K/%CIEF)D^SZKI;-*$65<L.IZ'D ?\
MUJTOL;V\WG?8M1:01,Q:*ZW*22>,9]\\"N"M?B)=VKQ66J-?:1>ER0FIPF2.
M7.,+N"Y'(].] ';7%_>K++'IM_9:FHPC6EP0'XX/.1G\:RKR?2[BY_XF=K=:
M'J!  GCSM/Y<=*BEN8;@O)KFB(<$EKRP;E?<X/\ .G>?]HMQ;Z;J=MJD!SBS
MU!0'_!CC^= %^0:K'9Q@VMIK]C_#(,>9CW]:BMVT2.0/'X5O1<KSL,)(!_$X
MJG%%#IH#6]S<Z)?D?ZFXRT#^P.",5H0ZKXQ<[4M+&4;1^\$BX^O#4 9/Q+U?
M48?A[>&ZMTM&O72UAM\[F.XYR2/]D'BNHTJP;2=*TJUN+EK."R"VZ1JXQ.0
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M2/*D^?RR#R.JG\ZS-2F%YI\I^R:@P@F'R1 HTF#V]5K3EWPE##'&$+YE).W
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M>1QNSP)&#C"YFM3Z-_?3\^* (IG1HV9HC,+AP=D8PDG^W'C[KCN#[TQ"C/+
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M('O[T 6**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTR4$6TS#<-O]T]Q_2L;Q ^@^#OLMS'KUY;QW9PD%J=[N/48[>YK6&I-IUO\
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M8R$A,+_"/K4/V<7+2I"&AMI@LQN(Y,,SYZ>PP!4SS1K$MW<&2VCB=LHW ;G
M)'O_ %IEQ']H+I=O&MBY0188JS-G/)_I0!>BFCD9T1MQC.UO8U+5=)DV+(3Y
M<1^7#C:<YP.M3YH 6BDS2T %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1+>]ET6ZN"BP2'[-<XYC;J 3_=.?P/-()D1)IIK?<-WE7MN.Q[2+Z'/ZGWH
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MQV%1^(/$%IX?MYA&X:]E^98R2<'ID^@KB1%/+J=_-JTBR3_86ESU W*,?SH
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MO4B?DI XR1Z ?X5Z);6[);P06L9M;(*2R$%92P.?U[UY7Y3QS"ZA=6B1L+*
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MPYD7( [\>M6!61HLU_=M)=W6U;:>*)X(QU3*Y8?G6Q0 4444 %%%% !1110
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M:CMO^7!"3B/2)' /3)S_ (T7JF+4M6WDCR=*1!^(05"'6-G /,6B*#[$[?\
M&@!\-WY*Z>_3[/I,C#ZG(K2T_=&WAY1SLLII,?45@7'R0@L",:0FW\2O^)K6
M,K">UC3_ )8:(S#V)6@!]A+Y<.C8&7CL[B;\P:IJQ2RM2WRA=(E<8]68_P"-
M3QI(J6AA*Y71G(R<;<YR:@O\1Z>FY<XT9 .>F7% $>HL$M[M%)!_LZVC;\2#
M3]3=(?[>7G!6V1?][ _PINIPF7^TVSCR8+5?T%-U;Y[G55SDO<VT8(Z#@T 6
MKLK);:YDX\R^@7![U!J-K$VL7%I'"!;/J4*,JGV/\\FDD?S3=QX+>=K**&SZ
M9J664OXH,94A)-6W9_W /\: ,K3QYZ"VG+1-N8:?.QP%<'[N?0Y%,BE,'FQ3
MPE+=VV740',;CHX].?ZBKDMH]YX>TB& _OI;R58R3ZD4Z.:2^+7 0-=VRE;R
M)L9N(AU/N1@_I0!3OFNUNK>%G1[V<",G&4GB/W6)_3UKH+;P_:Q0P"=Y)I85
MPLA<J5]ABN0NY$AU9&@O&:WB4-;L>2@Z[?P.:?=>)=3N$,?GA4/&44 D4 2S
MZW-I?B%[B.=KJ*%]H\T[CM[@$]#[UZAI>K)J=F^I6A::V:/*Q_QAQG*X_*O"
M[A^-O<G)KTKX82.-#OB%9RDWRJ#UR!G':@#OX)&E@21HVC9E!*-U4^AKG?$.
MN:9ITK13SSM.T>WR(&QG/<GL:F\2Z[_9UN+2U;.HW VQ(/X<_P 1K@M(B:75
M+&[NI?-:1I)Y-PR0$!YS]0>/:@!^L:Y:7]BQ2TFBD<((VDPP^4\X/7-9$'[^
M7][,)9N%16/WA[-V/UK>@BADL]+:X0%#;W<Q!Z?Q8K'?36C2*XC176.V2XF5
MCC.6(_PH 2VE$(E0@K*S8VO]V1?[K#^1K/O_ !?=^>]CH\ODV,) )=0[JXZJ
MK>@/>K^JQ;=&N=2C9F41G8[\E6 ^XP_D:\PM[N2VB/EOR?X2.* .FO\ 7-6B
M0W0U2\$ZG*L9B>:Z/P/\3+Z35TLM8_TNXF7RK:=GVX8GA6[8)[]:\RGNI;@Y
MD<D#MV%5&<APZ,593D$'&".] 'UHQ;[:X@RMV0CR-("45>X4],]:LR!0)$8-
M%  '\\2 9.<D>O\ ^NL'2M91O"NGWUW,8[46X6Y\Y#ND8J.GKR36'=7UUK\L
M,"%K?2)-XA13@LL:DDG]* +FL^*WO1/:Z+*(EB1I9;DC&0.R_B>M5M.M)WMM
M64!1<RV-NNZ1L9+*,DDUD!()+(I"@23[+;Q/C^,LX)_3%=IIT<8O-8VV[7&)
MXH2G& H5>F?3D_A0!IZ6;V.ZFM)8%2TMXXT@<?Q?+S6K4<;EMV49<,1SW]ZD
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@"&[N4L[.:ZD#%(8VD8+UP!DXK M_&4<D,-S=Z)JUA9RA
M66ZN(XC& W0MY<C%1SU( '>MC68GFT2_BB0O(]O(JJ!R25.!7+?VA<7_ (2B
MT.UT?4C=S6:VK&XM&BCBR@5F9GP"!SP,D]J$/L;FK^(HM&L[JYN(TVQND<(\
M]1YK/C'^[R>_;FJEKXHBU+6!I"V]I)((5>YQ=JZJ&+ !>/G^Z2>!@$5C7N@W
M1CU:$VDDZFZL3$S)NWJFP,P^F#FI-6\.W=QJ'B<:;:I!)<:?;QVTH38&8&7>
MH8="00"?<4VDB;L[&VFL1"R6DMOY4/#")EVI]<=*=]MM!"\OVJ'RD.&?S!A3
M[GM7 PZ;<74%XT-E=6[II\\1B73!;*[,F A.X[SGIMR/?FI[[0I[+2/#WV6Q
M M;6+%U EH)B'* !S'D;B,$=SSTI?U^8_P"OR.X-U;K$LIN(A&_W7+C#<9X/
MT!JM>:WIEAIYO[F^@2TW!?-#;@23C QUKB8O#TMS+H[2V=Q+9MK#7+P36HB2
M)?L[KD1Y.U2V#@XY)XYJSJ^@S&/Q+;VFFYMI!;301)& KNOW]@Z;L "G8#L4
MO1+=(D7EO;O"9!.LJG."!@#J1[]*;-J^G06-Q>R7L'V:W4M+(KA@@'7./Y5S
M-XEU<ZH+_3](D:+^QYXD@N(?+!<R)A"IQC(!.#6-%I5_?:O?QP63K:7.B3PE
MFT[[)&TQ9=BD$Y)&6P<=SC-)[:>?X7_R".KU\OT_S/08-4L+FP2^BO(6M74,
M)=X"X/J3T_&IFNK=;?[0T\0AQGS"XVX^O2N N+2\GTG0)8=/N(K:Q0Q7=K)8
M>8WF;% <1Y&\ AAD9ZY&:?!IDUO%9WMQ87=WIRW<LLEF;,(8]R!5=802=N03
MCKEB<4VE=B3=DV==8:S#J&JW]E"N1:"(^:&!5]ZDC&/3%:=<?X/LWB\0>(KM
M-)GTZSNI(&@65-F\!""P7^'GM^?)KL*0(*J7&FVMU+YDR.6QC(D9?T!JW10,
MS_[$L/\ GE)_W^?_ !K UO1--CU32;PRM$J3F%@9)#NW#ID'CD5U]<_K5OI^
MG:7/=&U$H6X6X=2Y^_D?-UX_E0!R=]IME;P:NJJ^;?4HI,^8_1L>]5]4TNU,
M'B3RP_[JXA< R-T)'O[U?UV)OMOB09X$<$H [X(J*ZD20^(=H"K-90S ?@IH
M R=5TR!FUXK&P5! _P#K6R,[??WJSJ&DVRW=\%-PWVG2DE7_ $F0\C;G^+T!
MJ9%>XNM:C(.)=,CE'U"H15VUS)-HG(/VK3'@_$ _X4 9#Z-:R?;&)N"LND1S
M+_I,G4;?]KI[4Z?1K5EN(LW06;28[@9N),%E /\ >^M:.F(LPTV$,,W.GS6[
M''=2>*AMYBZZ0S-_KM/FM_J5SQ^HH QWTFRN4OKIS=+/':0SP/\ :9.#P#_%
M3;6RBU">*YB\\:O&=SQ/*Q$Z8ZC<?O8[=ZM2N/L5LP)S+ICHP'?:Q_PIES";
MJYMY;>5DECTY9E93R60'/Z"HJ052#A+9E0DX24ET+2S(R;@3]".1[&HWD+<=
MJJFYO9T@FN;4RR79/E31$*[D'&"!P>G<9]ZB O)50B*0))+Y*,Y &_T.!G-?
M+SR.NIVBTUW/>AFE'EO).YMZ/!:2W+W=_+Y-E; YDW;<R$8 '<D D\>U4]=N
M%UAHH+..>WL&5RLDDCYFVC)[_P"<U%8VXEN;/[>QE5+S[,\)/R*,=@/?-7X6
MA-KID.,F/[6N".BXX%?0X/"K#4E37S/'Q.(=>HYLQ+/3[2:TNT2&2)?L&\YD
M;#LK=>M:C:?;33ZDQ1BS:2LF?-;KM&>_--T^#S(XD8@B33)B..ARQ_I4MHRN
M[[3UT9@?J 1_2NHYQ+;3[-=2TF7RI"KZ8^1YK<D!_>GZ+I=M+=>'E*2;9+>X
M!'FMZM[T^">-F\-*BXD\J13[@DC_ !JYIF8;;PK*% _>RQDCKR6&/I0!FZ3I
M]F+C0MR. MS/"W[UAWX[^]16FF62Q6+G[0 NK.A87$G3MCYO:K)8P3VL>/\
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M6=I7&X^@YX%1P&ZUF\TN;4[IYTNIG!A)PH5?8?C5G3V,5MHYC3,::C*5 ZG
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M]/QKT2;P=9RW#1'1[>W<"-V*R.0 Y '&<=^E=5I'AO2]/N+:U2 ><-2,88#
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MM6/;QB/19&89+694 >LDO'\JZ30[=MNHH+@P%;U$W<?,%"_+^/2@#IU50Q8
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M !\6$<WUVA3G^=5) WDW0)+&ZT^.88]5*_X&@!^I,IGUE20&,4$RCU/RY/\
MX]22S^;8ZI+G[MS#/^?']:?J2>>89% _?Z2&)'<KC_XFH !+#J2*N#+80RCO
M]W9F@"?4952VUV",_)]HBN%)Z\__ *ZGU23S=3U8HWW]/5R<=?NFJ4R&Y>[
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MN-.FAZ=U)_P%2:*6;6-.9L[?M5Q%CTR.GZT\R"UTRS5/OVU_- 6([,#_ (T
M06^Q8K23&!)I<J-QUVD_X4EN'ME\PC ET<[<=ZD@C+6&CG@*\%S'D^O-3H5-
MMHQ(W!].FC*_0&@"'1=QNKL%B,Z3QG_=%3Q 206&T YTB7<3TXS4FDQQM<6C
M#AYM)=64CKC(%1::DCQV2J<%M+G48^IH K6]J)(;F,' DTA9#]5(/]*M1Q[A
M? D RZ-&QYZX _PJ2!/D@ ;#2Z*P(/L35:W9+N.V#$1M+I,D9;UVGC^5 &I"
MX%VC$$B;1 3CG. *KZ2Z)JVEQ!@_FZ68PP/&>O\ 2FV]QNFT M@D6$@;W&T\
M?I3+#;''X9N5VJYDDA) SD9_^O0 _0Y52;PWD'/[^+Z'(K/\PQV48R?W&L$Y
M'8&M"T<0P:&PVY@U"2%F'0YK+N=RB^C3)QJJD#'7K_A0 R:,6TEQDC$6JJ0!
MZ4RW DU.*'&$&H.<=^@_PJ3421<:CW/]HH>!TZU$I U(2'*G^T\<4 68&Q%H
MCX)QY\9 ].>/UI=-#.?#Y;E,S(,_4\?K4%HP/]GQJQ#K>3?R%3Z<Q^SZ"_.5
MO9$/XD?XT %C&?L6BD @B]DCW#MG%6],PNC:0#G,6J[2?QI]D,^'[>5@N8=6
M7! Z#.*GN%%O9W;* %@UE7 ]!Q0!E6!8WVG@8#B>Y 0GIQTJ6RE$-GX?=SMV
MRSDGTY-16L;?VU;;?^?Z>,8'J!_C3;=6^S:.$SQ)<+@],\T 6?"S*=;TO'5H
M)R3Z_,W^%01S-#!II<J(UN[ALY[U-X>^6^T!VP,I.ON>6X_6J,ZAM*L7*Y7S
M[G@_3- %S1%W76AC/+17#?JU&F*'.@QDG.+CZ<TFAJZWVC< ?Z)/M/OEZ71>
M;C02200LYZ<=Z -'35=(?"\#9&)Y2<\'@<?SHTK_ )"5B022^IW+8^BXJMI$
MQ>X\.AR6*F>4M^?^%+HY,=SHURSE@5NI=GY\T 6K)"9=/9L'S-1N)23_ +(/
M^%5[ A[;1!CE[^:7/J!FGZ1-YEYHF3@"WN9V_$M2::5SX> '"QW,G_H5 #='
M!D729BN2^J3,2>_!J6(&.UA9N1)KA/OP6J#1SQX>4')\RXE(]ANY_2K=FV_1
M=$5S@S:@\V>^ 6- #XU#2V0[2:S*_/7C--A59/L88<OK;LP^A-.TXB:;P^H#
M,K2SR[B>^34^GB,W6G(0<_;KENO<9H S+Y=NE7#L1\VM9P#]*CN@3H2L@P\V
ML$JQ]CBIW0S:39(%S)<:NS<]\,?\*;,C3:+I5O'_ *R74W8 >SF@"SHD.ZYL
M)3GYI[J<G_QVJ%FZI:X.<KIUP_\ WU)_A4]I=K;V5NP4LZ07>-O8[NM59BT%
MA=;OX=(A52/]H@F@#5@?R5NYP.(=&C3@]"5Z5EV,)T[0]:612K-90#\6!J>Y
M)2QUM<C]XMK$N.HRO2G:H53^W8<$$RVT*\_7_"@!=7@\N/5(NNV*TC'Z\55N
M'$7VA>,MK*=NP JUK$OGWVJ)'R7N[>''<[<DUG0N+N\WC/S7=Q<C_=5!_A0!
M"&:73K6;.6GU&2;WP .?T-.M(FBLP6!#MILLGN2SX']*7;ML=+PO^JT^><XZ
M9)8 _P JT)&*&96&YEMK6TY[%B&- $EU%&([\*@0I]DMD'N,$BC>K6<Z$C,N
MM $#N <_TJ&XG,]^"!M$NK@%?78 *J&;=%:R+D&2_N)1^ H =:W6V;3;A^C7
MMQ<G'< #G]#3X+AQI>AJHY,EQ/GZ U4M7\M-.&<".QGFS[G=_@*5''DV@R0D
M&ER,<],MN&?U% #+? M-P(;RM+D)]F=V']:T'B6W@U6,  K86T?_ 'UM_P :
MHZ5"J>%];G*GGRH5)ZCYAFK]R<M?HCY$EY;0 GN% X_2@"6X>-]5E"G"F[MH
M0OKL7G\*I179EOH;A23L%U<L<>N0/Y"JUQJ&V19RP!:ZGE.WJ#MP*(8=MK-C
M.Y-.7GW=\_UH ?&C?94#$E;?3&D_%S_]>K+6X5KB%Q@B.SBQCID@D5>N;.,1
MZC&,;$^RV8QZ<9JU+&LFNRKM^2748HQ](TW4 0O&LR/$QP+K5^3ZJG_ZJJ+<
M+)&9%.&:VO+AF/\ M$J/Y5/;7"&XTX<C_2+N<_0 UCF;_09-@^9=.52!WWR_
MX&@"_HD$A74<^7C^S8D7S6PN& []N]=<]_IDNGM:-*1#%%&6:(G !("X(KDE
M@\RVU>(.%\R:VM0"> OR_P"%=?!;Q0W%Y+9HDS#RX6@ "[=N/Z'- &TOW1BE
MH'2B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *Y_Q7:^=:6<_G1Q+;74<K-(V!@&N@J&XMH;N%H;B))8FZHXR#0!Y]XCF2
M%]>M]ZE9&@N8^>6Z XK+N]2LV761%*"96AFA]V!&1]>3^5>DS:#I<X;S+&$[
MD$9^7'RCH/T%5E\):$K;AID/IR2?ZT >:ZCJT=U=:C+')Q,T4J?*1\ZXS^63
M^5=#9ZY9/XAANI[V/;-IHCG;&!OZD>QKJQX5T,?\PRW_ "IDG@_09!@Z;&/]
MUF'\C0!P^@W\<=_IS33Q"(QS0-N_@7J,_G6?;WT3I!$)%W"SFA<D8_O%1GOV
MKT,>"/#X&/L&??S7_P :5_!7A]U(_L\+[B1_\: .,N[Z&>/33Y\8SI<L4G(X
M.UL ^]9]A?1?8[Z-Y%0/I^S&?O,IX_&O0#X%T#<#]C;Z>:V/YTG_  @F@?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *#110 4444 %%%% !1110 55LO^7C
M_KLW\A5JJME_R\?]=F_D* +5%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9OY"@"U1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 9VO7$MIH=W/ Y25(\JP'0U2GUN!?#C2IJ%O]K^S;AB1=V_;Z>N:NZ];
MRW>A7D$"%Y7CPJCN:SI_#]H?#K(FG0?;/LV!A!NW[?7US7+5]I>7)V_SV.ZA
M['DC[3?F\O+?R+=MJCQ:-8S2PW%S--&"?)3))QSGH!4=SJ]M>Z'?3))=6_D
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MWU W/DE@"RB0G@].0:TM2AU2>]TK7K;36,UMYB2V4CJ'VMQD'IFKE&#?S?\
MP#*$ZR7R73SU^Y=#2LO$EI>)= PW-O/:Q^9+;SQ[9 N.H&<'\Z-#\16VOIYE
MI;7:P[-WFRQA5)[J#GDC\JRH;#4M2U/4-7N;(VFZQ:U@MV<,[9Y);' Y'%:W
MA:SFL/#&GVMQ$8IHX@'0]C42C!1;ZZ?J:PG4E))[:]-]K>G4UZ***Q.H****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?8Z::7*I6U84445!H%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %0P0F'S
M,G.]RWTJ:B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "JU[IUIJ$82[@24*<C/4?0]15FBDTI*S'&3B[Q=F4K/2+"PW_9[
M95+C#,26)'H2<FHH= TNWN5GBM%613E?F;"GU"YP/RK2HJ?9PTT6A?MJFOO/
M7S*;:79N+L-#G[6 )_F/SX&/7C\*LPQ)!"D,:[8T4*HSG %/HJE%+9$N<FK-
MA1113)"BBB@ HHHH **** "BBB@"GJ&EV.JPB*^MHYT!RNX<J?4'J*@L/#VD
MZ8SM:62*\B[7=B78CTRQ)Q6G134FE:^A+A%OF:U,>V\+:+9WBW=O8JDJ'<N'
M8JI]0N<#\!4\FA:;*]^[VV6OT"7)WM^\ & .O'![8K1HI\\GU$J4%HDB."&.
MV@C@B7;'&H55SG '2I***DM*VB"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@!" P((!!X(-9?_"-Z/YOF?84SG.W<VW/^[G'Z5JT5,H1E\2N7
M"I.'PMHHWFCZ??LK7%LK,@PK*Q4@>F00<4K:18O9)9FW'V=&#J@8C!!SG(.:
MNT4<D;MVW'[6I9+F>GF5X[*WBO)KM(\3S "1MQY Z<=*L444TDMB&V]PHHHI
MB"BBB@ HHHH **** "BBB@#&NO"FAWERUQ-IZ&1SERK,@?Z@$ _C5BZT'2[R
MSBM)[*(P0_ZM5RNSZ$8(_"M&BJYY=R/9PUT6IFV^@:7:Z?/8PVH6WN 1*N]B
M7R,<L3GI[U*FD6,=U;7*P8FM8O)A;>WRIZ8SST[U=HHYI=P5."TL%%%%26%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
:1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>img88009329_3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_3.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 1*#O # 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDI: "BBB@ HHHH ***2@!:*** *L]SY6>:IIJ>Z;9NK,UF\,3D UAV5[(^H
M<XIB/0T;<@/K3JBMSFW0^U2TAA37;:N:=56_?9 30!7GO_*S\U26=Y]H YS7
M&:GJ+@L!FM?PO.TR+N]* .I!S2T"B@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHI"<4 +FDR/45D:K??9@<&LV#6=S %J .JHJ
MO:2B6$-FGSOL7- $N1ZT5SU]J?E$X:K^FW1N(\^U &E12#I2T %%%% !2$TM
M,DR!Q0!EZAJGV5L;L<T6VJ>=CYJY[Q(9_-.Q">:CTMKC>NY"*8'=(VY :=4-
MKGR%SUJ:D 4444 %%%% !1110 4444 %%%% !29'J*JWL_DIG.*P9]8*'AJ
M.HR/449'J*Y :TY[U+%K)+<M18#JZ*RK/48Y",N*TU=7^Z<T .HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *,T44 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%9EEJ2W#<8K6I %4M4;;:$U=K,UI\6+4 >?:E+YDCCWKH/"*A47/I7)7,_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-+(^[:*[*HVB#=: . ;PZ V-HJ6#PR'/W17:FS0G-/2V5.E &;I&E"P4  #
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% #)5W1D5A7^DBX!&!704PQ@T 8.C:.+)P0 .:Z#'&*14"TZ@#.OK$
M7$1&.M<X/#*B=FVCDUV9&13/*&: ,W2]/%IC K4D7?&5]10JXIU '-W^@+,2
M^T5BMX>"L?E%=XR[ABH3:(30!QT7AL2D$J*Z*PTH6R 8%:*6ZITJ4#% $,L6
MZ'96!?Z(+G/RBNF(S3#&#0!C:-I8LD P!Q5^ZLQ+$RXZU;5 O2G$9% '%7/A
MP>:S[1S54Z&#_#7=-"K=:C^QI0!R-OX9#L&VCBNHL;$6T07%6DA"=*E'% %:
MZMA/'MKF[_PZLF?E%=;3'C#]: .#_P"$?"<;:F@\.@R [178FT0FG+;JO2G<
M1FV&E"VP0!6Q2 8%+2&!JG?V_P!H@*5;H*Y% '#R^%E>5FV#DTS_ (11?[@K
MN/)6D\E: .+3PFI(^45H6OAA86#;172B("G@8H J6UH(0..E6V&5(]12T4 <
MUJ.@BX<OM%9*Z$$D/RBNY9 PQ4/V1,YH YJ+0P^/E%5+KPZ/-!VCK79K"J]*
M1[=7.30!C:?IPAC Q5C4+ 75N$QVK36(*.*<4!% '+V&@"W;.T=:Z&&#RXBN
M.U3","G8H P;[2A<$\"J^F:&+6X+[1R<UTAC!H6,*: %Q\N/:N9U+0Q=7 ?:
M.M=13#&"<T 8MCI(@(.!6E<VHGB"X[59" 4Z@#CM0\/AB?E%0P:,$(7;79/"
MK]:8+1 <T <Y-H >#[HJC;^'Q&Y.T=:[8Q@KMJ,6R@T 5--M?LZXQVJ>XC65
M2I(Y]ZG*[$;'I7&ZIJ%W%=81#B@#1F\/1RN6^7GWJE/I"6/(V_G5$:Q=XY4_
MG52]U&[F!^4_G3 HZ@NZY7'/S5VNA6W^BAL5S5A927+*TB'UKN]-@\JV"T,1
M8:/<@6L75-$%V#\H.:Z"D*YI#."D\.",XVBE3P\&.-HKMFM48\TBVJ*<BG<#
M#TO01:2;PH'-=&!BD"@4ZD 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 (:R;VR$SY(SS6O28![4 9=M81I@[>:TT&U0!
M2X'I2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 U_N'Z5R][<O'==>*ZA_P#5M]*XW5N)C7G9C)Q@FCLP:3DT
MS5LM15F"DUMI*K@8KSFVN3#.26-=5INJ"3 R*PP6.4O=D:XG"\NJ.@HJ..3S
M!FI*]=.YYS5@HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%&: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ (R"*S+K3XI<DKS6G1@4 <O)I7S'"TL.D*3\RUTV
MQ?04;5]!0!0M+"*(?=J^JA1@4N** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** $S2T44 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%)0 M%%% !
M1110 4444 %%%% !1110 4444 %%%% !12&B@!:*** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **2B@!:*** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BCO10 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MI,TM% !1110 444E "T444 %%%% !1BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML*XZHWZ*8DBLHP:?7KIW/."BBBF 4444 %%%% !1110 4444 %%%% !1110
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M85Q=T;]%,CD\P9I]>NG<\[8****8!1110 4444 %%%% !1110 4444 %%%%
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M#M41EDS0)S-'(/>FE U4/.<5)',3182F6"@!I\7RM4 DR:E5P.])E19I1MN
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M% !5VTO3;D8JE150FX.Z)E%25F=SINH^8@RU;<;AD!S7G%K>O%(H'2NMT_4
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M]0Q_,U6DBR*9&Y5;.:!FIWBQ4)&#02]">*K2CBJ<+8-7XSE:&:1V*SCYJ8<
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M''X4[[)9_P![]*]*.5NVK.)XY7T1P;PNI^Z?RJ,J1U!KO9=,MF0E>?PK O\
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M)$96G(M3!0:D5!1<:1&JT\\+3MN*8^<4BK$+-3-U.(S3=M-$,4-3MV:;BB@
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MFG[I3_L&/_9JCJ.E);ID8Z5H_P!HK_>JAJ5VLB8![5Y5>.'4'RH[Z3J\RNS
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MHN-1)8US2M#N%30IQ4I2HN:<IG+:!7W583Y:E9:8%-%P2L0ROS5=CFK$HYJ
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M$&<4X-BDXHI#)/,-/5MU5ZLP*30QHE'W:@D-3L=HQ51SEJDJ6PVEI,4N#5$
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MX?4/O-7BYJ>G@#*HHHKYP]@**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@!,TM%% !1110 4444 %%%% !1110 4444 %%%%
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M@\4F_BFELT!<<&J["1Y9JBB;JO1IA#4LTB5Y?O&FHHS3I/O4T-BF3+<24 5
M:ED?-1$9-4B6&,TNRE5>:EVT,+7(PM(5J8"F-P:06&#(-2H:9UIZ"@:'YI ,
MM3B*$'STF58)5.RJ>*U98\QBL]X]M-,4HC5.*F5\"H@*<1Q02M![2<5"2336
M-"&F@N2 5*@YJ'=S4L1YI,I#YE^6J9J[<'"509Z$*9;LS_I"5W=GC[*M<'9<
MW"?6N\LQ_HBUC5.O"&7KH&P_2L:R4%EK8UW_ %9^E9-AR5IQ^$55?O#K;9!]
MA/%<WJH&6KJ+8?Z":YO5(\EJSAN;UO@1S/\ $?K3D/SBI#%R:18_G'UKINCS
ME%IG1Z7@E:V=3 %FOTK)TJ/&TUKZH/\ 0U^E<S?O'I4U^[9Q%R3DTMNK,P&:
M+A>36EIMEYA5L5LY61PQCS2-/3[,E0Q'%;:K'"@RHI((_)MAQ5"]O.",U@WS
M,]%)0B69K^!/X14!U*W(QM%<W>7!)/-41,0>IJU3,'B6F=)?W$,D!VJ*Y.;[
M[8]:MO=93&:I,V2:TC&QS5:G,P6G8IT4>ZK:665SBJNC-1;*8J134LEOL%0+
MUHN@LUN2DTPGFGA,BF,F*8PW4QGI<4GEYH$1LP-1&I7CQ41IF;&$TJ/MI"*8
M:9-]35@?,9^E5I.7I]N?D/TIKCYJDUOH(M(_-*!05S3$1$5&1S5@IQ493F@5
MB,4]305IHXH))0:4&F"G=J"D/&#37%(#B@MF@8S%!%.I,T"8S%.48-+BE!I[
MDK<L*?EQ4$Z\5*AR<4Z=/DJ2VKF<H)I<$4[.VC.:LSL-S0#2$4HYH"Q(K4\<
MTQ5S5B./D5+9:1)!'EJU;=0F.*IQKM&:G\[%0S:.A-/(,U6+YI';?3,4)#;N
M*2:86/K3CTJ,BF2V21DDCFM:%?W6:S8(\D5KQ#]UBLY&L-2I*^VJ4DP-7+N/
M"YK%E?&:J)-1V+0D!I2_'%5$?(IV_ JK&5R7>0>M2)/CO5)YJ:LFZBP*;1T5
MM,&6I7!*YK*M9<$"MA!OBK-JQT1E=&;.Y7O5,S>]:-U;Y%9C6Y6JBS*HF.WY
MHWTP+CBC;5$ _-0LAS4C';0K;J"04$+2Y-!; Q3-W-!0_=73Z(Q*BN5KJ-#^
MZM14V-L/\9V=K_JJFJ"U_P!54]<;/9CL%%%%(84444 %%%&: *M__P >YKB-
M0'S-7=W$?FQ[:PKG0C,2=IYKR\PH3J_"CNPE6,/B.+HKJ?\ A&&_NFC_ (1A
MO[IKQ?[.K]CT_KE+N<M174_\(PW]TT?\(PW]TTO[.K]@^N4NYRU%=3_PC#?W
M31_PC#?W31_9U?L'UREW.6HKJ?\ A&&_NFC_ (1AO[IH_LZOV#ZY2[G+45U/
M_",-_=-'_",-_=-']G5^P?7*7<Y:BNI_X1AO[IH_X1AO[IH_LZOV#ZY2[G+4
M5U/_  C#?W31_P (PW]TT?V=7[!]<I=SEJ*ZG_A&&_NFC_A&&_NFC^SJ_8/K
ME+N<M174_P#",-_=-'_",-_=-']G5^P?7*7<Y:BNI_X1AO[IH_X1AO[II_V=
M7[!]<I=SEJ*ZG_A&&_NFC_A&&_NFE_9U?L'UREW.6HKJ?^$8;^Z:/^$8;^Z:
M/[.K]@^N4NYRU%=3_P (PW]TT?\ ",-_=-']G5^P?7*7<Y:BNI_X1AO[IH_X
M1AO[IH_LZOV#ZY2[G+45U/\ PC#?W31_PC#?W31_9U?L'UREW.6HKJ?^$8;^
MZ:/^$8;^Z:/[.K]@^N4NYRU%=3_PC#?W31_PC#?W31_9U?L'UREW.6HKJ?\
MA&&_NFC_ (1AO[IH_LZOV#ZY2[G+45U/_",-_=-'_",-_=-/^SJ_8/KE+N<M
M174_\(PW]TT?\(PW]TTO[.K]@^N4NYRU%=3_ ,(PW]TT?\(PW]TT?V=7[!]<
MI=SEJ*ZAO#+!2=IXK'N[ V[$8K.I@ZM-7DBX8BG-V3,^BE(P<4E<IN%%%% !
M1110 4444 %6;>T:<C%%I;?:&QBNJTO2_* RM=F%PLJTO(YJ]=4UYAIFG!4!
M9<UOQ1JB  411!%QBI:^IH4(THV1X56JYNX4445T&04444 %%%% !1110 44
M44 %%%% !1110 4444 ,D^Z?I7$:VV)C]:[>3[I^E</KB9F/UK6EN<N*^$P'
M?YC31+[T2)\QJ+;76>4VR<2$]Z>C_,*@44]/O4F--F@&^6F'FA3\HICOMJ30
M4K3&%.63-+MW4R;7*Y'- %6/)H$.*+@XD]OD)3),YJ:,;4-5I'^:E8KH-)II
M-!-1EJI$,=332@YH/2@1&2:EB:H7XIT;4,$7-PVU YYHWTPG-*Q38H:G9%14
M;L4[$W+ /%*#S4(>GJ<FD4F3J<TV23;2%ME4YY<FA(;=D2F4[NM2K+6>).:D
M#\55C-3-%914HD%9J/4JR5+1HIEX-FG@YJHLE2H]38I2+ HI :7-!8[M2&F%
MZ53FD X#-2!>*1>*D!I#L,"\U*JT*.:DSB@H;TJ0&HF:@/B@=R>F,V*9YF:8
MYI6$V#/2!JB)I5ZTR;DZT^HU-/S2*0M%)FEH&+2$4H%.VT ,%.!I<4;:  FG
M+2!*=C%(H,TTFE(II% @+4W- HQ3$)NYIZFH]O-.'% $M-8XIOF4TMF@=Q^Z
MER*B%.% B2G"H\T]3Q2*0O>G9S3"<4@>@=Q^*"*;OHWT!<:128H9Z9YE,BY)
MBDQQ31)2[LB@!I/-*M)C)IZK0 HH)XI:830,.]+BFAN:=NH%<,4TTXM4;&@!
M<TX-4.^@/185R;(H4C=46^G)][-%@3+B@8J.7 I0^!4<C9I)&EQO%+BFBG,?
MEIDB%@*;O%1,](#03<EW<T;JC!I13L Z@BE S2GBD S/-2K4/4U*.!0-"2]*
MKFII3Q4&::)84X"D%/44"04 G-*>*0<F@9,?N54?J:M'A*IR-R:2'(;FG@9J
M,&I5Z51 N.*8QJ0GBHFYH*8T-S5A",55(YJ=#\M(E,>Y&*KYI[M4.ZG8+D@-
M.SQ4.ZG@T"N*:0T9II- F2*^*D$E5=W-.#46&I%D2 4R20-4)--)HL-L<>:C
M_BJ0=*8!\],D5OE%(D@-.F7*U6'R4"9<#BGH_-4Q)4BO04I%[>"*BD(J-9*&
M.ZDD-R$)I,T[;Q3=O-,FX$TF,FG;<T]8Z0[$J* M([<4N["XJ)CFA#V&DYIA
MIX7-#)3"UR/=BI8GR:A=<4V([6H(V99GYK/D8@UHX\P50N(_FH035R+S.*0$
MMWH6#<:M1VN.U5HB$F5O+8]ZB:!R>M:@BV]J-GM1S%<ES-B@<-U-:4,9XS2J
MF#TJ9#BI;*A%(@E7FF!:M.N^HBF*$-H8M/R*8>#32U!(V1N:B9^*5^:A9>::
M$Q-W-.5Z812"F3?4TX2#&?I525?GJW;#,9^E0.O[RD6U=$(3-/6(U(%Q3U.*
M&)1)XH\1FJ[C#UHQ)NC-59XL$FIZFCCH0*]2;ZJD[33T;=5-$)EA<EJL]%J&
M,<9I7D^7%26B.9\]*8@)ZTAIZ<"F3U'XPM0MUJ5FXJ!NM V 7=08N:53BIDY
M(%#$E<AVD"DW<UI?8]T6[%498-A-),J4;#0<T[M4(;%*9.#3L0F*7 -/2;%4
M6D^:GQG?Q56T$I:FD,35"]J2W2K%HFT"K>S/:L[V->2YG);X/2K"Q =15GR_
M:E*9I7*5.QRTD)':HO+/I6TT*M3/LRYK7F.9TS)$1]*FC!3M6G]G0"H)8P.E
M%Q\EB'SR*8\FX4UU(J%B<4T2Y ,%ZFV 544G?5E"3UILFXUQ41/-6C&6%5WB
M?/2A,&AI/%+&-U1LCCM4EN"#S0)&I;QC9^%0W"#!J6.0*A^E4YY<M4VU-6U8
MJE/F-!0"@L,TUGS56,62(V"*MJ_R]:SPU2++0T-2+9DVTQK@U"7R*;@FA(?,
M.\\[A5N*4$=:S&5MU2PLX:AH2EJ:Q(I-U098@4A8BIL:7)]U+FH ].#YI6'<
MG5LTC6XD&:C#8J9'R*![E"6VVG@5#MP:UG56%5)(N>!33(<"H3BE!S3GB;TJ
M/#"KN2]!U. I@-+FBPKBLM,(IV:3DT"(VJ(YJQY9-*L)IW%:Y5P3VJ5%;/2K
M:0#O5N.&,#FI;*4"I'$3U%7(H0M//EJ.*C:4#I4[FJ5B1WV'BI8YB:HLQ8U/
M%GBD-,OE_EJM+)BI&SL%4IRU)%R8IFYI=^5JJ,YJRH^6J(N,/6DSBI,4A6D
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M^E1;6!ID:IEL/Q07JL-U*=U*Q7,74;*&JDOWZEC)VU#)UH0-Z O)I6C%1)(
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M%7Y=#GWE)E/-3PMNJG(NUS4L$VTUUVT/*3UU-:*+<*#'\V,5-8OYBU;6UW2
MXK)NQU1BI;%%K<JN:C5"36Y-;8A'%48K?YCQWHYAN%BF8":0P8'2M/R?:G&V
MRG2ES"=.YC% *:8\U=F@V<XJMG%4F9N-AH3 J"5"15@OBHR^>*>HG:QG,C*3
MS306]:T6AW]JC-GCM5)F;B0(I-68QCDTWR]@J-I\<4;C6A9DD&.*KELU&9,T
M]%W4;";N**>$S1Y>*<'VT,:0X1XZT[*KU IHEW5'(<U([H=)(N#@51D!8FI6
MJ/=@U:1$G<@,1I/)8U9#9IP.*9%BH(6S3Q"U6D&YJLF'Y0<4KE*)G>6:D6,X
MJUY-2+!Q1<:@4L8HS5TVN1TJ%[?;1<?+8@JU"O>HEAS4ZG8N*3&D3[P%IHDY
MJNTG--#4K%7+RMFI5-4XVQ5F,YJ64F6.U,9J?_#4+&DBV(349ZTN:2F0*K<U
M,IJ +@U(IH&B<&D<C%(#Q4<CX%(IO09N^:G[JK+)EC4PYIV)3)U:E)J)32YI
M#N/5N:F1ZK#K3PV*+#3+(>GAJJ!\FIMV%S2L5<EDD&*A$E1/)FHPU%A-EK>#
M2;JK[\4HDIV%<GS2;L5'YE)NS0.Y8WX6H6EYIK-\M57DP:$B6RSYM*):H&6E
M$U.Q/,:BR#%*9*H+-[T_S:+%J1;\P5,CC%9OFU/'+\M38:D6FD%1M**JO/SU
MJ-IJ=A.1;,E)YE5%ES2-+BBP<Q;$O-2K(#6:).:E2;WHL+F+Y:I%&:H^=S5J
M.7*TK%IDKG"U49ZEDDR*J,<TT$A^<T &A%S3SP*9*$[4P@&D+9-.6D)D90T+
M&<U-3E/- TA57 IX8"D9N*A9Z2*V)BXH!R:KAJ>'H%S$^:,U$'S2[J!W%+4U
M7^:D/2H\X:@5R:8\539L5.S;A528X-4B9,1GJ,M32U,+9JK&39-')BI@^:IK
M4Z<BE8I,D5SOJZ&^45GK]\5;+X04FBXL9/)54RX/6B>2JI;FFD9REJ7A.,4;
M\U25JF1J+"3+.3ZU;B;$9JBK9JRI_=FIL:)D4LGS&HA)4,K_ +PT+S56,[LG
M+YIN[FD"4NR@>HX/Q36>D*TQA0)W&N_O2Q@EQ3",FK4,?>FP6Y:"YC%5IE(J
MV#A:AE&^I1J]BH#29J1H\5$1BJ,FAP-;.DGD5B+R:V])7D5,]C6C\1M,,H:R
M2O\ I-;&WY#]*RV&+FLHG5/H:,2_**R]70\UL0#*BHKVR\[/%2G9ERBW'0Y+
M8:GMT/F5KG2?:GQ:7M;.*U<E8Y52E<FL4Z5#JJ?,?K6G;V_EXJCJGWOQK-/4
MZ)*T#/MX<N*W8HECB#$50M(\X-7[J79;"B6K"FK*Y7N;M%'&*S)+W)ZU3N9\
ML>:I%\]ZTC!&$ZSN:WVS*]:K2S@U2W<=:-V35<J1FZC99C;)JTB,:;I]IYQ'
M%:ZV/E]JB4C2%-RU*&S"56D.*V9;;$1.*QKA<,10F.<>4B$E3(XJD3BG+)BJ
ML8\Q?# U(J55B;)JX&V@4K&B$<A*HS$LU3S/NJ'&:$*3(U'-3JU,VT#BFR5H
M2')I-M*AS3B>*10W.*-U122;15<7.3UIV)YBT[5$N?,%('W5(B\YH#<O*H9!
M4$T/H*>)=BBF-=!J1II8C6 T_P GCI3EG%*9N*9.A&J!3R*EW(.U5I)]M5VN
ML]Z+,5TB^90.E1-)[U2-Q[TUKCCK3Y27,LF2HWFQWJH;CGK3'FS3Y2',N>=[
MTTS52,OO3/.R:KE$YE[S\=Z>MS[UG%J:7Q1RH7.S:2?-2^>N*QXY\#K4R2;^
M,U+1:DRZ[J_:IH;;S!P*KPQ9K5M3Y>!4MV-(13>I VELR\"J,^D2*">:["W(
M9>@J6:W#ITK/G:.AT%)'!1Z;)GO74Z7;%(2#Z596PP?NU<AB\L8Q2E.XZ5%1
M=S,FL6=JISZ22.%KIU3/:E:($=*E3:-944SAI+'R>HJ$L$%=7?V/F9XKG+NS
M*-C%;1E<Y*E-QV*#RD\ TMN26Y-(;?YJDC7RS6C,%>Y._P M$%P%G49J"::J
MJR8E5JFUQ\UF>@V4H:!:O @5R-CJFQ0N:U&U8!1S6$H:GHPK1L<;_9P;M36T
M\*IXKH1; =J:UN".E;\YP.B<NMH?-QBM6SL@<9%75LUWYQ5V* +T%#G<<**1
ME7%E@\"D@M?W@&*W&@#=14.R-&J.8T]FKW8X62F$=*J26@6M!9T*[0:CE&[I
M24C1J+1A7,.,X%9$\KQMP#75/!N!R*R;RR!!P*UBSCJ4WT,-;]PV.:L)?L?6
MH)+-PYP*06LH[5IH<_O(MF\8TW[0<YJ-;64]JD-K*%Z4M"ES#UN33C<FJPMY
M0>E3I;2'M1H/WB>.9F/0U8E&8>:=;VQ Y%6)H&\G %0VD:J+:,+R [&G_8\=
MJMV]K)YAR.]:(M>.13YA*D88M\'I5J*V4^E33QA&J!9@K=:+W%RV9/):KCM5
M5[4=JL-<J1UI\4D;=32U'HREY17M4;L<8Q6HPC*U4D5,TTR7$I %NU68HQBE
M5!3]I XJKB2L1-@'K0FW/45#+O!JL9'4T(39J95>XIC,#5!9G-3*S'K18.:X
M]SCFHO-;-6-N5IGE<TP(3*U3PW3*0.:!#GM4@@]J3#6^AJ6MT6P#6BQ#*,FL
M* E&JX]SA1S6;1T1G9:D&H *3@UF-4]U(SFJV&JXHPF[L0TW<5J0(32^4357
M(W$CD)J]$_%54B([5*N0V*EEJZ+9.5J%_EJ5>E07/ J46R6.3CK36EPW6J@E
M(%1F0EJJQ/,7Q-[TR1P>]5<OBFEF[T6#G)CS2!<TB FK")1<%J$*X-22MBE&
M!44S5.Y6Q78Y<5;B7Y0:I?QBKL1^44V2MQ[GBH"<5*_2JSDT(J0C28-"R'-1
M'.:<I ID)EM),U<A&16=&ZUI6S K4R-(O4208JNW)JU*15-^#20Y";0*>& %
M5V<BF>8<5=B+EDS8/6G)-N.,UGM(<TJ2D&E8.8U-BOW%,:V4^E5EF/K5B.7/
M6EJBDTR)K09J)X"O:M)"K"G-$I%',Q\B9ANA]*C(Q6O+;CTJC-"1T%4F92A8
MJDTWBAU8&H\-5F>HK&@'BDP:<,8I"&TAXIX'-#+3 8.:4+S3T%.*T#L(.E(3
M28-2)$S=J3!(DB8XISIE>E2QQ$=:L!%Q@U-S11,@1G<>*E6 GM6BL*$U.D*4
M7'[,QC"1VI!$<]*VFACJ/R4!HN'L[%*&WR>E6A:"K,:(*D8#M4MEQ@BKY005
M7EF*\58E)JE,I--"GIL(ET2:D-T15-5(-/J[(S4F6A<DT&0FH54U*@YI-(:N
M.0DTXTX "F.:DIZ!FFMC%1,QS32YII$-BEL4]):@))I/FS5"N7E;/-68FYJA
M%NS6A&, 5#-8DK&JDKX-6)& JJY!J4AR8@?/%#1!A48/-3*U4+<KM;@5(MMD
M=*L *35N)%VTKC4$9+V^.U5VC/I6\\:8JNT49IJ02@8WE$]J!"<]*U3$@I5B
M3-%S/D*,5KGM5I;(>E7(UC%6-J]J7,:QIHHK:JHI'/ECBIY<CI5.4,:$$M"/
M[2=QI3<&JY1@<TY156,[L>;M@>]2)=LPQS59DR:<B'-(%)EII"130^*:P(6H
MLF@=R?S:<LW-5\TTL0:=A*1>,@8=:A:!7[BJWFM4L<A[T6L-ZDD< 1P16BMZ
MT<849JK&RD<TYP"O%2]32+Y=B&]NVF&#FJL,A0BIGC)I@B/I5*UC.3;=S6AU
M1E@*Y-4I[@RDU7PP%"@YYJ5'4IU&U8:(MQIK0D,.*O1(#4IB4T^;47+<2TG:
M+'6KT]ZTL04YZ54" =*1LXJ&M392:5B!D#&E4B/O39&VU7>0U:1DW8TX=0,;
M8S6I!J1DP":Y/S"#FK$-RRGK4R@:0K-'7&1'ZL*:2@&=PKFVOI!WI!?2GO4<
MC-?;IFW<3C9@&LT2[&)J'S78<U%,Y JE$S=2YN6ETI'+5=7RF^;>*XPW<B=#
M3UU*8#K2=-C6(2.OFN41,!A6/=7/F9&:Q_M\KG!-*9R>].,!3K\VQ?C />I/
M+'6J4,WO5Q7RM-Z$1LQKX J'<!WI9]P7-4/-(/--"EH6))L5 TV:C=\U$6-5
M8R<A[24@;-1%J<A%,FY)NYI^>*B)H).*!LGA/S5JVW2L6'.ZMJSZ<U$C2F+,
MQ -9[OAJT9R #61,_P YHBBILE$E2"3%4E?FIE<55C-2)C-@THFJHQ.>*56(
MZTK#YBYYF:-U0JX[T-*OK2L-2'NXVFJAE.XTCS9. ::BDMFK2(;N7K9LD5?#
M84UGPC;5@R *:AK4U@[(JW$AWD55;FII>7I@6J6AE)W9&%IVSBI0F:7RS3N+
ME*+Q\T1@YJX821TIJP'/ HN+D(6R.U1%23G%:'V<GJ*8T0'44[E<I#;Y#UH2
M280?2JL8 >GW#?+Q2>XXNR(FP_4TX1KMZUGR3,IJ:&<D8)ID7'R"H"#Z5=VA
MEIHA]J5Q-7((P<=*>S,!T-6DAJ9;8$]*ELM1,@[R?NFE6)CU!K=6TC[BE:VC
M':CF&J3,46Q/:GK 0>E:XA04*D6ZCF*]DC,>$A>E5G&*WITCV#%9%PG7%-,F
M4+%!S35!+5.+>1SP*L)9N!G%5<RY6,B6K(P.],$#CH*9)'*.U)EI,D-P$.,T
MIN_EZUER^:&IG[VFHD.;1HM<!N]5I9<=*J_O:D2.1NHIVL3S-C//;>!@UJV,
M9E89%5H;%V8'%;MA:%",BIE*R-:4&WJ65TQ6 Z5LZ=8K$!C%,C08%:EHHQ7-
M.1Z=*DD[EZ!=J8J6FI]VG5@=:#%%%% PHHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!K_ZMOI7&:O\ ZTUV;_ZM
MOI7&ZO\ ZTUYF9_PSMP7QG//]\TVG/\ ?--KY5[GNH*L6L#22@;3BB"V>1UP
M.*ZO3=-4*&8<UV87"RJR.>O75-":=I:KAL5T$4(C Q1%"J* !4M?4T*$:4;(
M\.K5<W=A111708A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 R3[I^E<=JZJ9\$]Z[&3[I^E<'KCLMQQZUK2W.7$NT2LUG&PSD55E
MM GW14:73!\,:T(9XG^\:Z-4>>N61%:,T6!@UNVKA@"363(\*GY31'?HC@9J
M9+F-(R4#HY"&CQ50)@U%#?1NH&ZK*E6Z5G9HWYE(J2L0XXJ["NZ/FF-"&.:L
MQ+M7%#'%:E2[MP$S6#<83-=)>?ZNN9O5<YQ5P,<1IL5C)4?FD&E$$I&<5$Z,
M#6NAR.Y.L]2B;-9YW+UIR2T6&I&APPJM)%WI%G'K4HD1N]+8=TRL%.>E2 [:
MF*J>E5I0RU2U$U8&G(--\S)JNQ.:4&G8CF+(?%#29J$&ES2L.XK/4>>:<128
MIB '%/!S30*>HH8(D0X.:G$QQBH0*<!2+1)OIZRD5#@TY:0TRT),BC :H,TH
M<U-BDR81@5!(,5*K$U%(>:82(,?-4BKFFC&:F3%,E#E7%6(Q4(]JFCJ&:(F8
MX2JS-5A_N528\T(J0_=2@U#NIZFG8BY+2J:9FE%(:8\O@55DFR<43/BJC.<T
MTB)2)PV#FI%EJGOH\S%4T2I&B)!CK1YO/6J'FFCS#2L5SFB)!ZTUYL52\TT>
M86IV#G+R2U(9OEZU30G;36=A4V*YBUYE(9<53,A%-,WO56)YR]YE-$O-4O.]
MZ/-I6#G- 2>]/$E9PE-2)(<BDT/F-$G*&J,IY-6U;,54Y3R:$AR>A"6IN\B@
MTTU=C.Y*)2*D$M5<\T[-%@4BR9*LQO\ (:SMU68WPAJ6BU(227#5$9LU#,_S
M5%EJ=C-RU+T<OO3]P/>L\%ZF1F[T[#YF6<\TX.142MQ4BD4K%)D\9W5>CQLK
M/5E%3K,.F:AHN+)V.33=M (-#,%J2[DBC J-S2"44XE2*8[D(^]4F:82 ::6
MID$A?%-\SFH2QIA?%%A<Q<\S/>FL:J+,,]:F1]U%@4KC6DVFE$OO5:=B&I@<
MT[$\Q?$E.$OO5(.:7>:+#4R_Y@QUJ(OSUJIYII-Y)HL-R+JMFJUP>:=$Q)I)
MES0#U15)I*'X--S5F3)5J93BJR&I0U2-$BGYJLYRM40WS5:1LBDRDR"X%535
MNYZ55XJD3(05(IIE*#3L*]B</BK4;;D-9V:OP'Y:EHI,8T0+YIRQ 5(V*CW4
MDRB3:!32!ZU&SFHS)S18=T6"!3=@-1>93E>BPKH?Y0J0?**$((I&H&)YAS1N
M- 6AN*0AC&H6%2'K3@N13!JY73.ZM_2!R*R @%;.D\$5,WH:45[QLMQ&?I6.
MS?Z36N_^K;Z5A.Q^UUG$Z*NEC=M3P*DN90G>J]JWRBJFK3%,XJ4KLU<K1N3&
MZ'K3DN@6ZUS;7;9ZU-;W+%^M:<ASJMJ=7%)NK+U0X?\ &K-D^[%4M9;#GZU"
M6IM-WA<LV>/+ZT[4"1;U1LK@# S6G=IYEH,4WHQ1=XG&3N=S?6HU.:M7EK(K
M,<51 9>M;IW."::9.2 M1QO\]1L6Q40+!J=B+G7:*RY'(J]>3%#\O/TKFM,G
MD0BM^*:-_P#6'FN>2LSOI3O"R*DEY*?EVG%4I6)Y-= UM$\185CWL6S.*<63
M4C)*[9F-30<&FLW--#9(K:QR7U+T)YJTS?**HQY"YI_FYXJ6:IV1*3FF%L&F
M%ZA:49ZT)"N6=](6JOYE-:3%.PG(L>;MI3+D52\PFI5#$4K I7"5RW%11)D]
M*GV>M/78M.XK$L48QS0[A.]5Y+@*#@U0EN27ZTDAN:1?DN.,5")C57S<T;JN
MQFYMEDW)!I?M1Q58<TX1L>E&@79*TQ:HBU.$+^E+Y+'M1H&I"6-,9VQT-6?)
M/I3UA'<47#E9G_-Z&EPQ[&M06Z'M3OLZ"CF#D9EA&/:IH[?)Y%: A04H5%-)
ML:@1I9J1SBG_ &!#W%.:0 <4U934NY:2'"QC'<4Y;9%/45 ]P1WJ-+AB_6BS
M"Z-)5"]#5N%2>0*SXF9L5OZ="&3YO2ID[&]-<S$AF9"!@UH0W 8 $U4N56-2
M162;TI(>:SMS;&_/R:,ZL%/[PI"RYZBN:75<=6H.L)N^]2]FRO;Q.I5E]:DR
M*YZWU:)B/FJ^=1A" [JEP9HJL67V0/69<V"N>U21:E"W1JD:ZB8=:%=!+ED9
M3::N>U07%@B+GBM-[F('K6?>W*%.#5Q;,)*"1A7<(!.*J>7WJY,V^F*F:V6A
MQ-79#$Q5NE67N&V]Z%AQR:;, !1HQZI'4/&/2HS'[5/NS1C-8W.VQ6\KGI4B
M)BI,4M&X)$;L$!K$N[H>;@&M"]FV \UREW<_Z2.:N,;G/6J6T-NU+.^<FM=8
MR0,USUC><CFN@@N=X%*2L52DFAQC '2J<T0/:M+[PJO)'S23-)(R3:*6/RTO
MV1!_"*T!'S3O*S5<QER%!8$'\(J3[*C#A15O[/STJ98\"CF*4$936(_NTJ6J
MC^&M1EXJ$C%%Q<B*ZP =JD955.14RBHKOY(2:DJRL1Q&(MPHJ=D&.!6/9W.Z
M8C/>MH'(IL4'<QKV$G)%8-PK(QYKJ[E<J:YZ\BR3Q6M-G-6C8RO-;/6I8[@K
MWJ,P\FCR">U:NQRJZ+JWGRXS0DV]JHF$@4L;^6U39%*3ZFNB$U+@*.:H)?[>
M]#7V\]:DT4D32E3VJE(O-6@-ZYJ*48%4F3(@B2K:1<5!"<FM:W@WIG%)L(*Y
M3^[2AP*GF@Q5&0;:6Y4E8LK,OH*G612.@K(,F*FCGQ3L*,S1*YY%,<-ZU$MS
MQUH-SGO18IR0>63UH\K Z4@GI_FY6GJ)68S@'I3Q(H["J[MS43OMI6$W8O&9
M!V%1>>NZJ#2YI <FBPN<UUN%Q44TH<5545($S0E8?-<@?.:6,?,*>T?-*JX-
M4*Q8P"HXJ-DI2^U:9YN:3 L1+@5*7 &*BCDRM-8Y-27<<7R:BD-+B@IFFE86
MK(<X-68GSQ4#1<TZ/Y6HW!:%Q_NU5DJ=I,BH'I(<F1$4T@T\TF*H@C!([UHV
MDN!UJBRU/!\HI-#B[,OE\U YXIN^F,_%)%MD3U'FGLV:C--,SN,8&D!Q4F.*
M85JB6.5ZD63!J)4I<8-#'%EZ.;'>K*7(K+W8%()L'K4N)HIM&V'5^U0R("#Q
M5:VGS5@OD5%K&E[E*2WR>E1?935LS8;%+YPJDS-Q12:V-1-;MFM'S-U(1FG<
M7*C/$)%*T1(J]Y=+Y5%PY$4%A-2B XJT4Q1OQQ1<.5%40$&K,*A>HI#)0&S2
M'9(F++Z5'G)I0N:>(N<TF4*HI^:0G:*9OI6&AQS3":7?Q49;)I@V/5\5,K[J
MJ,:6.3;185R9UR:B=!BI@VZADR* W,Z1,5&*M3K57I57,6M2PF-M)G!I@;"U
M&TE"07L3/+BF>:#5=VS2"JL',3F0$5'G)J%FP:<KT$W)U%2JH-0QG=4RMBDR
MD6(P :M#@54C.35H_=J&;1V(9GQ4&[-/F.:@IV)DQ]*,TW=3@:8B>/-78S\M
M4HN:N(/EJ&:Q&2,<=:@W$&K+Q\56E&RA!)B,U,WXJ)I*87XJK&5V6DGP>M7(
M)MU8F_!JW:S8/6AQ*A,TY%W5"4'I5B([Q0\=1<V=F4)4&.E53Q5^5>*J.E6C
M*2(Q@FIU QTJ#I3Q)QB@A#W((J$BG;LTA.::!C<X%1M4FW-(4XHN*Q$*D4$T
MPC%/1L4P1.@8=ZM*W&#559*>CY-2T:)EH -VI?+'I1"*?(=M07H0,@STJ,J!
M4K/Q5=Y:I$NQ+&X%3"450\RGJ]%A)EX2 FGD9%4D;FK225+12D5KE2*SW;!K
M1NWK(ED^:M(F<V3$96FJ2#0DF1BI5CWTV0AK.3WJ2-N:5K?%-V[:&%FF71*H
M2J\\H(J(MVJ*2E8MRT&,V:;FDI15&+%7K4A/%-5<FG.N!0,5)<$<UI6\F0*R
M O-7K=L$"ID:09HS@&*L:<%2:V'.8A6;.F[-3$N:N5%.:=LR*-FVI5-69)%<
MPMUII4K5UFXJLYS0)H:#4HY%1A:>O!I@30KS6I;' K.AZU>C;:*SD;0T&W,G
M6LJ4DL:MW,GS53;FJBC.;N1@X-2H2:B*U-$*IDH>.G-(S4XCBJ['!I#%:0KW
MJ(S$]Z20YIBQY(IZ$ML>H);.:N1NJCD4L5K^[SBH95VTG9CLUJ6C=**B:[!K
M.=L4P')%"BA*>IIB0/4@'>JT"\"K?:E<N-R2,@=:F&#VJ@\NRF_;]O>D5S)&
MBV .E,C=0W05FOJ/'6H?M_/6GRB=6*.@,T8'050N)UW< 5FMJ'O47G^:X'K3
MY295>Q>$HW5+@S# HMK$R '%;-II>".*ENQ<(.1S5Q:.#WJ% 48 FNQGTO<#
M\M85U8;)>E"FF*=%Q&0.,#-6#(H'05!'#@XITL>T4Q*Z)EN$7L*E6]C Z"L2
M:78:@^T>]/DN)U;'2_;D]JC>^0>E<\+GWH:?=WHY ]N;3Z@@]*@_M ;NM8;R
MG/6I($,CCK3<$C-UFW9&_'=>=QFIQ9M-TJ"PL2"#BNEL[?;CBL9.QUTHN6Y0
MM],PO*U8:R 7[M;*( O2F.H-9\S.KV22,-;0!N11+:*<_+6L8JB=,4^8AP1S
M-Q8Y?I48T_(Z5T+P;CG%"0<]*M3L8NBF<^-,)[5*FG[",BNECM\]J22U]J.=
ME>P21G6UNH&"HK0CMP.@I$BVL*O1KP*AR-H0L,2,BM"W&!4 &*M0UDV=,$6T
MZ4ZFITIU0;!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 U_N-]*XS5_\ 6FNS?_5M]*XW5_\ 6FO,S/\
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MC(Q0*5Z0#BD,0FE3DTUABEB;YJ8EN656J\JG=5G=BHF^8TBV0A33U!J39Q2
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M%A\Q.SU$[_+4;24QFR*+";&%R&/-6[1\]35)A5JS6F]B(O46X/S5$*=<<-4
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M?OFK6GH<N(NV59?,;HQJDZS@_?-;20YJ"6'YL5IS'-)%.W>96&7-:$ES*T8
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M*"%%->YV]#3)"<<53<M2L.3L)-<L6Z&FQRLS=#4T<!?M5N.Q8#.*=[$1BVR
M#CFI(\#O3YHBBU29V4T;CV9K)&C+U%1O;IZBJ*7) QFGFYR.M*Q7,B;[.I]*
M>ELN1TJO'<#/)J<7"CO2:8)QN;,5O&+<\BLVYA3)Y%-.H 1D UGRW3,3S0HL
MTE.-K#9XE&<$4R&-2Z@D=:B>1FJ)9'65?K6EK'-=)W.SL=-C>$'(JQ)IB*O:
MJVDW!,0!-;CC,0/M7,WJ>E3A&4;G,7=BHS6//;$'A:ZRYCSFJPM48\BK4C"=
M*[..EA<#[IJN$?/W37=2Z9&T>0M9K:8JL?EK55$<\\.[G.I S?PFM"ULLNI(
MK5CL4':KL-JH(XJ93*A2U'V=N%05K0IC%0Q0X4<5:0$5SR=SOA&PDI'3-5GL
M4E&[(IE[+L:F1:A&/E+<T),IRB]R"2P52<56DM0W:M@D2+D4SR">HJE*QFZ:
M9S%SI^3TJD; [L;:[![52>12K81GM5JH8/#W9QL]@43(6JL5LS'[IKNKBP0I
MC%4XM/C0\BJ50AX8Y![,^8/E[ULV.GC .*TI;%-XP*NV]L% XJ95+CIT+,2V
MM@H%:D*8J)(L"IU! K&3N=L8<J*UU=>4K<USL^MNLQ7)J_J@EPV*XVZ9UN#F
MM803.6O6E%G7Z?J37#X)K<";JX?1+D"7YCWKMH+B-N]345C;#U%):BF&A8N:
ML@JPXJ,E5/-9ZFS2'(F*5ES4?VF->]--W%ZT]1W0OE\U*O IBR*W(J04AH1W
MVU-!+G'-4K@G'%/M=_%)K0$]3;C.5I]10?<YJ6LSH6P4444#"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI* %HHHH :_W
M&^E<I?PM)=8V\5UIY%4GM$:3<17)BJ/M4D;T*GLW<R;'3%5@V*WHH1&!BE2)
M4 Q4E70H1I*R)JU7-ZA111709!1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% #'^Z:X[6I,2$5V,GW3]*X37G(F-:TEJ
M<F*=HG/SMF0U69,TLC_O#3E(-=JT1X[U97:'-)]F&,XJ\L8-/\L 47#D1CRQ
M;150Y%;,\8VUFO'R:M,RG ;',4JU]K8QXYJF5P:G1,K0TA)O8;'.R2%N:U;7
M4V&.M9C1$#.*:I*TFDRHR<3J8;[>1DUK6LJ-CYA7"I<NI'-:-KJ+JPR:RE3.
MJG7UU.\4*5'(H\H&L6RU)6P"U;,=S&W>L&FCOC*,A7B'E-]*P)[8-.<BNC+!
MD.*S98LR$BB+)J13,];!1SQ4%Q!LZ"MA8C3)8 0<BJYM3)T]-#G&E*'%*)2U
M)>H5FP*2.)B*U2.;6]A)$R*B\ENRFKZ0,>HK2M+)77D4.5BE3YCFF1P?NFDR
MX[&NIDTU>PJC/IQ X6DII@Z,D8ZR&E\RII+*5>U0M"X[56ADTT.63FIEDJKL
M8&GX8"G8:;+)?--\W'>JQ<BHRS&BP.1;,F:D@.6J@&;-7+7.ZDPB[LMRG%1@
MYI;@XJ)7 J;&C>I9S\M,W4S?Q32U%@N.=Z=&>15=FI5?!IV%?4TB1LJL_%(D
MN>*60@CBIL7>Y QI@/S4DAQ3%SN%6C-ET  9J*9\T,^$%57DS2!R)*8QI%;B
MHV)S3L3<.IIRQY[41(2W-7411UH;L$5<9' "M&P*U39 Z4P]:1=AZG H9Z9S
M33FE8+DP;-(X!6F XI02>*!W(2.:4<5/Y1/:HWC(IW)L1L,U$80>:E*FD7KS
M31+*[1X[4S!%:&Q2*K31X/%-,''0;&>14TW^K%5UX85-(?W8H"^A4#8-2AZB
MQS3U'%.Q*'[J1FS2&DI QT8-78Y2JXJ*WC!I)LJW%)EQ5E<>TF30*B0Y-3[3
MBD!)$!4I48JN-PJ16.*1HF(>#1NIV,TC*0* (G>H]WS4YP:BP<TR&7(GIUPV
M!5>(D&BZ<[?PI#;T(O,I"_%5]YHW&JL9MDF_FI%:H!2[B*=@N3,:86INXFFD
MT6"X_=5RT-45&35VW4BE(J(RZ/S53YW=*O31LS4Q8#GI0F#397R<=*!GTJYY
M''2FF*BXN5D !Q2@D&K BXI#%[47&HDMF26J[(V*JVL9!JS*,&H9O'1 #FG
MU$#3@U*P$C<T@0&D+4JF@+D@C %-/%(7XJ-F- "3*'JA-'@\"KI:FLJL#33(
MDKF4V0:3-69H3G(%5&5@:T3,6K%ZT/2K^?E-95LQ%7@_RFI:-H,BE;FJSM4L
MAR:KO31G)C2<TH-1T[M3('YIPJ M2JQ-%@N:5MTJX@YJE:\BKJ9J&=,-C0LO
M]95Z].U/PJC9GYZMWY^3\*R:U.F/PF%<OEJ;&F>:;<??_&IH\"/-:=#FW82C
MY*IXQ5IW!XJ$@4()(0=*C:I1TJ-J9#(&.*B9\5*XS4#(U4B'<@DE.:C#Y-+(
MIS2*IS5F3)XWQ4V\FH$4U,JU-BXWL+GFI8V(-,"'-2*M(I)EZ"6K/F9K.3<*
MNP D<UFT;Q=T6(X]["M!=/4H#Q52$@.*VK=D*@5FW8Z*<4]S,DT\#M4!L\'I
M71&-&%,-NI[5/.S1TET,VWMNG%:"VHVBI%B /%3@<5+D:1@D5OLPK,O( ":W
M,50NH]V:<6*<%8YW9^]Q5^",1X-1M"5FR:+F4+&,'G%:[G+'W=PO)^N#6>7R
MV:;YK/UIA.#5)6(E*[+B2<8JW -QK,C8EL5K6*Y(S4RT+AJ).A7.!6=*[@]#
M73-;JXZ51N+(8) J8R1I*FS!+FE60BIVM7\P@"E:SD Z5I='/RLC!+=J:00:
MT;6T;;\P[5!<1A":5RG!VN50Y%/#$U#YB!L5:MRK]*&2AZQ%E)Q5*<D';BNF
MMK96B/':LFZLF,_ XI1DKFLJ;L9UK!YDG([U9NX/*' J[:6A5\D5+?6S,.!0
MY:DJG[IS3.WF 8-:ME!OP2*:+%MXR*V+2WV*,BFY:"ITW?4LVT 4#--O2BY^
M84^XF6%!SVKF]2U$LWRGO6:3;.BI-0C89<)NN%(&>:V;",X&15+3XQ.H9NM;
ML,0C4&G.6EB*4-;EAK99%&:K/IB9[59^TH@Y-,:]BQUK-7.EJ+'PVR1CJ*F9
MT5?O"L>XU6),@-65<ZOG.UJI0;,Y5HQV.BFNT7^,5DW6J%3\IS7.SZG(V<-4
M27+R=36BI6U.:>*OHC;DU NA!-9LDHW$YJNSOMJLSOFM%$QG4;+HN"M5I;D[
MQ]:B!:HW5B:=C)R9L6MWC'-7I;K=&.>U<[&SK5J.5SP:EQ-(U':Q/)(34D48
M<9-1@!JM1+@4F-;A]G %,==M6<C%13#BA,M[%&7DT^,XICJ:D0?+5&1:AG.<
M5<($@K*0X:M"V?.,U#-H/H<;32*D*XIIKH//:(R*13@T\BFD4"MJ7[6;&,UJ
MQNA3) K C.*O1SX3&:AHVC(MSNN.!67.S'.#4TD^>]57;--*P39#N<?Q&G+)
M(&SN-!YI*LR-&VOFC(RQJU+J6\<-6$>:?&M0XHT55FTMWE#S5.6X;?D-4:\"
MHY%S0D-R986^9?XC4G]HD_Q5DR+BHP<4W%&?M))G1Q79?^*K#L6CZUA6TN"!
M6P)/W.:AQ-X2;169@A)J[9WRIBLBZFZU5CN,=ZKEN0JG*SO+?44*]JLK>*Y[
M5PL>H[.]7+?5L-]ZLG2.F.)OH=H'#4$XK$MM4WXYJ[]KW#K4<MCH51-%EIU6
MF+<JS8XK.EFRW6B Y>E87/J:Y(:DV4D?(%2$X%(T6H@&*&F51SBJT]QL!YK(
MN]2VYYIQC<SE4431NK]$STJ.'4%;TKE[F_\ -SS4MK,3CFM?9Z'/]8]X[&.Y
M5EJ57!K!@N< <UH07&>]9.%CHC4N:.:0@&H#-[U*CY%38UN0RH,=*J-$">E:
M#C(J'R^:I&<HW*8A [5(L8]*G*4Y5QS3;$H$0M\]JECM]G:E:;RQ2170E.,U
M*N4DD$@Q5&< J:T77=562+-4M!2.=O(20<5BR02 GDUV$EIO[54DTS/:M5(Y
M)TFSE=LB_P 1J6.X9#R:VY=*X/%9,]CM?&*TYDSG<)1)TOQC&:E6YW]ZSTLS
MNZ5?@L\8XI.Q4')DV[*FJ,IP];,5CE#Q5:XTW )Q23+E%LSX7&ZKR2*.U5HK
M7YR,=ZM_9=O:AM"BFAC2C-*MRHJM,NRJ;2X;%.PG*S-D72FHY9P:REEIS34*
M(G4+_GBD\T-6=YN34T;9--QL2I-EU<4XXQ1;IOJ62'':I1JEH9[\M3XTYJTM
MGO8<5;73]JYQ1S)"]FV43A>U0O, :N7,&T=*RIAAJ:LPG=(NPRC<*U(YT"C@
M5SJR[:D^VX'6DX7)C5L;TERC=A5*649K,^W>]--SN[T*(W6N73.,T+(&JDAW
MM6C;6NX]*;T"+N1LA:F&V8C-;,>G[NU61I_R'BH<C546]3EUB*O5R-:ORZ=M
M).*A$.T]*?,1R.+&"/-/\DXI&DV4Y;CCK2*TZD?DG-*(34H?-2!J!I(J-$13
M#&:MR-41-.XFBOL(-*7V5(S57D&ZF0/%QZ&I!+D52VX-2 \8HY17+2RC-..&
MJJ@R:MQ+2:L4M2-D-0M&:NE>:0QY%*XW$SSE>IIR-N(JS);;ATJ,0;#TIW%R
MLT[1,QU)<)^[IMJ^U,5-+\R5'4Z$O=,8?(QS3_M(6G3Q]:SY5P:T1SN3BS1%
MTNWM437*,<8%9Q? Q1",R4^4GVER_MW]*8T9%7;2#?BI)K?:>E1S6+Y-+F2R
M&F>2<U?\KYL5.MKD=*KF)Y#),)H$1!K8^R>U--GQTI<X_9%!"1QFI@#3S;;3
M2[<"B]Q\I"_%,#@5*ZYJ!EP:"6[$XD&* XJ$#BG 9HL"+"N*9(_'%-QBC;D4
M%$')?K4PCS0D7S5;2*BX*-RF8Z>$;'6K314FS I7*Y2HR$BF*F*N%,U&Z[::
M9+B6+95QTJWY(VYQ5*!\8K35LQ5#O<UA:Q0E8)58SAJFO!P:SXUR:M&<MRQC
M=2&,FIHDXIX7FE<+%86[-4R6I%7($R:M&/;2YBXPNC&>V.ZG"V;%7W W4XD!
M:7,PY$9C0&F>7MJY(^*KE]U4FR783>%6J\L^>,U,Z90FLR0D2$4TB),EY8]:
ME1344))JR.*IDI/<>D>:LI;GK4,<FTU:%SA>M0S2-NI+'%CJ*61 ,\5!]MQW
MJ-[W/>I46:-Q&28#=*BWCM4<MQD]:A23+5I8PYE<MC)Z&J\RMZFK40S1)%D'
MBDF4U<QW+;L9IT*,QZFK1M=TG2K]II^3TJG+0A4FV06\1&,UHQQKMZ"I)+3R
MNU5'N?*.*SO<VY>7<G:(>E1B,9Z4S[;D8S0MQSUI68-Q)Q$I[5$T2YZ4]9_>
MF/+[T[L'RC'0;>!51XS5GSLG&:"-U--D-(S9 P[U7R=W6K\\?6L^3Y7K1&4T
M6$SZU912>]4XI*MI+BDQQ8XQ$FI8X>],\[FIEN.,9J316'E!CI2QJ!VJ)Y^.
MM0_:]O>E9AS)%MW5>PJLTZY[52GO,GK422;WJN47-?8T5(<TV2&IK.#<16HM
MAO[5+E8I4^8S[6( C(K;C$;1!=HS47V#RT)QTJ""?;<[,U#=S:,>31CKJP+C
M@5CSZ:X]:[)5#H/I5>:UW=J2G8N=&YQ+V,B\Y-0&-@<9-=G+8;E/%9DFDY<G
M%:*:.:6'.=.Y>YIAE;UK>FTGCI5)],PW2KYT9.DT44220_>-65L9&&<FM.TT
MWIQ6Q'8X0<5+F7"BV<U'ISGUI#I;[P>>M=6MKM[5*MIGM4.H;?5[HRM.MGC8
M9)KI!_JE'M5=+79SBI&DVC&:R;N=5.'(K$,T6ZHE@((JW&WF4\I@$TBN5;C5
M0;,$5!/;C' I3<[7VYJ8-Y@H!V9FB#':IXXL$5;,%*(\"G<E0L.4 +TIK2A*
M:7QQ6?J%SY:]:25V6Y)(JZG<ALXKGO-D-VN'.*?>WV3UJO"V9 U="C9'!.I>
M6AV5B^(5W<UH"5".@KF[>^VQA<U?M[G>>M8N)TPJJQJX#=J>, 5'#R*<_ J3
M=,<2K#&*ADA]!3(I<R8S5S.10&Y0\CGD58CC"]JE(%5YK@1J>:+7)Y4M2:21
M47I4 O$'I6/>:K@$;JSTU#>>M6H-F4JZ3LC<N[B-HGX'2N(U!@UPV!73 >="
MQ]JP[JR_>EL5I3T9S5WS(IV 9),@GK72VERPQEJQK:#YJUXH,"JJ*YG031J)
MJBH,$BF3ZNFSM6#=#82:R)[LY*YJ(TS:>(Y3?EU@$G#5!_:W(^:N<,F3UHSF
MM?9HYGB&SM;778U7!(K2AUJ*4X&*\Y#$'K5VSN2DG6HE21M#%/8]$\]9!5ZU
MQQQ7)V>H9QS71V-QO YK"4+([J512-R/[M/J.$Y2I*P.Q;!1110,**** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*,"BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+$)K4Z"2!6'W144-HH<G:*JQ:KO_ (JMI>#UJ+,Z%*#'SVRL#A:PKK2F>4$
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MS31*K*2*KF4AZ1I=(L>6*0PYI8G#59P*3&DFBL(!3_*XJ;BC*T#LD5_+J5$
MIQQ4,DRH#0+8;<RB.,G-<[-J3B4@9JQ?7>20#6(VYI2:UC$Y*U76R-_3[TNP
MS6PKJW>N4MI#'BM*.^ (R:4HFE.KIJ;8 )J0+Q56WG5UJR6&VLF="?4=@4FP
M&H6F I5G4TT@NB0H,4W8,T><IHW"AC)%%1SN%B;GM2-,%K.N[L;6 -.*N1*5
MD9DMT?M9&>*U;29>/FKFY0[3EA5JWED3J:T<=#F534Z&XF&>#3H6#"L1[KGD
MU=MKQ,#)J7$T52[-;&13-E)'<(Z\&I.*SL;JS&^6*;Y?-2;@.M*&4TPT&JE.
MVTI90,U&]PB]Z2NP=D28&*IWBJ(2<TV2^C7O6?<WJNI -6DS.4U8STG*7#?6
MM_3YQ)C)KF75BY(K0T^5XR,U<EH84YVD=*S+ZTF0>]91NCGK4T-R"V":SL=/
M.B\4IRI0LBE11YBBI9>@&,&F^5S4@<&C>M ;B+&*<=J]ZBDN$0<FLR[U%%S@
MTTKBE-1+-W=;8V -<K>7;M(PP:M3WN\XS51H_,.:V@K'%5FY;#M-N61\X/6N
MDAO@1\S8KG8H2ASBHKFZ>(\&AQNPA-P6IUPND/\ $*GCD5OXA7$1:B^1\U:U
MA>L[@$U#A8UA74G8ZC:/6F$(.I%1"3*BLZ[O/+?&>]0HW.B4DE<UQCL:;(^T
M51@O%9>M23S )FBPN96N-EFSWK%O2&S4MQ>*N>:S9KQ&[UK&)RU9IF?-"#)F
MK-B@1\YJ%YD)I@N AX-;/8Y;I.Z.OL[A5 ^85I)<(?XA7"IJ)7HU6X-4.\#=
M6,J9U4\0MCM0P(ZT%0:RK6^5HQDU<6[3UK)QL=<9ID_EBEP *B^U1GO5:>_C
M53S0E<')(MF11U84GF(W\0KG+K55!.&J"UU7+<MWJO9LR=>-['5X7'6J-X!Y
M9-0PWRN.M$]RAC(S1RM%.::,NVD*W;9]:Z**92!EA7,;P)B5JP+QDZFKE$QI
MU.7<Z)F3/WA4BLN.M<N=2PWWJN1:I'MY:HY&:JLFS>#@]Z<6 [UCQ:C&QZT^
M:^7'!I<K+]JC2>5%4G<*R+K4=A(!JA<ZB1D!JR9KIF8\UI&!A4K]C5.JL2>3
M5>?42W>L:2<CO5<W#'O6J@<DJS-KSA)U---LK\UE1SMN'-;-G(&(S2DK"C+F
M>I!]E\KG%5KB4I6W>;!&,>E<Y=G)HCJ.HN78A>4DTQ92&II-,-:V.9MW+T=T
M14RW1)%98)%2HQR*7*BHS9O1WC>5CFJMQ,S"B#E*6X4;*G0V<FT9KG-1$4^3
MO3!5G,QHX-7;.0J]50M6;88:DRH73-9IR16)?99\UIEJI3@$U,=#2IJ9@7YJ
MFV<4_9\U2A1BM+F2B0*E2J,4[:!0!4ME6+5J SXKH+.U1L9(KG+8D25NV]R(
MP,FLI(Z:+74LW>F129Y%8-W8)'G&*VY+]"#S63=3*Y.#1&Y5;E>QB2+AR!3H
MEYJ9E!8FE4 5K<XU&Q+&,5)BFK3^U2S1#''%5R,598U U-,30VDQS2T#K3%8
M3%/04 "ID I,(H0#BHVZU,PJ!LYI(;&.*8M/:F59#19C;%6E;(JI'TJ3)Q4,
MTBQ\P!%5&6IRQ/6HSBFA,8!3@**<!0Q)#TKK] 'RBN04&NPT ':OTK*IL=>&
M^([.V_U53U#;?ZJIJXF>TM@HHHI#"BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,?+34BJ=8\"FV5&)&4I-F:G88%1!L5(]BO*-M5OXZM3G)J!$S(*I,SEJRU;
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M8,R_O*U;IF8FLV1?FHB[!4U(0M1R#!XJ?%,<<U:,&BY:Y*5)(ORTEJ5"U/(
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M0>:L*AVYI%Q0[ Q43T\Y%,:@)(05(1\M0;L,*L CRZ!(B!YIQYIA(!HW4 !
MI W:@FH]W-,28Z4Y%09Q4K9(J%@13$!>A)/FJ-CQ4:-\],B^I?+<5&S4W=Q3
M2:315R4&EY-1*W-6 1BD-#0,4=:'8=J=&,BF,;MI*D*T!#4A88%HQS4H I".
M: %W?)BJ\G%3GI5>?I0@EL$3U=C.16;$:T(F&RF*#)<T],57W'=4BDU+-$R!
M^:B90:4OFDS5)D$+)2*E3'FA5Q3)L2PQ\=*D*XHC; I2<FDRTANV@BG$TTM2
M B<56>,$]*M,:C(IW%)%*2+BJK)BM5DW"JTD'M5J1A*!43BK4;5$8L=J5>&H
M!:%Q6IX:H4J4"I9HF*7J/S.>M2;,BHFBQS2L-CM^::6IG2F.U4B>8G#T&3%5
M#+BFF7-.Q/.6Q.!09LU1WYJ6,9HL'.75?-2'I5=.*G'2IL:)C33":D(INW-(
M31%NP:D2XVFFO'Q5608JK$N5B\]V#WIGV@&LUGI5DIV%[0T1)DU*IS5)&J='
MI6+4KE@TF:3?FFEJ11(C?-5E>E9ZOAZM1RYI,$RP149%*7S0#S2+$V9IKIBI
MLX%1R/D4"(=E2!/EIH:I-WRT!8@DXJ#K4\G-,CCW4R6KCHK9I",9K;L;.16!
MR:DTVS#+G%;"1>6*RE(ZJ-+J31+B,"GD8ID;Y.*F(R*Q9V+8S[D J>*YN]7Y
MS71WC;0:YF\D)<BM:9RUB@?O&G"F,>32J:WZ'&V/I<<4 4[%(!@%2**-M.6@
M:0I'RU6?K5AFXJL_6@4AM%(*4"F(459A.#5<#FK$=24BP[ BJ<G6K#U"PS30
MV1]JC84\\4WK09C*44NRE"X-,"5*<PXIJTXGBD40N*9BI&IE,0!:>JT 4\4#
M2+$(XI7.!21' J.1N:GJ7T(G/-,S2GK3:HS$(S2@<T4]1S0 Y%J84U14H6D:
M10#I4+CFK&WBH6'-(;(C3"*D(IIJB+" 5-&O-1BIXNM)A%$^,"JEQ5UONBJ4
MXJ47+8JD4F*DVTA6K,61FE6G;:,8-#&6HQE:<4IL1XJ8_=J&RT0XQ36IY%-Q
M5!8A85&14S4PBFF2Q]N<5:ZJ:JQ"KB+E#4LJ)1D^]3*FE7YJAQS31#W#%.4<
MBC%*OWA3 MH/EILW2G(?EJ.4Y%2:="N:2EI":HAB$5$PJ6D(HN(2-:M(*AC%
M657BACBA7&5JLRU9<X6J[&DAR1$1BBE)HID O6KEN<537K5J&DRH/4LOR#5&
M4<U? RIJE,.:2+D5L\TQZ4]::U:(Q98@;&*NDYCJA#U%:&W]U4/<UCL4I!UJ
M'%6G7FH]M%R)(AVTHIY6DVU5Q6)H>M6>@JO",&IG;%0:1*LHRU0D<U+(W-1F
MK1$MQ *>!3 :D%(+" <U/&:BQ4D8YI#03-51AFKLJ5588--"DB BK5A%ND_&
MH@F35RS/EOFG+84(ZG4Z; J@945I>6OH*P[74-N.:T%OMR]:Y))W/3IR20Z]
M 6$\5R=ZZLS "MZ^O-T1&:YB9MSM6M-6.:O)-D(%!%**">:U.:XPBFD8J7'%
M-84T)H:M6HFP:KHM3HM*0T6G<&,50D[U:(^6J[BB(Y:E9EYI0M.(H%49CEJ]
M;2;:I 5/&*AEP)IGW&J[&IBO%0,.:$-L90:6D-,D0=:L1GFHE7-3HE)C0Z4_
M+4&:GD7BH",4(H<!1B@4HI@(5II6I":830(<M/D'RU&#S3W;*TAE8C)HQBG4
MAZTR6**DC'-(JYJ55Q28T3I4,HR:F0TUES2+*S+Q4)6K;+4++5(AHB J5:;B
MG+28(F05*3Q42G H=Z15]!LAYI@--9LTS?3)N2T"HP]2*:0$BTXC(I!3CPM,
MHBV9-(Z;:7S,&F22YIB=A,4AIH>@G-")N)WJ5*B)Q2JU)B3-*(_(:KS,.::L
M^%/-59KCWI)%N6@%N:3>*K^;D]:7=FKL9<Q,7I-^>],"YIZQ\T!<0D^M1LU6
M3%Q430TP=V5V;BHBYSUJRT-0F'GI3N9M,1'KN?#9RJUQ CQ7;>&AA5K*K\)T
MX3XSO[/_ %-6*KV?^IJQ7GO<^ACL%%%%(H**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH CD^XWTKS7Q(/\ 2#]:]+D'RGZ5YYXBBS,3BMZ&YQ8U7@<7)_K#3<T^<8E-
M1,:[D>"]Q2: ::#2@<TQ$BU:AXJLHJ:-L4F7$N U('JJ)*425+1K<ME^*EAD
MJEOR*>CXI-#3U)ITWY-94B8DK94[D-4)H_GS0F*:N5#TI!4KK@5%TJC)JPQU
MS3 O-3&D4?-3N38?$IJ5Q2QK4C+FI-8K0ILV#3?,'2EF&#4 '-4C*3U)<U+&
M:B JQ&F10QJXTMS2BF/PU.!XI#U'$XIZ/BHCS0#B@:>I9,OR]:K,Y)ZTA?BH
M6:BPW(<QJ>(\53+YJS"<BFR$]2<OQ49:E(XIN.:E%W8H&:GC&"*B48JP@XI,
MI$TC?N:RW;YC5V9\1UF%LL:J*)J,GC?%65?BJ2U,&P*;"+T)]],9ZC+TW=FI
ML/F+<)S5I&XJC$^*L+)29<66:8U-63/%.)J2KD+5&Q&*)7P:BWYJD9L<GWJM
M+51>#5A#0QIED'Y:KR)DU,.E,9N:1IT*QCP:NV:=*KDU9M6VT,4;7- -M0BJ
M4QY)J5I,BJTK9%2C23(2<FG*:A)P:<C9J[&-]2PK4Z0 ITJN'P:>9/EI%7*<
ML8YXJN4JZWS5$4YJDV9R0V&/+"M6"VX!Q52!,,*UX3\HJ9,TIQ*\T>T5C7:9
M-;]UTK'G&32@QU$4;:/;.#71"<"%1[5C!=IW5(+C/%6U<BFU$9J+A\UG+UJ_
M,OF54:/:U-&-1:W+$0-2RG"U$C[5HDDW#%#1:=D/AD'>KL8##.*S$&*T;=N,
M4F.GYDS@!>E4I3FM&2/]UFLV08)J4RYJQ78&F$5*>:3%696(UB)-*\!%3*=M
M*[[J+ARHK*-M68S0D.\BKJV>(\XI-E1B^@P$$8I?*W5&?D;%3P2;J3+78A:+
M JI*0IK8:/<AK(N4Q(11%DU%8JR/42O4CQT10[JT.?5D\1R*FV9%$4."*NK!
M\F<5#9M&-RAY5."8JS(FVH"U"*M80+DU,8ODS42O\PJX/F0"DQI%>%O+-;5F
MGG1GZ5D/%BMS2.(C_NU,NYK26MCF=4@*W%4%;!KH-6B!D)KGI!AS6L-4<M5<
MLF6$<&K*#(JA&<5HP<BDQ0=T5G3YJ5<BK;09YJ!H\4KE<K0^.<IWJ<76>]4B
MM/6/-%D-29.\FX558G/!J7:>E*(J:!ZD +#JQICRX[U>6WWU5GML-THN)Q=B
MMO);K4\="6_S=*G:+8O2G<E)[LDB-6D3^*J<1Z5K11[H#]*B1O'4;'?>4<9J
MY'JV/XJQ)HL2&HC\M3RIEJI*)H:A>><W![TVW?)%9^-U6;<X<4-$\S;NS9V
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<U7CR:FZ5++BR"853)PU6IC5)OO52,I;EF(YJ[&.*H6W7FM)!Q1(N!5D7YZ
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MLSH[7]Y$?I5*Z@^8G%7-./[OGTI]R@*$XK-:,Z&KQ,%H\G%+''BIBO[PU*B
MUHV8*))!%FKFS"4V%0!4[#Y*S9O&.AG3"JI7-7)D.34 7'6J1G)$&W!J>-CT
MI=H-/5.:&"0YN14T-R85P/2HV7 J"0XS1N5?EU&7=P7SFL=^7-6YB2:K;>:T
MCH<LW=A'6E;8Q5 #%686(I2'#0T@ 5J&2/BEC8D5.5!6HV.C=% 1^U6HH<T]
M8L]JLQQXH;",2/[,NW-02(%J^[!8ZSW<%C23'))!&<4XQ!Z@+>E3Q'-,6X+
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M5F$4,B+U)P3B@#)IRXQ2@<U)K8-H%/7BD-*M R4'BEIH/%*!FI*&L:C+&GR
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MC29J 2<4FZDD:<PYCFF$D4H-1R-BF0V.,N!41GJ)FJ$GFJ2(<F7XGW5,5JE
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MD)4.%[4FG:AYD2C=6L0)%'-<6L6>RK5(G!VNGAQR*9<Z>J X%;-@8W Q3KR
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)R:IRL:O2X(S5"7O3B$RLW-(HYI^W-2)&<U1A:Y:LQAQ6N6R.*RXEV8-7X9
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M3P])\@^E95GH=&%2YCK[88CQ4U10',=2UPL]I;!1110,**** "BBB@ HHHH
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M(XACQGI43E<Z*=+E5V$SK$.@KFM3NE+]NM6K_4.#S7-W5QYC4X1,ZU7HB82
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MX?,.*55!-:VE6@FEQ[U,I6+A#F=C%N;,J.]9[Q%6KT#4-("KT'2N/U" Q2X
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MF=]*@IQN>8W-D8F/%6='7]YCWKJM3T8%2VT5FZ7INR8_+WJO:)Q,_J[C-&#
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M%9.=F=5&FI(Y&XM]A/%4BO-=)J, 52<5SC'YC]:N+N8U(\K&XIXZ4VG U1"
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,,0P&#71&S1YLTXNQ=A&]P*W["S((:LS3K?>ZG%=7%&(H5-9S9U4*:>K%:$
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MS1UI&D#C'%9GVG I$NOFHY;#]HC5BM/-/2H[BU\KM6CHC"=AD]ZVKC25F!.
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M;\BIJ2*P]'JR1U5(1SVKF=9E7#8-;-_=JL>!7(ZC<E\\TJ:U-,1425BNK_O
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM=C"<M^M)<ZZACX;]:Y?9.YZOUF-C9O;R*('#UQ.N7XD8[6SS5?4=7=\[7K
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MP*LB7 QFJBM@4PR'=UI-%*5C?TK$LV#ZUW6FVJ*!BO.=(NEBFRWK7?Z5?QR
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MV*L1/S5;'-31#FDQP9=)S5:5:F!I&7=4FKU,]AS0!FIGCYZ5& 0>E7<P:U'
M8K6M/]6?I6:B[JT[==L9^E1+4VIJQ#)]^D4YHF/S&HT?!HL.Z3$GBS5)DP:U
M,;Z@D@/7%-.PI1OJBD!3U6E*8;I5RTM_-.,4,SC&['VJ\?A3)A\U:J6?ECI5
M"X3:_2I3-W%I$$8*MFK0D!%5Q3AQ0*+LB1TWGI3TBVC.*:C5/G]W1<N**UP_
MR8K.8<U=FZFJ,AQ51,9FEI\_ER)]:]'TBY#6H'%>6VQ^=379:/?[=J9K&M&Z
M.W!U+.QV$\ F3H*IKI@!^X/RJ]!.K1*=PZ>M2-,J_P 0_.N/5'K-1>I72U6-
M#\H_*LK5;A4@88%6[S4 BMAOUKC]6U(ON7-:P@V]3FK5(Q5D8E]<AI' QUJK
M!(<CFH)GW2,?>F))MKM4=#Q93]ZYU-AJ7DX!:NCM]?58P,BO/HI<\U:6Y*CO
M64J:9UT\3*)W,VOJ1U%9MQJ_F X:N9%R6J9#N%2J21<L3*1%?3&67.:I;,G-
M694^:F8K6.ARRU9%C;5J!JK/3X6P139$79FGLS&:IR1D$U>B.8Z;)%47U-VB
MK VP]:TXG#1GZ5G^6*N0\1GZ4I#BRG+_ *ZKMI;F8XJIM+W&,&NBTJUP0<4I
M2LBZ4')ZE&XT\QCI5)H]AKI]44(#7-7#_-4P=RJL%%@O/%#Q9%,C?+5="A@*
MIDQU15B3;5R%L,!4;)LIB.1(*6X+W6:D_P#Q[ UB,WSGZULL2UN!6+<KY9)H
MB74?4Z*_U #.UJY*^N&DDJ>661LY:LZ8DMS54XV,:U5R$4Y-6$%5HP=U7%7B
MJD8Q3.IT(@(/I6Q<C-LU8.C/M ^E= P\RW8"N:6YZM'6!Q&H#$S5FA^:Z'4=
M/D9F(K$_LZ8DUO"2L<-6$KC%RQ&*U+.T9V!*T6>ERD@D5TUG9K'%\R\U,YFE
M&BWN006"*@)K,UJ*-5.#6[=3I#'7)ZM>"3=@U%.[9K6<8QL8TH&[BK5G]\52
M+;C5^P0F85T/8\^.LM#JM,SQ5O4@,&DL(]J*:34VX-<O4]1*U,Y:\;;)^-0A
M^*2^;][^-5PYQ70EH>>WJRUN%*'JL&+59AMI)<8H8+4@DW'I59MP/(K?737V
M$D50O+?RU/%$97"5-I79F[LU<M1R*SPWS'ZUIV2EBN*J1%+5G2V<(,.:CO8E
M6.KUE'BVJCJ>5C-<U]3ODK1,-L9-0N,FF>;\QY[T]9%-;K8Y&[CHN&%7C)\@
MJB) *<)<\9I6&I6&W+=:HEN:N2QL_2J,BE#S5Q,IWW+4$F&%:2L74"L6)CNK
M;T]"Y J9+J:4]="":,CM58C%;UW;8SQ6//&5-*,KE3A89$ 7YJ[B,*.:S1E6
MI[2MCK3(3L6S@GBK<0Q'FJ%L"^,UI A8C4,UCJ5II.,52W\TZ>3YR*K,35)$
M3D6EDQWJRC$K68NXD5IPH3'FAA!C'-0,:GE&*J,30@; FHB.:=3EQFJ)'0(2
MW2KZQ>HJ&VV[NE7690*ELUBE8J2* ::H&:2:09J-)!OHL)VN7$&*@NGQFIPP
M*C%5+D$T(<GH5&.32"D;(- .:HPZDBTCXHVFC::!V'1D[@*OJF4JK#'\PK31
M0$&:ELUA$I/%BFK'5J=U J!94S2%*UQPCXJ*;IBK@93'520\F@;M8H.IYXIF
M,5:?%0,*M,R:(Z<@YI=M2Q)DTV)(L0*34C1U+ @%/? K.YM;0I^7S4T,?-)O
M7=5B(C-#8)$5Q\F:R9F):M:[YS65*OS4T14& 4_%-'%.W 5=S-(8X.>*GA!I
M%PU6X8LXJ6RHH0Q?+FH&CK4,?[NJDBXI)ERB50@J9(J0$9JS&!MIW)BB&10J
MU0D;-:-S]RLICS302T#M3>AIXZ5&U69$L3@&K:L&[UE[B#5NV8FID5&5]"WL
MS1Y?%68HLKFD9,&HN:\NA76/FK$:$"GQ1Y-3M'M%#948Z&;/WJ@XR:O7(^:J
MA'-4C&6Y%MQ5J!P*@(I%)!JF*.AIJ>,BG+<.IJ*$_+S4I Q4,M7)#>R"J\MV
M[FD9:9LH20W)@,L<FGN %I57 ILI^6@&4Y1FH<8-3XS3&'-4C)CXZGQQ5=#@
MU95P128T2PRM'TJ_%?,J]:S":;N/K2:N:*3B:DFHOCK5.2\DDZU6W$T]$+&D
MDD/GDQ"2W6F.< BK7EXZU5F'-4B9+0I.,L:9MJ<KS3&&*NYBT6+8@"K@QC-9
MJ,015Z)\K4LU@]+$RSE#5N&^8=ZSG!QFF1L0>M39,M2:+US=,YJH,L^33Q\U
M2"/ S2V#5C6&%JI)DU;D88Q55R#31+(<<U8C;M4>*16PU-DEIQ\O%26TICQ4
M:'<,4YU*]*3U-%W-^VOPL9RW:H[C4C@@&N?,L@X!H#2-U-3[-%NL[6+LEV\I
M(IBAR.E-@0D\U?38@^8=J-A+7<Q)R0V#59^:N7N&D^6J94FM$<\MR$BIH6P1
M4;(:<B&J9*T->"0%>M3%0167$[!@,UI1'<!42T.B$KD;H*15%32K@5&HJ0MJ
M*%[TR<_+5G9\E5)N]%P:*>W)YIVP8I:7'%5<S*S)S3D&#3RO-&S%,5BQ$]3;
M=U5$XJ]#R*EFD-1HA%!C%6=N!3"11<MI$&S%5Y<U?"Y%02Q9-*Y,D9I'S4I%
M3M'@U$:M,R(SUJW$,BJA/-7;8@D"DPB]20Q$KTJ/RR.U:J1AD'%03QA>U3<V
M<-"NBU.L8QFJ_F!2*N1L"E#8XE:X&$K-?FM2Z'R5F&A&<Q@!I"V*FP,57?@U
MI8S>@X-FI8\]JK*<FKUL <9I2%%W9>MXR4R:<P J>)E6(_2J-Q)R<5GJSI>B
M)U*D]:M1*I4X]*Q!,0>M:-I<C;S0TQQDF5;Q2'XJEWYK6N$$@)%94BE6-5%F
M<T1RCCBHES4C..],WK6A@[7)H#F0"MZV0;0:P+<9F%='"-L2FLY&]'42Z  K
M(FDVFM*ZE&*Q;ELGBB*'59,DV6ZU>B8'%8BL0_6M*V<G%-HSIR+LC 5FSR#=
MUK1>%Y!\M9%W#(C<U,=RZETKD@F'K3A)6> X/6IE)'>K:,HRN70Y-6XV_=FJ
M$39JT#\AJ6C6+(;@CFLYV&35NY)P:S>=QJHHQG+4O6\F,5H)\RUD1-BM.T;<
MX%*6A=-WT$DMWZ@579'7J*ZJ.T5X1Q6;J5GY0)Q4*>MC:5%I7,/>13DD;=2.
MG-*B8.:T,=C2MI#Q2:A(2M0QR!:9<RAQ4M:EN6AFR\FH1C-7#;.XR*K/$R-S
M6B9SRB]S1TL?O/QKM;"(,!7#:;*%EY]:[G295<"L:IW8.UK&7JEL=^0.]8DD
M:AL&NVO;7S$9@*XR^B:.8^E*G*XZ\+:E<QK0(EJ+S0#BE\X5K8Y;HO1,J+P:
M<6:3Y15!'9W !ZUN:?I\CL&/(J).QI33EHC*GM'QG;69.AC;D5W=[:I%$,KV
MKCM4*[_E'>G"5R,12Y2737Q,M=Y:;9+91FO.[*3;(IKL]+O 0JYJ*J.C"22T
M&ZW9DJ=HSQ2Z+&T84,,5N31).HXSQ44=F48;1BL>;W;'7[+W^9&_9_ZFK%5[
M12L6#5BN=[G?'8**!10,**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MAZT"F0/44XCBD7FI-IQ04BN>M.13FC;\]6(U%#!1U%1*7:,U,JBHW!J32Q+
MBEJNM NWBLV%]K\UJ0N)  *4C2%F9US'@U .M:%Y'@FL]N#33(FM1^ 14L'!
MJN&JQ%STI-!'<U[=QY9^E4+MLN:GBW!:JSYS4I:FTG[I4)YJS;2;:J'[QJ>!
M2W2J9E!ZFS$X:,Y]*S[D#<:LQA@A^E49V.XU*6IK-Z$2@;JD(J)#AN:F+ U1
MD )Q1CFGJN104-(HL6OWJFN2.:KVX(:I)U9JEFB>A!N -2[P5QFJ;JP-+&Q+
M8S5$<UF3L@-0.F*TK:T>?&VEN=,E3.:7,BW!M7,<KS4D8P:<\>Q\&EQ@9IW,
MTK#F; IR'=5=WJ>U(9U'O04GJ6XK-Y#]VI9].,<88K72Z59*\0)6K>IZ<&M@
M$7G%8>TU.V.&O"YP2(%-6H\XP*L/I$^3C^56[;29AC/\JMS1C"E*^QF/;.PR
M%JLT$B'E:[%;%4B^9:SM06)5.%J5.[*G1LKLSK"+?C-:G]F;XB0O:J%E,B$5
MV>F^5+;G([5-631K0IJ2L<!=6$B2'Y:LZ/;,TN".]=G=Z8DBDJE5M/TLQ2DE
M>]'M?=&L*XS0+8@J<CM7-:G $E(KOFB5%;CM7$ZTRB<BII2NS7$048F&>&IP
MYIK#YJ%KH/->Y(O6K7_+,U5!YJPIRF*3-(E*7[QJK*N:ORIWJHPJDS*2$A(7
M%:EK<F,@@UC%L&K"3?+BAJXH2Y6=5#K3JH&:=+K;]F_6N4,CCH:02N>K5G[-
M'3]9EL;-QJLCYYK)N)VDSFDW$CDU"02U7&*1C.;D08)8\4I0^E6XX,GI4K6^
M.U4V9\E]2M"IR!5_R#Y6<5#%'B05LF,?91Q6;D:TX73,(_*35JV;(JM=#:32
MVC]*OH2M'8NO'D9JL5(-:**&2H9(>:BYHXZ&?(O%$8.15DPDTY8<&K;(Y=2W
M!Q'22M@4Y%(2H9CQ6?4V>Q7>0U?M SK68U;VEQ[E%.>B%35V3VMD&E!(KH8H
M%@C4U7M8E# XJU?.%@&/2N9R;9Z%."BKF'K5P.<&N<=RQJ_J,C,3DUFUO!61
MQ59<TA\;8:M&!\XS6?&A)JX@*BFR8:$\YYXI(4RXS3<[JLQ)CFIN6]67PB"
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M'"7KYE'UI(H_,XK?FT8/(#M'6KEMHBK@X%;>T21PJA)R,>UTMG/0UT%EIOE
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M:UX0&["N'TF_R1DUV>GRB11S7%45CVJ%121J1C"TZFITIU8G:@HHHH ****
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MS19!=C 6?K2L@VU*% %03. IIIB90N .:IU/,^2:KYQ6J.:3U+D(&*N6YVR
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M?A.:HE&9T>G@' K8FME:W%8FFOEEKIPH-NN:QGHSNHKFB<I=P"//%4L5M:L
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M;5)) <FL-D<=ZD0-CK4<B-56EL3W$Q?)-9[]35AU.*JN*TB85&V-#8J>-Z@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@*QM7L3,2<5H:=*&QS5R2)9,\BN:_*ST[<\;'GW]EDW6,&NDTO3?)(8BM/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD-5I#P*@ ^:K""FR(C96Q6=,<M5^93S5"4?-0B:A585'S5DIFFF.M$S%IB1
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M3JH/WSM+3_4U8JO:?ZFK%<3W/:CL%%%%(84444 %%%% !1110 4444 %%%%
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MM@_)0QQ*\QXQ6;-SFK]P3BLN5SS5P1G496D&#2Q-AA3';)H7K6AS7U-6&3<
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MNSN?] 89[5R^HR9F:F)J;QQE.:IS3&1B>:RC"SN=%2LI12(@>:N6Q^9?K5$
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M9I*G&]:ZRQLXX0-HJ*"W5%&!BM"$8KEG*YZ5&DH(L(,#BGTB]*6LCJ"BBB@
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M.I#L5FB%-C7#U.Q%- YIDV))5#K4*0J.M64&:9*-IH&UU   <4 <TP&I!TH
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MHIY0$IH&[$$[**SY7S3IILYYJJ6)K1(YIS'YR:GMAEZKBK5KP]#(AJS5BAW
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MI+=F+ 5=UPJ)N!WJG98,P%=*=XGERC:=C46*1E&!37AD3J*WK"V5U7BGZC9
M X&*Q<M3K5'W;G,'CK2;J?=#RWQ5;=6R5T<[=G8E,A%.CF(JN7J6&)I>E)H$
M]="X+AMAYJA/,Q)K0%C)Y9/-95TI1B#2C8*ETB#S"36OIL9DQQ6&O+5UF@0;
MU'TJIZ(6'7-(TTML6I.*PKABLQ%=BT.+5ABN2OXBDK&L(RNSMJQY45O---:2
MH-_-&:UL<G-H68I/G%:!F C&#6,&PU64+2# -#1<9"74QYP:IF3(YK0;3Y).
MF:S;F%H#@TX-;&=7FW(N"]7;:(N>!6:C?O*WM)VEQD4YZ(FDN9EJ&SEQPM5[
MB"1#R*[&TBC8#Y16=J5LO)"U@IZGH2HVC<Y-F(.*0.12W/RS$5#G%;)7.%Z,
MNPR^M3%2ZG%9JOR*V[!-X&:EZ&D%?0R+B"4 DCBLR3@FNYOK-?L>0O-<;=0E
M';ZU4)7(KTW$KIU%:]DNX@5CIU%;>F<RK53V(HZLV?LC&$$"LR[A>+.17:6\
M*FV7*UBZY"JJ<#'%<\9ZGH5*7NW.:5FI?,(IN0M,9Q6U[G%L6$G(-.>X9N]5
M$R[8%7K?3Y)NF:&DBHMRV,Z=R:I.W-;EQI,JJ3SQ6%.A27::(M,QJ1:W);=C
MNKI=+@\T#(KG["V:1^*[?1K0Q ;A2JRLCHPL+F?=:>V"0M84T;)(017HLT"&
M%OE'2N-U.WVRL0*RA*YO7HV5S(W4FXTTG#$4A/-=!PLF1F8@"K@M)63.VEL+
M0R2*>U==!9(+9<K64Y6.FC1<D<'=VSQ#D5ENQ%=GKT"QH<+VKBYS@UI3=T<V
M(AR,=$V9!73:,JO( :Y6(_.*Z;0I,3"BHM PSO+4ZB\L4,8VCM7(ZG 8WZ=Z
M] 7$J+QVKE==M?G) [USPEJ>CB*=XW1S-!I)?D?%-#;JZD>7L[$T1)/%=9I-
MFDL66':N=L+-IR,5VVEVQABY]*PJR.W#0;>I4U'38EM"P'-<%>1[)7^M>CZG
M.HMF6O/-1<&1\>M.BVQ8Q);%*)N177:-)PHKCHNHKI-*G",HK6JM#GPLK2.Z
M$2R6@KEM;MO+4D"NHLY ]NHK/UJT,L? [5QQ=F>K5CS0NCSYLCK3X4+R 5>F
MTJ3/&:O6&CR;U)!KJ<E8\J-*3G8NZ38?,&(KK([=$48]*@LK,11+QS5J241C
MFN2;NSUZ=-0B9M_ A5L^E>?ZNH6X(%=OJ&I1JK#BN$U2=9)R1711B^IP8R2>
MQ3M\>;S78:%'"Y7-<7&?GXKIM"F*,,FM*JT.?"R7-J=FUA"\;8':N8U/3RC$
MJO%=;9.)$_"F7UFLD+?+S7)&33/5J4E*.AYI(K(Y!I@.3Q6[?:1)O8@&J<&D
MRD]ZZE)6/,=*7-8V=%LED4,17511)' ,UG:/:^1#\P[58O;H1PD5SS?,STZ4
M5".IF:\\1BP#VK@KD#)Q6[J5Z9"PW5@2-NK>E&R/-Q4U)BP\,*Z;1G_?"N:C
MX(K;TJ<),,TYK0C#Z2._^]"OTKD?$-I+(YV+GFNHM;I9$4>U23VR3=5!KE3Y
M6>M4@JD;'F0L+C>!MK9TO3)/-!9:ZH:9'O!V"KJ6\4*@[!5NK<PIX3E=V06\
M"0*.W%4M1OUC# -4VH7Z1KQ@5QNJ7K2$X:E&+DRZU505D4=4NC),2#62&^<U
M).Y9N34"_>KLBK(\:I-RD7(V-==H=R$4 FN0AYK8LIC&R\UG45T=%!\LKGHT
M1$T%4[C3(I,Y%5]/U)!"%.,UI?;HRH.!7'K%GLWC..IF)HL(/W?TK1@M8X%X
MIPO(CV%5+K4XT4CBB\F3:$=2Q-<PHN,US&NW,<D9 /:H+W4&=SM:L.ZF=\Y8
MFMH0U..O7NK(S)N321@9%.89I$'S"NKH>9U-"#Y,$5MZ;?-&PR:PXA\HJ<;E
MZ'%1-)HZ*<G'5'>VFIQ$?,U6QJ,']ZO.EGE7HYJ47DN,;S7/[,[8XMI'>3ZG
M $X>N>U'5&(.QJPFN)F'WS3 7;[Q)IJG8B>)<PGGDER6K,G8YK4*<&LVX3YJ
MWBK''4N4MS%JMVV>*@6/YJNP"KD90O<LI3LT*N12%2*S.A(>H!J0QCM4*'FK
M4:^M)HI*XQ4Q4A "U*$XJ"<X2E<IZ(HWCC'%91.:MW&23S5=82:UB<D]61C&
MX5;B.>*KF!@:GA!!IL4=&7$0FIUC-) 1Q5Q5!' K-LZ8Q3*GF.AXJ5;J4\4/
M'\U- %(K5$OF,W6NJT+[HKE *ZK0C\JUE4V-\._?.SM?]54]06O^JJ>N-GM1
MV"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH CD^Z?I7GOB#_CX/UKT*3[I^E>
M?>(!_I!^M;T=SCQGPG.,?GH/(I'^\:05UGD#@M!.*<IXICB@!0<FAE%1H"6J
M=EXH$-6,D5&T;9JU$ZJ.:5G4]J!VN4PF*7;4S"F!<T7%8C*5&PQ5T+\M0.O-
M-,+%8BA14I%(%IW)0FTFE5>:F7 %-R,TFRD@V9%&P"I%ILC!:6X-#&8 57=L
MFFR/EJ9S5)&;8I&:-AIRU* *=Q(B P:E#<4%:;M(H*V!\&H64&G2$TU6]:1#
MU9&8S4;(U7 PQTI&*^E5<'$HF-O2E6(Y'%6MR^E 90>E%R>5#1&VWI3&1O2K
MJRIC&!2X5^@I7*Y3.\L^E-,9J^\87J*@8J.U-,EP2(8XLMTJX+;CI4<;J&SB
MKJ3H0.!2;+BD9T\17I58J<UJS[7S@53>/YJ:9$HZE;;2[<U8\OBF^6:+DV*S
MKBHCG-73"33?LK=:?,)QN10ALUJVS,,9JK%%@U<08J9,TIJPDXW&J;1#=5YN
M:9LYI(MQN5EA]JD6$585!3]M%P4!D8"\5.5!2H<<U)N^7%2:+8JR1 ]*C$1'
M05;1,FI&0#M3YB>6YENC9Z5'Y1)Z5I,@/:D6,9Z57,0Z94AA(/(J25,&KNP
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M3HH^@JAKD*!#]*W7=47-<YKUZFT_2E"[957EC X+5 %?CUK,S5W4I1(_'K5
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MM<2M41+-UJ<*,4C "F-E.08JE+G-7ICFJK+FK3L8S16P2:M6J$FHPOS5<ML
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MMU-(3Q5J-C&51RW*DM4VZFKTHS51DYK5'+(8N!6A;X*UG,IJY;YXIM!%V9=
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-6XF!3%))"<9J;FC5T5DZU*33 ,&E(IDK07/%-[T8I0N30/<0BDQBI=M-(I
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME?F-4F'-:L\1:J8M6+FMDSDE%MB6D9)K>M8\+5*TM2I&16K& HJ),WI1LAC
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M0V-S3':GE343C%42]"-C30XS0[<54,F&IV,G(O[@>E=7H)^5:XF.<=Z[/0)
MRK6=5:'1AI7F=U:?ZJIZKV?^IJQ7"SWH[!1112&%%%% !1110 4444 %%%%
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MC"?&>A67^IJS5:R_U%6:\][GT4=@HHHI%!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M $<GW3]*\^\0#_2#]:]!D^Z?I7G^OC_2/QK:CN<>+^$YMU^:FGBIF'S4W:#7
M9<\AHB#8IWF<4XI32M AHEP:?YN:BV\TX*?2@$7(OF6J\J_-4D;;1BI&3<N:
M16Y54X-*3FD(P32$FJ)V' U*#QBJV3FID-($Q2M)BI.U,;B@H9LRPJPD6%S3
M47.#4S'$=)@D0R-QBH":>3DFF$4T)@*0\BG@4NVF%B)$P:'6I@N*:PI":T(-
MM-?@5/BDV;J+BL,M6YJRTN*((0IYILXP>*5RDFD0/)DU$>:D*9H"55R7<@*T
M]#@BIO+IA3!I[DV:+L1W)BG-'CFJL,A#XJ\Q!0<U#1JM456%-S4VT&E\M?6G
M<+$&ZE S4QC&*;MQ1<+ HQ4@/%1GB@,: %(YIIXIXYI&% R(\FIXQQ4)%31-
MR!FDP0Z086JAYK1E4>4#6>>M-!)" 5/"N&!J$ Y'%7HD&S-#8H+4F9_W8%4Y
M.:E=L"HAS4HJ3NQF.*83S4Y7BH64YIDV&TQA4JJ:D$8-,7*5,XJ1'YI9$ -,
M7[U K6+2FI NZHTQBG%PO>D:19($P*:QQ3?-]Z1CD4@;(I'S3%YI64^E( 1V
MIDB]*,TPYSTH!-,0[&:-E*M2 #% $.,4Y3S2LM)C% $H-1MUI0:#0.XA'%1X
MYIY/%,S0)L7%2A?E-1#)J=?NT@13D7FF)'DU889:E50*H5KLB,>*84JT1FF%
M.:+C<2OLH$>:GV4%<47)Y2,1<U:2/"TU%S5G&$J6RXQ*Y---.;K28S0#0W%.
M%-/%.%,5A3R*B<8J6HY*$#(B,U)$OS5'SFK,2=\4V)$V?E%-ZT]A@4P&H-!P
M'%-QS3@:0TQ"@4I%,#<T\'-(8@ZT_J*;BG4#&%:<@I#S4L:\4-B6X8XIC5(W
M J DYH0Y!3EZ4@%*.E,D1NE1#DU(YXJ./EJ$#W+,/%0SC+5808JO,3NI=2GL
M1@TM(!FI%0GM5$CXDW5(?E%301@#FHI\#.*AEVLKE5I,G%,-(?OT\CBJ1&X(
M<5*#4:BG4,!S'BH2<U(>E1,,4(3$SR*N(O[NJ.?F%78V_=T,<=2)Q@TBM2N<
MTP4(!Y-,8T\=*C(^:@!R<&GNV:6),FGRQXH&,0U,#Q4*C%/!I F*U,%./-*%
MH&-Q2H.:E"#%,?Y:![$ZTCKFJHF(H,S5-AW)]M*5XJ)9"109#3L*XI%2QQY&
M:K,QJ:*0[:&"',^TXJ)Y>*CD<EJ9G-"0-CM^ZD*YH"XIX'%5>Q Q&VM5E9\C
M%0%*,8HW*6A=C.^AQ@4RW)ITIX-1U+>Q7:7#8I!)FH&/ST\5=C.[)#S0.M H
MYS2&3JF:E6&H8V.:MJ:EEQ(63%-"<U.PS2A>*5RK#/NBE6?%(U1X HL&Q:6X
MS4H.1FJ2]15U/N4F4A2:C9=U!/-*IH&5G^4T]&J1HPW-1E=M,EJQ,#FGK5=&
M.:G4U+*3';,T%<4]3Q36(Q2&T1-30:'-+&N:JXAZU*),"HSQ3"U+<=R5WS4)
M&:":<HS0 T'%2J<TP+S4RJ!0 FRGJM*<4W=BD.P_;33Q2AJ.M(8BOBIEDJ K
MB@'D4 BZK<4YI-M1 D)4+.307?0?)/[TT'<*8%W5*BX%!-[D?E\U(D=/VTY1
MBE<=C'BN1_$:G$Z$=:Q&9E[T^.1MPYK;E.=5#7)'6F^:J]Z@,F(JINY8\&DD
M-RL7WG7L:;]H'K5 !O4TA#>M.Q/.:/VA?6@3KZUED-ZFE 8]S187.S6$R'O3
MEE3/6LQ0P'4TF]E;K18:FS9#*PICH*H17.#UJP;E:FQ?,F.*^E-V$GI0)U)J
M7S%"YP* T(R@7K5"]8<XJW/.","LZ4[JJ)G-E7G-2 '%+LYJ15JS%(B(- W5
M9"9H*8[4BK%;#4H#58" BDVX-%PL5GW**8':K4@!%0%<529+T$+,14)5\U81
M<D"K7V?"9Q2N-1N93AQ48SFKTX [55.*I&;1-$ZCK5ARI08K/YSUJ9'/<TFA
MJ0R534."*N, U,,7%- XE<$YJ3<0*"F#22# H%L2)(*#)S54$CO2C-.P*19W
MC%",I-5B3ZTZ/(/6E87,6F(J/O2<FG*.:5BEJ2J!BAB!THZ"HR<T6&W8"U-W
M&FM0HR:";DBC-.*TJKQ3]N:15B,<4X-S08S494YH G)4BH704Y4-2>631L%K
ME,QG-31)BK AXZ4>60:+@D*0,57D0GI5H+3MGM2+Y3-V/FK$8(ZU;V#'2H]N
M#3)Y;"/TXI@!J8BDVYH&1YXJ,CFI2AINPT"$C%2-BD Q3':@!K8S2%L"E"EJ
M'A.*8B%G)IRL:;Y1%/6(T") <BD- 0BAA@4#8SBG 5'FI5Z4A#QC'-#*E1%L
M&D!)ICN3QA14AQBH$R*>3Q04@PNZG[@*@)YHW4A7)2<TTT@<4O6F J]:65<B
MFJ<&IQAJ0T9DJD&A$+58N%^:B("G<SMJ-%N.N*BE0KTK1&-M0S)FBY;B4E4D
MU91>*18\5,%XI7)41AS3<&IMM&R@JPD:FIR?EH1<"D8X%(HJS9[5 -U6)'!J
M,8-4B!Z+D<T]0 :13@4[- T3(0*20BHUYH8XI%7(F/-(2,4K<U&P-,EL:YJ/
M-.--QDTR!"":9M)-653*T+%DT7#E(EBS5A(?:IXH<=JGV@=J5RE JB*I8T -
M/)%(&I7*L3KBGX&*A7FG[L"I9:(F.&J.4Y%.?DU$PIHEE.7BF!A4DZ$U6((K
M1(QDRT@0GFIR$ XJ@K8/6IEDS2L--$U3)C%0KS3P<4BT3<4C8-1%J;NI#)U
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW;4S=*C+ 4 .6G]146\4X.,TK#0\$BNBTAN!7.%@:W])/ J)K0VHOWCK+?\
MU=2U#;?ZNIJY6>JM@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW$9LFDI,4N*8A#\U(%Q3L8HH ,TF:"*!R:!,-U+F@B@#B@$)G!IX;-,QS2G
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M!#VQ357FG*A-.QB@=A"*:6 %*S@53EDYH1,G8E9QFF%\U$ 33PIJB;B]:7%
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M"58B?:PI,J&AJ!25I N.M+#,K "I9!Q6;.C<BP*7;2 4\=*!6&$4F<4XTPT
M+FG]J:JDT\J0M )C.*1J3O2XS0#&]Z>*3%. H&@R:>@!J-J=&:0$WEBFLJ@4
MOG "H'ER:!MC9&(Z5"78T\\TFS-58C<%)-/VYI N*D44 D,V4]<BI M,8XI#
ML%*&Q3,TA- %A6!ICGGBHD;%.)R*!W&[N:7K3,9:I%0T"ZCD3-/\L#M0K!.M
M,DN% (HW&/WHM1O.,<&J<LO?-5Q*2>M-1)<RU),QZ&EC?)YJJ7QUI5EQ3Y2>
M8T'">7FL^9EYQ3VGW+C-57!]::1,F*&Q4P==O-5::<^M6R+EAW':JSR4-G'6
MH)#18ER)1-CO4F_<M40I)ZU<AB-/82=P"L34T<9[U8CASVJ1D\OM4MFBAU(E
M1!U%..T#BF.>:;FD4*Q)Z4@#5(BY-2;*06(0#FK"@XH"U(HJ6788$I2M2XXI
M,4[CL5F4YXI$C8GFK8CR>E2B+ Z4FP2*PC HQZ5.RYJ/;1<+" "C:*-O-2!<
M"BX6$50*0BG$T 4 (.M2C&*B[TX-2*N2@#M3N*C5\4N<F@JX-FF#.:DQD4A7
M%!+1$]1FGR&HMU-$C6!I]NF3S0!N-685VFFP2N(\>*KL,&KTA!JLZ\U*8VB(
M]*;@U)TH)%42(HHP<XIP-.4<YI-C2$5#WI7VBI&8!:JR'=0ALAED8?=JE(TA
MJXPJ-E![52,I:F<RL3S0J&KA0>E-V55S+D*XWKTJ:.:0'DU*(\T-%@4FRDFB
MQ%/GJ:L;@>E9B@J:LQR8J;&B98-( <TBR FIMORYH*O<;@5&PQ4BC)I3'DT!
M8B"YI=AJRD!-/,6T=*5Q\I62,UU.BIA17.!@M=)H[@J*B>QOA])'4V_^KJ:H
M;?\ U=35R,]9;!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ,D^Z?I7#:W_KC
M]:[F3[I^E<+KC?OC]:VI;G)BOA.>EQN-1[<T]N9*>JUUH\G=D!0TH3GFIR0*
MA9Q0%AV%Q3<+49?-(&H$.9B.E-\QJ7K28YI@+O:DWF@]*;B@38NXYJ2-FS3
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M3*I=%T\.XNY+ ,1U+2*NT8I:Q.M!1110,**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M 9)]T_2N(UJ$M/T[UW)&15&?3(YFR<5<)<K,:U-S5D>=?93N^[3C"0.AKO?[
M$A]ORI#H<)]/RK?VR./ZG(\\DC/H:A-N3_":]'.@0GT_*D_X1^#V_*CVR)^I
MS/.?LQ_NFC[,?[IKT;_A'X?;\J/^$?A]ORH]N@^I2//!;G^Z?RH-N?[IKT3^
MP(?;\J/[ A]ORH]NA_4Y'G/V<_W3^5'V<_W37HO_  C\/M^5'_"/P^WY4_;H
M7U*1Y\EL?[IJ<VYV?=-=X-!A'I^5+_8<.,<?E2=9#6#D>=?9SN/RG\J:\!_N
MG\J]%_L&'V_*D/A^$^GY4>V0?4Y'G A.<;3^53+;$C[IKT#_ (1Z#V_*GC08
M0.WY4>V0E@I'GAMB/X343VY_NFO2/[!A/I^5-/A^ ^GY4>V0?4I'F_V<_P!T
M_E4D=N<_=/Y5Z'_PCT'M^5.&@0CT_*CVZ!8*1P#VQQ]TU UN?[IKT@Z%"?3\
MJ8?#\)]/RH]LAO!R/-A"0WW3^568@6XP?RKOCX=@]ORIR^'X%/;\J/;(2P<T
M<');$CH?RJ VI_NG\J]&.APGT_*D_L&'V_*CVR&\'(\[%L1_":# <=#7HG]@
MP^WY4G]@0^WY4>W0?4I'G0MB?X32_9B/X37H@T"'V_*C^P8?;\J/;H/J<CSP
M6Y_NFE%N3_":]"_L"'V_*E_L&$>GY4>W0?4Y' +:$_PFH9+4Y^Z?RKT<:'"/
M3\J:=!A)[?E1[= \%(\Z6U.?NG\JG%L?0UWPT&$>GY4O]AP^U#KH%@Y(\\DM
MB3]TT@MB!]TUZ&="A/I^5']@P^U'MD#P<CSHVQ_NF@6Q_NFO1/[!A]ORI?[!
MA]ORH]L@^I2//1;'T-,,)SC!_*O1?[!A]J3_ (1^#/;\J/;(7U*1P$=N0<[3
M5N*$GL:[4:%"/3\J>NBQ+Z4G61:PDD<2UN0>AIPC('0UVIT>(^E)_8T7M2]J
MA_59'"RQEAC!JF]H3_"?RKT4Z)$?2FG0H3Z?E3]LB7A),\Z%J?[IJ1;4_P!T
MUZ#_ &##[?E2C0H1Z?E3]LA?4Y'!K:D_PT\6Q3M7=C18AZ4'18CZ4O;(KZI(
MX;R3Z&D\@YZ&NZ_L6+VH_L6+VH]J@^J2.'$!]#3OLY]#7;?V-%[4O]C1>U+V
MJ&L+(XGR#Z&FFV/I7<?V/%[4?V/%[4>U0/"R.$-L1V---N?0UWAT:+VH_L6+
MVI^V1/U21P!MS_=-'V<_W37??V)#[?E1_8</M^5'MD'U.1P0@*]C4RP$CH:[
M;^PX?;\J<-&B'I^5+VJ']4D<(UF2<[349MB/X37H']CQ>U-.B1'T_*G[9">#
MD<$+<GL:D%H2,[:[D:)"/3\J<-&B [4>V0+"2. :W([&FK;ECT-=^=#A/I2#
M0X1Z4>V0?5)'&0VI7^&AXB.,&NW&D1#TI#HT1]*7M45]59PI@)[&I(82#T-=
MK_8L7M2C1HAZ4>U0?59'$SQD]C54VY+?=->@-HT3>E-_L2'V_*A54#PDCAU@
M..AIRVI;M7;_ -BQ>U.&CQ#TH]J@^J2.&:T*]J3RB!C!KNCH\1]*;_8L7M1[
M9!]4D<(T!/8U&;<_W37??V)%[4?V'#[4_;(7U21Y^;0G^&C[,?[IKT#^Q(?:
MD_L.'V_*CVR%]3D<!]F/]TTAMC_=->@?V'#ZC\J/[#A]ORI^V0OJ<CSS[*?[
MI_*GK:G^Z:] _L*'V_*@:'"/2CVR']3D<&+8_P!TTUK4G^$UW_\ 8L7M1_8D
M/M2]L@^J2."6T/\ =-2?9CCH:[H:+$/2C^QHO:CVR']4D<(+8YZ&G?92>U=S
M_8L7M2_V/%[4>V0?5)'"&V([4GD$=C7=G1HCZ4?V+%[4>V0?5)'!M 6[&D%J
M<_=-=Y_8D7M^5+_8L7M1[9!]4D<4(2$Q@U%]F)/2N[_L:+V_*D_L:+VI>V0_
MJDCC(K4^E2&$CM79#28QZ4'28SZ4>U0_JK.):,YZ&F-$?0UVYT:+VI/[%B]J
M/:H7U61PXA/H:>+<XZ&NU_L6+V_*E_L>+';\J/:H7U21PWDD-T-.,9QT-=M_
M8L6>U']BQ>U'M4/ZK(X<0D]C3A ?0UVPT6+VI?[&B]J/:H/JLCB&A(&<&EA0
MD]#7;'1HB.U(NBQ+Z4>U0+"RN<7-;DGI47V<^AKNSH\1]*;_ &-%[4>U0/"R
M9PHMSZ&E,!]#7<_V+%[4?V+%[4_;(/JLCAQ ?0TX6Y]#7;?V-%[4O]CQ>U+V
MJ#ZJSBQ;$]J<+<KVKLQI$0]*#I,9]*7M4/ZJSAWMR3T-)]G..E=Q_8\7M1_8
MT7M3]JA?5)'#?9SZ4A@/H:[K^QHO:D_L6+VI^V0OJDCA?LY]*5("#T-=S_8L
M7M1_8L7M2]J@^J2.-$9 Z&HI<KV-=Q_8\7M3&T.%O3\J7M44\-(XA<GL:F52
M>QKL1H<(]/RIPT6(>E/VJ$L+(X\1$]C4@@/I77#2(AZ4[^RH_:E[5%?5I'&O
M <=*K_9SNZ&NY.DQGTIO]CQ>U"JH3PLCCD@/H:E$!]*ZX:3&/2E_LJ/VH]JA
MK#,Y'RCCI3?*/I78?V5'[4G]DQ^U'M ^K2.0\H^AII0^AKL?[)C]J0Z1$?2C
MVB#ZM(XTY'8TQE+=C79_V-%[4?V-%[4_:H/JTCBO()[&D-J?2NW_ +'B]J7^
MQXO:CVJ)^JLX=8"IS@U912_&#77?V-%[4JZ1$O3%+VJ&L+)'%SVA)Z57-L1V
M-=ZVDQGTIAT:(^E-54)X5G!_9R3]TTIM3Z&N[_L6+VH_L6+VI^V0OJDCA!;'
MT-3+;G'2NU_L6+VI?['B]J7M4-81G&"W/I3O(([&NR_LB/VI?[)C]J/:H?U5
MG%F(^AIOE'/0UVO]D1>U)_8\7M2]J@^JR..$1]#4%Q"3V-=S_9$7M2-HT3>E
M"JH3PLCSTP'T- @.?NFN_P#["A]ORH_L*'V_*J]LB?J<C@_LYQ]TTTP'T-=_
M_8D/M^5)_8</M^5'MD'U.1P0@/\ =-'DG'0UWO\ 8</M^5']AP^U'MD'U21P
M/E'T-!@/H:[W^PH?:E_L.'V_*CVR#ZI(X#R#Z'\J;Y9'8_E7H/\ 84/M^5-_
ML"'V_*CVR#ZI(\]=2!T-5G5O0_E7I1\/0'T_*F'PW ?3\JI5HDO!S9YBT;'L
M?RJ%HF_NG\J]3_X1FW_V?RIO_"+V_P#L_E35>)#P$SRDP,?X3^5-^SM_=/Y5
MZO\ \(M;_P"S^5'_  BUOZK^5/ZQ$C^SYGDIMF_NG\J;]F;^Z?RKUS_A%;;_
M &?RI/\ A%;;_9_*G]9B+^SIGD9M6_NG\J:;1O[I_*O7O^$5MO\ 9_*C_A%;
M;_9_*CZRA?V=,\@^R-_=/Y4?9&_NG\J]?_X12V_V?RH_X12V_P!G\J/K*#^S
M9GD'V-O[I_*E^QG^Z?RKU[_A%+;_ &?RH_X16V_V?RH^LH/[-F>1"R/]T_E4
MT5B3_"?RKU?_ (16V_V?RIZ^&+=?[OY4OK**6721O4445Q'M!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>img88009329_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_4.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +G!9\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6UM58("6+,<LS'J2>Y-6ZRFTW=&T$U&S"BBBI+"BBB@ HHHH **** "BBB@
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M-$DD;J\;@,K*<A@>A!]*=0 4444 %%%% !1110 4444 %%0W-W;6:QM=7$4
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MV_\ C-=?10!R']J^/?\ H5M(_P#!NW_QFC^U?'O_ $*VD?\ @W;_ .,UU]%
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M^U?'O_0K:1_X-V_^,T?VKX]_Z%;2/_!NW_QFNOHH Y#^U?'O_0K:1_X-V_\
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M]6?_ *515V- !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !12$
MA022 !R2>U06M_9WP8VEW!<!#AC%('P??% 7+%%%% ''?%+_ ))_>?\ 7U9_
M^E45=C7'?%+_ ))_>?\ 7U9_^E45=C0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 <1J^D7U[?\ B(P6SL6^RR0[EPLNSDJ">#5^
MV-QK7BJSU$6-U:6UG;NK&YC,9=W_ (0#U ]>E=116GM':W];6,G23=_ZT=T%
M%%%9FIYA\1_#U[;>&[S4)/$NJW$'VVV;[#+Y7DX:YCPO"!L#/'/89S7I]<=\
M4O\ DG]Y_P!?5G_Z515V- !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %84O@WP]-=FZDTR
M(RD[CAF"D_[H./TK=HIJ36S%**EHU<155%"J % P !P!2T44AA1110 4444
M5KZPMM2M'M;N/S(7QE=Q7IR.0<T6&GVFEVJVUE L,*G.T<Y/J2>2?<U9HIW=
MK"LKW"BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH X[XI?\D_O/^OJS_\ 2J*NQKCOBE_R3^\_Z^K/_P!*HJ[&@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBCD0>U9L?;K?_GI_XZ:/MUO_ ,]/_'36/11R(/:LV/MUO_ST_P#'31]NM_\
MGI_XZ:QZ*.1![5FQ]NM_^>G_ (Z:/MUO_P ]/_'36/11R(/:LV/MUO\ \]/_
M !TT?;K?_GI_XZ:QZ*.1![5FQ]NM_P#GI_XZ:/MUO_ST_P#'36/11R(/:LV/
MMUO_ ,]/_'31]NM_^>G_ (Z:QZ*.1![5FQ]NM_\ GI_XZ:/MUO\ \]/_ !TU
MCT4<B#VK-C[=;_\ /3_QTT?;K?\ YZ?^.FL>BCD0>U9L?;K?_GI_XZ:/MUO_
M ,]/_'36/11R(/:LV/MUO_ST_P#'31]NM_\ GI_XZ:QZ*.1![5FQ]NM_^>G_
M (Z:/MUO_P ]/_'36/11R(/:LV/MUO\ \]/_ !TT?;K?_GI_XZ:QZ*.1![5F
MQ]NM_P#GI_XZ:/MUO_ST_P#'36/11R(/:LV/MUO_ ,]/_'31]NM_^>G_ (Z:
MQZ*.1![5FQ]NM_\ GI_XZ:/MUO\ \]/_ !TUCT4<B#VK-C[=;_\ /3_QTT?;
MK?\ YZ?^.FL>BCD0>U9L?;K?_GI_XZ:/MUO_ ,]/_'36/11R(/:LV/MUO_ST
M_P#'31]NM_\ GI_XZ:QZ*.1![5FQ]NM_^>G_ (Z:/MUO_P ]/_'36/11R(/:
MLV/MUO\ \]/_ !TT?;K?_GI_XZ:QZ*.1![5FQ]NM_P#GI_XZ:/MUO_ST_P#'
M36/11R(/:LV/MUO_ ,]/_'31]NM_^>G_ (Z:QZ*.1![5FQ]NM_\ GI_XZ:/M
MUO\ \]/_ !TUCT4<B#VK-C[=;_\ /3_QTT?;K?\ YZ?^.FL>BCD0>U9L?;K?
M_GI_XZ:/MUO_ ,]/_'36/11R(/:LV/MUO_ST_P#'31]NM_\ GI_XZ:QZ*.1!
M[5FQ]NM_^>G_ (Z:/MUO_P ]/_'36/11R(/:LV/MUO\ \]/_ !TT?;K?_GI_
MXZ:QZ*.1![5FQ]NM_P#GI_XZ:/MUO_ST_P#'36/11R(/:LV/MUO_ ,]/_'31
M]NM_^>G_ (Z:QZ*.1![5FQ]NM_\ GI_XZ:/MUO\ \]/_ !TUCT4<B#VK-C[=
M;_\ /3_QTT?;K?\ YZ?^.FL>BCD0>U9L?;K?_GI_XZ:/MUO_ ,]/_'36/11R
M(/:LV/MUO_ST_P#'31]NM_\ GI_XZ:QZ*.1![5FQ]NM_^>G_ (Z:/MUO_P ]
M/_'36/11R(/:LV/MUO\ \]/_ !TT?;K?_GI_XZ:QZ*.1![5FQ]NM_P#GI_XZ
M:/MUO_ST_P#'36/11R(/:LV/MUO_ ,]/_'31]NM_^>G_ (Z:QZ*.1![5FQ]N
MM_\ GI_XZ:/MUO\ \]/_ !TUCT4<B#VK-C[=;_\ /3_QTT?;K?\ YZ?^.FL>
MBCD0>U9L?;K?_GI_XZ:/MUO_ ,]/_'36/11R(/:LV/MUO_ST_P#'31]NM_\
MGI_XZ:QZ*.1![5FQ]NM_^>G_ (Z:/MUO_P ]/_'36/11R(/:LV/MUO\ \]/_
M !TT?;K?_GI_XZ:QZ*.1![5FQ]NM_P#GI_XZ:ECE29=T;9 ..E85:FF_\>[?
M[Y_D*4HI(J$VW8N4445!J%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !45Q<P6D)FN9XX8EZO(X51^)J6J][/:6]L7O9(8X20N9B
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MW0]5MO"FH7\OBB_N+7[7;L+%X81& ;F/"Y";L+D8Y[#.:V/MEU_S\-_WRO\
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M_A1R,/;+L;=%8GVRZ_Y^&_[Y7_"C[9=?\_#?]\K_ (4<C#VR[&W16)]LNO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !74^&_\ D'2?]=3_ "%<M74^&_\
MD'2?]=3_ "%9U?A.C#?Q#8HHHKE/0"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ KE-5U6<)<66M>&[FZLV8A9+0>:K+G@D9!4_C75T4XM)ZHF2;6C.!T
MF[TC2YV?1/"VK27+C&]XB /;<Q.VNTTZ6\FL8Y+^W2WN&R6B1]P7G@9[G&*M
M454Y\Q,*?+U_ ****@T"BBB@ HHHH **** .*^+/_).-0_Z[VG_I3%5.KGQ9
M_P"2<:A_UWM/_2F*J==%'J<6+W04445L<@4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !33)&LBQEU#MDJI/)QZ"G5A:W%-+JEC]G;;,BNZ>Y&#C\::5W83=
MD;;ND:%Y&54')9C@"E!# $$$'D$=ZYO4[TZK8,D&5CBC\V?V;LGY_P JN&XN
MII[>PM9E@(MUE:4IN/I@ \4^47,;-->2.( R.J G:-QQD^E8CZK=64-[%.4F
MGM]NV0# ;=TR.U1ZA%?Q+:&YO$G1KF/*B,+M.>Q'44*.H.1T-%<]>ZG>O?S0
M6PN$2$A<PVPEW'WR>*?)J&H/!8 +]GGFE,;B2/&??!Y]Z.5AS(WJ*QK^XNK5
M(+=;V1K@J6/E6H=GYZXS@"L^YN[J^\/W7FR,C02!7#1!2XXQD?PGZ4*-PYNA
MU-%8MY=W>FZ? GFM<3S/M#K$,@8[*.IHTJ]OY+LPW,=R\94D2RV_E8/IP2*.
M4.8UWECC*B215+':NXXR?0422QQ;?,D1-QVKN.,GTK*UYG3[ T:>8XN5*IG&
MXX/&:J:G<WLS62W-A]G07*$-YROD^F!0HW!RL='17/7NIWKW\T%L+A$A(7,-
ML)=Q]\GBI)=2NFT^ NTEK=.6&Q;8N[X]%/2CE=@YE>QNTV22.)"\CJBCJS'
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLJT6HG1A9Q=2R9OT445R'IA1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9AO$****Z3S@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P#(&F_Z^&_]!6L<1\!V8+^*=)1117">P%%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.!^M6XFN=;\2Z7=C3[JTAL(Y#*US'LR[#&U?7'KTKJZ*T]H_Z]+?D9>R7?\
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M7_/PW_?*_P"%'VNZ_P"?AO\ OE?\*AHHL@YGW)OM=U_S\-_WRO\ A1]KNO\
MGX;_ +Y7_"H:*+(.9]R;[7=?\_#?]\K_ (4?:[K_ )^&_P"^5_PJ&BBR#F?<
MF^UW7_/PW_?*_P"%'VNZ_P"?AO\ OE?\*AHHL@YGW)OM=U_S\-_WRO\ A1]K
MNO\ GX;_ +Y7_"H:*+(.9]R;[7=?\_#?]\K_ (4?:[K_ )^&_P"^5_PJ&BBR
M#F?<F^UW7_/PW_?*_P"%'VNZ_P"?AO\ OE?\*AHHL@YGW)OM=U_S\-_WRO\
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M]\K_ (4?:[K_ )^&_P"^5_PJ&BBR#F?<F^UW7_/PW_?*_P"%'VNZ_P"?AO\
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M7_/PW_?*_P"%'VNZ_P"?AO\ OE?\*AHHL@YGW)OM=U_S\-_WRO\ A1]KNO\
MGX;_ +Y7_"H:*+(.9]R;[7=?\_#?]\K_ (4?:[K_ )^&_P"^5_PJ&BBR#F?<
MF^UW7_/PW_?*_P"%'VNZ_P"?AO\ OE?\*AHHL@YGW)OM=U_S\-_WRO\ A1]K
MNO\ GX;_ +Y7_"H:*+(.9]R;[7=?\_#?]\K_ (4?:[K_ )^&_P"^5_PJ&BBR
M#F?<F^UW7_/PW_?*_P"%'VNZ_P"?AO\ OE?\*AHHL@YGW)OM=U_S\-_WRO\
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MM8E+#U';3\4<[14UW%%!=2103BXB4X64*5#>^#4-6G?4Q:L[,****8@HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO_K4<K#VD30HK/\ [3_Z8_\ CW_UJ/[3_P"F/_CW_P!:CE8>TB:%%9_]I_\
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MC_X]_P#6H_M/_IC_ ./?_6HY6'M(FA16?_:?_3'_ ,>_^M1_:?\ TQ_\>_\
MK4<K#VD30HK/_M/_ *8_^/?_ %J/[3_Z8_\ CW_UJ.5A[2)H45G_ -I_],?_
M ![_ .M1_:?_ $Q_\>_^M1RL/:1-"BL_^T_^F/\ X]_]:C^T_P#IC_X]_P#6
MHY6'M(FA16?_ &G_ -,?_'O_ *U']I_],?\ Q[_ZU'*P]I$T**S_ .T_^F/_
M (]_]:C^T_\ IC_X]_\ 6HY6'M(FA16?_:?_ $Q_\>_^M1_:?_3'_P >_P#K
M4<K#VD30HK/_ +3_ .F/_CW_ -:C^T_^F/\ X]_]:CE8>TB:%%9_]I_],?\
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M16?_ &G_ -,?_'O_ *U']I_],?\ Q[_ZU'*P]I$T*]1^&_\ R+MQ_P!?;?\
MH"5X]_:?_3'_ ,>_^M7K?PNG^T>&;E]NW%XPQG/\"5S8N+5,]#+)IXBR[,[:
MBBBO+/HPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *BN+:"[A,-S!'-$>J2(&4_@:EHH A@M;>V@\B"WBBA_YYQH%7\AQ3;6PL[$
M,+2T@MPYRPBC"9/OBK%%.[%9!1112&<+\8_^26:M_P!=+;_THBKQBO9_C'_R
M2S5O^NEM_P"E$5>,5Z6 VD>!G?Q0^?Z!1117HGA!1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5[+\)?^15NO^OU__0$KQJO9?A+_ ,BK=?\ 7Z__ * E<F-_A'IY
M3_O*]&=Y1117CGU(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 <+\8_\ DEFK?]=+;_THBKQBO9_C'_R2S5O^
MNEM_Z415XQ7I8#:1X&=_%#Y_H%%%%>B>$%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O9?A+_
M ,BK=?\ 7Z__ * E>-5[+\)?^15NO^OU_P#T!*Y,;_"/3RG_ 'E>C.\HHHKQ
MSZD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** .%^,?_)+-6_ZZ6W_ *415XQ7L_QC_P"26:M_UTMO_2B*O&*]
M+ ;2/ SOXH?/] HHHKT3P@HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBO
M4;K4/$]GX8\-IX>2Y9'M/WODVPE&>,9)4X[UE4GR6MU.BA153F;>ROHK]4NZ
M[GEU%>FZEX<T[6O%UM:W?^B7+Z=Y]XMKM&R48Z\$=ZP;30/#]\;[4(KO4$T>
MPC7SF=$\V60DC" < =.M1'$1:N_ZZ?\ #&L\#4C*R:_+I?\ !/7L<A179?V!
MX?EM+76;.?49-*%S]GNH9 @G1B.""/E()(_ UT_B>U@U_7U\/QWES;V]BAN+
MA#%'Y4<84?ZO W$\]^.:)8A)I6[W\K%0P,I1;OVMYWO_ )'DU%=;)H.A:II%
M]=^'[J_\ZP7S)8KU4^=.Y4K_ %J/5_#5G8>+-,TJ*6<P72P%V9AN&]L'!QC]
M*M58MVZF,L+-1YM&OZ1RU%=Q;^$M'^V^(UO+J\CM=*9=C)M9F4YSD8Y/''3K
M52]\,Z;>:59:CX?GNVCGNQ9M%>A=RN>ARO&.GYTE7@W]WX[%2P=5)[:7Z]MS
MDJ*])T72/#6E>,[33TO=0?5;>49=D00.X&2H_B%<)K7_ "'M1_Z^I/\ T(TX
M55.5EVN35PTJ4.:3UO:Q1HKTKQEX<_M35;6X_MG1[/\ T.)?+N[KRWXSSC!X
MJ?Q#X;?Q!XMTK3A.JQQZ:KR21_-E5./E]<DC'UK-8F.E_/\  W>7S]ZW2UO.
M_P ]#RZBN^\0> (;#1+C4;./4+<VV"\=ZT3;U)QE3&3C'O5NR^'5E?V(\N'6
MH)FCW">X$*Q;L9^YG?CM3^LT^7FN3_9]?FY;:GFU%=?;>']"M_"D&L:M<7ZR
M23/#Y5ML.Y@3C&1QTYR:UAID.KZ/X+TZX>18+@S!C&%##!/0XINNEMWM^#?Z
M$QP<WN];7_%+Y;GG5%=POA?PY?S:CIVF7NHG4;*-WW3*GE2;#@@8Y]N:IPZ%
MH>FZ'8W^OW&H>;?@O#%9*GRH.[%OZ>M-5XL3P=1;VMKK?32W^:.3HKHO%NA6
M&B36 T^XFN(;JV6?S)<<Y/8 # QVJ\__ "2>+_L)G_T"G[5<JDNKM^-B?JTE
M.4)/5*_?I<X^BM[PWH5OJJWUY?W$D%A81B28Q+EVST"YX['FM0>%M'U:RAO]
M%OKF.U%TEO<K?*N^/<0 V5XQS1*K&+LQ0PU2<>9>?X;G&T5V^O>%=(TQ6ACA
MUR&82*@NKJ-/LS9;&=R]!WYIVO\ A/2-&LY]L&O231Q[DNO+0VSGZCD#ZU*Q
M$';S-'@:JO>VG]?H<-1116YQA1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !7LOPE_Y%6Z_Z_7_ /0$KQJO9?A+_P BK=?]?K_^@)7)C?X1Z>4_[RO1
MG>4445XY]2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% '"_&/_DEFK?\ 72V_]*(J\8KV?XQ_\DLU;_KI;?\
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MFZ^U5+;Q'):^&UTJ&';*EZ+M+@/T(  &W'MUS6)135*"T2[?AL)XFJW=OO\
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M>!G?Q0^?Z!1117HGA!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5[+\)?^15NO\
MK]?_ - 2O&J]E^$O_(JW7_7Z_P#Z E<F-_A'IY3_ +RO1G>4445XY]2%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% '"_&/_DEFK?]=+;_ -*(J\8KV?XQ_P#)+-6_ZZ6W_I1%7C%>E@-I'@9W
M\4/G^@4445Z)X04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>R_"7_D5;K_K]?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4NO?\_>F_P#?Q_\ XBO9:*/KM4/[)PW9_>>-?\*EU[_G[TW_ +^/_P#$4?\
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M%>RT4?7:H?V3ANS^\\:_X5+KW_/WIO\ W\?_ .(H_P"%2Z]_S]Z;_P!_'_\
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MX_\ \11_PJ77O^?O3?\ OX__ ,17LM%'UVJ']DX;L_O/&O\ A4NO?\_>F_\
M?Q__ (BC_A4NO?\ /WIO_?Q__B*]EHH^NU0_LG#=G]YXU_PJ77O^?O3?^_C_
M /Q%'_"I=>_Y^]-_[^/_ /$5[+11]=JA_9.&[/[SQK_A4NO?\_>F_P#?Q_\
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MP54=P.?E-=-16=3$U*D>61M0P%&A/GAN%%%%8':%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ",JL,, 1Z$4M
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
&1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>img88009329_5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_5.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ,Y!OP# 2(  A$! Q$!_\0
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M%% !12T4 %%%%( HHHH ****8Q:*2EI %%%% !1110 4M)2T %%%% !112T
M%%)2T +124M !1110(6BBB@ I:2B@!:*** "BBB@ I:2EH$%+24M !1113 6
MEI*6@ I:2B@!:***!!2TE+3 ***6@04444@"BEHH 2BEHH *2EHH0"4M%%,0
M44M)0 M%%% @I:*2D,6BBBF(***6@04444 %+110 44M&* $I:2EH$%%%% !
M1110(**6B@ HH%% @I:2B@ I:** "BBB@04444 +1110 4444 %%&**8"TE+
M12$':DI:2@ HI:2@!:*** "BBB@04444 %%%% Q*6BB@0E%+10 E)3J2@84E
M+10 E&*6B@!**** "BBDH ****0!24M)0 4444#$HI:2@!**6B@!**6DH *2
MEI* "BBB@!**6DH&)12T4 )12TE "44M)0,2BEI* "BBBD,2BEI* $HI:2@!
M**6B@8VC%+10 E%+28H&)12TE "44M&* $HHHI#"BBB@!*2EHH 2BEI* "BB
MB@96HHHK40444M "4M%% !112T#$HHHH *6BB@ HHHH 6BBBD 4444 %%%%
M"T4E+0,2EHHH 2EHHH 2BEI*0!1110,6BBB@ HHHH *2EHH **** "BBBD,*
M*** "BEI* %HI** %HHHI %%)2TQA1110 4444@%HI*6@ HHHH **** "EI*
M* %HHHH **** %I:2B@!:***!!2TE+0 4444 %%%%,8M%%%(04444P%HHHH$
M+1112 6BBB@!:*2EI@%+24M !2TE% A12T@I:!!1110 M%%% !1110 4444
M%+24M, Q112TA"4M)2T %%%% !BBEHIB$I:** "BBEH 2EHHH$+1110 8HHH
MH ,444M @I*6DH$+1110 4444 +1110 4444""BBB@ HI:*!!1110 4449H
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MCY(]AWDP_P#/*/\ [Y%(8H!_RRC_ .^136:FE_>DZENH*G%]!YCA_P">4?\
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M>-*+BW%B44M)3$%)2T4 5:***U$%+110 4444 %%%% !0:** "BEHH ****
M"BEHH&%%%% !1110 4M)2T@"DI:* $HI:2@84444 %%%% !1110 4M)12&%%
M%% !1110 4444 %+244AA1110 4M)10 M%%%(84444P"BDZ4M !1112 ****
M "BBB@!:*** "BBB@ HHHH 6BDI: %HI*6F 4444 +1112 6BDHH 6BDI:
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MT44#$HI:* "BBD- !2TE+2&%%%% !24M)0 M)11VH ***6@8E%+12 2BBB@
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M3N4XV'"3GFG%ABFE 1[U&P9:N-2^XK)[#B^:<H[FHHR">:?)($7 K6Y-F/+
M<5&[X&:CC);GM4<KY.*PD^9V-81U!I":B)H8TS--(V%HI* :8"TZFDT+EC@4
M!<=G/2I8X2W)J2"#N:N*H XJDC.4^Q$D04>M3+QTI.]'Z4S.X\'-+4>X?C1N
M)H EW4G)--4<\U(!@4 "KS4HP*BW8I=Y- $F^C)--%+G% #L4N:9FHVDQTH
MG+XII<FH0233P0* )1S3N*BW4;Z0&5J__'VO^X/YFL^K^J<W2_[@_F:HUZ='
MX$>+B/XLA,44M%:&(E%&** *E%%+6Q(44E.H 2BBB@ HI:* $I:**0!1110,
M****8@HHHH&%%%%( HHI: "BBB@ HHHH&%%%%( HHHH ****0PHHHI@)2T44
M@"BBB@84E%% !10** "EI*6@84E+12 *2EI* "EHHH&%%%% !124"@!:***0
M!1110 4M)10,6D[T4M @HHHH&%%%% @I:2B@!:*** "BBBF M%%%(!:*2EH
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M* "BBB@8E+244 +1124@%HHHH ****!A1110(6BBB@8E+110 4444 %+24M
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M<%S1_$F,4]'N;5CI&G:AH21B)([E<@N.I/O7)ZEI3Q.\##:P/I70:/J<,<V
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M)10 M%%% !1110 4444 .HI*6@ HHHH *6DHH 6BBB@04M)2T %%%% SK?!
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M7'@<[?\ C^.?:/\ ^O79 KGK07QT%3[>KW+6$H]CC8?!$D,ZRK?MN4Y!V?\
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M44G>D,6BBB@ I*6DH ****!A1110 M%%%(!*6DI: $I:*!0,***2D M%)2T
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M ?U%7TB1$PY"A?EV@5P\CO!.\8=XVP1N0X(K?THR:?9A#(TQ/S;Y"23^=<N
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MWVN C[C_ 'F_PJ2X,FPL5;:.YIP>&.0(S ]\8J"XG+3_ .MP #\N: *DB @
M _-W% MI%E#;B".QJI);7DU]G:_E9R#FM*)/EQ,P) [\G\Z!DBS>6=I5W8=U
M'%/6;>P_=2$^I%(DK,Q\L +W [4VXO#$@"@L2>IYH L-\H)QQZ4B\QG)V+GK
MBL^WU2:3=O1$"=S5A+L.27!*COGK2 =.JA?W:;F'\76@6[! &E*D#G8,4CW"
MKCRE']:EM99/)8/R>H)I@5'MGD)9&E*8Z^M)%;1Q?(8W8,,$GI]*GF,[8>.8
M8(Z&A8F!""0ECUQ0!*"/L[MO550<J!TK$>9I7+$\'H*U;JWD6UD+2@_*>.YK
MF&G!;@\5YV.;;2Z'IY<E9RZFEE>*"!ZUGI-CEC@4"9I7 7\Z\^QZES0 Q01G
M@U75RO&<U&UTV#ZBBPKEKRT/!4$?2@PPCK&GY562Y?;EQBE:XXSC(^M'*%RR
M%7;\@ 'H!BHSP3A*@6^7&TKCTS5CS-R+C!)I\J%S$;HK,&\L$^I%. )ZD4DC
M2HN2B_3-,21"K,2%_P!G-+E#F1<M62**X)8 E,#WK%BN?(+@QRDEL_*A-+/?
MAG5$ -3_ &I$ME<KEO2H5*TW,AQ7-S#HKEG&1 X'^UQ4WFDJ24Q^-8QU=?-Q
M@@4\W[NF8\@>M:\I7,:GFJ!RV*;+<QQX#&N>FO)U8@_-]*@N;EI)!N) [T*!
M+F;\FHPQKGG!]*A?4XPFY1D'UKGI;MY!@# '2F^<73;W[FM%31FZC-.]OW<#
M#XSV%;?A2\V64Z,&;]X",#/;_P"M7&-)M7)KJ-$COK&-C"AD68!LH1P/QKLP
MT;2NCBQ4KQLSISJ,3X5CDBIS*4M\VZ9ST/4U2,$?E!V@D=VZ\8Q5@M+%; "-
MU3^Z#7<><-BFN@S":(@#H=M64F0C,D8)S@=JJB&=X \,DN[/W77%7+2TDE*?
M:,!R1D"E*2C%R?0#350+=4 Q\N<57OF\JRV_[-76Y+X_W16;JQRH0=20*^,<
MN:3DSH2'P1\0'_8!_2H95WSE?:M *%DP.BKBJ<0W7DA[!*28QKKML\>QI+09
MCC8=UJ2Z&VV_"BR3%I#_ +F:=] (\98GT:JNI_\ 'Q;_ /75?YU>C7(8_P"W
M5'4N;NW'_35?YT)@MS(\1?ZY?K6**VO$?^O%88-=<=D;4EH.']:5<M&5'4FF
M@TZ')90.I-4:J-W8@^R7ID($#$#OD8-/_LZ^/_+)1WSO%; +*HW8_"@N&&,8
M'K5G9]6AW8ZU5DM8TQM91ST/-/D69E 4K[Y%-0\=Z<6(.3579LHI(;Y16/@C
M=ZFH8[202;WE7'H!UJP#GDF@\C@T78]"M+;R.<+,%]MM,-E(5P)L'N2M7-V.
M,?C06.W'%%V+0R)=,N<Y6Y7\15*YL;M65MHDVC^ UT!S@YJ(*H;=T_&K4Y(B
M44SD))94ES(&5O0C%:/AZ]%OJRHV2LHQP<<]JDUK$I547>?4<FK?A71%N)Q?
M7*_(O^K4COZUW8>\I)GGXJT8N-SK_-EF8 #CL2W-4+N1HV,4IW(>AZC-:\EX
MD*G<,*.]4YDBN[8NF-PZ,.HKOEL>8<=J5Q+O\J6(KMZ#H:-/(,;ED+)T)[K4
MU_*U[<%)B \?3/>H[**2WC,RC<C<-[5QFW0BN4:VD$D1RG8BKD$RW"[AW'S"
MJLS&$E@"T+?>7TJON-NXEB;=&>],DT'C$1R.4_E2CD9'(IJ3[U\Q.1_$M.3
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MSRR@\Y&*O)@(JNX SSSUJ@%E>0(54*3UR>]4FAGE)$K*ONIXJQ/*O*[ 3_"
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MHH 2BBB@84444 %%%% Q****0!1110,*2EI*!BT4"B@!****0!1110,****
M"BBBD 4444 %%%% PHHHH ****0!1110,***6@ HHHH ***2@!:*** "BBEH
M *2EHH ****!A2TE+0(****!BBBD%+0(**** %HI*6@#T#X9&4C55B*C=Y.2
M?^!UW_E-$A.YY&[@5YM\/IY81J7EL5SY><#_ 'Z] LC+(<R_ZOJV3UK*6YW4
M?@1.%F8G*[!ZDYIX23=PHS_>QTIV]^/*8*.W%.,;*N[< QZDU)H0.DB@Y! Z
M#/>JMV'9 JN <\XR34\D2D@M*"/5B>:M6Z%%W[B /48H YZ:QOB-ZK(,]!4U
MM9ZE(R8W =]S<"MG[8COMW,Y/?M4$E[(TWDVZC &6)Z4 .,,\:!C-D#[S=J5
M9DWDN V.AZT_&0J2NS(>NWM2>99VL9?9N/3- $H$GEGD!3_=H3;'G:!GOCDF
MLZ:Y,S*(Y"7)X13@"GQ1NLZF>>,J.H3G% $\XDW9P=O4E>]0O',X5A&%4] >
MN*E-T'<E6$:#[O&2?PIK&5%$DLH&[HI&"?P% #&MW4GY5S]:?% -F&C5P!PI
M48J2-P' "J!ZXS2&:2-V(0R>G(H 8(+Q3@>7&GHHYIXM[O )F 'H:L1ERH>3
MC/\ #TQ2%NA*!L] : &Q1M$WS2!L_P!T4LBR,P"+N7W-.&]3E\+Z <4/+*X(
M4A?ZT *D8B!:3;N] *9-$]RAW-L3L*D@@"X=LEF_AS4[LJC?+M4#@"@"D+>W
MMT  "\]2<FD($2O)* 8SRJ 4LNHVT<N&3/\ O=:IW^K,J$P[01SCU% "EI'A
M:5+9%8] 5[?C5--3FCD\B2+RP>X6JZ:VTXVM(2&XP>QJPK /A=S\?Q]* +*W
M9FE.V4.%_O#%3+]GE7;-*Y?/4' J&6# &RWV@CYF'6H5M&B4LDP!/9Z )C;*
MCD6TK=>AJ:/3BYQ+G=]:K1)(GSR2(2>  2:MQCS92BR'(ZL.@H T+)$2[@50
MJ@.O0=>:TKZ: +-J\RYDL&D0H3]]@?W?\_TK)1PBG/0<;L]*R=0*R$@%BN<G
M<QYI- SH+MDDDOYY84:006C!FY;+ 5>F9!/;7!L7V$NHMOLX$D>!UQ_$!ZUP
M;M(H.YVP0,C)Y]*5YY<*PDE+8X;<<C\>U*PCK[^1(UOXY5CE>-[;&$"X#GIC
ML?44ES+#</JD!M8$6TND2/RT"'!8J<D5QL"2*S,B/N;EG+$Y^M.2\E@G$HD8
MNKA@1R,@Y&?6@#MO$)6RLI8S  IGPCK;A1&HZ*6[G-5M.B.HV-M;W%I-]GR[
M17<7RB+UW=L9%<Q>ZU)?02PI;6\/VB023F,,#(1R.I/<]J6";_1_+>5U0\%0
M2 ?K0@.NC:T@TV!DM))XGMBSR0VX8%\')+YR,'M4$6HQFXT_3S;P,EQ8M*[%
M!N+ ,0<_\!KD6W[&4;DAZX#'#?A51UF?!&],<!BV,"BP';17PDTNUGFMVLXD
M:%)1-"!OW'[Z2=\CDCM5FZN2D6H&]L4MDAF5+9R@7?ENBG^(;>:X;[&LL21N
MTSA/NKN.T?2EDM<A%83/L^[N8X4>U%@.[FNEOM8O=)$<$7#) 50!@XY'/O@U
ME:G]E.J^4&.R$K&-O&XC@DGW.:R-+:XM;U+Z-49TR5,@R <8S]:B(+SY?IU.
M:: [A[N'^V]2B%MY;K#*3+YA.<+_ ':BF18M#N#*J%8[994D$(503CD/U8\\
MUQLYEF<M'(2>A;-5WMI?]7+YAX^7+'&/I2"QVL\T5L-0FBMX&DC2V*ET!"[E
MY.*IZ(R3O?QQN#<RV[+& <9.02![XKF%M[QCM^;:V.2QIT:_9I&7:Y/J.0/I
M0!U.G07,%Q,MQ:S1LMN7MXS&&)(8 D(3R0*+J=734%6WEM_] #/YD00L=Z_-
MM'3-<P+DO,/+E8R_WV)R*J:G!-.K))<RQL_5@3S]: /0W9Y-8O(4C(=_*19Q
M")0F4'# ] ?7VKF&U98"T*X!4D%@>N#CCVKGX+&X/[PWTF<8;!(W#W]:6#2)
M+B5A)=.5V[<;<8%- C6N=6"[&\Q71@=O>ELV\V#S7MU:0GC?V^E4&\,,SQ-%
M>*HB'1QFMNWM1$I0SAS@=!5:#();L%EA>13MY*BIX9XOOF/<QX4+P!52/08(
M9&E>XD.[G! %78;)995;+"./ISP:0#(H9+P.#N"#J3P*8]O;1(04+!>1DX'Y
M5?FE"#:HP!VJE%%)<2MN#%2/3BF!GS:K(F-@!&?3I5R.\9D1Y"@8C.,=:D>Q
MG=PD4*"/D'(&*1]&68(6E",O7;T%)@'F^:H>0G.>@%.=RA#IG=^E1R1PQ)Y3
M7#DCID"HC ZH61LY[YP12&:-G+.N99V51V6EN)C* 1(P&>,8JC%'=$G=AU_O
M9 Q5Q!Y<8WE#CT-,"&Y1)D"E9#D?>!Y!J6UM$A7,C%R>F1S0LJ.6"1%F'3TI
MPD9%/G;1ZXZ"D!,9HX\  ;QT'6L/6;E7507+-NZ=A6J'M FX+G=UXK(U:.U:
MT+1#:RMG![UE7UIM&^'TJIF4T@7ITIAFQU8XJG+N5B-W&<TU7+28.:\>Q[BD
M:*REL$&A[K ^8?=ZBJCMM7 Z]JDBC\Q?WIZ]ZDHLP32.,K]W/?M5I)>.<CWJ
MLLB*?+0 +CK2B=%)"G)[8YH6HGH6/M()VXP:B^W(IP0<^U578GDM@^E"^46W
M,,GZT[!<OBX5N0,4CS#/+ 52=]WW#P.U,2<R#:8L^AHL%R\LD:L2S BAI8U*
M\C!/ K+D3:=P'-+;O(S\$'W-"0-FQM55,F[K2":(\;P<TBY*KR#]:5S%&AX4
M,.U.R%=C)'39E''':F[F90>@JE-)&DH;R@Q]1P*)[XK"01MR, 9X%+E079+<
MW(4@!A2POYRDAN%'-8JRM-,,GY5J]"VR(MO&">E%@N6I)D4?>_6HA<J5R&%9
M=S\W*R8JM$DA&T/GFFHB<M3:EOL+M7YJHOJ6<ALKBD(5$ )Z54FV2N<D*.WO
M0DA2;+-S>LT 96_"JPN/+@^?[[=JK2.O"*.!WJ)\EN:UC$QE(L).?GS]14<$
M[0744H."K@\U">M-D#2,J(I9V/ '6M8+WD85'[K/3TO"\*>7;*\C#L,U85;P
M\R;5^AZ55T*QG6PA-UNCE"]">16GY#Q!F$Q;/8CI7I/5'EE*X6<0\R;6]0*Q
M72^F9E6=6/\ =)Y-;DT,A!(FZ]0PK*,)CNMQ<#TYKDDK,T1EV4=U%J)#J=^#
MD&M8R DJPV-6==WDD.I!B&"G@DCK6@TD=S'\P^;';K4C*-]:ED+1C#>U58H_
M,0!^)%[^M72\EN<'YXZ:\8<>9$?P[B@!D=R5;;)P?6K1".NX#GKQ59MDRX;A
MA212M;G!Y6@"[_K%"MR#T8=14#27,;;)X1/#T#!<_F*<3O'F0GGNM3V=[&S;
M6^5_YT 5XQ9$DK!'N/9>#^1J]&SE0%A8+]*M_9;>Y ,L<;'L6%6XK81@!8P5
M[<FI8T%NS*GS @DU:4Y/!I)D9E1F4#U I8SQ@ "LV:HD ]:1E![$FG!NP&31
MR1Z4AD#QX[8K&U&S66)T(RC#D>GN*W60=ZJW$8/M3W!.SN<"@EMKS[/(?N\@
M^H]:O&_56Y' K0U:P\Q1(B_O4SCW%<I*TB-@\CO[5SRA9GI4:O-$UY=4W A&
MQ4 O2ZD;^*R0QF;"@@5:$4<2#<W)Z"@TN6UNS$I;M[=ZJRZM)(V *;*)MHW$
M*O855EVJ!G&^FA-DTMX> [#WI1>+$O(WDCBLTQ2229?D5',\F=J(2!3Y2>9D
MMX[2 N%P3U7TJO"S+R,X]34;7+JH39C^9HA#22C@A>M6E9&;=V7)%,G(;&?6
MD)=<#TI20%)Y/IFF^8@0%@-WIFDALM1-@9P*?\K'.<#WJFJ,2'+X'85:C(+
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MWN&Y)R W%48?$,JGYI2[D\<\ 46 DT[0=1DF5I;9DC)R0Y KLXH5C 0[5P,
M#K7/Q:]"J&1IW; Y["JLOB/S9E\EB%QR>XHL.YUI,0(4Y)]Z@GDMPVUC'U^Z
M*Y0>(GBMI)I&W'.U035"^U]':&!"0X7YV]Z+"N=J"BG$;19/;TIX)C)P>O\
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MC_:'GM'#'\^3\V*YFZNV#S3EN?*"]:D\/Z@=LHS@J-V:+!<[1LJ,K''"@'+
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MW +^=,/-,4@\@4X5PU)<SN=]./*K"CI2#WH[T'.:S-$2QQF1PHZUT$,:VMN
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MF,2N0I1R<,>X(P#V%%P. D^0=:K,Y?DG%=YH<L&F^$+:\.GV5S/-K'V=I+F
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MSZUT$"JB #FL?28AL!$>/<UMKTK=Z:([J44D<AXMYU6+_K@/_0FK!K=\6?\
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M=4CA&9%T^X,C*,9)P5&?H.:7-'N/DEV,'PKX7OO%^L'3-/EMXIA$TNZX9E7
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M!ZU]*:4\4&DV;0X7="C#C&T;1Q7%C<2\/!21I3@I.QS5_.NC6L%G:;4A@4*
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M!;?6;56E"\A9D # GIG&!]5-33M_PBGP<A@&4U#Q)-YC]F%NG3IV/'X.:L>
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MX'G.:AC\0P10ZC;C1K065\L8^SAW C:/.U@<Y)Y.<]:I1Z#J:WKVBZ9=FZC
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M[SA?TJVMK(J###Z4^TM@3YCYR>@JVUO)C*D8]#0Y!&'5F9*I#*K$[S3II-@
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M+25E*%X)6C8J>HR#TX'%5:6@+A1124 +WHHHH **** "BBB@84M)10 M%%%
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MVS2&)'  >A)^O IDLASY:].YITK[$P,Y/ ]:C1".3U]* (6XQGIZ52OI B$
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MZM;8/:A'"HTAW8#Y4G;D#ICO5^30/AMI<QL-2\1:K<WD9V33642B%6[XRI)
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MMJ-C)\$]!L([RW>]BU"1Y+=95,B*3+R5SD#D<^XHMMZBONGV.2\.?\C/I/\
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MO4,EPJ#FDXW*4K$OF$&D\PF@+NP1T-2K%BLV:HB^8T]0<]:>5%(HYHN,FC#
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M<[?XCSC/-<57H^F?\D UK_L+K_*&JV@^'_#NE>#(_%7B>&XO8[J=H+2RMWV
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M+@#UJW)(4).<+5.0P2-WW>HH0Y$*0N3PU70984PJ;B:6WA(&[&1V--GG=#M
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MS?:SXQAU^V'V4VA06<0.1$BG(!]<\Y^N.E='K&H> _'##5+_ %"Y\/ZPZ@7
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M2ZI<6<RS6LUU))%(JLH*LQ(X8 C@]Z(_$$OA,NBBBM" HHHI %%%% PI***
M"E%)2T %%%%( HHHH **** "BBB@!:***!A1110 4444 +1112 *2EI* %HH
M[T4 %%%%, HHHH&+1112$%%%% !1110!K:*7'GE,;L#!/4=:GE>>5B'E)^IJ
MGI;8$P!P3MP?SJUL+2_,<#UJ'N==+X4;-C;+%;1HIW2R\U;N+::P_>/+&05R
M &SS4-NZJRQPC<^.6/\ "*Q[R=VN6Y)P>YS2-":[N1]U?O'N>]9K,<<]:?*Q
M?'KZ4WR2!EL?3-,!JKG)-6(5 0MUJ!01D5,C%83G@T 12N6D)7I49SWIZ\@G
M'-(V<#-(0RFXIX[TE "#;4]K;R75U%;PKNEE<(@]R:@K?\&,O_"7Z9N ($I/
MZ&HJSY(2EV0XKFDD>X^&M L?#NF);V^TRE09I>[-_A5F[OHX\J#FL2>X9&/S
MG'>L/4=9$((#"OAZV83J[+5GN0PT8;LV;^.TU%2K'8YZ&N)UC1GTYC.6#1^H
MJPFJF1LAJT'O/-L)&D <(N[!&<XKC4I1E=F[2:."N7>67//L*U]*T]Y75GSB
MHK(17=]+,R@9;.WTK=6>.W7L,5T5JK2Y$C*G!/WF;NFH82H4@8Z5MO,6"GTK
MBH=6^;Y6K5M=4=P 3U.*X]5H;Z,\_P#%>A077Q(M+5\1P:A+&6V<8R<-_*O3
M-7\+^&4T\Z:VF6D,138C+&/,4XX.>N:\9\9:O-J?BQFL3(\D3".#RP2V5[C\
M:](BN]2U/0K:^U&"6WNF3#K("I)'&[!]:^EQU2O1PE*5[-6N>70C3G6FK:'G
MB_"SQ/<37'V2TCEACSMD,JC>.V/>MBS\/ZQH^G1"^TZ>WV@J2RY Y]17IWA2
M68V[M*0%48&3U-:LE^2YBE7 /3(X-%//)**<XH)8!-M19Y-:Z+JUPIF@TZ>2
M ]7"\?4>M5[FUE6=(/*,9)"D,,$5Z?>ZLZ2&!B0%7.5XX-<=KTIDN;*;?\PW
M;B>I':NO!YQ]8Q"I<MDS.K@_94^=LI7IBTV#9;R;II.&;TQ7.F"XF+-(^T$\
MXKI8[**:=+AV!51NV]/SJGJD]LR<N% /.SO7MG$4(XFDL#@?=R-U>F>![!+;
MP)&\JJ\MQ*[@N,[0. !GIT->8Q2?(\:$A2-P%>A>"]5%QX6:S9L2V<A&T]=C
M<@_GFO+SKF6"FXFV'M[17.=\113>>R@9%<PEBSR_-G%>@:PL;Y;(S7+-<11S
M;>#FODL+6DH62.ZI%7NSH-#MH+?3Y6E ">6=Q/IBO.I)4W'$8"YXQUQ75ZWJ
MGDZ,MK PWR_?]EKDX8Q(2&91QUKZ/(:$XTYUI?:>GR.7$R3:BNA/;VGVA=ZH
M2HZDGI3YHH$38CX;T]:CF:4 #?M7':ELH5DN097RJ\FO?.8LVULZ$."-V.]0
M7,;[_N,QS\QK6CM'NHFD1UC4=-QZU4N)O+'ENP<*.Q[T 9$@;)^3;49'%3RR
ML[9!^6HC\PI"&=L4Y4)I57YL4]VQ\HI@0E2#BG#"].33CGBF5(#9&)-1@#/-
M/8<T8 ZTP$(&>*G0"->F6-1+QEL?2IES]YC28"X)5B>M,(.T=LTYG^7(IBY/
MK]:0Q1QDTTG@^M*2"<"FM0(JS#(-9-R/WE;$G0\<UE7?# C@U+$0*I9@HZDX
MKHK=/*54'116! Y2>-R,X8'%=&1A^*<0+ YY]J5^,&D0Y4^U*[93(&:H17'^
MLP*BF)#DCJ*M8 YJK<H5;/K3!#1*!@LHSZBG?NW.[:,U&>4'/(IAZ=:3*1,[
MC&!BH/E Y.*,9Y%(>1TJ&45I!D\=*I3+\Y/<5=D'4BJ;C/)-0,ZNR?=%&[ <
M@9K3>WCD3<.O?%9E@N;:,?[(_E6I#A5P3FO-GHSU:6VI&L.T\=*4Y X; [5-
MCG(Z420[P"#@U%S7E[%/>V6$GS9_*IH8XR_"8]:E6/S!M?H*7[,R'JN.QS2;
M*28Z681I@8'M51!YLIP.3398)78* 3[U8CMF"D# .,9HT0]6R070MEV1C)/4
MBJ=S,S GS=GKZTZ>W"C(D.[&.:S)3\Y')Q512)G)K05I "<<G^\:C))Z\TJ1
ML_2G%54'/)JS'5D?6BG!&-31VX;EC1<2BV5P"3@5(L!;OQWJRWEQD*H^;Z4V
M6543"D$]Z5R^5+<JE1[TPBI<$KG!H\MFZ"G<BQ!THS3W0KWJ,U1.P4U^F0:<
M:8>F#0 P]*K'[Q%634$@^;(JD1(HW ^5OI69BM:?E366:VB<M3<B;BI],'^G
MQ_6JS=35O3.+R/ZUIT,'N>PSK_HZ'V%9[BM.3!LT_P!T5F/U-<C.Q$14&HG0
M5-4;GF@"JZ9J$I5IJB(YIIDM$(7FG^6#3P*>!3N*Q7:W5Q@BJTU@P&5&:TPM
M2*.*.9H?*F8*LT.-P.0>M:$%T"!S5J:))$*LHYK(DM9(&RI)7-6I)[F;A;8W
M8IDE38^"IJ7^S[<J3!Q[5@6]UL.WICL:OQWI5E'//>JL03/<O!)Y<D9*#^+%
M#6\%TNY"/PJ<7&]<-@CWJE.@Y:,;3_LFFF)H9)8S(O[MR1Z5"D-UGE/SIZ:C
M/%PP##U/6F-K#9_U0_.J$2?8IG7YFQ]*7^S<*/F^;/)JO_:\G_/,?G49U&Z?
MA<+]!0!K10I;)V]R:K->%Y"J=/6JA-Q*H\R0XJ10$Q@XQU-%P+GVUT0$'@'G
MZU.+V81X#GFL^1A(JJ/NCGZFKB(#&*SD:1()9V8\]:@+DU::#-,^S5.A=F09
MI=U2FW(IIMVHT#5"(W-2*^#47ELIQBC!':G8$RZLG%7+5TDLF1\;D8XS62LF
M*?$0\I5GV@C-8U(W1V49V=B_Y[Y"A<CT%*SXY/7TJC-+Y?RH^1TS4"SL9!DY
M&:QY3J]IT+4RM*PX/X5.EHD2EF))J'SV#  ?C4Q;(ZY-)W*5MQ%7<^*?(JD=
M,41'!.!4C+\N3QFD4MC*N%DSC!(I(@(USC+&M&3"K@8S4+0*P!/7VJE(S<-;
MF9=$F4$^E058NU"3  YXJO7N8?\ A1/E<9_'EZAFBBBM3F"BBB@#-I*6BMS
M2EI*6@8E%+24@"BBB@ HHHH*$HHHH **** %HHHI )1112&%%%% !24M)0,*
M***!A1110 444E( HHHH&%%%% !124M PI*6DH ****0"T4E+0,**2EH *2B
MBD,**** "DI:* $HHHH&%**2E% !1112 **** "BBB@ HHHH 6BBB@84444
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M4R=$2_:,$@ !1TJ-Y\].E18QR>*3.#FG9"<F!.>:CJ1CNIE40Q*8W3I3Z:U
M$3\'VJ-JE;I4+C%-$LJ3#@UDL,$UL3"LF0;9&'O6T#EJ%=JLZ<?]+C^M5GXJ
M:R;%W&?>M5L<[W/9BW^@)_NBLUCDU>0^9IL3>J _I5%UVFN5G4B-C@&H&;)I
M[MUJ GFBPVQQ:F&D)HH$.%.%,%.!H D6I0.*A0U,II#0CKFJSCJ#5K<*KO\
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ML.0.:68'=[8H7& :D#;P.F:H17F)"AA3XF6YMRHX=>U2,H92I%5 !"Y9>#3
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M24M)0,**** %I*6DH *6DI:0PHHHH ****!!2T4E Q:2BB@ I>])2T %%%%
M!1110 M%%%( HHHH&%%%% !2TE% !2TE+0 4444 :^A1^8TZG./ES^M:DRK"
MNU,#/3%96C,1'<X/7;QZ]:U?LWEQ":;=N;[J^@]ZE[G52^%$,<WEH<#YL\&I
M5<^0P+M\QR?:JI&U2<'VH24$;3WI&C'L"P"@84>O>G ,I#L=H[ =Z%)(.>*B
MN"XVL>>PI!<FD42$.SX0<_6J;R<G;T/04]7E8$9RI'I0J2G!1&(''2F!$890
MH8J1GI3XT^5MPR1TJ:9)R5$AP.PSS5F&)0A 'R*,DGUH SXV*D )ECZ]JD)?
M?S(&([5(5+_=^Z:=)LC(4*N1WQ0!"X.,X'X"H'&USZFI3*SYRV1VJ)\!AFD(
M4$#BI([V>UR()6C)]*9&,G/:JTC;YV],U,HJ2M)70TVG=%RUU"[M;Q;R.=_/
M4YW$YS]:[=M>_M*Q253^\QAU'\)K@0._I3H9Y89/,B=D8]P:X,;EU/%171K9
MF]#$2I/R.]LM!N]3.]4)'OTJ2319[16C$\D#-TEA8JR$=#G^E2>#_$[SZ9-:
MW,H\^-LH< %EJ2\U-?-.^08ZDGM7RE:%?#5_9]4>M!TZE/FZ,Y&_\;:JX^S7
M:P7$D)*&8J0S8XYQ6->>)M5O)=[W &%"JH484#L*J7CJ]U,Z\JSL1^=4VR#[
M5]A#"4(^\H*[WT/%E6F]+[$D5[+#>PW/G,)Q*#OSR.>M>JWNMO'(S&3@\Y!Z
MUXW==%(JY!X@OX8!#Y@=5&%\Q<D5R9C@'BN6SV-L-B/97OU/2=;\=2:;I4/E
MK%-.[@!)03\O<\5/_:7VZ**YAC*JZAB&XQ7E4+3:GJ40FD+L[ 9/85Z3 OR1
MQH,KG&!_*LH9)0=-1ENNJ+>.J<S:V-!K@W+[@.GRCZ56:(@D$9!;<1FK<FRT
MM%085VSDU562.*.*24Y!)8GWKUXP5&ERTUHEHCG7[R?O/=[E]%V(%ILL*3 !
M@>.>#20W,,_^KD#'T[U+7R3G5IU')W4ON/M8PHU*:BK./WF#J.C7<DAEMIE?
M_8;@UD7]O-;1A9$9<GH17:TUT612KJ&4]0PR*[Z.;58:5%?\&>;7R:C/6F^5
M_>C@XU:3 *Y]Z=Y+*,\;?6NIN-$MI4(BS 3_ '>GY5E3:%<QH03YB#H5_P *
M]:CF%"KI>S\SQZ^68BCK:Z\OZN9L<0;K6M<Z.8+>.7EEVCS%'4'_  J/3K/?
M?I&0<)\S9]JZ@@$$$9!ZBN?'XZ5"I&,/5G5E^7QQ%*<IZ=$<M9:X+*58&C/V
M?IUR5]ZZ='26-71@RL,@CO7-:KI*6;-<1)F)CSG^$_X5!IFK/8R%7RT+=5';
MW%98G"0Q</;T-^W]=37"XRI@Y_5\1MT?;_@'744R&:.>)98F#(PR"*?7A--.
MS/H4TU=#9&VQ.WHI-<=%Y<48+@$GJ375WQVV%P<X_=G^5<:X9TVJ0?>O>R:/
MNSEZ'SV>2]^$?4L-Y'WMW7H!5&X +9 X]:1SY9"YW'N:A^=B>"17M'A$HG?&
MU0,?2D\QR"&P!["FJ"QPV13D903N7CL*0B6&)=I=B<"B7;LP!R*-\O .W']W
M-.8<9"C-)C*9'/%2CI[TTJ1)BI..U# 81@"F9!XQQFAVW-QT%*..:0"2'L*K
M2 D9S4^"<L:C<9;B@EE"91CFJ<@49-7IAU%9\YW. .@J6!">>E;.C_\ 'M(/
MX@V:R,<<U:T^X^S72D_<?Y6_QH6X'2+\P'KB@ 9V]Z4#YAZ4UD(E!_6K$1RK
ML0^M4CR<UJ3*"I+>G6LT\].E,:&8XIN.].(I0"V !UI%$>*:1P15DPA1R>:B
M*CM4L:*,Z @\>U9F2K<=CQ6U,F5XK&=B'8$8P:SZA(]&TW)LHY#P6 -72156
MTYL(-W#>6"!^%2(^XY/3M7E2W/<AHDAY)<$U R$29'-3Y'0TN/2E>Q5KD*[8
M@6QCV]ZC#EV!(J0M\W(I#*C-]P CT[T *S/G*U#)'*Q^\H%+(^>5_6JS2.O"
M!B3WH2$V3[@!M+'([TA#2#&W-1HACC+2YR:/.D;'EJ=OTIV"_<>8.P(I/LYX
M7</I2DS'[L3<]Z56^SG,BDO1J/0D^PIC<R\GI2M:[\1[./6H7ORS $8 ]*>V
MHJD?W\?[O)HLPO$2:'RP$"54D:-200,TCWI8D[V/X4Q LS GKFFEW(<D]B[;
M1Q*-Q09]:9<298+N!)Z8I2K;>1A1WJDTRIN*@ECQN-"5QMV5A9I6^X#C'IWJ
MN6X '7O2[)9"#M8_A3S&!CC\:O8Q=V18QS3-N23VJ5DQ3'[ &F20L/FJ-QW%
M2M[?G37'RTQ%5_F%9-^NV4$=Q6P1UK(U(YD'TK6&YSU=C/!RQJ9.:KJ>:GCK
MI.$]-\&RXT"Z4]F!_0U9D;S8R:P_!MP387T6>@4_SK<A7*D5S27O,ZHOW446
M&#49J>9<,:BZBI*&;\"J[,6-2N, U"HR::)9+'UJ0FHU!Q2D\4AD4CX-(#D5
M$YR]/0<51(^GKQ3*=GBD,?NI":0 FE*D4AC<4A7BEZ4FZF P9!J56..::%R:
M&.!0(<3FH#]^@R<TA.::$V9^LG_13]*T]*A)TJ%JR-:;%M]:ZC1HA_8EN2.H
M-5)VB3%>\0+'@G-5;J$,IXJ_)\LA%1NN5J$RVCF+60Z=JF#_ *M^*ZI6!4&N
M>U:U+1EE'S+R*T=&NQ=684GYTX-:/4@N.,U7(YJRPJ)A@TAD)%(#@U(1FHV&
M#2N!,C5.N#Q5($BI8W.1BAC3+R H:DR#)EF(!YX]:@5LCFG$9P3TK*2NCHI2
MM)#I'VGKSZ&HC<;SC90R,[?*<@=Z00'E2>36.AW7?08T2MR.#4?"\ $'UJQL
MV#!.:%8/D!./6E<+$!4,/G<@^U"$PG<I+>_I2S8!Z$TQ8BQ!.0/2F+J5;UV>
M8%CD[:K9JW?ILF0>J _J:J5[6&_A1/F<=_O$_4,T44E;'(+1244#*=%%%;G.
M%%%% "4444#"DI:2D 4444#"BBDI#%I**6F 4E+24AA24M)0 4444#"EI*6D
M 4444AA3:=2&@!****!A1110 44M)2 *2EI*!A1110,**** "BBB@ HHHH&%
M%%% "TE%%(04444#"DI:2@84M)2T %)2FDH ****0Q:*2EH **** %I*** "
MBBB@ I:2E[T %%%% !1110 M%%%( HHHIC"BBBD "B@44 %+24M !1110!O>
M&9%BDN&9 WW>HZ=:N:EJ+W,IC^ZB]<=ZR-(E,7G8&?NG&?3-7268M(ZJ,U+W
M.NE\*& ,P).?:G0PL[CG '7%*CL0511@]ZG\W9 %4#/K2+);>%7EVYS@=*2^
MA021Q X.>:6"81$L -_>DO&VLLYY/I0!/+/!$BHD2_+T/>D%_*^X$C;CC/:L
M]YFEY!_#TJ,<D@L<GK0%R7879F4[VSRPZ"KTK+%;QQD9&,L/4U39"/+@4>^,
M_P Z?>3X4+D!A0!;N9AY*;GC08XC48_.LQCYC9W#:.I]:B=W?!8Y.,#BA8E)
M^9BO]:07$ PWR]*2=< 9J<&,#Y?SJ%U,DHXSZ4"!>$S5<K\Q('6K+ J #4 4
MLV.U $BK\F,TA^52:DV%5Y-5I6..#D"@!T<\D,@DB<HXZ$&I9]0NIU(DE)!Z
M@<9JNHZ_3-(P/%0X1;YFM1W=K$+YQFHFP14QZ$57<8.*9)1G?,A'85$:)#^]
M;GO25(R6VE,%U%*#@JP->OZ)$@M/M;'(9<IGT]:\>C4-(@.<%@#7J<UT $M8
MODC1%4(..W2JB!/J=RK[?FZ<TL.G->I&\A;9C*J>*FL;!(Q]KO1ELXCBZ\^]
M7+FZC(*)D<?,1TJAD3:=:0V^ X#L.H/.:S&O)K-B/,,BCC#5/#?P6\8F(#$Y
MVY[5F7.JF[E,:(N.I"CK43I0J*TU<TIU9TGS0=F:D.LP,=LRF-OS%:$<B2KN
MC=67U4YK!CCC:(M@!B><4Z2Y:W5%B&.>2*\NME%.6M-V_(]:AG56.E57_!F]
M161:ZM)+,4V!U4<MT-:27$<@&&P2<8->56P->CK)77='LT,PP];2,K/L]"3:
M-V[ W=,XYI:**XSM&NBR(R.H96&"#WKDM5TMK"8R)DV[=#_=/H:Z^F2Q)/$T
M4BAD88(-=>#Q<L/.ZV>Z.+&X..)A9[K9G':9JCV$O'S1,?F3/\O>NOM[B*ZA
M$L+;E/Z>QKC]2TN6PN0!EHF/R/\ T/O4NGW4UE.&C;*G[Z'H17L8K!PQ</:T
M=_S_ .">)A,;4P<_8UEI^7IY'0:XYCT><@\D ?J*XX3L , 8KI];N4GT;*'[
M[@8/4=ZQHH[>.W!D&9#W':KRJG*%%J2L[LC-ZBJ5TXNZLOU,TGDG;SFIM\OE
M86,A?7%75N(%("PH1W..:KSEGD)^ZO9<]:],\L(H\\$[F;MCI0ZA6(5034\'
MR0EV&&/ ]JEC"&'Y(E!S\SL>M %(QHJC<,OUSFF&4L-N  /2I)@6? 'XU!C:
MV!R*E@,<@.3GFACL@9L]N*)AB043#,6VD!!#R,FI6[+Z<TR%3G&.*F(P2: (
MVP3BHGQ3RP)/K3&S@T"*4_7(K*)&XFM:;[K9]*R<$U+$%*O+J!R211FK%@JO
M>1@^N:0'31 [0#U I0=V1Z&A> #WS3E4+*<^M:"%.UTZ<"LV12C\_A6FRX4@
M=A578;B-0!\P.":8T5 NX\ DU<55B3[M-6 (<%\?A39"2".N.](8QV5^2M0L
M0>@XJ8@,HX-1%1GKBDQHKR#Y36/,H^VJ#]UF'\ZVY1A"<UAW9S+D<8K)[E/8
M])3#J B$8& 33"&0[1_*H]-F,NG02 \E 3GK5\%7/*X->2]'8]N/O),BV;@.
MM+DQ]:D!#,2 <"HI#N8#UI%[$<G3>HSZ57'WRSC\!5W )P"O%1%22>!^%%P:
M(]H=>1BFF,KR,8I^3T IC*,X+&F(9NC0DD[OK2-?C[H"@#T%(;=7/WN/05!+
M%'G:H(/K35B6Y+8L&Y^3=NX/4FF;TD!.23V!JJ;=L@<U:2(1H=SY)_2G9($V
M]R(P[AD[0G<FHF>*(X1 Q]3S4T^Q@%RW%$, .9&/R^IIW$UKH57G+G#(,=AB
MIK: 9WL<>U.9H@P& 2>]*&4#&<9HN)+742XG=CLCY'L*6"PD?YICM'7;WJY!
M(EM#F.,%F[]Z;+<H$9I7!?\ N@TK]$5RK=C&BVJS$94#@9Q6:[LS' X![4LM
MPT@QN//6D4;8<DGFJ2MN9RE=Z$18ENM-).,FGDY[8H5#)CC@=ZHS(6!"Y-1D
MDU8D7>^.PJNW4BFA,ADZ&L:^Y85KR_=ZUDW_ -P'WQ6L-SGK;&<O+5,!@5#'
M]_%6'&U*Z3A.G\$RG[1<1_WD_K7;I%LC^M<#X(;_ (G.W^\AKT:7&2!VKGJ;
MG32^$R+E<9-4\UI7"9!JCY7S5!9&RY%1+'C-6V  J/%%PL-"X6HRI.15C%*(
MZ5PL4Q#ENE2K#5D1BI54"BX<I1:'!H$56Y%%1=*+A8;M %)BG&FT ,D7N*KG
M-6CS3"@:FA,A5L"F.V:) 4-1YS56)N)WI^*3%2*,U0C&US_5J*Z[33LT2U7_
M &*Y+7!\T8_V@*ZN ;-,MA_L"E/X0A\1',<R4QCQ22-\U,#9J$6R&YC#H>*P
M[.4Z=JN#Q&YKI0@="*P=6M24+J/F3D5I%D-'1, R@BHF7-5-%O1=62JQ^=.#
M6@P':F(J,,4SJ:LR)Q5<C!J;#$"U/&HS40I0Q%(>Q9)&*D3D<U4#$U9BSMI,
MN+U%=S&O"Y^E1+<EFZ59$32 [3@U&+=E)#1_B*YG9,]&-VDT-<F04!MHV@_C
M3S"R*23D4T)O&.U+0O4$7)SD5*IR?FQ4(MLCDE15E+1"!\Y'O2923,G5V#72
M8[1C^9K/J_J\8CNU4$GY!S^)JA7N8;^%$^5QW^\S]0HI**V.46DS110!4HHH
MK<YPHHHH *2EI* 04444AB4444#"BBBD,2EHI* "BEI*8PI*6BD E%%% PI:
M2EI %%%%(84444 --%+24#"BBB@ -%%%( HHHH&A****!A1124 +1110 444
M4#"BBB@ HHHI %%%% !1110,2BBE%, I*6DI %%%% PHHHI +1110 4444 %
M%%% !112T %%%% !1110 M%%%(84444P"BBBD 4M)VHH **** %HI** -#3,
MXEQU^7^M:SQ22P#*$$=:C\,(6CO-L:LWR ,?X?O5L3(GF,JSAS_%MZ U+W.J
ME\*,F*W+85<Y/I4QLV1=Q88SP,TK%(B4C8Y/5C40ANK@B.-7('.ZD:$B(%;/
MOS4-[,SRX4$J.U:'V1H8]S@E0.W>H?,$5M(X&7],=* *,:B-22#EAP*(U\N4
MEP,X[^M)'<%I-SD#'M43-ODW;N3WI"+D#C#L5W/UW'M4$Q,K9+ ?A1&=I/S9
MS3]A8Y4\GN:!$4:\_*3^(IYB+'@_C3G?9\N06]JB:4E>3A<T *YCB'J::2>"
M>,\TPR*6R1D4UW+\G 'I0,5"7))R:=PIS3$/84C/SB@ ED+?+4:@=*=U()H!
M .: $ P#FDS[8IX&3@#-(VW'O28%=^M03'Y2WH*LLN15.[;$#@4@,L]<TN:2
MBI E0E65QV.:].TETNYK6\E7C:':O+QQTKT71-PTBV;)SY61BG$#>U"]C@.Y
M.<].:YR>\FDC?#$ =,&I+A#*.I!ZU!Y211 LV<_G5A<!&TUO'&-R@9)/K4,3
MN@,<  +'EN]7HYP(P?O$=C6>#MDX/Y4 7[61XT9."1R*8TK;&$AZTEI$TSLY
MRJ*.?>I+J)!!M&2V>@IC&VU]Y4#+&@&.]:VC,\ZLT@^Z<_C6+;6VY2,'DUN6
MMW:V-N$.[<QR<"N/'.I[%QIJ[>AVY>J?MU*J[):FM160WB"$$;()&'J2!5>?
MQ(4XCM@?<M7S\<NQ,OL_D?22S3"1^W^9OT5S#>([MX\I%$K?0FH/[;U-Q_K5
M7/H@K:.4XA[V7S,)9SAEM=_(ZJ>".XB:*1<J?TKE;JS?3[L^8"5ZHW8BF->Z
MF^2UQ+CO@XJ%WFE.99G?T#,37IX'!UL.]9)I]#R\?C:&)6D6I+J/NG\V,-_"
M.HJL\P8?*!BG7,H1!&!P>M01*,[B?EKTSR0WMN!' J2/=&K/_$>]1 !I!GI4
MJE7?#9"KT ZT 3F0BW&1S[U6:9G4*> .< TZ5O.X _6HU0@]C[4F *LC-\K8
M]:F557ODCO32C'&!S00L:X)R?2I&1$%YBW)[?2DFZ?2G-*47(^E&-PR>:8#(
MPQ.:)20"!3RX13CK5<$ECDT"&Q\G-*P)IRKM)&,8H.,?A2!E&Y4F,GM62< <
M&MB?F%QW(K&QUJ6(3(Q5W2AOO5/8 U18$<UH:,?]*?UVTEN!T<!!4'K3Y!^]
M##I3;8=O>IGCW!<=CFM!#6(=0!^E)#&3&Y VGUJS&B -QD"FR+L4L3L%,95^
MS1R'<[G\!4DD=O%%@-\QX.:=;PF6%G&<9X&.M5I6W-M93Q2&,,:]FJ&2+/.:
M?M&?E)Q33& .9.3V!J))EHHS!^1VK$NC\X&>>]=)*D; +GI[UAZE;^5)N7E3
M4=0EL=Q8*%L[54.,1KS^%74[Y;)K.T29+G2("&P0NW\JT-OE@X!(/6O+G\31
M[--^ZFASS;!MSR>U0AOFR#DT,5/R]2.](H:-=WRGV%2:7.GL["UG\*I<6>F1
M:C<CS/MH\YEE@Q]UE4'E<<YP:K6OA&[N--AG$ZI/-;M<0P^4YWH,GEP-JD@'
M )J'3/$-II"QW,.DL=3A5E2X^T$(<Y&63') /3.*KMXM6;2H+2[M;I[BW@-O
M'+!>M$C+SM+H!R1GL1FMDHM:G,W4BW8T%\*F2TC9=3MOM<MG]LCM=K;B@&3D
MXP#@'COBJ<_AJ6.TT]Q=(]W?A#!;B-L,'.!\^-N1W':H(O%GE7UO=FUR(=.-
MCM\S[WR%=W3WSBEMO&7]FZ3%:6%G*D@DAF+SW)DC5XSNRB$?*6(YY/%"C$'.
MH3S^&5A@FDM-5MKPV\Z072QJR^4S':",CYAGC(I][X2%H^HQQZI;75SI\9EG
MAB1A@!@#@G@D Y/XU6NO%=F8)TT[2?LANKA)[HM.9-Q5MP5>!M7//>I-$UU)
MO'W]J7+16UG<S2M<),<KY3@[E/KP<#WQ1:.PN:=KE#5=/;29H8I)$>9X$F9
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MAD5RVL0':)E^\AS6QHUX+JS4D_,O!J_,DONO%5'&#5XC(JI,O-(9$#2TPY%
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M (***2@8M%%% !1112&%)2TE PI*6DH 444"B@ HHHH&%%%% !1112 ****
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M &9P":1>3FG''W130"#B@!W84*OS$>E/" <F@GDF@!I7(VJ>O6D*!!GOZ4X
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M2W*XE_"H>U2 N><UZ?H.H"\TZ"4,!A0K#T(KS"ND\'ZC]GU'[*_S1RC@>]-
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M,U"]3/\ 2J\GR@YI 9TS;I3[<4S ITB_,3WIE2 M;GA*V>X\1VVT$K&2[GT
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M$[]2)X"S<GCZ5+%;JHW9Y]Z&G<=%^N*9OD;DX ]Z>I.B8Z:)W P>.]0L=O\
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MYHC?YN:C/2E3[PJ[$7+C. M0YW'-)(V2 *!P*2139(JY-(_!J1!@9J*4XJB
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M\^TOE@.0!45M,JSK\V >*!DA$7VDC!^4$LQ/2J#RJSG:N/2KD@&)9,$]JJ(
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MRT.<\ XJ \KCN* ',.?FZ>U,R!R* Y Q29&.!S0 \/@TB-A\XS32V>U*.N:
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MG(%/$,?5VR/05"-^<+GZ4,C( &'6@5_(<YBZ(#41R:7KVXH('K3$]1N*6E(
MHS[4Q"J.,FF,>32Y-!&TT 1D8I*<QYIO6F2,DZ5S^JOF8CT%;LS  GL!7.WH
M))D_O&MJ*UN<N)E[MC/  YIHY8<4XC%$8^>N@XR2CM0:*0"GI7H/P[.;2^7T
M=3^AKS_J:[OX<MS?I[*?YU$_A+I_$==<+QFJ3]*TY0&C-9C]ZYT=3&2,"O%5
MQRU3.,"HN@H8D5YQ\U0XXJS(,C-5G.*:!C:>,8J/-(7Q0(CF;G%0BGORQIHJ
MT0Q13P*11DU(W%,0 96H=OS5:B&5-,V?-0 [.R,MZ"L?3XOM6IESR,UH:E-Y
M5H<=31H%OM1I3Z4]D+=F]/*$C"^@K-\S+DDTMS*>F:ILYQ@5G8TN3O<8Z5&+
M@YJ#K2U5A<S+#?.<U(BA1FHT' J?'%2RD YIV*8V5&::9:5@)@!FI%Z56$M2
MK)GI2L-,E)I@ZT;J0GFA QY&15.[@$L+(>A!%7 :9(,U:)9Y](K13$'@J:ZK
M0KP2*(V/#?H:Q=<@\F^+ ?*_-,TBX,-XHSPW\ZU>J,5HSN"F#4;KQ5B%A-$K
M#O3)5P.E9FA3/6BE?K24AA24M(: ,S43FX7_ '!_,U4JWJ/_ !\+_N_U-4\U
MZ5+X$>37_B,6BDS16AD+FDHS29H =11170<HE%+10 E%%%( I*6DH&)11104
M%%%%(!#24ZDIC"BBBD E%%% !24M%(H2EI*6@8E%%%( I***!A1110 4E+24
MABT444A"44M)04%)2TE !2TE% "TE+10,2BBB@84444 %%%%( HHHH&%%%%
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M_N#^9JE5W4SFY7_<'\S5*O3H_ CR:_\ $84445H9!1124 /HHHKH.0**2EH
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M>96_B,****T,@S11BDQ0!8I*6DKH.,****0!1110,0T444AB44M)0,*2EI*
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M+.I0[YVW.?NIGI5MD1;9&+[<CG H I1PO))MZ>]6&M\9CSP.M36BIO!;(#'
MSUJQ+&B2'(89'4T#,]\PJ7"Y/08J(K.REBA /0FK<DJ0<R'GKMJC-</<$EF.
M#T44 0EG9MN[/TJROR)M4 >XI?LSVUJ)6&-_3-$=M<R1!PFQ3W/% B%W)W+M
M_.HRN ,@''O5]-*E*%B3@^O%(NG%G 8D#O0%B@"A7H2?2D+,,<%?:M.Y6WME
MPJC=TK/=B^>.*06&;R1TP:!QDXZ4N!D9Z^E!Z[?SH$,/&*81GK3R=S'TIII
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MWIB%F)0'8N*LQVA,*,Q4$]!CM4JVD,9#-GU^M,9%#!$(03USEB:42QA21T[
M43R@H.@4=L55<'S,$X&.,=Z '-<DY[#TJ)Y6;GMT IWDCR5)SDMC%6)5BM@$
MVC=C.: *1C=SR*DVE?E(YI?-&<@4@)D<D]^M #068E:4A$X'6G^H6FF #!=O
MPH&1D<TL8V2AL]:>8XB.3@_6B/[V%7(]:!#I7)< GY>X]:BE.YOE'%3,H(X-
M5F!S]* &YQ[5,&  *D\\5&!D'^5/ ^49XI"'+SC]:;GYO:GD@)@=*C_AI 1N
M<FH6.!S4K<#-0N"1F@"E.W)/:L[@G-:,P^5JS<XJ6 %<U%_#BI23CK3"<"I
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MYXZUDL,,#5JUDV2JWI5,A'?6S"2$'N*FQQ61I]SMQD_*>M:_!'%9,U1S6O\
M_'^G_7,?S-9>:U-?_P"/]/\ KF/YFLJO1H_ CRZ_\1AFC-%)6AF+FC-)10!9
MI*6BNDXA****0!1110,0TE.IM(8M)2TE !24M(:!A11104%%%%( I*6DH 2B
MEI*0T%%%+0,*2EI*0PI*6DH *2EI#0,*2E[TE #J2EHI#$HHHI %)2TE PI*
M6DH !2T@I: "BBB@:"DI:2@84444@"BBB@84444 %%%)0 N:*2EI &:2BBF
M444E "YI***!A1110 M&:2BD N:3-%% "YHI** %I*** #-&:*2@!<T9I**
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M?=/$_+$<$4 #V+/'O)'T%(J>7B)<ENI Z"II7G"LI3!!Z56!F$OW<NXQM]J
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M-[*LLAFNFE5"ISB,$#8,_IQ4ZB.G.C^')M5@LXX(4E344@:*))1NB)P5<O\
MQ>XK,33M-O9[:>WTR.S:WUJ*TS#*Y,D1)^\2?O?+U&.M<NWB;6IXH//U6Y=H
MFWINE)V$="/<>M4[;4KV,A!>2K^^$V5<_P"L'1OKSUIZ@=UK4MO+X<6R^Q0E
M6UR>V\X[RT?W?GSGK@XYXXIFKZ591V^O6D>CK:?V8%,%R'8M)^\"X?)P2P)/
M&*YRWGU(0SQ_VA(MM,WF7$8<_O#U)([U/)JE]=6^Z_U6:XM8^8H7E) (Z<4
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M3?1Y[1 ?J:RJ[Z7P(\ZM_$89HS116AD&:,TE%("W11172<8E+110P$-%!HI
M@HHI*0PHHHH&)1110,2BBB@:"BEI*0PHHI*8!24M)4C"EI*6@ HHI*0PHHI*
M!A1VHHH&)111VH *6DHH!"TE+25(PHHHH 2DI:2@84N:2B@!:2BDH&+2444#
M"BDHH 6BDHH 6BDHH *6DHH ***2D M)110 444E Q:2BBF 9I:2BD,6DHHH
M **** %HIM+0(***2@8M%)10 M%)10 M%)10 M%)12 6BDHH **** -71?\
M62#ME?ZUT\RR1.Q"A8NU8'AD1R33QL>?E;&.PSG]2*W;AC/$3DA5^4>YJ);G
M72^$R]OS-ZYJ:,%^@YJ)58R;0"6Z8K5AMEB@5G&7;H!VI&A5$;N=B'IWJ.2>
M>$@9)QU%:UO9-(N\\*:DFM[>-,X&<<YZF@+&&+Y)"-PP:M).K<8QGO4$FG@H
M9 /F)X%51#-'DC( I"L:)A1_ND*?2H3;HIY89JG]JD1OF6IOML?&[!_I0(D
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MJC[2W*E#Z5(LI. KE0.O-1ELMG- !@E@!D4;64G*D"@.0V<9]ZD+LPW-Q[4
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M)1F@!:*2B@ HHHH **,TE(!:2BB@ HI**8Q:*2B@!:*3-%( I:2B@!:2BC-
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MY-_C3AXBN5 Q!;9_W6_QHY6'MHFY/#&X 6,CWK/FM=HXJHWB6]8Y*P_3:?\
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M^RV3_P"/4<K#VT#H+Z%=N]FY;@8J(6L<*[_M(#XR 17,R^([R5=IC@ ]E/\
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M4VDHKI.06BDHH 6BDHS0!>I*6DKH.(****!A24M)2 ****0Q**6DH&%)2TE
MPI*6@T#"DI:0T#"BBBD 4E'>BDQB4M)2T %%%%(8E!HH- Q#1110 4E+10 E
M%%% PI*6BD E%%%(!****8Q**** "BBBD 4E+24%!UI*6DH **** "BBB@ H
MHHH **2EH 2BBBD 4E+24QA1110 444E PI:**0"4M)2T %%%% "4444 %%%
M% !1110 4444 %%%% !1112 .]%%% "4444#"BBB@ HHHH **** "BBB@ HH
MHH **2EH **** "BBB@ HHHH **** "BBBF 4444 %%%% @I>U)10 444M !
M1^-%)0 OXT4E+0 4444 %%%% "TE%% "T444 %%%% !1110 4444 %%%% !2
MTE% A:*2EH **,T4 +1244 +1244 +124M !2TF:*!"T4F:7-, HHHH ****
M "BBB@ HHHH **** "BBB@0M%)10 M%)10 ZBFTM "T4E&: %HI** %HHHH$
M%)2YHH 2BEI*!A1110 4444 %%%% !1110 4444 %+244 +2444 %%%% !11
M10 4444 )12T4 )12TE !1110 4444 %%%% PHHI* %HI** %HI**0!1110
M4444 %%%% !1124 +2449H OTE+25T'$%%%% P-%!HI )1112&%)2TE PI*6
MDH&%)2T&@ I*6B@H2BBB@!#12TE( I***0PHHHH&%)2TE( I*6DIC"BBB@!*
M***0!1110,2BEHI )2444#"DH-% !1110 4444#"DHHH **** $HHHH ****
M!A1110 4E%%( S1124 %%%%,84444@"C-%% PHI*6@ HHHH **2B@ I:2B@
MHHHH ****0!1110 4444 %)2TE !1110 4444 %%%% !1110 4444 %%)2T#
M"BBB@04444 %%%% !1110 4444 %%%% !2TE% "T4E% "T4E% "T9I** %HH
MHH$%'-%% P_.ES244 +124M !1110 4444 %%%%, HHHH$%%%% !2TE% "T4
ME% "T4E% "T4E% "T444""BBB@ S1110 M%)2T %%&:* "EI** %S1FDI: "
MBBB@ HHHH **** "BBB@04444 &:*** %I*** %HI** %S1FDHI@+1FDHH 7
M-+FFT4 .HS244"%HI**0!1110 4444#"BBB@ HI*6@ HHHH **** "BC-% !
M1244 +FDS110 M)110 4444 %%%% !1124 +1244 +244M "4444 %+FDHH&
M&:,T44 %%%% !24M)0 4444 %%%% &A24M%;G$A****!A10:.U(!****0PI*
M6DIC"DI:0TAA1WHHH 2BBB@:$HHHH *2EI*0PI*#10 M%%% Q**!UI!4C"DI
M:* $HH-':F,2BBB@ HHHI#"BBBD AI*7TI#3 *3-%%( S1FBB@ S11104)12
MTE !1110 44=J* $HI:0=: "BCM1W- !24M)2&%%%% "444>M, HHHH&%%':
MEI )111Z4 %%%% !110* "DI?2CM0 4E HH **7O2=Z!A10>E'>D 44=J#0
M9HHI.U "T4E% "TE%% !11WH[T %%%% !112=J!BT4=J2@0M&:2EH&&:,T4E
M A:*2EH ,T444 %%':@T %%'^-% !1110 4M)13 6BD%%(!:*** "BBB@ HH
MHH$%%%%, HHHI %+244#%HI*.] "T9H-)WH 6BBBF 4444""C-!ZT4 %%%%
M!2YI** #-+244 +1FDHH 7-&:2@4 +1110(**** %HS244 +FC-)2T %%)2^
MM "YHI.]% "T4E'>F M%%% !1110 4444"%S1FDHI +FC-)10 9I<TE% !1F
MBB@ S111VH *6DHH ,TN:2BF M&:2B@!<T9I** %HS244 +124O:D 44E+0
ME%%%, HHHH **** "C-%% !1110 44E%(!:*0T=Z %HI** %HI** %S1FDHH
I 7FDS110,,T444 %%%% !1110 9HS124 +FDHHH **** "BBB@9__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>img88009329_6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_6.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +A!L(# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#R"BEHQ7H'
MF7 44AI0"Q"J"2>@'>F 4E=?H_PS\3:S$LT=GY$3='FR,UO#X(Z\1S=VO_?1
M_P *S<XKJ:*G)]#S*BO3O^%(:]_S]VO_ 'T?\*/^%(:]_P _=K_WT?\ "CVD
M>X>RGV/,:*]._P"%(:]_S]VO_?1_PH_X4AKW_/W:_P#?1_PH]I'N'LI]CS&B
MO3O^%(:]_P _=K_WT?\ "C_A2&O?\_=K_P!]'_"CVD>X>RGV/,:6O3O^%(Z]
M_P _=K_WT?\ "C_A2.O?\_=K_P!]'_"CVD>X>RGV/,:45Z;_ ,*1U[_G[M?^
M^C_A1_PI'7O^?NU_[Z/^%'M(]P]E/L>8FBO3C\$=>_Y^[7_OH_X4?\*1U[_G
M[M?^^C_A1[2/</93['F-%>G?\*1U[_G[M?\ OH_X4?\ "D=>_P"?NU_[Z/\
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MMO\ OH_X4O:1[A[*?8\ZHKT1_@[KJJ2MS;,?3<?\*YK6?!>O:"IDO+)C"/\
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MPH^PO_>%')(/:0[E6EJS]AD_O"E^PO\ WA1R2%[2/<JFDJW]A?\ O"C[ _\
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M.78/;T^YFTE:?]CR_P#/1:3^QI?^>BT>SEV#V]/N9M)6G_8TO_/1:3^QI?\
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MN#_RKZ/C%?./P;_Y'I?^N#_RKZ0BKEK?$=M#X2=13\4U:?6)N%%%% !1110
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M\N21TGMI/N3Q'*FDT7P]>:V[F$K%;Q_ZR>3A5I\RM<GDE?EL95* 68*HRQ.
M!WKJF\#M-$_]G:M:7LR#)A3(8_3-5O"6D->>((Q+/%;M;R M'*#ECGH*7M%:
MXU1ES)/J8$T4EO(8YD*..JGJ*O:EH]WI26S72J!<IYD>#VK?\>:,+75[N_\
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M91@&J@T;4M/=_P"R[I?))R(Y.@_&I],UBZ-^=/U&(1SXRI4Y#"B'NR7-=/\
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MZ&G)RS;BETU>R&?:=1T?48(KJ=;BWG.T-MP5-=-7&ZK!?1WE@U[<B0F9<*
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M?>CM@P_.IWM8JUN:Y1\?W32^(FLNEO:H$CC'04> +IX?$B6?)M[I&22/L?\
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MA56+_6?A5H5K YZVXX4X4T4X5H8A1110(**** "BBB@84444 %%%% !1112
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M 4444 (:8W2GFF-TH JO]\?6OEOQ1_R-6I?]=C7U(_WQ]:^6_%'_ "-.I?\
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M 4444 %%%% !1110 5A>+/\ D!RUNUA>+/\ D!RUCB/X4C?#?QH^I4\1;O\
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M110 4444 %%%% !1110 AIC=*>:8W2@"J_WQ]:^6O%/_ "-6I?\ 78U]2O\
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MUXTD&'16^HIJ0Q1_<C5?H*DHI60[O8.M1&WA9MQB0GUVU+10TGN";6P@ 48
M 'M2/&D@PZ*WU%.HHLA7&)#'']Q%7Z"GXR.11118+W(OL\.[=Y29]=M2!5!R
M  ?I2T460[MC'BCD&'16^HH6&-5VK&H'IBGT46078A52,%01Z8I:**8AK(KC
M#*"/<4U((HSE8T!]A4E%*R'=A534U+:=.%!)*'@5;HHDKJP1=G<QO#]M_P 2
M.W2>(;@O(8=*UDBCC&$15^@I^,45,(**2*G4<Y-]Q" 1@C-1_9H0V[RDSZ[:
MEHJK)DIM;"8&,8XH"A1@  >U+13$(5#=0#]:6BB@")K>%SEHD)]Q4BJJC"@
M>U+12LAW;$VJ#G SZXH(!&",TM%,0@  P!@4;5!S@9]<4M% "%0PP0"/>C Q
MCM2T4 1&VA+;C$A/KBI  HP  /:EHI62'=L8\22##HK?44+#&@PL:@>@%/HH
ML@NP  & ,"D(!&",BEHIB&-#$XPT:D>A%"1I&,(BK]!3Z*5D.[V,?5M86SW6
MZ1N\[+\H5?6I-"L6LK >:/WTA+O]3S6D44MD@9IU9JF^?F9HZBY.2*]0HZT4
M5J9$?DQ?\\T_[YH\B+_GFG_?(J2BE9#YF(54C!4$>F*7H***8A"H88(!'O0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** $-,;I3S3&Z4 57^^/K7RSXI_Y&K4O^NQKZF?[X^M?+/BG_ )&K
M4O\ KL:VH[F%?8R**6DKH.86EI**!6)8/]:*N"J<'^M%7!6L#EK[CA3A313A
M6A@%%%% @HHHH ***2@!:*2@4 +1110 HHI*6@ I:2EI@%%%% A1112B@04H
MZT4HH$%**;Q3@:$)BTM-'6ES5"'=J:32$TM(04ZD%+0 HIV*0"G=J9#8"E[T
MHI.^.IHDU%7EL$8N3M$7.*549O9?6GK%_$W7TJ3O7EXC'->[3/9PF6?;JB!0
MHX'XTM+17ERE*3NV>U""@K1$HI:*10444A- "T4@-+0 M.%,IPH =FG"F"G"
MD!(*>*8#3P:!D@IXJ,5(M2-$@J05&*E%24.%2"FBGBA@.%2+35%.%2P&O"DP
M(=0?>LVXTUXP6B^9?2M<=:=750QE2B]'H<6)R^E76JU.9Q@X(P?2M:$#2;+[
M0X'VR88C4_PJ>]:T.E02@WLZ[4C^Z/[[5SNH&XDO'DG!!8\>@'I7O4,5"OY,
M^7Q6 J86[W17)+,68Y).23124ZN\\R_42BEHI"N)12T4Q7$I*6BD-,2BBBD,
M2BEI* &GK13J::!A0:** &T4ZFTAB&B@T4 (:*6D-!0AHI:2D 4AI:0T#"DI
M:2@ I#2TAH*"CM110 "BBBD E%+24#%---+VI#0 QJR;[_CX_"M9JRK[_CX_
M"L:VQVX/XRK24ZD-<QZ@F**6B@#+HHHK8Q._^#W_ "/"_P#7!_Y5]&1=*^<_
M@]_R/"_]<'_E7T9%TKBK_$>AAO@+"T^F+3ZQ.@**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH JP
MG-W-[8_E3YCB:(>I-0P-_P 3&X7Z']*?='$\!_VC_*@"U1110 4444 %-D^X
MWT-.ILG^J?\ W30 RV.8%-2U7LCFU0U8H *JJ?\ B8L/]D5:JD#C5<>J4 7:
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH 0TQNE/-,;I0!5?[X^M?+/BG_D:M2_Z[&OJ9_O
MCZU\L^*O^1JU+_KL:VH[F%?8R****Z#E"BBBF,F@_P!:*N"J<'^M%7!6D#DK
M[CA3A313JT, HHI*! :***0!1110 4"B@4QBT444 %%%% "T4E**8A:.] I1
M0(*44E**!"TO:DHH$=#I]E:2^&[NZN+)AY?W)QW;L.E:=GHM@WA*/5#!YUT%
M/[H'EN>M<NFIWB61LUF/V<]4QQ21:A=PA%CG=0@PH!X%0X29HJD5T.P3PYIK
M31R;TR;3S/L^.2W-9>MV]O:Z#9_\2_R;N;YC(%XV\8_.L/[?=><)O.;S NT-
M[>E.NM4O;R%8;B<R1K]T$=*2A*^XW4@UL5*44"E%:G.Q:<*04X"@EL44M)FE
M +-M7KW-$I*"O(<(2J2Y8[@,DX'6IDC"#W]:5%"# _$TZO$Q6*=1\JV/H\'@
MHT5>6X44M%<1Z 4444 %%!I* "BD)I* '9HS3:* '4H--%+0 ZG@TRG"@"0&
MI :B%2"D,D6I5J):E6D-$@J45$*E%042+4BU&M2BA@/6GCK3!4BBI 4=:LV=
MJ;J<+]U%Y=O05"B-)(J*,L3@"K]Q(MM +2$\GF1O4^E"'KT&7EP)F$<0VP1\
M(O\ 6JDL"3IL<9'K3QTIP%"G*,KQ)E3C.-I(YZ[L7M6R!F/L:JUU90.I5@"#
MV-8E_I[0'S(^8SV]*^@P68*I[E3<^5S+*72;J4]BA124N*]<\ 2BEHH$)28I
M<44#0E)3J2D,2@]***0QM!Z4II* $H)H-&"2 !DTAH*0U;&EZ@>19S8_W:9)
M87D17S+:5=QP,KUJ>=%\DDKV*U%*RE6(8$,."*2J)$I*4T4#$I*EAMY[I_+M
MXGE;T49I]Q8WEF/])MI(O=ABI<E>Q?)*U[%>D-+13)$I*4TJQ2.C.J,57[Q'
M:BY23>PVDHI[12(BNR$*WW2>]%QJXRBBB@ HHHH ****0P---.--- #&K*OO
M^/C\*U6K*OA_I'X5C5V.W!_&5J,4N**YCTQ,44M% &31116QD=_\'O\ D>%_
MZX/_ "KZ,BZ5\Y_![_D>%_ZX/_*OHR+I7%7^(]##? 6%I],6GUB= 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!GH=NM.O]Y,_RJ34#M\EO1Z@NCY>LVK=G4K^M6-1&;-B.H(/
MZT 6Z*9"^^%']0#3Z "BBB@ IDO^J?\ W33Z9+_J7_W3_*@"#3CFS2K54],.
M;%?K5IG52 3R>E #JH3?)JD#=F4BK]9^H?+/;/Z/C\Z - 44@Z4M !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 (:8W2GFF-TH JO\ ?'UKY8\5?\C5J7_78U]3O]\?6OECQ3_R
M->I?]=C6U+<PK[&12YI**V.86BBBK E@_P!:/I5T51@_UH^E716D#EK[CP:7
M--%.JSF"BBB@ HHHH ****!A1110 $T T44QBT4E% A:44E**$P%%+2"EIDB
MBCO0*44$A12CK0.M A:!UI:*8A":2@THI **=2"KNGW%M [)=VXEA?@D=5]Q
M3%NRJ*=6A=Z4T47VJU?S[0]".J_45G9X^M%U:[$XMNR#DG:!R:L1H$&!U[FD
MB38,G[QZFI!7B8O$NI+ECL?18'"*E'FENPHI:*XCT=PHHHH *#2$TF:  FC-
M%% !0!2XIP% #,4H%.( ZD#ZU&]S GWI5'XT6 >!2XJO_:5HO\>:4:E;'^*B
MS L@4X"H4O+=^CU81XGZ.#^- "@4]13@HQQS3U6IN58114JBD"U(%I-@@ J5
M:0"I%%2RARU**8HIXI,!XJ1>E,%2IUSBD,LQ/]GCW#F5NGL*C'/).2:;R3D]
M:>*3 !3J!3A2* 4I0,"I&0>U+2BA-IW0I)-6,#4=.,#&6,9C/;TK/KKV174J
MPR#UKG=1L3:R;E&8FZ>U?19?CE/]W/<^2S?+/9/VM/8I44E+7KGSXE)FG4V@
M$!Z4W-:5MIO[K[3>/Y-N.Q^\WT%.;4+!3B/3E*C@%B,FHYNQHH=V9>129YK4
M.H6>/^0;%^E)_:-I_P! V+]*+L?+'N9A(I,BM3^T;7_H&0_I2?VE;#_F&0?D
M*5V-1CW,O-*"5(8<$=#6B^I6[(0-.@!(QG XK.[DU2U)>FQV7A'6=0N;NZCF
MN"ZI;DJ"!P<'VK-T;5;V_P#$-I%=3F1!)P"!ZU)X)_X_[[_KV;^1JAX:_P"1
MHM3_ --/ZUS.*NSOC-N$+L@U6UN/[3NY%MY/+$A^8+Q5!5:1@J*68] !7:VO
MB"_N?%QL)60VCR%&B"\$4:/96]K_ &S=+(L,L$FV-RN[8..WXT*KRK4)8>,Y
MOE9Q<UO- 0)HGC)_O"G6=L][>PVL?WI&VBNJU'4+.YT":*[U$7MT"#$_ED$>
MV:YS1KM;'6;2Z?[L;C=5QFY0;1E.DH5$KF_K&K_V"_\ 9&D*L1B&)9L99FK-
MB\5:@+>2"[*W<3J1B0=/RJ3Q;I\MMK,MTJE[:Y/F)(!D?G6''!-/N\F)Y"HR
M=JYQ4Q4>6[-*LYJ3BM@2&6XD(AB9SUPHSBF.CQL4D1D8=0PQ75R74V@>&[*7
M3L)-<DF6?'(()XS4EQ&FMZ9I=[?*J7#S^6\F,>8O%+VK70%AKZ)ZG)K:W$D9
ME2"1HQ_$%XK>T)2_AK60$W-@8&.:N:SXAU#2M9DL+)5CM8?D6'9PX]?>CP[?
MSVNDZW>+&JS==I7@'Z4I3;B73IQC.QR4UM/ H,L+Q@CC<,9K?UH8\,:0< 9#
M9_2KD&HW.O>&-3_M%A*T #1L1RO(I)8([S3/#D$OW)'PWT^6AS=U<J-)6=NI
MRRVERT1E6WD,?][;Q3(XI)GV11L[>BBO1+N_CT_5_L[:JD5I%A3:>2<$8^O-
M8MI&$U+4=2TZ\%GIZ'&_:<_0"A5[BEAK-69RTL$T#;9HFC;T88IE=?XHDCN_
M#MA=BX:Y<NR^<RD$CCUKCZTISYE<PK4_9RL+1116AF!IIIQIII ,:LR\&;C\
M*TVK-O/]?^%8U=CMP?QE;%&/>E-%<QZ8F**6B@#&HHHK<R._^#W_ "/"_P#7
M!_Y5]&1=*^<_@]_R/"_]<'_E7T9%TKBK_$>AA_@+"T^F+3ZP.@**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH RM9/EFVG_YYRC/TYJ_*OF0,OJM5M7A\[2YP!\P&14UA,+BQAE_
MO+0 S37W6:J>J'8?PJY6?:_N-1G@/1OG7^M:% !1110 4R7_ %3_ .Z?Y4^F
MR?ZMO]TT 4]*/^@K_O&KI4$@D<BJ.D_\>7T=A5V0E4)49([4 -24,[*,_+53
M5N+17_NR*:M0L73+KM;TJ'4DWZ?,/12: +,9S&I]0#3J@LW\RTB;_9%3T %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 AIC=*>:8W2@"J_WQ]:^6/%'_(UZE_UV-?4[_?'UKY7\
M4_\ (UZE_P!=C6M+<PK[&713:*W.8=1Q110 ^#_6CZ5=6J4'^M_"KJUM#8Y:
M^XX4ZFBG5H<P4444 %%%% !1110-!1110,**** "BBB@3%I124HH0@IU(*6J
M)N**44@I10(44O:D%+VH0A:#1VI#3$)3@*04X4 Q0*<*2G4R&RS97T]A+OB;
M@_>1N58>XK1%I::N/M-E^ZN?XK<]&]UK% +L$'XU:4M&04)4CH17FXVMR^Y$
M]?+</S?O)#G5HW*.I5AP0:2KXNH[U!'=C;*/NS#^M4YH'@?#<CLPZ&O(/=&Y
MHS24F: '&FFC-% !112@4 &,TO:H;F\ALX]TC<_W16!=ZK<79PG[N/T%5&-Q
M-V-JXU*UMLY?<P["LR;6YY"1"@5:SEB+')YJ=8<8XK3E2)YKC7FN)CEY6_ T
MHASW)^IJY#:22'"(3]!6G;Z#=2XRFT>IJ7)(%&YC+;X[5,EO[5TD7ALX_>3#
M\*M)X?@7K(34NHBE!G+K;$U,D!'0D5U T.W_ +S4O]B1=I"*GVB*Y68,33)T
M8GZU?BNST=?QJZ=%8?=D!J-M-E3JN1[5/,F.S)8RD@&TU,$JFL+(>,@U<AD[
M-4L:'A:>%J4(".*<(ZBXR-13P*?MI0M%QB**D% &*<!2 4#FGBFBGBD,6G 4
M@%/ I# "EH YIU( Q3)84GB:-Q\IJ2EJHR<7=$SIQG%QELSDKJU:UG*-T['U
MJ&NHO[,7=N1CYUY!K#MM-EG9FE/DPK]Z1OZ5]5@<6JU/7='PV98"5"KHM&58
M89+B410H7<] *T1':Z2,R;;B['\ ^ZGUILVH1P1&VT]-B]&E/WFK-R2<GD^I
MKKUD<%XPVW)+FYFNY3),V3V'8?05#3J3%6E8S;;U&TF*=10 TTE./2DH&F-Q
M0>E.I#0,N:9JDVE32R0*"9$*'/I4-C>26%^EY& 70Y /2H**GE6Y:F[6+<.I
M36^KC4E4&4/OQVS4]IKUU9ZC/=JB.+@_O8G&5-9M--2X)E*K-/1FKJ.M"^MQ
M!%86]NF<DH!D_CBLCO3J2FHI;"E-R=V;.G>)[RPM_LTD4=U;CHDP!Q]"0:EN
M_%EQ+;M!:6=O:(XPQC49/Z5@TE3[.-[FOUBI:S9K:9X@GT^V:VE@CNK=CNV2
MCH?:H=4UNZU2:)F588X?]7''P%K/-)1[.-P]M.UKG0IXPG\M#-8VTUP@PLS*
M,_CQS6:FLW$=O>P[5(O.9#C&/I6?125.(W6FRY::G-9V-U:(H*7  8GM23ZK
M<36=I;<*MJ<QL.O;_"J=)3Y4)5))'1?\)<[QJ;C3K::X5=HF91G\>*I:=K\U
M@UPK6\4T-P<O$PXS[<5E4E+V<2_;SO<U=4U^?5+2*U:"*&&(Y18QT_2LFEHI
MQBHJR)E)R=V%%':BJ) TTTXTTTAC&K-O/]?^%:35G7G^N_"L:NQVX/XRMBC%
M+17,>F)12T4 8M%%%;F1W_P>_P"1X7_K@_\ *OHR+I7SG\'O^1X7_K@_\J^C
M(NE<6(^(]##? 6%I],6GU@= 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%&: "JUQ?VMH,SW$<?LS#-8>IZS<W=X=,T<!YAQ+*
M>D8J6S\*VD?[V\:2ZG/+-(Q(S]* )9/%>E1])F<_["$_RJN?$TMT=MAIT\A/
M1G!4?J*V8].LH@ EK"/^ "K"HJC"J%'H!B@#G?)\2W7+3P6JGL%R?T-+]B\1
M6XWQW\4Y'\#(1G]:Z/%&* ,G2M8%[(]M/&8;N/[\9[^XK6!S6#K]FZ^7J=J,
M3VYRV/XE[_UK6LKJ.]M([B,_*Z@T 3.H>-E/0C%96@N4AGM6ZP2%0/:M<]*Q
M8C]F\2S)_#/&&'US_P#6H LWW[F[M[D=-VQOQK1!R*IZC'YEA)CJHW#ZBI;.
M3S;6-_5: )Z*** "FO\ <;Z&G4C=#0!0TC_CT<>DK?SJ\TBH,L<5GZ2?W<Z^
MDS?SJQ*P-VD9&1M)Q0!87#88'(--F3S('3U4BJU@S-;'!Z-BK2NK$@'..M %
M/2'W6"CNK$?K5^LS2?E>ZB/\$G\^:TZ "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0TQNE/-,;
MI0!5?[X^M?*_BG_D:]2_Z[&OJA_OCZU\K^*?^1KU+_KL:VI;F%?8R:***V.8
M=129I>U #X?]:*NK5*#_ %HJZM;4]CEK[CA3A312UH<PM%%% [!1110,****
M "BBB@ HHHH *44E H$Q:44E**$(44M)2U1(HI12"E% A:7M24HZ4T)B]J;3
MCTIM#$A13A2"G"A"8X4I/&:04JKYD@7MU-34FH0<F52INI44$30)M7<>K5)2
MT5\Y4FYR;9]92@J<%%!4L<[(GEN-T?H>U149J#0<ZC[R'*_RIE&2.129R: "
MEI*<* % XK.U'54M08XOFE_E3=5U,6ZF&$YD/4^E8*(7;<QR3W-7&/4EL5C)
M<2%Y6+,:F2'VJ6*$D@ 9)Z"NDTSP^6 ENLJ.H2J<U$239CV>FSW3!8D)]STK
MHK/P[%$ ;AM[>@Z5L1Q1PH$C4*!Z"G UA*HV:J%AL4$4(Q%&JCVJ0$T9HS6=
MRAP-+3<TN<T@'BE%-!I10!(*4&F@TZDQ@T:/]Y0:B>R4\H<>U3BGBBX6*L:M
M&<$<59" C(IV >HI47::3'89Y?M1MQ5G;D4WRZ L0XI0*DVT;:+A89BG@4N*
M4"D, *<*3%.%(!12XI *<* #%*!2TM)C'PM&D@:5-ZCM6/XC6:XVS@XB''EC
MH*UL4V2)98VC;HPQ75A:[I5$SCQV&5>DX]3B:*FNX&M;EXF'0\?2H<U]A":G
M%2CLS\^JTW3FXRW04=J3-+FJ($Q24M% "&FTZDQ2&)1110,2DIU-I#3"D-+2
M4#$HI:2D,2D-+10,2BBB@:$-)2FDI#$HHHH&A.]%%% Q****0T%%%%  :::<
M:::!C&K-O/\ 7_A6DU9UY_KOPK&KL=N#^,KT445SGIA1112 Q:*6BMS([[X/
M?\CPO_7!_P"5?1D72OG/X/?\CRO_ %P?^5?1D72N+$?$>AAO@+"T^F+3ZP.@
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L+Q'J<
MEK;I:6O-W<G8@';WK9GE2"%Y9& 1!DFN:T*%]6U2;6;A?E!*6X/8>OZ4 :VB
MZ3'I5DL8^:5N9'/5C6G110 4444 %%%% #74.A5AD$8(KG;=FT#4S;29^PW#
M9C?LC'M7256O;*&_MFMYUW(WZ'UH G!! QR#WK&U;]SJNGSCNY4_E5)-6ET"
M86=\QGB/^J>/YF ]"!DU+]H;7=2MS#%(MK;G>SNI7)QT&: .B90RE3T/%4-)
M8B&6$_\ +-R/SYK0K-T__C^O,=-X_E0!I4444 %(:6D- &;I7W[H?]-F_G5N
M2/$ZR^@P:IZ9Q<7B_P#30G]36B[[%R03]* *MJ/)20L,!GR*LI"L;,R]6ZTK
M$ #(S3Z ,N']SKDZ=!*NX?A@5J5E:E^XOK2Z_A#;&^AK5!R,T %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%('5B
M0&!(Z@'I2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% "&F-TIYIC=* *K_?'UKY8\4_\C7J7_78U]3O]\?6
MOE?Q3_R->I?]=C6M+<QK;&11FBBN@YK"TN::*6@+$L'^M%715*W_ -:*NK6L
M#DK[CA3A313A6A@%%%% !1110 4444 %%%)3 ,TN:2B@!:!0*44A!2BDI0*8
MA>]+2=Z6F2**!0*!0(=3A3>].%-"8AZ4@ZTII!UI"'#K3Q313A3);%%36Z?(
M7/>H",C ZDXJZHV@ =A7GYA4M'D1ZN54KR<V&*7M2TE>.>\)24M(: $HHHQ3
M 455U&]%G <<R,, 5:9UC1G?@ 9KE[B9KRY,AZ X7Z4X*[U);(E1I'+MDL>I
M-7;>W9V"HN6/040PDX '6NOT;2EMHUGE'[UN@/:JG*P1C<-)T=+1!+, TIYP
M>U:YI>_M337,W<V2L%%(31FD N:,TW-&: '@TH-1YQ3@: ) :>*B%/!I 2"G
MBHQ3P:0Q]/%,%/'6@8ZG4T4ZI D1MIJ7 (XJ&GHQ4^U#&.*4W;4^ 1D4TK2
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M"EY?:AX>M;W4'1IYT#G8   1G%;=8L-Y=P1+%%I$B(HPJ@C@?G4G]I:A_P!
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M#MZG%6<5X.,GS56?39?3Y:*&8HQ3\4VN0[1I%-(IYIM "8I0*,4X?*"3V&:
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M\JZ'(QP&/O0!M YHK)T74VO(C!<+Y=W%PZ'^=:U !11443[F93U4T 2T444
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MO&L@PZ@CT(H 5/N#Z4M%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^(]##? 6%I],6GU@= 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@#8NU"?92/X6Q^E:%4]0'[N,^C"KE !1110!'+@K@C/IBH/LSS,#,V4'1/\
M&K6*6@!,8&!67C['K/I%<#_QX?\ ZZU:H:M"7M/,0?/$=X_"@ U:U^U:=*@^
M^!N4^AI^F7/VNPBES\Q'/UJ6WE6XMDD'(9>:S-.;[#J<]B_".?,B]QZ?I0!M
M4444 %%%% !1110 5DZM;M$5U" 8EA^]C^)?2M:FR*'0JPR",&@!L$JSP)*I
M^5AD4VX@$RC^\IRI]#6?I+&WDFL'/,1RF>ZUK4 5#%+)<1LZ@!.ISUJR64G8
M<9]*0,V3D8'8U&[1++N;[P'6@!&BD4[HR/H:B%M--*K7#@HIR$4=ZN*0RY!R
M#2T  KQ+Q)I>MS>+-0UBQ@EW3L+ C:?N,2I;\J]MIF%!Q@?E0!XCI>F:YHR6
M]C9V\OFVH;8Y4XR23U_&F6YU>357O;#^T9+I;0++)<(V5.X[@N0.U>Y;!G.!
MGZ4@C0=% ^@H \)6SNK[49I[>+4+A2;;+W2-NW#.>H'%:FD3>,G\80Q333Q@
M2@,I0F,QXZ9Z>E>MW43_ &=Q;E(Y/X25&,U5TW4EN93;W"".\3[R^H]10!PW
MQ'G\21:G9IISSI9%.6A!)W\]<=NE8NK7'B**)!JMQJ)F^R VS6BMAI-O\6 >
M^*]E*@]0#]:"BG&5!QTR* .!^&\>JS+>7>K2W1ERJQK-G &T9X/O7?CI44LT
M-LFZ1E1?4\5ES>);*-L1[I,=2HXJ)5(1W9482ELC9-<MY?V35+BW;A7.]*Z*
MTNX[VW6:(Y4U2U>P:ZB6:'BXBY7W]JQQ$/:0NC2E+DEJ9%FBQK,5& 7)J_X<
M3,-Q.>KR$?D:SK&7S89@5*L"0RGL<5=\-WD?D/;$[9%D;@]^:XL+95%<Z:]W
M'0Z"FR2+&A9R HZTK$*,GH*PKN=KR3!.(0> .]>A5JJFKG'3@YLSM3?[0LUP
M!A2PQ]!3[OFQ1O0 T^^3=8RJ!T7BFJ/.TT#U3%>1)W;9Z,596+"ED=)HSAP/
MS%;%O?Q2I\Q",.H-8=JWFVJ'/..:;)&#,BLQQUK:E7E3,JE)3+MQ+YUPS#[O
M04_2$W7,\OI\HJOC P.E2Z7>QP02"17&7^]CBKHR4JMV345J=D;M%9TFM6<2
M[B]$>HR3KOAB!4_WCBO0]I':YR<DNQHU6OXO.LIX\?>0C]*@-U=X_P!2G_?5
M)]KN^\"$?[W_ -:CVD1\C*]MJ$<.C1S2D?*"O/L<5F?VEJM\Q-K:1QPGHT@Y
M/X53LEN9KV>*>W8Q6\F50<@D\\_G6V&O7P(X%1?]HUS5)RE*RV-H126IF26N
MNGYEE@!_V5Q_6H8]6UG3&_TZW+Q_WX^?TK;$.H=?-C^F!36>_B'[VW25.^TY
M/Y8K/EDG=-E<RV9+I^O6M\  X#?E^E:X(/(.17(7.D6NH%I].D\B[7DH.,_4
M4[1]=F@N/L.H+LE7J#_,5M"NT[3,Y4T]8G744U6#J&4Y![TZNLP"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH 0TQNE/-,;I0!5?[X^M?*_BG_D:
MM2_Z[&OJA_OCZU\K^*?^1JU+_KL:UI;F-;8R****W.<2EHI* )8/]:*O#I5*
MW_UPJZ.E;4]CDQ&XX4ZFBG5J<P4444 %%%% !1110 4444 %%%% !2BDH%(!
MU%(*<*8A:6DI:9(HI12"E% A:44E+0)BCK3J:*=3)"E[4E+0U= G9IG26WS6
MT;>U3;:KZ6WF62_[/%7,5\M67+-H^PP\N:FF,V^U&WVJ3%&*RN;$6VE"U)MI
M0M #0.:E";E(I M31K0!%;H4<5?Q4)3#@BIP.*ELJPF*3%/Q12N S%&*?1BB
MX#0*D7BD IX%( DZ;NN.M0_:81R7 ]C5@#(K*U"R=P6C'--:@07U[]J<11YV
M#K[U+IP1PQ'.WCBN?:QUB:?RD 1">6 [5V&FV*V5FD75L<D^M7*R6A*U9*D>
M!S4@%.V@45D6 %+BBEQ0 E*!2@44AG/^*>+>(UDZ)<GS@N>]:'BR0 0IWY-<
M[I$I6_ ]373%>Z8R?O'I$?S1@^U.Q3+;F%?I4N*YC80"E%%** #%8'BCB&$^
M]=!7.^*SB"$>]5#XB9;'+^;M?K6M83Y(YK!E;%7-,G^<#-=,E=&29WMDVZ,5
M=K-TQMT8K4KEEN;K8;BBG4X,!V%(8RBI!,1_ OY4\7+#HB?E0(@'/8TN#Z'\
MJL"]D'1(_P#OD4OV^7TC_P"^!1H%V5\-_=/Y5YUXYAE&LQLL4ARG9":],^W3
M?['_ 'R*X3QSK5];7\"Q-& 4[Q@UW9>TJNAY^9).CJ<4L-P?^7>;_OV:D%O<
M!2QMY@!U)0U-_P )'J?_ #V0?2,4CZ[J$R%'GRK<$!<5[Z;/F7"-B$&MCP[I
MT>JZLMO.^R( LWOBL)6YS5FVNIK699H)"DB]"*O=&224M=CK;/0;>7Q=]@G4
M);21ET]AV)JX^@V+2ZA;*GD"WCRD[\ACQS7'_P!I7;737)G;SF!4M[>E2MJE
MY+"89)V9",$'N*3C)]2O:4UT.RBT2QMKQ(VM1<P"V\R251WYZ5R,S(UQ(8T*
M(6.U3V%2V^N:C;KMCN"%V[<$9X]*JM(TDC.QRS')JX)IZF-:<9+W24&G XJ)
M33P:V1RM$F:6F TX&F386DHHH 0T444#$I*6DH&A****0T)1124%!1124AH*
M***  TTTII#0,C8UEWW^O_"M1JRKW_CX_"L:NQVX/XRM12TE<YZ84444 9U%
M%%;F)WWP?_Y'A?\ K@_\J^BXNE?.GP?_ .1X7_K@_P#*OHN+I7#B/B/1PWP%
MA:?3%I]8'0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5RNL_-X
MOTM?0,?Y5U5<IK/R^,-,)Z$,/Y4 =71110 5S6I#=XRTT>D9/ZUTM<]J QXN
MT]O6,C]: ->_'[@'T8?SJR.E07HS;'ZC^=3K]T4 +1110 4444 %(P!&",@T
M,P52Q. /6LUI[B_<K;'RX0<&0]3]* &6L@T^\:TD8")SNB8G]*GU&P%[&K1M
MLGC.Y'':HI="M9U'G/*[ Y#%NAI%>\T_B0&X@'1A]X#W]: $M=6PXM[Y3#..
M,G[K>XK5#!AD$$>HJH?LFIP895D7^ZPY'X50DAN-';S8&:6T'WHCR5'M0!MT
M5%;SQW$*RQ,"K#(J6@ HHHH **** ,K5(GAEBOX1\T9PX'=:T894FC61#E6&
M0:<ZAE*D9!&"*R(7.D7)@DS]ED.8V[(?0T :KHYE5@V%'4>M,E@+MN4X.,&I
ME8, 000>XI: &11^7&$ZXIYHHH BC61=V]LY/'L*<\BKUZTX]#BJ=N_F":,\
M2J2#_2@">*YBE)"N"?2FW#LFT@GKV[U7>)2@8KMF0\,.]7A]T$T "_,HR.M4
M=1TU;M5>,^7<)RDB]15M9T9]HI2S;\;?EQUH S]/U)I)#:7B^7=)^3^XK3/2
MLN]M4U%>/DF3F.0=5-)8:A()?L5\-ERHX;M(/44 8/B)Y&U4HS'8%X&:RB0!
M6UXG3;J,3_WDK%QSFO#Q%_:.YZE"W(C7TS7186?D"!F8-G/:KTWBA J^3"6)
M^]GM7-@Y]Z6G'$U$K)B>'@W<V(+J*?49S%T?YL>]10[8-0FA=MN\[T-9EO(;
M>991V/-:.JVHO;5+B'_6)\RD=<5GSMOFZE.*6AL-?S);M%(-X(P'%0HZ,!M8
M&L2SU9XD GR\?3=W'UK7589UWICGN.M7*JY[DJFH;$KKO0KZC%5-.;_1S&>J
M,0:FR\!!8[H_U%5X'6&]FC<XWD,I/0U(^@ZW/D74D#<*WS)4\ZA@"&PZ\BH-
M0"B)9,X=6&VK)Y0$KEB.E %<W\:9$@(?T]:;874UHY&-R3'@-_":E2V7?OD
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MY5]%Q=*X<1\1Z.&^ L+3Z8M/K Z HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "N5\2#R_$&D3=MY7]1755RWC,;([&Y_P">4Z_S% '4CD9HJ.%M
M\,;>J@U)0 5A:JNW7],D]]M;M8^NKM-I/_SSF!_0T :-V,V[?4?SJ6/[B_2H
M[CFV/X5)'_JU^E #J*** "BBHYI!%$SGH!0!3NBUU<"T0X0<R$?RJ[&BQH$5
M<*. *KV,12+S&^_(=S5;H *,444 9]U8G?\ :+7]W,.PZ-]:DM+M+M61AME7
MAT/:KE96J6<P(O;+BXCY*]G'I0!$P;1KHR $V4I^8?\ /,_X5L(ZR('1@RD9
M!'>L_3]1M]5MB"H#]'B;J#49T^YLG+V,H,9Y\E^GX4 :U%90U:2([;JSDC/]
MX8(JPFK6;_\ +8 ^A!H NT5"EU!)]R5#^-2A@>A!^E "U'-#'/$8Y%#*>H(J
M2B@#+&FSVY/V2Z95_NN-P_6G;-5SCS8@/7 K2HH SC;ZBHW+=*S?W2@ -.MM
M0WR>1<KY4X_A/1OI5^H+BTAN5Q(H/H>XH FS52XMG,HN(#B4<$'HPJL1-IC@
MEVEMCP<]4K0CGCE4,C@@^] $,2S2N'G4+MZ*#FK9IID4=6'YTTSQ#K(GYT "
MQ*K%@O)J3%1B:(])%_.G;U/\0_.@ "*I.% SZ"JM_I\5]%M?*NO*2+U4U;W#
MU%(6'J/SH Y+48[BYV6MSA;R/_5-VE'^-8<A/"'*G<%8=QS7>:E!;7%JPN"%
MV\J^>5->=/>EM1FAN3PQ_=R]G_\ KUYN-IQ3YEN=N&F[<O0WCI5M)<I%;EP%
M&9#G-0-IMR)76--RJ< U<\..?*FC=MSJW7VK4C(:Z<K]T#!^M8*$9),U<Y1=
MC#&C7/E%F*K@9Q3=/O?);R93\A. ?0UI:ZTRV&8B0,_/CTKGP 5&.1651*#L
MBX-R6I>U'2V!:XM!G=RR>OTIVF2"YAS$VRXCX=/7\*;::BT&(YLM'V;TJZUG
M!<.)X)-C_P!Y.]2NZ&^S'M]HE78R*H/4YJ26VCFC"R#..A'45787-HOF&7SD
M'W@>H%7$<.@<'@C-6B2O'811N&)=R.FYB<588GL!FG4R0;ACMWHL!4EW2G D
M.!]YAP!3@K.N?NQ@?>/4U,(0<9Z#HM$PRA!X7O0,J:>0EY*L:DR-_J\]/K73
MV=LMK#CJYY9CW-8FD3+]N560!F!Q[ 5JZI=&&$11G][)P/8>M>A0:C3YF<=9
M-SLBM>Z@\CFWMC@#AW]/I52.)8QQR>['DFE2,1H%'Y^M#R;, #+'H*Y*M5S=
MV;P@HHHZRO\ H'FCK$P>KJ2QNBL&'(]:KW5MY]I*DAR67I3-+"2Z9"Q7D+@U
MGT+ZE[@CBF2Q)*N&'XCJ*:82G,;8]CTIT<@<=,,.HI7&10RW27 @FO"D9_U;
M8_0UI"WO%^Y?@GT*BJ4T0EC*GKU!]ZNZ<T=Y:[95_>(=K<_K770FY>ZSFJQY
M=4174&JRVTD+B&>-Q@YX_I53PE/)%'/IT_$MNV,9[5K/IBGF.>2/Z&L-+=]+
M\61%IFD6Y3!)]>:VDG&:D9I\T7$ZT4M-%.KL, HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH 0TQNE/-,;I0!5?[X^M?*_BG_D:]2_Z[&OJA_OCZU\K>*3
M_P 57J7_ %V-:TMS&ML9-%%%;G.%%%+0 ^#_ %HJ\.E48/\ 6BKPZ5M3V.3$
M;CA3J:*=6IS!1110 4444 %%)10 M)FBB@ HHHH 44"@44 **6D%+0(!UIU(
M*6@0HI12"E%,0HI::*=02**<.M-I1UIH3'TM-%.[4R6*IVD,.H.:["TE%Q:1
MRCN.:XZMWP_<CY[9C[K7G9C1YJ?,MT>GE5?DJ<CV9N8I<4[%&*^?N?2C<4N*
M=BG8H 8!4@%&*4"D,>O%6(S4 %2IQ2&221Y&X=:B JRA]:9+'M^8=#2 BQ12
MT8H *44 <T[% ""EHI<4  I:!2TAA112XH 2EHI#0 M<GXKU0<64;=.7(K7U
MK5TTRV(!!G8?*/2O.;NY>61G9LECDFMZ4+ZLRG,@FDYZ\5UW@RR)#3D=>E<?
M#"UU<)$HR6->L:+8K96*(!SBM*TDE8B"UN: %+12XKC.@**** $R!R>U>;:O
M<_:-1G?_ &L5WVJW(M--FEST7 KS*63<2QZDYKHHK6YG4?0@E;WIMH<W:CWI
MDK4_35WWR?6NE[&*W/3]$7%LOTK8JAI4>RV7Z5H8KSYO4ZEL)112XJ1B4N*,
M4N* &XHIV** &XS7F7CQPVO!?[J5Z>.HKR/Q?-YWB.X(Y"X'Z5Z.6J]6YYF9
MRM2L81IA-.)IK5[C/ 2 'FI4-0=#3U-"8-%I6J9355#4RM5IF,D65-2J:KJU
M2J<UHF82B3J:D!J%34BU=S)HE!IX-1 T\55S-HDHIHIU,0O%&:2B@ I*** $
MHHHH&(:2EI*"@HHHI )1110,#333C330,C:LN^_X^/PK4:LN^_X^/PK&ML=N
M#^,K9I*6BN8],2BBB@#.HHHKH,#O_@]_R/"_]<7_ )5]%Q=*^=/@]_R/"_\
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MWIH74<K9.",$5%,"C"5>WWOI4CC&&[TKC<A'J*0Q<Y (HLG,.J[>BRK^HJ.
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MPH FHHHH **** *NH+NL9O4*34EJV^VC;U447G_'G-_N&HM-.;",T 6Z***
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M72N'$?$>EAO@+"T^F+3ZP.@**** "BBB@ HHHH **** "BBB@ HHHH ****
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M']QO^^C_ (T :'VJ#_GJGYT?:H/^>J?G6?\ \(]8?W&_[Z/^-'_"/6']QO\
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M LHFW89&4\>U;XZ5T61C<C$$0Z1(/PIX '0 4ZBA)(+A1113 **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $-,;I3S3&Z4 57^^/K
M7RIXJ_Y&O4O^NQKZK?[X^M?*GBK_ )&O4O\ KL:UI;F578R****V, I:2EH
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MO/=Z->6]LVV>2%E1L]"1Q5ZB@#QLVK7&BVNAV^@SPZS'-EKDPX"\GYM_4_\
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M>BC- $-W>Q6:;I"23]U1R35,'4KWYE(MHCTSRU&G0_:I6OYAN9CB,'HJUJT
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M5NL[69S#8,%/SR$(/Q- &/X>;$D]RXPMQ(0O^S@]/UKIATK-%@MK:QHH^4*
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M,DKMYJM2T!=B]23GK1245:);;%HI*44 %%%% "T444 !IIIQIIH C:L;4O\
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MA!_R/"_]<7_E7T3%TKYV^$'_ ".Z_P#7%_Y5]$Q=*X<1\1Z6%^ L+3Z8M/K
MZ0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA&+E))&]<1_9-)L;3^(KYC_4\52%6]3F$^HRE?NJ=J_2JE?$XJI[2K*3/TW
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MC%**8@H%%+0(***.:8!1110 4HI*44 %)2TE !11BB@!****!AWI3TIO>E-
MAC=ZY[5O^/T_2N@:N?U;_C]/TK&KL=F$^,HTE+1S6!Z0E%'-% %FDQ2T5T'(
M=Y\(?^1W7_KB_P#*OHB+I7SO\(?^1W7_ *XO_*OHB+I7!B/B/3POP%A:?3%I
M]8'2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !5.33HI8IHY,D2G)]JN44 9PTI5^5)66,_>7UJS!:K
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M^(]3"_ 6%I],6GU@=(4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-&: "BC-&: "BC-&: "BC-&: "BC-&: "BC-&: "BC-&: "BC-&: "BC-&:
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MX4F*6B@8AHHHI@+11FB@048HHS18!:***+ &**,TM,!:6DS2DT"$S2&ES24
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M;A1N%5?-H\V@"UN%)NJMYE)YM %DN*A=^*B,M4=1U2TTZV>XO;F.&)1DLQH
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M ,]31_:=Y_SU-5**.9A[.'8M?VG>?\]31_:=W_SU-5**.9A[.'8M_P!IW?\
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0&BB@:$H%%%,8M%%%2(__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>img88009329_7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_7.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" *O!)P# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% "&FM3Z8U $#U6?@U:>JTE &BIRH-+34^X/
MI3J "BBB@ HHHH *BF[5+7%_$37;_0M.M9;"41N\NUB1G(P:J$'.7*C.M55*
M#G+9'7+TJ05X5_PL3Q'_ ,_:?]\4O_"Q?$?_ #])_P!\5U_4:AYW]KT/,]VH
MKPG_ (6+XC_Y^H_^^*/^%B^(_P#GZC_[XI?4:@?VO0\SW:BO"?\ A8OB/_GZ
MC_[XH_X6+XC_ .?J/_OBCZC4#^UZ'F>[45X3_P +%\1_\_4?_?%'_"Q?$?\
MS]1_]\4?4:@?VO0\SW:BO"?^%B^(_P#GZC_[XH_X6+XC_P"?J/\ [XH^HU _
MM>AYGNU%>$_\+%\1_P#/U'_WQ1_PL7Q'_P _4?\ WQ1]1J!_:]#S/=J*\)_X
M6+XC_P"?J/\ [XH_X6+XC_Y^H_\ OBCZC4#^UZ'F>[45X3_PL7Q'_P _4?\
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M_:]#S/=J*\)_X6+XC_Y^H_\ OBC_ (6+XC_Y^H_^^*/J-0/[7H>9[M17A/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4+SAS6>Z.5HHHKK/-"BBB@04444 %%%% !1110 4444 %%%% !1110 4444
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MD;06;[9H(CQ*3TQZ<D57TZ31O$KS:<ND1V<WEL\$L1YR 3@_E533O^2=:O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*E%6_P"R]1_Y\+K_ +\M_A1_9>H_\^%U_P!^6_PJ^:/<S]G/L5**M_V7J/\
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M#E789Y4?]Q?RH\J/^XOY4^BB[#E789Y4?]Q?RH\J/^XOY4^BB[#E789Y4?\
M<7\J/*C_ +B_E3Z*+L.5=AGE1_W%_*CRH_[B_E3Z*+L.5=AGE1_W%_*CRH_[
MB_E3Z*+L.5=AGE1_W%_*CRH_[B_E3Z*+L.5=AGE1_P!Q?RH\J/\ N+^5/HHN
MPY5V&>5'_<7\J/*C_N+^5/HHNPY5V&>5'_<7\J/*C_N+^5/HHNPY5V&>5'_<
M7\J/*C_N+^5/HHNPY5V&>5'_ '%_*CRH_P"XOY4^BB[#E789Y4?]Q?RH\J/^
MXOY4^BB[#E789Y4?]Q?RH\J/^XOY4^BB[#E789Y4?]Q?RH\J/^XOY4^BB[#E
M789Y4?\ <7\J/*C_ +B_E3Z*+L.5=AGE1_W%_*CRH_[B_E3Z*+L.5=AGE1_W
M%_*CRH_[B_E3Z*+L.5=AGE1_W%_*CRH_[B_E3Z*+L.5=AGE1_P!Q?RH\J/\
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M]%'U_$?S!_9>%_E.P_X3V7_GR'YT?\)[+_SY#\ZX^BCZ_B/Y@_LO"_RG8?\
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MBBBOE3[8**** "BBB@ HHHH **** )DM9WM7N50F%#AF]#4-;MG_ ,BC??\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5J*L_P!FWW_/G-_WP:/[-OO^?.;_ +X-'LY]F'M:?\R^\K459_LV^_Y\YO\
MO@T?V;??\^<W_?!H]G/LP]K3_F7WE:BK/]FWW_/G-_WP:/[-OO\ GSF_[X-'
MLY]F'M:?\R^\K459_LV^_P"?.;_O@T?V;??\^<W_ 'P:/9S[,/:T_P"9?>5J
M*L_V;??\^<W_ 'P:/[-OO^?.;_O@T>SGV8>UI_S+[RM15G^S;[_GSF_[X-']
MFWW_ #YS?]\&CV<^S#VM/^9?>5J*L_V;??\ /G-_WP:/[-OO^?.?_O@T>SGV
M8>UI_P R^\K459_LV^_Y\YO^^#1_9M]_SYS_ /?!H]G/LP]K3_F7WE:BK/\
M9M]_SYS?]\&C^S;[_GSG_P"^#1[.?9A[6G_,OO*U%6?[-OO^?.;_ +X-']FW
MW_/G/_WP:/9S[,/:T_YE]Y6HJS_9M]_SYS?]\&C^S;[_ )\Y_P#O@T>SGV8>
MUI_S+[RM15G^S;[_ )\YO^^#1_9M]_SYS?\ ?!H]G/LP]K3_ )E]Y6HJS_9M
M]_SYS?\ ?!H_LV^_Y\YO^^#1[.?9A[6G_,OO*U%6?[-OO^?.;_O@T?V;??\
M/G-_WP:/9S[,/:T_YE]Y6HJS_9M]_P ^<W_?!H_LV^_Y\YO^^#1[.?9A[6G_
M #+[RM15G^S;[_GSF_[X-']FWW_/G-_WP:/9S[,/:T_YE]Y6HJS_ &;??\^<
MW_?!H_LV^_Y\YO\ O@T>SGV8>UI_S+[RM15G^S;[_GSF_P"^#1_9M]_SYS?]
M\&CV<^S#VM/^9?>5J*L_V;??\^<W_?!H_LV^_P"?.;_O@T>SGV8>UI_S+[RM
M15G^S;[_ )\YO^^#1_9M]_SYS?\ ?!H]G/LP]K3_ )E]Y6HJS_9M]_SYS_\
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M=B_W11L7^Z*=119!=C=B_P!T4;%_NBG446078W8O]T4;%_NBG446078W8O\
M=%&Q?[HIU%%D%V-V+_=%&Q?[HIU%%D%V-V+_ '11L7^Z*=119!=C=B_W11L7
M^Z*=119!=C=B_P!T4;%_NBG446078W8O]T4;%_NBG446078W8O\ =%&Q?[HI
MU%%D%V-V+_=%&Q?[HIU%%D%V-V+_ '11L7^Z*=119!=C=B_W11L7^Z*=119!
M=C=B_P!T4;%_NBG446078W8O]T4;%_NBG446078W8O\ =%&Q?[HIU%%D%V-V
M+_=%&Q?[HIU%%D%V-V+_ '11L7^Z*=119!=C=B_W11L7^Z*=119!=C=B_P!T
M4;%_NBG446078W8O]T4;%_NBG446078W8O\ =%&Q?[HIU%%D%V-V+_=%&Q?[
MHIU%%D%V-V+_ '11L7^Z*=119!=C=B_W11L7^Z*=119!=C=B_P!T4;%_NBG4
M46078W8O]T4;%_NBG446078W8O\ =%&Q?[HIU%%D%V-V+_=%&Q?[HIU%%D%V
M-V+_ '11L7^Z*=119!=C=B_W11L7^Z*=119!=C=B_P!T4;%_NBG446078W8O
M]T4;%_NBG446078W8O\ =%&Q?[HIU%%D%V-V+_=%-*KZ"I#3&HL@NR%P/0?E
M5:3\/RJT]59*+(+LT$^X/I3J:GW!]*=3$%%%% !1110 5%-VJ6HINU "+TJ0
M5&O2I!0 ZBBB@ HHHH **** "BBB@ HHHH **0D*I). *Q]*\4:9K%_<65I,
M6F@SO!4CH<<>M-1;5T2YQ32;W-FBBBD4%%9UGK=G>ZE<V$+,9[;_ %@*D 5H
MTVFMQ*2EL%%!X%9FG:[9:G>7=K;.QEM&VR@J1@_Y%"38G))V9IT5!;WMO=/(
ML$JR&,[7VG.#Z5/2&FGL%%9NG:Y9ZG=W5M;,QDMFVR J1@UI4VFMPC)25T%%
M%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 !IC
M4\TQJ (GJK)5IZJR4 :"?<'TIU-3[@^E.H **** "BBB@ J*;M4M13=J $7I
M4@J->E2"@!U%%% !1110 4444 %%%% !1110!A>+M4_LGP[<RJ?WKKY<8]6;
MC^M<0VGR>$SX?U90</\ N[H^N_)Y_$UH^,?M>O>)['1+!U#6_P"_D+C*J1TS
M^E2:SH'BS4=)FMKJ^LI(MN=JH0>.>./:NRFE&*3>YY5=NI-RBF[;?J=O<7L%
MM8O>2.!"B;RWM7(6WBCQ#JD37NG:/&UAD[3(^'<>H&:S$U2;5OA?>0G/VJU7
MR95[_*P'\A78^&)8)/#%@T)78($''K@9K-P4$[J^INJKK223LK7.4\%W_P!N
M\3ZW>>4\3, 3&_52,Y%=/X9UZ37K>YDDA$1AF,8 /7%<_P"''AD\9>(F@(*]
M"1Z\YJ?X=,!9ZBN1D73Y'IR:JK%--V[$8><HM1OW-9?$$C>,9-#\D;%M_-\S
M//TKF?#4EU%K/BE[.)9;@3#8C' )^:K5O(DGQ:N-C!MME@X[&CP7_P C-XE_
MZ[C_ -FI\JC%V[(AS<YJ[ZLI_#ZYU7S[I!9QFV>Y8S2%^5;CCKS7HYZ5Q7P\
M_P!1J?\ U]M_2NU/0UE7=ZC.G!JU%:GEVBZE?VGB37+?3+'[3<R3[OF.$48'
M4UTVC>*+Z773HVL6*VUTR;XRARK#\_:J/@H#_A(_$!QSYX&?P%2ZQ_R4W1_^
MO9__ &:M9<LI--=#F@YP@II];&K8>(9+SQ5?Z080J6J*P?/+9Q_C2Z[XADTC
M5--M$A5Q=R;"Q/W:Q-%(7XFZV"<$Q)C/?@4WQI*A\4>'XPP+B;./;!J.1<UO
M(U]M+V;=];E[6/%]QIWB!=)@L3<2R1[HMIY+>_M5*7QKJFCWJ6^N:8L9F'[D
MP-NW'TZFG.H/Q3A)&2+7BF^-U#>)?#P(!'GG^1JE&%TK=")3J-.2EL[#I_%N
MN:7+;SZKI,<5C,X4,CY9<],\UL^(/$ATE+6*UMFNKN[.(8UZ'W)K.^(O_(MI
M_P!=T_G46LZW<V]UI6EZ;;PO?3QY664<1C'6DHJ232*=24'*+EV$G\4Z[H\T
M#ZUID*6DKA#)"^2I/KS6CXG\5'P_<:>HMC.ER2#MZ\8Z?G7)>,[+6+?2H9-6
MUA)RTZ!8$0 =^>F:U_%8#:[X6!&1YIZ_A5JG%M/U,O;5$I)/MN/O?%?B'2HU
MOK_1HTL"1N*/EU'OS7:6UPEW;1SQG*2*&!KGO'G_ ")M_P#]<ZTO#?\ R+EA
M_P!<16,DG#F2.NDY1JN#=]+FI1116)U!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 !I
MC4\TQJ (GJK)5IZJR4 :"?<'TIU-3[@^E.H **** "BBB@ J*;M4M13=J $7
MI4@J->E2"@!U%%% !1110 4444 %%%% !0>E%% &)IGAR'3M8O=3,SS3W74O
M_"/0?E6T1D8-+13<F]R8P459&!IOA:UTW4+^XCD=HKW)D@8#;D]36;_P@K6[
MR)8:O=VMI(Q)@4Y ]@3TKL:*M5)=S-X>FUL<_H7A.ST"[N)[:21A.H#*YS^.
M:H77@?.I3W>G:G<V/VAMTL<9^4GUKKZ*/:RO>X/#T[<MCFM(\&VFCZO_ &C%
M/-)*8C&_F'.XGJ2?6K.C^'(](U+4;Q9VD-ZX=E(X7KT_.MRBDZDGNPC0IQV1
MR]EX.73M;>_M+^XCB=][VX/R$UU':BBE*3EJRX4XP5HF-I'AZ'2+Z^NHY7=K
MM][!N@^E.NM!ANO$-KJ[2N)+>,HJ#H0<_P"-:]%'.[W%[*-N6QS.M^$(]3U%
M-1M;R:RO%7:9(C]X>]5HO < O+:]N+ZYGNX7WF1SG=[8["NOHJE5DE:Y#P]-
MN[1CGP_"?$:ZSYK^:L?E[.V*35_#T.KZA8W<DKHUH^]0O0\'K^=;-%3SLOV4
M;6L96O:'%KU@+2:1HU#A\KUXJGK/A2#51:2I<2VUW:C$4\?4"NAHH4Y+8)4H
M2O='&S^ ([^-CJ6I7-S<<;)&. GT'2M:^\-Q7]SID\L\F^P.Y< ?.??\JW**
MIU9/J2L/370S]:TJ/6M*FL)9&1)5P67J*GL+-;"P@M$8LL2A03U-6:*B[M8T
MY5S<W4****104444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M 4444 %%%% !1110 4444 !IC4\TQJ (GJK)5IZJR4 :"?<'TIU-3[@^E.H
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M R>]5?N*QP'A[P_J>G>%-6N]5D>34K\-))%N)">@'YUH?#&":W\"V<<\312
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M4Z@ HHHH **** "HINU2U%-VH 1>E2"HUZ5(* '4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ -,:GFF-0!$]59*M/562@#0
M3[@^E.IJ?<'TIU !1110 4444 %13=JEJ*;M0 B]*D%1KTJ04 .HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *#10
M::W)EL>OZ9_R#;?_ '!5JJNF?\@VW_W!5JOL*?P+T/@:OQOU"BBBK("BBB@
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M_P#?-'V"T_Y]X_\ OFC^R7_,']NK^0\?VM_=;\C1M;^ZWY&O8/L%I_S[Q_\
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MR7_,']NK^0\?VM_=;\C1M;^ZWY&O8/L%I_S[Q_\ ?-'V"T_Y]X_^^:/[)?\
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M_P#?-'V"T_Y]X_\ OFC^R7_,']NK^0\?VM_=;\C1M;^ZWY&O8/L%I_S[Q_\
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M-92_Y@>>IJW(7=-_Y!MO_N"K5-C $:@# Q3J]B*M%(^?E+FDV%%%%42%%%%
M!44W:I:BF[4 (O2I!4:]*D% #J*** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BDR/6ER* "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHS10 4444 %%%% !1110 4444 %%%% !129&,YXI: "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***,T %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 !IC4\TQJ (GJK)5IZJR4 :"?<'
MTIU-3[@^E.H **** "BBB@ J*;M4M13=J $7I4@J->E2"@!U%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M11Z"JGB7P]9:)\1/#DUA'Y,-Q,VZ)3\H;:W(%%EL%SUNBBBI*"BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 !IC4\TQJ (GJK)5IZJR4 :"?<'TIU-3[@^E.H **** "
MBBB@ J*;M4M13=J $7I4@J->E2"@!U%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBQ\0>)/$$NIH;B"*Y(2 L0NX]3Q^%.\=7%E9^(=(\.NDT>BP1^;)!;JQ+\G
MXYQQ70_#ZPO+/5/$#W-N\2RW9:,L/O#U%'C;1]1@URP\3Z5;"ZFM5,<UOQEX
M_;/?DU5]2;:''^);[PS<Z3NT/3;VTU* AX)(K:13D<X/'/XUJ^(-0O/$4?A7
M1IFD@6_4270&5+!<Y!^NW]:O7GBS5]:BCL= \/W%K>2$!Y[F)0L0[GGK5KQC
MH&JF+1]9L +K4=,(,B !?-7^(#MW-%^X$_B?P-HP\+W?V*U6UG@@9DEC)#<#
M/)[YKF+O/_"B[;/7*Y_[^UH:]XTU36?#UW::?H5Y;S-"WGRS@*L:X^;'//&:
M=8://K?P6@L[7F?860?WBKYQ^E"O;4/0[BU_Y%.'_KQ7_P! KR[0M6FT;X3:
MK<V[%9C=2HC#MF0C/Y5MV?C+5YM#32(_#=ZNHK!Y!+@",87&<Y]J@\+>%+R_
M^&M_I%]$UO=23R,N\?Q;R0?H:6VXS*T6\\&VNAQV][IE[=74J SSR6TC,S$<
MD''K5[P;?2_V!XCTY5NC8P[FM&N$93L.>.?PJWIGBS4-&TQ-,U3PS=2W]NHB
M5X8U*28X!S6SI<.OW7A75+C6(T2>Y5C!:HB@Q+S@$CJ>E-L2,+X9>$M*U#P;
M;WNH6XNI9<@>:20B]@!VH\*S?\(YJ7C"SMBWV2R;?#&22%^]P*Z3X9V=S8^!
M;&WNX7AF4'<C]169H6CW$OB_Q:+JW=+:[8*CD<./FZ4KZL=BM\/O#5AK.A_V
M[J\(O;V]8N6E.X*.P [5NZ1X0'AW4]1N;*[==/N$RMF3E8VYY&?PKF]"U35/
M ,,FAZAI%U=VL3DVUQ; -N4]C6OX<_X2'5]7OM:U!9;2P>+R[:R?&>_S''UH
M=P1S>@ZM/HOPCU:\MSB87,JHWH2!@U4T"^\'VVBHFHZ9>7EW,NZ>:2VD8L3Z
M''\JWO#/A>XU+X;ZEH][$]M+//*4WCIP,&F:5XHO_#^FKI.J^&KJ:[MAY:20
M1JRRCL<T_012\%W%_/8^)=(T\W2VPC9[!IT92-RXV@D>M9>EWWA:UT8Z1XDT
M:XM;[#++=21,<L2?F#"N[T*+Q3>:+J5U>/'9W5P&-G"(US",<9P.>:P_^$JO
M/[*DT[7O"]S=ZD%:,NL*LDA['/:BX':>$K>UM?#EM#9:@U];J#LF<Y)&>E;E
M<A\.="O-"\-^5>KY<DTK2B'.?+!)PM=?4/<I;!1112&%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  :8U/-,:
M@")ZJR5:>JLE &@GW!]*=34^X/I3J "BBB@ HHHH *BF[5+44W:@!%Z5(*C7
MI4@H =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M >E9<M3^;\#;GH_R?C_P#)_X2&+_ )\[K_OD?XT?\)#%_P ^=U_WR/\ &M?
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M(H?^?2Y_[X'^-'_"10_\^ES_ -\#_&MC ]!1@>@HY:O\WX!ST?Y/Q_X!C_\
M"10_\^ES_P!\?_7H_P"$BA_Y]+G_ +X_^O6Q@>@HP/04<M3^;\ YZ/\ )^/_
M  #(_P"$BA_Y];G_ +XI/^$BA_Y];G_OBMC ]!1@>@HY:G\WX!ST?Y/Q_P"
M8_\ PD4/_/K<_P#?%'_"10_\^MS_ -\5L8'H*,#T%'+4_F_ .>C_ "?C_P
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M>@HY:O\ -^ <]'^3\?\ @&/_ ,)%!_SZW/\ WQ1_PD4'_/K<_P#?%;&!Z"C
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M_P#A(H/^?:Y_[XH_X2*#_GVN?^^:V,#T%&!Z"CDJ_P WX!ST?Y/Q_P" 8_\
MPD4'_/M<_P#?%'_"10?\^US_ -\5L8'H*,#T%'+5_F_ .>C_ "?C_P  Q_\
MA(H/^?:Y_P"^*/\ A(H/^?:Y_P"^*V,#T%&!Z"CEJ_S?@'/1_D_'_@&/_P )
M%!_S[7/_ 'Q1_P )%!_S[7/_ 'Q6Q@>@HP/04<M7^;\ YZ/\GX_\ Q_^$B@_
MY]KG_OBC_A(H/^?:Y_[XK8P/048'H*.6K_-^ <]'^3\?^ 8__"1P?\^US_WQ
M1_PD4'_/M<_]\5L8'H*,#T%'+4_F_ .>C_)^/_ ,?_A(H/\ GVN?^^*/^$B@
M_P"?:Y_[XK8P/048'H*.6K_-^ <]+^3\?^ 8_P#PD4'_ #[7/_?%'_"10?\
M/M<_]\5L8'H*,#T%'+5_F_ .>E_)^/\ P#'_ .$CM_\ GVN?^^*/^$BM_P#G
MVN?^^*V,#T%&!Z"CEJ_S?@'/1_D_'_@&/_PD5O\ \^]Q_P!\4?\ "16__/O<
M?]\5L8'H*,#T%')5_F_ .>C_ "?C_P  Q_\ A(K?_GVN/^^*/^$BM_\ GWN/
M^^*V,#T%&!Z"CDJ_S?@'/1_D_'_@&/\ \)%;_P#/M<?]\4?\)%;_ //M<_\
M?%;&!Z"C ]!1RU?YOP#GH_R?C_P#'_X2*W_Y]KC_ +XI?^$BM_\ GVN/^^*U
M\#T%&!Z"CEJ_S?@'/1_D_'_@&1_PD5O_ ,^]Q_WQ1_PD5O\ \^]Q_P!\5KX'
MH*,#T%'+4_F_ .>E_)^/_ ,?_A([?_GWN/\ OBC_ (2.W_Y][C_OBMC ]!1@
M>@HY:O\ -^ <]'^3\?\ @&/_ ,)';_\ /O<?]\4?\)%;_P#/O<?]\5L8'H*,
M#T%'+5_F_ .>C_)^/_ ,?_A(K?\ Y][C_OBC_A(K?_GWN/\ OBMC ]!1@>@H
MY:O\WX!ST?Y/Q_X!C_\ "16__/O<?]\4?\)';_\ /O<?]\5L8'H*,#T%')5_
MF_ .>C_)^/\ P#'_ .$CM_\ GWN/^^*/^$CM_P#GWN/^^*V,#T%&!Z"CEJ_S
M?@'/1_D_'_@&/_PD=O\ \^]Q_P!\4?\ "1V__/O<?]\5L8'H*,#T%'+5_F_
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M/N#Z4ZM3 **** "BBB@ J*;M4M13=J $7I4@J->E2"@!U%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%%  :8U/-,:@")ZJR5:>JL
ME &@GW!]*=34^X/I3J "BBB@ HHHH *BF[5+44W:@!%Z5(*C7I4@H =1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 UW6-
M&=V"JHR2>U5=/U6PU:)I;"[BN44X9HVR :YOXCZNVG>&'MX#_I5ZX@B Z\]_
MTKFO#-N? WCF'1&)%IJ-LI3/3S5Z_P ZI+2XKZGJM%5=1U"UTJPEO;R58H(E
MW,Q/05QH^):O;F]BT#4I--'/VH(=N/7&.E*S87.TO;^UTVU:YO9XX(%ZO(<
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MSETZS\+Z3:(AB29%"-PC.%/7\JZ#3_AXMGXYEULW"M:9,D5OC[KD8)_4UO\
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MS%)P< 5)XBTZVTKQ/8WVIVQGTZ2 0R, 2$8# )Q^%.U.;PG$D,6EZ=%?W<S
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M_P!>NOIJ1I&-J*% [ 4ZO2HTY4X\LG<\C$58U9\T8V"BBBMC **** "BBB@
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M4:]*D% #J*** "BBB@ HHHH **** "BBB@ J*.V@BD>2.%$=_O,J@$_6I:*
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MO2I!0 ZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<4^FI]P?2G5J8A1110 4444 %13=JEJ&?H/K0 +TJ05$M2@T .HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT9IFZC=0 _-&:9NHW4 /S1FF;J-U #\T9IFZC=0 _-&:9NHW4 /S1FF;J-U
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M]PT 3;Z-]0[)?[AHV2_W#0!-OHWU#LE_N&C9+_<- $V^C?4.R7^X:-DO]PT
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M]PT 3;Z-]0[)?[AHV2_W#0!-OHWU#LE_N&C9+_<- $V^C?4.R7^X:-DO]PT
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
B444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>img88009329_8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_8.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #W E0# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI$UM)>SM*WW7WG(KDV.:;FFXIJPW%-6-G_A+-=P?^)I<_P#?PTW_ (2O7O\
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M)7KW_05N?^_AK%'2G"D!L?\ "5Z]_P!!6Y_[^&C_ (2O7O\ H*W/_?PUCT4
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M%M>U74/')@N[Z::+R&.UW)&:^D*^7O@3_P C^?\ KW:OJ&MSI"BBB@ HHHH
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M_P#]<&_E7Q5)_KI/]X_SI -HHI* "BBB@ HHHH 6BDHH >B%V"KU-2R6[P.
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MI7_7<5SM=%X!_P"1YTK_ *[B@#[)7[H^E<)\8/\ DGE]^%=VOW1]*X/XP_\
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M&@4444 %%%% !1110 44TM@TF^@!]=%X!_Y'G2O^NXKFM]=)X!/_ !7&D_\
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MS8_]QORHV/\ W&_*OM/_ (1;0_\ H&6W_?L4?\(MH?\ T#+;_OV*!GQ9L?\
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ML4P/BU1(.J-^1J0!O[C?E7V=_P (MH?_ $#+;_OV*/\ A%M#_P"@9;?]^Q2
M^,MK_P!QORHV/_<;\J^SO^$7T3_H&6W_ '[%'_"+Z)_T#+;_ +]B@#XO*/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
7 "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>img88009329_9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_9.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 3]!*H# 2(  A$! Q$!_\0
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M8FZ.*E# ]#0 M%%(7 ZF@!:*A-U"IP7% NH3T<4 345";F(=7%.2:.3[K9H
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M- 'KNE^+;6X(0-S]:Z&;4$\H,#U%?.FD74ECJI5I&XQU->IVVL_:K>- W;%
M$^O>)X[)B&?&#ZUG6GC.&5E ?K[UP?Q 9_-<!V'/8U'X6\-3WVR4-(<<_>-
M'M-AJHE4/NXJSJ?B""TMPS'MZU@QZ:^FZ3O;=QZFN \1:R;S? KG*\<&@#JK
MWQM Y(1_UID/C.(+R_ZUP.@^%)]588:0Y/\ >-;\WPYN8X7;,O _O&@#H/\
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MM@<L!^-<[JTITS2(F+$87UKSJ>XDU]F5)&.3C@T =]/XSB=LH_ZU8L_&D D
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M7:?#S2)+94\Q,<4 8_B@E]4C!_OUV/ABP4P(_%<IXM0)J\0']^NX\+_\>:4
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M M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ Z4 9UW-';QCS%!P!UKR'QM?6SRL BY)KUS5+/[2I&.U>0^+M!(E+;3P<T
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MB"]JD(!H ^>]5\":B9LPR2*,]A6>G@;6"^&GF(^E?1LELKG[H_*HA9*&SM%
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MW%?0KVBN<[1^5"6BJ<[10!YQX7\(264JM*I//<5Z*MJD:X50.*MJH Z"E(H
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MU+C%+0 M%,:15ZU&+J,MCO0!/12!@12T %%%% !1110 4444 %%%% !1110
M4444 %%-:0+UJ(W2 XH GHIJL&&13J "BBB@ HHHH **** "BBFLX09- #J*
MA%RA.!4BN&Z4 .HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD
M)P,T +14)N4!Q3EF5NE $E%&:* "BD) &:B-P@/- $U%1I,K]*DH **** "B
MBB@ HHHH **** "BBB@ HI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO/=:U:QD9C#&J_2L#3=7E&M1!9"%]* /II+R/[,LA;@UR'BKQ&EI&WE2<@5
M^K%-!B;=SBO,/$-_-?%U20^E $M_XIU:=O\ 1OF&?[U,BU[7PNYDX'^T:V?!
M7A]KN-3*N[CN*[>[\,1)I\F(@#CTH \O/C'44.UC@_[U=+X3\0WM[< ,<\^M
M<9K6BS07\C<A:Z3X>IF\ /9J )_B+<WZM)Y:]_6O)_.NS>QEU^;=QS7T'XTL
MHI#)E :\=O+5%UB!0HQOH [CPA?:DBQ[EQ'ZYKT#5]>2VTZ,[\-MYK*TJSA@
M\.K*$ /K7 ^*]8<J\:OC'% $NK>*M1G+?93N].:R$UWQ#O!,?'?YC_A5+PWJ
M<*./M(#\]Z[+^VM+$#CR4SCUH ?H?BJ[$Z)<-@_6O5=+U>&X@3Y\L17SC>ZF
MO]IAX3M7VKN?"&N/).J&3."* /5=9U..S3+-CBO*O$GBVY60BW;//K6O\0]2
M>*URCX^0?RKSS2[&XU5T;<6&<T 2C7M?EE#(F5_WC2ZGK.I2V(6<8_&O3]'\
M,1?V<=\0+8ZXKF?%GAQH;1G5<#GM0!P/AJ4O=DGKNKWOP?\ <7Z5X)X;MVBO
M7![.:][\'_<7Z4 =C2$@#)HJO>R>5 6H SM:U2*SBW,^.*\O\0>+IB6^RON_
M&K7C[5G-NRQO@@=JX+PUIUUJ[+EV;)H FDU_7Y9 T:97/]XUNZ)XDU,W21S<
M?C7::3X4C2S<21 MM[BLIO"$Z:F)$!"_2@#NM(OFF@C+'DBI-9U:*R4EWQQ6
M?9VLEC"F\G@5P?Q)U=UB<1N5^7M0!#XA\6W'F$6S9Y]:Y=M?U]Y=ZIE/]XT>
M']*N=6*.69AUKU&Q\+1C32&B!?UQ0!P^D>*-128"Y.T?6O3= U^*\VCS,FO-
M_$V@2V,;2H"H^E9O@;4YHKLB20D!SU^M 'T#)=1JC'=T%>?^(O%"VSLB2?-V
MYJQ>:Z!&XW=C7D.N7%Q>:W&JR'!;I0!J7WB76)9F\@9';YJIPZ[XAC;,D>!_
MO&NV\.>%VE@261-P/J*Z/4?"L4D $<(!QV% ',^'/$-])L\[C\:]#CN#<:1.
M3_<KC;7PK<0D;<C'M77P6KVVD3J^<[* /#/$[E-7=A5&PU2[23%OR0?6KOBE
M#)JSJ.M3^#]'>:].\9&Z@"*\\1ZY /F7'_ C70^'O%]R61;A\$^]:_B7PXHC
M.V/''I7EMZ);'5(4#$#>!0!]$M=_:O#[R9STKQ?7?^/V7ZUZAHDC/X18L<GC
M^5>7ZY_Q^2_6@#J/AJ0)US_>_K7?ZUK<5D'!?!KS;P!.(IES_>JC\1-8DCN6
M"2$#=0!+K?BR^:<K;G/XU@C7?$/FE_+^7UW'_"LS3M21KA&EPP]Z[C^VM*_L
M]5\E-_KF@!FB>*;Z-Q]J.T9]:]1\/ZQ'?*"'SQ7@&MZI'AO(POTKK_AYK;1P
MIYKY^7O0!['?W\4-L[;N0*\J\0>+9DF>.!\MZ9K1UO7M\$BJ^,BO,H(KB_U\
MC>2I[4 7/^$AUZ25MB9&>/F-6HO$NL6X_?C;_P "KT#2/"B>1&[Q9R,]*R?%
MWAHX?R4V_04 <2?&FHG484W<%L?>KVWPQJ+SZ4LLIYXKYRN+1[35H%?/WZ]U
MT"7RO#0;/I_*@#:U_7([6VRK\XKRK5_%=_,6%J=WXT>+M8D9'42'BN5\.:E&
MLO\ I&&^;O0!HKKOB$L#Y?'^\:Z71?%=XLZ)<-@_6A-:TL0,/)3./6N)U'4U
M_M(/"=J\]* /HO2-8AN8$^?+&MY2" :\,\&ZV\MTJ&3/2O;;:3?"A]5% $]%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4U_NGZ4ZFO]T_2@#SGQ;_JI:\@TO_D;#^'\Z]@\
M6(QBEP#7D>EP2CQ63L../YT >G>)O^0)!_USKSS3P"X^M>C>)8V.B0@*3^[K
MSVPBD#CY#UH ]E\) ?V:_'\%<YXSC)M)#73>$%/V$@C'RTWQ/I8GT^3 R: /
MFA+4SZM,O^U746OAQI ,9_.H-0TJXL[^:186^]Z59T[4;E2 Z,,>M $DGA9C
MU!_.GZ;X/*ZC')M/%%QJEUY@"HQYKH] DNIKB,M$V* -W4].,.AQK@\"O,IO
MW,KY]37O<VGBYTI%8<XKRGQCHDEHKM#$6/7B@#LOAY<*84Z?=KN;^5?L,AXZ
M5\[:'K]_I:@>5(,#%;\WC._EM77RY.1ZT .\3W:FXD7BE^'ISJ!/^W7"W>H7
MMU>,6A?!KN_AU'(+L%E(^:@#NO%__+2O&;__ )#EO_UTKVCQ<K'S,"O&[Z"0
MZW;G8?OT >P6BY\)#_/:O'?$<!-Q+UZU[AHEOYWAQ4(K@_&.@-'&SQQDDC/
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_/-?RI?(B'2-?RH \=E\&E;V-DCX#>E>D:'8?9[%8V%;7V>$\^6OY4\(%&
M* ,R_P!*@NHMKIGBN)UCPE$-Q@BQ^%>E8S3&B1OO(#0!XN?"UR'&$XSZ5T6D
M^%D1U>2/YA[5Z)]FA_YY+^5.$4:]$ H J65E'!"H"XQ5X4 4M !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %&*** #%&*** "BBB@ HQ110 8HHHH
M**** "BBB@ I,4M% "8I<444 &**** "BBB@!,4M%% !1110 48HHH ,48HH
MH ,4444 %%%% !BC%%% "4M)2T %%%% !1BBB@ HHHH *,444 &*,444 &**
M** "BBB@ Q1BBB@ HHHH ,4444 &*,444 &**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*#24 +1244 +FBDHH 6BDHH 6BDHH 6C-)10 M%)2YH **3-% "T44E "T4E
M% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MI+'1-6,Z^:Y*]^* )])AF?6'<H=I/6O4+9-L2?05C:5I*0QJS)\W<UT*J H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 A /4"DV*/X1^5.HH 3 ]*,4M% "48I:*
M&E%;JH/U%*$4=% _"EHH 3%%+1B@!!2T44 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E
M+24 -E^[6#JGW36]+]VL'5/NF@ T/H*Z 5S^A]!70"@!:*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *2EI* &R_=K!U3[IK>E^[6#JGW30 :'T%= *Y_0^@KH!0 M%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %)2TE #9?NU@ZI]TUO2_=K!U3[IH -#Z"N@%<_H?05
MT H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *B>=5ZT]NAKG]3OO))YH
MV#>1BE6[C8\5P,_B,)+MW"KFFZT)Y,;N] '<*X;I3JI6DN\"KM "T444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH*Z 4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^&_B&-;X#K[+_5_A5JJME_J_PJU7TL/A1X<]PHHHJR0HHHH **** $-+110
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M@8 'I0 44N*2@!DGW:PM5^Z:WI?NU@:J<*: %T/H*Z 5S>BRHH&6 K>6>/\
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M*V60,A&* /%M>TF1;HE5XIGA:UDCU$Y'<5Z7J.CBXSA.:R].\.M;WADVG&:
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M7[M8.J?=-;TOW:P=4^Z: #0^@KH!7/Z'T%= * %HHHH **** "BBB@ HHHH
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M%% !24M)0 V7[M8.J?=-;TOW:P=4^Z: #0^@KH!7/Z'T%= * %HHHH ****
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M=3M%^\]><^(72YOT,7(WT =SH5T9;0$UNKR :YKP_&XLQQZ5TB?=% #J***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EI* &R_=K!U3[IK
M>E^[6#JGW30 :'T%= *Y_0^@KH!0 M%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0=:U]0L/LR=.U '$ZC_Q]I_O"O2_#/\ R#Q^%>::C_Q]I_O"O2O#/_(/'X4
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MH KW/W*Y36NC5U=S]RN4UKHU>?CO@9VX3XCGJ***\ ]<**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ I:2EH !UK:TK^&L4=:VM*_AK?#?Q#&O\
M =?9?ZO\*M55LO\ 5_A5JOI8?"CPY[A1115DA1110 4444 %%%% !1110 44
M44 %%%% !24M)0!G:PI:Q8 9KR?4X+A)Y"L9/->R3QB2,J1Q6)/HT,C$E.M
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M5/NF@ T/H*Z 5S^A]!70"@!:*** "BBB@ HHHH **** "BBB@ HHHH ****
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MA1115DA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 5[G[E<IK71JZNY^Y7*:UT:O/QWP,[<)\1SU%%%> >N%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4M)2T  ZUM:5_#6*.M;6E?PU
MOAOXAC7^ Z^R_P!7^%6JJV7^K_"K5?2P^%'ASW"BBBK)"BBB@ HHHH ****
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MEI* &R_=K!U3[IK>E^[6#JGW30 :'T%= *Y_0^@KH!0 M%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5[G[E<IK
M71JZNY^Y7*:UT:O/QWP,[<)\1SU%%%> >N%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4M)2T  ZUM:5_#6*.M;6E?PUOAOXAC7^ Z^R_U?X5:J
MK9?ZO\*M5]+#X4>'/<****LD**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%%% !1110 4M)2T  ZUM:5_#6*.M;6E?PUOAOXAC7^ Z^R_U?X5:JK9?ZO\
M"K5?2P^%'ASW"BBBK)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "F2MLC9O04^H+SBTE^E '+:UJP=&@4X:N/M])N+NZ=M[$$U8O9
M"VKE:ZS1(0-IR* .9N?"=RP^4L*K1>;I4Z1NYZXYKU@CY?PKS+Q1'G4$/^W0
M!W.BW/FV@.<UK Y%<SX?;;:**Z5#E10 ZBBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "DI:2@!LOW:P=4^Z:WI?NU@ZI]TT &A]!70"N?T/
MH*Z 4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% %>Y^Y7*:UT:NKN?N5RFM=&KS\=\#.W"?$<]1117@'KA111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %+24M  .M;6E?PUBCK6UI
M7\-;X;^(8U_@.OLO]7^%6JJV7^K_  JU7TL/A1X<]PHHHJR0HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J*Y&;=Q[5+4<XW0N!W%
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MO@9VX3XCGJ***\ ]<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MI:2EH !UK:TK^&L4=:VM*_AK?#?Q#&O\!U]E_J_PJU56R_U?X5:KZ6'PH\.>
MX44459(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
MA&:6D- $31*W50?PIGV:/_GFG_?-3%@.] =?[PH A-M'_P \U_[YH^RQ_P#/
M-?\ OFIFE1?O,!2":,]'7\Z (OL\?_/-?RIZPJO10/PIX(/0TZ@ '%%+BDH
M6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EI* &R_=K!U3[IK
M>E^[6#JGW30 :'T%= *Y_0^@KH!0 M%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *ANEW6T@'<5,
M*1AE2* /,M2TZ2&_:<YVUF:GJD;0"/C(&*]'U73?M$##;UKSK5/##([O@\T
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M><Z_<3P7Z!#@;Z /2;619(L@YJQ6#H%P7LAN/-;JG(H 6BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "DI:2@!LOW:P=4^Z:WI?NU@ZI]TT
M &A]!70"N?T/H*Z 4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MW44 <4-!20_,OZ5LV&APQ ''Z5M"",?PT\*%Z"@!D40B7:.E2TE H 6BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:2@!LOW:P=4^Z:W
MI?NU@ZI]TT &A]!70"N?T/H*Z 4 +1110 4444 %%%% !1110 4444 %%%%
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M,2 #0!Z116$NK*0/G%2)JBD@;Q0!LTM5X)A(N0<U.* %HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ I*6DH ;+]VL'5/NFMZ7[M8.J?=-
M!H?05T KG]#Z"N@% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBB@ HHHH *2EI* &R_=K!U3[IK>D^[6#JGW30 :'T%= *Y_0^@KH!0 M%%%
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MR?=K!U3[IK>E^[6#JGW30 :'T%= *Y_0^@KH!0 M%%% !1110 4444 %%%%
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M?9?ZO\*M55LO]7^%6J^EA\*/#GN%%%%62%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 )FFLRE2"14%Q+LS6-<ZCL?&: +FHV,<\)&1
M7&7>E+92-(@&2<\5NR:JH7YFXJB]_:W!*ELF@#$61YS@J:W-.T6.<J[8R.>:
M:B6R]#5^WNDC("F@#HK.W%O#L&*M"J=I+OCS5P4 +1110 4444 %%%% !111
M0 UAFJLUDLO7%6ZCDF2,?,: (51+:)N0,"N9U?4]P:(-FI-6U=4W(K<GBN:A
MBNKK4 Q&4- %K0[9C?LY4\M76ZE9">/\*=8V$4$*/CYL<U+=7EO"/WC8H YB
M;PPD_P Q JI/I'V!"ZKT]*[6UFMYURAR*JZNMO\ 8I.>: .0T;7)&OS <X!K
MT6)]T:GU KRG30HUN3;ZUZ=:%O*3/H* +E% HH ;+]VL'5/NFMZ7[M8.J?=-
M !H?05T KG]#Z"N@% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!7N?N5RFM=&KJ[G[E<IK71J\_'? SMPGQ'
M/4445X!ZX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2TE+0 #K
M6UI7\-8HZUM:5_#6^&_B&-?X#K[+_5_A5JJME_J_PJU7TL/A1X<]PHHHJR0H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"C=PM)G!-<
MY>:1<2/D,U=A2''M0!YUJ6CW,=J6WM7,Z;9W4EZZ^8W#5ZSK6/L+=*X?1L?V
MG)T^_0!>BT6Y('S-5B/1;E7!+-UKK+<C:.E6>/:@#/L8&BB 8FM =**6@ HH
MHH **** "DI:* "BBDH 1FVUS'B'51:[N<5TKKN%<[K7AW^TMW&<T >;7VJF
M6[1M_&ZNJTGQ#9PVX#HA;U-(WP_!/W*<O@''\- &];>(8+S"1[1]*R/$T,\B
M,8W89':KFE^$_L,N_;WK;N],%PN,=J .,TG6?[.BVS-DXQS4EWKJWJF-&Z^E
M7KSP;]H;.VFVO@KR)E?;TH R]&T:;^T#.2<,:]'A3;&H] *K6ED+>-5QTJ\.
ME !1110 V7[M8.J?=-;TOW:P=4^Z: #0^@KH!7/Z'T%= * %HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"O<_<
MKE-:Z-75W/W*Y36NC5Y^.^!G;A/B.>HHHKP#UPHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "EI*6@ '6MK2OX:Q1UK:TK^&M\-_$,:_P'7V7^K_
M  JU56R_U?X5:KZ6'PH\.>X44459(4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!5N)2F:Q[G4V1L9K3O(W?.VN;O;&Y=\K_*@"+5-3
M=[0@<UR>EW,R7[L01\U=*^E7+K@]/I4*:%*C;@O/TH UH=58 <U9356+ 9K'
M&F70_P#U5-%IUT'4GU]* .LM9C)'FK0JA8Q.D0#5H <4 +1110 4444 %%%%
M !1110 E)3J* $HI:* $HHI: $I<444 )12T4 )12TE #9?NU@ZI]TUO2_=K
M!U3[IH -#Z"N@%<_H?05T H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$<]1117@'KA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %+24M
M.M;6E?PUBCK6UI7\-;X;^(8U_@.OLO\ 5_A5JJME_J_PJU7TL/A1X<]PHHHJ
MR0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *2EI* &R_=K!U3[IK>E^[6#JGW30 :'T%= *Y_0^@KH!0 M%%% !24M%
M!5+4O]35VJ6H_P"IIQW)G\+//M<_BKFZZ77/XJYHUZ$-CP*WQB4M)15&0M%)
M10 M%)10 4444 4+E')XJLL$F_-;& >U&U?05DZ5W<ZH8EQ5K%6%6&,U;I,#
MTHK1*QSSES.XM%)13)%HI** %I**7- "59M?O56JS:_>I,:W.]\,?=7Z5U8K
ME?#'W5^E=6*X:OQ'NX;^&A*=24M9G0%%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!7N?N5RFM=&KJ[G[E<IK71J\_'? SMPGQ'/4445X!ZX4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4 %%%% %>Y^Y7*:UT:NKN?N5RFM=&KS\=\#.W"?$<]1117@'KA1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %+24M  .M;6E?PUBCK6UI7\-;X;^
M(8U_@.OLO]7^%6JJV7^K_"K5?2P^%'ASW"BBBK)"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@#,U?_4?A7'.,L<\\UVVI1[XL>U<-JC&TW'I0
M!UNA "/@=JN:K_QX25D^&KL2P@EAT[FM#5YE&GR88?G0!YY:@?VS)]:]#L#\
MB_05YMI\IDUR0<]:].LX]L:'V% %ZBBB@!LOW:P=5^Z:WY!E:P]5CRAXH @T
M:4*!6X+D5R,$[6_8U8_M-O?\J .H^TBC[0*Y@:FWO^5+_:;>_P"5 '2FY%'V
MD5S7]IM[_E2?VD_O^5 '3?:15/4+@&*L7^TF]_RJ*XOFD3'/Y4UN3-71A:V^
M[=7.FNCO(3/GY3^59_\ 9I_NG\J[(5(I'CU</-RN9=%:G]FG^Z?RH_LX_P!W
M]*OVL3/ZM4[&7BC%:O\ 9I_N'\J/[-/]P_E2]K$/JU3L96*,5J_V:?[A_*C^
MS3_</Y4>UB'U:IV,K%&*U?[-/]P_E1_9I_N'\J/:Q#ZM4[&5BC%:O]FG^X?R
MH_LT_P!P_E1[6(?5JG8RL48K5_LT_P!P_E1_9I_N'\J/:Q#ZM4[&5BC%:O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 )@>@HP/04M% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E%%
M123!.M $M%9[ZK'&V#BB/58Y#@8H T*6HDE#]*D% "T444 %%%% !1110 44
M4QY M #J6H//%2*VX4 /HI*6@ HHI* "BBHY9A$,F@"2BH8K@2]*FH 6BDI:
M "BBB@ HHHH **** "DI:2@ HH-5IKM8>M %FBLQM9B4XXI8]6CD; Q0!I45
M7^U+C/%/BG$G2@"6BD+@4WS!0!)257ENEB&35=-4C8]J -"BHHIA*,BGLX5<
MT .HJC)J*1GG%+#J*3' Q0!=HIH<$5#)=+'UH L45GKJL9?;Q5N.<2=* )J*
M!10 444QW"#F@!]%0I,'Z5** %HI*6@ HHHH **** "BBB@ HHHH *2E-)0
M44A.!4)N5#8H GHIBR!J<* '44"B@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1-LY&>]=<U<#XMV^:<G^*@"*WD-RN[FM&TA(E%4]':#R?F<#BMVU-N9!AP:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW9[_ $H Y'3O"J).)]HR:UM8T9;BV5,#A<5T"0*@P*5XU<8- '-^'-)%@%P
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M3;$J^@K!UO2Q>$Y%='CBF/$K]: ,K2[$6]JR8ZKBLV;1P][YF!74+&%&!33
MI.: ,A[ >2%QVK"O]/*YPM=L8E(Q4,EE%)]Z@#C+/0Q.RL5Z<\UV.GV_V:#8
M*DCM(XONU,!CI0 M+110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 )2T44 %%%% !24M% !1110
M 4444 &**** "DI:* $I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** #%%%% !BBBB@ HHHH **** "DI:* $I:** "BBB@!,4M%% "
M44M% !1110 4444 (5##!'%0/9P/]Z,&K%% %,:;:_\ /%:E6T@3[L8%3T4
M(JA1P*6BB@ HHHH *3%+10 4444 %%%% "44M% "4M%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44E% "T4E% "T
M9HS24 +1244 +11FB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **2E
MH **** "BD-)0 ZBDHS0 M%(** %HI** %HHHH **** "BBB@ HHHH ****
M"BBDH 7-%)10 M%-I: %HI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M$HHHH R]2M!.#D5PVIZ 7N 0G>O3"H;J*A:TA8Y* T <=IVC^7&,K5K4-,\V
MW"[>U=2MO&HX6E,",,%: /.;3P\ Y)3OZ5U^E60ME  [5JBUB'1!4BHJ]!0
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MUW>-^]0X)JK;:9+;W)>;D>]=-:7]E;@909'O0!J:79",#(K:10HXK/L]0@G
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M@.RBDD7S$!YKU"&VBB'RKB@!RMMCR:Q-<OFA@_=')Q6U<\0'%<E?L6=@QR*
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MX)E7GG%<YJ,,$6?+0 U)X=>1I<$Y&Z@#LZ*** "BBB@ HHHH **** "BBB@
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>BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>img88009329_10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_10.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2$!P(# 2(  A$! Q$!_\0
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M #LTFX>H_.L[4KP00;LUSD.O;I""_?UH [7-%9FGWJSK]ZM$$'I0 ZBDHS0
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M-&N6F S6UN ZT +2U'YJ#O2B53T- #Z*3.:0L!WH =149F0?Q4"9#WH DHI
MP/2D+@=30 M%,\U?6@RKCK0!7N+KR@>:H1ZOOG,>ZJ^J22;6V#-<O937)U0@
MJ<4 >C(^Y0:D%4[9B(DW>E61(OK0 ^EJ/S4]:42H>AH ?129!H) H 6BHS*@
M/)H\^/\ O4 244P2H>].!!Z4 %03SB(9SBIFZ5ROBR^>T@)7TH V#J0_OC\Z
M!J0)^\/SKRN'7;J7H"?QJX-1OMF[8<?6@#U&*Z5_XA^=60P/>O*;#Q!<"XVO
MD?C7=:1J(NMOS9H WA129 IIE0=30 ^BF"5#T-*&!H =129IID4=30 ^BHA,
MGK3PX/0T .HI,@4TRH.IH ?14?G(>AIP8'H: '44PR*.IH$BGH: 'T4A--,J
MCJ: 'T&FAP>]#.!U- #A147G)_>IPD4]#0 ^BDW4TR*.] #Z*C\U/6E\U/6@
M!]%,\U3WI=P/2@!U%-W =Z3S5SC- #Z*3.:": %HJNUU$C89L&I%GC8<-0!)
M12 YH-  :CEE5!]X?G4%Y/Y<+$'D5P^L:Y-%N"G]: .U^VK_ 'Q^=68I?,&<
MYKR6U\07+M\V>OK7H.@737$.6]* -ZHY) @ZBF7$HCA+$UR.LZT8U(C;)% '
M327RK_&/SIT=ZK_QC\Z\P75[V;[JD_C34UV[BN45@0,^M 'KBL&7.13JYG2-
M5\^-0S<UTJL-H/M0 M0RR^6A.:>TJ#J:RM3N0MLY4T 2Q:COF*;JN23A!G->
M>Z;J,CZLZ'IFM_7;YX(01_=% &P^H!3]\?G2#4@3]\?G7F%UKMSY@"YZ^M2K
MJ5\8=X0X^M 'J,5VKG[P_.K88'H17DMGKUTDI#Y SZUW&A:D;L+DT ='12 Y
MI: %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHS24 <EXD)^>O-G&_6(P>F:])\2?QUYI+)Y>L1MZ&@#T6/3
MHGTN,[.<5QGB&W-L&*\5UD>N+%ID8R.!7(Z[J(O@P&* -;PO<N(URW:NU75H
MXK;+&N'\/PE;8MZ+4&HZIM8P[OUH ZB?Q-"'(W?K38O$\(/+?K7 QVCW,I(9
MN3ZTV]LGM3]YOSH ]?LM6BN(BP/:H[S5$A0L3Q7":)J1BB"%NH]:OZM*9+ L
M": -,>*;<.06'!]:T[/6XK@94_K7D-K ]U=. S?>]:[/2K)[6(Y+<#N: .MG
MUV&)3DC\ZQY/$\.\C</SKC]2O&:\$.X\GUJS:^&9;L"0;^?<T =E8>(892.?
MUK<CU&-T)'I7%VGA:2UP3O\ S-37%V=/C9"W;'- &Q>^(8(7*D\_6LT^)X0Q
M^;]:X:]N&NKW 8\^AITFER",/EN?>@#T>Q\102XY'YUN)=K);LZ] ,UXO#<-
M8L,L>/4UZ+HMYY^D3'/\% !<^(X8+HHQZ>]))XHM]HP1^=>=:ON?5W 8_G5[
M3M$DOB "Y_$T =>/%, (^8?G6S;:U%- 2#^M>:ZMH,FGOR7&#ZFKVE7!4"+<
M>?>@#H?$&I@VIVFO/X-3=9FR_P#$:[35]*9M-$O/-<%%IK2S,.?O&@#O] U@
M;5!:NYLYA-%N%>?>'_#CN%;YN/>N_L+4VT.PYH NU6N;M+?.ZIG;:M<=XIU/
M[.&^;'% %J^\1P1-C(_.L_\ X2>'=G=^M<@;=]3E!#,<GL:TF\(2BT\WY_S-
M '66/B."5L9'YUIR:G&Z-@]J\JCA?3I6)9N#W-=3H\QOX^I.10!B>(]1_P!)
M(SQFLK2[F(WN7&:M:_IK-==^M5=(T=I;O;S0!Z?HDT$@38H!KI!7.Z)HK601
MCGUYKHZ $)P*Y[Q)<[+3@]JW;AMD1-</XCO/,B9,T <;(DEZ[ '/-9[026]U
M'D_Q5T_ANT\^7IGFH]<T_P N?=CH: .I\.WP^SHA/-=5),%A5O45Y;HE_P"7
M>K%FO0[A]UE&?]F@"C?Z[%;$[C^M51XGMRAY'YUQWBEV#D!CU]:@TW2)+R'(
M+=/6@#L!XH@\S[WZUL:9KD-VP"G]:\[O?#<MK#YV7_,U)X6N&BN=I8\-W- '
MIEY/$ VX5S+ZA9B_5=HW?6K5[,9$;GM7!2NW]N1_,>I[T >JF[CBLU<=,5E/
MXD@C)R1^=079/]C1\GI7GM\6W-\QZ^M 'H;>*(".H_.HT\4P>:!N'YUR>F:!
M)?0%P7/&>IJC>Z1)9R$DMQ[T >DMXFMO+'(Z>M4)O%$ /WA^=<)ID+W\QB#,
M<''6M.^\+RQC/S_F: .WL?$4$I R.?>MW[8GV<2=J\;MW:RO(XRQZXZUZ/:N
M;C2U&: )+W7H8L\]/>LEO$\.?O?K52]T*2Y+8W<^]9$WA:5%)^?CW- '6VGB
M:!Y F1D^]:UY=+-9AAWKQX![+4T0LW7UKO[:]\RP1<]J .:\1'AJZ#P@VVVS
M_LUSWB'[K?2MOPNV+)O]V@#IKC68;="">?K6/)XGAWD!OUKF]9N&:=D#'\ZR
MK/2Y+R<@%N3ZT >CZ?KT4V.?UKHK6<3)D5PVE^&Y(-N=WYUV>GVY@CP<]* +
MDAVKFL34]32U4EC6S*-R8KBO%ENQA.">E &EI^NQ3@8/ZULM>+]F:3L*\GTN
M=K8J"Q_.NP_M#=I,G/:@"9O$D*W31YY'O6S8:G'<XVFO%[BZ8:I(=QZ^M=IX
M7U#YERW>@#KM1U>.U?#'O5+^VHI!UX^M<IXGNR]T &/WO6FV=NSV^_)_.@#I
M;F^M N64?G4VE7]NW^K %<9J)98\9/YUI>$8&G(Y)_&@"MXFU(K<8#=ZP;#5
M&6]!+<5K>*-+8W&>>M8-CI;2W@3F@#TC3-56=$7/:N;\929E/^]6[I.@/;*C
MG=SSUKG_ !G'ME;ZT 1Z1JD<$8R:Z.'Q-"B@%OUKA]/TM[G &[GWK6O/"TMO
M9B;Y^?<T =UIFO0W3 *>_K7012B0<5XWH$K6LY!8\-W->I:-<>>@.>U &M6+
MXA_X]?PK:-8OB'_CT_"@#RG4W(9OK7?>$+A5LSG^[7G>LR;6:M31/$(M(-NX
M#B@#N_$%PIL6Q7FU@Y.H2<_Q5J:EXE$]N4W"L'2)?,O&;U:@#U7P^X5!GTJQ
M?:W#;DJ3S]:Q=.N_(CZ]JY'7M1,MZ$#'D^M '72^)X0Y^;]:FM/$L#-R?UK@
M5TR29 ^6Y]ZAFC?3QDLP_&@#V:SU".X3*^F:JWFL109!-<MX6U+S8,;LY6K%
M_ISW;$@MS[T 2S>)H0Y&X?G3(_%$(/+?K6#+X5E+%OG_ #-8FJ:5)8 DEACW
MH ]:T_58KF+<I[>M%WJ20QEB:X?PY>&.#!8]/6K^K2EK%FR: +A\4P+(06'!
M]:D7Q)#)T/ZUY?#$]U>R*&;[WK74Z=X>D?!^?\S0!V/V^"6!F(!&*R;74;-M
M1*!1N^M0SVS6EG(I)Z>M<AIKM_PD#?,>W>@#UFZOH[>!6]JR6\2P1]2/SJKK
MC$62<G[@K@KA7D< ,W)]: /07\408^\/SHMO$\#2XW#\ZY6V\-2W%H9?G_,U
MG3:9)82%B6X]Z /7++4X[K&TTV]U6*VR&-<7X3U$R.H+9YJ#Q+?D7&P-U.*
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M5YQ6M'801?=% '-Q:6MI:N !]VO.=8RNI$8KV:[@!@< =J\KUK3I?[0+XXH
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M:R*#7F4<,ESJ<@ZC- %[0[V6V8$*>M/U2[EFW$J:V;+1G !"U/<Z*QA<E>U
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M--N[62Y7#(:UM,DM$B59.M:SRZ>RC;0!3\/67V>'IC"TFI:J;8D*>:V[,1-
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MUD3II517GD5F8+R1I!QNH TK>27'"DU$;!IKI6*'K6[IDMD%'F5?66Q:9=M
M%>*T,=JO%<[KZ90CVKO)TB-F"E</KJ$AJ -7P?9J\2GCI7="T7[.5XKD/!JD
M0KGTKNHQE* ."\56/E6Q8#M7+>&K\VLO)Q@UZ3XGMA+9X [5Y%J"2V+,5XYH
M T-7O#<WZ8YRU=KX=LLPH^*\\TZ.2YN(V;GFO7]!MPEBO% &U$,1J/:GTB\"
MAONGZ4 12S1*AW.!7.:M/$T9"N":S]=GO!,5B-8,$.I3W/S\K0!G:I#)*6VH
M35S0K"3*9C(KK+#10X'FK6_;Z3;PCY5H 72T\NUP>*H>(R/LG7M6K(Z6\1[
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M%%ABQX[T^^TEY8"O-=0L6!0T>: .'T;07MKDL0?O9KL4@^4@CM4JP[34N,4
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MFN9N?#,_FY4L/I7IVWBH7@W&@#S-?#MWTWR5T6AZ3-;8WLQ^M=0+4"I4BVT
M95QIPEB8%<DBN0OO#,K3EU!'TKTC'%1/#NH \RC\.76<;WKJ]#TJ2VCP^3QW
MK?6V -2JNV@#EM3T/SR2%YKF)O#-P)25+BO42,BH6MP30!YK'X:N&^\SFNGT
MC1?LZC<OYUT:V^*F5-M $*PA;<IBN:UW1C=1$*OY5UM,>/<* /)XO"4H;)#=
M:[G0M,-I#M([5M"V%3(FT4 5;FV$L!3%<CJ?AYI"Q12,^E=U3'CW"@#RT>&[
MI>C.*LVOA^Z696+OQ7H9M0:5;?:: ,=-/<6BH<YK#U/07G!P#7=;/EQ4;09H
M YWP_IC6<8!STKID&%IJ1;:?0!GZL@:#!&>*\I\50A=^!BO5-9<I;Y&>E>:Z
MS&]X6&UC^% !X9T\RA&QTKU'3HO+M0N*YGPKI_EVXR,<5U\:[4Q0 ^D/(-+5
M"]NS!G&: *MUIOG3!BN>:M6]A%&!^[&?I7.7?B>2&3 W_D:K?\);+_M_D: .
MY6-%'"@4[M7"?\)=+_M_D:EB\52NP'S\^QH Z748'EMW52<FO/[_ ,/74T[G
M>^#7?65X;J')S5G[,&YH \I/A.X]6J[9^&[J*5#N< &O2?LE*+4 T 4+*S9;
M$1MDGWK(U;0S,IVK@^U=8J[1BE9-PH \L/AFY4_*SBK-KX9F\Y6;<<'O7HAM
M@:<L.V@#.L-.6&!5*C(JOK6E_:HL!>U;P&!0RYH \PG\,S@_+N'TJ2/PW<;.
M2YKT5K?=2B# H XC2?#[VUSO(-;6LZ:US%@ ],5OK%M.:5TW4 >67?A>9WR-
MW6D3PW= 8WOBO3C:AJ3[(!0!Y[:^&9]_S[C]:ZS2-*%IC*UM)!MJ4+B@!$4*
M.*=1BB@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *04M% !1110 4444 &**** "BBB@ HHHH *,444 &*3%
M+10 4444 %%%% !1110 4444 %%%% "4M%% !1110 4444 %%%% !1110 44
M44 &*,444 %%%% !1110 4444 %%%% !1110 4444 %&*** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HQ110 4444 %%%% !24M% !1110 4444 %
M%)2T %%%% !1110 4444 %&*** "C%%% !1110 4444 %%%% !1BBB@ HQ11
M0 4444 %%%% !1110 4444 %%%% #2@:L^YTF&X.6_E6E10!SS^&;5FSC]*=
M%X;M4.0/TK=P*7% %.WT^*WQLJX% % I: #%%%% !1110 8HHHH *,444 %%
M%% !1110 48HHH ,4444 &**** "BBB@ HHHH **** "C%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *2EHH **** $HI:2@ I:2EH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M 2@4M% !24M% "44N** $I:** "BBB@!,44M% !12&E% !1110 4444 &***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH 8[A>M5)-1AC;#&F7]QY61FN4O?,
MFER&- '6IJ<#M@&IS=1J,DUQ5NDD+[RS8^M6KC4\+C=VH Z.3485/6G+J,)'
M6N7B@DO%+JS=,\52FN6MI?++&@#M3J$([T^*\CDZ&N(^ULXX8U<LKPPD;FH
MZUKN-3@FI%D#C(KF#<&>52&/6M^S4^4": +@I:04M !1110 4E+FDS0 M%&:
M2@!:*,T9H **,T9H **,T9H **,T9H **,T9H **,T9H **,T9H **,T9H *
M*,T9H **,T9H **,T9H **,T9H **,T9H **,T9H **,T9H **,T9H **,T9
MH **,T9H **,T9H **,T9H **,T9H **,T9H **,T9H **,T9H **,T9H **
M,T9H **,T9H **,T9H **,T9H **,T9H **,T9H **,T9H **,T9H **,T9H
M **,T9H **,T9H **,T9H **,T9H **,T9H **,T9H **,T9H **,T9H **,
MT9H **,T9H **,T9H **,T9H **,T9H **,T9H **,T9H **,T9H **,T9H
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MT<>U% "*, "G444 %%%% !24M% "4M%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% "44M% !1110 4444 %%%% !
M1110 4444 %%%% !124M !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !12
M9HS0 M%)FC- "T4F:,T +129I: "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "DH-1M*%H DHJ(3 G%29H 4T5&TP4THD!% #Z*C,@%*KAJ 'T4TMBE!S0
M ZBD%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH ES1FHMXHWB@"7-&:BWBC>* )<T9J+>*-XH ES1FHMXHWB@"7-&:BWBC>*
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MR/[U.35P6QNH^MP%]4F=5D'H:6LBSO?-8<UK#I6\)J2NCGG!P=F+FEI*6M"
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"EJ)(AXKAM6D==V&-
M=SJ/^IK@]8'WJ\W'['J8#<QS,_\ >--\Z3^\:8:2O%NSVK(D\Z3^^:/.D_O&
MHZ,T78[(?YTG]XT>=)_>-,S1FB["R)/.D_O&CSI/[QJ/-&:+L+(D\Z3^\:/.
MD_O&H\T9HNPLB3SI/[QH\Z3^\:CS1FB["R)/.D_O&CSI/[QJ/-&:+L+(D\Z3
M^\:/.D_O&H\T9HNPLB3SI/[QH\Z3^\:CS1FB["R)/.D_O&CSI/[QJ/-&:+L+
M(D\Z3^\:/.D_O&H\T9HNPLB3SI/[QH\Z3^\:CS1FB["R)/.D_O&CSI/[QJ/-
M&:+L+(D\Z3^\:/.D_O&H\T9HNPLB3SI/[QH\Z3^\:CS1FB["R)/.D_O&CSI/
M[QJ/-&:+L+(D\Z3^\:/.D_O&H\T9HNPLB3SI/[QH\Z3^\:CS1FB["R)/.D_O
M&CSI/[QJ/-&:+L+(D\Z3^\:/.D_O&H\T9HNPLB3SI/[QH\Z3^\:CS1FB["R)
M/.D_O&CSI/[QJ/-&:+L+(D\Z3^\:E@FD\P?,:K9J6#_6"FF[B:5CK]$=C(,D
MUV(^Z/I7&:'_ *P5V:_='TKW\'\!\]C?X@M+1BC%=AQ!1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% %+4?]37":Q_%7=ZC_ *FN$UC^*O,Q^QZF
M7[F":2E-)7C'MA24M)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !4T'^M%0U-!_K!0MQ/8ZW0_P#6"NT7[H^E<7H?^L%=HOW1]*^@P?P'
MSV-^,6BBBNPX@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *,U'(VVLZ:\9&H U,TN:QDU#+8+5;6[7'+
M"@"]FC-9<U]M/#9IR7RE>7&: -+-&:SFO5 X84^"Z5S]X4 7LT54>X4-C<*E
M1]PS0!-12"EH **** #-&:2B@!<T4E+0 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% %+4?]37":Q_%7=ZE_J:X/5_XJ\S'['J9?N81I*4TVO&/;
M%I*6DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J:#_6B
MH:F@_P!:*%N)['6Z'_K!7:+]T?2N+T/_ %@KLU^Z/I7T&#^ ^>QWQCJ***[#
MB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,$TAI6I*\8]L2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% %+4?]37":O_ !5W>H_ZFN$UC^*O,Q^QZF7[F$:::4TE>,CV
MQ**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *E@_P!8
M*BJ:#_6"A;B>QUNA_P"L%=HOW1]*XO0_]8*[1?NCZ5]!@_@/GL=\8M%%%=AQ
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !11FB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MFDHH 7-)FB@4 +FC-)10 M%(*6@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** *6H_ZFN$UC^*N[U'_4UPFL?Q5YF/V/4R_<
MP324II*\8]L*2EI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** *6H_P"IKA-8_BKN]1_U-<)K'\5>9C]CU,OW,$TE*>M)7C'MA24M
M)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4T'^M%0U-!
M_K10MQ/8ZW0_]8*[-?NCZ5QNA_ZP5V0^Z/I7T&#^ ^>QWQCJ*2EKL.(****
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M"!7%H[0D#%:^GWLK2!<'% '5 TZHXCF-3[5)0 4&B@T 1L^VF>=3G&:BV>U
M#O.I?/IFRC90 _SZ//J/9[4NR@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&
MR@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&
MR@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&
MR@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&
MR@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&
MR@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&
MR@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&
MR@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&
MR@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&
MR@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&
MR@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&R@!_GT>?3-E&R@"MJ$V8:XC5
MFSNKM=03]S7$:L,;J\S'['J9?N8IZTE!ZTE>,>V+24M)0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !4L)Q(*BJ6'_ %@H6XGL=7HDF)!7
M8B;Y1]*XO11^\%=@%^4?2OH,'\!\]COC)//H\^H]E&SVKL.(D\^CSZ9LHV4
M/\^CSZ9LHV4 /\^CSZ9LHV4 /\^CSZ9LHV4 /\^CSZ9LHV4 /\^CSZ9LHV4
M/\^CSZ9LHV4 /\^CSZ9LHV4 /\^CSZ9LHV4 /\^CSZ9LHV4 /\^CSZ9LHV4
M/\^CSZ9LHV4 /\^CSZ9LHV4 /\^CSZ9LHV4 /\^CSZ9LHV4 /\^CSZ9LHV4
M/\^CSZ9LHV4 /\^CSZ9LHV4 /\^CSZ9LHV4 /\^CSZ9LHV4 /\^CSZ9LHV4
M/\^CSZ9LHV4 /\^CSZ9LI-GM0!*)<T\-FH IJ910 _-%%% $,\2R Y%<AJ>G
MW#3YCZ?2NV(J-HD;JH/X4 <39V-V9,2?=^E:D^E@H,+SBNA$* \(/RI^Q?04
M <--97<38BX'TJS:Z;*6#N/FKK3"A_@'Y4X1*!]T4 8SP2&$+Z5#%IYS\PK?
MV#T%+L'H* ./N]-D,PVCC-:%A8LA!(YK>,2D_=%*$ Z 4 +&,(!3J*#0 444
M4 )C-)M%.I"* $VBEVBEHH 3:*-HI:* $VBC:*6B@!-HHVBEHH 3:*-HI:*
M$VBC:*6B@!-HHVBEHH 3:*-HI:* $VBC:*6B@!-HHVBEHH 3:*-HI:* $VBC
M:*6B@!-HHVBEHH 3:*-HI:* $VBC:*6B@!-HHVBEHH 3:*-HI:* $VBC:*6B
M@!-HHVBEHH 3:*-HI:* $VBC:*6B@!-HHVBEHH 3:*-HI:* $VBC:*6B@!-H
MHVBEHH 3:*-HI:* $VBC:*6B@!-HHVBEHH 3:*-HI:* $VBC:*6B@!-HHVBE
MHH 3:*-HI:* $VBC:*6B@!-HHVBEHH 3:*-HI:* $VBC:*6B@!-HHVBEHH 3
M:*-HI:* $VBC:*6B@!-HHVBEHH 3:*-HI:* $VBC:*6B@!-HHVBEHH 3:*-H
MI:* $VBC:*6B@!-HHVBEHH 3:*-HI:* $VBC:*6B@!-HHVBEHH 3:*-HI:*
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M10 W:*7%+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!2U'_ %-<)K'\
M5=WJ/^IKA-8_BKS,?L>IE^Y@FDI325XQ[84E+24 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5-!_K!4-30?ZP4+<3V.MT/_6"NT7[H^E<
M7H?^L%=HOW1]*^@P?P'SV._B"T445V'$%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 &:*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !4L'^L%15-!_K10MQ/8ZW0_P#6"NT7[H^E
M<7H?^L%=FOW1]*^@P?P'SV._B#J***[#B"BBB@ HHHH **** "BBB@ HHHH
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M(]:,CUH 7-&:3(]:,CUH 7-&:3(]:,CUH 7-&:3(]:,CUH 7-&:3(]:,CUH
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M%% !1110 4444 %%%% !1110 4444 %%%% !4T'^M%0U-!_K!0MQ/8ZW0_\
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MAR6YB;%7+"VD\X-DXH ZM#E0:=3(N(E'M3Z "D-+10!!(6[5"3)5PBDV#TH
MIYDHW25<V#THV#TH I[I*-TE7-@]*-@]* *>Z2C=)5S8/2C8/2@"GNDHW25<
MV#THV#TH I[I*-TE7-@]*-@]* *>Z2C=)5S8/2C8/2@"GNDHW25<V#THV#TH
M I[I*-TE7-@]*-@]* *>Z2C=)5S8/2C8/2@"GNDHW25<V#THV#TH I[I*-TE
M7-@]*-@]* *>Z2C=)5S8/2C8/2@"GNDHW25<V#THV#TH I[I*-TE7-@]*-@]
M* *>Z2C=)5S8/2C8/2@"GNDHW25<V#THV#TH I[I*-TE7-@]*-@]* *>Z2C=
M)5S8/2C8/2@"GNDHW25<V#THV#TH I[I*-TE7-@]*-@]* *>Z2C=)5S8/2C8
M/2@"GNDHW25<V#THV#TH I[I*-TE7-@]*-@]* *>Z2C=)5S8/2C8/2@"GNDH
MW25<V#THV#TH I[I*-TE7-@]*-@]* *>Z2C=)5S8/2C8/2@"GNDHW25<V#TH
MV#TH I[I*-TE7-@]*-@]* *>Z2C=)5S8/2C8/2@"GNDHW25<V#THV#TH I[I
M*-TE7-@]*-@]* *>Z2C=)5S8/2C8/2@"GNDHW25<V#THV#TH I[I*-TE7-@]
M*-@]* *>Z2C=)5S8/2C8/2@"GNDHW25<V#THV#TH I[I*-TE7-@]*-@]* *>
MZ2C=)5S8/2C8/2@"GNDHW25<V#THV#TH I[I*-TE7-@]*-@]* *>Z2C=)5S8
M/2C8/2@"GNDHW25<V#THV#TH I[I*-TE7-@]*-@]* *>Z2C=)5S8/2C8/2@"
MGNDHW25<V#THV#TH I[I*-TE7-@]*-@]* *>Z2C=)5S8/2C8/2@"GNDHW25<
MV#THV#TH I[I*-TE7-@]*-@]* *>Z2C=)5S8/2C8/2@"GNDHW25<V#THV#TH
M I[I*-TE7-@]*-@]* *>Z2C=)5S8/2C8/2@#(OR_E5Q>JY^;-=]J*CR>E<+K
M ^]7F8_8]3+]S"I*4TE>,>V%)2TE !1112 ****8!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %30?ZT5#4T'^M%"W$]CK=#_ -8*[1?NCZ5Q>A_ZP5VB_='TKZ#!_ ?/
M8WXQ:***[#B"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "DQ2T4 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!2U'
M_4UPFL?Q5W>H_P"IKA-8_BKS,?L>IE^Y@FDI325XQ[84E+24 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5-!_K14-30?ZT4+<3V.MT/\
MU@KM%^Z/I7%Z'_K!7:+]T?2OH,'\!\]C?C%HHHKL.(**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHS24 +1110 44E+0 444E "T4E+0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% %+4?]37":Q_%7=ZC_J:X36/XJ\S'['J
M9?N8)I*4TE>,>V%)2TE !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %30?ZT5#4T'^M%"W$]CK=#_U@KM%^Z/I7%Z'_ *P5VB_='TKZ#!_
M?/8WXQ:***[#B"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ --I34,LH12<T 2TM9*:GNG*;JNM<!5!S0
M!8I:QKG53$V 34L.H[TR6H U**S7U':,[J?;7WG'DT 7Z2JDEUM;&:FCEWC-
M $PI:04M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M110 FT48%+10 8HQ110 F!1BEHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH I:C_ *FN$UC^*N[U'_4UPFL?Q5YF
M/V/4R_<P324II*\8]L*2EI* "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *F@_UHJ&IH/\ 6BA;B>QUNA_ZP5VB_='TKB]#_P!8*[1?NCZ5
M]!@_@/GL;\8M%%%=AQ!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% %+4?\ 4UPFL?Q5W>H_ZFN$UC^*O,Q^QZF7[F":2E-)7C'MA24M)0 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4T'^M%0U-!_K10MQ/8
MZW0_]8*[1?NCZ5Q>A_ZP5VB_='TKZ#!_ ?/8WXQ:***[#B"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS,*>R9J/R: '><*/.%-\JD\KVH ?YXH\\4SRO:CRO:@!_GBCSQ3/*]J/*]J
M'^>*//%,\KVH\KVH ?YXH\\4SRO:CRO:@!_GBCSQ3/*]J/*]J '^>*//%,\K
MVH\KVH ?YXH\\4SRO:CRO:@!_GBCSQ3/*]J/*]J '^>*//%,\KVH\KVH ?YX
MH\\4SRO:CRO:@!_GBCSQ3/*]J/*]J '^>*//%,\KVH\KVH ?YXH\\4SRO:CR
MO:@!_GBCSQ3/*]J/*]J '^>*//%,\KVH\KVH ?YXH\\4SRO:CRO:@!_GBCSQ
M3/*]J/*]J '^>*//%,\KVH\KVH ?YXH\\4SRO:CRO:@!_GBCSQ3/*]J/*]J
M'^>*//%,\KVH\KVH ?YXH\\4SRO:CRO:@!_GBCSQ3/*]J/*]J '&<5$]V$&:
M<T.%K$UJ<VT&X54(\SL)NR-,ZFOM2?VHOM7F=QXC>-CRW6JW_"4OZM76L(S!
MUT>K?VHOM1_:B^U>5?\ "4/ZM1_PE#^K4?5)![='JO\ :J^U']JK[5Y5_P )
M0_JU'_"4/ZM1]4D'MT>J_P!JK[4?VJOM7E7_  E#^K4?\)0_JU'U20>W1ZK_
M &JOM1_:J^U>5?\ "4/ZM1_PE#^K4?5)![='JO\ :J^U']JK[5Y5_P )0_JU
M'_"4/ZM1]4D'MT>J_P!JK[4?VJOM7E7_  E#^K4?\)0_JU'U20>W1ZK_ &JO
MM1_:J^U>5?\ "4/ZM1_PE#^K4?5)![='JO\ :J^U']JK[5Y5_P )0_JU'_"4
M/ZM1]4D'MT>J_P!JK[4?VJOM7E7_  E#^K4?\)0_JU'U20>W1ZK_ &JOM1_:
MJ^U>5?\ "4/ZM1_PE#^K4?5)![='JO\ :J^U']JK[5Y5_P )0_JU'_"4/ZM1
M]4D'MT>J_P!JK[4?VJOM7E7_  E#^K4?\)0_JU'U20>W1ZK_ &JOM1_:J^U>
M5?\ "4/ZM1_PE#^K4?5)![='JO\ :J^U']JK[5Y5_P )0_JU'_"4/ZM1]4D'
MMT>J_P!JK[4?VJOM7E7_  E#^K4?\)0_JU'U20>W1ZK_ &JOM1_:J^U>5?\
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MOM]:HU[4=CSV%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M***!A2C[PI*4=10!OZ(/]*2O6=-'^BQ_2O)]$_X^HZ]8TW_CUC^E>=B]SKH;
M&CBC% I:X3H$Q1BEHH 3%&*6B@!,48I:* $Q1BEHH HZB/W-<+K'\5=WJ/\
MJ:X36/XJ\S'['J9?N8)I*4TE>,>V%)2TE !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %2P?ZT5%4T'^L%"W$]CK-#_ -8*[11\H^E<7H?^
ML%=JOW1]*^@P?P'SV._B!BC%+178<0F*,4M% "8HQ2T4 )BC%+10 F*,4M%
M"8HQ2T4 )BC%+10 F*,4M% "8HQ2T4 )BC%+10 F*,4M% "8HQ2T4 )BC%+1
M0 F*,4M% "8HQ2T4 )BC%+10 F*,4M% "8HQ2T4 )BC%+10 F*,4M% "8HQ2
MT4 )BC%+10 F*,4M% "8HQ2T4 )BEQ110 4444 !I*4T8H 2BBEQ0 @HI:,4
M )12TE !1110 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_CU/TKIG^Z:YGQ+_ ,>I^E:T?B1%38\JO?OM]:HU>O?OM]:HU[4=CSV%%%%
M@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "E'44E*.HH&=!
MHG_'TE>L:=_QZQ_2O)]$_P"/I*]8T[_CUC^E>=B]SKH&B*6D%+7"= 4444 %
M%%% !1110 4444 4M1_U-<)K'\5=WJ/^IKA-8_BKS,?L>IE^Y@FDI325XQ[8
M4E+24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5-!_K14
M-30?ZT4+<3V.MT/_ %@KM%^Z/I7%Z'_K!7:+]T?2OH,'\!\]C?C%HHHKL.(*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BD-)N% "YI:;N!I: %HINX"C<* '44W<* V: '44TFC- #J
M*04M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 -?[IKF?$O_'J?I73/]TUS/B7_CU/TK6C\2(J
M;'E5[]]OK5&KU[]]OK5&O:CL>>PHHHH$%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4HZBDI1U% SH-$_X^DKUC3O\ CUC^E>3Z)_Q])7K&
MG?\ 'K']*\[%[G70-$4M(*6N$Z HHHH **** "BBB@ HHHH I:C_ *FN$UC^
M*N[U'_4UPFL?Q5YF/V/4R_<P324XTPUXQ[8M)110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !4T'^M%0U-!_K10MQ/8ZW0_\ 6"NT7[H^
ME<7H?^L%=HOW1]*^@P?P'SV-^,6BBBNPX@HHHH **** "BBB@ HHHH ****
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MZF1#$:@^E/H *#110!#(Q'2H#(_I5PJ#3=B^E %3S']*/,?TJWY:^E'EKZ4
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MF2>E7/+7TH\M?2@"GYDGI1YDGI5SRU]*/+7TH I^9)Z4>9)Z5<\M?2CRU]*
M*?F2>E'F2>E7/+7TH\M?2@"GYDGI1YDGI5SRU]*/+7TH I^8_I1YC^E7/+7T
MH\M?2@"H)'STJ=&)I_EKZ4H4"@ S13J* (98]^:R;C2O-?.VMRDQ0!@PZ2R/
MG!K06TP!D9J]BEQ0!C7&F&1\@=^U6(+(1I@KS6CBB@"I]F]J<L"C^$?E5FDQ
M0!FS6.]P=M6(;<1CI5O%&* $'%+110 4444 )12T8H 2EHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!C]*YGQ+_
M ,>I^E=,_P!TUS7B7_CU/TK6C\2(J;'E-[]]OK5*KU[]YOK5&O9CL>>PHHHI
MB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *4?>%)2C[PH&
M=!HG_'U'7K&G?\>L?TKR?1/^/N.O6-._X]8_I7G8LZZ!HBEI!2UPG0%%%% !
M1110 4444 %%%% %+4?]37":Q_%7=ZC_ *FN$U?^*O-Q^QZF7[F"U)3C3:\4
M]L2BE-)0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4T'^
MM%0U-!_K10MQ/8Z[0_\ 6"NS'W1]*XS0_P#6"NS7[H^E?08/X#Y['?&+1117
M8<04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 U_NFN9\2_\>I^E=,_W37,^)?^/4_2M:/Q(BIL>57OWV^M4:O7OWV^
MM4:]J.QY["BBB@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !2K]X4E*.HH&=!HG_'VE>L:=_QZQ_2O)]$_X^TKUC3O^/6/Z5YV+W.N@:(I
M:04M<)T!1110 4444 %%%% !1110!2U'_4UPFL?Q5W>H_P"IKA-8_BKS,?L>
MIE^Y@GK3:<:2O&/;#M24M)0 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !4T'^L%0U-!_K10MQ/8ZW0_P#6"NT7[H^E<7H?^L%=HOW1]*^@
MP?P'SV._B"T445V'$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !0*** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=WJ/^IKA-8_BKS,?L>IE^Y@FDI325XQ[84E+24 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5-!_K14-30?ZT4+<3V.MT/_6"NT7[H^E<7
MH?\ K!7:+]T?2OH,'\!\]C?C%HHHKL.(**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBHVDVT 245"LV
M3BI"V!0 ZBJTET$.*<L^X9H GHJ!I\4L<V^@":BHVDP:<&S0 ZBBB@ HHHH
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MS)&^TY%7]#@2:W)<?PUA:FF+[8E &D=8<KWJW8:F6(R:Q5LY@@8CBF[GAZ4
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MI NDKU;3I!]EC^E>=B]SKH&H*6H_,%'F"N$Z"2BH_,%'F#UH DHJ/S!1Y@H
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBC%&* "BC%&* "BC%&* "IH/]8*AJ:#_ %@IK<3V.MT/_6"NT7[H^E<7H?\
MK!79K]T?2O?P?P'SV.^,=124M=AQ!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )115:XN$B'S'%
M %@L!W%&1ZUAS7^6^0Y%30ZC'MPS<T :V[WI0P/>LN6_CV9#4EK>JQY:@#5S
M15%KQ V-U31R;^10!9HI!2T %%%% !2$TM)0 9I:2EH **** "BBB@ HHHH
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MW,,TE*:2O&/;"BBDH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH
M6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH 6BDHH
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M $QFC;2T4 )MHVTM% ";:-M+10 FVC;2T4 )MHVTM% ";:-M+10 FVC;2T4
M)MHVTM% ";:-M+10 FVC;2T4 )MHVTM% ";:-M+10 FVC;2T4 )MHVTM% ";
M:-M+10 FVC;2T4 )MHVTM% ";:-M+10 FVC;2T4 )MHVTM% ";:-M+10 FVC
M;2T4 )MHVTM% ";:-M+10 FVC;2T4 )MI,4ZB@ Q124M !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 F*,44M ";:-M+10 F
MVC;2T4 )MHVTM% ";:-M+10 FVC;2T4 )MHQ2T4 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !28I:* &XHQ3J2@!,4N*6B@
M!-M&VEHH 3;1MI:* $VT;:6B@!-M&VEHH 3;1MI:* $VT;:6B@!-M&VEHH 3
M;1MI:* $VT;:6B@!-M&VEHH 3;1MI:* $VT;:6B@!-M&VEHH 3;1MI:* $VT
M;:6B@!-M&VEHH 3;1MI:* $VT;:6B@!-M&VEHH 3;1MI:* $VT;:6B@!-M&V
MEHH 3;1MI:* &XI:6B@!**6B@ I,4M% "8HQ2T4 -(I<4M% "8HQ2T4 )BC%
M+10 E+110 4444 %%%% "4M&** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** $Q2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !28I:* $Q2T44 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 )2YI** %H-)2T )1FEHQ0 E%+2&@ HHI: "BBB@ HS1
M24 %%%% !2TE+0 444E !1110 444M !1110 4E+24 %+244 +1110 4444
M%%%% !1110 4444 %%%% !1110 4444 % HHH **** "BBDH **** #-+244
M +1244 +FBDHH 6BBB@ HHHH 3-+1BB@ HHHH **** $S12XI* %H-%)0 M%
M%)0 M&:2EH 3-%%% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M% !1110 4444 %%%% !1110 UW"#)JI+J<,7WOYTNH-MBS7":W?&,GYB/QH
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M W#F@#N@:*IV-X+J+<*N"@!:*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU?WR0Q.-W.* +TMS$@_UB_G587\>?]8OYUY[?:M>273)$<CZU7\S5CR%Z^]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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1%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>img88009329_11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_11.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" -[!O,# 2(  A$! Q$!_\0
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M@044M% "44M% @HHHI@%+110 44M% "44M)2 6BBBF(***6@!*6BB@044M%
M"4M%% @HHHI@+1110 4M%+2$)2TE** "BBB@ HHI:8@HHHH$%%+24 %+110
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M=;!UJ,>><;+OI_3V*-;'AO2H-8U1K:X>14$1?,9 .01Z@^M8]=/X%_Y#[_\
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M]<M->S8/\*,54?@*Z/2+6:#P+J<TRE1."Z9ZD8 S2Q?ME"+J-+WEHO7O_P
M> ^KN<U24G[LM6UV[)?J5/ /_(=G_P"O9O\ T):P-2O9-0U">ZD8L9')&>P[
M#\JW_ /_ "'9_P#KV;_T):Y:NBE%/%U)=;1_4Y:TVL#2CT;E^G^9UG@3_C\O
MO^O?^M5/!7_(R1?]<W_E5OP)_P ?E]_U[_UJIX*_Y&2+_KF_\JY:^^)]%^3.
MO#;83_$_S12\0WDM[KMV\C$A)&C0$]%!P*T_ LKKKCQ!OW<D+;E['&,?Y]ZP
M]4_Y"][_ -=W_P#0C6SX'_Y&(?\ 7%OZ5T8F*6!:2TY3FPDY2S&,F]7+]2/P
MW8Q7/BI(V4>7$S/M/^ST_7%4M?OI+_6KJ61B0LA1!Z*#@5>\.7:6?BT&0@)(
M[QDD]">GZXJCK]C)8:U=1R*0&D+H?52<BB'^]^]_*K??K^@JG^X^[_.[_=I^
MI+X9OY+#7;8JQ"2N(I%[$$X_0\U+XO\ ^1IO/^ ?^@+47AFQDOM=M0JDI$XE
MD/8 '/\ / J3Q?\ \C3>?\ _] 6CW?KVF_+K]Z'[_P#9NNW.K?<[F)73>!?^
M0^__ %P;^:US-=-X%_Y#[_\ 7!OYK6F/_P!VGZ&66?[Y3]3GKK_C[F_ZZ-_.
MHJENO^/N;_KHW\ZBKIC\*..?Q,ZWPP18Z!JVJ( 9T7RT)'W>/\2/RKDV9G8N
M[%F8Y))R2:ZSPQB^T#5=*0@3NOF(#_%Q_B!^=<FRLCE74JRG!!&"#7'AOX]6
M^]U]UM#OQ=_J]#E^&S^^^OZ'5>"K@RW-SI<WSVT\1)4]CT_D?T%1^%KBWT_5
M[RTN91&95:%93P 0?TS3_!4!BN;G4Y?EMK>)@6/0GK_(?RK*L],NM<FO)K;R
M]Z9E9&)RV<G XY_^O7/4C"52M&3M&T;OS_JQU4IU(4L/**O).5EY?U>Q;N_!
M^KVS'RX5N$[-$PY'T/-9UW=:BEK'IMV9$BB.Y8I$P5Z^V>YIMMJFH6>!;WD\
M87^$.<?ETKIKVY?5_ [7U^B_:890L4F,%QD G]3^5;2G5I2C[9*2;2OLTWUM
M_D80IT*T9N@Y1:3;3=TTMU?3\1FE1QZUX4;2()TBO(Y/,V.<;QG/]?T%9%QX
M<UFQ;S#9R'8<AXCN_'CFH&TBZBTB/5E9&@9]OR$[E.2.>..1_*GV?B'5;-U,
M5Y*X!^Y(V\'VP:(PJ1<G0DFFW=/OUU_X 3J4I1A'$Q::2LUVZ:/]&5;Z^N[^
MY,MY(7F VDE0.!VP*K5U/C6&);JSN!&(YYXMTJCUXZ_J/PKEJZ,+4C4HQE%6
M78Y<;2E2KRA.5WW[G0>#/^1CB_W'_E5C0+Q8/%-U;2\PW;R1,.V<G'^'XU!X
M,_Y&.+_<?^59-W(T.K3RH<.D[,#Z$-7+4I*K7J0?6*_-G92K.CAJ51=)O\D)
M?V3V6I3V9!+1R%!W)';\QBM[Q.1I^FZ=HJ$9B3S9<=V/_P!?=6RVG1ZMKFF:
MRJ@6[P^;+Z!EZ9_$@?\  :XS5[XZCJUS=9^5W^3_ '1P/T J:-5XFI"_V5=_
MXMO\R\116$I5+?;=E_AW_P D;'B?_D$Z!_UZ#_T%:L,[:5X#B,/RRWLA#NO7
M'/\ 0 ?B:K^)_P#D$Z!_UZ#_ -!6K#(VJ^ XA"-TME(2Z+UQS_0@_@:Q5O84
MN;;FU^]V_$WE?ZS6Y?BY%;[HW_"YR==9I,AU+P?J=G.=WV1?-C)_A&"0/_'3
M^=<E76:3&=-\'ZG>3 K]K7RHP?XA@@'_ ,>/Y5V8^WLUWNK>M_\ *YP99?VL
MK_#RROZ6_P ["Z6QTOP7>7\6!<3OY8;NHSC_ !-<GU-=9I2G5/!EYI\7-Q _
MF*@ZL,Y_Q%<GTHPGQU;_ !<WX6T'CK^SHV^'E_&[O^)U_AV^DF\,:Q:2,6$-
MN[)GL"K<?I^M1^";;=/>W:1B2:"("-<]6;/^&/QI_AVQDA\-:Q>2*56:W=8\
MCJ K9/Z_I47@R5'?4+ OL>YA^1@<'(R./?YL_A7#6MR8CV?=?I?];GHX?F]I
MA?:]G;\>7]+%6?PQX@N9WFFM"\CG<S&9.3_WU6QX9T;5M.O9([RVVV<T960&
M12,]N ?J/QKE;B?4;6XD@FN+A)$.U@9&JYI=KJNK-*(+N1%B7<TDDK!1[9]:
MZ:\*LJ+4Y14?1_*VOW')AJE"&(3IPFYI[77SO[OWE[PQ +;Q>\ S^[,J<^V1
M6)J?_(6O/^N[_P#H1K6\($MXF0L^\E7RWKQUK)U/_D*WG_7=_P#T(UI3NL7*
M_P#*OS9C6L\%%K^>7Y(JT445WGFA1110 44M% A,4N*** #%%%% !2XHHH$&
M*,44M !11BB@04M%% !1110 444M,0E+110 4M%% "4M%% !BBBB@ HHI:8A
M,4M%% !1110(*6BB@ Q1110 M%%% @I:2EH ****0!2XI*6F(**** #%%+10
M(2EQ12T"$I:2EH **** "EI*6@ HHH- @HHI:!"4M)2B@ I:2EH **** "BB
MB@ HI:2@ I:2EH$)2TE+0 4444 %%%% !1110 4444"$HI:,4#$I:,4E !12
MTE !11BB@ HHHH *3%+12 2C%+24 )BBEI* "BBB@ I*6B@!*3%+10,2BC%%
M !1110 E%+24 %)2T4AB4E+10 E%%% "4444##%)BEHH 2DI:* $I*6B@8E%
M&** #%)2T4 )24M% Q*,4N*2D,2DI:*8"4444AB44M)0 4E+24 %)2T4#$HH
MHH 3%%+10,2BEI*0!BBBBF!6I:**T*->^UW[9H5GI:VWE+;G<7WYWG![8XZF
MFZ5K?]E6-_ EOODNX]@EWXV#!'3'/6LFEK#ZM2Y'"VC=_G>_YG1];K>T52^J
M5NFUK?D%:VGZU]@T>^L5M]SW8P9=^-HQC&,<]^_>LFBKJ4XU%RR6G^1E2JSI
M2YH.SU7WZ"T4E+5F85T4_BR:7P]'I4=OY9$:Q--YF2RCMC'&?K7.T5E4H4ZK
M3FKVU1O1Q%6BI*F[<RL_06M;1-:_L;[4RV_FR3Q^6K;]NSWZ'/;\JR*6JJ4X
MU(N$U=,FE5G2FIP=F@K=T3Q++HEC<V\4 D:4[D<O@(V,9QCGMZ5A44JM&%:/
M)45T.C7J4)\]-V8YF:1V=V)9B22>I-2VEU-974=S;N4E0Y5A4-%6XIJSV(4F
MGS)ZG3OXKM+K$E_H5K<3XP9 VW/Z'^=5-2\375]:_9((H[.TQCRH1C(]":PZ
M*YHX*A%IJ.WFW^#T.N>88F<7%RWWT2;]6E=A11174<1J:#K']B:@;KR/.S&4
MV[]O4CG.#Z5G2OYDSR8QN8G'IFF45FJ<5-S2U?Z&CJS=-4V]%>WS"MB37?,\
M,PZ/]FQY;[O-W]?F)Z8]_6L>EHG3C.W,MG=>HZ=:=/FY':ZL_0GLKVXT^Z2Y
MMI"DJ'@CO['U%;[^*K.Z(DOM!M9Y\<R!MN?T/\ZYFBLZN&I57S26O?5?D:4<
M76HQ<8/3LTFON=S8U7Q%<ZG MJD4=M9IT@B&!^-5=)U:YT:[^T6Y!R,.C=&'
MO5&BFL/25/V:CHQ2Q5:5557+WEU.E/B;3O,\U?#MJ)\YW%\C/KC;48\774T5
M]%>Q"=+J,1JJML$7!Z#!]?TKGJ2LOJ-#^7\6_P!=#;^T<3TE;T27EK9:_,UM
M UG^P[][G[/Y^^,Q[=^W&2#G.#Z5E445T*G&,G-;NU_D<TJLY05-O17M\]S6
MT+6_[%FGD^S^=YL>S&_;CWZ&HM%U3^Q]26\\GSMJD;=VWJ/7!K.I:B5"G+FN
MOBW+CB:L>2S^#5>1+=3_ &F\GN-NWS9&?;G.,G-7-#U;^QM1^U^3YWR%=N_;
MU]\&LZBJE3C.'LY+38F%:<*BJQ?O)W)0)+N[Q$A,DK_*HZY)Z5T \2S1Q"SU
MK2X[MHNGG#8Z\=\BN<CD:*19$8JZ$,I'8BNEDUW1M5"2:QITIN57!EMVQN^H
MR/ZUS8J%W&\.9>6Z_%'7@ZEE+EJ<LGW^%KST>OJB;3-;?4-5L[#3[**QMS,L
MDBP\LX7GDX''%97BF59O$MZRD$!@O'LH']*OKX@TO2XI/[%TYTN'&WSYSDJ/
M89-<RS,[EV)+,<DGN:SPU"U5U%'E5K:[ONWN:XS$7H*BY\TKW=MEI9):+N]D
M)6GH6K_V+J!NO(\[,93;OV]2.<X/I6917;4IQJ1<);,\ZE5E2FJD'9HZ<^)M
M*9BQ\-6Q).23(/\ XBD_X272?^A9M?\ OL?_ !%<S17-]1H=G_X%+_,[/[2Q
M'=?^ Q_R)[.\GL+I+FVD*2H>"*WV\4VER1)?:%:W$^.9 VW/UX-<S16M7#TZ
MKYI+7YK\C"CBZU%<L'IV:37W.YM:IXCN=1MA:1Q1VMF/^6,0X/UJAI]_<:9=
MK<VK[9%XYZ$>A]JJ4M.-"G"'LTM!3Q-6=15)2]Y=>WH=*_B:PG8RW/A^UDG/
M+.'QD_3%9^KZ]<ZLJ1,B0VT?W(8QA165140PE&$E**U7FW;TN:5,=7J1<92T
M>^B5_6RU-;2->N=)5XE1)[:3[\,@R#5]/$UA PEMO#]K'..0Y;(!^F!7-4M$
M\)1G)R:U?FU?UL%/'5Z<5",M%M=)V]+K0LW]_<:G=M<W3[I&XXX 'H!Z56H%
M%;QBHKEBK(YI2E.3E)W;-#1=3_L?4EN_)\W:I&S=MZCUP:IW$OGW,LV-N]RV
M,YQDYJ.BI5.*FYVU>A3JS<%3;T3O]YNV7B6:ST";2UBW;]P27?C8&ZC&.>_?
MO6%112IT84VW%6OJRJE>I548S=U%67H:>J:O_:5I80>1Y?V2+R]V_._@#/3C
MI4>EZM=:1<F:U<?,,.C#*L/>J%+25&FH>SMIV&\15=3VM_>[^FATO_"2Z<S^
M:_AZU,Q.2V[C/KC;69JVMW>L2*9RJ1)]R)!A5_\ KUFT5%/"T:<N:*U]6_S-
M*F-KU8N$I:/LDK^MDKEJPU"YTVZ6XMI-CC@^A'H16V_B>QG8RW&@VLDYY+[L
M GW&*YNBG4PU*I+FDM?FOR)I8NM1CR0>G9I/\[G1MXNN98KR*:!#'/"88T1M
MJQ @C.,'/7]*P(9I+>9)H7*2(<JRGD&HZ*JG0I4TU!6N*KBJU9IU)7:V.E/B
MJ&Z1?[2TBVNI5&/,SM)_0U6O_$DMS9FRM+:*RM3]Y(NK?4UABEK..#H1::CM
MYNWW;&L\PQ,TTY;^2N_G:YH:-J?]D:BMWY/F[5(V[MO4>N#56YG^TW<T^W;Y
MCL^W.<9.<5#16RIQ4W/J]#F=6;IJFWHG?YBTM)15F84M)13 6BBB@ HHHH *
M,44M @HHI: "BBB@ I:2EH$%%%% !2T44 %%%%,044M% !112T"$HI:2@ I:
M** "BBBA %%%+0(**** "BEHH ****!!2T44P"BBB@ I:2EI"$IU)10 M)2T
M4P"BBEH$)2BDI:!,**** "EI** %I*6B@0444M "4M%% @HHHH *6DI: "BB
MB@ HHI:!"4M)2T#$HI:*!!1110 4444 %%%+2$)1113&%%%%(044<44 %%%%
M !124M "44M)0 4444#"BBB@ I*6@T )1110 E%+24 %%%% !24M)0 4444
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M44M% QM%+10 E%%% %:BBBM1A12TE "T444 %%%+0 E%%% "T44"D 44N**
M 444M "444M !1110,**** "BBB@ HHHI %%%% !1110,***6@ HHH[T %%)
M2T@"BBB@ HHHH&%%%% !1110 444M "4M%% !1112 **!13 *6DHI#%HHHH
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M*2EI*!"TE+10 E%+10 E%%% Q**6B@!,44M)0 4444 )1112 **** $HHHH
M*2EHH&)24M% "44M)0 4444 )1110 4E+10,2DI:* $HI:* $I*6B@8E)2T4
M )1112 *2EI*!A24M)0 4E+10,2DIU)0 F**6B@!*2EQ10,2DI:* $HI<4E(
M84444 %)2TE "44M% "4444 5J***U **1W6-=SL%'J:J-J=NIXWM]!2<DMV
M4HRELBY15+^U8/[DGY#_ !H_M2#^Y)^0_P :GVD.Y7LI]B]15'^U8/[LGY#_
M !H_M6#^Y)^0_P :/:0[A[*?8O451_M6#^Y)^0_QH_M6#^Y)^0_QH]I'N/V4
M^Q>HJC_:L']R3\A_C1_:L']V3\A_C2]I'N'LI]B_15'^U8/[DGY#_&C^U8/[
MDGY#_&CVD.X>RGV+U+5#^U8/[DGY#_&C^UH/[DGY#_&CVD>X>RGV+]%4/[6@
M_N2?D/\ &C^UK?\ N2?D/\:/:1[A[*?8OT51_M:#^Y)^0_QI/[6@_N2?D/\
M&CVD>X>RGV+]+6?_ &M!_<D_(?XTO]K0?W)/R'^-'M(]P]G/L7J*H_VM!_<D
M_(?XT?VM!_<D_(?XT>TCW#V<^Q?I*H_VM;_W)/R'^-']K0?W)/R'^-'M(]Q^
MSGV+])5'^UH/[DGY#_&C^UH/[DGY#_&CVD>X>SGV+U%4?[6@_N2?D/\ &C^U
MH/[DGY#_ !I>TCW#V<^Q>I:H?VM!_<D_(?XT?VM;_P!R7\A_C1[2/</9S[%^
MBJ']K6_]R3\A_C1_:T']R3\A_C1[2/</9S[%^BJ']K0?W)?R'^-']K6_]R3\
MA_C1[2/</9R[%^BJ']K6_P#<D_(?XT?VM!_<D_(?XT<\>X>SGV+]%4/[6M_[
MDGY#_&C^U[?^Y+^0_P :.>/<?LY=B_15#^U[?^Y)^0_QH_M>W_N2?D/\:/:1
M[A[.78OT50_M>W_N2?D/\:/[7@_N2_D/\:7M(]P]G+L7Z6L_^UK?^Y)^0_QH
M_M>W_N2?D/\ &CGCW#V<NQH45G_VO!_<E_(?XT?VO;_W)?R'^-'/'N'LY=C0
MHK/_ +7M_P"Y+^0_QH_M>W_N2_D/\:.>/<?LY=C0HJA_:]O_ ')?R'^-)_:]
MO_<E_(?XT<\>X>SEV-"BJ']KV_\ <E_(?XT?VO;_ -R7\A_C1SQ[A[.78T*!
M6?\ VO;_ -R7\A_C1_:]O_<E_(?XT<\>X>SEV-"BL_\ M>W_ +DOY#_&C^U[
M?^Y+^0_QHYX]P]G+L:%%9_\ ;%O_ ')?R'^-']KV_P#<E_(?XT<\>X>SEV-"
MBL_^V+?^Y+^0_P :/[8M_P"Y+^0_QHYX]P]G+L:-%9W]L6_]R7\A_C2_VQ;_
M -R7\A_C1SQ[A[.78T**S_[8M_[DOY#_ !H_MBW_ +DOY#_&CGCW#V<NQHT5
MG?VQ;_W)?R'^-']LV_\ <E_(?XT<\>X>SEV-*BL[^V;?^Y+^0_QH_MFW_N2_
MD/\ &CGCW%[.78T:6LW^V;?^Y+^0_P :7^V;;^Y+^0_QHYX]P]G+L:-%9W]M
M6_\ <E_(?XT?VU;?W)?R'^-'/'N'LY=C1HK._MJV_N2_D/\ &C^VK;^Y+^0_
MQHYX]P]G+L:-+6;_ &U;?W)?R'^-']M6W]R7\A_C1SQ[A[.78TJ*S?[:MO[D
MOY#_ !H_MJV_N2_D/\:.>/</9R[&E2UF_P!M6W]R7\A_C1_;5M_<E_(?XT<\
M>X>SEV-*EK,_MNV_N2_D/\:7^V[;^Y+^0_QHYX]Q>SEV-*EK,_MNV_N3?D/\
M:/[<MO[DWY#_ !HYX]P]G/L:=+67_;EM_P \YOR'^-+_ &Y:_P#/.;\A_C1S
MQ[A[.?8TZ*S/[=MO[DWY#_&C^W;7_GG-^0_QHYX]P]G/L:E+65_;MM_<F_(?
MXTO]NVO]R;\A_C3YX]P]G/L:E**RO[=M?^><WY#_ !H_MZU_YYS?D/\ &CVD
M>XO93[&K167_ &]:_P#/.;\A_C1_;UK_ ,\YOR'^-'M(]P]E/L:E+65_;UK_
M ,\YOR'^-']OVO\ SSF_(?XT>TCW#V4^QJT5E?V_:_\ /.;_ +Y'^-']OVO_
M #SF_P"^1_C1[2/</93[&K165_;]K_SSF_(?XTO]OVO_ #SF_P"^1_C2]I'N
M'LI]C4I:RO[?M?\ GG-_WR/\:/[?M/\ GG-^0_QI^TCW%[*?8U:,5E?V_:_\
M\YOR'^-'_"06G_/.;_OD?XT>TCW#V4^QJT5E?\)!:?\ /.;_ +Y'^-/37;-C
MAO,0>K+_ (4<\>X>RGV-.BF12QS('C<.I[@T^J,[!1BBEH 2BE) &3P*@-Y:
M@X-S"#[N*=P2;)Z*@^VVG_/U#_W\%'VVT_Y^H?\ OX*5T'*^Q/2U7^W6G_/U
M#_W\%'VZT_Y^H/\ OX*+H.5]BQ2U7^W6G_/U!_W\%'VZT_Y^H/\ OX*+H.5]
MBQBBH/MUI_S]0?\ ?P4?;K3_ )^H/^_@HNA<K[$]%0?;K3_GZ@_[^"C[=:?\
M_4'_ '\%%T'*^Q/14'VZT_Y^H/\ OX*/MUI_S]0?]_!1="Y7V)Z6J_VZT_Y^
MH/\ OX*7[=9_\_4'_?P470<K[$]%5_MUI_S]0?\ ?P4OVZT_Y^H/^_@HN@Y7
MV)Z6J_VZT_Y^H/\ OX*/MUI_S]0?]_!1="Y7V+%%5_MUI_S]0?\ ?P4?;[3_
M )^H/^_@HN@Y9=BQ15?[=9_\_4'_ '\%'VZS_P"?N#_OX*+H.5]BQ15?[?:?
M\_4'_?P4OVZS_P"?N#_OX*=T+EEV)Z6J_P!OL_\ GZ@_[^"C[?9_\_4'_?P4
M70<K[%BBJ_V^S_Y^X/\ OX*/M]G_ ,_<'_?P4KH.678LT57^WV?_ #]P?]_!
M1]OL_P#G[@_[^#_&BZ#EEV)^:*K_ &^S_P"?N#_OX/\ &C[?9_\ /W!_W\%%
MT+EEV+-%5_M]G_S]P?\ ?P?XT?;[/_G[@_[^#_&BZ'RR[$]+5?[?9_\ /W!_
MW\'^-'V^S_Y^X/\ OX/\:+H7)+L6**K_ &^S_P"?N#_OX*/M]G_S]P?]_!1=
M!RR[%BBJ_P!OL_\ G[@_[^"C[?9_\_<'_?P470<LNQ8HJO\ ;[/_ )^X/^_@
MH^WV?_/W!_W\%%T+EEV+%%5_M]G_ ,_<'_?P4?;[/_G[@_[^"BZ#EEV+%%5_
MM]G_ ,_<'_?P?XT?;[/_ )^X/^_@_P :+H?)+L3TM5_M]G_S]P?]_!2?;[/_
M )^X/^_@HN@Y)=BQ15?[?9_\_<'_ '\%'V^S_P"?N#_OX*+H.678L457^WV?
M_/W!_P!_!1]OL_\ G[@_[^"BZ#EEV+%)4'VZS_Y^X/\ OX*/MUG_ ,_<'_?P
M?XT70<DNQ8I*@^WV?_/U!_W\%)]OL_\ GZ@_[^"BZ%R2[%BBJ_VZS_Y^H/\
MOX*/MUI_S]0?]_!1=#Y)=B?%%0?;K3_GZ@_[^"C[=9_\_4'_ '\%%T'++L3T
M57^W6G_/U!_W\%'VZT_Y^H/^_@I70<DNQ/14'VZT_P"?J#_OX*/MUI_S]0?]
M_!1=!R2[$]%0?;K3_GZ@_P"_@I/MUI_S]0?]_!1=#Y9=B>BH/MUI_P _4'_?
MP4?;K3_GZ@_[^"BZ#EEV)Z*@^W6G_/U#_P!_!2?;K3_GZA_[^"BZ#EEV)Z*@
M^W6G_/U#_P!_!1]MM/\ GZA_[^"BZ#EEV)J*@^VVG_/U#_W\%'VVT_Y^H?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH LV=Y+93!T.5_B7L17712I-$LJ'*L,BN(KI]!D+Z=M/\  Y4?
MH?ZUM1EK8YL1%6YC3IDLJP1-*YPJC)I]9FO.5TX '[S@']3_ $K>3LKG-&/,
MTC#OM0FO9"68K'V0'@54HHKC;;U9Z*22L@HHHI#"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** +-I>RVCC:24[H3P:Z2.19HUD0Y5AD5R5;^C,6L2#_  N0/T/]
M:VI2=['-B(*W,:%%+16QRB8HHS10!5JCJO\ QZK_ +X_D:O51U7_ (]5_P!\
M?R-54^%E4OC1D4445PGHA1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5T
MGA[_ (\)/^NI_D*YNND\/_\ 'A)_UU/\A6E+XC&O\!KUD>(?^/"/_KJ/Y&M>
MLCQ#_P >"?\ 74?R-;S^%G+2^-'-T445R'H!1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5O:)_QY/_UT/\A6#6_HG_'D_P#UT/\ (5I2^(QK_ :-%%%=
M)Q"44N** *M4=5_X]5_WQ_(U>JCJO_'JO^^/Y&JJ? RJ7QHQZ***X#T0HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZC^1K>?PLY:7QHYNBBBN0] **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'XDD:=H_A3PU<SB?5=)LG%Z0P;RFD?<L1([H./RKSZ@ HHHH **** "BBB@
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MZY&1D'D<$5M?\)WXP_Z&O7/_  8S?_%5C7M]=ZE=R7=]=3W5S)C?-/(7=L#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;_"S_F=?^Q4OO_9*\_JQ:W]Y8^?]CNY[?SXF@F\F0IYD;?>1L=5.!D'@U7H
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MU6^OS%GRS=7#R[,XSC<3C.!^54* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MZ#0_^/)_^NA_D*Y^N@T+_CR?_KH?Y"M*7Q&-?X#3HHHKH.(**** *54=5_X]
M5_WQ_(U?JAJW_'JO^^/Y&KJ_ RJ7QHQZ***X#T0HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHQ2XH 2BEQ13L E%+118!**6BBP"44M%
M%@$HI:*+ )12T46 2BEHHL E%+118!**6BBP"44M%%@$HI:*+ )12T46 2BE
MHHL E%+118!**6BBP"44M%%@$HI:*+ )12T46 2BEHHL E%+118!**6BBP"4
M4M%%@$HI:*+ )12T46 2BEHHL E%+118!**6BBP"44M%%@$HI:*+ )12T46
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>PJ['?%(RC R'MGTID&PN[G"E>0#TJ_J&&G*"I5+WW3TM\]@N^I 8)%4ED(
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M HHHH **** "BBB@ HHHH **** "BBB@ I*6B@!****0!1110 4444 %%%%
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MGIP%V*-ZYR*$#1,5!4Y&::)"^]V R!@8.*N#4'S3^-WOIM;73T_4&-(=ML9
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MOA:?(Y05FOGV^5AIE6BEQSTH((ZBO+LQB4444@"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@!**4TE2 4444 %%%% !1110 4444
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M*** "BBB@ HHHH **** "DI:0TF 4444@"BBB@ HHHH **** "BBB@ HHHH
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M&K_\>B_[X_D:OU0U?_CT7_?'\C55?@8Z/QHQ:***X#T@HHHH **** "BBB@
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M;$!6,\9I\>YR4GR&/('M7;&M.6(G3D[WLE[ME==6_6Z0K*PC&"*'L6(Q52
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M/DSQUZT?[3.<)-6Y4DO3H]0/-HIO+E+E<YI&A8Q>=P%)Z4X1*S.6? !["O2
M/A)J$6W=K6F@GH26(_\ 0ZSDYJ/)55UJU:V_</0\Y,H,:$_,0>A[T>>C%B5
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M0:E-OF5UIUZ+[B;7)&21(]S-@MUYJR#L3#L"Q7@XJLKRA S8('8U)+*X"R;
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M5I051KW6KW_KJ5<91117, 4444 %%%% !1110 4444 )2T44 %)2T4 %%%%
M"4444@"BBB@ HHHH **** "BBB@ KIO#O_(/D_ZZG^0KF:Z;P[_R#Y/^NI_D
M*TI?$8U_@-:BEHKI.(3%%+10!EU0U?\ X]$_WQ_(U?JAJ_\ QZ+_ +X_D:NK
M\#"C\:,6BBBO//3"BBB@ HHHH **** "BBB@ I:2EIH HHHI@%%%% !1110
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M"<D>E1UC.E*'Q(84445F 4444 %%%% !1110 AHH-%2P"BBB@ HHHH ****
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M L5(41J.XXJ$K+'(3%RHIP  "-+UYP!GFO?>)YKJ4+/JW:SZ+MHR;(. -T2
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MSWI&3CG[PZTW8H*YR%/6FM\L@(8^].I)<GO1_K>_]>9*W)L \E02.HJ)U##
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M7KW_ !XI_P!=1_(UJ5EZ]_QXI_UT'\C6\_A9S4_C1SM%%%<AW!1110 4444
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M^/%/^N@_D:U*R]>_X\4_ZZ#^1K>?PLYJ?Q(YVBBBN0[@HHHH **** "BBB@
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M@Y7(QU-"/P%SQT)]J[JBA*,8TVXKHU??;OLP]3LO$]MX,@TN*Z\.:C>3W!E
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M "#9/^NQ_D*Y6NK\,_\ (-D_Z['^0K2E\1C7^ V:***ZCB"BC-% &+5#6/\
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MCA8RWR]O:NB\(^&+OQ)XD@TRV)\K[]Q+CB./N?KV'N:^?O2J0LT^1==+IO\
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M_>_X/_#!RE1U;^(8XR!34+$#/W1TJXX)DE8\A5Q1Y?RPH .>34RPK]HVI/\
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M]W&2#VKZBE7YXKW=)*_IV_#L0T0"! S!AN;JM50[/=[@ I]#5YRTJJ\9&X'
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M_D:T*S]8_P"/1/\ KH/Y&JJ_ PH_&C$HHHKSSTPHHHH **** "BBB@ HHHH
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MY]Z>'WX?[K=*SHQ2?*WY^OGY26S[C;&YP2HZ'YEI(W.YFY))I9"K?7N*;NY
M'%-^Y45GHOZ_ FY*3\Q7L0,4I"%_4U$2.#NYP>M(S+N#Y/3K6SK*VJ3U_#^F
M \;CDG !/6DWC<=IP>A!J)Y&*A2W3F@L6/.,8ZUS_6.B_K_(3)#]\DG@#BH]
MYRYQD=J:&&?7GJ*&RSY)P,\CVK&=7FUCW_,+BK(64X[=J08(P?O9I3L!.P@C
M-*I0#.X5"A+2,Y)V_K0+B!3@G?P#32FZ4 MQVI1(I8E0-O<]J0RKTP*F2HV5
MWI\]178A#9P,CG\* ?,#-@@#@>](LA\SKE<=?2@7!61>G!STK'GI6NY.VU@U
M$(*\]!WIRDLP*^E D23J,TXO$OW/QJHTX-\ZDN7\?D%QHD*J1G+'TI-[$Y.>
MF*0LN3C@>M29C(7)(P*(<T].?8+D0';-2'E@2V2HY%!90F #N]32PE0W'(/K
M3HTHJ2A?<'(0(TG7@'I3EER K<[32[E&20,U [@95!D>M.I*-"/,GJ]_/Y!N
M/8[CC@G.:?!A2Q/KP,U"B;06SGCBEQE@QY'?-80J24HU6M1^1?4D'/&/7UIH
M_> L_5N%6JOFLA8*1CI4D<I*Y.1CI7K0Q\)R4)7Z^G]?J%B?8!ED7YLXHXW^
M9C)/RK_C4#RDLJJ<#V/-2@D*S;CD<!?2MHXBG.3C#1)^5K[W7];V%9BG D:0
M\!!BHH0TADE?YAT ]:=A3(D;9V@9QZFI48%V)4_+T44U^\JQ;=DF].[MJWZ+
M9=0LBK+:K@G=ANK$]!5)L?=QSZBM2Y7*(I.W<W-5YX06VKA,<\]37F9E@4Y/
MV,;6M?SO_6XEIN4EP#[^M3! "23G(ZU"5*L5(Y'6GJ<G#=*\2A))\LHC:)4^
M3:<9/4X[5&68O\BX%2@L1L7A<9.* C $ \GM7HN$IQ48MV7;OY$[$'DM\QR"
M?2E5V1 %7D<DTYLE".F.ISR::[98!B0N/SKD<84G>&C_ ,_4-R;?@*R@+GKW
MHPY(D!VD=ZB7< 0' !Z9[U+$<H%8;O6NR$_;KDGU^Z_R^_82NG=&D+A+]&1A
MC: &YR3[UC3PF.5AC:O;-:-G<06<[O)%YF5P 3C!J>X2*XMGE,*QNW()["O)
MQ5%PD[I:?E_P#V++%45)R]_7^OF9$"EE; &?>G*6^<8R346TJQ ;IWIY;A0!
M^-:T*BY%NK?C<\IJSL1+PY!!YXJ0#&$V#.>#2S(O+!MN*;$PSECC%*$?95/9
MR?STV)>NH]RS,<@?+Z41NJDDJ>G2F!F5B^1D]CWI%+.26X'>MU7]]27Q7ZK\
M2;%U&7*%@I8^E,WD%LD Y^Z:KIRW7 ]<U)(@?8<_-CH.M>G'%U*E.\%JOQZ$
MVL.*LXD5R,-T]C5!U*.5;J*T =X_>8R.,"HKD12 NK89>"/6N3,,-&M1]HG[
MR[O5K5M?((NS*8)'0XI*<IPPJ64(IXX->#"DYTW*^Q=R"BE8@G(&*2L'HQB&
MB@T5# **** "BBB@ HHHH **** "BBB@ KH=!_X\7_ZZ'^0KGJZ'0?\ CQ?_
M *Z'^0K2E\1E6^$U:R]>_P"/%/\ KH/Y&M.LS7O^/%/^N@_D:WG\+.>G\2.=
MHHHKD.T**** "BBB@ HHHH ***6F E+13D0NP [TXQ<G9   V]\U=BAC-OA\
M(Q_B-1&V9)%"X)/(ILSR,^).HXXKV*$/JBE*M"[VM;3SU[^@M]ALD6R0JK!L
M=Q2*I9PH&3GI3XI?+5N,D]*2,MYH9>N:Y>2DY1<7N]5V5_Q*U+6 \A6;Y !P
M%J6+,(CCWIACD\=*D&\X5BH(Y!/>FA#+$P.S<W4]Q7UD<.Z<^>&LM;/9VTT>
MORV7<A.XVXD^SD94,S')([BJK7#'S"B *_7CI1*4,0!SY@IUL=T;QD@#'4UY
M-;$U*]?V<)<J:NK6=G;9O3SN59(<EN!"QD SC(Q74:%XXCT+P7?:/8V9AU&\
M?$U\'R6CP1@#L0.!]2>M2:#X,@NO!6J^(]9O9K.SA4I9^6 3+)GT/49XX([\
M\5Q4<9D;:"!QWKSJE2$Y0A2I[=^K_4:7<41Y0N&P,X J:..'(SD\4^)(HU(D
M.0>XJ5#&6V1@<<YKT,+@XWC*7+?L]7?T\P8U@/+"QDY^M5@69N#R:FW&,.77
M[W0TRU9!,I<]ZRQ#52K"/PWZ;6[%Q\P@B=[@+MR<]ZWV1-/B ?D$>O2FR6JD
M-=HNU2 <>]9\\^\$NP.. *VPN%E1?M-/^!^M]CT6XX:#B_B>PYFDD)(DZ#JU
M,0YML@D-_6FEGDVDQ\ = >M1R$LZ)NVYZCTKU/:0I+FC'2UETWMM?:QYDI.3
MNWJ/# [3YGS#TJ*16DN&S@?6E941@<?(?T-)E9'+L24''%<M7WU[.=KW77RW
MU%<8B9)8_-CJ/6M#2M,GUG48=.LXT^T3OLCWL%&3ZDUU&@_#NXO])FUK5KM-
M'TQ(RT<MP.9#CY2!_=SCW/:N-6:2.=)(7*L&&V12000>"#7/1E32E&#N]N][
M]0/44TOPA\/2K:M(FN:^HR+5,>5$?]K.<?4\]P*\TO[F.;4);B&W2W21V;R4
M^Z@)R%&>PJ*;H3)G>223GFF$[3_>]ZU5)T$TW[^EW_P!+4F,B20C<W)[5$UQ
MM&U5QV--9$#GWZ"E4?*V.W:MJN+K2=M%+:ZU>@U% K[ASC-0G'4=:G6W)D7@
M[33EM" Q/\)S]17).CB:T4G';J6DA(T#2 .,#%3+"K;6;E6.!BI%0"XC8#Y&
M&,U(N$BD7'*-Q7ITL)&-U*SLW\]$_FK7+BK[C F+>1.ZGTIRPHSJV>JX-.)#
M2*><.N#3%=E@R#RIQ75)4U)<VJ2_)W7X,I(E1=H3<.5.*C8@HYQQYF:89#YB
M.3D&E# I(,_Q<4I5XS7)'I?\M L3$@B10.@R/>@,/.W+R2O(%0LQ\Q3GV-(A
MQ,QZ\4/%>^DEU_S?ZV'8E5QY88\9!!-)N!>)>P&:AW?N=I]:4M\V0>@K+ZR[
M)>G_  ?R"P_<#%+[M4F_$QZ85*JAQC;ZG-*7P6Y^]Q6<,99)KI_P7^H6+2G<
M8UX  R149<;"<?>;&:BW=6S[4H.0@QTYK1XJZLOZV7Y7"Q*RC<SCJJXJ-TW0
MQQ'N<F@$DN3^0HWMS+T'054ZL))Z;WOZ7U?W)(FPV2($EF_U:<"JQ5]X4#YF
M[5>&UMJG_>:FJ02\F/G8X6LJ^'C5DFG:^_Z_=HEYBL4'A8.4XSWJ,#YJO/ #
MEAU(QBF-&JJB'C/)KS*N!E&3:T2_ST%8J$G<5!.,T^(_.,YJ5X0N<'+'D >E
M0,Y P!TKF<70G>I_G\A6)FF+L03S49)Z=J0 L0>!CK2X*MGUK5U*E1\TF*P[
M:"GJQI(R%SGG'M1SG &!WI1C&3S[5I%>\I+0D:Y 7TS2Q>6'&TG(IV$95YYH
M)\LAACK3E2Y9JJVK*WF"?0F 8DMR">/PIY+*&;( ]>]5FE:5@%SGT%*H^1MS
M<YZ9KM6*CJJ:;WUO97M_P=MP2++2*2C(NYNU6;>X\TB!L(>I)JJ6&515YQD>
MU&5D.TC<R_Q48K"QQ#YE/W].CL]/ON=.'Q,J+VT+EQ:+*",AE P&]ZQ&5[:?
M/]T\9%;MI<(LL4$J[83U)INIP).2J\!?N\<FO'Q5!Z65IK<]"K2A6I^UILS[
MRYBG2W*A057# #O49*,IR,DC JJ\;(^UAAAZT)*8W!]*SAC???.E9[_J_P!3
MRYN4G>6Y910&".WR]Q37"I*<*=I[4C3!I-^,'VIS@RH&/%=?-"<'"EJT[KT,
M[=Q) X4?+\AZ4W>5!4ID&GL9GB (PJ_G31+NE&Y=W':JG**FK2:O:UU]_P B
M; DC%!%CG/%6#*/,;><,% &WG-5]I9F(&,'I0A9E,:[>N<FM\/7G"T=^WG;;
M\R6BZ"D? R%ZX]::0$.TA@K]>>],#;>F6'1N^*F^22,CL.YKWZ-154XJR:V7
MYKTM]Q+1D3PF"3:W/<&DBE:)MR]:NN!*B[AO9#^8JM(GE2AMOR^XKY#%8)T*
MGMZ#M&ZMW5_\F-.^C$1WE<Y).>N*N)$D3 @C.,<BJ;S 3AX@!BI9%DN$$A8=
M. *ZL%5C#GLO:5(NZ?EW3%)?(9/F*X#*0".F*AN"&F9E& >U6! AA\QG.<XQ
M2I!'+YB@C<!\I[5S5L'7K-QBDE-\R5_)_F--(HT4^2)HFPP^E,KPIPE"3C)6
M:*"BBBI ***2@ HHHI %%%% !1110 4444 %%%% !75>&?\ D&R?]=C_ "%<
MK75>&?\ D&R?]=C_ "%:4OB,:_P&U129HKJ.(6BDHI 8]9^L?\>B?]=!_(UH
M5GZQ_P >B?\ 70?R-75^!BH_&C$HHHKSSU HHHH **** "BBB@ HHHH *>#3
M*6JB[ /I\3LCAEZBH<TX-6M.IR34ET&6YI AX )<9-10 ,V6.1Z5#4D/WO>N
MU8AUL0I-:=A6LA6C_>$8XH!\M3@\FABV\CO2>6[$C:20,G SQ6<VH-R@AGJ-
MM)'X+^#;3*^-3\1L0"IY6$<'_P =S^+^U>8,,1JRXP*6/F/ECA22%]_\@4@&
M)/G4A3VHIQ<8:]?P"VHI42 -GYO2A <$9'/8TP'#G:2!4[1(H^_\W6M*:YVY
MI;;ZCL1CY$;YN<]*59"Q )X)Q@4Z.,@ECCIWJ-BF01D53BXJ,F[>7S"X_ #E
M,X'K2*25(4]/2C(,H(^;CG-;9\*ZB/"\?B,PK'8/,8E9G 8D=P.XSD<>AK2,
M>9VC;=KU].A+?<ZW4]>TSPM\.K70O#UZEQ>ZHGG:A=Q=5!X*<\CTP<< GO7F
M@7=DYZ5*ZX^5CGZ5%L)SCH*YYT.25K7*0WJ*503P._:@#-6XX@1N4;EQ^(J*
M%"566A2""(%^I60'@$=:NB('=N 4$=/>E8*JH).5QPX[4JEB^3M8$8W5]=A<
M-2H?NFK_ /#=5^%UHPL]R,@N-I($J<@CO2NRNH!7YCT]C0PYV'(8'@T##L/5
M>W:AIR;AWT=_+]4OOT96PG!0=LC!^M*'Z*QPRXQ2D+D[1PPSCWJ,<;68=1C-
M4U*G)6^?;^MFB6QX.';W_G3 =S$$D'MBFM(V>0.G%-!Y&"3Q6,Z\92LME^H#
MMV"0 <YY)IASGCH#369CZ#'.*0$!\CO7(ZO,U'H(E9E*=:802"0<#%-&<Y_,
M&GX]>">U4FZNK0KD2JY(.[(J7#'L,8Y%,:01+MZFHQ*[D+T';%<W/2I/DNVP
M+&<#Y>F,4QI%VX/7/:HDRV=S$FDVX/)ISQ,W!.*T>@#V;:,*.,5'G=@+2L?<
M ?SI%!!! KFFVY)= N/^7'(IC'+<#!H=SNW;>*<C@-N'(H<HS?)LO3H(C^8$
MG/T]Z522"#U]<4>9EB2,4N\$Y]*QCR])#%7)^7OZ^U-!W-\IYI-V3UXI6/0J
M.157ON]$*X$%>"<D'I07..12,Y;MCWI0?EYI7BVU!Z!=CO,)4G/--23!/)I0
M0PZ#ZTTG(QMQBG*4G:2=QDBN7(4'J>AI[,!(&R/0@4U(4:#S#)^\W?<QU'KF
MHV4@Y X[BM(5JB@Y-=5^ VK6)S@C@]\TUU(CSCD&F;MJ=?I4D3[SSC/K6T90
MJOD>C8AJYP<G_P"O3U;&,Y![9I2B@@]_K1(G P3CITIJA4IIOL-, P#93/'>
MI1)GD'IUJ!"> H&:4  XSR>M72JRBKKK_6@Q_GR/+D8! P*M9V( !U(R3U8U
M3:,JNX$#-3VVYCG&2!@$]JZ\%5JJK[.;;E+K_7]?(;6A(S8+$D%U&<]A38E(
M!=_GE;D#TI#M#[0"SGDD>M21[ED)8#>W7'85Z-.7/63ET?R3?7LWLOO(:T*3
MQ9)4#+]6/857!*<]:T9D,@*K\L8.68]Z@=$.1&H '\1[UY&,P3Y^:#V_'T[V
MZM[L7J0QR'/3KWH"_/\ >./2F;N@I=P8@#(]:X8UE91;O8+"OSEEXYX6FE0
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M/,",?QJ5>%S48CW<,QSZ5U5:,+Q<(ZOST_IDIOJ*D:EF*MC'H:6-  =Q'S<
M&I%2-3A1G%,5D5B[#'H*U^K0IN+G;K?M_7ZAS,')B<#/3IFI6@W ,&PQZG/%
M1)F20-(!CTIZ[0I;/&[CGH*="$9<W,KQ>VMFK=2G(L,A)4YX7GZU=6X$L1R
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MC\:,2BBBO//4"BBB@ HHHH **** "BBB@ I:2EIH HHHI@&33@V#FFU/! )
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M54[22#BL[N[NM?R 5%3&6.#FE0J7*CD5%(3T-$3!2<_G4QK1C-1M81*Q4$D
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MM\)J5EZ]_P >*?\ 70?R-:E9>O?\>*?]=!_(UO/X6<]/XD<]1117(=H4444
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MI,Y8X]*WDW]K<!X8H-HY/4FFESSS3"22:7M]:EUI2]U; )YIW9J=7W@>U5L
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MFG"5[:Z76O\ P"E9NY7HIS(5/((]*;7A2BXNS+"BBBD 4E%%( HHHH ****
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MHT8 9LDG %2)$ZNQ4J,]NM=U.G.=-4>5VZZ7?7Y7\]S",W&7,F7XIWGCS+C
MX'%9E_ %;S1@!NWI3W:1)-Q4A3QU[U<:,3P[>S=6/:N.K14I2H<KO%:-]?\
MASO<W7IW;U*4$WG6;Q32$X&%'<>U(\#&UBF4X)R&'I55@;>X^4YVG@^M2R!X
M\-N+(YSCMGTKSHXB4DE).T5;1^>G](PTLU)79*H8$J^0A&<'O2B,22_< 4#
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MOCA?2JP56<[SDGK5Q!E2H.6/4TPQJO 7'JV*VJ4G/EET\_ZW[]$)Q*+(>3@
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MRO:)"8U'.0P&*J2P^7<;&!49[]JT+D0W)CL[<$M&< XZUYF%J55>G"5NMO\
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M4!!Z'@+Q@UYV+J2OIJNFA)&5PK,,@#I49;=TQS4CXY!.!4#X_@S7AXB7(DD
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MVJH&#@D=Z]&=&"JKET7XC6Q'M,CG .[KG-3VY9<EF8!3G &122>4=HZ-ZBK
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MOT_X=[?(J#<'S1=F699C<SFZG;=[4H=905V_,?NJ>M0QQQB0MO  Z U.P+,
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M3AI*2O\ /\PN9U%6VC@:3(R/4"HI80A^4Y'O7%5PDX)R332[#(:*7!':DKE
M****0!1110 4444 %/";D!4$GO3*?&Y5NM:4^7FM+8!PC.[;W]J?&@P",[L\
MT])%R648;'7UI48F/+8P>!7J4J%)--.^_P#5R6R _++P<CUIPY;=U&::$^<C
MOFI(P<8/ KGC%MVMNREN.)VL".U.PI8GKQ2#[Q/48HC;!/%=,+<RYMFRAZ*S
MJ<*#3EM8W3=(2K9HBQ')DD[:FV\[FQLZBO1H4:<X)S5VKII[>O<13GME1<HV
M[\*+:8PR .,H>H-6CM!VJ/\ @5-DCW+@ <]*YY8;DJ^UH:-=%JAV$ !F+!@!
MU'TJ6^<F *J!AW.<D4R!2<J2H!]1Q3)K62V;S4(9!R:ZH.K]5FX1=I;M=/EK
MI]P2,^I8L'@YQZBK$TEM+'\L91_TJ%24&%.017B3H0HU-)J2[K_(E#P@W\D>
MM29W84M@&HU4-C(Q[U+L"KS@@]Z[,/%N+<5IUU*8, O4Y(_$&FH68D[L;>U/
M1"$SM /:E)!'R_*W<XKL5)NTWIY$W$+ +NDY/;BHXCE]P S3_++9RY8=J(BA
M8)(<!?[IY-95%4=2+>BZ=V_4%;8FAW2;V9COS2V\J1M@H6;.,FD3[^U1D <X
MZYJ2.2,-(D@(8X (%=&+C?#QOO=KUN;89VJ:.P^[MR(SM=3M^]Q6,W4UKWP4
M6X;>VX]5SUK)XSSTKYRJKU'J=.,LI))6)(ER1Q4S*S*1DX[4B9,8P!FA\I'P
M_3M7J4::A3;=VK>APM]"-AA54_=S4;\M@$D#I4C ,H.3_A3041VXW#M7)52>
MCT6GW .6/8^)#@8SQ4XSS&6)8]\\8IH)+HP1?F'0FA<*GS'J>0!7K8>G&G=1
MV[^5O^#\C-A)L\ME4D8/7'>J3KM<@U;9W>-AZ<]*IL23D]:\[-)1DXV7Z#B-
M-%!HKQF4%%%% !1110 4444 %%%% !1110 5OZ'_ ,>3_P#70_R%8%;^A_\
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MHQ6;KU'NQ79.DS.<$BFR,.@.?>HJ*3JR:LPNQP/K2=Z2BL[B+@VB,5%YGS$
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MA!"D#L13T),69CSVID:JL8^7@G'7BEE4<!I%Q7I)S2]M+5M*ZV7SV)TV'02
M3;%"MQQ5X_.@!1,?6L^$0I+R-P[8-7@L;G:$()'?BM,#.4H.,[;VM_29TPVT
M(Y4"@8C!S_=/2D9 Q()(.,<4K>7"^ &)]J:2HY8%<=Z3<$VG;S716\[(J2&*
M-@*(2&SU/2G;LKM8$MZT])4*XSGZTO'\*\>U;T:<>5.G.Z[>7X_>92\R%E!/
M(Y ZBJY1V#;B% ]*L2, R\D9IKG:,?G7/6I4YMWZ;_=U,VV502%)XP#C-1'Y
MQUY)YI[_ '7(/&:CW!"#@X[U\]7J)6C+;_@C2%*?(< <#K4" $\U.3F,]JA
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ML^0,X)%4WQN.WI5U\K$X8DEAFJ%>?FEHN,5ZZ[CB(:*#17C,H**** "BBB@
MHHHH **** "BBB@ K?T/_CR?_KH?Y"L"M_0_^/)_^NA_D*TI?$9U?A-.LS7/
M^/)/^N@_D:TZS-<_X\D_ZZ#^1K:?PLPA\2,"BBBN4ZPHHHH **** "BBB@!:
M***8!4UM(8Y0P-0T5=*HZ<U..Z T?+9U,@.>YYJ17_=[BVXD=ZKVS22@HIP,
M<^]$,09V#L1MXXKZ&C6;Y72B_>NM7I<HZCQ-X1BT/PUX?U*.[D>7583*\3*
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MRE\JW>K^HE)YE_TCS2J ,2.]4+@*L"KP.:[INK&G*2TBKO7KT:L<F(255ZW
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MY_QY)_UT'\C6G69KG_'DG_70?R-;3^%F$/B1@4445RG6%%%% !1110 4444
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ML4PZ9Q@^U>=@Y2^&J]-K->3U^78BDDI.;=E<S3;2Q8E*-L8G:Q'6HKJ/!!W
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M(;)/L*SZTYYD@5Q&,L_WL]C697S.=V=9-R3EK>VRUT_X(H[!1117BE!1110
M&DHHI %%%% !1110 4444 %%%% !71Z!_P >#_\ 74_R%<Y71Z!_QX/_ -=3
M_(5I2^(QK_ :M&:*2NDY!:*2B@"M6=K7_'FG_70?R-:-9VM?\>:?]=!_(UI5
M^!F=#^(C"HHHKSCU0HHHH **** "BBB@ HHHH *?&<.#C/M3*>OW@:NF[23
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M'%2$C (Y]S4?F.Q5E) &<UQ3A!3<IMN_1?C^8QZ \[5"X'..]!DC(&W[W2F
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MM&W>W*D=17I4,32I5.7D27YV.FCA)U8RDNA3D0%3@#C]*H2H!NX[XS6L\>U
M3N(QR16?+!O3Y7.*]#,(QQ,6Z:NT83IRI[E/:,'YN*$7<,4.J)MZ^]./W_3
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M<%B2?YUAS-R45UT_'_@#0XJXMV)7!(P32QJ/)4<$X.,]J9N/ ?D=C37!8%B
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MAN*@E-.X(>"?E&WYC_$M*%9>2<X!IBL48!6R3ZTZ3<44C!R>@JXS7*WJVO\
M@=MQB'$F"JG(/7'6GB!#(1W/I3,D#&1DCI1&S*2WJ<8J8NFYKGC?O_7],!94
MVGRE.5')S4T,N(]I!) Y/I44T1*@QD@DX-0KN5@H/S=Z4ZU3#8AS@O+RMT2*
M26QH9/4C((SQ0Q^7:O#8[T!3M^4$G'/-1NOW2<^@]Z]N<IQCZ_UN20-(K2CG
M##@&D52DI"<C'S4J6SY8LO3I[5(T6Q0&&">]>+3I5I_O*D;:WO\ A^/Y%,C#
MON^7@C@@]Z>26W+NP2.@/2HB,;MK$XZ_6E)PHV@8[^M)5I1TEK\_EI85A8V
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MRBI=23BH]AW%HI,T5 B6) 22P/K49.2:,G&,TE:SJ1<%&*V%8****Q&%%%%
M!1110!/&"$.XD*13@@VCL3W-1Q,VX'@@=C4V,MR<KZCM7K4%&4%9>6HA&P5R
M ,]*9\R[AU]33BI*@ #.::2 Q R!W!J:CUN]!B9PAS]ZGJQ*_=^AIK9(!QQV
MI0"HQZUE%R4O(:%96^\>?>K-S9O':K*D@>,\D#L:A"EP""#Z@U8>&>!$;<H2
M0<KFMG14M+/78VALVU_P!;*3R_+9QU;[QJU?1*9!)DD/Z5GR03QR)YBCYAD*
M&SQ6F29=-R8]H3D_2O1A4E[2,9Q]U*VJ_,THKFHSIO?<S"NQN !SU-(RE3N^
M]NZ'-*V ZDG'&33"X"J&'.<]*4I02:EIV_KYG%8>9@K<[MWH#2E=XR58GN.V
M:B=@WW%^7/WJ&$N[Y6S@=:'B)/F4O>7E_P '<5AQ!!90#T^;/:I6 & K=N]1
M\*.02W1O>E<A4PO+>G>JBU!2?_#^G^8QF]@2&7..].4A@=C9SZ]:-H9-P.,<
M,#U--\W=\@7'I[5ES>S:<WH]OZ7ZC)X2"QW,?84I"1G@ D]:;&1&264$#J:&
MV2#)'3GCO7=!I4DM.;7<-RQ$07P 57UZT],,S%3QC&:I(?-8*"00.E6(&PQW
M.#_LUUX7$\SBFM&][_UL,EW?+L!R#W(J/S%D0_,14[J0,8W9'Y5!P>53&1CF
MNVNIQ?+?2VUG^!)"0V"JY))ZFG-"3'DCY@>,'K4_0[0P#=V-($(94ST!YKD^
MJ)O6[Z>G_!U'<HX9W !/7@&K42Y #\C'-2?)YFT*" O4T E9%4 !6'(':L\/
M@XT9<TGS:V_K^M@;$01L$<#(&0*55 .QCEOO<#BFHC'8H(4;CTZU* #S_>^7
M)KLHPYDFXV?_  %?] &Y8-G!PQP<]J,,7^8#:XQ]#3B1P#T88./44UW54 /)
MZ@^]:2LD[O1:_P# ^=_Q!(,^7M8C++\I]Q3F=%.WT^Z?Z51GE);<&PK#I3'E
M;;TR, 9KRYYK&FY0BM%_7XZ?,=B0W#M$R;>,\'/2H6R6))Y//%(K%EPN=V:<
M" /FSN[UXLJTJ\5SRO9?+T*V&DGD%=P['TI2I$8QP>XIXW@!@,X/.*>06R0.
M3VJX8?GOO=KMT%<BZH/EP1WJ93(H'(.>],<["H(^7'/%()OD^]D@UT4Y0I2]
MZ5FE_7X$L=M89RH)]3498[B>21UI\J.1D=^>*:DQ#<C:1Z=ZBLU&7))M>;_K
M\P0C(#'N'&>2,TU,XV8R3S2A#+)A&Z\U)$A1_63TKGC!U*B<59;-]_3U*V1*
M %^=LG ZU/:(EQ(\IDPR\*!5:5B1Y8^\WWJO!HHHD18ECE0?,S=S6^/K-/V,
M=EJ_4Z\#3BY<\N@Z5ML?EEQ\O?WK%E<LYR<X/6I[N<R$9'([U62-I7VJ,GTK
MPIRO*_\ 3-,56]HU")+:X$F\Y..F*<Q/F'*X.>1Z5):QN(VVQ;B> 2.E/N1&
M0A".LH'SENYKT:-)\D7&WGWW_0YG&T-2L=N N,'O3%(63"\CL33W<[\JO..<
MBH<#823\V:FM*TUR[KY;&(]U8[CG@4X*S;%&%R.N>M,0X5@02#TJ0*J@9RQV
M_E6E**F^;OO]_P#6Q+')_#A>HQD^M-*EAA =Z]3FC+;<DX [4XJNPG<!QFNM
M14XVZ?)?=\R;E=Y&*%6'.<Y[U%2DDG)I*\"K4<Y7;N6%%%%9@(:*#14L HHH
MH **** "BBB@ HHHH **** "M[1/^/)_^NA_D*P:WM$_X\G_ .NA_D*TI_$9
MU?A-.LW6_P#CR3_KH/Y&M&LW6_\ CR3_ *Z#^1K:?PLQA\2,&BBBN4Z@HHHH
M **** "BBB@!:***8!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2BBOSYMMW9J%%%%( HHHH 2BBBD 4444 %%%% !1110 4444 %=#H7_'B_\
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M^V3CC'K79A)U%4M%+YZ+^OU8A&2,L6WL&QU%-2)D<.&XZYI[XPRL1SW(Z5$
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MY_9TLUA/(\[M+NPJC^(5S3E4FFZ:=^^BO;KY'JTVZD;I7T?]?Y%&VO 01*P
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M[=DGK[4T*=W))4]32J[88"+K02 2'/RXXKT%R.$;/;U2^=^C)ZBR; Q!.[/
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M %T/\A7/UT&A?\>3_P#70_R%:4OB,:_P&G11174<8449HI#(ZS=:_P"/-/\
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MY0"Q^3D8J18UV]<9Z&E92PPK *W./<4CY4*QY3./I79&E[)6:NDOZ^6WH3<
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MH.16C0Y8'BHG;S\J_!'W:552<N0S9%"P;8Q(C?-Z5E/VM6*C25Z=G?6]TO\
M(:LM]P%LX7!?Y".:LJ/+0+DE<<&F(0&R^?F7GVI4(,8\US@\ 5UT84,.G.FM
M;/KLE_GT\QI.3L/A2.-P'8[CVSQ5PF*VCR>!V(ZYI%6&WB\T*"-O\1YK&NKD
MSRL5R$)X!/2O*Q.*Y+-*S^RNU^K[W/226'AW;&33-)(68YY[UK6P5PD\CJL
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M/'K4AB:3YF<\#IFHDA)/#\_RH#E)-LARI[BKI<M**]K!J+TWT\KC>KT$>89
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M** "BBB@ HHHH 0T4&BI8!1110 4444 %%%% !1110 4444 %;>C_P#'F_\
MUT/\A6)6WH__ !Z/_P!=#_(5I2^(SJ_":-9VL?\ 'HG_ %T'\C6C6=K'_'HG
M_70?R-;3^%F,/B1B4445RG4%%%% !1110 4444 +1113 **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_(5@UO:)_P >3_\ 70_R%:4OB,JWP&E129HS72<8N:*3-% "UFZW_P >2?\
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M_/\ I$ZL@N"AD/EYQ[U%2L<L325\K5GSU'*VYH%%%%9@%%%% !1110 4444
M(:***D HHHH **** "BBB@ HHHH **** "MO1_\ CT?_ *Z'^0K$K:TC_CT?
M_?/\A6E+XC.K\)HUGZQ_QZ)_UT'\C5^L_5_^/1/]\?R-;3^%F,/B1BT445RG
M4%%%% !1110 4444 +1113 **** "BBB@ HHHH **** "BBB@ HHHH ****
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MDA<GBC=N16[XX KZ?DIRCO?S7;\;$$)4;1'E5!ZY'0U$5*!2OWAUJPS2 XV
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MO^/1?]\?R-;3^%F,/B1C4445RG4%%%% !1110 4444 %+244 +1113 ****
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M<\'N:JK&$KZ6?;T_ :(/*+9<?)SP/_KTOEDJS%LL.JU*6>3 *?=YZT%@^XL
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MBBB@ HHHH 6BDI::8!1113 **** "BBB@ HHHH **** "BBB@ HHHH ****
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M34.4<SLW4\>E-HHKQFVW=E!1112 **** "BBB@ HHHH **** "BBB@ HHHH
M**,TE%P%S2445(!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %:^
ME?\ 'JW^^?Y"LBM?2O\ CU;_ 'S_ "%:4OB,ZOPE[-4=5_X]5_WQ_(U>JCJO
M_'JO^^/Y&MI_"S"'Q(R****Y3K"BBB@ HHHH **** "BBB@ HHHH **** "E
MS244 +1244P%HHS10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/S'^%/V4@]K$RJ*U?[,A_O2?F/\ "C^S(?[TGYC_  H]C(?M8F516K_9D/\
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M9D/]Z3\Q_A1[*0>UB95%:O\ 9D/]Z3\Q_A1_9D/]Z3\Q_A1[*0>UB95%:O\
M9D/]Z3\Q_A1_9D/]Z3\Q_A1[*0>UB95%:O\ 9D/]Z3\Q_A1_9D/]Z3\Q_A1[
M*0>UB95%:O\ 9D/]^3\Q_A1_9D/]Z3\Q_A1[*0>UB95%:O\ 9D/]Z3\Q_A1_
M9D/]Z3\Q_A1[*0>UB95%:O\ 9D/]Z3\Q_A1_9D/]Z3\Q_A1[*0>UB95%:O\
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MO%+=&>!9&=W4.5W$94 , -N*GF*L<W16GX@L8=.UVZMK?(@5@T8)R0K ,!^
M.*=!H4DEG!<W%[9V:W&?(6X=@T@'&<!3@9R,G XIW6XK/8RJ*ZO7-&NKG68+
M4M%";73+<SR2OA(P(U4Y(SW('&<UG+X;GEDLA;WMG/#=RF&.=&8(), [6W*"
M"<C''>ES(.5F+15RUTV>ZDND&V/[+$TLID)&T+QCIU)( ]S5YO#4Z'RGOK%;
MSR_,^R-(1)C&0,[=N<=MV:=T%F8M%*B-(ZH@+,QP .I-;3^&)U:>%+ZQEO+=
M&>2TCD8R#:"6&=NTD8.0">E%[ E<PZ*ZZ0&U\':9%;ZQ;VJ7;2FX4"4>;DJ,
M-A.=HX(Z>F:J:OX=1?$MQI^FS0-%&GF.2S 0J ,EV8#Z\9Z_A2YA\ISE%:DV
MAR+ L]M>6MY"95B=X"W[MCTW!E! .#SC'%/UC0)=$9XKF]LGN$DV-!$[,X_V
MC\N,?CGD<470K,R**V]'TJTOM(U:YN+N&&2WC0Q^9YGR$R*-QVJ<@@E?J>F.
M::_AR:'2X-0N+ZR@BN(3+"KNV]\$@J %//'TY'-%T.S,:BMI/#4Y>*"6^LH+
MR504M99&$ASR 2%*J3D<$CK4%MH<TUO-<7%Q;V4,4IA+W)89D'50%!)([\47
M069F45T>E>'$_P"$HM=/U&> P2H)4=&8K.I&1M(&?7KCH?:H$L+Z313#!>V\
MNGOJ,<0VAANF*'#<J&VXR/Z4706,.BM^7PE=17,UI]NL&OH@Q-JLK>80HR<?
M+MS@9QG/M5*UT62XL1>SW=K9V[N4C>X9OWA'7:%4G XR<8]Z+H+,S:*T-7T:
MXT6:".Y>%S/")T,3[@5+$ Y]]N?H16=36HA:*** "BBB@ HHHH **** "BBB
M@ HHHI@%%%% !1110(6DHHH 6BBB@ H_&DHH 6BBB@ HHHH **** "EI*6@
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MM6GE-V+K[JB98A$&"J%&%' &!C\*U-0MH]<EM;VWO[.,-!%%-'/.L9A9$"G
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M['PY \CHTD.LP7!AW#<R*C9./3M^-7='L;6U\90:G)K%A]A%QYJRFY7>P).
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M4444 %%%% "T4E% "T4E% "T4E% "T4E+0 4444""ES244 %+244 +111F@
MYHHHH 7-&:2B@!:*** "BBB@ HHHH ****!!1110 49HHH *6DHH ,TM)10
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M,!<T4E% "YHS244 +FBDHH 7-&:2B@!:*2BD 444=J "BBBF 4444 %%)2T
M%%)2T@"BBDH 6BBDH 6BDHH 6BDHH 7-&:2B@!:*2B@89HS110 4444 %%%%
7 !1FBCO0 9HS244 %%%% !1110,__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>img88009329_12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_12.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +P!C # 2(  A$! Q$!_\0
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M_O&@"U157+_WC1E_[QH M455R_\ >-&7_O&@"U157+_WC1E_[QH M455R_\
M>-&7_O&@"U157+_WC1E_[QH M455R_\ >-&7_O&@"U157+_WC1E_[QH M455
MR_\ >-&7_O&@"U157+_WC1E_[QH M455R_\ >-&7_O&@"U157+_WC1E_[QH
MM455R_\ >-&7_O&@"U157+_WC1E_[QH M455R_\ >-&7_O&@"U157+_WC1E_
M[QH M455R_\ >-&7_O&@"U157+_WC1E_[QH M455R_\ >-&7_O&@"U157+_W
MC1E_[QH M455R_\ >-&7_O&@"U157+_WC1E_[QH M455R_\ >-&7_O&@"U15
M7+_WC1E_[QH M455R_\ >-&7_O&@"U157+_WC1E_[QH M455R_\ >-&7_O&@
M"U157+_WC1E_[QH M455R_\ >-&7_O&@"U157+_WC1E_[QH M455R_\ >-&7
M_O&@"U157+_WC1E_[QH M455R_\ >-&7_O&@"U157+_WC1E_[QH M455R_\
M>-&7_O&@"U157+_WC1E_[QH M455R_\ >-&7_O&@"U157+_WC1E_[QH M455
MR_\ >-&7_O&@"U157+_WC1E_[QH M455R_\ >-&7_O&@"U157+_WC1E_[QH
MM455R_\ >-&7_O&@"U157+_WC1E_[QH M455R_\ >-&7_O&@"U157+_WC1E_
M[QH M455R_\ >-&7_O&@"U157+_WC1E_[QH M455R_\ >-&7_O&@"U157+_W
MC1E_[QH M455R_\ >-&7_O&@"U157+_WC1E_[QH M455R_\ >-&7_O&@"U15
M7+_WC1E_[QH M455R_\ >-&7_O&@"U157+_WC1E_[QH M455R_\ >-&7_O&@
M"U157+_WC1E_[QH M455R_\ >-&7_O&@"U157+_WC1E_[QH M455R_\ >-&7
M_O&@"U157+_WC1E_[QH M455R_\ >-&7_O&@"U157+_WC1E_[QH M455R_\
M>-&7_O&@"U157+_WC2?/_>- %NBJF9/[QH$TB=\B@"W14<<JR#C@^E24 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*GQ36% %0YC<,*NJ=R@^M591Q4\'^I6@"2BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "@]
M**#TH J)]XU86JZ?>_&K"T /HHHH *0L!U('UI:\X\=1WUWXHLX4L]4N+&*U
M9W%DQ4%]PZG![9H ]&W#&<C'KFE!!&0<BO*4U"VUIO#VA:9=7L6GSR2FZ$CX
MERA(:,GV;^5=)X0:;3]?US0FN)9K:T:-[<R-DHK@DKGTZ4 =E1144]S%;@&5
M@H/2@"6BJ?\ :EG_ ,]EH_M2S_Y[+0!<HJG_ &I9_P#/9:/[4L_^>RT 7**I
M_P!J6?\ SV6C^U+/_GLM %RBJ?\ :EG_ ,]EH_M2S_Y[+0!<HJG_ &I9_P#/
M9:/[4L_^>RT 7**I_P!J6?\ SV6C^U+/_GLM %RBJ?\ :EG_ ,]EH_M2S_Y[
M+0!<HJG_ &I9_P#/9:/[4L_^>RT 7**I_P!J6?\ SV6C^U+/_GLM %RBJ?\
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M_:=I_P ]10!<HJG_ &I9C_EL*/[4L_\ GLM %RBJ?]J6?_/9:/[4L_\ GLM
M%RBJ?]J6?_/9:/[4L_\ GLM %RBJ?]J6?_/9:/[4L_\ GLM %RBJ?]J6?_/9
M:/[4L_\ GLM %RBJ?]J6?_/9:/[4L_\ GLM %RBJ?]J6?_/9:/[4L_\ GLM
M%RBJ?]J6?_/9:/[4L_\ GLM %RBJ?]J6?_/9:/[4L_\ GLM %RBJ?]J6?_/9
M:/[4L_\ GLM %RBJ?]J6?_/9:/[4L_\ GLM %RBJ?]J6?_/9:/[4L_\ GLM
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRI:* $V+_='Y4;%_NC\J6B@!-B_W1^5&Q?[H_*EHH 38O]T?E1L7^Z/RI:*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ H/2B@]* *B?>_&K"U73[WXU86@!]%%% !1110
M4444 %(>AI:0]#0!1HHHJ@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH MP?ZH5)4<'^J%25(!1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% %>YZK4%3W/5:@IH HHH
MI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #XO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !0>E%!Z4 5$^]^-6%JNGWOQJPM #
MZ*** "BBB@ HHHH *0]#2TAZ&@"C1115 %%%% !1110 4444 %%%% !1110
M4444 %<E<>+I[7Q]'H,D$8LW5?W_ #N#$D >G:NMKA_$?@R_U?4-4N[:>.*2
M>.,6S$\HZECD_F*:MU$R30O'7]H7VK?;HXK:QLP&CE&<L,D?TK7A\7Z+/9SW
M0N62.WQY@DC964'H<$9Q7.-\/[KR;J))XE#01+'GH71F)W>QR*?<^$-7U1;Z
MYN_LL-S/#' D4?W=JDG)_.GH+4UKOQWI,&F7=Y 997M@"8C$RDYZ'D=.>M5V
M\=VT.I0)<1NEG-9BXW+$Q<')!&/08ZU'J'A"[NI=1>-H5%Q91P1C'\:^OM4L
M7AS4);DW-RMNCG3#9[%Y ?! /TY%&@:G12:G ND_VE$'GA*!T$:DLV>F!7-6
M7C=Y?#.H:O=68A:VG\I(<\G)P-U=%H5C)IFB6=E,5,D*;6*].M<Z/!]Q)X?U
M:PFEC\VZNOM$1'3[VX TE8;N26?BC4KC1KN[^QVUQ-#MV+:OG.<<$9)R,U9;
MQ!J2W.F1C2GV72YE/_//COZ4GAK1+ZPO[S4+]+>&2XC2(06X^0!0!N^IQ^M=
M+QZ"AV!7+<'^K_&I*C@_U8J2H&%%%% !1110 4444 %%%% !1110 4444 %%
M%% '+>./$]WX8TZWN+.VCN'DE"%7ST_"LZY\>R_\)+H^G6EM%);W@1I923E-
MW3'/L:VO$NA2ZW)IVPIY<%P)) W=:YC2OA]>V,EO)+<1R/'?+)NYR(5/ 'OR
M:I6L2[W.I@\8:-/JO]G1W+&8OL5O+;8S>@;&"?QID7C;0YKQ+5+ER[.8P?*;
M;N';.,9KGK/P;JT4MGITC6PTZTNQ=+<*#YCX((7]*FMO!E[#:641>'?#J8NV
M('5,KQ]>*+(+L;+\2(WTZ>[M[4@0WJ6["1&^X2 6'OR>*ZK1M?L-<BE:RD9F
MA.V1'0JRG&>AY[UR'_"&ZJT%S9G[-Y)U*.[1^[*"I(/Y5T.B:%<:;KVL7SF/
MR[QU:-5[84#G\J'8%<S9/%FLV>M6L%]ID,=K=SM%$JMF7 'WB,]/PJSI_BZX
MU#Q3<:6NGO##%"9$>4$-(0<<#TK.T_0?$D7BR75;X65RKOM0L6S#'Z*.F?\
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M/;J*+(+L['4]4M]*TYKV8221C[JQ*6+$] ,5D6GBFYOO#$&K6NF%Y9GV"$L
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M HHHH MP?ZH5)4<'^J%25(!1110 4444 %%%% !1110 4444 %%%% !1110
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M 4444 %!Z44'I0!43[WXU86JZ?>_&K"T /HHHH **** "BBB@ I#T-+2'H:
M*-%%%4 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% %N#_5"I*C@_U0J2I **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH KW/5:@J>YZK4%- %%%%, HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ?%_K15B;_5&J\7^M%6)O
M]4:0%2BBBF 4444 %%%% !1110 4C?<;Z&EI&^XWT-3+9CCNCRNZ_P"/R?\
MWS_.HJENO^/R?_?/\ZBKXZI\;/OJ7P+T"NU\&?\ (-F_ZZ5Q5=KX,_Y!LW_7
M2N[+/XYYV<?[LSI:***^E/D0HHHH **** "BBB@ HHHH O+]T?2EI%^Z/I2U
M(!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M444 %%%% !1110 4444 %-:G4UJ ().E2P?ZH5%)TJ6#_5"@"2BBB@ HHHH
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M/_/FW_?7_P!:C[7<_P#/FW_?7_UJ );GJM05'-<W!(S9L/\ @7_UJB^T3_\
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MY9VFH?V/;:=L);2=T_E_[.&Y_P"! 5D?VG)+:Q^,MK_NRNGL/81E&_\ 'P*
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M "BBB@ HHHH **** "BBB@ HHHH MP?ZH5)4<'^J%25(!1110 4444 %%%%
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MQI&HPJJ !0 ZBBBF 4444 /B_P!:*L3?ZHU7B_UHJQ-_JC2 J4444P"BBB@
MHHHH **** "D;[C?0TM(WW&^AJ9;,<=T>5W7_'Y/_OG^=15+=?\ 'Y/_ +Y_
MG45?'5/C9]]2^!>@5VO@S_D&S?\ 72N*KM?!G_(-F_ZZ5W99_'/.SC_=F=+V
M/TKSQFG7696M@3,)6*@#/<UZ'V/TKSFXE>#5)I8F*NLK$$?6O0S-V43Y$WV,
MMWIMFT99F6YPYG&#NYX'MUJ36&6;3M1$3.QCF'F"0<+U^[7/W.JWMWL\V7A#
MN 4 <^O%%SJM[>0^5-+E.I 4#=]<5P/$0LUY =#X0_X\[C_?']:Z*N=\(_\
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M+:]]SLABZ:IWD[RM;;7[S8G1I+9T0[6*D ^E</8Z?J5G]IM3IBRRR,V)W((
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M]+"*25!/!Q2T45U'&%%%% !1110 4444 %!Z44'I0!43[WXU86JZ?>_&K"T
M/HHHH **** "BBB@ I#T-+2'H: *-%%%4 4444 %%%% !1110 4444 <=XP@
MTV75;"2_N[RU:**0PRP*=I;T)'(-8.BZA/:ZC%J&N>;LGT^6&"9XSEP"H7(
MX)ZUZ3<26J@+=&'!Y"R@'^=1/=Z?(H622W=1T# $#Z5#G%.S9:IS:NDSRH:9
M?VEIH%JMO(!J]L+6<;?]6!MQN].];WAC3Y8O&US8&!DL]&\S[.Q7 (D(QCZ;
M/UKN3?61()N(21T)/2G)>6COM2>(NWH>32]I#N/V51?99/1116AF%%%% !11
M10 4444 %%%% %N#_5"I*C@_U0J2I **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH KW/5:@J>YZK4%- %%%%, HHHH
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MCHK"\-:C>:I;RW-R%"%L1@#M6[713FIQYD<M2FZ<G%[A1115D!1110 4444
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M "BBB@ HHHH *1ON-]#2TC?<;Z&IELQQW1Y7=?\ 'Y/_ +Y_G452W7_'Y/\
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MQ KKM"FNKC0K.>]8-<RH7<@8ZDX_3%,#0HHHH **** +<'^J%25'!_JA4E2
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!7N>JU!4]SU6H*: ****8!1110 4444 %%%% %'6/^0-=?[AKS(=!7INL
M?\@:Z_W#7F0Z"O S?^)$^GR/^'+U%H/2B@]*\E'ML]'\/_\ ("MO]VK6H_\
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MX'P)_P A"Y_W!_.N^KZ7+?\ =T?'YO\ [T_D%%%%=YY@4444 %%%% !1110
M4444 %%%% !36IU-:@""3I4L'^J%12=*E@_U0H DHHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ H/2B@]* *B?>_&K"U73[WXU86@!]%%% !7/ZUXJBTJ_6P@LKF]O/+,S1
M6Z;MB#N?TKH*Y7Q%J%A<7,^BC5&TS4&@,GGXQE.^#WZT *_CO3#I-I>VT<]Q
M+=RF&&V1/WC2+G<N/;!_*M'0/$-OKT4_EQ2P7%L_ESP2KAD;_(KROP[<QP7G
MAFZN-B6<-W<VRW'197W-B3ZL 3^-=QX5ECO?&GB:]M7#VI:&/>O1G52&_(T
M=I2'H:6H;A9V4>3(J'OE<T 5J*K>7>?\]X_^^/\ Z]'EWG_/>/\ [X_^O5 6
M:*K>7>?\]X_^^/\ Z]'EWG_/>/\ [X_^O0!9HJMY=Y_SWC_[X_\ KT>7>?\
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M_P#OW_\ 7H\J_P#^?F/_ +]__7H N453\J__ .?F/_OW_P#7H\J__P"?F/\
M[]__ %Z +E%4_*O_ /GYC_[]_P#UZ/*O_P#GYC_[]_\ UZ +E%4_*O\ _GYC
M_P"_?_UZ/*O_ /GYC_[]_P#UZ +E%4_*O_\ GYC_ ._?_P!>CRK_ /Y^8_\
MOW_]>@"Y15/RK_\ Y^8_^_?_ ->CRK__ )^8_P#OW_\ 7H N453\J_\ ^?F/
M_OW_ /7H\J__ .?F/_OW_P#7H DN>JU!4<\5Z",W$9_X!_\ 7J+R[S_GO'_W
MQ_\ 7IH"S15;R[S_ )[Q_P#?'_UZ/+O/^>\?_?'_ ->F!9HJMY=Y_P ]X_\
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M_P#KT@"BJWEWG_/>/_OC_P"O1Y=Y_P ]X_\ OC_Z],"S15;R[S_GO'_WQ_\
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MC% $]%%% !36IU-:@""3I4L'^J%12=*E@_U0H DHHHH **** "BBB@ HHHH
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MZE1G%=!H-U.)8+><R*I4B!=ORO\ 6IHFEM+*P6$[6DNR)=HZ\CBO&AAU))W
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M(/"UB.GF?]]52E7[(EQPW23^XTQJ%F>ES'_WU2B^M3_RWC_[ZK.'ANR7IO\
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MX:J^'_\ D!6W^[5K4?\ D&W/^X:^LA_NZ]#X3%?QY^K/-U^Z*6D7[HI:^7,
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M-6G4E&-C.M?$-_?ZIX<D:4HEU$QE0=&(R/Z57O+F^U*[\66;7TB0V\>Y N.
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MUT'\Z]&KSG3O^0G;?]=!_.O1J]O*O@8!1117K %%%% %N#_5"I*C@_U0J2I
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M<_[AKZR'^[KT/A,5_'GZL\W7[HI:1?NBEKY<P"N\\._\@.W_ !K@Z[SP[_R
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M '5_D*RGM;B.(2O"ZQGHQ'%>?6Q-95)*+T1YAT7_  FUW_SZQ_\ ?7_UJU=
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MUGPZ="8\[Y?^^JD_LV'^_+_WU4@7,CUHR/6J?]FP_P!^7_OJC^S8?[\O_?5
M%S(]:,CUJG_9L/\ ?E_[ZH_LV'^_+_WU0!<R/6C(]:I_V;#_ 'Y?^^J/[-A_
MOR_]]4 7,CUHR/6J?]FP_P!^7_OJC^S8?[\O_?5 %S(]:,CUJG_9L/\ ?E_[
MZH_LV'^_+_WU0!<R/6C(]:I_V;#_ 'Y?^^J/[-A_OR_]]4 7,CUHR/6J?]FP
M_P!^7_OJC^S8?[\O_?5 %S(]:,CUJG_9L/\ ?E_[ZH_LV'^_+_WU0!<R/6C(
M]:I_V;#_ 'Y?^^J/[-A_OR_]]4 7,CUHR/6J?]FP_P!^7_OJC^S8?[\O_?5
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M(Z"O1M6LXDTFY8-)D)W:O.1T%?,9M_$B?:9'_#EZBT'I10>E>4CW&>C^'O\
MD!6W^[5K41_Q+;G_ '#6=H5I')HMNQ9\E>S59O[.)=/N&#29"'JU?64_]W7H
M?"8K^//U9Y^OW12TB_=%+7RY@%=[X=_Y <'XUP5=MH-K')HT#L7!.>AKTLL_
MBL#:HJM]AB_O2?\ ?5'V&+^])_WU7O@6:*K?88O[TG_?5'V&+^])_P!]4 7(
MO]8*L3?ZHUG1V$)D W2?]]5-+IT(C)WR_P#?5( HJM]AA_O2?]]4?88O[TG_
M 'U3 LT56^PQ?WI/^^J/L,7]Z3_OJ@">3_4O_NFOG*Z_X^YO]\U]"2640B?Y
MI/NG^*OGNYXNI1_M&O1P'4\+.=HD5%%%>B>">P?#'_D6)/\ KN?Y"NS8?*WT
M-<-\-K9)O#<C,7!\\]#CL*[$V,6T_-)T_O5X.*^.1]E@/X,#S.Z_X_)_]\_S
MJ*I+D8NY@.SG^=1U\14^-GZ12^!>@5VW@S_D&S?]=*XFNP\(VZ3:=*6+ A^Q
MQ7=EG\<\[./]V.JQP?I7FU[_ ,?]Q_UT;^=>@?88L'YI.G]ZO/KP;;V<#H)&
M'ZUW9K\,3Y$AHHHKQ0.N\(?\>=Q_OC^M=%BN8\+6Z36DY8L,,.AQ6]]AB_O2
M?]]5]-@OX$0+-%5OL,7]Z3_OJC[#%_>D_P"^JZP+-%5OL,7]Z3_OJC[#%_>D
M_P"^J -=3\H^E+D>M4ETV':/GE_[ZI?[-A_OR_\ ?52!<R/6C(]:I_V;#_?E
M_P"^J/[-A_OR_P#?5 %S(]:,CUJG_9L/]^7_ +ZH_LV'^_+_ -]4 >$>-_\
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MI6CBBBI45%MI%2G*22;V$P/2EQ115$A1110 4F!Z"EHH *,#THHH **** #
M]*,#THHH ,4444 )@4M%% !@>E%%% "8'H*7 ]*** "C ]*** #%&!Z444 &
M*,#THHH ,4444 )@>E+@>E%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4'I10>E %1/O?C5A:KI][\:L+0 ^BBB@ I"JGJH/U%+10 FU<8VC'IB@
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M ZW(]: 0>AKD;Z!]*T)9X)93+<;!([-V./RI+-;FTU&!H(C$C1DNC2AM_!Y
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M<_R%=FWW&^AKC/AC_P BQ)_UW/\ (5V;?<;Z&O!Q7QR/LL!_!@>5W7_'Y/\
M[Y_G452W7_'Y/_OG^=15\14^-GZ12^!>@5VO@S_D&S?]=*XJNU\&?\@V;_KI
M7=EG\<\[./\ =F=+V/TKS:]_X_[C_KHW\Z])['Z5YM>_\?\ <?\ 71OYUWYK
M\,3Y$@HHHKQ .N\(_P#'G<?[X_K715SOA'_CSN/]\?UKHJ^FP7\"(!11176
M4444 7E^Z/I2TB_='TI:D HHHH **** /GWQQ_R.&H?]=#7/5T/CC_D<-0_Z
MZ&N>KZ"E\"/B\1_%EZA7I'PB_P"/_4?]Q/ZUYO7I'PB_X_\ 4?\ <3^M9XO^
M"S?+O]YB>MUY;XH_Y&&Y^M>I5Y;XH_Y&&Y^M?'YK_"7J?HV2?QWZ&11117SY
M]4=7X$_Y"%S_ +@_G7?5P/@3_D(7/^X/YUWU?2Y;_NZ/C\W_ -Z?R/.O%?\
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M7C*?ZQ/]X5[%:_\ 'M'_ +HKT,!BIU[\_0\G,\%3PW+R=2:BBBO2/)"BBB@
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MA'_CSN/]\?UKHJ^FP7\"(!11176 4444 7E^Z/I2TB_='TI:D HHHH ****
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M 4444 %!Z44'I0!43[WXU86JZ?>_&K"T /HHHH **** "BBB@ I#T-+2'H:
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M%B3_ *[G^0KLV^XWT-<9\,?^18D_Z[G^0KLV^XWT->#BOCD?98#^# \KNO\
MC\G_ -\_SJ*I;K_C\G_WS_.HJ^(J?&S](I? O0*[7P9_R#9O^NE<57:^#/\
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M-\:_Z^U^AKEJZGQK_K[7Z&N6KXG'_P =GZ5E?^[1"KVC?\AFU_WQ5&KVC?\
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M_G452W7_ !^3_P"^?YU%7Q%3XV?I%+X%Z!7:^#/^0;-_UTKBJ[7P9_R#9O\
MKI7=EG\<\[./]V9TO8_2O-KW_C_N/^NC?SKTGL?I7FU[_P ?]Q_UT;^==^:_
M#$^1(****\0#KO"/_'G<?[X_K715SOA'_CSN/]\?UKHJ^FP7\"(!11176 44
M44 7E^Z/I2TB_='TI:D HHHH **** /GWQQ_R.&H?]=#7/5T/CC_ )'#4/\
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MI8B3,XX&$>IQ5[H][<^,II5@<6\EBT0EQP&(K"2VUN/PNWA?^Q93(7*?:?\
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MB5-1//H0Q'_CIH ]C!# $'(/(-<UXX_Y R_[XKI0 H  P!P*YKQQ_P @9?\
M?%<V,_@2]#KP'^\P]3SRBBBOE#[@5/\ 6)_O"O8[;_CVC_W17CB?ZQ/]X5['
M;?\ 'M'_ +HKVLIWD?/9[]CYF-XN_P"0$_\ OC^M>?5Z#XN_Y 3_ .^/ZUY]
M669?QOD?.A0:*#7GK<#UBS_X\X?]P5/4%G_QYP_[@J>OK8?"@"BBBJ ****
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MY@5TG@O_ )"TO_7(_P Q7-UTG@O_ )"TO_7(_P Q5X/^/$#NZ***^F ****
M"BBB@ HHHH *:U.IK4 02=*E@_U0J*3I4L'^J% $E%%% !1110 5SEW?O'XR
MM+07[HKPEC;;.&]\UT=<;J-I</\ $6QN%@D,*VS R!3M!YXS6E-)O4PQ#:C=
M$S_$'1D!;]^463RW<1':A]S5NP\8Z9J&I+8Q&59)%W1LZ$+(/8]ZXM=*O/\
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M?\A"Y_W!_.N^KZ7+?]W1\?F_^]/Y'G7BO_D/R_[J_P A6+6UXK_Y#\O^ZO\
M(5BUXN)_BR]3S KI/!?_ "%I?^N1_F*YNND\%_\ (6E_ZY'^8J\'_'B!W=%%
M%?3 %%%% !1110 4444 %-:G4UJ ().E2P?ZH5%)TJ6#_5"@"2BBB@ HHHH
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MU[R?O'ZUY>.^-'TF3_PF<;XU_P!?:_0URU=3XU_U]K]#7+5\1C_X[/TK*_\
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MX:\R'05Z;K'_ "!KK_<->9#H*^,S?^)$_2<C_AR]1:#THH/2O)1[;/1_#_\
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MZ4M(OW1]*6I **** "BBB@#Y]\<?\CAJ'_70USU=#XX_Y'#4/^NAKGJ^@I?
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MPLB.:"*==LL:.HYPPS61IOAY-.UJ^U!92PN@!Y>W 7%;=%4I-*R)E3BVF^A
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MPT)!X<L?-^_Y0SFM:F11K#$D:#"J  *?7-)W=SO@K12"BBBD4%%%% !1110
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M11711HPHJT$!R_\ ;-__ - "\_S^%']M7_\ T +S_/X5U%%;W Y?^VK_ /Z
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M@2:II-I)%-HET[,V[*C_ .M7?45I1PE*E+FBM3*OF%>O#DF]#E_[9O\ '_(
MO/\ /X5R=QI^LS7,LHT>X =RP&/4_2O5**TK485E::.(\G_LO6O^@/<?E_\
M6H_LO6O^@/<?E_\ 6KUBBN?^SZ'8#@]#FU32X)8Y=#NG+MD8_P#U5J?VS?\
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M0!!)TJ6#_5"HI.E2P?ZH4 24444 %%%% !1110 4444 %%%% !1110 4444
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MQ4U<%I.E?V7\2)%:YEN9I;,/)+*<DG+?I7>T- @HHHI#"BBB@ HHHH ****
M"BBB@ HHHH **** (KFY@L[=Y[F5(HD&6=S@"J.G>(=)U:5HK&_@FD7DHC@G
M'K6;XTTJXU;3(([62/SHYEE6&5L++@@[3^58B7UHVNZ:-8T6;2;R-RL,T9!C
M<X(VD@8II";/0*A:[MTNTM6E03NNY8R>2/7%<UI>NWMUI>N3R%-]F\BQ8'8
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MEEX9U5)K5+O4(/LML>!#"%>0#H&)_IBNICBBBSY<:)N.3M4#)I^:.8+'(?\
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M: +.X4;A5;<W]TT;F_NF@"SN%&X56W-_=-&YO[IH L[A1N%5MS?W31N;^Z:
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M: +.X4;A5;<W]TT;F_NF@"SN%&X56W-_=-&YO[IH L[A1N%5MS?W31N;^Z:
M+.X4FX>M5]S?W31N;^Z: +&ZHV>HRS?W32!)'X"X]S0 AR[A1U-75&U0/2HX
MH1'SU;UJ6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MYXQZUQ6A^'+Z#R3=VJ92WG3D[B&9R1^E:D&C79\%/IC!4N"I &>/O9Q^E*R
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M#]@4'OL7./?=_6I18W5Q;:I>7AG^VQ0PA.?NDJ-V/?-.P7.^\Q/[Z_G074$
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH I:=IEOID3I#O9I&WN[G+,?4G\*NT44 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/QHN%B[1114C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ IH8DXV$>YQ3J* "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>img88009329_13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_13.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +>!DD# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7Z"H_ ^DV,OA=9)K:.9YV=9&E4,2JL5 Y[  5U-E96^G6<=I:Q^7!$,(NXG
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#[O6+7P^@ATP7ML\DAB9)U1D^<@A@WN,Y'K5Q]"U*70M=EG1&U/4QGR4<;4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8=SI]U)XTLM0
M6+-K':/&\FX<,3P,9S2^'["YL9M7:YBV"XOY)HOF!W(0,'@\=.];=%5SNUB%
M32=S&TRQN;?Q)KEW+'M@NC!Y+;@=VV/!XZCGUK5N(([JVEMY1F.5"C#U!&#4
ME%)MMW&HI*QR?@[0]1TV2YGU4?O41;6W.\-^Y7..A.,\?E44GAN]/C,3!0='
M:87K_,.)@I&,9SUYZ8YKL:*OVLKM]R/8QY5'L8NNZ==W%S8:EI^QKNQ=BL4C
M;5D1AAESV/ P:I7]KJWB%K:TN=.%C9),LLS/.KL^WD*H7ISW-=/124VANFG?
MS,33["Y@\5:Q>R1;;>X2 1/N!W%5(/&<C\:AGL]2TSQ#<ZG86RWD%ZB">#S
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M )ZI_P!]4?:(?^>J?]]4 245']HA_P">J?\ ?5'VB'_GJG_?5 $E%1_:(?\
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M>J?]]4 245']HA_YZI_WU1]HA_YZI_WU0!)14?VB'_GJG_?5'VB'_GJG_?5
M$E%1_:(?^>J?]]4?:(?^>J?]]4 245']HA_YZI_WU1]HA_YZI_WU0!)14?VB
M'_GJG_?5'VB'_GJG_?5 $E%1_:(?^>J?]]4?:(?^>J?]]4 245']HA_YZI_W
MU1]HA_YZI_WU0!)14?VB'_GJG_?5'VB'_GJG_?5 $E%1_:(?^>J?]]4?:(?^
M>J?]]4 245']HA_YZI_WU1]HA_YZI_WU0!)14?VB'_GJG_?5'VB'_GJG_?5
M$E%1_:(?^>J?]]4?:(?^>J?]]4 245']HA_YZI_WU1]HA_YZI_WU0!)14?VB
M'_GJG_?5'VB'_GJG_?5 $E%1_:(?^>J?]]4?:(?^>J?]]4 245']HA_YZI_W
MU1]HA_YZI_WU0!)14?VB'_GJG_?5'VB'_GJG_?5 $E%1_:(?^>J?]]4?:(?^
M>J?]]4 245']HA_YZI_WU1]HA_YZI_WU0!)14?VB'_GJG_?5'VB'_GJG_?5
M$E%1_:(?^>J?]]4?:(?^>J?]]4 245']HA_YZI_WU1]HA_YZI_WU0!)14?VB
M'_GJG_?5'VB'_GJG_?5 $E%1_:(?^>J?]]4?:(?^>J?]]4 245']HA_YZI_W
MU1]HA_YZI_WU0!)14?VB'_GJG_?5'VB'_GJG_?5 $E%1_:(?^>J?]]4?:(?^
M>J?]]4 245']HA_YZI_WU1]HA_YZI_WU0!)14?VB'_GJG_?5'VB'_GJG_?5
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA_GK77A<5&O'S.#'8&>%EWB]F3T445UG %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 445 _FJZ 2##$C[OMF@">BD4$* 3D^N*6@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MCY91D$#UP>H]ZKEEV(]I"Z5UKL:=%%%26%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 5')_K8?]X_R-25')_K8?
M]X_R- $E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45!>WMMIUI
M)=7<RPP1C+.W05!>ZSI^G6*7MY=)#;OC:S@@MD9&!US[8IJ+>R)<XQW9>HJK
MI^I6>JVHN;&X2>$G&Y#T/H?0U:H::T8TU)704444AA1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %>%5[K7A5>/FWV/G^A]#D/\
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M^0_PJ2B@"/RW_P">S_D/\*/+?_GL_P"0_P *DHH C\M_^>S_ )#_  H\M_\
MGL_Y#_"I** (_+?_ )[/^0_PH\M_^>S_ )#_  J2B@"/RW_Y[/\ D/\ "CRW
M_P">S_D/\*DHH C\M_\ GL_Y#_"CRW_Y[/\ D/\ "I** (_+?_GL_P"0_P *
M/+?_ )[/^0_PJ2B@"/RW_P">S_D/\*/+?_GL_P"0_P *DHH C\M_^>S_ )#_
M  H\M_\ GL_Y#_"I** (_+?_ )[/^0_PH\M_^>S_ )#_  J2B@"/RW_Y[/\
MD/\ "CRW_P">S_D/\*DHH C\M_\ GL_Y#_"CRW_Y[/\ D/\ "I*:SJF,YY]
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M0^U6*CD_UL/^\?Y&@ \M_P#GL_Y#_"G*I7.7+?4"G44 %%%% !1110 4444
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M_P#/9_R'^%'EO_SV?\A_A4E% $?EO_SV?\A_A1Y;_P#/9_R'^%244 1^6_\
MSV?\A_A1Y;_\]G_(?X5)10!'Y;_\]G_(?X4>6_\ SV?\A_A4E% $?EO_ ,]G
M_(?X4>6__/9_R'^%244 1^6__/9_R'^%'EO_ ,]G_(?X5)10!'Y;_P#/9_R'
M^%'EO_SV?\A_A4E% $?EO_SV?\A_A1Y;_P#/9_R'^%244 1^6_\ SV?\A_A1
MY;_\]G_(?X5)10!'Y;_\]G_(?X4>6_\ SV?\A_A4E% $?EO_ ,]G_(?X4>6_
M_/9_R'^%244 1^6__/9_R'^%'EO_ ,]G_(?X5)10!'Y;_P#/9_R'^%'EO_SV
M?\A_A4E% $?EO_SV?\A_A1Y;_P#/9_R'^%244 1^6_\ SV?\A_A1Y;_\]G_(
M?X5)10!'Y;_\]G_(?X4>6_\ SV?\A_A4E% $?EO_ ,]G_(?X4>6__/9_R'^%
M244 1^6__/9_R'^%'EO_ ,]G_(?X5)10!'Y;_P#/9_R'^%'EO_SV?\A_A4E%
M $?EO_SV?\A_A1Y;_P#/9_R'^%244 1^6_\ SV?\A_A1Y;_\]G_(?X5)10!'
MY;_\]G_(?X4>6_\ SV?\A_A4E% "*"!@L6/J:6BB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *\*KW6O"J\?-OL?/]#Z'(?^7GR_4***Z2;PE>#2K.
M2& &Z=G\X&=, <;<<X]:\N%*<[\JO8]RI6ITFE-VN<W16[-HHT[1+J745B2[
M9T%LJS!F//S<*2,8_E6%2G3E"RD.G5C4NX[(])^'W_( G_Z^F_\ 04KK*Y/X
M??\ ( G_ .OIO_04KK*^DP?\"/H?&YA_O4_4*S=>OO[/T>:<0K,QP@C<95BQ
MQS[5I5@Z[=Z=?65WI\FHK;M&5\YO++;<G('\NE:U96@[/4QH1YJBNKKJ5='T
M/4]/O4F*:9$C?ZT1(V_'H":ZBN1TRXC-_;QKXJ>Z^8 0F+&_VS775&'Y>7W?
MS3_(TQ?-SIR_)K\PHHHK<Y0HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ J.;K'_OC^1J2HYNL?^^/Y&@"2BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH CM_P#CWC_W14E1V_\ Q[Q_[HJ2@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#_&CS3_SRD_(?XU)10!'YI_YY2?D/\:/-/\ SRD_(?XU)10!'YI_YY2?D/\
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M]I'1'+\5+:#_ "_,Z_-%<9_PE^KSG%MH;^Q(9OY 4AU+QA/]RQBA![E0,?\
M?1J?KE-_"F_1,O\ L^JOC<5ZM':45Q)M/%]Q_K-1CB![!@,?]\BD/AC59^;G
M79#GJ 6;^9%'UBH_AIOYV0?5*4?CK1^5V=H\T40S)(B#_:8"J<NN:5#P^H6P
M/H) 3^E<PG@BT)S->W#MWP /\:MQ^#](0?-%-(?]J3_#%'/B7M!+U?\ D'LL
M''>HWZ+_ #9>E\8:)%Q]LWG_ &(V/]*I3>/=+3_5PW,GOM '\ZMQ>'M)B&%T
M^$_[^6_F:N16-M#_ *JU@3_=C _I1RXI[R2^3#GP4=HR?JTOR, ^.I9>+32)
M9/JY_H*3_A(?$UR/]'T<(/5XV_J174!6 P.![4OEDT>PJOXJC^22#ZU07PT5
M\VV<IYGC.Y[Q6X_X /\ &F_V/XEN.+C6M@_V)&_H!77"$THAH^J1?Q2D_F'U
M^2^"$5\O\SCQX-DE/^EZO-+]%)_F:GB\%:8GWY;F3VW ?TKJQ"*41"FL%07V
M27F.*?V[>EE^1S\7A71HCD6>X_[<C'^M7(]'TZ+F/3[8'U\L'^=:WEBEV"M8
MT*4=HK[C"6)K2^*;?S932%4&$C1!_LJ!45UIL=\8VE+K)']R6-MKK]#Z>U:6
MT48%6XIJS1G&<HOF3U,FQTN.#%P6EFN'3!EF?<P'H/05>\DU+ /]'C_W14F*
M<8J*L@E.4G>3*_DTODU/13)(?)%+Y0J6C% $7E"E\L5)BC% #/+'I2[!3\48
MH 9L%+M%.Q10 W:*,"G44 -Q2XI:* $Q12T4 )12T4 )BC%+10 F*CD_UL/^
M\?Y&I:KR2_O8OW<G#'^'V- %BBD4[E!P1[&EH **** "BBB@ HHHH **** "
MN8NKN^U*[OH-/TVPF@@?9,;I<F5QV ]O>N@O(KB:T>.UN?LTQQMEV!]O//!X
M/''XU@1^&]5BEN)8_$#(]P<RE;11D],]>#[BL*W.[**=OE^IU8?D5Y2:3Z7O
M^B-?1;V+4-)@N(81"K CRAT0@X(_2K]4M)T_^R]+AL_-$OE@C>$VYR2>GXU=
MK6%^5<VYA5Y>=\NU] HHHJB HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM% "48I:* #%&*** "BBB@".W_X]X_\ =%25';_\>\?^Z*DH **** "BBB@
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M%% !1110 4444 %%%% !1110 4444 ,>01]58C&>!FA)!)T5@,9Y&*29BL;
M(S?*>1BB%BT:@HR_*.3B@"2BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH CF_U8_WE_F*DJ.;_5C_ 'E_F*DH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHS29H 6BDS10 M%)5:_O4T^U,[J
MSG(5$7J['@ 4FTE=CC%R=EN31_?E_P!_^@J2L$ZEJ=HKW-S9P&#.Z189"708
MZ\C#8QVK;CD66-9$8,C ,I'<&IC-2T+G3<%=[#Z***LS"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KPJO=:\*KQ\V^Q\_T/H<A_Y>?+]0K3LKS3?LHM
MM0L"P!.VX@;;(,^H/#?C696_H89X2+#1UN[U.7GG;,<8SQ@' S[DUYE%-RLO
MRN>UB&E"[_.WXD5]H!ATXZG9W N+'(&YE*.N3CD'KVY%8M:^NKK0D1M7\W#?
MZO+ I_P';\OY5D45E%2M%6##N3A>4D_3^M?N1Z3\/O\ D 3_ /7TW_H*5UE<
MG\/O^0!/_P!?3?\ H*5UE?18/^!'T/D,P_WJ?J%9?B*>WM]%FDN;=;A00%B;
MHS$X%:E9FOFT&C3B^21K=L*QC'*Y(P?P.*VJ_ _0PH_Q(^I@V=H^D:O9?VAI
MVG@7+[8I+92&B?' YKL:P[+0&2[@N[O4IK[R1F /C:N1U]S[UN5G0@XIW5C3
M$U%.2:=W\_U"BBBMSF"J6J7TNGV1F@LI[R3<%6*'&23W)/0>]7:SM;NK^STN
M673;,W=W]V./( !/<^PJHJ[2(J.T&S)C\9Q0P:B=4L)K&XL45Y(2ZR;@W"[2
M."2<?G4^E^)I+O4TT_4-+GTZXFC,L D<,)%'7D=#[5S,6AZEJ.A:A;3:==1Z
MK<;+B2[N63;*Z,"$ !X&,X[5L6L.JZYXGT[4KW3'T^#3XI.)'#&21Q@@8[#U
MKHE"FD_\_+IZLX(5JS<;WZ=/-WOII96[?,ZZBBBN4](***:Z*X 89Q[T .HJ
M/[/%_=_4T?9XO[OZF@"2BH_L\7]W]31]GB_N_J: )**C^SQ?W?U-'V>+^[^I
MH DHJ/[/%_=_4TGV>+^[^IH EIDLB0QM+(P1$!+,>@%-\B/^[^IKBM;O)-=U
M1=&TLXA4_OY020<=?P'ZFL:U94HWW;V7<Z,-AW6E;9+5OLB.1YO&>LX&]-*M
MC]-W_P!<_H*ZP1*B0Q1H$C1E55 X P:AL].MK*V2V@C^11R2>6/J?>K1MHQY
M?R_QCN?>IH47!.4M9/<K%8A5&H05H1V7Z^K)TBQU%2;!Z4W[/%_=_4T?9XO[
MOZFN@Y1^T4;:9]GB_N_J:/L\7]W]30 _;1BF?9XO[OZFC[/%_=_4T 28HQ4?
MV>+^[^II?L\7]W]30 _%%,^SQ?W?U-'V>+^[^IH 2'_EI_OFI*KQ01GS/E_C
M/<U+]GB_N_J: 'XHQ3/L\7]W]31]GB_N_J: ),45']GB_N_J:/L\7]W]30!)
M14?V>+^[^IH^SQ?W?U- $E%1_9XO[OZFC[/%_=_4T 245']GB_N_J:/L\7]W
M]30!)14?V>+^[^IH^SQ?W?U- $E%1_9XO[OZFC[/%_=_4T 245']GB_N_J:/
ML\7]W]30!)14?V>+^[^IH^SQ?W?U- $E%1_9XO[OZFC[/%_=_4T 245']GB_
MN_J:8\*+C;'N_P"!8H ?;_\ 'O'_ +HJ2JEM$K1)NBP-HYWU/]GB_N_J: )*
M*C^SQ?W?U-'V>+^[^IH DHJ/[/%_=_4T?9XO[OZF@"2BH_L\7]W]31]GB_N_
MJ: )**C^SQ?W?U-'V>+^[^IH DHJ/[/%_=_4T?9XO[OZF@"2BH_L\7]W]31]
MGB_N_J: )**C^SQ?W?U-'V>+^[^IH DHJ/[/%_=_4T?9XO[OZF@"2BH_L\7]
MW]31]GB_N_J: )**C^SQ?W?U-'V>+^[^IH DJ.3_ %L/^\?Y&C[/%_=_4U%)
M!'YL7R_Q'N?0T 6:*C^SQ?W?U-.2-4SM&,^] #J*** "BBB@ HHHH **** "
MN-NK)]5U2^.G:9IQ6WD*R/<*2TLG4CCI795S']G)J.IZ@VGZC=6+B39=1J!A
MFQ]X<\9]:Y\1'F21U867*Y.]OOMOY&KH%Q!=:);RV\"P1D$>4O12"<C\\UI5
M7L;*'3K**T@!$<8P,]3[U8K:":BD]S"HTYMQVN%%%%409.K:K?6,T<-CHUQ?
MNZEBR.J(H'8L>_M6:/&L$NG64UI83SWEY(\<=F" VY/O9/0 >M.\77.N"&*S
MT>SF=9O]?<1%=R+W"Y(^8^O:LI-.O++^Q]2TW1)XUTXR0O9R2+YCHX&7!S@G
M)-=,(0<4W^?YG!5JU%4:BW;T\UMIK97.ET/7$UE+A&MI+6[M7\N>WD()0]N1
MU!]:UJYOPS8WHU#5M7O[?[+)?R)LMRP8HB# )QW-=)6-1)2LCJH2E*"<M_ZM
M^ 4445!J%%,:)'.6&3]:3[/%_=_4T 245']GB_N_J:/L\7]W]30!)14?V>+^
M[^IH^SQ?W?U- $E%1_9XO[OZFC[/%_=_4T 245']GB_N_J:/L\7]W]30!)14
M?V>+^[^II/L\7]W]30!+157[-%]H*[3C:#C<?6I?L\7]W]30!+14?V>+^[^I
MH^SQ?W?U- $E%1_9XO[OZFC[/%_=_4T 245']GB_N_J:/L\7]W]30!)14?V>
M+^[^IH^SQ?W?U- #I/\ 5/\ 0T1_ZI/H*BD@C\M_E['N:(X(_+7Y>P[F@">B
MH_L\7]W]31]GB_N_J: )**C^SQ?W?U-'V>+^[^IH DHJ/[/%_=_4T?9XO[OZ
MF@"2BH_L\7]W]31]GB_N_J: )**C^SQ?W?U-'V>+^[^IH DHJ/[/%_=_4T?9
MXO[OZF@"2BH_L\7]W]31]GB_N_J: )**C^SQ?W?U-'V>+^[^IH DHJ/[/%_=
M_4T?9XO[OZF@"2BH_L\7]W]31]GB_N_J: )**C^SQ?W?U-)]GB_N_J: %G_U
M8_WE_F*DJI<1 +\L61N7G?[BI5A0CYH]I_WB: )J*B\B+^Z?S-'D1_W?U- $
MM%1>1'_=_4T>1'_=_4T 2T5%Y$?]T_F::T4*#+8 ]2Q% $]%9TU_I,'^MO+=
M/8S#_&J,WB3P_#UO%8^B!FK.5:G'>2^\UCAZL_ABW\C?HKDI?&FBQ_ZN*YE_
MW5Q_,U5;QHDO%II$TI[9D/\ 0&L7C:"^T=$<NQ3^Q]^GYG;45P_]N>(+D?Z-
MHFSW=7_J12;?%]S_  Q6P^JC_&E]<B_ABW\BOJ$U\<XKU?\ D=S2$@#).![U
MPRZ#XBF.9]9\O_<D;^@%/'@^27_C[U::7Z)_B:?MZKVIOYM(3PU&/Q55\DV=
M;+J5C!_K;VW3_>E _K5&7Q3HL(^:_C;_ ' 6_D*R(O!NFI]^2YE^K ?R%78O
M#6D0_=L@W^^Q/]:+XE[)+\1<N#CNY/TLOS(Y?'6CQCY//E_W8\?S-5&\>QOQ
M:Z;-*?=L?R!K831]/0Y2PMU/J(Q5E;6-1A8PH]!D4O9XA[S2]%_F/VN$CM3;
M]9?Y(YP>)_$%SQ:Z(5]V1S_A2?:?&=SP(8K?/?"#^9-=-]E0_P /ZFG"T3^Y
M^IH^K3?Q5'^0_KD(_!2C\[O]3E?[*\57'^OU<1@_W'(_]!%">&=1MI8[PZ@]
MY- XD6%\X?'49)ZXS75BTC_N?J:<+2+^Y^IH^IT]VVWZL7]HUMDDEY)&++J3
MW<,EO:6=TURX*;9(BBH3W8GC K<LK<6EC!; EA%&J9]<#%,BMH]\OR_Q^I]!
M4WV>+^[^IK>,&G>3NSFG43CRQ5D2T4BJ$7 &!2UH9!1110 4444 %%%% !11
M10 4444 %%%% !1110 5X57NM>%5X^;?8^?Z'T.0_P#+SY?J%=#'#/>>#TBL
M%9S'<LUU'&,L<@;6P.HXKGJWK'2;V31TU+2A>"Y21DD\LD97L4QR>X(R>:\V
M@FVTE?0]C$M)1;=M>NWS_K<<L%Q9^$;M+]&C66:,VL<@P=PSN8 ]!CC-<_6A
M?6NL%3<:A!?%5X,MPCX'XFL^E5>J5K674J@K)NZ=W?38])^'W_( G_Z^F_\
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MEQ/_ *UX\L?7MFN?"NS<'O\ \,=6-CS*-1;?CU_X)H4445V'GA1110 4444
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M'_JD_P!T5FWVIR)<-96=M]HG"9D+/L2,'ID\\GTJ.WUJ.)OL^I*EE*J;E+2
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M4DW^K_X$O\Q4N* &;12[13L44 -P*7%+10 E%+10 F*7%%% !BBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@"./[\O^_\ T%25'']^7_?_ *"I* "BBB@
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M?\* )**CS/\ W8_^^C_A1F?^['_WT?\ "@"2BH\S_P!V/_OH_P"%&9_[L?\
MWT?\* )**CS/_=C_ .^C_A1F?^['_P!]'_"@"2BH\S_W8_\ OH_X49G_ +L?
M_?1_PH DHJ/,_P#=C_[Z/^%&9_[L?_?1_P * )**CS/_ '8_^^C_ (49G_NQ
M_P#?1_PH DHJ/,_]V/\ [Z/^%&9_[L?_ 'T?\* )**CS/_=C_P"^C_A1F?\
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M65C6C4]I#F]?P=@HHHJ#4**8QEW?*J$>Y/\ A29G_NQ_]]'_  H DHJ/,_\
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M/^% $E%1YG_NQ_\ ?1_PHS/_ '8_^^C_ (4 245'F?\ NQ_]]'_"C,_]V/\
M[Z/^% $E%1YG_NQ_]]'_  HS/_=C_P"^C_A0!)14>9_[L?\ WT?\*,S_ -V/
M_OH_X4 245'F?^['_P!]'_"C,_\ =C_[Z/\ A0!)14>9_P"['_WT?\*,S_W8
M_P#OH_X4 245'F?^['_WT?\ "C,_]V/_ +Z/^% $E%1YG_NQ_P#?1_PHS/\
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MI/J6O^)24L8_L5D>#(3C(_WNI_"M'3?"^GZ?AY%^U7'=Y1P#[+_C6X%)  &
M. !VJ5(O6JAA8I\]1\S\_P!$14QLG'DI+DCV7ZO=F.F@V'V@ 0-Y87<(C(QC
M!S_=SBM80U(J@7!_W!_.I<5T1A&/PJQRSJ3G\3N0B$4OE"I:,51 SRQ2[!3L
M4N* &[11@4ZB@!,44M% #)/]4_\ NFB/_5)_NBJ>J:M8Z7"#>W*1&0$(IR68
M^P')IVF:I9:I;[[*Y28)A7 X*GT(/(_&GRNU[:$\\>;EOJ7,4N***104444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1S_ZO_@2_P Q
M4E96JZ[IFFNL%U=JDQ*MY:@NP&1R0H) J]9WMM?VRW%I.DT+='0Y%-Q:5[$J
M<6^5/4GHHHI%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!'']^7_ '_Z"I*CC^_+_O\ ]!4E !1110 4444 %%%% !1110 4444
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MQ]<DL1@GIT%/T_1[?3TE DN+AYL>;)<RF0OCZ\#KV K0HH<GT&J:T;U:
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M_O#T%2>?#_SU3_OH4 244BL&&5((/<4M !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ J.;K'_OC^1J2HYNL?^^/Y&@"2BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHIKH'QG=QZ,1_*@!MO_Q[Q_[HJ2F)"D>-N[@8
MP6)I] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5')_K8?]X_R-25')_K8?]X_R- $E%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!'_
M ,O)_P!P?SJ2H_\ EY/^X/YU)0 4444 %%%% !1110 4444 -D_U3_[IHC_U
M2?[HHD_U3_[IHC_U2?[HH =1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 1S_ .J_X$O\Q4E1S_ZK_@2_S%24 %%%% !1110
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $<_\
MJ_\ @2_S%25'/_JO^!+_ #%24 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!'']^7_?_H*DJ./[\O\ O_T%24 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%244 1^6_P#SV?\ (?X4>6__ #V?\A_A4E% $?EO_P ]G_(?X4>6_P#SV?\
M(?X5)10!'Y;_ //9_P A_A1Y;_\ /9_R'^%244 1^6__ #V?\A_A1Y;_ //9
M_P A_A4E% $?EO\ \]G_ "'^%'EO_P ]G_(?X5)10!'Y;_\ /9_R'^%'EO\
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M;_\ /9_R'^%'EO\ \]G_ "'^%244 1^6_P#SV?\ (?X4>6__ #V?\A_A4E%
M$?EO_P ]G_(?X4>6_P#SV?\ (?X5)10!'Y;_ //9_P A_A1Y;_\ /9_R'^%2
M44 1^6__ #V?\A_A1Y;_ //9_P A_A4E% $?EO\ \]G_ "'^%'EO_P ]G_(?
MX5)10!'Y;_\ /9_R'^%'EO\ \]G_ "'^%244 1^6_P#SV?\ (?X4>6__ #V?
M\A_A4E% $?EO_P ]G_(?X4>6_P#SV?\ (?X5)10!'Y;_ //9_P A_A1Y;_\
M/9_R'^%244 1^6__ #V?\A_A3D5ESERWU IU% !1110 4444 %%%% !1110
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M?_GL_P"0_P */+?_ )[/^0_PJ2B@"/RW_P">S_D/\*/+?_GL_P"0_P *DHH
MK>6_VD_OG^X.P]?I4OEO_P ]G_(?X4?\O)_W!_.I* (_+?\ Y[/^0_PH\M_^
M>S_D/\*DHH C\M_^>S_D/\*/+?\ Y[/^0_PJ2B@"/RW_ .>S_D/\*/+?_GL_
MY#_"I** (_+?_GL_Y#_"CRW_ .>S_D/\*DHH ADC?RW_ 'S]#V'^%$<;^6G[
MY^@[#_"I)/\ 5/\ [IHC_P!4G^Z* &^6_P#SV?\ (?X4>6__ #V?\A_A4E%
M$?EO_P ]G_(?X4>6_P#SV?\ (?X5)10!'Y;_ //9_P A_A1Y;_\ /9_R'^%2
M44 1^6__ #V?\A_A1Y;_ //9_P A_A4E% $?EO\ \]G_ "'^%'EO_P ]G_(?
MX5)10!'Y;_\ /9_R'^%'EO\ \]G_ "'^%244 1^6_P#SV?\ (?X4>6__ #V?
M\A_A4E% $?EO_P ]G_(?X4>6_P#SV?\ (?X5)10!'Y;_ //9_P A_A1Y;_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^5244 1^:?\ GE)^5'FG_GE)^5244 1^:?\ GE)^5'FG_GE)^5244 1^:?\
MGE)^5'FG_GE)^5244 1^:?\ GE)^5'FG_GE)^5244 1^:?\ GE)^5'FG_GE)
M^5244 1^:?\ GE)^5'FG_GE)^5244 1^:?\ GE)^5'FG_GE)^5244 1^:?\
MGE)^5'FG_GE)^5244 1^:?\ GE)^5'FG_GE)^5244 1^:?\ GE)^5'FG_GE)
M^5244 1^:?\ GE)^5'FG_GE)^5244 1^:?\ GE)^5'FG_GE)^5244 1^:?\
MGE)^5'FG_GE)^5244 1^:?\ GE)^5'FG_GE)^5244 1^:?\ GE)^5'FG_GE)
M^5244 1^:?\ GE)^5'FG_GE)^5244 1^:?\ GE)^5'FG_GE)^5244 1^:?\
MGE)^5'FG_GE)^5244 1^:?\ GE)^5'FG_GE)^5244 1^:?\ GE)^5'FG_GE)
M^5244 1^:?\ GE)^5'FG_GE)^5244 1^:?\ GE)^5'FG_GE)^5244 1^:?\
MGE)^5'FG_GE)^5244 1^:?\ GE)^5'FG_GE)^5244 1^:?\ GE)^5'FG_GE)
M^5244 1^:?\ GE)^5'FG_GE)^5244 1^:?\ GE)^5'FG_GE)^5244 1^:?\
MGE)^5'FG_GE)^5244 1^:?\ GE)^5'FG_GE)^5244 1^:?\ GE)^5'FG_GE)
M^5244 1^:?\ GE)^5'FG_GE)^5244 1^:?\ GE)^5'FG_GE)^5244 1^:?\
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M*L!V+8Q72:4FIQ^$7EN99)-1FA>;#')1F!*J/3' Q6<Z+CNS>GBHU'9+I?\
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MFRMS=#I,8AO_ #QFK=%+F?<?)'L%%%%(H**** "BBB@ HHHH **** "BBB@
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M-/>>5+EY?)56MY K/Z!MNT_G6M4N+6Z*C.,OA=PHHHI%!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH BM[6WM(_+MH(H8R2VV- HR>IP.]2T44 E;1!1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #)H8K
MF%X9XDEB<89'4,K#T(/6E1%C1410J* %51@ >@IU% 6ZA1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG#Q[I)4$QW(..1L'^-/N/[1UB,V<5C-:0R<33SX!"]PH[DU?'AC10H']GQ'
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ME!X7')S45AXCT?4[D6UEJ$,\Q!(1#S@5I+%&J%%10IZJ!Q34@BC;<D2*?55
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
%HHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>img88009329_14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_14.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '7 =H# 2(  A$! Q$!_\0
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MVN[FR0/=374NQ%/]T?G6;J/C?_A,?A)XK6YM/L>IV$307=ONR%;/4'TX/Y4
M>E2^)-%AL+:^EU2T2UNF"P3-* LA]%/>M0$$9'3%>!7.IV6F?!SP.UYI%OJ*
MR7"HBS.RB,Y;YACO78^)?B+K&D>/+;POI6BQ7TMQ:B2+,I0ACGJ>@48YH ]-
MHKS3PE\0]7O/%^H>&/$^F06-]:PF</!)N0J,'O['.:Q#\5_$^I6NH:YHGA^U
MFT"QD97>:?;+(J]2!]* /9J*XF[\8ZGJ'@2Q\0>%=*_M&>Z9/]&=L%%.=V?H
M1BNPMGDDM8GF39*R NG]TXY% $U%%% !1110 4444 %%%% !1110 4E+24 %
M%%% !2TE+0 4444 >0ZGX:O]1^.=Q<R6,W]F3Z2]NUQL^3+(1C/K7%> _ FO
MV5KXLEU#3KI98M,EL[-74_.6SPGJ./UKZ2HH ^>]0\!ZW?\ P=\-!--F>^TN
M=Y9K%LJ[H6.0/?I6EX4T:VU/QGI\UIX!N]/M;4"62\U">0-'(/[@S@\U[E10
M!\]3Z9K$GBG7H_$WA;5=>NYI6&FLKG[,BG..X '3\JCM/"^O)\!-2T=](NUU
M :B&$'EG<RY'(]17T310!X]\3-"U74/A-X?L++3YY[N&6V,D,:99<1D'(]C7
MK5BK)I]LC AEB4$'L<"IZ* .1^(FI7]IX<-CI,$LFHZE(+2%D4D1[OO.2.@
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MU:* /+;W1M2?]H2QU5;*8Z>NGE&N OR!L-QGUIO@G1-1L_C%XQU&YL9HK2X
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M&[H&9#_"2.E2T4 +1110 4444 %%%% !1110 4444 %)2TE !1110 4M)2T
M%%%% "4M)2T %%%% !24M)0 M)2TE !7D%[>W>@?M#6B2W,W]GZO:[4C:0[
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M=H S5M65P"I!!Z$4M "T4E% "T44E "TE%% "T4E% "T4E% "T4E+0 44E%
M"T4E+0 44E% "T4E%  >E>:Z_P".O%.BW=X3H,8L(92B7$BOAES@'.<<UZ57
M'_$[_D1+S_?C_P#0Q6^'Y?:*,E>Y$[\MTRCX7\7>)];U*U6[T)8=/F4M]I16
M  QD$$G'-=]Z5A>#!_Q1FD?]>J?RK=J:S3FU%6L.-[:BT4E%9%"T444 %%)2
MT %%%% !1110 444E "TE+24 %%%% !2TE% "T4E+0 E%%% 'CNE_P#)S.J?
M]@\?^@K7>>+_ !#J>@BT.G:1)J'G;M^S=\F,8Z ]<G\JX+2_^3F=4_[!X_\
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M_*O7!P *PO!8QX,TC_KU3^5;M8XBHY2MT6B*@K*_<6BDHK L6BBB@ HI*6@
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M5'H!3Z**YC06DI:2@ HHHH *6DI: $HI:J7>IV.GE!>WMO;;_N^=*J;OIDT
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MX:C_ (7?X%_Z"DG_ 'X:L"ST6DKSO_A=_@7_ *"DG_?AJ/\ A=_@7_H*2?\
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M8KI/O.BMD'KCG%>X48H \G^'.L>/()M,T+5_"WV/2[>#RC='J-HXSSWKUBC
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M24M !1110 E%%% 'CNE_\G,ZI_V#Q_Z"M>QUXYIG_)S.J?\ 8/'_ *"M>QT
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M10 4444 +24M)0 M%%% !1110 4444 %%%% !1110 4E+24 %%%% !2TE+0
M4444 )2TE+0 4444 %)2TE "UD:WXETKPZ+7^TKI86NIEAA7!)=C[#^=:]>-
M_%CPS9VVJ:7X@:6XEO;C5;:-1)(2D2#J%7MDC)H ]&\1^,-$\)Q02:S>"V6X
M8K'\I;<1UZ"K.@>(=,\3Z;_:&DW'GVV\IOVE?F'48/UKC/'?AG4?$7B[0Y-/
MU;3K22RAD=8KE!([$\;@AZCCK6A\,-?NM:T*]@OX+>.\T^\>UF>V0+'*5_B
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?%%% !1110 M)110 M%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>img88009329_15.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_15.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (* ^H# 2(  A$! Q$!_\0
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MHH **** "DI:2@!:2EI* %I*6DH 6BBB@!*6DI: $I:2B@!:*3BB@!:2BB@
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M^\>^%=-U+^S[O7;**Z!P8VD'RGT)[5I:AKVE:5:P7-_J%O;P3N$BDD<!78]
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M;A"!*TQ(W#/4]^/:@9] YS2U@^"Y;N?P7H\M]N-TUI&9"_4G;WK>H 2BBB@
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M$CO)(R/,..6;T_&I]#^*?ACQ!KPT:SNI1=-DQ>;$467']TGK7D_B>*.?P/\
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MHOA_2?#MG]DTBPALX2=Q6)<9/J3U-6=1TZSU:PFL;^!+BUF7;)$_1A[U:HH
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M"&U6XM-+L7BD:+YF+'&&/<>GI6B_B+7?#6M/#KEW;WUO+IL]\HAA\LQ-'@E
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MYHOB'P_#?Z$L<=JY(,2H$,;]P0.]7+1;".AI*6DJ!A12T4 %)2T4 )2TE+0
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M^7C&>N*Z/PKIVHI=:KK&JVZVUUJ,RL+<.',4:*%4$C@GJ3CUKIL"B@!:***
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M>'-:B7.U-0*C/H%KV*O'_P!G_P#Y 6N_]A)OY5[!0 E+24M !1110 4E+24
M%%%% "T444 %)2TE !2TE+0 4=Z*.] "4M)2T %)2TE !1110 CJ'0J>A!%>
M%^.?!^E^&)=/6VO)G:YD(D$K*2J\<\#W->R:]J4FD:'=W\5LUS) A81+W_\
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M(]9F+*\:PD%VW$C+8P>*QYGW*/8XT$<80=  *=2TE(8M)110 4444 %+244
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MZ/X@TXW&B7,<]I&WEYC7 4CMBL93E+=E)(UZ6DI:D84E+24 +1110 4E+24
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MRM[FTF:.RB\F$"X<87.<'GGDTM]\,O#&H6-C9W%I,8;%#' !.P(!.3DYYYH
MZXRQ@ EU /0YZT&6, '>N#T.:Y&\^&?AF_TVQT^>TE-O8AE@ G8$!CDY.>>:
M6Z^&GAF\TFRTR:TF-K9%C"HG8$;N3DYYH ZTRQ@9+K@]\T>;'C=O7'KFN2N/
MAIX9NM%M-)EM)3:6CN\2B=@06ZY.<FB7X:>&9M#M]&>TE-E;RM-&HG;(9NO.
M<T <!\=/$VJ03Z9X=L;A8+:_4O+)&<LP!P0?;O[UY'XLT;1='NK6T\/:O=:E
M>-%YEW+C:BY'0=\^N:Z/XR:?X?T?4=-T/0$D$]IO,R[RYR^#C)YSQ^M<-IKV
MK6LME_9TMQ?S#:KL^T1L3C)]@,UTQ5TD]+?U]Y+/HWX#1VD?P[2XCMX89'N'
M664'+2$=V_EBO41+'@MO7'KFO-_!_P ,-)A^'5KH^I_Z3Y[B[F>&8A3(1QM(
M/0#BMR+X:^&8="GT9+27[%/*LSKY[9+#@<YS7.]QG6>;&03O7 ZG- EC()#K
M@=3FN2@^&OAJVT6ZTB*TE%G=2+)*IG8DE>F#G(I;7X:^&K/2+W2X;246MX5,
MRF=B3MZ8.>*0SK!+&02'4@=3F@2QD$AU('4YZ5R=E\-?#6GZ7?Z=;VDHMKX*
M)P9V)(4Y&#GBDL/AKX:TVPO[*VM95@OXQ'.#.Q)4'(P<\4 =:)8R,AU..N#T
MH$L;9PZG'7!KDM.^&OAG2K6^M[6TE6.^B\F<-.Q)7K@9/%&F?#7PUI$5Y'9V
MDJK>0F";=.S90]0,GB@#K1+&V=KJ<>AH$L;9VNI^AKDM*^&GAG1C=&SM)5^T
MP-!+NG9LH>HY/%&D?#3PSH<T\MC:2J\\#0/NG9LHPP1R: .M$L;<!U)]C0)8
MV.%=2?8UR6C_  T\,Z%=O=6-I*DKQ-$2T[,-K#!ZGTHT;X9^&=!OQ?6%I,DX
M1D!:=F&&&#P30!UHEC8X#J3Z T"6,G =2?0&N1T?X9^&="U./4+"TF2X0,%+
M3LPY&#P3[T:5\,O#&BZK'J=E:3)=1DE6:X9AR"#P3[T =;YL9. ZD^F:7S8R
M<!USZ9KD-.^&7AC2M8CU6UM)ENXW,BL;AB 3GL3[T67PP\+Z?K,>JV]I,MW'
M+YRL;AR W7IG% '7>;&6QO7/IFCS8]V-ZYZ8S7(6_P +_"]MK*:K%:3"[2;S
MU8W#D;\YSC..M"?"_P +IK(U9;2;[6)_/#?:'QOSG.,^M '8JZ,V%8$CJ :6
ML'2/!^CZ)K5[JUE Z7=X29F:5F!R<G )P.:WJ %I*6DH 6BDHH 6BBDH *6D
MI: "BDHH **** "O-_B79C3[^R\36?B:VT+4H8VM@]TN])D)SMVX)X/M7I%>
M1?%G2;ZXUN&]M=+360=.FMA9A@9(&8\3*IZXZ9H Z#X?:&]KJ&JZOJ6NPZQK
M5SLCN'A7:L2@950O;@YZ5WU>9_#32]6;6-3U_4=*;28[JWAMTM7/S.R#!D8=
MB:]+H 6N+\?>,[SPH-*@TVQAO+W4)S$D<LOEJ %R3G\J[2O-_B2?"JZOHC^+
M--N)K3,BI=9/DPD@<.!ZXH ?=^/M:T;P@=4UG1((=1GNDMK&UAN ZS%NAW#H
M.OY5H^#/&-_K>JZIHNM:='8ZMIQ1I(XI-Z,C#((->0+97B^#I-3M8;E_#]AX
MC2ZLU=6)6V&0S*#SMR17?^ KJ/Q#\3O%/B33]SZ7+##;PSE2HD8 9QGTQ0(]
M)?4K&-V1[RW5@<%6E4$?K7D_P;EC;Q5XX8.I5M0)!!X/S-6EJWP-\/:QJ]WJ
M4]]J*2W,K2NJ2@*"3VXKA/A=\/=$U?7_ !+;7OVIUTR\$<#).4. S=<=>@H&
M?1)D0'!8 _6E,B X+ ?C7&ZU\,/#NO:J^I7R7AN&"@^7=,H^48' ^E+KGPQ\
M.^(=0%[?I=F81K&/+N64848' H [ N@ZL!]:-Z#JP%<?K?PR\.^(+J&XODNS
M)%"L"^7<LHVKTZ=_>C6/AEX=UTVAO4NS]E@6WB\NY9?D'3..I]Z .P+H,98#
M\:/,0#)8 'IS7'ZK\,_#NLP6$-VEV4L8!!#LN67Y1ZXZGWHU+X9>'=5L-/LK
MI+LPZ?$8H-ERRG;[GO0!V!D0#)88/3FC>F,[ACZUQ]]\,O#VHZ3I^F7"7?V:
MP#"';<L&PQR<GO2W7PR\.WNAV6D3)=_9+)F:';<L&RW7)[T =?YB8SN&/6E\
MQ,9W#'KFN.G^&7AZX\/VVB2)=_8[:5I8P+E@VX]<MU-#_#+PZ_AV/0BEW]B2
M<S@?:6W;B,?>ZX]J .Q\Q,9W#'K2;TQG<,>N:X\?#+P\/#K:$$N_L33_ &@C
M[2V[?C'WNN/:B+X9^'8?#UQH:)=_8IYEF<&Y8MN'3#=0* .QWI@G<,>N:/,0
M@G<,#KS7'6WPS\.VFA7NC1+=_8[QU>7-RQ;*G(P>U9][X+\)^$O"6K12_:UL
M;H+YRFY8NY!RJJ>Q)II-NR%<V_%WC&R\.:7*Z2QRWK?)#"&R=WJ?0"L3P#X8
MDCDD\2ZVWF:E<Y=!)UB4]SZ$C\A7*^$/!.E^++?==K,EA#$R) )3N^9CC+]>
M *R/%=EI^B:K)X)\")<RZOJBB&]D>=I!#%G)'/0^I[#ZUK&KRTW!;W=_D[6,
M:4G47.S3\8:W??%'Q4/!7AV8II%N^[4KU#\K 'D9[C^9^E>JZ?X9T6P\-+X>
MBM8FTX1>6\)Y#CN6]2:XOP+X!TW1CJ>E/F21+86TTR'89 _+=/<<>E;NB_#+
MP[H$\\UBEV'GA:!_,N68;6ZXSW]ZYX24E=&D)<RN.'PR\"-T\.:>?HO_ ->M
MW1=$T?0+5K32+2"T@9BYCBZ%O6L#1/AEX=\/7KWE@EV)6B:(^9<LPVL,'@TF
MB_##P[H&IC4+%+L3A64>9<LPPPP>#5%G8B1"<!@30)$)P&&?K7':1\,/#FB:
MPFJ6:7@N4+$%[IF7G@\'ZT:;\+_#FE:Y'J]LEY]K20R*7NF9<GV_&@#LMZ9Q
MN&?3-)YB9QN&?3-<;:_"[PW9ZZFLQ)>?:UF,X+73%=Q.>GI[4+\+O#BZ]_;0
M2\^V>?\ :/\ CZ;;OSGIZ>U '9>8F<;AGTS1YB X+#/IFN-G^%WARXUYM9D2
M\^V--YY(NF"[LYZ>GM1?_"[PYJ6N2:Q<)>?:Y)1*Q6Z8+N'M^% '9F1 <%@#
M]:0N@."P!^M<;JOPO\.:SK,NJW:7GVJ1@S;+IE7(Z<#Z4NM?##PYKVK/J5\E
MX;APH/EW+*ORC X% '8F1!U8#ZF@N@ZL!]37':W\,?#OB#4!>WR79F$:QCR[
MEE&U1@<"EUKX8^'=?N89[U+LO%"L*^7<LHVJ,#IWH [ R(.K ?C070=6 S[U
MQ^L?#+P[KAM3>I=DVL"V\>RY9?D'3..I]Z-5^&/AW6(+&*[2[*64(@AV7++\
MOOZGWH [ N@ZL!GIS1YB  [A@UQ^I?#'P[JMC86=REWY5A&8H=ERRG:3GD]Z
M+[X9>'=1TJPTV=+LV]@&$.VY8'YCDY/>@#L/,3 .X8^M'F)@'<,>M<==?#'P
M[>:+9:3*EW]ELV9HMMRP;+=<GO2S?#'P[<:#;:+(EY]CMY6EC N6#;FZY/>@
M#L-Z8SN&/7-+O3&=PQZYKCG^&/AU_#T>AE+O[$DYN%'VEMV\C'WNN/:D'PP\
M.CP\VAA+O[$TXN"/M+;M^,?>ZX]J .SR#TI:@L[6*QLH;6'(BA01IN.3@# Y
MJ>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **2EH XKXIVIO? MS E
MQ:V\S30^5+<N517\P8Y'>J&@CXHKJEFFL_V&VG!@)VAW>85QV[9K<^(.D1ZW
MX+O[.74(M/CPLC74J[A$%8-GZ\5Y]X!U*\U;Q%;P6_Q+.J1VQW26;VNPS(!C
M@GK0(]H["EI.PHH&! ]*,#THI P(SGB@!0!39/\ 5-]*<"",BFR?ZIOI0!Y%
M^S__ ,@+7?\ L)-_*O8*\?\ V?\ _D!:[_V$F_E7K] "T4E+0 4444 %%)10
M M%)10 M%)10 M%)10 M%)10 M<;\1_'%OX*\-R7.X-?SYCM(N[/ZX]!6]K^
MNV/AS1KG5-0E$=O NXGNQ[ >I->->"=+O?BGXTE\9Z]&PTJS?;86K?=)!R..
MX'4^IJHKJ!A6GPH\5ZCX?3Q& DNO7TWF&.X;;Y<1!Y.?XB<?05DZ?\,/'<NH
MWTEM;V9G5]DV9A@'VKZKP*YWPX/^)EK9_P"GL_UJ7B*D912?5_D93^)+N7/"
M]E<Z=X7TRRO%5;F"W1)0IR P'.#6O244V[N[-1:*2BD M%)10 M%)10 M%)1
M0 M%)2T %%)10 M%)2T %%)10 M%)10 M)2TE "T4E% "T44E "T4E+0 44E
M% "T4E% "UY=XXL-;N?B/I4_AG4--M]5BL7S'<[BTD9;GC&,?K7J%>5_%BQB
MM=2T[Q#)XM&@26\;0QF.#S))"3D@8.2,=NE '5^$D\9I+<_\)5-ILB;1Y'V-
M2"#WSFNJKS[X8S7-_9W-^_C(^(;:3"*&A\LPL.N1UR:] H 6HY(8YDV2QJZ'
MJK#(J2DH :(HQ'Y81=F,;<<8HCABA0)%&J*.BJ,"G44 !KR#X.?\C9XZ_P"P
MB?\ T)Z]?->0?!S_ )&SQU_V$3_Z$] 'L%%)2T %%)10 4M)10 M%)10 M%)
M2T %<1XR\,:SJMV;^PUR6RAA@.Z%68 D9.>#7;5P/Q$\>6OA^U;2[>:,ZE<(
M5PS#$2GC)]_05M0Y^=<FY,[6U./\*Z7K>MZ:^L2>)[BUM;6;$GFS.>% )/7'
M0UI*+KXG^*=QWQ>'[%OIO_\ LC^@KB$O[BT2/PO/JUG!8W4Z22O',KKS@<E3
MT&.GJ*]=U[7M%^&'@A7C"MM7;:Q C=<2'O[^I-=V(J>S]Y:M[>2_S,81NK/Y
MG)^+/&/_  A)U+3](MR^J7LJV]C#&N0F!C./;(P*Z'X8> /^$5L)-2U0^?KU
M_P#/=3.<E,\[0?Y^]9?P[TO_ (2*^C\3:]!NU:%-R*ZX$9<DY ]<8 KU4=J\
M:C\'S?YE4'>%_-_F<[HG_(SZY_O1_P!:Z.N<T3_D9=<_WT_K714J'P?-_FQT
M?A^;_,6BDHK8U%HI*6@ HHI* %HI** %HHI* %HI** %HI** %HI** %HI**
M %HI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDHH Y+XE
M:/>ZWX(N[2PB\^</'+]GSCSE1PQ3\0*X>QEG\7^+_#LFG>$+K1(])E,MU<SP
MB+"[2/+7 YR:Z0ZCJNK_ !D?3$OVM=-TBU6=[=?^7EG!'/L,U'XAO=8\/?$S
M0[B/4VGTS6)/LDE@XXB(7(=?ZT"/11T%+2=J*!G#?$7Q#=6UI%X?T615UK4E
M8(V?]1$!\\A],#@>]><VM[=R_"3PGHR7LR'5=3^RW$R.0Y3><C/49XKU#Q1\
M-]#\57YU&^6X%ZL/DH\4[( .<=/K7(V?PBN;#P);Z?:WL<>MVUZM]',S,T>]
M2<#!Z CKCO0(O_#H/HGC3Q5X5CN)YK"R:*:V$TA<QAUR1DUGW_QSAM+RYM#X
M5U5_*D:/>O1L$C/2NI\#^%=3TC4-7UK79[>75M4D4R"W!V1HHP%&:[&1%\MO
ME'0]J!GD/[/,GF^&]:EP1OORV#VRM>QUX_\ L_\ _("UW_L)-_*O7Z %HI*6
M@ HHHH **2B@!:*2B@!:*2B@!:*2B@!:BN+B*UMY)YY%CBC4L[L<!0.I-2$X
M&:^??BUX^E\1ZDWA'09C]D1L7TZ?QD'[@/H/U-5&+D^5;B;MJ4-?UB_^,OCJ
M#2-.+IH-M*=I[/CK(W]/_KU]":/I5KHFE6VG6482W@0(H'\_K7)_#'P5%X3\
M/HSQ;;VY4-)D<HO9?ZGW^E=S5U++W(]/Q8EW85S_ (<'^G:T?^GPUT%8'AO_
M (^M8/\ T^M_*N6?\2/S_(F?QQ.@HI**U-!:*2B@!:*2B@!:*2B@!:*2B@!:
M*2EH **2B@!:*2EH **2B@!:*2B@!:2EI* %HI** %HHI* %HI*6@ HI** %
MHI** "O,O'\%UI7C32O%#Z)+K.FV]L]O)!"F]X7)R) I_*O2IW\J"23!.U2V
M/7%<#\+[[6/$&BWVO:GJ1E^WSMY%NH^6V525 % %;X<6EW>>)==\2G2)=&T^
M_6.."TE78SE<YD*]LUZ77G7@'4=8M?%>O^%=5U!M2%ALG@NF^]L?^!O<5Z)0
M M<CX\\27&C:9%8Z6!)K>HL8;*/T..7/^RHYS775Q/BSX=6WBC6(=6.J:A9W
M<$!AC-K(%X//ZT >=V?B;6XO@YHT:ZC<?VCJFJ&R>\9RTB*7.2">^!@5UW@*
MZU#2O'/B'PE=:E<ZA;64<5Q;2W3[I & R"?J:YS3_A3KEI\.X[83LVLVVH+?
M06\LN8@4)^4'MN!R?>NO\#>'M<C\3ZWXH\0VT-I>:BL<26T4F\1H@[GWQ0(I
MZM\</"VD:K=Z=<17YFMI3$Y2$$9'IS6#\"[Z+4]:\87\ 817-X)4##!PQ8C-
M>NR:3ITKL\EA:N[')9H5))_*O*O@RBQ^*?'"(H55U @*HP -ST#/8J*2EH *
M*2B@ I:2B@!:*2B@!:*2B@ KYW^+WAC1(_%!NDE=YY8S+/$7.$/7K[^E>T>,
M/$\'A?1GNGP]P^4@B)^\W^ ZFOF:X \1^-+NW\1:C-9P1(TUP^TEG?&0,=LY
M'T%=F&CRKGDKIZ6[_P##&<W?1%#PAX=T_4[.?4M0D-O96+>9<3[ONKV4#NQ/
M %>G^ O#%Q\0-<@\2ZS#)'H&G_NM+LI#D,%/!.>HSR3W/L*\0>)<SSVBN;"%
MUWJ[G$G-?:GAR:VN/#6FS6<"P6\ELC1Q(,! 1TK*JVDHVLOS\RHKJ4/#PQKF
MMXZ"91^AKI*YSP__ ,AO6S_TW']:Z*N+#_!]_P"9%'X?O_,YW0_^1DUS_KHG
M]:Z.N<T+_D8M<_ZZI_6NBHH?!\W^;"C\/S?YBT4E%;&HM%)2T %%%)0 M%)1
M0 M%%)0 M%)10 M%)10 M%)10 M%)10 M%)2T %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 <7XO\ A_;>)K^'4[;4;K2M5A3RUN[5L%E_
MNL.XKBO"L'AS2_&L4VJ:WJ^LZDDIM;:\N[=Q;)(>"J/TW=16YXTU;3-$\2&>
MT\4RZ9JS(IEMI(WGMG7H/,4 [/KD5DZ1I^F0>)[8^(K74K"62Y%Q:1K<M+IT
MTQ.0R8'!).0&Q0(]B'04M(.@HH&+17/^)?&6C>%%@_M2X=9)\^5#%&TDCXZD
M*.<#UIC^.?#R>%QXC.HH=,)VB4*22V<;=N,[L]J .CIDG^J;Z5C>&_%>D^*[
M22XTJX,@B?9*CH4>-O1E/(K9D/[IOI0!Y%^S_P#\@+7O^PDW\J]@KQ_]G_\
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MZ4#/'_V>5=?#>M+(VYQ?D,?4[>:]CKQ_]G__ ) 6O?\ 82;^5>P4 )2TE+0
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M&@8HQ@4M(: .>\.?\A36_P#KYKHJYWPW_P A+6O^OJNBK&A\'W_F94?@^_\
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M",UJ7'CCPM$98I-?T]9$RK*9UR".HH X']G_ /Y 6O?]A)OY5[!7CW[/K!]
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M^/\ R%=+7-^#?^/;4?\ K\?^0K&?\2/S,9_Q(_,Z6DI:2MC8**** %I*6DH
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M+Z_JD3W,K2E$8;5)/05D_ FQ73-8\7V*2-(MO=B(.W5@I89/O7M1KR#X.?\
M(V>.O^PB?_0GH ]?I:2EH *2EI* ,;Q5?76G>'+VYL[/[7,L9'E$9&#P21W
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MJWZ=#X%\_P QTO@^_P#,2EI*6M302EI*6@ I*6DH 6BBB@ I*6DH 6DI:2@
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MI*6DH **** "BBB@ HHHH **** "EI*6@ HHHH **** "BBB@ HHHH ****
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M4M)0 4M)2T %'>BCO0 E<YX-_P"/&]_Z^W_I71USO@[_ )!]Y_U]R?TK*?\
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MTE+25L:A1110 M)2TE "TE+24 +1110 4444 %%%% "4M)2T )1110 4444
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M=\!_] &+_OX_^-'_  IWP)_T 8O^_C_XT 7O^%F^"_\ H8['_ONC_A9O@O\
MZ&.P_P"^ZH_\*=\"?] &+_OX_P#C1_PIWP)_T 8O^_C_ .- %[_A9O@O_H8[
M'_ONC_A9O@O_ *&.Q_[[KR?Q+X"\-6/QB\-Z);Z:D>GW<3-/"';#D;N^<]J]
M*'P=\"8_Y ,7_?Q_\: +W_"S?!?_ $,=C_WW1_PLWP7_ -#'8_\ ?=4?^%.^
M _\ H Q?]_'_ ,:/^%.^!/\ H Q?]_'_ ,: +W_"S?!?_0QV/_?='_"S?!?_
M $,=C_WW5'_A3O@/_H Q?]_'_P :/^%.^!/^@#%_W\?_ !H O?\ "S?!?_0Q
MV/\ WW1_PLWP7_T,=C_WW7#_ !'^&7A#1/ &K:CI^D1PW<$0:.0.QVG<!W-6
M? OPN\':MX'T:_O=&CFN9[97DD,C#<3WZT =?_PLWP7_ -#'8_\ ?='_  LW
MP7_T,=C_ -]U1_X4[X$_Z ,7_?Q_\:/^%.^!/^@#%_W\?_&@"]_PLWP7_P!#
M'8_]]T?\+-\%_P#0QV/_ 'W5'_A3O@3_ * ,7_?Q_P#&C_A3O@3_ * ,7_?Q
M_P#&@"XWQ,\%E2!XCL>G]^L;PM\0O"5GI3QW&OV4;F9VP7[&KO\ PIWP)_T
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M73^\OYU\V?#GX<7'C?P_-J4_B;4K9DN&A"(Y((&.>3[UV'_"A6_Z''5OS_\
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M(7#$>OM0!]";T_O+^=)O3^\OYUXY_P *%;_H<=6_[Z_^O1_PH5O^AQU;\_\
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MV&C:#IL\]E(H:_>*4(74?\LP2>,\YKU"B@#EO 9OD\/K:WGAY=#2V;RX;=9
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MZ*2EH **2B@!:*2B@!:2EI* %HI** %HHI* %HI*6@ HI*6@ HHI* %HI**
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MKNVLD5[FZ0!(US_=+?>Q[5@ZM\1M2?QWX7MM+L+R72K^#SR$09G# <CV3/-
M'K%+7FNE^-=,T2V\6ZE>7>HS16>I&$QSD,=Y PD0'8GM6GX?^(L>K:[%HVHZ
M+?Z/>W$1FMDNU&)E'7!'?VH [>DS7$?$W5KRRT>PTW3YGAN]6O8[-98SAD4G
M+$'L<"N)^(.JW&G^-X;'6]6UK2_#JVB_9[BPS\\G0EV')H ]MS17B.KZMK%E
M\%;V[M_%"ZG(MTBVM_;.1((RPPKGKN]:AN/'NI:IX,T)&N)K36;36;>RU!%;
M:S<]3[,* /=,T9KP76M4AG^*/B.RUGQMJ&AV=MY9MEAGVJQ*C(Q5[P[J/B#5
M_ 7BMDU6]N8-/D\W2M1D!1Y0GS<GC(X_6@#VREK'\+:R/$/A?3M6"A3=0+(P
M'9L<C\\UKT +1244 +124M !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1124 +1110 4E+10 4444 )2T44 )2T44 %<_P"+_"=CXPT@
M6%Z\L1202PSQ'#Q..A%=!10!P>B?#?[#X@M];U?7K_6;RU0I;&YP%B!ZD =3
M6#XG\"VVA>!S:06FI:GMU)KT2V9"SVS,<[E'\6/2O6J3% 'BO@OPS<ZSXIUR
M^E365L;K3/L;7>J)MFED;J0IZ "NS?X<6<GA[P_HYO9Q'HMPD\;[1F0KG@_G
M7;XQ2T >;ZA\)H+Z76HX]<OK>PU>0SSVL:KCS.N=QYQGM6[I_@FWLO$]OKAN
MI99HM.2P\ME&UE7^(^]=710!S'B_P9:>*M#&F^<UD5F2>.:!!E74\''>LK4O
MAR]Y>6NIVGB"_L=7CMA:SWL04FX4=V4\9KO** ,#PUX1TSPSHJZ;;(9EWF62
M2?#-)(>K'WID?A.UB\9W'B,2L9)K);,P;1L"@YS7144 <%I'PJT325\00(TL
MEGK0Q);G $8R3A3]34>D_"^*RU/3[G4-;O\ 4[?3.;"VN,!(?0\?>(]Z]!HH
M X5OAM;?8=4@AU6^MY;Z_-^LT+;6B?T]Q[&FV'PQLD?5I]8OI]4NM4M_LT\K
MHL8$?H%7C.0#FN\HH XGPYX!ET/4[6[N/$&H7\=G$8;6"7"I&A]<?>..YK4\
M6>%+?Q7!817%Q)"+.[2Z4H =Q7L<UT5% '*:[X(MM8\2:7X@ANI;+4; X\R(
M ^:G]QAW'7\ZYRX^#\$]KJ-@FOW\.FWER;K[*JIA9"<Y+8R1[5Z=10!QK>!
MOC"+Q#;ZK<P2?95M;F%5!6=5&!GT[50'PJTX>%K'1TO[J.>PG:XM;Z/"R1NQ
MR?;%>@T4 <IX6\$0^'K^\U2YU"YU/5;P!9;NXP#M'10!P!5'Q383V7COPWXC
MMK>29%+V-UY:EBJ2?=8@=@W\Z[FDQF@#SJ_^%8?4M0N='\1ZEI-OJ+E[JUM\
M%'8]2,],UIP?#K3+.'PY!9RRPPZ',TT2\,96(P=Q_'-=EBEH XYOA[IH^(4?
MC"&1XKL1E)(E V2$C;N/OBG:-X TW2_#FIZ'*[W=IJ,TDLHD !&_L,>G8UU]
M% 'E6K^#[FR\.Z%X(MY[J_M9K]9))I4XAMXSO*DCCT ^M>IJ JA1P!P!2[:6
M@!*6BB@!**6B@!**6B@ I*6DH 6BBB@ HHHH 2EHHH **** "BBB@!**6B@!
M*6BB@ I*6B@ HHHH *2EHH 2EHHH *2EHH Y?QQ8>(KS289/#%XL-_;S+(8G
M("3J.J,:XS2_"_B;7/B!I?B+5M"T_0XM/1MPMY0[W#$8YQV^M>M4M '@^K>%
M+_0?!]O+>W5G8ZA;Z_)>6BW$G[N;<V0I8< D>M3:3)K.O_%;6&OHK);N306B
M$5I-YB1[N%4OZ]_QKV75-)L-:L9++4K6*ZMI/O1R#(-5-"\*Z'X:CD31M-AL
MQ)RYC!RWU)YH \YD\!Z\WPS\+Z*+:/[;87T<UPGFC"J&))SWZUG^+? GBK6]
M6\0K+IL>HB[_ .0?=RWI1+9,?=$?][WKVZB@#S'2_!NKKXO\/W]U;HEI:Z']
MBN<2#*R8P0,=?K5;Q/\ ":WM?!.I6'A:&1KNYEAE*3W!(;RVS@$].IKU>B@#
MRN\T3Q=:>)=-\8Z?I%M/>MI_V.\TY[D#9SD%7Z'M4N@?#-K_ $;51XL4"YU6
M^^VRP6LI B(SM7<.O4UZ?10!YQ'X -EXYTI[:V#Z#;:1+9/YLFYB78G!SR>M
M<]X9^%&IZ/KOBBTD<?V1?6+VMG,9,LJL<@$=1C->T44 >++X/\:ZKH6B^$-2
MT^SMM-TV='DU!)PQE1#\H5>H-:L_@O7?[3\;SPV5C<1ZH8?LT=V=R2JHPP('
M(/H?6O4Z6@#Q;PO\.]9BUF^/V"30M(N-/DMIK0WOGB21@1N4=@,U6\,?#35[
M*_TBRO\ P[:"*PG\R747OG<2 '*E(PWRM^%>Y44 <?\ $O0;_P 2>!;W2]-C
M62ZE:,JK,%!PP)Y-<]K_ ($U*QU#0_$GA:V@CU>S1(;RW!"+<1X ()Z9KU&B
M@#Q3Q5X)\5:[K>N-/IBZA%>1 :?++?;([/CD;.YSWJ^/"GB;3[OP)?VNG17$
MFE6AM;R$SA=F[ + ]^]>N44 >.W?PVUO4-)\4P_N8;FYUE=1L2SY60+T#8Z9
MK5TW1/%7B'QQI.N^(M.MM,@TB)UBBBF$C32,,$\=!7IM% 'GOQ35K8>&]9QF
M+3M5B>8_W4;Y<_AFH_$=OXVM/$LU[I5G:Z[HUU"J_8+F14$+CN,CH:[S4-/M
M-5L9K*^@2>VF7;)&W1A4\420Q)%&-J(H51Z 4 >*)\-/$*_#K6[(VUK'J.J7
MZ72V4,@$<"ALX!Z5=\<?##4=1\6:+K>BHG^N@.HQ>8%!\L@A_<XR*]AHH \U
MM/ +WOCOQ=>:U80RZ7JD4<<#,0S<+@D=U-4=/LM<\$^ /$^EZSMFTNTMY1IU
MSO!9D8$!".N<D5ZQ5/4=,L]6M1;7\"SPAUDV-G&Y3D'\Q0!B?#W3)='\ Z+9
M7"E9H[52ZGJ"><?K73T@&.E+0 E+110 E+110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
<0 4444 %%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>img88009329_16.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_16.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" //!OH# 2(  A$! Q$!_\0
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M"/'VH11P-%/J%JZSPL\1CE4J0V5) )&0,C\Q7(?'RXF":%;!B(&,TC+V+#8
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MGC&8Z8K)+)(#BWNX<>8 .<9X/TZ\5YE\3_ L'AN>+4],4KI]R^QHLY\J3&0
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M2#_XBJE!\JBB8U%S.4CWGQEX)C\9I#!=ZK>6UK%SY$&T*S?WFR#D^GI7(?\
M"A-#_P"@MJ/Y)_A7FW_"W/'/_0<_\E(/_B*/^%N>.?\ H.?^2D'_ ,14J$UH
MF4ZE-N[14^'?A=/%GC"VL)O^/2)3<7(!P3&I''XDJ/QKZI6%8K<0P*L2HNU
MJ\* ,# ]!7R%H'BG6?"\\TVC7GV:290DC>4CY .<?,#BM_\ X6YXY_Z#G_DI
M!_\ $43A*3%3J1@M3U&_^">G:I?S7U]KVJ3W,S;Y)'V98_\ ?/Z=JX+XD?#;
M3_!6DV=Y9WMU.T\_E,LP7 &TG(P!Z5E_\+<\<_\ 0<_\E(/_ (BLG7_&WB'Q
M/:Q6VL:A]IBB?S$7R8TPV,9RJCL:<8S3U8I2@UHM3 I4=HW5T8JZG*L#@@^M
M)16IB?4?P^\>6?C#1XXY98TU:),7%N3@MC^-1W!_3I6/KGP3T#5+][NSN;C3
MC(2SQ1 -'G_9!Z?3./:OGB&:6WF2:"5XI4.Y'1BK*?4$=*ZRV^*7C2TA6*/7
M9F51@&6*.0_FRDFL73:=XLW55-6FCWOP?\/=%\&"26S$D]Y(NU[J<@MM]!CA
M1_/O7FOQC\>VVI(OAS2IUFA1P]W,ARK,.B ]\'DGUQZ&N!U?QYXHUVW-OJ&L
MW$D#9#1IB-6'H0@ (]C7.4XTW>\A2J*W+%'M'P2\96UM%+X:OYA&TDAELW=N
M"2/F3V/&1ZY/X]3XY^$UIXNU3^U+:^-C>.H6;,6]),# .,@@XP,^@'%?-U=7
M8?$KQCIMNL%MKMP8UZ"94E(_%P31*#OS1"-1<O+)'O7@7X?V/@6UN)!<FZO)
MP/-N'78 HYPHR<#N>>:\=^+GBZV\3^(X;?3Y%EL=/1D25>1([$;R#W'"@?0G
MN*Y[6/'7B?7H#!J6LW$L)X:-,1JWU"  _C7/4XP:?,PG437+%:'UOX'_ .1$
MT'_KPA_] %?*>J_\AB]_Z^)/_0C71V/Q.\8Z;86]E::QY=M;QK%$GV:$[5 P
M!DID_C7*2RO/,\TAW22,68XQDGDT0@XMMBJ34DDC[#_YEW_MT_\ 9*^1-*_Y
M#%C_ -?$?_H0KIO^%J>-/LWV?^V?W6S9M^RP_=QC'W*Y&*5X)DFC;:\;!E.,
MX(Y%$(.-[A4FI6L?6GCC_D1->_Z\)O\ T UXA\$/^1_;_KSD_FM8M]\3O&&I
M6%Q97>L>9;7$;1RI]FA&Y2,$9"9'X5M?!'_D?V_Z\Y/YK4J+C!W*<U.:L>X>
M+O#5AXMT1M(O9/*9V\R"1<%D=?X@#UX)!'H37 >'?@?%I>N6]_J.JK=PV[B1
M8$AV;V!R-Q)/'MWJW\;[NXL-"TBZM)Y(+B.^RDD;%64[&Z$5Y</BMXV$7E_V
MZ^W&,_9XL_GMS4PC)QT9<Y04O>1['\6_%-MHGA&YTY9%-_J,9A2+/(C/#L1Z
M8R![GZUR'P _X^-?_P!R#^<E>0WU]=ZE=O=WUS+<W$G+22N68_B:TO#_ (LU
MOPLUPVC7OV8W 42_ND?=MSC[P..IZ5?L[1LC/VMY\S/0?CW_ ,C!I/\ UZM_
MZ&:]!^&'BNU\2>$[:T>5?M]E$()XF;+,JC ?W!&/QS7SUK_B?6/$]Q%/K%Y]
MIDA38C>4B8&<X^4"LZTO+FPN4N;.XEMYTY62)RK+]"*?L[QLQ*I:;DCV74_@
M,TNJ22:;K$<-D[EECEB+-&/0$'YL?A74W'@#P-X<\)_\3JS@D@M8\RWDF4DD
M;.>JD'))P /85X['\5O&T<81=<<CU:WB8_F4S6#K/B36?$,HDU;49[HCE5=O
ME7Z*.!^ I<DWNQ\]-;(FTR\LHO&UE>Q1?9;!-0CE5&8GRXQ(" 23V'>OJ'Q7
MH"^*?"][HYN# +E5Q*%W;2K!AQW&5%?(E=7I_P 2O&&EV<=I:ZW*(8QM19(X
MY"!Z9=2<4YP;LT*G444T^IKWVCR_"7X@:/<O<_;HE03,ZQ;,JQ9'4#)YV_S%
M>V>(=%TOXB>$!!%=J8)L36UU& VQQT./Q((X/)'%?,^N>)=8\2W$<^KWSW4D
M2E4+*JA0>N H I=%\3ZWX==FTG4I[4-RR*<HQ]2IR">.N*'!NSOJ$:B5U;0]
M8T/X%?9=6BN-6U2*YM(G#&"*(CS0.@8D\#UZ_P!:C^*^D>"?#^D^7;:7;QZU
M<8$"0.R^6N>7900,<8&1R?H:X>7XJ^-IHS&VNN >,I!$I_,*#7)7-S/>7#W%
MU/)//(<O)*Y9F/N3R:%"5[R8.<$K11[#\#_%5O;_ &GPY=R"-Y9//M2S<,V
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M)0 E%+24#"DI:2@ I*6DH&%)2TE !24M% "44M)2&)1113&)10:*0!24M)0
ME%+24#"DI:* (:***LL**** "EI*6@ HHHH&%%+10 4444@"BBB@ HHHI@+1
M112$%%%% PHHHH .U+110 4444@"BBB@ HI*6F 4444ABT444""BBB@84444
M +124M !1110 444M "444M !1110(****!A2TE+0 5TG@CQ9_PANOG5/L7V
MS,+1>5YOE]2.<X/IZ5S>**35]&"=G='?>/?B9_PF^F6ME_9'V+R)O-W_ &GS
M-WRD8QL&.M<#110DDK(<FY.["BBBF(**6B@0E%+10 4444 %%%+0 4444 %%
M%% @HHHH 7-%)2T %%%)3 6BDI: "BBB@0M%%% "T9I*6@04444 %+110 44
M44"%HI**8"T444 +124M @HHHH *6DI: "BBB@ HHHH$%+110(*!110 M%%%
M, I:2EH *6DHH$+1112 6BBB@04444P%HI*6@0N:,TE% @I0:2B@!:*** %H
MI*6@ I:2@4"%HHHH !2TE+0 4444 %%%% A:*!10 4444 %%%% '<^"?B*W@
M[3I[,:6MVLTQE+^?Y9'R@8^Z?3]:L>*OBMJ/B/3'TZWLDL+:48EQ*9'<>F<#
M ]>.:\^I:CDC>]C3VT^7DOH%%%%49!1110 44E+3 ,T444A!1110,**2B@!:
M2BB@ HS11Q0 444E !1110 4444 &:2BB@ HHHH&%%%%(!**** #-(3110 9
MHI**!A24M)0 4444#"DI:2@ HHI* "BBB@8E%%%(!**6DH&%)2TE !24&B@8
M4444 )1110 E%%%(!**#13&)12TE !24M)2&%)2TE, I*6DI#"BBB@!***2@
M84444 %%%% $%%%%66%;7A6PMM2UR.VNXO,B*,2NXCD#U%8M='X(_P"1FB_Z
MYO\ RKFQDG'#S<79V9UX",98JG&2NFT6KFZ\(VUU+ VC7):)RA(E;!(./[]1
M_P!H>$/^@-=?]_6_^+K"U7_D,7O_ %\2?^A&JE90PD7%-SE_X$S>ICI1FTH0
MW_E7^1+<M"]U,UNA2 NQC1CDJN>!^51U?T?2)]9OA;0$* -SR-T1?6MA]/\
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M>C?3IIIZG1C\'"A"G*+6L5?7=ZZ^A7J:U19;N"-QE6D4$>HS453V7_(0MO\
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MQC\N?K7 75S)>7<US*<O*Y<_B:UH5/K56,^D5_Y,_P#)?F8XBE]3HRI]9O\
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MJMGO&3S^A_2EBI*E.%9[*Z?H_P#@I#P<77ISPZW=FO5?\!LM070TJ\T'3"0
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ME+28I:!!24M)0 4444 +2&EHH 2BBB@ S11BB@8448HI )11BC% !128HQ0
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MZTRV:WAB@=&?>?,4DYP!V(]*RJ*PEAJ4DXN.C=WZG3#&5X24HR=TK+T[&_\
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M !1110 4444A!1110,**6DH **2EH *0TM% !Q124M "4444""BBB@8444E
M"TE+24 %)2T4 )12TE !24M)0 4444 %%%%(8E%%%,!****0!24M% Q****
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M45Q<K%':6=TTSE\':=NT?3ZD4<_O6#D]WF//889;F>."")Y9I&")&BEF=CP
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M4F:'3[*XNY50NR6\32,%! )( /'(Y]ZL6&@:SJL#3Z=I%_>0JVPR6]L\BAL
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M8];#?\B;'_V$&_\ 1:UCTD5(6BBBF2:EII]LNGB_U"61(78I%'$!OD(ZGG@
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MFBBBNP\\[#X=_P#(8NO^O?\ ]F%8&O'_ (J'4?\ KYD_]"-;_P //^0Q=?\
M7O\ ^S"L#7O^1@U'_KYD_P#0C4KXC:7\)>IG4M%%48%FPLGO[H0JP10"SNW1
M5'4U=CM]&GF%O'/=H[':LL@783VR.H%-T-D-S<6[.$:YMWA0GIN.,?RI;70+
M^XD9?+\MD<*P?@X]1Z@5Q5JB4Y*<^5)*W^?F>GAZ+=.+IT^=MN_RZ>6FO<KQ
MZ7</J$EF=B/%GS&9L*H'?/IR*35+6.QU"2WB<NBA2&/?*@_UJ76[A+G6;J6/
M[I;;]< #^E+KO_(7E_W(_P#T!:JE.I*<')[QO;ST_P S.M3HQIU%!7Y9I7\O
M>_R,ZDI:*ZSSQ*UM2_Y FC?]<I?_ $:U95:NH_\ ($T;_KE+_P"C&H94=G_7
M4RJ***"0K32QM+:TBGU"2;=,-T<4.,[?[Q)K,K:OK:6_M;"YME,B+ D#[>=C
M+QS[5S8B5G%-V3W?Z'9A::<9R4>:26B^>KMUL5KFP@:S6\L9':#?L=9<!HSV
MSCC'O5F/3M-DO5T])YVN&&!,NTQEL9Z=<?C4LMC+I6BW<4X!DNI(UB"\YV\Y
M'YXI!;2:-%^[ADEU!UY95)6$'T]6_E7)[9RBU&=]6H^>VK\EM_P3T%AXPFG.
MG;1.6^FKT2[R237;R1A.I1V4]0<&DI6R"00<CKFDS7J(\-A6KX>_Y"C?]>\W
M_HMJRZU?#W_(4;_KWF_]%M2>PX?$C)HHHIDAFK5A9&^N3'O$<:J7DD/1%'4U
M5K5T1E=KNTW!7N8"D9)P-W4#\:QQ$Y0I.4?Z\_D=.$IQJ5HQGL_Q\OGL+%;Z
M1=3"WAGNHY&.U))0NPGMD#D5!#901/<_VA*R>0=OE(1O<Y[9[>]6+#0KZ:X#
M&/R_+D =7X(&>ON*==QR7VI7M_:HDBPR#,97<2.F=N.1Q7)[1<[A&=U;[G==
M?/\ X8[_ &,G352=*SN[*SU5G=VZ\O\ PY3O[2"&"VN;9I##.&PLF-RE3@]*
MHUMZP7FTVRN+A/)N6W)Y8! V#H0O:L6NG#3<J=WO=_G^/J<6-IQA6M%:63^]
M+IT].@E%%%=!R&KK'_'GI'_7G_[4>LFM;6/^//2/^O/_ -J/65214]Q**6BF
M2:AL;*RMX7U"2<S3*'6*' *J>A)/\JBO;&&.TCO;.5I+9VV$.,,C>AQ5W5;2
M749;6\ME+PRQHA8<B-AP0V.E2O:C2])6TU A?/N0QV?-A .2*\R-=KEES7DW
MJOS5O(]N>%3<X<EH):2_)M_WON[;%&VTD2:1<7TSE2J[HD'\6" 2?;FLJNK6
M2QNTU!TO6\KR @40$") 1C'/-<LP 8@'(SP<=:WPM651SYN_9JVFQS8ZA"E&
MGR6M9ZW3OJ]='_6VXVBBBNL\X[OX;==3_P"V7_L]<3=_\?D__71OYUVWPWZZ
MG_VR_P#9ZXJ[_P"/R?\ ZZ-_.I6[-Y_PH_,@HHHJC N:=8?;I7+R"*")=\LA
M&=H_QJU#::5?2_9K66ZBG;B-I]I5CZ<<C-+HP%Q:W]BK!9KB-3&"<;BISC\:
MDTK0[U[J&=T\M(I@9 _#*!SG'I7GUJO+*;E/EMM]V_GKI\CUL-0YHTU"GS<U
M[_?:WE96?S[%&RTN6[N7B9EA6)L2NY V<X_$^U1:E;)9ZC<6\98I&Y4%NM27
M$ZW.M23H,))/N&!CC=Q3]<_Y#EY_UU-;0E4=5<ST:V^XYZD*2H2Y%JI6OW6O
M^1G4E.HKJ.(;6MKO33/^O"+^M95:VN]-,_Z\(OZTBELS(I*6BF(2M=["PL(8
MO[1DN&GE4/Y4&!L4],D]_:LFM_5K&;4KV&]M07M[E4 ?J(R  0V.F,5RUYVG
M&+=D[_\ #?G]QVX6G>$YQCS25K+R=[NWW+YE*YTR();7%K<;K2X?R]\N%,3=
MPW;WS5A=-TVYN)[.UFN3<1*Q61]OEN5Z\#D"IKNPGL-%BTV1 UU<W6]$7G@#
M&0?<TV:"31[>2UM8)9;R1=LUPJ':@[JO]37+[64HI1GKK;S5]WZ;>9W?5XPD
MW.G967-OHVOA7F]_+T.>HI:*],\02M?0O]7JW_7A)_Z$M9-:VA?ZO5?^O"3_
M -"6AEPW,BDI:*"1*O:;IXO7E>67R;:!=\LF,X'8 >IJE6OHZ?:M/U*P0C[1
M.J/$I.-VPDD?7FL<1-PIMIVV^6NK^2.G"4XU*JC)7WT[M)M+YO06"QTK49/L
MUE+=17)!\O[1M*N?3CI56VM;)+>6:_ED#))Y8@B(#D]R<]!^%:&C:'>"\M[R
M1?+BAF#2!N&0+SD@]CC%5O)N)YY]7M88YD^T-^Z*;RN[)!*XZ<_G7+[1<TH1
MG=:=>O:_F=WL7R1J2IV>O3I9:V\OQZ[%;5+&*S>!X'9H;B(2H'QN /8X^E4*
MW/$(+BQN)E\NZFAS+%D_+@X& >F1VK$KIPTG.DF]_P"OZ\SBQE.,*\HQ5E_F
MK_+TZ;"4445N<YK^(O\ CZLO^O"W_P#18K'K8\1?\?5E_P!>%O\ ^BQ6/214
MOB8E%+3HW\N5'QG:P.*8EN:TVGZ9INR'4)+E[HJ&>.WV@1Y[$GJ:K:EIR6D<
M%S;2F:TG!,;D8((ZJWO6EJ^EW&H:S]IM@'MKS#1S<[1QT8CH:GFA@TRRTW3]
M5X'GO/*%&["@8 _$UYD*[2A+FO)[KY/9>3T_,]F>%4G4BX*,5M+YI*[ZW3O^
M*T,PZ,L?A^2_FD(GRA2('HC$@$_7!Q]*R*ZR1K*\T[59SJ3N)'B+'[,1LP6V
MJ!GIV]L5RE=&%J2GS<V]^S71::G)CJ,*?)R;-=T[V;5]&]_^!T$HHHKJ.$](
M^'O_ "+FI_\ 70_^@"O-J])^'O\ R+FI_P#70_\ H KS:DMV;3^"(E%+13,B
MI1116HA:]!T3QGX<N/!\'ASQ9I5U<06DADMKBQ(#C.>&R1TW'UXQQQFO/J*3
MC<<9-;'I&L?$33+G4/#%KI>G7%KH6B745QLD(:5]K ^N.@..>2:FL_B+I%O\
M2=>\1O;7QL]0LC;Q($3S%8B,98;L8^0]">U>8TM3[-%>TD>F?#KXH0>%-'NM
M)U:&ZN+4DO;&!58QD_>!W,.#UX[Y]:S_  GXZTZR\-W'ACQ-ITNH:-(_F1^2
MV)(FR#QR.,\]1WZ@UP=%'(M0526AZ5?>//#&F>%-0T'PGHMY$NH*5N)KV3D<
M8R &;)QGN!]:L'QKX(U7P?HFBZ]8ZU(^FQ!<VPC"EL8."7R1^ KRVBCV:'[1
MGIGA[QAX+T"X\0VD-EK)TC5;5( A$9E'RN'R=^!][CK6/JVH^!H+-9_#%KKE
MMJ\,J202W1C**0P.>&//''%<713Y%>XN=VL=9%X^UF]US1[G7M0N+RTL+Z*Z
M,81<_*P)QTYQGJ:["[\<?#JX\3OXE?1M;N-3WK*BRF-8]Z@!3@.>FT>M>1T4
MG!,:J-'>Z7\4+^S\<:AK]Q:I-;:CB.YL\\&,#"@$]U ].>?7C7L_''@+PY<S
M:KX=\.7XU8JPB^U./*B+=<8<G],]LC->644."!5)([OPOX[L[6WUC3O$^GMJ
M-AJTIGG:( 2B4G)(Y Z@'J,$5-KOC3P_%X,G\+^%=,O+>UNYEFN9KUP7)!4\
M ,>Z+^73FO/J*.17N+G=K'K6O>-OA[XH^Q2:OI^OM-:P"%3"(U&._P#'ZUYK
MK3Z7)J]PVBQW,>G$CR4N<>8!@9S@D=<]ZH44XQ4=@E-RW/3#XW\'^(-(TZ+Q
M;HE])?6$?E++8LJK(O'7YEQG'^'7%<[X]\8?\)EK<=S%;&VL[>(06\3'+;02
M<D^IS^@KE:*2@D[C<VU8[3Q]XOT_Q3;:%'8PW,9L+7R9?/50&;"_=PQXX/7%
M:FF>./#5_P"$+'0?%^E7MR-/;_1YK-@"5[ Y9<<<=\X'>O-Z6CD5K!SN]ST#
MQ!X^T_4M9\-)IUC<6NB:'+&T<3,#(X5E)XSC.%P,GN>>:VK_ ,;?#F_\3MXC
MGT?7)]1W)(JOL6/<@ 4X#_[(]:\EI*7(A^T9Z3H7Q-AB^(&J^)=9MI]EY9M;
M1PVP#F/YDVCYBO&$.3ZGIS5?PGXN\,V/@.^\->(+74YH[J\^T$V:IT CP,E@
M<Y3TKSZBCD0<[.X?Q%X3T'6=+U;PGI^H_:+65C/'J)4I(A7;@;6.#@GG^==#
M!X^\!Z;K<WB/3M U,:S)O<+)(HA#L#N/#'KD]N_2O)J*'!,%-HGOKR74-0N;
MV;;YUQ*TK[1@;F))Q^=:7A/_ )&O3/\ KN*QJV?"?_(UZ9_UW%4]A1^)&U\3
M?^1FA_Z]%_\ 0GKC*[3XF_\ (S0_]>B_^A/7%TH[#J?$PHHI:9)8BU"]@B\J
M*\N(X_[B2L!^6:2>_N[I81/.\GDC$9)Y7\>M5Z*CV<+WMJ7[6=N6[L3W%]=W
M:A;BZFF"]!)(6 _.H***I1459(4I.3O)W"BBBF2;5I_R*&I_]?5O_*2L6MFT
M_P"10U/_ *^K?^4E8](I[(2BBB@0^.62&0212-&XZ,IP15M-9U-)?,%]<,VT
MKEY"V0>W-4:6IE",OB5RXU)P^%M"H[QR+(C,KJ0593@@CH0:&9F8LQ+,3DDG
M))I**?F3=[!1113 W_!/_(XZ=_OM_P"@-5[XC?\ (V-_UQ3^M4?!/_(XZ=_O
MM_Z U7OB-_R-;_\ 7!/ZU/4T7P?,Y*BBBF9AWJS'J%[##Y,5Y<)%TV+*P'Y9
MJM12<5+=%1E*.L78L7-]<WBQ"YF:7REVH6Z@?6HFED>-(VD9DCR$4G(7)R<#
MM3**%&*5D@<Y2=VQ:***9(5M)_R)4O\ V$4_]%M6+6RG_(E2_P#813_T6] T
M8]%)10(6I(9I;>020RO&XZ,C$'\Q4=%#2>C&FT[HO+J^H@N3>SL9$*-O<MD?
MC2+JVI(H5=0NU4#  F8 #\ZIT5'LJ?\ *ON-/;U?YG]X^6:6XE,LTCR2-U=V
M))_$TRBBK225D9-MN[%JYI/_ "&;'_KXC_\ 0A5.KFD_\AFQ_P"OB/\ ]"%
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M_KUIT4<D0]O4[F9_9'_3?_QS_P"O1_9/_3?_ ,<_^O6G11R1#V]3N9O]D_\
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M^FW_ ([_ /7H_LO_ *;?^.__ %ZT:*?)$/;U.YG?V7_TV_\ '?\ Z]']E_\
M3;_QW_Z]:-%')$7MZG<:;?\ XD*66[I=-+OQZJ!C'X51_LS_ *;?^.__ %ZU
M?^74?[Y_E45'LXC=>IW,_P#LS_IM_P"._P#UZ7^S/^FW_CO_ ->K]%+DB'MZ
MG<H?V9_TV_\ '?\ Z]+_ &;_ --O_'?_ *]7Q13Y(B]O4[E#^S?^FO\ X[_]
M>C^S?^FO_CO_ ->K]%'LXA[>IW*']F_]-?\ QW_Z]']F_P#37_QW_P"O5^BC
MDB'MZG<M>&&_LC6%NL>;A&7;]WK[\U#KR?VEK=S>9\OS"#LZXPH'7\*DLO\
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MJW11R1#VT^Y4^Q?]-/\ QVC[%_TT_P#':MT4<D1>VGW*GV+_ *:?^.T?8O\
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M ([5RBCDCV#VL^Y3^P_]-/\ QW_Z]7=1C^U"TYV^5;)%ZYQGG]:2I)O^6?\
MN"ER1'[:=MS/^P?]-/\ QVD^P?\ 33_QVKM)3Y(B]K/N4_L'_33_ ,=H^P?]
M-/\ QVKE%'LXC]K/N4_L'_33_P =I/L'_37_ ,=_^O5VBCV<0]K/N4OL'_33
M_P =H_L__IK_ ..__7J[11[.(>UGW*7]G_\ 37_QW_Z]7=.B^RK>C=N\ZV:+
MIC&2#G]**EAZ2?[AI>SCV&JTT]S-_L__ *:_^.__ %Z3^S_^FO\ X[_]>KU%
M')$7M9]RC_9__37_ ,=_^O2?V?\ ]-?_ !W_ .O5ZBG[.(>UGW*/]G_]-?\
MQW_Z]']G?]-?_'?_ *]7J*/9Q[![6?<H_P!G?]-?_'?_ *]']G?]-?\ QW_Z
M]7J*/9Q#VT^Y1_L[_IK_ ..__7I/[-_Z:_\ CO\ ]>K]%'LXA[:?<35(?MDU
MN^[9Y=M%%C&<[5 S5'^S?^FO_CO_ ->M2?[R_P"XO\JBH]G'L-UIWW*']F_]
M-?\ QW_Z]']F_P#37_QW_P"O5^BER1#VT^Y0_LW_ *:_^.__ %Z/[,_Z;?\
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M;^;4#&98XAYKC][A<@9/0<>PI*JMFAN@]T[JUSAZ*NW>CZGI\0EO=-O+:,G
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M% @HHHH **** "BBB@ J2#_6?\!/\JCJ2#_6?\!/\J 1'1110 4444 %%%%
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M(TMPJJHP  1@"N>I6M)1B=E##<T'.6UM#YTHHHKH.,*EMO\ CYC^M15+;?\
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M0!>Z!9ZKYUK\IN O[O"IG&5/7/Z5S7Q*\2Z/XALM,_LFX\WR#)YJ^6R;-VW
MY ST/3TJCX^U_3-:L-!BT^Y\Y[6W9)AY;+M.$XY ST/2IC!R4;KN:SJ*+GRO
ML=#X6\9Z3J7B:QL[?PCIME+*Y"W$03<GRDY&$'\ZK0_\EZ/_ %W;_P!$FN-\
M':A:Z5XLT^^O9?*MH7)=]I; VD= ">];T?B'2E^+9UPW7_$M\TMYWEMT\HK]
MW&>OM3E3M)\JZ$PK<T8\SUYD8GCC_D=M7_Z^&K KTO5H?ASK&JW.H3^([Y);
MAR[*D#[03Z9CKD_$UGX:M/LO_".ZG<7N[?Y_G(5V8QMQE5Z_-Z]*TIST4;/[
MC"K3LW*Z^\S-(:X36;)[2W6XN5F0Q1,,AWSP",CO7HNK:'KUYJ7]H^(?%.GZ
M-(X!2".Y8&/ Z*N1CUX)YK@O#FK+H?B&RU)XS(D$FYD'4@C!Q[X-=CJK> =4
MUF;6KG6KZ0S,)7LDMV#$X^[N(P!QZ_C4U+\W_ N71Y>1W?7:]C3^("1MXI\)
M7 =99)/+#3!<;P'4@_\ CQ/XUG?%77=13Q0MA!>3PV\$*,$C<J"QYR<=>WTQ
M3/%_BK1M:U3PU?6=P52V8&XB,; PC<AQTP>AZ9Z5A_$#5['6_%<M[IT_G6[1
M(H?8R\@<\, :BG%WC==S6O45I\KW:_(ZC4Y9=9^''A6XO9#)<O>&$S-RVW,B
M]?HJY]<56^*>IW=EK-II%G/);V-O:H4BB8J,DD<XZ\ #_P#76;/K>GS_  [T
M+2(KC.H6UT\DL6QAM4F0@YQ@_>'0]ZT]4U7PKXNAMI=>O;C3-5MXQ$\L<1D2
M5>N< 'W/;&3UH46G=K2["4E*+2>K2_X(^WUF]U;X,ZTM],TSVT\4:2.<L5\R
M,@$]\9->:5Z/?ZYX4M?A[J6@:-<S/,\D;*TT3!IVWH2V<8  7'..GY^<5I26
M^EM3#$._*KWT_P SO]'_ .2+^(?^OV/_ -"AJ_9.OQ$\%-I\K Z_I2[H&)^:
M9.F,GUX!]PI/6L#3=;TZW^&.LZ/+<;;^XN4DBBV,=RAHR3G&!]T]3VK!T+6;
MG0-8M]1M3\\3?,F<!U[J?8BIY&[M;WT-/:I<J>S5G][.U\;*R?#KPHC*594P
M01@@[13OBE_R"_"__7JW_H,=-^(_BK1O$6E::FEW!>2-V>2(Q,I3('4D8/.>
MA-9_CW7],UJPT&/3[GSGM;=DF'ELNTX3CD#/0]*F"?NMKN75E&TTGT1VWC;Q
M'8:%%I*7OA^SU0RP$JUP%S'C;P,J>N?TK,\)>,M)U/Q196=MX2TZQFE+!;B(
M+N3"D\80>F.O>N>^(OB#2]=_LC^S;KS_ +/ R2_NV7:?E_O 9Z'I6-X*U&TT
MCQ?87U]+Y5M$SEWVEL91@. ">I%*-)>SU6HYXA^WLFK77;\SK-+_ .2[O_U\
M3_\ HIZX_P 4?\C)K?\ V$IO_0VK>L/$&EP_%E];DNL:<9I6$WEMT:-@/EQG
MJ1VK2U"T^'6HW=W>R^([Y6N;AIG"P-@,Q)P/W?3FJ3<9)M=$1)*<&DU\3ZGF
ME2VUM->7,=O;1/+-(P5$09+'VK9\36?ANT:V_P"$>U*XO58-YQF0KLZ;<95>
MO/KTK'M+J:RO(;NW;9-"ZR(WHP.16Z=U='*X\LK,[T?$#5=+5]&\3Z-;:B8
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M@!W#-S^H_*N3T'3'UG5+'3T4GS[D*V.RXRQ_  FMGXEZI'J?C.=82#':1K;
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MKFH>*+/7-+UJ<WEN;4N/, RIY!P0/H?;'%87@F_UJ'2M0LO#VCM-J$[#-^'
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M]:1702BBBF(**** "BBB@ HHHH *DF_Y9_[@J.I)O^6?^X* (Z*** "BBBD
ME%+24P"BBB@ J6'I)_N&HJEAZ2?[AH!$5%%% !1110 4444@$HI:*8"44M%
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MSNH5IU>=R['@]%%%=AYP5+;?\?,?UJ*I;;_CYC^M $M__P ? _W?\:JU:O\
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MV^]M7Q#+O8;1A>P.#U/45QE3&2;:[%R@XI-]2:T_X^D_SVI]]_Q\_@*9:?\
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M445J8!1110 4444 %7-*N(+35;6XN;474,<@9H&;:']B<'BJ=.C_ -:G^\*
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M]2.BNWUKP"= \%)JM]+(-2:55,*L"B*>QXY;Z''\ZXBB,U)70JE.5-VD2/\
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MZG&<X(%;G@2PO-.^(NE0WMI/;2DNP2:,HV/+?G![<&J&E>,->T?2C:6&H-#
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M)3QAL>N./PJ#1;"?PMX%M=7TK2&U'6]0((D6!I?)C.2.!T& /J3[5+;^'O\
MA'/AGXAM9[J":^=0\Z0ON$0XVJ??J?Q_&F:%JEYXC\$V>EZ+JZZ?K6G_ "F)
MGV">/H,'Z8_$=L@U.EGR[7+UNN;XK?K^9;T8ZOXR@NM-\4Z'+!,D1DM;Y[1H
MMC=,9(Z\CCN :B\)7=MIGP^UN[O;9)X[>ZW^3)P&<"/:#_P+;1!;>(-&MI[S
MQ7XHN+=53]Q;6UPK22OZ<C&/I]3C%95NS/\ "+Q&[$EFO(R2>YW14[75NET%
M[.[WL]]S*E\<GQ#K&FOXDM(Y;"T=G^SV<7,A(X!W-R <<9]1WKK;#Q!XVO\
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M[F_Z=V^6WYW,[X=?\@;Q9_V#F_\ 07KA[K_CY?\ #^5=Q\._^0-XL_[!S?\
MH+UP]U_Q\O\ A_*MX?'(Y*G\*'S_ #(:***U, HHHH **** "BBB@!:D;_CW
M3_>/]*CJ1O\ CW3_ 'C_ $I /LKI[&_MKN, O!*LJ@]"5((_E7I&I0^#_'=P
M=276O[)U*15$L=R!M) P.I / QPWIQ7GVCS64&LVDNHP>?9K*/.CR>5[]/3K
MCOBNT\4?#Z\N-1.H^&H(;O2[D!XUMW7]WQR.3R,\\5E4MS*[MYG314N1V7,N
MWZD>I>$_$WA?1;UM.U!+K29U_P!(-L>J8()(/08)S@GCKTK9\&:S_P 6]UM_
M[-T[_0H@-OD<3X4\R\_,?RI?"6G7_@C0M6U#Q PM[66+$=H9 S2/SV!QD\#^
M>,5G> 8)+[P/XHL;9?,N9$ 6,'DY4X_D:RD[Q=];-:G1!<LU;2Z>G8K^%UL]
M;TSQE?W.F6"2)9>9"D< "0MLDY0'.WH#Q6!X'MX+OQGID%S#'-"\A#1R*&5O
ME/4'@UU'@"PFB;Q/X=NA]FU"ZLO+6.3J#M8?^S@TWP3X)UVP\66E[?V?V6WM
MF)9Y'7YB00%7!Y))%4Y)<RO_ %8SC3E+V;MUU^_J%EX5L-6^(VM1W$:0Z58,
MTDD40V+CLHQT'4\>E5AXN\,WU[]BN?"EC;Z;(VP3Q*%F1>@8D#KWQG\ZW-(U
M&U@^)7B73+J01#4MT,<A./G[#\<G\1[UR</PX\2/JHLY;(QQA\-<E@8PN?O9
MSSZXZTDTW[[Z(<E)+]VKZN^AU'C2\L[+XIZ7-?P03V;6T:3+.BNFUF<;N1CC
M.?PKE_%/AYM-\>MIUK$%CNI5>V4<##G@#T ;(_"M#XM +XLMP#D"RC _[Z>N
MN\/266O:/HWB>\D_?Z+#+'/SDL57@GU./F'NU)-PC&7D5**J5)0?>_\ F</\
M0XM.T[4;+1=/MH$-C;JL\R1@/*Y ^\0.3@ _\"-<[H=@-4UZPL2"5GG1'P<?
M*3S^F:AU*_EU/4[F^G/[RXE:1N<XR<X^@Z5=\*W267BO2KB3&Q;I-Q)Q@$X)
M_#.:W2<86ZG(Y*=6_2_X&S\3+TW/C.XMP L5G&D$:CH!MW']6/Y5SUYJNIZP
M+2WNKB6Y\@>7 A&2,X&!CD]!6W\1K=[?QUJ.]2!(4D4^H*#^N1^%=IX?\)W7
MACP_'JMMI0U'Q!.N8D=E"6P(ZG)'..N.>W R:S4XPA$V=.=2K-=+ZF6+1? G
M@"_BORO]K:TGEBW#<QI@CGZ!F/U(%5_$2B#X1>'8H^%><NWN3O/]367K?A7Q
ME=O<ZMJUE+(41I)96EC.U0"3@!N !G@5L65K+XN^%T.G6)$NHZ7<;C"6&YT)
M;&,]L-_X[BEHK2O?74O5W@HVTT^\K_"-B?%-U"2?+DLG#+G@_,O^)_.N5T'Q
M!>^'+N:ZT_RQ/+"8=SKNV@D'(]^!US7<^#=(N_!MKJOB+68&M1';&*"*0@-(
MQ(/3ZJ!^)KS*KC:4I=M#*?-"$.CU/2M2O+G4/@VEU=S/-/+?%GD<Y).YJ\UK
MT.;_ )(A;_\ 7Z?_ $-JY[PWXSU/PM!/#81VS+.P9O.0L<@8XP113ND[+J%:
MSE'F?1&1;7EQ826UU:2M%/&Q*.O4&K=I9ZMXMUW9&&N;VX;=)(W  [LQ'0"M
MF_UC6/B'J6DV$T=LDV]UC,2E0 <%B<D] N:[?4]$UGP]I(T?P?I3YE0?:M1+
MH)'/HN2"._/;/'K2E4Y;7W80H\UVFW%?C\CE_B!>VEEIFE>%;243G3ES/*.F
M_&,?J21VR*?I$9UGX1ZK:R89],G\^$D?=7AC_-_SKE]8\+ZYHD"W6J630QR/
ML#M(K98@GL3Z&NJ\+2"P^%GB6[DX2=O(3CJ2H7_V?]*324%9WU*BW*K+F5M'
M]UCSRBBBN@XPHHHH **** +5E_K6_P!VH9O]>_\ O&IK'_6M]*AF_P!>_P#O
M&D/H1TM%%,04444 %%%% !1110 5(_\ JHOH?YU'4C_ZJ+Z'^= $=%%% !11
M10 4444 %%%% !4D/^L_X"?Y5'4D/^L_X"?Y4 1T444 %%%% !1110 4444
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M_(U%4H_X]3_OC^1JB"*BBB@ HHHH **** "BBB@ IT?^M3_>%-IT?^M3_>%
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MX"?Y4 B.BBB@ HHHH ***6@!**** "BBB@"27[L7^[_4U'4DOW8O]W^IJ.@
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M\*?]S_R8/^$7_I[_ .2!_8.I_P#/M_Y$7_&D_L#4_P#GV_\ (B_XT?V_J?\
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M$7_I[_Y(']A:E_S[?^/K_C1_86I?\^W_ (^O^-']NZE_S\_^.+_A1_;NI?\
M/S_XXO\ A1_PI_W/_)@_X1?^GO\ Y(;GACP5=:IJ >^C\JRB.9"&!+G^Z,&O
M7HXTAB2*-0B( JJHP !VKQC0O&6H:5J*2S2&:U8XEB"@9'J..HKV.TNH+ZTB
MNK:020RKN1AW%=,?:\J]M:_EM^)R2^K\[^KWY?[UK_AH<EXW\(G5XO[0L(Q]
MNC&'0<>:O_Q0_EQZ5P%AX>F>8F]4QQ@< ,"6/X5V?CGQBUHYTK3)0)A_KY0
M=O\ LCW]:XVP\03),1>N9(R."% *G\*YL;]<]D_J]OU^70[,M_L[VZ^MWW\N
M7Y]?ZU+>HZ% +-GM@4:,%@N<@^M<Q73ZEKEN;)DMR7:4%0<8 ]:YBIRCZU[)
M_6+[Z7W*S_ZE[>/U2VVMMO\ +[@HHHKUCP0HHHH **** "BBB@"U8_ZUO]VH
M)O\ 7O\ [QJ>Q_UK?[M03?Z]_P#>-(?092TE+3$%%%% !1110 4444 %2/\
MZJ+Z'^=1U(_^JB^A_G0!'1110 4444 %%%% !1110 M20_ZS_@)_E4520_ZS
M_@)_E0"(Z7M24M "44M)0 4M)10(****!A112T /E^['_N_U-1U++]V/_=_J
M:BH **6DH **** "BBB@ HHHH MV/_+3\*JM]X_6K5C_ ,M/PJJWWC]:0^@E
M%%%,04444 %%%% !1110 5)+_!_N"HZDE_@_W!0!'24M% "44M)0 4444 %%
M%% !4D/23_<-1U)#TD_W#0"(Z*** "BBB@ HHHH 2C%+10 E%+12 DG^\O\
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M_(U%4H_X]#_OC^1H BHHHH **** "BBB@ HHHH *='_K4_WA3:='_K4_WA0
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M $HI:2@ HHHH *DAZ2?[AJ.I(>DG^X: 1'1110 4444 %%%% !1110 4444
M23?>7_<7^51U)-]Y?]Q?Y5'2&%%%% !1110 4444 %%%% '8>#?^01JG_73_
M -D%>:UZ5X,_Y!&J?]=/_9!7FU<C^)GK?\NH>@E%+1009U%%%;&85(+B90 )
M9 !P &-1U(+>8@$0R$'D$*:!.W47[3/_ ,]I/^^C1]IG_P">TG_?1H^S3_\
M/&3_ +X-+]FG_P">,G_?)IZB]T3[3/\ \]I/^^S1]IG_ .>TG_?1H^S3_P#/
M&3_ODT?9I_\ GC)_WR:-1^Z'VF?_ )[2?]]&C[3/_P ]I/\ OHTOV:?_ )XR
M?]\FD^S3_P#/&3_ODT:B]T7[3/\ \]I/^^C1]IG_ .>TG_?1H^S3_P#/&3_O
MDT?9Y_\ GC)_WR:-1^Z'VB?_ )[2?]]&C[3/_P ]I/\ OHT?9Y_^>,G_ 'R:
M/LT__/&3_ODT:A[H?:)_^>TG_?1H^T3_ //:3_OHT?9Y_P#GC)_WR:/LT_\
MSQD_[Y-&H>Z'VB?_ )[2?]]&C[1/_P ]I/\ OHTOV>?_ )XR?]\FC[//_P \
M9/\ ODTM0]T3[1/_ ,]I/^^C1]HG_P">TG_?1H^SS_\ /&3_ +Y-'V>?_GC)
M_P!\FGJ'NA]HG_Y[2?\ ?1H^T3_\]I/^^C1]GG_YXR?]\FC[//\ \\9/^^32
MU#W0^T3_ //:3_OHT?:)_P#GM)_WT:/L\_\ SQD_[Y-'V>?_ )XR?]\FEJ'N
MA]HG_P">TG_?1H^T3_\ /:3_ +Z-'V>?_GC)_P!\FC[//_SQD_[Y-&H_=#[1
M/_SVD_[Z-'VB?_GM)_WT:/L\_P#SQD_[Y-'V>?\ YXR?]\FC4/=#[3/_ ,]I
M/^^C1]HG_P">TG_?1H^S3_\ /&3_ +Y-'V>?_GC)_P!\FC4/=$^T3_\ /:3_
M +[-:WA>1YO$^G1RNSQM, RL<@CW%9/V:?\ YXR?]\&M?PQ&\/B?3I)49(UF
M!9F& ![FD[V+CRW1K_$0"T\10QVX\E#:J2L?RC.YN<"N1^TS_P#/:3_OHUUW
MQ$(N_$4,EN?.06J@M'\PSN;C(KD?LT__ #QD_P"^32C>PZG)SL/M,_\ SVD_
M[Z-'VF?_ )[2?]]FC[-/_P \9/\ ODT?9I_^>,G_ 'R:>I/NA]IG_P">TG_?
M1H^TS_\ /:3_ +[-'V:?_GC)_P!\FC[-/_SQD_[X-&H_=#[3/_SVD_[Z-)]I
MG_Y[R?\ ?9I?LT__ #QD_P"^#2?9I_\ GA)_WP:-0]P7[3/_ ,]Y/^^C1]IG
M_P">TG_?9I/LT_\ SQD_[X-+]FG_ .>,G_?!HU#W#6MI'/A7492[&1;F *Y/
M(!#Y /X"LC[3/_SVD_[[-:]M&X\*ZC$482-<P%4(Y( ?) _$5D?9I_\ GA)_
MWP:6I3Y--@^TS_\ />3_ +[-'VB?_GM)_P!]FC[-/_SQD_[X-'V:?_GC)_WP
M:-1>X'VF?_GO)_WT:/M,_P#SWD_[Z-'V:?\ YX2?]\&C[-/_ ,\9/^^#1J'N
M!]IG_P">TG_?1H^TS_\ /:3_ +[-'V:?_GC)_P!\&C[-/_SQD_[X-&H>X'VF
M?_GO)_WT:/M,_P#SVD_[Z-'V:?\ YXR?]\FC[-/_ ,\9/^^#2U'[AN>#G>X\
M66$4S&2-F;<CG(/RGL:N>/S]E\3M';_N8_)0[8_E'?L*J>#D:#Q982S*T<:L
MV7<8 ^4]S5OQ_P#Z5XG:2W_?1^2@W1_,._<4M>8M<G)T.7^TS_\ /:3_ +Z-
M'VF?_GO)_P!]FC[-/_SQD_[Y-'V:?_GA)_WR:>I'N>0?:9_^>TG_ 'T:/M,_
M_/:3_OHT?9I_^>,G_?)H^S3_ //&3_ODT:C]SR#[3/\ \]I/^^S1]IG_ .>T
MG_?1H^S3_P#/&3_ODT?9I_\ GC)_WP:-0]SR#[3/_P ]I/\ OHTOVF?_ )[2
M?]]FD^S3_P#/&3_O@TOV:?\ YXR?]\FC4/<\A/M,_P#SVD_[Z-;"R/\ \(?+
M+O;S1?HN_/./+8XSZ5D?9I_^>,G_ 'P:UUC?_A#Y8MC>8;]&V8YQY;#./2EJ
M-<GD9'VF?_GM)_WT:/M,_P#SVD_[Z-'V:?\ YXR?]\&C[-/_ ,\9/^^33U%[
MGD'VF?\ Y[2?]]&C[3/_ ,]I/^^C1]FG_P">,G_?)H^S3_\ /&3_ +Y-&H>Y
MY!]IG_Y[2?\ ?1H^TS_\]I/^^C1]FG_YXR?]\FC[-/\ \\9/^^32U#W/(7[3
M/_SVD_[Z-)]IG_Y[2?\ ?1H^S3_\\9/^^31]FG_YXR?]\FC4/<\A?M,__/:3
M_OHU;TN:5]7LD>5V5IT!!8D$;A53[//_ ,\9/^^35O2X94U>R9XG55G0DE2
M!N%&HUR7Z"ZM-*FL7R)(ZJMQ(  Q  W&JGVB?_GM)_WT:MZK#*^L7SI&[*UQ
M(00I((W&J?V>?_GC)_WR:-0]R_07[1/_ ,]I/^^C1]HG_P">TG_?1H^SS_\
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M1I/)E_YYO_WR:/)E_P">;_\ ?)I:A[HOG2_\]'_[Z-'G2_\ /1_^^C1Y,O\
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M8E,& 9#M!.X>M8>M@R:[?N@+*UPY#+R"-QJ5?F-'R>S6Q1\Q_P"^WYT>8_\
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M9Y3_ -QORK3T<>6FI;_EW63JN>,G*\"D[E1Y;F9YC_WV_.D\Q_[[?G2^6_\
M<;\J/+?^XWY4:D^Z)YC_ -]OSH\R3_GHWYTOEO\ W&_*D\J3^XWY4:C]T/-D
M_OM^='FO_?;\Z/*?^XWY4>4_]QORHU#W1/,D_OM^='FR?WV_.E\I_P"XWY4>
M4_\ <;\J-0]T3S9/^>C?G1YLG_/1OSH\I_\ GFWY4>5)_P \V_*C4/=-/7"8
M[BU"94&S@8A>,DH,FLOS9/\ GHWYUJ:X#)<6I0;@+.!25YP0@R*S/*D_N-^5
M)7L5+EN)YLG_ #T?\Z/-D_YZ/^=+Y4G]QORH\J3_ )YM^5/47NB>;)_ST;\Z
M/-D_YZ-^='E2?\\V_*CRI/\ GFWY4:A[HGFR?\]'_P"^J/-D_P">C_\ ?5+Y
M4G_/-ORH\J3_ )YM^5+4/=$\V3_GH_\ WT:3S9/^>C_]]&E\F3_GF_Y4>3)_
MSS;\J-0]T[_P(2V@:D223YAY/^X*\\KT3P("N@ZB""#O/!_W!7GG%0MV=$_@
MB)12XI,51D9M%%%;&85T-M_QZP_[@_E7/5T-M_QZP_[@_E5P,*^R):***T.8
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****0!1110 4
M444#"I;;_CYC^M15+;?\?,?UH EO_P#CX'^[_C56K5__ ,? _P!W_&JM /<*
M*** "BBB@ HHHH **** )5_X]I/]Y?ZU%4J_\>TG^\O]:BH *2EI* %HHHH
M*2EI* "BBB@">T_X^D_SVI]]_P ?)^@IEI_Q])]?Z4Z^_P"/D_04#Z%:BBB@
M I:2EI %%%% !1110 5*/^/4_P"^/Y&HJE'_ !ZG_?'\C0!%1110 4444 %%
M%% !1110 4Z/_6I_O"FTZ/\ UJ?[PH 67_7/_O&F4^7_ %S_ .\:90 4444
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M_E0'0AHHHH *6DHH$+1113 **** "I6_X]D_WC_2HJE;_CV3_>/]* (J***
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M3I7<IMT?X.F:+(FU>[V.PZ[5)&/I^[/_ 'T:Y+1-:N= U);^S6)IU5E7S5W
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M>H:=N^PWUS:[OO>1*R9^N#2=-Z^H*M'2Z>BMH>F>,'N+OX>17/B:TM[?6O/
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M>*;E08[" QP@]&D(Z#W^Z/\ @=7)&;Q=\-(;UR9-1T>8B1L#+(>I^FT@_P#
M#6+J-3\CJC1BZ=_M;KT1Q?ASP[>>)]2:QLI((Y5B,I,S$+@$#L#SR*-'\.WF
MMV&IWEM) D>G0^=,)&(++AC\N <GY3UQ73_"+_D<)O\ KS?_ -"2CP!_R+'C
M/_L''_T"2G*;3=NEA4Z49*-^M_P1P-;_ (9\(W_BMKH6,UK%]F"ES.S+G=G&
M,*?0U@5Z5\*8GGLO$D,:[I)+=%49QDD2 5563C!M$4(*=1193_X5)KG_ $$-
M)_[_ #__ !%<Q?>'+^R\1MH2B.YO0RJ!;L2K%E##!('8\Y]ZU/\ A6OB[_H$
M_P#DS%_\55WP'96VF^.X[/5H[J/4H9=L"1,A0-M;=O/IC&-M1SM)OFN:.FFU
M'D<;OK_PQS4FAW47B-=#=HA=M<+;YW'8&8@=<9QSZ5'K6DW&A:O<:;=/$\T!
M 9HB2IR >,@'OZ5UWBFST/4?'\=C =16ZN=16&\,A0( S ?N\<]^]9>H>$&;
MQ[-X<TII'564+),02J[ Q9B .F3V]*J,[V;[$3I6NHJ^MCEZL6%G)J.HVUE"
MRK+<2I"A<X +$ 9QVYKMI] \!6%X=.O-=U%KN-MDLL2#RE?N/NGO[FJK^&)_
M"_C_ $.!Y1/;S7D$D$ZC =?,7]1_4>M'M$]@]A)/78Y[7-)GT+4'TVZ>-YH#
MAFB)*G(!XR >_I697>>+-'NM>^)MSIUH!YDLBY8]$ C4DGV%.GT#P%87ATZ\
MUW46NXVV2RQ(/*5^_P#">_N:%45E?<<J#YG;1)VU.!HKI/$'@V]T77K;38F%
MTMX1]EE48$F3C'L1_4&MN]\+^#M!F2PUK6KYM1"@R_94&R,GGG*D_P!?89I^
MTCI;J0J$[N^ENYP%;/B'PU>^&Y+6.\E@D-S%YJ>2Q.![Y YK?\6^"]-\/^&+
M+4[._ENWN9]HDRHC9"&92 !G. ._K53QAX3M]#O]+M=-:XFDO80VV5E)+DX
M& *2J*35F4Z,HIW6JM^)R5%>@7?A+PKX<2"V\1:O>'49$#O'9*"L8/KE3_\
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MT% ="M1110 4M)2T %%%% !1110 5*/^/4_[X_D:BJ4?\>A_WQ_(T 14444
M%%%% !1110 4444 %.C_ -:G^\*;3H_]:G^\* %E_P!<_P#O&F4^7_7/_O&F
M4 %%%% !1110 4444 %%%% $O_+H/]\_RJ.I#_QZ#_?/\JBH 6BBB@ HHHH
M**** "BBB@"Q9?\ 'P/H:;=_\?3_ (?RIUE_Q\#Z&FW?_'T_X?RH#H0T444
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M0FH5%*6Q2_X2+7/^@SJ'_@4_^-:W@6:6X^(&F332/)*\K%G=BQ8[3R2:UO\
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M-/K$9.2>EW?:YK>(]2@?X=V]O:>'9[#399PUM++<!_FRQ. 26Y^;VJ]#IO\
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MQB%N4'R22Q;23G!'/W3[9/3-8=]JO@"33[E++P_?1731,(9&F8A'P=I/[P\
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M:?A55OO'ZUL<KV#M2444Q!1110 4444 %%%% !4DO_+/_<%1U)+_ ,L_]P4
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M-R',\;5=6M./WNR]-#BJV?"?_(S6?U?_ - :LNZ18[N9$&%61@![9K4\)_\
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ME !1110 4444 %%%% !1110!+_RZ#_?/\JCJ3_ET'^^?Y5%0 M%%% !1110
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MF/ZT 2W_ /Q\#_=_QJK5J_\ ^/@?[O\ C56@'N%%%% !1110 4444 )12TE
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MY"_^O3H_#/ER*WVS.#G'E?\ UZYNI+?_ (^$^M7]5QO_ $$?^2HR^O9;_P!
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M>%'0<U2KT\%2J4L/&%5WDCQ<SK4J^+G4HJT7M_7GN%%+25U'"%%%% !1110
M4444 6['_EI^%56^\?K5JQ_Y:?A55OO'ZTAO82BBBF(**** "BBB@ HHHH *
MDE_Y9_[@J.I)?^6?^X* (Z*** "BBB@ HHHH **** "I(NDG^X:CJ2+I)_N&
M@$1T444 %%%% !1110 4444 %%%% $DWWE_W!_*HZDF^\O\ N#^51T PHHHH
M **** "BBB@ I:2B@#LO!W_((U+_ 'S_ .@"O/<UZ#X._P"0/J7^^?\ T 5Y
M[7&_B9Z__+J'H+FC-%%,@Q:6BBMC(*W[?_CUB_W!_*L"M"/4_+B1/)SM4#.[
M_P"M51=C*K%R6AJ45F_VM_TP_P#'_P#ZU']K?],?_'__ *U5S(Q]E/L:5%9O
M]K?],/\ Q_\ ^M1_:W_3'_Q__P"M1S(/93[&E16;_:W_ $P_\?\ _K4?VM_T
MQ_\ '_\ ZU',@]E/L:5%9O\ :W_3'_Q__P"M1_:W_3#_ ,?_ /K4<Z#V4^QI
M45F_VM_TP_\ '_\ ZU']K?\ 3#_Q_P#^M1S(/93[&E16;_:W_3'_ ,?_ /K4
M?VM_TP_\?_\ K4<R#V4^QI45F_VM_P!,/_'_ /ZU']K?],/_ !__ .M1S(/9
M3[&E16;_ &M_TP_\?_\ K4?VM_TP_P#'_P#ZU'.@]E/L:5%9O]K?],/_ !__
M .M1_:W_ $P_\?\ _K4<Z'[&?8TJ*S?[6_Z8?^/_ /UJ/[6_Z8?^/_\ UJ7.
M@]C/L:5%9O\ :W_3#_Q__P"M1_:W_3#_ ,?_ /K4<Z#V,^QI45F?VM_TP_\
M'_\ ZU']K?\ 3#_Q_P#^M1SH/8S[&G169_:__3#_ ,?_ /K4?VO_ -,/_'__
M *U'.A^QGV-.I;;_ (^8_K6/_:__ $P_\?\ _K5?T6[_ +0UJTM-GE^;(%W9
MSC\*.>(*A4OL7K__ (^!_N_XU5JYXN7^P]7CM<^=NA#[ON]2PQCGTK _M?\
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M'_C_ /\ 6H_M?_IA_P"/_P#UJ/:1#ZO4[&G169_:_P#TP_\ '_\ ZU']K_\
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M'M(A]7J=C2HK-_M7_IA_X_\ _6H_M;_IC_X]_P#6H]I$/J]3L:5%9O\ :O\
MTQ_\>_\ K4O]J_\ 3'_Q[_ZU'M(A]7J=C1HK._M7_IC_ ./?_6H_M7_IC_X]
M_P#6H]I$/J]3L:-%9W]J?],?_'O_ *U']J?],?\ Q[_ZU'M(B]A4[&S9?\?
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MO_K4<\0]A4[%VBJ7]H?],O\ Q[_ZU']H?],O_'O_ *U'M(A["IV+M%4_M_\
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MC]:/M/\ L?K3YXD^RGV)Z*@^T_['ZT?:?]C]:.>(>RGV)Z*@^T_['ZT?:?\
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MQ^M'VK_8_6CVD0]C/L6**K_:O]C]:/M7^Q^M'M(A[&?8[GP=_P @?4O]\_\
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M)KN:61,N[LS')Y)/-1?V?:_\\O\ QX_XT>R8?6H=F8=%;G]GVO\ SR_\>/\
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M_P!AM_\ GG_X\:/L5O\ \\__ !XT>R8?6H=F9%%:_P!BM_\ GG_X\:/L5O\
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MT5:\F/\ N_K1Y,?]W]:/9L/;Q*M%6_)C_N_K1Y,?]W]:/9L/;Q.L^'G74?\
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M4 %%%% !1110 4444 %2VW_'S']:BJ6V_P"/F/ZT 2W_ /Q\#_=_QJK5J_\
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MZG^E:GB;PK?>%+J"WOI;>1YD+J8&8@#..<@5/,KVZE*$G'FMH8=%%%4(***
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M.6VL".1GIU-7*I.SDNAC"C3YHPE>[_4X"VTR]O=0^P6UM)-=;BOEH,G(Z_\
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M8+>.$,C* IR>-N<]QVKB=7T74-"NDMM2M_(EDC$JKO5LJ20#\I/<&NK^+/\
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M^X:CJ2+I)_N&@$1T444 %%%% !1110 4444 %%%% $DWWE_W!_*HZDF^\O\
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M6:5FDSJOB)K>GZ]XBBN].G\Z$6J(6V,N&#,2/F ]17,V4BQ7]O(YPB2JS'T
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MV\CKM)\66%QXFU*]\0V$<]OJ2E&98PSP#&T;3UQMX..> >U:>DW'@CPOJ/\
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M^U[/4Y_[1\J-!9M"P&,\Y;&,@$]^U6M1U;PAXPM+&YUB_N=.U&WA$4@2$N'
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M44$F924M%;F E=!;_P#'M%_N#^5<_6_;_P#'M%_N#^55 QK;(EHHHK0YSK]
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M7_H8JA5_0_\ D8--_P"OJ+_T,4I;%0^)'KGQC_Y%BR_Z_1_Z ]>*5[7\8_\
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M8V==N,HVW.^^('_(L>#/^P</_0(ZUO&W_)7O#_\ O6O_ *.->5T4*E:VO?\
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M%X6CV'MU S6/1RMOFB[ IJ*Y)J]O,]$\5>+K6#Q;HK:;(+BVT<!3(ISYG0,
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M.?-"<I/>QS%C_P M/PJJWWC]:M6/_+3\*JM]X_6MCF>PE%%%,04444 %%%%
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M%%% !1110 4444 %%%% !3H_]:G^\*;3H_\ 6I_O"@!9?]<_^\:93Y?]<_\
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M1_PC5[_SU@_[Z/\ A1_:>$_Y^(/[%S#_ )],QJ*V?^$:O?\ GK!_WT?\*/\
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M]"N?HHYP]@NYT'VF#_GM'_WT*/M,'_/:/_OH5S])1SC^KKN=#]I@_P">T?\
MWT*/M,'_ #VC_P"^A7/T4O:!]77<Z#[3!_SVC_[Z%'VF#_GM'_WT*Y^DH]HP
M^KKN=#]I@_Y[1_\ ?8H^TP?\]X_^^Q7/4E'M!_5EW.B^TP?\]X_^^Q1]I@_Y
M[Q_]]BN=HH]HP^K+N=%]I@_Y[1_]]BI[*1)KV&.)U=V;"JIR2?85RU;/A/\
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M2]J^PUA(]S9GFB2XE1Y45E<@@L 0<U']I@_Y[1_]]BLO6/\ D.7_ /U\R?\
MH1JE1[5A]4CW.A^TP?\ />/_ +[%'VF#_GM'_P!]BN>HI^U8?5%W.A^TP?\
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M^^A6)11[5A]57<V_/A_YZI_WT*//B_YZI_WT*Q*6G[5A]57<VO/B_P">J?\
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M6'U9=S6\V/\ YZ)_WT*/.C_YZ)_WU6511[5A]67<UO.C_P">B?\ ?5'G1_\
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M(_[Z_G4UQ^[\G?\ +NC#+NXR/4>U9%:NN=--_P"O&/\ K2]JQK#*VY'YD?\
M?7\Z/,C_ +Z_G6=13]JQ?5UW-'S(_P"^OYT>9'_?7\ZSJ*/:L/JZ[FCYD?\
M?7\Z/-C_ +Z_G6=11[5A]77<T/-C_OK^='FQ_P!]?SK/I*/:L/JZ[FCYL?\
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M@@C>>1_N"O-Z]"\!?\B_J/\ UT/_ *!7GF:QO=MG:U:$4+2444S,I4445T&
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MF?\ "M>BCD0_;S,?^RI_[\?YG_"C^R9_[\?YG_"MBBCD0>WF8_\ 9,_]^/\
M,_X4?V3/_?C_ #/^%;%%'(@]O,Q_[)G_ +\?YG_"M'0+22PUZRNI2ICBE#,%
M/./:IZEMO^/F/ZT>S0UB)ID_C8_VUK<5S;?(BVZH1)P<AF/;/K7-_P!DS_WX
M_P S_A717_\ Q\#_ '?\:JTE3C8<L3-NYC?V3/\ WX_S/^%']DS_ -^/\S_A
M6Q13]FA?6)F/_9,_]^/\S_A1_9,_]^/\S_A6Q11R(/K$S'_LF?\ OQ_F?\*/
M[)G_ +\?YG_"MBBCV:#ZQ,Q_[)G_ +\?YG_"C^RI_P"_'^9_PK8HH]F@^L3(
M;>TDC\/7MH2OF2SQ.I!XPH?.?S%9O]DS_P!^/\S_ (5NK_QZR?[R_P!:BI>S
MB/ZS,QO[)G_OQ_F?\*/[)G_OQ_F?\*V:*?LXA]8F8_\ 9,_]^/\ ,_X4?V3/
M_?C_ #/^%;%%+V:%]8F8_P#9,_\ ?C_,_P"%)_9,_P#?C_,_X5LT4>S0_K$S
M&_LFX_OQ?F?\*/[)G_OQ_F?\*V:*/9H/K,QGAFW?3?$=G>3%6CB9B0G)^Z1W
M^M6O&2G6-?:[M_EC,2KB3@Y'TS26G_'TGU_I3[__ (^3]!2]G&]ROK53EL<[
M_9,_]^/\S_A1_9,_]^/\S_A6S13]FB?K,S&_LF?^_'^9_P *7^R;C^_%^9_P
MK8I:/9Q#ZS4,;^R9_P"_%^9_PH_LF?\ OQ?F?\*V:*/9Q#ZS4,;^R9_[\?YG
M_"C^R9_[\?YG_"MFBCV<0^LU#&_LF?\ OQ_F?\*TEM9!X:DLLKYAO%ESGC 1
MA^?-3U*/^/4_[X_D:7LXC6)J&#_9,_\ ?C_,_P"%']DS_P!^/\S_ (5LT4_9
MQ%]9J&-_9,_]^/\ ,_X4?V3/_?C_ #/^%;-%'LXA]9J&/_9,_P#?C_,_X4?V
M3/\ WX_S/^%;%%'LXA]9J&/_ &3/_?C_ #/^%']DS_WX_P S_A6Q11[.(?6:
MAC_V5/\ WX_S/^%6=/T^6WU*UF=D*QS(Y )S@$'TJ_3HO]:G^\*7LXC^LU#.
MU'3Y;C4[N=&0+),[@$G."Q/I5;^RI_[\?YG_  K;E_US_P"\:91[.(?6:AC_
M -E3_P!^/\S_ (4?V5/_ 'X_S/\ A6Q11[.(?6:AC_V5/_?C_,_X4O\ 94_]
M^/\ ,_X5KT4>SB'UFH9']E3_ -^/\S_A1_94_P#>C_,_X5KT4>SB'UFH9']E
M3_WX_P S_A1_94_]^/\ ,_X5KT4>SB'UFH1&V<^&DLLKY@O&ESVP4 _/BLW^
MRY_[\?YG_"MP_P#'J/\ ?/\ *HJ/91!XFH9']ES_ -^/\S_A2_V7/_?C_,_X
M5K44>SB'UFH9/]E3_P!^/\S_ (4?V7/_ 'H_S/\ A6O11[.(?6:AD?V7/_?C
M_,_X4?V7/_>C_,_X5KT4>SB+ZS4,G^RY_P"]'^9_PH_LN?\ OQ_F?\*UJ*/9
MQ#ZS4+'A ?V1KRW5Q\T8C9<1\GGZXJOXEA;4O$-W=PD+'(5(#\'A0.WTJQ9?
M\?(^AIMW_P ?+_Y[4>RC<KZU4M8P_P"S)_[T?YG_  H_LR?^_'^9_P *UJ*/
M9Q)^LU#)_LN;^]'^9_PI?[,G_OQ_F?\ "M6BCV<0^LU#*_LR;^]'^9_PH_LR
M;^]'^9_PK5HH]E$/K-0RO[-F_O1_F?\ "C^S9O[T?YG_  K5HI^SB'UFH97]
MFS?WH_S/^%:4T#/X?M+0$>9'/*Y)Z88*!_(T^I6_X]D_WC_2E[.(_K-0QO[-
MF_O1_F?\*7^S9O[T?YG_  K3HI^SB+ZS4,S^S9O[T?YG_"E_LZ;^\GYG_"M.
MBE[.(?6:AF?V=-_>3\S_ (4?V=-_>3\S_A6G11[.(?6:AF?V=-_>3\S_ (4?
MV=-_>3\S_A6G11[.(?6:AF_V?-_>3\S_ (5H:'"UCKEG<R$%(I Q"]<4ZI;?
M_CX3ZT>SB-8FI<R#I\O]Y/S/^%']GR_WD_,_X5I44_9Q%]9F9O\ 9\O]Y/S/
M^%']GR_WD_,_X5I44>SB'UF9F_V?+_>3\S_A1_9\O]Y/S/\ A6E11[.(?69F
M=]@E_O)^9H^P2_WD_,UHT4>SB'UB9G_89?[R?F?\*/L,O]Y/S-:%%'LXB^L3
M"ZC,NC:=;J1OA:4L3T.XC&/RJA]AE_O)^9K4?_41?C4=+V<1O$S,_P"PR_WD
M_,T?89?[R?F:T**?LXB^L3*'V&7^\GYFC[#+_>3\S5^BCV<0^L3*'V*3^\GY
MFC[%+_>3\S5^BCV<0^L3*/V*3^\GYFC[%)_>3\S5ZBCV<1?6)FIX.N4TC49Y
MK@,RO%M CY.<@]\>E9.JQ-=:O>7"$!)9G=0W7!)-7+'_ %K?[M0S?Z]_]XTO
M9QN4\34Y;&=]BD_O)^='V.3^\OYFKU%/V<2?K$RC]CD_O+^='V.3^\OYU>HH
M]G$/;S*7V.3U7\Z/L<GJOYU=HI^SB'MYE+[')ZK^='V23U7\ZNT4>SB'MYE+
M[))ZK^=:%XIFTS38%X:!'#$]#ER>/SIE22?ZF+Z'^=+V<1K$3,_[))ZK^='V
M23U7\ZN4M'LXB]O,I?9)/[R_G1]DD]5_.KM%'LT'MYE+[))ZK2_9)/5?SJY2
M4>SB+V\RI]DD]5H^R2>JU;S1FG[-![>94^R2>JU?T@?9+XRR<KY,B?+UR4('
M\ZCS4L'^L_X"?Y4O9Q&L1-,S_LDGJOYT?9)/5?SJWFC-/V<1>WD5/LDGJM'V
M63U6K>:,T>SB'MY%3[*_JM'V5_5?SJW11[.(>WF5/LK^JT?97]5JW11[-"]O
M,J?97]5H^ROZK5NBCV:#V\R34!]HMM/1.##;^6V>YWL>/SJA]E?U7\ZOR_<B
M_P!W^IJ.E[.(W7FRI]E?U6C[*_JM6Z*?LXB]O,J?97]5H^ROZK5NBCV:'[>9
M4^ROZK1]E?U6K=%'LT+V\RI]E?U6C[*_JM6Z*/9Q#V\S=\'7\6D&]^T*[>;L
MV^6 >F[U(]:YJ>W=[F5P5PSDC/UK4L?^6GX?UJHWWS]:7LXW+>(FXI%+[+)Z
MK^='V63U7\ZN44_9HCV\RI]ED]5_.C[*_JOYU;HH]F@]O,I_97]5_.C[))ZK
M^=7**/9Q'[>93^R2>J_G1]DD]5_.KE%'LXA[>93^R/ZK^=7]3'VD66SCRK5(
MVW>HST]J94DW_+/_ '!2]G$/;SL9_P!DD]5H^R2>JU<HI^SB+V\RG]DD]5I/
MLDGJOYU=HH]G$?MYE+[))ZK^='V23U7\ZNT4>SB'MYE+[))ZK^='V23U7\ZN
MT4>SB'MYE+[))ZI^=7],4VRWP?!\VU:-=O8DCK[<4VI(>DG^X:7LXC5>9G?8
MY/5?SH^QR?WEJ[13]G$7MYE+[')ZK2?8Y/[R?G5ZBCV<0]O,H_8Y/5?SH^QR
M>J?G5ZBCV<1^WF4?L<G]Y?SH^QR?WD_.KU%+V<0]O,H_8Y/[R?G1]CD_O)^9
MJ]11[.(>WF+JR&ZFMVCP EK%&=WJJ@&J'V*3^\GYUI3?>7_<7^51T>SB#KS;
M*/V*3U3\Z/L4G]Y*O44>SB'MYE#[%+_>3\Z/L4O]Y/S-7Z*/9Q#V\RA]AD_O
M)^9H^PR?WD_,U?HH]G$/;S*'V*3^\GYFC[%)_>3\ZOT4>SB'UB9UG@9#'H6I
M(<9$AZ?[@KSJO2?!G_((U3_KI_[(*\UKFM:3/1O>G%OL+1244R2G12TE=!S!
M6];_ /'M%_N#^58-;UO_ ,>T7^X/Y543*MLB2EI*6K.<2BBB@ HHHH ***M:
M?8RZE?16D+(LDF<%R0. 3V^E+8$KNR*M%%%, HHHH **** "BBBD,**** "B
MBB@ HHHH **** "BBB@ J6V_X^8_K452VW_'S']: );_ /X^!_N_XU5JU?\
M_'P/]W_&JM /<*2EI* "BBB@84444 %%%% $J_\ 'K)_O+_6HJE7_CUD_P!Y
M?ZU%0 4444 %%%% !1112 **** )K3_CZ3Z_TI]__P ?)^@IEI_Q])]?Z4^_
M_P"/D_04!T*U%%% !2TE+0 4444 %%%% !4H_P"/0_[X_D:BJ4?\>A_WQ_(T
M 14444 %%%% !1110 4444 %.C_UJ?[PIM.B_P!:G^\* %E_US_[QIE/E_US
M_P"\:90 4444 %%%% !1110 4444 2_\NH_WS_*HJE_Y=1_OG^514 %%%% "
MT444 %%%% !1110!8LO^/D?0TV[_ ./E_P#/:G67_'R/H:;=_P#'R_\ GM0'
M0AHHHH **** "BBB@ HHHH *E;_CV3_>/]*BJ5O^/9/]X_TH BHHHH 6BBB@
M HHHH **** "I;?_ (^$^M15+;_\?"?6@"*BBK.GV-QJ>H6]C:INGG<(@]SW
M/M1L"5]$5J*]"NO"O@O09A9:WK]X]^H!D6UC^5,]ONM_//M6=XD\%V]AHL6O
M:)?_ &_2G(#,PP\>3@9_'CH"#VK-58LVE0FDWV\SCJ***T,0HHHH **** )7
M_P!1%]6J.I'_ -1%]6J.@ HHHH$%%%==XX\+6/AG^S/L4MQ)]JA+OYS*<$8Z
M8 ]:3DDTNY2@W%R70Y&BMGPII,&N^)K+3;IY$AG+!FB(##"D\9!';TJ'Q%IT
M.D>(;[3[=G:*WE**9""Q'O@"CF5^4.1\O/TV,RBBBJ)+5C_K6_W:AF_U[_[Q
MJ:Q_UK?[M0S?Z^3_ 'C2'T&445LZG;:#%HNGRZ=>SS:BX_TN%U(6,X_A^4=_
M<TF[ E=-F-1113$%%%%, HHKJ/"_ANSUO0_$-[<R3I+IMMYT(C8 ,=KGYL@Y
M'R#ICO4RDHJ[*A!S=D<O4DG^IB^A_G4=22?ZF+Z'^=421T444 %%%% !1110
M 45T'A/PM+XFNYP;A+6SM4\RYN&YV#GMZ\'\C6^FB?#N:<6L?B'4%F8[1*Z@
M1Y^NP<?C^-9RJ).QK&C*2OHO5G 5)!_K#_NG^5:_BCPS=>%]5^QW#B5'7?%,
MHP'7^A]15SQ'X8'AEM.C:X,TUS;-+(0,*I]!W_'^55SQ=K=2?925[K8YBBBB
MJ,PHHKJO!'AFR\2SZ@EY+/&+:W\U/)8#)SWR#Q4RDHJ[*A!SERHY6BBBJ)"B
MBK^BZ3<:YK%MIUL/WDSXW=E7J6/T&32;LKL:3;LBA16IXBM-.L-<N;/2Y)I;
M>!O+,DS EV'#$8 XSP/I74>%/AU-J]A/J.J^?:V@B+0*N%>0]<\@X7^=2ZD8
MQYF7&C*4N2)P\OW(O]W^IJ.I)?N1?[O]375^"_ MUXFN!/<K+!IBYW3#AG/H
MF0<_7I3E)15V*$)3ERQ.0HJYJEHMEK-[90[V2&X>)-W+$!B!G'?BNQF\(>'?
M#UI;CQ1JEVM_<)Y@MK-5S&O^UD'OGGCOC.*3FE;S'&E*5_(X*BNK\4>%;32]
M+L]:TB^:\TJ[;8K.,.C8/!Z>C=AC%0:SX=MX/#NG:]I;S265P/+G64AFAF'4
M9 '!P<<=O>A33L#I25UV.;HHHJS,**** +EC_P M/P_K51OOGZU;L?\ EI^'
M]:J-]\_6D/H)1113$%%%% !1110 4444 %23?\L_]P5'4DW_ "S_ -P4 1T4
M44 %%%% !1110,**** "I(>DG^X:CJ2'I)_N&@".BBB@ HHHH **** "BBBD
M 4444 23?>7_ '%_E4=23?>7_<7^51T %%%% !129HH ****8!1110!V/@S_
M )!&J?[_ /[(*\TQ7I7@S_D$:K_UT_\ 9!7FM<;^)GK+^%#T#%%%% BK1116
MYS"5O6__ ![1?[@_E6%6[;_\>T7^X/Y5<3&MLB2EI*6K.<2BBB@84444 %;/
MA/\ Y&:S^K_^@-6-6UX3_P"1FL_J_P#Z U3+X673^->IBT4451 4444 %%=Y
M\-?"#ZUJB:I=Q_\ $NM'R-W_ "UD'('T'4_@.YK0^,W_ "&M-_Z]V_\ 0JR]
MJO:<B.A4'[+VK/,Z***U, HHK?\ "'ABX\4ZTEJ@9;:/#W$H'W%]/J>@_P#K
M5,FHJ['&+DU%;F!17LWQ;MXK3P?IMO!&L<,5TJ(BC 4"-@!7C-13GSQYC2O2
M]E/EO<***]&^'OP_BUN$:OJP8V.XB&$''FD<$DCD*#Q[D>G5SFH*[%2I2J2Y
M8GG-%>XWOQ$\*^&YCI^GVAE$7RM]CB58U/<9R,_A^=2:?XH\(^.G_L^[LU%P
M^=D5W& S<?P,#U_$&LO;2M=QT.CZK!OE4U<\*HKLO'O@EO"UVEQ:LTFFW#;8
MRWWHVZ[3Z]R#['TYXVMHR4E='+.$H2Y9;A4MM_Q\Q_6HJEMO^/F/ZU1)+?\
M_'P/]W_&JM6K_P#X^!_N_P"-5: >X4E+24 %%%% PHHHH **** )5_X]9/\
M>7^M15*O_'K)_O+_ %J*@ HHHH ****0!1110 4444 36G_'TGU_I3[_ /X^
M3]!3+3_CZ3Z_TI]__P ?)^@H#H5J*** "EI*6@ HHHH **** "I1_P >A_WQ
M_(U%4H_X]3_OC^1H BHHHH **** "BBB@ HHHH *='_K4_WA3:=%_K4_WA0
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MJ,V 1U.1S^/>N(^,W_(:TW_KW;_T*N?^&G_)0=+_ .VO_HIZZ#XS?\AK3?\
MKW;_ -"KGC!0K)+L=DZKJX:4GW_R/,Z***[#SCL_"/P[O_$L4=[+*EMIK,?W
MF0SO@X(4=NA&3^M>CRZSX>\"QVNA:8B/=S3)&8D.6!8@%Y&]<=NO3H.GDMOX
MTUNST&+1K.Z^S6T>[YH1AVW$DY;J.O;%9^BL6\1:<S$EC=QDD]3\XKFG3E-M
MS>G8[*=>%-)4UJ]W_D>M_&/_ )%BR_Z_1_Z ]>*5[7\8_P#D6++_ *_1_P"@
M/7BE&&_ABQW\9DD$+W%Q'!&,R2.$4>I)P*]V\=7B^%_A_P#9+(F)G5+.$KU
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M?>7_ '%_E4= !1110 4444 %%%%( HHHH [#P9_R"-5_ZZ?^R"O-*]+\&?\
M((U7_KI_[(*\SKD?Q,]9?PH>@4444"*]%+25T'*%;UO_ ,>T7^X/Y5A5NV__
M ![1?[@_E51,JVR)*2EHJSG$KH_#NF9/VZ9>G$0/\ZRM*T]M0O G2)>9#[>G
MXUV%U<0Z=9&0@!$&%4=_0"O!SC&R26%I?%+?_+Y_D?5<.Y=%MXZOI"&WJNOR
M_/T+.:P?%/\ QYP?]=/Z58T"XDNK2>:4Y=YR3_WRM5_%/_'G!_UT_I7C8*BZ
M&8QIO=/]#Z+,\0L3E$ZT5HU^IRU;7A/_ )&:S^K_ /H#5BUM>$_^1FL_J_\
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MJU?_ /'P/]W_ !JK0#W"BBB@ Q24M)0 4444#"BBB@"5?^/63_>7^M15*O\
MQZR?[R_UJ*@ HHHH ****0!1110 4444 36G_'TGU_I3[[_CY_ 4RT_X^D^O
M]*???\?/X"@.A6HHHH *6DI: "BBB@ HHHH *E'_ !ZG_?'\C452C_CU/^^/
MY&@"*BBB@ HHHH **** "BBB@ IT?^M3_>%-IT?^M3_>% "R_P"N?_>-,I\O
M^N?_ 'C3* "BBB@ HHHH **** "BBB@"7_EU'^^?Y5%4O_+J/]\_RJ*@ HHH
MH **** "BBB@ I:2B@"S9?\ 'R/H:;=_\?3_ .>U.LO^/D?0TV[_ ./I_P#/
M:@.A#1110 4444 %%%% !1110 5*W_'LG^\?Z5%4K?\ 'LG^\?Z4 14444 %
M%%% !2TE% "T444 %2V__'PGUJ*I+?\ X^$^M $=%%;7A+1CKWB>QL2N8FDW
MS<?P+RWYXQ^-)NRNQQBY-)'9S7K^!_ 6B0Q+B_OKE;V9>02BD-M/I_ /SK,^
M)VFQ+J]KKEI\UIJD*RAATW #^8*G\ZU_%OBKPG=Z]-#J.A3WTEH3;K*MTT:X
M4G("@@=<U9:73/&OP]O;#2;*2VDTHB6""20R,  3P2<G(WC'T]JY8MQ:DUZ_
M,[YI34J::=MOD9,/_)#[C_K]'_H:T>*/^23^&?\ KI_1J(?^2'W'_7Z/_0UH
M\4?\DG\,_P#73^C52^+YDOX7_A7YGG=>LWVA:EK_ ,*O#]MIEMY\R.)&7>JX
M7#C.6([D5Y-7I^N7MW8?"3P[)9W4UN[2A2T,A0D8?C(JZM[QMW,L/:T^;:WZ
MG*W?P_\ $]C9S7=SIFR"%#)(WGQ':H&2<!LUUO@/^PO^$-\1?\A'=]D7^T/N
M8QB3'E>^,_>]J\]EU[6)XGBEU6^DC<%61[AR&!Z@C/-==X#_ .1/\:?]>:_^
M@RTJBER>]Y#HN"J>XNCW]"+0?#.A^(3K$EO+J"6EG!YMOYC()"<'._ (ZCMC
MBLWPKX436[>[U+4;O[%I%F/WTX&6)QG:H_$?F.#FNB^&7_(,\0?]>9_DU1Z8
MK7OP6U*"U!>6"ZWRHO7:"IS[C'/X'TI2DTVK]BHPBXQDUT;^XBL_"O@_Q!))
M9:#K5ZFH[28EO$&R3'IA1_CWP<5:^'5K-8CQ7:W"%)H;4HZGL1O!KF_A_;3W
M/C?3?(1F\N3S'(_A4#DG^7XUZ!I4\5SXK\=20$%/("Y![JK _J#2J75XWO\
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M_EI^']:J-]\_6D/H%%)13$%%%% !1110 4444 %23?\ +/\ W!4=23?\L_\
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M 4444 %%%% !4K?\>R?[Q_I452M_Q[)_O'^E $5%%% !1110 4444 +244M
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MOK7N->ZTCYF$O?3?<S****H@**** .L^&G_)0=+_ .VO_HIZZ#XS?\AK3?\
MKW;_ -"KS[3-3O-'U"*_L)O)N8L['VAL9!!X((Z$U8UGQ!JGB&>*;5+K[1)$
MNU#Y:I@9S_"!6+IMU5/H=$:T50=/JV9E%%%;'.%7]#_Y&#3?^OJ+_P!#%4*D
M@GDMKB.>%MLL3AT;&<$'(/-)JZ*B[.Y[/\8_^18LO^OT?^@/7BE;>L^+M<\0
M6J6VJ7WGPH_F*OE(N&P1G*J.Q-8E948.$;,VQ-55:G-$*][\+ZY8>._"LFFZ
M@5:Z$7EW41/)])%_0^QKP2IK6[N+&Y2XM9Y()D.5DC8JP_$45:?.O,*%9TGW
M3W.RUCX6>(+"Z86,*W]L2=CQNJL!_M*2.?IFI=!^%6MWUVAU1!86@(+DL&=A
MZ* 3CZG]:9:?%GQ+;1!)/L=T1_'-"<G_ +Y(IM[\5_$UW"8XVM+0G^."(Y_\
M>+5'[^UM#7_9;\VOH=]XZ\267A3PX-'L"J7DL/DP1)_RRCQC<?3CIZGZ&O":
MDN+B:[G>>XE>69SEY)&+,Q]R:CK2E34%8QKUG5E?H%2VW_'S']:BJ6V_X^8_
MK6AB2W__ !\#_=_QJK5J_P#^/@?[O^-5: >X4444 %%%)0 4444#"BBB@"5?
M^/63_>7^M15*O_'K)_O+_6HJ "BBBD 4444 %%%% !1110!-:?\ 'TGU_I3[
M[_CY_ 4RT_X^D^O]*???\?/X"@.A6HHHH *6DI: $HI:2@!:*2EH *E'_'J?
M]\?R-15*/^/4_P"^/Y&@"*BBB@ HHHH **** "BBB@ IT?\ K4_WA3:='_K4
M_P!X4 ++_KG_ -XTRGR_ZY_]XTR@ HHHH **** "BBB@ HHHH E_Y=1_OG^5
M15+_ ,NH_P!\_P JBH ****!A1110(**** "BBB@"S8_\?(^AIMW_P ?3_Y[
M4ZQ_X^1]#3;O_CZ?_/:@?0AHI*6@04444 %%%% !1110 5*W_'LG^\?Z5%4K
M?\>R?[Q_I0!%1110 4444 %%%% !1110 5H:5I\U]<Y3 1#EF/:L^NB\,WD2
M++;.P5V;<N?XN.GZ5Q9A6JT</*=)7:/1RG#T<1BX4J[M%_CY%/4-"GL8#,)!
M+&/O8&"*RJ[C4-2AT^$NQ#R?PQ@\FLG_ (2K_IR_\B__ %J\W X_'5*7-[+G
M\[J)[.9Y7EE&ORJOR:;6<OQ7Y,YVBNB_X2K_ *<O_(O_ -:C_A*O^G/_ ,B_
M_6KL^M8W_H'_ /)D>?\ 4<M_Z"__ "21SM%=%_PE7_3E_P"1?_K4?\)5_P!.
M7_D7_P"M1]:QO_0/_P"3(/J.6_\ 07_Y)(YVBNB_X2K_ *<O_(O_ -:C_A*O
M^G+_ ,B__6H^M8W_ *!__)D'U'+?^@O_ ,DD<[171?\ "5?].7_D7_ZU'_"5
M?].7_D7_ .M1]:QO_0/_ .3(/J.6_P#07_Y)(PG_ -1%]6J*NE;Q/B-6^Q_>
MSQYO_P!:F?\ "5?].7_D7_ZU'UK&_P#0/_Y,@^HY;_T%_P#DDCG:*Z+_ (2K
M_IR_\B__ %J/^$J_Z<O_ "+_ /6H^M8W_H'_ /)D'U'+?^@O_P DD<[171?\
M)5_TY?\ D7_ZU'_"5?\ 3E_Y%_\ K4?6L;_T#_\ DR#ZCEO_ $%_^22.=HKH
MO^$J_P"G+_R+_P#6H_X2K_IR_P#(O_UJ/K6-_P"@?_R9!]1RW_H+_P#))'.T
M5T7_  E7_3E_Y%_^M1_PE7_3E_Y%_P#K4?6L;_T#_P#DR#ZCEO\ T%_^22,>
MP_UK?[M0S_Z^3_>-=)!XC\]ROV3;@9_UF?Z5&_BC9(R_8\X.,^;_ /6H^M8W
M_H'_ /)D'U'+?^@O_P DD<W171?\)5_TY?\ D7_ZU'_"5?\ 3E_Y%_\ K4?6
ML;_T#_\ DR#ZCEO_ $%_^22.=HKHO^$J_P"G+_R+_P#6H_X2K_IR_P#(O_UJ
M/K6-_P"@?_R9"^HY;_T%_P#DDCG:*Z+_ (2K_IR_\B__ %J/^$J_Z<O_ "+_
M /6I_6L;_P! _P#Y,@^HY;_T%_\ DDCG:*Z+_A*O^G+_ ,B__6H_X2K_ *<O
M_(O_ -:CZUC?^@?_ ,F0?4<M_P"@O_R21SM2R?ZF+Z'^=;O_  E7_3E_Y%_^
MM3V\3[41OL?W@?\ EK_]:E]:QO\ T#_^3(/J.6_]!?\ Y)(YNBNB_P"$J_Z<
M_P#R+_\ 6H_X2G_IS_\ (O\ ]:CZUC?^@?\ \F0?4<M_Z"__ "21SM%=%_PE
M/_3G_P"1?_K4?\)3_P!.?_D7_P"M1]:QO_0/_P"3(/J.6_\ 07_Y)(YY%:1U
M1%+,QP !R37LG@OPLNA6(N+A =0G7YS_ ,\U_NC^OO7%:/XR@M=4AEN;+]UG
M#-YF2F?X@,<XKUN*6.>))8G5XW4,K*<@@]"*Z*=6M.-ZL.5]KW.6K1P].=J%
M3G7>S7X,\X^('A3RV?6K"/Y&.;J-1T/]_P#Q_/UKSNO?M;U:UT72Y;R[P4 V
MJG>1CT45Y*_BL,[,+$*"<A1+T]NE*K6KP2]E3Y_FE^8Z&'PM1OV]7V?_ &ZY
M7^[8YNMC3-%FNHQ.SB-&!"Y&2?>K7_"4_P#3G_Y%_P#K5K:?J,-_"'4A9/XH
MR<D5YF.Q^.ITN;V7)YW4CVLLRO+*U?E=?VFFUG'\?T1R>H:;-IT@63#*WW7'
M0U3KH/$EW#((K>-@SJ=S$'./:N?KT\OK5*V'C.JK-GBYMAZ.'Q<Z5!WBOZM\
M@HHHKM/."BBB@ HHHH **** ))?N1?[G]34=22_<B_W/ZFHZ "BBB@04444
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MD,**** "BBB@ HHHH **** "I;;_ (^8_K452VW_ !\Q_6@"6_\ ^/@?[O\
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M&VW=BU)!_K/^ G^519J6#_6?\!/\J!$=%)FES3 **** "BBB@ HHHH ****
M))?N1?[G]34=22_<B_W/ZFHZ "BBB@ HHHH **** "BBB@"Y8?\ +3\/ZU4;
M[Y^M6[#_ ):?A_6JC?>/UI#Z"4444Q!1110 4444 %)BEHH 2I9O^6?^X*CJ
M2;_EG_N"@"*BBB@04444 %%%% !1110 5+#TE_W#452P])?]PT B*BBB@ HH
MHH **** "BBB@84444 2S_>7_<7^515+/]Y?]Q?Y5%2 **** "BBB@ HHHH
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MNQ\D>Q9_M"Z_YZ_^.C_"C^T+K_GK_P".C_"JU%%V')'L6?[0NO\ GK_XZ/\
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M' XJ"PU34-*E:73KZYLY&7:SV\S1DCT)4CBD^P7/_//_ ,>'^-'V"Y_YY?\
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MM(]PCU*^BT^73X[VY2RE8-);K*PC=AC!*YP3P/R%/L-8U32M_P#9VI7EGO\
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M_C3?[/NO^>7_ (\/\:7*^PO:1[EV'Q7XCMX(X(-?U6*&-0B1I>2*JJ!@  '
M ':LNXN)KJ=Y[B:2:9SEI)&+,Q]23UJ;^S[K_GE_X\/\:/[/NO\ GE_X\/\
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MW(*6IOL5S_SS_P#'A1]BN?\ GG_X\*.5]@YX]R&BIS8W0 )BZ\CYA1]BN?\
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MS4_V*Y_YY_\ CPH^Q7/_ #S_ /'A1ROL'/#N09HS4_V*Y_YY_P#CPH^Q7/\
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M*X7="\L942#@Y4D<CD=/45Z!XY_Y)UX1_P"N*_\ HM:A^(7_ "*/@G_KP/\
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M *2BB@ HHHH !2T@I: )5_X]9/\ >7^M0U,O_'K)_O+_ %J&@84444 %%%%
M!1112 **** )K3_CZ3Z_TI]__P ?)^@IEI_Q])]?Z4^__P"/G\!0'0K4444
M%+24M !24M)0 4M)2T %2C_CU/\ OC^1J*I?^70_[X_D: (J*** "BBB@ HH
MHH **** "G1_ZU/]X4VG1_ZU/]X4 ++_ *Y_]XTRG2_ZY_\ >-,H 6BDHS0
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MH? 7BO0_"T%V]_:7DE[.=JRP(IVQXZ E@0<Y_(5G%N,79:W-91C.<7)V32_
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M:C_A*O\ IR_\B_\ UJP]CG/=_?'_ #.KZQP[V7_@,O\ (Q+V!;:]FA0DJC$
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MT=A^ P/PKFI^_5<ELCNJKV>'C3>[U*-2VW_'S']:BJ6V_P"/F/ZUTG"2W_\
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ME $5%%% !1110 4444 %%%% !1110!+/]Y/]Q?Y5%4L_WD_W%_E45 !1110
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MK]&>=5L^$_\ D9K/ZO\ ^@-5?6[1;34G"#".-X'IG_Z^:L>$_P#D9K/ZO_Z
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MF/ZU%4MM_P ?,?UJB"6__P"/@?[O^-5:M7__ !\#_=_QJK0#W"BBB@ HHI*
M"BBB@ %+2"EH E7_ (]9/]Y?ZU#4R_\ 'K)_O+_6H:!A1110 4444 %%%%(
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MKZ7?-$N.)!C<>..X_+/>L27PWI4UV;BV\?6T>GL=P22X_>HOI@MDG\OI4/\
M:>A?\)[HTFF2/%IMM. UQ<S,0Q[MES\HZ>E)*^W;L4W;XNZW:?W%OQ[XZUJQ
M\37>F:;<BUM8 $(2-278J"221[XX]*31+KQ9J'A6QT_POI+V$$;'SKT2J//;
MN06 [YZ9[#M7*^.;F"[\::G/;31S0O("LD;!E;Y1T(X-=A<2Z?XJ\':+9VWB
M>UTMK*W$-S;7,OEB0A5&<9&>A]?O53BHPCH0IRE4G=_CY]"_XBLM5'PKU!?$
M-S;7E]:W"-%+&V\H"Z+@G Y^9OP-49=8U1?@U;WJZE>"[-WM\\3MYF-S<;LY
MQ1<_\(]I_P ,]8T+3-;MKJ[#I+(SN$\UPR$A 3\P"IVSS]:K:')I6N_#5= G
MUFSTZZBN3(3=.%!&2>,D9Z_I4I::]RV_>LGJX]^OJ:7@_3M2M?AY-JF@VPN=
M<OY67S7908U#$$Y8@=B?J1UQ5_PQ8^-);N:P\5V9NM)NHV60S2Q/Y9QD$;6S
MST]N#QBN8\/ZMIEYX;N/"6I:H+%X)V>SOXVPA.3U.>G)],@^HJ6VTS0="$UY
MK?BN/58U0B*TL;EBSMV)*MQ_+WHDG=W_ ""$E:+6R6NJMYW18\/V8T[P=XZL
M0Q86SR0Y/4[0P_I5/1#_ ,)-\+]2T<C=>:4WVFW&"24Y.!ZG[X_$4SPSJEBG
M@GQ9'-<P6\UR"88))AO;*G@9.6K&^'NKMI/C&RR"8KIOLLB@9R'( _\ 'MIJ
M^5^\^J,U.-X+HTU][-G0#_PC?PTU36B=MUJC_9+8YYVC()'H?OG_ ("*X.V_
MX^8_K7;_ !.O88=0L?#ME\MII<(7:#_&PSSZ\8_,UQ%M_P ?,?UK2GJN9]3"
MOI)073^F=-X5\67?ANSN8IM.6^T>Y?;+%*N%W8['!&2!T/7%;BR_#77G*-;W
M>C3R, ) 2$!_-E _ 56\*Z_H][X8F\*>(96M[=G\RVNE'$9SG!].<G/3DCBE
MC\#>&X)1-=^-M/DM5Y982OF,/0#<<?D:SERW=[I^1M#FY4E:2\[:$:^ SIOQ
M#TS1KR47%E<MYJ2*,>8B@DJ1V/RX_&NK\20?$*;6G70K9K73(,);I%+"H8#N
M06[^GICBN6U[Q['/XUTW4]/B8V6F8CB#C!D4\,?;(X'T!]JT=5TW2?$-^^K:
M9XSM[&&Y/F26UU/L:-C][ +#\OUJ7S73EV[%QY+2C3[]';0M^-4O=.L/#WBN
M[M%M=:AG6*Z1&7$A )&2I(Y"'\&QVK&^(&C?VAXLTV]T[#1:['&T3=B_"GZ#
M!0_B:R_%\^A16]GIND7$]]-",W-Z\KE)&Z?*I)'KR/;D\UU?@?Q'I'_",0?V
MQ=Q1W6B2R2VRR2 -(K(V H/+?>(P/1::3A%20-QJ3<&^WWK?\!NNPVFJ_$#0
M/"*D_P!G:=&J.G/S$)N(/KE54?B:T?$D'Q"FUIUT*V:UTR#"6Z12PJ& [D%N
M_IZ8XKS+3O$5Q9>+8]?D423?:#-(O]X-G<!^!(%=KJNFZ3XAOWU;3/&=O8PW
M)\R2VNI]C1L?O8!8?E^M*4>5J^UO74(U%-2MO?H[:= ^).F7$GAO2-<U&S6U
MU9G^SW:H5(8X)!RI(_AR.>C8[5J?$SQEJFA:M;:?I4RVS-")I90BLS9) 7D'
M@8)_&N)\7SZ%%;V>FZ1<3WTT(S<WKRN4D;I\JDD>O(]N3S5OXIW]GJ/BN*:R
MNX+F(6B*7@D#KG<W&1WY%.,+N*?F*=2RFXO70ZGPO;:L/ -QK.C6ZW6OZE/(
M3,Y0%!O(8_,0.Q./4CC JUX8L?&DMW-8>*[,W6DW4;+(9I8G\LXR"-K9YZ>W
M!XQ7+^&M8TW4?!W_  C.J:@VFR+(TMI=@X53DG#'/N?3KZBIK;3-!T(37FM^
M*X]5C5"(K2QN6+.W8DJW'\O>IDG=I_D:0DK1:VMKJK>=T<%JEF-.U>]L0Q86
MT[PY/4[6(_I7=?"[_CS\3?\ 7E_1Z\^N)!-<RRJI4.Y8*6+8R>F3R?K7H/PN
M_P"//Q-_UY?T>MJO\,Y</_&5O/\ (\^@N)K6=9[>:2&5?NR1L58?0BN\\",S
M^$/&[,Q9FLU)).23MEKS^NW\%7]G:>%/%\-S=P0RSVBK"DD@5I#MDX4'J>1T
M]13JKW?N_,G#NT]?/\C"\)Z=?ZIXFLK?39_L]R'\P3XSY87DM[_3OT[UWFM^
M*/!B>)2;_1'U"[MG\N:\50H=EX)V9 ;&,<^G'&*X?P=KX\-^);?4)%+08,<R
MKUV'J1]#@_A727_A'PYJFI2ZA9>+].@LKAS*8IF DCSR0%)!/XXJ*B7/[VQK
M1;]G[EKWZ_\ !#QUHFJZSXFT^XM)QJ$6J0[K#&(\(HW%>2 , YR>N:PKWP!X
MGTZRFO+K3/+MX4+R/Y\1P!U. V:TO&GBBVFETO3O#]S.MKI,1CCN5<JSM@+D
M'@]!U[Y/:N8FUW6+B%X9M5OI(G&&1[AR&'H03S3@I\J)JNESRO=_U_F>LW\^
MDZ=X,\,ZA?60OI4LDCM[=SA,LB%F;UQM'^>1D6\&A^/]+U2"VT6WTS5K-#)$
M]N %D^N .XP<COD57T34]+\4>$;;0M2OTL+_ $\YMYY?N.GH3T'! Z]@>>:D
MM[C1_ .EZG-;ZS;ZGJ]\ABB6U(9(ASR2#ZG//ICUK*UE;[5SHYE)INW+;7;M
M]]S%\+^.(/#7AF]L!IXN;N:?S8VEP8APN-PZG!&?\*Z7POXJ/CRZFT#Q!8VL
MB2PLT,D2;2A'IDG!QR"/2N?\-S^']8\)S>'M4FM]-O5E\VWO7C #>S-^8Y(X
M(QTK4T2+P_X ^T:O+KEGJNH&(QV]O9L& )[DC..G7C SUS534==-2*4I^[>2
MY>IYU?VC6&HW5FS!FMY7B+ 8R5)&?TKM?AE>Q3W>H>'+MC]FU2W95YZ. >GN
M5)_[Y%</<W$EW=37,QW2RN9'/J2<FI-.OIM,U*VOH#B6WD61><9P<X^AZ5M*
M/-&QRTYJ$U+H=QX!TC^RO$&K:IJ:;8]#CDW]?]9R./7@-^8J+P'(;[Q=J/B2
M_P"4LH9KR5NP=L\?D6Q]*Z#XD:K:VGAJ..Q5HY->D6[F!!!V!$_+)"\?[U<Y
M9_\ $E^$U[<_=GUBZ$"%>OEIUS^(<?C6*;E%R?73^OQ.II0DHK:-W_E^A:^'
M[1/+XC\3WD*W%U80F>-6'&]M[$_7Y<?B:S+'XD^(X-62[N;]YX=X,MN57:RY
MY &...])X#\0V&D7%_I^K _V=J</DS. 3LX(!X[88_I6E;>#/#5G?K=WGB_3
M9]/B;>8HV!DD YVE02?RS3?*I/F1$7-PC[-V[ZE'XG:1;:1XP<6J"..YA6XV
M*  I)(./Q7/XU<^+O_(X1_\ 7JG\S6#XT\1+XF\237T2%+=5$4(8<[!GD^Y)
M)_&M[XN_\C?'_P!>J?S-5%-.*?9_H*;BXU'':Z_4X&BBBMSD"BBB@ HHHH *
M*** "I;?_6_\!;^515+;_P"M_P" M_*@"*BBB@ HHHH **** "BBB@ HHHH
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M\0U"Z^VZG=7>"//F>3!Z_,2?ZUU?P[\(#Q)JK7-VF=.M2#(#_P M&[)_4_\
MUZXNOH'PY9R>&_AM&]G;/+>&U-SY:H2SRLNX# Y/4#Z"G7FX1LNIGA::J5+R
MV6ISGQ(\<FQW^']'?RY NVYF3CRQC[B^AQU].GKCR&MF7PYXEGF>:71-5>21
MBSLUI(2Q/))XIG_"+>(?^@#JG_@')_A54U"$;)DUI5*LN9HR:*UO^$6\0_\
M0!U3_P  Y/\ "J5[IU]IKJE]97%J[C*K/$R$CU&16BDF8N,ENBM4MM_Q\Q_6
MHJEMO^/F/ZTQ$M__ ,? _P!W_&JM6K__ (^!_N_XU5H![A1110 4E+10 E%%
M%  *6DI: )5_X]9/]Y?ZU#4R_P#'K)_O+_6H:!A1110 4444 %%%% !1112
MFM/^/I/K_2GW_P#Q\GZ"F6G_ !])]?Z4^_\ ^/D_04!T*U%%% !1110 4444
M %%%%, J4?\ 'H?^N@_D:BJ4?\>A_P"N@_D: (J*** "BBB@ HHHI %%%% !
M3HO]:G^\*;3HO]:G^\* %E_US_[QIE/E_P!<_P#O&F4 %%%% !1110 4444
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M/6/^%U?]2_\ ^3G_ -KI/^%U?]2__P"3G_VNO***GZO3[&GUVO\ S?@CU?\
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M]-_A1_9U]_SYW'_?IO\ "M+_ (2F]_YY6_\ WRW^-'_"4WO_ #RM_P#OEO\
M&O2]KF'_ #[C]YX_L,I_Y^R_\!,W^SK[_GSN/^_3?X4?V=??\^=Q_P!^F_PK
M2_X2F]_YY6__ 'RW^-'_  E-[_SRM_\ OEO\:/:YA_S[C]X>PRG_ )^R_P#
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M^Z?;WH]KF'_/N/WA[#*?^?LO_ 3*_LZ]_P"?.X_[]-_A1_9U[_SYW'_?IO\
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M_6N:I4QJDU"":]3KHT<M<$ZE22EULKF5_9U[_P ^=Q_WZ;_"C^SKW_GSN/\
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MM%)17K'@"T444 %%%% !1110!+-]R+_<_J:BJ6;[D7^Y_4U%0 4444 %%%%
M!1110 4444 7M._Y:?A_6J3_ 'V^M7=._P"6GX?UJD_WV^M(?02BBBF(****
M "BBB@ HHHH *EF_Y9_[@J&I9_\ EG_US% $=%)2T %%)10 M%)10 M%%)0
MM2P])?\ </\ 2HJEAZ2_[A_I0!%1124 +1124 %%%% !1110 4444 2W'WD_
MW%_E452W'WD_W%_E45 !1110 4444 %%%% !1110!V'@G_D$:S_UT_\ :8KR
M:O6?!/\ R"-9_P"NG_M,5Y-7(_B9ZZ_A0] HHHH$7:***Z3A"MN#_CWB_P!P
M?RK$J['J.R-4\K.T 9W?_6HB[$U(M[&E16?_ &G_ -,?_'O_ *U']I_],?\
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MZ8?^/_\ UJ3^U_\ IA_X_P#_ %J7/$/8S[&G169_:_\ TP_\?_\ K4G]L?\
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M_P#3O_X__P#6H_MO_IW_ /'_ /ZU'/$/85.QK4^+_6I_O"L;^V_^G?\ \?\
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MJ.>/</J]3L=!8?\ 'R/H:;>?\?<GX?RK%A\0F&3>+8'V+_\ UJ277S+(SFV
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M?_\ K4?VW_T[_P#C_P#]:CGB/ZO4[&M2UD?VW_T[_P#C_P#]:C^V_P#IW_\
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M03;] !]_T_"F?VS_ -,/_'__ *U'/$/85.QJT5E?VS_T[_\ C_\ ]:C^V?\
MIW_\?_\ K4<\0]A4[&K165_;/_3O_P"/_P#UJ/[9_P"G?_Q__P"M1SQ#V%3L
M:M%97]L_].__ (__ /6H_MG_ *=__'__ *U'/$/85.QJT5E?VS_T[_\ C_\
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M@!:*2B@!:6FT9H =129HS0 M%)FC- AV:*;FC- #J*2C- "T4F:,T +1244
M+1244 +1244 +1244"%HI** %HHS29H =1249H 6C-)FB@!:*3-&: '44W-&
M: '44W-+0(6DHHH ****!A1124 +129HS0 M%)10 M%)10 M%)10 M%)1F@!
M:*3-&: %HI,T9H 6BDS1F@!:*3-&: %I*,TE "T4E% "T4E% "T4E% Q:2BD
MH 6BDHH 6BBB@ HHI,T@%HI** %HI** %HI** +]%%%=)PA5W2=)N];U.'3[
M*/?/*>/11W)/8"H+6UGOKN*UMHVEGE8(B*.237T!X*\(0>%M,P^V2_F ,\H[
M?[(]A^M1)V*2N>(>)?#=[X8U1K*[ 92-T4RCY9%]1_4=JQZ^EO$WANS\3Z2]
ME=#:X^:&8#YHV]1[>H[U\[ZOI%YH>IS:??1[)HCVZ,.S ]P:(RN-JQ1-%%=)
MH_@_^V--2\_X2/P]9;B1Y%[?>7*,'&2NTT-I;A&+EL<U172ZQX/_ +'TY[S_
M (2/P]>[2!Y%E?>9*<G&0NT=*/A]_P E T3_ *^EI<RM=%*#YE%G-4E>EZ]\
M4/%>F>+M5M8[^*6SMKV:)+>6VC*E%=@%) #'@#OFJGCC0(+^[\/:IH-B(F\0
M0;A9PXVK,-NX#L!\P].A-2IO2Z-'!:\KV//Z2NVD^&.J@745OJFC7=[:QM)+
M8V]WNG4+U&W;C(^M:>F^#].N/A3<ZBU]I*7TMXI%U+*V(D" ^43M^5\D\ <Y
M'-#J1$J4KGFU!KJ]/\ ZA>:7;:C=:CI.EP763;C4;GRFF [J,'BL;7]"OO#>
ML2Z;J,:I/'@Y4Y5@>A![BFI)NR$XM*[,VBO2?AMJ5WI'@SQK?V,OE74$-LT;
M[0VTYD[$$&M;P5XDUCQS_:NG>*!%?:0MG)(]S);HGD,,8(90 #R3Z\9[5+FU
M?38TC332UU9X_170Z%X-U'7;";45N+*QTZ%MC7E]-Y4>_CY0<$D\CM3-;\(:
MIH<EGO,%Y!>\6MS9/YL4QSC"G'7VQ5<RO8GE=KV,$TE=ROPMUAI_L?\ :FBC
M4]F_^SC>?Z1TW8VXQG'O6)H/A#5-?EO!$8+2&R&;JYO)/+CA[88X//![=J7/
M'N')+:Q@45ZF?#\^@_"'Q('O+&]AN+BV:*XLIO-C;$@!&<#D'VKF+'X?:C<Z
M7;:A>:EI&E0W8W6PU&Z\IIE_O* #QSWQ4J:93IM6.3HKJ8?A_K<GBQ_#DH@M
M[U8FF#2N?+= ,[E(!R#]/RK-\-^'+SQ1J,EC92P1RQP/.3,Q VKC/0'GFJYD
M+E>QD4E>D#P;IS?"2WU);_2HKZ6\$CW,LS?<$;D0#Y3A\GE1P2.O KS>DI)C
ME%QW"DHS15$A1249H&%%&:2D M%)FB@8M%)12 2B@FDI@%%%)FD M%)FES0
M44F:*"@HHI* %HI** "BBB@ HI** %HI** "BBDI#%I*** "BBDI@+1244#%
MHI**0!2TE% Q:*2B@ I:2B@ HHHH ***2@!:*2B@!:*2BD M%)FB@!:2BB@
MHHHH ***2@!:**2@!:*2B@!:*2C- "TE&:,T +1249H 6BDS1F@!:*3-% "T
M4F:,T +1249H 6BDHS0 M%)FES0 4444 %%%% !1110 M%)10(6BDYHH&+^=
M%)S10 M+3:.: '44VEYH 6BDHS0 M%)1FF M)110(6BDHH 6BDHS0 M%)FEH
M **2ES0 449HH 6BDS1F@0M%)FC- "T4F:* %I:;1F@!V:*3-&: %I:;FC-
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M P.*YLT4-7"+:V.DUC6O#%[ISP:9X1_LVZ)!6Y_M*6;:,\C:PP<CBCX??\E
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M +1244 +1244 +1244 +1244 +1244 +1244 +1244 +1244 %%%% !1110
M4444 %%%% !1110 44E'% "T4E% "TE%% !1110,**2B@!:*2B@!<T4E% "T
'G%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>img88009329_17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_17.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" -:!:@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBHY9/+7W/2@!SR+&/F-0FY/\*?G4(!=LMR34@2@!?M#_W11Y[_
M -U:=LHV4 )Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_
M -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_
M -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_
M -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_
M -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_
M -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_
M -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_
M -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_
M -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_
M -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_
M -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_
M -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_
M -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_
M -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_
M -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_
M -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_
M -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_
M -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W11Y[_ -T4[91LH ;Y[_W12>>_
M]U:?LI-E #?M#_W12BZ_O+CZ4%*8R4 65=7&5.:=5'YHVW+UJW&XD0,/QH ?
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4Y3OF/H.*
MN52 RY^M $J+4H%-45(!0 F*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB
M@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*
M,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB
M@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*
M,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB
M@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*
M,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB
M@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*,4ZB@!N*:14E-(H KNM);MME
M*]C4CBH4_P!>OUH NT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !5-?O'ZU<JFOWC]: +"]*>*8O2GB@!:*** "BBB@ HHHH **** "B
MBB@ HHKD/$7BC5M/\26NC:3IT%W-/"9?WLA7&#BA:NP=+G7T5Q1USQQ /,E\
M+6LJ#DK#=C=CVS6SX=\46?B**41));W<!VSVLPP\9_P]Z?*Q7-RBBBD,****
M "BBHYYH[:"2>9PD<:EF8]@* )**XRU\0>)]?5KO0K#3X=/R1%)?L^Z8#N O
M0?6M+0/$<VHW=QIFI6@L]4M@"\2MN1U/1E/I3Y6*Z.AHKF]=\1W5KJD&C:/:
M1W6IS+O/FL5CB3^\V.?PJC)XCU_0;NV'B.SL397#B,7-BSXB8]-P;M0E<&['
M944@(8 @Y!Y!K!\2^()= DTUA DEO<W AE<D@IGH122N[#Z7-^BD+ +N)XQG
M-<=X5\</XBUV]L)+188XLM X)_>*#@FFE<3=E<[*BLGQ+K7]@:#<ZB(Q(\8
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M>*UJ72X!1110 4444 %%%<EJWBK4&UI]%\.Z?'>7L2AIY9W*Q0Y['')-"UT
MZVBN&N_$GBSP\JW6O:5I\^GY DET]WS$#W(;J*[2VN(KNVBN(6#12J&5AW!I
MVTN*_0EHHHI#"BBB@ HHHH **** "BBB@ HHK)\2:TN@:)-?;!)(N%CC)QO<
MG % &M16!X3\1-XBTQYIX!;W<,ABFA!SM(K?IM6=A)W"BBBD,**** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "J:_>/UJY5-?O'ZT 6%Z4\4Q>E/% "T444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *IK]X_6KE4U^
M\?K0!87I3Q3%Z4\4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4AI:0T 1/4*?ZY?K4SU"G^N7ZT 7**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ JFOWC]:N537[Q^M %A>E/%,7I3Q0 M
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?]\M_P#%4?\ "PM3_P"?6T_[Y;_XJC^T:'?\ _L?%=E]YZ/17G'_  L+4_\
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M6I_\^MI_WRW_ ,51_P +"U/_ )];3_OEO_BJ/[1H=_P#^Q\5V7WGH]%><?\
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MUR_6@"Y1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY!&>XYKE:=*+2U0L1*,FN5W7:UK!7N'PO_Y$R/\ Z[R?SKP^O</A?_R)D?\
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M4O\ H'W?_?EO\*]IHH_LJ/\ ,']NS_D7WGBW]D:E_P! ^[_[\M_A1_9&I?\
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M4O\ H'W?_?EO\*/[(U+_ *!]W_WY;_"O::*/[*C_ #!_;L_Y%]YXM_9&I?\
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M@")ZA3_7+]:F>H4_UR_6@"Y1110 4444 %%%% !1110 4444 %%%% !1110
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M@#<HK#_X24?] ?5O^_ _^*H_X24?] ?5O^_ _P#BJ -RBL/_ (24?] ?5O\
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M@#<HK#_X24?] ?5O^_ _^*H_X24?] ?5O^_ _P#BJ -RBL/_ (24?] ?5O\
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M .*H W**P_\ A)1_T!]6_P"_ _\ BJTK"^^WP&46UQ;X.-LZ!6_F: +5%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8?B92U
MM;X!/[SM6Y00#U&::=F R'_4Q_[H_E3Z**0!1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %(:6D- $3U"G^N7ZU,]0I_
MKE^M %RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *IK
M]X_6KE4U^\?K0!87I3Q3%Z4\4 +1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !65KE]/8PPM P!9\'(S6K6%XG_ ./:W_ZZ4X[@;<9+1(QZD FG4R'_
M %$?^Z/Y4^D 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !2&EI#0!$]0I_KE^M3/4*?ZY?K0!<HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "J:_>/UJY5-?O'ZT 6%Z4\4Q>E/
M% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C(K_ 'E!^HI:S-9U
M"73X8GB"DN^T[A0M0-.BFQL6C5CU(!IU !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %(:6D- $3U"G^N7ZU,]0I_KE
M^M %RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *IK]X
M_6KE4U^\?K0!87I3Q3%Z4\4 +1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !6%XG_X]K?\ ZZ5NTR6&*8 2QJX'(W#--.S (?\ 41_[H_E3Z  !@=**
M0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_2NCKZC"-NA%OL?%XY)8F:7<****Z#E"BBB@ HHHH **** "BBB@ I#2TAH
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M*** "BBB@ HHHH **** "BBB@ HHHH \K\2_\C'>_P"__05E5J^)?^1CO?\
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M6LMM!:6LU_<7$1F2.#'^K_O$DTO_  E%D^APZG$LCB9Q%'#C#ER<;?J.?RH
MW**122H)&"1T]*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@#YZ\:?\ (YZK_P!=S6#6]XT_
MY'/5?^NYK!KZ&E\"]#XJO_%EZO\ ,****LQ"BBB@ HHHH ^A?!7_ ")FE?\
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MT@"JUW;13%)3#"]S$"8&D'W6Q5FL3Q!H4VJM:75G=FUOK1R\4A7<ISU##N*
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M +:U/_H7;O\ [^Q_XT?VUJ?_ $+MW_W]C_QK<HH P_[:U/\ Z%V[_P"_L?\
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M ^=?%<KS>*M2DEA:%VF),;$$K[<5C5O>-/\ D<]5_P"NYK!KZ&E\"]#XJO\
MQ9>K_,****LQ"BBB@ HHHH ]N\)ZKJ$/A738XM#N9D6$ 2+(@#>_)K9_MK4_
M^A=N_P#O['_C3?!7_(F:5_UP'\S6]7SU7XWZGVN'_A1]%^1A_P!M:G_T+MW_
M -_8_P#&C^VM3_Z%V[_[^Q_XUN45!L8?]M:G_P!"[=_]_8_\:/[:U/\ Z%V[
M_P"_L?\ C6Y10!A_VUJ?_0NW?_?V/_&F2>(;N  W.C3P \ O*O)].,UOUA>)
M_P#CVM_^NE-*[ 4:WJ1&1X>NR#T/FQ\_K1_;6I_]"[=_]_8_\:V8?]1'_NC^
M5/I 8?\ ;6I_]"[=_P#?V/\ QH_MK4_^A=N_^_L?^-;E% &'_;6I_P#0NW?_
M ']C_P :/[:U/_H7;O\ [^Q_XUN44 8?]M:G_P!"[=_]_8_\:/[:U/\ Z%V[
M_P"_L?\ C6Y10!A_VUJ?_0NW?_?V/_&C^VM3_P"A=N_^_L?^-;E% &'_ &UJ
M?_0NW?\ W]C_ ,:/[:U/_H7;O_O['_C6Y10!A_VUJ?\ T+MW_P!_8_\ &C^V
MM3_Z%V[_ ._L?^-;E% &'_;6I_\ 0NW?_?V/_&C^VM3_ .A=N_\ O['_ (UN
M44 8?]M:G_T+MW_W]C_QH_MK4_\ H7;O_O['_C6Y10!A_P!M:G_T+MW_ -_8
M_P#&C^VM3_Z%V[_[^Q_XUN44 8?]M:G_ -"[=_\ ?V/_ !H_MK4_^A=N_P#O
M['_C6Y10!A_VUJ?_ $+MW_W]C_QH_MK4_P#H7;O_ +^Q_P"-;E% &'_;6I_]
M"[=_]_8_\:/[:U/_ *%V[_[^Q_XUN44 8?\ ;6I_]"[=_P#?V/\ QH_MK4_^
MA=N_^_L?^-;E% 'DVMRR3ZS=2RP- [-DQL02O ]*SZU?$O\ R,=[_O\ ]!65
M7R-?^++U?YGWF&_@0]%^04445B;A1110 4444 =GX8U*]M=(\N#2)[I/,8^8
MDB@9XXY-;7]M:G_T+MW_ -_8_P#&H/!/_( _[;-_2NCKZO"?P(>A\/C_ />9
M^IA_VUJ?_0NW?_?V/_&C^VM3_P"A=N_^_L?^-;E%=)R&'_;6I_\ 0NW?_?V/
M_&C^VM3_ .A=N_\ O['_ (UN44 8?]M:G_T+MW_W]C_QK2L+J>Z@,EQ9R6C@
MXV2,"2/7BK5% !1110 4444 %(:6D- $3U"G^N7ZU,]0I_KE^M %RBBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M HHHH ^A?!7_ ")FE?\ 7 ?S-;U8/@K_ )$S2O\ K@/YFMZOGJOQOU/M</\
MPH^B_(****@V"BBB@ JM>6,-\B+,"0IR,'%6:J7^H1:>B/*&(=MHVT("TJA5
M"CH!BEI%8,H8=",TM !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!Y7XE_P"1CO?]_P#H*RJU?$O_ ",=[_O_
M -!657R-?^++U?YGWF&_@0]%^04445B;A1110 4444 >C>"?^0!_VV;^E='7
M.>"?^0!_VV;^E='7U>$_@0]#X?'_ .\S]0HHHKI.0**** "BBB@ HHHH ***
M* "D-+2&@")ZA3_7+]:F>H4_UR_6@"Y1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=[_O_P!!656KXE_Y&.]_W_Z"LJOD:_\ %EZO\S[S#?P(>B_(****Q-PHHHH
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M.N:$]F%M;'5* J!0<@#%+4-FCI90)*<R+&H;ZXJ:FQ+8****0PHHHH ****
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M45TG(%%%% !1110 4444 %%%% !2&EI#0!$]0I_KE^M3/4*?ZY?K0!<HHHH
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MA0%OKCFIJ9%_JDX(^4<'K3Z;W$M@HHHI#"BBB@ HHHH **** "BBB@ HHHH
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M $!(_P#P*'^%']I:[_T!(_\ P*'^% &Y16'_ &EKO_0$C_\  H?X4?VEKO\
MT!(__ H?X4 ;E%8?]I:[_P! 2/\ \"A_A1_:6N_] 2/_ ,"A_A0!N45A_P!I
M:[_T!(__  *'^%']I:[_ - 2/_P*'^% &Y16'_:6N_\ 0$C_ / H?X4?VEKO
M_0$C_P# H?X4 ;E%8?\ :6N_] 2/_P "A_A1_:6N_P#0$C_\"A_A0!N45A_V
MEKO_ $!(_P#P*'^%']I:[_T!(_\ P*'^% &Y16'_ &EKO_0$C_\  H?X4?VE
MKO\ T!(__ H?X4 ;E%8?]I:[_P! 2/\ \"A_A1_:6N_] 2/_ ,"A_A0!N45A
M_P!I:[_T!(__  *'^%']I:[_ - 2/_P*'^% '#^)?^1CO?\ ?_H*RJT-;DFE
MUFZ>XA$,I;YHPV[;P.]9]?(U_P"++U?YGWF&_@0]%^04445B;A1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \K\2_\C'>_[_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "J:_>/UJY5-?O'ZT 6%Z4\4Q>E/% "T444 %%%%
M')>();K6M0ET2QL[.00('N)[M-ZIGD +W.*R=(5=(\,V>NVFDV!92?MACB"-
MLSC<OTK;U*UU72M:N-4TNT6^AND59[??M<,HP&4GCI6%IMMXDO/#T>@-I#6$
M3Y6>YGD!^0G)"@=Z41OS/0HI%FA25#E74,/H:?4<$2P01PK]U%"C\*DILE;:
MA1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^>O&G_ ".>J_\ 7<U@
MUO>-/^1SU7_KN:P:^AI? O0^*K_Q9>K_ #"BBBK,0HHHH **** /H7P5_P B
M9I7_ %P'\S6]6#X*_P"1,TK_ *X#^9K>KYZK\;]3[7#_ ,*/HOR"BBBH-@HH
MHH ***Q?$<LD5O 8W929,'!II78&U13(CF%"?[HI]( HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \K\2_P#(
MQWO^_P#T%95:OB7_ )&.]_W_ .@K*KY&O_%EZO\ ,^\PW\"'HOR"BBBL3<**
M** "BBB@#T;P3_R /^VS?TKHZYSP3_R /^VS?TKHZ^KPG\"'H?#X_P#WF?J%
M%%%=)R!1110 4444 %%%% !1110 4AI:0T 1/4*?ZY?K4SU"G^N7ZT 7****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JFOWC]:N537[Q
M^M %A>E/%,7I3Q0 M%%% !1110!S0>[U3QC/!]KD@M-."'R8SCS689RWM3O%
M<%S;VAUFSO98)K)-QCW?NY5SR&%0ZI9QW7B%FTO5A8:RL0#H5#+*G;*GKCVK
M/U6SO(H4;Q3XAC>RWC%K;0;#,<\*>I/TI+9#ZG:6LWVBUAFQCS$#8^HJ6F1;
M?*38,+M&!Z"GU3W)6P4444AA1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '
MSUXT_P"1SU7_ *[FL&M[QI_R.>J_]=S6#7T-+X%Z'Q5?^++U?YA1115F(444
M4 %%%% 'T+X*_P"1,TK_ *X#^9K>K!\%?\B9I7_7 ?S-;U?/5?C?J?:X?^%'
MT7Y!1114&P4444 %8WB&WEN+> 11LY$F3BMFBFG8!D0(A0'J%%/HHI %%%%
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M?K5RJ:_>/UH L+TIXIB]*>* %HHHH ***QO$6JSZ5!9/ %)GNXX6W#^%LYH
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M:)HBZ0EPS7#W-S<R>;-,X +-]!T%:M(8AS@XZ]JQ6F\2[CMM-/QGC,C5MT4
M8?G>)O\ GTT[_OXU'G>)O^?33O\ OXU;E% &'YWB;_GTT[_OXU'G>)O^?33O
M^_C5N44 8?G>)O\ GTT[_OXU'G>)O^?33O\ OXU;E% &'YWB;_GTT[_OXU'G
M>)O^?33O^_C5N44 8?G>)O\ GTT[_OXU'G>)O^?33O\ OXU;E% &'YWB;_GT
MT[_OXU'G>)O^?33O^_C5N44 8?G>)O\ GTT[_OXU'G>)O^?33O\ OXU;E% &
M'YWB;_GTT[_OXU'G>)O^?33O^_C5N44 8?G>)O\ GTT[_OXU'G>)O^?33O\
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M,2:TND8L+>T>'S&YE<@YX]*VO.\3?\^FG?\ ?QJ@\$_\@#_MLW]*Z.OJ\)_
MAZ'P^/\ ]YGZF'YWB;_GTT[_ +^-1YWB;_GTT[_OXU;E%=)R&'YWB;_GTT[_
M +^-1YWB;_GTT[_OXU;E% &'YWB;_GTT[_OXU:5@U\\!-_'#'+G@0L2,?C5J
MB@ HHHH **** "D-+2&@")ZA3_7+]:F>H4_UR_6@"Y1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %4U^\?K5RJ:_>/UH L+TIXIB]*>*
M %HHHH *IZCJ4&EPK-<+)Y1;:SHA8)[G':KE4=5U.VTJS\^Y#,&8(L:+N9V/
M8#O0P*FLZJ4\-7-_ILR2$("DB?,%!(!/X#)_"N:O(+?3]*;5+7Q3<RWBJ'4-
M<AUE;^[L]^E!FC_M!3!97VA3W+;4,J!H)CZ,H. 35NUCTK2[Y6U?0[:RN=WR
MW<:9B8^N?X3]:$!UUM(\MK%)(NUV0%AZ'%2TBLKH&1@RD9!!R#2T,2V"BBB@
M84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!\]>-/\ D<]5_P"NYK!K>\:?
M\CGJO_7<U@U]#2^!>A\57_BR]7^844459B%%%% !1110!]"^"O\ D3-*_P"N
M _F:WJP?!7_(F:5_UP'\S6]7SU7XWZGVN'_A1]%^04445!L%%%% !6'XF5FM
MK?:I/[SL*W*0@'J ?K33LP&P_P"IC_W1_*GT44@"BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#ROQ+_R,=[_O
M_P!!656KXE_Y&.]_W_Z"LJOD:_\ %EZO\S[S#?P(>B_(****Q-PHHHH ****
M /1O!/\ R /^VS?TKHZYSP3_ ,@#_MLW]*Z.OJ\)_ AZ'P^/_P!YGZA11172
M<@4444 %%%% !1110 4444 %(:6D- $3U"G^N7ZU,]0I_KE^M %RBBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *IK]X_6KE4U^\?K0!8
M7I3Q3%Z4\4 +1110 5E:[ID^HP0/:2K%=VTHFA+C*DX(P1Z8-:M% '+-8>(=
M7GMX]6%C;VD,JRL+<LS2%>@YZ"NFEBCFC:.5%=&&"K#(-/HH ;'&D,:QQJ%1
M1A5'0"G444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'SUXT_Y'
M/5?^NYK!K>\:?\CGJO\ UW-8-?0TO@7H?%5_XLO5_F%%%%68A1110 4444 ?
M0O@K_D3-*_ZX#^9K>K!\%?\ (F:5_P!<!_,UO5\]5^-^I]KA_P"%'T7Y!111
M4&P4444 %96N7T]C#"T# %GP<C-:M87B?_CVM_\ KI3CN!MQDM$C'J0":=3(
M?]1'_NC^5/I %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB9I7_7 ?S-;U8/@K_D3-*_ZX#^9K>KYZK\;]3[7#_P */HOR"BBBH-@HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO_%EZO\ ,^\PW\"'HOR"BBBL3<**** "BBB@#T;P3_R /^VS?TKHZYSP3_R
M/^VS?TKHZ^KPG\"'H?#X_P#WF?J%%%%=)R!1110 4444 %%%% !1110 4AI:
M0T 1/4*?ZY?K4SU"G^N7ZT 7**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ JFOWC]:N537[Q^M %A>E/%,7I3Q0 M%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*AN_^@G#_P!^S_C1_P *AN_^@G#_ -^S_C1]=I!_9.)[+[SS6BO2O^%0W?\
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M *"%K_W[/^-'_" ZK_T$+7_OV?\ &C^S,1V7WA_;.%[O[CF:*Z;_ (0'5?\
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MVL+Q/_Q[6_\ UTII78&XC;T5O49I:9#_ *B/_='\J?2 **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2TAH B>H4_U
MR_6IGJ%/]<OUH N4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!Z-[UHVWB37)M22VE\*W<4!DVFX,JD >N*?9(7=LKM#XFUS4[TB]DTBS@?9
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M!<.O54;G\J34/$6CZ3*(K_48()#T5VY_*N'OM/UN76-*O$T:PTR2"8#S([@
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M=(U*74%N4GA$4UO*8G"MN4G /!_&J1\0SR:E-;6UJDBP2B)U,H$AZ98+Z<T
M;]%<HNN7T-WJMU-"'MH94MX4#_QY'\]P_*M74-=BTZ[:&5"52W:=V!Z<@ ?4
MDT :U%<IJ&HZI/<:=:RV?V<7,P<%),G:OS%6_*M&'7Q<6VG-%!NGO&(\K/W
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M [=*[!1M4 DG QD]Z;%*DT2RQ.'1QE6!X(I],0R6&.>,QRH'0]0:<JA5"J,
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MB3>,KENH]?I1<:G8VF//NHH\@,-S=0>] &6UO=PWL6JZO=0"&VB91'$AP&;
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MO'ZT 6%Z4\4Q>E/% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB@ HHHH YY](N;/Q@FJV2J8+J/RKM,XP1]UA6\D4<6[RXU3<<G:,9-/HHZ6
M8D4<6[RXU3<<G:,9-/HHH 9+%'-&8Y45T/56&0:AM=/L[+/V6UAASUV(!FK-
M% %9M.LG8LUG;ECR28ER?TJ.>W%I93MI]K$+@H=BJH7<>V35VB@#%\+Z*VBZ
M2(IF#W<SF:X<=W;DUM444, HHHH **** "BBB@ HHHH **** "D-+2&@")ZA
M3_7+]:F>H4_UR_6@"Y1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %4U^\?K5RJ:_>/UH L+TIXIB]*>* %HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ K"\3_\>UO_ -=*W:CE@BG $J*X!R,BFG9@+#_J(_\
M='\J?0   !T%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "D-+2&@")ZA3_7+]:F>H4_UR_6@"Y1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %4U^\?K5RJ:_>/UH L+TIXIB
MT\4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4A
MI:0T 1/4*?ZY?K4SU"G^N7ZT 7**** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ JD#AS]:NU3E&R8^AYH F4U(#4"-4H:@"3-%,S2YH =1
M3<T9H =13<T9H =13<T9H =13<T9H =13<T9H =13<T9H =13<T9H =13<T9
MH =13<T9H =13<T9H =13<T9H =13<T9H =13<T9H =13<T9H =13<T9H =1
M3<T9H =13<T9H =13<T9H =13<T9H =13<T9H =13<T9H =13<T9H =13<T9
MH =13<T9H =13<T9H =13<T9H =13<T9H =13<T9H =13<T9H =13<T9H =1
M3<T9H =13<T9H =13<T9H =13<T9H =13<T9H =13<T9H =13<T9H =13<T9
MH =13<T9H =13<T9H =13<T9H =13<T9H =13<T9H =13<T9H =13<T9H =1
M3<T9H =13<T9H =13<T9H =13<T9H =13<T9H =13<T9H =13<T9H =13<T9
MH =13<T9H =FFDTF::6H :YJ%.9U^M.=J+9=TI;L* +=%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5'+&)%QW'2I** *'S(<,,&I ]6
M717&&&:A-J/X6(^M ";Z-]'V9O[]+]F/]^@!-]&^E^S'^_1]F/\ ?H 3?1OI
M?LQ_OT?9C_?H 3?1OI?LQ_OT?9C_ 'Z $WT;Z7[,?[]'V8_WZ $WT;Z7[,?[
M]'V8_P!^@!-]&^E^S'^_1]F/]^@!-]&^E^S'^_1]F/\ ?H 3?1OI?LQ_OT?9
MC_?H 3?1OI?LQ_OT?9C_ 'Z $WT;Z7[,?[]'V8_WZ $WT;Z7[,?[]'V8_P!^
M@!-]&^E^S'^_1]F/]^@!-]&^E^S'^_1]F/\ ?H 3?1OI?LQ_OT?9C_?H 3?1
MOI?LQ_OT?9C_ 'Z $WT;Z7[,?[]'V8_WZ $WT;Z7[,?[]'V8_P!^@!-]&^E^
MS'^_1]F/]^@!-]&^E^S'^_1]F/\ ?H 3?1OI?LQ_OT?9C_?H 3?1OI?LQ_OT
M?9C_ 'Z $WT;Z7[,?[]'V8_WZ $WT;Z7[,?[]'V8_P!^@!-]&^E^S'^_1]F/
M]^@!-]&^E^S'^_1]F/\ ?H 3?1OI?LQ_OT?9C_?H 3?1OI?LQ_OT?9C_ 'Z
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>img88009329_18.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_18.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" /$!LD# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !6/XL_Y$W7/^P?<?^BVK8K'\6?\
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M1)B+/0YIHL\-+<",G\ K?SK1T/XQ:-J=TEO?VLNG,Y $C.)(\^YP"/KBO/O
MOB+PII%O/!X@T1+N623<ERT*S;5P/EVMT[G(]:Z2W\+_  \\6:T9=/UF2U\W
M&+&/$1W?[.\<YXX&>_X-QBN@DV>R @C(Y%%5["S33M/M[*-Y'C@C6-6D.6(
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MXQL/\Z@U'XRZ39VEL;>RDNKN6%))8DD 2)F4$H7QR1G' _PKA/B[_P C]/\
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MV<:R7UXAPZ0D!4/H6/?Z UI?$#6I="\&7]W;L5N& AB8?PLQQGZ@9/X5XAX
M\*IXM\1FWNG=;2&,S3E3RPR %!]R?R!JHQ5KL4GT1W4/QR@:8"?0)$B[LET&
M/Y%1_.O0O#OBG2?%%F;C3+C<5_UD+C;)']1_4<5S^L?"KPW?:6\%C9"RN@O[
MJ9'8X/;=DG(]>]>-^#M6N?#?C*SE#,@\X07" ]4)PP/KCK]0*?+&2T%=IZG:
M?%'QR;HZAX6&G[!%,F;GSL[L8;[NWCKZUR/@CQ@/!NH7-W_9XO#/$(P/-\O;
MSGKM/I7I'Q;T#2H/#<^K1642W\EQ&'G&=QSQ_05R/PET/3-<U;4(M3LX[I(X
M%9%?/!W=:I6Y1._,>U>']6_MW0+/5/(\C[3'O\O?NV\XQG S^5:=065E;:=9
MQ6EI$L-O$-J1KT45/6)H?.GQ8_Y*%??]<XO_ $!:]F^'W_(@Z-_UP_J:\9^+
M'_)0K[_KG%_Z M4;0^.(-(BGLI->33@F8V@DE$87VP< 5LU>*,T[-GK?Q:LM
M+;P9<W=S%$MZCH+>7:-Y8L 1GN-N>/;VKSKX0>;_ ,)Y'Y?W?L\GF?[N!_7%
M<B;F]UR_ACOM2=W=MHFO)F94SW).<"OH'P)X%M?"-I)*9EN;ZX4"2=1A0O4*
MOMWSWI/W8V!>\[G0:QK6GZ!I[WVI7"PP+P">2Q] .YKS:[^.-HDQ%GH<TT6>
M&EN!&3^ 5OYURGQ9UR;4_&$MCO/V:P B1,\;B 6/USQ^%;?AJ;X7Z;HT":C<
M17=\Z!IWFM9FPQ'*J-N !TXZTE%)78W)MZ'5>'/BSHNMW:6=U%)I]Q(0J>:P
M:-CZ;N,'ZBN_) &3P*^9/&L?AD:LDWA>Y,EI*F9(MCJ(GSVW@'!'U[UZUH6J
M7_B#X.W+H[/?I:36^[JSE00/Q*X_&B4>J!2Z$&M_&31].NGM]/M)=19#@R!Q
M'&3['!)^N,?6L^S^.-G),JWFB301D\O%<"0C\"J_SKR_PQJ.F:5KL%WJ^G"_
MLTSNA.#SV.#PV/0\5Z%J$OPR\6+!'%,NASJWWDMA$&&.AP-GIR:;BET%S-GK
M.DZM9:WIT5_I\ZS6\@X8=0>X([$>E>>Z_P#%_P#L/7KW3/["\_[-(8_,^U[=
MWOC8<?G76^#_  OIOAC3I$TN\GN8+DB3?)(KJ3C&5V@#G^@KP3Q[_P CYK/_
M %\M_2E%)L<FTCU?7_C!I&DWDEK86LFHO&2KNKB.//H#@D_7&/K3=!^,6DZI
M>);:A9R:<TAPLAD$D>>V3@$?EBE\&?#/0X?#]K=:K:+>7ES$LK>83B,,,A0/
M;N?6O/\ XG>$;7PMK%M)IZE+*\1F2,L3L92-P!/..5/XT)1>@-R6I]#@@C(Y
M%<KXJ\?Z-X4<07+/<7A&1;PX+ =BQ/"_S]JQO GB>3_A5D^H7#>9)I:2QY;/
MS;%#*#^#**\?T/3KKQCXO@M9YW,U[,7FF/) Y9C^0./PI*&KN#EV/1A\<XO-
MP?#[^7G[WVL9_+9_6NW\+^.M&\5@QV<K17:C+6TP ?'<CG##Z?I5-_A;X3;3
MC:+IS(V,"<2MY@/KG./PQCVKPN[BO/!WBZ6.&;%SI]Q\DB\;@.A^A'4>]-*,
MM@NUN?17BWQ%_P (MX?EU7[+]J\MU7RO,V9W''7!_E7':7\9M-NK:[GU&P:S
M$(7RTCF\UYF.> -JXQCJ3CFKOQ,NEOOA>UX@PD_D2J/0,0?ZUY=\-_#-MXG\
M3_9[X%K2WB,\J!L;\$ +D<]3^0HC%<MV#;OH=J?CE#Y^!H$GE9^]]J&['TV?
MUKT+PSXITWQ7IQN]/=@4.V6&08>,^X_D:XCXE>"M!L?!MQJ-A816EQ:-&0T0
MQO#.%(/K][.?:N<^"<SKXKOH W[M[$NP]2'0#_T(T-)QN@NT[,]9\2^*]+\*
M62W&HRMND)$4,8R\A'7 _J>*\]D^.<0E(B\/NT?9FNPI_+8?YUB_&J.Y7Q9:
M229-NUH!$>P(9MP^O(_,4[PGXH\"6VA0V&M:!']J4$27+6RR^9[[OO#Z#IVI
MJ*M<&W>QZ!X6^)NC>)KI+(I)97K_ '(I2"KGT5AU/L<5VC,J(SNP55&22< "
MO)/#W@7P1J^IF\TGQ!<3-')YT4$3B-H\'(X9=V!ZUJ?&36YM.\.6^G0.4;4)
M&60@X)C7!(_$E?PJ6DW9#3=KL36_C+HVGW+0:=:2ZB4.#('$<9/L2"3]<?G5
M33_C=I\TZI?Z1/:QDX,D4PEQ[D86N'\!KX,A,]WXIN@9%8+!;-%(RXQRQVJ<
M^F,]CQTK4\;2?#R^T=IO#\\<&I1$%(XK>5%E&<$'*X!QSGCI5<JO:Q-WN>X6
M-_:ZG917EE.D]O*,I(AX-6*\9^"6L3"]U#1G<F$Q?:8U)^ZP(5L?7</RKV:L
MY*SL6G=!1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^_F 49X&> /90/R KK_B'\/E\-Z987]@"\"1K!=M_P!-/[_T;I[<>M=C\,?
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M@ &:^?\ _A5OC/\ Z W_ )-0_P#Q=6+#X9>,(=1M99-(VHDJ,Q^TPG !!/\
M'3DD^HDVNA]$4445D:'@_P :_P#D<K/_ +!Z?^C)*] ^$O\ R3^T_P"NLO\
MZ$:YWXH>#/$'B+Q-;7>E6'VB!+-8F?SHTPP=SC#,#T(KB?\ A5OC/_H#?^34
M/_Q=:Z.-KF>J=SWG6O$VD:!9R7%_>PH4!Q$'!=SZ!>I-?-9%WXJ\4-Y29NM1
MNBP4= 7;/Y#/Y"NBMOA-XOGD"R6,-N,_>EN$('_?))KU+P1\.K3PFQO)Y1=Z
MDR[?-VX6,'J%']?Y4*T0UD1_$37+GPAX+M;?3',<TA6UCEQS&@4Y(]\ #\:\
MR\$>"9?'<][=7FIO$D#*'8CS))&;/J>.G4U[3XQ\+P^+=!?3Y)/*E5A)#+C.
MQQD<^Q!(_&O'X/ASX^T6]8Z8KH3\IGM+U8PP]\L#C\*46K>8Y+4;\1/!FC^#
M[33X[*YN)KN=F,GG.I^4 <@ # R:['X(_P#(O:E_U]C_ - %<U>?";Q1<Z;-
MJ-W=+=ZHS+MMS-N9AGDM(Y R/3)^M=?\*_#^O>&X]1M=7TXV\4Q22.3SD?)&
M01A6/M^5.37+N)+4X#XN_P#(_3_]<(OY5[)X%8-X%T4@@C[*@XKD/B7\/=1\
M0ZG%JVD".2;RA%-"[A2<9PP)X[XY/85@>#/ /B[2?%.G7UU9B"VMY=SYN4/R
MD$' 5CV)H=G'<>J9D?$OQ5J6J>)K[3/M$D>GVDIA6!&PK%>"S>ISGKTKK=)^
M"MA]EBFU759W<J'=;?:JCC.-QSD>]'CWX6WNK:Q-J^B/$SW!W36TC;3N_O*3
MQSW!Q_A@6O@'XB7ELFFW%Q-:V(&WRYK_ '1A?3:K'CVQ1=6T8K:ZHXB\BM8?
M$<\5DQ:T2[98&)R2@?Y3GOQBOJ^OGW5?A+XEL]1:+3;;[=;*JE;@2QQY.!N^
M5FR,'->]V4D\MC;R74)AN&C4RQ$@[&QR,@D'GTI3:=K#BK$]>*?$7Q=XLT+Q
M3<6$&I/!9,JRV^R) 2I'][;DX.1U[5[77.>,/!UAXOTX0W!\FYBR8+E5R4/H
M1W!]*F+2>I4E=:%/P'XQL_$6@VJ37D?]IQ((YXG8!V8<;@.^>O'<U5^)^I:*
MGA"]M+V:W>[=<6\.09!)D8('48[GTX[UYI?_  B\56LS+;06]ZF>'BG5<CZ.
M118_"+Q7=2A;B"WLT[M+.K8_!,U=HWO<F[M:Q'\)8I9/B!:/&#LCBE:3 _AV
M$?S(K0^-?_(Y6?\ V#T_]&25ZCX-\$V/@^R=87,]Y,!YUPPQG'91V'^?3'&?
M%#P9X@\1>)K:[TJP^T0)9K$S^=&F&#N<89@>A%"DG*XK-1.J^%O_ "3C2?\
MMM_Z.>O//C;_ ,C/I_\ UYC_ -#:O3_ .E7NB^"M/T_4(?)NH?,WQ[@V,R,P
MY!(Z$5QOQ2\':]XCUVSN=)L/M$,=MY;-YT:8;<QQAF'8BE%KF&U[II_#FU:^
M^%#VB'#3K<1 GU8L/ZUX[X7U!= \8:?>7:LJ6UQB8$<J.5;CVR?RKWOX=Z/?
MZ%X/M[#4H/(N4DD9DWJV 6)'*DBN>\<_"Q==O9=4T>:."\D.Z:&3(20_W@1T
M)^F#[4*2NTP:=D>BQW=M+:"[CGB:V9=XE#C:5]<],5\U>/M7M]=\::A>V;;[
M<LL<;C^,*H7(]B0:T3\,/&RYMUT_,)/.+N/8??&[^E=KX,^$ATV^BU+7I8I9
M8B'BMHOF4,.A8D<X]!^=-6CK<3O+0[;0]$$7@2ST6[7&ZR$,RD="R_,.?<FO
MGO3+^Y\):_>JP(FCBN+1P.,,590?P;!_"OJ.O%O'_P .==U+Q=<W^C:>)[:Y
M59&(FC7#XPPPS ]L_C2@]7<<EV*_P>T*/4I-;N+A086M?L>3_P!-,[L?@H_.
MN*LM1N?#DNM6/S+)/;R6,@]#O ;/X!A^->[_  W\.77AKPHMM?0B*\FF>65
MP;;V R"0>%!_&O/O&WPW\0W_ (OO[W2=.$]I<.)0_G1K\Q W##,#][-4I+F8
MFG9%CX):1YFH:CJ[KQ"@MXR?5N6_( ?]]5Z)XMU_PWIEG]A\1.#%=(<0F%GW
M@'G&!QCCN*9X \/S>&_"-M974?EW;,TLZ[@V&)Z9''0*/PI_C/P?:^,-)6VE
MD\FYA):WG SL)Z@CN#@?D*AM.6I25D>>V?PR\.^++ ZEX<U>YMX&9E\J>,2;
M&!Z'D$=CR3UKA?%OA6[\'ZM'97-Q%,9(Q+')%D<9(Y!Z'(-=&OPX\>Z)</\
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MIS-&GF8P?NELCFO;]4TY=<\/W-A<*T/VN HP."8R1[<$@_RI3:NF.*>IX?\
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M9XY8 B'S4?)W9_A8UZE4SW''8^>OB[_R/T__ %PB_E7L'P^_Y$'1O^N']37
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MOO\ KG%_Z M>S?#[_D0=&_ZX?U->>?$+P)XEUSQE=W^G:;Y]K(D85_/C7.$
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "OF+Q[_P CYK/_ %\M_2OIVBJC+E%)7*6C_P#($L/^O:/_ -!%7:**D844
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1137=8X
MVD<X5022>P% #J*Y""XUCQ--)):W)L+!&VJR_>;_ .O^(JQ)H&M6R>9::]/+
M*O(2;)!_,D?I7(L3*2YH0;7?0[G@XP?+4J)2[:Z>KL=/16+X>UF35()8KE!'
M>6[;95 QGWQ^!J:>ROW\0VUY'<[;&.,K)#YC#<WS<[>AZC\JUC64H*<%=/\
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MEYXOCT^'4+FUC>'=^[<@ @$] 1Z5G6J^R2=KW=C3#T/;2:;LDF_N.OHKFO\
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M>,)TXV;[?U?YEOQ$Q?PE<,QRS1H2?Q%6- 8+X=LF8@ 0@DGM577_ /D4)_\
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M1_2M91=&I"TFTW9W=^ASQG&O2GS12<5=65NJ1G:]:ZI'JVE"XU!)7DG(@81
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M6MPEW:Q7$9^25 Z_0BN:\#_\>E]_UW_I6KX:_P"1=LO]S^IK*\#_ /'I??\
M7?\ I6[DY5*4GU3_ "1S*"A1KQ71K\V=51117:><%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *9+%'/$T4J*\;##*PR"*?11
MN"=M4<\W@[3MY,4UW I.=D<O'Z@U>TW0;#2G,EO$3*>#)(=S?_6K3HK&.'I1
M?-&*N=$\77G'EE)V"BBBMCG"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ JG<:;#<7]O>EI$G@R R$#<I_A/'(JY12E%25F5&<HN\6%%%%,D****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "JU_9+J%F]K)))&C\,8R 2/3D&K-%*24E9CC)Q:D
MMT,AACMX4AB0)&@"JH["GT44TK W?5A1110(**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HK+UK;BS^T?\>?G_Z1GIC:<;O]G=C-48;CRDNX;!E$$\P2T*_=7Y1O9?\
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MY2R;5<-_"PP>0#VZ=:A_X1WQE_T/?_E(A_QH\??\RO\ ]C!:?^S5V% ''_\
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MU#?:!I]S;E3%);H5V]!\HX_#I7)^/'6X\3^#["+#7/\ :2W&WN(T(+'^?Y4
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MQ3XDN="\.6(LD\_5;]H[>U5N<NP'S'UQ_,BJT/@C5V@$]SXSUG^TB,EHI0(
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M "BBB@ HHHH *X_Q]_S*_P#V,%I_[-785Q_C[_F5_P#L8+3_ -FH ["BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#(UG8MS82W(S91R,9<C*AMORDCTS5
M=KVUD\2V!LF5Q*LD<TD?W6PNX#(X)&#],UJWQO$6*2T <HV9(20/,7'0$]".
MM5HXKF\U.*ZG@:WBMU81HS*69FX)."0!CW[URSB^?3NGMZ=?Z_$[:<XJG[W1
M-;][]/5_EV*5F+Q(KB8Z.K[YI)#YD@5R"QQ@8/;'4BIYIHYY=+U&**22T57X
M2,L4) P=HYXP1QZU(DVJV\3P-:?:90Q\N?S%56!)P6'48XX -6=/M?[-TN*
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MGP-;V4:/#!"_)9(%VH"3VJJ+FY>]\_ZL375-1]SRMM^.OYEJBBBNDXPHHHH
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M-%NIW\\!L+)( -BL<],D?F?2J/C32-*T'4= F\/VT5IK;7J)%#;#:98SG=N
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M'6L6EVN>!,/]6_UQQ] : .WHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ K)\3?\B]=?\ _]#%6]1ANI[0I9W @
MER#O(SQZ5S6L6&KP:5-)=:BLT(V[D Z_,,=O7%5%:@=+I7_('LO^O>/_ -!%
M6ZJ:5_R![+_KWC_]!%6Z3W ****0!1110 4444 %%%% ''^/O^97_P"Q@M/_
M &:NPKC_ !]_S*__ &,%I_[-784 %%%% !1110 4444 %%%% !1110 4444
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ML>$_^1-T/_L'V_\ Z+6@#8KB-0_Y+)I'_8,D_P#0FKMZXC4/^2R:1_V#)/\
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M#'##&D<4:A$1% 55'   Z 4^B@ J!K*U>\2\:VA:Z12BSF,%U7T#=0/:IZ*
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MHHHK<Y0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M (JC[5-_SX7'_?4?_P 518"S15;[5-_SX7'_ 'U'_P#%4?:IO^?"X_[ZC_\
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MG1DI;69Z%1117U)\4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI#+!+(PC4_>8@KRP'0=,]34/_"+'3)M*N-":.*6T'D3B9B!<PDY;<0#\V[+
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MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N/\ 'W_,K_\
M8P6G_LU=A7'^/O\ F5_^Q@M/_9J .PHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *6L?\@2__P"O:3_T
M$U=JEK'_ "!+_P#Z]I/_ $$U=J%\;]%^IH_X:]7^@44459F%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3K^MZ?XHL8=&T6X6\N+BYA9S$I(@1)%=F<X^7A<8/.36CHO_ ".WBC_MT_\
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M_P!1A$%ROVNY<M&[E5.V/@+D 9.T=QZ5T/@S_CVUG_L,WG_HPUTM% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7'^/O^97_ .Q@M/\
MV:NPKC_'W_,K_P#8P6G_ +-0!V%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!2UC_D"7_P#U[2?^@FKM
M4M8_Y E__P!>TG_H)J[4+XWZ+]31_P ->K_0****LS"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M LT56\N^_P"?BW_[\'_XNCR[[_GXM_\ OP?_ (N@"S15;R[[_GXM_P#OP?\
MXNCR[[_GXM_^_!_^+H LT56\N^_Y^+?_ +\'_P"+H\N^_P"?BW_[\'_XN@"S
M15;R[[_GXM_^_!_^+H\N^_Y^+?\ [\'_ .+H LT56\N^_P"?BW_[\'_XNCR[
M[_GXM_\ OP?_ (N@"S15;R[[_GXM_P#OP?\ XNCR[[_GXM_^_!_^+H LT56\
MN^_Y^+?_ +\'_P"+H\N^_P"?BW_[\'_XN@"S15;R[[_GXM_^_!_^+H\N^_Y^
M+?\ [\'_ .+H LT56\N^_P"?BW_[\'_XNCR[[_GXM_\ OP?_ (N@"S15;R[[
M_GXM_P#OP?\ XNCR[[_GXM_^_!_^+H LT56\N^_Y^+?_ +\'_P"+H\N^_P"?
MBW_[\'_XN@"S15;R[[_GXM_^_!_^+H\N^_Y^+?\ [\'_ .+H LT56\N^_P"?
MBW_[\'_XNCR[[_GXM_\ OP?_ (N@"S15;R[[_GXM_P#OP?\ XNCR[[_GXM_^
M_!_^+H LT56\N^_Y^+?_ +\'_P"+H\N^_P"?BW_[\'_XN@"S15;R[[_GXM_^
M_!_^+H\N^_Y^+?\ [\'_ .+H LT56\N^_P"?BW_[\'_XNCR[[_GXM_\ OP?_
M (N@"S15;R[[_GXM_P#OP?\ XNCR[[_GXM_^_!_^+H LT56\N^_Y^+?_ +\'
M_P"+H\N^_P"?BW_[\'_XN@"S15;R[[_GXM_^_!_^+H\N^_Y^+?\ [\'_ .+H
M LT56\N^_P"?BW_[\'_XNCR[[_GXM_\ OP?_ (N@"S15;R[[_GXM_P#OP?\
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M "BBB@ HHHH **** "BBB@ KC_'W_,K_ /8P6G_LU=A7'^/O^97_ .Q@M/\
MV:@#L**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L
M36?".B>(+N*ZU.S::>)/+1Q/(F%SG'RL/6MNB@##TGP?H>AWOVS3[-XI]I3<
MUQ*_!Z\,Q':HY?!'AR:^>\DTN-I7?S'7>_ELWJ4SM)_"N@HIW8K(BNK:*\M)
MK:<,8ID*.%8J2",'D$$?A52[T+3+[2XM-N+1&M(=OE(I*^7M^Z5((((]0<UH
M44AE+3-)L=&M3;6$ AB9S(PW%BS'JQ)))/'4FKM%% %+6/\ D"7_ /U[2?\
MH)J[5+6/^0)?_P#7M)_Z":NU"^-^B_4T?\->K_0****LS"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#QCQ/X=\8Z
M%8WVL7'C"=+5'++&EY/N.6PJ@=,\BDT[P;\1-1TJ&^_X2BX@\Z,2)%)?S;L$
M9&<9 ->C^-_#Y\2^%KG3DE6*8E7A9SA=X/ /UZ?C7GMKK?Q/T:S32AH8N/)4
M1I.UN9" .!\RMM/U-:)MHAJS-/X6RZR=:UJUUK5;NXN;3$3VUQ.TFTY^\I)(
M(X(X]O6O4*X/X=^%M5TJ;4=:UYO^)EJ# LFX$J,Y.<<9)/0= *[RIEN5'8**
M**D84444 %%%% $-U:07L/DW$8DCSG:?6L#7M&T^TT6XG@ME21=N&!/&6 ]:
MW;V]@T^W\^X<K'D#(!/-<[KFOZ?>Z//;P2LTC[< H1T8'^E5&]P-_2O^0/9?
M]>\?_H(JW532O^0/9?\ 7O'_ .@BK=)[@%%%%( HHHH **** "BBB@#C_'W_
M #*__8P6G_LU=A7'^/O^97_[&"T_]FKL* "BBB@ HHHH **** "BBB@ IDL2
M3(4D0,I[$4^BC<$[:HS6T.S+9 =1Z U;M[2"U7$,87/4]S4]%1&G"+ND:2JS
MDK2844459F%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %<?X^_YE?_ +&"T_\ 9J["N/\
M'W_,K_\ 8P6G_LU '84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI*2>S*<9+5H6BBBF2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %<?X^_YE?\ [&"T_P#9
MJ["N/\??\RO_ -C!:?\ LU '84444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% %+6/^0)?_ /7M)_Z":NU2
MUC_D"7__ %[2?^@FKM0OC?HOU-'_  UZO] HHHJS,**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%%%=9P!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH I:Q_R!+_ /Z]
MI/\ T$U=JEK'_($O_P#KVD_]!-7:A?&_1?J:/^&O5_H%%%%69A1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !7E_BO_ )&:\^J?^@+7J%>7^*_^1FO/JG_H"UY>;?P5Z_HSV<C_
M -XEZ?JC&HHHKY\^J"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K<\(_
M\C-:_1__ $ UAUN>$?\ D9K7Z/\ ^@&M\-_&AZK\SFQG^[U/1_D>FT445]:?
M"A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MAJ2D-.X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!2
MUC_D"7__ %[2?^@FKM4M8_Y E_\ ]>TG_H)J[4+XWZ+]31_PUZO] HHHJS,*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *\O\ %?\ R,UY]4_] 6O4*\O\5_\ (S7GU3_T!:\O
M-OX*]?T9[.1_[Q+T_5&-1117SY]4%%%% !1110 4444 %%%% !1110 4444
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M_P"O:3_T$U=JEK'_ "!+_P#Z]I/_ $$U=J%\;]%^IH_X:]7^@44459F%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %>7^*_P#D9KSZI_Z M>H5Y?XK_P"1FO/JG_H"UY>;?P5Z
M_HSV<C_WB7I^J,:BBBOGSZH**** "BBB@ HHHH **** "BBB@ HHHH ****
M"MSPC_R,UK]'_P#0#6'6YX1_Y&:U^C_^@&M\-_&AZK\SFQG^[U/1_D>FT445
M]:?"A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <3\5UMW\!
MW0N)&C/F(8B%SEP> ?8\BN9T'XG>$[/1+2UN=(EAFAB5'6*W1E) QD'(//7F
MO2/$4^D6NB7%UKD,$MA" [I-$) 3G PIZG)P/K7F9\??#<'_ )%+/_<-M_\
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M%A".&8@9 ![&H]$UNTUVP6ZM6YZ21D_-&WH?\:S?$OB?^RBEC81BYU2; CB
MSLSW/^%7&$^?E6Y%2K2]ESM^ZR?PQKUEJ]@(K:(6TMNH1[4GF,#@8]16GJ.H
MVNE6,EW=R!(D'XD]@!W-<?XFTR2P@B\36TD5AJ<84SQAODD8]0/4_P ZI:/Y
MGCS5S<ZG-&MK: %;)&ZGU^GJ?PK;V,9?O$_=Z_Y'(L54A^X:O/IV:[OMYK[C
MLO#^L/KFF_;'M)+8%R$#'.Y>Q%:M<WKVO7/AV]LR;%6TAEV22(/F1NP Z 8_
M.M^WN(;NWCN+>19(I!N5U/!%83B_B2T9UTJB?[MN\EOT^9C^)O#D6NV@=&$-
M]#\T$XX(/7!/I_*N*BUW5_%/V;PZTL4+EBMQ<*XS*J^F.OX=?89K6US7;OQ%
MJ1\/Z"<QGY;FY'3'?!_N^_?H/>YJ'@2T&DP)I9,&H6OS1SYP9&Z_,?Y>E==-
MJG%*IOT\O,\^M%UIRE06B^+^]Y+_ #^1T6G:39Z7IJV%O"OD 88,,[\]2WKF
MN(U+S_ &K"YL&673;PG-H[X*L/3O^/X'M6A9>/(K;2YTU>-HM3M?D:'&#*>Q
M'I[_ )TFB:#<:]=MKOB&,.9!BWM6'RHGJ1_(?C4PC*FY2J[?G_7<NK.%90CA
M_B6W]WU_*POA72'U:<>)=6D2>XE.8(P<K$ >/Q'8=OKT[6O/;E;_ , 7DLMH
MAN='N,X1R?W3XXR?Z]Q[UN>%O%D>NH;>Y58-009,8^ZX]5_PJ*\)2_>+6/Y%
MX6M3I_N9:3Z^;[W\SIJ*S=;UNTT&P:ZNFR3Q'&#\TC>@_P :C\.7VHZCI2W6
MI6R6\CL2BKGE.V0>E8<DN7GZ';[6/M/9]36HHHJ#0**** "BBB@ JU8?Z]O]
MW^HJK5JP_P!>W^[_ %% &A1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% %+6/^0)?_\ 7M)_Z":NU2UC_D"7_P#U[2?^
M@FKM0OC?HOU-'_#7J_T"BBBK,PHHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR_P 5_P#(S7GU
M3_T!:]0KR_Q7_P C->?5/_0%KR\V_@KU_1GLY'_O$O3]48U%%%?/GU04444
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MAP]>->'/$^4Q6%GAJGLY!1116YS!1110 4444 %%%% !1110 5SOBW_F!_\
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M[O\ 455JU8?Z]O\ =_J* -"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!1_:-E_S^6__ '\%6:* *W]HV7_/Y;_]_!1_:-E_S^6__?P59HH K?VC9?\
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MGQ"S/"ZAXF/4J1D9]^Q]Q4T]JXT>R4]3)*X^AV#^:FMR'2YGTRR9D.%@Y9N
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M/6CPS_;?]I2?V#_Q]>2=_P!S[F1G[_'7;[U%H,^KVMS<W&CMMEBMF>9L(<1
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M=84444 %%%% !1110 4444 %6K#_ %[?[O\ 455JU8?Z]O\ =_J* -"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *6
ML?\ ($O_ /KVD_\ 035VJ6L?\@2__P"O:3_T$U=J%\;]%^IH_P"&O5_H%%%%
M69A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !7E_BO_D9KSZI_Z M>H5Y?XK_Y&:\^J?\ H"UY
M>;?P5Z_HSV<C_P!XEZ?JC&HHHKY\^J"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ K<\(_P#(S6OT?_T UAUN>$?^1FM?H_\ Z :WPW\:'JOS.;&?[O4]
M'^1Z;1117UI\*%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
MXK\.A;+\4-9&I[?[0WS>3YO7S/,^;&?XL?IFO8=12S?3KA=06)K/8?.$N-NW
MOG-<7XQ^&5KXDOCJ=C=&PU XWMMRDA'0G!R#[C\JYG_A4GB6\98=0\2(]MGD
M;Y)/_'3@?K5NSUN0KK0/@L&_M?7?LY<V6U,9]=S;<^^,U['6/X:\-6'A;2EL
M+!21G=)*_P!Z1O4_X5L4I.[N4E9!1114C"O/?&WQ6MO"VN1:#INCW6N:TZAS
M:6Q(V C(!(5CNQS@ \>E>A5X3X!8W7[27BZ6?YWC@N A/\.)8D'_ ([Q0!Z#
MX!^(]AXZ%W;BSGT[5+(XN;*<Y9><9!P,X/!R 0>W2NUKPK26^P?M6:K! -L=
MQ 1(/7-O'(?_ !X9KW&:>*WC\R:5(TZ;G8 ?K0!!J-D-0M# 9I(LD'<AYXKF
MM8\/BQTJ:X^VW$FS;\CG@Y8#^M=+_:NG?\_]K_W^7_&L#QGXCT73_#-Q+=:I
M:QHS(B_O0<G<#@ >P/Y546T!8L/^0=;?]<D_D*L5QEG\3/!D=E;H_B"T#+&H
M(^;@X^E3?\+.\%?]##:?^/?X4F!UM%<E_P +.\%?]##:?^/?X4?\+.\%?]##
M:?\ CW^%(#K:QM2_Y&71/^V__H K+_X6=X*_Z&&T_P#'O\*R[[XC>$)=>TF=
M->M6BA\[S&&["Y4 =J<=P/0:*Y+_ (6=X*_Z&&T_\>_PH_X6=X*_Z&&T_P#'
MO\*0'6T5R7_"SO!7_0PVG_CW^%'_  L[P5_T,-I_X]_A0!UM%<C_ ,+1\$_]
M##:_]\O_ (4?\+1\$_\ 0PVO_?+_ .% '745R/\ PM'P3_T,-K_WR_\ A1_P
MM'P3_P!##:_]\O\ X4 ==17(_P#"T?!/_0PVO_?+_P"%'_"T?!/_ $,-K_WR
M_P#A0!UDL1GMYH5^])&Z#ZE2/ZUR&FL+=7M+I6^SNV[<!S&_3/T]1_A3_P#A
M:/@H'_D8;;\G_P *K2>-_ VHW68/$=A%,Y^82L40GUW$ #\:X<70E-J<=T>E
M@,5&FI4Y[,VAI#R+NA"S)V:,[A_]:I;NTBCMH/MTB6\N?+B:0X#@=CZ8]3[5
MFP:AH\EI<WEEJ.GZA]F"C9;7*38=L[=VTG X)YZ[35)C+J6DF:20R2I=,TA/
M7YU7!^GR&N"HU3]WEUML>I2C*K:?-[J=KFT-'F8 K$64]&7D'\1Q56YEM-)R
M[M'-=+]R%3N"GU?'8>G4UA?8F]#1]B;T-<SK:>[&S.N.'5_?G=>EOU+=Q&-2
MM4U  "?>8[C:,!FZAL>XSGW'O546+D@ $D] *W-)L1'I,[S21Q)),H4RN%'R
MAO7_ 'J?]NTJS=@+HM<8.R6.+>D;>O.,GZ9%/V*:4INUQ+$.+<*:O;^OP+<N
MEO*P\L"7RT2-C&0V&50I!QT.13H=!D;YY8V6,=0!EC[ ?XUS,VF,$\^.9;B%
MC_K4)//H<\@_6H/L3>AJW62>L/Q_X!"P\G&RJ?A_P3K+B"$SL;@H#%&2EJCC
M?M49Q[>I)]ZYFZCFO+J2XE^^YR<# 'H![ <5)9-::29]1U&Y2ULH(F\V:3.U
M=XV#./=A4W]N^%]N_P#X2?0]N,Y_M"+/Y;L_I5^RGB(<RCU,O;4\+/E<KNPF
MBV#MK-H0#\D@<_1>3_*NUKB+7XC^ [%6">(;9Y6X9PCXQZ#Y:G_X6IX(_P"A
M@M_^^'_^)KT\%A_80:>[/&S#%K$U$ULCL**X_P#X6IX(_P"A@M_^^'_^)H_X
M6IX(_P"A@M_^^'_^)KL. ["BN/\ ^%J>"/\ H8+?_OA__B:/^%J>"/\ H8+?
M_OA__B: .PHKCC\5?! _YF"#\(Y/_B:3_A:_@?\ Z&"'_OU)_P#$T =E17&_
M\+7\#_\ 0P0_]^I/_B:/^%K^!_\ H8(?^_4G_P 30!V59VLZS#HEM#--#<3>
M=,L*) @9BQ!(X)'I7/?\+7\#_P#0P0_]^I/_ (FLG7/B#X5U7^S?L.L13?9+
MZ*ZGQ&XV1+G<W*]LBKIQ4I),QKR<*;E'<L>+_%4-UX?GL'TS4[66XV^6;J 1
MJ=KJ3W_SD58UG7++6_)L)M+\10SPNMT@@MPLHQD!N23C)Z^M<SXT\5Z'XG^P
M_P!C:@EW]G\SS=JL-N[;CJ!UVG\JUO\ A8/A7_A+?[8_MB+^S_L/V7S_ "WQ
MYOF;MN-N?N\UV+E5.,DN[_(\UNI*O.#E_*MN]V8^JWFGZCI$[6USXDNFA*-F
M\=7AC).,MCH2-P'O6#J=REWJ,T\<EU)&Q^5[J3?*0!@%CZ\?ATYZTZUU>*RT
MR^TZ6]L[<7WE@).'+RE#D!-H(!R0/FQU%4O,M$XN;^WMI&XBCEW[ICZ+M4C/
M3J1U%=\.6%[O;];'CU.>KRV6Z_*_Z&G<7B-);744>HI&)VD9Y+O>6?Y2Q5M@
MVOTR>3]VFVUYCQ#;WMO!<3,+E)5BDE\R21MP."P49)/MW[U0,\9B6 WJ&56+
MBTRVX*< R=-N#@#KG@<41RB*1)(+@>;&028R0T3#D#/KC!X]1WZ6E&UEZ&;E
M.]WY,V/#.O\ _".:E)>?9OM&^$Q;/,V8R0<YP?2JEK.EK92N8KU9)P\0FAN/
M+C88&58;#N'()&1P1TZU0S&>$E1V'#JN<H?0Y'7&#QG@CW%/-Q;R1+#;ZE#=
M&,DR01%_W#' (8,H&3C'&?N_2DU#F\W^@U*IR6Z1_"]C5M9'MM+98[754:ZC
MDS)%<;(I@H.25V?,JC.?F]>E6K%IDMA8PZ?KQ\Z'S7A@NRJRJ0 7V"(_*>G?
MTR:H#Q S65G:6\]I<1V<<\.8U?*-*"'5LXRPSVX]S5VS\<1Z?>P7IU/28Q;V
M2V!>6.<HI4YV-@9W\<D?+[UC.5E?]3II0O)1N]++9=?^#<=I"PS/=Z7<6VO&
M+>SM;64@8C! P\949(QRW'(' KJ]/TFR\1_;+*74/$R>1L\Z"^F SNR5^7!]
M,\^U>?-K]I_:5SJ</B:TMEN'8O=0&=$WL=QCX3=[],<=<UI:/XAT&&:ZN=8\
M87D GV>3<VDLH%QMR&R2FX[>!R!WQ65646G)2MU_(Z,/":DH2A=7:[=&['I/
MBW_F!_\ 87M__9JZ*O*5\5?#_P"TVTTWC;4KG[/,LR).TCKN4Y'!C_SFNB_X
M6SX&_P"@_%_WXE_^)KSYN/*DG>Q[=*,^:4I*U[':45Q?_"V? W_0?B_[\2__
M !-'_"V? W_0?B_[\2__ !-9&YVE%<7_ ,+9\#?]!^+_ +\2_P#Q-'_"V? W
M_0?B_P"_$O\ \30!VE%<7_PMGP-_T'XO^_$O_P 31_PMGP-_T'XO^_$O_P 3
M0!VE%<4?BWX%'_,?C_"WE_\ B:3_ (6YX%_Z#Z?^ \O_ ,10!VU%<3_PMSP+
M_P!!]/\ P'E_^(H_X6YX%_Z#Z?\ @/+_ /$4 =M17$_\+<\"_P#0?3_P'E_^
M(H_X6YX%_P"@^G_@/+_\10!VU<MXOUZ&VMSI$$"WE_=KL$&-P4'N1_(?C5(_
M%OP*00/$"#/<6\O'_CE8&A>-/A_I%U/>S^)1=WTSDF>2VER 3_N]?6M:3A%\
MTNG0Y\0JDDH0Z[OLB6PL+SP'J%O?W]M'<6LZ!))(QEH">P]_YUW6I>(M.TW1
MUU)YUDBD&80AYE/H/\\5S=Q\5/A_=V\EO<:U%)%(-K(UM+@C_OBN4T[7OAS9
M:K]HF\3_ &FUB):WMY+:;"$GO\O/Z5JZD*OO5-U^)SQH5</[E#6+[]/\RZ=!
MU4C_ (2@:? %\[S_ +#L_@ZYQ_GUKT'3/$>G:EH[:DLRQ11KF97/,1]#_3UK
M _X6YX%_Z#R?^ \O_P 17(:EKOPYO=5^TP^)A;6\C!KBW2VFPY]OEX_*FZL*
MVE32VW^0HX>IAM:/O7W3[]_^ :M_8WGCW4;B_L+:.WMH$*1R2##3D=B?7^5=
M/X0UZ&YMQI$\"V=_:#8T&-H8#N!_,5F6_P 5OA]9VZ6\&M1QQ1C:JK:S8 _[
MXK%USQO\/-7NK>]B\2FSOH6!$\5I-D@=C\G7T-)UHS7)+1=/((X6I1?M8.\G
MOY^G:QZM17#_ /"W_ G_ $'A_P" LW_Q%+_PM_P)_P!!Y?\ P%F_^(KE/1.W
MHKB/^%O^!/\ H/+_ . LW_Q%'_"W_ G_ $'E_P# 6;_XB@#MZ*XC_A;_ ($_
MZ#R_^ LW_P 11_PM_P "?]!Y?_ 6;_XB@#MZ*XC_ (6_X$_Z#R_^ LW_ ,11
M_P +?\"?]!Y?_ 6;_P"(H [>BN(_X6_X$_Z#R_\ @+-_\11_PM_P)_T'E_\
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M_P#/C:_]^5_PH_LO3_\ GQM?^_*_X5;HH J?V7I__/C:_P#?E?\ "C^R]/\
M^?&U_P"_*_X5;HH J?V7I_\ SXVO_?E?\*/[+T__ )\;7_ORO^%6Z* *G]EZ
M?_SXVO\ WY7_  K*U6[T?3)# FFVL]P!\R^6H5/J<<GVK>DE\B&6;&?*C:3'
MT!/]*\T=WDD:1R6=B2Q/<FO-S#%2HI1ANSU\JP4,1)SJ;+H;@N4U72[N&.SM
M;9XV27%NFW<HRISZXW#\ZKZ>TMA.7""2-QMDB;HZ_P!#W!JA9W4MC<I/%C<O
M!!&0P/4'V(KJ+%+/5MQM&\N0+N>"3JOT;H1D_6O,IR=>2;?O?F>S5C'#1<4O
M<?X?UW)(;2VN_P#CUF4G&?+D^5A_0_A33;645TEO/=1B5I!&(HR';<3C!QP/
MQJGKI;3+5+2,A9;@%I&4\[.@7([$YS]!1="PL==%]<S2&1IEN!!&GS)DAOG)
MZ?3D_2MY2479I75K_,YHPE)<RD[.]K;Z&7K-\;R^9$^6VA)2% > N>OU/4UG
M5JW6EF"ZDCZ@-\I'<=C^(J'[ ?2N"I"<I-RW/3I5*<8)1V$TF[^RWR!^8)2$
ME4]"I[_4=1]*ZI-)5YVA$\&Y2<C>">.O YKG+72S/=1Q= S<D]AW/Y5W(MXK
M>:9T&9)6+,_L3G ]J]# 49334EHCRLSQ$:;3@]6C.OI=-T:P"31B;S#D1D#,
MA'<YZ 5SO]OP^9G^QK#R\]-G/Y__ %J@\0SO<:Y<[LXB;RE'H%X_Q/XUEX/I
M6-?'5%-QI.T4=&&RZDZ:G67-)ZL[K3FTG5(&D@LX%=?OQ-&N5_3D>]7/[.LO
M^?.W_P"_2_X5QOAZ=[?7+;;G$K>4P]0W'^!_"N[KUL#B77IWENCP\RPD<-5M
M#9ZE;^SK+_GSM_\ OTO^%']G67_/G;_]^E_PJS17:><5O[.LO^?.W_[]+_A1
M_9UE_P ^=O\ ]^E_PJS10!7%A9@\6D ^D8_PI?L5I_SZP_\ ?L5/10!!]BM/
M^?6'_OV*/L5I_P ^L/\ W[%3T4 0?8K3_GUA_P"_8KGO%5K;I_8FR")=VK0*
M<(!D?-Q7452U/2;'6;9;>_@\Z)7#A=[+AL$9X(]35TY*,DV95X.=-QCN<]XC
MTJQO?$WA^SGMD,$OVG>B_)NP@(Y&#U%4?^$3T3_A-O[/^Q?Z+_9WG^7YK_?\
MS;G.<].W2MK_ (03PW_T#?\ R/)_\51_P@GAO_H&_P#D>3_XJNB-:,8J*D]O
MZ>YQ3PM2<G*4(MMI[^25OA//_#.DV.H:)K]Q=0>9+:6V^%M[#8VUSG@\_='6
MD\.)?2:%K@LX-/,:0%KB2X#F3:5;A,< C#?B?RW-'T?PH9-4CU0VL<D.H2Q1
M++=F,B,8QQN&1UYIMAI?A&3Q!J\5Q):"SC\G[*6O"%.4)?#;OFY]SBNR55/F
MWZ/;T\SS:>'E%4VFENM]>N^GR.7V77_"&^9MMOL?]H;=V#YWF>7TSTVX_'-)
M-!--X6M[TP6HB@N#:K(I?S6.&DP1G;CYCSC/ I\6BV4FF:?=-K%NDMU<B&6
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MX%2T4 1BWA'2&,?111Y$7_/)/^^14E% $?D1?\\D_P"^11Y$7_/)/^^14E%
M$?D1?\\D_P"^11Y$7_/)/^^14E% $?D1?\\D_P"^11Y$7_/)/^^14E% $?D1
M?\\D_P"^11Y$7_/)/^^14E% $?D1?\\D_P"^11Y$7_/)/^^14E% #1&@& B@
M?2C8G]U?RIU% #=B?W5_*C8G]U?RIU% #=B?W5_*C8G]U?RIU% #=B?W5_*C
M8G]U?RIU% #=B?W5_*C8G]U?RIU% #=B?W5_*C8G]U?RIU% #=B?W5_*K=@
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ K<\(_\C-:_1__ $ UAUN>$?\
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MUJBLGP]K?]N6<[R6K6MU:W#VMS 7W^7(N,X; W @J0<#@UK4 %%%% !1110
M4444 &U7!1_N."K?0C!KC;C27MIWB=>5/7U'K794CK',H6:,.!T/0CZ&N3%8
M95DGU1W8+&/#MKHSBOL'M6_H.G_9(9;AQAI0%3_=!R3^>/RK26TM4.1"6/\
MMMD?TJ8L6.36.'P*ISYY=#HQ>9.K3=./4R-9MA'(FJE=WV6!@ 1D!]WR9_%\
M_A7#LS.Y9F+,QR23DDUZ)J)MY+-[.:94>Z&R)2?O,#D?AD=:X\Z<58JRD$'!
M!'2N',:7[SW?Z9Z64UK4??WZ>G_#W)-/UB)85MK]'=$&(Y4Y9!Z$'J/Y5K0R
M:7.Q6.^0D(SD>6X.%!)[8Z ]ZQ/L'M5VQL/)BN;EAP(FB7W9QC^1)K*E*HK1
M:3-Z\*3O*+:?EW(-0UB(PO;6".J.,23.,,P] !T'KZUN>%KM[K2GA<EFMF !
M_P!@]!^!!KG?L'M6KIX.FSZ?"!^\NKE68>D>"@S]=S?E5X:I4C64Y;;?U\S/
M&4J4\.Z<-]_N_P" .UO2\7[W"K^[G.[/HW<?G_.LW[![5V_!4HZAT/56Z5#]
MCM-V?*;Z;^/Y5VU<OYIN4>IYM#-7&"C/H8&B:7_IZ7#+^[@.[/\ M=A^?\JZ
M2EX"A$4(@Z*O2DKLP]!48<J.#%XJ6(GS,****Z#E"BBB@ HHHH **** "BBB
M@ HHHH X&TT.YUZ]U:X6[LH%BU":$*VEPRDX.<EB,D\]ZP]-T^*76-7ANM7T
MRR:WF$0:>R@*R[2RY56P%Z#./7FNX\)?\QS_ +"]Q_[+7)+:->Z\]G";6*2Z
MU6^5II;2.<@(J,!\PZ<GN.M>E";O*/1>2]>QX=6E%1A-*[;?5Z]%UTW,RSBB
MBT;391JFF![BY$,D,MG [P*6;+LS98@8!YQP1S66J*GAEY1=6OF/=>6;8PH9
M=NT-O#GY@N1C XZ^IIT<EN+72XS>VXS,6G!L5+6X#<%FQF4$$G;TXQZ59U&X
MM3J5I!#J-I/:[T=[E-+2+RSD@Y4+EP!SCH:ZTFG_ ,#_ (!YC:<?E;?NEY_\
M#O8V->?1XO!VCR6(TXZ@IA:41K&TG$9SO'<;L9![]:YRX1;?2M*N8[JUEE8R
M,8!"FZ+##&\]7!Z@,.G'2H[Z^:YMX%+6K%AO<16<<)1LL-NY5!(Q@^G/M5UX
MYY-%!9[41BR%QA;.-7XG\K&\#=GC.<\]#ZT1CR)7?4=2HJLFTNGY6UW+&MV\
M=I<W<<&L65RC62EFMH(HUD_?+^[PAQN& V>N!Z5?_LVT_P"$D\C_ (2#2/+^
MR;_M/V.W\K._&S;G;N[YZX]JTO\ A'+O_A&_[7^VV'_'I]J\K^R(/[F[;G'X
M9Q63_95Q]I^T?:+3?_8O]H8_LZ+;C.=FW&W/^WC-8J::LI?A_P  Z94I1E=P
M>MGOTU_O&MIBZ3:^)&M+^_T2^LS:&43?9;>)1)O VY'?&3C/?I6SX8^Q?\)-
MXA_L_P"S_9?]&V?9\;/N-G&..N?QK.T?3["Z\26 FL+1EET*.=T^SH%,A<9;
M:!C-=G:Z?96._P"QV=O;[\;O)C";L=,X'/4UR5II775K]3TL+2DVI:63?>^U
MOU+-%%%<9Z84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5:L/]>W^[_455JU8?Z]O]W^HH T**
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH I:Q_R!+_\ Z]I/_035VJ6L?\@2_P#^O:3_ -!-7:A?&_1?J:/^&O5_H%%%
M%69A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !7E_BO_D9KSZI_P"@+7J%>7^*_P#D9KSZI_Z
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M** "BBB@ HHHH **** "BBB@ HHHH X?1?$ND:-<ZU;W]WY,K:I.X7RW;*Y
MSP#Z&L&PUW38/$T%Y)<[8%U&]G+[&.$D10AQC/)!XZCO7JU<IXGO[;3/$WAZ
M\O)/+@C^T[GVDXR@ X'/4BNRE4C*32B[M/KY>AY=>A.$(MR5HM=/-;ZF#XF\
M2Z1J&MZ!<6MWYD5I<[YF\MQL7<ASR.?NGI5?6M6L=9\?Z+<6$_G1*\"%MC+A
MO-)QR!ZBM74O%FB7'B;0[R*]W06OG^<_E.-NY %XQDY/I1_PEFB?\)M_:'VW
M_1?[.\CS/*?[_F;L8QGIWZ5M%.*5H/1/\_0YJDHSE+FJ1UDOP2UW^1BZ)_QX
M2_\ 8NW7_H]ZQOM]M_9/D>9^\_L[R-NT_?\ M7F8_P"^><]/QK9\)Z[INF:A
M9RWESY:1Z<\#'8QPYG9P.!_=(.>E4]+U:QMK21)9]K'19[4#8Q_>M*[*O3T(
M.>E;V:D].O\ F<=XN$5S+9K\O,Z;_A+-$_X0G^S_ +;_ *5_9WD>7Y3_ '_+
MVXSC'7OTK%_MW3?^?G_F7?L/W&_UW]WI^O3WK:_X2S1/^$)_L_[;_I7]G>1Y
M?E/]_P O;C.,=>_2C_A+-$_X0G^S_MO^E?V=Y'E^4_W_ "]N,XQU[]*PC%QV
M@]_ZZ';.:E:]2.B_I?$'A2_MK[Q)9?9I-_D:$D$GRD;75UR.>O7KTKO*SO#_
M /R+>E_]>D7_ * *T:XJTE*>AZF%IN%-7=[ZA11161T!1110 4444 %%%% !
M1110 4444 %%%% !1110 5R>MZWJGA[7$N;E!-HDP"?NU^:)NY)]?T(]ZZRJ
MVH"T.GSB_P#+^R;#YOF?=VU=.24M5=&->$I0]V5FM?\ A_(!J%H=/^WBXC^R
M;-_FY^7;ZUSFC:WJGB#76N;1!#HL(*?O%YF/J/?^5<$3C(!O_P#A&/M?^?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5Y?XK_P"1FO/JG_H"UZA7E_BO_D9KSZI_Z M>7FW\%>OZ,]G(
M_P#>)>GZHQJ***^?/J@HHHH **** "BBB@ HHHH **** "BBB@ HHHH *W/"
M/_(S6OT?_P! -8=;GA'_ )&:U^C_ /H!K?#?QH>J_,YL9_N]3T?Y'IM%%%?6
MGPH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6"-WS?*=V>./2MHJ2CK)]?R]?N.:;A*=E"*^'KW:\OD_(['_ (03PW_T#?\
MR/)_\55+3-)L=&\?M;V$'DQ-I9<KO9LMYH&>2?05!H5KI%IXZ>/16A:V.F%F
M,4WF#?YHSSD\XQQ6I_S4C_N$?^UJYFYJZ<FU;J=T8TVHRC!)J5M/\[(Z*BBB
MN0](**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD];T;5?$.N+:
M7+"#1(0'_=MS,?0^_P#*NGBN8)I)8XIHW>([9%5@2A]#Z5+5PFX.ZW,JM*-:
M/*WI^?D5?[.L_P"S_L'V>/[)LV>5CC%<[HFB:IX>UQ[:V<3:),"_[QOFB;L
M/7]"/>ND^W6GVW[%]IB^U;=WD[QNQZXJQ34Y133Z_P!7)E1A.2DMX]OR"BHI
M;F""2*.69$>9ML:LV"YQG ]:EK,VN@HHHH&%%%% !1110 4444 %%%% !5JP
M_P!>W^[_ %%5:M6'^O;_ '?ZB@#0HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@!"2%) )('0=Z\UTK_ (33PCX3^T3:=I;6]J9+BY@,K&=E
M+%F8,#L& >G/ ]>*](FC$T,D19U#J5W(VUAGN#V-<5)X>\72Z*_A]]5T]]/=
M3"U\X=KDPG@@J?E)QQG-4A,L7#7\VLZ?XJTG3?[0M[G3/*\GS5BD3<1(K98X
MP>A[_6N<TNX&ER:78ZA')<)I<SJEM:+N,U](6<JN< B)'ZY !/M7HALYK#01
M8Z2(Q+!;B&V\]CM!5<+N(!]!VK E\)7-G9Z))I4\+:AI<CR%KG(6X:12)2Q
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MH^TS?\^,_P#WU'_\55FB@"M]IF_Y\9_^^H__ (JC[3-_SXS_ /?4?_Q56:*
M*WVF;_GQG_[ZC_\ BJ\V\3L7\1W;,C(25^5L9'RCT)%>I5Y?XK_Y&:\^J?\
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M=L..#@]<>E &?15/_A'=;_Z&3_R13_&MV.RC6%5?YY H!?IDXZXH SJ*I_\
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MBBB@ HHHH **** "BBB@ HHHH **** *6L?\@2__ .O:3_T$U=JEK'_($O\
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M_P#Z :PZW/"/_(S6OT?_ - -;X;^-#U7YG-C/]WJ>C_(]-HHHKZT^%"BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MWK?OKN*PL+F]F)$5O$TKX_NJ"3_*OF>_\4'6_%?]LZW:M>P!LBS6;RU"C[J
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M\;C_ +Y7_&MF&59X(Y5!"NH8 ]<$9KSBO0M/_P"0;:_]<4_D*F22&6****@
MKR_Q7_R,UY]4_P#0%KU"O+_%?_(S7GU3_P! 6O+S;^"O7]&>SD?^\2]/U1C4
M445\^?5!1110 4444 %%%% !1110 4444 %%%% !1110 5N>$?\ D9K7Z/\
M^@&L.MSPC_R,UK]'_P#0#6^&_C0]5^9S8S_=ZGH_R/3:***^M/A0HHJIJM[_
M &;I%Y?>7YGV>%Y=F<;MH)QGMTII7=D)M)79;HKRS_A<3?\ 0"'_ (%__84?
M\+B;_H!#_P "_P#["NCZG6[?D</]IX7^;\'_ )'J=%>6?\+B;_H!#_P+_P#L
M*/\ A<3?] (?^!?_ -A1]3K=OR#^T\+_ #?@_P#(]3HKRS_A<3?] (?^!?\
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M19H[>)8D+G)(4 #/OQ5BLY.\FS:FG&*3"BBBI+"BBB@ HHHH **** "BBB@
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M 'H?_9Z]/KQ,7_&E_70^MRW_ '6'S_-A1117,=P4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%>(?%#XVQ:='_97@^^634%<>?>
MI&KQQ =57<"&)[G&!ZYZ 'M]%<YI&OF+X;:?XBU:4NPTF*]NI H!8^4'8@#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ[Q5_P @V+_KL/Y&N1K6&P@HHHJ@"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ KT+3_^0;:_]<4_D*\]KT+3_P#D&VO_ %Q3^0J)@6****S&%>7^*_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0Q%2A+FINS.+_P"$ _ZB?_D#_P"RH_X0#_J)_P#D#_[*NTHKG_L[#?R_B_\
M,Z_[5QG\_P""_P CB_\ A /^HG_Y _\ LJ/^$ _ZB?\ Y _^RKM**/[.PW\O
MXO\ S#^U<9_/^"_R.+_X0#_J)_\ D#_[*C_A /\ J)_^0/\ [*NTHH_L[#?R
M_B_\P_M7&?S_ (+_ ".+_P"$ _ZB?_D#_P"RH_X0#_J)_P#D#_[*NTHH_L[#
M?R_B_P#,/[5QG\_X+_(XO_A /^HG_P"0/_LJ/^$ _P"HG_Y _P#LJ[2BC^SL
M-_+^+_S#^U<9_/\ @O\ (XO_ (0#_J)_^0/_ +*C_A /^HG_ .0/_LJ[2BC^
MSL-_+^+_ ,P_M7&?S_@O\CB_^$ _ZB?_ ) _^RH_X0#_ *B?_D#_ .RKM**/
M[.PW\OXO_,/[5QG\_P""_P CB_\ A /^HG_Y _\ LJ/^$ _ZB?\ Y _^RKM*
M*/[.PW\OXO\ S#^U<9_/^"_R.+_X0#_J)_\ D#_[*K>F>#Y-+U".\BU!7=,X
M5H..01_>]ZZFBJC@</"2E&.J\W_F1/,\5.+C*6C\E_D5ME]_S\6__?AO_BZ-
ME]_S\6__ 'X;_P"+JS177<X2MLOO^?BW_P"_#?\ Q=5=2T^\U+2[JQ>[@1;B
M)HBPMR2 PQG[_O6G133:=T)I-69Y=_PIW_J/?^2?_P!G1_PIW_J/?^2?_P!G
M7J-%='URM_-^1P_V9A?Y?Q?^9Y=_PIW_ *CW_DG_ /9T?\*=_P"H]_Y)_P#V
M=>HT4?7*W\WY!_9F%_E_%_YGEW_"G?\ J/?^2?\ ]G1_PIW_ *CW_DG_ /9U
MZC11]<K?S?D']F87^7\7_F>7?\*=_P"H]_Y)_P#V='_"G?\ J/?^2?\ ]G7J
M-%'URM_-^0?V9A?Y?Q?^9Y=_PIW_ *CW_DG_ /9T?\*=_P"H]_Y)_P#V=>HT
M4?7*W\WY!_9F%_E_%_YGEW_"G?\ J/?^2?\ ]G1_PIW_ *CW_DG_ /9UZC11
M]<K?S?D']F87^7\7_F>7?\*=_P"H]_Y)_P#V='_"G?\ J/?^2?\ ]G7J-%'U
MRM_-^0?V9A?Y?Q?^9Y=_PIW_ *CW_DG_ /9T?\*=_P"H]_Y)_P#V=>HT4?7*
MW\WY!_9F%_E_%_YGEW_"G?\ J/?^2?\ ]G1_PIW_ *CW_DG_ /9UZC11]<K?
MS?D']F87^7\7_F<GX4\&S^%%NQ#J<<_V@H3OMB,;<^C^]='LOO\ GXM_^_#?
M_%U9HK&<Y3?-+<ZZ5*-**A!62*VR^_Y^+?\ [\-_\71LOO\ GXM_^_#?_%U9
MHJ+FA6V7W_/Q;_\ ?AO_ (NC9??\_%O_ -^&_P#BZLT47 K;+[_GXM_^_#?_
M !=&R^_Y^+?_ +\-_P#%U9HHN!6V7W_/Q;_]^&_^+HV7W_/Q;_\ ?AO_ (NK
M-%%P*VR^_P"?BW_[\-_\71LOO^?BW_[\-_\ %U9HHN 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!4U$7IM#]@,8GR/O\ 3'>N:U@:\-*F
M^VM;FW^7?LQG[PQ^N*["LGQ-_P B]=?\ _\ 0Q51>H%O2O\ D#V7_7O'_P"@
MBK=5-*_Y ]E_U[Q_^@BK=)[@%%%%( HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M +?1M3L]2AU*[:\B\S[5*<9N]YS\^<]*S_AMX?O=/^U:A?:)9Z6TPV1)'O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO+2*^M7MI@3&^,X.#P<_TJ>B@"."%+>".&/.R-0BY] ,5)110 4444 %%%%
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MGI7-?\7(_P"I4_\ )BNEU*Q_M+3IK/[5<VOF@#SK639(G(/RMVZ5S7_" ?\
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MIKR*?1_$>H_$RWT]_%'G7>G69N%O#I\8$6X[=NS."2".3_2O6XU98U5G+L
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMYSUDAMT1C^(&:O444 0)8VD=Y)>):P+=2J%DG6,!W Z MU(XJ>BB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(,95<[MQ [C@U5&GZW8:9J6BVVG)<1W4DQBNS.JHBR9^^I^;(R>@.:KDA?\
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M&L;D^,XM0$?^BKI[PF3</OF16 QUZ U7/%I7MMY;ZF?LY)OE;W75O2R[C?\
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M=_\ ".:PFFQZ;'I4:W\-P98M92X5>2V=Y'WR2.",5UOAJVNK#P_;6M[%Y4T
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M6D:*)$,C;W*J!N;U/J:DHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
%HH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>img88009329_19.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_19.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .Z!M,# 2(  A$! Q$!_\0
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M.O(XIMYJ-EIZ![V\M[9#T::54'ZFI*+-%9MMXAT2\D$=KK&GSR$X"Q7*,3^
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MKZ2J91LQQ=T%%%%24%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#\OFYF^NWY/TI*;<K XI(O?!'_D7M2_Z^Q_Z *]0KR_X(_\ (O:E_P!?8_\
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M<MF@YKH\D^$__)0K'_KG+_Z U=W\;O\ D7M-_P"OL_\ H!KA/A/_ ,E"L?\
MKG+_ .@-7=_&[_D7M-_Z^S_Z :I_&B5\)YKX4T/6?%COHEA<>59JWVB<NQ"
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MU%RWDF*81-G:2<,2,<9[^U$5JV$GHD=\_P $]86Q,BZE:-<A<^3A@"?3=_\
M6K,\ ^+M0\*^(DTF_DD^P/-Y$T$ASY#YQN'I@]?6KG_",_%?_GXU7_P;+_\
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M*V?%WPUU#PIIB:BUW#=6^\)(44J4)Z<'J*V_@@!_;NJ' R+91G_@5=M\6O\
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MN,_C7B?Q#\'V_A#5X(K2X>6VN8S(@DQN3!P02.HZ<U2Y9$^\CVKQEH#^,/#
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M'.=IQQ]6+'\:^@-"TJ/1-"LM,BQMMXE0D?Q-W/XG)_&AZ1L"UE<T*YKX@_\
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M6[W4+'PK:RZ;<W5O,;Y%9[:1D8KL?@E><9 _2L;.]C6^ESO:*^7/^$B\6?\
M09UK_P "I?\ &O:OAOJDY\"&^UF]E8QS2&2>[E)*J,=2W:G*%D)2N=?J=Y_9
M^DWE[Q_H\#R_-T^52>?RKYU\1?$77_$UDUE=RPPVKD%X;=-H;'(R222,\XS7
MO%EXM\/:O?#3K/4[>YN)%8B-,D, .><8Z57\6^'-)U3PU?)<6<"M' \D<JH
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M(?YDUS/QPF5M9TJ$'YTMW<_0M@?^@FNJ^#5NT/@B21@<37DDB_3:J_S4T/X
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MHCU21 P/X&IC*PW&YX'K'Q<U_5=+DLEAM;3S5VR2P!MQ!Z@9)QG\_>KGPO\
M ]Y>ZO;:[?P/#8VS>9#O&#,X^Z0/0'G/M7L4/AO0K>42P:+IT4@.0Z6J*1^(
M%:=-STL@Y==3R_XW?\B]IO\ U]G_ - -5/@;_P >FM?]=(?Y/7J-]IEAJ<:Q
MW]E;7:*=RK<1+( ?4 BDL=*T[2PXT^PM;028+BWA6/=CIG &:7-[M@MK<\J^
M.G_, _[>/_:=;'P4_P"1-O/^P@__ *+CKO+_ $G3=4\O^T-/M+OR\[/M$*R;
M<XSC(.,X'Y4^RTZRTR$PV%G;VD3-O*01+&I; &< =>!^5'-[M@MK<\5^-O\
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M<:3_ -MO_1SUV%0VMI;6-LEM:6\5O F=L4*!%7)R< <#DDU-4MW8T?*_A/\
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MTQFN](T^XE/5Y;9'8_B12C*V@W&YY[=WNI?$CX4W<\=O']NAN<^1 #A]F#@
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MTG3=4\O^T-/M+OR\[/M$*R;<XSC(.,X'Y4^RTZRTR$PV%G;VD3-O*01+&I;
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M0X J>[LK74+<V][;0W,!()CFC#J2.G!XI.5Y7!+2QXG\$O\ D9]0_P"O,_\
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MZBNN_P"%N^+/^>]K_P" XKVW_A$_#?\ T+^E?^ 4?^%'_")^&_\ H7]*_P#
M*/\ PJG-/="Y6NIC?#WQ+>:_X4FU/5I8]\<[JS*FT!%53T'U->#>)=>N/$FO
M7.I7!/[QL1H?X$'W5_+]<U]06VF6%E:/:6MC;06SYW0Q1*J-D8.5 P<BJ/\
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M*/8#BMO1/B#KGA[34L--^RQ0*2Q_< LQ/4D]S7OW_")^&_\ H7]*_P# */\
MPH_X1/PW_P!"_I7_ (!1_P"%7SKL+E9Y-X:^)_B74_$VF6-S-;F"XN4CD"P@
M':3@\U[C67!X9T&VG2>#1--BFC8,DD=I&K*1T(('!K4J)-/8I)K<****D844
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M' :C\(= U/4[N_FO-366YF>9PDL84,S$G&4Z<UW]%%-ML5K!1112&%%%% !1
M110 4444 %%%% !1110 56O]/M-4LY+2^MX[BWD&&CD&0:LT4 >?7/P;\+SR
MEXWU"W!/W(IE(_\ 'E)JWI?PI\+:9.LS6\UXZ\K]JDW '_=  /XBNVHJN9BY
M4( %4*H  & !VI:**D84444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Y
M_/\ "#P_<:C+>O>:F)9)3,0)8\9)S_<Z5Z!113;;W$E8****0PHHHH ****
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MBR>Y):PT6ZN8@<;\X_D#3X?%T*W @U&RGL7;H9!D?R!_2NB5510J*%4#  &
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MT36R!WD?&W!QTYR3R.U4&\9Z:"2(;MH\_P"L$0V_SJ98FE'>2*CA*\_AB_\
MASHJ*K6-_;:C;"XM91)&>/<'T([4Z[O+>PMVGN95CC7N>_L/6M>>/+S7T,>2
M7-R6U[$]%<[_ ,)GIWWA;WAC_P">@B&W^=;%AJ5KJ=OYUI*'4<$="I]"*B%>
ME-VC*[-:F&K4ES3BTBU14%W>6]A;M/<RK'&O<]_8>M8G_"9Z?U%O>F/_ )Z"
M(;?YT5*].F[3=@I8:K55X1;1T5%5;#4;74[?SK242+T(Z%3Z$=JM5I&2DKIZ
M&4HRB^62LPK*T76O[8^T_P"C^3Y#[/O[MWOT%:M<KX+_ .8G_P!=_P#&L*DY
M*K"*V=_R.BE3C*A4FUJK6^;.JHK-FUNTM]4-A-O1Q'YAD; 0#ZY_I5!_&6FJ
MS;(KN5 <&1(AM_4BJEB*4=Y$PPE>?PQ9T-5;_4;;38/.N9-H)VJ!R6/H!3=.
MU2TU6W\ZTDW '#*1@J?<5RGC'4DG:*U%O<*T$_+LF%;C^$YYJ,1B%3I>TB_0
MTPN$E5KJE--=SMZ*SM-UB/4WD5+6ZAV $F>/:#].31J>MV.D[1<RGS&^[&@R
MQ_"M?;0Y.>^AA["IS^SY=>QHT5SZ>,=-+JLL5W I. \L6!^A-;T<B31K)&ZN
MC#*LIR"**=:G4^!W'5H5:7QQL.HK&;Q/IT8O/-,D?V67RF#*,NW/W<'GH?2C
M2_$MGJ]PT%M%<!U4M\Z #'U!J5B*3:BI:LIX2LHN3B[(V:*H:7JUOJT4CP+(
MAC?8Z2 !@?P)_P BK]:1DIKFB]#&<)0DXR5F%%9]EJ]O?WUU:P)*3;'#R$#;
MG., Y]C^50ZCXCT_39_(D9Y9^\<*[B/Z5#K4U'F;T-%AZKGR*+N:U%<_%XPT
MUY5CE2YM]W1IH\#]":WP0P!!!!Y!%.G5A4^!W%5H5*5O:1M<R]#UG^V89Y/L
M_D^5)LQOW9]^@K5KE? __'I??]=_Z5U59X6<IT8REN:XVG&G7E""LD%%%%=!
MRA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-,GL)D=RP25H^AR<=>_!-;GBG_D6KW_=7_T(5BZO':6_BK1[:UBBCV.I98U
MQEAC.._%;?B@$^&[W']T?^A"L(WY*R?GMZ'3/E]IAW&]M-]_B)?#_P#R+]C_
M -<A7/+/9ZCXNNI=2G@2"S_=Q1S.%!8''?KR"?RKH?#_ /R+]C_UR%<YI]A9
M2^+-5L]0MTD>1S+%OST))X_ C\J=6[A22\M]MM":'*JE>3O=7VWWU.G.K:4R
ME3J%D5(P09EP1^=<]I$MO9>+Y[2QECDL[J/>HC<,JL!GM^/YBMK_ (1K1O\
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M93D]W%?^DF[K'_($O_\ KVD_]!-9GAV<6O@R*X(R(HY7Q]&8UIZQ_P @2_\
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MXY^OY"NC&K:4JA1J%D% P )EP!^=<R]E:'QU<07\2R1W*;HM_ S@?X,*W_\
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M6F"_@1,LQ_WJ?]= HHHKJ.(**** "BBB@ HHHH **** "BBB@ HHHH ****
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MDH21RQ/?ZUH45?LUS\_6UC/VLO9^SZ7N<]>>'IX]0:_T>[%K._\ K$891O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG\0)//!R,4 ;FC>)]$\0;AI>HPW#*,E!E7 ]=IP<?A6I)(D4;22.J(HRS,<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0O&-V%3[D%\OFICTSS@?1:3Q%9ZKX:\8'Q9I=G)?6ES$L.H6T0S( , .H[X
M'Y'L>)S\5_#6W:GVY[C'%N+8[R?3TS^- %GPEXHU&_U2]T#7K6.#5[)0[&(_
M)*AQ\P_-?S[=*K^!/^1@\8_]A,_UIOA#3]2U#Q/J7B[4[1K'[5"MO:VK_?6(
M8.6]"=H_7VIW@3_D8/&/_83/]: *?PITZWCL]8U'8IN9M0EB+XY"+@@?F2?R
M]*E^*2K#9:#?(H%S#JT(CD[@$,2/S4?E4_PN_P"1?U'_ +"<_P#[+4/Q7_Y
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M?*BYP6[_ /?1_'TB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MXE^9;6NA:H(GD@T_5(IYP@)*H.2?IQC\10!9^*7_ "3C5O\ MC_Z.2NHL?\
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MW?/2NTHH YOP3X>G\/:$T5ZZ/?W4S7-RR=-[=L^P _6NDHHH **** "BBB@
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MVAYF!*CT&  *2HRY[OR^7EM<<L1%P:3[_.[>N]O\K%VBBBNLX0HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#COAA97
M6G^![:WO;::VG$LA,<T91@"QQP>:[&BB@ HHHH **** "BBB@ HHHH \[UB?
M4_%/BO1K*'0M0M;73-1%S+=W,6R-U0\;3WSC]17HE%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5DZ]K;Z)!%(FE:CJ!D8KLL
M8?,9>.I]!6M10!R?@[2[X7.I^(-7@,%_J<@*P,<F"%>$4^_K^%=9110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5C9&AF%R?D((QCY!G/3KSFK-E;0OKFK3/$C/YD:@L <#RU/%-59MJ-OS[/\
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MJBER1;O8%.25DS/BT33X)4D2WY0Y0%V*J?4*3@?E5N.WBBFFE1</,0SG)Y(
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MRV6J3V%S'.AC\AF5[AB"HB&"#SG/?[O2@#L**CMU=+:)923($ 8DYR<<U)0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@#-O=$MKW5;'4R\L5W9DA)(B!O0]4;(.5/_ .HBM*BB@ HHHH **** "BBB
M@ K.TC1;;1H[@0M+++<S--//,07D8^I  P.@ ' K1HH **** "BBB@ HHHH
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M5;[!#_?N/_ F3_XJC[!#_?N/_ F3_P"*H LT56^P0_W[C_P)D_\ BJ/L$/\
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M"9/_ (JC[!#_ '[C_P "9/\ XJ@"S15;[!#_ '[C_P "9/\ XJC[!#_?N/\
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M5;[!#_?N/_ F3_XJC[!#_?N/_ F3_P"*H LT56^P0_W[C_P)D_\ BJ/L$/\
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M3:ZA-B;+'F]1G..>G7=WZUU?BO2?#ZVEQK.JV'GR1Q@%5D9?/(/R(0I ?)(
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M<?\ @3)_\51]@A_OW'_@3)_\50!9HJM]@A_OW'_@3)_\51]@A_OW'_@3)_\
M%4 6:*K?8(?[]Q_X$R?_ !5'V"'^_<?^!,G_ ,50!9HJM]@A_OW'_@3)_P#%
M4?8(?[]Q_P"!,G_Q5 %FBJWV"'^_<?\ @3)_\51]@A_OW'_@3)_\50!9HJM]
M@A_OW'_@3)_\51]@A_OW'_@3)_\ %4 6:*K?8(?[]Q_X$R?_ !5'V"'^_<?^
M!,G_ ,50!9HJM]@A_OW'_@3)_P#%4?8(?[]Q_P"!,G_Q5 %FBJWV"'^_<?\
M@3)_\51]@A_OW'_@3)_\50!9HJM]@A_OW'_@3)_\51]@A_OW'_@3)_\ %4 6
M:*K?8(?[]Q_X$R?_ !5'V"'^_<?^!,G_ ,50!9HJM]@A_OW'_@3)_P#%4?8(
M?[]Q_P"!,G_Q5 %FBJWV"'^_<?\ @3)_\51]@A_OW'_@3)_\50!9HJM]@A_O
MW'_@3)_\51]@A_OW'_@3)_\ %4 6:*K?8(?[]Q_X$R?_ !5'V"'^_<?^!,G_
M ,50!9HJM]@A_OW'_@3)_P#%4?8(?[]Q_P"!,G_Q5 %FBJWV"'^_<?\ @3)_
M\51]@A_OW'_@3)_\50!9HJM]@A_OW'_@3)_\51]@A_OW'_@3)_\ %4 6:*K?
M8(?[]Q_X$R?_ !5'V"'^_<?^!,G_ ,50!9HJM]@A_OW'_@3)_P#%4?8(?[]Q
M_P"!,G_Q5 %FBJWV"'^_<?\ @3)_\51]@A_OW'_@3)_\50!9HJM]@A_OW'_@
M3)_\51]@A_OW'_@3)_\ %4 6:*K?8(?[]Q_X$R?_ !5'V"'^_<?^!,G_ ,50
M!9HJM]@A_OW'_@3)_P#%4?8(?[]Q_P"!,G_Q5 %FBJZ6<4;A@TY(_O3N1^1-
M6* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"G?Z3INJ>7_:&GVEWY>=
MGVB%9-N<9QD'&<#\JAM?#VB6-RES::/I]O.F=LL-LB,N1@X(&1P2*TJ*+@4;
MC1=*O+H75SIEG/<+C$LL"LX_$C-76571D=0RL,$$9!%+10! +*U%D+(6T(M0
MFP0>6-FWTV],>U)9V%GIT/DV-I!:Q9SL@C"+GUP!5BB@ HHHH I:/_R!+#_K
MVC_]!%7:I:/_ ,@2P_Z]H_\ T$5=J*?P+T-*W\27JPHHHJS,**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0)8?]>T?_H(J[5+1_P#D"6'_ %[1_P#H(J[44_@7H:5OXDO5A1115F84444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %4M5_P"/2/\ Z^8/_1J5=JEJO_'I
M'_U\P?\ HU*BI\#]#2C_ !(^J+M%%%69A1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% %+1_^0)8?]>T?_H(J[5+1_\ D"6'_7M'_P"@BKM1
M3^!>AI6_B2]6%%%%69A1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P"18TG_ *\X?_0!7FOQNC2*PT..-%1%>4*JC  PG05Z5X=_Y%C2?^O.'_T
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M8?\ 7M'_ .@BKM13^!>AI6_B2]6%%%%69A1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 52U7_ (](_P#KY@_]&I5VJ6J_\>D?_7S!_P"C4J*GP/T-*/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *I:K_QZ1_\ 7S!_Z-2KM4M5_P"/2/\ Z^8/_1J5%3X'Z&E'
M^)'U1=HHHJS,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /+M4U748]6O$2_NE19W"JLS
M  ;CP.:J?VQJ?_01N_\ O^W^-)JW_(9OO^OB3_T(U3KY&I4GSO5GW=*E3]G'
MW5LNA=_MC4_^@C=_]_V_QH_MC4_^@C=_]_V_QJE14^TGW9I[&G_*ON+O]L:G
M_P!!&[_[_M_C1_;&I_\ 01N_^_[?XU2HH]I/NP]C3_E7W%W^V-3_ .@C=_\
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M!-^9\GF\5'$M)=$%%%%=YY@4444 %%%% !1110 4444 %%%% !1110 4444
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M_:-C_P _EO\ ]_!_C5FB@"M_:-C_ ,_EO_W\'^-']HV/_/Y;_P#?P?XU9HH
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M6_\ W\'^-']HV/\ S^6__?P?XU9HH K?VC8_\_EO_P!_!_C1_:-C_P _EO\
M]_!_C5FB@"M_:-C_ ,_EO_W\'^-']HV/_/Y;_P#?P?XU9HH K?VC8_\ /Y;_
M /?P?XT?VC8_\_EO_P!_!_C5FB@"M_:-C_S^6_\ W\'^-']HV/\ S^6__?P?
MXU9HH K?VC8_\_EO_P!_!_C1_:-C_P _EO\ ]_!_C5FB@"M_:-C_ ,_EO_W\
M'^-']HV/_/Y;_P#?P?XU9HH K?VC8_\ /Y;_ /?P?XT?VC8_\_EO_P!_!_C5
MFB@"M_:-C_S^6_\ W\'^-']HV/\ S^6__?P?XU9HH K?VC8_\_EO_P!_!_C1
M_:-C_P _EO\ ]_!_C5FB@"M_:-C_ ,_EO_W\'^-']HV/_/Y;_P#?P?XU9HH
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M6_\ W\'^-']HV/\ S^6__?P?XU9HH K?VC8_\_EO_P!_!_C1_:-C_P _EO\
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M//X=*Z'P387>F>#M.M+Y#'<(K$QL<E 79E4_12!^%)C1T%4=794L59F"JMQ
M22< #S4J]5+5?^/2/_KY@_\ 1J5E4^!^AK1_B1]42?VC8_\ /Y;_ /?P?XT?
MVC8_\_EO_P!_!_C5FBK,RM_:-C_S^6__ '\'^-']HV/_ #^6_P#W\'^-6:*
M*W]HV/\ S^6__?P?XT?VC8_\_EO_ -_!_C5FB@"M_:-C_P _EO\ ]_!_C1_:
M-C_S^6__ '\'^-6:* *W]HV/_/Y;_P#?P?XT?VC8_P#/Y;_]_!_C5FB@"M_:
M-C_S^6__ '\'^-']HV/_ #^6_P#W\'^-6:* *W]HV/\ S^6__?P?XT?VC8_\
M_EO_ -_!_C5FB@"M_:-C_P _EO\ ]_!_C1_:-C_S^6__ '\'^-6:* *W]HV/
M_/Y;_P#?P?XT?VC8_P#/Y;_]_!_C5FB@"M_:-C_S^6__ '\'^-']HV/_ #^6
M_P#W\'^-6:* *W]HV/\ S^6__?P?XT?VC8_\_EO_ -_!_C5FB@"M_:-C_P _
MEO\ ]_!_C1_:-C_S^6__ '\'^-6:* *W]HV/_/Y;_P#?P?XT?VC8_P#/Y;_]
M_!_C5FB@"M_:-C_S^6__ '\'^-']HV/_ #^6_P#W\'^-6:* *W]HV/\ S^6_
M_?P?XT?VC8_\_EO_ -_!_C5FB@"M_:-C_P _EO\ ]_!_C1_:-C_S^6__ '\'
M^-6:* *W]HV/_/Y;_P#?P?XT?VC8_P#/Y;_]_!_C5FB@#R'5&5]7O64AE,[D
M$'@C<:J5<U;_ )#-]_U\2?\ H1JG7QU3XWZGW]+^''T04445!H%%%% !1110
M 4444 %%%% !1110 4444 %%%% '2^"9XH-7G::5(U,! +L ,[EKN_[1L?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ JEJO_'I'_P!?,'_HU*NU2U7_ (](_P#KY@_]&I45/@?H:4?XD?5%VBBB
MK,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH \BU;_D,WW_7Q)_Z$:IU<U;_D,WW_ %\2
M?^A&J=?'5/C?J??TOX<?1!1114&@4444 %%%% !1110 4444 %%%% !1110
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M10J@*H& !T%+116QSA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% %'4M/\ M:++"PCNXOFBE]_0^QIVG7OVVW)=/+GC;9+'_=8?TJY63<C[
M!K<%TO$5WB&4?[7\)^O:L9KDESKY_P"9T0?M(^S>ZV_R_KJ:U%%%;'.%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 4M'_Y EA_U[1_^@BKM4M'_P"0)8?]>T?_ *"*NU%/X%Z&
ME;^)+U844459F%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5+5?^/2/_
M *^8/_1J5=JEJO\ QZ1_]?,'_HU*BI\#]#2C_$CZHNT4459F%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% 'D6K?\ (9OO^OB3_P!"-4ZN:M_R&;[_ *^)/_0C5.OCJGQO
MU/OZ7\./H@HHHJ#0**** "BBB@ HHHH **** "BBB@ HHHH **** .I\"?\
M(9G_ .O<_P#H2UZ!7G_@3_D,S_\ 7N?_ $):] KZ3+/]W7JSY#./]Z?HC*O/
MW^O6$!^[$KS$>_05JUEG_D:A[67_ +/6I773WD_,X:VT5Y?YA1116IB%%%%
M!14-U=6]E;27-U-'!!&,O)(P55'N37CWC7XLW#7L=MX6NS'#%GS;DQ*WFGT4
M.#@#U[_S:BWL)M(]GHJ&T=I;*"1SEFC5B?4D5XM;^+?B#XCUS4HO#MSYD$,K
M%8Q'  D98A1EQSQ[YH4;@W8]OHKB/ __  G7VZZ_X2S_ (]_+'D_ZC[V>?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8U/Y7]P?6J'\Z^]'4T5RW_"QO"G_ $%#_P" \O\ \31_PL;PI_T%#_X#R_\
MQ-'L:G\K^X/K5#^=?>CJ:*Y;_A8WA3_H*'_P'E_^)H_X6-X4_P"@H?\ P'E_
M^)H]C4_E?W!]:H?SK[T=317+?\+&\*?]!0_^ \O_ ,31_P +&\*?]!0_^ \O
M_P 31[&I_*_N#ZU0_G7WHZFBN6_X6-X4_P"@H?\ P'E_^)H_X6-X4_Z"A_\
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MC_\ BJ/M4W_/A<?]]1__ !56:* *WVJ;_GPN/^^H_P#XJC[5-_SX7'_?4?\
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M56:* *WVJ;_GPN/^^H__ (JC[5-_SX7'_?4?_P 55FB@"M]JF_Y\+C_OJ/\
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MS"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=?\ (<A_Z]E_]":N8KY7&_[Q/U/MLO\ ]UAZ!1117*=H4444 %%%% !1110
M4444 %%%% !1110 4444 7M&_P"0Y8?]?$?_ *$*];KR31O^0Y8?]?$?_H0K
MUNO>RGX)>I\SGO\ $AZ!1117K'A!1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4M5_X](_^OF#_
M -&I5VJ6J_\ 'I'_ -?,'_HU*BI\#]#2C_$CZHNT4459F%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M110 4444 %%%% !1110 5[[\/?\ D1=,_P!V3_T8U>!5[[\/?^1%TS_=D_\
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M$*];KWLI^"7J?,Y[_$AZ!1117K'A!1110 4444 %%%% !1110 4444 %%%%
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M[*?@EZGS.>_Q(>@4445ZQX04444 %%%% !1110 4444 %%%% !1110 4444
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M   'H!0VF"1K4445)1E:2]X-&L=L$!7[/'@F8@D;1_LU<WWW_/O;_P#?]O\
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M\^]O_P!_V_\ B*-]]_S[V_\ W_;_ .(JS10!6WWW_/O;_P#?]O\ XBC???\
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MIUG?P :@K0"3*HNTLK$C8=G!X-3V7@BPM;JSEEO]3O([)@]K;W5QOCA(Z$
M$X[9)Q6QJVE0:S9?8[IY1;F17D1"!Y@4YV-Q]TXYQCZT7L%C@]"GU9-66#3;
M>UAO;RQ6Z!O@S""T0^7#$ I!R<%B?4]*[3PSK)\0>';34VB$3S!@Z Y 96*M
MCVRIIFJ^'+?4[R*]2[O+&[CB,(GLY C-&3DJ<@C&>>F0:O:7IMKH^F0:?9H4
MMX%VH"<GU))]223^-#:8)%NJ.K[A8KM +?:(, G )\U*O52U7_CTC_Z^8/\
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MW_Q%6:* *V^^_P"?>W_[_M_\11OOO^?>W_[_ +?_ !%6:* *V^^_Y][?_O\
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M_P#H2UZ!7TN6?[NO5GR&<?[T_1&'ON_^$GSY,&_['T\TXQO]=O\ 2M/???\
M/O;_ /?]O_B*J?\ ,UC_ *\?_9ZU*ZJ7VO4X:WV?1''?$1KH^"+\2PPJF8\E
M923_ *Q>VT5X;7O'Q(_Y$34/K%_Z,6O!Z]S ?PGZGRF<?QUZ?JPHHHKM/)"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KW7P"UV/!&FB.&%DP^"TI!_U
MC=MIKPJO??A[_P B+IG^[)_Z,:N+'_PUZGKY-_'?I^J-W???\^]O_P!_V_\
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M -"-4Z^.J?&_4^_I?PX^B"BBBH- HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?\@J\_ZX/_Z":\:?PL^GI_&O4-,_Y!-G_P!<$_\ 015JJNF?\@FS_P"N"?\
MH(JU2I_ @J_&_4****L@**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HKSH:QJ6I:WJZGQI;Z-;V]\UK;V\D,#%MH&2"^">3
M[UMZM=:M;3Z!HL.J!;B]:037YA3<1&FX[4(*@M].*=A7.JHKAH/$FJ#1KRP\
M^.YUH:E)IEK,(PHD( )E9>@VJQ)QQ\N.]=M"CQP1I)(9750&D8 %CCDD#CGV
MH:L%Q]%%%(92T?\ Y EA_P!>T?\ Z"*NU2T?_D"6'_7M'_Z"*NU%/X%Z&E;^
M)+U844459F%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 >>^.O^0Y#_ ->R_P#H35S%=/XZ_P"0
MY#_U[+_Z$U<Q7RN-_P!XGZGVV7_[K#T"BBBN4[0HHHH **** "BBB@ HHHH
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M I_\"DH^WZK_ - 4_P#@4E:E%'LY?SO\/\@]K#^1?^3?YF7]OU7_ * I_P#
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M?E'_ /$T?99?^?ZX_*/_ .)JS15W,RM]EE_Y_KC\H_\ XFC[++_S_7'Y1_\
MQ-6:*+@5OLLO_/\ 7'Y1_P#Q-'V67_G^N/RC_P#B:LT47 K?99?^?ZX_*/\
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M_7'Y1_\ Q-'V67_G^N/RC_\ B:K:QKVF:#'!)J5SY(GD\J(!&<NWH H)K2H
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M %Q^4?\ \35FBBX%;[++_P _UQ^4?_Q-'V67_G^N/RC_ /B:LT47 K?99?\
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M!KPZO>/B1_R(FH?6+_T8M>#U[F _A/U/E,X_CKT_5A1117:>2%%%% !1110
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M^2:U*R['_D/ZM_VQ_P#036I7HT?A?J_S9Y&(^)>D?R04445J8A1110 4444
M8>L^,/#_ (?F$.IZG%!,1GRP&=@/4A02*GT7Q+HWB%';2K^*YV?>495E^JD
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M;=FG:W*B( 0DD\<8SMS[UN^#HW\7>+K[QA=*?LD!-KIJ-V ZMCZ'\V/I0XI
MF>C4445!04444 %%%% !67K7#:<PZB]C'YYK4K+UOIIW_7]%_6LJWP,VP_\
M$1J4445J8A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %4M5_P"/2/\ Z^8/_1J5=JEJO_'I'_U\P?\
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M %\1_P#H0KUNO>RGX)>I\SGO\2'H9=C_ ,A_5O\ MC_Z":U*R['_ )#^K?\
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MM4J?P(*OQOU"BBBK("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ*+ 6?[0O?\ G\N/^_K?XT?VA>_\_EQ_W];_ !JM118"S_:%[_S^7'_?UO\
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M.'_"2:[_ -!K4?\ P*?_ !KMH8=UKV=K'F8S&QPW+=7N?2%%?-__  DFN_\
M0:U'_P "G_QH_P"$DUW_ *#6H_\ @4_^-=']GR_F.+^VH?RL^D**^;_^$DUW
M_H-:C_X%/_C1_P ))KO_ $&M1_\  I_\:/[/E_,']M0_E9](45\W_P#"2:[_
M -!K4?\ P*?_ !H_X237?^@UJ/\ X%/_ (T?V?+^8/[:A_*SZ0HKYO\ ^$DU
MW_H-:C_X%/\ XT?\))KO_0:U'_P*?_&C^SY?S!_;4/Y6?2%%?-__  DFN_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6J5/X$%7XWZA1115D!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 4M'_ .0)8?\ 7M'_ .@BKM4M'_Y
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MX/7O'Q(_Y$34/K%_Z,6O!Z]S ?PGZ_Y'RF<?QUZ?JPHHHKM/)"BBB@ HHHH
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M4UN!Q%%%%;""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH [C0/\
MD"6__ O_ $(UI5FZ!_R!+?\ X%_Z$:TJQ>XPHHHI >>^.O\ D.0_]>R_^A-7
M,5T_CK_D.0_]>R_^A-7,5\KC?]XGZGVV7_[K#T"BBBN4[0HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH O:-_R'+#_ *^(_P#T(5ZW7DFC?\ARP_Z^(_\
MT(5ZW7O93\$O4^9SW^)#T,NQ_P"0_JW_ &Q_]!-:E9=C_P A_5O^V/\ Z":U
M*]&C\+]7^;/(Q'QKTC_Z2A#]T_2OEVOJ(_=/TKY=KU\O^U\OU/G,[^Q\_P!
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M73%^SPFXE5!+=E1YK#.,[0=H]RU=LK*ZAE8,K#((.012:L%Q:I:K_P >D?\
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M10 4444 %%%% !7OOP]_Y$73/]V3_P!&-7@5>^_#W_D1=,_W9/\ T8U<6/\
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ME_PH_LZQ_P"?.W_[]+_A5FBBX%;^SK'_ )\[?_OTO^%']G6/_/G;_P#?I?\
M"K-%%P,.RL;1M<U1#:P%5\K:#&,#*GI6G_9UC_SYV_\ WZ7_  JI8_\ (?U;
M_MC_ .@FM2LJ+]U^K_-FV(^->D?_ $E%;^SK'_GSM_\ OTO^%']G6/\ SYV_
M_?I?\*LT5K<Q*W]G6/\ SYV__?I?\*/[.L?^?.W_ ._2_P"%6:*+@5O[.L?^
M?.W_ ._2_P"%']G6/_/G;_\ ?I?\*LT47 K?V=8_\^=O_P!^E_PH_LZQ_P"?
M.W_[]+_A5FBBX%;^SK'_ )\[?_OTO^%']G6/_/G;_P#?I?\ "K-%%P*W]G6/
M_/G;_P#?I?\ "C^SK'_GSM_^_2_X59HHN!6_LZQ_Y\[?_OTO^%']G6/_ #YV
M_P#WZ7_"K-%%P*W]G6/_ #YV_P#WZ7_"C^SK'_GSM_\ OTO^%6:*+@5O[.L?
M^?.W_P"_2_X4?V=8_P#/G;_]^E_PJS11<"M_9UC_ ,^=O_WZ7_"C^SK'_GSM
M_P#OTO\ A5FBBX%;^SK'_GSM_P#OTO\ A69K%C:(+#9:P+NO(U.(P,CGBMRL
MO6^FG?\ 7]%_6LJS_=LVP_\ %1;_ +.L?^?.W_[]+_A1_9UC_P ^=O\ ]^E_
MPJS16MS$K?V=8_\ /G;_ /?I?\*/[.L?^?.W_P"_2_X59HHN!6_LZQ_Y\[?_
M +]+_A1_9UC_ ,^=O_WZ7_"K-%%P*W]G6/\ SYV__?I?\*/[.L?^?.W_ ._2
M_P"%6:*+@5O[.L?^?.W_ ._2_P"%6%544*JA548  P *6B@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *P/&>D7&M^%KNTM/^/L;98 3C+HP8#\<8_&
MM^BA: <%JMU>^,ETO3$T34K-%NX[B]ENX#&D:IR54G[Q)X&*ZCQ#<WUMI+KI
MD+R7T[""$JA81LW&]O15&3D^@'>M6BG<5CSZ?1HO#FN0M+I%UJFF#2OLL(AM
MS,5EWEGW 9P7SG<>^:Z3P987FF>#M+L[\$7,4(#J3DKR2%_ $#\*W:*&[A8*
M;)&DJ%)$5T/56&0:=12&5O[.L?\ GSM_^_2_X4?V=8_\^=O_ -^E_P *LT47
M K?V=8_\^=O_ -^E_P */[.L?^?.W_[]+_A5FBBX%;^SK'_GSM_^_2_X4?V=
M8_\ /G;_ /?I?\*LT47 K?V=8_\ /G;_ /?I?\*/[.L?^?.W_P"_2_X59HHN
M!6_LZQ_Y\[?_ +]+_A1_9UC_ ,^=O_WZ7_"K-%%P*W]G6/\ SYV__?I?\*/[
M.L?^?.W_ ._2_P"%6:*+@5O[.L?^?.W_ ._2_P"%']G6/_/G;_\ ?I?\*LT4
M7 K?V=8_\^=O_P!^E_PH_LZQ_P"?.W_[]+_A5FBBX%;^SK'_ )\[?_OTO^%'
M]G6/_/G;_P#?I?\ "K-%%P*W]G6/_/G;_P#?I?\ "C^SK'_GSM_^_2_X59HH
MN!6_LZQ_Y\[?_OTO^%']G6/_ #YV_P#WZ7_"K-%%P*W]G6/_ #YV_P#WZ7_"
MC^SK'_GSM_\ OTO^%6:*+@5O[.L?^?.W_P"_2_X4?V=8_P#/G;_]^E_PJS11
M<"M_9UC_ ,^=O_WZ7_"C^SK'_GSM_P#OTO\ A5FBBX%;^SK'_GSM_P#OTO\
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M%6*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH R['_D/ZM_VQ_P#036I678_\A_5O^V/_
M *":U*RH_"_5_FS;$?&O2/\ Z2@HHHK4Q"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "LO6^FG?]?T7]:U*R];Z:=_U_1?UK*M_#9MA_XJ
M-2BBBM3$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+F!9SY8#S-LA0*K%E'\)XZCGD^M=5<:/XLT+P7-;Q>(H9;UIRTE]?7##RXL
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M\?B-&-2\LS_V=]K7IUV[=V-V/X=O7BN@OOB3>?\ "K[?58=L>JSSFT+JO"L
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MMJLMQY>L3H]P2RY4R2E3LXXXZ9S5SXJ:<OA^Q\)6.GR2D6GGB%W(+Y!C()P
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M&EO,Y)(64[%Y/7:02,T. *1[-7G?PI\3ZQXEM]4?5[S[2T#QB,^4B;<AL_=
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M7J&F?\@FS_ZX)_Z"*M55TS_D$V?_ %P3_P!!%6J5/X$%7XWZA1115D!1110
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M&;>K8 /W>>HR#@CG%.\+^'[G4/%=O>1^"H-'TZW=9-UV9?-#*<@KEADYQU7
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M[Z^3$A:*SL]I,W3)(([= <CJ>M>::[]GTS6-%O\ 2O#M_H0$F4:YD;,Q4KR
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MIY50'\S3[2]M+^$36=U#<Q'^.&0.OYBO&O#6EV_Q \?:U<Z^SSQ6Q(CMQ(5
M&\A1D<@ #MCDU-8VH\$_&*WTK2I9/L%XJAX6<G 8'@^N",@^AI<O0?,>S5EZ
MWTT[_K^B_K6I67K?33O^OZ+^M<];^&SHP_\ %1J4445J8A1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7J&F?\@FS_ZX)_Z"*M55TS_D$V?_ %P3_P!!%6J5/X$%7XWZA1115D!1110
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M8+:B$A022 !R2:X7X8 WEAK&MO\ >U+49)!Q_ .GZDUW=%%] "BBBD,****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF7Q+X=N]>UK09 \ T^PN#<7$;L=TC#&S Q@XYSD]ZZ:BB[W%8****0PHHHH
M**** "LFW/V[79;E>8;53"A]7/WB/Y4Z_OGDF_L^Q.;E^'<=(5[D^_M5VSM(
M[*U2WB^ZHZGJ3W)K%OGE9;+\SH2]E!M[O;T[_H3T445L<X4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG$A9G*_3<3C\*WZ*+@%4+?1M/M=7NM5A@VWUVJK-*78[@H  P3@=!T J_10
M4444 %%%!.!D]* #H,FLBS(U/57ONMO;YC@]"?XF_I39[B367:TLR5M <37
M_B'=5]?K6M%%'!$L42A448 ':L;^TEILOQ9T6]C%W^)_@O\ -_D/HHHK8YPH
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]M_A6I11:KW7W?\ !#FH_P K^]?_ ")E_P#"1Z3_ ,_8_P"_;?X4?\)'I/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M *?116NQ@W?5A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-O<11QQ)N>1ST51W/7\JJ:=XBM[^_-C):7EE=E/,6*[C"%U!P2N"0:%"35[
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8L0O[MXC%'LSN0!2.N3N]:;-!)?V^C_:;W3=2N$L"3;WCR1I(N_ E1B!\V
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MAV\%UX#@]N.".^!5M;:W2Y>Y6")9Y %>4( S = 3U--U%KYH(T7:-]T_\_\
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MP4445)84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
F444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>img88009329_20.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_20.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" /0!O,# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHI:,,5WNQ. 2.<8#4HQ5KL;;O9';:3\:M+N[E8M2TZ:Q1CCS5D\U5]SP#CZ
MUZ9#-'<0I-#(LD4BAD=3D,#T(->'_%3P3IOAZ"SU+28#!!+(898MQ8!L94C)
M)' ;\JZCX,:S+>^'[O39G+&QD!CR>B/G _ JWYTY15KH2;O9GI=<CXW\>6W@
MV.V4VWVRZG)(@$NS:@_B)P>_ XYY]*Q_'WQ+D\,WSZ3860>\\L,9I3\B9'&
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M/]G^T*6\K?OVX8CK@9Z>E?+U^M\;@7&H"8SW*^=OFSND!)^;GDYQ7T7\-?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\W^-?\ R)MG_P!A!/\
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M-\\0T?2[<L/.:X9PO?:%P3^9%"DW*P.*L=)\./%,GB3PN);QP;RT;RIW/&X
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M_GS6!\</^01I/_7=_P#T$5Y=X0GEM_&6C20@E_ML2X!QD%@"/Q!(KU'XX?\
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M/_1DE>F_#7_DGND?]<W_ /0VKS+XU_\ (Y6?_8/3_P!&241=Y#:]T]-^&O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M02P99X.<@-CD8[&HY/BEXPGM38BX196&TR1P 2GC]#[@5]#T4^?N@Y>QX1X
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M2[[1]0:TU%"EUM61U+9(W#<,^_-?6-%4IVZ"Y/,Y^U_Y)[#_ -@I?_15>!>
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ K.U70=)UR-4U.P@N@OW3(OS+]#U%:-
M% '(K\,/!ROO&C+GWN)2/RW8KH].TJPTBW^SZ?9PVL7=8D"Y/J?4_6K=%.[8
MK(****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "JU_86NJ6$UC>PK-;3+MDC.1D?AR*LT4 96A^&])\-PS1:3:FW
MCF8,Z^:[@D<9^8G'X5JT44 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBBB@ HHHH **** "BBB@ HHHH **** "L#QE_P B[+_OI_.M^L#QE_R+LO\
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MG;BU9KH%6AR14XN\7U7Y$M%%%;'.%%%% !1110 4444 %%%% !1110 4444
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M]G>]EMONC<_X1;1?^?%?^^V_QK%U2TD\*2PWVFRR"U>3;+;LV5]?Z'Z5M?\
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M_O9P/Z?E6YXMB8:;#>QC]Y9S+*"/3./YXK!2=2$J_:WX;_FSH<%1J1PO>_\
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M4U>^FT[3WNXK?S_+(+INQ\O<U>HZTI1;BU%V*A)*2E)7,>&ZT/584N9!9.[
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 444R66."%YII$CBC4L[NP"JHY))/04 /HK*T[Q/H&KW/V;3-<
MTR]N-I;RK:[CD; ZG"DG'-6-2UC3-&A2;5-1M+&)VV*]U.L2LV,X!8C)X- %
MVBLZ'7]&N=,EU.#5K"73XLB2Z2Y1HDQURX.!U'?O0-?T8Z0=7&KV!TP'!O!<
MIY(^;;]_.WKQUZ\4 :-%06=[:ZA:1W=E<PW-M(,I-#('1ATX8<&G7-S!9VTE
MS=3QP01*7DEE<*J*.I)/ % $M%5=/U*PU:U%UIU[;7EN25$MO*LB$CJ,J2*M
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !17GGQ,^*7_"NKC3HO[&_
MM#[:DC9^U>5LVE?]ALYW>W2N@\#>+8O&WA2VUN*V^S&5G1X/,W^6RL1C=@9X
MP>G>@#HZ*\:?X^Q'QK_PC\'A[S8CJ'V);O[;C</,V;]OE_CC->RT %%%% !1
M7"?$OXD?\*[MM.F_LG^T/MCNN/M'E;-H!_NMGK7=T %%%% !1110 454U/5+
M'1M.FU#4KJ*UM(1F265L ?\ U^P'>F:-J]IKVCVVJ6+,UK<IOB9UVDKGKCM0
M!>HHHH **** "BBB@ HHJ**1I))U(&(W"C'IM4_UH EHHHH *\/^-?C[Q5X4
M\3Z;8^']2-M%<6F]HQ;QR%GWL/XE)[#@5[A7@WQ;C2;XW>!HI%#(\ELK*>X-
MSR* /1_AQXL?Q+\.K+6M0G#7,:.MW)M"_,A.20, 9 !X]:\7\*?%[QGK?Q$T
MNSGU0KIE[?JOV?[+"/W3/]W=LW<#C.<\57TS7I/!'@[XB^$)9"LT<_E6H8\N
M';RG/_? 4U#8:+_87Q"^&5JRE99;*UN9,CG=)<2O@_0$#\* /JBBO!O&,^J?
M$/XR'P,NI3V.BV:9G6%L&3]V'8D=SE@HSD#KZUF:WIEW\$/&N@RZ)JMY<:/J
M+E9K2Y<'<%90X(  SAP0< @YH ^C*\G^+7C+7_#/B?PM9Z/?_9H+Z4K<)Y,;
M[QO0=64D<,>F.M<SXQ&H?$?XUMX*EU">ST6R0&1(FQOP@=FQT+$L%&<X'..H
MKFOB#X,;P3XQ\*Z?;ZI>7FE/,KVJ7;AG@;S$#J, #!^4\ =_J0#ZCHKP3XS^
M*Y)O&^G>$KG5YM(T(1I+?W$*L6;=G@A020 !@=,G)Z"N.F\0>&_ 'B/2M1^'
M_B6_OK-GQJ%G<(Z@J"OJB@Y&>V010!]645\Y?$>PU#5_C_:Z7IM\]C/>VT4#
M7$9PR1E6WD8Y^Z#W&>G>N]@^'EMX"\"Z];Z?XKETUKPJ\FIW2@F%1Q@8(P3D
MC<.>1U(% 'J%<UXZ\8VW@;PS)K%S;27/SB***,@;G(.,D]!P>>?I7S-KT'@_
M3M'%[X<\0Z]J'B*%U::^6-HX22<$Y(#+[')_PZ_XH6$?B#X4>&O&U[/.^JF"
M"U<941N"&+,1C.XD=CCGI0![YX=U*36?#&DZI*BQR7MG#<.B=%+H&('MS6G7
MA2HGPL^!2:QH4]R=0UN*UD+S%6$,DD8+%  , #=C.><=:\^6+P0?";:N_C?5
M#XT,)G^Y-CS<9\K=LSGMNWXSSTH ]U^,GB75_"G@==1T6[^RW9O(XC)Y:/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M.KJ>A!DC!%5_AQKS>!-*^(.A7#D2:,TES;[C]XC,?ZD1?]]5;^/'_(Z>"/\
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MOH/X0Z -#\'%O['NM):\F,YM;JY\YP-H 8_(NW./ND9'KV !W]%%% !1110
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M@@S^4OF$'(W8&?UH GHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB#'%>S*T:XZ<*JY'L<BO3** ,SQ!H5EXET"\T6_#?9;J/8_ED!EYR"N01D$
MCCM6?X+\$Z5X%T>33=*:=XY)C,\EPRL[,0!R0 ,  8XKHZ* .'\6_"CPQXPU
M'^TKR.YM-0P UU92B-WQTSD$$]LXS[\"K'@[X9^&_ \LEQI<$LMY(NQKJZ??
M)M]!@ #WP!FNPHH Y/PQ\/=)\*:_JVL6%Q>R7&IL6F6=T**2Q;Y0%!')[DU=
M\5^#=$\::<EEK5KYJQL6BD1MLD1/4JP]>XZ'CCBM^B@#S;1/@=X/T74XK]A?
M:C+"08EOIE=$(Z?*JJ#CT.17I-%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7G6L3/K_BM
M+2-OW2OY*X[ ?>/\_P J[Z\F-M8W$XZQ1L_Y#-<)X(A\[6Y9GY,<1(^I('\L
MUYV.?/.%'HWJ>MEJ]G3J8CK%:>K._BB2"%(HU"HBA5 [ 5"NG6BWKWHMT^TO
MC,A&3P,<>G [59HKO<4[76QY:G)7L]SS;_F>_P#M^_\ 9J])KS;_ )GO_M^_
M]FKTFO/R[_EYZGJYM_RZ_P (5%<_\>DW^XW\JEJ*Y_X])O\ <;^5>C+9GE1^
M)'G7@W_D8HO]Q_Y5O>/?^0=:_P#74_RK!\&_\C%%_N/_ "K>\>_\@ZU_ZZG^
M5>'1_P!PGZ_Y'T>(_P"1G3]/\S+\.>&(=7LGNKN:55W%(UC(!X[G(-.\4O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@"NG_(1F_P"N4?\ -ZL573_D(S?]<H_YO5B@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M"O>_ZA?^NL?_ *&M6*KWO^H7_KK'_P"AK5B@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JO;_P"ON_\ KJ/_ $!:
ML57M_P#7W?\ UU'_ * M %BBBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBF/(L;QJ0<R-M&/7!/\ 2@!]%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO-Z^;"BBBM3$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** *Z?\A&;_KE'_-ZL573_ )",W_7*/^;U8H **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH KWO\ J%_Z
MZQ_^AK5BJ][_ *A?^NL?_H:U8H **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *KV_^ON_^NH_] 6K%5[?_ %]W_P!=
M1_Z M %BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "J]Q_K[3_ *ZG_P! :K%5[C_7VG_74_\ H#4 6**** "BBB@
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MAA(GJCCAO\]><6_$_C"P\,"VADBGO-0NVVVUC;+NEE/KCL/>@#H:*\_G\?\
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M .ON_P#KJ/\ T!: +%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %5[C_7VG_74_P#H#58JO<?Z^T_ZZG_T!J +%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1LW/OC:/PKG_ !98W7_"P[SPG"C?8_$UQ:7<A X1(]WG8QW.P'\*]-\9*J>
MO$"JH55TRX  & !Y34 4OAK_ ,DXT+_KV'\S6'\$?^2<0_\ 7S+_ #%;GPU_
MY)QH7_7L/YFN+^$_B73]"L(_!^IBXM]:%Y*HA>%L'/.<XP!P>M %_0K*&?X_
M^*;N10TEO:0"/(^Z6BB!(]\ C\37<^*463PCK*NH938SY!&0?D-<?X<_Y+AX
MR_Z]K7_T6E=CXG_Y%/6?^O&?_P! - &)\+"3\,]$))/[IAS_ +[5V%<=\*O^
M29:)_P!<G_\ 1C5V# E2 <$C@^E 'EFE)XL^'#WFGP^'FUS19+EYX)[20"9
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M03D=,8Z 9P:P?B7XIN?%.D64NF6=Q%H,%]%ON[A#']HE.=H13R5 R2?7'IR
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M* "BBB@ JO<?Z^T_ZZG_ - :K%5[C_7VG_74_P#H#4 6**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *]E_J&_
MZZR?^AM5BJ]E_J&_ZZR?^AM5B@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ I'#%&"MM8C@XS@TM% 'G-A\2?[!\W3?'<4MA?PR,JW26SM!<)_"RE0>W^
M>H&=J^I-\4M6TC3-&M+L:%:W2W=[?3PF.-]HX1<\G.3^8/;->KT4 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!73_D(S?]<H_YO5BJZ?\ (1F_ZY1_S>K% !1110 4R2:*
M'9YLJ)O8(FY@-S'H!ZGVJ.\O;:P@\ZZF6*/<%#-W). *I_V+%+K9U.ZE:X=
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,U2XF^U*6N8V("R,A7S%('52&&,\CUS7K?Q5\9'PYX/\O3W8ZIJO^CV83.X
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M]V-DWU9R/A?4M2T;Q6-$N)VFA,AA9"VY0>S+GI6]XZO-; BL]+M[KR77=--
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M/$?_ )'HV^//3Q'_ .1Z/J7]]!_:G_3MGO5%>"[?'GIXC_\ (]&WQYZ>(_\
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M=?RV0G88:15VD,WOAOTH Z2BN>\6ZK=V%G9VFG.L=]J-TEI#*R[A%G)9\=\
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MZ9EDR@Y<'[S<]356QN[75KJ\36_%5_IFL+<2(+1;O[,D2AB$"J>'^7!SSG-
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MD,MXMS)!)C*N&SG:<8(- '?4444 %%%% !1110 4444 %%%% !1110 4444
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MZ]IOCNX\)^(KN'4Y'L?MMGJ4=NL+.@?:R.J\9!/&/ZT 5T^('BG4=0U2+0/
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M]"MKI&29+./<C#!7(S@^XSBJ=K\+/!%EJ(OX/#UN)PVX;W=T!]D9BH_*NPH
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MLZ9,VHZS UCX<6PL(E9IKB]L_*E9OX5C7@CGDDBNKHH **** "BBB@ HHHH
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MZQ-\L@_(Y_"M6KEJD[DK2Z"BBBH*"BBB@ HHHH **** "BBB@ HHHH ****
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M (?A6C117E-W=V?0QBHI170****1057N/]?:?]=3_P"@-5BJ]Q_K[3_KJ?\
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M10!7LO\ 4-_UUD_]#:K%5[+_ %#?]=9/_0VJQ0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !17':MJ&OS>/4T/2[N*WMGT
MU;B222)7\H^8REE'=CA1@G'4XJ2"[UK1/%6FZ7J.I#4[74TE$<C0+%)$\:[C
M]T $$?Y]0#K:*YWPWJ=YJ&I^((;J;S([2_,, V@;$V@XX'/)[TG]J7G_  E6
ML67G?Z/;Z?%-$FT?*Y+Y.<9/0=: .CHKS_PTWC'Q)X9M]3DUZ.RDD0^2BVD;
M>9@D;I"1QD]E XQWJ7P_<^*O%F@PZP-7BTL2*1%!%:K('*\%G+Y/+ \#&!0!
MTOB'6_[!LK>X^S^?YUU%;[=^W&]L9Z'IZ5K5YIK^N7.K_#32=6>W5KHW\6Z)
M#@.Z2LO'IDK^M;UW9^+[2QDU%-<@FN8D,K:?]D40OCDH'^_[ Y_*@#K:*Y&[
M\5W&H6&AQZ&L:7NM*71IQN6W11EV('4CH!W-1ZE/K_A6&/5+K6!JFGI(JW<4
MMLD31HS!=Z%,="1P<\4 =E17$:E?^([SQ]/H6EZ@EI:BR2=YF@60Q?,0=H(Y
M)XZG  /%==I\%S;6,4-Y>&\N%!WSF,1[^?[HX'I0!9HKE]2U+5-2\2OH&CW*
M60MH5GO+QHQ(R[L[413QD]<GM40O=:\.ZWI]KJM^NIZ?J,GD)<&!8I(9L$JI
MV_*0<'MG^H!;N_$5^==N-*TG1_MS6J(US+)<B%4WY*@9!W' SVKHJ\_\-:;J
MJ>._$/F:]-)Y$ML;C-M$/M(,60#@?+@<?+BNVU*9[?2KR:)MLD<#NIQG!"DB
M@"U17">&SXM\2>';34I]=73S)&/+6*TCD,F.-[[ACD\X4#C%68?&-Q9>'-7F
MU2"-M3TF;[/(D/"SNV/+9?0-N'TYH [*BN3.F^,OL7VO^WX/MVW?]B^R)Y&[
MKLW??QVSFJ\GBZ[U33-"BT>..+4=8#_-*-RVRQ_ZQB.^#D =S0!VE%<7JLWB
M/PI:C5KC5QJUA$R_:X9+5(G5"0"R%,<C/0YXHU;5=>F\>PZ)I%U#':S::MP\
MKQ!Q%^\8%QZD@* "<<YQ0!VE96GZU]NU[6-,^S[/[.:%?,WY\SS$W],<8Z=3
M6+-=ZYX:U73AJ.I+JFFWTZVK.\"1202-]P_+@%2>.1Q4%IJ,.D>)O'6H3Y,5
ML+:1@.IQ!T'UZ4 =M17(V=IXMU33X]1?78K":=/-CLDM$>- 1E59F^8G'4@B
MM;PSK,FMZ1Y]Q"L-Y#*]O<Q+T25#A@/;O^- %S4=4M=+2W:Z9A]HN([:(*N=
MSN< ?U_"KE</\0[2]FDT*2#4Y+>-M4MHUC6%&"R%CB3)&<CTZ5H:OJ.J:<ND
MZ'9W*7.KWS,OVN>,!41!EY"JX&<$ #@$T =117&ZE/K_ (5ACU2ZU@:IIZ2*
MMW%+;)$T:,P7>A3'0D<'/%/O=1U+4O%UWHUMK46D):Q1L@$*22W!<$DC?QM&
M,<#K0!U]4]*U2UUG3TOK)F>W=G569<9VL5)QZ94UG6=KXA>PO;*^U"))U<"U
MU"")=S+P<M&05!ZCTKF? LTVB?#]M8O=1DFL8HYW6U\I $*ROG# 9)8COZT
M>AT5R-G:>+=4T^/47UV*PFG3S8[)+1'C0$9569OF)QU((J%_&=VWA>":*TB&
MMS7ITT6Y8[$N Q!)[[1C/Y"@#J]1N_L&F7=YL\S[/"\NS.-VU2<9[=*-.N_M
M^F6EYL\O[1"DNS.=NY0<9[]:Y#7[+Q/IWAK4+I]:34U^S.)[9[5(AM*D,49>
M01G.#G.*Z;P[_P BSI/_ %YP_P#H H TJ*XWQ%JNO1^---T?1YHD2ZM7:0RQ
MAECPW,GJ2!P!D#)&:6^NM=\*SVEY?:J-4TR:=(+A9+=(G@WG"NI3&0#C(/\
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M"FDR:'X6T[39L>;!"!)@Y 8\D?F36Q110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!73_D(S?]<H_P";U8JNG_(1F_ZY1_S>K% !
M1110!D2WEY8Z^D=Q^\TZ[ 6)U7_42@?=;V;L?7BM>BLBRFU&UU26QOE:>WD+
M26UVJ]NIC<#H1V/0@>O%7\2TZ$[&O1114%!1110 4444 %%%% !1110 53U2
MR;4=.FM$F,)D&-X&>/2KE%*45).+ZE0DX24ENCF?#7AJ32;J>XNBCR?<B*G(
MQW/]/SKIJ**SHT8T8\D-C2O7G7GSSW"BBJ4FJVJ:I'IH9GNY%+E$7.Q?5CV'
MUK9)O8P;2&W-S;W4T^DQW;Q7;0%B8OO1J>,YQ@'FIK"QM],L8K.U39#$N%'\
MR?<]:BTS2;?2TF\HO)+,YDEFE.7D/N?;L*O54FOACL)+J]PHHHJ"BO>_ZA?^
MNL?_ *&M6*KWO^H7_KK'_P"AK5B@"AJ]Y/I]B;R*(2QPL'G7^+ROXBON!SCO
M@CJ:NQ2I-$DL3J\;J&5E.0P/0BG5FS:@NG:E:64L*16EPHC@E!PHE&?W9'09
M ^7UP1Z9I*ZLB&^5W;T-*BBBI+"BBB@ HJK=:E9V0/VBYC0C^$G)_+K6-<^,
M+./(MX99CZGY1_C^E7&$I;(SG5A#XF='17$3^+[^0D11PQ#MP6/Z_P"%9\NO
M:I-]Z]D'^YA?Y5HL/+J82QM-;:GH]%>7/>W4GW[F9O\ >D)J(NQZL3]35?5O
M,S>.7\IZM17E 9AT)_.I%N;A/NSRK]'(H^K>8?7E_*>IT5YK'K.I1?=OI_\
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M44 %%%% !1110 4444 %%%% %>R_U#?]=9/_ $-JL57LO]0W_763_P!#:K%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS)*Y)+.Q]2>?PZ"K(4*,  <YXI:');1T!+N%%%%04%%%% %>]_U"_P#76/\
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M^V34M("& (((/((I:YSL22V"J]O_ *^[_P"NH_\ 0%JQ5>W_ -?=_P#74?\
MH"T#+%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %5[C_7VG_74_P#H#58JO<?Z^T_ZZG_T!J +%%%% !1110 4444
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M.YU&7Q_I @T^/4GM])^T1137(A"R,^UG!*G)  'XT =7I?BG1M8N3;65Z&N
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M%=)110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %=/^0C-
M_P!<H_YO5BJZ?\A&;_KE'_-ZL4 %%%% !1110 45'+*4BE:-#+(BDB-2,L<<
M#GIGWJAI;:O,[W&I);V\;C]W:Q_,R>[/T)]@,52CI<5];$W]KZ?_ &DNG"[B
M:\;/[I3DC R<XZ?C566;7I=2\NWM;."S1QNFFD+M*O'W57&WOU-7;'3;+38C
M'96L4"$Y(1<9/OZU:I\T4_=7W_U_F*S:U,W4M&34YD::]O8XE7:T$$QC1_\
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MPM/$7A:R?38=(M=7TU6D9'BG$4Q5F+$.K##'D]#S6]X7O--OO#MK+I,!M[,
MHL!7:8R"05(]0<T ;%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT(JT4CRIN\FPHHHJB1CQ1R[?,17VL&7<,X(Z$>]9EQ)JUGJPD2,7FG3LJ&-
M%DMSTW#^\O<]QGT%:U%5&5A-7"BLF?3;N'64U"PN,),RK=V\K$HZ@8W+_=8#
M\#6HDB2;MCJVUMK;3G!]#[T-):I@GW'5Q/B?6/M4YLH&_<QGYR/XF_P%;GB/
M5?[/L?+B;%Q-D+C^$=S7 UO0I_:9PXRM;]VOF/B^^?\ =;^1IE/B^^?]UOY&
MF5T]3@?PK^NP44451(4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH J/+'!=74
MTK!(XX$9V/0 %R33--M+2%9KNT8N+Y_M#2,<[L@8Q[8Z"J^JZ>VJQ7UBLY@\
MZ")2X&?EW-D?B,C\:U$18T5$4*JC  Z 55THZ,74=1114C"BBB@ HHHH ***
M* "BBB@ HHHH *:\B1(7D=40=68X IU5=1MOMFFW-MC)DC91]<<?K2DVDVBH
M).23V%MM1L[V1TMKF.9DP6"-G%6:\X\%W/D:\(F; FC9,$]^H_D?SKT>N;"8
MCV]/G>YUX_"K#5>1.ZM<****ZCB"BBB@#E/&=SQ;6H/K(P_0?UKDJV/$\_GZ
MY,!TC 0?ED_J36/7H4E:"/%Q$N:JV%(P+*0"02,9':EHK0Q(M.>5[=?.!$JJ
MRMD=2 1G\:EJ.*=AJ36[ ;3"74_F#_2I*3^(?V5_78****8@HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "GO]R/_=_J:93W
M^Y'_ +O]34O=%1V8RBBBJ)"N8U&]^T:GM4_NX\H/<]S^=;NI7/V6PED!PV-J
M_4UQP."#W%;4H]3EQ$[6B:-% .0#15F04444 %%%% !1110 4444 %%%% !1
M110 4444 %6=/OI=-U""\@.)(G##W]1]".*K44-75F--IW1[W97<5_90W<!S
M',@=?Q[?6IZX?X<:F9K"XTYVR8&\R//]UNH_ _SKN*\:K#DFXGU%"K[6FI]P
MJO<?Z^T_ZZG_ - :K%5[C_7VG_74_P#H#5F;%BBBB@ HHHH **** "BBB@ K
M@/%.L7D/B!X[2ZEB$2*A5&(!/7IWZUWQ(4$DX Y)KR>2^MY->>_O) EMYYE=
MC_<!SC\N*\[,92M"G#>3/6RJ$%*=6I\,5_7Y'JELLBVD*S,6E"*'8]SCFL/5
M_&^@:,62XOEDF'!B@^=L^AQP/Q->7>*?B#J.NN]O:,]GIYXV*?GD'^T?Z#CZ
MUQU?14<!HO:,^.Q6<>\U17S_ ,D>M7'Q?LE8BVTF>1>QDE"?R!J./XPP%OWN
MBR*/5;@-_P"RBO*:*ZOJ='L>?_:F*O\ %^"/=--^)7AW4'5))Y+-VXQ<I@9_
MWAD#\<5UD<L<T:R1.LD;#*LIR"/8U\OUM:!XIU7PY.&LK@^23E[=^8W_  ['
MW'-85, K7@SLH9Q).U9:=T?1-%8?AGQ38^)[$S6W[N=/]=;L<LA_J/?^5;E>
M;*+B[2W/<A.-2*E%W3"BBBI+"BBB@ HHHH **** *]E_J&_ZZR?^AM5BJ]E_
MJ&_ZZR?^AM5B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,'Q1
M"EQ!IL,J[HY+^)&&<9!# U)_PB6A_P#/C_Y%?_&CQ%_S"?\ L)0_UK:KE5*G
M.K)SBGMNCM=:K3HP4)-;[.W4Q?\ A$M#_P"?'_R*_P#C1_PB6A_\^/\ Y%?_
M !K:HK3ZM1_D7W(R^N8C_GY+[V06EI!8VJ6ULFR%,[5R3C)R>3[FIZ**U225
MD8-N3N]PHHHIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M45L<PCV-2T,:V"BBBD,***0D*"20 .230 M%9UAKNFZG<M;V=R)954L0$8<
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MZZ<PNK[4B,_8K"$S2@>X' ZCJ>]5=.^)&C7FIQ:;>VVI:/>3'$,6J6I@,A]
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MM8KA)=+G\B<RJH5FYY7!.1P>N*P]*^*&BZWK4.G6%CJTJS2%([L6N(#[[LY
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MMM;Q^:PA 9F7VR0#U]:Y*Y^+OAZ$VZV]MJ=])+!'.\=I;B0PAU# /\V <$9
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MDO 'B&YU[1I1>MON;9PC/C&]2,@GWZC\*ZVMXR4E='%.#A)Q844451(4444
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M0Q>8SEN"0,D8_.F^%-5F'AS4X=Y+VD3219[ J3C\Q^M=3K1']@Z@<\?9I/\
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M_C7E_P#PJ37?^?S3O^_C_P#Q%'_"I-=_Y_-._P"_C_\ Q%'L,/\ SA];QO\
MSZ/4/^$GT#_H-Z=_X%)_C0/$V@L0%UK3R3T N4)/ZUY?_P *DUW_ )_-._[^
M/_\ $54F\&77AR]B>^N;65V4E$A9B1[G*CWKGQ/U>A1E4Y[V.K!2QN)Q$*/L
M[)O5]EU9J?$J]AUS7=)T^PNX)A@KN20,JN[ 8)&<=!6KX:T.TT-9X([A9[PA
M3,PX*@YP,=AP?K7"^(TGMOL,V"GF!I(Y!PW!QD'MR*W/ANQ9M59B2Q,1))Y)
M^>NC#SE5P4:C5O+YG'BH0H9G.DGS.^^W3M^!RWAS3DU77K:UE!,1):3']T#.
M/QQC\:[M_$$<?BE?#PLH?L>!$>.Y7/3ICMBN2\#2*GBF ,<%T=1]=N?Z5H30
MO_PM%5QR9E?\-@-=E5*4VGT1YN'DX4DX[N5GZ=B6'PS:_P#"?26C(#9I']I$
M?8C@;?IN/Y"M>V\0PZCXDN-!ELX3:#?&F1G++G.1TQP?RJ:.9&^(LR!AE=/V
M$>^\-_(US>B6TH^),V5_U<T[M]"& /\ X\/SK+XTW+HCH_AR2AUE9_Y%_P /
MZ3!IFOZYB,2O9*#!NYP&!;\\ #-0:V&U[P?IVI211_VA)/Y:[%QORS*%_0&J
M6M:Y=:1XVO[FS9<G:CJPRK811R/J*TM.URZO+2;7-2CA2UL 1;PQ*55Y2,>I
M[''_  *K:EI4]/RV,U*FU*CZ_GO\D9/B>:/3;.U\/6S K;@27##^.0C_ .OG
M\1Z52\(7RZ=XMTVYDD6.-9@KNQP%5@5))/08-=AY.GVCZ1#=Z=;W=SJA9YYY
M%!(8@$D9'3+>W KD;[0M_C%]&L2%\R94BWDX7< >3UP,U<)1E%P?9_\ !,JM
M.<*BJ1Z-:=NJ1[C_ ,)/H'_0;T[_ ,"D_P :/^$GT#_H-Z=_X%)_C7E__"I-
M=_Y_-._[^/\ _$4?\*DUW_G\T[_OX_\ \17%[##_ ,YZOUO&_P#/H]0_X2?0
M/^@WIW_@4G^-'_"3Z!_T&]._\"D_QKR__A4FN_\ /YIW_?Q__B*/^%2:[_S^
M:=_W\?\ ^(H]AA_YP^MXW_GT>H?\)/H'_0;T[_P*3_&C_A)] _Z#>G?^!2?X
MUY?_ ,*DUW_G\T[_ +^/_P#$4?\ "I-=_P"?S3O^_C__ !%'L,/_ #A];QO_
M #Z/4/\ A)] _P"@WIW_ (%)_C1_PD^@?]!O3O\ P*3_ !KR_P#X5)KO_/YI
MW_?Q_P#XBC_A4FN_\_FG?]_'_P#B*/88?^</K>-_Y]'I=OXBT2&(K+K%@C&1
MV :Y0'!8D'KT((/XU+_PD^@?]!O3O_ I/\:\TG^%^LWL@ECN[ *J)$0SOG**
M$/\ #TRIJ+_A4FN_\_FG?]_'_P#B*2HT+:S'+%8Q-I4CU#_A)] _Z#>G?^!2
M?XT?\)/H'_0;T[_P*3_&O+_^%2:[_P _FG?]_'_^(H_X5)KO_/YIW_?Q_P#X
MBG[##_SB^MXW_GT>H?\ "3Z!_P!!O3O_  *3_&C_ (2?0/\ H-Z=_P"!2?XU
MY?\ \*DUW_G\T[_OX_\ \11_PJ37?^?S3O\ OX__ ,11[##_ ,X?6\;_ ,^C
MU#_A)] _Z#>G?^!2?XT?\)/H'_0;T[_P*3_&O+_^%2:[_P _FG?]_'_^(H_X
M5)KO_/YIW_?Q_P#XBCV&'_G#ZWC?^?1ZA_PD^@?]!O3O_ I/\:/^$GT#_H-Z
M=_X%)_C7E_\ PJ37?^?S3O\ OX__ ,11_P *DUW_ )_-._[^/_\ $4>PP_\
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M&Z8'8KHJKM)'3[I_,=C5[QE\0=(N?#U[I?A^Y35=4O8'BCBM?G$:E2&=FZ
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M1V9TU,1">\=?4Y3XC7)M_!MRJG!F=(__ ![)_053^%MN(O"\LV/FFN6.?8
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M>G>([VVU![B^T_4K93'%?:?/Y4RH>J$X(*]>"#U/K71T4 8'A[P?I?AR"\6
MW%W<7S;KRZOI/.EN"!@;R>",$C  '/2L'_A4FA"/['_:&M_V-OW_ -D?;C]E
MZYQMQNQGMNKO:* &111P0I%$BI&BA411@*!P !7E_P 36TOQIJ.F^![0O<:J
ME_%+=>6C#[);["7=FQCE6  SR2*]3HH S-6\/Z7KFAR:-J%HDM@Z!/*&5VA<
M;=I'((P,8K LOAMIEOJ%I=W^JZUK'V.02VL.IWGFQP..C!<#)'8MFNRHH Y+
M4/A]87FM7FJVFJZSI4]]M^UKIUUY:SE1@%@5.#CC*X/7UJ&T^&>AV/A_6]#M
MI[]+'5VW3*9@S1G !*,5)R< G=NYKLZ* ,ZZT.PO_#[:)>0_:+%X! Z.>64#
M'48YX!R.]<Y9?#/3+:\LYKK5M;U."QD66UL[^\\R&%U^ZP4 9([9)Q7:44 <
M)-$WB?XK6TB -IWAF)][@\/>3*!L]]J8)]"PKNZ** "BBB@ HHHH **** ,;
M4;Z+3M5@GD@WM*T-J),X,8=GY^F57]*V:S;VQAU*2YM9]P1HXFRIP05=F!'X
M@5:L;ZWU*RCN[5]\,@)5L$=#@\'W!JW9Q31/4L4445!04444 %%%% !1110
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M("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%%;GBCP_)H.IE%!:TERT+GT_NGW'^%8==<9*2NCSIPE"3C+=!1113)"BBB@
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M<+1EYEO+:3YX0J7E'R/3****],\<**** "BBB@ HHHH **** "BBB@ HHHH
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M6_VV/^&ZNQU72;?6+5;>Y+JJN'#1D @_B#ZTS2-%MM%BDCMFD;S&#,9""?T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P!W< /TJ)U(PMS=78TITI5+\JV5WZ(V****LS"BBB@ HHHH **** "BBB@
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MA_Q!%K-OM;"7:#YX_7W'M_*MJO;IU(U(J47H?.5:4Z4W":LT%%%%69A1110
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MZK9>O;R(E5IO"<DI):=&M7Z-7OYK[SJZ***]<\$**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH KI_R$9O\
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MQ_#WH KZC(([=?[WF1D#Z.*Y37M$-TSWELO[X\N@_C]Q[UN7;M(H9CR9$_\
M0A3ZV@W!W1S58JHK,\T(()!&".H-,* ^U=MJ^A1WP,T.([C]'^OO[UQ\\$MM
M*T4R,CKU!K>=.EB8<M17.&G4Q&"J<]*5GW_S(E&!2T45K2I1I04(;(PKUIUZ
MDJM1W;"BHV+!L]*4/ZUY\<VH>U=*I>+3Z_UI\SUIY#BO8QK4K335]-U_G\A]
M% (/2BO234E='BRBXOEDK,****9(4444 %%%% !1110 4444 %%%% !1110
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MLT%%%<_XB\2+HVV"%%DNG&[#=$'J:56K&E'GF]!T:,ZTU""NSH**\V_X2CQ
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MXB_YA/\ V$H?ZUM5C#^)/Y'14_@P^?YA1116QSA1110 4444 %%%% !1110
M5EV^A6MMK$NII),9Y,Y4D;>?PS^M:E%3*$9--K8N%24$U%[Z,****H@****
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M#WNYR&E^,-0OM4MK66&U"2N%8JK9Q[?-74:KJEOI%F;B<D]D0=6/H*\V\/\
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MBBBN@Y HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.N.[5IHZR(KHP9&&593D$>HI.-M>@T[CJ***D84444 %5[C_ %]I_P!=3_Z
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MG3+&X*K4C7J)J2Z>AG> [.13=7C B-@(U_VCG)_I7:4R**.")8HD5$4855&
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M4 %%%% !1110 4444 %%%% !1110!73_ )",W_7*/^;U8JNG_(1F_P"N4?\
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M^5L#YAZ ^GO70U%%_K)_]\?^@K7-]1P_\B.W^TL7_P _&4+'0;33[D3PM*7
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M75^-/%D?A/2$G2W:ZO[J46]G;+UED/3\/_K#O0!TE<3_ &_J?_"XO[!^T_\
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M1;'4H_&MI&EW;QW"HVGQ$J'4-@_)[UT/Q5_Y)EK?_7)/_1BUJ^"_^1$\/?\
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M2/'#)!*45BNZ5%((8$9P2#76Z9-)<:39SRMNDD@1W;&,DJ": +5<3_;^I_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"058>XHL+^#4K-;JW+>6Q*X88(()!!'8Y%6:SK2TM=,O[A4GVM?R&98"0!N
M&XKWYX)JUK&S)>C-&BBBH*"J]Q_K[3_KJ?\ T!JL57N/]?:?]=3_ .@-0!8H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH KV7^H;_KK)_Z&U6*KV7^H;_KK)_Z&U6* "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH Q?$7_,)_["4/]:VJQ?$7_,)_["4/]:VJQA_$
MG\CHJ?P8?/\ ,****V.<**** /*_AM8VEYXM\>FYM8)RNKOM,L8;'[R3IFO1
MQH^EJP9=-LP0<@B!>/TKDO 7A[5-%\0^+[K4+7R8=0U)I[5O,5O,0NYS@$D<
M,.#@\UW5 #7=8T9W8*BC+,QP /4UY5;6:?%GQ-<:A>K(?"NG;[>SCR5^TRD8
M:3UP.WX>]=%\0=/\1Z_;6N@:-!Y5C>-C4+\R*/*BSRH7.XY[X'H.YQU.DZ7:
M:)I5MIMC'Y=M;($C7V]3ZDGDGU- ' ^ =4NO#FMW/@#6I2TML#)IEPW_ "W@
MZA?J!V]B/X:Z?Q5/XN@^R?\ "*VFF7&=_P!I^W%AM^[MVX8?[6?PK/\ B'X1
MN/$.FP7^DMY6O::XFLI00I8@Y*$GCG'&>,CT)KH]$N-0NM&M9=6LOL=^4 GA
MWJX5AP2"I(P>HY[T <WH-W\19=:MTU[3M#ATP[O.>U9S(/E.W&7(^]CMTS73
M66L:?J-Y>6EI=)-<63A+B-<YC8YP#^1J]7":WX8US3/%<OBGPFUM)/=1K'?:
M?<':EQMZ,K=FP._]2* .LU?1M/UW3Y;'4K6.X@D4@AQR,]P>Q]Q7(?"&_N;S
MP=-;7,S3C3[V6SAE8Y+QJ%*\_P# L?A3+R]^(VO6SZ?!X?M- $J[)+V:_6X*
MJ>I14Z'TS_\ 7&K%X>N/"7P\GTGPS$T]_' PA8LJL\S=7)8@#DYP3V H J>(
MO&EV^JOX;\)6J:AK8'[^5C^XLA_>D/<^W]>#>\)^"X?#\DVHWMR^HZY=?\?-
M]*.3_LH/X5]O;Z <9X3C\=^$M%6PM? 4,LC,9)[E]4AWSN>K-S^%;G_"2_$?
M_H0(/_!K#_C0!W=S<P6=M+<W,J101*7DD<X50.I)KSF75-<^)4DEKH3RZ5X9
M#%)M28$370Z%8@>@]S_]:K'Q/TOQ+KVGZ58:5I37EH9?.U"%;J.+>%QMCW,0
M<$[N1Z"B'7OB%;01P0?#RVCBC4*B)JD("@= !G@4 =GHFAZ?X=TJ+3=,MU@M
MHN@')8]V)[D^M:%<CH6M>,[W5HX-8\)1:=9$,7N%OXY2I X&T')R>*N:S>>*
M8/$>E0:1IMK<:1(P^WSRL \0W<[1O';V- '157OO^0?<_P#7)OY&K%0W:-+9
MSQH,LT;*!ZDB@#S7X,:;8W7P]BDN+*VED^TRC=)$K'J.Y%>A#1M+!R--LP1_
MTP7_  KRCP?#\2?!^@)I-OX/MKB-9&D\R2_B!^;Z/6__ ,)%\4/^A&L__!A'
M_P#%T >BDA5+,0 !DD]J^>O,TV/QU_PD"V<[>!QJQYW?N!<[<>;LQ]S=_G^&
MO2_%-OXN\1>']-TBWL!8OJ  U:X6="+5/XD7YLL3SR,C'UXZ+_A%M)_X13_A
M&OLP_LSR/(\O/./7/][/.?7F@#85E=0RL&5AD$'((KSGP=_R5SQS_P!N_P#Z
M#6MX L?$.AV=SH6M0F6TLGV6%\)%/G1=E*@[@1QU'3CMSB7.E>+O#?C_ %K6
MM#T6#5K/55BR&NEA:)E '.X_7IGJ* ,[6K/5+_XZR0:=K7]D7)TD&&=K5+C<
MN[E0K<#^(Y]CZUTO_"+^._\ HHW_ )1(/\:E\9>$+W7)].US1KE+'Q!I_,+O
MRCJ>L;>W)Y]SZ\4SK7Q+F@-JGA/3K>Y(V_;7OU:$'U$8.[^= &AX.\'7OAK5
M-7U"]UP:G-J;(\I%HL #KNYPK$<[NP%8WP/14^'2,HP7NY6;W/ _D!72>#/"
MI\+:9.EQ=M>:C>3-<WER1CS)#Z#T_P#KUG_"S0=2\.>"H]/U:V^SW0GD<Q^8
MK\$\<J2* ,WXT?\ (FV?_83@_DU,\=;?^%G^ _M&/LWG3;=W3S,+M_'.VM7X
MG:#J7B'PU;6FE6WVB=+Z*9DWJF$&[)RQ [BM#QIX3C\6Z.ENMPUK?6T@GL[E
M>L4@Z?A_^OM0!TE>;X@_X:#/E??.B?O?][?_ /$[:L0ZQ\3+>%;.;PMIUU<#
MY?MZWZI$W^T8_O>G3'TK.\+>#/$FE_$Z77M7D2[6ZLF^T74;*$68L,1JN=VT
M*H ..U &3X5TSQ!J7C/QL-)\4?V/*FJ/YL9T^.X,B;GV'+$8&,UUS>%_'14A
MOB*-N.<Z)!_C47B#PGK=AXK/BOPC+;_;)D$=]8W!VQW( X(/9N!Z=,YZ@P7U
MQ\1O$=F^F+H=GX?CF7RY[U[U9V"G[VQ4Z''K^8Z@ YOQIX5D\'?"&/29+\WL
M"ZFDDD@A\H"-B<C )[^_>O9X_+\I/*V^7M&W;TQVQ[5SJ>"=+7P+_P (F0[6
M7D>47.-Y;.=_UW<USFFM\1/"MFFD#1K3Q!;0+Y=M=K>+ X0?=#ANN!Z?F>M
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MQMTGLYX[JPMQNMP"R90*<@CDC'3DCIQ5GX7:+I4_QK\8V\VF6<D%G/<-:QO
MI6 K<X4H",+@=,8Q0![/XC\9^'?"2QG7-5AM&D&4C(9W8>H106Q[XI_A[Q=H
M'BN%Y=#U2&\$>-ZKE73/3*L 1^(KYX?4KR[^-WB.\N?"<OBJ:UFFBALBWRQ(
MCA$<J5;(  [8RV:VO"]EK_\ PN>PUNQ\$W?AVPE'E7ENH)B"E2"QPJA03M.,
M=1F@#V/Q#\0/"OA6Z6UUK68;:X8 ^4%:1P#T)5 2!]:\CN]4L=:_:7T"_P!-
MNXKJTE@4I+$V0?W4GZ^U1?##1]-\6?%/Q?=^)+6&_NX)7,<%T@=1F1E)V'@[
M0%49Z9J%=%TO0?VG["RTF-(;<MYA@C&%B9H&)4#L.^.V: /HRBBB@ HHHH *
M*** *Z?\A&;_ *Y1_P WJQ5=/^0C-_URC_F]6* "L^VTS[/K-]J+3;VNEC14
MVX\M5!XSWR236A63X;L[FRT94O4V74DLLLHW!N6=CU'L15K2+=_Z_I$O=&M1
M114%!1110 4444 %%>?^._BUHW@BZ_L\P27^I;0S6\3!1&",C>QS@GK@ \?A
M6!X;^/\ HVKZE%9ZKILNE>:P1)_/$L8)Z;CM4J/?!]Z /7Z*Q?%'B?3O".@3
M:OJ3MY*85$3EI7/15]S_ (FO-M.^/UI+?VJZMX=NM-L+HXBO#+O!&<;L;!D#
MO@G% 'L=%075Y;V=C+>W$R);11F5Y"> H&2?RKF/ /C6?QSI]WJ(T=K"QCF,
M5O(\^]I\=3C:,8X[GG([4 ==1110 4444 %%%(QPC'VH RF.YR?4YJAK*W+:
M1=?8V=;E4WQ[.I(YQ^.,?C5ZBMHNSN<S5T-C?S(D?:R[@#M88(]C3JI:1>27
M^F17$JJLA+*P7H"K%3_*KM$E9M G=7(KC_5C_?3_ -"%2U%<?ZL?[Z?^A"I:
M170****!!1110 4444 %%%% !14%Y<?9+&XN=N_R8VDVYQG SC->,?\ #0G_
M %*__E0_^UT-V&DWL>W45XC_ ,-"?]2O_P"5#_[77>ZC\0]/TCP/8>([^!T:
M^B1H;1&W,S,,XS@< =3C^@I70.+1V-%>7:'\9[6_UFUT_5M$N-*6[V^1,\F]
M6W?=)RJX!]1D5Z)K&JVNAZ/=ZG>/MM[:,R/ZG'0#W)P![FG<&FB[17.^"_$E
MSXL\/IJUQI?]GI*Y$*&;S"ZCC=]U<#.1^%=%0(**** "BBB@ HHHH **** "
MHHO]9/\ [X_]!6I:BB_UD_\ OC_T%:!DM%%% @JC+I_G:S;W[R K!$R)'MZ,
MQ&6S]!BKU9NEVUQ%=:G/<IM:>YS'R#E JJIX^AJXZ)NXF=);G-NA]L5+4%H<
MP#V)J>L'N="V"BBBD,**** "BN#\>?%71O TZV4D,E]J++O^S1,%"*>A=CTS
MZ8)KF?#W[06CZGJ$=KJVERZ6DC!5G$XFC7/=OE4@>^#0![%161XC\2:=X7T"
M?6=1D(MH@,!.6D8_=5?4G_Z_2O,;+]H"U>[MCJ7AN\L=-N&(CO?-W@@'!.W8
M,@=\$T >RT5"]W;Q637CS(MLL9E:4GY0@&=V?3'-<KX"\<2^.8;^\CTAK/3H
M)O*MYWFW&XZY.W:-N!M[GDX[4 =A1110 4444 %9FJZ;+>W6FW-NZ)-:7(D+
M-WC((=1]0?TK3JCK4,MQH5_#!N\Y[>01[#R6VG&/QJH.TD3):%ZBJ^GR32Z;
M:R7"LLS0HTBL,$,0,@CZU8I-6=BD%5[C_7VG_74_^@-5BJ]Q_K[3_KJ?_0&I
M 6**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** *]E_J&_ZZR?\ H;58JO9?ZAO^NLG_ *&U6* "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH Q?$7_,)_["4/\ 6MJL7Q%_S"?^PE#_
M %K:K&'\2?R.BI_!A\_S"BBBMCG"BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH XGX=Z!J>A?\)#_ &E;>1]KU26X@_>*
MV^,]#\I./H>:[:BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "O/_  A\,CX;\::KXHO=8_M*]OP^!]F\H1;VW-CYVST
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M]5BJ]E_J3_O58K![G1'8****0PHHHH ^7/"T47C+X]O+J*I<0/>SSE'^965
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M%_SYZC_W[3_XNG?\*ET#_GZU'_OZG_Q%'_"I= _Y^M1_[^I_\13_ -D\Q?\
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M*ET#_GZU'_OZG_Q%'_"I= _Y^M1_[^I_\11_LGF'_"CY#?\ A;>A?\^>H_\
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M^%2Z!_S]:C_W]3_XBC_9/,/^%'R&_P#"V]"_Y\]1_P"_:?\ Q='_  MO0O\
MGSU'_OVG_P 73O\ A4N@?\_6H_\ ?U/_ (BC_A4N@?\ /UJ/_?U/_B*/]D\P
M_P"%'R&_\+;T+_GSU'_OVG_Q='_"V]"_Y\]1_P"_:?\ Q=._X5+H'_/UJ/\
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MSJTI4IN$U9H****LS"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "N%\?3OJNJ:%X,A=E35Y6DOF0X(M(AN=<]M
MYPN?K7=5P&H_N?CKHKR#"3Z+/%$3W=9 Q _X#0!D>.-1TF]\:QZ'K]_]C\,:
M98+<W4"2,GVJ9V*QQ$)\S *"=HZ^E:?PZM= 74M1NO"&NB?07C56THAR;6<$
MY8;SN0$9^4CD]^,5GZM%IFA?'>UUK7/*BM+[2_)L[N? CCN5;E=QX5MG0D_Q
M$=ZDTZZM=3^-6I:GX=,=W;V^B^5?202#RI;@OE%W#(+;1U[8Q[4 >=:,G@+4
MK'4-?\1^%M;U-KG4;F>XU&VBF^SVZ-(2 S(ZCIR2 <9YKZ#T"/2XO#VGIHI4
MZ6MN@M2CEAY>/EY/)X]>:X_3_B1X5G\!SW]X;/33%'*ESI#R*)(W!(:/9@$D
MGVYS]:S_  ;\.M+UKX5>&M/\6Z8T\UK'+-'&\TD9C$CLP!VL#G:5X/2@#KO!
MWB2;Q-9:E/-;I ;34I[)0A)W",@!CGN<UT,C%(V8(SE02%7&3[#->2> OA%H
M-O\ :[W5] >.^MM6E>Q9[B48A5@8B 'P1QWSGO7KM &)X?\ %.F^(_#2:]:F
M6&T(<NMPH5XMA(8. 3@C![UDM\2M%7P]I>K-;:COU4L+&P2W#W,^">5121C'
M.21P17GWB)KS0=:\2>!;$,H\4W<,^GL 2(UG.VY)]@$/T!J]XSTV70_B/X8E
MM]<'A_3%TMM/M;UK>.5(I%).P[_E7<F!G_9^M 'H&@>-=/U[4)=--K?Z;J<4
M8E-EJ,'E2M&3C>HR0PSZ$X[UE7OQ3TBVDO#;:7K>H6=D[)<W]E9[[>(K][+$
MC..Y -<[I$*7GQ1TN:;QI/XCOM.M9I"+6Q@6*.-UV[9)(R.22"!SR.V<UCVO
MBFYU#P'>:A!KWA[POI;+<+'I%K9K)< [F&P@L!O8Y/"_Q=/0 ]'UOXC>']!T
MK2-4N99Y+#53_H\\,>X ;=P)&0>>F "<]JB'Q'TY-$74KK2-<LVEN1:VUG<6
M16YN9",CRT!.1CN<"N T^**X\-?"%)%#J+P-@^JJQ'Y$5VWQ+&B-;:,NLWE]
MIK_;A]CU2U*J+6;:<%V/ 4C(Z?E0!IZ%XSTWQ)?W.CRV&H:?J$</FO8ZG;"-
MWB)QN R0RY..M9W@&ZDT[4-=\&SLS?V-.K6;,<DVDHW1KGN5Y7/H!6/X7UO5
M;;XB1:!+XBLO%%I-9/.;V&&-9;3:>%=D)!!SWYY[=]#2_P!]\=-?DB^Y;Z1;
MPSX/_+1F++G_ (#0!Z!1110 4444 %%%% !1110!73_D(S?]<H_YO5BJZ?\
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M $!J0%BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@"O9?ZAO\ KK)_Z&U6*KV7^H;_ *ZR?^AM5B@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** ,7Q%_S"?\ L)0_UK:K%\1?\PG_
M +"4/]:VJQA_$G\CHJ?P8?/\PHHHK8YPHHHH X"Y77/$M_);_,EHDA7.-L8
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MU*]BG+G@I=T>!5AR5)0[-H****LS"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "N5\;Z%>ZC!IVK:/&LFLZ/<BYM49@HF4_+)%N/ W
M+QGU KJJ* *MW8V>JV7V?4;&&X@< M!<QK(N?<'(I;#3K'2[46NGV=O9VX.1
M%;Q+&@/T  JS10!FS>'=$N-1&HS:/I\E\I!%R]JAE!'3YB,UI444 %%%% '"
M:7I&M:[X^B\2Z_I$>F0:9;O;Z?;F=)I'=S\\I9> -OR@=>37:7=G:W]L]M>6
MT-S;N,/%,@=6^H/!J>B@"GIVDZ;I$!@TS3[6RA)R8[:%8U)]<*!4 \.Z&-1.
MHC1M/^W-UN?LJ>:?^!8S6G10!0BT/2+>&TAATJQCBLV+VJ);H%@8YR4 'RDY
M/(QU-6KFUM[VW>WNH(IX'&&CE0,K#W!X-2T4 4+'2-,T2WE72=*M;13\QBLX
M$BWG\,#/UK$\$:#>:7:ZAJ>K(%UC6+DW5T@8-Y(Z1Q!AP0BX&?4FNJHH ***
M* "BBB@ HHHH **** *Z?\A&;_KE'_-ZL573_D(S?]<H_P";U8H *S;UK+3]
M1@U"?<LT^VR5@,CYB2N?3G/YUI53U73H]5TR>RD8IY@^5UZHP.58?0@&J@U?
M784MM"Y14-M<1SHPCF25HF,<A7LXZ@^AJ:I:L,**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@#-N5VSO[G-9DE[)_;4%A$JE?)::9CU49 7'U.?RK
M6U$I"OG.P5%4EF/0 <YK-L)TO;6.]6 Q&9 1N W;><9_G^-;0VNSGGO8M444
M4@(KC_5C_?3_ -"%2U%<?ZL?[Z?^A"I:!] HHHH$%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5%%_K)_\ ?'_H*U+447^L
MG_WQ_P"@K0,EHHHH$%9FM6L\T%O<6JEKBUG69%'5QT9?Q4FM.I(%WSH/?-5&
M7*[A:^AI*-J@>@Q2UD:1)>07U_I]YYCB.3SK>9CG?$Y)"Y]5.1],5KUE*/*[
M&Z=T%%%%2,**** "BBB@ HHHH **** "BBB@ HHHH *R(8;N?Q3<7,JR):6]
MNL4 )^61F.YFQ[8 _.IM;OYM/TN26VA::Z<B."-1G+MP,^PZGZ5;LXYH;*".
MXE\Z=4 DDQC<V.3^=6KQC?OH2]78FHHHJ"@JO<?Z^T_ZZG_T!JL57N/]?:?]
M=3_Z U %BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@"O9?ZAO^NLG_H;58JO9?ZAO^NLG_H;58H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#%\1?\ ,)_["4/]:VJQ?$7_ #"?
M^PE#_6MJL8?Q)_(Z*G\&'S_,****V.<**** "O-?!O\ R,47^X_\J]*HKFK8
M?VLX3O;E.S#XOV-.I3M?F5O3?_,SM;TXZII4MLC;9/O(<_Q#_.*X:PU;5/##
M2VTEM\K-G9*" #Z@UZ514U\+[2:J0ERR16&QOLJ;I3CS1?0\XT_3;_Q)K/VR
MZC98&<-(Y&%P/X5_#BO1Z**K#894$];M[LC%XN6(:TLEHD<WK'AF74]72]6Y
M2-5"C:5)/!KI***UA2A"3E'=[F52O.I&,9/2.P5R?CW_ )!UK_UU/\JZRBIK
MTO:TW"]KCPU;V%6-2U['+:9:?;OA^+<#):.0J/<.Q'Z@5R&@VGVW7+2$C*[P
MS#V')_E7K%%<M3 1FX-OX4EZV.VEFDJ:J)1^-M[[7^6OX'!^/?\ D(VO_7(_
MSK2U_P#Y$>W_ .N</\A7545;PEY5)<WQ+[C-8^T:4>7X'???\#D_ 7_(.NO^
MNH_E6#X<_P"1RA_WY?\ T%J]*HJ?J7NTUS? ^VY?]H^]5ER_&K;[:6[:GGOC
MO_D-P_\ 7LO_ *$U;?B/_D3(O]V+^E=/15?4]:CYOC_ GZ_[M)<OP>>_X:'(
M>!XUETF]C<91Y-K#U!6L:2TU/PGJIN(8R\7(63;E74]CCH?\*](HJ7@4Z<8\
MUG'9E+,FJLYN-XRW7_!/-K_6]3\2*EG%;?+NSLB4G)]SZ5U-CI)T?PK=PR$&
M9XI'D(]=O3\*Z"BJI8/EDYSES2>ER:V/YX*G3ARQ3O;N<!X#_P"0M<?]</\
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M.>YQZ#J3T%-)MV0FTMRIJ5Q9ZA<S:+)$\S>1YLV/NHI. &.>IYX]J  JA5
M'  [5=M-.M;)KEX(\/<R&65V))8GW/8=AVJK(A21E/8UI=;(RDGNQM%%%!)%
M<?ZL?[Z?^A"I:BN/]6/]]/\ T(5+0/H%%%% @HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "HHO]9/\ [X_]!6I:BB_UD_\
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MQ^5$EY;0S)#+<0I*^-B,X#-G@8'>N6\ _P#'I>_[Z_R-,\1_\CCH_P#O1?\
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M9&WF+(RL'BE0X:)QT93ZBKU%--Q=T)I-691M;IK:.TL]2N8#?R(<;3@2E>I
M]<8./KZ5>JGJ6F6NK6OD72$@'<DB':\;#HRGL15:ZU2/0X;2/4'F>)AL>\V?
M*K#&-^.F?7I]*NW-\._;_(5[;[&K138Y$EC62-U=' 964Y!!Z$&G5F4%%%%
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M 4444 %%%% !1110 4444 %%%% !1110!B^(O^83_P!A*'^M;58OB+_F$_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M26H4445(PHHHH JWD61Y@ZCK5*M<C(P>E9L\)BDQ_">E7%]#*<>I5N/]6/\
M?3_T(5+45Q_JQ_OI_P"A"I:HGH%%%% @HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "HHO\ 63_[X_\ 05J6HHO]9/\ [X_]
M!6@9+4]M%YDF3]U>M0HI=@JCDUIQ1B) H_&E)V'%78^BBBLS8**** "BBB@
MJ"\LK;4+9[:[@2:%^J.,C_\ 74]%--K5!N9UCHUOID,T-E)/%'(/E4REQ&<8
MRN[.*CLK'6+:Y#7.LI=P=T>T5&_!E('Z5JT57M):WZD\J,NY37?M1-K<:=]G
MSD"6!]X'ID/@_7%2:A;:G<!!9:C%9X'SDVWFDGVRPQ^1K0HHYWI_D'*9YTV6
MXTP6E[?SROG+31'R6;V^7H*73=&T_2!)]BMQ&9#EV+%F8^Y))J_12YY6M?0?
M*MPHHHJ1A1110 4444 %%%% !5>X_P!?:?\ 74_^@-5BJ]Q_K[3_ *ZG_P!
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH KI_R$9O^
MN4?\WJQ5=/\ D(S?]<H_YO5B@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@"O>_P"H7_KK'_Z&M/F@69?1AT-,O?\
M4+_UUC_]#6K% -7,IT9&*L,&FUJ21+*N&'T/I6?+"T1YY'8UHG<QE&Q'1113
M)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "CJ<"G(C2-M
M49-7H;=8N3RWKZ4F[%*+8RWMMF'?[W8>E.M_]?=_]=1_Z M6*KV_^ON_^NH_
M] 6H;N:I6+%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !5>X_U]I_UU/\ Z U6*KW'^OM/^NI_] :@"Q1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!7
MLO\ 4-_UUD_]#:K%5[+_ %#?]=9/_0VJQ0 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5T_Y",W_ %RC_F]6
M*KI_R$9O^N4?\WJQ0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!7O?]0O_76/_P!#6K%5[W_4+_UUC_\ 0UJQ0 4A
M (P1D&EHH IRV?\ %'_WR:JD%3@@@^]:U,>-)!AE!]ZI2(<.QET5:DLV',9W
M#T/6JS*RG# @^]6G<S::$HHHH$%%%% !1110 4444 %%%% !1110 44=:GCM
M9'Y/RCWHN-)L@JQ%:N_+?*OZU:CMXX^0,GU-2U+EV+4.XU(UC7"C IU%%0:!
M5>W_ -?=_P#74?\ H"U8JO;_ .ON_P#KJ/\ T!: +%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5[C_7VG_74_P#H
M#58JO<?Z^T_ZZG_T!J +%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% %>R_P!0W_763_T-JL57LO\ 4-_UUD_]
M#:K% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J]Q_K[3_KJ?\
MT!JL57N/]?:?]=3_ .@-0!8HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH KV7^H;_KK)_Z&U6*KV7^H;_KK)_Z
M&U6* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@"%487LLA'RM&B@^X+9_F*FHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH AN4:2)549(D1OP#
MG]!4U%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !4,*,DMPS# >0,ON-JC^8-344 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %0S(SRV[*,A)"S>PVL
M/YD5-10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 0VR-'$RL,$R.WX%B1^AJ:BB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
8@ HHHH **** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>img88009329_21.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_21.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .K!M<# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\3ZQX:M]+?2+S[,T[R"0^4C[L!<?>!]37#I\7]?BT);?S4FU)I69[J2)0$3
MVJJ@ 9SGDC_ZT*#:N4Y)'OE%>2?#/QEXH\1^(GM;^[CN+.*%I)6:!5([* 5
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MHI'@_P :_P#D<K/_ +!Z?^C)*]'^%PS\-]*!SSYW0X_Y;/7G'QK_ .1RL_\
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M]LEQ(P&"S.H8D^O7'T KQ7XIPQ0?$'41$@0.(W8#NQ09/XU[MX3_ .1-T/\
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M)]CW;!V&=XS@8%>GT4<SO<?*MCQ__A1?_4Q_^2/_ -LH_P"%%_\ 4Q_^2/\
M]LKV"BCGD+E13TFP_LO1K'3_ #/-^RV\<'F;=N[:H7..<9Q5RBBI*.2\<^"/
M^$TALH_[0^Q_96=L^3YF[=C_ &ACI3O _@S_ (0RTNX/M_VS[1(K[O)\O;@8
MQ]XYKJZ*=W:PK*]PHHHI#.#\;?#;_A,=9AU#^UOLGEVZP>7]F\S.&9LYW#^]
M^E=)X6T+_A&O#EII'VG[3]GW_O=FS=N=FZ9./O8Z]JV**=W:PK+<\UUWX-Z5
MJ=[)=:?>R:<9#N:(1B2,'OM&01],TFC_  8T>RN%FU*]FU#:<B/9Y2'Z@$D_
MG7I=%/F8<J/,=$^$4FA:_::K;>(,FWEWB-K/[R]"N=_<$C.*]%O]/M-4L9;*
M^@2>VE&UXW'!_P #[U9HI-M[@DD>57_P0L)IV:PUB>VC)R$EA$N/;(*U<T7X
M-:/I]RD^HW<NHE#D1E!'&3[C))^F:])HI\\@Y4(JJBA54*JC  & !7&>*/AE
MHOB6Y:\!DLKU^7EA PY]64]3[C!KM**2;6PVKGD4?P,B$F9/$#M'_=6T /Y[
MS_*O0/#/A#2?"EL\6G0MYDF/,GE.YWQZGL/85NT4W)O<221RGCCP9_PF=I:0
M?;_L?V>1GW>3YF[(QC[PQ7/V_P &M*70VLKJ^DENQ,TD=Y%$(V4%5&PJ2=PR
MI/X_GZ7124FM LCR6'X&VZS@SZ]*\.>52V"M^98_RKTG1-#L/#VFI8:= (H5
MY/=G/<L>YK1HH<F]P22,_6-%T_7]/>QU*W6:!N0#P5/J#V->;W?P.LWF)L]<
MFACSPLMN)"/Q#+_*O6**%)K8&DSSO0?@_HFEW*7-_/+J4B'*HZA(\^Z\Y_$X
M]J]# "J%4  #  [4M%#;>X))!1112&-=%D1D=0R,"&5AD$>AKSW6O@]H6HSM
M/8S3:<S')2,!X_P4\C\\5Z)133:V$TF>1P_ R%9 9O$#NG<):!3^9<_RKO/#
M7@O1?"L9_L^W)G88>XE.Z1OQ[#V&*Z"BFY-[@HI!7%>*/AEHOB6Z>]!DLKU^
M7EA *N?5E/4^XQ7:T4DVMAM7/(XO@9")<RZ_(\?]U+4*?SWG^5>@^'/">D>%
MK5H=-@(=_P#632'=(_U/I[# K;HIN3>XDDCF_&WA/_A,=&AT_P"V_9/+N%G\
MSRO,SA67&,C^]^E4_ O@7_A"OM__ !,?MGVOR_\ EAY>S9N_VCG.[]*["BE=
MVL%E>YSWC/PO_P )=HBZ;]L^R;9EE\SRO,Z C&,CU]:S/ W@#_A#+B\E_M/[
M9]I15QY'E[<$G^\<]:[2BB[M8+*]SGO%WA"Q\7Z=';7;O%)"Q>&:/!*$]1@]
M0>./85PUO\$(X;E9&\02%5;< EH%/7UWG^5>M44U)K8&DSDO'/@C_A-(;*/^
MT/L?V5G;/D^9NW8_VACI4O@CP?\ \(;IUS:?;_MGGR^9N\GR]O &,;CZ5U%%
M*[M8+*]PKFO%/@?1O%B![V-XKI!A+F$X<#T/8CZ_ABNEHI)V&>1-\#(O-ROB
M!Q'_ '3: G\]_P#2NR\+?#[1?"K_ &BW1[B\(Q]HGP2O^Z.B_P _>NKHJG)L
M2BD9GB#2?[=T"\TOS_(^TQ[/,V;MO.<XR,_G7'^$/A?_ ,(KKZ:I_;'VK;&R
M>7]FV9R,9SO/\J]#HI)M*P61R7CGP1_PFD-E'_:'V/[*SMGR?,W;L?[0QTJ7
MP1X/_P"$-TZYM/M_VSSY?,W>3Y>W@#&-Q]*ZBBB[M8+*]S"\2^$M)\56RQ:C
M ?,3_5SQG;(GT/I['(K@)?@9"9<Q>('2/^Z]H&/Y[Q_*O7**:DUL#29Q/A?X
M8Z+X;NDO6:2]O4Y228 *A]54=#[G-=M112;;W!*QYYXB^$6CZQ>27=C<2:;-
M(2SJB!XR?4+D8_ XJGI'P6TNSNDFU'49;]$.?*6(1*WL>2<?B*]/HI\S#E1Y
MAI'P?&E>(+35!K@D%O<+,(19[<X.<9W\?E7I]%%)MO<$D@KSKQ9\*_\ A*/$
M,^J_VS]F\U47ROLN_&U0.N\>GI7HM%";6P-7,SP_I/\ 86@6>E^?Y_V:/9YF
MS;NYSG&3C\ZTZ**0PKRO5O@S_:FLWVH?V_Y7VJXDG\O['NV[F+8SO&<9KU2B
MFFUL)I/<*\NUKX._VQK=[J7]O>3]JF:7R_L>[;DYQG>,_E7J-%";6P-)E2;3
M;:ZTHZ;>1K/;O$(I%8<,,8_#^E>9WOP/LI;AGLM:FMXB<B.6 2$>V0R_RKU>
MBA2:V!I,\U@^#&C1:7<P->3RWLJ;4N77Y8CD'(0$9Z8Y-:'@KX=R^#=4GNEU
MD744T7EO";79W!!SO/3GMWKNJ*?,PY4<CXJ^'>C>*IOM4OF6M[C!GAQ\_IN!
MX/Z'WKD!\#(_,R?$#&/^Z+3G\]_]*]=HH4F@<4SFO"O@?2/"2,UFCRW3KM>Y
ME.6(]!V K8U72;'6]/DL=1MTGMWZJW8^H/4'W%7:*5WN.QY1>_ ^RDF9K+6I
MX(R>$E@$A'XAEJ]HOP:T:PN%GU&[FU$J01&4$<9/N,DG\Z])HI\\A<J$551%
M1%"JHP !@ 4M%%2,X[QSX%D\:/9?\37['':A\)]G\S<6QS]X>E<A_P *+_ZF
M/_R1_P#ME>P452DUL)Q3/'_^%%_]3'_Y(_\ VRNU\#^#/^$,M+N#[?\ ;/M$
MBON\GR]N!C'WCFNKHH<F]P44CS#7_A!_;FO7NI_V[Y'VF0R>7]DW;?;.\9_*
MI=;^#6DZC>/<:=>R:=YAW-$(Q)&#_LC(('MFO2J*.=ARH\WT'X.Z3I=Y'=:A
M=R:BT9W+&T8CCS[C)S],XKT@  8' HHI-M[@DD%-DC2:-HY45XV&&5AD$>A%
M.HI#/-M8^#6BWT[3:?=SZ>6Y,842(#[ D$?G6;!\#;=9 ;C7I9$]([4(?S+'
M^5>MT57/(GE1A>'/".C^%H&33;<B1QB2>0[I''H3Z>PP*UKVS@U&QGLKJ,20
M3H8Y%/<$8J>BIN4>27'P-MVG+6^O2QPYX22V#L!]0P_E7?\ AKPS#X>\.+HK
M3&\A&_<94 #!NHQZ<G\ZW**IR;W$DD>6ZG\$]/N;IY=/U66SC9L^4\(E"^P.
MX''US5BQ^#>DVFGW4<MY)<7DL31QSR1C9"2,;@@/)^IKTJBCG8<J//\ P=\,
MO^$2UW^TO[7^U?NFC\O[-Y?7'.=Y]/2NTU32K+6M/EL-0@6:WD'*MV/8@]C[
MU<HI-MZ@DD>3W?P.M)+@M9ZW-#"3PDMN)"/Q#+_*K9^"^EKH\EK%?R?;9&4F
M[DB#;0.H5 1C/KDFO3:*?/(7*CC_  +X%_X0K[?_ ,3'[9]K\O\ Y8>7LV;O
M]HYSN_2NNDD2*-I)'5$0%F9C@ #J2:=7B/B[P1XUU;Q-J5S;VS2VEQ,2@6[0
M*4& N5+#L!VH7O/5@]%H<!>PPZGXGN(-(B)AN;MEM4QSAGPH_45]/Z-ID6C:
M-9Z=#C9;1+'GU(')_$Y/XUY[\/?AE<:%J(U?6C$;F,$00(=P0G@LQZ9],?6O
M4*<Y7T0HJP4445!8UT61&1U#(P(96&01Z&O/=:^#VA:C.T]C--IS,<E(P'C_
M  4\C\\5Z)133:V$TF>1P_ R%9 9O$#NG<):!3^9<_RKO/#7@O1?"L9_L^W)
MG88>XE.Z1OQ[#V&*Z"BFY-[@HI!7%>*/AEHOB6Z>]!DLKU^7EA *N?5E/4^X
MQ7:T4DVMAM7/(XO@9")<RZ_(\?\ =2U"G\]Y_E7H/ASPGI'A:U:'38"'?_63
M2'=(_P!3Z>PP*VZ*;DWN))(YOQMX3_X3'1H=/^V_9/+N%G\SRO,SA67&,C^]
M^E4_ O@7_A"OM_\ Q,?MGVOR_P#EAY>S9N_VCG.[]*["BE=VL%E>YR7CGP1_
MPFD-E'_:'V/[*SMGR?,W;L?[0QTJ7P1X/_X0W3KFT^W_ &SSY?,W>3Y>W@#&
M-Q]*ZBBB[M8+*]SB/''P]_X3*^M;G^U/L?D1F/;]G\S=DYSG<,5L>#_#7_"*
M:"NF?:_M6)&D\SR]G7MC)_G6_11=VL%E>YY7JWP9_M36;[4/[?\ *^U7$D_E
M_8]VW<Q;&=XSC->J444-M[@DD>56OP8^S:M#??V_N\J=9MGV/&<-G&=]>G7E
MO]KL;BVW;/.C:/=C.,C&<5/10Y-[@DD>8:!\(/[#UZRU/^W?/^S2"3R_LFW=
M[9WG'Y5Z7<6\-U;R6]Q$DL,BE71QD,#V(J2BAMO<$DCS'5O@MI-W<-+INH3V
M*L<^4R>:J_3)!Q]2:AT_X(Z?#.KZAJ\]U&#GRXHA%GZG+5ZI13YY"Y45K"PM
M=,LHK.R@2"WB&U(T' '^>]<!XI^%'_"2^([O5_[:^S?:-G[K[+OV[45>N\9^
M[GIWKTBBDFUL-I,IZ38?V7HUCI_F>;]EMXX/,V[=VU0N<<XSBN&\6?"O_A*/
M$,^J_P!L_9O-5%\K[+OQM4#KO'IZ5Z+10FUJ@:3,_0],_L70K+3?.\[[-$L?
MF;=N['?&3C\ZYWQ5\-M&\47!NV,EG?$?--"!A_\ >4]?KP:[*BB[6H6/(X_@
M9")<RZ^[1_W5M I_/>?Y5Z#X;\*:5X5LV@TV$AGQYLTAR\A'J?Z#BMNBAR;W
M!)(H:QHNGZ]I[V.I6RSP-S@\%3Z@]0:\VN_@=9R3%K/6YH8R>%EMQ(1^(9?Y
M5ZQ10I-; TF><:'\'-%TVY2XU"YEU%T(*QL@CCS[KDD_3./K7HP 50J@  8
M':EHH;;W!)(XKQ5\,]'\3W+7H>2RO6^_+$ 0_NR]S[@BN=LO@?913JU[K4UQ
M$#DI% (B?;)9J]7HIJ30<J/*=2^"=O=ZA-/::P+2W=OW< M-VP8Z9WC/UKU:
MBBDVWN"204444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1163KVM'1
M;>&46WGF1]FW?MQQ]#45)QIQ<I;(NG3E5FH05VS6HKFO^$CU7_H6[G_OL_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M97U5B;Q=J*1:=/8F"X9Y8U82*F47YNYS[?J*7PUK$<MI9V M;I7$>/-:/$?
MSUS5OQ3_ ,BU>_[J_P#H0J;P_P#\B_8_]<A4\L_K>_3MTOL5S0^H_#]KOUMO
M_P  TJ**R?$E\^GZ'/+&2LC81".Q/?\ +-==2:A%R?0X*5-U)J$=WH1WOBG3
M;.X, ,MQ*/O+ N['XY J%O$-AJ>GWL$;213^0_[J9=K'Y3TJQX;TN+3M)A8*
M#/,@>1\<G/./H*;XFTR.^TF:4*!<0(7C<<'CDC/IC-<K>(=-S;6VUOU[G=%8
M55532>_Q7_2VWS#PE_R+%G_P/_T-JGU+7]/TIQ'/(6F/_+*,;F_^M5+P[/\
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M_P"AK6<ZTDZMOLJZ^YFD,/!JBW]IV?WI!=>*--M5BRTDDDB!Q%$NY@",C/.
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M_D6+/_@?_H;5$HS>*5GT[>:-(RIK!.\;^\NO6SU-*\O;:PMS/=2K'&.Y[GT
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M\O6NH@@BMH5A@C6.-1A548 KG5LO%B*%6_L H&  O '_ 'Q2_9/%W_01L?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5S%_'XAU57L6M8;6U=\--O!)3/IFNGHK*K2]HK-M+R-J-;V3YDDWY]"&U
MMH[.UBMXAB.-0HJ:BBM$DE9&3;;NPHHHIB"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "H9_X?QJ:H9_X?QH0$-%%%4(**** "BBB@ HHHH
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MVW_HYZ6Z'U.PHHHJ1A1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4,_P##^-35#/\ P_C0
M@(:***H04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3I\YGLM+LK:8]9(;=$;\P*OT4 %5[VPL]2@$%]:074(;=Y<\8=<^N".M6**
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M'3!KT"PEFGTZVEN(S',\2-(A&"K$ D8^M)H:8S4=3L=(LVN]0NH[:W4X+R'
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M ,/XU-4,_P##^-" AHHHJA!1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5+!]\_
M2HJE@^^?I2 GHHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H9_P"'\:FJ&?\ A_&A
M 0T4450@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M ***ANXY9K.>*WG\B9XV6.;:&\MB.&P>N#SB@##\3^+K/PU]EB=1/=W,JHD
M?:0I."QX. /UKHJ\Q\8>&;31-$M+GS);O4)]2@\Z\N&W2/UX]A["O3J;M82.
M8O/%TC:M/I>B:3-JMU;'%PRR+%%$?0N>_7CVHL_%TJZK!IFN:1-I5S<';;LT
M@EBE/]T.._3CWK2T+0;;P_:SP6SRR>=.T\DDI!=F;KD@"N=^([)=6VDZ5!AM
M1N+^-H%'WE"YR_L!GK1IL&IV]<WXP\8VOA&PCEDB^TW,K8CMP^TD=V)P< ?3
MJ:VM2U"VTG3I[^\DV6\";G;^@]STKR[Q987-QX*U'Q'JD92_OGB$4)_Y=H-X
M*I]3U/O1%=P;/6Z***0SEM2\9F+5I-*T;2KC5[V'_7")@D<1]&<\ U6/CFYT
MVZAB\1^'[G2HI7"+<B99X@3TW,HXK&\.:U:^"]8UC2-?W6KW-X]S#=NA*3*W
MN/IGZD]*[*[71O%^BW%@E[#<VTZ@,UO*K,O.0>^"#ZBJT1)L @@$$$'H12US
M'B35)_"?A_3A8JDN)X;3-P"Q*8(SP1SQ_P#6KIZDHCGD\FWDEQG8I;&>N!6;
MX9UO_A(_#UKJWV?[/Y^_]UOW[=KE>N!GIGI6;HVNW6M0^)(KF.%%L;N:UB\L
M$$JN<%LD\_3%<MX#UC6KCPG9:9X?L;9GMO,^T75ZS")&:1F"@+RQP0?;(IVT
M%<]1K+?5+I?$T>EC39FM6MO.-\,[%;<1Y?3&<#/7OTK%LO$VK6&NV^C^)K*V
MA>[R+6[M&8Q2,/X2&Y!J[+KMTGC^'01'#]E?3S=%R#OW;RN,YQC ]*+!<Z&B
MN4U3Q-J$NO/H7AVRANKV%0]S/<.1# #T!QR3[#_'$$OB37O#]U;_ /"2V=@;
M">01?;+!GVQ,>F]6YQ[T6"YV5%87B7Q&N@PVT4-LUYJ-X_EVMJAP7/<D]@.,
M_6LN>_\ '=C;&]FT[1KF)!N>VMGD$P'?!/!/THL%SK9YH[:WDGF8)%$I=V/8
M 9)J#3-1M]7TV&_M2Q@F&Y"PP2,XSC\*YS5M7N=>\"R:EH3VGDS6TIG%T&+*
M@4AE&T\,#Z\5!\/#K">&K%[Q]/&E"U)B\M7$P.[^(D[<8W=/:BV@7U.UHKBK
M#7_%7B2)K_0[/2H--+LL+W[2%Y@#@D!.@R#UK7\.ZW?:E)=V6J:<UE?VC /M
MRT4@/(9&_I[BBP7-ZBBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "I8/OGZ5%4L'WS]*0$]%%%(84444 %%%% !1110 4444
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MCHHHJ1A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M]2>V:UI82=6FZD;61C7QU.C5C2G>[^[L<%16YX6TJ'5=5*7*%X(XRS#)&3T
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M_,G]_P"7XA_PDV@_]!O3?_ N/_&C_A)M!_Z#>F_^!<?^-'_",Z#_ - 33?\
MP$C_ ,*/^$9T'_H":;_X"1_X4?N_,/W_ )?B'_"3:#_T&]-_\"X_\:U*R_\
MA&=!_P"@)IO_ ("1_P"%:E1+E^R7#VGV[?(****DT"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "H9_P"'\:FJ&?\ A_&A 0T4450@HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@".='EMY8XI#%(R%5D SM)'!QWQ7/:'X6N-/UJ;6-4
MU:35-0DA$"R-"L2HF<X"@GO_ %]:Z6BBX!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4L'WS]
M*BJ6#[Y^E(">BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "I8/OGZ5%4L'WS]*0$]%%%(84444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5S'CO_D"0_\ 7RO_ *"U=/7,>._^0)#_ -?*_P#H+5RXW_=Y^AV9?_O4/4\]
MHHHKY4^W"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KT+P)_
MR!)O^OEO_05KSVO0O G_ "!)O^OEO_05KT<L_P!X7HSRLY_W5^J.GHHHKZ,^
M1"BBB@ HHHH *Y;7?^1\\)_]OG_HH5U-<MKO_(^>$_\ M\_]%"M:7Q?)_DS#
M$_ O6/\ Z4CJ:***R-PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ J&?\ A_&IJAG_ (?QH0$-%%%4(**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "I8/OGZ5%4L'WS]*0$]%%%
M(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5S'CO_ ) D/_7RO_H+5T]<QX[_ .0)#_U\K_Z"U<N-_P!WGZ'9E_\
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M "BBB@ HHHH **P_"^O/XALKNZ:!85BNY($4')PN.2?7DUN4 %%%% !1110
M445EW$&KMXALYH+J%-)2-Q<0,/G=^=I!V]!QW% &I17,6FK7TOQ&U#27GS8Q
M6*2I%L7AR1DYQGOZT>&M6OM0\1>)+6ZG\R"SN42!=BC8I!R,@9/3OFG85SIZ
M**YCP]JU]?>+?$UC<S[[:RD@%NFQ1L#*Q/(&3T'7-(9T]%%% !1110 4444
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MX%ZQ_P#2D=311161N%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M67N>>OL*MP_;?%OBG6+6;6KW3K73I1%':V4GE.X[NS=<'^M6?AG_ ,@'4/\
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M5E4_,P)Y.1G)K,T>^;Q1J/A.V<;AI]JUY=#_ *:(3$N??<I-:NK?\E8\/_\
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MH<Q64WDQPD\[=N.<=/\ .:L>&-4U&'6]0\-:Q<?:;JU19K>ZVA3-">,D>H)
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MXPFF[K9HWJ***]\^7"BBB@ HHHH *Y;7?^1\\)_]OG_HH5U-<MKO_(^>$_\
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MB(1M?0L)XO\ 57$3%)$^A']:V:* ./\ ^%<Z9,Z?VAJ6L:C$F-L-Y>%D&/8
M5U26EO%9BTC@C6V">6(@H"A<8QCTJ:BB["QR ^'6F1%TM-2UBTM7)+6EO>%8
MCGMC&?UK3TCPII>A:C)>:>CQ>9 L'E9!0 '.>F<D]22:W**=V*R.4D^'NBR3
M75QONTNKBZ>Z%S'+LDB9NH1@!\OL<U-8>"-.M-3BU&YNM0U.[AYADOY_-\L^
MJC %=+11=A9'$^+G23QCX/C1E9_M4C[0<G&!S].#^5=%K?A[3?$-ND5_"6:,
M[HI4;:\9]58=*AT[PEH6E:G)J-GIZ1WDA8M*79CD]<;B<9]JVJ+]@L<FO@#3
MI'C_ +0U+5]2AC(*P7MV7C!'3@ 9_&NFGM+>YLWM)H(WMW38T17Y2OIBIJ*5
MQV.0_P"%>:?&C06^K:W;V9ZVD5Z1%CTP03C\:Z/2]*LM&L(['3X%AMX^BCN>
MY)ZD^]7**+L+'.6G@RRL-:?4K._U*W$DQFDM([C$#N>I*XY_.G:IX-T[4M1.
MHQSWNGWS ![BQG\IG'OP0?RKH:*=V%C!T?PEI^CWSWXEN[V^9=GVJ]F,L@7T
M![5O444@*>JZ;!K&EW.G76[R;A"C%3@CW&>XZTS1=(MM"TBWTRT+F" $*9""
MQR223@#N35^B@#%T7PMIV@W^HWEGYGFW\GF2;R"$Y)VK@# RQ]>U37&A6MSX
MAL]:>287-I&\<:J1L(;.<C&<\^M:E%%PL9<.A6L/B.XUQ9)C=3P"!D)&P*"#
MD#&<\>M&FZ%:Z5J.I7T$DS2ZA())0Y!"D9^[@#CGOFM2BBX!67I^A6NFZOJ>
MI0R3--J+(TRN0578"!MP,CKW)K4HH R_$&A6OB/2)--O))DA=E8M"0&X.1U!
M'Z4FN^'K#Q#;1Q7JN&A??#-$VV2)O53VK5HHN!S$/@733/'+J-YJ6K&/F--0
MN?,13Z[0 /SK5T+1;?P_I$6FVLLTD$18H9F!89).,@#C)-:5%%V%C$;PKIK>
M*U\1D2?;5C\O;D;,XQNQC.[''7I6RZ)+&T<B*Z,"K*PR"#U!%.HH Y+_ (5_
MI\+R?8-3UC3H)#EK>SO"D?Y$''YUMZ+H.GZ!:M!I\.S>VZ21CN>1O5F/)K2H
MHNPL%8FM^%=-UR>*ZF\^WO8AB.[M9#'*H],C^M;=% ')/\/-*N(IQ>W>I7T\
ML9C%Q=7'F21@]=F1@?E6KJ?ANSU6PT^SGEG6.QFCGB*, 2R @;L@\<\XQ6Q1
M3NPL9&N^'-/\0Q0K>"5)8&WPSP/LDB/^RW^>E9T?@33&F$NHW>HZJR@B/^T+
MCS!'D8R!@#/X5U%%*["Q@"TT_P )>#I+:1;F\T^TC;>KJLCLA.2", $#)_"L
M>Q\':'=V NM+UK5;?2YE\PV]M?;8<'D@C!(]QFNV(#*58 @C!![US4OP]\*S
M3-*VD1AF.2J2NBG_ ("& _2FF*QB^"K6R?QEK5WI,:+I5M#'90,GW688+8/?
MD=>^<]ZZS2M"M=(N]1N;>29GOYS/*)"" WHN ..>^:NV=E:Z?:I:V=O'! @P
ML<:A0*GH;!(R]=T*U\06D-M=R3(D4Z3J8B 2RYP#D'CFI-8T33]>L3::C;B:
M+.Y3G#(WJ".0:T**5QG)'X?:?*$CO=5UJ]M4((M;F\+1<=!@ ''XUT<VF64^
MF'39+:-K(QB/R<87:.@QVJU11=A8Y ?#VQ6+[/'K&N1V73[(MZ?*QZ8QG'XU
MTEAIMGI>GQV%G;I%;1KM6,<C'?/KGWJW11=A8Y1O &FQW$DNG:AJNEK(<O#8
M71C0GZ$''X5JZ)X<TWP_%(MC$WFRG,L\K%Y)#_M,:UJ*+L+&!J_A#3=6OQJ'
MF75E?@;3=64WE2,/0GD'\JH2?#O1YX)5N;C4+FYE*[KN>?S)0%(8*"1@#(["
MNNHIW8K(****0PHHHH **** "BBB@ J6#[Y^E15+!]\_2D!/1112&%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!X+_S57_N-_\ M>O>J\%_YJK_ -QO_P!K
MU[U7=C?L>AY.5_\ +SU"BBBN$]8**** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *Y;7?^1\\)_\ ;Y_Z*%=37+:[_P CYX3_ .WS_P!%"M:7Q?)_DS#$_ O6
M/_I2.IHHHK(W,?Q9_P B;KG_ &#[C_T6U5_ W_(C:+_UZ)_*K'BS_D3=<_[!
M]Q_Z+:N/\*?$3PKIOA32[*[U7R[B"W5)$^SRG:0.F0N*I)M"OJ=;XPUF3P_X
M3U#4X0#-#&!'D9 9F"@GZ%@:X^ST;P++91R:UKUA?ZJZ[IKN35!N#D<[</@
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M1_:.)_F_!?Y!_96#_D_%_P"9VO\ PG__ %#/_(__ -C1_P )_P#]0S_R/_\
M8UQ5%']HXG^;\%_D']E8/^3\7_F=K_PG_P#U#/\ R/\ _8T?\)__ -0S_P C
M_P#V-<511_:.)_F_!?Y!_96#_D_%_P"9VO\ PG__ %#/_(__ -C1_P )_P#]
M0S_R/_\ 8UQ5%']HXG^;\%_D']E8/^3\7_F=K_PG_P#U#/\ R/\ _8T?\)__
M -0S_P C_P#V-<511_:.)_F_!?Y!_96#_D_%_P"9VO\ PG__ %#/_(__ -C1
M_P )_P#]0S_R/_\ 8UQ5%']HXG^;\%_D']E8/^3\7_F=K_PG_P#U#/\ R/\
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M/_(__P!C7%44?VCB?YOP7^0?V5@_Y/Q?^9VO_"?_ /4,_P#(_P#]C1_PG_\
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MM\5-:MK3PK/I@D5KR[*@1*<LJ!@Q8CL.,?C3?&;K:1>$M1F^6UMKV(S/_<!
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M<9@> O\ D1=(_P"N']371U6L+"VTRQALK./RK>%=L:;BV!]3DU9I,:"BBB@
MHHHH **** "BBB@ HHHH *E@^^?I452P??/TI 3T444AA1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7,>._\ D"0_]?*_^@M73US'CO\ Y D/_7RO_H+5RXW_ '>?H=F7_P"]0]3S
MVBBBOE3[<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH [[QY_R#+7_KM_[*:X--N]=^=F1NQUQ79'Q\&ZZ6#]9__L:J
MW_C);VPGM1IHC\U"N_S<XSWQMKU,4\/6FZBJ?*S/&P*Q6'IJDZ7SYD='XCET
MR"Q@.I6TT]OOP@B) !QQGYAVJA!JFG0Z%,MGI.H_87#@G9O4<<GEC@?I6-IW
MC">TLEM+JU2[C0;5W-M..P/!S4>K>++C4;0VD$"6L###!6R2/3.!@5M/&4G>
MHGK;:VOW]CGIY?6C:E*+:3WYM/N[FA8Z2D7AU;K5M2NELW"L((V.T GCCGKQ
MTK;T0Z=)HER--BE2WW.#YF<L=HR1STZ?E7+:=XL>TTX6-U91W<*C:H9L<>AX
M(-6HO'!C1XCIL0@(VHD<FW:._;G]**.(P\.5WZ6V=_O[>@8C"8NIS*U];K5)
M6]._J:6@;O\ A")OLN?/VR_=Z[N<?CC%8G@DR_VX0F[RS$WF8Z>V?QJEHOB"
MXT61Q&@D@<Y:)CW]0>QK9/CMEE5H]-C1,DN/,Y;CUQQS[&LJ=>C+V<I2LX]+
M&U7#8B/M80AS*>M[K3^N@V_337\<7@U0J+?8OWF(^;8N.GXTS6H?#*:5*VG&
M/[5E=F)')ZC/4XZ9K!U;4/[4U.:]\KRO,V_)NW8PH'7 ]*I5SU,3&\THIW;U
MMKJ==+!RM3E*;3BEHGIH=]JG_)/8?^N,/\UI;QVC^':E&(/D1C(]"P!_0US]
MUXE^T^'DTK[)MVHB>;YF?NX[8]O6B?Q+YWAP:1]DVX14\WS,_=(/3'MZUU2Q
M5*[L_L6Z[G#'!5THIQVJ7Z;:&YX")-E>+G@2 X_"N$K=T#Q'_8<,T?V3S_,8
M-GS-N,?@:PJXZ]6,J-.*>JO<]##T9PQ%6<EI*UOD@HHHKD.X**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KT+P)_P @2;_K
MY;_T%:\]KT+P)_R!)O\ KY;_ -!6O1RS_>%Z,\K.?]U?JCIZ***^C/D0HHHH
M **** "N6UW_ )'SPG_V^?\ HH5U-<MKO_(^>$_^WS_T4*UI?%\G^3,,3\"]
M8_\ I2.IHHHK(W*FIZ;;:OIESI]VI:WN$*. <'![CW'6N;M;#QMIEHMA;7FC
MWD,2[(;FZ$BRA1TW*H(8@>XKKZ*=Q6,/PUX>_L*&ZEN+IKS4;V3S;JY9=N]N
MP [*.P]ZW***0SCO%7@R;7M<L[N"XCBMG58-1C;.9X5<.H'!YR".<<'\*W?$
M>F2ZOX;U#3;9HTEN(&C0R$A02.^ >/PK4HIW%8Y:_P##-]-H^B"ROUM=5TI$
M$<G+1.=@5E8<$J<=>M5+[0?%'B6!=/UZYTFWTPNKSI8"1I)@I!"Y?A1D#UKM
M**+A8Y^;0[F3QY:ZZ)(?LL5BULR$G>6+9R!C&/QJG/H6N6?C.YUK29=/>"]C
MBCN8[LNK($XRFT'/'KWKK**+A8Y2[T/7K#7+O4_#]Y9LE[M,]I?[]@8#&Y&7
M)'N.G])-*T#5)/$(U[7[JU>[C@,$%O9JPBB4G).6Y8FNGHHN%@KCD\.Z]H%]
M=OX9NM/:QNY#,UG?APL3GJ49.<'T(KL:*$QV.*M/"FMMXQT_Q%JFH6T\T22I
M+%$&5(U*X18P0<\EB22.HJWJ'AW5;37I]:\-WEM#-=*HN[2[4F&8KP&RO*MC
M\ZZJBB[%8Y6UT37]1U>UO_$%_:I%9MOAL]/WA&?'WG9L$X],8_J:SH>M_P#"
M60^(-#EL#-]B-E+#>[PNW?O!!4$YS_*NJHHN%CF-8\.W[ZS'KVAW<-KJ?E"*
M>*=2T-P@Z!L<@CU'-0'1/$NM7EL=?OK&WLK>02_9M-,F9F'3>[8('L*ZZBBX
M6.?FT.YD\>6NNB2'[+%8M;,A)WEBV<@8QC\:7Q?H=SX@TB&TM)(4D2ZBF)E)
M VJ<GH#S6_11<+%#7+*34] U*PA9%EN;66%"Y(4,R$#..W-&AV4FF:!IMA,R
M-+;6L4+E"2I94 .,]N*OT4AG$0>#M0C\ ZKH336OVJ[EE>-PS; &8$9.W/Z5
M?U#PY>7<WAAXY( -*E5Y]S'Y@$"_+QSSZXKJ**=V*Q0URRDU/0-2L(619;FU
MEA0N2%#,A SCMS6-<^$C?>$-)TN6Y^SZAIT4)@NX1GRY8U R,XR.#QQFNHHH
MN%CCY++QY=VYLIM0T6WB<;'O+=)#-M[D*<*#^-6]0\)^=X;LM,L;^>WN;!TE
MM[EF+$NO.7]02>1_A72T47"QQ=]I'C+7;&32]2N]&MK*8;)Y;1)&E9>X ;@9
M_&NOM;>.SM(;:$$10QK&@/8 8'\JEHH;"P4444AA1110 4444 %%%% !1110
M 5#/_#^-35#/_#^-" AHHHJA!1110 4444 %%%% !1110 5Q_P 1;VYL]%LT
MCGEMK2XO(X;RYB.&BA.=Q'I_D=Z["L7Q%K=CHT%L-2MVDM+N80.Y4-''GN^>
MU-;B9SR^!_#5[8&;P[=F"^"[HKVWO&=MW8M\Q!!/6M#Q5K&H^'_", 65)=6N
M'CM(Y57 ,C?QX^@)^M4M=\&^%(M*GU2%4TUXXS)%=VLQ3!QD8 .#SCI^%8>L
MQ7VM?"S1=5U&%[F:TF6XN$/62$,RY/U7:<_4U6XMCH[?X;Z*UL&U+[3?:@PS
M)>27#A]W<K@X ST_7-.\(W=Y9:QJOAF_N)+EK'9+:SR'+O"PX!/<C@?G4=CX
M.\"ZE8)>VFGVTMNR[MXF? 'O\W'XU+X0@\+_ -I:BWAW3VC-N1!)= DQR9Y(
M4ECG&.>*0')_#SPK'X@\-)+K$\\VGQR.EO9)(R1]<L[;<$G)P.>U;*:>G@SQ
MUH]IIDLRZ7JJRQO:/(75'0 AESTZC]:N_"K_ )$.U_ZZR_\ H1H\5_\ (^>#
M/^NMS_Z"E-O6P6T,W5_L&K_$*[TSQ+=M%I\$$;65N\YBCF+#+,2",G.1U[5M
M:?X1BTG5[6^\/7K6U@<BYM#(TD4H[%<DX/O4UU>:#K^O7/A_5+!&N;95>,72
M+^\##K&<Y]/3]*YO5])L_"7B+13X:GEM[J[O$BFT]9BR21'[S%23C'K[Y[4O
M(#2UEKKQ/XT;PW'=S6NFV< GO3"VUYBV-J9[#!!_/VI=1^'MA9V,ESX;-QIV
MIPJ7BDBG=A(1SM8,3G/3\>_2F&YC\/?%*[FOG$-KK%M&(IFX7S$ 7:3VX'ZB
MNGU[7+/0-(GO[J9%"(3&A;F1L<*!W[4:]!Z=3@/%6NOKWPEL]4*@3O/&)% X
MWJQ!X]R,_C71Z1X"L;>XM=5U*6YN]95A+).\QQOZX '& >@KDK[3)]*^#FFP
M7*E)GNXY60C!7<Y('Y8KURANVPEYG%^"/^0]XN_["1_K7-^ O"Z^(=)N'U:X
MGDTV.YD2&R21D1FSEG;;@GK@<]C72>"/^0]XN_["1_K1\+_^12?_ *_)OYT7
M HOID?@KQGHD6D231Z=J;/#-:-*SJ& R&7)/K^GO5C5C<^*_&LWAY;J:VTJP
MA62\$#[6F=L%5SZ8(_(^V)O&/_(V^#_^OR3^2UBW^BZ(GQ-OH_$-M&]MJ422
MV<LKE5#J &7((Y/O[>M-=P-36?!%GHVF3ZGX9\[3]0M$,JB.9V64*,E6#$YR
M,U4\6:HNM>$_"NI*NW[1JELY4?PMM?(_ YJWK7A?P'H&FO?7^F1+&H^55E<M
M(?11NY-5?&4%K9>"="GL[22UL+6_M[EH7&6B0[B<\GG+>O>A >B5Y]X-_P"1
M6\5_]A&\_P#0%KM9]5T^WTXZA+>0+9[=WG;QM(]CW_"N%\"3BZ\%^);@*RB6
M]NG"MU&8U.#4K8;W,_P1X+M_$7A>TO=;FN)HAN2TMUE*)$@8@G [EMU=;K/A
MN]U2\T[3TNFM_#\$.V>*&5EEE8<*I/\ =P!W]?8TOPZ_Y$'2?]Q__0VK+UDO
MKOQ!7P_?7\UIIT=H)DAAD,9NG)Z%NI YX']TT[NXNAG^+O#NA^%M'DU/0YSI
MFIVQ1HU2Z8F7Y@"I5F.>"36C\1)S=>!+2X("F6>W<@=L\UD^/-)\)^'/#-S;
MVEC;)J5P%6$9,DH^8$MEB2!@'G\*T/')S\.--(Z;[7^0I]@[GH-<1\569?!F
MY!EA=1$#U.37;UQ?Q0_Y%)/^OR'^=3'<;V'Q_#W3;Z!9]>>XU#4W&Z2X:=UV
M-Z( 0 !VX[5%X*OI[%-?TN]NI+F+2+@B.:0Y?RB"0"?;;^M=M7!>'K7[;K?C
MJTSM\^81Y]-R,/ZT[WW"UB'P_H:^.+9O$'B-IKB&XD;[)9>:RQ11@D#A2,G(
M-2RV7_"">(M*.GRS#1-1F%I+:RR%UAD/W&4G)'O]#^&7X(\-^%M4TPV.IZ;%
M_;5H[1743R,KD@G#8STQCIZ5K2Z)X'TWQ'8:9#I/FZE*^]%@=F\G;SN?+<#C
MW^E-[V$:FM^'K[Q!KT4=[=%- BBR;>"5E>:7/1\8^7'H>WO7,>+M(T?P7:1:
MKH$QL=0@F0FW2Y)$R'@@HQ.>*T+R,^)?B'?Z)J5]/#86D$;PVD4IC^T%E!9B
M1R<9(_R:Q/B+IGA;P_X>:RT^SMH]1E=<!3OD1 <DDDD@'I[YH78&;7Q2-R+?
M039MMNO[23R6/9\?*?SQ6QHW@/2='OX=2WW-SJ* [[F:8DR,1@DCIWJEX](-
M]X3(((.LP8(^M=K2OH.VIY_X)_Y$?7O^OJ[_ /016=X%\(0Z_P"%+2YUV6>Y
MM?F6ULQ*R1QJ&.6(4@EB<G/IBM'P3_R(^O?]?5W_ .@BMCX=?\B#I/\ N/\
M^AM0W:XD9.F6?_")_$&VT:QGF.EZA:O(MO)(7$+KDY7/; _7Z4YH'\<>*]2M
M+N>5-$TIA";:-RGVB7G)8CG P1^7O5C5O^2L>'_^O.?^35!X;N8]#\;^(-(O
M7$+7UQ]MM"YP)0V2P!]1Z>Q]*/,#-\;>#X-#\,7EYH#S6D00+<VHE9HY4) )
MPQ."#@Y^M=YX?_Y%O2_^O.+_ - %<Y\3-8MK'PE=V)=7N[M=D<(.6QG+,1Z
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M3US'CO\ Y D/_7RO_H+5RXW_ '>?H=F7_P"]0]3SVBBBOE3[<**** "BBB@
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MY"/ST]N#^E.K*=12:J76]M0H0ITG!.DHO9/3>W6W<PZ***X3T0HHHH ****
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MBBB@ HHHH **** "BBB@ J6#[Y^E15+!]\_2D!/1112&%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<QX[_Y D/\
MU\K_ .@M73USWC2W:;P^749\F59#].1_6N;&)NA.W8Z\ TL3!ON>;T445\H?
M<!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%=-X7B>;2];BC4L[P!54=22&KF:FM[RYM"WV:YFAW?>\MRN?KBMJ%14YJ3\_
MR,,32=6FX1>NGX.Y='AW5R<?V?-^5:\%O_PC&E7,URZ+J-U'Y442G+(IZD_Y
M["L+^V-3/_,1N_\ O^W^-5'D>5R\CL[GJS')-:1JTJ>M-._GT,I4:U7W:K7+
MY7U.F\/"5-!U"73D5M35@!@ N(^.@_.C2;+6+O4X+G49+F.VBE5V:Y8@$@\
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M2/8B@"2BJ5]J^F:85%_J-I:%N5%Q.L>?IDU9@N(;J%9K>:.:)ONO&P93]"*
M)**I/K.EQ0RS2:E9I%#*897:=0J2#JK'/##T/-2V=_9ZC#YUE=P7,6<;X) X
MS]0: +%%4K[5],TPJ+_4;2T+<J+B=8\_3)JS!<0W4*S6\T<T3?=>-@RGZ$4
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M_P#C1_9-;NOQ_P @_MS#_P LOP_S/,**]/\ ^$2T/_GQ_P#(K_XT?\(EH?\
MSX_^17_QH_LFMW7X_P"0?VYA_P"67X?YGF%%>G_\(EH?_/C_ .17_P :/^$2
MT/\ Y\?_ "*_^-']DUNZ_'_(/[<P_P#++\/\SS"BO3_^$2T/_GQ_\BO_ (T?
M\(EH?_/C_P"17_QH_LFMW7X_Y!_;F'_EE^'^9YA17I__  B6A_\ /C_Y%?\
MQH_X1+0_^?'_ ,BO_C1_9-;NOQ_R#^W,/_++\/\ ,\PHKT__ (1+0_\ GQ_\
MBO\ XT?\(EH?_/C_ .17_P :/[)K=U^/^0?VYA_Y9?A_F>845Z?_ ,(EH?\
MSX_^17_QH_X1+0_^?'_R*_\ C1_9-;NOQ_R#^W,/_++\/\SS"BO3_P#A$M#_
M .?'_P BO_C1_P (EH?_ #X_^17_ ,:/[)K=U^/^0?VYA_Y9?A_F>845Z?\
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M0HHHH **** "BBD) !)( '4F@!:*SX==T>XN1;0ZK8R7!.!$EPA8GZ YK0H
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M *"5G_W_ %_QH_MC2_\ H)6?_?\ 7_&CVD.Z#V-3^5_<7:*I?VQI?_02L_\
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M *"5G_W_ %_QH_MC2_\ H)6?_?\ 7_&CVD.Z#V-3^5_<7:*I?VQI?_02L_\
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M -!*S_[_ *_XT>TAW0>QJ?RO[B[15+^V-+_Z"5G_ -_U_P :/[8TO_H)6?\
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M -!*S_[_ *_XT>TAW0>QJ?RO[B[15+^V-+_Z"5G_ -_U_P :/[8TO_H)6?\
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MRI&0<'VH EHHHH **9++'!$\LTB1QH,L[L %'J2>E/H **** "J>IG418/\
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M1'>Z7X=A35[A)[FVB/FS(20P7.#SCG&,^]8EQ\.M%%N6T\7%EJ"C,=['<.9
MWJ<GGG_ZV*3P_>WWBOP#<V\\JQZ@5ELI92,C>!C=@>Q'XT 5O WA[2[[PI;7
M^HZ58W-U=O).\DUNKM\SG')&>F*ZNRT72M.F,UCIEE:RLNTO! J,1UQD#IP/
MRKFM.^&^D1Z?##JQFU.9(PFZ65U1 !C"*" !^OYU#IR3>%/&]KH45U-/I6I0
MO);Q3.7:W= 20">=N!^OYMZ@M#N:***D84444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %2P??/TJ*I8/OGZ4@)Z***0PHHHH ****
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MQ[TS3$N?%'C*W\0FUFM=,L(7CM//7:\[."&;'9<'^7X=O11<+!1112&%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4L'WS]*BJ6#
M[Y^E(">BBBD,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *YCQW_R!(?\ KY7_ -!:NGKF/'?_ "!(?^OE?_06KEQO
M^[S]#LR__>H>IY[1117RI]N%%%% !1110 4444 %%%% !1110 4444 %%%%
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M8'6L[Q1+:R_9?LVE36&-^[S+<1;_ +N,8ZX_K6WXN_Y"^B_]=3_Z$M0>/_\
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M:QS?:+:\F,@C=/NJ1C:22=WUXJE#X.U72T:UT/Q1/9:=DE+:6U2<Q9ZA&)!
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M-A=I=0:4AFC.Y#+*\H4^H#L0#71TV]+ D%%%%2,**** "BBB@ HHHH ****
M"BBB@ J&?^'\:FJ&?^'\:$!#1115""BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ J6#[Y^E15+!]\_2D!/1112&%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<
MQX[_ .0)#_U\K_Z"U=/7,>._^0)#_P!?*_\ H+5RXW_=Y^AV9?\ [U#U//:*
M**^5/MPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "O2]8_L768(X9]5MT5&W QSIG.,=Z\THKJH8CV491<;IG'BL)[>49*3
MBXWV\ST#3X_#OAYI;J+4EE=EV_ZU7.,YP OT%4M#\0V;:_J$]R1 MT5\MGZ
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M !1110 4444 %%%% !1110 5#/\ P_C4U0S_ ,/XT("&BBBJ$%%%% !1110
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MW5C*<)*HZ'T(_P _A5RP\DG)-.W9F<<5!R46FF]KJQDT445@=(4444 %%%%
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M444 %%%% !1110 4444 %%%% !1110 5S'CO_D"0_P#7RO\ Z"U=/7,>._\
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M')'FY^NW]?>%%%%26%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %>A>!/^0)-_U\M_Z"M>>UZ%X$_Y DW_ %\M_P"@
MK7HY9_O"]&>5G/\ NK]4=/1117T9\B%%%% !1110 5RVN_\ (^>$_P#M\_\
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M333O^>-U_P!\+_\ %4?\)IIW_/&Z_P"^%_\ BJ/KN'_G0?V=BOY&='17.?\
M"::=_P \;K_OA?\ XJC_ (333O\ GC=?]\+_ /%4?7</_.@_L[%?R,Z.BN<_
MX333O^>-U_WPO_Q5'_"::=_SQNO^^%_^*H^NX?\ G0?V=BOY&='17.?\)IIW
M_/&Z_P"^%_\ BJ/^$TT[_GC=?]\+_P#%4?7</_.@_L[%?R,Z.BN<_P"$TT[_
M )XW7_?"_P#Q5'_"::=_SQNO^^%_^*H^NX?^=!_9V*_D9T=%<Y_PFFG?\\;K
M_OA?_BJ/^$TT[_GC=?\ ?"__ !5'UW#_ ,Z#^SL5_(SHZ*YS_A--._YXW7_?
M"_\ Q5'_  FFG?\ /&Z_[X7_ .*H^NX?^=!_9V*_D9T=%<Y_PFFG?\\;K_OA
M?_BJ/^$TT[_GC=?]\+_\51]=P_\ .@_L[%?R,Z.BN='C/3C_ ,L;K_OE?_BJ
M>/%^GG_EC<_]\K_\51]<H?S(3R_$K[#-^BL(>*[$_P#+*Y_[Y7_&GCQ/9'_E
ME<?]\K_C5?6J/\Q+P6(7V&;5%8X\1V9_Y9S_ /?(_P :>-?M3_RSF_[Y'^-/
MZQ2_F)>$K+[)JT5F#7+8_P $OY#_ !IXU>W/\$OY#_&J]M3[DO#U5]DT**I#
M5(#_  R?D/\ &G#4(C_"_P"0_P :?M(=R71FNA;HJN+R,]F_*GBX0]FJN9$N
M$ET):*8) >QIX.:=Q6"BBBF(**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ J6#[Y^E15+!]\_2D!/1112&%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '/ZYX
M5M]5<W$+>1='JV,J_P!1_6N4F\':S&^$@24?WDE4#]<5Z717%6P%&K+F>C\C
MT</FF(H1Y4[KS/,/^$2US_GQ_P#(J?XT?\(EKG_/C_Y%3_&O3Z*Q_LFCW?X?
MY'1_;F(_EC^/^9YA_P (EKG_ #X_^14_QH_X1+7/^?'_ ,BI_C7I]%']DT>[
M_#_(/[<Q'\L?Q_S/,/\ A$M<_P"?'_R*G^-'_"):Y_SX_P#D5/\ &O3Z*/[)
MH]W^'^0?VYB/Y8_C_F>8?\(EKG_/C_Y%3_&C_A$M<_Y\?_(J?XUZ?11_9-'N
M_P /\@_MS$?RQ_'_ #/,/^$2US_GQ_\ (J?XT?\ "):Y_P ^/_D5/\:]/HH_
MLFCW?X?Y!_;F(_EC^/\ F>8?\(EKG_/C_P"14_QH_P"$2US_ )\?_(J?XUZ?
M11_9-'N_P_R#^W,1_+'\?\SS#_A$M<_Y\?\ R*G^-'_"):Y_SX_^14_QKT^B
MC^R:/=_A_D']N8C^6/X_YGF'_"):Y_SX_P#D5/\ &C_A$M<_Y\?_ "*G^->G
MT4?V31[O\/\ (/[<Q'\L?Q_S/,/^$2US_GQ_\BI_C1_PB6N?\^/_ )%3_&O3
MZ*/[)H]W^'^0?VYB/Y8_C_F>8?\ "):Y_P ^/_D5/\:/^$2US_GQ_P#(J?XU
MZ?11_9-'N_P_R#^W,1_+'\?\SS#_ (1+7/\ GQ_\BI_C1_PB6N?\^/\ Y%3_
M !KT^BC^R:/=_A_D']N8C^6/X_YGF'_"):Y_SX_^14_QH_X1+7/^?'_R*G^-
M>GT4?V31[O\ #_(/[<Q'\L?Q_P SS#_A$M<_Y\?_ "*G^-'_  B6N?\ /C_Y
M%3_&O3Z*/[)H]W^'^0?VYB/Y8_C_ )GF'_"):Y_SX_\ D5/\:/\ A$M<_P"?
M'_R*G^->GT4?V31[O\/\@_MS$?RQ_'_,\P_X1+7/^?'_ ,BI_C1_PB6N?\^/
M_D5/\:]/HH_LFCW?X?Y!_;F(_EC^/^9X9]M']L_V3Y,OVO[1]FV_+C?NVXSG
MUKI/^$2US_GQ_P#(J?XURA_Y*K_W&_\ VO7O5=6*R7#0Y>6ZNN__  #SL!Q'
MC*O/SI.S[?\ !/,/^$2US_GQ_P#(J?XT?\(EKG_/C_Y%3_&O3Z*Y?[)H]W^'
M^1Z/]N8C^6/X_P"9YA_PB6N?\^/_ )%3_&C_ (1+7/\ GQ_\BI_C7I]%']DT
M>[_#_(/[<Q'\L?Q_S/,/^$2US_GQ_P#(J?XT?\(EKG_/C_Y%3_&O3Z*/[)H]
MW^'^0?VYB/Y8_C_F>8?\(EKG_/C_ .14_P :/^$2US_GQ_\ (J?XUZ?11_9-
M'N_P_P @_MS$?RQ_'_,\P_X1+7/^?'_R*G^-'_"):Y_SX_\ D5/\:]/HH_LF
MCW?X?Y!_;F(_EC^/^9YA_P (EKG_ #X_^14_QH_X1+7/^?'_ ,BI_C7I]%']
MDT>[_#_(/[<Q'\L?Q_S/,/\ A$M<_P"?'_R*G^-'_"):Y_SX_P#D5/\ &O3Z
M*/[)H]W^'^0?VYB/Y8_C_F>8?\(EKG_/C_Y%3_&C_A$M<_Y\?_(J?XUZ?11_
M9-'N_P /\@_MS$?RQ_'_ #/,/^$2US_GQ_\ (J?XT?\ "):Y_P ^/_D5/\:]
M/HH_LFCW?X?Y!_;F(_EC^/\ F>8?\(EKG_/C_P"14_QH_P"$2US_ )\?_(J?
MXUZ?11_9-'N_P_R#^W,1_+'\?\SS#_A$M<_Y\?\ R*G^-'_"):Y_SX_^14_Q
MKT^BC^R:/=_A_D']N8C^6/X_YGF'_"):Y_SX_P#D5/\ &C_A$M<_Y\?_ "*G
M^->GT4?V31[O\/\ (/[<Q'\L?Q_S/,/^$2US_GQ_\BI_C1_PB6N?\^/_ )%3
M_&O3Z*/[)H]W^'^0?VYB/Y8_C_F>8?\ "):Y_P ^/_D5/\:/^$2US_GQ_P#(
MJ?XUZ?11_9-'N_P_R#^W,1_+'\?\SS#_ (1+7/\ GQ_\BI_C1_PB6N?\^/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&?\
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M'VO_ 'Y7_"KE%'LH=D'MJG\S^\I_V3IW_0/M?^_*_P"%']DZ=_T#[7_ORO\
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M*** "BBB@ HHHH **** "BBB@ J6#[Y^E15+!]\_2D!/1112&%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!X*__ "50_P#8:_\ :U>]5X++_P E4/\ V&?_
M &M7O5=V-^QZ'DY7_P O/4****X3U@HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "H9_X?QJ:H9_X?QH0$-%%%4(**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "I8/OGZ5%4L'WS]*0$]%%%(8444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5YOH>AW/B6]\07-SXE\06WV?6+FVCBM;XHBHI!  (./
MO8], 5Z17'^ /^9H_P"Q@N__ &6J6PF'_" ?]3=XK_\ !E_]C1_P@'_4W>*_
M_!E_]C7844N9A9''_P#" ?\ 4W>*_P#P9?\ V-'_  @'_4W>*_\ P9?_ &-=
MA11S,+(X_P#X0#_J;O%?_@R_^QH_X0#_ *F[Q7_X,O\ [&NPHHYF%D<?_P (
M!_U-WBO_ ,&7_P!C1_P@'_4W>*__  9?_8UV%%',PLCC_P#A /\ J;O%?_@R
M_P#L:/\ A /^IN\5_P#@R_\ L:["BCF861Q__" ?]3=XK_\ !E_]C1_P@'_4
MW>*__!E_]C7844<S"R./_P"$ _ZF[Q7_ .#+_P"QH_X0#_J;O%?_ (,O_L:[
M"BCF861Q_P#P@'_4W>*__!E_]C1_P@'_ %-WBO\ \&7_ -C7844<S"R./_X0
M#_J;O%?_ (,O_L:/^$ _ZF[Q7_X,O_L:["BCF861Q_\ P@'_ %-WBO\ \&7_
M -C1_P (!_U-WBO_ ,&7_P!C7844<S"R./\ ^$ _ZF[Q7_X,O_L:/^$ _P"I
MN\5_^#+_ .QKL**.9A9''_\ " ?]3=XK_P#!E_\ 8T?\(!_U-WBO_P &7_V-
M=A11S,+(X_\ X0#_ *F[Q7_X,O\ [&C_ (0#_J;O%?\ X,O_ +&NPHHYF%D<
M ?A)I!NOM1UG73<;_,\[[2F_=G.[=LSG/.:O_P#" ?\ 4W>*_P#P9?\ V-=A
M13<Y/=B4(QV1Q_\ P@'_ %-WBO\ \&7_ -C1_P (!_U-WBO_ ,&7_P!C7844
MN9CLCC_^$ _ZF[Q7_P"#+_[&C_A /^IN\5_^#+_[&NPHHYF%D<?_ ,(!_P!3
M=XK_ /!E_P#8T?\ " ?]3=XK_P#!E_\ 8UV%%',PLCC_ /A /^IN\5_^#+_[
M&C_A /\ J;O%?_@R_P#L:["BCF861Q__  @'_4W>*_\ P9?_ &-'_" ?]3=X
MK_\ !E_]C7844<S"R./_ .$ _P"IN\5_^#+_ .QH_P"$ _ZF[Q7_ .#+_P"Q
MKL**.9A9''_\(!_U-WBO_P &7_V-'_" ?]3=XK_\&7_V-=A11S,+(X__ (0#
M_J;O%?\ X,O_ +&C_A /^IN\5_\ @R_^QKL**.9A9''_ /" ?]3=XK_\&7_V
M-'_" ?\ 4W>*_P#P9?\ V-=A11S,+(X__A /^IN\5_\ @R_^QH_X0#_J;O%?
M_@R_^QKL**.9A9''_P#" ?\ 4W>*_P#P9?\ V-'_  @'_4W>*_\ P9?_ &-=
MA11S,+(X_P#X0#_J;O%?_@R_^QH_X0#_ *F[Q7_X,O\ [&NPHHYF%D<?_P (
M!_U-WBO_ ,&7_P!C1_P@'_4W>*__  9?_8UV%%',PLCC_AZ]S]BURVN;Z[O/
MLFL3VT<MU*9'V($ !)_/TR3785Q_@#_F:/\ L8+O_P!EKL*);@M@HHHI#"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "H9_P"'\:FJ&?\ A_&A 0T4450@HHHH **** "B
MBB@ HHHH **** "BBB@ HJKJ.HV>DV$U_J%S%;6L(S)+*V%49P/U('U-<AX*
M^(!\9^)M;M+>U\G3;*.%K=Y$999=^X[B">%( (XS@Y[X !W-%</<^)?$FL^(
MM3TGPI:Z8D>ELL=S=ZF9"KR,,[$5,'@=23^%:7A#Q-=:[_:=CJ=FEIJVEW'D
M74<3EXVR,JZ$C.".QYH Z:BN$USX@M9?$+1_"^G013B:81W\[ D0EE)5 00-
MY )YSQCCT[N@ HHHH ***YOPUXAN]9UOQ)97$<*QZ9>BWA,:D%E*!LMDG)R>
MV* .DHJIJG]H_P!F7']D_9?M^S]Q]KW>5N_VMO./I5B'S?(C\_9YVT>9Y>=N
M['.,\XS0 ^BBB@ HK#\3^)K;PQ:V,UQ#),U[?16,2I@?.Y/)/8  FMR@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHJO?7UKIEE->WUQ';VT*[I)9&VJH]S
M0!8HKA/"'Q#'C#Q=JMC9VWEZ7:V\<D$TD;+),6)R_)^X1C'&>_? GU/Q+KU_
MXJNO#WA6#3C-I\227UUJ.\QH7&4150@EB!G.<4 =I17!0_$.:U\+^(KO6-/2
M+5M /EW5M"Y,<C,/W;(3R%;(Z\CFK>F^(/$5GXGT[1O$EOIN=4@EEMI+'>/+
M:,*6C<,3GAA\PQ]* .RHK!\.ZW<Z]<ZG<HD2Z3%.;>SD .^8ID2.3G&W=E5P
M/X2>XK>H ***P_$_B:V\,6MC-<0R3->WT5C$J8'SN3R3V  )H W**Q-;\2VV
MB:KHVG2PR23ZK<&"(K@*F!DDG\N*VZ "BJ#_ -K?V['L^Q?V/]G/F9W_ &CS
ML\8_AV8_'-9>C^)7\4:)JMUHL*17%M//:6WVS.QY4 PS!>0NX]N<>_% '1T5
M7L?M?]GVW]H>1]M\I?M'V?/E^9@;MF>=N<XSSBK% !1110 4444 %%%% !11
M10 4444 %%%% !4L'WS]*BJ6#[Y^E(">BBBD,**** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *X_
MP!_S-'_8P7?_ ++785Q_@#_F:/\ L8+O_P!EIK9BZG84444AA1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 8?C'4+K2O".I7UE+Y5S#%NC?:&P<C
ML01659:/XKNK&WN?^$TD4RQK)M.F0D#(!Q5SX@_\B#K/_7#^HK">Z\?V'A>&
MZMH]#GBCMD8)%'*9=FT<@%L$@=JI;$O<WO"FM7VH2ZIIFJ>4U]IDXBDEA&%E
M5AE6QV/7(KI*Y?PC96JZ!-JEIJ+7-QJF;B:^D0+EL$#Y,X4+TVY['FN86R\&
MW$!ACAU#7M3(/FW]K%+(YD[L),A1STPV!1:['<]/HKRS4;R\U?X2Z!/)<,+N
M6[MT\]N2&$A4,?4\ UJ^)_"&DZ/X9O=5T])H=4LXO/COO.8RLZ\Y8D\Y[@\<
MT<H7.^K#\3ZA=:?!IC6LOEF;4[:"3Y0<H[@,.1W'?K6'>M+XH\1:5HMU(Z6
MTU=1NHXV*^>S-M5"1SM!R<55\1^%[+19]"N-(#6D#:O:I/;(Q,<G[P8;!Z,#
MW'8FA+4&ST*BN+GLD\5^-=3L-2+OIFDQPJMJ'*K++(N\L^.N!@ =*CGTZ#P=
MXHT9M(WP6&I3-:W%F')CW;25=0?ND$<XZBE8+G<45YSX<\,6.N:OXFGU16N;
M9-7F2*U9R(U?"EG*CJ2"HY]*;X:\+V.I:GKEEJ!FN]-TZ[,%E:33,8X@1N/&
M>>H SG&*=D%ST*[CFFLIXK:?[/.\;+'-L#^6Q'#;3P<'G'>EMDEBM8HYYO.F
M5 KR[0N]@.6P.F3SBO/K?-IX<\>:1&[FRL8YEMD=BWEJT!8J"><9Z5LIHGA^
M_P#">E7^N6EO(EMIT1,LV<(NP$T6"YUM%<!X+\.V4%U<^*QIRV$,D9%C;*,%
M(.N]O]INOL*Q=(U+PMK=D=3\4O<WFH7+L_EM;7#QVZY.U(]J[< 8Y'<T<H7/
M6:*XWP)?B6;5].MI[JXTVTDC:SFN4=6V.I)3YP"0I4CGMBNRI-6&@HHHI %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!Q_@#_F:/^Q@N_\ V6NP
MKC_ '_,T?]C!=_\ LM=A3EN);!1112&%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %0S_P
M_C4U0S_P_C0@(:***H04444 %%%% !1110 4444 %%%% !1110!!=V=M?VYM
M[RWBN(&*L8Y4#*2I# X/H0#^%<%X6 'QH\> # $5C@#_ *XBO1*YW2_"W]F^
M-->\1?;/,_M98%^S^5CRO+3;][/S9Z]!CWH C\6>,+?PYY-E;6[ZAKEY\MGI
M\/WY#S\S?W4&#ECZ'WKF)#>_#3P-JFNWY%_XCU2X$DS1H3&)F&%4 <[$&?K@
M^HJ:;X=^)$\6:IX@T[QN+.XOVQAM)CF,<0/RQAG8\ 8Z 9QFNI\-:3X@TS[5
M_;OB;^V_,V>3_H$=MY.,[ON$[LY'7IM]Z0'CS>(/"NDS^$%@U2:ZN(-3>\U2
M[:RG5I9'0[GP4!//  R0 *]ZMKB*[M8;F%BT4R"1&((RI&1P>1QZUCZ[X<_M
MO5M"OOM?D_V5=&XV>7N\W*E<9R-O7KS6[0!XUXBT1HO%&LWGBOPKK&NV<TH>
MPO=.E,AM8MH^41AAM(/.>YJS>W=G>Z)\.);#4[C4[<:U$BW5R,2M@.,/[C&/
MP[]:ZBX\%:M:ZMJ%YX=\4RZ5%J,WGW-O)9I<+YA&"R%B-I./>F3_  TT_P#X
M1"PT.ROKFUGL+D7MM?@!I%N,DER. <Y/'T]* (_'9'_"6>!AGG^U&X_[9FL#
M0O"&F>)_''C5]9$MU:1:@JI9^:RQ[R@)=@I&XXP!GISZUNCX?ZK>>(-'UK6O
M%<NH7.F3%XT%DD46TC! 56X)."6)/0#%'_"O]6L_$6L:WHWBN6PN-3F#R1&R
M66(*!P"K-RP.<,".I&* ./U59-%T?XC>%(9YI=+LK.&XLTE<N8!(N6C#$YVY
MQ@5<\9:G+/J/A/P]-::M=Z7)I_VJ[M=+'[RYPH55)W+\HZGGN/;%[Q=H=AX2
M^&WB=KS5?M6K:M&7GNKEE1[EQ@!54= ,\*,XS727_A(:[I6@WD%]/I>L:="I
MMKR) Q3<@#*RMPRGN#_C0!R7AI)M,\=::OAOPOXAT?1+E)(]1M[Z$B $+E)%
M^=L-D8/3M4G@SPQI7Q"T6;Q-XFAGO;V\NIA$LDSH+1%8JJ(JL N,9SUS76:1
MX0O8==BUK7]?FUB^MXVCM@(%MX80WWB$4G+'IDG^F*9\!ZGIMY>-X9\4S:19
M7LS3S6C6:7"H[?>,98C9GTY&: ./\?\ A>TL_#OA.WO+S^V)8]>@LQ=SC,A@
M;>3$Q!.>@&?85J^-/#$L.L:7M\.7&L>$[6R:'^R[*;88IM^1)LW#>-O ';K6
MY>?#:T?P?:Z%8:A/;36UXM^E]*@F=K@$DNX.-V2?:I;[P9JMQ=V.K6OB:2TU
MZ"V-K/=K9HT5PA;=\T). <]P: *WPSN-&-KJEGI$VJ0K!<!GTO4U*RV&X<(
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M7_TU\S?NS^&,?C5:'P9;?VYXJOKR<7-MX@C@BEM3'M\M8XS&?FSSG.>@Q[T
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M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)M!_Z#>F_P#@7'_C1R2[![6G_,OO-2BLO_A)M!_Z#>F_^!<?^-'_  DV@_\
M0;TW_P "X_\ &CDEV#VM/^9?>:E%9?\ PDV@_P#0;TW_ ,"X_P#&C_A)M!_Z
M#>F_^!<?^-')+L'M:?\ ,OO-2BLO_A)M!_Z#>F_^!<?^-'_"3:#_ -!O3?\
MP+C_ ,:.278/:T_YE]YJ45E_\)-H/_0;TW_P+C_QH_X2;0?^@WIO_@7'_C1R
M2[![6G_,OO-2BLO_ (2;0?\ H-Z;_P"!<?\ C1_PDV@_]!O3?_ N/_&CDEV#
MVM/^9?>:E%9?_"3:#_T&]-_\"X_\:/\ A)M!_P"@WIO_ (%Q_P"-')+L'M:?
M\R^\U**R_P#A)M!_Z#>F_P#@7'_C1_PDV@_]!O3?_ N/_&CDEV#VM/\ F7WF
MI7'^ /\ F:/^Q@N__9:W/^$FT'_H-Z;_ .!<?^-<IX'US2+;_A)//U6QB\W7
M;J2/S+A%WH=N&&3R#ZTU"5M@]I#NCOZ*R_\ A)M!_P"@WIO_ (%Q_P"-'_"3
M:#_T&]-_\"X_\:7)+L'M:?\ ,OO-2BLO_A)M!_Z#>F_^!<?^-'_"3:#_ -!O
M3?\ P+C_ ,:.278/:T_YE]YJ45E_\)-H/_0;TW_P+C_QH_X2;0?^@WIO_@7'
M_C1R2[![6G_,OO-2BLO_ (2;0?\ H-Z;_P"!<?\ C1_PDV@_]!O3?_ N/_&C
MDEV#VM/^9?>:E%9?_"3:#_T&]-_\"X_\:/\ A)M!_P"@WIO_ (%Q_P"-')+L
M'M:?\R^\U**R_P#A)M!_Z#>F_P#@7'_C1_PDV@_]!O3?_ N/_&CDEV#VM/\
MF7WFI167_P )-H/_ $&]-_\  N/_ !H_X2;0?^@WIO\ X%Q_XT<DNP>UI_S+
M[S4HK+_X2;0?^@WIO_@7'_C1_P )-H/_ $&]-_\  N/_ !HY)=@]K3_F7WFI
M167_ ,)-H/\ T&]-_P# N/\ QH'B702<#6]-S_U]I_C1R2[![6G_ #+[S4HJ
M"VO;6\7=:W,,ZCO%(&'Z5/4VL6FGJ@HHHH&%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M''^ /^9H_P"Q@N__ &6NPKC_  !_S-'_ &,%W_[+784Y;B6P4444AA1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !4,_P##^-35#/\ P_C0@(:***H04444 %%%% !1110
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M.73H!IEU>23?VP]T@2*W:7S6+)][>!D=,>] 'HU[K=M9:QI^E%)9;N^WE$B
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M**** "BBB@ HHHH *Q?%O_(L7G_ /_0UK:K%\6_\BQ>?\ _]#6L<3_!GZ/\
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M !1110 4444 %%%% !1110 5#/\ P_C4U0S_ ,/XT("&BBBJ$%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!S7Q#_P"2<^(O^P?-_P"@FO-O#GA7
MX/W'A?29]3N-'&H264+W(DUED82E 7ROFC:<YXP,5Z3\0_\ DG/B+_L'S?\
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MVUQ<0QSW#V)AC>0!I/W3$[1U. 1G'2@#N]7U:RT+2;G5-1F$-I;)OD<C.!T
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MOI,L_P!W7JSY'.?]Z?H@HHHKT#R@HHHH **** "BBB@ HHHH **** "BBB@
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MY-_K;B*!5D?ZL!D_C5ZB@ K-G\/:+<WZW\^CZ?+>J<BXDMD:0?\  B,UI44
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MBBB@ HHHH *AG_A_&IJAG_A_&A 0T4450@HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHKDO'/B'4M'32=/T<6ZZAJUX+6*>YYCA&,EB!
MU/H* .MHKSG4/^$_\)+;ZE)JX\46GG(EU9QZ8L4RHQQNC\L\D9'!KL)Y)/\
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M1110 4444 %%%% !1110 4444 %%%% !4L'WS]*BJ6#[Y^E(">BBBD,****
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MAX9_Y&O1_P#K^A_]#%?1]>7F'Q1/H<E_AR]0HHHKSSV@HHHH **** "BBB@
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M,DTR8P%+<8 [8 [>E95S\*-)OM,_LV^UG7[NR5-D$$UZ"D&.A4!>2!TW;L4
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MD ]PI%:NI>"=#U+1+/2C;/;06)#6<EK(8Y+9AT9&'(/USGO0!P]M8:U#\0=
MU%/"VG>&QF2&Y6#4HF^UQ%>GEJJ[BIP>,UZ'XH_Y%'6O^O"?_P!%M6=HW@;3
M])U9=6GOM3U748T,<-SJ5QYK0J>H0  #/KC/YUOW]G'J.G75C,S+%<Q/"Y0X
M8!@0<9[\TP/#KMKR\T_X8Z2NE)JMI)8-<?8);E88[F1(Q@,S @[0<XQSFN@M
M]/UF+X@Z!J"^%M-\-J3)!<K!J43?:XBO3RU5=Q4X/&:[.Y\":-=^&M-T.8W7
MEZ:J"SNDFV3PLHP'5UQAOPQ[4FC>!M/TG5EU:>^U/5=1C0QPW.I7'FM"IZA
M  ,^N,_G2 X)M6G\$:%XO\*VP/VJ*Y4:,BG!9+LX0+_N,6_*J^MZ/<Z9XO\
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ME15+!]\_2D!/1112&%%%% !1110 4444 %%%% 'RY1117TA\(%%%% !1110
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MCZ^</#/_ "->C_\ 7]#_ .ABOH^O+S#XHGT.2_PY>H4445YY[04444 %%%%
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M5])EG^[KU9\CG/\ O3]$%%%%>@>4%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !44X^4'
MWJ6FNNY"* *M%%%4(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "I8/OGZ5%4L'WS]*0$]%%%(84444 %%%% !1110 44
M44 ?+E%/EC,4KQL,,C%3^%,KZ0^%"BBB@04444 %%%% !1110 4444 %%%%
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MI-9%;T^7E]S8Y:WM'-NHK,****HR"BBB@ HHHH **** "BBB@ HHHH ****
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MY04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% $$J8.X=#457",C!J!XB.5Y%.XB*B
MBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M5+!]\_2HJE@^^?I2 GHHHI#"BBB@ HHHH **** "BBB@#P'QYH[Z/XLNUVXA
MN&-Q$<<88Y(_ Y'X5S5?07B_PO#XHTKR=RQW<1+02D=#W!]CQ^0/:O!]1TV\
MTF]DL[Z!H9T/*MW]P>X]Z]O"UU4A9[H^4S#"2HU')+W7_5BK11172>>%%%%
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M  IW_J/?^2?_ -G1_P *=_ZCW_DG_P#9UZC11]<K?S?D']F87^7\7_F>7?\
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MBC^S,/V?WA_;.*[K[CSW_A!-4_Y[V?\ WVW_ ,31_P ()JG_ #WL_P#OMO\
MXFO0J*/[,P_9_>']LXKNON//?^$$U3_GO9_]]M_\31_P@FJ?\][/_OMO_B:]
M"HH_LS#]G]X?VSBNZ^X\]_X035/^>]G_ -]M_P#$T?\ "":I_P ][/\ [[;_
M .)KT*BC^S,/V?WA_;.*[K[CSW_A!-4_Y[V?_?;?_$T?\()JG_/>S_[[;_XF
MO0J*/[,P_9_>']LXKNON//?^$$U3_GO9_P#?;?\ Q-'_  @FJ?\ />S_ .^V
M_P#B:]"HH_LS#]G]X?VSBNZ^XY;PUX:O-&U&2XN)8&1HB@$;$G.0>X'I74T4
M5UT:,:,>2&QPXC$3KSYY[A1116I@%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M(!F2QA#B+/0,20 ?;.:+!<WZ*YQ?&FF-HU_J*Q7>=/Q]JM&BVSQ?521VYZ]
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M (P>17(^"1_9D^L>'&R!I]T7MP3_ ,L)?G3'T.X46&=1<W5O9QB2ZN(H$+!
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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=%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>img88009329_22.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_22.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" .=!O4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#R&BBBO0/.
M"BO:/A'X$\->*/"=U>ZQIOVFX2^>)7\^1,($C(&%8#JQ_.N^_P"%0^!?^@'_
M .3<_P#\763JI.QK&C*2N?+5%?4O_"H? O\ T __ ";G_P#BZ\;^*WA_1_"?
MC*QM=*L%CM#9QSR0-+(P=O,<')+;@"% X(HC44G9"E2<5=GGU%?2/A[X??#K
MQ-H%KJMEHI$5PF<?:YMT;="I^?J#Q7AOC+PO<>$?$MSI<VYHE.^WE/\ RTB/
MW3]>Q]P:<9J3L*5-Q5S HKUCX2_#>R\26USJ^NVS2V /E6\6]D\QA]YLJ0<#
MIUZY]*=\6=#\&>%;2#3M(TI8]6N,2%_M,K^3&#UPS$98C R.F?:CG7-RA[-\
MO,>2T"EHJB HK;\*>&+WQ=KT6E615"P+R2MTBC'5CZ]0,>I%>]Z=\%_!UA:*
MM];S7T@^]--<,F3[!" !^=3*HH[EPIREL?--%?1FN_!#PW?6;?V/YNG7(&4/
MF-+&3_M!B3CZ'\Z^?]4TRZT;5+G3;V/R[FWD,;K[CN/4'J#Z&B,U+8)P<=RG
M2TE>C_"GX?1^+;^6_P!4A9M(MLH5W%?.D(^[D8. #DX/I52:2NR8Q<G9'G%+
M7L'Q>\$>'?"^@V%SHVG_ &::6Y\MV\^1\KM)QAF/<5Y B-(ZHBEG8X55&23Z
M4HR4E=#E%Q=F)17U!!\(/!*6\2RZ-OD" .YNIAN..3P^*D_X5%X&_P"@'_Y-
MS_\ Q=9^VB:>PD?+=%=]\6_#FD^&/%=K9:/:_9K=[%)63S&?+%W!.6)/11^5
M<%6B=U<RDFG9B48I:*8A,48I:* $I:** "BBB@ HHHH ****8!12T4"$I:**
M "BBBD 4444P"C%+10 F**6B@ HHHH **** "EI** %HQ110 4444""BBB@
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M%%%)0 M%%)0 4M)10,*6DHH ,4444 %)110 4444 &**0T4 !HHHH *2EHH
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MO"E+9LJ?\(CKG_/C_P"14_QJ&Y\-ZQ:1F26QDVCDE"&Q^1-17.IWXNI0+ZY
M#D >:WK]:N:/XBU*UOX0]U++"SA721BPP3VSTK!O%J/-[K\K-?JSH4<#*?)[
MR\[I_A9&)16]XOM(K/7W$*A5E02%1T!.<_RS6,;:X6!)S!*(7.$D*':Q] >_
M0UT4JT:E.-3:YRU\/*E5E3>O*1459ETZ]AB\V6SN$C_OM$P'YXJ!(WE<)&C.
MYZ*HR36BDFKIF3A*+LT-HJU)IE_#'ODL;E$'.YHF _/%5:(R4MG<4H2CI)6"
MBG(CR.$C5F8\!5&2:M-I6HHF]K"Z"^IA;'\J'.,=&QQISDKQ5RG2XH[\TJJ6
M8*H)). !WID6$JT-.NSIQOQ%_HH;87W#K],YH?3;^*/S)+*Y2/\ O-$P'YXK
M>3_DGDG_ %\_U%<]:ORJ+A9W:7WG9A\+SN:J)JT6_N.7HHHKI.,V(?"^L7$$
M<T5GNCD4.I\U!D$9'>G_ /"):Y_SX_\ D5/\:TO$-U<6VAZ!Y$\L6ZV^;RW*
MY^5/2N=_M/4/^?ZY_P"_K?XUY]&IBJT.>+BEKT?1V[GJ8BC@J$_9R4F[+JNJ
M3[>9+?Z)J.F1++>6_EHS;0=ZMD]>QJA4TUY<W"A9[F:50<@.Y8 _C0]I<QVZ
MW#V\RPM]V0H0I^AZ5V0<E%>T:OY'!44)2;HIV\]?R2(:**GFM+FWC1YK>:-'
M^ZSH5#?3/6K<DG9F:BVKI$&*,5+);3Q+&TL$B+*,QED(#CU'KUJ;^R]0\OS/
ML-ULZ[O);'YXI.I%;LI4IO1)E2EQ1C% !)  ))XP*HSL&**M_P!EZ@$WFPNM
MG][R6Q_*JI!!P>#2C.,MG<J4)1^)6"BE1&D8*BEF)P !DFK+Z9?QIO>QN53&
M=S1,!_*ASBG9L4:<I*\5<JTN*2II+:XAB262"5(Y!E'9" WT/>FVEN)1;5T1
M8HHJ6:VN+<(9X)8@XRI="NX>V>M#:3L"BVKI$6*,5*;:=8$G,,@B<X20H=K'
MT![]*DDT^]AB\V6TN$C_ +S1D#\\4N>/<?LY[V97Q1BG1QO*X2-&=CT51DFI
MY=.OH8R\ME<1H.2S1,!_*ASBG9L2ISDKI:%:BBBK(+UAH]]J:NUG!Y@0X8[U
M&/S-7/\ A%-:_P"?+_R*G^-9<-U<6X(AGEB!ZA'*Y_*N@\*7MU/KL:2W,TB;
M&^5Y"1TKAQ53$4HRJ0<;)7V=_P STL'2PE:<*4U+F;M=-6_(I_\ "*:U_P ^
M7_D5/\:I76EWEE=1VUQ#LFD *KN!SDX'(..HJUJNH7J:O>HEW<*JSR  2$ #
M<?>JMO/-<:E;/-*\C"1 "[$G&?>JI2Q#CSS:M:^B?^9%:&%4O9TU*][:M6_)
M#+VQN=/G\BZC\N3 ;;N!X_"JU='XOC>7Q#LC1G<Q+A5&2>M8LMA>6Z;YK2>-
M/[SQD#]15X>O[2E&4FDVC/%X;V5:<()M1=BO114[6=TDRPO;3+*PRJ&,AB/4
M"MW)+=G*HR>R(,45-/:7-KC[1;RQ9Z>8A7/YTD-O-<-M@ADE;T12Q_2CGC;F
MOH#IR4N6VI%2U//975L,SVTT0]7C*_SJ"FI*2NF*491=I*P8HQ4L]M/;%1/#
M)$6&0'0KD?C48!8@ $D] *%)-70G%IV:U"BI)K>:VD\N>&2)\9VR*5./QIJ1
MO(X2-&=CT51DFA235[Z XM/E:U&T58EL+R!-\UI/&G]YXR!^HICVT\<*3/#(
ML3_=<J0K?0]Z2G%[,;IS6Z9*=/NET];XQ?Z,S;0^X=?IG/:JU=-+_P B#!_U
MW/\ Z$:PDTZ^DC\Q+.X9#SN$3$?RK"AB.=2<[*TFON.O$X3V;@J:;O%-_/\
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MBBB@!:*** "BBBD 4444 +1110 4444#%HHHH **** %HHHH **** "BBBD
M4444 %%%% !1110,*6DI: $HI:* $HI:*0!1110 444"@84444 %%%% !2TE
M% !2TE+0 4444@"BC-%, I:**0PHHHH **** "EI*6@ HHHH *6DHH 6BBB@
M04M)2T %%%% !2TE+0 4444 +1110 4444P"BBBD M+244"%I:2B@!:***8"
MT444""BEHH ****!!12T4P$I:*6@!*,4M%(!,44N**8"8HI:*0@HHHI@%%+1
M0(**!2T %%%% !12T4 )12T4Q!112T@$I:** "BEHH$%%%%, HHHH$+1112$
M)2T44P"B@4M !112T@$HI:2@044M%,!*6BB@ HHHQ0(*6BBD E+113 ****0
M!1110(****8!12BBD E%+10 E+110 F**6DH **** "BC%% !24M(: "BEHH
M 2BEI* "BBB@8E%+10 E%%%(!**6DH 2BEHH 2BBB@ I*6DH ****!B44M)0
M E%+10 E)2T4 )1BBB@8E%+28H *2EHH 2BBB@8E)BG4F* $HI:*!B44M)2
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MDK2_L6Y_OQ?F?\*0Z+<_WXOS/^%'LY=@^L4^YG45H_V-<_WXOS/^%']BW/\
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M1J7LY=@5>F^I0HJ26"6$XDC9?J*CQ4[&J:>J"BC%&*0Q,44N/>DH 2BEI,4
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MN+K1=2@A49,DMJZJ!ZY(Q2;"QETM)6A8Z%J^IQ&33]*OKN,'!:WMWD /U -
M%"BI[RPO-.F\F]M)[:7&=D\91L?0U JL[!5!9B<  9)- !5V?2=2M;"*^N-/
MNXK.8@1W$D++&Y()&&(P> 3QZ5/-X9U^WMVN)M#U*.!1DRO:2*H'KDC%>F^.
M/^2%^%O^NL'_ *)DJ7*UBE&Z=SQ^DI:2J)%HI**8"TM)10(6EI*6D 4M)3D7
M>ZKZG%,3+UI%M7S#U/2K-(   !T%+70E96//E+F=PHHHIDA1124 +2444@"B
MBB@ I:**8"T44"F(6@44M !2TE+0(*6D%+0(*6BB@0HHHHIH!:**44R0I124
MM !2TE+F@04A-(312 *44E+0 4M%+3$%+BBEH$%+1BEQ0*X8I<48I<4Q !2T
M44Q !2TM(2!UH)W"EIN[T!-!)]A^M8SQ%*&[.FG@Z]3X8CNM*:B)/J2*8:YY
M8^FME<[89/5?Q-(FWJ#]X4>8H]?RJ DTVLWCWT1TQR:'VI%@S*.QI/M '\)_
M.J](:GZ[49JLHH+>Y9^U#^[^M)]J7^[^M5C252QE0K^R</YEO[4O]T_G3A<Q
MGKD51I*I8N9+RC#]+FB)XSW_ $IPD0]&%9=&3ZUJL4^J,99+#[,F:XYHK)$C
M+T-2+=R+WK6.)B]SEGDU5?#),TZ*I)?_ -Y:G2ZB?OCZUJJD7LSAJX'$4]XD
MU+2*0W((/TI<59R.ZW =:6BB@D6BBBF(**6B@ HHHH$%%+1U.!0 45Z!I'AI
MK#2+Q9[&2:^N;)W5PF5B'&U0>['K61X&MXYM3OX;@JB_9'#,RYV<CG\*Q]LK
M-KH=?U22E&+^T<M17>[%MO&&EZ1%;+'8PME"0&\[(/SD]Z;8:38P7FJ2Q:G;
M73^1)^Y5&!7\QBE[=6V']3;=D^MCA.?2BNWL]9NK#PC)-=F(M*OE6B>2H(]6
MSC-<3UK2$G*^AA5IJ"5GN)12XI,59B%%%% !1110 E%+10,2BBB@ I*6DH *
M2EHI -HI:2@84444 )11104%)2TE "T&DI:!C:*#10(.U)2]J2D,****!B44
M44 %)2TE PHHHI %(:6D- !1110 4444#"BBB@!#12TE !6;JUKYD7GJ/F0<
M^XK2I&4,I4C((P:4H\RL:4YN$E)')45)-'Y,SQG^$D5'7">VG=70E%+10,2B
MEHI 5****V)"NC\%6EM=:X?M 5S%&7C1AD%L@9_#/^<5SE2V\\MK.D\$C1RH
M<JRG!%8XBG*K2E"+LVCHPM:-&M&I)72>QZ;XNM+6;0+B695#Q -&^.0<]/QZ
M5Y=6A?ZWJ6IQK'>732(IR%P%&?H ,UGURY=A9X:ER3=]3KS7&T\9752G&RM;
MS84458T][:+4K62]B,UHLR--&"070$;AD8(R,BN\\T]8T;XH:!K>B6^B^.=,
M\\0J%6Z5-X.!C<0/F5L=USGVJXOP_P#AQXI&/#OB VURZGRX?.W<^\<F'/YB
MJ7Q,^'T<MO8:[X1L$ETYH%62*R3<>I*R #EL@X)[8%>:V/AS7+Z\2"STJ]><
ML-H6%A@^I../J:Q235XNQO*4D^62N:'C+P3J?@K4([>^*2P39,%Q']V0#KQV
M(R,CW[UZ]J=OJOPX\&Z?I7A/1;B\U2Y4M=7D-HTNU@!DG /.3A0<@ &L;XP3
MM9^!_#>CZC<+-K";'F(.XG;'M9L^['KWP:W_ (A:_P")3X<TGQ%X0O)/L$L9
M:X$,2R$ @%6(*G 'S ],'%2Y.2C<I147*QD^"_$GCN[UE-+\5Z)?WFE7N8I)
M+C36019'4D( 5['/KG/%8=M\.+/_ (7-)H;(3I42?;1&6Y:+ PF?3<=OT%1^
M$?$_Q'\8:PEE9ZU*D(YFN3:QE(ACO\O4] *T_"^L7&G_ !NFMM=UF/4;EK=K
M!;M45%WY#!<# SD%?KQ3::;MV!-22OWZE/QO\5M9LM?N=(\.R1:?8V$A@!2%
M2SE>#]X$ 9!  ':H+WXBZ7XK\ WFG^*8=^M19^QSP0#EL95B>B\C#8['@5S?
MQ'\.7^@^,=1>YA?[-=W#SP3[?E=78MC/J,X(]O0BM#0_AP;WP1J/B36+N738
M84+VP,0/F@#K@D=3@"JY8**9/--R:.L\.+:?#CX5KXJ^S13:UJ.%@:3D+NSL
M7Z;06('7IGICFM*^,WBFUU9)]0N8[VS9_P!Y;F%%^7/.T@ @XZ9)]\UTUU:2
M>-/@-IT>E*TUUI;J9+=/F<F,,I&/7:VX#Z5Y)I6B:CK.JQZ;8VLDMTS["@4_
M)S@EO0#N32BD[N02E*-E$[_XR^&['3M1L-<TR)8[;5$9I%087>,'<!VW!OS!
M/>N_^*WC.X\'Q6?]EPPC4[U67[3(@8QQIC@#U);OD<&N1^-]Y!;6^@>'XI \
MMI"7D]0,!5_/:WZ4_P"/_P#R$=#_ .N,O\UJ4K\M_,MOEYK>1I?##QUJ?C*^
MO_#_ (C$-]%):M(':)5R,A2C!0 0=WIV_+FOAOX,M-0^(VIP7<0FLM(DDPDF
M"'<.50,.XX)_ 4SX%_\ (]W'_7A)_P"AI6_\--5@M/BQXHT^9E5[VXF\HDXR
MR2L=H]\$G\*)+EYK"B^91YCG_$?QC\13Z[,=&NX[/3HI"L,:Q(_F*#PS%@>O
M7 QC/XUWMAXEB\5_"'Q#J9M8K>]-M/'>")<*\@BX;\5V_P NU>'>)/#M]X:U
MRXTV[AD4HY$3LN!*F>&4]\C'\J]>\*>'[W0O@GXB?4(6@FO+>>=8G&&5/*P,
MCL3@GZ$4YQBDK!"4W)W/"J[/X7>&[;Q/XTBMKU0]I;1-<RQGI(%( 7Z989]A
M7&5Z+\%=2MM/\?>7<2!#>6KV\1/0N65@/QV'\:TG?E=C*%G)7-#QG\6==AU^
MZT[0)8]/L;*5H$V0HS/M."3N! &1P!CBHM5^(6D^+O $]GXDA/\ ;T)/V2>W
MA')X(8GHH/(8#Z@=,<QX_P##M_H'BW4!=PN(;BX>:";'RR*S$C!]1G!%:FF_
M#DR^ +_Q-J]W-IHB!:VC>('SA@8X)!&YCM'Y\CK%H))E\TVVCIO^;9_^VO\
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M;9_^VO\ [=5*V7J4]WZ'C?2O0?@O_P E%M_^O>7_ -!KSZO0?@O_ ,E%M_\
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M^$XU/_A!O^$2\BT_L_=N\S8WFY\S?UW8Z^W2N9I:.5!S,2O0?@O_ ,E&M_\
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M:M %)0:2K0!24II*M )24M)5H!*2EI*M"$I#2TE:(!#3:=3:T0#3UI112UH
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M=[:7$2VT< W++)NR ?E/RGY3VX-+G17(SI+[X;>!_#-O9P>*/$E[!J%PF<0
M;,]^-C$#/&21TKR?48[6+4[J.RD:6T29U@D;JR!CM)]R,5[=\7[/PA-J#SZO
MJ5]!K:::?L=O$N8Y,&0IN.P]7R#R./3K7A J:;;5V.HDG9"TE=MX$\!+XJBO
M-2U&^%AH]C_KI^,DXR0,\# Y)/J.#VZ33_ OPZ\1W#:=H/BF^_M$J?+%P@VN
M0.P*+NZ9P#G%4YI"4&SR:BMJY\*ZK;>+6\->2)-1$PB"H<ALC(;/I@YSV%=]
M>?#SP1X7BA@\5^)[E=0==S16:CY?PV,<>YQFAR2!0;/)Z*]%\3?#:SM_#O\
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MM)2U0"BBBB@0M HI10(*6DI:!!2T@JQ9V=Q?W26UM&9)7Z** (115_5-%O\
M1I$2^@,?F#*-G*L/8BK*>&=5>XM8$M]SW,9E3#<!!U)/84N9;W'R2O:QD4M7
M;G2;JUL4O) A@>1HE=6SDCK^%7(/"^I3W$$*K$K3P"XCWRA04SCJ?Y4^9"4)
M7M8QJ":T]:T&^T&:.*_6-7D7<H1PW'X5E4735T2XN+LPI:!2TQ!2T4M,0"E
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MTMHZ^&M,%V5!U6[3]P#U@C/\?^\>WM0W;8 U>>+1M._L&T<-*2&OIE/WW_N
M]U'\ZYRE)+,68Y).230*<59#%IR.4;*G!IM%,32:LS5M;L2 (YPWKZU<KGU)
M!K2M;S=A)#SV-:QET9\WF65<MZM%:=47J**,5H?/!11BB@ I*6B@!**7%)TH
M'<,4E+12 2DI:*!B448HI (1BBEIM Q<9IM.I"* "DHI:0"4444#$(I*6DH
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MF+J__'VG^X/YFJ&*T-7_ ./M?]P?S-9]<=3XF>UA_P"%$,4E+28K,V"BC%%
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MH 6BBB@ HHHH *6DI: "BBB@ HHHH 6BDI: %HI*6@04444 %+24M !1110
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M29E1QL&W:/,'&,#IU!KE/BOJ,EG\5I;JRF*7-HL#*P'W7"AA]>HK;O\ Q3X
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MDI10#"EI*6F(444@I:8A:!10*!"TM)2T"%% HH% A:6D%+5"8AZT@I3UH%2
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M#$I:3O2TF-#:*#UHH&)1110 &DI324%!24M(: "BBBD,**** $HHHH ****
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MF#+%^Z1-H.,_= ST'6CD=TV]AN:LTEN=?\$?^1^;_KSD_FM:?@K_ )+YJ_\
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M0* "BBB@ HHHH *6DHH 6BBB@84444 %+244 +1110 4444 %+24M( HHHH
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M24M !5JP_P!>W^[_ %%5:M6'^O;_ '?ZBJCNC.K\#-&BBBMSSPHHHH ****
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M@:<#57(:)0:<#48-.!IIDM$@-.!J,&G TR6B0&EI@-.!IDV'44E% "T449H
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M(HI;5FV^?;N60-Z'(!'XBNX^'W_)%?%W_;Q_Z(6M^^T+4M%^!VIZ7K<L=Q/
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M*D$<$$*34'Q)_P"20>#/^N5O_P"D]>47&KZG=V,-C<ZC=S6D./*@DG9HX\#
MVJ3@8!(XI;G5]2O+.&SNM1NY[6  0PRSLR1@# VJ3@8''%)0M8'.]RE2TE+6
MA 4444@"BBB@ HHI: "BBB@ I:2B@!:*** %JU8?Z]O]W^HJK5JP_P!>W^[_
M %%7'=&=7X&:-%%%;GG!1110 4444 %+24M "T4"B@0M**2@4Q"TM)2TQ"BB
MD%+0(6EI*6@!:6D%**:)8M**2E%,3 T"EI*!#JZ#2FWV*?[.17/ULZ))\LL1
M/0Y%<&8PYJ-^QZ.53Y:]NYJ8I<4[% %?/GTPW%&*=BEQ0 S%&*?BC;0 P"G
M4X"E H  *E04T"I%%(8KID9%/BXIZ#(H"[6I7&.Q1BG8I,4K@)BBEHH 2C%.
MQ1B@!,48I<4H%(8"GCK28I0* !UW(16)?6SKED'-;HIKQ*XY%-.PFKG!7-[=
M0,0+<'WYJQHUI>:E>+/= B)#\JXP*ZUM-@8Y9 ?PJS% D*X10/I6CJJVA"AJ
M.5 J@#M2XIV*2L32PF*,4N*7% 6$Q12XI: L)BEHHI#"D8X4GT%.JO?2^393
M/Z*:: X#4'W3R'U8TW29,7.,U!<ODDTFF-_IBUV6]TY^IZ18G,(^E6ZJ:?\
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MZ_-3]&@E^'OPBUC4+A?)U;49WM8P?E92"8QCUQB1Q_DUD_ ?_D>;W_L&R?\
MHR*B3NFQ15N5%_6_$G@7P9J4VCZ?X1L]7F@<BYN+G:1O[JN5;H>,  #%)KWA
MGPWXR\#7'BOPK9BPNK,,;FT487"C+#:. 0OS CKWYZ>;>*+6>R\5ZM;W(83)
M=R[MPP3EB0?Q!S^->I_!Y6L? WBG4;MB+#:<!AQE(V+GWR&4?A3:Y5=!%\SY
M68?P^\&Z,?#MWXQ\5 MIEL2(8,X$A!P2?7YL*%[G.:M0?$/P-=7PM+SP%8V^
MG.VW[1&B&55_O$!0?R;/IFNE\-ZG!IOP"MKR32(-7BMFD\ZTE *D>>W)!!Z
M@]*Y#_A9_AS_ *)OHG_?,?\ \:J=9-Z#TBEJ4_'WP^CT#Q+IL6ER[M-U9P+9
MG)/EL2 5)[CY@0>N#[9/5^)Y_"7PQ>ST>/P?;ZM<20B5[J]"G=R1U96YRO0
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MT@)R RX-5V4J<&I@:1L$<TAD%+2D8I*8@I:** "E%%% (*<!28I:0PI:2EH
M***6@ HHHH ***"0JEF( '4F@ KD/$FN"4FSMF^0'YV'<^E/U[Q&K(UK9MP>
M'D'?V%<?)+DFNBE3ZLRG/HA)9,FJK-3G>BWA>YG6)!DL:Z=C$V/#>G-=W8D(
M^4&O3;>(11!163H&EK96BC'..:W*XJL^9G1"-D%%%%9%A11BEH 2EHHH IZK
M=BQTRXN"<;4./KVKQ>YD,LK.3R3FO0O'FH^5:Q62'YG.YOIVKSB0UZV!IVCS
M/J857K8A<U QJ5S4#&N\Q%7K6UIR_+6,G6M^P3;$*VHJ\AQW+ZBGTU>E.KM-
M0HHHH **** "BBB@ HHHH **** ,_4&_>J/052-6+ULW+>W%5C7-)ZGS>*?-
M6DQ#332FFFH,D)0#0:2D,E4U(IJ!34BFFB9(L*:D4U IJ135IF31.IJ0&H0:
M>IJT9-$P-/!J(&G@U2,VB44\&H@:>#5&;1(*>*C!IX-,ACJ6FTM4*PZBDHH$
M+129HH **** "DHHH&%)110,*0TM)2&%%%%  :2BB@ HHHH&%%%% !1110!F
M:C_Q\+_N?U-5*MZC_P ?"_[@_F:IUQS^)GM8?^%$****@W#-%)10(RZ***W,
M@H'6BBD M%%'>@ I*6DH&%%%% !1110,**2B@!:***0!1110 4E+24#0444E
M Q:*2EI )1110,*0TM)0 44M)0,**** "BBBD 4444#"DHHI %+24M !1110
M,2BEI* "BBB@84444@"BBB@8E%%% "T444@"BBB@ HHHH **** %HHHH ***
M*!A1110 "EI!2T %%%)0 O>BBBD 4444P"BBB@84M)2T %%%%(04444 +124
MM !1110 M6K#_7M_N_U%5*MV'^O;_=_J*J.Z,ZOP,T:***Z#S@HHHH'8****
M L%+24M ,6BDI:!"T"BBF(6EI*6@0"EI*6@0M I!2TQ"TM)2T"%I:;2T"8ZE
MIM+5"' TM(*6@EBTY&*.&4X(.0:;10U?0+VU1VUA<K>6B2@\XPP]#5H"N4T6
M_P#LET$<XBD.#['UKK:^8QE!T:ENCV/K<#B57I)]5N)BEQ2T5R7.T3%+BEQ1
MBD 8HQ2@4X"@8@%.I*<*! *>*:*<*0R130::*=VI#(V-,\P \T]Q5:2J0BR,
M$9%+6<9GC.5/X4]-23.)01[BBPKHO4ZHXYXI1^[D5OH:DI%!2XI*6D 444M
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M8444E "TE%%( I*6DH&%%%% !1112&%%%% !24M)0,3O2T44P"BBBD,****
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M.G8U UM./X#7I[:3$W\(J,Z)">JBM%71/LSS'[-/_<-.6QN7Z1FO3ET2W'\
MJ=-*@3^ 4>W0>R/-(=!O)B/D(K8L_![N092:[U+2).BBI@BKT%9RKM[%*FC!
ML/#EM:@$(,^M;<5ND2X4"I:*Q<F]S1)(****0PHI:* #%%%% !1110 5C>(M
M:32;%L$>>XP@]/>KNIZC!I=F]Q,>GW5[L?2O)]6U2;4[MYIFSD\#T%=.'H\[
MN]C.<[(I7$[S2M([99CDFJCM3G:H':O62L<S&LU0L:<QJ(FK) <FMC2K8D^8
M16;;0F:55 [UU%O"(HPHKHH0N[E15W<E48%/H I:[S4**** "BBB@ HQ110
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M_CW\,_[EQ_**O&:YZ49.*LSJJRBIN\3N_ /@B#Q'XWN;"XE,VFZ>SM-(G F
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M[?\ ?-144KA8?B/LS?E1A/4_E3:*!BX7U-&![TE+0 <4444@"BBB@88I:**
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MRA'!9P2^5Y?N6VG/T %>34E3[.)7M)=SL_ WCQ?!%WJ4T6F-=)>*JHIN-AC
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MG;(N<?@1W%)3BW9 Z<HJ[.>H-=]X7^%U[KFC'6M2U&#1],(W)-<+DLO][!(
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MC-=9X0^&6H^*-/?5;B[ATS2E!_TF<9W8ZD#(X'<DC\:Z/2OA;'%JVGZGX?\
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MX[9Q7H7P*_Y'RX_Z\)/_ $-*YN\T*_\ $GQ(U72]-B#W$NH7'+'"H [99CV
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M5JA:ZZ-'[4BXQZL0"EI>E)78D:!24II*H HHHI %%%% !1110 4444 %%%%
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M)<]<+-&!_*M;2[;2O@WH-_<WVI6][X@NT"QV\)R 1G ]=N3DL<=!@9Z\_P#
MN1YO'NH2R,6D?3Y&9CW)ECR:AZJ31:T<4]SS[Q'_ ,C/JW_7Y-_Z&:S*T_$?
M_(SZM_U^S?\ H9K,K=;&+W/:/C!.^D>"O"^A6;-'9R1DNH;[PC5 H/KR^?J
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M?"*0?\Q=/^_'_P!E3Q\)I!_S%T_[\?\ UZR^NX?^?\S9T<7_ "_B>19U(_\
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M4#"DHHH 6BCM24 %%%% PHHHI %+24M !1110 4444 %%%% "BBBB@ HHHH
M*6D[TM PHHHH$%%%%(84444 ':BBB@!:*2B@ I124O:@ HHHH 6K6G_Z]O\
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M#[5=T7Q%';:*NG2W<]F8I&D62*%9-X/4$'I]:JWFMI=66H0R2S323S(Z22*
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M$,<*<.E-%.%,@6EI*44Q!2TE+0 48HI130A,48I:*8!BBBB@ HHHH *6DHH
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M"1LMCOZ >I%0I>\RW'W4<37I?@CPIHNL?#?Q/JU]9>=?64<S6\OFNNPK#N'
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MT)ETKP[\-_'T<UCH$=[H^JJA>-)G9MV.^"S!AZ@$&GSH.1GCU%=KX0\*1O\
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M*6D'2G51#%%**04X4" 4M(*6F(!2T44 %%%%-"'4444Q!1110 4444 %%%%
M!1110 4444#L%%%% S$UC_C[3_KF/YFL^M#6/^/M/^N8_F:SZXZGQ,]BA_#0
M44E%0;"T4E% ""B@45TG*)10:*0PHHHI"$-.BBDGF2&)2\DC!54=23P!25K>
M%-H\9:'O^Y_:$&[Z>8M)NR*2N['K^LWUM\'_  99:?ID,,FMWHS).ZYR0/F<
M^H!("C^?.?,O^%D^,?/\[^WKK?G.,+M_[YQC]*ZCX[B7_A,+ G=Y7V!=OIN\
MQ\X]_N_I7EM94XIQYGNSHJS:ERK1(]AU/Q;H'CKX:S-K]Q;6FO6FX0$ [G<
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MU;K%(R?D:KY(.1U'2MOQ,HEO+74%^[>VR3$_[6-K?J*EZ2%U,2BBBJ&%%%%
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MM)0" TE+24#"BBB@H2EI*6D E%%% "44M)2!!11104%%%%(8E%%% !24M)0
ME+124#%I:04M(8E%%%( I#2TE Q**** "EHHH *2EH[T#04E+24#"BBB@ HH
MHI %%%% PHHHH **** "BBBD 4E+24QA1110 M%%%( HHHH **** "BBB@ H
MHHH&%)110 4444 %%%% !1110 4444 %%%%( HHHI@%%%%( JWIS8NOJI%5*
MEM7\NYC8],\U47J145XM&[11170>8%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 8HQ110 4444  I:2EH !2TE+0(!2TE+3$***04M "T4@I:8A
M1124M "T5VW@VZ=K65;NRL1HMM&[7<TD +OD<*&/.[.,8K0TEK73[/PY;0Z=
M;3Q:O,_VEIH@[%=VT*#VP/2LG4L[6-HT.9)W/.J*Z_0;&WMOB7'9*JO D[J
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M$%+110 4M)2TQ,****!!1110 4444 %%%% !1110.P4444#"BDS10 9HHHH
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M%&**!!2T44 %%%+3 ****!,****!!1110.P4444!8****!A11FDH 7-)110
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M ,=/^%']JV7_ #V_\=/^%'-'N'LJG\K^XNYI*I_VK9?\]O\ QT_X4?VK9?\
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M44 %+FDHH 7-&:2B@!<T9I** %S1FDHH 7-+FFTM "YHI** %HHHH *6DHH
M6BDHH$+1110 4444 %%%% "T4E% A:*2B@!<T9HHH 6BDHH 6BDHH 6BC-%,
M I<TE% A<T9I** %S1FDHH 6BDHH 7-&:2B@!:,TE% "YI:;10 ZBFTM "T4
ME% A:*2B@!<TE%% PHHHH ****!!1110 449HS0 449HH **,T9H **,T9H
M*2ES10 44E%(84N:2B@!:*2DH 7-&:2BF N:,TE%(!<T9I** %S1FDHS0 49
MHHH&%&:,TE "YHS244 +FC-)10 9HHHH **2C- "T444 6Z2EI*Z#B"C%%%
MPI*6D[T@"BBBD,0T444#04E+24#"DI:2@ HHI:"A****0"&BBBA@)0**6D,*
M***0Q**6DH&)1110 4E+24#"BBB@!:**2D,****0"4&EI*8Q****0!1FBB@
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94@"BBB@ HHHH **** "BDHH 6BDHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>img88009329_23.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_23.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" *=!=X# 2(  A$! Q$!_\0
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M*,4M% "8HQ2T4 )BC%+10 F*,4M% "8HQ2T4 )BC%+10 F*,4M% "8HQ2T4
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MBC%+10 F*,4M% "8HQ2T4 )BC%+10 F*,4M% "8HQ2T4 )BC%+10 F*,4M%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTH[2IY9_0&@#HZ*YH:MXBM\"YT1)!W-M+N_F!3CXOMX3MO+"^MCW+QC _(T
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M5(#, 3TR:=G/2N$U#07/B+2([[4KR=IC)O*RF->%)& #Q6R?#%Q$?]#UN^B
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M$@\6Z'/P+^-&_NOP:U8;NWG7=%.CCU#4 344 @]#FB@ HHHH **** "BBB@
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MKH%W;"&=;5-JXY24+U^O6N9^']AXQB\(ZCX5U."YL)8D*V5Z#T]L_EBO8J*
M/ +NU^)^H^''\&WFD><KG8^I22D@I^7ZUI>-O .J6_A7PMI&EVTEX;%_WK(.
MGW>?TKVVB@".W4K;1*PP0H!'X5)110 4444 %%%% !1110 4444 %%%4[[5+
M+38O,N[E(E]SUH N4UY$C4L[!0.Y.*YU]=U+4AC1M.;RSTN;GY%^H'.:2#PZ
MVIQK-K-[)>9Y\D?+$/\ @/.: +%QXIM/-:WT^.6^N1_!"N0/J:@6SU_5AF]N
METZ _P#+*V.YR/=N,5O6UK!9PK#;0I%&O15& *FH Q=)T+3]/N9GB@#3!O\
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MW2:,C_OL5O*<J#ZBL+QA_P B])_UTC_]#6MQ/]6OT% #J*** "BBB@"O??\
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MN;/OZ5630+_4ANUO47=3S]GM_D3Z'KFM$:=::;!$EI;I$H<<*.M &;M\1ZN
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MI0!1FK/E^]6A-6?+]Z@#;B[5;CJI%VJW'0!.M2BHEJ44 .%**04HH 6BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJM>7]II\7F
MW=Q'"GJ[ 9H LTA( ))P!7-R>)KB\!71]/EF&<">8%(Q],]?PI4\.WFH,)-;
MU!YAU^SP?)'_ (_K0!9NO%.GPRF"VWWMS_SRMAOP??'2JQB\1:LV9)$TRV/\
M*?-*1]>@_*MNTT^TL(Q':VZ1*/0?UJS0!@Z?X>T^QU!G\MIIMN?-F.YC_2MT
M  8 P*K]-0^J?X59H *BN1FVD^E2U'.,P./:@ MSFW0^U25#:G-K&?\ 9J:@
M JM!Q<S_ %S5FJT)_P!+G'T- %FBBB@"N_\ Q_1_[M6*K2<7T7NI%6: ,'Q@
M#_PCTI["2//_ 'VM;D9!B0@Y! K&\7?\BQ=_5/\ T-:U;/\ X\H/^N:_RH F
MHHHH **** *]]_QZ2?2IU^Z/I4%]_P >DGTJ=?NCZ4 +1110 4444 (>AJ"S
M_P"/?_@3?SJ<]#4%G_Q[_P# F_G0!8HHHH **** "JT__'W;_C5FJTW-Y /0
M$_RH LT444 %%%% !1110!6A_P"/V?\ #^56:K6_-S<'_:'\JLT %(0#U /U
MI:* *\UA:7"[9;:)Q[J*S)?"6B2\BR5&_O(2#6W10!SG_")B#FQU6_MSV D!
M7\L5"MEXF@=TMM7MY]G.)X22?Q#"NIJM;\W,Y]\4 8B7_B>VS]ITN"Y4=X9@
MN?P.:</%+1$_;-'OX0/XEB+C\P*Z*D(!&" 1[T 8</C#0Y6"M>I"WI/\A_6M
M2WU&RNQFVNHI?]QP:66QM9EQ);1,#ZH*S9O">BSDDV2JV<[D8@_SH VJ*YS_
M (1%(>;/5+^W/4!9 1^HIO\ 9GB6VR;?6(9P.@N(B2?R(H Z6BN<LM8U6#68
M=-U6WAW3J6CD@/''J,GTKHZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH .]%'>B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***CGGAM
MHC+/*D<:]6<X H DHKG9?%<4\OD:3:2W\IX#(,1C_@?2F#2-9U4YU6_\B$_\
MN]KQ^!)SG\* +]_XCTW3Y/)>?S;CM!%\SG\!S5%KGQ#JV!:P)IMN>LDXW.1[
M#C%:MCHVGZ<N+:V13W8\D_B:OT <[IWARS,SSWK2WMRK?ZR=LX^@KH$147:B
MA1Z 8J"V_P!;./\ :_I5F@ JM>_ZI3Z,*LU6O1^XSZ$4 6:***  ]*K67$!'
MHQJR>E5[/_5,/]LT 6**** *T7_'[-]!5FJT7_']*/\ 9%6: .;\4?\ (0T3
M_KZ/_H-=)7,^,/\ F%'N+Q.?Q%=([;4+>@I-V5V!SVK3^==E>R<50J25M\SM
MZL:;7PF(Q#J5929Z\(<L4AM%.I,5G[0NPE&*6BFJ@K"44M&*KV@6$K2LM6>'
M"3?,GKW%9V**VHXN=&5X,B=.,U9G5&9)K5WC8,"IZ4ZV_P"/9/I7+PW$L!/E
MM@$8([5OZ?>Q31+'G#J.0:^DP>94Z_NRTD<%6@X:K8O4445Z9@%%%% !59^=
M0C]D/]*LU6;G4$]D/]* +-%%% !1110 4444 5;;_CXN/]_^@JU5:T^]/_O_
M -!5F@!" 1@@'ZU!+8VLZD2V\; ^JBK%% &)/X2T2?)-DJ,?XD)!J >$TMQF
MRU34(". !("!^E=%10!S)TSQ/;'-OK,$P!^[<0DDCZAA2Q:AXE@+"?3;>YV?
M>,,H3/X'-=+5:U_ULY_VJ ,4>*I(B1>:+J$('4I&9!^8%31^,=$=MLEXL#>D
M_P G\ZW" >HS4,ME:S*5DMXF!]5% #+;4K&\ -M=PS9_N.#5JL:;PIHLQ)-B
MBM_>1B/ZU5_X1%(3NL]4O[8CH%D!'ZB@#HZ*YH:7XDMN8-9BF [7$1.?R(I1
M>>*;;)FTZUNE'>&0)G\R: .DHK#T_P 1&ZU(:?=6$UG<,NY YR& Z\X]JW*
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MK-5IO^/R _7^56: ,3Q=_P BQ=_5/_0UK5L_^/*#_KFO\JS/%8W>&;SZ*?\
MQX5H:>Q?3;5CU,2']!0!9HHHH **** *]]_QZ2?2IU^Z/I4%]_QZ2?2IU^Z/
MI0 M%%% !1110 C'"$^U067_ ![ ^I/\ZF?_ %;?0U#9?\>J_4_SH L4444
M%%%% !5:3_C^A_W3_2K-5G_X_P"/_=- %FBBB@ HHHH **** *UJ<RSD=-_]
M*LU5L^LQ]7JU0 4444 %%%% !5:U_P!;.?\ ;-6:KV?W)#ZN: +%%%% !111
M0 4444 <[=KYOCJR'41VC-QV.[']:Z*N>A;S/'=P/^>=F!Q[L*Z&@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** #O11WHH **** "BBB@ HHHH
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M36-_;^HZDVW1].;R\X^T7(*+_P!\\&GIX:L+%//96N;C()EG8N>OH>!^%=
M H &!Z"@#G8_#,MW*)M9U"6[/_/%#LC'Y8)_&MVVL[:SC$=O!'$H[(N*FHH
MKWO_ !['V-3CH*AO!_HDGL*E0Y13[4 .HHHH K7?!A/^V*LU6O/]6A]'7^=6
M1TH **** *T?%_+[J#5FJPXU!O=/ZU9H *ANO^/63Z5-45S_ ,>[_2@!T/\
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MVWDW</\ ;D-[_:&XYV%\@[>G3 QTKH/ _A?5['6=4\0>()(&U&_VJ4A^ZB@
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MTJ=?NCZ4 +1110 4444 -D_U3_[IJ.T_X]DJ23_5/_NFH[3_ (]DH FHHHH
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M4 =UWJ.:58(7E?.U!DXJ3O2$ C!&10!YEX:^(>I>(OB1)I7V1[32Q;&2-9D
M=\?Q>H%9NN^/O%+:EKMWHJVJZ5H1Q-'*N6GQDG!QQP*W$TJ^'QO.HBT<6/\
M9WEB;C;NYXKC]=T;Q+I-]XGT6QT:2\M]=;,%RC#;'NR#NR?I2 Z#5/'6OZWJ
MECI/A8V\$\EE]LEEG&0!S\O0_P!TUUO@/Q++XI\-)>W$:I<H[13!>FX=<5Y]
M>:!KG@?7=/U?3],DU*(Z<+26.(C<KC=SR1Q\WZ5VWPST"[T#PFL5]'Y=U<2M
M/)'G.PMVJM!=BW?^+)%U2/3--L)9[F0D"20;8Q@9/)YZ>E//A^_U-@^L:D[)
M_P ^]L2BCVR,$TOB%C#K6A2C@><ZGTY7%='2&5++3++3HPEI;1Q=B549/U/4
MU;HHH @NQFU?\/YU*ARBGVIER,V[_2E@.8(S_LB@"2BBB@"*Y&;:0>U+ <P(
M?:EF&87!]*9:G-K'_NT 34444 5[W_4#_>'\ZG7[H^E07O\ QZO4R?<7Z"@!
MU%%% %8\7Z^Z?UJS5:3B_C/JI%6: "HY^8'^E24R49B8>U #+4YM8O\ =%35
M!:?\>D?^Z*GH *K0?\?4_P!15FJT'_'Y./H?YT 6:*** *K?\A%?]S_&K55F
M&-00^JXJS0!S/CI@GAX/W6YA(/I^\6LPON.X]^:Z'Q&EO/IC0RD'YE8#W!!K
MF@:^;SN?-.,.Q<'8DS1FF9I<UX+B:J8_-&:9FC-+E*YR3-&:9FC-+E'SC\T9
MIF:,TN4?.29HS3,T9I<H^<?FC-,S1FCE'SC\TN:CS2YI<H<X_-&:9FC-'*/G
M) Q5@RD@CH16OINI S$7#?.P #5B9HS75A,54PT^:&W8F=IK4[@$$9%%<YIV
MKM 1%.2T?9O2NA1UD4,I!![BOL<)C*>)C>._8Y)1<6.HHHKL)"F2G$3GV-/J
M.?B"3_=- #;3_CU3Z?UJ:HK88MD!]*EH **** "BBB@".<X@<^U):C%K$/\
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M\^PS2Z%()=!L&&?^/= <^RBI]07?IMTOK"X_0UG>$Y?-\-VIR?E!3GV./Z4
M;5%%% !5:U^_./1S5FJUOQ<7 ]P: +-%%% !5:V/[^=?]K-6:JP<7DX^AH M
M4444 (>5(J"R/^C@>C'^=6*K6?\ JV'^T?YT 6:*** *U[_JT_WA5FJ][_Q[
MGZBK% !1110!7M>&F'8.:L56M_\ 73C_ &LU9H *K./]/C/8J:LU7D_X_(?H
M: +%%0272*=J N_HM,\J:?F9MB_W5/\ 6@".]G3?$J?.X;H*D\J:?_6OL7^Z
MI_K3+F-(5B$:A?G%7: ,O6K>,:!>QJ-H,1Y%/T%M_A_3SC_EVC'_ (Z*?K7_
M "!;W_KBW\JC\/\ _(O:?_U[I_Z"* +S0Q/]Z-3]141LHNJ%D/\ LMBK-% %
M403I]RX)]F&:-]VG6-''L>:M44 9]W='[*ZO$Z$CTJS'=0LH D&<=Z2]_P"/
M23Z4\PQ2*-\:MQW% $@93T(/XTM5C91#[FY/]TXH\B=/N7!/LPS0!9HJKONT
MZQHX]C1]K*_ZR&1?PH L2?ZI_P#=-1VG_'LE,>[A>%\2#.T\&G6I7[,F".E
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M.5C7U<59H **** "BBB@ K)\3/Y?AV]/',>W\^*UJP?&)_XIJ<?WGC7\W H
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MFI*RGRX)&! ZY!% '34444 %%%% !2&EI#0 TU&U2&HVH A>JDO2K;U4EZ4
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M?[HI"'T444 %%%% !5>SY20^KFK!Z57L_P#5-_OF@"Q1110 4444 %5;O[\
M_P!NK55KG_70?[Q_E0!9HHHH **** "BBB@"J.=1/LE6JK)S?2X[**LT %%%
M% !1110 5STH$OCN'/\ RRLB>/4L170USMH_F^.;[/\ RSM57]0: .BHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** ,?Q6+L^%=3%CG[3Y#;,=<__
M *J\.\+R?#&/P&QUE$;5=A%QYV[S?,]A]:]I\6>+]*\(:?\ :=4=T1P0F(F8
M%L< X'%>+V/C[X>:JG]I:MX64ZJ78E8(W*]>#QQ0!Z'\%/M?_"OH3<>;Y1F?
M[/YOWO+[?ABO1:X/X9>);[Q+9ZE//8&SLHIPMDAC*?N^>WY5WE !1110 444
M4 %<UI!*>,=:C(QO"2#WX _I72USL $/CNX!X\VS4C/?YC_A0!T5%%% !5:7
MB]A/J"*LU6N!BY@/^UC]* +-%%% !5:3B^B/JI'\J=)=(AVKEW]%YJK,DLMQ
M"93L4DC"]: +4ETB':,N_P#=7FF;)Y_OMY:?W5ZU/'$D0PB@4^@"..&.(85<
M>]0P<7<X]\U:JM$,7TONH- %FBBB@"&Z&;9_I3X>84_W127 S;R#_9-%N<V\
M?^Z* )**** *T/%W./I5FJT?%[*/4"K- !5:?_CZ@_'^E6:K7'%S ?<B@"S1
M110!2U)_*B5_[IS7GDC[Y7;U8FNY\2.8](D8=<@5P6:UA&Z/3P,5RMCLT[-,
M!I<U$Z9UR@.I<TW-&:PE3,G =FES3:*S=,S<!V:,TVES4NF3R"YI<TW-&:GV
M8N07-+FFYHS2]F+D'9HS3<T9I>S%R#LT9IN:,T>S#D'9HS3<T9H]F'(.S1FF
MYHS1[,.0=FC--S1FCV8>S'9HS3<T9I>S#V8[-&:;FC-+V0O9CLTN:;1FE[(7
MLQU&:;FC-+V8O9ENROYK"<21-Q_$O8BNVT[4H=1AWQG##[RGJ*\^S4UM=36D
MRRPN58?K6U*3AZ$2HWV._7G4)#Z**LUC:/JL>H2NS827 !7_  K9KL335T<S
M33LPHHHIB"BBB@ KG&'F>/U_Z960/YLPKHZYNQ82^.-1;_GG;(G/^\3_ %H
MZ2BBB@ HHHH *0TM(: &FHVJ0U&U $+U4EZ5;>JDO2@"C-6?+]ZM":L^7[U
M&W%VJW'52+M5N.@"=:E%1+4HH <*44@I10 M%%% ')^./&L?A"TMQ%:O>:A=
MOLMK9.KGN?ITKDM-^+M\UGIUYJFCK!;3W;VMS)&3B!AC&<GW/Y5M_$GP]J&H
M2:5K6CR0_P!IZ9*6AAF8 2@]1SWX%><Z1X1\=>(&ETG5--CT[29[_P"VSL74
MG.>BX)- 'T&K!E##H1D4M-C3RXU3^Z *=0 4444 %%%% !7-^,EQ8V<W_/*Y
M0Y],G']:Z2L/Q>H/AR=R/N/&P_[[6@#<HJ.!M]O&_P#>4']*>2 ,DX% "U#=
M#-K(/:FM=9)6%#(WJ.E1R6TDL;&>0]/NKP* !+O,:K$ID?';I3Q;O*<SOD?W
M%X%.LP!:1X 'R]JGH :J*@PJ@#VJ*\_X]7]A4]170S:RC_9- #X_]6OTIU1P
M',"'VJ2@ JM<<7%N?]H_RJS5:[^_ ?1Z +-%%% !5:S^[+_OG^=6:K6GWY_]
M^@"S1110!6GXNX/Q_I5FJUQQ<P'W(JS0 57O?^/?/HP-6*KWO_'LWUH G7E1
M]*6D3[B_2EH @O/^/5ZECYB3_=%1W7_'M)]*?#_J8_\ =% "3KOMY%]5(_2L
M+P6<: 4_N7$R_7#FMNXG2.-@3EB#@#K7/>$YQ%I$@".RFZF.X#OO/% '2R.(
MXV=C@*,FO,-2NS?:A-/G(9CM^E=CXDU5(=)9(V/F2_+@C!%<"#@8KJP\=.8:
ME8?FE!IF:6NBQHJ@[-&:;FC-%BE4'4M-S1FE8I3' E2""01W'%;.G>)KRRPD
MI\Z+T;J*Q,T9I2BGN#DGN>AP:W9ZC:/Y<@63'*-P:U8O]2G^Z*\G!*G<I(/J
M*Z#2_%-Q:!8KD&6(< ]Q7/.@U\)E*'8[NBJMEJ-K?Q![>4-ZCN*M5SM6,PHH
MHH 0]#5>Q_X]\^K&K!Z&J]B/]&'N<T 6:*** "BBB@ JM/\ \?<'U/\ *K-5
MI?\ C]A^AH LT444 %%%% !1110!6AYNYS]!_.K-5K;_ %\Y_P!K%6: "BBB
M@ HHHH *YO1_G\7:X_\ =*)_XZIKI*YOPP?,U/7)?6Z YZ\(* .DHHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** *M_IUGJEJUM>V\<\3=5D4$5D:1
MX.\.^'K5H+73[5$9R^94#')]S70U\Z^,;W5M=U?7]2DUB:UCT:]2"*R239O7
M)&XCOT_6@#Z&ACBB39"B(@[( !^E25Y7X+U.ZM?B=K&BIJ+7]A<1?;58MN$+
M$_<!_'I[5ZI0 4444 %%%% !7.W7R>.K)O\ GI:%/R+&NBKG=7 C\6:)*>-W
MF)G_ (": .BHHHH *K7?!A;T?^E.DND0[5R[^BU5NTFEB5I#L0,/E'6@"U)<
MHAVKEW]%IGESS_ZQO+3^ZO6IXXDB&$4#WI] #(XDB&$4"H;D?OH#_MU9JM=\
M"(^CB@"S1110 577B_;W0?S-6*K'C4![I_C0!9HHHH 9+_J7_P!TTRU_X]H_
MI4DG^J?Z&HK,YMEH GHHHH K*<7[CU459JJ.-1/NE6J "JUQ_P ?%N?]JK-5
M[G_60?[XH L4444 <_XMEV:8J?WW%<3FNG\93?O;>$'H"U<N#7527NGI85\L
M!]%(#15-'<ICLTN:;14.!6C'9HIM+FH=,7(.S1FFYHS4.F3R#LT9I,T5/LR>
M0=1FFT9I>S#D'9HIM%+V8N0=FBFYHS1[,7(.S13<T4>S#D'44W-%'LQ\@[-%
M-HH]F'(.HIM%'LPY!V:,TE%'LPY!:*2DS1[,7LQU%-S2YJ?9"]F+FC--S2YI
M>R%[,DBE>&19(V*N.A%=EHVO1WJB&<A)Q_X]7$YI5<JP920PZ$4U!HSJ4%-'
MJ%%<WHGB 3;;:[8"3HKG^*ND!STJSS9TY0=F%%%%! 5S6B8?Q3KDG7:ZQY_
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MB2TU$!&(BF_N-_2N.=&417-D_=/TJ"R_X]4J9ON$CTJ&R_X](_I60%BBBB@
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MKP9MF]L?SJQ4-T,VSCVH E4Y4&EID1S"A]A3Z "J][Q"#Z,#5BJ][_QZO[4
M3CH*6D7[H^E+0 56?_C_ (_=35FJTW%W ?J/TH LT444 (WW&^E067_'L/J?
MYU.>AJO8_P"H/^^W\Z +-%%% %8\:@/=#_2K-5FXU!/=#_2K- !5>Z^]"?\
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M-J (7JI+TJV]5)>E %&:L^7[U:$U9\OWJ -N+M5N.JD7:K<= $ZU**B6I10
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MH8J=)HY/N.&^AIVT$8(!J)[2%^J 'U% $U%5C:NH_=3NOL>12 W:=0D@]N*
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M4EL<VT9]J ):0C((I:* *]F?]&4>A(_6K%5[+_4?B:L4 (1E2#4%E_Q[_P#
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MDA:***LS"BBB@#GL"7QWGJ8K(=/=C70US>G'S/&^J-_<@5/U!_K724 %%%%
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M]O3L*;=(L<4>T  ..E6J    8%%%% %9N-00^JFK-5I>+R ^Q'\JLT %%%%
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M^Z?UJQ59^+Y/=*LT %078S:R?2IZANAFVD^E $D1W1*?44ZHX#F",_[(J2@
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M^5-8O<-^]0'@KSSG% 'U"HPH&<\4M0VDJSVD,J9VL@(S4U !1110 C,%4LQ
M Y)-9&C^)]*UV\O;;3KD3/9OLE*] < ]?QJSK.EKK.E36#SRPI*,,\3%6QW&
M17FGPBT^#2O$7BJQM@1##=!5W')^XO>CJ#V.R\;SV\.F6[2RJLBW,112>3\X
M[5O!IKE01^[C(Z]S6)XQTZUFTB6\>%7GB*%'89VX<'CTK>LW\RQMW)R6C4_I
M0 ^*%(1\HY[D]34E%% %>]'^CD^A%6*@O!FUD^E2QG,:GU% #J*** *UQQ<6
MY_VB*LU6NN'@/^V*LT %%%% %:UXEN!_M_T%6:JV_%U<#_:!_05:H *JWG6
M^C_TJU5:]^Y&?1Q0!9HHHH CG_U#_2FVO_'K%_NBG3E5A<N0%QR2<5S@UNZO
M MCHL(E=0%DN7XCC_J3^% &SJ.K6FEQ;[B3YS]V->68^PK'6TU/Q$ ]\6L;
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MAUGA>/RO#=DN,?(3^9)K7JCHR"/1;-1G_4J>?I5ZO0.4**** "BBB@ HHHH
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M2TB/RM(M$P!B,=*NT %%%% !1110 4AI:0T --1M4AJ-J (7JI+TJV]5)>E
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M!9HHHH 1AE2/:H+(_P"C+[$_SJQ5:R_U3#T8T 6:*** *MUQ+;G_ &_Z5:)
M&36;K%_;6$,<EQ(%PV0HY9O8"LM8]3\1'=,SV&G'I&IQ)*/?T'MS0!8O?$#/
M.UCI$)N[L<,1Q''_ +QIUEX?!N$OM5F-Y>#E=P^2,_[([?6M2RL;;3K=8+6%
M8HU[**L4 ,>*.08= P]Q4)LU7_5.T?T/'Y59HH J_P"EQ]-DH_(THO O$L;Q
MGU(XJS1C- #$ECD&4<&GU ]I"YR4 /J.#58F82;+:4OCKOY _&@"Y+,D2Y8_
M0>M0A)+CF7*1]E'4_6HD$L+[YH3(_P#>4YQ^%6$O('.-^T^C<&@"955%"J,
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M%/K4V"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /.OB/\
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M0 4444 %%%% !7.3GRO'MJ<?ZVS<?DRUT=<UJYV>,-&?^\KI_7^E '2T444
M%5NFH?5*LU6?B_C/JIH LT444 %5K/CS1Z/_ $JS6/=:O:Z0TWVAB9'?]W"@
MR[G Z"@#7)"@DG %8%SKTM[,]IH<0N)0=KW!_P!7&?KW/M40L-2U^3?J3-:6
M!Y6UC/S./]L_TQ6_;6L%G L-O&L<:C 510!F:=X?BMYA>7LK7E\>LLG1?91V
M%:+6<1.Y,HWJIQ5BB@"KLNH_N2+(/1AS^=+]K*?ZZ)U]QR*LT?6@"..>*7[C
M@_0U)44EM#)RR#/J*B-M+'_J9CCT?D4 6J9)*D2[G.!5,WDZDQ^3YCCNAX%+
M#)"7W32?O?1^,?2@"3;+<_>S'%Z=S5A$6-=J@ 4X$$9'2B@ ICQ1R##H#]:?
M10!6-FJ\Q.T9]CQ2?Z7&?X)5_(U:HH K?;%7_6QO'[D<5-'+'*,HX;Z&E8J%
M);&!US5)H%NFS&GEIGE^Y^E %B2XPWEQC?)^@^M$<&&\R4[Y/7T^E1+:20#]
MQ+QZ.,T_SYHQ^]A)]TYH LT5 EY YQO"GT;@U/UH **** (I+>*3[Z GUJ,V
MK)_JIF7V/(JS4<LRQ#GECT4=30! TMS""9%5U'<'%0M=B<@/NAC/=AC=5A87
ME;?/T_A0=OK5@JI&"!B@"N+:TEC $<;+]*KRZ'ILWWK6/Z@59:SA)R 5/JIQ
M33#<Q_ZN8,/1QF@EPB]T9<OA'3'^ZKH?]DU1E\%1G/E73+[,,UT?VB6/_6P-
M[E>:<EW YQO /HW!H,GAZ3Z''OX+N@/DN4;ZKBH'\(:DHX,3?C7?44&;P=(\
MX?PUJJ?\L WT-5VT?44?8;23<>P%>CR3,S&*$9;NW9:?%"(QDG<YZL:+$O P
MZ,\Q.FWRG!LYO^^:8;.Y'6WE_P"^:]5VCT%&Q?[H_*E8GZCYGDQAE R8G'X4
MT!L9P<5ZR8HR,%%Q]*KOIMJW2,*?]FBQ/U%_S'EV:3=CK7IIL&3[@B<>C+S^
M=(T4(XFL1CU49HL'U&7\QYGO'J*-P/>O3%ATQ@?W<0QU!&*%L;>=LBW181[<
MM18/J,OYCS.EYKU46=L!@0ICZ4OV2W_YXI^5%@^HR_F/*>3T!H/'7BO5Q:P+
MTB3\J1K2W?.Z%#GVHL'U&7\QY1N'J*-PKU%M+L6ZVT?Y5$VA::V<VD?/M183
MP4^C/-,TE>B2>&-+D!_<;?=36+JFC:9I:("&FFD.(H5/SN?046)^J53+T.:&
MRN&OIP6"_+%&HRSN>P_2NJT[2YKFY&IZH ;CK##_  PC_&LKPGI<]M>3/J.G
MR1W Y1RVY%'HO'6D\;:1KFK36ZVFL_V7I,2%[J5#A^,GKZ=*-CNH4W"%F=G1
M7GGPFU35]2T>_&H7+7EM!<M':73CF5!W]^<UZ'3-@HHHH \_^('C'4?#NL:5
M8V5Q8VR7@8O/>#Y5Q^(I/"OCVYOM-U.?44BNELY1&D]B-RS$YX4?AZU)X[\*
MZOK6N:3J6EQ6<WV,,'BN?NMG\:PX?A]XE^P:I,+JUM+J\E1OLMN,1[5SD9SU
M- '5+\1='&GW-Q,L\4UO.+=[=TP_F'.!C_@)J>?QQI]IHTFHWEM=V^R7R1"\
M6'=^<!1WZ5R5I\/M6BL-;AEM=/=;Z=)4@;)50 V1G/7GK43_  QU>;P]/;&\
M59%NEN+2VD;>D8&?E)XSG(_*@#T#P[XFL?$EO+):B2.6!MDT,R[7C;T(K:KD
M_ _AVZT*UNI+ZWM8KNYDW/\ 9P<$#IDY.>M=90 4444 %%%% !1110 4444
M%%%% $<SK'#([#*JI)%>%P>-O$^K>(--U&U6VM?#]W?&U@C"_,V.[5[LRAU9
M&Z,,&O#-;^&>J#6I-/\ #GB:"&VBF^V)9.07MVY^8<T =W\.?$FIZJ-4TC6E
MC_M/2Y_+E>/[K ]#^AKNJ\^^%.FZ59:5>3VFLIJVH3R[KRY4C);Z=N]>@T %
M%%% !1110 5S7A91#?ZW#T*W0.#[KG^M=+7.Z1B/Q7K<0_B,;X_X"HH Z*BB
MB@ JM:\-,/1S5FJUOQ<3CW!H LT444 1SC,#CU4TVU.;:/Z5*XRA'M5+[;;V
M&F"XNIDBB4<LQP* +U8^HZ_#:S_8[6,W=^>D$?4>[>@JDUUJOB A;(-8Z>3\
MT[C]Y(/]D=OKS6OIVDVFEQ;+:+#'EG/+,?4F@#+BT&YU(_:-<F$KYW1VZ?<C
M_P 3[UKJES H5-CH.@QBK=% %;[8$_UT;Q^Y''YU-'-'*,HX;Z&GD ]14#VD
M+G)7!]10!/154P3QG]U-D>CC-+Y\T?$L!/NG- %FD9@JDDX [U6-_ . V7/1
M.]*L+S'?.>.R#I^- "&62XX@^5.[G^E310I$/E&2>I/4T\  8 P*6@"-X8Y/
MOH#7G_B:R2RU8B-0J.NX 5Z)6%XETB74K9&@ \V,DX/<>E)JYSXF#E#3<X"E
MI9(WBD:.12KKP5--K&43CI5==1U%)16,HGH0JBTM)163B=D*PM%)2U#B=$:H
M4M)14.)NJHM%)14\IK&J+1112Y2U5"EI**GE+54*6DHHY2U5%HI**7*/VHM%
M)11RA[46BDHHY0]J+1244<H>U%HI**.47M1:2BBGRA[46BDHHY2?:BTE%:.B
M6)O]3C3'R(=S_2JC3YG9$2K\JNSJ/#4$5I8#>RB:3YB#UK?ZU&T$3*%9 0*B
M^QJO,3O&?8\5[,(J,4D>%4FYR<F6:*J@7<?\22#Z8-1W&IQ65N\]XIAC099C
MT_.J()+Z.R^RR/>I%Y*C+EQP!7)V'AJRU35H=2AL_LEA X>%5X,S#HQ'I5C3
MKR#QC=-,\R&QA(*VH;YF/]YQ_3ZU%XK\1ZYIE_;:3X=T5KNYE0N97^6)%'8G
M'6@#LZ*Y7P+XN;Q;I4TTUJ;:ZMI3!/'G(W#'0_C754 %%%% '->(_&=GX<U"
MTL)+2[NKFZ!:..VCWD@9_P *ET+QAIFNVUU+&9+9[1MMQ'<KL:,^XKB?B9;D
M^,]!NIAJ*6D<;B2:P3+J?FQV-<[81:E:Z-K;VNDW=WIT]W&8YKR)O-(XRS 8
MW <^E"V#J>VIJEC)9F\2[B:V7K*&^4?C0FI64MF;N.ZB:W7K*&^4?C7AUCI%
MU-HNN),+^%1>I- Z6S;3P>2G7;SZTMU8^(;WP9*@TT"WAOQ)*]O RBYCPV3L
MR3U([T >YP7,-W LUO*DL3='0Y!I6KAOA?8-::;?S*9UMYY]T<4L#1!.N=H)
M/%=RU $+U4EZ5;>JDO2@"C-6?+]ZM":L^7[U &W%VJW'52+M5N.@"=:E%1+4
MHH <*44@I10 M%%% !1110!Q?Q*T/0]6\/";6KW["+5MT-T&"E&/I]<5XYIE
MWX"TW6(+_6O%%]J[6SAH8O*.P$=,UZ=\;+>%O!<=W<9>*VN4=H><2C^[^E<C
M9?$;P1!;QBR\&3RN%&52$GG\10![E;2QSVT4L7^K= R_3%2U3TJ\34-*MKM(
M6A25 PC<8*^QJY0 4444 %%%% !7.^(ALU;0Y?2[V_\ CK5T5<WXQ&VUT^4=
M8[M6_0C^M '24444 %5I^+J _459JO<_ZV _[>* +%-=UC1G=@JJ,DDX %9V
MJ:Y:Z9B-MTURWW+>+YG;\!T'O6>FDWVM2K/K$ACMQREG&>/^!'O^&* ";6[K
M59&MM"BW+G#WD@_=K_N_WC]#5JR\/0VI\]Y7FO#RT[\D_3VK6AAC@C$<2*B#
MHJC%/H J_P"EQ?W91^1I1>(.)$:,^XX_.K-(5##! /UH 1)$D&48,/8TZH'L
MXF.0"C>JFF>7<Q_<E#CT<4 6J*K?:F3B:%E]UY%(U[&Q"0D/(>V>GUH L/(L
M:%F. *K_ +VYZ9CB_4TY+<EO,F.Y_3L*L4 ,CC2)=JC H>))!AE!I]% %8V:
MCF)VC/L>*3_2X_[LJ_D:M44 5A>*.)4>,^XX_.ITD2091@WT-*0#U -0O:0M
MDXVGU!H GJ.698L \L>BCJ:IYN Y2VE\P#J7' IT;-;G,L+,QZN.: )5A>9@
M\_3L@Z"K(&!@5"ES#)T<9]#P:FH **** &/%'(,,@-0FS4',3O&?8\59HH J
M_P"EQ_W)1^1I1>*O$J.A]QQ^=6"0 23@#O58LUU\L8VQ]W(Z_2@!6N@YV6Y#
MO]>!3XH AWL=TAZL:;]B@VX"X/J.M-\B>/\ U<V1Z.,T 6J*J^?/'_K82?=.
M:>EW"_&_:?1N* )Z* <C(HH *8\,<@PR T^FNZQJ68X% %=K14RT<C1_0\5!
MOO)05C*O&.K]"?I5@*]R0SY6+LO<_6K  48 P* *D=Q' NUHGC'J1D?G5E)H
MY/N.K?0TX@'J,U"]I"_)3!]1Q0!/157[/,G^JG./1^:/.N(Q^\AW#U0_TH M
M4572\A;@DH?1QBIPP89!!'M0 M-DD6-"S' ILLRQ+D\D] .IJ..)G;S)NO9>
MPH 9Y NF#S( @^ZO^-.-F%_U4CQ^P/%6:* *O^EQ_P!R4?D:47@7_6Q.GOC(
M_.K-(0#U&: &)-%)]QU/T-25"]K"_)09]1Q4?V:5/]5.P'HW(H M456\VYC^
M_$''JIQ6/K7BNUTM4@R!>3':B2<*ONQ["@"_JNK+8!(84\^\EXBA4\GW/H/>
MHM+TEH93?7S":^DZMV0>BT:+ID,"?;GF6ZNIQEYP<@^R^U8'B+XBV6B>+=,\
M.QQ?:+J[D59-K<1 G S^M ';5YY\3-"\5>(A:6>BB V"D/<)))M\T@_=//3I
M7H8.0#10!S'@J#7K33&MM;LK&T$1"P):'C;COR?>NGHHH ***RO$$6L2Z6XT
M.:"*]!RIF4E3[<$4 :M%>;Z1\2;JQUI-"\8:>-.OG.V*X7_4R_0__7KT<$$9
M!R#0 M%%% !1110 4444 %%%% !1110 4444 %%%% "'H<5X98^)M)\"?$?Q
M+-XI2Y2YNI2;:?865HB3P/TKW3O7D7C/Q/K.H^,)O#^@>&K'49K6,-)+=KP,
M^AR/2@"K\+G@U3Q_K.LZ#92VF@RQJH#*0LC\\C->SUYSX)B\?QZNG]O6.FV>
ME^6W[NU(R&[< FO1J "BBB@ HHHH *YVT7R_'5Z.GF6JO]<$"NBKG9SY/CRW
M(Z3694Y]0W_UJ .BHHHH *K1\7LP]0#5FJHXU$^Z4 6J*JWVHVNFVYFNIEC7
ML">6/H!WK$/]J^(N!OT_36[XQ+(/Q^Z/PH M7WB!%N&L=-C^V7W0JA^6/_>/
M:JUOH,WGI=ZF?MDJ\K&#A(_H*VK#3;738!%:PJB]SU)^IJU0!62[B4!64Q>S
M# JPK*XRI!'J*&56&&4'ZU UG&3E"T9]5- %BBJNRZC^ZZR#T;@TOVS:<2Q.
MGOC(H LT4Q)HY/N.I^AI)9TA R<L>BCJ: )"0!DG JLTSSDK ..[GI^% BDG
M.Z;Y4[(/ZU850HP!@4 0K:1!3N7>QZL>IIIM-G,,KI[9XJS10!5W74?WE60?
M[/!I1>1@XD#1G_:&*LTA56Z@'ZT (KJXRK CV-.JNUG$QRN4/JIIOEW4?W)%
MD'HPYH R_$FC+?6C30H!/'R"!U'I7 ]#@]1P:]/DOS&2CPMOQT7D5S>I^'1=
MLUS9RIYK<M%G'Y4FKG#B:#OSP.4I:=-#+;2F.:-D<=F&*96;B<T*K3LQ:,T4
M5DXG7&L+1245#B=,:PM%%%0XFT:PM%)14N)LJPM%)2U/*:*J%%%%+E+54***
M*7*4JH4444<I7M1<T9I**7*/VHM%)11RA[47-)111RB]J%&:**?*'M1:2BBC
ME%[4****.47M0KO/"^G_ &33O.=<22_-^':N1TBQ?4-0CB7H/F8GIBO0%DF@
M0*T&5' V'M]*ZL/3UYCFK5;KE+=%5UO(2<,2A_VABF7VHV]A:&XE?(Z*J\EC
MZ =Z[#F'WU]!I]JUQ<.%C7\R?0>]8]M8W&M7*W^HJR6ZG,%H>W^TWO3K'3[G
M4;I=2U48QS!:]HQZGU-7+W7M,T_4K73[FZCCNKH[88B>6H N16EO#*TD4*([
M#!*C&:\X^*7C.ZT<P:/IT5PDUR/WUW%"7,,9XR,=^M>FU&]O#*VZ2*-SZLH-
M(#C_ (:2Z,?#AAT:&Z2.-SYKW,91Y'XRQR!7:4R.*.(8C14'HHQ3Z;!!1103
M@9[4 -9$?[RJWU&:-B!=NU=OICBJMKJVGWLSPVM[;S2QG#HD@)4^X%7* &^6
MF"-BX/;%)M4+M"@+Z8XI](: & !1@  >@%,:I#4;4 0O527I5MZJ2]* *,U9
M\OWJT)JSY?O4 ;<7:K<=5(NU6XZ )UJ45$M2B@!PI12"E% "T444 %%%% &%
MXQU>ST+PO>ZG>VR7,5NA<1, 0Q'0<UY,E[\2#II\2PZ1I<>GA3,+0(@)0<],
MYKUWQ7H<'B3PU>Z3<2B);F,H),_=)'!KR6XT+XFVND?V!<:K8V^ED>0+V61%
MRIXQR<T >L^$]>B\2^&;+58H_*$R9:/^Z1P16U6+X2T&+PUX9LM*AE\T0I@R
M?WR>2:VJ "BBB@ HHHH *P/&*;O#\CYQY;HW_CPK?K'\5)O\,WP[[ ?_ !X4
M :ZMN0-ZC-+533)/.TNUD_O1*?TJIJ>O6]A*+:)&N;QONP1<G\3V_&@#3EFC
M@B:2:18T7DLQP!7.RZE>Z\S0Z3&T,"GF]D&!G_9!Z_7D4^'1;O4YENM<D! Y
M2TC/R)]?4_CBN@1$C0(BA5' "C % &-INFV^D9=X))+AOOW#?.S?X?A6M'<1
M2?=<9]#P:EJ)[>*3[R#/J.* ):*JBVEC_P!3,<?W6Y%'GSQ_ZV'(_O)0!:HJ
M%+J&3@-@^C<?SJ;.: "FLZHI9B !ZU'+<+&=B@NYZ**:ENSMOG.X]E'04 -+
M27/"92/^\1R:=]B@VXV#ZCK5CI10!5^S2Q_ZJ=L?W6Y%!GGB_P!;#D>J?X5:
MHH @2[A<XW;3Z-Q_.IP<]*8\,<@PR _A4!L]IS#*Z>V<C]: +5%5MUU'U19!
MZC@U&VHQCY-K"3IM(Z?C0!;DD6-=SG JOB2ZY.8XO3NU+#$)#YDCB1NP!X%6
M: &HBHH51@4ZBB@"-X(I/O(#4)M&0YAF=?8\BK5% %;?=1_?C60>JG%*MY$3
MA]R'_:&*L4UD5QAE!^HH 565AE6!'L:;+*L2Y8_0#J:ISQ1JVR#<)?\ 9/3Z
MT+;W,3>8769_]KM]* )1$]PP>7Y4[)_C5D  8 P*K?:]AQ-$Z>X&1^E3)-')
M]UU/MF@"2BBB@ ICPQR##(#3Z* *QLPIS%(\9] <C]:/]+C[)(/R-6:@EGPW
MEQ#<Y_(?6@")]02,8DC=6[#&<TZ%1.PDD=6/90>!4D5N%RTAWN>I-(]I"YSM
MVGU4XH GHJJ()X_]7/N'HXH^T31_ZV X]4YH M45"EU"_&_!]&XJ8$$9!S0
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M,@US>H^ ] U'5+#4)+&*.2R<NBQQ@!CQ]X=^E"WN#VL=)&ZR1JZG*L,@TZD
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M144LZQ< %G/110 2QPLI,BKCU-4Q#)(Q^S2/&GJ><_3-6%@>4AYS]$'059
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MH+J(X9#]1VK/\-)XQL-0ATO7K6VU"SC!\O4$QN''&0<<UW5% !1110 4444
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M[;=5TF38/^6UL=R?K@_I0!TE%9MGKVF7_$%VA;NK?*1^=:(((R#D4 +1110
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M5MIUHNV"! B#VI]">I7\.:*/#VAVVF+<RW*P+M$DIRQK5HHH&%%%% !1110
M4AI:0T --1M4AJ-J (7JI+TJV]5)>E %&:L^7[U:$U9\OWJ -N+M5N.JD7:K
M<= $ZU**B6I10 X4HI!2B@!:*** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MT48I] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M 4444 %%%% !2&EI#0 TU&U2&HVH A>JDO2K;U4EZ4 49JSY?O5H35GR_>H
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MKK]%\;^']=L([NVU*!%=M@29PC;O3!YS0!T-%("" 0<@]"*6@ HHHH ****
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M^N3<R/:Q[VD))(C8@' R?TKT[X8V^JFTO[Z]BDM;&XE_T"T=<&*(9QQ],4=
M>YGZ5\)#8:XTLVL33Z.MP;B.P(XWDGDGOU->F(BQH%10JCH , 4ZB@ HHHH
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M&74#YD?#R\XZ'/Z4=0/H@%74,.0>105# A@"#V-1VTHFM8I0NT.@8#TR*EH
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M5L#B@#L:I:AI%AJK6[7ULDQMY/,B+9^1O4?E4ME>0:A90W=L^^&90R-ZBK%
M$4UK!<0O%-$KHZ[6!'4>E0Z;I=EI%FMI86Z00+DA%Z#-6Z* "D) !). .I-(
M[K&C.[!449+$X %>>7?Q.\,:KJ,OAZ2>>*.YW0+>!2L98C& V* (O%7Q531M
M3FM+/2;F_M+;"WEU"I*Q9]"._(KC/#?B2]\$W-]<6>G3ZSH>K2-<036J[G1V
MYVMCI@DCFKFAM-\-/$$WA[6XS>Z%J\G[BZ*[\D] QKO?"/@*'PIJU_<65[(V
MG7?SQV;<K&3@Y&?QH H_#+1=4BL-1U'7(F5M1N3<16TQW&)23@<].#7H0
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M!L:,^^:Z%[B)+=I]X,:KN+*<\4 2T52TK5;/6M/COK"836\GW7%7: "BBB@
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MHU97AO0X?#GA^STJ#E+>,)G^\?6M6J>XD%%%%(84444 %%%% !1110 4444
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MF:3- #J*;FES0 M%)FC- "T4F:,T +129HS0 M%)FC- "T4F:,T +129HS0
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M129HS0 M%)FC- "T4F:,T +129HS0 M%)FC- "T4F:,T +129HS0 M%)FC-
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MH]U&Z@"3-&:CW4;J ),T9J/=1NH DS1FH]U&Z@"3-&:CW4;J ),T9J/=1NH
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M6L^4_-5V5JH2GYJ -*)^E6T>LN.2K22T :"O4H>J*R5(): +H>E#U3$M*):
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M0!?\ZCSJH>8:/,- %_SJ/.JAYAH\PT 7_.H\ZJ'F&CS#0!?\ZCSJH>8:/,-
M%_SJ/.JAYAH\PT 7_.H\ZJ'F&CS#0!?\ZCSJH>8:/,- %_SJ/.JAYAH\PT 7
M_.H\ZJ'F&CS#0!?\ZCSJH>8:/,- %_SJ/.JAYAH\PT 7_.H\ZJ'F&CS#0!?\
MZCSJH>8:/,- %_SJ/.JAYAH\PT 7_.H\ZJ'F&CS#0!?\ZCSJH>8:/,- %_SJ
M/.JAYAH\PT 7_.H\ZJ'F&CS#0!?\ZCSJH>8:/,- %_SJ/.JAYAH\PT 7_.H\
MZJ'F&CS#0!?\ZCSJH>8:/,- %_SJ/.JAYAH\PT 7_.H\ZJ'F&CS#0!?\ZCSJ
MH>8:/,- %_SJ/.JAYAH\PT 7_.H\ZJ'F&CS#0!?\ZCSJH>8:/,- %_SJ/.JA
MYAH\PT 7_.H\ZJ'F&CS#0!?\ZCSJH>8:/,- %_SJ/.JAYAH\PT 7_.H\ZJ'F
M&CS#0!?\ZCSJH>8:/,- %_SJ/.JAYAH\PT 7_.H\ZJ'F&CS#0!?\ZCSJH>8:
M/,- %_SJ/.JAYAH\PT 7_.H\ZJ'F&CS#0!?\ZCSJS_,-'F&@#0\ZCSJH>8:3
M>: -#SJ/.JAYAH\PT 7_ #J/.JAYAH\PT 7_ #J/.JAYAH\PT 7_ #J/.JAY
MAH\PT 7_ #J/.JAYAH\PT 7_ #J/.JAYAH\PT 7_ #J/.JAYAH\PT 7_ #J/
M.JAYAH\PT 7_ #J/.JAYAI/,- %_SJ3SJH^8U)YAH O&:F&;WJF9#3#(: ++
:35!)+4#2&H7<T .DDJI(_-$CFJSL<T ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>img88009329_24.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img88009329_24.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +P!W<# 2(  A$! Q$!_\0
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M  THIM+0#'9HI*!0(=129I: $HHHH$%%%% "T444 %%%% !1BBEH$)2BDHH
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MRJ*/:S#V,.QJ_P!K+_SQ/_?5)_:R_P#/(_\ ?59=%'M9A[&'8U/[67_GD?\
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M>UD'U>GV.A_X2*+_ )]V_P"^J/\ A(XO^?=O^^JYZBCVL@^KT^QT/_"1Q?\
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M_GW?_OJC_A)(O^?=_P#OJN<HH]K(/JU/L='_ ,))%_S[M_WU1_PDD7_/N_\
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M.D_X2*W_ .>,GYBC_A(H/^>,GZ5S=%'M9!]6IG2?\)%;_P#/&3]*3_A(K?\
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M%G]L-G<"U/\ RV\IMG_?6,4NF6$NJ:G;6,"EI;B18U ]2:^MI=-T>;1)/AP
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M\,=I_&JE3V?_ !^P?]=%_G3CN3)7BSJZ2BE%=9YXE%+10,I4445L9A61JO\
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M6/#%_K5N\.+:6SD<(G3C"GJ>*^=[[QCKFI>&+/PY=7:OI=FP>&$1("I ('S
M9/#'J:VO#_Q;\7>'--33[2^26UC&(TN(EDV#T!/./:JDU)OUN3!.-O2QV?QF
MU62;PEH.GR>'+S2HX6S;/<S(Y,80#;P2V?N]:\4K8\1^*=9\6:A]NUF]>YF
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M91+MDB0L&!R,-C(^F:<];V[I_<*.F_9_B>E?'^[G32_"MLLK+$UN7*@\$A5
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M''MFDA',S>I/7'H.:&W=-='^@)*SOU1TGC;Q%\,M1\,S6_AG0;BSU-G0QS/
MJ@ ,-W(<]L]JSO@K_P E4TG_ +:?^@&O/ZT=#UW4/#FK0ZII<PAO(<['*!L9
M&#P01WIP:C*XI*ZL>@^*+Z+3?VAGO9B!%#J,+.3V&%KT#XE3^,E^*.@_V(]^
M=/=8RGV?=Y1.[YMV..F.O:OGO6-8OM>U:?5-1F$MY.P:1PH7) QT& .E=AI7
MQE\::1I*:=!J*/%&NR)YH5=T'H"1_.E#W8Q3Z#GK*374[+XQ>'3XF^+>FZ3I
M*(;^YME$Y'1>3\S?09KJ=7TZ_P#AMX3'A_P3H5Y>ZG=)FYU)(2<'USZ^@Z"O
M"--\<^(M)\13Z_:Z@3J<X*R3RQK(2#U^\"!71?\ "\OB!_T&8_\ P#A_^)I)
M6AR_?_D-N\N;[CA-0MKRSU">#4(I(KM&_>I*/F#'GGWYJM5W5M5O-<U6XU/4
M)1+=W#;Y'"A<G&.@X'2J5"VU![A1113$%%%% !1110 4444 %%%% !1110 4
M444 %%%% !112X- "44N#Z48/I0 E%+M/H:,'TH'9B44N#28- @HHQ10 444
M4 %3V?\ Q^P?]=%_G4%3V?\ Q^P?]=%_G36XI;,ZNBBBNL\X**** *5% I:V
M("LC5?\ CY3_ '/ZFM>LC5?^/E/]S^IK*O\  ;8?XRA1117$=X4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !12BB@!**7&>@J>.SFD&0A ]32;2W*C"4W:*N5Z*O#3B!\\B@^E*;.%#
MS(Q'TJ?:1-_JE6UVK%"BK#Q1JIP3GM48A8C(P:JZ,G3DG8CHI[1,APRD4A1L
M9P<4[D<K&T4N#Z4E @HHHH **** "BBB@ HHHH **** "BBB@ HHHH *4,5.
M5)!]1244 *26.223ZFDHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHI<4 )14D<,DQQ'&S'_9&:F2RD=6;@!>H)YI.21<:<Y;(JTN*NV]I
M"[D23A2.@ SFI[V"UAG18OG!4'.:GVBO8V6%FX\[LD9>*4*:V$8+-"JV-LI<
M<%N0<]SDU82[CLH[A9;:WD<G&-HP1[5+J6V1<<*FKN5OD<^:;4P9#-N9!C/W
M15F06DLN88_*7NK-G]:MNW0YU3OLRA16_J/]D?V;;_9K+RYF7YG\TL<_3M61
M]E8IO7[OOQ4QJ<RNU8N>'E%V3OZ%>BG,A0X(Q3:T,6K!1110(**** "BBB@
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M4I:-LDK@]L4UE4=#57,'$912D<4F*9-@HHI<4 )1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%+B@!
M**<$9ONJ3]!1M(/(- [,;15RUTN\O)%2&!F+=,\#\ZU;/0K>*[":E,0J$;TA
MY/TS6<ZL([LZ*6$K57[J.?IRQNYPJDGV%;FKVEKI]ZZ6]M*%'193DBEL)Y88
M)BMLI 7)8CA?>H]M>/-%&RP5I\DY$<'AN]>P>\D39$JY&>IJ[96%C;:>)+V
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M\I_N?U-:]9&K?\?*?[G]365?X#;#_&4****XCO"BBB@ HHHH **** "BBB@
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M,4E33*"H=<8/6H::9G*/*[!1113)"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBEH 2@#-3QV\DI 1"<].*DELS;HC/*F6&<*<D?6DY(
MTC2FU=+0JXIR1LY^49IRLJL#@-[&D>4LQ(^7/84:B2747R\#YF'TI $##.33
M,T?2BP771%QO*(_=J,GH*CAG,1;Y4.X8PPSBJ^:,TE$J55MW6A*\DA!Y(![#
MI41JRUSNMEB*KP2<A1G\ZK=#30I^MQ01^-(:.]%,@7/&,"@#^+M2G&T<?6DX
MSC/%(>P4'!/ HQU]*FM6C296D&5SR/6A[%17,[$)!'6C)QBIKITDG9D7"D\#
MTJ  YX%"%)<KLB1$:0[4'4=ZCP0:4' /)S1UY- G82G*Q4'C(I\,#S-M0$GV
MIK1NC%2*+J]AJ,DN8<8U*;E/U%1&K-M(/,02?<!YX[4:A]G^UN;4DPY^7(P:
M2>MBY03ASIE6BBBJ,0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:,<("MNKAP0Q(P#R/\YJ%-\$F".1ZC-6(KA;6)U"*Q<=2,E><\4AN7^T&:5
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MBLLN%9@HX['/2B1]^,DDXYJ.1\ZE?3L;.M%T73:U[D-%%%:G&%%%% !1110
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M8P<TH&[FC'%%Q<HRE R*=CBG!<GY?QI7&H$9!S6S#I DTQK@2KD#.,UF$CC
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M*9EL[DLDBNQ(4#VIBYZ]Z0<D<5(C!2=V3CIB@=[N[$91@DD@]JD\AS;_ &@
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MV ,'KWQ4MI-!%(&ECWKW7.,U69_,?+<"@+D@#FBUU9C]HU*\1T[!VRBX%1J
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M:JDDX%/2Y._YNE2W%RDDQ>.)$!&-HZ4M;V-&J=KQ8QYF,"0G&T$D<>M0N1L
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M#$C@GM0]-@C%3?O.Q4QGBC:,FG<$' I,T$V74:1BFYJ1CFHS5(F6@I!QR*%
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MXK1O4EQF]8K02WFLEM62YB)<_=93[?\ ZJI6SF&=IHU#*.S#/%7+/3TEMIY
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M2K,5*QA,##8.<GUH5[A)P<=-R)" X+9V]\5)(5,I$)8H3QGK2QB$@[B13T6
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MY^M,/J3FEZEV4?A'8W+GUIA#=>PJ6)?XL<=32.0Q)4;5]*$]1N*<;D9?=QC
M]J7&1TX'6DVC'%/3)^4<YID)7>HB\?2E'KC(H"_*V3@CM2 %@0.HI%^0TG/
MJPEH54/,2B,#M8CJ?2JV2&Z=*M7-_+<V\,+?<B&%%#OI84.2S<M^A5/RMR.:
M3!)S0<DCUI64IU!%49;^A&20:<N&X/%# $9%,I[F;NF/9&'8TTC%21S%<!OF
M7TJ>2)'7=$^X8Y'<4KV-%!25XLI44\K@^]-P:JYBTP&>U*#@TF<49[TAD@D=
M*:9">YI6D+  G@4W&!18IR>R8VB@]:*9F%%%% !4D?!R:9BIO)80^9VS29<$
MV]"/.XGC)IT<3RMM123Z 4L$BQ2;F0/[&G)(4<E<K]*3;*BD]6QF"#C'2K-O
M/+;.KQN4?U7@BFQ(\L@5 2S< #O2.K*Y5AAAVJ6[Z&\(N/O(?<%Y6WL2S-WJ
M$*PXQSZ4_<V<'-.57.3@_6ELBVN:5QHR/N@Y[T@W'(Q4T:$MUP?6I"57C:21
MUI.1<:5]6[(BC20*7VY7WJ:WEC4'>,^@I&G?RA'M^4U&XVD$FIWW-4^2SCT&
M.=S<=*C(.>]/5N3[U,ACMI1YJI,,9QGBJV,'[VHQ80R'<P7 [U%@#@<GM3RW
MF9XP.U-4,S !N1QBFA2M=60YHY -K@K@9 (Q3K:-I)%1F"J>YJ5PZ7/E7##=
MTR3D"J<K,'(4Y [BA782M!\Q8NO*@GVHPDQW[5%+ON&,FP*OH*@ RV34[N<;
M4<E?IBFE8AU.>[>B[$&TYP*>F4Y!(/8BG! $W;AGTIA8CI3O<SY5'4D3)<[B
M..3GO4UW)#(5\F,H  #SGFH(FVMN8;O8TH(>3:#M5CWI6U-5+W+=QK+TQ]::
M1ZU)C86'#=J9]QBKCD]<CI31G)68)\F3C(/K4T3K&P+1A@1WJ%V PB$E:FNT
MCBV")F.5!;(Q@]Q28XOEU70DX,+HB Y88..?I5%@0<$8Q4ADV-\A)'K2#:2=
MQ--*Q,Y*1&,YIY V\4S/-+G SBJ,EH,IZ/M//(IN*2F2G9DQ"N>.*CY!^E(K
M%3D=:"V:13DF22RR3;=[EBHP,]A2*N,Y.#CBFKZTXN3SB@:MNQI5@>0:G2XF
M:$6WF8CW9P>F?6HS,S Y.<]S3.G6@5[/0MWIVR*A$>54#*'(/O54 L3M!/'8
M4 9[TY=Z9VY'%*UD4WS.Y%1115&0HJWY?EP _P 554ZCZU:N7PV,YX[5$MTC
MHHI*,I,B20 G@T@.3G J->M2*,FFQ1;:' =*T+!;8S 7!8)W*]15(#!I0>*S
MDKJQUTFH.]KD]VD:S$1'Y<\5"P(P#2,V0*:,D\]*$M!SDG)M+<EBV;QOSM[X
MI2O4J>,\4@7<,@&FMQWI#V0$?6FFGAMH(/>C"D9S@^E,EJXP!@>](3SD\T.Q
MSU]J;N 4C ^M49-VT N2NW/R]::#28&/>E &.>M,RNV* <@^M3/&BQ@[N?2H
M1@?2I0D;V[N9<,.BXY-)FD&DGIJ0LQIN">:>H_6ESP1@8IF5K[C HS@\5(NT
M=>:3&1GK3<Y;THW*2Y1X8;NIQ36P3QR.U&%'6EX*E@0,=O6@>^C)K>,RR@'
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MUQ'YRM;R11?NRG<]L_A6']H!(='?S\G+?X4^^,T<A9HBJR@$!N3CJ*I*3&W
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M.:6X:5"21R35U[53)#)/,K+(#D@Y(^HJEIT@6Y4.?E[UKW+6DMX[1QL8]N%
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M&A,",YVTU@2Q.,49 YSS4@8'[QZ]Z@Z='HQ(I#&XX!JS+=2%&2,[4DY(%5\
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MR7*]+V(]Q;':G*-LBYZ9[TTYZT/(S\L<GUH%>SU+=TD<#XC=7##.15,D%<X
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M8J)1G/2EQTI,N+:U%X)Y%-< .0.E3'&"0*@?[QI(<U9"44451D6+(!KR$$D
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M.>E(H/)%'0\]Z7(S\HQ3)'H[K&PW$ ]AWJ)B2*=N*'L:55+J2,8ZTBGKH,Z
M@KDTG&"-O-.5>"1U'>GQ@R*02.N:=R%%O0B*GCBAA\Q!;&!]:<X(ZFF!@N>,
MDTT3-6T"-CD*Y.VDQ@G'0TI8\@#//7%(6R>PID)JUA1D=NM+@$GL13=XVD=^
MU"AL$]J!W5[(;N(-.=RYR?TJ:&WCFAFE:0)L'RJ>K&F+&' /0"BZ$H2^\:5
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MR/+'  ';BE>2T9481;YHZ>O<@\I&MWF,RJZCA>Y^E5](MUN;\"0,R!2S;>N
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M.G6JL0I63%B4;MS8P"*FN!$&/DY*<=>.:KN %R*9YA ('?BBU]27-17*T#$
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M9/S9_2I5V]3:248IQ>K%0EY,GO70[V@TG[/+&1YAW*U84 #/]*W+Z_\ MEM
MA&WRDV@ 5A6UDET/0P"482E?5G.2_P"M?ZTRGR_ZY_K3*Z5L>//XF%%%%,D*
MEACDE<)$"SGH *BJ6"9X)-\;%6'0BD]M"HVOJ*(I&W (25Y.!TI3#(8]^P[>
MF:>)9"-PRN[@GUITUS(L7V42[XE;(QTS2NV:\L5NRJ3VZXI,FIC;2I"LS*0C
M'@D=:D@>'8RR(2YQM([47[$*#O9Z%;G&.U.V\$YYSTJXZB\N-EO"(R1C8#_C
M4*0!F<.X3:#U_E0I%>SUTU*ZGGFK\)M4LG)WF<GY<=,51P 32 D'BAJZ"$^1
MWL3Q1&5S\P7@GDXJS#&DS0Q1@B=FP6)X]JKM<M)"D>!\O0XYIJ;PRD>M2TV:
M0E&+[E[6=/?3[TQO('R <@U3*JI&3G(SP:)99)7'FL3VYJ-N&X.:44U%)E59
M1<W**T)(V*,=O<8IC"A&QSBE)4M\W2JZDZ.)=LK6*Y#!Y5C(4G+=SZ55F@"S
M%$;=[TU3ME^1B%Z4Z7/F_>!]Q4V:>YHY1=.UM2(;0I!'/:E5BF2.*7:&88P!
M[U.[*UOL2,;AU>J;,XPW=RH,ELU,RQ-]UB/K1L4*"#SW%1$<^E&Y-N5:CE;L
M1FE\I@0"0-PR.::=HY!S2D[LG.,4!TU&KD2#/ZTYCN) Z>E*"WREEW(/2D$@
M&["#GI[4Q:+0EV@1JRX! Z5#OR /0T@+%>AVYZU(\2B,-D9SZTMMQM\VL1T\
MJM"BA0"O<#K4,:AN/XCT%*_08%-/'3K32LK"D[RNQ0H63YATZTLDF7)48%-Y
MP03UZTC,&;@8%%B;V5D6K2&&XD(FE\L!2<XZGTJM*H5R >!2@$M@'DFD*D%L
M@G%'4).\;6#/R@'FF#K3@V",=:!ELBF1N788DN+8K&O[Y<L26 &*HG.[FG?,
M@QT-!Y0=,TDK&DI<R7=!ST'>K*6DQM3<!?D'!)J"-ML@R._>K$EVRH8E/R9S
M@=*4K]"Z:A9N9 '8#'IP*>(3Y+L6'!QC-,FE$K9P%XY IRC]V=IH81M?NBM1
M115G,*.E3VS$2E<XW#%5Z?$VV52>QI/8N#M),)!AB*94]P-LQ]*AQFA;!-6D
MT+N('6I&N9'C",QVKT'I4>TX!]:62-XB Z,I(R 1BBR$G); .3STHJ2 1LX$
MK%5]0*C;&>*"K:7$Q24IZ9/6E1<G).!ZT$V%P#CFGX0#G.>U-88P<#V-,/)I
M%WL2J[(VX#D4-(\C%F.3ZTP=.M.5RH*\<TK%*71O0>H&"333QTI4;((S@4-@
M$X)I%Z6$P6[]*3<203VHX'6K=O;+/&Y#JNU<G<:;=@C!R=D5"V33HXBP)QP*
M9C#$"KZW,"V7E>4/,)'SD]/PI-M;#IQC)OF>Q3$@3=Q@X[4T8;);BE<<YI /
MEQSNID-O9CC"RIN_A-*KKA..0>:NL\7V #;R.]4E:-!@\Y]NE2G<UE!0:LR>
MX*@+L;+,.3Z56,9!QW%:3?93IZNJ$29P3GK6<.3CKFB+T'6CJKO<:N!@8YI[
M<=#4DUOL< NK'&?E-12*H)"DX]Z=TS/E<1%(R">0>PIQ7(R*:IV,#Z4XS$L2
M1G--^0)JVH%3L#<\4YY2P"T&4NNWHF<TTJJX/)I>I3=E[HH &..35B(+'G/I
MFJJ'JQ_"K"J7!R,\5,C6B^J*T8#LY-*,J1GM5A(6AB8NN&/8BH6SCK57NS/V
M;C%-[FRVM-<Z8EA-@1IR"!S6*0 QYX[4?PT$$8)_"HA!1O8TJUI5+<W04,0A
MIR@.#N;&*8V0N?6F'KWJ[&7-;<=CYC32>>.E!/I0.AYIF;?0?&I8\4^[R(T4
MCH:=;':V[."IR*;>R&3#'KFI^T;62HM]RG1116IPA1110!;M(7G+)&FYL$GZ
M56;AB*OZ+=?9-3AEVAAG!4]\\5%J-J;.^F@<8*MTZ\5%_?L;N*=)214I*EAB
M\V0(" 3W)P*25/+D*Y!P<<55];&7*[7&X(IT:!VP3BG02B+>"BMD8Y'2F9.<
MBC4:Y59EJ\LFM&4/CE0W# \'Z5#C(7/W<TDA=QDDD#CFFDG')Z=J2O;4TDX\
MSLA\L:I(0C!U'?UJ,%E]JD5@%!R.O2HSEFXH1,K;H&.3TH W$ 5(\#QHK.I
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M6Z?[4F9G82$(>!D>@X'44R"1S)]GCMV:20C.W[Q]JSG"4ES7L=5.<8KE-J6
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M_"KD,BQ*K@9*G(JB0RN V0?<580[R44<XX%*2-:4U&XIDDN5DG>3YB_0]:A
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M96)G)R=V]1<^W.>M.'))/--["DSS05>Q>M/LJ[S<!B-IVA3CFJCD>8=O H)
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MW4.232S3[;1;<(4<$[R&.&].*;C=IIW%&IRIKELB:$7=],[IE\\N!W '-.U
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M]:D,T;RK;6DLMP8)2T>>\9&3]#UI5$W4371&5%<O,WU;,K2FAAFN8;TLI()
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M/)ENPHHHIB"BBB@ IRDJP(IM+F@%H69$8Q>:5.&/!JOQCWJ>-F>$JQ^13TJ
M\9J4:U+.S1,NPQL'0ER1AL]*==QP12@0.SKM!RPQS39',D2@* %'.*A(/&:+
M:@VDK6'_ '^3R:/-95* D*>U-7@C/ -6;@6S1IY&[>!\X/K[4/<<;M-ID  8
M<DY[4@!Z\8%30V<L\#21QLRIRQ X%-BA#3!'<(N>2>U%T')+1VW)7$/V9-A;
M?_'Z>V*K[.>..*<T>UB V5SC-.MHU><(S#:3C-+97*LYR2L0D$#IUI0V$/'X
MU=O[#[)*0'#)_"WK5#VIIJ2NB9PE3ERL<B[SC-."L.E-*X .X<CM2KNYVY-
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M\LTNJN>WE%:/O4I==C%L@/LL\T4-N65"#&X)+#N<5C13M;Q-]GG*-,2)(P,
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MTKGS #B,=6K9N;S?H=@L5C#OA?;D?,6/N/K4(LI+F&S,<JL'9E:)!AE/?_\
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M+"%#QQ0L;,>!3U#,X /--9R#@&BX<J6K I@D-P1322!Q3]Q((!ZTU2,'=^%
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MD$5#11OHQIV=T=;;S,ERDEIME>Z!!1UZ$]JYR_1XKR5)%VN&.1Z5<TNX5O\
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M6K1=KQ6A652>.E.4,QVKU]*5'QR12(Q#E@VTBM#"R23!25<9'2K5Y?O>;-X
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M/TV>_,OECY8EW,<X %4&4AV&>AJ?[7(FX0LR(PP0#UJ#>>>])<UW<)N#22W
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MTN9Z/3S,@C#<TK-DY P*EN-DDKO"I"#M4:@N0N>_>K3ZF#C9M(38Q7..*3(
M([^M7Y;L"T6S:-,H?OCJ?QJAM)&0#0FWN.<5&W*[@2.U!//.:52$8'KZT^61
M9YM^T+GLO2F3;0B.,T5=_LR<V379'R*<?6JZH7Y I*2>Q;HS35UN)&"3QU]:
MNW%DUJB/(582+N!!J&(*#EATJSJ=Q#,RB$84*!C-9R;YDD=,*<53<GN9K8)J
M_H]Z=-OTN/+#E>1D52QBI8GVMG''O53LXM,RHWC44EN6+JY>\NY)Y.KG-0$'
M\J<<%N.]-8_,1TJ4K*R-Y.[NQPX&>.:J3?ZUJLXYSGO5>?\ US54=S"O\'S(
MZ***T.0**** "BBB@ J2*5X9%DC<JZG(([5'10"T/5]!\;0:OI,.G7)6WU1&
M&RYP,,._XU:O+6WM9Q+:7KW5^K\;1D8/MVKR!7*G()!'0BNL\)>(8+.^"WDD
MD98X68<A?J*\;$9<J=ZE'[OZZ>1[^ S-)>SK/YG32^?>V%S$<A@5#>8,LQ]!
MZ"N>U?P_?I('6(KA=VT=A[UV>I:[:V>DB%I(S<R@MYJ#A@><BFPW]K/HJ>7J
M8<SLHE5P-P^E<=*O5I^\HV5SVJM.E67(WJ>>-%';6WE3QRI<DYRW Q4-JMRD
M-S(CJH9=K9/)!KN/%>CMJ4LEU%/&Z0* 2 !D^@%<I_9=ZBJ;F)HP> 6& :]*
MCB8U(7OJSS*N%<9J*6BVM^IF6<2RSX:41D X)Z9J[%>!(I#(TCSKCRW!Z8-6
M(-/62V4+ [3O+A2.A'I5(+-'!<?(-K'!;'0CGK6[E&9@J<Z*5AK7-U*QDRQ)
M;<3[UKV4SRE9;N1E2(X^4X;GTK*AN)I(EM%951G!R?7I_6IK4?:2PEEVX].A
MQ45(JVQMAZCONVV;,S-]F6-=SB<[GXRW'3FJ+V4-Q&\,,<C3!R<X_AK1 FLX
MH[B&X1XEQR1T/7%/T^^+W37/G"V<DDOM['M7*I2BFXGI3A&;LS&AL(9-2^RQ
MN<E,G<O(/I4%UNB;R7924Y(ZTRZN3;:RDT<AR3RW>I3:70CFNO++1]68BNI7
MT;9YMTU*$5L_P*D$L#02Q/'NG8_*Q/ _"BVLIGG=XXP5B&]QV IL00!6;# G
MG'45I3"':(K0,B2[09'/MR/SK24K:(Y:=/F2;Z#KO9JJ^;;VB0V\"@.RY^8G
MO595BMV6VN8RL;.&WX^;;_DTC17$$[65M,)58X^7I3$M+MKDR2PO+Y(!88/'
M'^ J(I)6OH:/R7O=602NS,Z1[O*#9/ICUJY?S1>5%%:@.D: E@F"3CG)J4PR
MZQ=,+&U6':/G0-P<=^:-+U"*V^TPSVZ2F1"@W= ?7--O2Z6JZ$I.[3>_4KI@
MHD\J<9P4(_6KHTJ":>XEL9BR01AV?ISWJO=2R)?)%+(LJQK\FTY&.PJI&[VP
ME>0.J2C (XI6;5XNQ?/&+2DKV-^'2[:TNC=2[[^W!&3'GN?YU8MYX[**>ZGP
MXN7:)DSAE]*YJVUJ\M]J6\I W!MO8D=*O37L;7!EOXQ+)(WF$HV!R*QG1FW[
MVIO2Q%+>&EAEU-#?6\PMK4QN7&W']W_(K RT;X.00>E=E-J4=L+(6$<4S"%@
MP5.1G/!]2/6L*XBM[E2L,#F[9L[5Y&,>E;T9VT:T./%TN:TE+5%R2^OM0TTS
MRVZ.JJD?GE<E0.@SVJ4":UN[>6X<NNP8\C@@?XU'9SK:Z; VUYO*DWO 0=C#
MWI^DZC ]Y$H@ FDF#>8_(49Y&/3%9R32=EH;0:YH\S]ZQ1T[2I-;UAK>-@K8
M+Y<X  ]ZT+M'2,PO,[1VWW>,@'O2S1)!?W4B2D3^9A%C7Y67N*NR1RWMK>1:
M;E;9D5I3,!G(&< _G4SJ-R3Z:&E*BH1EI[SN497N;^Y@D_U<('E+,1@''(S[
MUGR:6T1AD9P!*<_0>IJRLDD-G$HN%=<APGHW2GI]LN;:0%5*Q@,Y/7%6FX[;
M#=.,U[U[ENR$R6KI*C-!&N\+G&,CK_*I[4?8X3#-M<W"9!4\C)X&>U75:*!'
M@NHO-DDA#(RMC P,?ABJ>D&6]#VS&%(X"9-S]P.<5R.5TWT/1C%1DHLM)9V5
MG?Q)<"=X8HQYQ3G#'W].:HVIM3J5RH262%L^4JMSGWJ?4;H6+R)&YEMYAF3;
MD -C@9],U2TBXVW<#6\;&7S,D]<C_.:(QER.3[ Y+VBAV&S)/+<"!HB&@R21
MUQ61X@>)OLRHI#KN#GUZ8_K79:_!]G+RV\4J39VREO4UQ_B.S6W2RE657\Y6
M+ =B,9!_.M\)-3E%G'FD.7#S6^WYHPJGLO\ C_M_^NB_SJ"I[+_C_M_^NB_S
MKU5N?)RV.PHHHKL//$HI:* *M%!HKH.4*P]9_P"/I/\ <_J:W*P]9_X^D_W/
MZFL<1\!TX7^(9U%%%<!Z04444 %%%% !1110 4444 %%%% !2TE% %JVN F8
MW)V']*OI*\$>Z%MR'O6-4T5P\2%5)VGJ*SE33.RABG3T9H;E<9]::R#.  .*
MKI.A4[N#4D4@/N*S<6CLC6A/<@DC."1TI@; J^=C*V1DGIBJK1 <=*N,CGJ4
M>5WB1;J>,'&0*:4 /6GA/;Z4V914KB2=L4UCM4#;SZU;$3%< 9Z5')%@'^M)
M21K.C+<BCPWN::QP2,4@&UZ<V>HZU1C>Z$V[ATYH  8*>E&6)Z<TUB0<$8/>
M@EV6I<N$M%M8S"29C]X'M51#ACV-*,L0*:< GO0E96'.7-+FM87+9.>:<6"@
MCC)I 23QQ2 !SZ8'% KOH.!QGUI "QP_2G(,?>I9EC20"-]XQG.,47*MI<9M
M ;CM0H^;)IP!YVT]8VQN(.,XI7&HW'2>5A=F[/?-0G@\'BGN1G& ,<9%(H4N
M.N/>A%2U=B(\FK$43/@*,D\ #O39%02_+S4BED8,IP1WI-CIPL]246IV%F./
M:HT!)-79(8DLU<SAI&ZJ#421KY9.>:R4CO=%)JPL"HTJALA>]2:E]F2Z(M6)
M0=,U69MK8%,*Y!QDGUH4=;BE4M#E2&R3'I3$FQP0.>,FH9.O)IB[<\YK915C
MSIUFY"2',C'WIM*^ YP<C-)6B.5[A1110(**** "BBB@ HHHH **** "I89Y
M()%DC<JX.0145% TVM4:TNI?V@$$ZKYH&W=T!I;B".*U4,CK*>>>A'M615T:
MA*UNEO*Q>)3E0>H^AK)T[?"=<,3?28CP_*"#D4PH,AL#![59A5'.8W)7'3N*
M1]B94CD]/:ES=#5TXM<R'2&WA6,P[B^WYL^OM5)_F;<?RJTL3$%]F5 _*FSE
M?+38NWC#<]?>G%V9-6+<=59%+H:>N6SQ2E&9O>CS6";  ,'KWJSD2L]26&$R
MS+'_ !$X&:OW\ M&$#)L=>&P<UF(\F\,#R.]6G\V9=\A)8]SWJ))\R?0ZZ$U
MR-):E4D"7<HXS4Z7,X9BC%<KCKVIJ[!( 02.]7-22UBDC%JS,NT$Y'0]Z&U=
M(F$)*+E>QG2%V4!@.#3<&-@5/OD5=M(;>9)FFE\LJN5&,Y/I5<K'L&&.[/(Q
M5*70S=-V4NX^"4>8QGRPP3@GJ:8)I%'!(7=G%, !?D\>M&U2Q&>.U%D3>5M"
M>XD^U.TQVJ?[HJO\K-CD#O4YM72(2$K@]!GFH]I4D$X!YYH5NA4TV[R)[6UE
MF<").3T).*CNY9WE*W+LS+QR<XIWVJX:W$8X13GBH1)U8\D^M)7O=E3<>7EB
MV1U8M62&<2$*X3G:W0^U!MR8O,3)3N<=*@Q\X]*K1JQERN#3)KF9997D5%0,
M?NKTJ!>AYJU?0002@02^:A .<8JL W! Z4HVMH$T^;4M6,D8EQ,"RX/'O5>4
M_.1VIH#9R.*NPVT!MI)9I=LB]%QUI.T7<UBI5(\G8J!O+8%#_P#6J:YE$I5@
MS%R/F)JLW4D=*E@@:=]@(SZDXJFEN9QE+6" 1,!NJ5"[X44V&":>411*6<\
M#O5WRQ9KY<Z,LP/7M6<GTZG31A?79",TT2F/<<$<^]9SMDG%6Y/-GD5 "6/
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M[?3M4HE58?+VCGOCFI[ZP-@_EEAGH1G.#51FR,8 [5DFI:HZVITG:6Y/#=)
MCJT2ONXY[5!=W"7-P72,1KV4=JAZ\9J5K9HXTD.,.,C!JN5)W,7.<URK8C[4
M^(98"D )/0FE!(;TQ381T=V7+FR>UVAL$L 00<CFEM;$W"2N&'[L9/-0LSO'
MRV<=J:96084X!&#BL_>L=3=-.]M!2!D\=*IS_P"N:K!8XJJ_+FM((Y,1*ZL-
MHHHK0Y HHHH **** "BBB@ I5.#244 6X)G<JDDS +G;D]*=#?3VS+M8X4Y
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MKB22';;*Z$;1T(]*N*Y$S*5ZLDUL0"\MR)7\DB7"["#T(QDU;N=5M=0LB)H
MLB)M39P-V1R?PS3;&R:XB>WC@5G8\2,< 8SQFG6D>GV]E(MY"WFEOE?MT/\
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M$S3EH*!N;-3E]L>.M5AP<&I ><&K:,:<K;;DGF;@.U SVIR1%QP,FE=#"V&
M%3=&_+*UV"D\X/6F-C!YY':KB"W%NS,3YN<  <54<!22<XS23NRJBM%:DD<4
MMRF(T9MHR<#-4I5VRLOI6@UTMJB_9;AB77#C&,>WO6<[%W+$Y)JH7OY'/7E!
MQ26XVBBBM#E"BBB@ HHHH **** "BBB@ HHHH *E@GD@D#QL0:BHH:N.,G%W
M1T.E7<,MVFZX:"5C@'MGZ]JZ47DUI//%=1_O)?D8R<D#'7->=9(YS6O9Z[<1
M>7'<D7$"\;9.2!Z UQ5\+SZH]G!YJZ?NU%IW.K5[>WL;J"WG=G9NH'RD9J]J
MENNI165JEU#OQ\RHN,#T)[USXNE$<CVL.;:;[N.=OM6_:Z?"FC&69C')M\V-
MD')([9[5YU6/(U*^MSWX256.FJ.0U>V$%Y*LR^6Z' 0# %2+=V:01>4K/*&&
M<_=QWI=7A_?K(;@W#28)8FBRTIS.L,["$2+N4L.M=R<733DSRW&<:TE!6N;?
MVIECB$L^R"1@Z0JV0I]Z6^,2&:UB$<K.=RR(,;<__K_2J36,4<BJ)&V1CF0<
MC=S@5JZ7:0R3)<S-NGD.!&!@Y[$5QSY8^\CTX*4O=:*T'AIHK:XE+QR", YS
MSR,G'\JH:C>PW$$,,"':H.\J.><?X5J7J27+NJ3,;AP?W:\55BLTL+9=A(G8
M$N7'!^E.G/[4W=DSI.W)!:=6<Y'+<*P>$LJPG@D]*?:/-YK*P4%VW;G[XI@=
M#<LDTK",L2=HJV;LZDEK8D1H(OE67&"<GN:]!^AXL=]]2GM=I=['9&."PJ\;
M:VM$M;OSA/$Q.Z('!%-ENWMD2TEQ):QODX'#GZT_2WB@::[N(XFMMVTPL?F
M.>E1)RY;_P!,T2BI\O\ 2_X!&M^K3"T$Q@M7?)/4J,T]H1*CQ_;$DABRZ[OX
MCTXK.U.>"6Z,=H@$ 8E,CGGUK2NXUN+"W:,CS8E/F*BXV#C!/US5.-K6TN9P
MJN3E?5(>FE7,IC3($[(/+&0!MZYS394EMH)[.Y>5G@;*A3\H/>J$$EY=!@K$
M!3G=GIVZTRZGN;.ZDC,^YB,,RG(-"A)RLV#JTXQYTFD7+:<JH,N94=2#M/W
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MN?U-;M8>L_\ 'TG^Y_4UCB/@.G"_Q#-HHHK@/2"BBB@ HHHH **** "BBB@
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M/4UBGK3A+FOY$UH.G:_742BBBK.<**** "BBB@ HHHH **** "BBB@ HHHH
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M$#YABM2ZTZ2SF43M@\=>U5YO(>0*AP .3ZTXU.9:$3PRA)MZ>15B9(I SJ&
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M=6..<<_K51?/O9&E.68#G=3"'N9#A=B(,MM&<>]4H*^H3K2:]U>@^-@J&0N
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MP#5"6>28Y8_A23E(N:I4_-DES<>:0B\1KT%5J6DJTK').;F[L****9(4444
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M&H6\=I,4BD#@=2.]10/F1,@<5,;<NAK/G=5J>XR96"X[5 2,#%6KYMTNTX!
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M]JHTJG!R.M3*-U8TI5'3E=&C=VHC<$,&)'..U4'7::M03M(P1^<\ FI+BW"
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MUT7^=0U-9_\ '[!_UT7^=-;BEL=7FBDH!KL//%HHS12 912FDKJ.02L36?\
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MVY_[J@<FCOY!V\SDZ*ZOQ1X(E\/Z?:ZI::A;ZII-T2L=W;@@;A_"0>0:Y2@
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MYR"VTX-%NH' T5T7BKPS!X;EMT@UJRU,3 DM:GA,8Z_G7.T7"P4444 %%%%
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M4OS+;7\<D6?X20 <?G7FB\L![UZ=KB0^"OA@WAF6[MY]7U&[%Q<);R!Q$BC
M!([UYBOWA]::LY_=^2#:*^?YGLGBN/P5X%U.PMQX:CU"6ZMHY9A-(=L8(_A'
MJ>M)XKM_!'@'6XH8_#PU/[<BW#)<R';;QM_"OO[US_Q?N[:[\4V$EM<13(+"
M!2T3A@"!R,BCXOW=M=^*;![:XBF1;"%2T;A@"!R.*7;_ !-?+7_($OR3^>G^
M9LWWPVTJX^*L6EVQ>#1WM!J$BYR4CVY*@U#I&J>!?$'BJVT&3PK%9V<DXBAN
MHI#YI.>-_J#T_&MW5?%NEZ/\4]-N9[F.73[C2$L[B2%P^P,N">/2LOPS\.[6
MP\=V&H3^(M*FTT72O;^1.&EE.?E&P<C\:<%[R3VU_/\ RM8F3]UOK9?E_GN9
MND^';*'XWW5G#$$T[3+F6X9>H5(\D?KBM?P<;WQ9HGQ"-M&TUW?M&40=R9*?
MK++H\WQ&UPL!+/='3[<]\L<M^E8?PYUG^Q_ WC.6&^2UO&@C$/[P*['=@[>Y
MX/:HB[PUZ1_.WZ6-)*T]/YOR_P"#<@\4>'M'\)6=MX9%M]L\2W#(;BY?(2#=
MC"H._P!:TO$!\(^ ;N#P_)X<AU:Z2)&O;J=R&W,,D)CIC-%SJEMXU\%VNM2W
M,$?B7067S!+(%-U$#D$9ZD8J7Q7H%E\0M2B\3:1KNF6Z7$2"[@O)Q&\+  '@
M_>Z=JIW_ !_#I\B5;\/QZF/\3=!T#2=/\.W>@0-'!?6GG,7;+')[UQN@75A9
MZW:S:I:"ZL0X$T1.,J>N/<5Z+\8+6TL=%\(6MC.)[>/3]J2@8WC/6O/_  SH
M@\0:_;:>US#:Q.V99IG"*B#J<GO1'XG;NPE\*OV/39OAUH.B7M[XHOI5N/"@
MA$UE&'YG=A\L?X5Y!=2I-=2RQ1+%&S$K&O11Z5[:_B?PWXG>Z^'Y,-KHT,03
M3+QS@"9!]YB>S5XK?V;Z??SVDC(SPN4+(P93CN".M+KIMT_KN/IKOU-73;VX
MU>.RT#4=;^Q:3'(SJTH+1Q$]3@<UW_B^PBT3X366GZ%<)JNDRW?G7.HH>!)C
MA=O5?QK#T?PIHWBOP5"ND7$%MXDMI3]HBN9]@G0]"N>.*U]1B@\#_"J^\/7U
M];7.K:G<+)]GMY!((%&.21WXISV:]/GM_7R%'=/U^6YY9;PO<W,4$8R\CA%^
MI.*]3U__ (1+X?W%OH$OAV'5[P1(][<SN00S#.$QTQ7EUG<&TO8+E1EH9%D
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MP94;'!R.V:9\-_ ,.A>.[2\O==TRX"EOLL=I.)'E..I ^Z,>M$=E?:WXZ_\
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M.<L<G.3[U/70KH>EVG_)NE__ -AA?Y)7*_#[4[K2O'FC3VLC*S721N ?O*Q
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MJM%#U=P6B'"1U4JKL%/4 \&FT44 %%%% !1110 4444 %%%% !1110 4444
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M!59E.5)!]0:&8L<L22>Y-)10 4Y7=00K, >H!ZTVB@ IS.[ !F8@= 3TIM%
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MY'K13**+!<L4M%%=-CB"BDHI !ZTE**#0-"4444#"DI:*0"4AI32&@ HHHH
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MT\0:8N@ZK;7^DK<ZG>,6BO"0#$3UXKFZ**I)(EML6BDHIW$+2TW-% "T444
M%%%%, HHHH 6E%-I10(6BDHS0 M%)FEH$%%%% !1110 4444 +1244 +1244
M '%%%% !11786'P^N[G0X=5N]2LK"*X!,"3OAI /2DW978TFW9''TAIS !B,
MYP>M-I@%%&*,4 .65T!"NR@]@<59M-4OK!)DM+J6%)D*2*C$!E/4&JF*,46
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MO#=XOA5?$):/[&UQ]G S\V[&>GI611<=@-)2FDH$+Q3F=G #,Q Z9/2F9HH
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M8]:)-I/Y?F$4K_-_D>6W%E=V@!N;6:$-T\R,KG\ZCAAEN)!'#$\CGHJ*23^
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M/D<B,=*\\JKZM=B;:)]PHHHIB"BBBF 4N:2B@0N:6FTHI +1FC-% !FBBBF
M4M)10 4444 +70>"M!7Q%XGMK*4'[,,R3D<80<FN>KUGX>:!J$?@;6=6L(-]
M_>+]FMLD#"_Q'FE)\L6Q1CS22.?^(?AO3=*:PU/0U8:7>(0N6W8=3@\UQ*12
M.K,B,P7EB!G%>RVG@_6I_AAJ.CZK:A)[-_M-F=X8GU'%8GPNFBL]$\474UO'
M-Y%J'"2+D9!J%*REK>QI*/,XZ6N>=R6%Y% )Y+2=(CTD:,A3^.*Z+PMX3_MW
M3-7OI6E5;&W,D:JO^L;TS77^ O%^J^*-<N-&UB2.YL;BWD/E-&,)@9&WTI_@
M'6K^R\.^*K:&;$=A [6XVCY3N_6B4FD_2XHQ3:];'G^D_P!F16.IIJ5A<RW7
ME8MV3($3>K5B9KTKP==RZKH/C2]O"LEQ)9[F8J.M<UH_@#Q'KVG)?Z=8>;;N
M2 ^X#D55]7?R)Y=%;NS5^%WA_2?$.M7D.KQ-);PVYDP&*X.:R?'6@Q>'?%-Q
M9VP/V1PLMN2<Y0CCFNL^'.EWFBZ]XAL;Z/RKF+3WW+G.*J>*$/B3P%H.MQC?
M<VS?89\=?]G/Z5,G[R:VT_&Y2C[C3WU_"Q=^&G@?2=<T:[O]9B9][,EJH8KD
MJN2:\UN+=EN+@1QL8XW8$@$@#/<U[?H+KIGB;1_#41P++3))9P/^>KJ2<_2N
M1\-(K>!_'#%02.A(Z<FAR]YOI;];#44XI=;_ *7/.8XY)6Q&C.<9PHS3H;>>
MYD\N"&25_P"[&I8_D*[KX2(K^)KL.H8?8I>",_PFM;P"?.\+ZK:Z+>VMGXA:
M?*/,0I:/T4GI5RE;[K_C8SC&Z^=OPN>7SVUQ:OLN()87_NR(5/ZTZWL[J[)%
MM;338Z^7&6Q^5>B^,_\ A)QH%M8>)=+26;SQY6IJ0>#_  DCK^-6?&&O7?@:
M+3= T!A9[;9)IYD4;Y&;U-2IZ%.&IY=+%)#(8Y8VC<=588(_"IH=.OKB/S(+
M*XEC_O)$S#\P*Z/7?%T'B6QTX7VG!M3MWQ-<I@><GH0.]=S]I\=7LMM/I%HF
MAZ0BJ(X9Y%C4@=2<]:=W;4FR;T/'?+D,GEB-O,SC;CG/TJ5;&[,33"TG,2'#
M.(SA?J>U>N:_8P6_QF\/NL42M<+"\PC VLW<BL/QQXYU./6M5T*Q$-MI@=HF
MB2,9;/4D^N:2FW:W7]"G!*]^EOQ.1UXZ9+)9+I-C<6_[A1*LN27?N1[5G1:?
M>S[O*L[B39][9$QV_7BO4O$<<8\;^"0$4 VT&1CKTJOXP\>:MHWCB[L=)>.T
MM8)@&C2,8D/!);UH3Z+K?\&)Q6[Z6_%'G>D_98]8MAJ-O+-;+(/-A3AF'<#W
MIFJ?9GU6X^PP20VQD/E1/]Y1V!KU/6;2V3XQ^'YXH4C^V)!-(BC@L>O%-TJQ
MLX?&/C#7KFW2;^RM\D,3#Y=_8XHY]F^S_ ?)T7E^)Y7+IU[!%YLUG<1QG^-X
MF _,BJ]=UI_Q1U<:B[:SC4-.E!62T90%P?[OI7%7<D,MY-);QF*%G)1"<[1G
M@5:;OJB&E;1G5^#/"5MK%O>:OK$[6^CV(S*Z_><_W16G'K_P]EN!9OX8GCM2
M=OVD3_O /[U3DE?@-^X_BO\ ]]C\,9KS2E\4FGLA_#%-;L[O5/!EGI7C?2K*
M.?[5I6H.CQ,&Y*$]#^=8?C'2[?2O&.HZ=8QLL$4NV-,Y/04_PLMR/%NB-.LP
M0W">69 <$9[9KLKB\FL_BUKKV>CMJ=\Q*VZ@9$;;1\Q!I:II>OZ#TDF]MOU/
M-9M.OK:/S)[*XBC_ +SQ,H_,BHX+:>ZDV6\,DS_W8T+']*]U\,6GBVZN;RV\
M5SVTUE-;OFVED5G4XXPHZ5SW@A6?PAJ%CX?OK6S\0"Z.6F8*SQCH%)_&CGW#
MV>QY7/;SVTGEW$,D3_W9%*G\C4D%A>W,9D@M+B5!U:.,L!^(%=[XYD\1QZ':
M6OB?2E:>.7*:DN#N7^Z2.OXUULJ:]>Z7I,W@74+,6,5L@EM%=5<N/O;AWHY]
M+AR:V/#2"K%6!!'!![49KI?'D]U<>)'DOM(&F76Q1+$!@.W][\:YFJB[JY$H
MV=A<T9I**HD7-%)10 M%&:* "BBB@ HHHH 7J<"O03X<\->%M'L;CQ,+JZOK
MV,2I:V[[/+0]"37G\;!)48] 0:](^)EA=:N='UW3X9+FRGL8X]T2EMC+U!QT
MZU$G:WJ7!;^2*&M>&-#72;/Q+I$MQ)HSS"*Z@<_O(3Z9KH_B"_AW_A#= 'EW
MFXVC_8?F&!T^_65);RZ!\&KBVU%##<:E=JT$+\-M7!)QVZ5#\0?^12\&_P#7
MFW\Q42[>?Z&D=-;;I_F>?Q*'F1#T9@#7IFO^&O!7A"_ACU,WUVT\*R+!$^W8
M#U)/]*\TM_\ CYB_WQ_.NZ^+W_(WP?\ 7C#_ %K271&<+6;*OB[PA:6%QI%Q
MH4DDUEJR9@23[RMD#!_.M+4=&\%>$YX]+UE;Z_U$*#</!)L2$D=!ZUI:G>1:
M?HWPZNY_]5"Q=_H'%:'C?Q#XBTSQ+*MIH]G=V=QM>WG%F)-ZD#OCK4-M>[YO
M\"TDUS>2_$PHOA_I/_"4Z=;_ &J672-6@:2SF!PP<#.UOY5E>"_!<.M^*[W3
M=3=XK:R5_.=3C!!VC]:U?%^M>(-.NO#LFJM9Q2P,+F.WMTVM",CA@*Z'QD(?
M#V@ZKK=FX#:]/ T)7J%QN:ES-:OS7XZ?UY!RIZ>C_#7^O,X?2O!:77Q#NM!N
M6=;2U>1I7!Y$:C(/XC%;,HM5^#]P(MQM!K1"Y/)3C'Z5TOB-X=.\.ZGXPB91
M-K-A#!%CJ'88?^0_*N07_DA;_P#84_H*5W:SZ6^^X^5)W76[^5C&\<^&K;P_
M?V3Z<[R:??6ZS0.YR>>H_E1XH\.V7A[0]%):0ZI>1>?.I/"(?NC%=EX4L(_'
M?@W3K&9AY^C7J[R>OD,>?Z_E7#>.M9&N^+KVYC/[B-O)A Z!%X&/Y_C5W=^7
MS_#I^?X$V7+S^7X_TOQ,O0](GU[6K73+; EN'" GH!W-=M>:?\/M-U1M$E.H
M27$;>5)?J_RJ_?Y>X!K%^&U_!IOCS39[E@D18QECT!8$ _F:9X@\+:S%XRO+
M,6-Q(\MRS1LJ$APS9!ST[U3^)(F/PMG:>/-)AO/'WA;27F9H'M88#)&<$C.,
MBI? FGZ/I'Q.U'3_ /27NX'E2!RV5V!#G=[U)XEMWM/B;X+MI&#/%!;HQ!SD
MAL&J_A__ )+QJ?\ O3_^@&LH[?*7YFDM[V_E_(N> 9/"K>,K[^S8K];KR9=Q
ME8$8YW5QVE^&-'\3>(+J2REN+31+.$S74LQ!<8SD#ZU?^%O_ "/VH?\ 7O<5
M;^%%\R6_B33[40MJ,\&^WCE (D*Y^7!Z]:-M5_+_ )CWT?\ -_D4M/TGP)XF
MO3H^EK?V-[("+>XFDW+(PZ CMFJ_A+P-9ZJ?$$.L3O:R:6/F=3PN"=Q/KTK=
MT'Q#XQU+7%LX-%L;26,DO/)9!%BQW)Q4.@W<U[I?Q#N9Y(Y)G@.]XAA6/S#(
M]J;;2?H)*+:OW,F/P]X9\4ZU8Z9X6^V0_>:[GN3D"-1]X"IHK/X=76J#1HO[
M121G\I-0,GRENF=OIFF?!V_AM/%\L,C(LEU:O%"7Z;^"!^E:D.O^,G\0#25\
M/6*W/F[-QL1M'/WLXZ=\U334E$E6<7(S- ^'<5QXMUK0M5G:,V-NTJ2IP#R,
M,?;!J?1=$\!^(;_^PK(ZC'?.K"&\D;Y9& S]WMTK=T2[OKOQQXL.H7%O/=1:
M4\;R6XPA(QTKA_AA_P E$TG_ 'V_]!-*-Y:-]/\ ,<K1U2Z_Y'6?"ZWTRQNO
M$%G<K.=0@MIXYV4_(8P0#CWR*Y[PYH&B>(=8UE;)KN*RMK!IX@S_ #%AC@^U
M;W@A3)X\\8PH-TDEO=*JCJ3YE9_PQM+BRU'Q#!=020RC2924D4@CD=JEMV<N
MO+_F4DKJ/3F_R,7PYI'AY="N=:\073ND<@BBLK=P))#ZGT%:5]X>\-:MX/NO
M$.@QW=K]AE1;BWG??E6/4&K7A[3]/T?X>#Q(-&35]0ENC"$D4LL '<@?YY%=
M!)=ZOJ/PB\07.I6$-DC;/L\,4(C^4$9)'7\_2JG*UVNEOT)IQ3LGUO\ K]Q6
M\3/X9_X5;H1\J]^SDS?8QN&X/D_>]LUSEOX;\/>'O#MCJGBC[3<7.H+OM[.W
M?80G]XFKFMV5U??!_P +O:V\DZPRS&0QKG8,MU]*Z/Q!XBU2+PGX>U/1=/M;
MZR-HL,I:W$K12* ,>W>D]'*W<:5[7['#Z_X8TB?PRGB7PW)/]C640W%M.<M"
MQZ<]QR/SJ]<>'?"WA+3;$>)$O+S4[R(3&"WDV"%#TR>YJ]K.L^)9? $ESJ4%
MA8V-U.J"W$ CDEP0=P'X57^*5A=:MJ>G:]8027-A>6481XE+!6&<J<=.M%WM
MY_H%EOY?J:'B:TTRU^#-N='N'FLIM1$J>8/F3*D%3[@BO)37I^JZ5=Z3\#K6
M.]1HY9=1$HC;@JI4XR.W3/XUYA51^*7K^B(GM'T_5B44459 4444 %%%)0,6
MDHHH **** "BBB@ I,TM)0 9HHHI 6C2&G4AKI. *6DHJB@/6DHHI %!HH-(
M$)1110-!2&EI#2&%)2TE  *6D%% P/2DI:* $HHHH&(:2E-)0,**** "D-+2
M&@!*#112&@I#2TAI *.M.IHZTZDRD%%%%(8AZTE*:2F,****E@%%%%( HHHH
M 0]:2@T4 )24IHIE"4M%% !1110,****0'I6@?\ )$/$?_7XG_LM<GX(_P"1
MWT;_ *^D_G6*L\RPM"LKB)CED#'!^HIB.T;AT8JP.0RG!%"TDY#;O%1.E^('
M_)0]8_Z^V_G70_%>YDL_&6F7,+;9(K.%U/H1S7G,DCR2%Y'9W/)9CDFM'2;:
M/6M6BM]1U5;.)@0;FXRP7'05,8V45V_R*E.[D^_^9[)K-U8V/A^^\>6[*+G5
M;&.WB ZK(1A_T%<;\,26T[Q<2>3IK$_^/5G^-]:TXZ;I?AO1;DW.GZ>A+SXP
M)9#U(]JXV.>6$,(I70.,,%8C(]#4*-U*W71>A3E9QOTLWZG7_"_5[72/&D37
MD@C@N8GMVD/1=W0_I5J;X8>(SXB:U6R+6K2Y%V&'E[,_>S]*X*M%==U1;3[*
M-1NO(QC9YIQ5M.ZDB4U9IGL5KJMKJ7QNT^&SD66&RM3;^8IR&*KSC\:X/PC_
M ,E8LO\ K];^M<='<20R>9%(Z./XE8@_G2+.Z2B5)&60'(8'!S]:F,>5I_UO
M<<I737];6.QO?^2OO_V%A_Z'7<Z=_P E\U7_ *XR?^@BO%#.YE\TR,9,YWYY
MSZYIXO+@3&83RB4]7WG<?QI*'NI=DU]Z&Y^\WW:?W'H_A?\ Y$7QS_P'_P!"
MJO\ ##_D'>*_^P:W]:\^6YE1'199%5_OJ&(#?7UHCN)(0PCE= PPVUB,CWI\
MET_-6_ %.UO)W_$[[X1?\C+J'_8.F_D*Z'PEJFI7_P /+K2?#UWY.M65TTHB
M! :6,DDXS]:\?CN)(&+12O&Q&"48CBE@NYK:8303/%(.C(Q!IRCS?UYW",K?
M?^ECURWF\=1:+J-_XBUFXTNVBB(C60+NF8_P@53TS3+SQ'\&S9Z:@N+J'4#+
M)&& 8+SS^M>:WFK7^HX^V7D\^.GF.3BHH;N>W#"&>6,-U".1G\JEP=G\OP*Y
MU='HLVZ#X)6F1\T>J'(]P35SQSH5[XS33?$6@0F]AEMDBFCB(+1.HQ@BO+3<
MRF+RC+(8\YV%CC/KBI[/5;[3\_8[R>#=U\MR,TW&[OYW_"PE*VG];W.D\1^$
M8/#/AVQDOKAEUNX8E[0$$1IV)]#61X7UD^'_ !+8:G@E8)06 [KT/Z5ESW,M
MS*99Y7ED/5G8DFH\BG&ZU9,K/1'I_C'P)>ZYJDFO^%T74;"^/FE86&Z-CU!%
M,L/!UGX3\.:AJGB^"(74L1CL[)F!?<?XL#I7GUGJU_I^?L=Y/!GJ(W(J.ZOK
MF]E\RZN)9G_O2,2:CE:7*MB^=-\SW/09-K? ^VW?*AU,Y]AS74ZW'XCTR'3;
M+P1IT0TV2W1OM<,:L68CDECTKQ+[1)Y/D^:_E9SLW';GZ5:AUK4K>U-M#?W$
M<!ZQK(0*;C?[_P!+"4K?UYW/6_'MB]Y;^#8-1U7YFS%-?*VX+)QSGZU;TQ_B
M#IWB*+2KJ(:IHP<*;BX161HO[V[MQ7A[W,LD:QO-(R*<JI8D#\*MC7M56U^S
M#4;H08QL\TXH46OQ!RN>CV^CK<>,O$4W@_5?LEY:MNMK>(@"8=P/4=:V5N=;
MU'P;K?\ PG>GPQ1Q0_Z+/+&J2&3L!CK7B<-S+;S"6&5XY!R'5B#^=6+S6-0U
M !;R]GG"]!(Y(%)TWR\I2FN:Y4HI-PHW"M#(6DHW"DW"@8M%)D49% "TM-R*
M,B@!U%-R*,B@!U%-R*-PH =13=PI=PH 6O0_AAJFCV5MKUGJVI16*WML(D>0
M$\\^E>=[A2;A2:NFNX)V::Z'I$/A+P);RK-<>-HYHD.6CBB.YO;D5:D\<:9J
MGQ2T?4=WV72; "%))>NT \FO+=PHW"DHN]V-O1I'I.B^*M)A\1^(]/U"8G2-
M79E\]!G8<\-]*FT70_#7A+5DUV\\2VM_%;$R6]O;J=\C=L^E>8;A1N%)0LM/
M0;E>]_4]'\/>,[#4+W7[#7W,-EK;%C*!GRG[$^W2GZ=H/A3PM/+J>J:Y9:O&
MB-]GLX4),C'INSTKS7<*-PHY.VG0.>^^IZ!-X@L&^%<FGPW*0WK:B9A;)D%4
MSD?A3M9UK2O%O@>WFOKN.#Q!IP\L!\YN(_\ &O/0PI=PIN <[/1M7U[2[C2_
M!445Y&SV(7[2!G]U\V>:Q/B)J5GJWC:^O;"X6>VD*[9%Z'BN3R*,BCEUOZO[
MQ<VEO3\#TWQ!XMMHM<\*:AI$ZW<MA:HLB1@Y#=UHU?3?!6LZQ)K1\0&S29O,
MGT]X3YH;NH[5YU97LEA>P7<)Q)"X=<^HKNYO&7@[4+T:KJ/A>9]2X9_*N-L3
ML.Y6AQM9^OXC3OH_+\"U\9&@.J:*+92L(L%V*>H7MFL3X:ZW8:%XK6XU!_*B
MDB>)9L9\IB.&K(\4>);CQ1K+ZA<(L8P$CB7HB#H!6+N%*$6HV?G^(3:;T\OP
M/6M)M]#\/^*X=<UGQ;%J $Q:&.'<QR?XFST J#2=?T>S\7>+KB348?L]Y!(M
MO)SB0GH!Q7EFX4;A1R:6?9K[PY];^:?W'5?#S4K/2?&^GWM].L%M&Q+R-T'%
M;OA'Q#I%GXQUXWUX(;/4(Y8DN,$J,DX-><9%&X4W&^_:PE*VW=/[CTGPK=:'
MX8U77X/[:@N+>:P:.&<*0)&/8"I?#]_X<O?AD^@:KJB6EU+=EXR5)\L]F/M7
MF6X4FX4G&^_E^#N/GMM_5U8]0TK^P_A[8W]\NM6^IZK<0M#;QVP.$!ZL2:JZ
M-JND>)_!B^&M8OUT^[MIC+:W,@RASU!KSG(HR*?+?<7-;8].M9M%^'^AZE]G
MU>#4]8OHC @MP=D2GJ235?3+_2/%G@JV\/:IJ,>G7]@Y:VGE!*.I[&O.<BC(
MHY;[_P!6#FML>L:6_ACPKX6U_3O[<@N]2N[? >-2$]E![FL7X47J#Q+)H]PI
M>TU.%H)%_4&N!R*[/P]XNT;PWI+R6FDRMKK1M&+MY<HH/<+ZT6M=O6X<U[):
M#?B1JT>H^*Y;>V/^B6""UA Z87@G\ZY"EDE:61I')+,223W--W"B,;*P2DF[
MBT4FX4;A5$BT4FX4;A0 M%)N%&X4 +12;A1N% "TN:;N%&X4 .I:9D4;A0 ^
MBFAA2[A0%Q:*3<*-PH >BAI%4L%!(!)[5WGCCQ#9C3=%T/0;[?:64 ,DD)*A
MI#U_K7 ;A1N%#5[#3L=9X'\4RZ'XJM+J\NI6M&)CG#N2-AX/%=-;:GX?TEO&
MEO;:G \%[ ?LA7/SDG.T<5Y;D49J91O^0HS<7^)V/PUU6QT?Q:EUJ%REO ()
M%WOG&2O K2\$:UI$$_B.PU*^6TAU*)DCN"I*CYL\UYYFC--QOOVL"E;;O<]$
M\/WNC:#IOBS3_P"UH9Q/:^7;2A2!,?85Q$&J7]M$(H+VXBC'14D(%4\T;A0H
MZW8G+2QWGP]UZTL+_6)]6OA&T]D\:/*22['H*N?#/Q%H]C#J&F:_,D=E)MGC
MWYQYBG@5YON%&10X_E8%*WWGHOA3Q59M\2+_ %K4[I8(9TF"N^<<@A1_*F^"
MM8TEH?$.AZG>"TAU0$1W)&54Y.,UYYD49%+D5K>5A\[O?SN>N>$X?#'@G4+J
M2[\26UW<SV[QQF%3L0$=SZFN:\.VWAO5]&N[&[O$TW5Q-OM[R3.UE_NG'2N(
MR*,BCEZL.?HD>HZGJUGX>\ W6@MKJ:Q>W,JNGEY98 /<TFIG0_B#86%X^LP:
M9JUM"L$\=R#MD Z$$5YAD4;A1R=7N'/TZ'H&HWGA;0(M'T^P$6HW%M<":[OE
M3&X9^ZN>U;7B:#1_$&NMKDOC"(:6VUA:C=YB@#[@7I7DNX4;A1R]>H<_2VAZ
MSKGB30;GXB^&M5M+^/[#!'&LA.<Q!>S<5P/BF[@OO%NI75M*LD$MPS(XZ,/6
ML3<*,BA1LUY7_$4IW3^7X'INN>(=)N?%OA.ZAOHW@M((5G<9Q&1C(-<KXSOK
M74?'&HWMI,LMM).&21>A&!S7.9%&134;._K^(G*ZMZ?@>I:MXCT>?XC^&M0B
MOXFM+6"!9I1G"$=0>*KZ;XMTJV\;>(8KR7S-&U<O&TR#H#T:O-2129%'(OS_
M !*YWT\OP/2K#PWX4T'4?[4U'Q%9ZC8Q9>*UB0EYO0$5P.HW$5WJ-Q<00+!#
M)(62).B#/ JGN%+D4<KO=L3DFK6.Z\$^*-.M--OO#NOJYTF^Y\Q>3$_]ZKB>
M!O"\5P+J?QG9OIX.[:B'S"/3ZUYSD49%#6MT)2TLST75/&&G:EXTT,6BBVT;
M2W1(F<<[01EC6UIWBC1F\9^*U&I);+J:;+6_ .%.!^(KR'=1N%'LU:WK^)7M
M'>_I^!Z[X3_X1[PCK3W.J^)HKV[GB>-&CW,D8(ZL3ZUSVD6GAK6-+N[*34(M
M-UA+EGAO7)V2IGIQTK@]PHR*.3JQ<_2QZ=K>K6.C> '\./K*:S>33K)E,E85
M!SC)]:C.D>'=7CL[_0O$,&BNL2BYMI68%7'5@1UKS7(I=U'+UZAS].AV_P 2
M?$%EK>H:?!97!NQ8VXA>[(QYS<9/Z5Q I,BC(IQC96)E+F=QU%-R*,BF(=13
M<BC(I@.HIN:,T .HIN:7=0 M%)N%&X4"%K;T?Q;KF@Q-#IVH2Q0MR8\Y7/T-
M8>ZC(H"YHZKK6HZW=?:-2NY;F7& 7.<#VIEWJM_?V]M;W=U)-%;+LA1SD1CT
M%4<U9DT^\BDACDM9E>< Q*4(+@],>M*R6@[MZD()5@P."#D&K6HZG?:M<"XO
M[F2XF"A \AR=HZ"JUQ!-:SO!<1O%*APR.,$?A46ZC<-B_=:K?WMI;6MS=22V
M]L"(8V/$8/7%:NG>.?$>EV8M+35)E@7[JDYV_3/2N;W"C<*+!=HMWM]=:C=/
M=7D\D\[G+/(<DU->:SJ5_96]G=WLTUM;#$,;MD)]*S]U200RW,Z0P1O)*YPJ
M(,DGVHMT"_4N7&LZE=:;!IT][-)90',4+-\J'V'XFFC5+\Z9_98NI/L)D\SR
M,_+N]:J2QO!*\4J,DB'#*PP0:9N%%D%V>GZ7#_PK_P *:G?3:E;2:AJ4 AMH
M+>8.5#<EFQT(KS*D+9ZTF124=6QN6B2' X.0<$5T2>//$T>GBR75[CR0NT<_
M,!Z9ZUS>14UK:W%[-Y-K!)-)@G9&N3@4VK[B3ML79M?U6>]M;R6_G>YM0%@E
M9LM&!TP:2'7=5@U5]4BOIDOGSNG#?,<C!YK./RD@@@C@BDW46"Y>L=6U#3+M
M[JRNY8)W!5I$."0>M06UW<6=TES;3/%.AW+(AP0:@W4;J+!<Z2^\>>)M1LVM
M;G5IVB<8< X+#W(ZUD6FJW]C;7-M:W4D4-TNR=%.!(OH:I;J-PI<J#F?<?'(
M\4BR1N4=3E64X(-=(_Q!\4R6?V9M8N-A7:6S\Q'IGK7,;A1R02 2!U]J;5]P
M3:V+MEJ^H:;).]G>2PO.ACE9&Y=3U!J*QO[K3+R.[LIW@N(SE)$."M5LBC(H
ML!>MM8U&SU)M1MKR:*\9BQF1L,2>M63XGUQKVXO3J=P;FXC\F67=\SI_=/M6
M1D49%%AW9LZ-XHUGP^LB:;?20QR<O&.5)]<4MSXLUZ[^U>?JERZW2!)E+\.H
MZ#'IS63!#+=3I#!&\DKG"H@R2?84DL;P2O%*C)(AVLK#!!]#2:3W!2:V-*R\
M2:SIUA)8V>I7$-K)G?$C_*<]>*DT;Q3K6@*Z:;?RP1O]Z,'*G\*Q2>:3-.P7
M-35]>U37IUFU.\EN&487>>%'L.U6](\7Z]H5LUOI^HRQ0,<^7G*@^H!K'BM+
MF>WEN(H)'AAP9'520F?4]JAW4K+8+N]S5OO$6L:E;/;WNHW$\+R^<R.V07QC
M/Y5F4S-&10E8&[[CC12#)S@$X&3@5-':7,MK+=1V\C01$"20*2JYZ9-,1%13
M=U&: %- /--S1F@8X]*2DS1D4 +12;A1N% "T4FX4;A0 M%)N%&:0"T4W-%
M%VD-+2&NHX HHHIC#%&*!0:3&)B@TM)2 2BBB@:"DI:*0Q*0TZFF@ HHHH *
M44E**!C:***!B&DI32&@ HHHH&%(:6D- "&B@T4AH*0TM(:!BCK3J:.M.J6-
M!1112&(:#0:#3 2BBBI8PHHHI %%%% #310:* $-%!HIE!1110 4444#"BBB
MD 4444 (:2E-(: "BBB@ HHHH&%%%%( Q24M)0 4AI:2F 4E+0*!H2E%% H
M6BBBD,***0T +244"@044M(: $HHHH&&:*** "BBB@ HHHH **** "BBB@ H
MHHH *2EI* %S1FDHH 7-&:2B@!<TE%% !1110 4444 %%%% "T4E% "T444
M%%%% !1110(6BDHH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3BFOZV_S"BBDJR0HHHH'8**** "BBB@ HHHS2 **,T4@+QHH-%=1P"44M)3
M*#12&DRD+124M(!M%% H&@HH-% PIIIU(:0"44&B@ I:2@T#$HI:2@8AI#2F
MD- !1110,*#110 TT4X]*04AH2D-.I#0,!UIU-'6G4F-!1112&(:#0:#0 E%
M%%2QA1112 **** $/6DIU-[T (:*#13*"BBB@ HHHH&%%%%( HHHH 0TE*>M
M)0 4444 %%%% PHHHI (:*** "BBBF AHI:;0-"T"DI10 M%%%(84E+10 E%
M+2&@!:2BDH$%%%% PHHHH **** "BBB@ HHHI %%%% !1110 444E, HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** %I#110 "EI*6@ HHHH$+124
M"@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!:*2B@!:*2B@!:*
M2B@!:*2EH =FBFTHH 6DH-(.M "TM%% @HHHH **2EH ****=PL%+24M(5@H
MHI*!"T4E+3 6BDHI +1110 4444 % HHH 6D-+24"$HI:*8Q*6BBD(#24M%.
MX"4M%% !1110 M%)12 ****8!1111< HHHI@+7::=X^4:/!I6NZ/;:M;6W^H
M:7(>,>F?2N*HI-75F--IW1TWB7QE<>(+>WL8K6&QTVV.8K6 ?*#ZGU-.U'QM
M=:CJ>BWKVD*/I4:1QJ"<.%QC/Y5R^:<H9CA02?84DD@<FSN-"U/6/$_Q%EU3
M39X+'4ILRHA)*,0OW.>N0*Z_PYK.NWOBZ")/"5KIL_FC[9>K;E3L!^8Y/ _"
MO&H9Y;:9)H9&CE0Y5E."#6]/XW\4WUHUI-K-Y)"1AEW]1[U+C:UNA2EO?J:N
ML>+KC2OB9JFM:3*K SLN#RLB@ $'U!Q5E?B/96<DEYI7ABPL]3D!_P!)7)V$
M]2HK@"<TE"@N5+MH-S;DVNINZ'XLU+0]<DU6&02RS9\]9>5E!ZAJZ2W^)-KI
M=XMYHOAFPLKDL#+("26'=1Z UY]15.*9/,T=+8^-=1TWQ5=:];+&LET[-- >
M4=6/*GVK:_X6-9V)EN=%\-6-AJ$JD&Y7+%,]2H[5P%%)Q5K!SRO<Z#1/%MWH
ML.KH(4N&U2!H97D)R,]2/>H/#'B&;PQKL.JP01S21*RA)"0#N!';ZUC44Q79
MTV@^-+S0M0O9E@BN+2^+?:;2491P23_6MRR^)T6B7!?0O#MC91N")E!),F1T
MSV ZUY[2[6"AL'![XI.*92DT;^G^++C3]#UG2TMHFCU0@R.Q.4P2>/SK.T;6
M+S0M5@U&PE\NXA;*GL?4'VK/-%-)+43;>YZ&/B181W1U*#PKIT>K'YOM'. W
M]X#UKF]/\8:OI_B9]?2XWWDC$R[^5D!ZJ1Z5@44**6PW)O<]!'Q(L[262]TK
MPQ866IR YN5R=A/4J*P_"MIK>K^++2\L8YI;C[4LCS[20K9R2Q_.N:K5TWQ+
MK.CVD]IIVHSVT$_^L2-L!J$E'5;B;<M'L=)\5M?77/&DZ0N&MK,>1'MZ$CEC
M^?\ *J'AKQM/X>TR[TQ]/M;^QNF#O#< X##OQ7+$EB2223R2:2E&"4>4J4VY
M<QV&B^/)=-MKO3KO3;:^TFYE,OV.7.V,D_PGM1K/CG[7HKZ-I&F6^E:?*P:9
M(<EI3_M'TKCZ*.5"4FCL]+\>1Q:'!HVMZ/;:K:6Q)MS*2'CSV!]*H^)_%\WB
M*&TLHK2&QTVS!\BUA^ZI/4GU-<U13<4W<.9VL:6@ZQ)H&N6FJ0Q)+);2"14<
MD D>N*V-.\<76G:WK.J):0O)JD<D<B,3A YR<5RM%#2>XDVMC5\.:Y+X<UZU
MU:"%)9+=BP1R0#P1V^M5-0O&U'4KJ]=0CW$K2E5Z L<X_6JM%.VMQ=+'4^%?
M'-[X3L;^VM+6"87A3>9<G 7/&.X()%:?_"Q;>PMISH7AZRTR]N$*/<QY+*#U
MVYZ5P=)4N*>Y2DUL;_AGQ9?^&+^:X@"3Q7"E+B"89253ZUO/\1+>QMKA?#WA
M^STNYN$*27,9+.H/4+GI7!T4.*>X*36QTGA;QE=>&/MT8M+>]MKY L\%QDJ^
M,^GU-//C.5=%UO2H-.MH;?594D8(2/*VG.%'I7,49H<4]P4FMC=\+^*)_"]S
M>36]O',;JV:V82$C:&QR,=^*PJ3-&:=M;BOI86DHS1F@044447 **2@4#%HH
M-)0 M)110 44E%%@-&BEI#72< E)2TE,!**6@=:3&%%!I*0Q<4E%&:!B&BBC
M% !2&EI#2&)10:* "@T4&@84E+24#"D/2EH/2@!M%%%(84444P ]*2EI*!H*
M0TM(:0P'6G4T=:=28T%%%%(8AHH-% !24M)2:&%%%%*P!1112 *;WIU-[T (
M:*#13*"BBB@ HHHI#"BBB@ HHHH *0TM(: $HHHH&%%%% !1112 2BBB@ HH
MHH *;3J3%,!****!@.M.I**0Q**7%&* $HI<44 %)2TE !1110 4444 %%%%
M !1110 4444@"BBB@ HHI*8"TE%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 M%)10 M%%% @HHHI %+244P%HI** %HI** %H
MI** %HI** %HI** %HI*!0 M%%% !1110 4444 %%%% "T4E% "T444@"G4V
MES3 6@TF: : "BEH- @HI*!0 M%%% PHHHIB:"@444"L+1112$%%%% "T4E%
M "T4F:,T[ +124M !1112 **** "BBB@ HHHH$%%%%, HHHH ****0!128HH
M 6DI:,4P'0Q-/,D28W.P49/<U?U30M0T;5CIE[!LNOEP@.<YZ8K/4E6# X(.
M17L_]FIXKU7P9X@(#1F$I=GWAYY^N#2<K6;VZE)7NEN>6:YX=U/PY>1VFIVY
MAFD0.HSG(-=U\-_#MWI7C:*#4K9 UQI\DT:-AOE*\'%;>KP#XB+X=U1!N*ZC
M):SD=H]VX$_\! IOAO6?[6^-6I741_=0V\L,..@5%P,?B#67.W%I[V?Y?\$T
M<$I)K:Z_/_@,XS_A6'B:XBDN([: -RXMS,!+C_=JIX,36K?5[Z/2[&&>Y2W=
M9HYU'R*.IY[BIO"6JWL_Q,T^XDN93)-? .2QY!;D?2NV\.(J?%KQ:J@ ?9Y^
M!^%#;4=>S_ =DY:=U^)C^#_ DFI>!M:OWM89+N>)19.T@^7D[OITKCM,\'ZU
MJ^J7%A9VP>2V)$SE@$3'JW2NJ\'2R#X8^,<.WRK'MYZ=>E;.BPZ5!\&HFOM3
MN+".]O&$\]NFYG(Z*?;BJDVI2?I^(HQ3BEZ_@<%K?@77-!LOMMS#%-: X::V
ME$BJ?<CI7.5ZUX?O_!^BZ=JUI%K>H7]O>6S(\$EM\H/9N.E>29YXIQ;;:9,H
MI)-'0:#X-UGQ%!)<64,:VT9PT\\@C0'TR:/$'@[6/#4<,U_#&8)CA)X7#HQ]
M,BNGTW1[^\\"69US7H-)T+S6:WCV9>5N<GCK^-:VM1:7'\%Y(]+OKB^MXM14
M"6=-I#<9"^U*4FG\T.,$U]YQ]K\.?$ET82+6.**6)9EFEE")M;IR>_M69XA\
M+:KX8N(XM3@""4;HY$;<CCV-=G\4K^Y73/"MHDSK --20JIP"< 9-/U,F^^%
M/A0W3ES_ &@T>]CDA>>,T)MOYV_&PG&*^Z_X7.:TOX>>(-5TZ.^CB@@@E_U1
MN9A&9/\ =!ZUT'BO2)]'^$^BVU[:B"[34'5\@9(VMCGN*K?%Z[N$\:?84=DM
M;2WC2"-3A0,=1_GM5GQ/J%UJ/P9\.RW;L\B7K1AVY)4*V/\ #\*GF<H\W2_Z
MCY5%VZV_0\UKJM,^'7B'5-.CODA@@@EYB-S,(S)_N@]:YRP1)-0MDD.$:10W
MTS7=?%^ZN8_&OV-79+6VMXUMT4X4+CJ/\]JTD[62ZDQ2=V^AS.K^$=:T*UBN
M=1LS!'+,84W'DL/Z5KV_PM\4W#R+]CCC$:!]TLH4-D9 ![FMSQ+>W=_\)/"D
MUXS/(+QD#-U*C<!2?&'5;U?$=A:1W,L<$5C&RJC$#)SD\?05+E+;SM^!?+'?
MRO\ B<KHW@;7-<BEGMH8H[>)S&T\\HCC+#L">M)JO@?7-'O+.WNH(\7CA()8
MY T;L>VZNGMM&O;OP1IK>(_$$.E:.&9K2$(3)+SR>.OXUI>)/[/M_@]8G2;V
MXNX(-3_=SSKM8'!SCVH<K/YB4$U\F>8:KI5YHNI3:??Q&*YA(#K]1FI=2T'4
M-(M+*YO8A''>Q^9#SRR^N.W6O1_$6C'QQ=^$M;MER=25;6[(_A=.I/X!ORKE
M/B5K":KXPN(K<C['8J+2!1T"IP?US34GHGOK?Y XK5]-/Q_IG/:3I5WK6I0Z
M?8Q^9<RDA%SC.!FNEM_A?XHN;=I%M85<9(@>8"1@.X6D^%9_XN/I/^^W_H)J
M[I^J7L_QIBFDN9"QU4Q_>.-N_&/IBF[\RBNI*LHN3Z&?IWPU\2ZG:B>.VBB)
M)"13RA'?'!PIY-84.A:G/K1T>.SE;4 YC,..01UKK?%.JWK_ !@F?[1(##?(
MD8#$!0".!72:K::U/\:=9&@S0VL@@!GN)5RL<91=QJ(S;2D^J;_(MP5W%=+'
M(7'PN\2P6TLRQVL[1*6>&"X5Y% ZY45L^ O [:KX8US4)[6&25[5DLF=Q\K\
M@DCM]36WX TWP_IOC:W%MXFGU+4760%(HSY3?*<[B:S/"KM'I7Q%1&8*D,FT
M _=^9^E*4G9KRN5&"NGYD?P^\ 2W&H:L^IVL$HMK>2.(&0$"; P?I@]:XC_A
M%-8;Q!_8D5KYU]P=D3!@ 1G.1Q77?"2:1K_7\R,?^)5*>3WR.:O_  N%K'X4
M\5:E=7<MO(L21-<QKNDB0YR1_GM5-N+;?1+\V2DI)+NW^AR^H?#7Q'I]E+=&
M&WN$A&95MIQ(R#W K(T;POJ^OV]Q/IMJ9UMV19 IY!8X%>@>%;OP?X>U^._M
MO$NIW+<B2 V^1*".0?6I/#.H)9>&OB'>Z2S1QA@;<XVE5)?'T(!I.;2;\OU!
M03:7F<%XD\(:KX5^SC4UA4W )3RY W3&<^G6L"I);F:XP9II)".F]B<?G456
MK]3-VOH+1244P%HI** "BBB@04444AA11BDI@+124M !2444 %%%%.X&E2&E
MI#70< E)2TE !1WHH[T,8'I24M)2&%)2T4 A*6DI:"A*2EHI --%*>M)0 4&
MBB@84E+24#"@]**#TH ;1112&%%%%- %)2TE T%(:6DI# =:=31UIU)C0444
M4AB&B@T4 %)2TE PHHHI, HHHJ0"FFG4AH ::*#104%%&:2F M%)2BD,****
M "BBB@ I#2TAH 2BBB@84444 %%%% "4444@"BBB@!#1F@TE,:"BBB@ S1FB
MBD,6BBB@ HHI* #-&**6@!****0!1113 ****0!1110 4444 %%%%  :2E-)
M0 4444 %%%% !1113 **** "BBBD 4444 %%%% !1110 4444 %%%%, HHHH
M ****  4M)2T %%%(:!"T9I** "EI** %HI*6@ HHHH&%%%% !1110 4444
M+124"@0M%%% !1110 4444 %%%% !2TE% "T444@"@'%%%,!<T9I** #-**2
ME'2@0M%&:3- "T4E+0 4444 %%%% 6"EI,T4 +2444Q!112T %%%% "T4E%(
M0M%)10 M%)2YH *3%+FB@!**6DQ0 M%)10 M%)10 M)110 "EI*6@05W/AOX
MA'0/!VHZ&UJ\LL^XV\P8#RBRX-<+12:4DTQQ;BU)'<^"_B#_ ,(IH>IZ>UH\
M[W/S0.& $3X(S^M9?@OQ1'X7U]]2N+=[@-"\956 .6&,\US5%#BFV^^@^9V2
M[&IH>JII/B6SU5XFD2WN!,44X) .<9KIM-\>V]CXSUG76L97CU")T6(.,INQ
MU/X5PM%#BGH_3[P4VG?Y_<=;X0\76>@V.J:;J>G/>V&H*!(B/L8$9Q@_C5O1
M_&NEVEMJ&BWVE23^'KJ7S(X/,_>0'U#5PU%/E3U8U)K8[RY\6^'](T:\L/"^
MES137J[)KJZ<,P3T4=JX.BBA12!N^AWMGXNT'4?"MCHGB2PNI/[/)-O-;2;2
M0>Q%.U;QYI=[X,G\-66CO:6RRJ]LPD!(P<DOZDUP%+2<4]1J;1TWB[Q1#XEC
MTA8K9X?L-FMLVY@=Y&.12WWBJ*Z\"Z9X?2VD2:SN&F,Q88;.> /QKF**++;Y
M_J3S.]_E^AZ#+XP\.>(K&U_X2G2[F34+6,1"YMI-OFJ.@;WJIXK\;V6O>%['
M1++2S9164Y>/#@C9M( /OSDFN)HI.*'S,5<[A@X.>#7I^LZW;1VNG6_C;PV]
MW>);J;:[MYMOFQ_P[CWKR\UUFF?$;7]+L(K)7MKF&$8B%U LA0>@)[4Y*Z"+
MLSK?B)J2S?#WPOOLTLF:9I8[5>-D8R!_,?G7%>-O$T7BO6HK^&V>W5+9(=CL
M"25SSQ]:S=<\0:EXBOOM>IW!FD VJ,85!Z =A6;4J-M7WN5*71=K'?0^+O#V
MK^&].TOQ)I]T\NFJ4@EMI-NY3V(_*F:]X[T[5/!O_".6FD-9PPSB2V*N#A1U
MW>I.3S7"4J.8Y%=0"5.1D9%/E3>I*FTM#UCP!KMQH7PVUV]N8_W-NX-BS_\
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MB@ R:,FDHH 7-&3244"%R:,FDHH 7-&:2B@!<T9I**+ +FC-)12 7-&3244
M+DT9I** N+FC)I**8"Y-&3244#%R:,FDHHL N32;C124K +NHW4E% A=QHW&
MDHH&+N-&XTE% "[C1N-)10 NXT;C244 +N-&XTE% "[C1N-)24 .W4;J;10
MN:-QI** %W&C<:2B@!<T9I** %S1FDHH"XN:,TE% 7%S1FDHH 7-&:2C- PS
&1244 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>34
<FILENAME>freq-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-03-14T18:34:42.6586+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://frequencytx.com/20211231" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:freq="http://frequencytx.com/20211231" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" namespace="http://fasb.org/srt/2021-01-31"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" namespace="http://fasb.org/us-gaap/2021-01-31"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" namespace="http://xbrl.sec.gov/dei/2021q4"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" namespace="http://xbrl.sec.gov/stpr/2021"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="freq-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="freq-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="freq-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="freq-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation link" xlink:type="simple"/>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" id="Role_StatementConsolidatedBalanceSheets">
        <link:definition>100010 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationPretaxIncomeDetails2" id="DisclosureIncomeTaxesScheduleOfReconciliationPretaxIncomeDetails2">
        <link:definition>100020 - Disclosure - Income Taxes - Schedule of Reconciliation Pre-tax Income (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails2" id="DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails2">
        <link:definition>100030 - Disclosure - Leases - Schedule of Reconciles the Undiscounted Cash Flows to the Operating Lease (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" id="Role_StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>100040 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations" id="Role_StatementConsolidatedStatementsOfOperations">
        <link:definition>100050 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveLoss" id="Role_StatementConsolidatedStatementsOfComprehensiveLoss">
        <link:definition>100060 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity" id="StatementConsolidatedStatementOfStockholdersEquity">
        <link:definition>100070 - Statement - Consolidated Statement of Stockholders Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" id="Role_StatementConsolidatedStatementsOfCashFlows">
        <link:definition>100080 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganization1" id="DisclosureOrganization1">
        <link:definition>100090 - Disclosure - Organization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>100100 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurements" id="Role_DisclosureFairValueMeasurements">
        <link:definition>100110 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssets" id="DisclosurePrepaidExpensesAndOtherCurrentAssets">
        <link:definition>100120 - Disclosure - Prepaid Expenses and Other Current Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipment" id="Role_DisclosurePropertyAndEquipment">
        <link:definition>100130 - Disclosure - Property and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpenses" id="Role_DisclosureAccruedExpenses">
        <link:definition>100140 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebt" id="Role_DisclosureDebt">
        <link:definition>100150 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStock" id="Role_DisclosureConvertiblePreferredStock">
        <link:definition>100160 - Disclosure - Convertible Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterest" id="Role_DisclosureNonControllingInterest">
        <link:definition>100170 - Disclosure - Non-controlling Interest</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquity" id="Role_DisclosureStockholdersEquity">
        <link:definition>100180 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensation" id="Role_DisclosureStockBasedCompensation">
        <link:definition>100190 - Disclosure - Stock-based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlan" id="Role_DisclosureEmployeeStockPurchasePlan">
        <link:definition>100200 - Disclosure - Employee Stock Purchase Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxes" id="Role_DisclosureIncomeTaxes">
        <link:definition>100210 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreements" id="Role_DisclosureResearchAndLicenseAgreements">
        <link:definition>100220 - Disclosure - Research and License Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreement" id="Role_DisclosureCollaborationAgreement">
        <link:definition>100230 - Disclosure - Collaboration Agreement</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeases" id="DisclosureLeases">
        <link:definition>100240 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" id="Role_DisclosureCommitmentsAndContingencies">
        <link:definition>100250 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeBenefitPlan" id="Role_DisclosureEmployeeBenefitPlan">
        <link:definition>100260 - Disclosure - Employee Benefit Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureRelatedPartyTransactions" id="Role_DisclosureRelatedPartyTransactions">
        <link:definition>100270 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>100280 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>100290 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" id="Role_DisclosureFairValueMeasurementsTables">
        <link:definition>100300 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables" id="DisclosurePrepaidExpensesAndOtherCurrentAssetsTables">
        <link:definition>100310 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentTables" id="Role_DisclosurePropertyAndEquipmentTables">
        <link:definition>100320 - Disclosure - Property and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesTables" id="Role_DisclosureAccruedExpensesTables">
        <link:definition>100330 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityTables" id="Role_DisclosureStockholdersEquityTables">
        <link:definition>100340 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" id="Role_DisclosureStockBasedCompensationTables">
        <link:definition>100350 - Disclosure - Stock-based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesTables" id="Role_DisclosureIncomeTaxesTables">
        <link:definition>100360 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesTables" id="DisclosureLeasesTables">
        <link:definition>100370 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails" id="DisclosureOrganizationAdditionalInformationDetails">
        <link:definition>100380 - Disclosure - Organization - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>100390 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails">
        <link:definition>100400 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails">
        <link:definition>100410 - Disclosure - Summary of Significant Accounting Policies - Schedule of Basic And Diluted Net Loss per Share Attributable to Common Stockholders (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails">
        <link:definition>100420 - Disclosure - Summary of Significant Accounting Policies - Computation of Diluted Net Loss per Share Attributable to Common Stockholders (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails" id="Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails">
        <link:definition>100430 - Disclosure - Fair Value Measurements - Schedule of Financial Assets Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" id="DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails">
        <link:definition>100440 - Disclosure - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" id="Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails">
        <link:definition>100450 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails" id="Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails">
        <link:definition>100460 - Disclosure - Property and Equipment - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" id="Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails">
        <link:definition>100470 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails" id="Role_DisclosureDebtAdditionalInformationDetails">
        <link:definition>100480 - Disclosure - Debt - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails" id="Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails">
        <link:definition>100490 - Disclosure - Convertible Preferred Stock - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterestAdditionalInformationDetails" id="Role_DisclosureNonControllingInterestAdditionalInformationDetails">
        <link:definition>100500 - Disclosure - Non-controlling Interest - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails" id="Role_DisclosureStockholdersEquityAdditionalInformationDetails">
        <link:definition>100510 - Disclosure - Stockholders' Equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails" id="Role_DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails">
        <link:definition>100520 - Disclosure - Stockholders' Equity - Schedule of Common Stock Shares Reserved for Future Issuance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" id="Role_DisclosureStockBasedCompensationAdditionalInformationDetails">
        <link:definition>100530 - Disclosure - Stock-based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails" id="Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails">
        <link:definition>100540 - Disclosure - Stock-based Compensation - Summary of Stock Option Activity under 2014 Plan and 2019 Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfGrantDateFairValueOfStockOptionsGrantedOnWeightedAverageBasisDetails" id="Role_DisclosureStockBasedCompensationSummaryOfGrantDateFairValueOfStockOptionsGrantedOnWeightedAverageBasisDetails">
        <link:definition>100550 - Disclosure - Stock-based Compensation - Summary of Grant-date Fair Value of Stock Options Granted on Weighted Average Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails" id="Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails">
        <link:definition>100560 - Disclosure - Stock-based Compensation - Summary of Status of Restricted Common Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlanAdditionalInformationDetails" id="Role_DisclosureEmployeeStockPurchasePlanAdditionalInformationDetails">
        <link:definition>100570 - Disclosure - Employee Stock Purchase Plan - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" id="Role_DisclosureIncomeTaxesAdditionalInformationDetails">
        <link:definition>100580 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationPreTaxIncomeDetails" id="Role_DisclosureIncomeTaxesScheduleOfReconciliationPreTaxIncomeDetails">
        <link:definition>100590 - Disclosure - Income Taxes - Schedule of Reconciliation Pre-tax Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionDetails" id="Role_DisclosureIncomeTaxesScheduleOfProvisionDetails">
        <link:definition>100600 - Disclosure - Income Taxes - Schedule of Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails" id="Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails">
        <link:definition>100610 - Disclosure - Income Taxes - Schedule of Reconciliation of U.S. Federal Statutory Income Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails" id="Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails">
        <link:definition>100620 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails" id="Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails">
        <link:definition>100630 - Disclosure - Research and License Agreements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails" id="Role_DisclosureCollaborationAgreementAdditionalInformationDetails">
        <link:definition>100640 - Disclosure - Collaboration Agreement - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" id="DisclosureLeasesAdditionalInformationDetails">
        <link:definition>100650 - Disclosure - Leases - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfLeasesDetails" id="DisclosureLeasesScheduleOfLeasesDetails">
        <link:definition>100660 - Disclosure - Leases - Schedule of Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails" id="DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails">
        <link:definition>100670 - Disclosure - Leases - Schedule of Reconciles the Undiscounted Cash Flows to the Operating Lease (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails" id="DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails">
        <link:definition>100680 - Disclosure - Leases - Schedule of Future Aggregate Minimum Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" id="Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
        <link:definition>100690 - Disclosure - Commitments and Contingencies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeBenefitPlanAdditionalInformationDetails" id="Role_DisclosureEmployeeBenefitPlanAdditionalInformationDetails">
        <link:definition>100700 - Disclosure - Employee Benefit Plan - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" id="Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails">
        <link:definition>100710 - Disclosure - Related Party Transactions - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="freq_AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent" name="AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="freq_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" name="AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="freq_AdditionalFundingPaymentsMadeAsConsiderationToSupportResearchActivities" name="AdditionalFundingPaymentsMadeAsConsiderationToSupportResearchActivities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="freq_AgreementTerminationNoticePeriod" name="AgreementTerminationNoticePeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_AmountOfFundingReceivedAsGrant" name="AmountOfFundingReceivedAsGrant" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="freq_AnnualLicenseFee" name="AnnualLicenseFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="freq_AnnualLicenseFeePerShare" name="AnnualLicenseFeePerShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones" name="ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="freq_CumulativeChangeInOwnershipPercentage" name="CumulativeChangeInOwnershipPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_DebtInstrumentFloorInterestRatePercentage" name="DebtInstrumentFloorInterestRatePercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="freq_DebtInstrumentInterestOnlyPaymentMaturityDate" name="DebtInstrumentInterestOnlyPaymentMaturityDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_DebtInstrumentPrepaymentPremiumPercentage" name="DebtInstrumentPrepaymentPremiumPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_DeferredTaxAssetsLeasingArrangements" name="DeferredTaxAssetsLeasingArrangements" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="freq_DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment" name="DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="freq_DeferredTaxAssetsRightOfUseAssets" name="DeferredTaxAssetsRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="freq_DescriptionOfConditionsToTerminateLicenseAgreement" name="DescriptionOfConditionsToTerminateLicenseAgreement" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_DescriptionOfFutureDevelopmentObligations" name="DescriptionOfFutureDevelopmentObligations" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_FairValueOfTermLoan" name="FairValueOfTermLoan" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="freq_FairValueOfTermLoanIssuedTerm" name="FairValueOfTermLoanIssuedTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_FundingPaymentsMadeAsConsiderationToSupportResearchActivities" name="FundingPaymentsMadeAsConsiderationToSupportResearchActivities" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="freq_GrantTermPeriod" name="GrantTermPeriod" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" name="IncreaseDecreaseInOperatingLeaseRightOfUseAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="freq_IncreaseDecreaseInResearchAndDevelopmentExpense" name="IncreaseDecreaseInResearchAndDevelopmentExpense" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="freq_LeaseExpirationYear" name="LeaseExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_LeaseExpirationYear1" name="LeaseExpirationYear1" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_LicenseAgreementEnteredDate" name="LicenseAgreementEnteredDate" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_LicenseAgreementExtendedDate" name="LicenseAgreementExtendedDate" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_LicenseFeePayment" name="LicenseFeePayment" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="freq_LongTermAssets" name="LongTermAssets" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="freq_MilestonePayments" name="MilestonePayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="freq_NetOperatingLossCarryforwardsExpirationWithLimitation" name="NetOperatingLossCarryforwardsExpirationWithLimitation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="freq_NetOperatingLossCarryforwardsExpirationWithoutLimitation" name="NetOperatingLossCarryforwardsExpirationWithoutLimitation" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="freq_NonCashLeaseExpenses" name="NonCashLeaseExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="freq_OperatingLeaseAgreementAmendedDate" name="OperatingLeaseAgreementAmendedDate" type="xbrli:gYearMonthItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_OperatingLeaseCommencementDate" name="OperatingLeaseCommencementDate" type="xbrli:dateItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_OperatingLeaseNumberOfAdditionalExtensionTerms" name="OperatingLeaseNumberOfAdditionalExtensionTerms" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="freq_OperatingLeasesAdditionalExtensionTerm" name="OperatingLeasesAdditionalExtensionTerm" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_OperatingLeaseTerminationFee" name="OperatingLeaseTerminationFee" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="freq_OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange" name="OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="freq_OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange" name="OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="freq_OperatingLossCarryforwardsExpirationYear" name="OperatingLossCarryforwardsExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_OperatingLossCarryforwardsUsageAfterOwnershipChange" name="OperatingLossCarryforwardsUsageAfterOwnershipChange" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="freq_PercentageOfEligibleEmployeeCompensation" name="PercentageOfEligibleEmployeeCompensation" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_PercentageOfRoyaltyOnSublicenseRevenue" name="PercentageOfRoyaltyOnSublicenseRevenue" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_PercentageOfSharesOfCommonStockIssued" name="PercentageOfSharesOfCommonStockIssued" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_PercentageOfVoteOfHoldersOfPreferredStock" name="PercentageOfVoteOfHoldersOfPreferredStock" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance" name="PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_PeriodOfCumulativeChangeInOwnership" name="PeriodOfCumulativeChangeInOwnership" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_PreferredStockSharesPurchased" name="PreferredStockSharesPurchased" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_PrepaidAccountsReceivableCurrent" name="PrepaidAccountsReceivableCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="freq_PrepaidRentAndDepositsCurrent" name="PrepaidRentAndDepositsCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="freq_PrepaidResearchAndDevelopmentExpenseCurrent" name="PrepaidResearchAndDevelopmentExpenseCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="freq_RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration" name="RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="freq_RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization" name="RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="freq_RevenueRecognitionTransactionPrice" name="RevenueRecognitionTransactionPrice" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="freq_RightToTerminateAgreementIfBreachRemainsUncured" name="RightToTerminateAgreementIfBreachRemainsUncured" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_RightToTerminateAgreementIncaseOfNonpayment" name="RightToTerminateAgreementIncaseOfNonpayment" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_RightToTerminateAgreementUponPriorWrittenNotice" name="RightToTerminateAgreementUponPriorWrittenNotice" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent" name="RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_RightToTerminateLicensedPatentsUponPriorWrittenNotice" name="RightToTerminateLicensedPatentsUponPriorWrittenNotice" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_RoyaltyExpensePerShare" name="RoyaltyExpensePerShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_SalesAgentCommission" name="SalesAgentCommission" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_TaxCreditCarryforwardExpirationYear" name="TaxCreditCarryforwardExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_TermOfAgreement" name="TermOfAgreement" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_UpfrontFeeRecognizedAsRevenue" name="UpfrontFeeRecognizedAsRevenue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="freq_IncomeTaxesDisclosureLineItems" name="IncomeTaxesDisclosureLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_SummaryOfSignificantAccountingPoliciesLineItems" name="SummaryOfSignificantAccountingPoliciesLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_AREMARegionNo20LLCMember" name="AREMARegionNo20LLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_AstellasPharmaLimitedLiabilityCompanyMember" name="AstellasPharmaLimitedLiabilityCompanyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_CaliforniaInstituteForBiomedicalResearchMember" name="CaliforniaInstituteForBiomedicalResearchMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_CambridgeEnterpriseLimitedMember" name="CambridgeEnterpriseLimitedMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_ConversionOfFrequencyJapanPreferredStockMember" name="ConversionOfFrequencyJapanPreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_DelawareLimitedLiabilityCompanyMember" name="DelawareLimitedLiabilityCompanyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_FurnitureAndOfficeEquipmentMember" name="FurnitureAndOfficeEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_HaydenLLCMember" name="HaydenLLCMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_LabEquipmentMember" name="LabEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_LeasesTerminationAgreementMember" name="LeasesTerminationAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_LexingtonLeaseMember" name="LexingtonLeaseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_LexingtonMassachusettsFacilityMember" name="LexingtonMassachusettsFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_LicenseAndCollaborationAgreementMember" name="LicenseAndCollaborationAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_LoanAndSecurityAgreementMember" name="LoanAndSecurityAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_LongTermMarketableSecuritiesMember" name="LongTermMarketableSecuritiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_MassachusettsEyeAndEarMember" name="MassachusettsEyeAndEarMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_MassachusettsInstituteOfTechnologyMember" name="MassachusettsInstituteOfTechnologyMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_NonExclusivePatentLicenseAgreementMember" name="NonExclusivePatentLicenseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_OutstandingStockOptionsAsConvertedToCommonStockMember" name="OutstandingStockOptionsAsConvertedToCommonStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_OutstandingStockOptionsMember" name="OutstandingStockOptionsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_PatentLicenseAgreementMember" name="PatentLicenseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_Phase2bClinicalTrialMember" name="Phase2bClinicalTrialMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_Phase3ClinicalTrailMember" name="Phase3ClinicalTrailMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_PrepaymentOccursAfterFirstAnniversaryOfClosingDateAndOnOrPriorToSecondAnniversaryOfClosingDateMember" name="PrepaymentOccursAfterFirstAnniversaryOfClosingDateAndOnOrPriorToSecondAnniversaryOfClosingDateMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_PrepaymentOccursAfterSecondAnniversaryOfClosingDateMember" name="PrepaymentOccursAfterSecondAnniversaryOfClosingDateMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_PrepaymentOccursOnOrPriorToFirstAnniversaryOfClosingDateMember" name="PrepaymentOccursOnOrPriorToFirstAnniversaryOfClosingDateMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_ResearchAndDevelopmentMember" name="ResearchAndDevelopmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_ScrippsOptionAgreementMember" name="ScrippsOptionAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_SeriesA1ConvertiblePreferredStockMember" name="SeriesA1ConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_SeriesAConvertiblePreferredStockMember" name="SeriesAConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_SeriesAPreferredAsConvertedCommonStockMember" name="SeriesAPreferredAsConvertedCommonStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_SeriesB1ConvertiblePreferredStockMember" name="SeriesB1ConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_SeriesBConvertiblePreferredStockMember" name="SeriesBConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_SeriesBPreferredAsConvertedToCommonStockMember" name="SeriesBPreferredAsConvertedToCommonStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_SeriesCConvertiblePreferredStockMember" name="SeriesCConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_SeriesCPreferredAsConvertedToCommonStockMember" name="SeriesCPreferredAsConvertedToCommonStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_ShortTermMarketableSecuritiesMember" name="ShortTermMarketableSecuritiesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_TermLoanMember" name="TermLoanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_TwoThousandAndFourteenStockIncentivePlanMember" name="TwoThousandAndFourteenStockIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_TwoThousandAndNineteenIncentiveAwardPlanMember" name="TwoThousandAndNineteenIncentiveAwardPlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember" name="TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_UnvestedRestrictedCommonStockMember" name="UnvestedRestrictedCommonStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_UnvestedRestrictedStockUnitsMember" name="UnvestedRestrictedStockUnitsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_WoburnMassachusettsFacilityMember" name="WoburnMassachusettsFacilityMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_PatentCostsPolicyTextBlock" name="PatentCostsPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_SignificantSuppliersPolicyTextBlock" name="SignificantSuppliersPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_IncomeTaxesDisclosureTable" name="IncomeTaxesDisclosureTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_SummaryOfSignificantAccountingPoliciesTable" name="SummaryOfSignificantAccountingPoliciesTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="freq_PropertyAndEquipmentTableTextBlock" name="PropertyAndEquipmentTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock" name="ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" name="SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_EmployeeStockPurchasePlanDisclosureTextBlock" name="EmployeeStockPurchasePlanDisclosureTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_PrepaidExpensesAndOtherCurrentAssetsTextBlock" name="PrepaidExpensesAndOtherCurrentAssetsTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_ResearchAndLicenseAgreementsDisclosureTextBlock" name="ResearchAndLicenseAgreementsDisclosureTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="freq_TemporaryEquityTextBlock" name="TemporaryEquityTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>35
<FILENAME>freq-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-03-14T18:34:46.2059+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="freq-20211231.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" xlink:href="freq-20211231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:href="freq-20211231.xsd#Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations" xlink:href="freq-20211231.xsd#Role_StatementConsolidatedStatementsOfOperations" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveLoss" xlink:href="freq-20211231.xsd#Role_StatementConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity" xlink:href="freq-20211231.xsd#StatementConsolidatedStatementOfStockholdersEquity" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" xlink:href="freq-20211231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganization1" xlink:href="freq-20211231.xsd#DisclosureOrganization1" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="freq-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurements" xlink:href="freq-20211231.xsd#Role_DisclosureFairValueMeasurements" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssets" xlink:href="freq-20211231.xsd#DisclosurePrepaidExpensesAndOtherCurrentAssets" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipment" xlink:href="freq-20211231.xsd#Role_DisclosurePropertyAndEquipment" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpenses" xlink:href="freq-20211231.xsd#Role_DisclosureAccruedExpenses" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebt" xlink:href="freq-20211231.xsd#Role_DisclosureDebt" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStock" xlink:href="freq-20211231.xsd#Role_DisclosureConvertiblePreferredStock" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterest" xlink:href="freq-20211231.xsd#Role_DisclosureNonControllingInterest" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquity" xlink:href="freq-20211231.xsd#Role_DisclosureStockholdersEquity" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensation" xlink:href="freq-20211231.xsd#Role_DisclosureStockBasedCompensation" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlan" xlink:href="freq-20211231.xsd#Role_DisclosureEmployeeStockPurchasePlan" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxes" xlink:href="freq-20211231.xsd#Role_DisclosureIncomeTaxes" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreements" xlink:href="freq-20211231.xsd#Role_DisclosureResearchAndLicenseAgreements" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreement" xlink:href="freq-20211231.xsd#Role_DisclosureCollaborationAgreement" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeases" xlink:href="freq-20211231.xsd#DisclosureLeases" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:href="freq-20211231.xsd#Role_DisclosureCommitmentsAndContingencies" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeBenefitPlan" xlink:href="freq-20211231.xsd#Role_DisclosureEmployeeBenefitPlan" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureRelatedPartyTransactions" xlink:href="freq-20211231.xsd#Role_DisclosureRelatedPartyTransactions" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="freq-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:href="freq-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" xlink:href="freq-20211231.xsd#Role_DisclosureFairValueMeasurementsTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables" xlink:href="freq-20211231.xsd#DisclosurePrepaidExpensesAndOtherCurrentAssetsTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentTables" xlink:href="freq-20211231.xsd#Role_DisclosurePropertyAndEquipmentTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesTables" xlink:href="freq-20211231.xsd#Role_DisclosureAccruedExpensesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityTables" xlink:href="freq-20211231.xsd#Role_DisclosureStockholdersEquityTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" xlink:href="freq-20211231.xsd#Role_DisclosureStockBasedCompensationTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesTables" xlink:href="freq-20211231.xsd#Role_DisclosureIncomeTaxesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesTables" xlink:href="freq-20211231.xsd#DisclosureLeasesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails" xlink:href="freq-20211231.xsd#DisclosureOrganizationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails" xlink:href="freq-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails" xlink:href="freq-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" xlink:href="freq-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails" xlink:href="freq-20211231.xsd#Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" xlink:href="freq-20211231.xsd#DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:href="freq-20211231.xsd#Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:href="freq-20211231.xsd#Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureDebtAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterestAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureNonControllingInterestAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureStockholdersEquityAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails" xlink:href="freq-20211231.xsd#Role_DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails" xlink:href="freq-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfGrantDateFairValueOfStockOptionsGrantedOnWeightedAverageBasisDetails" xlink:href="freq-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfGrantDateFairValueOfStockOptionsGrantedOnWeightedAverageBasisDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails" xlink:href="freq-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlanAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureEmployeeStockPurchasePlanAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationPreTaxIncomeDetails" xlink:href="freq-20211231.xsd#Role_DisclosureIncomeTaxesScheduleOfReconciliationPreTaxIncomeDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionDetails" xlink:href="freq-20211231.xsd#Role_DisclosureIncomeTaxesScheduleOfProvisionDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails" xlink:href="freq-20211231.xsd#Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails" xlink:href="freq-20211231.xsd#Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureCollaborationAgreementAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" xlink:href="freq-20211231.xsd#DisclosureLeasesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfLeasesDetails" xlink:href="freq-20211231.xsd#DisclosureLeasesScheduleOfLeasesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails" xlink:href="freq-20211231.xsd#DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails" xlink:href="freq-20211231.xsd#DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeBenefitPlanAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureEmployeeBenefitPlanAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentAnnualReport" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityVoluntaryFilers" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="31" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityPublicFloat" order="32" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="33" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_IcfrAuditorAttestationFlag" order="34" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="35" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorName" order="36" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorFirmId" order="37" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorLocation" order="38" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermLoansFromBank" xlink:label="us-gaap_LongTermLoansFromBank"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LongTermAssets" xlink:label="freq_LongTermAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LongTermLoansFromBank" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LongTermDebtCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedCashNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="freq_LongTermAssets" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses" xlink:label="us-gaap_RealizedInvestmentGainsLosses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_InterestExpense" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_RealizedInvestmentGainsLosses" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_OtherNonoperatingExpense" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_NetIncomeLoss" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveLoss" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_13"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_14"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_NoncontrollingInterestMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_13" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding_14" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_NonCashLeaseExpenses" xlink:label="freq_NonCashLeaseExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaidInKindInterest" xlink:label="us-gaap_PaidInKindInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_5"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_InterestPaidNet" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockPlans" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="freq_NonCashLeaseExpenses" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_PaidInKindInterest" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_GainLossOnDispositionOfAssets1" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganization1" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurements" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssets" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PrepaidExpensesAndOtherCurrentAssetsTextBlock" xlink:label="freq_PrepaidExpensesAndOtherCurrentAssetsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="freq_PrepaidExpensesAndOtherCurrentAssetsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipment" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpenses" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebt" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStock" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TemporaryEquityTextBlock" xlink:label="freq_TemporaryEquityTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="freq_TemporaryEquityTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterest" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncontrollingInterestAbstract" xlink:to="us-gaap_MinorityInterestDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquity" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlan" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_EmployeeStockPurchasePlanDisclosureTextBlock" xlink:label="freq_EmployeeStockPurchasePlanDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="freq_EmployeeStockPurchasePlanDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxes" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreements" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ResearchAndLicenseAgreementsDisclosureTextBlock" xlink:label="freq_ResearchAndLicenseAgreementsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentAbstract" xlink:to="freq_ResearchAndLicenseAgreementsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreement" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeases" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeBenefitPlan" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureRelatedPartyTransactions" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SignificantSuppliersPolicyTextBlock" xlink:label="freq_SignificantSuppliersPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementAccountingPolicy" xlink:label="us-gaap_CollaborativeArrangementAccountingPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PatentCostsPolicyTextBlock" xlink:label="freq_PatentCostsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConsolidationPolicyTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_MarketableSecuritiesPolicy" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="freq_SignificantSuppliersPolicyTextBlock" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CollaborativeArrangementAccountingPolicy" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="freq_PatentCostsPolicyTextBlock" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PropertyAndEquipmentTableTextBlock" xlink:label="freq_PropertyAndEquipmentTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="freq_PropertyAndEquipmentTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:label="freq_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="freq_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock" xlink:label="freq_ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="freq_ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dei_EntityIncorporationDateOfIncorporation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SummaryOfSignificantAccountingPoliciesTable" xlink:label="freq_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LexingtonMassachusettsFacilityMember" xlink:label="freq_LexingtonMassachusettsFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201811Member" xlink:label="us-gaap_AccountingStandardsUpdate201811Member"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="freq_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201815Member" xlink:label="us-gaap_AccountingStandardsUpdate201815Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_WoburnMassachusettsFacilityMember" xlink:label="freq_WoburnMassachusettsFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201601Member" xlink:label="us-gaap_AccountingStandardsUpdate201601Member"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_FairValueOfTermLoan" xlink:label="freq_FairValueOfTermLoan"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_FairValueOfTermLoanIssuedTerm" xlink:label="freq_FairValueOfTermLoanIssuedTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member" xlink:label="us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201912Member" xlink:label="us-gaap_AccountingStandardsUpdate201912Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:label="freq_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_StatementGeographicalAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="freq_LexingtonMassachusettsFacilityMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201811Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="freq_SummaryOfSignificantAccountingPoliciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201815Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RestrictedCashNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="freq_WoburnMassachusettsFacilityMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_SummaryOfSignificantAccountingPoliciesTable" xlink:to="freq_SummaryOfSignificantAccountingPoliciesLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201601Member" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="freq_FairValueOfTermLoan" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="freq_FairValueOfTermLoanIssuedTerm" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201613Member" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201912Member" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OperatingLeaseLiability" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="freq_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SummaryOfSignificantAccountingPoliciesTable" xlink:label="freq_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="freq_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LabEquipmentMember" xlink:label="freq_LabEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_FurnitureAndOfficeEquipmentMember" xlink:label="freq_FurnitureAndOfficeEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="freq_SummaryOfSignificantAccountingPoliciesTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="freq_LabEquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_SummaryOfSignificantAccountingPoliciesTable" xlink:to="freq_SummaryOfSignificantAccountingPoliciesLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="freq_FurnitureAndOfficeEquipmentMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_UnvestedRestrictedCommonStockMember" xlink:label="freq_UnvestedRestrictedCommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_UnvestedRestrictedStockUnitsMember" xlink:label="freq_UnvestedRestrictedStockUnitsMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OutstandingStockOptionsMember" xlink:label="freq_OutstandingStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesCPreferredAsConvertedToCommonStockMember" xlink:label="freq_SeriesCPreferredAsConvertedToCommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesBPreferredAsConvertedToCommonStockMember" xlink:label="freq_SeriesBPreferredAsConvertedToCommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesAPreferredAsConvertedCommonStockMember" xlink:label="freq_SeriesAPreferredAsConvertedCommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ConversionOfFrequencyJapanPreferredStockMember" xlink:label="freq_ConversionOfFrequencyJapanPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OutstandingStockOptionsAsConvertedToCommonStockMember" xlink:label="freq_OutstandingStockOptionsAsConvertedToCommonStockMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="freq_UnvestedRestrictedCommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="freq_UnvestedRestrictedStockUnitsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="freq_OutstandingStockOptionsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="freq_SeriesCPreferredAsConvertedToCommonStockMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="freq_SeriesBPreferredAsConvertedToCommonStockMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="freq_SeriesAPreferredAsConvertedCommonStockMember" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="freq_ConversionOfFrequencyJapanPreferredStockMember" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="freq_OutstandingStockOptionsAsConvertedToCommonStockMember" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ShortTermMarketableSecuritiesMember" xlink:label="freq_ShortTermMarketableSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LongTermMarketableSecuritiesMember" xlink:label="freq_LongTermMarketableSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="freq_ShortTermMarketableSecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="freq_LongTermMarketableSecuritiesMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasurySecuritiesMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PrepaidRentAndDepositsCurrent" xlink:label="freq_PrepaidRentAndDepositsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PrepaidResearchAndDevelopmentExpenseCurrent" xlink:label="freq_PrepaidResearchAndDevelopmentExpenseCurrent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PrepaidAccountsReceivableCurrent" xlink:label="freq_PrepaidAccountsReceivableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="freq_PrepaidRentAndDepositsCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="freq_PrepaidResearchAndDevelopmentExpenseCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="freq_PrepaidAccountsReceivableCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidInsurance" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_Depreciation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" xlink:label="freq_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent" xlink:label="freq_AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="freq_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="freq_AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LoanAndSecurityAgreementMember" xlink:label="freq_LoanAndSecurityAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TermLoanMember" xlink:label="freq_TermLoanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PrepaymentOccursOnOrPriorToFirstAnniversaryOfClosingDateMember" xlink:label="freq_PrepaymentOccursOnOrPriorToFirstAnniversaryOfClosingDateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="us-gaap_DebtInstrumentPaymentTerms"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PrepaymentOccursAfterFirstAnniversaryOfClosingDateAndOnOrPriorToSecondAnniversaryOfClosingDateMember" xlink:label="freq_PrepaymentOccursAfterFirstAnniversaryOfClosingDateAndOnOrPriorToSecondAnniversaryOfClosingDateMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PrepaymentOccursAfterSecondAnniversaryOfClosingDateMember" xlink:label="freq_PrepaymentOccursAfterSecondAnniversaryOfClosingDateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DebtInstrumentInterestOnlyPaymentMaturityDate" xlink:label="freq_DebtInstrumentInterestOnlyPaymentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DebtInstrumentFloorInterestRatePercentage" xlink:label="freq_DebtInstrumentFloorInterestRatePercentage"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DebtInstrumentPrepaymentPremiumPercentage" xlink:label="freq_DebtInstrumentPrepaymentPremiumPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtInstrumentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="freq_LoanAndSecurityAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="freq_TermLoanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="freq_PrepaymentOccursOnOrPriorToFirstAnniversaryOfClosingDateMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPaymentTerms" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="freq_PrepaymentOccursAfterFirstAnniversaryOfClosingDateAndOnOrPriorToSecondAnniversaryOfClosingDateMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="freq_PrepaymentOccursAfterSecondAnniversaryOfClosingDateMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="freq_DebtInstrumentInterestOnlyPaymentMaturityDate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseDebt" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="freq_DebtInstrumentFloorInterestRatePercentage" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="freq_DebtInstrumentPrepaymentPremiumPercentage" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesAConvertiblePreferredStockMember" xlink:label="freq_SeriesAConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesBConvertiblePreferredStockMember" xlink:label="freq_SeriesBConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesCConvertiblePreferredStockMember" xlink:label="freq_SeriesCConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesA1ConvertiblePreferredStockMember" xlink:label="freq_SeriesA1ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesB1ConvertiblePreferredStockMember" xlink:label="freq_SeriesB1ConvertiblePreferredStockMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="freq_SeriesAConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="freq_SeriesBConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="freq_SeriesCConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="freq_SeriesA1ConvertiblePreferredStockMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="freq_SeriesB1ConvertiblePreferredStockMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterestAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember" xlink:label="srt_SubsidiariesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DelawareLimitedLiabilityCompanyMember" xlink:label="freq_DelawareLimitedLiabilityCompanyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesA1ConvertiblePreferredStockMember" xlink:label="freq_SeriesA1ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesB1ConvertiblePreferredStockMember" xlink:label="freq_SeriesB1ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PercentageOfVoteOfHoldersOfPreferredStock" xlink:label="freq_PercentageOfVoteOfHoldersOfPreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PreferredStockSharesPurchased" xlink:label="freq_PreferredStockSharesPurchased"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockVotingRights" xlink:label="us-gaap_PreferredStockVotingRights"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_ConsolidatedEntitiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_SubsidiariesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NoncontrollingInterestAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="freq_DelawareLimitedLiabilityCompanyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="freq_SeriesA1ConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="freq_SeriesB1ConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="freq_PercentageOfVoteOfHoldersOfPreferredStock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="dei_LegalEntityAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="freq_PreferredStockSharesPurchased" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockVotingRights" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis" xlink:label="us-gaap_DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionTypeDomain" xlink:label="us-gaap_DistributionTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareDistributionMember" xlink:label="us-gaap_ShareDistributionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SalesAgentCommission" xlink:label="freq_SalesAgentCommission"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis" xlink:to="us-gaap_DistributionTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DistributionTypeDomain" xlink:to="us-gaap_ShareDistributionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_ClassOfStockLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="freq_SalesAgentCommission" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember" xlink:label="us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_StockCompensationPlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TwoThousandAndFourteenStockIncentivePlanMember" xlink:label="freq_TwoThousandAndFourteenStockIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TwoThousandAndNineteenIncentiveAwardPlanMember" xlink:label="freq_TwoThousandAndNineteenIncentiveAwardPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance" xlink:label="freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription" xlink:label="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="freq_TwoThousandAndFourteenStockIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="freq_TwoThousandAndNineteenIncentiveAwardPlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TwoThousandAndNineteenIncentiveAwardPlanMember" xlink:label="freq_TwoThousandAndNineteenIncentiveAwardPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TwoThousandAndFourteenStockIncentivePlanMember" xlink:label="freq_TwoThousandAndFourteenStockIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember" xlink:label="freq_TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2" xlink:label="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="freq_TwoThousandAndNineteenIncentiveAwardPlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="freq_TwoThousandAndFourteenStockIncentivePlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="freq_TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_11" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfGrantDateFairValueOfStockOptionsGrantedOnWeightedAverageBasisDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlanAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PercentageOfEligibleEmployeeCompensation" xlink:label="freq_PercentageOfEligibleEmployeeCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance" xlink:label="freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="freq_PercentageOfEligibleEmployeeCompensation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_IncomeTaxesDisclosureTable" xlink:label="freq_IncomeTaxesDisclosureTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="us-gaap_InternalRevenueServiceIRSMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_IncomeTaxesDisclosureLineItems" xlink:label="freq_IncomeTaxesDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MA" xlink:label="stpr_MA"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_NetOperatingLossCarryforwardsExpirationWithLimitation" xlink:label="freq_NetOperatingLossCarryforwardsExpirationWithLimitation"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLossCarryforwardsExpirationYear" xlink:label="freq_OperatingLossCarryforwardsExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_NetOperatingLossCarryforwardsExpirationWithoutLimitation" xlink:label="freq_NetOperatingLossCarryforwardsExpirationWithoutLimitation"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TaxCreditCarryforwardExpirationYear" xlink:label="freq_TaxCreditCarryforwardExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_CumulativeChangeInOwnershipPercentage" xlink:label="freq_CumulativeChangeInOwnershipPercentage"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PeriodOfCumulativeChangeInOwnership" xlink:label="freq_PeriodOfCumulativeChangeInOwnership"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLossCarryforwardsUsageAfterOwnershipChange" xlink:label="freq_OperatingLossCarryforwardsUsageAfterOwnershipChange"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange" xlink:label="freq_OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange" xlink:label="freq_OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration" xlink:label="freq_RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="freq_IncomeTaxesDisclosureTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_InternalRevenueServiceIRSMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_MA" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureTable" xlink:to="srt_StatementGeographicalAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_NetOperatingLossCarryforwardsExpirationWithLimitation" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_OperatingLossCarryforwardsExpirationYear" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureTable" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureTable" xlink:to="srt_RangeAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_NetOperatingLossCarryforwardsExpirationWithoutLimitation" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureTable" xlink:to="freq_IncomeTaxesDisclosureLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_TaxCreditCarryforwardExpirationYear" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_CumulativeChangeInOwnershipPercentage" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_PeriodOfCumulativeChangeInOwnership" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_OperatingLossCarryforwardsUsageAfterOwnershipChange" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationPreTaxIncomeDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment" xlink:label="freq_DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DeferredTaxAssetsLeasingArrangements" xlink:label="freq_DeferredTaxAssetsLeasingArrangements"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DeferredTaxAssetsRightOfUseAssets" xlink:label="freq_DeferredTaxAssetsRightOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsOther" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="freq_DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="freq_DeferredTaxAssetsLeasingArrangements" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="freq_DeferredTaxAssetsRightOfUseAssets" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AstellasPharmaLimitedLiabilityCompanyMember" xlink:label="freq_AstellasPharmaLimitedLiabilityCompanyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_MassachusettsInstituteOfTechnologyMember" xlink:label="freq_MassachusettsInstituteOfTechnologyMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PatentLicenseAgreementMember" xlink:label="freq_PatentLicenseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LicenseAgreementEnteredDate" xlink:label="freq_LicenseAgreementEnteredDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember" xlink:label="us-gaap_RoyaltyMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_CaliforniaInstituteForBiomedicalResearchMember" xlink:label="freq_CaliforniaInstituteForBiomedicalResearchMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DescriptionOfFutureDevelopmentObligations" xlink:label="freq_DescriptionOfFutureDevelopmentObligations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantMember" xlink:label="us-gaap_GrantMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_NonExclusivePatentLicenseAgreementMember" xlink:label="freq_NonExclusivePatentLicenseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LicenseFeePayment" xlink:label="freq_LicenseFeePayment"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ResearchAndDevelopmentMember" xlink:label="freq_ResearchAndDevelopmentMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ScrippsOptionAgreementMember" xlink:label="freq_ScrippsOptionAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PercentageOfSharesOfCommonStockIssued" xlink:label="freq_PercentageOfSharesOfCommonStockIssued"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_MassachusettsEyeAndEarMember" xlink:label="freq_MassachusettsEyeAndEarMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_CambridgeEnterpriseLimitedMember" xlink:label="freq_CambridgeEnterpriseLimitedMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PercentageOfRoyaltyOnSublicenseRevenue" xlink:label="freq_PercentageOfRoyaltyOnSublicenseRevenue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RoyaltyExpensePerShare" xlink:label="freq_RoyaltyExpensePerShare"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_MilestonePayments" xlink:label="freq_MilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DescriptionOfConditionsToTerminateLicenseAgreement" xlink:label="freq_DescriptionOfConditionsToTerminateLicenseAgreement"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RightToTerminateAgreementUponPriorWrittenNotice" xlink:label="freq_RightToTerminateAgreementUponPriorWrittenNotice"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RightToTerminateAgreementIfBreachRemainsUncured" xlink:label="freq_RightToTerminateAgreementIfBreachRemainsUncured"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RightToTerminateAgreementIncaseOfNonpayment" xlink:label="freq_RightToTerminateAgreementIncaseOfNonpayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForManagementFee" xlink:label="us-gaap_PaymentForManagementFee"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RightToTerminateLicensedPatentsUponPriorWrittenNotice" xlink:label="freq_RightToTerminateLicensedPatentsUponPriorWrittenNotice"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_FundingPaymentsMadeAsConsiderationToSupportResearchActivities" xlink:label="freq_FundingPaymentsMadeAsConsiderationToSupportResearchActivities"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TermOfAgreement" xlink:label="freq_TermOfAgreement"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LicenseAgreementExtendedDate" xlink:label="freq_LicenseAgreementExtendedDate"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AdditionalFundingPaymentsMadeAsConsiderationToSupportResearchActivities" xlink:label="freq_AdditionalFundingPaymentsMadeAsConsiderationToSupportResearchActivities"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent" xlink:label="freq_RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AnnualLicenseFee" xlink:label="freq_AnnualLicenseFee"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AnnualLicenseFeePerShare" xlink:label="freq_AnnualLicenseFeePerShare"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AmountOfFundingReceivedAsGrant" xlink:label="freq_AmountOfFundingReceivedAsGrant"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_GrantTermPeriod" xlink:label="freq_GrantTermPeriod"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_IncreaseDecreaseInResearchAndDevelopmentExpense" xlink:label="freq_IncreaseDecreaseInResearchAndDevelopmentExpense"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="freq_AstellasPharmaLimitedLiabilityCompanyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentAbstract" xlink:to="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="dei_LegalEntityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="freq_MassachusettsInstituteOfTechnologyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="freq_PatentLicenseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_LicenseAgreementEnteredDate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_DirectorMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="freq_CaliforniaInstituteForBiomedicalResearchMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_DescriptionOfFutureDevelopmentObligations" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_GrantMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="freq_NonExclusivePatentLicenseAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_LicenseFeePayment" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="freq_ResearchAndDevelopmentMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="freq_ScrippsOptionAgreementMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_PercentageOfSharesOfCommonStockIssued" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="srt_CounterpartyNameAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="freq_MassachusettsEyeAndEarMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="srt_ProductOrServiceAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_EntityDomain" xlink:to="freq_CambridgeEnterpriseLimitedMember" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_PercentageOfRoyaltyOnSublicenseRevenue" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="srt_TitleOfIndividualAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="us-gaap_RoyaltyExpense" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="srt_StatementScenarioAxis" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_RoyaltyExpensePerShare" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_MilestonePayments" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_DescriptionOfConditionsToTerminateLicenseAgreement" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_RightToTerminateAgreementUponPriorWrittenNotice" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_RightToTerminateAgreementIfBreachRemainsUncured" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_RightToTerminateAgreementIncaseOfNonpayment" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="us-gaap_PaymentForManagementFee" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_RightToTerminateLicensedPatentsUponPriorWrittenNotice" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_FundingPaymentsMadeAsConsiderationToSupportResearchActivities" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_TermOfAgreement" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_LicenseAgreementExtendedDate" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_AdditionalFundingPaymentsMadeAsConsiderationToSupportResearchActivities" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_AnnualLicenseFee" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_AnnualLicenseFeePerShare" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_AmountOfFundingReceivedAsGrant" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_GrantTermPeriod" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_IncreaseDecreaseInResearchAndDevelopmentExpense" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollaborators" xlink:label="us-gaap_ProceedsFromCollaborators"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AstellasPharmaLimitedLiabilityCompanyMember" xlink:label="freq_AstellasPharmaLimitedLiabilityCompanyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_Phase2bClinicalTrialMember" xlink:label="freq_Phase2bClinicalTrialMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember" xlink:label="srt_EuropeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LicenseAndCollaborationAgreementMember" xlink:label="freq_LicenseAndCollaborationAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaMember" xlink:label="srt_AsiaMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_Phase3ClinicalTrailMember" xlink:label="freq_Phase3ClinicalTrailMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones" xlink:label="freq_ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization" xlink:label="freq_RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AgreementTerminationNoticePeriod" xlink:label="freq_AgreementTerminationNoticePeriod"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RightToTerminateAgreementIfBreachRemainsUncured" xlink:label="freq_RightToTerminateAgreementIfBreachRemainsUncured"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RightToTerminateAgreementIncaseOfNonpayment" xlink:label="freq_RightToTerminateAgreementIncaseOfNonpayment"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RevenueRecognitionTransactionPrice" xlink:label="freq_RevenueRecognitionTransactionPrice"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_UpfrontFeeRecognizedAsRevenue" xlink:label="freq_UpfrontFeeRecognizedAsRevenue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromCollaborators" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="freq_AstellasPharmaLimitedLiabilityCompanyMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="freq_Phase2bClinicalTrialMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_EuropeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="freq_LicenseAndCollaborationAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_AsiaMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="freq_Phase3ClinicalTrailMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="freq_ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="freq_RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="freq_AgreementTerminationNoticePeriod" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_StatementGeographicalAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="freq_RightToTerminateAgreementIfBreachRemainsUncured" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="freq_RightToTerminateAgreementIncaseOfNonpayment" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="freq_RevenueRecognitionTransactionPrice" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="freq_UpfrontFeeRecognizedAsRevenue" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LeasesTerminationAgreementMember" xlink:label="freq_LeasesTerminationAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AREMARegionNo20LLCMember" xlink:label="freq_AREMARegionNo20LLCMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LexingtonLeaseMember" xlink:label="freq_LexingtonLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MA" xlink:label="stpr_MA"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLeaseAgreementAmendedDate" xlink:label="freq_OperatingLeaseAgreementAmendedDate"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_HaydenLLCMember" xlink:label="freq_HaydenLLCMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLeaseTerminationFee" xlink:label="freq_OperatingLeaseTerminationFee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetRentableArea" xlink:label="us-gaap_NetRentableArea"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLeaseCommencementDate" xlink:label="freq_OperatingLeaseCommencementDate"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLeaseNumberOfAdditionalExtensionTerms" xlink:label="freq_OperatingLeaseNumberOfAdditionalExtensionTerms"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LeaseExpirationYear" xlink:label="freq_LeaseExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LeaseExpirationYear1" xlink:label="freq_LeaseExpirationYear1"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLeasesAdditionalExtensionTerm" xlink:label="freq_OperatingLeasesAdditionalExtensionTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="freq_LeasesTerminationAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="freq_AREMARegionNo20LLCMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="freq_LexingtonLeaseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_StatementGeographicalAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeLeaseDescriptionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_MA" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="freq_OperatingLeaseAgreementAmendedDate" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="freq_HaydenLLCMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LeaseExpirationDate1" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_CounterpartyNameAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="freq_OperatingLeaseTerminationFee" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LeaseContractualTermAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_NetRentableArea" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="freq_OperatingLeaseCommencementDate" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="freq_OperatingLeaseNumberOfAdditionalExtensionTerms" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="freq_LeaseExpirationYear" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="freq_LeaseExpirationYear1" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="freq_OperatingLeasesAdditionalExtensionTerm" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseExpense" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfLeasesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LexingtonMassachusettsFacilityMember" xlink:label="freq_LexingtonMassachusettsFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyLossInPeriod" xlink:label="us-gaap_LossContingencyLossInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_SegmentGeographicalDomain" xlink:to="freq_LexingtonMassachusettsFacilityMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_LesseeLeaseDescriptionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_StatementGeographicalAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_RestrictedCash" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LossContingencyLossInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LossContingencyAccrualAtCarryingValue" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeBenefitPlanAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:label="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" xlink:label="us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForManagementFee" xlink:label="us-gaap_PaymentForManagementFee"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_TitleOfIndividualAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_DirectorMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_PaymentForManagementFee" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_RelatedPartyTransactionLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>36
<FILENAME>freq-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-03-14T18:34:45.6784+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesBConvertiblePreferredStockMember" xlink:label="freq_SeriesBConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RightToTerminateLicensedPatentsUponPriorWrittenNotice" xlink:label="freq_RightToTerminateLicensedPatentsUponPriorWrittenNotice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent" xlink:label="freq_RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PrepaidAccountsReceivableCurrent" xlink:label="freq_PrepaidAccountsReceivableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesBPreferredAsConvertedToCommonStockMember" xlink:label="freq_SeriesBPreferredAsConvertedToCommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLossCarryforwardsExpirationYear" xlink:label="freq_OperatingLossCarryforwardsExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AgreementTerminationNoticePeriod" xlink:label="freq_AgreementTerminationNoticePeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareDistributionMember" xlink:label="us-gaap_ShareDistributionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesPolicy" xlink:label="us-gaap_MarketableSecuritiesPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_HaydenLLCMember" xlink:label="freq_HaydenLLCMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AnnualLicenseFee" xlink:label="freq_AnnualLicenseFee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesCPreferredAsConvertedToCommonStockMember" xlink:label="freq_SeriesCPreferredAsConvertedToCommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TermLoanMember" xlink:label="freq_TermLoanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_NonExclusivePatentLicenseAgreementMember" xlink:label="freq_NonExclusivePatentLicenseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_NonCashLeaseExpenses" xlink:label="freq_NonCashLeaseExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LeaseExpirationYear1" xlink:label="freq_LeaseExpirationYear1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockVotingRights" xlink:label="us-gaap_PreferredStockVotingRights"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLeaseNumberOfAdditionalExtensionTerms" xlink:label="freq_OperatingLeaseNumberOfAdditionalExtensionTerms"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLeaseTerminationFee" xlink:label="freq_OperatingLeaseTerminationFee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember" xlink:label="srt_EuropeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent" xlink:label="freq_AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_UnvestedRestrictedCommonStockMember" xlink:label="freq_UnvestedRestrictedCommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock" xlink:label="us-gaap_DebtDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLeasesAdditionalExtensionTerm" xlink:label="freq_OperatingLeasesAdditionalExtensionTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PrepaidRentAndDepositsCurrent" xlink:label="freq_PrepaidRentAndDepositsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember" xlink:label="us-gaap_RoyaltyMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_CumulativeChangeInOwnershipPercentage" xlink:label="freq_CumulativeChangeInOwnershipPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201912Member" xlink:label="us-gaap_AccountingStandardsUpdate201912Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract" xlink:label="us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OutstandingStockOptionsMember" xlink:label="freq_OutstandingStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MA" xlink:label="stpr_MA"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DescriptionOfFutureDevelopmentObligations" xlink:label="freq_DescriptionOfFutureDevelopmentObligations"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LicenseAgreementEnteredDate" xlink:label="freq_LicenseAgreementEnteredDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201601Member" xlink:label="us-gaap_AccountingStandardsUpdate201601Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LicenseAgreementExtendedDate" xlink:label="freq_LicenseAgreementExtendedDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_UnvestedRestrictedStockUnitsMember" xlink:label="freq_UnvestedRestrictedStockUnitsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet" xlink:label="us-gaap_InterestPaidNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DebtInstrumentFloorInterestRatePercentage" xlink:label="freq_DebtInstrumentFloorInterestRatePercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_UpfrontFeeRecognizedAsRevenue" xlink:label="freq_UpfrontFeeRecognizedAsRevenue"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AmountOfFundingReceivedAsGrant" xlink:label="freq_AmountOfFundingReceivedAsGrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ShortTermMarketableSecuritiesMember" xlink:label="freq_ShortTermMarketableSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="us-gaap_InternalRevenueServiceIRSMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLossCarryforwardsUsageAfterOwnershipChange" xlink:label="freq_OperatingLossCarryforwardsUsageAfterOwnershipChange"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_EmployeeStockPurchasePlanDisclosureTextBlock" xlink:label="freq_EmployeeStockPurchasePlanDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="freq_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PercentageOfEligibleEmployeeCompensation" xlink:label="freq_PercentageOfEligibleEmployeeCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaidInKindInterest" xlink:label="us-gaap_PaidInKindInterest"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LongTermMarketableSecuritiesMember" xlink:label="freq_LongTermMarketableSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_FurnitureAndOfficeEquipmentMember" xlink:label="freq_FurnitureAndOfficeEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SummaryOfSignificantAccountingPoliciesTable" xlink:label="freq_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesAPreferredAsConvertedCommonStockMember" xlink:label="freq_SeriesAPreferredAsConvertedCommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member" xlink:label="us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PercentageOfSharesOfCommonStockIssued" xlink:label="freq_PercentageOfSharesOfCommonStockIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_NetOperatingLossCarryforwardsExpirationWithoutLimitation" xlink:label="freq_NetOperatingLossCarryforwardsExpirationWithoutLimitation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DebtInstrumentPrepaymentPremiumPercentage" xlink:label="freq_DebtInstrumentPrepaymentPremiumPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LoanAndSecurityAgreementMember" xlink:label="freq_LoanAndSecurityAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PropertyAndEquipmentTableTextBlock" xlink:label="freq_PropertyAndEquipmentTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_FundingPaymentsMadeAsConsiderationToSupportResearchActivities" xlink:label="freq_FundingPaymentsMadeAsConsiderationToSupportResearchActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember" xlink:label="srt_SubsidiariesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_MassachusettsEyeAndEarMember" xlink:label="freq_MassachusettsEyeAndEarMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesB1ConvertiblePreferredStockMember" xlink:label="freq_SeriesB1ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TaxCreditCarryforwardExpirationYear" xlink:label="freq_TaxCreditCarryforwardExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentForeignTaxExpenseBenefit" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription" xlink:label="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PercentageOfRoyaltyOnSublicenseRevenue" xlink:label="freq_PercentageOfRoyaltyOnSublicenseRevenue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LeasesTerminationAgreementMember" xlink:label="freq_LeasesTerminationAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestAbstract" xlink:label="us-gaap_NoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RightToTerminateAgreementUponPriorWrittenNotice" xlink:label="freq_RightToTerminateAgreementUponPriorWrittenNotice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLeaseAgreementAmendedDate" xlink:label="freq_OperatingLeaseAgreementAmendedDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" xlink:label="freq_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaMember" xlink:label="srt_AsiaMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration" xlink:label="freq_RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_MassachusettsInstituteOfTechnologyMember" xlink:label="freq_MassachusettsInstituteOfTechnologyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LabEquipmentMember" xlink:label="freq_LabEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AREMARegionNo20LLCMember" xlink:label="freq_AREMARegionNo20LLCMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RightToTerminateAgreementIfBreachRemainsUncured" xlink:label="freq_RightToTerminateAgreementIfBreachRemainsUncured"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_NetOperatingLossCarryforwardsExpirationWithLimitation" xlink:label="freq_NetOperatingLossCarryforwardsExpirationWithLimitation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentAbstract" xlink:label="us-gaap_ResearchAndDevelopmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TermOfAgreement" xlink:label="freq_TermOfAgreement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201811Member" xlink:label="us-gaap_AccountingStandardsUpdate201811Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TwoThousandAndNineteenIncentiveAwardPlanMember" xlink:label="freq_TwoThousandAndNineteenIncentiveAwardPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDisclosureTextBlock" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_FairValueOfTermLoan" xlink:label="freq_FairValueOfTermLoan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermLoansFromBank" xlink:label="us-gaap_LongTermLoansFromBank"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_IncomeTaxesDisclosureLineItems" xlink:label="freq_IncomeTaxesDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LexingtonMassachusettsFacilityMember" xlink:label="freq_LexingtonMassachusettsFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ResearchAndDevelopmentMember" xlink:label="freq_ResearchAndDevelopmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AnnualLicenseFeePerShare" xlink:label="freq_AnnualLicenseFeePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment" xlink:label="freq_DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DebtInstrumentInterestOnlyPaymentMaturityDate" xlink:label="freq_DebtInstrumentInterestOnlyPaymentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_CambridgeEnterpriseLimitedMember" xlink:label="freq_CambridgeEnterpriseLimitedMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember" xlink:label="us-gaap_StockCompensationPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange" xlink:label="freq_OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RevenueRecognitionTransactionPrice" xlink:label="freq_RevenueRecognitionTransactionPrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract" xlink:label="us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_IncreaseDecreaseInResearchAndDevelopmentExpense" xlink:label="freq_IncreaseDecreaseInResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock" xlink:label="freq_ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange" xlink:label="freq_OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DelawareLimitedLiabilityCompanyMember" xlink:label="freq_DelawareLimitedLiabilityCompanyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RightToTerminateAgreementIncaseOfNonpayment" xlink:label="freq_RightToTerminateAgreementIncaseOfNonpayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PrepaidExpensesAndOtherCurrentAssetsTextBlock" xlink:label="freq_PrepaidExpensesAndOtherCurrentAssetsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesAConvertiblePreferredStockMember" xlink:label="freq_SeriesAConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_GrantTermPeriod" xlink:label="freq_GrantTermPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_IncomeTaxesDisclosureTable" xlink:label="freq_IncomeTaxesDisclosureTable"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LexingtonLeaseMember" xlink:label="freq_LexingtonLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ConversionOfFrequencyJapanPreferredStockMember" xlink:label="freq_ConversionOfFrequencyJapanPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis" xlink:label="us-gaap_DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TwoThousandAndFourteenStockIncentivePlanMember" xlink:label="freq_TwoThousandAndFourteenStockIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DeferredTaxAssetsLeasingArrangements" xlink:label="freq_DeferredTaxAssetsLeasingArrangements"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_CaliforniaInstituteForBiomedicalResearchMember" xlink:label="freq_CaliforniaInstituteForBiomedicalResearchMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TemporaryEquityTextBlock" xlink:label="freq_TemporaryEquityTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PrepaymentOccursOnOrPriorToFirstAnniversaryOfClosingDateMember" xlink:label="freq_PrepaymentOccursOnOrPriorToFirstAnniversaryOfClosingDateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RoyaltyExpensePerShare" xlink:label="freq_RoyaltyExpensePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PrepaymentOccursAfterFirstAnniversaryOfClosingDateAndOnOrPriorToSecondAnniversaryOfClosingDateMember" xlink:label="freq_PrepaymentOccursAfterFirstAnniversaryOfClosingDateAndOnOrPriorToSecondAnniversaryOfClosingDateMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLeaseCommencementDate" xlink:label="freq_OperatingLeaseCommencementDate"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_WoburnMassachusettsFacilityMember" xlink:label="freq_WoburnMassachusettsFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesCConvertiblePreferredStockMember" xlink:label="freq_SeriesCConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PrepaidResearchAndDevelopmentExpenseCurrent" xlink:label="freq_PrepaidResearchAndDevelopmentExpenseCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyLossInPeriod" xlink:label="us-gaap_LossContingencyLossInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantMember" xlink:label="us-gaap_GrantMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AstellasPharmaLimitedLiabilityCompanyMember" xlink:label="freq_AstellasPharmaLimitedLiabilityCompanyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PercentageOfVoteOfHoldersOfPreferredStock" xlink:label="freq_PercentageOfVoteOfHoldersOfPreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SignificantSuppliersPolicyTextBlock" xlink:label="freq_SignificantSuppliersPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="us-gaap_DebtInstrumentPaymentTerms"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization" xlink:label="freq_RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForManagementFee" xlink:label="us-gaap_PaymentForManagementFee"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DeferredTaxAssetsRightOfUseAssets" xlink:label="freq_DeferredTaxAssetsRightOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LicenseAndCollaborationAgreementMember" xlink:label="freq_LicenseAndCollaborationAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LicenseFeePayment" xlink:label="freq_LicenseFeePayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PrepaymentOccursAfterSecondAnniversaryOfClosingDateMember" xlink:label="freq_PrepaymentOccursAfterSecondAnniversaryOfClosingDateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PeriodOfCumulativeChangeInOwnership" xlink:label="freq_PeriodOfCumulativeChangeInOwnership"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DescriptionOfConditionsToTerminateLicenseAgreement" xlink:label="freq_DescriptionOfConditionsToTerminateLicenseAgreement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_Phase2bClinicalTrialMember" xlink:label="freq_Phase2bClinicalTrialMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember" xlink:label="freq_TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LongTermAssets" xlink:label="freq_LongTermAssets"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesA1ConvertiblePreferredStockMember" xlink:label="freq_SeriesA1ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones" xlink:label="freq_ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:label="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" xlink:label="us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2" xlink:label="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LeaseExpirationYear" xlink:label="freq_LeaseExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ScrippsOptionAgreementMember" xlink:label="freq_ScrippsOptionAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_Phase3ClinicalTrailMember" xlink:label="freq_Phase3ClinicalTrailMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201815Member" xlink:label="us-gaap_AccountingStandardsUpdate201815Member"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PatentCostsPolicyTextBlock" xlink:label="freq_PatentCostsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses" xlink:label="us-gaap_RealizedInvestmentGainsLosses"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ResearchAndLicenseAgreementsDisclosureTextBlock" xlink:label="freq_ResearchAndLicenseAgreementsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance" xlink:label="freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionTypeDomain" xlink:label="us-gaap_DistributionTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:label="freq_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SalesAgentCommission" xlink:label="freq_SalesAgentCommission"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AdditionalFundingPaymentsMadeAsConsiderationToSupportResearchActivities" xlink:label="freq_AdditionalFundingPaymentsMadeAsConsiderationToSupportResearchActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementAccountingPolicy" xlink:label="us-gaap_CollaborativeArrangementAccountingPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetRentableArea" xlink:label="us-gaap_NetRentableArea"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PatentLicenseAgreementMember" xlink:label="freq_PatentLicenseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_MilestonePayments" xlink:label="freq_MilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollaborators" xlink:label="us-gaap_ProceedsFromCollaborators"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OutstandingStockOptionsAsConvertedToCommonStockMember" xlink:label="freq_OutstandingStockOptionsAsConvertedToCommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_FairValueOfTermLoanIssuedTerm" xlink:label="freq_FairValueOfTermLoanIssuedTerm"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PreferredStockSharesPurchased" xlink:label="freq_PreferredStockSharesPurchased"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:label="freq_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Impairment, Long-Lived Asset, Held-for-Use, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment losses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Expiration Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseExpirationDate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease expiration date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options vesting period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segment Information</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesBConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series B convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesBConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series B Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesBConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesBConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series B Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating Loss Carryforwards, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioForecastMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Forecast [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioForecastMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Scenario Forecast</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, authorized shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive income loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Comprehensive Income (Loss), Net of Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RightToTerminateLicensedPatentsUponPriorWrittenNotice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Right to terminate licensed patents upon prior written notice.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RightToTerminateLicensedPatentsUponPriorWrittenNotice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right To Terminate Licensed Patents Upon Prior Written Notice</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RightToTerminateLicensedPatentsUponPriorWrittenNotice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right to terminate licensed patents upon prior written notice</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finite-Lived Intangible Assets by Major Class</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in lease liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Right to terminate agreement upon prior written notice if insolvent.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right To Terminate Agreement Upon Prior Written Notice If Insolvent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right to terminate agreement upon prior written notice if insolvent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PrepaidAccountsReceivableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid accounts receivable current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PrepaidAccountsReceivableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Accounts Receivable Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PrepaidAccountsReceivableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts receivable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesBPreferredAsConvertedToCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series B Preferred as converted to common stock member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesBPreferredAsConvertedToCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series B Preferred As Converted To Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesBPreferredAsConvertedToCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B Preferred (as converted to common stock)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLossCarryforwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating loss carryforwards expiration year.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLossCarryforwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards Expiration Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLossCarryforwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating loss carryforwards expiration year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AgreementTerminationNoticePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Agreement termination notice period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AgreementTerminationNoticePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Agreement Termination Notice Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AgreementTerminationNoticePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agreement termination notice period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockPlans_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from Employee Stock Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockPlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Stock Plans</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Prepaid Expense and Other Assets, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average fair value, Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareDistributionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Distribution Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareDistributionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Distribution [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares available for future grants</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MarketableSecuritiesPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Property, Plant, and Equipment, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementGeographicalAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.001 par value; 200,000,000 shares authorized, 34,611,213 and 33,964,000 shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Value, Issued, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Value, Issued, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Value, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Status of Restricted Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_HaydenLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Hayden LLC.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_HaydenLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Hayden L L C [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_HaydenLLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Hayden LLC</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address State Or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Reconciliation Pre-tax Income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AnnualLicenseFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Annual license fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AnnualLicenseFee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Annual License Fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AnnualLicenseFee_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual license fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Future Aggregate Minimum Payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Convertible preferred Stock, shares issued upon conversion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized loss on marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average shares of common stock outstanding-basic and diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted-average shares of common stock outstanding- basic and diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Estimated Useful Lives</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold improvements, estimated useful lives</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Legal Entity [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LegalEntityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Legal Entity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employers matching contribution</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesCPreferredAsConvertedToCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series C Preferred As Converted To Common Stock [Member].</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesCPreferredAsConvertedToCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series C Preferred As Converted To Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesCPreferredAsConvertedToCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series C Preferred (as converted to common stock)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining contractual term (in years), Options exercisable as of December 31, 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_TermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term loan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_TermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term Loan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_TermLoanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term Loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCash_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security deposit classified as restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCash_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Security deposit classified as restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCash_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCash_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Restricted Cash, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_NonExclusivePatentLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non-exclusive patent license agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_NonExclusivePatentLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non Exclusive Patent License Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_NonExclusivePatentLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-Exclusive Patent License Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-sale, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-sale, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue recognized potential development milestone payments to receive</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Related Party Transactions By Related Party [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Grant-date Fair Value of Stock Options Granted on Weighted Average Basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_NonCashLeaseExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Non cash lease expenses.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_NonCashLeaseExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Non Cash Lease Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_NonCashLeaseExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash lease expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Treasury Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Government Treasury Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LeaseExpirationYear1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease, expiration year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LeaseExpirationYear1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Expiration Year 1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LeaseExpirationYear1_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease Expiration Year 1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adopted [true false]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, adopted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockVotingRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Voting Rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockVotingRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, voting rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLeaseNumberOfAdditionalExtensionTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease number of additional extension terms.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLeaseNumberOfAdditionalExtensionTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Number Of Additional Extension Terms</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLeaseNumberOfAdditionalExtensionTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of additional lease extension terms</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLeaseTerminationFee_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease termination fee.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLeaseTerminationFee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Termination Fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLeaseTerminationFee_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment of fee to landlord</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computation of Diluted Net Loss per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_EuropeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Europe [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_EuropeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Europe</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in Private Placement, net (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock shares issued and sold</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-sale, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-sale</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Market Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument, Interest rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementScenarioAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_StatementScenarioAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Scenario</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidated Entities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalty payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued income taxes and other accrued liabilities, current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Income Taxes And Other Accrued Liabilities Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase under Employee Stock Purchase Plan (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Denominator:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_UnvestedRestrictedCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unvested Restricted Common Stock [Member].</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_UnvestedRestrictedCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unvested Restricted Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_UnvestedRestrictedCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unvested Restricted Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, immaterial effect</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash (used in) provided by investing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchases of property and equipment included in accounts payable and accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Credit Carryforward</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLeasesAdditionalExtensionTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating leases additional extension term.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLeasesAdditionalExtensionTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases Additional Extension Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLeasesAdditionalExtensionTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease extension term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of shares issued from outstanding number of shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax Credit Carryforward, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Employee-related Liabilities, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee-related Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payroll and employee related expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">General and Administrative Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Net, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Net, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Liability, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Shares, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, issued shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PrepaidRentAndDepositsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Rent and deposits.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PrepaidRentAndDepositsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Rent And Deposits Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PrepaidRentAndDepositsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rent and deposits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of shares, Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares, Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RoyaltyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalty</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_CumulativeChangeInOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cumulative change in ownership percentage.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_CumulativeChangeInOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cumulative Change In Ownership Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_CumulativeChangeInOwnershipPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cumulative change in ownership percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortization Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right of use assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other comprehensive loss:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Furniture and Fixtures [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FurnitureAndFixturesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture and Office Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss attributable to common stockholders</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Liabilities, Noncurrent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201912Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2019-12 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201912Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update 2019-12</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Legal contingencies, accruals recorded</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingency Accrual</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Loss Contingency Accrual, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Loss Contingency Accrual, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OutstandingStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OutstandingStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Outstanding Stock Options [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OutstandingStockOptionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Outstanding stock options.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_MA_lbl" xlink:role="http://www.xbrl.org/2003/role/label">MASSACHUSETTS</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="stpr_MA_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Massachusetts</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, authorized shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Deferred Income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating Lease, Liability, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Current lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: current lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DescriptionOfFutureDevelopmentObligations_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Description of future development obligations.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DescriptionOfFutureDevelopmentObligations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Description Of Future Development Obligations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DescriptionOfFutureDevelopmentObligations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of future development obligations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LicenseAgreementEnteredDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement entered date.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LicenseAgreementEnteredDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement Entered Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LicenseAgreementEnteredDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License agreement entered date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosures:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201601Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2016-01 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201601Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update 2016-01</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive securities excluded from computation of earnings per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LicenseAgreementExtendedDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement extended date.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LicenseAgreementExtendedDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Agreement Extended Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LicenseAgreementExtendedDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License agreement extended date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_UnvestedRestrictedStockUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unvested Restricted Stock Units</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_UnvestedRestrictedStockUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unvested Restricted Stock Units [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_UnvestedRestrictedStockUnitsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Unvested restricted stock units.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense, Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpenseDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest Expense, Debt, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Maturity Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loan maturity date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Loss on disposal of assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Gain (Loss) on Disposition of Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GainLossOnDispositionOfAssets1_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Gain (Loss) on Disposition of Assets, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestPaidNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effective income tax rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DebtInstrumentFloorInterestRatePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument floor interest rate percentage.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DebtInstrumentFloorInterestRatePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Floor Interest Rate Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DebtInstrumentFloorInterestRatePercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest rate floor percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net (decrease) increase in cash, cash equivalents, and restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_UpfrontFeeRecognizedAsRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Upfront fee recognized as revenue.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_UpfrontFeeRecognizedAsRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Upfront Fee Recognized As Revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_UpfrontFeeRecognizedAsRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Upfront fee recognized as revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AmountOfFundingReceivedAsGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Amount of funding received as grant.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AmountOfFundingReceivedAsGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amount Of Funding Received As Grant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AmountOfFundingReceivedAsGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amount of funding received as grant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOther_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncontrolling Interest [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-controlling Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ShortTermMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ShortTermMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short Term Marketable Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ShortTermMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Short-term marketable securities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InternalRevenueServiceIRSMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Internal Revenue Service (IRS) [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InternalRevenueServiceIRSMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Internal Revenue Service</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLossCarryforwardsUsageAfterOwnershipChange_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating Loss Carryforwards Usage After Ownership Change.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLossCarryforwardsUsageAfterOwnershipChange_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards Usage After Ownership Change</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLossCarryforwardsUsageAfterOwnershipChange_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating loss carryforwards, utilization after ownership change</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Frequency of Periodic Payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Frequency of interest-only payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_EmployeeStockPurchasePlanDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Employee stock purchase plan disclosure.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_EmployeeStockPurchasePlanDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock Purchase Plan Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_EmployeeStockPurchasePlanDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Stock Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_CounterpartyNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2022</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SummaryOfSignificantAccountingPoliciesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Private Placement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrivatePlacementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Private Placement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Face Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentFaceAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principal balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PercentageOfEligibleEmployeeCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of eligible employee compensation.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PercentageOfEligibleEmployeeCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Eligible Employee Compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PercentageOfEligibleEmployeeCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of eligible employee compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Provision</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development tax credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State and Local Jurisdiction [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaidInKindInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash interest expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaidInKindInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Paid-in-Kind Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LongTermMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LongTermMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Marketable Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LongTermMarketableSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Long term marketable securities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Income Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Costs and Accruals</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_FurnitureAndOfficeEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Furniture and office equipment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_FurnitureAndOfficeEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Furniture And Office Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_FurnitureAndOfficeEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture and Office Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Software and Software Development Costs [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Software</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss before income taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Domestic Tax Authority [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued or outstanding at December 31, 2021 and December 31, 2020, respectively</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Value, Issued, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Value, Issued, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Preferred Stock, Value, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Value, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Noncurrent lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating Lease Liability Noncurrent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease liabilities, net of current portion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Accrued Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SummaryOfSignificantAccountingPoliciesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesAPreferredAsConvertedCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A Preferred as converted to common stock member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesAPreferredAsConvertedCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A Preferred As Converted Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesAPreferredAsConvertedCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A Preferred (as converted to common stock)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201613Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2016-13 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201613Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update 2016-13</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-term Debt, Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term Debt, Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Arrangement, Contract to Perform for Others, Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining contractual term (in years), Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PercentageOfSharesOfCommonStockIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of shares of common stock issued.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PercentageOfSharesOfCommonStockIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Shares Of Common Stock Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PercentageOfSharesOfCommonStockIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of shares of common stock issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redemption of marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Sale and Maturity of Marketable Securities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Income taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total provision (benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net tax benefit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_NetOperatingLossCarryforwardsExpirationWithoutLimitation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Net operating loss carryforwards expiration without limitation.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_NetOperatingLossCarryforwardsExpirationWithoutLimitation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Operating Loss Carryforwards Expiration Without Limitation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_NetOperatingLossCarryforwardsExpirationWithoutLimitation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards without expiration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, Date of Incorporation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Date of incorporation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss per share-basic and diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic and Diluted, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic and Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share attributable to common stockholders-basic and diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DebtInstrumentPrepaymentPremiumPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument prepayment premium percentage.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DebtInstrumentPrepaymentPremiumPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Prepayment Premium Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DebtInstrumentPrepaymentPremiumPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument prepayment premium percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leases [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LoanAndSecurityAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Loan and security agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LoanAndSecurityAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loan And Security Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LoanAndSecurityAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loan Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PropertyAndEquipmentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Property and equipment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PropertyAndEquipmentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property And Equipment Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PropertyAndEquipmentTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property And Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidation, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Principles of Consolidation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Number of shares, Unvested, December 31, 2020</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Number of shares, Unvested, December 31, 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidInsurance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Insurance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidInsurance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Insurance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_FundingPaymentsMadeAsConsiderationToSupportResearchActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Funding payments made as consideration to support research activities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_FundingPaymentsMadeAsConsiderationToSupportResearchActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Funding Payments Made As Consideration To Support Research Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_FundingPaymentsMadeAsConsiderationToSupportResearchActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Funding payments as consideration to support research activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Operating Loss Carryforwards, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, outstanding shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current State and Local Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SubsidiariesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiaries [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SubsidiariesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Frequency Japan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accumulated depreciation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of shares, Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Income Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total Deferred</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_MassachusettsEyeAndEarMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Massachusetts eye and ear.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_MassachusettsEyeAndEarMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Massachusetts Eye And Ear [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_MassachusettsEyeAndEarMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">MEE</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">IPO [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">IPO</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Unrealized Loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted average exercise price, Ending balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted average exercise price, Beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operating activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesB1ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series B-1 convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesB1ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series B1 Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesB1ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B-1 Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesB1ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series B-1 Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Reconciles the Undiscounted Cash Flows to the Operating Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrealized Gain</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_TaxCreditCarryforwardExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax credit carryforward expiration year.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_TaxCreditCarryforwardExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward Expiration Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_TaxCreditCarryforwardExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credit carryforwards expiration year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock future issuance, description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Reconciliation of U.S. Federal Statutory Income Tax Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentration of Credit Risk and Off-balance Sheet Risk</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average discount rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Foreign Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentForeignTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated other comprehensive (loss) income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Other Comprehensive Income (Loss), Net of Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Address Line</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value, Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Number of shares, Ending balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Number of shares, Beginning balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based compensation arrangement by share-based payment award, award vesting description.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PercentageOfRoyaltyOnSublicenseRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of royalty on sublicense revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PercentageOfRoyaltyOnSublicenseRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage of Royalty on Sublicense Revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PercentageOfRoyaltyOnSublicenseRevenue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of royalty on sublicense revenue.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LeasesTerminationAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease termination agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LeasesTerminationAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leases Termination Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LeasesTerminationAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Termination Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of Individual [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NoncontrollingInterestAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncontrolling Interest [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RightToTerminateAgreementUponPriorWrittenNotice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Right to terminate agreement upon prior written notice.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RightToTerminateAgreementUponPriorWrittenNotice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right To Terminate Agreement Upon Prior Written Notice</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RightToTerminateAgreementUponPriorWrittenNotice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right to terminate agreement upon prior written notice</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total minimum lease payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product and Service</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred stock, net proceeds from shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lab Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLeaseAgreementAmendedDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease agreement amended date.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLeaseAgreementAmendedDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Agreement Amended Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLeaseAgreementAmendedDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease agreement amended date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Research And Development Arrangement Contract To Perform For Others [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued third-party research and development expenses current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Third Party Research And Development Expenses Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Third-party research and development expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash, cash equivalents, and restricted cash at end of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash, cash equivalents, and restricted cash at beginning of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Proceeds from Issuance of Long-term Debt, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Long-term Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from Term Loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_AsiaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asia [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_AsiaMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asia</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Remaining pre ownership change in operating loss carryforwards written off due to expiration.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Remaining Pre Ownership Change In Operating Loss Carryforwards Written Off Due To Expiration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Remaining pre ownership change in operating loss carryforwards written off due to expiration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrimeRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prime Rate [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrimeRateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prime Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address City Or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Federal, State and Local, Tax Expense (Benefit) [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_MassachusettsInstituteOfTechnologyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Massachusetts Institute of Technology.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_MassachusettsInstituteOfTechnologyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Massachusetts Institute Of Technology [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_MassachusettsInstituteOfTechnologyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">MIT</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (in years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LabEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lab equipment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LabEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lab Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LabEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lab Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transactions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from investing activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Less: amount of lease payments representing interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: amount of lease payments representing interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders&#8217; equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AREMARegionNo20LLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">ARE-MA Region No. 20, LLC.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AREMARegionNo20LLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">A R E M A Region No20 L L C [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AREMARegionNo20LLCMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ARE-MA Region No. 20, LLC</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Unrecognized Tax Benefits, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Unrecognized Tax Benefits, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RightToTerminateAgreementIfBreachRemainsUncured_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Right to terminate agreement if breach remains uncured.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RightToTerminateAgreementIfBreachRemainsUncured_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right To Terminate Agreement If Breach Remains Uncured</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RightToTerminateAgreementIfBreachRemainsUncured_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right to terminate agreement if breach remains uncured</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_NetOperatingLossCarryforwardsExpirationWithLimitation_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Net operating loss carryforwards expiration with limitation.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_NetOperatingLossCarryforwardsExpirationWithLimitation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Operating Loss Carryforwards Expiration With Limitation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_NetOperatingLossCarryforwardsExpirationWithLimitation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards expire through 2037</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Preferred Stock, Shares Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, issued shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Shares Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Shares Outstanding, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, outstanding shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred stock, outstanding shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_TermOfAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Term of agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_TermOfAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Term Of Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_TermOfAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Agreement term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Leases [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201811Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2018-11 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201811Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update 2018-11</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Deferred Tax Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_TwoThousandAndNineteenIncentiveAwardPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand and nineteen incentive award plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_TwoThousandAndNineteenIncentiveAwardPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Nineteen Incentive Award Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_TwoThousandAndNineteenIncentiveAwardPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2019 Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Noncontrolling Interest Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MinorityInterestDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-controlling Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of Long-Lived Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research Tax Credit Carryforward [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Rate [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableRateDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_FairValueOfTermLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value of term loan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_FairValueOfTermLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Of Term Loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_FairValueOfTermLoan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of term loan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermLoansFromBank_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term Loan, net of current portion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermLoansFromBank_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loans Payable to Bank, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Useful Life</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, estimated useful lives</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments Due</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total minimum lease payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of employer matching contribution</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Additional Paid in Capital, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Additional Paid in Capital, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Additional Paid in Capital, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_IncomeTaxesDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income taxes disclosure.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_IncomeTaxesDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes Disclosure [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_IncomeTaxesDisclosureLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes Disclosure [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Financial Assets Measured at Fair Value on Recurring Basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LexingtonMassachusettsFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lexington Massachusetts facility.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LexingtonMassachusettsFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lexington Massachusetts Facility [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LexingtonMassachusettsFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lexington Massachusetts facility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ResearchAndDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Research and Development.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ResearchAndDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research And Development [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ResearchAndDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AnnualLicenseFeePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Annual license fee per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AnnualLicenseFeePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Annual License Fee Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AnnualLicenseFeePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Annual License Fee Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible preferred stock, issued shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets liabilities property plant and equipment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Liabilities Property Plant And Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fixed assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transaction [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Related Party Transaction [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DebtInstrumentInterestOnlyPaymentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Debt instrument interest only payment maturity date.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DebtInstrumentInterestOnlyPaymentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument Interest Only Payment Maturity Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DebtInstrumentInterestOnlyPaymentMaturityDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Monthly interest only payments due</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_CambridgeEnterpriseLimitedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cambridge Enterprise Limited.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_CambridgeEnterpriseLimitedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cambridge Enterprise Limited [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_CambridgeEnterpriseLimitedMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cambridge</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity By Class Of Stock [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2022</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments Due, Next Twelve Months</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Lease, Description [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee Lease Description [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2027 and beyond</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments, Due Thereafter</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Depreciation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-term Purchase Commitment, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitment payments related to research</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State income taxes, net of federal benefit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockCompensationPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockCompensationPlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares Available for Future Grant Under Stock Option Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock in Private Placement, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating loss carryforwards annual usage for next each after five years and thereafter after ownership change.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards Annual Usage For Next Each After Five Years And Thereafter After Ownership Change</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating loss carryforwards, utilization after 15 years thereafter after ownership change</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other items</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Interest expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Interest Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Interest Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-sale, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RevenueRecognitionTransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Revenue recognition transaction price.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RevenueRecognitionTransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Recognition Transaction Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RevenueRecognitionTransactionPrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Transaction price allocated to single combined performance obligation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign exchange gain (loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Foreign Currency Transaction Gain (Loss), before Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Foreign currency exchange (losses) gains</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-based Payment Arrangement, Noncash Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense and Other Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Option Activity under 2014 Plan and 2019 Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RelatedPartyTransactionsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Related Party Transactions [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_IncreaseDecreaseInResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase (decrease) in research and development expenses.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_IncreaseDecreaseInResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Research And Development Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_IncreaseDecreaseInResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Decrease in research and development expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of common stock shares reserved for future issuance.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Common Stock Shares Reserved For Future Issuance Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Common Stock Shares Reserved for Future Issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Federal Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating loss carryforwards annual usage for next each five years after ownership change.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards Annual Usage For Next Each Five Years After Ownership Change</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating loss carryforwards, utilization after five years after ownership change</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DelawareLimitedLiabilityCompanyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Delaware Limited Liability Company.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DelawareLimitedLiabilityCompanyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Delaware Limited Liability Company [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DelawareLimitedLiabilityCompanyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">LLC(FT-FJ)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Term loan, current portion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-term Debt, Current Maturities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongTermDebtCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Long-term Debt, Current Maturities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RightToTerminateAgreementIncaseOfNonpayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Right to terminate agreement incase of nonpayment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RightToTerminateAgreementIncaseOfNonpayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right To Terminate Agreement Incase Of Nonpayment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RightToTerminateAgreementIncaseOfNonpayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right to terminate agreement incase of nonpayment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares, Options exercisable as of December 31, 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PrepaidExpensesAndOtherCurrentAssetsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid Expenses and Other Current Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PrepaidExpensesAndOtherCurrentAssetsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid expenses and other current assets.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PrepaidExpensesAndOtherCurrentAssetsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expenses And Other Current Assets [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets in exchange for lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average fair value, Vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 2</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Leases [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesAConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesAConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesAConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesAConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series A Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of options (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Options exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of shares, Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_GrantTermPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Grant term period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_GrantTermPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Grant Term Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_GrantTermPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grant term period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_IncomeTaxesDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Income taxes disclosure.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_IncomeTaxesDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Taxes Disclosure [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_IncomeTaxesDisclosureTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes Disclosure [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LexingtonLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lexington lease.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LexingtonLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lexington Lease [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LexingtonLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lexington Lease</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ConversionOfFrequencyJapanPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of Frequency Japan preferred stock member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ConversionOfFrequencyJapanPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion Of Frequency Japan Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ConversionOfFrequencyJapanPreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of Frequency Japan Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional-paid in Capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Distribution Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_TwoThousandAndFourteenStockIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand and fourteen stock incentive plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_TwoThousandAndFourteenStockIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand And Fourteen Stock Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_TwoThousandAndFourteenStockIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2014 Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well-known Seasoned Issuer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Well-known Seasoned Issuer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DeferredTaxAssetsLeasingArrangements_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets leasing arrangements.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DeferredTaxAssetsLeasingArrangements_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Leasing Arrangements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DeferredTaxAssetsLeasingArrangements_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Options expiration period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Income, Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Property and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_CaliforniaInstituteForBiomedicalResearchMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">California Institute for Biomedical Research.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_CaliforniaInstituteForBiomedicalResearchMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">California Institute For Biomedical Research [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_CaliforniaInstituteForBiomedicalResearchMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">CALIBR</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Arrangement, Contract to Perform for Others, Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in deferred tax asset valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, Options unvested as of December 31, 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Subsidiary Sale Of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares, Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaboration Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchase of marketable securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Marketable Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Marketable Securities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Voluntary Filers</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scenario [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ScenarioUnspecifiedDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Scenario</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money Market Funds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated by Reference [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average fair value, Awarded</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_TemporaryEquityTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_TemporaryEquityTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_TemporaryEquityTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease, description of option to extend</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Option to Extend</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PrepaymentOccursOnOrPriorToFirstAnniversaryOfClosingDateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepayment Occurs on or Prior to First Anniversary of Closing Date.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PrepaymentOccursOnOrPriorToFirstAnniversaryOfClosingDateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepayment Occurs On Or Prior To First Anniversary Of Closing Date [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PrepaymentOccursOnOrPriorToFirstAnniversaryOfClosingDateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepayment Occurs on or Prior to First Anniversary of Closing Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Percentage of employee annual compensation matched by the employer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retirement Benefits [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">AOCI Attributable to Parent [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Other Comprehensive Income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Firm Id</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm ID</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-term Debt, Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LongtermDebtTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term Debt, Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RoyaltyExpensePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Royalty expense per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RoyaltyExpensePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Royalty Expense Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RoyaltyExpensePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Royalty Expense Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PrepaymentOccursAfterFirstAnniversaryOfClosingDateAndOnOrPriorToSecondAnniversaryOfClosingDateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepayment Occurs After First Anniversary of Closing Date and On or Prior to Second Anniversary of Closing Date.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PrepaymentOccursAfterFirstAnniversaryOfClosingDateAndOnOrPriorToSecondAnniversaryOfClosingDateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepayment Occurs After First Anniversary Of Closing Date And On Or Prior To Second Anniversary Of Closing Date [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PrepaymentOccursAfterFirstAnniversaryOfClosingDateAndOnOrPriorToSecondAnniversaryOfClosingDateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepayment Occurs After First Anniversary of Closing Date and On or Prior to Second Anniversary of Closing Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLeaseCommencementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease commencement date.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLeaseCommencementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Commencement Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OperatingLeaseCommencementDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease commencement date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_WoburnMassachusettsFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Woburn Massachusetts facility.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_WoburnMassachusettsFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Woburn Massachusetts Facility [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_WoburnMassachusettsFacilityMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Woburn Massachusetts Facility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Auditor Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesCConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series C convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesCConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series C Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesCConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series C Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesCConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series C Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, authorized shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred stock, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, Options exercisable as of December 31, 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accrued Liabilities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PrepaidResearchAndDevelopmentExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepaid research and development expense current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PrepaidResearchAndDevelopmentExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Research And Development Expense Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PrepaidResearchAndDevelopmentExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest and penalties</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencyLossInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Loss Contingency, Loss in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LossContingencyLossInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Losses related to indemnification obligations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining contractual term (in years), Options unvested as of December 31, 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of stock options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Grant [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GrantMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Grant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total value of restricted stock awards, vested based on estimated fair value of stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares, Awarded</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AstellasPharmaLimitedLiabilityCompanyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Astellas pharma limited liability company.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AstellasPharmaLimitedLiabilityCompanyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Astellas Pharma Limited Liability Company [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AstellasPharmaLimitedLiabilityCompanyMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Astellas Pharma LLC</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Organization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Annual Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PercentageOfVoteOfHoldersOfPreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Percentage of vote of the holders of preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PercentageOfVoteOfHoldersOfPreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Percentage Of Vote Of Holders Of Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PercentageOfVoteOfHoldersOfPreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Voting percentage of preferred stock holder</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SignificantSuppliersPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Significant suppliers.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SignificantSuppliersPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Suppliers Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SignificantSuppliersPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant Suppliers</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Valuation Allowance, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPaymentTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Payment Terms</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPaymentTerms_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment terms, description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from financing activities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Domestic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Instrument</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign Currency</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Revenue recognition potential commercial milestone payments eligible upon successful commercialization.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue Recognition Potential Commercial Milestone Payments Eligible Upon Successful Commercialization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Potential commercial milestone payments eligible to receive upon successful commercialization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentForManagementFee_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payment for Management Fee</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentForManagementFee_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment to director</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DeferredTaxAssetsRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets right of use assets.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DeferredTaxAssetsRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Right Of Use Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DeferredTaxAssetsRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Right of use asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares, Options unvested as of December 31, 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Construction in Progress [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConstructionInProgressMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Construction in Progress</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average grant date fair value of stock options granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Retained Earnings (Accumulated Deficit), Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Retained Earnings (Accumulated Deficit), Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accumulated deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LicenseAndCollaborationAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License and collaboration agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LicenseAndCollaborationAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License And Collaboration Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LicenseAndCollaborationAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License and Collaboration Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LicenseFeePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License fee payment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LicenseFeePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Fee Payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LicenseFeePayment_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License fee payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payables and Accruals [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PrepaymentOccursAfterSecondAnniversaryOfClosingDateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Prepayment Occurs After Second Anniversary of Closing Date.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PrepaymentOccursAfterSecondAnniversaryOfClosingDateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepayment Occurs After Second Anniversary Of Closing Date [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PrepaymentOccursAfterSecondAnniversaryOfClosingDateMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepayment Occurs After Second Anniversary of Closing Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Temporary Equity [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PeriodOfCumulativeChangeInOwnership_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Period of cumulative change in ownership.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PeriodOfCumulativeChangeInOwnership_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Period Of Cumulative Change In Ownership</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PeriodOfCumulativeChangeInOwnership_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period of cumulative change in ownership</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred Stock, value per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Numerator:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net proceeds from private placements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Private Placement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from Private Placement, net of issuance costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Permanent differences</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt instrument final payment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other expense, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Nonoperating Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherNonoperatingExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Nonoperating Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DescriptionOfConditionsToTerminateLicenseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Description of conditions to terminate license agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DescriptionOfConditionsToTerminateLicenseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Description Of Conditions To Terminate License Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_DescriptionOfConditionsToTerminateLicenseAgreement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Description of conditions to terminate license agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized unvested stock options, weighted-average period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Consolidated Entities [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ConsolidatedEntitiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Consolidated Entities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_Phase2bClinicalTrialMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Phase 2b clinical trial.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_Phase2bClinicalTrialMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Phase2b Clinical Trial [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_Phase2bClinicalTrialMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Phase 2b Clinical Trial</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adoption Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, adoption date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold Improvements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of authorized shares reserved for issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average remaining lease term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Lease, Description [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee Lease Description [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Revenue from Contract with Customer, Excluding Assessed Tax, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Total revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accounts Payable, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based Compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2014 and 2019 Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Fourteen And Two Thousand Nineteen Stock Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two Thousand Fourteen And Two Thousand Nineteen Stock Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Commitments and Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value, Options unvested as of December 31, 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Present value of future lease payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Present value of future lease payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_DirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Director [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_DirectorMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dr. Langer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Gross, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Gross, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property, Plant and Equipment, Gross, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Professional fees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Public Float</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted average fair value, Unvested, December 31, 2020</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted average fair value, Unvested, December 31, 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development tax credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research And Development Arrangement Contract To Perform For Others [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LongTermAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LongTermAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long Term Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LongTermAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Long term assets.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesA1ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A-1 convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesA1ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A1 Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesA1ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A-1 Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SeriesA1ConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series A-1 Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedStockUnitsRSUMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Stock Units</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Forfeiture of restricted stock (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Restricted Stock Award, Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Contract with customer liability revenue recognized from commercialization milestones.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract With Customer Liability Revenue Recognized From Commercialization Milestones</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Revenue recognized commercialization milestone payments to receive</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum percentage of employee contribution to retirement plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Research and Development Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Contract with Customer, Liability, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue, net of current portion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Federal, State and Local, Tax Expense (Benefit), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Federal, State and Local, Tax Expense (Benefit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal and state deferred tax benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employers matching contribution vesting percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average remaining contractual term (in years), Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term2</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options granted weighted average remaining contractualterm2.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LeaseExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Lease expiration year.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LeaseExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Expiration Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_LeaseExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease, expiration year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ScrippsOptionAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Scripps option agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ScrippsOptionAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Scripps Option Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ScrippsOptionAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Scripps Option Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_Phase3ClinicalTrailMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Phase 3 clinical trail.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_Phase3ClinicalTrailMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Phase3 Clinical Trail [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_Phase3ClinicalTrailMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Phase 3 Clinical Trial</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected dividend yield</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Number of shares, Vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intangibles</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseContractualTermAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Contractual Term [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseContractualTermAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S federal statutory income tax rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders&#8217; equity:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseContractualTermDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Contractual Term [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseContractualTermDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201815Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting Standards Update 2018-15</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdate201815Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update 2018-15 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PatentCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Patent costs.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PatentCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Patent Costs Policy [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PatentCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Patent Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Basic and Diluted Net Loss per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RealizedInvestmentGainsLosses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Realized (loss) gain on investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RealizedInvestmentGainsLosses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Realized Investment Gains (Losses), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RealizedInvestmentGainsLosses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Realized Investment Gains (Losses)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ResearchAndLicenseAgreementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Research and license agreements disclosure text block.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ResearchAndLicenseAgreementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research And License Agreements Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_ResearchAndLicenseAgreementsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and License Agreements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price, Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Aggregate intrinsic value of stock options exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Period for automatic increase in common stock available for future issuance.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Period For Automatic Increase In Common Stock Available For Future Issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Period for automatic increase in common stock available for future issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Period for automatic increase in common available for future issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DistributionTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Distribution Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SoftwareDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Software Development [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SoftwareDevelopmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Software</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock compensation deductions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares of common stock reserved for future issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock, shares reserved for issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase (decrease) in operating lease right of use assets.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase Decrease In Operating Lease Right Of Use Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in right-of-use asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, sale of price per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retirement Benefits [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Benefit Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority, Name [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Tax Authority, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ICFR Auditor Attestation Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">ICFR Auditor Attestation Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SalesAgentCommission_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sales Agent commission</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SalesAgentCommission_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sales Agent Commission</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SalesAgentCommission_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Sales agent commission</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AdditionalFundingPaymentsMadeAsConsiderationToSupportResearchActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Additional funding payments made as consideration to support research activities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AdditionalFundingPaymentsMadeAsConsiderationToSupportResearchActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Funding Payments Made As Consideration To Support Research Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_AdditionalFundingPaymentsMadeAsConsiderationToSupportResearchActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional funding payments made as consideration to support research activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchase under Employee Stock Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Counterparty Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Counterparty Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementAccountingPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement, Accounting Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementAccountingPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense (in shares)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Stock by Class [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Stock By Class [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetRentableArea_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Rentable Area</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetRentableArea_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Rentable area of office space</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Product and Service</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total grant date fair value of stock options vested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred revenue</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and Cash Equivalents, at Carrying Value, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and Cash Equivalents, at Carrying Value, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, at Carrying Value, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recently Adopted Accounting Pronouncements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of Individual [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of Individual</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income (Loss) from Equity Method Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PatentLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Patent license agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PatentLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Patent License Agreement [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PatentLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Patent License Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credit carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total unrecognized stock-based compensation expense relating to unvested stock options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recurring Basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_MilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Milestone payments.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_MilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Milestone Payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_MilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Milestone payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromCollaborators_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Collaborators</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromCollaborators_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payments received under collaboration agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property Plant And Equipment [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2019 Employee Stock Purchase Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Collaborative Arrangement and Arrangement Other than Collaborative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Geographical [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_SegmentGeographicalDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Geographical</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OutstandingStockOptionsAsConvertedToCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Outstanding stock options as converted to common stock member.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OutstandingStockOptionsAsConvertedToCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Outstanding Stock Options As Converted To Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_OutstandingStockOptionsAsConvertedToCommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Outstanding Stock Options (as converted to common stock)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate intrinsic value, Options exercisable as of December 31, 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_FairValueOfTermLoanIssuedTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value of term loan issued term.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_FairValueOfTermLoanIssuedTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Of Term Loan Issued Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_FairValueOfTermLoanIssuedTerm_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of term loan issued term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PreferredStockSharesPurchased_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Preferred stock, shares purchased.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PreferredStockSharesPurchased_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock Shares Purchased</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_PreferredStockSharesPurchased_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares purchased</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Finite-Lived Intangible Assets, Major Class Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Summary of prepaid expenses and other current assets.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Summary Of Prepaid Expenses And Other Current Assets Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="freq_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Prepaid Expenses and Other Current Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net proceeds from issuance of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of common stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseExpirationDate1" xlink:to="us-gaap_LeaseExpirationDate1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_SeriesBConvertiblePreferredStockMember" xlink:to="freq_SeriesBConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioForecastMember" xlink:to="srt_ScenarioForecastMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_RightToTerminateLicensedPatentsUponPriorWrittenNotice" xlink:to="freq_RightToTerminateLicensedPatentsUponPriorWrittenNotice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent" xlink:to="freq_RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_PrepaidAccountsReceivableCurrent" xlink:to="freq_PrepaidAccountsReceivableCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_SeriesBPreferredAsConvertedToCommonStockMember" xlink:to="freq_SeriesBPreferredAsConvertedToCommonStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_OperatingLossCarryforwardsExpirationYear" xlink:to="freq_OperatingLossCarryforwardsExpirationYear_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_AgreementTerminationNoticePeriod" xlink:to="freq_AgreementTerminationNoticePeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockPlans" xlink:to="us-gaap_ProceedsFromStockPlans_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareDistributionMember" xlink:to="us-gaap_ShareDistributionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MarketableSecuritiesPolicy" xlink:to="us-gaap_MarketableSecuritiesPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_StatementGeographicalAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_HaydenLLCMember" xlink:to="freq_HaydenLLCMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_AnnualLicenseFee" xlink:to="freq_AnnualLicenseFee_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_SeriesCPreferredAsConvertedToCommonStockMember" xlink:to="freq_SeriesCPreferredAsConvertedToCommonStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_TermLoanMember" xlink:to="freq_TermLoanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCash" xlink:to="us-gaap_RestrictedCash_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_NonExclusivePatentLicenseAgreementMember" xlink:to="freq_NonExclusivePatentLicenseAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_NonCashLeaseExpenses" xlink:to="freq_NonCashLeaseExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_LeaseExpirationYear1" xlink:to="freq_LeaseExpirationYear1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockVotingRights" xlink:to="us-gaap_PreferredStockVotingRights_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_OperatingLeaseNumberOfAdditionalExtensionTerms" xlink:to="freq_OperatingLeaseNumberOfAdditionalExtensionTerms_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_OperatingLeaseTerminationFee" xlink:to="freq_OperatingLeaseTerminationFee_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_EuropeMember" xlink:to="srt_EuropeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_StatementScenarioAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_ConsolidatedEntitiesDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyExpense" xlink:to="us-gaap_RoyaltyExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent" xlink:to="freq_AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_UnvestedRestrictedCommonStockMember" xlink:to="freq_UnvestedRestrictedCommonStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureTextBlock" xlink:to="us-gaap_DebtDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_OperatingLeasesAdditionalExtensionTerm" xlink:to="freq_OperatingLeasesAdditionalExtensionTerm_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_PrepaidRentAndDepositsCurrent" xlink:to="freq_PrepaidRentAndDepositsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RoyaltyMember" xlink:to="us-gaap_RoyaltyMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_CumulativeChangeInOwnershipPercentage" xlink:to="freq_CumulativeChangeInOwnershipPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FurnitureAndFixturesMember" xlink:to="us-gaap_FurnitureAndFixturesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201912Member" xlink:to="us-gaap_AccountingStandardsUpdate201912Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="us-gaap_LossContingencyAccrualAtCarryingValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtDisclosureAbstract" xlink:to="us-gaap_DebtDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashNoncurrent" xlink:to="us-gaap_RestrictedCashNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_OutstandingStockOptionsMember" xlink:to="freq_OutstandingStockOptionsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="stpr_MA" xlink:to="stpr_MA_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_DescriptionOfFutureDevelopmentObligations" xlink:to="freq_DescriptionOfFutureDevelopmentObligations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_LicenseAgreementEnteredDate" xlink:to="freq_LicenseAgreementEnteredDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201601Member" xlink:to="us-gaap_AccountingStandardsUpdate201601Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_LicenseAgreementExtendedDate" xlink:to="freq_LicenseAgreementExtendedDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_UnvestedRestrictedStockUnitsMember" xlink:to="freq_UnvestedRestrictedStockUnitsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpenseDebt" xlink:to="us-gaap_InterestExpenseDebt_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentMaturityDate" xlink:to="us-gaap_DebtInstrumentMaturityDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnDispositionOfAssets1" xlink:to="us-gaap_GainLossOnDispositionOfAssets1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaidNet" xlink:to="us-gaap_InterestPaidNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateContinuingOperations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_DebtInstrumentFloorInterestRatePercentage" xlink:to="freq_DebtInstrumentFloorInterestRatePercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_UpfrontFeeRecognizedAsRevenue" xlink:to="freq_UpfrontFeeRecognizedAsRevenue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_AmountOfFundingReceivedAsGrant" xlink:to="freq_AmountOfFundingReceivedAsGrant_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOther" xlink:to="us-gaap_DeferredTaxAssetsOther_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_ShortTermMarketableSecuritiesMember" xlink:to="freq_ShortTermMarketableSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InternalRevenueServiceIRSMember" xlink:to="us-gaap_InternalRevenueServiceIRSMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_OperatingLossCarryforwardsUsageAfterOwnershipChange" xlink:to="freq_OperatingLossCarryforwardsUsageAfterOwnershipChange_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_EmployeeStockPurchasePlanDisclosureTextBlock" xlink:to="freq_EmployeeStockPurchasePlanDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_CounterpartyNameAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="us-gaap_DebtInstrumentNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="freq_SummaryOfSignificantAccountingPoliciesLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrivatePlacementMember" xlink:to="us-gaap_PrivatePlacementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentFaceAmount" xlink:to="us-gaap_DebtInstrumentFaceAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_PercentageOfEligibleEmployeeCompensation" xlink:to="freq_PercentageOfEligibleEmployeeCompensation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaidInKindInterest" xlink:to="us-gaap_PaidInKindInterest_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_LongTermMarketableSecuritiesMember" xlink:to="freq_LongTermMarketableSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_FurnitureAndOfficeEquipmentMember" xlink:to="freq_FurnitureAndOfficeEquipmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_SummaryOfSignificantAccountingPoliciesTable" xlink:to="freq_SummaryOfSignificantAccountingPoliciesTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_SeriesAPreferredAsConvertedCommonStockMember" xlink:to="freq_SeriesAPreferredAsConvertedCommonStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201613Member" xlink:to="us-gaap_AccountingStandardsUpdate201613Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="us-gaap_LongtermDebtTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_PercentageOfSharesOfCommonStockIssued" xlink:to="freq_PercentageOfSharesOfCommonStockIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_NetOperatingLossCarryforwardsExpirationWithoutLimitation" xlink:to="freq_NetOperatingLossCarryforwardsExpirationWithoutLimitation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationDateOfIncorporation" xlink:to="dei_EntityIncorporationDateOfIncorporation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_DebtInstrumentPrepaymentPremiumPercentage" xlink:to="freq_DebtInstrumentPrepaymentPremiumPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_LoanAndSecurityAgreementMember" xlink:to="freq_LoanAndSecurityAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_PropertyAndEquipmentTableTextBlock" xlink:to="freq_PropertyAndEquipmentTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidInsurance" xlink:to="us-gaap_PrepaidInsurance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_FundingPaymentsMadeAsConsiderationToSupportResearchActivities" xlink:to="freq_FundingPaymentsMadeAsConsiderationToSupportResearchActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_CurrentStateAndLocalTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SubsidiariesMember" xlink:to="srt_SubsidiariesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_MassachusettsEyeAndEarMember" xlink:to="freq_MassachusettsEyeAndEarMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_SeriesB1ConvertiblePreferredStockMember" xlink:to="freq_SeriesB1ConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_TaxCreditCarryforwardExpirationYear" xlink:to="freq_TaxCreditCarryforwardExpirationYear_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="us-gaap_CurrentForeignTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription" xlink:to="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_PercentageOfRoyaltyOnSublicenseRevenue" xlink:to="freq_PercentageOfRoyaltyOnSublicenseRevenue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_LeasesTerminationAgreementMember" xlink:to="freq_LeasesTerminationAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestAbstract" xlink:to="us-gaap_NoncontrollingInterestAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_RightToTerminateAgreementUponPriorWrittenNotice" xlink:to="freq_RightToTerminateAgreementUponPriorWrittenNotice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquipmentMember" xlink:to="us-gaap_EquipmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_OperatingLeaseAgreementAmendedDate" xlink:to="freq_OperatingLeaseAgreementAmendedDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" xlink:to="freq_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_AsiaMember" xlink:to="srt_AsiaMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration" xlink:to="freq_RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrimeRateMember" xlink:to="us-gaap_PrimeRateMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_MassachusettsInstituteOfTechnologyMember" xlink:to="freq_MassachusettsInstituteOfTechnologyMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_LabEquipmentMember" xlink:to="freq_LabEquipmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="us-gaap_RelatedPartyTransactionsDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_AREMARegionNo20LLCMember" xlink:to="freq_AREMARegionNo20LLCMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_RightToTerminateAgreementIfBreachRemainsUncured" xlink:to="freq_RightToTerminateAgreementIfBreachRemainsUncured_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_NetOperatingLossCarryforwardsExpirationWithLimitation" xlink:to="freq_NetOperatingLossCarryforwardsExpirationWithLimitation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentAbstract" xlink:to="us-gaap_ResearchAndDevelopmentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_TermOfAgreement" xlink:to="freq_TermOfAgreement_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201811Member" xlink:to="us-gaap_AccountingStandardsUpdate201811Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_TwoThousandAndNineteenIncentiveAwardPlanMember" xlink:to="freq_TwoThousandAndNineteenIncentiveAwardPlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDisclosureTextBlock" xlink:to="us-gaap_MinorityInterestDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchMember" xlink:to="us-gaap_ResearchMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_VariableRateDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_FairValueOfTermLoan" xlink:to="freq_FairValueOfTermLoan_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermLoansFromBank" xlink:to="us-gaap_LongTermLoansFromBank_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_IncomeTaxesDisclosureLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_LexingtonMassachusettsFacilityMember" xlink:to="freq_LexingtonMassachusettsFacilityMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_ResearchAndDevelopmentMember" xlink:to="freq_ResearchAndDevelopmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_AnnualLicenseFeePerShare" xlink:to="freq_AnnualLicenseFeePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment" xlink:to="freq_DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_RelatedPartyTransactionLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_DebtInstrumentInterestOnlyPaymentMaturityDate" xlink:to="freq_DebtInstrumentInterestOnlyPaymentMaturityDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_CambridgeEnterpriseLimitedMember" xlink:to="freq_CambridgeEnterpriseLimitedMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermPurchaseCommitmentAmount" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockCompensationPlanMember" xlink:to="us-gaap_StockCompensationPlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange" xlink:to="freq_OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestExpense" xlink:to="us-gaap_InterestExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_RevenueRecognitionTransactionPrice" xlink:to="freq_RevenueRecognitionTransactionPrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RelatedPartyTransactionsAbstract" xlink:to="us-gaap_RelatedPartyTransactionsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_IncreaseDecreaseInResearchAndDevelopmentExpense" xlink:to="freq_IncreaseDecreaseInResearchAndDevelopmentExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock" xlink:to="freq_ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange" xlink:to="freq_OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_DelawareLimitedLiabilityCompanyMember" xlink:to="freq_DelawareLimitedLiabilityCompanyMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtCurrent" xlink:to="us-gaap_LongTermDebtCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_RightToTerminateAgreementIncaseOfNonpayment" xlink:to="freq_RightToTerminateAgreementIncaseOfNonpayment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_PrepaidExpensesAndOtherCurrentAssetsTextBlock" xlink:to="freq_PrepaidExpensesAndOtherCurrentAssetsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_SeriesAConvertiblePreferredStockMember" xlink:to="freq_SeriesAConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_GrantTermPeriod" xlink:to="freq_GrantTermPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_IncomeTaxesDisclosureTable" xlink:to="freq_IncomeTaxesDisclosureTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_LexingtonLeaseMember" xlink:to="freq_LexingtonLeaseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_ConversionOfFrequencyJapanPreferredStockMember" xlink:to="freq_ConversionOfFrequencyJapanPreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis" xlink:to="us-gaap_DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_TwoThousandAndFourteenStockIncentivePlanMember" xlink:to="freq_TwoThousandAndFourteenStockIncentivePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_DeferredTaxAssetsLeasingArrangements" xlink:to="freq_DeferredTaxAssetsLeasingArrangements_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_CaliforniaInstituteForBiomedicalResearchMember" xlink:to="freq_CaliforniaInstituteForBiomedicalResearchMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiarySaleOfStockLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="us-gaap_CollaborativeArrangementDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioUnspecifiedDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_TemporaryEquityTextBlock" xlink:to="freq_TemporaryEquityTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_PrepaymentOccursOnOrPriorToFirstAnniversaryOfClosingDateMember" xlink:to="freq_PrepaymentOccursOnOrPriorToFirstAnniversaryOfClosingDateMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_RoyaltyExpensePerShare" xlink:to="freq_RoyaltyExpensePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_PrepaymentOccursAfterFirstAnniversaryOfClosingDateAndOnOrPriorToSecondAnniversaryOfClosingDateMember" xlink:to="freq_PrepaymentOccursAfterFirstAnniversaryOfClosingDateAndOnOrPriorToSecondAnniversaryOfClosingDateMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_OperatingLeaseCommencementDate" xlink:to="freq_OperatingLeaseCommencementDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_WoburnMassachusettsFacilityMember" xlink:to="freq_WoburnMassachusettsFacilityMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_SeriesCConvertiblePreferredStockMember" xlink:to="freq_SeriesCConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_PrepaidResearchAndDevelopmentExpenseCurrent" xlink:to="freq_PrepaidResearchAndDevelopmentExpenseCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LossContingencyLossInPeriod" xlink:to="us-gaap_LossContingencyLossInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GrantMember" xlink:to="us-gaap_GrantMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_AstellasPharmaLimitedLiabilityCompanyMember" xlink:to="freq_AstellasPharmaLimitedLiabilityCompanyMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_PercentageOfVoteOfHoldersOfPreferredStock" xlink:to="freq_PercentageOfVoteOfHoldersOfPreferredStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_SignificantSuppliersPolicyTextBlock" xlink:to="freq_SignificantSuppliersPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPaymentTerms" xlink:to="us-gaap_DebtInstrumentPaymentTerms_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization" xlink:to="freq_RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentForManagementFee" xlink:to="us-gaap_PaymentForManagementFee_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_DeferredTaxAssetsRightOfUseAssets" xlink:to="freq_DeferredTaxAssetsRightOfUseAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConstructionInProgressMember" xlink:to="us-gaap_ConstructionInProgressMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_LicenseAndCollaborationAgreementMember" xlink:to="freq_LicenseAndCollaborationAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_LicenseFeePayment" xlink:to="freq_LicenseFeePayment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_PrepaymentOccursAfterSecondAnniversaryOfClosingDateMember" xlink:to="freq_PrepaymentOccursAfterSecondAnniversaryOfClosingDateMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="us-gaap_TemporaryEquityDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_PeriodOfCumulativeChangeInOwnership" xlink:to="freq_PeriodOfCumulativeChangeInOwnership_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingExpense" xlink:to="us-gaap_OtherNonoperatingExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_DescriptionOfConditionsToTerminateLicenseAgreement" xlink:to="freq_DescriptionOfConditionsToTerminateLicenseAgreement_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_Phase2bClinicalTrialMember" xlink:to="freq_Phase2bClinicalTrialMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember" xlink:to="freq_TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_DirectorMember" xlink:to="srt_DirectorMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="us-gaap_FairValueOfFinancialInstrumentsPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_LongTermAssets" xlink:to="freq_LongTermAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_SeriesA1ConvertiblePreferredStockMember" xlink:to="freq_SeriesA1ConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockUnitsRSUMember" xlink:to="us-gaap_RestrictedStockUnitsRSUMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones" xlink:to="freq_ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredForeignIncomeTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage" xlink:to="us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2" xlink:to="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_LeaseExpirationYear" xlink:to="freq_LeaseExpirationYear_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_ScrippsOptionAgreementMember" xlink:to="freq_ScrippsOptionAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_Phase3ClinicalTrailMember" xlink:to="freq_Phase3ClinicalTrailMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="us-gaap_LeaseContractualTermDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdate201815Member" xlink:to="us-gaap_AccountingStandardsUpdate201815Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_PatentCostsPolicyTextBlock" xlink:to="freq_PatentCostsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RealizedInvestmentGainsLosses" xlink:to="us-gaap_RealizedInvestmentGainsLosses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_ResearchAndLicenseAgreementsDisclosureTextBlock" xlink:to="freq_ResearchAndLicenseAgreementsDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance" xlink:to="freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DistributionTypeDomain" xlink:to="us-gaap_DistributionTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareDevelopmentMember" xlink:to="us-gaap_SoftwareDevelopmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:to="freq_IncreaseDecreaseInOperatingLeaseRightOfUseAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_SalesAgentCommission" xlink:to="freq_SalesAgentCommission_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_AdditionalFundingPaymentsMadeAsConsiderationToSupportResearchActivities" xlink:to="freq_AdditionalFundingPaymentsMadeAsConsiderationToSupportResearchActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementAccountingPolicy" xlink:to="us-gaap_CollaborativeArrangementAccountingPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetRentableArea" xlink:to="us-gaap_NetRentableArea_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromEquityMethodInvestments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_PatentLicenseAgreementMember" xlink:to="freq_PatentLicenseAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAmount" xlink:to="us-gaap_TaxCreditCarryforwardAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_MilestonePayments" xlink:to="freq_MilestonePayments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromCollaborators" xlink:to="us-gaap_ProceedsFromCollaborators_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockMember" xlink:to="us-gaap_EmployeeStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_SegmentGeographicalDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_OutstandingStockOptionsAsConvertedToCommonStockMember" xlink:to="freq_OutstandingStockOptionsAsConvertedToCommonStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_FairValueOfTermLoanIssuedTerm" xlink:to="freq_FairValueOfTermLoanIssuedTerm_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_PreferredStockSharesPurchased" xlink:to="freq_PreferredStockSharesPurchased_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="freq_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock" xlink:to="freq_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>37
<FILENAME>freq-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-03-14T18:34:46.5912+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets" xlink:href="freq-20211231.xsd#Role_StatementConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationPretaxIncomeDetails2" xlink:href="freq-20211231.xsd#DisclosureIncomeTaxesScheduleOfReconciliationPretaxIncomeDetails2" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails2" xlink:href="freq-20211231.xsd#DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails2" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations" xlink:href="freq-20211231.xsd#Role_StatementConsolidatedStatementsOfOperations" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveLoss" xlink:href="freq-20211231.xsd#Role_StatementConsolidatedStatementsOfComprehensiveLoss" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows" xlink:href="freq-20211231.xsd#Role_StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails" xlink:href="freq-20211231.xsd#Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" xlink:href="freq-20211231.xsd#DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:href="freq-20211231.xsd#Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:href="freq-20211231.xsd#Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionDetails" xlink:href="freq-20211231.xsd#Role_DisclosureIncomeTaxesScheduleOfProvisionDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails" xlink:href="freq-20211231.xsd#Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails" xlink:href="freq-20211231.xsd#Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails" xlink:href="freq-20211231.xsd#DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails" xlink:href="freq-20211231.xsd#DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails" xlink:type="simple"/>
  <link:calculationLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_PreferredStockValue" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_CommonStockValue" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_ContractWithCustomerLiabilityNoncurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_AdditionalPaidInCapital" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_ContractWithCustomerLiabilityCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LongTermLoansFromBank" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_RestrictedCashNoncurrent" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LongTermDebtCurrent" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="freq_LongTermAssets" order="5" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent" xlink:label="us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermLoansFromBank" xlink:label="us-gaap_LongTermLoansFromBank"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_LongTermDebtCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LongTermAssets" xlink:label="freq_LongTermAssets"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationPretaxIncomeDetails2">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails2">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OperatingIncomeLoss" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_InvestmentIncomeInterest" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_IncomeTaxExpenseBenefit" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_InterestExpense" order="2" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_RealizedInvestmentGainsLosses" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_OtherNonoperatingExpense" order="5" weight="-1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_InterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RealizedInvestmentGainsLosses" xlink:label="us-gaap_RealizedInvestmentGainsLosses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingExpense" xlink:label="us-gaap_OtherNonoperatingExpense"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveLoss">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLoss" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockPlans" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_Depreciation" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="freq_NonCashLeaseExpenses" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfLongTermDebt" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_PaidInKindInterest" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_GainLossOnDispositionOfAssets1" order="5" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="6" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable" order="7" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInContractWithCustomerLiability" order="8" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities" order="9" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_NonCashLeaseExpenses" xlink:label="freq_NonCashLeaseExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaidInKindInterest" xlink:label="us-gaap_PaidInKindInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:label="us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="2" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="freq_PrepaidRentAndDepositsCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="freq_PrepaidResearchAndDevelopmentExpenseCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="freq_PrepaidAccountsReceivableCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidInsurance" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent" order="6" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PrepaidRentAndDepositsCurrent" xlink:label="freq_PrepaidRentAndDepositsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PrepaidResearchAndDevelopmentExpenseCurrent" xlink:label="freq_PrepaidResearchAndDevelopmentExpenseCurrent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PrepaidAccountsReceivableCurrent" xlink:label="freq_PrepaidAccountsReceivableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidInsurance" xlink:label="us-gaap_PrepaidInsurance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" weight="-1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="freq_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="freq_AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent" order="3" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent" xlink:label="freq_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent" xlink:label="freq_AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentIncomeTaxExpenseBenefit" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit" order="0" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:label="us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" order="5" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="6" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:label="us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome" order="5" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOther" order="6" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="freq_DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment" order="7" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="freq_DeferredTaxAssetsLeasingArrangements" order="8" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="freq_DeferredTaxAssetsRightOfUseAssets" order="9" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:label="us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="us-gaap_DeferredTaxAssetsOther"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment" xlink:label="freq_DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DeferredTaxAssetsLeasingArrangements" xlink:label="freq_DeferredTaxAssetsLeasingArrangements"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DeferredTaxAssetsRightOfUseAssets" xlink:label="freq_DeferredTaxAssetsRightOfUseAssets"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="5" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" order="5" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>38
<FILENAME>freq-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-03-14T18:34:46.4256+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity" xlink:href="freq-20211231.xsd#StatementConsolidatedStatementOfStockholdersEquity" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" xlink:href="freq-20211231.xsd#Role_DisclosureStockBasedCompensationTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails" xlink:href="freq-20211231.xsd#DisclosureOrganizationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails" xlink:href="freq-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" xlink:href="freq-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails" xlink:href="freq-20211231.xsd#Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:href="freq-20211231.xsd#Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureDebtAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterestAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureNonControllingInterestAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureStockholdersEquityAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails" xlink:href="freq-20211231.xsd#Role_DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails" xlink:href="freq-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails" xlink:href="freq-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlanAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureEmployeeStockPurchasePlanAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureCollaborationAgreementAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails" xlink:href="freq-20211231.xsd#DisclosureLeasesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:href="freq-20211231.xsd#Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails" xlink:type="simple"/>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" xlink:label="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:label="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:label="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" xlink:label="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_NoncontrollingInterestMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems" xlink:label="us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="dei_EntityIncorporationDateOfIncorporation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="freq_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SummaryOfSignificantAccountingPoliciesTable" xlink:label="freq_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LexingtonMassachusettsFacilityMember" xlink:label="freq_LexingtonMassachusettsFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201811Member" xlink:label="us-gaap_AccountingStandardsUpdate201811Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201815Member" xlink:label="us-gaap_AccountingStandardsUpdate201815Member"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_WoburnMassachusettsFacilityMember" xlink:label="freq_WoburnMassachusettsFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashNoncurrent" xlink:label="us-gaap_RestrictedCashNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201601Member" xlink:label="us-gaap_AccountingStandardsUpdate201601Member"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_FairValueOfTermLoan" xlink:label="freq_FairValueOfTermLoan"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201613Member" xlink:label="us-gaap_AccountingStandardsUpdate201613Member"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_FairValueOfTermLoanIssuedTerm" xlink:label="freq_FairValueOfTermLoanIssuedTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201912Member" xlink:label="us-gaap_AccountingStandardsUpdate201912Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:label="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" xlink:label="freq_IncreaseDecreaseInOperatingLeaseRightOfUseAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="freq_SummaryOfSignificantAccountingPoliciesTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="freq_SummaryOfSignificantAccountingPoliciesTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="freq_LexingtonMassachusettsFacilityMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201811Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201815Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="freq_WoburnMassachusettsFacilityMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="freq_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_RestrictedCashNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201601Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="freq_FairValueOfTermLoan" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201613Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="freq_FairValueOfTermLoanIssuedTerm" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201912Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_OperatingLeaseLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="freq_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails">
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:label="freq_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SummaryOfSignificantAccountingPoliciesTable" xlink:label="freq_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LabEquipmentMember" xlink:label="freq_LabEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareDevelopmentMember" xlink:label="us-gaap_SoftwareDevelopmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_FurnitureAndOfficeEquipmentMember" xlink:label="freq_FurnitureAndOfficeEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="freq_SummaryOfSignificantAccountingPoliciesTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="freq_SummaryOfSignificantAccountingPoliciesTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="freq_LabEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareDevelopmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="freq_FurnitureAndOfficeEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_UnvestedRestrictedCommonStockMember" xlink:label="freq_UnvestedRestrictedCommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_UnvestedRestrictedStockUnitsMember" xlink:label="freq_UnvestedRestrictedStockUnitsMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OutstandingStockOptionsMember" xlink:label="freq_OutstandingStockOptionsMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesCPreferredAsConvertedToCommonStockMember" xlink:label="freq_SeriesCPreferredAsConvertedToCommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesBPreferredAsConvertedToCommonStockMember" xlink:label="freq_SeriesBPreferredAsConvertedToCommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesAPreferredAsConvertedCommonStockMember" xlink:label="freq_SeriesAPreferredAsConvertedCommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ConversionOfFrequencyJapanPreferredStockMember" xlink:label="freq_ConversionOfFrequencyJapanPreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OutstandingStockOptionsAsConvertedToCommonStockMember" xlink:label="freq_OutstandingStockOptionsAsConvertedToCommonStockMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="freq_UnvestedRestrictedCommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="freq_UnvestedRestrictedStockUnitsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="freq_OutstandingStockOptionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="freq_SeriesCPreferredAsConvertedToCommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="freq_SeriesBPreferredAsConvertedToCommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="freq_SeriesAPreferredAsConvertedCommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="freq_ConversionOfFrequencyJapanPreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="freq_OutstandingStockOptionsAsConvertedToCommonStockMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ShortTermMarketableSecuritiesMember" xlink:label="freq_ShortTermMarketableSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LongTermMarketableSecuritiesMember" xlink:label="freq_LongTermMarketableSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="freq_ShortTermMarketableSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="freq_LongTermMarketableSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_USTreasurySecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember" xlink:label="us-gaap_EquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember" xlink:label="us-gaap_FurnitureAndFixturesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConstructionInProgressMember" xlink:label="us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_EquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_FurnitureAndFixturesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ConstructionInProgressMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems" xlink:label="us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable" xlink:label="us-gaap_DebtInstrumentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LoanAndSecurityAgreementMember" xlink:label="freq_LoanAndSecurityAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis" xlink:label="us-gaap_LongtermDebtTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain" xlink:label="us-gaap_LongtermDebtTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TermLoanMember" xlink:label="freq_TermLoanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis" xlink:label="us-gaap_VariableRateAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain" xlink:label="us-gaap_VariableRateDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrimeRateMember" xlink:label="us-gaap_PrimeRateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis" xlink:label="us-gaap_DebtInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain" xlink:label="us-gaap_DebtInstrumentNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PrepaymentOccursOnOrPriorToFirstAnniversaryOfClosingDateMember" xlink:label="freq_PrepaymentOccursOnOrPriorToFirstAnniversaryOfClosingDateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount" xlink:label="us-gaap_DebtInstrumentFaceAmount"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PrepaymentOccursAfterFirstAnniversaryOfClosingDateAndOnOrPriorToSecondAnniversaryOfClosingDateMember" xlink:label="freq_PrepaymentOccursAfterFirstAnniversaryOfClosingDateAndOnOrPriorToSecondAnniversaryOfClosingDateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPaymentTerms" xlink:label="us-gaap_DebtInstrumentPaymentTerms"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PrepaymentOccursAfterSecondAnniversaryOfClosingDateMember" xlink:label="freq_PrepaymentOccursAfterSecondAnniversaryOfClosingDateMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" xlink:label="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DebtInstrumentInterestOnlyPaymentMaturityDate" xlink:label="freq_DebtInstrumentInterestOnlyPaymentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentMaturityDate" xlink:label="us-gaap_DebtInstrumentMaturityDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:label="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt" xlink:label="us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DebtInstrumentFloorInterestRatePercentage" xlink:label="freq_DebtInstrumentFloorInterestRatePercentage"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DebtInstrumentPrepaymentPremiumPercentage" xlink:label="freq_DebtInstrumentPrepaymentPremiumPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" xlink:label="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="freq_LoanAndSecurityAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LongtermDebtTypeAxis" xlink:to="us-gaap_LongtermDebtTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LongtermDebtTypeDomain" xlink:to="freq_TermLoanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VariableRateAxis" xlink:to="us-gaap_VariableRateDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VariableRateDomain" xlink:to="us-gaap_PrimeRateMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DebtInstrumentAxis" xlink:to="us-gaap_DebtInstrumentNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="freq_PrepaymentOccursOnOrPriorToFirstAnniversaryOfClosingDateMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFaceAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_LongtermDebtTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="freq_PrepaymentOccursAfterFirstAnniversaryOfClosingDateAndOnOrPriorToSecondAnniversaryOfClosingDateMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPaymentTerms" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_VariableRateAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentNameDomain" xlink:to="freq_PrepaymentOccursAfterSecondAnniversaryOfClosingDateMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentFrequencyOfPeriodicPayment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtInstrumentTable" xlink:to="us-gaap_DebtInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="freq_DebtInstrumentInterestOnlyPaymentMaturityDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentMaturityDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_InterestExpenseDebt" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="freq_DebtInstrumentFloorInterestRatePercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="freq_DebtInstrumentPrepaymentPremiumPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DebtInstrumentLineItems" xlink:to="us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems" xlink:label="us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable" xlink:label="us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesAConvertiblePreferredStockMember" xlink:label="freq_SeriesAConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesBConvertiblePreferredStockMember" xlink:label="freq_SeriesBConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesCConvertiblePreferredStockMember" xlink:label="freq_SeriesCConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesA1ConvertiblePreferredStockMember" xlink:label="freq_SeriesA1ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesB1ConvertiblePreferredStockMember" xlink:label="freq_SeriesB1ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityByClassOfStockTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="freq_SeriesAConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="freq_SeriesBConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="freq_SeriesCConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TemporaryEquityLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="freq_SeriesA1ConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="freq_SeriesB1ConvertiblePreferredStockMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterestAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis" xlink:label="srt_ConsolidatedEntitiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain" xlink:label="srt_ConsolidatedEntitiesDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember" xlink:label="srt_SubsidiariesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesA1ConvertiblePreferredStockMember" xlink:label="freq_SeriesA1ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DelawareLimitedLiabilityCompanyMember" xlink:label="freq_DelawareLimitedLiabilityCompanyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SeriesB1ConvertiblePreferredStockMember" xlink:label="freq_SeriesB1ConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PercentageOfVoteOfHoldersOfPreferredStock" xlink:label="freq_PercentageOfVoteOfHoldersOfPreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PreferredStockSharesPurchased" xlink:label="freq_PreferredStockSharesPurchased"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockVotingRights" xlink:label="us-gaap_PreferredStockVotingRights"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_ConsolidatedEntitiesAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ConsolidatedEntitiesAxis" xlink:to="srt_ConsolidatedEntitiesDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ConsolidatedEntitiesDomain" xlink:to="srt_SubsidiariesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="freq_SeriesA1ConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="freq_DelawareLimitedLiabilityCompanyMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="freq_SeriesB1ConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="freq_PercentageOfVoteOfHoldersOfPreferredStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="freq_PreferredStockSharesPurchased" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockVotingRights" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:label="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis" xlink:label="us-gaap_DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionTypeDomain" xlink:label="us-gaap_DistributionTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionTypeDomain" xlink:label="us-gaap_DistributionTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareDistributionMember" xlink:label="us-gaap_ShareDistributionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrivatePlacementMember" xlink:label="us-gaap_PrivatePlacementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_SalesAgentCommission" xlink:label="freq_SalesAgentCommission"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:label="us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis" xlink:to="us-gaap_DistributionTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis" xlink:to="us-gaap_DistributionTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_DistributionTypeDomain" xlink:to="us-gaap_ShareDistributionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_PrivatePlacementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="us-gaap_DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="freq_SalesAgentCommission" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfPrivatePlacement" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockCompensationPlanMember" xlink:label="us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_StockCompensationPlanMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TwoThousandAndFourteenStockIncentivePlanMember" xlink:label="freq_TwoThousandAndFourteenStockIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TwoThousandAndNineteenIncentiveAwardPlanMember" xlink:label="freq_TwoThousandAndNineteenIncentiveAwardPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance" xlink:label="freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription" xlink:label="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="freq_TwoThousandAndFourteenStockIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="freq_TwoThousandAndNineteenIncentiveAwardPlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TwoThousandAndNineteenIncentiveAwardPlanMember" xlink:label="freq_TwoThousandAndNineteenIncentiveAwardPlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TwoThousandAndFourteenStockIncentivePlanMember" xlink:label="freq_TwoThousandAndFourteenStockIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember" xlink:label="freq_TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2" xlink:label="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="freq_TwoThousandAndNineteenIncentiveAwardPlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="freq_TwoThousandAndFourteenStockIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="freq_TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember" xlink:label="us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_RestrictedStockUnitsRSUMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlanAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember" xlink:label="us-gaap_EmployeeStockMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PercentageOfEligibleEmployeeCompensation" xlink:label="freq_PercentageOfEligibleEmployeeCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:label="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance" xlink:label="freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_EmployeeStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="freq_PercentageOfEligibleEmployeeCompensation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_IncomeTaxesDisclosureLineItems" xlink:label="freq_IncomeTaxesDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_IncomeTaxesDisclosureTable" xlink:label="freq_IncomeTaxesDisclosureTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MA" xlink:label="stpr_MA"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis" xlink:label="us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain" xlink:label="us-gaap_IncomeTaxAuthorityNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember" xlink:label="us-gaap_InternalRevenueServiceIRSMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_NetOperatingLossCarryforwardsExpirationWithLimitation" xlink:label="freq_NetOperatingLossCarryforwardsExpirationWithLimitation"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLossCarryforwardsExpirationYear" xlink:label="freq_OperatingLossCarryforwardsExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_NetOperatingLossCarryforwardsExpirationWithoutLimitation" xlink:label="freq_NetOperatingLossCarryforwardsExpirationWithoutLimitation"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TaxCreditCarryforwardExpirationYear" xlink:label="freq_TaxCreditCarryforwardExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAmount" xlink:label="us-gaap_TaxCreditCarryforwardAmount"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_CumulativeChangeInOwnershipPercentage" xlink:label="freq_CumulativeChangeInOwnershipPercentage"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PeriodOfCumulativeChangeInOwnership" xlink:label="freq_PeriodOfCumulativeChangeInOwnership"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLossCarryforwardsUsageAfterOwnershipChange" xlink:label="freq_OperatingLossCarryforwardsUsageAfterOwnershipChange"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange" xlink:label="freq_OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange" xlink:label="freq_OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration" xlink:label="freq_RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_IncomeTaxesDisclosureTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="freq_IncomeTaxesDisclosureTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_MA" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="us-gaap_IncomeTaxAuthorityNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="us-gaap_InternalRevenueServiceIRSMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="us-gaap_IncomeTaxExpenseBenefit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="freq_IncomeTaxesDisclosureTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="freq_IncomeTaxesDisclosureTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_NetOperatingLossCarryforwardsExpirationWithLimitation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="freq_IncomeTaxesDisclosureTable" xlink:to="us-gaap_IncomeTaxAuthorityNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_OperatingLossCarryforwardsExpirationYear" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="freq_IncomeTaxesDisclosureTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_NetOperatingLossCarryforwardsExpirationWithoutLimitation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_TaxCreditCarryforwardExpirationYear" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="us-gaap_TaxCreditCarryforwardAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_CumulativeChangeInOwnershipPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_PeriodOfCumulativeChangeInOwnership" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_OperatingLossCarryforwardsUsageAfterOwnershipChange" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="freq_RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="freq_IncomeTaxesDisclosureLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:label="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_MassachusettsInstituteOfTechnologyMember" xlink:label="freq_MassachusettsInstituteOfTechnologyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PatentLicenseAgreementMember" xlink:label="freq_PatentLicenseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AstellasPharmaLimitedLiabilityCompanyMember" xlink:label="freq_AstellasPharmaLimitedLiabilityCompanyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyMember" xlink:label="us-gaap_RoyaltyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementScenarioAxis" xlink:label="srt_StatementScenarioAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioUnspecifiedDomain" xlink:label="srt_ScenarioUnspecifiedDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScenarioForecastMember" xlink:label="srt_ScenarioForecastMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LicenseAgreementEnteredDate" xlink:label="freq_LicenseAgreementEnteredDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_CaliforniaInstituteForBiomedicalResearchMember" xlink:label="freq_CaliforniaInstituteForBiomedicalResearchMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_NonExclusivePatentLicenseAgreementMember" xlink:label="freq_NonExclusivePatentLicenseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrantMember" xlink:label="us-gaap_GrantMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DescriptionOfFutureDevelopmentObligations" xlink:label="freq_DescriptionOfFutureDevelopmentObligations"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ScrippsOptionAgreementMember" xlink:label="freq_ScrippsOptionAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ResearchAndDevelopmentMember" xlink:label="freq_ResearchAndDevelopmentMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LicenseFeePayment" xlink:label="freq_LicenseFeePayment"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_MassachusettsEyeAndEarMember" xlink:label="freq_MassachusettsEyeAndEarMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PercentageOfSharesOfCommonStockIssued" xlink:label="freq_PercentageOfSharesOfCommonStockIssued"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_PercentageOfRoyaltyOnSublicenseRevenue" xlink:label="freq_PercentageOfRoyaltyOnSublicenseRevenue"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_CambridgeEnterpriseLimitedMember" xlink:label="freq_CambridgeEnterpriseLimitedMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RoyaltyExpense" xlink:label="us-gaap_RoyaltyExpense"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RoyaltyExpensePerShare" xlink:label="freq_RoyaltyExpensePerShare"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_MilestonePayments" xlink:label="freq_MilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_DescriptionOfConditionsToTerminateLicenseAgreement" xlink:label="freq_DescriptionOfConditionsToTerminateLicenseAgreement"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RightToTerminateAgreementUponPriorWrittenNotice" xlink:label="freq_RightToTerminateAgreementUponPriorWrittenNotice"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RightToTerminateAgreementIfBreachRemainsUncured" xlink:label="freq_RightToTerminateAgreementIfBreachRemainsUncured"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RightToTerminateAgreementIncaseOfNonpayment" xlink:label="freq_RightToTerminateAgreementIncaseOfNonpayment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForManagementFee" xlink:label="us-gaap_PaymentForManagementFee"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RightToTerminateLicensedPatentsUponPriorWrittenNotice" xlink:label="freq_RightToTerminateLicensedPatentsUponPriorWrittenNotice"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_FundingPaymentsMadeAsConsiderationToSupportResearchActivities" xlink:label="freq_FundingPaymentsMadeAsConsiderationToSupportResearchActivities"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_TermOfAgreement" xlink:label="freq_TermOfAgreement"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LicenseAgreementExtendedDate" xlink:label="freq_LicenseAgreementExtendedDate"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AdditionalFundingPaymentsMadeAsConsiderationToSupportResearchActivities" xlink:label="freq_AdditionalFundingPaymentsMadeAsConsiderationToSupportResearchActivities"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent" xlink:label="freq_RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AnnualLicenseFee" xlink:label="freq_AnnualLicenseFee"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AnnualLicenseFeePerShare" xlink:label="freq_AnnualLicenseFeePerShare"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AmountOfFundingReceivedAsGrant" xlink:label="freq_AmountOfFundingReceivedAsGrant"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_GrantTermPeriod" xlink:label="freq_GrantTermPeriod"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_IncreaseDecreaseInResearchAndDevelopmentExpense" xlink:label="freq_IncreaseDecreaseInResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="dei_LegalEntityAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="freq_MassachusettsInstituteOfTechnologyMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="freq_PatentLicenseAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="freq_AstellasPharmaLimitedLiabilityCompanyMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_RoyaltyMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_DirectorMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_StatementScenarioAxis" xlink:to="srt_ScenarioUnspecifiedDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ScenarioUnspecifiedDomain" xlink:to="srt_ScenarioForecastMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_LicenseAgreementEnteredDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="freq_CaliforniaInstituteForBiomedicalResearchMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="freq_NonExclusivePatentLicenseAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_GrantMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_DescriptionOfFutureDevelopmentObligations" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="freq_ScrippsOptionAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="freq_ResearchAndDevelopmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_LicenseFeePayment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="freq_MassachusettsEyeAndEarMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_PercentageOfSharesOfCommonStockIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_PercentageOfRoyaltyOnSublicenseRevenue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_EntityDomain" xlink:to="freq_CambridgeEnterpriseLimitedMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="us-gaap_RoyaltyExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_RoyaltyExpensePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="srt_StatementScenarioAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_MilestonePayments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_DescriptionOfConditionsToTerminateLicenseAgreement" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_RightToTerminateAgreementUponPriorWrittenNotice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_RightToTerminateAgreementIfBreachRemainsUncured" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_RightToTerminateAgreementIncaseOfNonpayment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="us-gaap_PaymentForManagementFee" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_RightToTerminateLicensedPatentsUponPriorWrittenNotice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_FundingPaymentsMadeAsConsiderationToSupportResearchActivities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_TermOfAgreement" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_LicenseAgreementExtendedDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="18" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_AdditionalFundingPaymentsMadeAsConsiderationToSupportResearchActivities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="19" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="20" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_AnnualLicenseFee" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="21" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_AnnualLicenseFeePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="22" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_AmountOfFundingReceivedAsGrant" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="23" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_GrantTermPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="24" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="freq_IncreaseDecreaseInResearchAndDevelopmentExpense" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LicenseAndCollaborationAgreementMember" xlink:label="freq_LicenseAndCollaborationAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AstellasPharmaLimitedLiabilityCompanyMember" xlink:label="freq_AstellasPharmaLimitedLiabilityCompanyMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:label="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_Phase2bClinicalTrialMember" xlink:label="freq_Phase2bClinicalTrialMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EuropeMember" xlink:label="srt_EuropeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollaborators" xlink:label="us-gaap_ProceedsFromCollaborators"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_Phase3ClinicalTrailMember" xlink:label="freq_Phase3ClinicalTrailMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AsiaMember" xlink:label="srt_AsiaMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:label="us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones" xlink:label="freq_ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization" xlink:label="freq_RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AgreementTerminationNoticePeriod" xlink:label="freq_AgreementTerminationNoticePeriod"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RightToTerminateAgreementIfBreachRemainsUncured" xlink:label="freq_RightToTerminateAgreementIfBreachRemainsUncured"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RightToTerminateAgreementIncaseOfNonpayment" xlink:label="freq_RightToTerminateAgreementIncaseOfNonpayment"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_RevenueRecognitionTransactionPrice" xlink:label="freq_RevenueRecognitionTransactionPrice"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_UpfrontFeeRecognizedAsRevenue" xlink:label="freq_UpfrontFeeRecognizedAsRevenue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="freq_LicenseAndCollaborationAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="freq_AstellasPharmaLimitedLiabilityCompanyMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="freq_Phase2bClinicalTrialMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_EuropeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ProceedsFromCollaborators" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="freq_Phase3ClinicalTrailMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="srt_AsiaMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ContractWithCustomerLiabilityRevenueRecognized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="freq_ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="freq_RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="freq_AgreementTerminationNoticePeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="freq_RightToTerminateAgreementIfBreachRemainsUncured" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="freq_RightToTerminateAgreementIncaseOfNonpayment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="freq_RevenueRecognitionTransactionPrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="freq_UpfrontFeeRecognizedAsRevenue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ResearchAndDevelopmentExpense" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LexingtonLeaseMember" xlink:label="freq_LexingtonLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_AREMARegionNo20LLCMember" xlink:label="freq_AREMARegionNo20LLCMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis" xlink:label="srt_CounterpartyNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LeasesTerminationAgreementMember" xlink:label="freq_LeasesTerminationAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd#stpr_MA" xlink:label="stpr_MA"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLeaseAgreementAmendedDate" xlink:label="freq_OperatingLeaseAgreementAmendedDate"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_HaydenLLCMember" xlink:label="freq_HaydenLLCMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseExpirationDate1" xlink:label="us-gaap_LeaseExpirationDate1"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLeaseTerminationFee" xlink:label="freq_OperatingLeaseTerminationFee"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetRentableArea" xlink:label="us-gaap_NetRentableArea"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLeaseCommencementDate" xlink:label="freq_OperatingLeaseCommencementDate"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLeaseNumberOfAdditionalExtensionTerms" xlink:label="freq_OperatingLeaseNumberOfAdditionalExtensionTerms"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseOptionToExtend"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LeaseExpirationYear" xlink:label="freq_LeaseExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LeaseExpirationYear1" xlink:label="freq_LeaseExpirationYear1"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_OperatingLeasesAdditionalExtensionTerm" xlink:label="freq_OperatingLeasesAdditionalExtensionTerm"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="freq_LexingtonLeaseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="freq_AREMARegionNo20LLCMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_CounterpartyNameAxis" xlink:to="srt_RepurchaseAgreementCounterpartyNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="freq_LeasesTerminationAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="stpr_MA" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="freq_OperatingLeaseAgreementAmendedDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="freq_HaydenLLCMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_CounterpartyNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LeaseExpirationDate1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LeaseContractualTermAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="freq_OperatingLeaseTerminationFee" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_NetRentableArea" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="freq_OperatingLeaseCommencementDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="freq_OperatingLeaseNumberOfAdditionalExtensionTerms" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseOptionToExtend" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="freq_LeaseExpirationYear" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="freq_LeaseExpirationYear1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="freq_OperatingLeasesAdditionalExtensionTerm" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_OperatingLeaseExpense" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain" xlink:label="srt_SegmentGeographicalDomain"/>
    <link:loc xlink:type="locator" xlink:href="freq-20211231.xsd#freq_LexingtonMassachusettsFacilityMember" xlink:label="freq_LexingtonMassachusettsFacilityMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis" xlink:label="srt_StatementGeographicalAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCash" xlink:label="us-gaap_RestrictedCash"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermPurchaseCommitmentAmount" xlink:label="us-gaap_LongTermPurchaseCommitmentAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyLossInPeriod" xlink:label="us-gaap_LossContingencyLossInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue" xlink:label="us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_SegmentGeographicalDomain" xlink:to="freq_LexingtonMassachusettsFacilityMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_StatementGeographicalAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_StatementGeographicalAxis" xlink:to="srt_SegmentGeographicalDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_RestrictedCash" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LongTermPurchaseCommitmentAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LossContingencyLossInPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LossContingencyAccrualAtCarryingValue" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems" xlink:label="us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:label="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis" xlink:label="srt_TitleOfIndividualAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember" xlink:label="srt_DirectorMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentForManagementFee" xlink:label="us-gaap_PaymentForManagementFee"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="srt_TitleOfIndividualAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_TitleOfIndividualAxis" xlink:to="srt_TitleOfIndividualWithRelationshipToEntityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="srt_DirectorMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_RelatedPartyTransactionLineItems" xlink:to="us-gaap_PaymentForManagementFee" priority="2" use="optional"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417840707976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 08, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001703647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FREQUENCY THERAPEUTICS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-2324450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line</a></td>
<td class="text">75 Hayden Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Lexington<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">02421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">781<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">315-4600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FREQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 306.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,976,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Portions of the Proxy Statement for the registrant&#8217;s 2022 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K.</span></p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">RSM US LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm Id</a></td>
<td class="text">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Boston, Massachusetts, USA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417839993608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 79,635<span></span>
</td>
<td class="nump">$ 220,341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term marketable securities</a></td>
<td class="nump">51,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">4,041<span></span>
</td>
<td class="nump">4,723<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">134,748<span></span>
</td>
<td class="nump">225,064<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term marketable securities</a></td>
<td class="nump">11,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">5,522<span></span>
</td>
<td class="nump">7,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets</a></td>
<td class="nump">31,350<span></span>
</td>
<td class="nump">30,551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">1,699<span></span>
</td>
<td class="nump">1,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_LongTermAssets', window );">Long-term assets</a></td>
<td class="nump">320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">185,358<span></span>
</td>
<td class="nump">264,722<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">2,748<span></span>
</td>
<td class="nump">5,506<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">6,101<span></span>
</td>
<td class="nump">6,663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,068<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities</a></td>
<td class="nump">1,747<span></span>
</td>
<td class="nump">397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Term loan, current portion</a></td>
<td class="nump">833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">11,429<span></span>
</td>
<td class="nump">26,634<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities, net of current portion</a></td>
<td class="nump">28,851<span></span>
</td>
<td class="nump">30,597<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLoansFromBank', window );">Term Loan, net of current portion</a></td>
<td class="nump">14,167<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Long-term liabilities</a></td>
<td class="nump">87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">54,534<span></span>
</td>
<td class="nump">72,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued or outstanding at December 31, 2021 and December 31, 2020, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 200,000,000 shares authorized, 34,611,213 and 33,964,000 shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">310,936<span></span>
</td>
<td class="nump">287,829<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="num">(62)<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(180,085)<span></span>
</td>
<td class="num">(95,399)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">130,824<span></span>
</td>
<td class="nump">192,491<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 185,358<span></span>
</td>
<td class="nump">$ 264,722<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_LongTermAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long term assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_LongTermAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLoansFromBank">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of loans from a bank with maturities initially due after one year or beyond the operating cycle if longer, excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLoansFromBank</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417839976824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized shares</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized shares</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued shares</a></td>
<td class="nump">34,611,213<span></span>
</td>
<td class="nump">33,964,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding shares</a></td>
<td class="nump">34,611,213<span></span>
</td>
<td class="nump">33,964,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417937541384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 14,068<span></span>
</td>
<td class="nump">$ 36,984<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">60,923<span></span>
</td>
<td class="nump">37,415<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">37,176<span></span>
</td>
<td class="nump">27,119<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">98,099<span></span>
</td>
<td class="nump">64,534<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(84,031)<span></span>
</td>
<td class="num">(27,550)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">397<span></span>
</td>
<td class="nump">994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(764)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Realized (loss) gain on investments</a></td>
<td class="num">(23)<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign exchange gain (loss)</a></td>
<td class="nump">16<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Other expense, net</a></td>
<td class="num">(266)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(84,671)<span></span>
</td>
<td class="num">(26,476)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes</a></td>
<td class="num">(15)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (84,686)<span></span>
</td>
<td class="num">$ (26,511)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share-basic and diluted</a></td>
<td class="num">$ (2.47)<span></span>
</td>
<td class="num">$ (0.82)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average shares of common stock outstanding-basic and diluted</a></td>
<td class="nump">34,351,274<span></span>
</td>
<td class="nump">32,253,227<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417937576696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (84,686)<span></span>
</td>
<td class="num">$ (26,511)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized loss on marketable securities</a></td>
<td class="num">(89)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total comprehensive loss</a></td>
<td class="num">(89)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (84,775)<span></span>
</td>
<td class="num">$ (26,538)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417840858392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statement of Stockholders Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional-paid in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 31, 2019</a></td>
<td class="nump">$ 167,358<span></span>
</td>
<td class="nump">$ 31<span></span>
</td>
<td class="nump">$ 236,161<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
<td class="num">$ (68,888)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,844,507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">9,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">1,545<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">769,385<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in Private Placement, net</a></td>
<td class="nump">40,143<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">40,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in Private Placement, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,350,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income loss</a></td>
<td class="num">(27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(26,511)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(26,511)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 192,491<span></span>
</td>
<td class="nump">$ 34<span></span>
</td>
<td class="nump">287,829<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="num">(95,399)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">33,964,000<span></span>
</td>
<td class="nump">33,964,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 21,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Purchase under Employee Stock Purchase Plan</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Purchase under Employee Stock Purchase Plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">1,298<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">642,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited', window );">Forfeiture of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,165)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income loss</a></td>
<td class="num">(89)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(89)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(84,686)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(84,686)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 130,824<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 310,936<span></span>
</td>
<td class="num">$ (62)<span></span>
</td>
<td class="num">$ (180,085)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">34,611,213<span></span>
</td>
<td class="nump">34,611,213<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares related to Restricted Stock Award forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417841577560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (84,686)<span></span>
</td>
<td class="num">$ (26,511)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">21,750<span></span>
</td>
<td class="nump">9,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">2,775<span></span>
</td>
<td class="nump">1,146<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_NonCashLeaseExpenses', window );">Non-cash lease expense</a></td>
<td class="nump">1,066<span></span>
</td>
<td class="nump">434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaidInKindInterest', window );">Non-cash interest expense</a></td>
<td class="nump">347<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss on disposal of assets</a></td>
<td class="nump">16<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(173)<span></span>
</td>
<td class="num">(626)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(2,292)<span></span>
</td>
<td class="nump">4,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(14,068)<span></span>
</td>
<td class="num">(36,984)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="num">(794)<span></span>
</td>
<td class="nump">3,083<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(76,059)<span></span>
</td>
<td class="num">(45,188)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(2,914)<span></span>
</td>
<td class="num">(6,671)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of marketable securities</a></td>
<td class="num">(92,445)<span></span>
</td>
<td class="num">(26,345)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Redemption of marketable securities</a></td>
<td class="nump">29,233<span></span>
</td>
<td class="nump">43,418<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in) provided by investing activities</a></td>
<td class="num">(66,126)<span></span>
</td>
<td class="nump">10,402<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">1,298<span></span>
</td>
<td class="nump">1,545<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from Employee Stock Purchase Plan</a></td>
<td class="nump">60<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from Private Placement, net of issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">40,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from Term Loan</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">15,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">1,358<span></span>
</td>
<td class="nump">56,688<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(140,827)<span></span>
</td>
<td class="nump">21,902<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents, and restricted cash at beginning of period</a></td>
<td class="nump">222,161<span></span>
</td>
<td class="nump">200,259<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents, and restricted cash at end of period</a></td>
<td class="nump">81,334<span></span>
</td>
<td class="nump">222,161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">703<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets in exchange for lease liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">31,335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchases of property and equipment included in accounts payable and accrued expenses</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 2,145<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_NonCashLeaseExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non cash lease expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_NonCashLeaseExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaidInKindInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaidInKindInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417926462808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">1. Organization</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Frequency Therapeutics, Inc., together with its wholly owned subsidiaries, Frequency Therapeutics, PTY, LTD, Frequency Therapeutics Securities Corporation and Frequency Therapeutics Japan KK (Frequency Japan) (the Company), headquartered in Lexington, Massachusetts, was incorporated in </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_7f4715db-25ee-4490-aad3-011a331de8ce;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">November 2014</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> as a Delaware corporation. Frequency Japan was closed down in February 2021. The Company is a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person&#8217;s innate regenerative potential to restore function.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Liquidity and capital resources</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has funded its operations primarily with proceeds from the sale of its capital stock, convertible notes and amounts received under a collaboration agreement. The Company has incurred recurring losses since its inception. In addition, as of December 31, 2021, the Company had an accumulated deficit of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">180,085</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company expects to continue to generate operating losses for the foreseeable future. The future viability of the Company is dependent on its ability to raise additional capital to finance its operations. The Company&#8217;s inability to raise capital as and when needed could have a negative impact on its financial condition and ability to pursue its business strategies. There can be no assurances that additional funding will be available on terms acceptable to the Company, or at all. The Company believes that existing resources will be sufficient to fund planned operations for at least 12 months from the date the financial statements were available to be issued.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417847205736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2. Summary of significant accounting policies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Basis of presentation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying consolidated financial statements have been prepared in accordance with accounting standards set by the Financial Accounting Standards Board (FASB). The FASB sets generally accepted accounting principles (GAAP) that the Company follows to ensure its financial condition, results of operations, and cash flows are consistently reported. References to GAAP issued by the FASB in these notes to the consolidated financial statements are to the FASB </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accounting Standards</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Codification (ASC).</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Principles of consolidation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The consolidated financial statements include the accounts of Frequency Therapeutics, Inc. and its wholly owned subsidiaries Frequency Therapeutics Securities Corporation, Frequency Therapeutics PTY, LTD and Frequency Japan through the date of its dissolution. All intercompany transactions and balances have been eliminated.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of the Company&#8217;s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of expenses during the reporting period. On an ongoing basis, the Company&#8217;s management evaluates its estimates, which include but are not limited to management&#8217;s judgments of accrued expenses, revenue recognition, fair value of common stock, valuation of share-based awards, present value of lease liabilities and income taxes. Actual results could differ from those estimates.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Comprehensive loss</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Components </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">of comprehensive income or loss, including net income or loss, are reported in the financial statements in the period in which they are recognized. Other comprehensive income or loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Net income (loss) and other comprehensive income (loss) are reported net of any related tax effect to arrive at comprehensive income (loss). Comprehensive loss includes net loss as well as other changes in stockholders&#8217; equity that result from transactions and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">economic </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">events other than those with stockholders which for the years ended December 31, 2021 and 2020 consist of unrealized loss on marketable securities. </span></span><span style="font-size:10.0pt;font-family:Times New Roman;"/><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Segment information</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision-maker in deciding how to allocate resources and assess performance. The Company and the Company&#8217;s chief operating decision-maker, the Company&#8217;s chief executive officer, views the Company&#8217;s operations and manages its business as a single operating segment, which is in the business of discovering and developing small molecule drugs that activate progenitor cells within the body to create healthy tissue.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Foreign currency</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:12.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All periods presented are reported in US dollars. The functional currency for entities outside the United States is the US dollar. Realized and unrealized gains and losses from foreign currency transactions are reflected in the consolidated statements of operations as other expense.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> During the years ended December 31, 2021 and 2020 the Company recorded $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">of foreign currency exchange gains and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of foreign currency exchange losses, respectively.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cash and cash equivalents</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company considers all highly liquid investments with an original maturity of six months or less at acquisition to be cash equivalents which are stated at fair market value. Cash and cash equivalents at December 31, 2021 and 2020 consists entirely of cash and money market funds.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Restricted cash</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,700</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of restricted cash as of December 31, 2021 which represents a security deposit on the Company's Lexington, Massachusetts facility. The $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,800</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of restricted cash at December 31, 2020 represented the security deposit on the Lexington, Massachusetts facility as well as a $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> security deposit on the Company's previous Woburn, Massachusetts facility.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Marketable securities</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Marketable securities represent holdings of available-for-sale marketable debt securities in accordance with the Company&#8217;s investment policy. Short-term marketable securities mature within one year from the balance sheet date while long-term marketable securities mature after one year. Investments in marketable securities are recorded at fair value, with any unrealized gains and losses reported within accumulated other comprehensive income as a separate component of stockholders&#8217; equity until realized or until a determination is made that an other-than-temporary decline in market value has occurred. The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization and accretion are reflected as a component of other expense. Interest on securities sold is determined based on the specific identification method and reflected as interest income. Any realized gains or losses on the sale of investment are reflected as realized (loss) gain on investments.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Concentration of credit risk and off-balance sheet risk</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instrument that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents and marketable securities. The Company maintains its cash, cash equivalents, and restricted cash at several accredited financial institutions, in amounts that exceed federally insured limits. Marketable securities consist of short term and long term investments. Management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which its money market accounts are maintained.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has no significant off-balance sheet arrangements such as foreign exchange contracts, option contracts, or other foreign hedging arrangements.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Significant suppliers</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is dependent on third-party manufacturers to supply products for research and development activities of its programs, including preclinical and clinical testing. In particular, the Company relies and expects to continue to rely on a single manufacturer of its product candidates for use in clinical trials. The Company would be adversely affected by a significant interruption in the supply of product for use in clinical programs.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Fair value measurements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Fair value is defined as the price that would be received upon sale of an asset or paid to transfer a liability between market participants at measurement dates. ASC Topic 820, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Fair Value Measurement</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (ASC 820), establishes a three-level valuation hierarchy for instruments measured at fair value. The hierarchy is based on the transparency of inputs to the valuation of an asset or liability as of the measurement date. The hierarchy defines three levels of valuation inputs, of which the first two are considered observable and the last is considered unobservable:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:4.533%;text-indent:-10.836%;padding-left:9.333%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 1	Quoted prices in active markets for identical assets or liabilities.</span></p><p style="margin-left:4.533%;text-indent:-10.836%;padding-left:9.333%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 2	Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable,     such as quoted market prices, interest rates and yield curves.</span></p><p style="margin-left:4.533%;text-indent:-10.836%;padding-left:9.333%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 3	Unobservable inputs developed using estimates or assumptions developed by the Company, which reflect those that a market participant would use in pricing the asset or liability.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&#8217;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The carrying values of other current assets, accounts payable, and accrued expenses approximate their fair values due to the short-term nature of these assets and liabilities. The fair value of the Company&#8217;s Term Loan is </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t materially different from the carrying value as presented.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:12.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Property and equipment, net</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:12.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment consist of lab equipment, computer equipment, furniture and office equipment and leasehold improvements recorded at cost. These amounts are depreciated using the straight-line method over the estimated useful lives of the assets as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:71.997%;"/>
          <td style="width:1.002%;"/>
          <td style="width:27.001%;"/>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.175in;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.175in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Estimated useful life</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Lab equipment</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Software</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furniture and office equipment</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Leasehold improvements</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Shorter of the estimated useful</span></span></p><div><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">life or lease term</span></p></div></td>
         </tr>
        </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon retirement or sale, the cost of the assets disposed of and the related accumulated depreciation are eliminated from the balance sheet and related gains or losses are reflected in the consolidated statements of operations.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Impairment of long-lived assets</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company continually evaluates long-lived assets for potential impairment when events or changes in circumstances indicate the carrying value of the assets may not be recoverable. Recoverability is measured by comparing the book values of the assets to the expected future net undiscounted cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the book values of the assets exceed their fair value. The Company did </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t recognize any impairment losses for the years ended December 31, 2021 and 2020.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and development costs and accruals</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">and development expenses include salaries and benefits, materials and supplies, preclinical and clinical trial expenses, stock-based compensation expense, depreciation of equipment, contract services and other outside expenses. The Company has entered into various research and development-related contracts with research institutions, contract research organizations, contract manufacturers and other companies. These agreements are generally cancelable, and related payments are recorded as research and development expenses as incurred. Costs of certain development activities, such as manufacturing, pre-clinical and clinical trial expenses, are recognized based on an evaluation of the progress to completion of specific tasks. Payments for these activities are based on the terms of the individual arrangements, which may differ from the pattern of costs incurred, and are reflected in the consolidated financial statements as prepaid or accrued research and development costs. Nonrefundable advance payments for goods or services to be received in the future for use in research and development activities are deferred and capitalized. The capitalized amounts are expensed as the related goods are delivered or the services are performed. Costs incurred in obtaining technology licenses are charged to research and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">development </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">expense as acquired in-process research and development if the technology licensed has not reached technological feasibility and has no alternative future use.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Leases</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company elected to early adopt ASC 842, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Leases</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (ASC 842) as of January 1, 2020 and elected the transition method under ASU 2016-02 whereby the Company records a right-to-use asset and a lease liability on the consolidated balance sheet for all leases with terms longer than 12 months. The Company also elected to apply the package of practical expedients intended to ease transition. Accordingly, the Company has only applied ASC 842 to leases existing at January 1, 2020. The Company determines if an arrangement is, or contains, a lease at inception. Operating leases are included in operating lease right-of-issue (&#8220;ROU&#8221;) assets, other current liabilities, and operating lease liabilities on the consolidated balance sheets.</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments to be made over the lease term. The ROU asset also includes any lease payments made at or before the lease commencement date and excludes lease incentives received. As the Company&#8217;s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Operating lease expense is recognized on a straight-line basis over the lease term. The Company has elected to not apply the recognition requirements of ASC 842 for short-term leases, which is defined as a lease that, at the lease commencement date, has a lease term of 12 months or less and does </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t include an option to purchase the underlying asset that the Company is reasonably certain to exercise.</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For real estate lease agreements entered into or modified after the adoption of ASC 842 that include lease and non-lease components, the Company has elected to account for the lease and non-lease components, such as common area maintenance charges, as a single lease component.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Collaborative arrangements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company analyzes its collaborative arrangements to assess whether they are within the scope of ASC 808, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Collaborative Arrangements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#8220;ASC 808&#8221;) to determine whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards dependent on the commercial success of such activities. This assessment is performed throughout the life of the arrangement based on changes in the responsibilities of all parties in the arrangement. For collaboration arrangements within the scope of ASC 808 that contain multiple elements, the Company first determines which elements of the collaboration are deemed to be within the scope of ASC 808 and those that are more reflective of a vendor-customer relationship (e.g., a licensing arrangement) where the contracted party has obtained goods or services that are an output of the Company&#8217;s ordinary activities in exchange for a consideration and therefore within the scope of ASC 606, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Revenue from Contracts with Customers</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#8220;ASC 606&#8221;). For those elements of the arrangement that are accounted for pursuant to ASC 606, including those to which ASC 606 is applied by analogy, the Company applies the five-step model described in the Company&#8217;s revenue recognition policy. For elements of collaborative arrangements that are accounted for pursuant to ASC 808, an appropriate and rational recognition method is determined and applied consistently. Reimbursements from the counterparty that are the result of a collaborative relationship with the counterparty, instead of a customer relationship, such as co-development or clinical activities, are recorded as a reduction to research and development expense as the services are performed. Similarly, amounts that are owed to a collaboration partner related to the co-development clinical activities are recognized as research and development expense.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company enters into out-licensing agreements that are within the scope of ASC 606. The terms of such out-license agreements include licenses to functional intellectual property (IP), given the functionality of the intellectual property is not expected to change substantially as a result of the licensor&#8217;s ongoing activities. Such arrangements typically include payment of one or more of the following: non-refundable up-front license fees; reimbursement of certain costs; development and regulatory milestone payments and milestone payments based on the level of sales; and royalties on net sales of licensed products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company considers the economic and regulatory characteristics of the licensed IP, research, development, manufacturing and commercialization capabilities of the licensee and the availability of the associated expertise in the general marketplace to determine if it has standalone value at the inception of the licensing arrangement, which would make the license distinct. In addition, the Company considers whether the licensee can benefit from a promise for its intended purpose without the receipt of any additional good or services promised in the contract, whether the value of the license is dependent on the remaining goods and services, whether there are other vendors that could provide the remaining promise, and whether the license is separately identifiable from the remaining good and services. For licenses that are combined with</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">other goods and services, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of progress and related revenue recognition. The measure of progress, and thereby periods over which revenue should be recognized, are subject to estimates by management and may change over the course of the research and development and licensing agreement. Such a change could have a material impact on the amount of revenue the Company records in future periods.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Revenue is allocated to the licensed IP on a relative standalone selling price basis and, for functional IP, is recognized at a point when the licensed IP is made available for the customer&#8217;s use and benefit, which generally occurs at the inception of the arrangement. However, in cases, where the functionality of the IP is expected to substantively change as a result of activities of the Company that do not transfer additional promised goods or services, or in cases, where there is an expectation that the Company will undertake activities to change the standalone functionality of the IP and the customer is contractually or practically required to use the latest version of the IP, revenue for the license to functional IP is recognized over time.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Development and regulatory milestone fees, which are a type of variable consideration, are recognized as revenue to the extent that it is probable that a significant reversal will not occur. The Company recognizes royalty revenue and sales-based milestones at the later of (i) when the related sales occur, or (ii) when the performance obligation to which the royalty has been allocated has been satisfied.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has entered into a collaboration arrangement with Astellas Pharma Inc. (&#8220;Astellas&#8221;), as further described in Note 13 of notes to consolidated financial statements.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Revenue recognition</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company accounts for contracts with customers in accordance with ASC 606, including all amendments thereto. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as collaborative arrangements and leases. The Company&#8217;s disclosure within the below sections or elsewhere within these consolidated financial statements reflects the Company&#8217;s accounting policies in compliance with this new standard.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under ASC 606, an entity recognizes revenue when or as its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To recognize revenue for arrangements that an entity determines are within the scope of ASC 606, the entity performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price, including variable consideration, if any; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies its performance obligations. The Company only applies the five-step model to contracts when it is probable that the entity will collect substantially all of the consideration to which it will be entitled in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and identifies as a performance obligation each promise to transfer to the customer either (a) a good or service (or bundle of goods and services) that is distinct, or (b) a series of distinct goods and services that are substantially the same and have been the same pattern of transfer to the customer.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company assesses whether each promised good or service is distinct for the purpose of identifying the performance obligations in the contract. This assessment involves subjective determinations and requires management to make judgments about the individual promised goods or services and whether such are separable from the other aspects of the contractual relationship. Promised goods and services are considered distinct provided that: (i) the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (that is, the good or service is capable of being distinct) and (ii) the entity&#8217;s promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (that is, the promise to transfer the good or service is distinct within the context of the contract). In assessing whether a promised good or service is distinct, the Company considers factors such as the research, manufacturing and commercialization capabilities of the collaboration partner (the &#8220;customer&#8221; in this type of arrangement) and the availability of the associated expertise in the general marketplace. The Company also considers the intended benefit of the contract in assessing whether a promised good or service is separately identifiable from other promises in the contract. If a promised good or service is not distinct, an entity is required to combine that good or service with other promised goods or services until it identifies a bundle of goods or services that is distinct. For each arrangement that results in revenues, the Company identifies all performance obligations, which may include, for example, a license to IP and know-how, research and development activities, and/or manufacturing services.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to any upfront payment, if the consideration promised in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the promised goods</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">or services to a customer. The Company determines the amount of variable consideration by using the expected value method or the most likely amount method. The Company includes the estimated variable consideration in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, the Company re-evaluates the estimated variable consideration included in the transaction price and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis in the period of adjustment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If an arrangement includes development and regulatory milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. There is considerable judgment involved in determining whether it is probable that a significant revenue reversal would not occur. If it is probable that a significant revenue reversal will not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or of the licensee such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of all milestones subject to constraint and, if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For contracts that include sales-based royalties (including milestone payments based on the level of sales) promised in the exchange for licenses of intellectual property, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes royalty revenue and sales-based milestone payments at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied. In determining the transaction price, the Company adjusts the promised amount of consideration for the effects of the time value of money if the timing of payments provides the Company or the Company&#8217;s customer with a significant benefit of financing the transfer of goods and services. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be one year or less. The Company assesses each of its revenue generating arrangements in order to determine whether a significant financing component exists. The Company recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) each performance obligation is satisfied, either at a point in time or over time.  For performance obligations satisfied over time, the Company measures progress toward completion of its performance obligations using an input method based on the Company&#8217;s efforts and inputs to satisfy its performance obligations relative to total expected inputs to the satisfaction of that performance obligation.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Amounts received from a customer prior to revenue recognition are recorded as deferred revenue. Amounts received from a customer that are expected to be recognized as revenue within the 12 months following the balance sheet date are classified as a current liability in the accompanying consolidated balance sheets.</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Patent costs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company expenses patent application and related legal costs as incurred and classifies such costs as general and administrative expenses in the accompanying consolidated statements of operations.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-based compensation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company accounts for its stock-based compensation in accordance with ASC Topic 718, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Compensation&#8212;Stock Compensation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (ASC 718). ASC 718 requires all share-based payments to employees and directors to be recognized as expense in the consolidated statements of operations and comprehensive loss based on their grant date fair values. The Company adopted FASB Accounting Standards Update (ASU) 2016-09 which identifies areas for simplification of several areas of share-based payment transactions. The Company treats non-employee grants in a manner consistent with employee grants. The Company estimates the fair value of options granted using the Black-Scholes option pricing model for stock option grants to both employees and non-employees. The Company believes the fair value of the stock options granted to non-employees is more reliably determinable than the fair value of the services provided.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Black-Scholes option pricing model requires inputs based on certain subjective assumptions, including (a) the expected stock price volatility, (b) the expected term of the award, (c) the risk-free interest rate and (d) expected dividends. Due to the lack of sufficient company-specific historical and implied volatility data, the Company has based its computation of expected volatility on the historical volatility of a representative group of public companies with similar characteristics to the Company, including stage of product development and life science industry focus. The historical volatility is calculated based on a period of time commensurate with the expected term assumption. The Company uses the simplified method as prescribed by the SEC Staff Accounting Bulletin No. 107, Share-Based Payment, to calculate the expected term for options granted to employees as it does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The expected term is applied to the stock option grant group as a whole, as the Company does not expect substantially different exercise or post-vesting termination behavior among its employee population. For options granted to non-employees, the Company utilizes the contractual term of the share-based payment as the basis for the expected term assumption. The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected term of the stock options. The expected dividend yield is assumed to be zero as the Company has never paid dividends and has no current plans to pay any dividends on its common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company expenses the fair value of its share-based compensation awards to employees and non-employees on a straight-line basis over the requisite service period, which is generally the vesting period.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span>&#160;</p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income taxes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company accounts for income taxes using the asset and liability method in accordance with ASC Topic 740, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income Taxes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (ASC 740) which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the Company&#8217;s tax returns. Deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. At December 31, 2021 and 2020, the Company has concluded that a full valuation allowance is necessary for its deferred tax assets (see Note 11).</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Net loss per share</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed using the weighted-average number of shares of common stock outstanding during the period and, if dilutive, the weighted-average number of potential shares of common stock. Diluted net loss per share is the same as basic net loss per share for the years ended December 31, 2021 and 2020 since all potential shares of common stock instruments are anti-dilutive as a result of the loss for such periods.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s convertible preferred stock contractually entitled the holders of such shares to participate in dividends but did not contractually require the holders of such shares to participate in losses of the Company. Accordingly, in periods in which the Company reported a net loss, such losses are not allocated to such participating securities. In periods where the Company reported a net loss attributable to common stockholders, diluted net loss per share is the same as basic net loss per share, since dilutive shares of common stock are not assumed to have been issued if their effect is anti-dilutive. The Company reported a net loss attributable to common stockholders for the years ended December 31, 2021 and 2020.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Basic and diluted net loss per share attributable to common stockholders was calculated as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:52.878%;"/>
          <td style="width:1.378%;"/>
          <td style="width:2.061%;"/>
          <td style="width:18.687%;"/>
          <td style="width:1.378%;"/>
          <td style="width:1.492%;"/>
          <td style="width:2.061%;"/>
          <td style="width:18.687%;"/>
          <td style="width:1.378%;"/>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended <br/>December 31,</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Numerator:</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">84,686</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26,511</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Denominator:</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average shares of common stock<br/>&#160;&#160;&#160;outstanding-basic and diluted</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">34,351,274</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32,253,227</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss per share-basic and diluted</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.47</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.82</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
         </tr>
        </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company excluded the following potential shares of common stock from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:55.109%;"/>
          <td style="width:1.478%;"/>
          <td style="width:0.853%;"/>
          <td style="width:19.199%;"/>
          <td style="width:0.853%;"/>
          <td style="width:1.606%;"/>
          <td style="width:0.853%;"/>
          <td style="width:19.199%;"/>
          <td style="width:0.853%;"/>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended <br/>December 31,</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested restricted common stock</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,093</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested restricted stock units</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">626,300</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding stock options</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,830,037</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,816,798</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,456,337</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,819,891</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
        </table></div></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recently adopted accounting pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In August 2018, the FASB issued ASU No. 2018-15,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> Intangibles - Goodwill and Other - Internal-Use Software</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract. This standard addresses the accounting for implementation costs incurred by a customer in a cloud computing arrangement that is a service contract and also adds certain disclosure requirements related to implementation costs incurred for internal-use software and cloud computing arrangements. The amendment aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The Company adopted this standard on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2021</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, using a prospective approach. The adoption of this new standard did not have a material </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">impact</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> on the consolidated financial statements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2019, the FASB issued ASU 2019-12 amending accounting guidance that simplifies the accounting for income taxes, as part of its initiative to reduce complexity in the accounting standards. The amendments eliminate certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The amendments also clarify and simplify other aspects of the accounting for income taxes. The Company adopted this standard on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2021</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and it did not have a material </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">impact</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> on the consolidated financial statements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recently issued accounting pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. The Company is an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012, as amended (Jobs Act). The Jobs Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. Thus, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company elected to avail itself of this extended transition period and, as a result, we will not be required to adopt new or revised accounting standards on the relevant dates on which adoption of such standards is required for other public companies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Financial Instruments - Credit Losses</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (Topic 326): Measurement of Credit Losses on Financial Instruments. The FASB has subsequently issued amendments to ASU 2016-13, which have the same effective date and transition date. These standards require that credit losses be reported using an expected losses model rather than the incurred losses model that was previously used, and establishes additional disclosures related to credit risks. For available-for-sale debt securities with unrealized losses, this standard now requires allowances to be recorded instead of reducing the amortized cost of the investment. These standards limit the amount of credit losses to be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. This standard will become effective for the Company on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2023</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company is still evaluating the </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">impact</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of this standard on its consolidated financial statements.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417845270648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Fair value measurements </span><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:12.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s financial assets measures at fair value on a recurring basis by level within the fair value hierarchy at December 31, 2021 and 2020 are summarized as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:41.9%;"/>
        <td style="width:1.302%;"/>
        <td style="width:12.95%;"/>
        <td style="width:1.302%;"/>
        <td style="width:1.272%;"/>
        <td style="width:11.409%;"/>
        <td style="width:0.636%;"/>
        <td style="width:1.302%;"/>
        <td style="width:1.272%;"/>
        <td style="width:11.201%;"/>
        <td style="width:0.865%;"/>
        <td style="width:1.302%;"/>
        <td style="width:1.272%;"/>
        <td style="width:11.379%;"/>
        <td style="width:0.636%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Fair Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Amortization</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Unrealized</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Fair Market</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Hierarchy</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Cost</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(Loss)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">48,160</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">48,160</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Short-term marketable securities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">51,116</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">51,072</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Long-term marketable securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,764</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">45</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,719</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">    </span>&#160;</p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">111,040</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">89</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">110,951</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:41.894%;"/>
        <td style="width:1.302%;"/>
        <td style="width:12.971%;"/>
        <td style="width:1.302%;"/>
        <td style="width:1.272%;"/>
        <td style="width:11.42%;"/>
        <td style="width:0.636%;"/>
        <td style="width:1.302%;"/>
        <td style="width:1.272%;"/>
        <td style="width:11.391%;"/>
        <td style="width:0.636%;"/>
        <td style="width:1.302%;"/>
        <td style="width:1.272%;"/>
        <td style="width:11.391%;"/>
        <td style="width:0.636%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Fair Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Amortization</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Unrealized</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Fair Market</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Hierarchy</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Cost</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Gain</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">214,522</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">27</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">214,549</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">     </span>&#160;</p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">214,522</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">27</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">214,549</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417845274984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses and Other Current Assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_PrepaidExpensesAndOtherCurrentAssetsTextBlock', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">4. Prepaid expenses and other current assets</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prepaid expenses and other current assets consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.816%;"/>
        <td style="width:1.481%;"/>
        <td style="width:1.282%;"/>
        <td style="width:13.192%;"/>
        <td style="width:0.636%;"/>
        <td style="width:1.481%;"/>
        <td style="width:1.282%;"/>
        <td style="width:13.192%;"/>
        <td style="width:0.636%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Rent and deposits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">470</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_1798d1a5-8d3c-4e74-b507-c3d76c7abeb0;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development expenses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">858</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,729</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accounts receivable</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">144</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">340</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Insurance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,384</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,552</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">185</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">102</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,041</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,723</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_PrepaidExpensesAndOtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_PrepaidExpensesAndOtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417845107432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">5. Property and equipment</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment include the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.446%;"/>
        <td style="width:1.879%;"/>
        <td style="width:1.282%;"/>
        <td style="width:17.642%;"/>
        <td style="width:0.964%;"/>
        <td style="width:1.879%;"/>
        <td style="width:1.282%;"/>
        <td style="width:17.662%;"/>
        <td style="width:0.964%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Lab equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,177</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,166</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furniture and office equipment</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,238</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">283</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Software</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">291</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">291</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Leasehold improvements</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,419</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Construction in progress</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,340</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9,706</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,499</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accumulated depreciation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,184</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,212</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment, net</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,522</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,287</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company recognized </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,775</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,146</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of depreciation expense for the years ended December 31, 2021 and 2020, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417847515544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Accrued Expenses</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">6. Accrued expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses consist of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.2%;"/>
        <td style="width:1.392%;"/>
        <td style="width:1.282%;"/>
        <td style="width:12.742%;"/>
        <td style="width:0.964%;"/>
        <td style="width:1.411%;"/>
        <td style="width:1.282%;"/>
        <td style="width:12.762%;"/>
        <td style="width:0.964%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Payroll and employee related expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,375</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,062</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Professional fees</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">767</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">647</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Third-party research and development expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">840</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">874</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">119</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">80</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,101</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,663</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417845122776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">7.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> Debt</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On December 11, 2020, the Company entered into a Loan and Security Agreement (the &#8220;Loan Agreement&#8221;) with a commercial bank for a Term Loan with a principal balance of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,000</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company will make monthly interest only payments through </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">November 30, 2022</span></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The principal balance and interest will be repaid in equal </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">monthly</span></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> installments after the interest only period and continue through </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">May 1, 2024</span></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (the &#8220;Loan Maturity Date&#8221;)</span></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Advances under the Loan Agreement will bear an interest rate equal to the greater of either (i) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.50</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% plus the Prime Rate (as reported in</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> The Wall Street Journal</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, subject to an interest rate floor of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">zero</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) or (ii) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.75</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%. The interest rate at December 31, 2021 was </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.75</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Interest related to the Loan Agreement was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">764</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for the year ended December 31, 2021 and immaterial for the year ended December 31, 2020.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company may prepay the advance made under the Loan Agreement in whole, at any time subject to a prepayment premium equal to: (a) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.0</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the then-outstanding principal amount of the advance, if such prepayment occurs on or prior to the first anniversary of the Closing Date; (b) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.0</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the then-outstanding principal amount of the advance, if such prepayment occurs after the first anniversary of the Closing Date and on or prior to the second anniversary of the Closing Date; and (c) </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.0</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the then-outstanding principal amount of the advance, if such prepayment occurs after the second anniversary of the Closing Date. The prepayment premium is waived if the Term Loan is refinanced by the bank (in its sole and absolute discretion) on or prior to the Loan Maturity Date.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company will pay a final payment of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">150</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, which will occur on the earliest of: (i) the Loan Maturity Date; (ii) the date that the Company prepays all of the outstanding principal in full; (iii) the date the loan payments are accelerated due to an event of default; or (iv) the termination of the Loan Agreement. The Company is recording the final payment as interest expense over the term of the loan. The Term Loan is secured by substantially all of the Company&#8217;s assets, excluding intellectual property.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417845092968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">8. Stockholders&#8217; equity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Preferred stock</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">   </span>&#160;</p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">    </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has authorized </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> par value preferred stock of which </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares were issued or outstanding as of December 31, 2021.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Common stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has authorized </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">200,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> par value common stock of which </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">34,611,213</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> were issued and outstanding as of December 31, 2021. Common shares are voting, and dividends may be paid when, as and if declared by the Board of Directors.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has reserved the following shares of common stock for future issuance as of December 31, 2021 and 2020:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.146%;"/>
        <td style="width:1.779%;"/>
        <td style="width:1.004%;"/>
        <td style="width:11.33%;"/>
        <td style="width:1.004%;"/>
        <td style="width:1.779%;"/>
        <td style="width:1.004%;"/>
        <td style="width:15.951%;"/>
        <td style="width:1.004%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock options outstanding</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,830,037</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,816,798</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Shares available for future grant under stock option plan</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,552,630</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,475,923</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,382,667</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,292,721</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Equity Offerings</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In July 2020, the Company completed a private placement of common stock to new and existing investors, or the Private Placement. In the Private Placement, the Company issued and sold </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,350,108</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock at a purchase price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18.00</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share. The Company received approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">40,100</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> in net proceeds, after deducting placement agent fees and other offering expenses. In connection with the Private Placement, the Company entered into a Registration Rights Agreement, or the Registration Rights Agreement, with the investors purchasing shares in the Private Placement. Pursuant to the Registration Rights Agreement, the Company filed a registration statement with the Securities and Exchange Commission, or the SEC, which was declared effective on September 3, 2020, registering the resale of the shares sold in the Private Placement.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On December 10, 2021, the Company entered into an Equity Distribution Agreement (the "Sales Agreement") with Oppenheimer &amp; Co. Inc. (the "Sales Agent") to sell shares of the Company&#8217;s common stock, par value $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.001</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share, with aggregate gross sales proceeds of up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">125,000</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, from time to time, through an &#8220;at the market&#8221; equity offering program. Subject to the terms and conditions of the Sales Agreement, the Sales Agent may sell the shares by methods deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415 promulgated under the Securities Act of 1933, as amended, including sales made through The Nasdaq Global Select Market, on any other existing trading market for the Common Stock, to or through a market maker, or, if expressly authorized by the Company, in privately negotiated transactions. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company or Sales Agent may terminate the Sales Agreement upon notice to the other party and subject to other conditions. </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company will pay the Sales Agent a commission equal to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.0</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the gross proceeds of any Common Stock sold through the Sales Agent under the Sales Agreement and has provided the Sales Agent with customary indemnification rights.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Issuance costs incurred related to the Sales Agreement are classified as long-term assets on the balance sheet at December 31, 2021.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417845254136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-based Compensation</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">9. Stock-based compensation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On November 13, 2014, the Company adopted the 2014 Stock Incentive Plan (2014 Plan). All of the Company&#8217;s employees, officers, directors, and consultants are eligible to be granted options to purchase common shares and restricted stock under the terms of the 2014 Plan. The Company reserved an aggregate of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,550,415</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock for issuance under the 2014 Plan. As of December 31, 2021, there were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock available for future grants under the 2014 Plan.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On September 17, 2019, the Company&#8217;s board of directors and on September 19, 2019, its stockholders approved and adopted the 2019 Incentive Award Plan (&#8220;the &#8220;2019 Plan&#8221;).  Under the 2019 Plan, the Company may grant stock options, stock appreciation rights, restricted stock, restricted stock units, and other stock and cash-based awards to individuals who are then employees, officers, directors or consultants of the Company, and employees and consultants of the Company&#8217;s subsidiaries.  A total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,100,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock were approved to be initially reserved for issuance under the 2019 plan.  The number of shares under the 2014 Plan subject to outstanding awards as of the effective date of the 2019 Plan that are subsequently canceled, forfeited or repurchased by the Company will be added to the shares reserved under the 2019 Plan. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> In addition, the number of shares of common stock available for issuance under the 2019 Plan will be automatically increased on the first day of each calendar year during the </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ten-year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> term of the 2019 Plan, beginning with January 1, 2020 and ending with January 1, 2029, by the amount equal to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the outstanding number of shares of the Company&#8217;s common stock on December 31, of the preceding calendar year or such lesser amount as determined by the Company&#8217;s board of directors.</span></span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All stock option grants are non-statutory stock options except option grants to employees (including officers and directors) intended to qualify as incentive stock options under the Internal Revenue Code of 1986, as amended. Incentive stock options may not be granted at less than the fair market value of the Company&#8217;s common stock on the date of grant, as determined in good faith by the Board of Directors at its sole discretion. Nonqualified stock options may be granted at an exercise price established by the Board of Directors at its sole discretion (which has not been less than fair market value on the date of grant) and the vesting periods may vary. Vesting periods are generally</span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> four years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and are determined by the Board of Directors. Stock options become exercisable as they vest. Options granted under the 2014 Plan and the 2019 Plan expire no more than </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ten years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> from the date of grant.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock options</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A summary of the stock option activity under the 2014 Plan and the 2019 Plan are as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:42.779%;"/>
        <td style="width:0.736%;"/>
        <td style="width:0.507%;"/>
        <td style="width:12.355%;"/>
        <td style="width:0.686%;"/>
        <td style="width:0.736%;"/>
        <td style="width:1.044%;"/>
        <td style="width:12.056%;"/>
        <td style="width:0.507%;"/>
        <td style="width:0.736%;"/>
        <td style="width:0.517%;"/>
        <td style="width:12.494%;"/>
        <td style="width:0.507%;"/>
        <td style="width:0.736%;"/>
        <td style="width:1.044%;"/>
        <td style="width:12.056%;"/>
        <td style="width:0.507%;"/>
       </tr>
       <tr style="height:7.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Number of<br/>shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Weighted<br/>average<br/>exercise price</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Weighted<br/>average<br/>remaining<br/>contractual<br/>term (in years)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Aggregate<br/>intrinsic value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Outstanding as of December 31, 2019</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">5,968,672</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">5.21</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">9.08</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">73,561</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">1,645,859</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">24.22</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">9.30</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">769,385</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">1.99</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">16,667</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Forfeited</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">28,348</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">16.38</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Outstanding as of December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">6,816,798</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">10.11</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">8.45</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">171,415</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">1,357,426</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">32.76</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">8.07</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">642,314</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2.02</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">11,652</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Forfeited</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">701,873</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">16.48</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Outstanding as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">6,830,037</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">14.72</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">7.76</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">6,987</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Options exercisable as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">3,993,231</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">9.77</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">7.34</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">6,275</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Options unvested as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2,836,806</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">21.70</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">8.36</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">712</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock option valuation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The assumptions that the Company used to determine the grant-date fair value of stock options granted to</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">employees and directors were as follows, presented on a weighted average basis:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:53.724%;"/>
        <td style="width:1.364%;"/>
        <td style="width:0.981%;"/>
        <td style="width:17.268%;"/>
        <td style="width:3.525%;"/>
        <td style="width:1.364%;"/>
        <td style="width:0.981%;"/>
        <td style="width:17.268%;"/>
        <td style="width:3.525%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Risk-free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected term (in years)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.0</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.0</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected volatility</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">79.8</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">79.1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected dividend yield</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.0</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.0</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The weighted-average grant date fair value of options granted to employees during the years ended December 31, 2021 and 2020 was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">22.39</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16.41</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The total grant date fair value of options vested during the years ended December 31, 2021 and 2020 was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16,304</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,907</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Restricted common stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company issued common stock to founders, employees and advisors which was subject to vesting over four years. If any of these individuals ceased to be employed or to provide services to the Company prior to vesting, the Company had the right to repurchase any unvested Common Stock at the price paid by the holder.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A summary of the status of restricted common stock as of December 31, 2021 and 2020 is presented below:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.673%;"/>
        <td style="width:1.491%;"/>
        <td style="width:0.646%;"/>
        <td style="width:13.627%;"/>
        <td style="width:0.865%;"/>
        <td style="width:1.491%;"/>
        <td style="width:1.282%;"/>
        <td style="width:13.289%;"/>
        <td style="width:0.636%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Number of<br/>shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Weighted<br/>average fair<br/>value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested, December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,093</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.75</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Awarded</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vested</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">928</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.75</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Forfeited</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,165</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.75</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested, December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The total value of restricted stock awards that vested during the years ended December 31, 2021 and 2020, based on estimated fair values of the stock underlying the restricted stock awards was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Restricted stock units</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In April 2021, the Company issued restricted stock units to employees which will </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">vest in equal installments in the first quarter of 2022 and the third quarter of 2022.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></span><span style="font-size:10.0pt;font-family:Times New Roman;"/></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A summary of the status of restricted stock units as of December 31, 2021 and 2020 is presented below:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.547%;"/>
        <td style="width:1.481%;"/>
        <td style="width:0.636%;"/>
        <td style="width:13.799%;"/>
        <td style="width:0.865%;"/>
        <td style="width:1.481%;"/>
        <td style="width:1.282%;"/>
        <td style="width:13.272%;"/>
        <td style="width:0.636%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Number of<br/>shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Weighted<br/>average fair<br/>value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested, December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Awarded</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">800,000</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.54</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vested</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Forfeited</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">173,700</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.54</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested, December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">626,300</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.54</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-based compensation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock-based compensation expense of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21,750</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9,983</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for the years ended December 31, 2021 and 2020 respectively, is included in research and development and general and administrative expenses in the Company&#8217;s consolidated statements of operations and comprehensive loss.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021 and 2020, total unrecognized stock-based compensation expense relating to unvested stock options, restricted stock awards, and restricted stock units was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">39,112</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31,006</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively. This amount is expected to be recognized over a weighted-average period of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.49 </span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">years and </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.08</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> years, respectively.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417845203112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Stock Purchase Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_EmployeeStockPurchasePlanDisclosureTextBlock', window );">Employee Stock Purchase Plan</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">10. Employee stock purchase plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On September 20, 2019, the Company&#8217;s board of directors and stockholders approved and adopted the 2019 Employee Stock Purchase Plan (the &#8220;ESPP&#8221;) which became effective on the date of the Company&#8217;s initial public offering of shares of its common stock. The ESPP permits participants to purchase common stock through payroll deductions of up to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of their eligible compensation.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The number of shares of common stock available for issuance under the ESPP will be automatically increased on the first day of each calendar year during the first </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ten years</span></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of the term of the ESPP, beginning with January 1, 2020 and ending with January 1, 2029, by an amount equal to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the outstanding number of shares of the Company&#8217;s common stock on December 31 of the preceding calendar year or such lesser amount as determined by the Company&#8217;s board of directors. The Company&#8217;s first offering period of 2021 concluded on June 30, 2021 with the purchase of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,064</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares in July 2021 related to this offering period. A</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">s of December 31, 2021, a</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> total of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">956,021</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares remain for future offering periods.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company's second offering period of 2021 concluded on December 31, 2021 with the purchase of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31,832</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares in January 2022 related to this offering.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_EmployeeStockPurchasePlanDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee stock purchase plan disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_EmployeeStockPurchasePlanDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417845092968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">11.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> Income taxes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since inception in 2014, the Company has generated cumulative federal and state net operating loss and research and development credit carryforwards for which we have </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t recorded any net tax benefit due to uncertainty around utilizing these tax attributes within the respective carryforward periods.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021, the Company had federal net operating loss carryforwards of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">149,071</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and Massachusetts state operating loss carryforwards of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">83,467</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> which may be available to offset future taxable income. The U.S. federal net operating loss carryforwards include $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">22,399</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> available to reduce future taxable income through </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2037</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">126,672</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> which do not expire and are available to reduce future taxable income indefinitely. The state net operating loss carryforwards are available to offset future taxable income through </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2041</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. As of December 31, 2021, the Company also had federal and Massachusetts research and development tax credit carryforwards of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,241</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,071</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, which are available to offset federal and state tax liabilities through </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2041</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2036</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Realization of future tax benefits is dependent on many factors, including the Company&#8217;s ability to generate taxable income within the net operating loss carryforward period. Net operating loss and tax credit carryforwards may become subject to an annual limitation in the event of certain cumulative changes in the ownership interest of significant shareholders over a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">three-year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> period in excess of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%, as provided under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, respectively, as well as similar state provisions. These ownership changes may limit the number of carryforwards that can be utilized annually to offset future taxable income. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by more than 50% over a three-year period. The Company has completed several financings and has conducted a study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception and has determined that an ownership change did occur in March 2017. Accordingly, utilization of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12,400</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the U.S. net operating</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">loss </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">carryforwards which were incurred prior to March 2017 (pre-ownership change) is limited under Section 382. After the Section 382 limitations, the Company may utilize approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,800</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of its pre-ownership change net operating loss carryforwards based upon an annual usage of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,600</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for each of the next five years after the ownership change and approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">180</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for each of the 15 years thereafter. The remaining pre-ownership change net operating losses of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,600</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> were written off due to expiration under limitation. The limitation has been determined by first multiplying the value of our stock at the time of the ownership change by the applicable long-term tax-exempt rate. These carryforwards may be subject to further annual limitations under Section 382 in the event of future changes in ownership.  Additionally, the Company has determined an ownership changed occurred in October of 2019 as a result of the IPO.  Accordingly, utilization of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">46,123</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of the U.S. net operating loss carryforwards incurred prior to October 2019 is also limited under Section 382. The Company has determined it will be able to utilize the entire $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">46,123</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of its pre-ownership change net operating loss carryforwards based upon the limitations calculated from the October 2019 ownership change. These carryforwards may be subject to further annual limitations under Section 382 in the event of future changes in ownership.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ASC 740 requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of the evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. After consideration of all the evidence, both positive and negative, the Company has recorded a valuation allowance against its deferred tax assets at December 31, 2021 and 2020 because the Company&#8217;s management has determined that it is more likely than not that the Company will </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t recognize the benefits of its federal and state deferred tax assets primarily due to its cumulative loss position and, as a result, a valuation allowance of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50,931</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26,995</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> as of December 31, 2021 and 2020 has been established.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> unrecognized tax benefits. The Company has not, as yet, conducted a study of its research and development credit carryforwards. Such a study may result in an adjustment to the Company&#8217;s research and development credit carryforwards; however, until a study is completed, and any adjustment is known, no amounts are being presented as an uncertain tax position. A full valuation allowance has been provided against the Company&#8217;s research and development credits and, if an adjustment were required, this adjustment would be offset by an adjustment to the valuation allowance. Thus, there would be no impact to the consolidated balance sheet or consolidated statements of operations if an adjustment were required. The Company has elected to recognize interest and penalties related to income tax matters as a component of income tax expense, of which </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> interest or penalties were recorded for the years ended December 31, 2021 and 2020.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company files income tax returns in the U.S. and Massachusetts. The statute of limitations for assessment by the Internal Revenue Service and Massachusetts tax authorities remains open for all years since 2014. To the extent the Company has tax attribute carryforwards, the tax years in which the attribute was generated may still be adjusted upon examination by the Internal Revenue Service or state authorities to the extent utilized in a future period. No federal or state tax audits are currently in process.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A reconciliation of the Company&#8217;s pre-tax income for the years ended December 31, 2021 and 2020 is as follows:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.763%;"/>
        <td style="width:0.845%;"/>
        <td style="width:2.048%;"/>
        <td style="width:12.245%;"/>
        <td style="width:1.461%;"/>
        <td style="width:0.865%;"/>
        <td style="width:2.048%;"/>
        <td style="width:12.265%;"/>
        <td style="width:1.461%;"/>
       </tr>
       <tr style="height:10.8pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.95pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Domestic</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">84,624</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25,744</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:12.95pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Foreign</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">47</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">732</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:13.7pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">84,671</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26,476</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s provision at December 31, 2021 and 2020 consist of the following:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.121%;"/>
        <td style="width:1.123%;"/>
        <td style="width:2.067%;"/>
        <td style="width:12.514%;"/>
        <td style="width:0.706%;"/>
        <td style="width:1.163%;"/>
        <td style="width:2.067%;"/>
        <td style="width:12.534%;"/>
        <td style="width:0.706%;"/>
       </tr>
       <tr style="height:10.1pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.25pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Current:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.25pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;&#160;&#160;&#160;Federal</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">35</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.95pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;&#160;&#160;&#160;State</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.95pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;&#160;&#160;&#160;Foreign</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.25pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total current</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">35</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.25pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deferred:</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.95pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;&#160;&#160;&#160;Federal</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.25pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;&#160;&#160;&#160;State</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.95pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;&#160;&#160;&#160;Foreign</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.25pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total Deferred</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.25pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total provision (benefit)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">35</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A reconciliation of the U.S. federal statutory income tax rate to the Company&#8217;s effective income tax rate for the years ended December 31, 2021 and 2020 is as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:62.7%;"/>
        <td style="width:1.859%;"/>
        <td style="width:0.636%;"/>
        <td style="width:14.355%;"/>
        <td style="width:2.137%;"/>
        <td style="width:1.859%;"/>
        <td style="width:0.636%;"/>
        <td style="width:13.679%;"/>
        <td style="width:2.137%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S federal statutory income tax rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Permanent differences</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_ac776299-523f-419b-b2ba-1e3e866cfec3;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.2</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">State income taxes, net of federal benefit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.7</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development tax credits</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.6</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11.2</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock compensation deductions</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.6</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other items</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.7</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.6</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Change in deferred tax asset valuation allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">28.2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">40.7</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Effective income tax rate</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_ded4314f-4db0-4f7e-8996-c64ecbefa332;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s deferred tax assets at December 31, 2021 and 2020 consist of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:62.662%;"/>
        <td style="width:1.038%;"/>
        <td style="width:2.119%;"/>
        <td style="width:14.105%;"/>
        <td style="width:1.408%;"/>
        <td style="width:1.038%;"/>
        <td style="width:2.119%;"/>
        <td style="width:14.105%;"/>
        <td style="width:1.408%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">36,590</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17,885</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development tax credits</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,026</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,992</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Intangibles</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">392</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">360</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock compensation</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,554</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">850</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">107</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deferred revenue</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,606</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">176</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">142</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Fixed assets</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">265</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">56</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Lease liability</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,269</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,285</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Right of use asset</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,448</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,181</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total deferred tax asset</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50,931</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26,995</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50,931</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26,995</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417845254696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and License Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentAbstract', window );"><strong>Research and Development [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_ResearchAndLicenseAgreementsDisclosureTextBlock', window );">Research and License Agreements</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">12. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Research and license agreements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Massachusetts Institute of Technology</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 2016</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the Company entered into an exclusive patent license agreement (MIT License Agreement), with the Massachusetts Institute of Technology, (MIT), under which the Company received an exclusive, worldwide, royalty-bearing license to certain patent rights to develop, make, have made, use, sell, offer to sell, lease and import products (Licensed Products) and to develop and perform processes (Licensed Processes) which incorporate the licensed technology for the treatment of disease, including but not limited to the prevention and remediation of hearing loss. The Company also has the right to grant sublicenses of its rights under the MIT License Agreement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Company is required to use diligent efforts to develop and commercialize the Licensed Products or Processes, and to make such products or processes reasonably available to the public and to spend certain minimum amounts on research</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">development of Licensed Products and/or Processes each year until the first commercial sale of a Licensed Product and/or a first commercial performance of a Licensed Process. The Company is also subject to certain development obligations with regards to a first Licensed Product. The Company has satisfied certain obligations related to preclinical studies and the filing of an IND for a first Licensed Product with its development activities related to FX-322. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s future development obligations are: (i) to commence a Phase III clinical trial for such Product within five years of the IND filing for such product, (ii) to file a New Drug Application or equivalent with the FDA or comparable European regulatory agency for such Product within nine years of the IND filing for such Product, and (iii) to make a first commercial sale of such Product within 11 years of the IND filing for such Product.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The Company also has certain development obligations for a second Licensed Product. In the event that the Company has failed to fulfill the development timeline obligation with respect to a second Licensed Product and fails to cure such breach within ninety (90) days of written notice by MIT, MIT may restrict the licensed field to the prevention and remediation of hearing loss in humans and animals. The Company does not have the right to control prosecution of the in-licensed patent applications, and its rights to enforce the in-licensed patents are subject to certain limitations.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon entering into the MIT License Agreement, the Company paid a $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> license fee payment and issued to MIT shares of our common stock equal to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of total then-outstanding capital stock. The Company is required to pay certain annual license maintenance fees which may be credited to running royalties during the same calendar year, if any, and to make potential milestone payments up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,900</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> on each Licensed Product or Licensed Process. In addition, The Company is required to pay a low single-digit royalty on Licensed Products and Licensed Processes and a low-twenties royalty on sublicense revenues.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The MIT License Agreement will remain in effect until the expiration or abandonment of all issued patents and filed patent applications licensed thereunder remain in effect, unless terminated earlier. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has the right to terminate for any reason upon a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-month prior written notice. MIT shall have the right to terminate if the Company ceases to carry on any business related to the MIT License Agreement. MIT may terminate the MIT License Agreement for the Company&#8217;s material breach uncured within ninety (</span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) days (or thirty (</span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) days in the case of nonpayment). MIT may also terminate the MIT License Agreement if the Company or our affiliates commence any action against MIT to declare or render any claim of the licensed patent rights invalid, unpatentable, unenforceable, or non-infringed (a patent challenge), or if our sublicensee commences such actions and the Company does not terminate such sublicense within thirty (30) days after MIT&#8217;s demand. MIT has the right to increase all payments due, instead of terminating the MIT License Agreement in the case of a patent challenge. </span></span><span style="font-size:10.0pt;font-family:Times New Roman;"/></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In May 2019, the Company entered into an amendment with MIT, updating the diligence milestones for a second Licensed Product.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2022, the Company entered into an amendment with MIT, removing a patent and certain patent applications from the MIT License Agreement which were unrelated to the Company&#8217;s hearing and MS programs and which were not being utilized by the Company.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The patents in-licensed by the Company from MIT pursuant to the MIT License claim inventions created by, among others, Dr. Langer, one of the Company&#8217;s directors. Pursuant to MIT&#8217;s policy on the ownership, distribution and commercial development of MIT technology, or the MIT Policy, inventors of intellectual property invented at MIT, including the inventors of patents licensed to the Company under the MIT License, are entitled to a portion of the net royalty income derived by MIT from such inventions, but not amounts received by MIT from the sale of common stock previously issued by the Company to MIT pursuant to the MIT License. Accordingly, pursuant to the MIT Policy, Dr. Langer is entitled to receive a portion of the amounts the Company pays to MIT under the MIT License, including the Astellas Royalty Payment and future milestone payments or royalties, if any, that the Company may receive pursuant to the Astellas Agreement. Accordingly, Dr. Langer has received $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,980</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> from MIT under the MIT Policy during the years ended December 31, 2021 and 2020, respectively. Refer to Note 17 for all related party disclosures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The Scripps Research Institute (California Institute for Biomedical Research)</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">September 2018</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the Company entered into a license agreement, (CALIBR License Agreement), with the California Institute for Biomedical Research, (CALIBR), under which the Company received an exclusive, worldwide, royalty-bearing license to certain patent rights to make, have made, use, sell, offer to sell, and import products (CALIBR Licensed Products) which incorporate the licensed technology for the treatment of multiple sclerosis. The Company also have the right to grant sublicenses of our rights under the CALIBR License Agreement. CALIBR reserves the right to use for itself and the right to grant non-exclusive licenses to other nonprofit or academic institutions, for any internal research and educational purposes.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is required to use commercially reasonable efforts to develop, manufacture, and sell at least one CALIBR Licensed Product. The Company is also subject to certain milestone timeline obligations, which may be extended in certain circumstances as set forth in the CALIBR License Agreement. In October 2021, the Company entered into an amendment with CALIBR which updated the milestone obligations to: (i) initiate a Phase II clinical trial (or equivalent) for a CALIBR Licensed Product by December 31, 2023 and (ii) initiate a Phase III clinical trial (or equivalent) for a CALIBR Licensed Product by December 31, 2025. EW do not have the right to control prosecution of the in-licensed patent applications , and our rights to enforce the in-licensed patents are subject to certain limitations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon entering into the CALIBR License Agreement, the Company made a $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> license fee payment and are required to make milestone payments up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for each Category of CALIBR Licensed Products (Category 1 is any CALIBR Licensed Products containing a compound that modulates any muscarinic receptor and Category 2 is any CALIBR Licensed Products not included in Category 1 that could differentiate oligodendrocyte precursor cells from </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> studies and/or are active in animal models relevant to MS. The Company is also required to pay a middle single-digit royalty on CALIBR Licensed Products and a royalty on sublicense revenues ranging from low-teen percentage to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The CALIBR License Agreement shall continue in effect until expiration of all Company obligations to pay royalties. Royalties shall be payable on a country-by-country and CALIBR Licensed Product-by-CALIBR Licensed Product basis upon the later of (1) the expiration or abandonment of all valid claims of the licensed patent rights in such country and (2) ten years from the first commercial sale of each CALIBR Licensed Product. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company may terminate the CALIBR License Agreement at will upon a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-day prior written notice. The Company may also elect to terminate its license to one or more licensed patents in any or all jurisdictions by giving ninety (</span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) days&#8217; prior written notice to CALIBR. CALIBR may terminate the CALIBR License Agreement for material breach uncured within thirty (</span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) days. CALIBR has the right to terminate or reduce the license to a non-exclusive license if the Company fails to use diligent efforts to develop and commercially exploit CALIBR Licensed Products. </span></span><span style="font-size:10.0pt;font-family:Times New Roman;"/></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The Scripps Research Institute</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In September 2018, the Company entered into a Research Funding and Option Agreement, or the Scripps option agreement, with Scripps (CALIBR is a division of Scripps), under which the Company provided funding to Scripps to pursue certain MS research activities on selected targets. In the same agreement, the Company was granted an exclusive option to acquire an exclusive, sublicensable, worldwide license under certain intellectual property arising from the MS research activities on the selected targets. The Scripps option agreement, including the MS research activities and the exclusive option, terminated on December 31, 2021. The CALIBR License remains active.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Massachusetts Eye and Ear (Formerly Massachusetts Eye and Ear Infirmary)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">February 2019</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the Company entered into an Non-Exclusive Patent License Agreement (MEE License Agreement) with the Massachusetts Eye and Ear (MEE) under which it received a non-exclusive, non-sublicensable, worldwide, royalty-bearing license to certain patent rights to develop, make, have made, use, sell, offer to sell, lease and import products and to develop and perform processes which incorporate the licensed technology for the treatment or prevention of hearing loss (MEE licensed products).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is obligated to use diligent efforts to develop and commercialize the MEE licensed products. The Company met one of its milestone timeline obligations by dosing a first subject in a Phase II trial by December 31, 2020. The Company is still subject to a milestone timeline obligation to dose a first subject in a Phase III trial by December 31, 2024. The Company does not control the filing, prosecution, enforcement, and defense of any licensed patent rights.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon entering the MEE License, the Company made a $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> license fee payment. The Company is obligated to pay certain annual license maintenance fees between $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per each MEE patent family case number included in the licensed MEE patent rights prior to first commercial sale of an MEE licensed product. The Company is also obligated to pay a minimum annual royalty payment of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per each MEE patent family case number included in the licensed MEE patent rights after first commercial sale of an MEE licensed product. The Company is also obligated to make milestone payments up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">350</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> on each product or process that incorporates the licensed patent rights. In addition, the Company has agreed to pay a low single-digit royalty on products and processes that incorporate the licensed patent rights.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The MEE License Agreement shall remain in effect until all issued patents and filed patent applications within the licensed patent rights have expired or been abandoned, unless terminated earlier. </span><span style="font-size:12.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has the right to terminate the MEE License Agreement at will by giving thirty (</span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) business days advance written notice to MEE. MEE has the right to terminate the MEE License Agreement if the Company fails to make any payment due within thirty (</span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">business days after </span></span><span style=""/></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">MEE </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">notifies the Company of such failure. MEE shall have the right to terminate if the Company fails to maintain the required insurance. MEE shall also have the right to terminate the MEE License Agreement upon forty-five (</span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">45</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) business days written notice if the Company becomes insolvent. MEE has the right to terminate for any other default not cured within sixty (</span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">60</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) business days written notice. MEE also has the right to terminate if the Company or its affiliates challenge the validity of the licensed patent rights.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cambridge Enterprise Limited</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 2019</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, we entered into an Exclusive Patent License Agreement ( the &#8220;Cambridge License&#8221;) with Cambridge Enterprise Limited (the technology transfer arm of the University of Cambridge)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(&#8220;Cambridge&#8221;) under which we received an exclusive worldwide royalty-bearing license to certain patent rights to make, have made, sell, offer to sell and import products, or the (the &#8220;Cambridge License Product&#8221;) which incorporate licensed technology for the treatment of demyelinating diseases. We also have the right to grant sublicenses under the Cambridge License. Cambridge reserves the right to use for itself (as well as for the inventors and the funder) to grant nonexclusive licenses to other academic institutions for any academic publication, research and teaching and clinical patient care.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has agreed to use diligent and good faith efforts to develop and commercially exploit at least one Cambridge Licensed Product.  Upon entering into the Cambridge License, the Company made a $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> license fee payment.  The Company is obligated to pay an annual license fee of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company is also obligated to make milestone payments up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,500</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> on each Cambridge License Product.  In addition, the Company has agreed to pay a low single-digit royalty on products that incorporate the licensed patent rights, subject to offset in certain circumstances.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Cambridge License continues in effect on a country-by-country basis until the expiration or revocation, without right of further appeal, of all licensed issued patents and filed patent applications, unless terminated earlier.  </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have the right to terminate for any reason upon </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90 </span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">days&#8217; prior to written notice.  Each party has the right to terminate immediately if the other party ceases to carry on its business.  Either party may also terminate the Cambridge License for material breach if such breach remains uncured for </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> days.  Cambridge may also terminate the Cambridge License if we fail to diligently develop and commercially exploit at least one Cambridge Licensed Product or we or our affiliates or sub-licenses commence any action against Cambridge to declare or render any claim of the licensed patent rights invalid, unpatentable, unenforceable, or not infringed.</span></span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Department of Defense</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In June 2018, the Company received a grant (the Grant) from the Department of Defense (DoD) under which the Company is receiving funding to further the Company&#8217;s research and development of a therapeutic drug to treat hearing loss. The Company received funding of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,596</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> over </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">two years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> from the date of the Grant. The Company has determined that the DoD is not considered a customer under ASC 606, therefore funding received from the DoD under the Grant is recorded as a reduction of research and development expenses. The Company has recorded $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">323</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> as a reduction in research and development expenses for the year ended December 31, 2020. No funding was received in 2021.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_ResearchAndLicenseAgreementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and license agreements disclosure text block.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_ResearchAndLicenseAgreementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417847189048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Collaboration Agreement</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">13.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> Collaboration agreement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In July 2019, the Company entered into a License and Collaboration Agreement with Astellas (the &#8220;Astellas Agreement&#8221;), under which the Company granted Astellas an exclusive, royalty-bearing, sub-licensable, nontransferable license to certain patent rights to research, develop, manufacture, have manufactured, use, seek and secure regulatory approval for, commercialize, offer for sale, sell, have sold and import, and otherwise exploit licensed products containing both a GSK-3 inhibitor and an HDAC inhibitor, (the &#8220;Astellas Licensed Products&#8221;), including the product candidate FX-322, outside of the United States. The Company also granted Astellas a right of first negotiation and a right of last refusal if it entered into any negotiation or agreement of any kind (other than an acquisition of all of the stock or assets of the Company) with any third party under which such third party would obtain the right to develop, manufacture, or commercialize Astellas Licensed Products in the United States.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These parties have agreed to use commercially reasonable efforts to carry out development activities assigned to it under an agreed-upon development plan. Astellas has agreed to use commercially reasonable efforts to obtain regulatory approval for at least one Astellas Licensed Product in sensorineural hearing loss and in age-related hearing loss, in each case, in one major Asian country and one major European country. The Company has agreed to use commercially reasonable efforts to obtain regulatory approval for at least one Astellas Licensed Product in the United States. Astellas has the sole right to commercialize the Astellas Licensed Products outside of the United States, and the Company has the sole right to commercialize the Astellas Licensed Products in the United States. Astellas has agreed to use commercially reasonable</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">efforts to commercialize Astellas Licensed Products in a major Asian country and a major European country following receipt of regulatory approval in such countries.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The collaboration is governed by a joint steering committee (&#8220;JSC&#8221;) established under the Astellas Agreement and shall be comprised of three representatives each from the Company and Astellas. The JSC shall oversee and coordinate the overall conduct of the development, manufacture and commercialization of the Astellas Licensed Products. All decisions of JSC shall be taken through a unanimous vote with each party&#8217;s representatives collectively having one vote. Both the parties shall be responsible for carrying out the development and manufacturing activities in their defined territory in accordance with the plan as reviewed and approved in the JSC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">   </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As consideration for the licensed rights under the Astellas Agreement, Astellas paid the Company an upfront payment of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">80,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> in July 2019 and has agreed to pay potential development milestone payments up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">230,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and commercialization milestones of up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">315,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Specifically, the Company would receive development milestone payments of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">65,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> upon the first dosing of a subject in a Phase 2b clinical trial for SNHL in Europe and Asia, respectively and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">40,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> upon the first dosing of a subject in a Phase 3 clinical trial for SNHL in Europe and Asia, respectively. If the Astellas Licensed Products are successfully commercialized, the Company would be eligible for up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">315,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> in potential commercial milestone payments and also tiered royalties at rates ranging from low- to mid-teen percentages. The parties shall share equally, on a 50/50 basis, all out-of-pocket costs and joint study costs for all the joint activities conducted pursuant to the development plans or the joint manufacturing plan.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Astellas Agreement remains in effect until the expiration of all royalty obligations. Royalties are paid on a licensed product-by-licensed product and country-by-country basis until the latest of (i) the expiration of the last valid claim in the licensed patent rights with respect to such Astellas Licensed Product in such country or (ii) a set number of years from the first commercial sale of such Astellas Licensed Product in such country. Astellas may terminate the Astellas Agreement at will upon </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">60</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> days&#8217; written notice. Each party has the right to terminate the Astellas Agreement due to the other party&#8217;s material breach if such breach remains uncured for </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> days (or </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">45</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> days in the case of nonpayment) or if the other party becomes bankrupt.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Astellas Agreement is a collaborative agreement that is within the scope of ASC 808. The Company analyzed the joint research and development activities to assess whether they fall within the scope of ASC 808, and will reassess this throughout the life of the arrangement based on changes in the roles and responsibilities of the parties. Based on the terms of the arrangement as outlined above, both parties are deemed to be active participants in the collaboration. Both parties are performing research and development activities in their defined territory and will be performing joint clinical studies in accordance with the development plan and the study protocol approved by the JSC. Additionally, Astellas and the Company are exposed to significant risks and rewards dependent on the commercial success of any product candidates that may result from the collaboration. As such, the collaboration arrangement is deemed to be within the scope of ASC 808.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The arrangement consists of two components; the license of IP and the research and development activities, including committee participation, to support the co-development and research plan. Under the provisions of ASC 808, the Company has determined that it will apply the guidance in ASC 606 to recognize the revenue related to the license since that component of the arrangement is more reflective of a vendor-customer relationship. The Company determined that the license and the related research and development services associated with the Phase 2a clinical study were not distinct from one another, as the license has limited value to Astellas without the performance of the research and development activities and the Phase 2a study is essential to the use of the license. As such, the Company determined that these activities should be accounted for as a single combined performance obligation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Revenue associated with this single performance obligation was recognized as the research and development work was performed, using an input method on the basis of research and development costs incurred to date relative to total research and development costs expected to be incurred. The transfer of control occurred over this time period and, in management&#8217;s judgment, is the best measure of progress towards satisfying the performance obligation. The Company determined that the period of performance of the research and development services began upon the signing of the Astellas Agreement and continued until the completion of the Phase 2a clinical trial of FX-322 (FX-322-202). The transaction price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">80,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> was allocated to the single combined performance obligation and recognized over such period. The completion date of the Phase 2a clinical trial (FX-322-202) and the total research and development costs incurred in performing the trial was June 30, 2021. As such, the Company recognized the $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">80,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> upfront fee as revenue over the period from July 2019 until June 30, 2021, the completion date of the Phase 2a clinical trial (FX-322-202), using the input method.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">80,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> upfront </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">payment received from Astellas in July 2019 was initially recorded as deferred revenue and was recognized as revenue according to the policy described above. As of June 30, 2021, the Company completed its performance</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">obligation </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">with respect to the upfront payment and, accordingly, recognized all remaining revenue related to the Astellas Agreement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The potential development and regulatory milestone payments are fully constrained until the Company can conclude that achievement of the milestone is probable and that it is probable that recognition of revenue related to the milestone will not result in a significant reversal in the amount of cumulative revenue recognized when the uncertainty associated with the variable consideration is ultimately resolved and as such these have been excluded from the transaction price. As part of its evaluation of the constraint, the Company considers numerous factors, including the fact that achievement of the milestones is outside the control of the Company and contingent upon the future success of clinical trials, the licensee&#8217;s efforts, and the receipt of regulatory approval. Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as these amounts have been determined to relate predominantly to the license granted to Astellas and therefore are recognized at the later of when the performance obligation is satisfied, or the related sales of licensed products occur. The Company re-evaluates the transaction price, including its estimated variable consideration included in the transaction price and all constrained amounts, at each reporting period and as uncertain events are resolved or other changes in circumstances occur, and, if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Astellas Agreement contains joint research and development activities that are not within the scope of ASC 606. The Company will recognize research and development expense related to the joint study costs for all the joint activities in future periods and reimbursements received from Astellas will be recognized as an offset to research and development expense on the consolidated statements of operations during the development period. In the year ended December 31, 2021 and 2020, the Company invoiced Astellas $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">885</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,046</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for joint costs.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI http://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417845221496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">14. Leases</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In 2016, the Company entered into a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">five-year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> operating lease for the Company&#8217;s primary office and laboratory space in Woburn, Massachusetts. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">November 2019</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, this lease was amended to add additional laboratory and office space as well as extend the termination date for all spaces to </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_ed329d69-2529-48fa-9178-d9e728957db7;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">February 2025</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The lease and amendment do not contain any material residual value guarantees or material restrictive covenants.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;">  </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On December 11, 2020, the Company entered into an Agreement for Termination of Lease and Voluntary Surrender of Premises (the &#8220;Lease Termination Agreement&#8221;) with ARE-MA Region No. 20, LLC (the &#8220;Landlord&#8221;). The Lease Termination Agreement provides that the Lease Agreement, dated as of August 14, 2016, by and between the Company and Landlord (as the same may have been amended, the &#8220;Lease&#8221;) will terminate on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 31, 2021</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, unless the Company elects to extend the term of the Lease. The Company exercised the option to extend the lease until May 31, 2021.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As consideration for the Landlord&#8217;s agreement to enter into the Lease Termination Agreement and accelerate the expiration date of the term of the Lease, the Company has agreed to pay to Landlord a fee of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">200</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On January 7, 2020 the Company entered into an indenture of lease (the &#8220;Lexington Lease&#8221;) with HCP/KING 75 Hayden LLC, for the lease of approximately </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">61,307</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> square feet of rentable area in Lexington, Massachusetts or (the &#8220;Lexington Premises&#8221;).  The Lexington Lease commenced on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 11, 2020</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the second quarter of 2021, the Company began using the Lexington Premises as its principal executive offices and laboratory for research and development. The term of the Lexington Lease is expected to end on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">May 31, 2031</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company also has the option to extend the Initial Term for </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">two</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> additional terms of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">five years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> each.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company continues to lease a small office space in Connecticut.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company's rent expense for the years ended December 31, 2021 and 2020 was $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,960</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">835</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:77.097%;"/>
        <td style="width:1.67%;"/>
        <td style="width:0.805%;"/>
        <td style="width:18.28%;"/>
        <td style="width:2.147%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Other information</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average remaining operating lease term</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.4</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;years</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average discount rate</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.5</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The table below reconciles the undiscounted cash flows to the operating lease liability recorded on the consolidated balance sheet as of December 31, 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:77.452%;"/>
        <td style="width:1.833%;"/>
        <td style="width:1.278%;"/>
        <td style="width:18.457%;"/>
        <td style="width:0.981%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,159</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2023</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,284</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2024</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,412</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2025</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,545</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2026</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,681</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Thereafter</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">22,389</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total minimum lease payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44,470</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Less: amount of lease payments representing interest</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13,872</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Present value of future lease payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30,598</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Less: current lease liabilities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,747</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Noncurrent lease liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">28,851</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:11.0pt;font-family:Calibri;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Future aggregate minimum payments under the noncancelable operating leases and short term leases, including the Lexington, MA lease and Connecticut lease, which is not subject to ASC 842, as of December 31, 2021 are as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:76.935%;"/>
        <td style="width:1.653%;"/>
        <td style="width:2.133%;"/>
        <td style="width:17.956%;"/>
        <td style="width:0.248%;"/>
        <td style="width:1.075%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,161</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2023</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,284</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2024</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,412</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2025</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,545</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2026</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,681</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2027 and beyond</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">22,388</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total minimum lease payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44,471</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417926462808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">15. Commitments and contingencies</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Contract commitments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has contracted with a research institution to provide research for a therapeutic drug to treat multiple sclerosis. In September 2020, the Company extended the term of this contract through December 2021. As consideration for this extension, the Company committed to total payments of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">600</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> through December 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">   </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company enters into contracts in the normal course of business with CROs, CMOs, universities, and other third parties for preclinical research studies, clinical trials and testing and manufacturing services. These contracts generally do not contain minimum purchase commitments and are cancelable by us upon prior written notice although, purchase orders for clinical materials are generally non-cancelable. Payments due upon cancellation consist only of payments for services provided or expenses incurred, including non-cancelable obligations of our service providers, up to the date of cancellation or upon the completion of a manufacturing run.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Guarantees</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has identified the guarantees described below as disclosable, in accordance with ASC 460, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Guarantees</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As permitted under Delaware law, the Company indemnifies its officers and directors for certain events or occurrences while the officer or director is, or was, serving at the Company&#8217;s request in such capacity. The maximum potential amount of future payments the Company could be required to make is unlimited; however, the Company has directors&#8217; and officers&#8217; insurance coverage that should limit its exposure and enable it to recover a portion of any future amounts paid.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is a party to a number of agreements entered into in the ordinary course of business that contain typical provisions that obligate the Company to indemnify the other parties to such agreements upon the occurrence of certain events. Such indemnification obligations are usually in effect from the date of execution of the applicable agreement for a period equal to the applicable statute of limitations. The aggregate maximum potential future liability of the Company under such indemnification provisions is uncertain.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company leases office space in Lexington, Massachusetts under a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ten-year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> noncancelable lease. The $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,700</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> security deposit for this lease is classified as restricted cash as of December 31, 2021. The Company exited the Woburn, Massachusetts facility in the second quarter of 2021. The Company has standard indemnification arrangements under these leases that require it to indemnify the landlord against all costs, expenses, fines, suits, claims, demands, liabilities, and actions directly resulting from any breach, violation, or nonperformance of any covenant or condition of the lease.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021 and 2020, the Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t experienced any losses related to these indemnification obligations, and no material claims with respect thereto were outstanding. The Company does not expect significant claims related to these indemnification obligations and, consequently, concluded that the fair value of these obligations is negligible, and no related reserves have been established.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Legal Contingencies</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company accrues a liability for legal contingencies when it believes that it is both probable that a liability has been incurred and that the Company can reasonably estimate the amount of the loss. The Company reviews these accruals and adjusts them to reflect ongoing negotiations, settlements, rulings, advice of legal counsel and other relevant information. To the extent new information is obtained and the views on the probable outcomes of claims, suits, assessments, investigations or legal proceedings change, changes in the Company&#8217;s accrued liabilities would be recorded in the period in which such determination is made.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, in accordance with the relevant authoritative guidance, for any matters in which the likelihood of material loss is at least reasonably possible, the Company will provide disclosure of the possible loss or range of loss. If a reasonable estimate cannot be made, however, the Company will provide disclosure to that effect. The Company expenses legal costs as they are incurred.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On June 3, 2021 and June 22, 2021, purported stockholders of the Company filed putative class action lawsuits in the U.S. District Court for the District of Massachusetts against the Company entitled Evans v. Frequency Therapeutics, Inc. et al. and Hingston v. Frequency Therapeutics, Inc. et al., respectively. The lawsuits allege violations of Section 10(b), 20(a) and Rule 10b5 of the Securities Exchange Act of 1934, as amended, due to allegedly false and misleading statements and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">omissions about the Company&#8217;s Phase 2a clinical trial (FX-322-202) for its product candidate FX-322 in the Company&#8217;s public disclosures between November 16, 2020 and March 22, 2021. The lawsuits seek, among other things, damages in connection with the Company&#8217;s allegedly artificially inflated stock price between November 16, 2020 and March 22, 2021 as a result of those allegedly false and misleading statements and omissions, as well as interest, attorneys&#8217; fees and costs. These matters are at the very early stages of the legal process, and as a result, the Company is not able to estimate a range of possible loss. The Company is vigorously defending against all claims asserted in both lawsuits. The Company has not yet filed a responsive pleading. Since an estimate of the possible loss or range of loss cannot be made at this time, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> accruals have been recorded as of December 31, 2021.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On June 24, 2021, two purported stockholders of the Company filed a lawsuit in the Court of Chancery of the State of Delaware against (i) the Company, (ii) the Company&#8217;s Chief Executive Officer, President, and Director, David Lucchino, (iii) Computershare Inc., and (iv) Computershare Trust Company, N.A., entitled The Gregory J. Parseghian Revocable Trust, et al. v. Frequency Therapeutics, Inc., et al. The lawsuit asserts causes of action against the Company of conversion and, in the alternative, unjust enrichment, and against Mr. Lucchino for breach of the fiduciary duty of loyalty, based on allegations that actions were taken to prevent the purported stockholders from selling their shares in the Company. The lawsuit seeks monetary damages, as well as interest, attorneys&#8217; fees and costs, against all defendants. This matter is at the very early stages of the legal process, and as a result, the Company is not able to estimate a range of possible loss. We are vigorously defending against all claims asserted and have filed a motion to dismiss the complaint, which remains pending. Since an estimate of the possible loss or range of loss cannot be made at this time, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> accruals have been recorded as of December 31, 2021.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417847519192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Employee Benefit Plan</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">16. Employee benefit plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Employees of the Company are eligible to participate in the Company&#8217;s 401(k) retirement plan (the &#8220;401(k) Plan&#8221;). Participants may contribute up to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of their annual compensation to the 401(k) Plan, subject to statutory limitations. Under the 401(k) Plan Safe Harbor Match, the Company matches </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the first </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of employee contributions and vests </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% at time of match. For the years ended December 31, 2021 and 2020, the Company made matching contributions of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">723</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">400</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417845212680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">17. Related party transactions</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As disclosed in Note 12, the Company entered into the MIT License Agreement in December 2016. The patents in-licensed by the Company from MIT pursuant to the MIT License Agreement claim inventions created by, among others, Dr. Langer, one of the Company&#8217;s directors. Accordingly, Dr. Langer has received $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,980</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> from MIT under the MIT Policy during the years ended December 31, 2021 and 2020, respectively.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company's lease for its Woburn, Massachusetts facility, terminated in May 2021 as disclosed in Note 14, was with an entity affiliated with one of the Company's directors and shareholders.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417839622792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Basis of presentation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying consolidated financial statements have been prepared in accordance with accounting standards set by the Financial Accounting Standards Board (FASB). The FASB sets generally accepted accounting principles (GAAP) that the Company follows to ensure its financial condition, results of operations, and cash flows are consistently reported. References to GAAP issued by the FASB in these notes to the consolidated financial statements are to the FASB </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accounting Standards</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Codification (ASC).</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Principles of consolidation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The consolidated financial statements include the accounts of Frequency Therapeutics, Inc. and its wholly owned subsidiaries Frequency Therapeutics Securities Corporation, Frequency Therapeutics PTY, LTD and Frequency Japan through the date of its dissolution. All intercompany transactions and balances have been eliminated.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of the Company&#8217;s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of expenses during the reporting period. On an ongoing basis, the Company&#8217;s management evaluates its estimates, which include but are not limited to management&#8217;s judgments of accrued expenses, revenue recognition, fair value of common stock, valuation of share-based awards, present value of lease liabilities and income taxes. Actual results could differ from those estimates.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive loss</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Comprehensive loss</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Components </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">of comprehensive income or loss, including net income or loss, are reported in the financial statements in the period in which they are recognized. Other comprehensive income or loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Net income (loss) and other comprehensive income (loss) are reported net of any related tax effect to arrive at comprehensive income (loss). Comprehensive loss includes net loss as well as other changes in stockholders&#8217; equity that result from transactions and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">economic </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">events other than those with stockholders which for the years ended December 31, 2021 and 2020 consist of unrealized loss on marketable securities. </span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Segment information</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision-maker in deciding how to allocate resources and assess performance. The Company and the Company&#8217;s chief operating decision-maker, the Company&#8217;s chief executive officer, views the Company&#8217;s operations and manages its business as a single operating segment, which is in the business of discovering and developing small molecule drugs that activate progenitor cells within the body to create healthy tissue.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Foreign currency</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All periods presented are reported in US dollars. The functional currency for entities outside the United States is the US dollar. Realized and unrealized gains and losses from foreign currency transactions are reflected in the consolidated statements of operations as other expense.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> During the years ended December 31, 2021 and 2020 the Company recorded $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">of foreign currency exchange gains and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of foreign currency exchange losses, respectively.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cash and cash equivalents</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company considers all highly liquid investments with an original maturity of six months or less at acquisition to be cash equivalents which are stated at fair market value. Cash and cash equivalents at December 31, 2021 and 2020 consists entirely of cash and money market funds.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Restricted cash</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,700</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of restricted cash as of December 31, 2021 which represents a security deposit on the Company's Lexington, Massachusetts facility. The $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,800</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of restricted cash at December 31, 2020 represented the security deposit on the Lexington, Massachusetts facility as well as a $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> security deposit on the Company's previous Woburn, Massachusetts facility.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Marketable securities</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Marketable securities represent holdings of available-for-sale marketable debt securities in accordance with the Company&#8217;s investment policy. Short-term marketable securities mature within one year from the balance sheet date while long-term marketable securities mature after one year. Investments in marketable securities are recorded at fair value, with any unrealized gains and losses reported within accumulated other comprehensive income as a separate component of stockholders&#8217; equity until realized or until a determination is made that an other-than-temporary decline in market value has occurred. The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization and accretion are reflected as a component of other expense. Interest on securities sold is determined based on the specific identification method and reflected as interest income. Any realized gains or losses on the sale of investment are reflected as realized (loss) gain on investments.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk and Off-balance Sheet Risk</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Concentration of credit risk and off-balance sheet risk</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instrument that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents and marketable securities. The Company maintains its cash, cash equivalents, and restricted cash at several accredited financial institutions, in amounts that exceed federally insured limits. Marketable securities consist of short term and long term investments. Management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which its money market accounts are maintained.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has no significant off-balance sheet arrangements such as foreign exchange contracts, option contracts, or other foreign hedging arrangements.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_SignificantSuppliersPolicyTextBlock', window );">Significant Suppliers</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Significant suppliers</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is dependent on third-party manufacturers to supply products for research and development activities of its programs, including preclinical and clinical testing. In particular, the Company relies and expects to continue to rely on a single manufacturer of its product candidates for use in clinical trials. The Company would be adversely affected by a significant interruption in the supply of product for use in clinical programs.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value Measurements</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Fair value measurements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Fair value is defined as the price that would be received upon sale of an asset or paid to transfer a liability between market participants at measurement dates. ASC Topic 820, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Fair Value Measurement</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (ASC 820), establishes a three-level valuation hierarchy for instruments measured at fair value. The hierarchy is based on the transparency of inputs to the valuation of an asset or liability as of the measurement date. The hierarchy defines three levels of valuation inputs, of which the first two are considered observable and the last is considered unobservable:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="margin-left:4.533%;text-indent:-10.836%;padding-left:9.333%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 1	Quoted prices in active markets for identical assets or liabilities.</span></p><p style="margin-left:4.533%;text-indent:-10.836%;padding-left:9.333%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 2	Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable,     such as quoted market prices, interest rates and yield curves.</span></p><p style="margin-left:4.533%;text-indent:-10.836%;padding-left:9.333%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 3	Unobservable inputs developed using estimates or assumptions developed by the Company, which reflect those that a market participant would use in pricing the asset or liability.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&#8217;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The carrying values of other current assets, accounts payable, and accrued expenses approximate their fair values due to the short-term nature of these assets and liabilities. The fair value of the Company&#8217;s Term Loan is </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t materially different from the carrying value as presented.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Property and equipment, net</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:12.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment consist of lab equipment, computer equipment, furniture and office equipment and leasehold improvements recorded at cost. These amounts are depreciated using the straight-line method over the estimated useful lives of the assets as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:71.997%;"/>
          <td style="width:1.002%;"/>
          <td style="width:27.001%;"/>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.175in;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.175in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Estimated useful life</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Lab equipment</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Software</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furniture and office equipment</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Leasehold improvements</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Shorter of the estimated useful</span></span></p><div><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">life or lease term</span></p></div></td>
         </tr>
        </table></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon retirement or sale, the cost of the assets disposed of and the related accumulated depreciation are eliminated from the balance sheet and related gains or losses are reflected in the consolidated statements of operations.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Impairment of long-lived assets</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company continually evaluates long-lived assets for potential impairment when events or changes in circumstances indicate the carrying value of the assets may not be recoverable. Recoverability is measured by comparing the book values of the assets to the expected future net undiscounted cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the book values of the assets exceed their fair value. The Company did </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t recognize any impairment losses for the years ended December 31, 2021 and 2020.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development Costs and Accruals</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and development costs and accruals</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">and development expenses include salaries and benefits, materials and supplies, preclinical and clinical trial expenses, stock-based compensation expense, depreciation of equipment, contract services and other outside expenses. The Company has entered into various research and development-related contracts with research institutions, contract research organizations, contract manufacturers and other companies. These agreements are generally cancelable, and related payments are recorded as research and development expenses as incurred. Costs of certain development activities, such as manufacturing, pre-clinical and clinical trial expenses, are recognized based on an evaluation of the progress to completion of specific tasks. Payments for these activities are based on the terms of the individual arrangements, which may differ from the pattern of costs incurred, and are reflected in the consolidated financial statements as prepaid or accrued research and development costs. Nonrefundable advance payments for goods or services to be received in the future for use in research and development activities are deferred and capitalized. The capitalized amounts are expensed as the related goods are delivered or the services are performed. Costs incurred in obtaining technology licenses are charged to research and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">development </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">expense as acquired in-process research and development if the technology licensed has not reached technological feasibility and has no alternative future use.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Leases</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company elected to early adopt ASC 842, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Leases</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (ASC 842) as of January 1, 2020 and elected the transition method under ASU 2016-02 whereby the Company records a right-to-use asset and a lease liability on the consolidated balance sheet for all leases with terms longer than 12 months. The Company also elected to apply the package of practical expedients intended to ease transition. Accordingly, the Company has only applied ASC 842 to leases existing at January 1, 2020. The Company determines if an arrangement is, or contains, a lease at inception. Operating leases are included in operating lease right-of-issue (&#8220;ROU&#8221;) assets, other current liabilities, and operating lease liabilities on the consolidated balance sheets.</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments to be made over the lease term. The ROU asset also includes any lease payments made at or before the lease commencement date and excludes lease incentives received. As the Company&#8217;s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Operating lease expense is recognized on a straight-line basis over the lease term. The Company has elected to not apply the recognition requirements of ASC 842 for short-term leases, which is defined as a lease that, at the lease commencement date, has a lease term of 12 months or less and does </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t include an option to purchase the underlying asset that the Company is reasonably certain to exercise.</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For real estate lease agreements entered into or modified after the adoption of ASC 842 that include lease and non-lease components, the Company has elected to account for the lease and non-lease components, such as common area maintenance charges, as a single lease component.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementAccountingPolicy', window );">Collaborative Arrangements</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Collaborative arrangements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company analyzes its collaborative arrangements to assess whether they are within the scope of ASC 808, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Collaborative Arrangements</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#8220;ASC 808&#8221;) to determine whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards dependent on the commercial success of such activities. This assessment is performed throughout the life of the arrangement based on changes in the responsibilities of all parties in the arrangement. For collaboration arrangements within the scope of ASC 808 that contain multiple elements, the Company first determines which elements of the collaboration are deemed to be within the scope of ASC 808 and those that are more reflective of a vendor-customer relationship (e.g., a licensing arrangement) where the contracted party has obtained goods or services that are an output of the Company&#8217;s ordinary activities in exchange for a consideration and therefore within the scope of ASC 606, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Revenue from Contracts with Customers</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#8220;ASC 606&#8221;). For those elements of the arrangement that are accounted for pursuant to ASC 606, including those to which ASC 606 is applied by analogy, the Company applies the five-step model described in the Company&#8217;s revenue recognition policy. For elements of collaborative arrangements that are accounted for pursuant to ASC 808, an appropriate and rational recognition method is determined and applied consistently. Reimbursements from the counterparty that are the result of a collaborative relationship with the counterparty, instead of a customer relationship, such as co-development or clinical activities, are recorded as a reduction to research and development expense as the services are performed. Similarly, amounts that are owed to a collaboration partner related to the co-development clinical activities are recognized as research and development expense.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company enters into out-licensing agreements that are within the scope of ASC 606. The terms of such out-license agreements include licenses to functional intellectual property (IP), given the functionality of the intellectual property is not expected to change substantially as a result of the licensor&#8217;s ongoing activities. Such arrangements typically include payment of one or more of the following: non-refundable up-front license fees; reimbursement of certain costs; development and regulatory milestone payments and milestone payments based on the level of sales; and royalties on net sales of licensed products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company considers the economic and regulatory characteristics of the licensed IP, research, development, manufacturing and commercialization capabilities of the licensee and the availability of the associated expertise in the general marketplace to determine if it has standalone value at the inception of the licensing arrangement, which would make the license distinct. In addition, the Company considers whether the licensee can benefit from a promise for its intended purpose without the receipt of any additional good or services promised in the contract, whether the value of the license is dependent on the remaining goods and services, whether there are other vendors that could provide the remaining promise, and whether the license is separately identifiable from the remaining good and services. For licenses that are combined with</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">other goods and services, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of progress and related revenue recognition. The measure of progress, and thereby periods over which revenue should be recognized, are subject to estimates by management and may change over the course of the research and development and licensing agreement. Such a change could have a material impact on the amount of revenue the Company records in future periods.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Revenue is allocated to the licensed IP on a relative standalone selling price basis and, for functional IP, is recognized at a point when the licensed IP is made available for the customer&#8217;s use and benefit, which generally occurs at the inception of the arrangement. However, in cases, where the functionality of the IP is expected to substantively change as a result of activities of the Company that do not transfer additional promised goods or services, or in cases, where there is an expectation that the Company will undertake activities to change the standalone functionality of the IP and the customer is contractually or practically required to use the latest version of the IP, revenue for the license to functional IP is recognized over time.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Development and regulatory milestone fees, which are a type of variable consideration, are recognized as revenue to the extent that it is probable that a significant reversal will not occur. The Company recognizes royalty revenue and sales-based milestones at the later of (i) when the related sales occur, or (ii) when the performance obligation to which the royalty has been allocated has been satisfied.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has entered into a collaboration arrangement with Astellas Pharma Inc. (&#8220;Astellas&#8221;), as further described in Note 13 of notes to consolidated financial statements.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Revenue recognition</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company accounts for contracts with customers in accordance with ASC 606, including all amendments thereto. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as collaborative arrangements and leases. The Company&#8217;s disclosure within the below sections or elsewhere within these consolidated financial statements reflects the Company&#8217;s accounting policies in compliance with this new standard.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under ASC 606, an entity recognizes revenue when or as its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To recognize revenue for arrangements that an entity determines are within the scope of ASC 606, the entity performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price, including variable consideration, if any; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies its performance obligations. The Company only applies the five-step model to contracts when it is probable that the entity will collect substantially all of the consideration to which it will be entitled in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and identifies as a performance obligation each promise to transfer to the customer either (a) a good or service (or bundle of goods and services) that is distinct, or (b) a series of distinct goods and services that are substantially the same and have been the same pattern of transfer to the customer.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company assesses whether each promised good or service is distinct for the purpose of identifying the performance obligations in the contract. This assessment involves subjective determinations and requires management to make judgments about the individual promised goods or services and whether such are separable from the other aspects of the contractual relationship. Promised goods and services are considered distinct provided that: (i) the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (that is, the good or service is capable of being distinct) and (ii) the entity&#8217;s promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (that is, the promise to transfer the good or service is distinct within the context of the contract). In assessing whether a promised good or service is distinct, the Company considers factors such as the research, manufacturing and commercialization capabilities of the collaboration partner (the &#8220;customer&#8221; in this type of arrangement) and the availability of the associated expertise in the general marketplace. The Company also considers the intended benefit of the contract in assessing whether a promised good or service is separately identifiable from other promises in the contract. If a promised good or service is not distinct, an entity is required to combine that good or service with other promised goods or services until it identifies a bundle of goods or services that is distinct. For each arrangement that results in revenues, the Company identifies all performance obligations, which may include, for example, a license to IP and know-how, research and development activities, and/or manufacturing services.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to any upfront payment, if the consideration promised in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the promised goods</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">or services to a customer. The Company determines the amount of variable consideration by using the expected value method or the most likely amount method. The Company includes the estimated variable consideration in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, the Company re-evaluates the estimated variable consideration included in the transaction price and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis in the period of adjustment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If an arrangement includes development and regulatory milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. There is considerable judgment involved in determining whether it is probable that a significant revenue reversal would not occur. If it is probable that a significant revenue reversal will not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or of the licensee such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of all milestones subject to constraint and, if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For contracts that include sales-based royalties (including milestone payments based on the level of sales) promised in the exchange for licenses of intellectual property, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes royalty revenue and sales-based milestone payments at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied. In determining the transaction price, the Company adjusts the promised amount of consideration for the effects of the time value of money if the timing of payments provides the Company or the Company&#8217;s customer with a significant benefit of financing the transfer of goods and services. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be one year or less. The Company assesses each of its revenue generating arrangements in order to determine whether a significant financing component exists. The Company recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) each performance obligation is satisfied, either at a point in time or over time.  For performance obligations satisfied over time, the Company measures progress toward completion of its performance obligations using an input method based on the Company&#8217;s efforts and inputs to satisfy its performance obligations relative to total expected inputs to the satisfaction of that performance obligation.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Amounts received from a customer prior to revenue recognition are recorded as deferred revenue. Amounts received from a customer that are expected to be recognized as revenue within the 12 months following the balance sheet date are classified as a current liability in the accompanying consolidated balance sheets.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_PatentCostsPolicyTextBlock', window );">Patent Costs</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Patent costs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company expenses patent application and related legal costs as incurred and classifies such costs as general and administrative expenses in the accompanying consolidated statements of operations.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-based compensation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company accounts for its stock-based compensation in accordance with ASC Topic 718, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Compensation&#8212;Stock Compensation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (ASC 718). ASC 718 requires all share-based payments to employees and directors to be recognized as expense in the consolidated statements of operations and comprehensive loss based on their grant date fair values. The Company adopted FASB Accounting Standards Update (ASU) 2016-09 which identifies areas for simplification of several areas of share-based payment transactions. The Company treats non-employee grants in a manner consistent with employee grants. The Company estimates the fair value of options granted using the Black-Scholes option pricing model for stock option grants to both employees and non-employees. The Company believes the fair value of the stock options granted to non-employees is more reliably determinable than the fair value of the services provided.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Black-Scholes option pricing model requires inputs based on certain subjective assumptions, including (a) the expected stock price volatility, (b) the expected term of the award, (c) the risk-free interest rate and (d) expected dividends. Due to the lack of sufficient company-specific historical and implied volatility data, the Company has based its computation of expected volatility on the historical volatility of a representative group of public companies with similar characteristics to the Company, including stage of product development and life science industry focus. The historical volatility is calculated based on a period of time commensurate with the expected term assumption. The Company uses the simplified method as prescribed by the SEC Staff Accounting Bulletin No. 107, Share-Based Payment, to calculate the expected term for options granted to employees as it does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The expected term is applied to the stock option grant group as a whole, as the Company does not expect substantially different exercise or post-vesting termination behavior among its employee population. For options granted to non-employees, the Company utilizes the contractual term of the share-based payment as the basis for the expected term assumption. The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected term of the stock options. The expected dividend yield is assumed to be zero as the Company has never paid dividends and has no current plans to pay any dividends on its common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company expenses the fair value of its share-based compensation awards to employees and non-employees on a straight-line basis over the requisite service period, which is generally the vesting period.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income taxes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company accounts for income taxes using the asset and liability method in accordance with ASC Topic 740, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income Taxes</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (ASC 740) which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the Company&#8217;s tax returns. Deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. At December 31, 2021 and 2020, the Company has concluded that a full valuation allowance is necessary for its deferred tax assets (see Note 11).</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Net loss per share</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed using the weighted-average number of shares of common stock outstanding during the period and, if dilutive, the weighted-average number of potential shares of common stock. Diluted net loss per share is the same as basic net loss per share for the years ended December 31, 2021 and 2020 since all potential shares of common stock instruments are anti-dilutive as a result of the loss for such periods.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s convertible preferred stock contractually entitled the holders of such shares to participate in dividends but did not contractually require the holders of such shares to participate in losses of the Company. Accordingly, in periods in which the Company reported a net loss, such losses are not allocated to such participating securities. In periods where the Company reported a net loss attributable to common stockholders, diluted net loss per share is the same as basic net loss per share, since dilutive shares of common stock are not assumed to have been issued if their effect is anti-dilutive. The Company reported a net loss attributable to common stockholders for the years ended December 31, 2021 and 2020.</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Basic and diluted net loss per share attributable to common stockholders was calculated as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:52.878%;"/>
          <td style="width:1.378%;"/>
          <td style="width:2.061%;"/>
          <td style="width:18.687%;"/>
          <td style="width:1.378%;"/>
          <td style="width:1.492%;"/>
          <td style="width:2.061%;"/>
          <td style="width:18.687%;"/>
          <td style="width:1.378%;"/>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended <br/>December 31,</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Numerator:</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">84,686</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26,511</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Denominator:</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average shares of common stock<br/>&#160;&#160;&#160;outstanding-basic and diluted</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">34,351,274</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32,253,227</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss per share-basic and diluted</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.47</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.82</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
         </tr>
        </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company excluded the following potential shares of common stock from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:55.109%;"/>
          <td style="width:1.478%;"/>
          <td style="width:0.853%;"/>
          <td style="width:19.199%;"/>
          <td style="width:0.853%;"/>
          <td style="width:1.606%;"/>
          <td style="width:0.853%;"/>
          <td style="width:19.199%;"/>
          <td style="width:0.853%;"/>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended <br/>December 31,</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested restricted common stock</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,093</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested restricted stock units</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">626,300</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding stock options</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,830,037</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,816,798</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,456,337</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,819,891</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
        </table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recently adopted accounting pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In August 2018, the FASB issued ASU No. 2018-15,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> Intangibles - Goodwill and Other - Internal-Use Software</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract. This standard addresses the accounting for implementation costs incurred by a customer in a cloud computing arrangement that is a service contract and also adds certain disclosure requirements related to implementation costs incurred for internal-use software and cloud computing arrangements. The amendment aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The Company adopted this standard on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2021</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, using a prospective approach. The adoption of this new standard did not have a material </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">impact</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> on the consolidated financial statements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2019, the FASB issued ASU 2019-12 amending accounting guidance that simplifies the accounting for income taxes, as part of its initiative to reduce complexity in the accounting standards. The amendments eliminate certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The amendments also clarify and simplify other aspects of the accounting for income taxes. The Company adopted this standard on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2021</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and it did not have a material </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">impact</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> on the consolidated financial statements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recently issued accounting pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. The Company is an &#8220;emerging growth company&#8221; as defined in the Jumpstart Our Business Startups Act of 2012, as amended (Jobs Act). The Jobs Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. Thus, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company elected to avail itself of this extended transition period and, as a result, we will not be required to adopt new or revised accounting standards on the relevant dates on which adoption of such standards is required for other public companies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In June 2016, the FASB issued ASU No. 2016-13, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Financial Instruments - Credit Losses</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (Topic 326): Measurement of Credit Losses on Financial Instruments. The FASB has subsequently issued amendments to ASU 2016-13, which have the same effective date and transition date. These standards require that credit losses be reported using an expected losses model rather than the incurred losses model that was previously used, and establishes additional disclosures related to credit risks. For available-for-sale debt securities with unrealized losses, this standard now requires allowances to be recorded instead of reducing the amortized cost of the investment. These standards limit the amount of credit losses to be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. This standard will become effective for the Company on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2023</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The Company is still evaluating the </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">impact</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of this standard on its consolidated financial statements.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_PatentCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Patent costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_PatentCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_SignificantSuppliersPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Significant suppliers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_SignificantSuppliersPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementAccountingPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for collaborative arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementAccountingPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=d3e62652-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417926335672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_PropertyAndEquipmentTableTextBlock', window );">Property And Equipment</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment consist of lab equipment, computer equipment, furniture and office equipment and leasehold improvements recorded at cost. These amounts are depreciated using the straight-line method over the estimated useful lives of the assets as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:71.997%;"/>
          <td style="width:1.002%;"/>
          <td style="width:27.001%;"/>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.175in;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.175in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Estimated useful life</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Lab equipment</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Software</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furniture and office equipment</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Leasehold improvements</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Shorter of the estimated useful</span></span></p><div><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">life or lease term</span></p></div></td>
         </tr>
        </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Net Loss per Share</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Basic and diluted net loss per share attributable to common stockholders was calculated as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:52.878%;"/>
          <td style="width:1.378%;"/>
          <td style="width:2.061%;"/>
          <td style="width:18.687%;"/>
          <td style="width:1.378%;"/>
          <td style="width:1.492%;"/>
          <td style="width:2.061%;"/>
          <td style="width:18.687%;"/>
          <td style="width:1.378%;"/>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended <br/>December 31,</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Numerator:</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">84,686</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26,511</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Denominator:</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average shares of common stock<br/>&#160;&#160;&#160;outstanding-basic and diluted</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">34,351,274</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32,253,227</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss per share-basic and diluted</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.47</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.82</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
         </tr>
        </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Computation of Diluted Net Loss per Share</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company excluded the following potential shares of common stock from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:55.109%;"/>
          <td style="width:1.478%;"/>
          <td style="width:0.853%;"/>
          <td style="width:19.199%;"/>
          <td style="width:0.853%;"/>
          <td style="width:1.606%;"/>
          <td style="width:0.853%;"/>
          <td style="width:19.199%;"/>
          <td style="width:0.853%;"/>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended <br/>December 31,</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:8.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested restricted common stock</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,093</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested restricted stock units</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">626,300</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding stock options</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,830,037</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,816,798</span></p></td>
          <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,456,337</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,819,891</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
         <tr>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
         </tr>
        </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_PropertyAndEquipmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Property and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_PropertyAndEquipmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417845087976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of Financial Assets Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s financial assets measures at fair value on a recurring basis by level within the fair value hierarchy at December 31, 2021 and 2020 are summarized as follows:</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:41.9%;"/>
        <td style="width:1.302%;"/>
        <td style="width:12.95%;"/>
        <td style="width:1.302%;"/>
        <td style="width:1.272%;"/>
        <td style="width:11.409%;"/>
        <td style="width:0.636%;"/>
        <td style="width:1.302%;"/>
        <td style="width:1.272%;"/>
        <td style="width:11.201%;"/>
        <td style="width:0.865%;"/>
        <td style="width:1.302%;"/>
        <td style="width:1.272%;"/>
        <td style="width:11.379%;"/>
        <td style="width:0.636%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Fair Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Amortization</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Unrealized</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Fair Market</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Hierarchy</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Cost</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(Loss)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">48,160</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">48,160</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Short-term marketable securities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">51,116</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">51,072</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Long-term marketable securities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,764</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">45</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,719</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">    </span>&#160;</p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">111,040</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">89</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">110,951</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:41.894%;"/>
        <td style="width:1.302%;"/>
        <td style="width:12.971%;"/>
        <td style="width:1.302%;"/>
        <td style="width:1.272%;"/>
        <td style="width:11.42%;"/>
        <td style="width:0.636%;"/>
        <td style="width:1.302%;"/>
        <td style="width:1.272%;"/>
        <td style="width:11.391%;"/>
        <td style="width:0.636%;"/>
        <td style="width:1.302%;"/>
        <td style="width:1.272%;"/>
        <td style="width:11.391%;"/>
        <td style="width:0.636%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="10" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Fair Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Amortization</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Unrealized</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Fair Market</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Hierarchy</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Cost</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Gain</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">214,522</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">27</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">214,549</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">     </span>&#160;</p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">214,522</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">27</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">214,549</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417847523080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses and Other Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock', window );">Summary of Prepaid Expenses and Other Current Assets</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prepaid expenses and other current assets consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.816%;"/>
        <td style="width:1.481%;"/>
        <td style="width:1.282%;"/>
        <td style="width:13.192%;"/>
        <td style="width:0.636%;"/>
        <td style="width:1.481%;"/>
        <td style="width:1.282%;"/>
        <td style="width:13.192%;"/>
        <td style="width:0.636%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Rent and deposits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">470</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_1798d1a5-8d3c-4e74-b507-c3d76c7abeb0;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development expenses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">858</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,729</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accounts receivable</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">144</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">340</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Insurance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,384</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,552</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">185</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">102</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,041</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,723</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary of prepaid expenses and other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417847521976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment include the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:56.446%;"/>
        <td style="width:1.879%;"/>
        <td style="width:1.282%;"/>
        <td style="width:17.642%;"/>
        <td style="width:0.964%;"/>
        <td style="width:1.879%;"/>
        <td style="width:1.282%;"/>
        <td style="width:17.662%;"/>
        <td style="width:0.964%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Lab equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,177</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,166</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furniture and office equipment</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,238</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">283</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Software</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">291</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">291</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Leasehold improvements</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,419</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Construction in progress</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,340</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9,706</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,499</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accumulated depreciation</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,184</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,212</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment, net</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,522</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,287</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417847198600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses consist of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.2%;"/>
        <td style="width:1.392%;"/>
        <td style="width:1.282%;"/>
        <td style="width:12.742%;"/>
        <td style="width:0.964%;"/>
        <td style="width:1.411%;"/>
        <td style="width:1.282%;"/>
        <td style="width:12.762%;"/>
        <td style="width:0.964%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Payroll and employee related expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,375</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,062</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Professional fees</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">767</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">647</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Third-party research and development expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">840</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">874</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">119</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">80</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,101</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,663</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417845261080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock', window );">Schedule of Common Stock Shares Reserved for Future Issuance</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has reserved the following shares of common stock for future issuance as of December 31, 2021 and 2020:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.146%;"/>
        <td style="width:1.779%;"/>
        <td style="width:1.004%;"/>
        <td style="width:11.33%;"/>
        <td style="width:1.004%;"/>
        <td style="width:1.779%;"/>
        <td style="width:1.004%;"/>
        <td style="width:15.951%;"/>
        <td style="width:1.004%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock options outstanding</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,830,037</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,816,798</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Shares available for future grant under stock option plan</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,552,630</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,475,923</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,382,667</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,292,721</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of common stock shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417839979704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity under 2014 Plan and 2019 Plan</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A summary of the stock option activity under the 2014 Plan and the 2019 Plan are as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:42.779%;"/>
        <td style="width:0.736%;"/>
        <td style="width:0.507%;"/>
        <td style="width:12.355%;"/>
        <td style="width:0.686%;"/>
        <td style="width:0.736%;"/>
        <td style="width:1.044%;"/>
        <td style="width:12.056%;"/>
        <td style="width:0.507%;"/>
        <td style="width:0.736%;"/>
        <td style="width:0.517%;"/>
        <td style="width:12.494%;"/>
        <td style="width:0.507%;"/>
        <td style="width:0.736%;"/>
        <td style="width:1.044%;"/>
        <td style="width:12.056%;"/>
        <td style="width:0.507%;"/>
       </tr>
       <tr style="height:7.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Number of<br/>shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Weighted<br/>average<br/>exercise price</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Weighted<br/>average<br/>remaining<br/>contractual<br/>term (in years)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Aggregate<br/>intrinsic value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Outstanding as of December 31, 2019</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">5,968,672</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">5.21</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">9.08</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">73,561</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">1,645,859</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">24.22</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">9.30</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">769,385</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">1.99</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">16,667</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Forfeited</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">28,348</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">16.38</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Outstanding as of December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">6,816,798</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">10.11</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">8.45</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">171,415</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">1,357,426</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">32.76</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">8.07</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">642,314</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2.02</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">11,652</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Forfeited</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">701,873</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">16.48</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Outstanding as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">6,830,037</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">14.72</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">7.76</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">6,987</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Options exercisable as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">3,993,231</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">9.77</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">7.34</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">6,275</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Options unvested as of December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2,836,806</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">21.70</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">8.36</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">712</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Grant-date Fair Value of Stock Options Granted on Weighted Average Basis</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The assumptions that the Company used to determine the grant-date fair value of stock options granted to</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">employees and directors were as follows, presented on a weighted average basis:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:53.724%;"/>
        <td style="width:1.364%;"/>
        <td style="width:0.981%;"/>
        <td style="width:17.268%;"/>
        <td style="width:3.525%;"/>
        <td style="width:1.364%;"/>
        <td style="width:0.981%;"/>
        <td style="width:17.268%;"/>
        <td style="width:3.525%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Risk-free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.5</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected term (in years)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.0</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.0</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected volatility</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">79.8</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">79.1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected dividend yield</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.0</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.0</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Status of Restricted Common Stock</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A summary of the status of restricted common stock as of December 31, 2021 and 2020 is presented below:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.673%;"/>
        <td style="width:1.491%;"/>
        <td style="width:0.646%;"/>
        <td style="width:13.627%;"/>
        <td style="width:0.865%;"/>
        <td style="width:1.491%;"/>
        <td style="width:1.282%;"/>
        <td style="width:13.289%;"/>
        <td style="width:0.636%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Number of<br/>shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Weighted<br/>average fair<br/>value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested, December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,093</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.75</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Awarded</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vested</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">928</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.75</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Forfeited</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,165</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.75</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested, December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Summary of Status of Restricted Common Stock</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A summary of the status of restricted stock units as of December 31, 2021 and 2020 is presented below:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.547%;"/>
        <td style="width:1.481%;"/>
        <td style="width:0.636%;"/>
        <td style="width:13.799%;"/>
        <td style="width:0.865%;"/>
        <td style="width:1.481%;"/>
        <td style="width:1.282%;"/>
        <td style="width:13.272%;"/>
        <td style="width:0.636%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Number of<br/>shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Weighted<br/>average fair<br/>value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested, December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Awarded</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">800,000</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.54</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vested</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Forfeited</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">173,700</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.54</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Unvested, December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">626,300</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.54</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417848031272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Reconciliation Pre-tax Income</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A reconciliation of the Company&#8217;s pre-tax income for the years ended December 31, 2021 and 2020 is as follows:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.763%;"/>
        <td style="width:0.845%;"/>
        <td style="width:2.048%;"/>
        <td style="width:12.245%;"/>
        <td style="width:1.461%;"/>
        <td style="width:0.865%;"/>
        <td style="width:2.048%;"/>
        <td style="width:12.265%;"/>
        <td style="width:1.461%;"/>
       </tr>
       <tr style="height:10.8pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.95pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Domestic</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">84,624</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25,744</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:12.95pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Foreign</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">47</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">732</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:13.7pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">84,671</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26,476</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Provision</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s provision at December 31, 2021 and 2020 consist of the following:</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:67.121%;"/>
        <td style="width:1.123%;"/>
        <td style="width:2.067%;"/>
        <td style="width:12.514%;"/>
        <td style="width:0.706%;"/>
        <td style="width:1.163%;"/>
        <td style="width:2.067%;"/>
        <td style="width:12.534%;"/>
        <td style="width:0.706%;"/>
       </tr>
       <tr style="height:10.1pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.25pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Current:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.25pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;&#160;&#160;&#160;Federal</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">35</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.95pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;&#160;&#160;&#160;State</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.95pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;&#160;&#160;&#160;Foreign</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.25pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total current</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">35</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.25pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deferred:</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.95pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;&#160;&#160;&#160;Federal</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.25pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;&#160;&#160;&#160;State</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.95pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;&#160;&#160;&#160;&#160;Foreign</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.25pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total Deferred</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:12.25pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total provision (benefit)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">35</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of U.S. Federal Statutory Income Tax Rate</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A reconciliation of the U.S. federal statutory income tax rate to the Company&#8217;s effective income tax rate for the years ended December 31, 2021 and 2020 is as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:62.7%;"/>
        <td style="width:1.859%;"/>
        <td style="width:0.636%;"/>
        <td style="width:14.355%;"/>
        <td style="width:2.137%;"/>
        <td style="width:1.859%;"/>
        <td style="width:0.636%;"/>
        <td style="width:13.679%;"/>
        <td style="width:2.137%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S federal statutory income tax rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Permanent differences</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_ac776299-523f-419b-b2ba-1e3e866cfec3;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.2</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">State income taxes, net of federal benefit</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.7</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.0</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development tax credits</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.6</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11.2</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock compensation deductions</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.6</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.1</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other items</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.7</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.6</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Change in deferred tax asset valuation allowance</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">28.2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">40.7</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Effective income tax rate</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_ded4314f-4db0-4f7e-8996-c64ecbefa332;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s deferred tax assets at December 31, 2021 and 2020 consist of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:62.662%;"/>
        <td style="width:1.038%;"/>
        <td style="width:2.119%;"/>
        <td style="width:14.105%;"/>
        <td style="width:1.408%;"/>
        <td style="width:1.038%;"/>
        <td style="width:2.119%;"/>
        <td style="width:14.105%;"/>
        <td style="width:1.408%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">36,590</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17,885</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development tax credits</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,026</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,992</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Intangibles</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">392</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">360</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock compensation</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,554</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">850</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">107</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deferred revenue</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,606</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">176</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">142</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Fixed assets</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">265</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">56</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Lease liability</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,269</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,285</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Right of use asset</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,448</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,181</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total deferred tax asset</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50,931</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26,995</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50,931</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26,995</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417926516488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Leases</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:77.097%;"/>
        <td style="width:1.67%;"/>
        <td style="width:0.805%;"/>
        <td style="width:18.28%;"/>
        <td style="width:2.147%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Other information</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average remaining operating lease term</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.4</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;years</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average discount rate</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.5</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Reconciles the Undiscounted Cash Flows to the Operating Lease Liability</a></td>
<td class="text"><p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The table below reconciles the undiscounted cash flows to the operating lease liability recorded on the consolidated balance sheet as of December 31, 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:77.452%;"/>
        <td style="width:1.833%;"/>
        <td style="width:1.278%;"/>
        <td style="width:18.457%;"/>
        <td style="width:0.981%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,159</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2023</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,284</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2024</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,412</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2025</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,545</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2026</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,681</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Thereafter</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">22,389</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total minimum lease payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44,470</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Less: amount of lease payments representing interest</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13,872</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Present value of future lease payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30,598</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Less: current lease liabilities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,747</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Noncurrent lease liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">28,851</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Aggregate Minimum Payments</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Future aggregate minimum payments under the noncancelable operating leases and short term leases, including the Lexington, MA lease and Connecticut lease, which is not subject to ASC 842, as of December 31, 2021 are as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:76.935%;"/>
        <td style="width:1.653%;"/>
        <td style="width:2.133%;"/>
        <td style="width:17.956%;"/>
        <td style="width:0.248%;"/>
        <td style="width:1.075%;"/>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,161</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2023</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,284</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2024</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,412</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2025</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,545</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2026</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,681</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2027 and beyond</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">22,388</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total minimum lease payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44,471</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417926262888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary Sale Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationDateOfIncorporation', window );">Date of incorporation</a></td>
<td class="text">Nov. 30,  2014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 180,085<span></span>
</td>
<td class="nump">$ 95,399<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationDateOfIncorporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when an entity was incorporated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationDateOfIncorporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417839769336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency exchange (losses) gains</a></td>
<td class="nump">$ 16,000<span></span>
</td>
<td class="num">$ (4,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">1,699,000<span></span>
</td>
<td class="nump">1,820,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_FairValueOfTermLoan', window );">Fair value of term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right of use assets</a></td>
<td class="nump">31,350,000<span></span>
</td>
<td class="nump">30,551,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liability</a></td>
<td class="nump">30,598,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_IncreaseDecreaseInOperatingLeaseRightOfUseAssets', window );">Increase in right-of-use asset</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201815Member', window );">Accounting Standards Update 2018-15</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate', window );">Change in accounting principle, accounting standards update, adoption date</a></td>
<td class="text">Jan.  01,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect', window );">Change in accounting principle, accounting standards update, immaterial effect</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member', window );">Accounting Standards Update 2016-13</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate', window );">Change in accounting principle, accounting standards update, adoption date</a></td>
<td class="text">Jan.  01,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect', window );">Change in accounting principle, accounting standards update, immaterial effect</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201912Member', window );">Accounting Standards Update 2019-12</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate', window );">Change in accounting principle, accounting standards update, adoption date</a></td>
<td class="text">Jan.  01,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect', window );">Change in accounting principle, accounting standards update, immaterial effect</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=freq_LexingtonMassachusettsFacilityMember', window );">Lexington Massachusetts facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=freq_WoburnMassachusettsFacilityMember', window );">Woburn Massachusetts Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_FairValueOfTermLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of term loan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_FairValueOfTermLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_IncreaseDecreaseInOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in operating lease right of use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_IncreaseDecreaseInOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary Of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date accounting standards update was adopted, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123341672&amp;loc=SL120154346-209984<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 65<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121483254&amp;loc=SL120254523-199619<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120254519-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31010-122693<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123602790&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124440516&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201815Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201815Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201613Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201912Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201912Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=freq_LexingtonMassachusettsFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=freq_LexingtonMassachusettsFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=freq_WoburnMassachusettsFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=freq_WoburnMassachusettsFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417844067672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=freq_LabEquipmentMember', window );">Lab Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=freq_FurnitureAndOfficeEquipmentMember', window );">Furniture and Office Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful lives</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Leasehold improvements, estimated useful lives</a></td>
<td class="text">Shorter of the estimated usefullife or lease term<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary Of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123364984&amp;loc=d3e1205-110223<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=freq_LabEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=freq_LabEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=freq_FurnitureAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=freq_FurnitureAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417839624360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Basic And Diluted Net Loss per Share Attributable to Common Stockholders (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss</a></td>
<td class="num">$ (84,686)<span></span>
</td>
<td class="num">$ (26,511)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average shares of common stock outstanding- basic and diluted</a></td>
<td class="nump">34,351,274<span></span>
</td>
<td class="nump">32,253,227<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share-basic and diluted</a></td>
<td class="num">$ (2.47)<span></span>
</td>
<td class="num">$ (0.82)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417840805304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Computation of Diluted Net Loss per Share Attributable to Common Stockholders (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">7,456,337<span></span>
</td>
<td class="nump">6,819,891<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=freq_UnvestedRestrictedCommonStockMember', window );">Unvested Restricted Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,093<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=freq_UnvestedRestrictedStockUnitsMember', window );">Unvested Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">626,300<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=freq_OutstandingStockOptionsMember', window );">Outstanding Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share</a></td>
<td class="nump">6,830,037<span></span>
</td>
<td class="nump">6,816,798<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=freq_UnvestedRestrictedCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=freq_UnvestedRestrictedCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=freq_UnvestedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=freq_UnvestedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=freq_OutstandingStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=freq_OutstandingStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417843761704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Financial Assets Measured on Recurring Basis (Details) - Recurring Basis - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortization Cost</a></td>
<td class="nump">$ 111,040<span></span>
</td>
<td class="nump">$ 214,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(89)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Market Value</a></td>
<td class="nump">110,951<span></span>
</td>
<td class="nump">214,549<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember', window );">Money Market Funds | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortization Cost</a></td>
<td class="nump">48,160<span></span>
</td>
<td class="nump">214,522<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Market Value</a></td>
<td class="nump">48,160<span></span>
</td>
<td class="nump">$ 214,549<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=freq_ShortTermMarketableSecuritiesMember', window );">Short-term Marketable Securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortization Cost</a></td>
<td class="nump">51,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(44)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Market Value</a></td>
<td class="nump">51,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=freq_LongTermMarketableSecuritiesMember', window );">Long-term Marketable Securities | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortization Cost</a></td>
<td class="nump">11,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Loss</a></td>
<td class="num">(45)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Market Value</a></td>
<td class="nump">$ 11,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=freq_ShortTermMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=freq_ShortTermMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=freq_LongTermMarketableSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=freq_LongTermMarketableSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417843821944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract', window );"><strong>Prepaid Expense and Other Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_PrepaidRentAndDepositsCurrent', window );">Rent and deposits</a></td>
<td class="nump">$ 470<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_PrepaidResearchAndDevelopmentExpenseCurrent', window );">Research and development expenses</a></td>
<td class="nump">858<span></span>
</td>
<td class="nump">1,729<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_PrepaidAccountsReceivableCurrent', window );">Accounts receivable</a></td>
<td class="nump">144<span></span>
</td>
<td class="nump">340<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidInsurance', window );">Insurance</a></td>
<td class="nump">2,384<span></span>
</td>
<td class="nump">2,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other</a></td>
<td class="nump">185<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total</a></td>
<td class="nump">$ 4,041<span></span>
</td>
<td class="nump">$ 4,723<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_PrepaidAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid accounts receivable current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_PrepaidAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_PrepaidRentAndDepositsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rent and deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_PrepaidRentAndDepositsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_PrepaidResearchAndDevelopmentExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid research and development expense current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_PrepaidResearchAndDevelopmentExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417847313368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 9,706<span></span>
</td>
<td class="nump">$ 10,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(4,184)<span></span>
</td>
<td class="num">(3,212)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">5,522<span></span>
</td>
<td class="nump">7,287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Lab Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">6,177<span></span>
</td>
<td class="nump">4,166<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and Office Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">3,238<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">291<span></span>
</td>
<td class="nump">291<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,419<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,340<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417840027176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 2,775<span></span>
</td>
<td class="nump">$ 1,146<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417843821912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Payroll and employee related expenses</a></td>
<td class="nump">$ 4,375<span></span>
</td>
<td class="nump">$ 5,062<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
<td class="nump">767<span></span>
</td>
<td class="nump">647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent', window );">Third-party research and development expenses</a></td>
<td class="nump">840<span></span>
</td>
<td class="nump">874<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 6,101<span></span>
</td>
<td class="nump">$ 6,663<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued income taxes and other accrued liabilities, current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued third-party research and development expenses current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417839547032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 11, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=freq_LoanAndSecurityAgreementMember', window );">Loan Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest Expense, Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 764<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=freq_LoanAndSecurityAgreementMember', window );">Loan Agreement | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal balance</a></td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPaymentTerms', window );">Payment terms, description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company will make monthly interest only payments through November 30, 2022. The principal balance and interest will be repaid in equal monthly installments after the interest only period and continue through May 1, 2024 (the &#8220;Loan Maturity Date&#8221;)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment', window );">Frequency of interest-only payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">monthly<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_DebtInstrumentInterestOnlyPaymentMaturityDate', window );">Monthly interest only payments due</a></td>
<td class="text">Nov. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentMaturityDate', window );">Loan maturity date</a></td>
<td class="text">May  01,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.75%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_DebtInstrumentFloorInterestRatePercentage', window );">Interest rate floor percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid', window );">Debt instrument final payment</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=freq_LoanAndSecurityAgreementMember', window );">Loan Agreement | Term Loan | Prepayment Occurs on or Prior to First Anniversary of Closing Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_DebtInstrumentPrepaymentPremiumPercentage', window );">Debt instrument prepayment premium percentage</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=freq_LoanAndSecurityAgreementMember', window );">Loan Agreement | Term Loan | Prepayment Occurs After First Anniversary of Closing Date and On or Prior to Second Anniversary of Closing Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_DebtInstrumentPrepaymentPremiumPercentage', window );">Debt instrument prepayment premium percentage</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=freq_LoanAndSecurityAgreementMember', window );">Loan Agreement | Term Loan | Prepayment Occurs After Second Anniversary of Closing Date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_DebtInstrumentPrepaymentPremiumPercentage', window );">Debt instrument prepayment premium percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=freq_LoanAndSecurityAgreementMember', window );">Loan Agreement | Term Loan | Prime Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Debt instrument, Interest rate</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_DebtInstrumentFloorInterestRatePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument floor interest rate percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_DebtInstrumentFloorInterestRatePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_DebtInstrumentInterestOnlyPaymentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument interest only payment maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_DebtInstrumentInterestOnlyPaymentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_DebtInstrumentPrepaymentPremiumPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt instrument prepayment premium percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_DebtInstrumentPrepaymentPremiumPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFrequencyOfPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the frequency of periodic payments (monthly, quarterly, annual).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFrequencyOfPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=freq_LoanAndSecurityAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=freq_LoanAndSecurityAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=freq_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=freq_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=freq_PrepaymentOccursOnOrPriorToFirstAnniversaryOfClosingDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=freq_PrepaymentOccursOnOrPriorToFirstAnniversaryOfClosingDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=freq_PrepaymentOccursAfterFirstAnniversaryOfClosingDateAndOnOrPriorToSecondAnniversaryOfClosingDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=freq_PrepaymentOccursAfterFirstAnniversaryOfClosingDateAndOnOrPriorToSecondAnniversaryOfClosingDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=freq_PrepaymentOccursAfterSecondAnniversaryOfClosingDateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=freq_PrepaymentOccursAfterSecondAnniversaryOfClosingDateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_PrimeRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_PrimeRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417839075832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 10, 2021</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,611,213<span></span>
</td>
<td class="nump">33,964,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,298<span></span>
</td>
<td class="nump">$ 1,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,611,213<span></span>
</td>
<td class="nump">33,964,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Net proceeds from private placements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">$ 40,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,611,213<span></span>
</td>
<td class="nump">33,964,000<span></span>
</td>
<td class="nump">30,844,507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock shares issued and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,350,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | Equity Distribution Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Common stock, sale of price per share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_SalesAgentCommission', window );">Sales Agent commission</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock | Maximum | Equity Distribution Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">Private Placement | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock shares issued and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,350,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_SalesAgentCommission">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales agent commission</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_SalesAgentCommission</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis=us-gaap_ShareDistributionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis=us-gaap_ShareDistributionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417840923448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Common Stock Shares Reserved for Future Issuance (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares of common stock reserved for future issuance</a></td>
<td class="nump">8,382,667<span></span>
</td>
<td class="nump">8,292,721<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares of common stock reserved for future issuance</a></td>
<td class="nump">6,830,037<span></span>
</td>
<td class="nump">6,816,798<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember', window );">Shares Available for Future Grant Under Stock Option Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class Of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares of common stock reserved for future issuance</a></td>
<td class="nump">1,552,630<span></span>
</td>
<td class="nump">1,475,923<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417839235832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 17, 2019</div></th>
<th class="th"><div>Nov. 13, 2014</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, shares reserved for issuance</a></td>
<td class="nump">8,382,667<span></span>
</td>
<td class="nump">8,292,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Options vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value of stock options granted</a></td>
<td class="nump">$ 22.39<span></span>
</td>
<td class="nump">$ 16.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Total grant date fair value of stock options vested</a></td>
<td class="nump">$ 16,304<span></span>
</td>
<td class="nump">$ 7,907<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Total unrecognized stock-based compensation expense relating to unvested stock options</a></td>
<td class="nump">$ 39,112<span></span>
</td>
<td class="nump">$ 31,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized unvested stock options, weighted-average period</a></td>
<td class="text">2 years 5 months 26 days<span></span>
</td>
<td class="text">3 years 29 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 21,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total value of restricted stock awards, vested based on estimated fair value of stock</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription', window );">Vesting description</a></td>
<td class="text">vest in equal installments in the first quarter of 2022 and the third quarter of 2022. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Options expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=freq_TwoThousandAndFourteenStockIncentivePlanMember', window );">2014 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, shares reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,550,415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Common stock, shares available for future grants</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=freq_TwoThousandAndNineteenIncentiveAwardPlanMember', window );">2019 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of authorized shares reserved for issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance', window );">Period for automatic increase in common stock available for future issuance</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Percentage of shares issued from outstanding number of shares</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription', window );">Common stock future issuance, description</a></td>
<td class="text"> In addition, the number of shares of common stock available for issuance under the 2019 Plan will be automatically increased on the first day of each calendar year during the ten-year term of the 2019 Plan, beginning with January 1, 2020 and ending with January 1, 2029, by the amount equal to 4% of the outstanding number of shares of the Company&#8217;s common stock on December 31, of the preceding calendar year or such lesser amount as determined by the Company&#8217;s board of directors.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period for automatic increase in common stock available for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award, award vesting description.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=freq_TwoThousandAndFourteenStockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=freq_TwoThousandAndFourteenStockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=freq_TwoThousandAndNineteenIncentiveAwardPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=freq_TwoThousandAndNineteenIncentiveAwardPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417843808680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Summary of Stock Option Activity under 2014 Plan and 2019 Plan (Details) - 2014 and 2019 Plan - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of shares, Beginning balance</a></td>
<td class="nump">6,816,798<span></span>
</td>
<td class="nump">5,968,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Number of shares, Granted</a></td>
<td class="nump">1,357,426<span></span>
</td>
<td class="nump">1,645,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of shares, Exercised</a></td>
<td class="num">(642,314)<span></span>
</td>
<td class="num">(769,385)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Number of shares, Forfeited</a></td>
<td class="num">(701,873)<span></span>
</td>
<td class="num">(28,348)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of shares, Ending balance</a></td>
<td class="nump">6,830,037<span></span>
</td>
<td class="nump">6,816,798<span></span>
</td>
<td class="nump">5,968,672<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Number of shares, Options exercisable as of December 31, 2021</a></td>
<td class="nump">3,993,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of shares, Options unvested as of December 31, 2021</a></td>
<td class="nump">2,836,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, Beginning balance</a></td>
<td class="nump">$ 10.11<span></span>
</td>
<td class="nump">$ 5.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Granted</a></td>
<td class="nump">32.76<span></span>
</td>
<td class="nump">24.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Exercised</a></td>
<td class="nump">2.02<span></span>
</td>
<td class="nump">1.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price, Forfeited</a></td>
<td class="nump">16.48<span></span>
</td>
<td class="nump">16.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, Ending balance</a></td>
<td class="nump">14.72<span></span>
</td>
<td class="nump">$ 10.11<span></span>
</td>
<td class="nump">$ 5.21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price, Options exercisable as of December 31, 2021</a></td>
<td class="nump">9.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, Options unvested as of December 31, 2021</a></td>
<td class="nump">$ 21.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual term (in years), Outstanding</a></td>
<td class="text">7 years 9 months 3 days<span></span>
</td>
<td class="text">8 years 5 months 12 days<span></span>
</td>
<td class="text">9 years 29 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2', window );">Weighted average remaining contractual term (in years), Granted</a></td>
<td class="text">8 years 25 days<span></span>
</td>
<td class="text">9 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term (in years), Options exercisable as of December 31, 2021</a></td>
<td class="text">7 years 4 months 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted average remaining contractual term (in years), Options unvested as of December 31, 2021</a></td>
<td class="text">8 years 4 months 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, Outstanding</a></td>
<td class="nump">$ 6,987<span></span>
</td>
<td class="nump">$ 171,415<span></span>
</td>
<td class="nump">$ 73,561<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value, Exercised</a></td>
<td class="nump">11,652<span></span>
</td>
<td class="nump">$ 16,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value, Options exercisable as of December 31, 2021</a></td>
<td class="nump">6,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate intrinsic value, Options unvested as of December 31, 2021</a></td>
<td class="nump">$ 712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options granted weighted average remaining contractualterm2.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=freq_TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=freq_TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417840942328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Summary of Grant-date Fair Value of Stock Options Granted on Weighted Average Basis (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">79.80%<span></span>
</td>
<td class="nump">79.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417840912584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-based Compensation - Summary of Status of Restricted Common Stock (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of shares, Unvested, December 31, 2020 | shares</a></td>
<td class="nump">3,093<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Number of shares, Vested | shares</a></td>
<td class="num">(928)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of shares, Forfeited | shares</a></td>
<td class="num">(2,165)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of shares, Unvested, December 31, 2021 | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average fair value, Unvested, December 31, 2020 | $ / shares</a></td>
<td class="nump">$ 1.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value, Vested | $ / shares</a></td>
<td class="nump">1.75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted average fair value, Forfeited | $ / shares</a></td>
<td class="nump">1.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average fair value, Unvested, December 31, 2021 | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of shares, Unvested, December 31, 2020 | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Number of shares, Awarded | shares</a></td>
<td class="nump">800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Number of shares, Forfeited | shares</a></td>
<td class="num">(173,700)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of shares, Unvested, December 31, 2021 | shares</a></td>
<td class="nump">626,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average fair value, Unvested, December 31, 2020 | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value, Awarded | $ / shares</a></td>
<td class="nump">9.54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Weighted average fair value, Forfeited | $ / shares</a></td>
<td class="nump">9.54<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted average fair value, Unvested, December 31, 2021 | $ / shares</a></td>
<td class="nump">$ 9.54<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417843860264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Stock Purchase Plan - Additional Information (Details) - shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 20, 2019</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares of common stock reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,382,667<span></span>
</td>
<td class="nump">8,292,721<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember', window );">2019 Employee Stock Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_PercentageOfEligibleEmployeeCompensation', window );">Percentage of eligible employee compensation</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares of common stock reserved for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">956,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance', window );">Period for automatic increase in common available for future issuance</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Percentage of shares issued from outstanding number of shares</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,064<span></span>
</td>
<td class="nump">31,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_PercentageOfEligibleEmployeeCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of eligible employee compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_PercentageOfEligibleEmployeeCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period for automatic increase in common stock available for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417838359192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Feb. 28, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_IncomeTaxesDisclosureLineItems', window );"><strong>Income Taxes Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Net tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit', window );">Federal and state deferred tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,931,000<span></span>
</td>
<td class="nump">26,995,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Interest and penalties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Internal Revenue Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_IncomeTaxesDisclosureLineItems', window );"><strong>Income Taxes Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_PeriodOfCumulativeChangeInOwnership', window );">Period of cumulative change in ownership</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_OperatingLossCarryforwardsUsageAfterOwnershipChange', window );">Operating loss carryforwards, utilization after ownership change</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange', window );">Operating loss carryforwards, utilization after five years after ownership change</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange', window );">Operating loss carryforwards, utilization after 15 years thereafter after ownership change</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration', window );">Remaining pre ownership change in operating loss carryforwards written off due to expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Internal Revenue Service | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_IncomeTaxesDisclosureLineItems', window );"><strong>Income Taxes Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_CumulativeChangeInOwnershipPercentage', window );">Cumulative change in ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_IncomeTaxesDisclosureLineItems', window );"><strong>Income Taxes Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Net tax benefit</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_MA', window );">Massachusetts | Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_IncomeTaxesDisclosureLineItems', window );"><strong>Income Taxes Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credit carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,241,000<span></span>
</td>
<td class="nump">$ 2,071,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_IncomeTaxesDisclosureLineItems', window );"><strong>Income Taxes Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_NetOperatingLossCarryforwardsExpirationWithLimitation', window );">Net operating loss carryforwards expire through 2037</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,399,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_OperatingLossCarryforwardsExpirationYear', window );">Operating loss carryforwards expiration year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_NetOperatingLossCarryforwardsExpirationWithoutLimitation', window );">Net operating loss carryforwards without expiration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 126,672,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_TaxCreditCarryforwardExpirationYear', window );">Tax credit carryforwards expiration year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | Internal Revenue Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_IncomeTaxesDisclosureLineItems', window );"><strong>Income Taxes Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 46,123,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | Massachusetts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_IncomeTaxesDisclosureLineItems', window );"><strong>Income Taxes Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 149,071,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_IncomeTaxesDisclosureLineItems', window );"><strong>Income Taxes Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_OperatingLossCarryforwardsExpirationYear', window );">Operating loss carryforwards expiration year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Massachusetts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_IncomeTaxesDisclosureLineItems', window );"><strong>Income Taxes Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83,467,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_TaxCreditCarryforwardExpirationYear', window );">Tax credit carryforwards expiration year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_CumulativeChangeInOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cumulative change in ownership percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_CumulativeChangeInOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_IncomeTaxesDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income taxes disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_IncomeTaxesDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_NetOperatingLossCarryforwardsExpirationWithLimitation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net operating loss carryforwards expiration with limitation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_NetOperatingLossCarryforwardsExpirationWithLimitation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_NetOperatingLossCarryforwardsExpirationWithoutLimitation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net operating loss carryforwards expiration without limitation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_NetOperatingLossCarryforwardsExpirationWithoutLimitation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating loss carryforwards annual usage for next each after five years and thereafter after ownership change.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating loss carryforwards annual usage for next each five years after ownership change.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_OperatingLossCarryforwardsExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating loss carryforwards expiration year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_OperatingLossCarryforwardsExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_OperatingLossCarryforwardsUsageAfterOwnershipChange">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards Usage After Ownership Change.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_OperatingLossCarryforwardsUsageAfterOwnershipChange</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_PeriodOfCumulativeChangeInOwnership">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of cumulative change in ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_PeriodOfCumulativeChangeInOwnership</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Remaining pre ownership change in operating loss carryforwards written off due to expiration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_TaxCreditCarryforwardExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax credit carryforward expiration year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_TaxCreditCarryforwardExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state, local, and federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=us-gaap_ResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417848221048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Reconciliation Pre-tax Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">Domestic</a></td>
<td class="num">$ (84,624)<span></span>
</td>
<td class="num">$ (25,744)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Foreign</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(732)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Total</a></td>
<td class="num">$ (84,671)<span></span>
</td>
<td class="num">$ (26,476)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417840872984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Provision (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred Income Tax Expense (Benefit)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision (benefit)</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417839769048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Reconciliation of U.S. Federal Statutory Income Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">U.S federal statutory income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential', window );">Permanent differences</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Research and development tax credits</a></td>
<td class="nump">3.60%<span></span>
</td>
<td class="nump">11.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock compensation deductions</a></td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent', window );">Other items</a></td>
<td class="num">(0.70%)<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in deferred tax asset valuation allowance</a></td>
<td class="num">(28.20%)<span></span>
</td>
<td class="num">(40.70%)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417839570296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Deferred Tax Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 36,590<span></span>
</td>
<td class="nump">$ 17,885<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credits</a></td>
<td class="nump">7,026<span></span>
</td>
<td class="nump">3,992<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangibles</a></td>
<td class="nump">392<span></span>
</td>
<td class="nump">360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="nump">6,554<span></span>
</td>
<td class="nump">850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">176<span></span>
</td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment', window );">Fixed assets</a></td>
<td class="nump">265<span></span>
</td>
<td class="nump">56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_DeferredTaxAssetsLeasingArrangements', window );">Lease liability</a></td>
<td class="nump">7,269<span></span>
</td>
<td class="nump">7,285<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_DeferredTaxAssetsRightOfUseAssets', window );">Right of use asset</a></td>
<td class="num">(7,448)<span></span>
</td>
<td class="num">(7,181)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax asset</a></td>
<td class="nump">50,931<span></span>
</td>
<td class="nump">26,995<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(50,931)<span></span>
</td>
<td class="num">(26,995)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_DeferredTaxAssetsLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_DeferredTaxAssetsLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets liabilities property plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_DeferredTaxAssetsRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets right of use assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_DeferredTaxAssetsRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417836557496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Research and License Agreements - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Feb. 28, 2019</div></th>
<th class="th"><div>Sep. 30, 2018</div></th>
<th class="th"><div>Jun. 30, 2018</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research And Development Arrangement Contract To Perform For Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,068<span></span>
</td>
<td class="nump">$ 36,984<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Dr. Langer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research And Development Arrangement Contract To Perform For Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForManagementFee', window );">Payment to director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">1,980<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_GrantMember', window );">Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research And Development Arrangement Contract To Perform For Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_IncreaseDecreaseInResearchAndDevelopmentExpense', window );">Decrease in research and development expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">323<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=freq_ResearchAndDevelopmentMember', window );">Research and Development | Grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research And Development Arrangement Contract To Perform For Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_AmountOfFundingReceivedAsGrant', window );">Amount of funding received as grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_GrantTermPeriod', window );">Grant term period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=freq_MassachusettsInstituteOfTechnologyMember', window );">MIT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research And Development Arrangement Contract To Perform For Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_DescriptionOfFutureDevelopmentObligations', window );">Description of future development obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company&#8217;s future development obligations are: (i) to commence a Phase III clinical trial for such Product within five years of the IND filing for such product, (ii) to file a New Drug Application or equivalent with the FDA or comparable European regulatory agency for such Product within nine years of the IND filing for such Product, and (iii) to make a first commercial sale of such Product within 11 years of the IND filing for such Product.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_LicenseFeePayment', window );">License fee payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_PercentageOfSharesOfCommonStockIssued', window );">Percentage of shares of common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_DescriptionOfConditionsToTerminateLicenseAgreement', window );">Description of conditions to terminate license agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company has the right to terminate for any reason upon a 3-month prior written notice. MIT shall have the right to terminate if the Company ceases to carry on any business related to the MIT License Agreement. MIT may terminate the MIT License Agreement for the Company&#8217;s material breach uncured within ninety (90) days (or thirty (30) days in the case of nonpayment). MIT may also terminate the MIT License Agreement if the Company or our affiliates commence any action against MIT to declare or render any claim of the licensed patent rights invalid, unpatentable, unenforceable, or non-infringed (a patent challenge), or if our sublicensee commences such actions and the Company does not terminate such sublicense within thirty (30) days after MIT&#8217;s demand. MIT has the right to increase all payments due, instead of terminating the MIT License Agreement in the case of a patent challenge. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_RightToTerminateAgreementUponPriorWrittenNotice', window );">Right to terminate agreement upon prior written notice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_RightToTerminateAgreementIfBreachRemainsUncured', window );">Right to terminate agreement if breach remains uncured</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_RightToTerminateAgreementIncaseOfNonpayment', window );">Right to terminate agreement incase of nonpayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=freq_MassachusettsInstituteOfTechnologyMember', window );">MIT | Dr. Langer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research And Development Arrangement Contract To Perform For Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForManagementFee', window );">Payment to director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 1,980<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=freq_MassachusettsInstituteOfTechnologyMember', window );">MIT | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research And Development Arrangement Contract To Perform For Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_MilestonePayments', window );">Milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=freq_MassachusettsInstituteOfTechnologyMember', window );">MIT | Patent License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research And Development Arrangement Contract To Perform For Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_LicenseAgreementEnteredDate', window );">License agreement entered date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2016-12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=freq_CaliforniaInstituteForBiomedicalResearchMember', window );">CALIBR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research And Development Arrangement Contract To Perform For Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_LicenseFeePayment', window );">License fee payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_PercentageOfRoyaltyOnSublicenseRevenue', window );">Percentage of royalty on sublicense revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_DescriptionOfConditionsToTerminateLicenseAgreement', window );">Description of conditions to terminate license agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company may terminate the CALIBR License Agreement at will upon a 30-day prior written notice. The Company may also elect to terminate its license to one or more licensed patents in any or all jurisdictions by giving ninety (90) days&#8217; prior written notice to CALIBR. CALIBR may terminate the CALIBR License Agreement for material breach uncured within thirty (30) days. CALIBR has the right to terminate or reduce the license to a non-exclusive license if the Company fails to use diligent efforts to develop and commercially exploit CALIBR Licensed Products. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_RightToTerminateAgreementUponPriorWrittenNotice', window );">Right to terminate agreement upon prior written notice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_RightToTerminateAgreementIfBreachRemainsUncured', window );">Right to terminate agreement if breach remains uncured</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_RightToTerminateLicensedPatentsUponPriorWrittenNotice', window );">Right to terminate licensed patents upon prior written notice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=freq_CaliforniaInstituteForBiomedicalResearchMember', window );">CALIBR | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research And Development Arrangement Contract To Perform For Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_MilestonePayments', window );">Milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=freq_CaliforniaInstituteForBiomedicalResearchMember', window );">CALIBR | Patent License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research And Development Arrangement Contract To Perform For Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_LicenseAgreementEnteredDate', window );">License agreement entered date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2018-09<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=freq_MassachusettsEyeAndEarMember', window );">MEE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research And Development Arrangement Contract To Perform For Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_LicenseFeePayment', window );">License fee payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_DescriptionOfConditionsToTerminateLicenseAgreement', window );">Description of conditions to terminate license agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The Company has the right to terminate the MEE License Agreement at will by giving thirty (30) business days advance written notice to MEE. MEE has the right to terminate the MEE License Agreement if the Company fails to make any payment due within thirty (30) business days after MEE notifies the Company of such failure. MEE shall have the right to terminate if the Company fails to maintain the required insurance. MEE shall also have the right to terminate the MEE License Agreement upon forty-five (45) business days written notice if the Company becomes insolvent. MEE has the right to terminate for any other default not cured within sixty (60) business days written notice. MEE also has the right to terminate if the Company or its affiliates challenge the validity of the licensed patent rights. <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_RightToTerminateAgreementUponPriorWrittenNotice', window );">Right to terminate agreement upon prior written notice</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_RightToTerminateAgreementIfBreachRemainsUncured', window );">Right to terminate agreement if breach remains uncured</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_RightToTerminateAgreementIncaseOfNonpayment', window );">Right to terminate agreement incase of nonpayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent', window );">Right to terminate agreement upon prior written notice if insolvent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">45 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=freq_MassachusettsEyeAndEarMember', window );">MEE | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research And Development Arrangement Contract To Perform For Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_MilestonePayments', window );">Milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_AnnualLicenseFeePerShare', window );">Annual license fee per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=freq_MassachusettsEyeAndEarMember', window );">MEE | Minimum [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research And Development Arrangement Contract To Perform For Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_RoyaltyExpensePerShare', window );">Royalty expense per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_AnnualLicenseFeePerShare', window );">Annual license fee per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=freq_MassachusettsEyeAndEarMember', window );">MEE | Non-Exclusive Patent License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research And Development Arrangement Contract To Perform For Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_LicenseAgreementEnteredDate', window );">License agreement entered date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2019-02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=freq_CambridgeEnterpriseLimitedMember', window );">Cambridge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research And Development Arrangement Contract To Perform For Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_LicenseFeePayment', window );">License fee payment</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_DescriptionOfConditionsToTerminateLicenseAgreement', window );">Description of conditions to terminate license agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">We have the right to terminate for any reason upon 90 days&#8217; prior to written notice.  Each party has the right to terminate immediately if the other party ceases to carry on its business.  Either party may also terminate the Cambridge License for material breach if such breach remains uncured for 30 days.  Cambridge may also terminate the Cambridge License if we fail to diligently develop and commercially exploit at least one Cambridge Licensed Product or we or our affiliates or sub-licenses commence any action against Cambridge to declare or render any claim of the licensed patent rights invalid, unpatentable, unenforceable, or not infringed.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_RightToTerminateAgreementUponPriorWrittenNotice', window );">Right to terminate agreement upon prior written notice</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_RightToTerminateAgreementIfBreachRemainsUncured', window );">Right to terminate agreement if breach remains uncured</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_AnnualLicenseFee', window );">Annual license fee</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=freq_CambridgeEnterpriseLimitedMember', window );">Cambridge | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research And Development Arrangement Contract To Perform For Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_MilestonePayments', window );">Milestone payments</a></td>
<td class="nump">$ 10,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=freq_CambridgeEnterpriseLimitedMember', window );">Cambridge | Patent License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research And Development Arrangement Contract To Perform For Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_LicenseAgreementEnteredDate', window );">License agreement entered date</a></td>
<td class="text">2019-12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_AmountOfFundingReceivedAsGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of funding received as grant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_AmountOfFundingReceivedAsGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_AnnualLicenseFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual license fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_AnnualLicenseFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_AnnualLicenseFeePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual License Fee Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_AnnualLicenseFeePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_DescriptionOfConditionsToTerminateLicenseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of conditions to terminate license agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_DescriptionOfConditionsToTerminateLicenseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_DescriptionOfFutureDevelopmentObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of future development obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_DescriptionOfFutureDevelopmentObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_GrantTermPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Grant term period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_GrantTermPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_IncreaseDecreaseInResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) in research and development expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_IncreaseDecreaseInResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_LicenseAgreementEnteredDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License agreement entered date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_LicenseAgreementEnteredDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_LicenseFeePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License fee payment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_LicenseFeePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_MilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Milestone payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_MilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_PercentageOfRoyaltyOnSublicenseRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of royalty on sublicense revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_PercentageOfRoyaltyOnSublicenseRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_PercentageOfSharesOfCommonStockIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of shares of common stock issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_PercentageOfSharesOfCommonStockIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_RightToTerminateAgreementIfBreachRemainsUncured">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right to terminate agreement if breach remains uncured.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_RightToTerminateAgreementIfBreachRemainsUncured</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_RightToTerminateAgreementIncaseOfNonpayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right to terminate agreement incase of nonpayment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_RightToTerminateAgreementIncaseOfNonpayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_RightToTerminateAgreementUponPriorWrittenNotice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right to terminate agreement upon prior written notice.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_RightToTerminateAgreementUponPriorWrittenNotice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right to terminate agreement upon prior written notice if insolvent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_RightToTerminateLicensedPatentsUponPriorWrittenNotice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right to terminate licensed patents upon prior written notice.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_RightToTerminateLicensedPatentsUponPriorWrittenNotice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_RoyaltyExpensePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Royalty Expense Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_RoyaltyExpensePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForManagementFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount paid to managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForManagementFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_GrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_GrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=freq_ResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=freq_ResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=freq_MassachusettsInstituteOfTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=freq_MassachusettsInstituteOfTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=freq_PatentLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=freq_PatentLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=freq_CaliforniaInstituteForBiomedicalResearchMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=freq_CaliforniaInstituteForBiomedicalResearchMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=freq_MassachusettsEyeAndEarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=freq_MassachusettsEyeAndEarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=freq_NonExclusivePatentLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=freq_NonExclusivePatentLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=freq_CambridgeEnterpriseLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=freq_CambridgeEnterpriseLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417843731656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Collaboration Agreement - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,923<span></span>
</td>
<td class="nump">$ 37,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=freq_LicenseAndCollaborationAgreementMember', window );">License and Collaboration Agreement | Astellas Pharma LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromCollaborators', window );">Payments received under collaboration agreement</a></td>
<td class="nump">$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_AgreementTerminationNoticePeriod', window );">Agreement termination notice period</a></td>
<td class="text">60 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_RightToTerminateAgreementIfBreachRemainsUncured', window );">Right to terminate agreement if breach remains uncured</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_RightToTerminateAgreementIncaseOfNonpayment', window );">Right to terminate agreement incase of nonpayment</a></td>
<td class="text">45 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_RevenueRecognitionTransactionPrice', window );">Transaction price allocated to single combined performance obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_UpfrontFeeRecognizedAsRevenue', window );">Upfront fee recognized as revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 885<span></span>
</td>
<td class="nump">$ 1,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=freq_LicenseAndCollaborationAgreementMember', window );">License and Collaboration Agreement | Astellas Pharma LLC | Phase 2b Clinical Trial | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized potential development milestone payments to receive</a></td>
<td class="nump">$ 65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=freq_LicenseAndCollaborationAgreementMember', window );">License and Collaboration Agreement | Astellas Pharma LLC | Phase 2b Clinical Trial | Asia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized potential development milestone payments to receive</a></td>
<td class="nump">25,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=freq_LicenseAndCollaborationAgreementMember', window );">License and Collaboration Agreement | Astellas Pharma LLC | Phase 3 Clinical Trial | Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized potential development milestone payments to receive</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=freq_LicenseAndCollaborationAgreementMember', window );">License and Collaboration Agreement | Astellas Pharma LLC | Phase 3 Clinical Trial | Asia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized potential development milestone payments to receive</a></td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=freq_LicenseAndCollaborationAgreementMember', window );">License and Collaboration Agreement | Maximum | Astellas Pharma LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized potential development milestone payments to receive</a></td>
<td class="nump">230,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones', window );">Revenue recognized commercialization milestone payments to receive</a></td>
<td class="nump">315,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization', window );">Potential commercial milestone payments eligible to receive upon successful commercialization</a></td>
<td class="nump">$ 315,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_AgreementTerminationNoticePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Agreement termination notice period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_AgreementTerminationNoticePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract with customer liability revenue recognized from commercialization milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue recognition potential commercial milestone payments eligible upon successful commercialization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_RevenueRecognitionTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue recognition transaction price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_RevenueRecognitionTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_RightToTerminateAgreementIfBreachRemainsUncured">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right to terminate agreement if breach remains uncured.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_RightToTerminateAgreementIfBreachRemainsUncured</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_RightToTerminateAgreementIncaseOfNonpayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right to terminate agreement incase of nonpayment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_RightToTerminateAgreementIncaseOfNonpayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_UpfrontFeeRecognizedAsRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Upfront fee recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_UpfrontFeeRecognizedAsRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollaborators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received from collaborators during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollaborators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=freq_LicenseAndCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=freq_LicenseAndCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=freq_AstellasPharmaLimitedLiabilityCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=freq_AstellasPharmaLimitedLiabilityCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=freq_Phase2bClinicalTrialMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=freq_Phase2bClinicalTrialMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=freq_Phase3ClinicalTrailMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=freq_Phase3ClinicalTrailMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417838921864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 11, 2020</div></th>
<th class="th">
<div>Jan. 07, 2020 </div>
<div>ft&#178; </div>
<div>Term</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Lease expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,960<span></span>
</td>
<td class="nump">$ 835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=freq_HaydenLLCMember', window );">Hayden LLC | Lexington Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">May 31,  2031<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetRentableArea', window );">Rentable area of office space | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_OperatingLeaseCommencementDate', window );">Lease commencement date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 11,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_OperatingLeaseNumberOfAdditionalExtensionTerms', window );">Number of additional lease extension terms | Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_OperatingLeasesAdditionalExtensionTerm', window );">Lease extension term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=freq_LeasesTerminationAgreementMember', window );">Lease Termination Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_OperatingLeaseTerminationFee', window );">Payment of fee to landlord</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=freq_LeasesTerminationAgreementMember', window );">Lease Termination Agreement | ARE-MA Region No. 20, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseExpirationDate1', window );">Lease expiration date</a></td>
<td class="text">Mar. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_MA', window );">Massachusetts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_OperatingLeaseAgreementAmendedDate', window );">Lease agreement amended date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2019-11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseOptionToExtend', window );">Lease, description of option to extend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">In November 2019, this lease was amended to add additional laboratory and office space as well as extend the termination date for all spaces to February 2025.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_freq_LeaseExpirationYear1', window );">Lease, expiration year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2025-02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_LeaseExpirationYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Expiration Year 1</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_LeaseExpirationYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_OperatingLeaseAgreementAmendedDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease agreement amended date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_OperatingLeaseAgreementAmendedDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearMonthItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_OperatingLeaseCommencementDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease commencement date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_OperatingLeaseCommencementDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_OperatingLeaseNumberOfAdditionalExtensionTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease number of additional extension terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_OperatingLeaseNumberOfAdditionalExtensionTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_OperatingLeaseTerminationFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease termination fee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_OperatingLeaseTerminationFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_freq_OperatingLeasesAdditionalExtensionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating leases additional extension term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">freq_OperatingLeasesAdditionalExtensionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>freq_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseExpirationDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date which lease or group of leases is set to expire, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseExpirationDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetRentableArea">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net rentable area for properties owned.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetRentableArea</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=freq_HaydenLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=freq_HaydenLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=freq_LexingtonLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=freq_LexingtonLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=freq_LeasesTerminationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=freq_LeasesTerminationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=freq_AREMARegionNo20LLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=freq_AREMARegionNo20LLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_MA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_MA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417847493624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Leases (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term</a></td>
<td class="text">9 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">8.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417839662696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Reconciles the Undiscounted Cash Flows to the Operating Lease (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 4,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">4,284<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">4,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">4,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">4,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">22,389<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">44,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: amount of lease payments representing interest</a></td>
<td class="num">(13,872)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of future lease payments</a></td>
<td class="nump">30,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: current lease liabilities</a></td>
<td class="num">(1,747)<span></span>
</td>
<td class="num">$ (397)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Noncurrent lease liabilities</a></td>
<td class="nump">$ 28,851<span></span>
</td>
<td class="nump">$ 30,597<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417847704552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Future Aggregate Minimum Payments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent', window );">2022</a></td>
<td class="nump">$ 4,161<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2023</a></td>
<td class="nump">4,284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2024</a></td>
<td class="nump">4,412<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2025</a></td>
<td class="nump">4,545<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2026</a></td>
<td class="nump">4,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter', window );">2027 and beyond</a></td>
<td class="nump">22,388<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">$ 44,471<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123403562&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406913&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417843902472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermPurchaseCommitmentAmount', window );">Commitment payments related to research</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyLossInPeriod', window );">Losses related to indemnification obligations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Legal contingencies, accruals recorded</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=freq_LexingtonMassachusettsFacilityMember', window );">Lexington Massachusetts facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Security deposit classified as restricted cash</a></td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermPurchaseCommitmentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum amount the entity agreed to spend under the long-term purchase commitment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermPurchaseCommitmentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyLossInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyLossInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=freq_LexingtonMassachusettsFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=freq_LexingtonMassachusettsFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417840799640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Maximum percentage of employee contribution to retirement plan</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Percentage of employer matching contribution</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Percentage of employee annual compensation matched by the employer</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage', window );">Employers matching contribution vesting percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Employers matching contribution</a></td>
<td class="nump">$ 723<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employer's matching contributions to a defined contribution plan that vests in a given year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140417847994936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_DirectorMember', window );">Dr. Langer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForManagementFee', window );">Payment to director</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 1,980<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForManagementFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount paid to managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForManagementFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>freq-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:freq="http://frequencytx.com/20211231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2021"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="freq-20211231.xsd" xlink:type="simple"/>
    <context id="C_9a6459ef-90a2-45d3-bb28-8c54d3edc4d6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis">us-gaap:ShareDistributionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-10</instant>
        </period>
    </context>
    <context id="C_10cead94-19bf-43da-bf2a-3aa91fbb188c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">freq:UnvestedRestrictedCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_06abad24-e21e-42ba-b771-10d1643ab3f6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:CaliforniaInstituteForBiomedicalResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-09-30</instant>
        </period>
    </context>
    <context id="C_1d3c986e-4a0f-4b46-957f-19f2213ac557">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">freq:LongTermMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_fb927f4e-76df-424a-920e-b43ae68e4b30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">freq:PrepaymentOccursOnOrPriorToFirstAnniversaryOfClosingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">freq:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-11</startDate>
            <endDate>2020-12-11</endDate>
        </period>
    </context>
    <context id="C_549428fd-e30a-428e-9b6b-925a65a7eaa2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_86cb445a-0d20-403b-b211-6cec00f8b29a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="C_a2aa7323-25ff-4251-80f3-998eec4375b1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_f16d2dd7-db5e-4985-9658-6e9c9f5382ec">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_90c637f8-8aac-4313-bec9-a8d318734b7f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">freq:TwoThousandAndNineteenIncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-17</instant>
        </period>
    </context>
    <context id="C_f970257d-5f8c-4f69-a8af-6c7b98ed7be9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_f02c82d0-ac2f-4ce8-8c28-dace93e62425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201912Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0342be7e-519c-43c8-ab77-ca720271c910">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:AREMARegionNo20LLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LeasesTerminationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-11</startDate>
            <endDate>2020-12-11</endDate>
        </period>
    </context>
    <context id="C_419cd7aa-c2d9-47e1-b2f2-d57d5c727db3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_9b494e1f-e9d7-4e68-8c4e-6503e6471f18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">freq:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_d31917a1-75da-46d6-8ef7-52754985fa8f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_dcccf903-dd0c-4b08-adcc-14b5fde28ebb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">freq:TwoThousandAndNineteenIncentiveAwardPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_63fbb0a1-d118-421f-b0be-baa522b2c4c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">freq:TwoThousandAndFourteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_49bd1a34-70e0-4358-af75-4f83449a848f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis">us-gaap:ShareDistributionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-10</startDate>
            <endDate>2021-12-10</endDate>
        </period>
    </context>
    <context id="C_815714a9-1c63-462b-be7a-be127a4674d0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_bbfcdb78-4741-401f-8112-443fb777bdf1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201613Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_ff34e46d-05f9-400b-970a-b5976aa47ab4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">freq:PatentLicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-12-01</startDate>
            <endDate>2016-12-31</endDate>
        </period>
    </context>
    <context id="C_fa37d2a6-9437-44d8-82ac-ad9b23ac3a6b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0d93812e-8c05-49cd-9223-e00467bcba4d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_dfc08580-a6c7-489e-9745-b9dfdc59a70d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_e4d444fc-edc2-40cf-ab70-0c120e61141a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_36f8045c-3f63-4117-a53e-1768fa09baac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_f6fd7cfb-c8de-4aa0-bb14-1baec943103c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">freq:WoburnMassachusettsFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_9ee00bb1-b451-49aa-8278-506702da2a88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:HaydenLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">freq:LexingtonLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-07</startDate>
            <endDate>2020-01-07</endDate>
        </period>
    </context>
    <context id="C_f955b24a-1210-4587-a090-44353cb3e0a3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">freq:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:PrimeRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-11</startDate>
            <endDate>2020-12-11</endDate>
        </period>
    </context>
    <context id="C_37c7af32-e4c8-439d-8648-1ffe795bcb36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="C_fd9346ee-0123-48e4-a5e9-177e9e88d4c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_9a711a28-f230-4980-b126-e2e78357768d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:CambridgeEnterpriseLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_5acfbb01-3b1d-498b-b247-28b787110380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_b7c53ec7-6b2a-4521-bec1-3cfbee53835a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">freq:PrepaymentOccursAfterFirstAnniversaryOfClosingDateAndOnOrPriorToSecondAnniversaryOfClosingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">freq:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-11</startDate>
            <endDate>2020-12-11</endDate>
        </period>
    </context>
    <context id="C_e8ed63ae-2752-4e17-8e6b-1b8e47c58699">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_639ebc28-c88b-4d67-a3ae-091fbf1f8c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:CambridgeEnterpriseLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_f92ea8d8-789c-4c65-915c-479148f6a96f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_8f05e1d9-5717-4801-93c4-ba371f31a50e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_88431303-989b-46e7-871d-38ecd5178aee">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
        </entity>
        <period>
            <instant>2022-03-08</instant>
        </period>
    </context>
    <context id="C_d5705e72-9931-4ce1-ae42-4f74ee48fe5f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="C_242a50fc-c372-4fff-a068-1d46d8ada8fc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_3518f4db-a6ab-442b-9131-2ac71642f3dc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">freq:TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_5f444349-7223-41bf-bdbf-3c460376bd0e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:CaliforniaInstituteForBiomedicalResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="C_635de625-e8b1-4d5c-9ee3-b354458b428c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">freq:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0f0e0f6b-efeb-4ef1-b44a-ccadd9a887cd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">freq:PrepaymentOccursAfterSecondAnniversaryOfClosingDateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">freq:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-11</startDate>
            <endDate>2020-12-11</endDate>
        </period>
    </context>
    <context id="C_7a257f5b-ab22-4c07-8bef-38a92a6dc698">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:AstellasPharmaLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LicenseAndCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_3b0f514e-4e02-4094-a8b5-6f2ea6aca5d4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsEyeAndEarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-02-28</endDate>
        </period>
    </context>
    <context id="C_be99fc1c-8083-4f95-90f4-0e839dbb422d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_394b00a6-d93c-4bb0-9bba-bc11145aea27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_51d717fb-7e75-44ae-bee6-68ee19956485">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_bd09e8d5-eab7-4713-8061-e03dbe21d25f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">freq:UnvestedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_78fdf8df-07e6-446d-b5a9-2f520f345e58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">freq:PatentLicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:CaliforniaInstituteForBiomedicalResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="C_17ed3f9d-c233-4f9d-80c1-fd64ea247cb7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_76fdd776-fb2d-4e7e-946f-9baef372cfc0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_fe2774ae-4979-4575-894a-1f57dedae7e9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_768ee818-71ae-4ce4-8037-4961cf5029cc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_45970929-9cc5-4976-bf18-cee30c4707f1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">freq:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-11</instant>
        </period>
    </context>
    <context id="C_c51b15b1-1d54-4248-ae05-78c643fea245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">freq:TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_81e252a8-16c5-427e-a03f-1106ff94238b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0c30c3e8-0228-45a8-9bfc-3207d2e201fc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_be7fbd4c-1845-482f-953d-2642af2fb06e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_2f466342-40f3-44b7-934b-9ce9617ba401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsEyeAndEarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-02-28</endDate>
        </period>
    </context>
    <context id="C_746daa8a-e230-4375-9cc8-fcf4f87699a6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_58f5a961-03f6-4320-a30e-9ed5284f4e0a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_46cac2fb-9412-44da-9032-89c8b384ae1e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsEyeAndEarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_f644c8ed-481c-4510-a475-3d938a78a2e1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:AstellasPharmaLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">freq:Phase3ClinicalTrailMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LicenseAndCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-31</endDate>
        </period>
    </context>
    <context id="C_50db1a66-c934-4741-b3a2-b2969bdf7bf1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_7f631c9f-2ca8-42db-859b-91805fd36959">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-12-31</startDate>
            <endDate>2014-12-31</endDate>
        </period>
    </context>
    <context id="C_c1ca8ce4-5cf1-421c-b2f3-843fbb4b6877">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="C_cc3ef655-c17e-488c-8981-986ec4c9084c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_afc37fa6-10a6-4cfc-b132-46416981a53b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_55a858d8-b30a-41c7-bb81-5e2b9474ff72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_5d611fcf-f5e9-4ee1-96e1-00b7bbb48319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_3a7f3500-4681-4b89-b3ee-9823efb5714a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_ecc116a0-70fc-4e40-92ed-6d00d8ab497a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="C_7d7f8a9d-9d6d-47a1-b8ea-fd4b0fa83331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">us-gaap:ResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_3d40bafe-0686-48fd-af67-9a140619ba32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_36d6826a-c031-4794-9b6c-6a3f3d257de7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:AstellasPharmaLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LicenseAndCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_2ca9c59f-69d7-4fec-9a05-50e04ddc9998">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_7186f7f7-8d1b-4a52-9633-5bf6e27f4982">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">freq:TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_314d3398-4d13-4f53-b054-20b54a955ba4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">freq:TwoThousandAndFourteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2014-11-13</instant>
        </period>
    </context>
    <context id="C_1136a968-0349-44e0-8596-79d8ce8e10d1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_7b227e56-bafa-4e07-a541-a4c468281188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsEyeAndEarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_742c5792-c6e5-48a5-b310-178c83269552">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">freq:UnvestedRestrictedCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_27210ea1-a4d8-4337-a254-d92c29bebf12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:AstellasPharmaLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">freq:Phase3ClinicalTrailMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LicenseAndCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-31</endDate>
        </period>
    </context>
    <context id="C_54ac7307-3cc3-42f9-b337-69f60c51b471">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_e07d7cda-060f-41bc-aed2-892bed256b7c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_23b528ed-dd66-4d9c-8b20-60a086d86ba5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">freq:LabEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_ab8f2bc9-2386-4491-8d49-6ec657154d28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_83f34b69-48ab-4eeb-affa-ce666d46960a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_b9d233e8-2d05-48fa-b3db-72146492d1a0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:CaliforniaInstituteForBiomedicalResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="C_48cf3447-6d32-4520-8654-49cad8c660d5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_a6c92f46-0d7d-45d4-8e0d-11c1797e8585">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsEyeAndEarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="C_ac62a1b7-c43f-4181-a7f5-94b13f47cb97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">freq:TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_602a4133-255d-4026-bf0c-6e87837e587b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:AstellasPharmaLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LicenseAndCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="C_b4e6b702-2e18-4b8d-b021-d0ca35b2f1ec">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_fcb1bda2-b216-4764-a4c2-09a3d13f32ac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LeasesTerminationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_b4192ab1-1392-4775-850f-0b32e8099e98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_6ed16120-fd10-493e-aced-7ba0d3024b61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_f6dcc9b6-8e32-4d98-bffb-d9bddefb3adf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">freq:TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_a8197e94-f689-4588-95d8-113863133fd1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_5cd63438-4bcf-47ba-83d5-992899a88d69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_389d9cd1-a5f9-4537-a214-aae7847e6a94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">freq:TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LoanAndSecurityAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-11</startDate>
            <endDate>2020-12-11</endDate>
        </period>
    </context>
    <context id="C_e6d90f27-4552-437d-96bb-a911e3141b0e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_cf3edb08-0022-48b3-8d33-0b7ecf23a4eb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_e468091a-59de-4c2e-9cae-c71034b0d9a8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:AstellasPharmaLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">freq:Phase2bClinicalTrialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LicenseAndCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-31</endDate>
        </period>
    </context>
    <context id="C_96ab2203-ccc4-4423-a539-b0358bf75478">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_6b618c84-e67f-47f3-a70b-580a46e694b4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_e8bc2828-4017-4ef6-bfea-d1f31df30f70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">freq:ShortTermMarketableSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_49c37535-f895-4807-a0bd-aba968e19e1d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_774fe501-efdb-4b83-b9f8-19875ffb2b41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:CaliforniaInstituteForBiomedicalResearchMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_5b1c30df-3436-4ba5-a445-bc2cba68d121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_8464360a-28a5-4526-89c7-192cc0292849">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="C_9c459f52-c125-4fea-a2f0-f75d77c58396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">freq:OutstandingStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_875116db-7306-464c-bdd4-f7030d1b80b3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201815Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_1ffc57b1-4997-466a-89cb-19ba9650731e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:HaydenLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">freq:LexingtonLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-07</instant>
        </period>
    </context>
    <context id="C_962eb6f1-dfe5-4536-a514-2f4945f570af">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">freq:ResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-01</startDate>
            <endDate>2018-06-30</endDate>
        </period>
    </context>
    <context id="C_51ed66a1-ea9a-4086-b613-ef93bdcffe77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_becb1019-1881-4f79-9f76-55c0d3336ef7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_a03b4b17-c9bb-4e37-9fb7-544f7db43dca">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_a3c46bd6-df2a-4676-94dc-776e2b2317ad">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">freq:LexingtonMassachusettsFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_659cc924-ac55-436f-91ee-94a2aaf8f068">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:CambridgeEnterpriseLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0699cfb2-3e40-4b40-9c53-76a5fb6da6fe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_50ecffe0-e791-47f3-a7b0-8430f4d7aedb">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_2c72469d-cb8e-4588-8128-2bea9727b19f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">freq:LexingtonMassachusettsFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_d4edc7de-0885-4db2-96f1-84fc825e4ca5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:AstellasPharmaLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">freq:Phase2bClinicalTrialMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LicenseAndCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-31</endDate>
        </period>
    </context>
    <context id="C_8547fe2d-e68e-4291-9f90-da18d274d639">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_02bfcdf4-c4aa-45c7-8d3c-0e389bcfa619">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">freq:OutstandingStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_5d72a168-259a-44dd-9d7b-8058d6b3899a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:AstellasPharmaLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LicenseAndCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-31</endDate>
        </period>
    </context>
    <context id="C_f8a74942-bd20-4ca8-bf18-3a482101a0a2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_14a91b0e-22cb-42cd-8677-a4630683bcaf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_6cb0fef5-08a6-44b1-8683-04aaee45ba50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-12-01</startDate>
            <endDate>2016-12-31</endDate>
        </period>
    </context>
    <context id="C_011eaa78-a982-439b-9cbe-570f4099f0e2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">freq:UnvestedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_b285e24e-c01a-491d-bc76-fbdb9109846f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_3248f726-ed7b-4ffd-ae3b-b39e2f79d1c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsInstituteOfTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-12-01</startDate>
            <endDate>2016-12-31</endDate>
        </period>
    </context>
    <context id="C_aef0c60c-efa8-489b-aeea-79457818c6d2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_ad952da4-5b38-4e64-a1f0-d990bf170c57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-20</startDate>
            <endDate>2019-09-20</endDate>
        </period>
    </context>
    <context id="C_0a19bf2f-1258-4062-91ef-67f93a769e1f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_31fe05e6-676e-4a62-ac60-318d537f9748">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-02-28</instant>
        </period>
    </context>
    <context id="C_961e7065-ef44-44fe-a970-97b4c237d73a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_7b7e8741-8d9b-4c87-a41b-14d39da56ae6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_cdbc9d91-abb1-471d-8577-f5ca0f7f45b1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_f8e0e336-1655-4b45-be69-22f29e76c3ee">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_c58972d9-4eff-40b9-999f-af1bc8c7e65c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsEyeAndEarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_81406c60-6425-4fce-9724-dd646af7f352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">freq:AstellasPharmaLimitedLiabilityCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">freq:LicenseAndCollaborationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-01</startDate>
            <endDate>2019-07-31</endDate>
        </period>
    </context>
    <context id="C_6ad987ee-9ba1-42bf-b041-260c412a34d4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:MA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_8f8e9273-079c-4fb5-a1f5-9391aab3c140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_2d3ea299-2712-49d7-9a62-f5bd2236cb7b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_514ddae0-918c-4159-afcf-c75cb08a52fd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">freq:TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_5bbe5741-fe10-4417-b986-c463fe4c347d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">freq:PatentLicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:CambridgeEnterpriseLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_227c25ee-a3e6-4434-8f48-824b730e370e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">freq:NonExclusivePatentLicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:MassachusettsEyeAndEarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-02-28</endDate>
        </period>
    </context>
    <context id="C_2ae98e31-ab5c-4c24-810c-110edeacf851">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001703647</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">freq:CambridgeEnterpriseLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_UnitedStatesOfAmericaDollarsShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_Term">
        <measure>freq:Term</measure>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <us-gaap:ProceedsFromStockPlans
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      id="F_f3fea894-401b-42b7-a411-98f6c2335c88"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_6cc8354e-b09a-486a-a3bb-72248169c646"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_61d0d67c-f4cd-4d4b-8d9e-d7034d0a2bef"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_32214a13-ed73-4cf7-9633-40ed5fcef2f1">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:AmendmentFlag
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_a1ba2582-5a42-4603-807e-439544ec19e9">false</dei:AmendmentFlag>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_ddc3cbc9-ebdc-4197-a73d-3719f2462855"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:EntityIncorporationDateOfIncorporation
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_7f4715db-25ee-4490-aad3-011a331de8ce">2014-11-30</dei:EntityIncorporationDateOfIncorporation>
    <us-gaap:InterestPaidNet
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      id="F_137eb426-abf4-4990-891b-091eb5ac7e50"
      unitRef="U_USD"
      xsi:nil="true"/>
    <freq:LeaseExpirationYear1
      contextRef="C_815714a9-1c63-462b-be7a-be127a4674d0"
      id="F_ed329d69-2529-48fa-9178-d9e728957db7">2025-02</freq:LeaseExpirationYear1>
    <dei:EntityCentralIndexKey
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_33a1a1f8-0cd6-4834-b151-886edae55ebb">0001703647</dei:EntityCentralIndexKey>
    <freq:PrepaidRentAndDepositsCurrent
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      id="F_1798d1a5-8d3c-4e74-b507-c3d76c7abeb0"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_119e31d0-176a-42b1-86b8-f27ae33f50c7">FY</dei:DocumentFiscalPeriodFocus>
    <us-gaap:PaidInKindInterest
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      id="F_6fbc1e93-2815-4047-9fa0-937dffc4cfe1"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="2"
      id="F_ded4314f-4db0-4f7e-8996-c64ecbefa332"
      unitRef="U_pure">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="2"
      id="F_ac776299-523f-419b-b2ba-1e3e866cfec3"
      unitRef="U_pure">0</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      id="F_61d18edd-8162-4f61-97f0-1bcc5dfcfd2d"
      unitRef="U_USD"
      xsi:nil="true"/>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_cdd6ec79-42ae-4060-abec-f2ff3f16e689"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:DocumentType
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_34694310-e3ef-4f6d-b7e7-7078eeafeaa6">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_da80ec0a-1e97-4251-9a4a-03e51e1ed971">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_bd8c29e2-6b1a-4a65-aee9-ad7058f9c930">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_b999d91f-8055-4f3f-8877-006248bfbeff">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_412a52c4-84be-4053-8791-dd688a8fbb42">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_02a5de0d-57fb-45a5-b332-f19dede06e66">001-39062</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_2c9e28dc-e8fd-479f-9153-43aa5e579e16">FREQUENCY THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_4473d060-4c14-491d-a62e-1cb08f46337f">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_9165bf65-ae86-4f2b-93b5-6091d9e552c7">47-2324450</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_86e39c85-33e3-4bfe-ac9b-e965c07f6448">75 Hayden Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_69759c77-adee-4789-91e3-16781914cb65">Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_0203d912-8c98-41d6-a060-4bd8ebf72e33">Lexington</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_d99899ba-f14e-4c7d-a3b8-37af30012e89">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_99ddbbea-32e4-4803-a719-08716d56bafb">02421</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_7d6567da-90da-4628-adde-17d6d38d01b4">781</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_f1142072-5aec-49eb-ad2a-2372aa4ae482">315-4600</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_1b002cf5-9c9b-4291-a682-0a83168c4cad">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_4f52ccb1-27dc-4182-9078-209d9c523f28">FREQ</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_e83c50ce-80db-4df3-9131-25d06f996279">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_caebea74-f7c4-41f5-8d0b-ea3ffd159c47">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_75809f84-3387-4f73-8e1e-a693c357d7a6">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_b33828f9-23fb-43cb-ba0b-0253f53ebf0f">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_29d43dab-b4c3-42d0-93f2-a35f4af34154">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_54259686-1622-4cf1-8279-f49f68449d7d">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_29bd0b4b-8fbc-411b-a614-425adb32cfc2">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_f63c7a9b-55f4-4d99-b10d-026bec705527">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_d00d34c4-1950-4c2b-8da4-19bc41180098">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_32e8dd93-852b-4d61-9c6e-60e66af4fbe7">false</dei:EntityShellCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_87105965-c592-41cc-ab84-8a5d91f89346">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityPublicFloat
      contextRef="C_f8e0e336-1655-4b45-be69-22f29e76c3ee"
      decimals="-5"
      id="F_88f02971-dd37-459a-aad1-8acaa0a88b69"
      unitRef="U_USD">306000000.0</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_88431303-989b-46e7-871d-38ecd5178aee"
      decimals="INF"
      id="F_bc9f6923-214c-417a-9183-9b9575698d9c"
      unitRef="U_shares">34976409</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_ce3fea7a-a805-4798-9b99-4110d6a57b07">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Portions of the Proxy Statement for the registrant&#x2019;s 2022 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K.&lt;/span&gt;&lt;/p&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_ada15885-8667-45b2-a10d-ebe69814c2f1">49</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_5e39d4ea-f941-4676-95f4-18bddb177e7a">RSM US LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_f3489c08-a3ee-466b-8496-3200f9e5e581">Boston, Massachusetts, USA</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_1e3eba26-e433-4357-8f67-e13f822bc60d"
      unitRef="U_USD">79635000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_eefc3185-5aad-4109-9a2e-f411665b788f"
      unitRef="U_USD">220341000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_167eb624-46ab-4408-931c-fa44b1c18e63"
      unitRef="U_USD">51072000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_48f948ba-317a-4bf1-9cbd-3532ebb5d1db"
      unitRef="U_USD">4041000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_273aedde-264b-4617-af1a-df72d03260b1"
      unitRef="U_USD">4723000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_53a1193c-6a28-41aa-8e57-33452b12045f"
      unitRef="U_USD">134748000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_4207fbc5-be6f-4b02-9099-5f8965acdee2"
      unitRef="U_USD">225064000</us-gaap:AssetsCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_c7723c6b-346f-4782-adab-2b02c9404c3c"
      unitRef="U_USD">11719000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_cb7de139-5416-4cd5-bc8a-4490ae2aae0f"
      unitRef="U_USD">5522000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_4ef0167e-a9a3-4b8c-b79e-739368a33254"
      unitRef="U_USD">7287000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_3f6fdf0e-1b74-43e5-aa35-e43f9d70b36d"
      unitRef="U_USD">31350000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_a9aeb045-139b-4906-abaf-4e0212c9023b"
      unitRef="U_USD">30551000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_0df1fa63-d016-49e0-82ee-6176250611f7"
      unitRef="U_USD">1699000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_b682162e-bcad-4c50-b52c-470298684b09"
      unitRef="U_USD">1820000</us-gaap:RestrictedCashNoncurrent>
    <freq:LongTermAssets
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_704ccc40-6470-421e-b335-38ff6447df31"
      unitRef="U_USD">320000</freq:LongTermAssets>
    <us-gaap:Assets
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_dddf0a0b-8ca0-4e4c-b1fc-2e6ecc7ae004"
      unitRef="U_USD">185358000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_7d2f3720-a78a-46c4-929f-9030ee68b865"
      unitRef="U_USD">264722000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_84580d76-05fe-4df1-a04a-3cb94cd80c37"
      unitRef="U_USD">2748000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_b82d290f-4075-4e73-9555-7b0e5ae09552"
      unitRef="U_USD">5506000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_26d9a6e2-6379-4d1e-aa28-cbade91b3711"
      unitRef="U_USD">6101000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_4b5ed6fc-b10b-409e-8418-1fd34b5f567b"
      unitRef="U_USD">6663000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_4083149c-053c-4dac-ac56-c96ee6727153"
      unitRef="U_USD">14068000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_018b2019-d823-4627-8231-bd78dc4297c1"
      unitRef="U_USD">1747000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_e271a781-c984-4e13-b19e-a17c0f7dff1d"
      unitRef="U_USD">397000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_1220c7ce-ee53-4d89-a03f-c9acdd5a2c99"
      unitRef="U_USD">833000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_d76896e2-f983-4ef4-aebc-22607d8f66bb"
      unitRef="U_USD">11429000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_aa6251f5-c121-46b7-84ee-e1c593002259"
      unitRef="U_USD">26634000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_6bd794fc-dfd2-4178-84ba-0edac4fad090"
      unitRef="U_USD">28851000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_7513d05e-af23-4846-a07a-dc59b1118380"
      unitRef="U_USD">30597000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermLoansFromBank
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_4bff210a-96db-450f-96b0-76b80e685b28"
      unitRef="U_USD">14167000</us-gaap:LongTermLoansFromBank>
    <us-gaap:LongTermLoansFromBank
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_e5547b22-0b6d-4d2b-8cef-f97ed00643de"
      unitRef="U_USD">15000000</us-gaap:LongTermLoansFromBank>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_210d0120-fb8e-44c3-ab8a-9cb5855df9d6"
      unitRef="U_USD">87000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_44a83cf1-e58b-497b-be11-c8bd7a7efe55"
      unitRef="U_USD">54534000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_1106d006-df4f-4f59-b540-4a7a1c852191"
      unitRef="U_USD">72231000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="3"
      id="F_df184f34-5461-48c8-87fa-915d169476ef"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="3"
      id="F_871556b5-2a58-4ef0-be9d-8e15724c46e8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="0"
      id="F_9a74ddb2-b2d3-40da-86a5-3a9cff836a2c"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="0"
      id="F_d4bd91a9-5709-4ea9-9d04-316faf2bf39b"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="0"
      id="F_ff48505c-7981-4c54-9eae-371401553aea"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="0"
      id="F_47af5c86-5172-44d2-af6d-8d54d53038fb"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="0"
      id="F_34fc4922-5497-4057-a9f3-1b45bd58f3f1"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="0"
      id="F_cbcad50c-40ba-46de-9f8e-38135b3896cc"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_f474cfc4-3ec7-45ee-b540-c88a72257dfe"
      unitRef="U_USD">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_6d557ced-ed45-4c9f-a8a2-4621826939f4"
      unitRef="U_USD">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="3"
      id="F_f0b3fed8-7fa1-4dd7-ad63-19177eb4961e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="3"
      id="F_a7223039-5bc5-422a-b7bb-d76a2909c7c9"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="0"
      id="F_e2a0ff64-a95a-4a1f-bd75-7ee46b86e0cb"
      unitRef="U_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="0"
      id="F_8ccabd4e-b9bc-456c-a8a4-781f23477474"
      unitRef="U_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="0"
      id="F_1f50127c-be02-4cd1-b15f-07b06affb27d"
      unitRef="U_shares">34611213</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="0"
      id="F_7e2be2ad-5d06-4cab-a431-1a732a94acc8"
      unitRef="U_shares">34611213</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="0"
      id="F_d77f327c-5362-4466-a4fa-001c5b797213"
      unitRef="U_shares">33964000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="0"
      id="F_c874784b-dcee-4009-a708-cbd41356fa22"
      unitRef="U_shares">33964000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_dc8496a4-6057-4bca-be86-1c96275f9d78"
      unitRef="U_USD">35000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_3175bd70-da9c-40af-bd03-da0184b84482"
      unitRef="U_USD">34000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_1896e835-cbda-43aa-bfd7-5b246abb9607"
      unitRef="U_USD">310936000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_57744e5d-1fcc-4e5a-afc2-d9b0f7d3410f"
      unitRef="U_USD">287829000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_ef0fab7e-e492-43d1-943f-a49f8d0f9227"
      unitRef="U_USD">-62000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_921eda9c-8f7c-4860-b7b2-8b9a2943e995"
      unitRef="U_USD">27000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_86cf5ff7-648d-4752-936e-6ef297e14348"
      unitRef="U_USD">-180085000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_a588a213-633f-4197-abeb-a557f0ba8a43"
      unitRef="U_USD">-95399000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_562a6550-4f85-4cde-951e-ec9b71d960b5"
      unitRef="U_USD">130824000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_c4b99ef1-17dc-4d51-bc54-3c568a307e77"
      unitRef="U_USD">192491000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_9355b33f-8555-4eec-a6c2-14dd4c28c523"
      unitRef="U_USD">185358000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_7eb4f440-e260-44b2-a8f7-6cb3017186ab"
      unitRef="U_USD">264722000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_83ea6ecb-0552-4275-a2fc-a382c936ccf2"
      unitRef="U_USD">14068000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_327c92ac-9144-4ea0-9f3c-f73946b74b0c"
      unitRef="U_USD">36984000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_39889f52-4bea-475d-b7bc-5971b0d70802"
      unitRef="U_USD">60923000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_0fb69c88-8650-4505-9d8b-d18b3ccfef56"
      unitRef="U_USD">37415000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_a4e2c6e6-9a32-49bc-b2e2-bd095a60293e"
      unitRef="U_USD">37176000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_10d0d2ca-fd46-4239-ab98-349a2f870eea"
      unitRef="U_USD">27119000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_679fb530-b1c3-4fec-914f-9b135e7fb94b"
      unitRef="U_USD">98099000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_bf216791-5b63-481c-8038-b2f4db5eebfd"
      unitRef="U_USD">64534000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_94450e47-c64c-450e-8497-b7d993c10c6f"
      unitRef="U_USD">-84031000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_37d9a9de-4d15-4d0e-a666-629a9765d7ee"
      unitRef="U_USD">-27550000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_5b338fd3-70f2-4247-bc7f-a28820ddc9ef"
      unitRef="U_USD">397000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_54312493-bfd4-4d00-912a-d0c416445e24"
      unitRef="U_USD">994000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_ee66cf8c-68ef-4a34-8908-be4ca3111086"
      unitRef="U_USD">764000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_691fe35f-50bb-4361-942a-d2b26c67a875"
      unitRef="U_USD">0</us-gaap:InterestExpense>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_2c0f47c9-e6f1-414b-825a-5956f8c18b79"
      unitRef="U_USD">-23000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_75fbf065-8c56-4b0a-acde-1dff6b86297b"
      unitRef="U_USD">84000</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_d0b56caf-6f6c-40be-bddb-2997ce96c352"
      unitRef="U_USD">16000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_1dd16e5e-324d-4e31-8a82-bd8ac0f5b121"
      unitRef="U_USD">-4000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:OtherNonoperatingExpense
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_b9c0b0c3-c8fb-4b84-90be-c6083933261d"
      unitRef="U_USD">266000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_ee38de9d-7074-4680-b579-3e34e1f2471a"
      unitRef="U_USD">0</us-gaap:OtherNonoperatingExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_5a61a5c6-3808-4fa4-901d-3584a228c941"
      unitRef="U_USD">-84671000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_5e938cee-8b0d-4984-a85c-f565053b7d66"
      unitRef="U_USD">-26476000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_6288649c-448c-4a0e-8ba1-ffcba82f22e0"
      unitRef="U_USD">15000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_229cc83a-1f8e-41c8-9bd5-da220814fcf7"
      unitRef="U_USD">35000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_19921682-e35d-49b4-9369-ce879df2ce96"
      unitRef="U_USD">-84686000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_2d68f7a3-03ff-493a-8399-c2e5aff1d81e"
      unitRef="U_USD">-26511000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="2"
      id="F_c9f05a2d-d222-4bc0-b7aa-f49082dda8f5"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-2.47</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="2"
      id="F_efb47cc0-c88c-4cb8-93a8-c89d654e4a72"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.82</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="0"
      id="F_56074ad0-2060-400f-a085-3da86a7b6126"
      unitRef="U_shares">34351274</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="0"
      id="F_bba8e658-5225-418e-8931-3eabaee41ae2"
      unitRef="U_shares">32253227</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_c31e8564-93f0-4bc8-bc24-3e6549728f8a"
      unitRef="U_USD">-84686000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_93293f10-9878-4467-aa90-b0c15261fa6a"
      unitRef="U_USD">-26511000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_6cce7e55-6a19-440f-bd79-ea87a433cac3"
      unitRef="U_USD">-89000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_4b29617a-5cae-422f-a57e-ada3edf8bafc"
      unitRef="U_USD">-27000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_2d91f2ce-1335-4d9f-87d6-24024f808aab"
      unitRef="U_USD">-89000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_cd95b9b0-3f4f-42c3-b98f-4c40f4afb49b"
      unitRef="U_USD">-27000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_c65abb1c-b9f9-460e-acec-136d5c34ce7e"
      unitRef="U_USD">-84775000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_7606b8c2-19fc-4efb-9fdf-5f59347f484c"
      unitRef="U_USD">-26538000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_b4e6b702-2e18-4b8d-b021-d0ca35b2f1ec"
      decimals="INF"
      id="F_b75d8c47-6958-45b7-a6ce-facdfe0084dd"
      unitRef="U_shares">30844507</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_b4e6b702-2e18-4b8d-b021-d0ca35b2f1ec"
      decimals="-3"
      id="F_4740eb31-eabb-498f-a8be-e6bd2f3b1ac2"
      unitRef="U_USD">31000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_0699cfb2-3e40-4b40-9c53-76a5fb6da6fe"
      decimals="-3"
      id="F_709ac7e2-9aee-4806-b60f-502568b30bfc"
      unitRef="U_USD">236161000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_394b00a6-d93c-4bb0-9bba-bc11145aea27"
      decimals="-3"
      id="F_b0da2f5f-81a2-4ea4-b204-5d2c4904f9e0"
      unitRef="U_USD">54000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_55a858d8-b30a-41c7-bb81-5e2b9474ff72"
      decimals="-3"
      id="F_5f7984d9-05de-4243-b234-9fa9e7594a10"
      unitRef="U_USD">-68888000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_fa37d2a6-9437-44d8-82ac-ad9b23ac3a6b"
      decimals="-3"
      id="F_bfe68604-fd0b-4766-8fd1-550ec68b3fff"
      unitRef="U_USD">167358000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_dfc08580-a6c7-489e-9745-b9dfdc59a70d"
      decimals="-3"
      id="F_5f9b2658-373c-45fa-9b40-171da2f84e34"
      unitRef="U_USD">9983000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_9ab8701a-f02c-46df-b8db-d2772a2862a8"
      unitRef="U_USD">9983000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_e8ed63ae-2752-4e17-8e6b-1b8e47c58699"
      decimals="INF"
      id="F_89de2c2d-3a0a-4193-a541-6b5c0912d5ca"
      unitRef="U_shares">769385</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_e8ed63ae-2752-4e17-8e6b-1b8e47c58699"
      decimals="-3"
      id="F_750a8da9-6c9c-4375-9d3f-5da2eed9c480"
      unitRef="U_USD">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_dfc08580-a6c7-489e-9745-b9dfdc59a70d"
      decimals="-3"
      id="F_803ac913-905b-4377-83bc-cca6715c2b8c"
      unitRef="U_USD">1544000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_8b1f48ed-6c53-4be9-90a9-715710681361"
      unitRef="U_USD">1545000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_e8ed63ae-2752-4e17-8e6b-1b8e47c58699"
      decimals="INF"
      id="F_d7de0bfe-f1ba-455e-b749-ac284d83474c"
      unitRef="U_shares">2350108</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_e8ed63ae-2752-4e17-8e6b-1b8e47c58699"
      decimals="-3"
      id="F_5ac4b365-f929-4d98-8d8c-b34221d4289a"
      unitRef="U_USD">2000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_dfc08580-a6c7-489e-9745-b9dfdc59a70d"
      decimals="-3"
      id="F_69af13d2-acb0-4975-b6b7-64c03a8f7ab2"
      unitRef="U_USD">40141000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_d4720e1b-17f4-420f-a016-cc524394d262"
      unitRef="U_USD">40143000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_2d3ea299-2712-49d7-9a62-f5bd2236cb7b"
      decimals="-3"
      id="F_fb33c142-4d0f-4e10-9ae5-850bc908433c"
      unitRef="U_USD">-27000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_09fc89dc-72bf-426e-80d2-26a50f3be1be"
      unitRef="U_USD">-27000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_51ed66a1-ea9a-4086-b613-ef93bdcffe77"
      decimals="-3"
      id="F_8db57257-e330-46e7-9695-87f92d4c07c7"
      unitRef="U_USD">-26511000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_448de5d0-ec46-4e2b-9d73-7817b3ba6f83"
      unitRef="U_USD">-26511000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_3a7f3500-4681-4b89-b3ee-9823efb5714a"
      decimals="INF"
      id="F_c79e0501-e273-4832-ba7b-60ae69f2a026"
      unitRef="U_shares">33964000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_3a7f3500-4681-4b89-b3ee-9823efb5714a"
      decimals="-3"
      id="F_b6b02661-24ed-40fd-b880-9f05a0e4c546"
      unitRef="U_USD">34000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_83f34b69-48ab-4eeb-affa-ce666d46960a"
      decimals="-3"
      id="F_85857d8c-4c73-4b72-a4ad-661b554d13e8"
      unitRef="U_USD">287829000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_8f8e9273-079c-4fb5-a1f5-9391aab3c140"
      decimals="-3"
      id="F_58fba303-b7b8-4096-a77d-942e4e2b2792"
      unitRef="U_USD">27000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_48cf3447-6d32-4520-8654-49cad8c660d5"
      decimals="-3"
      id="F_7c7a4a73-8cac-4e60-b79c-f515f0c7e641"
      unitRef="U_USD">-95399000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_41c1956f-4a99-47e0-9619-98127f412db1"
      unitRef="U_USD">192491000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_a2aa7323-25ff-4251-80f3-998eec4375b1"
      decimals="-3"
      id="F_c0f63721-5be7-4a62-9e68-979ee0690bf9"
      unitRef="U_USD">21750000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_a17e2d24-229a-4797-98c5-453675cad5e6"
      unitRef="U_USD">21750000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="C_96ab2203-ccc4-4423-a539-b0358bf75478"
      decimals="INF"
      id="F_4aecada3-8e1c-4c03-8a6f-d65166376e8d"
      unitRef="U_shares">7064</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_a2aa7323-25ff-4251-80f3-998eec4375b1"
      decimals="-3"
      id="F_3b02b6b1-576c-4256-afe7-d48ec9c38f84"
      unitRef="U_USD">60000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_2ad0ce0a-898e-4388-b01f-b5bf82cff15d"
      unitRef="U_USD">60000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_96ab2203-ccc4-4423-a539-b0358bf75478"
      decimals="INF"
      id="F_586598bc-93c1-47a3-8a7f-cdb3138f5748"
      unitRef="U_shares">642314</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_96ab2203-ccc4-4423-a539-b0358bf75478"
      decimals="-3"
      id="F_22bac9d4-2279-425d-bb05-e9bc559996d8"
      unitRef="U_USD">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_a2aa7323-25ff-4251-80f3-998eec4375b1"
      decimals="-3"
      id="F_96a9af97-86a0-4691-ad96-743c31fe9341"
      unitRef="U_USD">1297000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_aaf562e9-21cb-4243-bfcb-5c58e40f517e"
      unitRef="U_USD">1298000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
      contextRef="C_96ab2203-ccc4-4423-a539-b0358bf75478"
      decimals="INF"
      id="F_6d21e075-a15a-45d3-b633-181533de9ccf"
      unitRef="U_shares">2165</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_242a50fc-c372-4fff-a068-1d46d8ada8fc"
      decimals="-3"
      id="F_1bf1053d-c030-496a-ba96-90a465d08358"
      unitRef="U_USD">-89000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_410b2633-d519-43b0-bc4a-128baf05682d"
      unitRef="U_USD">-89000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss
      contextRef="C_3d40bafe-0686-48fd-af67-9a140619ba32"
      decimals="-3"
      id="F_f67ab4b1-a28c-4aac-a20a-04e005a84d29"
      unitRef="U_USD">-84686000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_494686bd-7cd3-4194-a681-2e04e227a9a5"
      unitRef="U_USD">-84686000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_36f8045c-3f63-4117-a53e-1768fa09baac"
      decimals="INF"
      id="F_c711c393-1664-4933-9b84-2e5d47ce66d1"
      unitRef="U_shares">34611213</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_36f8045c-3f63-4117-a53e-1768fa09baac"
      decimals="-3"
      id="F_a65229ee-5217-415b-9ec7-259c86913ea6"
      unitRef="U_USD">35000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_f8a74942-bd20-4ca8-bf18-3a482101a0a2"
      decimals="-3"
      id="F_20da4d6c-1bd7-49a3-8b99-91ae76879d8e"
      unitRef="U_USD">310936000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_6ed16120-fd10-493e-aced-7ba0d3024b61"
      decimals="-3"
      id="F_e224c467-9e63-4d72-a082-489a39699c4e"
      unitRef="U_USD">-62000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_b285e24e-c01a-491d-bc76-fbdb9109846f"
      decimals="-3"
      id="F_a90ead00-2bc2-4fed-a14d-9af983fc2f61"
      unitRef="U_USD">-180085000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_6414c939-3bd4-41e9-af24-5d1f52aaedc4"
      unitRef="U_USD">130824000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_4f13b4ae-c90a-4108-8b56-3ab8de0e680f"
      unitRef="U_USD">-84686000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_4ce215c8-0ef1-46e0-8438-7ef7cbc5e340"
      unitRef="U_USD">-26511000</us-gaap:ProfitLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_dbe7b631-1297-4aae-ba95-0f67b3ab7296"
      unitRef="U_USD">21750000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_4333ef35-3911-4296-bc4e-e46677afb11e"
      unitRef="U_USD">9983000</us-gaap:ShareBasedCompensation>
    <us-gaap:Depreciation
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_79fd5bc8-068c-4dcc-a916-97ac19068f86"
      unitRef="U_USD">2775000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_1022b323-7d5b-4f0d-bcff-e3696f22e3a5"
      unitRef="U_USD">1146000</us-gaap:Depreciation>
    <freq:NonCashLeaseExpenses
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_2da490f4-2e13-43a3-a87a-c9b599b44e1e"
      unitRef="U_USD">1066000</freq:NonCashLeaseExpenses>
    <freq:NonCashLeaseExpenses
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_75425ed6-ffc7-4c38-941b-cf55c559aefd"
      unitRef="U_USD">434000</freq:NonCashLeaseExpenses>
    <us-gaap:PaidInKindInterest
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_7dba5c6d-270e-4d39-a389-2d37173cd828"
      unitRef="U_USD">347000</us-gaap:PaidInKindInterest>
    <us-gaap:GainLossOnDispositionOfAssets1
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_e8449907-ba4c-48c2-87d4-e7c37acb723e"
      unitRef="U_USD">-16000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_b1095c27-1f45-4301-8947-a629179ae08e"
      unitRef="U_USD">173000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_c362b962-4ed1-42d6-b0db-91bfa32bd2a6"
      unitRef="U_USD">626000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_81e68175-a1d1-47f5-a4ff-d9f49b9f17e0"
      unitRef="U_USD">-2292000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_7f94d3d7-829f-403c-8db6-07a8d3c99331"
      unitRef="U_USD">4287000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_8c4ec800-864a-4da3-a740-6f2fd4518a33"
      unitRef="U_USD">-14068000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_732da880-5cf4-4a68-aecb-5924268d2dbf"
      unitRef="U_USD">-36984000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_fbb9d3e7-19fc-4d35-8179-099ebf616135"
      unitRef="U_USD">-794000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_b80e24ee-e849-4cfd-a78e-2f5199c2cc68"
      unitRef="U_USD">3083000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_d745e238-71c9-4ee0-8db0-a483315be4d5"
      unitRef="U_USD">-76059000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_2972117d-d933-4651-a6a1-280cffd5f47a"
      unitRef="U_USD">-45188000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_c06e51f2-2e12-4ef5-bc98-d8bb5d2c4307"
      unitRef="U_USD">2914000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_499e02ca-6812-456d-907b-8a4515b9fe15"
      unitRef="U_USD">6671000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_69f100e9-5403-4ecc-a5f4-67c9f99fd41b"
      unitRef="U_USD">92445000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_0039700a-0bd5-4689-872a-08333fdf86a7"
      unitRef="U_USD">26345000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_f556539c-2c4b-4b13-b422-04c374156251"
      unitRef="U_USD">29233000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_cd829ada-a4cd-43fe-ae87-746d21c87b0a"
      unitRef="U_USD">43418000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_cf33dd61-c348-4613-a122-ddf934fb14f4"
      unitRef="U_USD">-66126000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_103045c1-f062-4427-91b7-9907a55ca99c"
      unitRef="U_USD">10402000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_c6cbc8cb-5d89-447a-a20f-dca347293516"
      unitRef="U_USD">1298000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_3d5863fc-ba88-435f-9aed-85116aedc0cb"
      unitRef="U_USD">1545000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromStockPlans
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_4ab724ae-5578-4689-883a-8ad91e51fda9"
      unitRef="U_USD">60000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_91f45205-6b6e-4d7f-baba-a2ac832b87b3"
      unitRef="U_USD">40143000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_74ab7261-4523-41e6-852d-00760e410fc3"
      unitRef="U_USD">15000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_616abc50-3120-4548-af04-e478f9e55b24"
      unitRef="U_USD">1358000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_114d8698-10df-45f7-8d13-7385a0289a99"
      unitRef="U_USD">56688000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_76d91013-68aa-44f4-85a9-928060300c65"
      unitRef="U_USD">-140827000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_1f28bfb3-4095-4838-94fa-39b698984635"
      unitRef="U_USD">21902000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_c3959906-9cc0-4d70-9656-041b1814d5f2"
      unitRef="U_USD">222161000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_fa37d2a6-9437-44d8-82ac-ad9b23ac3a6b"
      decimals="-3"
      id="F_6fca6aac-e328-46c4-bec1-1feb5aa2787a"
      unitRef="U_USD">200259000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_bab4b962-9ddd-4d2d-84d5-f95c1bcdf871"
      unitRef="U_USD">81334000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_7e553283-5ca1-44ab-86ba-4cbb44710878"
      unitRef="U_USD">222161000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_ebab044f-2c5f-4cb5-b4e9-12985636f7ad"
      unitRef="U_USD">703000</us-gaap:InterestPaidNet>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_5ddbae01-fa65-402d-a944-51a5065fe6e7"
      unitRef="U_USD">31335000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_3f0bbf7d-eab4-43e0-8f91-14235fd613f2"
      unitRef="U_USD">2145000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_879dfe11-82a7-4d86-9f78-5ec742e5c3cd">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;1. Organization&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Frequency Therapeutics, Inc., together with its wholly owned subsidiaries, Frequency Therapeutics, PTY, LTD, Frequency Therapeutics Securities Corporation and Frequency Therapeutics Japan KK (Frequency Japan) (the Company), headquartered in Lexington, Massachusetts, was incorporated in &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_7f4715db-25ee-4490-aad3-011a331de8ce;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;November 2014&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; as a Delaware corporation. Frequency Japan was closed down in February 2021. The Company is a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person&#x2019;s innate regenerative potential to restore function.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Liquidity and capital resources&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has funded its operations primarily with proceeds from the sale of its capital stock, convertible notes and amounts received under a collaboration agreement. The Company has incurred recurring losses since its inception. In addition, as of December 31, 2021, the Company had an accumulated deficit of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;180,085&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. The Company expects to continue to generate operating losses for the foreseeable future. The future viability of the Company is dependent on its ability to raise additional capital to finance its operations. The Company&#x2019;s inability to raise capital as and when needed could have a negative impact on its financial condition and ability to pursue its business strategies. There can be no assurances that additional funding will be available on terms acceptable to the Company, or at all. The Company believes that existing resources will be sufficient to fund planned operations for at least 12 months from the date the financial statements were available to be issued.&lt;/span&gt;&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_90c910bd-df0b-4caf-9e3b-7d18e27557ae"
      unitRef="U_USD">-180085000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_55ce9377-3192-43f0-8c1d-9bd47ec7e104">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2. Summary of significant accounting policies&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Basis of presentation&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The accompanying consolidated financial statements have been prepared in accordance with accounting standards set by the Financial Accounting Standards Board (FASB). The FASB sets generally accepted accounting principles (GAAP) that the Company follows to ensure its financial condition, results of operations, and cash flows are consistently reported. References to GAAP issued by the FASB in these notes to the consolidated financial statements are to the FASB &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Accounting Standards&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; Codification (ASC).&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Principles of consolidation&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The consolidated financial statements include the accounts of Frequency Therapeutics, Inc. and its wholly owned subsidiaries Frequency Therapeutics Securities Corporation, Frequency Therapeutics PTY, LTD and Frequency Japan through the date of its dissolution. All intercompany transactions and balances have been eliminated.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Use of estimates&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The preparation of the Company&#x2019;s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of expenses during the reporting period. On an ongoing basis, the Company&#x2019;s management evaluates its estimates, which include but are not limited to management&#x2019;s judgments of accrued expenses, revenue recognition, fair value of common stock, valuation of share-based awards, present value of lease liabilities and income taxes. Actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Comprehensive loss&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Components &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;of comprehensive income or loss, including net income or loss, are reported in the financial statements in the period in which they are recognized. Other comprehensive income or loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Net income (loss) and other comprehensive income (loss) are reported net of any related tax effect to arrive at comprehensive income (loss). Comprehensive loss includes net loss as well as other changes in stockholders&#x2019; equity that result from transactions and&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;economic &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;events other than those with stockholders which for the years ended December 31, 2021 and 2020 consist of unrealized loss on marketable securities. &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"/&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Segment information&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision-maker in deciding how to allocate resources and assess performance. The Company and the Company&#x2019;s chief operating decision-maker, the Company&#x2019;s chief executive officer, views the Company&#x2019;s operations and manages its business as a single operating segment, which is in the business of discovering and developing small molecule drugs that activate progenitor cells within the body to create healthy tissue.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Foreign currency&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:12.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;All periods presented are reported in US dollars. The functional currency for entities outside the United States is the US dollar. Realized and unrealized gains and losses from foreign currency transactions are reflected in the consolidated statements of operations as other expense.&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; During the years ended December 31, 2021 and 2020 the Company recorded $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;16&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;of foreign currency exchange gains and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of foreign currency exchange losses, respectively.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company considers all highly liquid investments with an original maturity of six months or less at acquisition to be cash equivalents which are stated at fair market value. Cash and cash equivalents at December 31, 2021 and 2020 consists entirely of cash and money market funds.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Restricted cash&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,700&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of restricted cash as of December 31, 2021 which represents a security deposit on the Company's Lexington, Massachusetts facility. The $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,800&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of restricted cash at December 31, 2020 represented the security deposit on the Lexington, Massachusetts facility as well as a $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;100&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; security deposit on the Company's previous Woburn, Massachusetts facility.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Marketable securities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Marketable securities represent holdings of available-for-sale marketable debt securities in accordance with the Company&#x2019;s investment policy. Short-term marketable securities mature within one year from the balance sheet date while long-term marketable securities mature after one year. Investments in marketable securities are recorded at fair value, with any unrealized gains and losses reported within accumulated other comprehensive income as a separate component of stockholders&#x2019; equity until realized or until a determination is made that an other-than-temporary decline in market value has occurred. The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization and accretion are reflected as a component of other expense. Interest on securities sold is determined based on the specific identification method and reflected as interest income. Any realized gains or losses on the sale of investment are reflected as realized (loss) gain on investments.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Concentration of credit risk and off-balance sheet risk&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Financial instrument that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents and marketable securities. The Company maintains its cash, cash equivalents, and restricted cash at several accredited financial institutions, in amounts that exceed federally insured limits. Marketable securities consist of short term and long term investments. Management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which its money market accounts are maintained.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has no significant off-balance sheet arrangements such as foreign exchange contracts, option contracts, or other foreign hedging arrangements.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Significant suppliers&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company is dependent on third-party manufacturers to supply products for research and development activities of its programs, including preclinical and clinical testing. In particular, the Company relies and expects to continue to rely on a single manufacturer of its product candidates for use in clinical trials. The Company would be adversely affected by a significant interruption in the supply of product for use in clinical programs.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Fair value measurements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Fair value is defined as the price that would be received upon sale of an asset or paid to transfer a liability between market participants at measurement dates. ASC Topic 820, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Fair Value Measurement&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (ASC 820), establishes a three-level valuation hierarchy for instruments measured at fair value. The hierarchy is based on the transparency of inputs to the valuation of an asset or liability as of the measurement date. The hierarchy defines three levels of valuation inputs, of which the first two are considered observable and the last is considered unobservable:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:-10.836%;padding-left:9.333%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 1	Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:-10.836%;padding-left:9.333%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 2	Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable,     such as quoted market prices, interest rates and yield curves.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:-10.836%;padding-left:9.333%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 3	Unobservable inputs developed using estimates or assumptions developed by the Company, which reflect those that a market participant would use in pricing the asset or liability.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&#x2019;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The carrying values of other current assets, accounts payable, and accrued expenses approximate their fair values due to the short-term nature of these assets and liabilities. The fair value of the Company&#x2019;s Term Loan is &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;t materially different from the carrying value as presented.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Property and equipment consist of lab equipment, computer equipment, furniture and office equipment and leasehold improvements recorded at cost. These amounts are depreciated using the straight-line method over the estimated useful lives of the assets as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:71.997%;"/&gt;
          &lt;td style="width:1.002%;"/&gt;
          &lt;td style="width:27.001%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.175in;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.175in;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Estimated useful life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Furniture and office equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Shorter of the estimated useful&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;life or lease term&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Upon retirement or sale, the cost of the assets disposed of and the related accumulated depreciation are eliminated from the balance sheet and related gains or losses are reflected in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company continually evaluates long-lived assets for potential impairment when events or changes in circumstances indicate the carrying value of the assets may not be recoverable. Recoverability is measured by comparing the book values of the assets to the expected future net undiscounted cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the book values of the assets exceed their fair value. The Company did &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;t recognize any impairment losses for the years ended December 31, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Research and development costs and accruals&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;and development expenses include salaries and benefits, materials and supplies, preclinical and clinical trial expenses, stock-based compensation expense, depreciation of equipment, contract services and other outside expenses. The Company has entered into various research and development-related contracts with research institutions, contract research organizations, contract manufacturers and other companies. These agreements are generally cancelable, and related payments are recorded as research and development expenses as incurred. Costs of certain development activities, such as manufacturing, pre-clinical and clinical trial expenses, are recognized based on an evaluation of the progress to completion of specific tasks. Payments for these activities are based on the terms of the individual arrangements, which may differ from the pattern of costs incurred, and are reflected in the consolidated financial statements as prepaid or accrued research and development costs. Nonrefundable advance payments for goods or services to be received in the future for use in research and development activities are deferred and capitalized. The capitalized amounts are expensed as the related goods are delivered or the services are performed. Costs incurred in obtaining technology licenses are charged to research and&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;development &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;expense as acquired in-process research and development if the technology licensed has not reached technological feasibility and has no alternative future use.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company elected to early adopt ASC 842, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Leases&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (ASC 842) as of January 1, 2020 and elected the transition method under ASU 2016-02 whereby the Company records a right-to-use asset and a lease liability on the consolidated balance sheet for all leases with terms longer than 12 months. The Company also elected to apply the package of practical expedients intended to ease transition. Accordingly, the Company has only applied ASC 842 to leases existing at January 1, 2020. The Company determines if an arrangement is, or contains, a lease at inception. Operating leases are included in operating lease right-of-issue (&#x201c;ROU&#x201d;) assets, other current liabilities, and operating lease liabilities on the consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments to be made over the lease term. The ROU asset also includes any lease payments made at or before the lease commencement date and excludes lease incentives received. As the Company&#x2019;s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Operating lease expense is recognized on a straight-line basis over the lease term. The Company has elected to not apply the recognition requirements of ASC 842 for short-term leases, which is defined as a lease that, at the lease commencement date, has a lease term of 12 months or less and does &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;t include an option to purchase the underlying asset that the Company is reasonably certain to exercise.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;For real estate lease agreements entered into or modified after the adoption of ASC 842 that include lease and non-lease components, the Company has elected to account for the lease and non-lease components, such as common area maintenance charges, as a single lease component.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Collaborative arrangements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company analyzes its collaborative arrangements to assess whether they are within the scope of ASC 808, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Collaborative Arrangements&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (&#x201c;ASC 808&#x201d;) to determine whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards dependent on the commercial success of such activities. This assessment is performed throughout the life of the arrangement based on changes in the responsibilities of all parties in the arrangement. For collaboration arrangements within the scope of ASC 808 that contain multiple elements, the Company first determines which elements of the collaboration are deemed to be within the scope of ASC 808 and those that are more reflective of a vendor-customer relationship (e.g., a licensing arrangement) where the contracted party has obtained goods or services that are an output of the Company&#x2019;s ordinary activities in exchange for a consideration and therefore within the scope of ASC 606, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (&#x201c;ASC 606&#x201d;). For those elements of the arrangement that are accounted for pursuant to ASC 606, including those to which ASC 606 is applied by analogy, the Company applies the five-step model described in the Company&#x2019;s revenue recognition policy. For elements of collaborative arrangements that are accounted for pursuant to ASC 808, an appropriate and rational recognition method is determined and applied consistently. Reimbursements from the counterparty that are the result of a collaborative relationship with the counterparty, instead of a customer relationship, such as co-development or clinical activities, are recorded as a reduction to research and development expense as the services are performed. Similarly, amounts that are owed to a collaboration partner related to the co-development clinical activities are recognized as research and development expense.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company enters into out-licensing agreements that are within the scope of ASC 606. The terms of such out-license agreements include licenses to functional intellectual property (IP), given the functionality of the intellectual property is not expected to change substantially as a result of the licensor&#x2019;s ongoing activities. Such arrangements typically include payment of one or more of the following: non-refundable up-front license fees; reimbursement of certain costs; development and regulatory milestone payments and milestone payments based on the level of sales; and royalties on net sales of licensed products.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company considers the economic and regulatory characteristics of the licensed IP, research, development, manufacturing and commercialization capabilities of the licensee and the availability of the associated expertise in the general marketplace to determine if it has standalone value at the inception of the licensing arrangement, which would make the license distinct. In addition, the Company considers whether the licensee can benefit from a promise for its intended purpose without the receipt of any additional good or services promised in the contract, whether the value of the license is dependent on the remaining goods and services, whether there are other vendors that could provide the remaining promise, and whether the license is separately identifiable from the remaining good and services. For licenses that are combined with&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;other goods and services, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of progress and related revenue recognition. The measure of progress, and thereby periods over which revenue should be recognized, are subject to estimates by management and may change over the course of the research and development and licensing agreement. Such a change could have a material impact on the amount of revenue the Company records in future periods.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Revenue is allocated to the licensed IP on a relative standalone selling price basis and, for functional IP, is recognized at a point when the licensed IP is made available for the customer&#x2019;s use and benefit, which generally occurs at the inception of the arrangement. However, in cases, where the functionality of the IP is expected to substantively change as a result of activities of the Company that do not transfer additional promised goods or services, or in cases, where there is an expectation that the Company will undertake activities to change the standalone functionality of the IP and the customer is contractually or practically required to use the latest version of the IP, revenue for the license to functional IP is recognized over time.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Development and regulatory milestone fees, which are a type of variable consideration, are recognized as revenue to the extent that it is probable that a significant reversal will not occur. The Company recognizes royalty revenue and sales-based milestones at the later of (i) when the related sales occur, or (ii) when the performance obligation to which the royalty has been allocated has been satisfied.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has entered into a collaboration arrangement with Astellas Pharma Inc. (&#x201c;Astellas&#x201d;), as further described in Note 13 of notes to consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Revenue recognition&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company accounts for contracts with customers in accordance with ASC 606, including all amendments thereto. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as collaborative arrangements and leases. The Company&#x2019;s disclosure within the below sections or elsewhere within these consolidated financial statements reflects the Company&#x2019;s accounting policies in compliance with this new standard.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Under ASC 606, an entity recognizes revenue when or as its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To recognize revenue for arrangements that an entity determines are within the scope of ASC 606, the entity performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price, including variable consideration, if any; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies its performance obligations. The Company only applies the five-step model to contracts when it is probable that the entity will collect substantially all of the consideration to which it will be entitled in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and identifies as a performance obligation each promise to transfer to the customer either (a) a good or service (or bundle of goods and services) that is distinct, or (b) a series of distinct goods and services that are substantially the same and have been the same pattern of transfer to the customer.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company assesses whether each promised good or service is distinct for the purpose of identifying the performance obligations in the contract. This assessment involves subjective determinations and requires management to make judgments about the individual promised goods or services and whether such are separable from the other aspects of the contractual relationship. Promised goods and services are considered distinct provided that: (i) the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (that is, the good or service is capable of being distinct) and (ii) the entity&#x2019;s promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (that is, the promise to transfer the good or service is distinct within the context of the contract). In assessing whether a promised good or service is distinct, the Company considers factors such as the research, manufacturing and commercialization capabilities of the collaboration partner (the &#x201c;customer&#x201d; in this type of arrangement) and the availability of the associated expertise in the general marketplace. The Company also considers the intended benefit of the contract in assessing whether a promised good or service is separately identifiable from other promises in the contract. If a promised good or service is not distinct, an entity is required to combine that good or service with other promised goods or services until it identifies a bundle of goods or services that is distinct. For each arrangement that results in revenues, the Company identifies all performance obligations, which may include, for example, a license to IP and know-how, research and development activities, and/or manufacturing services.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In addition to any upfront payment, if the consideration promised in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the promised goods&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;or services to a customer. The Company determines the amount of variable consideration by using the expected value method or the most likely amount method. The Company includes the estimated variable consideration in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, the Company re-evaluates the estimated variable consideration included in the transaction price and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis in the period of adjustment.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;If an arrangement includes development and regulatory milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. There is considerable judgment involved in determining whether it is probable that a significant revenue reversal would not occur. If it is probable that a significant revenue reversal will not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or of the licensee such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of all milestones subject to constraint and, if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;For contracts that include sales-based royalties (including milestone payments based on the level of sales) promised in the exchange for licenses of intellectual property, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes royalty revenue and sales-based milestone payments at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied. In determining the transaction price, the Company adjusts the promised amount of consideration for the effects of the time value of money if the timing of payments provides the Company or the Company&#x2019;s customer with a significant benefit of financing the transfer of goods and services. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be one year or less. The Company assesses each of its revenue generating arrangements in order to determine whether a significant financing component exists. The Company recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) each performance obligation is satisfied, either at a point in time or over time.  For performance obligations satisfied over time, the Company measures progress toward completion of its performance obligations using an input method based on the Company&#x2019;s efforts and inputs to satisfy its performance obligations relative to total expected inputs to the satisfaction of that performance obligation.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Amounts received from a customer prior to revenue recognition are recorded as deferred revenue. Amounts received from a customer that are expected to be recognized as revenue within the 12 months following the balance sheet date are classified as a current liability in the accompanying consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Patent costs&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company expenses patent application and related legal costs as incurred and classifies such costs as general and administrative expenses in the accompanying consolidated statements of operations.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Stock-based compensation&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company accounts for its stock-based compensation in accordance with ASC Topic 718, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Compensation&#x2014;Stock Compensation&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (ASC 718). ASC 718 requires all share-based payments to employees and directors to be recognized as expense in the consolidated statements of operations and comprehensive loss based on their grant date fair values. The Company adopted FASB Accounting Standards Update (ASU) 2016-09 which identifies areas for simplification of several areas of share-based payment transactions. The Company treats non-employee grants in a manner consistent with employee grants. The Company estimates the fair value of options granted using the Black-Scholes option pricing model for stock option grants to both employees and non-employees. The Company believes the fair value of the stock options granted to non-employees is more reliably determinable than the fair value of the services provided.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Black-Scholes option pricing model requires inputs based on certain subjective assumptions, including (a) the expected stock price volatility, (b) the expected term of the award, (c) the risk-free interest rate and (d) expected dividends. Due to the lack of sufficient company-specific historical and implied volatility data, the Company has based its computation of expected volatility on the historical volatility of a representative group of public companies with similar characteristics to the Company, including stage of product development and life science industry focus. The historical volatility is calculated based on a period of time commensurate with the expected term assumption. The Company uses the simplified method as prescribed by the SEC Staff Accounting Bulletin No. 107, Share-Based Payment, to calculate the expected term for options granted to employees as it does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The expected term is applied to the stock option grant group as a whole, as the Company does not expect substantially different exercise or post-vesting termination behavior among its employee population. For options granted to non-employees, the Company utilizes the contractual term of the share-based payment as the basis for the expected term assumption. The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected term of the stock options. The expected dividend yield is assumed to be zero as the Company has never paid dividends and has no current plans to pay any dividends on its common stock.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company expenses the fair value of its share-based compensation awards to employees and non-employees on a straight-line basis over the requisite service period, which is generally the vesting period.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Income taxes&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company accounts for income taxes using the asset and liability method in accordance with ASC Topic 740, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Income Taxes&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (ASC 740) which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the Company&#x2019;s tax returns. Deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. At December 31, 2021 and 2020, the Company has concluded that a full valuation allowance is necessary for its deferred tax assets (see Note 11).&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Net loss per share&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed using the weighted-average number of shares of common stock outstanding during the period and, if dilutive, the weighted-average number of potential shares of common stock. Diluted net loss per share is the same as basic net loss per share for the years ended December 31, 2021 and 2020 since all potential shares of common stock instruments are anti-dilutive as a result of the loss for such periods.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s convertible preferred stock contractually entitled the holders of such shares to participate in dividends but did not contractually require the holders of such shares to participate in losses of the Company. Accordingly, in periods in which the Company reported a net loss, such losses are not allocated to such participating securities. In periods where the Company reported a net loss attributable to common stockholders, diluted net loss per share is the same as basic net loss per share, since dilutive shares of common stock are not assumed to have been issued if their effect is anti-dilutive. The Company reported a net loss attributable to common stockholders for the years ended December 31, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Basic and diluted net loss per share attributable to common stockholders was calculated as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:52.878%;"/&gt;
          &lt;td style="width:1.378%;"/&gt;
          &lt;td style="width:2.061%;"/&gt;
          &lt;td style="width:18.687%;"/&gt;
          &lt;td style="width:1.378%;"/&gt;
          &lt;td style="width:1.492%;"/&gt;
          &lt;td style="width:2.061%;"/&gt;
          &lt;td style="width:18.687%;"/&gt;
          &lt;td style="width:1.378%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;84,686&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;26,511&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted-average shares of common stock&lt;br/&gt;&#160;&#160;&#160;outstanding-basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;34,351,274&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;32,253,227&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net loss per share-basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.82&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company excluded the following potential shares of common stock from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:55.109%;"/&gt;
          &lt;td style="width:1.478%;"/&gt;
          &lt;td style="width:0.853%;"/&gt;
          &lt;td style="width:19.199%;"/&gt;
          &lt;td style="width:0.853%;"/&gt;
          &lt;td style="width:1.606%;"/&gt;
          &lt;td style="width:0.853%;"/&gt;
          &lt;td style="width:19.199%;"/&gt;
          &lt;td style="width:0.853%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested restricted common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,093&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested restricted stock units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;626,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Outstanding stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,830,037&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,816,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,456,337&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,819,891&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Recently adopted accounting pronouncements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In August 2018, the FASB issued ASU No. 2018-15,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; Intangibles - Goodwill and Other - Internal-Use Software&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract. This standard addresses the accounting for implementation costs incurred by a customer in a cloud computing arrangement that is a service contract and also adds certain disclosure requirements related to implementation costs incurred for internal-use software and cloud computing arrangements. The amendment aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The Company adopted this standard on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;January 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, using a prospective approach. The adoption of this new standard did not have a material &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;impact&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; on the consolidated financial statements.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In December 2019, the FASB issued ASU 2019-12 amending accounting guidance that simplifies the accounting for income taxes, as part of its initiative to reduce complexity in the accounting standards. The amendments eliminate certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The amendments also clarify and simplify other aspects of the accounting for income taxes. The Company adopted this standard on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;January 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and it did not have a material &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;impact&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; on the consolidated financial statements.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Recently issued accounting pronouncements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. The Company is an &#x201c;emerging growth company&#x201d; as defined in the Jumpstart Our Business Startups Act of 2012, as amended (Jobs Act). The Jobs Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. Thus, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company elected to avail itself of this extended transition period and, as a result, we will not be required to adopt new or revised accounting standards on the relevant dates on which adoption of such standards is required for other public companies.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In June 2016, the FASB issued ASU No. 2016-13, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (Topic 326): Measurement of Credit Losses on Financial Instruments. The FASB has subsequently issued amendments to ASU 2016-13, which have the same effective date and transition date. These standards require that credit losses be reported using an expected losses model rather than the incurred losses model that was previously used, and establishes additional disclosures related to credit risks. For available-for-sale debt securities with unrealized losses, this standard now requires allowances to be recorded instead of reducing the amortized cost of the investment. These standards limit the amount of credit losses to be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. This standard will become effective for the Company on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;January 1, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. The Company is still evaluating the &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;impact&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of this standard on its consolidated financial statements.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_c5738b27-9d26-4c5c-916d-808d9705bd95">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Basis of presentation&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The accompanying consolidated financial statements have been prepared in accordance with accounting standards set by the Financial Accounting Standards Board (FASB). The FASB sets generally accepted accounting principles (GAAP) that the Company follows to ensure its financial condition, results of operations, and cash flows are consistently reported. References to GAAP issued by the FASB in these notes to the consolidated financial statements are to the FASB &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Accounting Standards&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; Codification (ASC).&lt;/span&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_b2a09fae-49a7-4549-840d-4d5c2769cd59">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Principles of consolidation&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The consolidated financial statements include the accounts of Frequency Therapeutics, Inc. and its wholly owned subsidiaries Frequency Therapeutics Securities Corporation, Frequency Therapeutics PTY, LTD and Frequency Japan through the date of its dissolution. All intercompany transactions and balances have been eliminated.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_1c22d6ff-7af2-4c09-9254-e83ee612d449">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Use of estimates&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The preparation of the Company&#x2019;s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of expenses during the reporting period. On an ongoing basis, the Company&#x2019;s management evaluates its estimates, which include but are not limited to management&#x2019;s judgments of accrued expenses, revenue recognition, fair value of common stock, valuation of share-based awards, present value of lease liabilities and income taxes. Actual results could differ from those estimates.&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_1d64f18e-2f23-40f3-b6ed-2d1ba6011556">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Comprehensive loss&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Components &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;of comprehensive income or loss, including net income or loss, are reported in the financial statements in the period in which they are recognized. Other comprehensive income or loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Net income (loss) and other comprehensive income (loss) are reported net of any related tax effect to arrive at comprehensive income (loss). Comprehensive loss includes net loss as well as other changes in stockholders&#x2019; equity that result from transactions and&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;economic &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;events other than those with stockholders which for the years ended December 31, 2021 and 2020 consist of unrealized loss on marketable securities. &lt;/span&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_ceeaf197-5d8f-47d8-a70e-f97126849e32">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Segment information&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision-maker in deciding how to allocate resources and assess performance. The Company and the Company&#x2019;s chief operating decision-maker, the Company&#x2019;s chief executive officer, views the Company&#x2019;s operations and manages its business as a single operating segment, which is in the business of discovering and developing small molecule drugs that activate progenitor cells within the body to create healthy tissue.&lt;/span&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_e8e14f63-63c0-42ae-b1f3-0748a354df58">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Foreign currency&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;All periods presented are reported in US dollars. The functional currency for entities outside the United States is the US dollar. Realized and unrealized gains and losses from foreign currency transactions are reflected in the consolidated statements of operations as other expense.&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; During the years ended December 31, 2021 and 2020 the Company recorded $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;16&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;of foreign currency exchange gains and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of foreign currency exchange losses, respectively.&lt;/span&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_1ab6662d-0251-4796-a86d-a390b4c7882a"
      unitRef="U_USD">16000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_a5fdc91a-0ba6-47b5-9d06-f062d9f211fe"
      unitRef="U_USD">-4000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_09d9cf7d-ade2-4b14-afab-a5c7a83aed8f">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company considers all highly liquid investments with an original maturity of six months or less at acquisition to be cash equivalents which are stated at fair market value. Cash and cash equivalents at December 31, 2021 and 2020 consists entirely of cash and money market funds.&lt;/span&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_9b817321-5a62-4f1f-8e87-8731cd9907f7">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Restricted cash&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,700&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of restricted cash as of December 31, 2021 which represents a security deposit on the Company's Lexington, Massachusetts facility. The $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,800&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of restricted cash at December 31, 2020 represented the security deposit on the Lexington, Massachusetts facility as well as a $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;100&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; security deposit on the Company's previous Woburn, Massachusetts facility.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_a3c46bd6-df2a-4676-94dc-776e2b2317ad"
      decimals="-3"
      id="F_2a2e8dae-c922-4d27-8b1a-79e05699a21e"
      unitRef="U_USD">1700000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_2c72469d-cb8e-4588-8128-2bea9727b19f"
      decimals="-3"
      id="F_c30f7e57-c6d3-4fe3-914f-f7e0ca9b51fc"
      unitRef="U_USD">1800000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="C_f6fd7cfb-c8de-4aa0-bb14-1baec943103c"
      decimals="-3"
      id="F_c87d5918-c100-4b26-90cd-a5ef7852db17"
      unitRef="U_USD">100000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:MarketableSecuritiesPolicy
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_4bfea9d9-31fd-4b38-883a-c1077a1817cf">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Marketable securities&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Marketable securities represent holdings of available-for-sale marketable debt securities in accordance with the Company&#x2019;s investment policy. Short-term marketable securities mature within one year from the balance sheet date while long-term marketable securities mature after one year. Investments in marketable securities are recorded at fair value, with any unrealized gains and losses reported within accumulated other comprehensive income as a separate component of stockholders&#x2019; equity until realized or until a determination is made that an other-than-temporary decline in market value has occurred. The amortized cost of debt securities is adjusted for amortization of premiums and accretion of discounts to maturity. Such amortization and accretion are reflected as a component of other expense. Interest on securities sold is determined based on the specific identification method and reflected as interest income. Any realized gains or losses on the sale of investment are reflected as realized (loss) gain on investments.&lt;/span&gt;&lt;/p&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_b7bd2b34-aafb-474d-ab29-56565d138875">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Concentration of credit risk and off-balance sheet risk&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Financial instrument that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents and marketable securities. The Company maintains its cash, cash equivalents, and restricted cash at several accredited financial institutions, in amounts that exceed federally insured limits. Marketable securities consist of short term and long term investments. Management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which its money market accounts are maintained.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has no significant off-balance sheet arrangements such as foreign exchange contracts, option contracts, or other foreign hedging arrangements.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <freq:SignificantSuppliersPolicyTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_93105077-3051-4eec-802f-f32222a1a409">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Significant suppliers&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company is dependent on third-party manufacturers to supply products for research and development activities of its programs, including preclinical and clinical testing. In particular, the Company relies and expects to continue to rely on a single manufacturer of its product candidates for use in clinical trials. The Company would be adversely affected by a significant interruption in the supply of product for use in clinical programs.&lt;/span&gt;</freq:SignificantSuppliersPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_25127b2b-bacb-4cb1-a93d-e6e3aff811ab">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Fair value measurements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Fair value is defined as the price that would be received upon sale of an asset or paid to transfer a liability between market participants at measurement dates. ASC Topic 820, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Fair Value Measurement&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (ASC 820), establishes a three-level valuation hierarchy for instruments measured at fair value. The hierarchy is based on the transparency of inputs to the valuation of an asset or liability as of the measurement date. The hierarchy defines three levels of valuation inputs, of which the first two are considered observable and the last is considered unobservable:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:-10.836%;padding-left:9.333%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 1	Quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:-10.836%;padding-left:9.333%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 2	Inputs other than quoted prices included within Level 1 that are either directly or indirectly observable,     such as quoted market prices, interest rates and yield curves.&lt;/span&gt;&lt;/p&gt;&lt;p style="margin-left:4.533%;text-indent:-10.836%;padding-left:9.333%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 3	Unobservable inputs developed using estimates or assumptions developed by the Company, which reflect those that a market participant would use in pricing the asset or liability.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&#x2019;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The carrying values of other current assets, accounts payable, and accrued expenses approximate their fair values due to the short-term nature of these assets and liabilities. The fair value of the Company&#x2019;s Term Loan is &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;t materially different from the carrying value as presented.&lt;/span&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <freq:FairValueOfTermLoan
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="INF"
      id="F_a397f2a1-bd45-40ee-b2d8-3a3ef82493b6"
      unitRef="U_USD">0</freq:FairValueOfTermLoan>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_8caa6183-0e0a-4a27-8ef3-deb6eb6ce494">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Property and equipment consist of lab equipment, computer equipment, furniture and office equipment and leasehold improvements recorded at cost. These amounts are depreciated using the straight-line method over the estimated useful lives of the assets as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:71.997%;"/&gt;
          &lt;td style="width:1.002%;"/&gt;
          &lt;td style="width:27.001%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.175in;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.175in;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Estimated useful life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Furniture and office equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Shorter of the estimated useful&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;life or lease term&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Upon retirement or sale, the cost of the assets disposed of and the related accumulated depreciation are eliminated from the balance sheet and related gains or losses are reflected in the consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <freq:PropertyAndEquipmentTableTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_e5e26dcf-0e10-47dd-a656-2cbf235dadf6">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Property and equipment consist of lab equipment, computer equipment, furniture and office equipment and leasehold improvements recorded at cost. These amounts are depreciated using the straight-line method over the estimated useful lives of the assets as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:71.997%;"/&gt;
          &lt;td style="width:1.002%;"/&gt;
          &lt;td style="width:27.001%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.175in;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;border-bottom:0.750pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.175in;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Estimated useful life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Furniture and office equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.100in;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Shorter of the estimated useful&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.75pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;life or lease term&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;</freq:PropertyAndEquipmentTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_23b528ed-dd66-4d9c-8b20-60a086d86ba5"
      id="F_6d6025f8-bedd-435a-87a6-9ffcb6cc2353">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_a03b4b17-c9bb-4e37-9fb7-544f7db43dca"
      id="F_fbbb4bc0-8ff1-4ada-96e9-ca7a72798ee1">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_635de625-e8b1-4d5c-9ee3-b354458b428c"
      id="F_8a91b05f-b8f4-4fa3-98d2-27913e0bdf6b">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="C_549428fd-e30a-428e-9b6b-925a65a7eaa2"
      id="F_e0491f57-db49-4bd3-825c-ec4e04ed77d2">Shorter of the estimated usefullife or lease term</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_d6723ade-4c43-4a7b-b310-9339d21d83f9">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.0829166666666667;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company continually evaluates long-lived assets for potential impairment when events or changes in circumstances indicate the carrying value of the assets may not be recoverable. Recoverability is measured by comparing the book values of the assets to the expected future net undiscounted cash flows that the assets are expected to generate. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the book values of the assets exceed their fair value. The Company did &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;t recognize any impairment losses for the years ended December 31, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="INF"
      id="F_73bb0ed6-8c8f-4793-95d8-23269853fbeb"
      unitRef="U_USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="INF"
      id="F_779a8ddd-dacc-4720-96a4-7a2ec4062e9e"
      unitRef="U_USD">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_e4228fdb-77d5-442f-b4b9-5a07ad2891db">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Research and development costs and accruals&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;and development expenses include salaries and benefits, materials and supplies, preclinical and clinical trial expenses, stock-based compensation expense, depreciation of equipment, contract services and other outside expenses. The Company has entered into various research and development-related contracts with research institutions, contract research organizations, contract manufacturers and other companies. These agreements are generally cancelable, and related payments are recorded as research and development expenses as incurred. Costs of certain development activities, such as manufacturing, pre-clinical and clinical trial expenses, are recognized based on an evaluation of the progress to completion of specific tasks. Payments for these activities are based on the terms of the individual arrangements, which may differ from the pattern of costs incurred, and are reflected in the consolidated financial statements as prepaid or accrued research and development costs. Nonrefundable advance payments for goods or services to be received in the future for use in research and development activities are deferred and capitalized. The capitalized amounts are expensed as the related goods are delivered or the services are performed. Costs incurred in obtaining technology licenses are charged to research and&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;development &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;expense as acquired in-process research and development if the technology licensed has not reached technological feasibility and has no alternative future use.&lt;/span&gt;&lt;/p&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_e601af30-08b6-4c9c-ad99-d449fdd59da4">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company elected to early adopt ASC 842, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Leases&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (ASC 842) as of January 1, 2020 and elected the transition method under ASU 2016-02 whereby the Company records a right-to-use asset and a lease liability on the consolidated balance sheet for all leases with terms longer than 12 months. The Company also elected to apply the package of practical expedients intended to ease transition. Accordingly, the Company has only applied ASC 842 to leases existing at January 1, 2020. The Company determines if an arrangement is, or contains, a lease at inception. Operating leases are included in operating lease right-of-issue (&#x201c;ROU&#x201d;) assets, other current liabilities, and operating lease liabilities on the consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments to be made over the lease term. The ROU asset also includes any lease payments made at or before the lease commencement date and excludes lease incentives received. As the Company&#x2019;s leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Operating lease expense is recognized on a straight-line basis over the lease term. The Company has elected to not apply the recognition requirements of ASC 842 for short-term leases, which is defined as a lease that, at the lease commencement date, has a lease term of 12 months or less and does &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;t include an option to purchase the underlying asset that the Company is reasonably certain to exercise.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;For real estate lease agreements entered into or modified after the adoption of ASC 842 that include lease and non-lease components, the Company has elected to account for the lease and non-lease components, such as common area maintenance charges, as a single lease component.&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <freq:IncreaseDecreaseInOperatingLeaseRightOfUseAssets
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="0"
      id="F_3a660ac7-14e1-4b73-83d8-81d48270006a"
      unitRef="U_USD">0</freq:IncreaseDecreaseInOperatingLeaseRightOfUseAssets>
    <us-gaap:CollaborativeArrangementAccountingPolicy
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_3bc568f3-9c94-4adc-93cc-dda70df81ee7">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Collaborative arrangements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company analyzes its collaborative arrangements to assess whether they are within the scope of ASC 808, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Collaborative Arrangements&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (&#x201c;ASC 808&#x201d;) to determine whether such arrangements involve joint operating activities performed by parties that are both active participants in the activities and exposed to significant risks and rewards dependent on the commercial success of such activities. This assessment is performed throughout the life of the arrangement based on changes in the responsibilities of all parties in the arrangement. For collaboration arrangements within the scope of ASC 808 that contain multiple elements, the Company first determines which elements of the collaboration are deemed to be within the scope of ASC 808 and those that are more reflective of a vendor-customer relationship (e.g., a licensing arrangement) where the contracted party has obtained goods or services that are an output of the Company&#x2019;s ordinary activities in exchange for a consideration and therefore within the scope of ASC 606, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (&#x201c;ASC 606&#x201d;). For those elements of the arrangement that are accounted for pursuant to ASC 606, including those to which ASC 606 is applied by analogy, the Company applies the five-step model described in the Company&#x2019;s revenue recognition policy. For elements of collaborative arrangements that are accounted for pursuant to ASC 808, an appropriate and rational recognition method is determined and applied consistently. Reimbursements from the counterparty that are the result of a collaborative relationship with the counterparty, instead of a customer relationship, such as co-development or clinical activities, are recorded as a reduction to research and development expense as the services are performed. Similarly, amounts that are owed to a collaboration partner related to the co-development clinical activities are recognized as research and development expense.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company enters into out-licensing agreements that are within the scope of ASC 606. The terms of such out-license agreements include licenses to functional intellectual property (IP), given the functionality of the intellectual property is not expected to change substantially as a result of the licensor&#x2019;s ongoing activities. Such arrangements typically include payment of one or more of the following: non-refundable up-front license fees; reimbursement of certain costs; development and regulatory milestone payments and milestone payments based on the level of sales; and royalties on net sales of licensed products.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company considers the economic and regulatory characteristics of the licensed IP, research, development, manufacturing and commercialization capabilities of the licensee and the availability of the associated expertise in the general marketplace to determine if it has standalone value at the inception of the licensing arrangement, which would make the license distinct. In addition, the Company considers whether the licensee can benefit from a promise for its intended purpose without the receipt of any additional good or services promised in the contract, whether the value of the license is dependent on the remaining goods and services, whether there are other vendors that could provide the remaining promise, and whether the license is separately identifiable from the remaining good and services. For licenses that are combined with&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;other goods and services, the Company utilizes judgment to assess the nature of the combined performance obligation to determine whether the combined performance obligation is satisfied over time or at a point in time and, if over time, the appropriate method of measuring progress for purposes of recognizing revenue. The Company evaluates the measure of progress each reporting period and, if necessary, adjusts the measure of progress and related revenue recognition. The measure of progress, and thereby periods over which revenue should be recognized, are subject to estimates by management and may change over the course of the research and development and licensing agreement. Such a change could have a material impact on the amount of revenue the Company records in future periods.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Revenue is allocated to the licensed IP on a relative standalone selling price basis and, for functional IP, is recognized at a point when the licensed IP is made available for the customer&#x2019;s use and benefit, which generally occurs at the inception of the arrangement. However, in cases, where the functionality of the IP is expected to substantively change as a result of activities of the Company that do not transfer additional promised goods or services, or in cases, where there is an expectation that the Company will undertake activities to change the standalone functionality of the IP and the customer is contractually or practically required to use the latest version of the IP, revenue for the license to functional IP is recognized over time.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Development and regulatory milestone fees, which are a type of variable consideration, are recognized as revenue to the extent that it is probable that a significant reversal will not occur. The Company recognizes royalty revenue and sales-based milestones at the later of (i) when the related sales occur, or (ii) when the performance obligation to which the royalty has been allocated has been satisfied.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has entered into a collaboration arrangement with Astellas Pharma Inc. (&#x201c;Astellas&#x201d;), as further described in Note 13 of notes to consolidated financial statements.&lt;/span&gt;</us-gaap:CollaborativeArrangementAccountingPolicy>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_3549af38-8f93-4d21-8c40-8e9cc82e0bd0">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Revenue recognition&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company accounts for contracts with customers in accordance with ASC 606, including all amendments thereto. This standard applies to all contracts with customers, except for contracts that are within the scope of other standards, such as collaborative arrangements and leases. The Company&#x2019;s disclosure within the below sections or elsewhere within these consolidated financial statements reflects the Company&#x2019;s accounting policies in compliance with this new standard.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Under ASC 606, an entity recognizes revenue when or as its customer obtains control of promised goods or services, in an amount that reflects the consideration that the entity expects to receive in exchange for those goods or services. To recognize revenue for arrangements that an entity determines are within the scope of ASC 606, the entity performs the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price, including variable consideration, if any; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) the entity satisfies its performance obligations. The Company only applies the five-step model to contracts when it is probable that the entity will collect substantially all of the consideration to which it will be entitled in exchange for the goods or services it transfers to the customer. Once a contract is determined to be within the scope of ASC 606, the Company assesses the goods or services promised within each contract and identifies as a performance obligation each promise to transfer to the customer either (a) a good or service (or bundle of goods and services) that is distinct, or (b) a series of distinct goods and services that are substantially the same and have been the same pattern of transfer to the customer.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company assesses whether each promised good or service is distinct for the purpose of identifying the performance obligations in the contract. This assessment involves subjective determinations and requires management to make judgments about the individual promised goods or services and whether such are separable from the other aspects of the contractual relationship. Promised goods and services are considered distinct provided that: (i) the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer (that is, the good or service is capable of being distinct) and (ii) the entity&#x2019;s promise to transfer the good or service to the customer is separately identifiable from other promises in the contract (that is, the promise to transfer the good or service is distinct within the context of the contract). In assessing whether a promised good or service is distinct, the Company considers factors such as the research, manufacturing and commercialization capabilities of the collaboration partner (the &#x201c;customer&#x201d; in this type of arrangement) and the availability of the associated expertise in the general marketplace. The Company also considers the intended benefit of the contract in assessing whether a promised good or service is separately identifiable from other promises in the contract. If a promised good or service is not distinct, an entity is required to combine that good or service with other promised goods or services until it identifies a bundle of goods or services that is distinct. For each arrangement that results in revenues, the Company identifies all performance obligations, which may include, for example, a license to IP and know-how, research and development activities, and/or manufacturing services.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In addition to any upfront payment, if the consideration promised in a contract includes a variable amount, the Company estimates the amount of consideration to which it will be entitled in exchange for transferring the promised goods&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;or services to a customer. The Company determines the amount of variable consideration by using the expected value method or the most likely amount method. The Company includes the estimated variable consideration in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, the Company re-evaluates the estimated variable consideration included in the transaction price and any related constraint, and if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis in the period of adjustment.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;If an arrangement includes development and regulatory milestone payments, the Company evaluates whether the milestones are considered probable of being reached and estimates the amount to be included in the transaction price using the most likely amount method. There is considerable judgment involved in determining whether it is probable that a significant revenue reversal would not occur. If it is probable that a significant revenue reversal will not occur, the associated milestone value is included in the transaction price. Milestone payments that are not within the control of the Company or of the licensee such as regulatory approvals, are generally not considered probable of being achieved until those approvals are received. At the end of each subsequent reporting period, the Company re-evaluates the probability of achievement of all milestones subject to constraint and, if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;For contracts that include sales-based royalties (including milestone payments based on the level of sales) promised in the exchange for licenses of intellectual property, and the license is deemed to be the predominant item to which the royalties relate, the Company recognizes royalty revenue and sales-based milestone payments at the later of (i) when the related sales occur, or (ii) when the performance obligation to which some or all of the royalty has been allocated has been satisfied. In determining the transaction price, the Company adjusts the promised amount of consideration for the effects of the time value of money if the timing of payments provides the Company or the Company&#x2019;s customer with a significant benefit of financing the transfer of goods and services. The Company does not assess whether a contract has a significant financing component if the expectation at contract inception is such that the period between payment by the licensees and the transfer of the promised goods or services to the licensees will be one year or less. The Company assesses each of its revenue generating arrangements in order to determine whether a significant financing component exists. The Company recognizes as revenue the amount of the transaction price that is allocated to the respective performance obligation when (or as) each performance obligation is satisfied, either at a point in time or over time.  For performance obligations satisfied over time, the Company measures progress toward completion of its performance obligations using an input method based on the Company&#x2019;s efforts and inputs to satisfy its performance obligations relative to total expected inputs to the satisfaction of that performance obligation.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Amounts received from a customer prior to revenue recognition are recorded as deferred revenue. Amounts received from a customer that are expected to be recognized as revenue within the 12 months following the balance sheet date are classified as a current liability in the accompanying consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <freq:PatentCostsPolicyTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_8d9a7528-ca0d-4276-b978-f7398473cadb">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Patent costs&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company expenses patent application and related legal costs as incurred and classifies such costs as general and administrative expenses in the accompanying consolidated statements of operations.&lt;/span&gt;</freq:PatentCostsPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_71f32c21-dd43-4e3d-9a2e-12137693857d">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Stock-based compensation&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company accounts for its stock-based compensation in accordance with ASC Topic 718, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Compensation&#x2014;Stock Compensation&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (ASC 718). ASC 718 requires all share-based payments to employees and directors to be recognized as expense in the consolidated statements of operations and comprehensive loss based on their grant date fair values. The Company adopted FASB Accounting Standards Update (ASU) 2016-09 which identifies areas for simplification of several areas of share-based payment transactions. The Company treats non-employee grants in a manner consistent with employee grants. The Company estimates the fair value of options granted using the Black-Scholes option pricing model for stock option grants to both employees and non-employees. The Company believes the fair value of the stock options granted to non-employees is more reliably determinable than the fair value of the services provided.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Black-Scholes option pricing model requires inputs based on certain subjective assumptions, including (a) the expected stock price volatility, (b) the expected term of the award, (c) the risk-free interest rate and (d) expected dividends. Due to the lack of sufficient company-specific historical and implied volatility data, the Company has based its computation of expected volatility on the historical volatility of a representative group of public companies with similar characteristics to the Company, including stage of product development and life science industry focus. The historical volatility is calculated based on a period of time commensurate with the expected term assumption. The Company uses the simplified method as prescribed by the SEC Staff Accounting Bulletin No. 107, Share-Based Payment, to calculate the expected term for options granted to employees as it does not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. The expected term is applied to the stock option grant group as a whole, as the Company does not expect substantially different exercise or post-vesting termination behavior among its employee population. For options granted to non-employees, the Company utilizes the contractual term of the share-based payment as the basis for the expected term assumption. The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected term of the stock options. The expected dividend yield is assumed to be zero as the Company has never paid dividends and has no current plans to pay any dividends on its common stock.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company expenses the fair value of its share-based compensation awards to employees and non-employees on a straight-line basis over the requisite service period, which is generally the vesting period.&lt;/span&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_4437dfe4-760f-4f80-93be-9278ced720f4">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Income taxes&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company accounts for income taxes using the asset and liability method in accordance with ASC Topic 740, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Income Taxes&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (ASC 740) which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the consolidated financial statements or in the Company&#x2019;s tax returns. Deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. Changes in deferred tax assets and liabilities are recorded in the provision for income taxes. The Company assesses the likelihood that its deferred tax assets will be recovered from future taxable income and, to the extent it believes, based upon the weight of available evidence, that it is more likely than not that all or a portion of the deferred tax assets will not be realized, a valuation allowance is established through a charge to income tax expense. Potential for recovery of deferred tax assets is evaluated by estimating the future taxable profits expected and considering prudent and feasible tax planning strategies. At December 31, 2021 and 2020, the Company has concluded that a full valuation allowance is necessary for its deferred tax assets (see Note 11).&lt;/span&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_fe2aa8cf-90c0-4eaf-9054-0995ba08ab1e">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Net loss per share&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed using the weighted-average number of shares of common stock outstanding during the period and, if dilutive, the weighted-average number of potential shares of common stock. Diluted net loss per share is the same as basic net loss per share for the years ended December 31, 2021 and 2020 since all potential shares of common stock instruments are anti-dilutive as a result of the loss for such periods.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s convertible preferred stock contractually entitled the holders of such shares to participate in dividends but did not contractually require the holders of such shares to participate in losses of the Company. Accordingly, in periods in which the Company reported a net loss, such losses are not allocated to such participating securities. In periods where the Company reported a net loss attributable to common stockholders, diluted net loss per share is the same as basic net loss per share, since dilutive shares of common stock are not assumed to have been issued if their effect is anti-dilutive. The Company reported a net loss attributable to common stockholders for the years ended December 31, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Basic and diluted net loss per share attributable to common stockholders was calculated as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:52.878%;"/&gt;
          &lt;td style="width:1.378%;"/&gt;
          &lt;td style="width:2.061%;"/&gt;
          &lt;td style="width:18.687%;"/&gt;
          &lt;td style="width:1.378%;"/&gt;
          &lt;td style="width:1.492%;"/&gt;
          &lt;td style="width:2.061%;"/&gt;
          &lt;td style="width:18.687%;"/&gt;
          &lt;td style="width:1.378%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;84,686&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;26,511&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted-average shares of common stock&lt;br/&gt;&#160;&#160;&#160;outstanding-basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;34,351,274&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;32,253,227&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net loss per share-basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.82&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company excluded the following potential shares of common stock from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:55.109%;"/&gt;
          &lt;td style="width:1.478%;"/&gt;
          &lt;td style="width:0.853%;"/&gt;
          &lt;td style="width:19.199%;"/&gt;
          &lt;td style="width:0.853%;"/&gt;
          &lt;td style="width:1.606%;"/&gt;
          &lt;td style="width:0.853%;"/&gt;
          &lt;td style="width:19.199%;"/&gt;
          &lt;td style="width:0.853%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested restricted common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,093&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested restricted stock units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;626,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Outstanding stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,830,037&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,816,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,456,337&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,819,891&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_32066afe-84dc-452b-a4ac-991d742556df">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Basic and diluted net loss per share attributable to common stockholders was calculated as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:52.878%;"/&gt;
          &lt;td style="width:1.378%;"/&gt;
          &lt;td style="width:2.061%;"/&gt;
          &lt;td style="width:18.687%;"/&gt;
          &lt;td style="width:1.378%;"/&gt;
          &lt;td style="width:1.492%;"/&gt;
          &lt;td style="width:2.061%;"/&gt;
          &lt;td style="width:18.687%;"/&gt;
          &lt;td style="width:1.378%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;84,686&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;26,511&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted-average shares of common stock&lt;br/&gt;&#160;&#160;&#160;outstanding-basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;34,351,274&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;32,253,227&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net loss per share-basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.82&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_d6bd4af6-575d-4b72-a649-4cf64d40ddaf"
      unitRef="U_USD">-84686000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_79bc56b1-f418-45f6-a07c-b6a3a2ad200b"
      unitRef="U_USD">-26511000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="INF"
      id="F_c71bb297-2ed4-44eb-82ca-0637f38143f5"
      unitRef="U_shares">34351274</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="INF"
      id="F_17360805-d85a-4b85-97ab-d905a5c8eb9b"
      unitRef="U_shares">32253227</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="2"
      id="F_a8d97944-2969-4a2c-9872-b3ad84a2a7ae"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-2.47</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="2"
      id="F_ff4ab991-7438-41c4-a134-72b98514bcaf"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-0.82</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_eacee7a9-9da8-494b-903b-934160be5b29">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company excluded the following potential shares of common stock from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:55.109%;"/&gt;
          &lt;td style="width:1.478%;"/&gt;
          &lt;td style="width:0.853%;"/&gt;
          &lt;td style="width:19.199%;"/&gt;
          &lt;td style="width:0.853%;"/&gt;
          &lt;td style="width:1.606%;"/&gt;
          &lt;td style="width:0.853%;"/&gt;
          &lt;td style="width:19.199%;"/&gt;
          &lt;td style="width:0.853%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:8.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested restricted common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,093&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested restricted stock units&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;626,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Outstanding stock options&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,830,037&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,816,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,456,337&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,819,891&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_742c5792-c6e5-48a5-b310-178c83269552"
      decimals="0"
      id="F_b3af5ba7-e034-4892-9afe-1061a8a555c6"
      unitRef="U_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_10cead94-19bf-43da-bf2a-3aa91fbb188c"
      decimals="0"
      id="F_b9357404-4657-4e54-b765-f3b0f964b6eb"
      unitRef="U_shares">3093</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_011eaa78-a982-439b-9cbe-570f4099f0e2"
      decimals="0"
      id="F_d6f11405-5014-4c03-84f7-24a5bf675bdd"
      unitRef="U_shares">626300</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_bd09e8d5-eab7-4713-8061-e03dbe21d25f"
      decimals="0"
      id="F_8537fc2d-8dea-44cb-ba12-d22c553e61d6"
      unitRef="U_shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_02bfcdf4-c4aa-45c7-8d3c-0e389bcfa619"
      decimals="0"
      id="F_5cde1764-3ce6-45a0-b647-4be4c93a4e7a"
      unitRef="U_shares">6830037</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_9c459f52-c125-4fea-a2f0-f75d77c58396"
      decimals="0"
      id="F_3e4c028b-7ca3-4d6a-ae06-1ca9c229d944"
      unitRef="U_shares">6816798</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="0"
      id="F_901a071f-732b-421e-9076-4f9a0c2daeb1"
      unitRef="U_shares">7456337</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="0"
      id="F_f15a3341-ba36-40f9-94c6-580a29c97883"
      unitRef="U_shares">6819891</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_2f437cac-bd18-496a-af2f-94cf46a74f07">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Recently adopted accounting pronouncements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In August 2018, the FASB issued ASU No. 2018-15,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; Intangibles - Goodwill and Other - Internal-Use Software&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract. This standard addresses the accounting for implementation costs incurred by a customer in a cloud computing arrangement that is a service contract and also adds certain disclosure requirements related to implementation costs incurred for internal-use software and cloud computing arrangements. The amendment aligns the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The Company adopted this standard on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;January 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, using a prospective approach. The adoption of this new standard did not have a material &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;impact&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; on the consolidated financial statements.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In December 2019, the FASB issued ASU 2019-12 amending accounting guidance that simplifies the accounting for income taxes, as part of its initiative to reduce complexity in the accounting standards. The amendments eliminate certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The amendments also clarify and simplify other aspects of the accounting for income taxes. The Company adopted this standard on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;January 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and it did not have a material &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;impact&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; on the consolidated financial statements.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Recently issued accounting pronouncements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies and adopted by the Company as of the specified effective date. The Company is an &#x201c;emerging growth company&#x201d; as defined in the Jumpstart Our Business Startups Act of 2012, as amended (Jobs Act). The Jobs Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. Thus, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company elected to avail itself of this extended transition period and, as a result, we will not be required to adopt new or revised accounting standards on the relevant dates on which adoption of such standards is required for other public companies.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In June 2016, the FASB issued ASU No. 2016-13, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Financial Instruments - Credit Losses&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (Topic 326): Measurement of Credit Losses on Financial Instruments. The FASB has subsequently issued amendments to ASU 2016-13, which have the same effective date and transition date. These standards require that credit losses be reported using an expected losses model rather than the incurred losses model that was previously used, and establishes additional disclosures related to credit risks. For available-for-sale debt securities with unrealized losses, this standard now requires allowances to be recorded instead of reducing the amortized cost of the investment. These standards limit the amount of credit losses to be recognized for available-for-sale debt securities to the amount by which carrying value exceeds fair value and requires the reversal of previously recognized credit losses if fair value increases. This standard will become effective for the Company on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;January 1, 2023&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. The Company is still evaluating the &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;impact&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of this standard on its consolidated financial statements.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
      contextRef="C_875116db-7306-464c-bdd4-f7030d1b80b3"
      id="F_9fe14f18-8e6f-4693-a5f1-e05784e091b2">2021-01-01</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
      contextRef="C_875116db-7306-464c-bdd4-f7030d1b80b3"
      id="F_fb059a0c-c5a7-42d2-b75e-078d9f289487">false</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
      contextRef="C_f02c82d0-ac2f-4ce8-8c28-dace93e62425"
      id="F_f8b12a90-5efb-4478-942a-e67ba22fab9f">2021-01-01</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
      contextRef="C_f02c82d0-ac2f-4ce8-8c28-dace93e62425"
      id="F_7023f076-c663-46b9-85a6-5fc0d21364b6">false</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
      contextRef="C_bbfcdb78-4741-401f-8112-443fb777bdf1"
      id="F_24787a3a-bcd7-450c-92d7-779afde38f4b">2023-01-01</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
      contextRef="C_bbfcdb78-4741-401f-8112-443fb777bdf1"
      id="F_0521c36a-c143-48a6-a163-07f44b291199">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_c818ed8c-466f-4fe2-aec7-784eea969991">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Fair value measurements &lt;/span&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:12.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s financial assets measures at fair value on a recurring basis by level within the fair value hierarchy at December 31, 2021 and 2020 are summarized as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:41.9%;"/&gt;
        &lt;td style="width:1.302%;"/&gt;
        &lt;td style="width:12.95%;"/&gt;
        &lt;td style="width:1.302%;"/&gt;
        &lt;td style="width:1.272%;"/&gt;
        &lt;td style="width:11.409%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
        &lt;td style="width:1.302%;"/&gt;
        &lt;td style="width:1.272%;"/&gt;
        &lt;td style="width:11.201%;"/&gt;
        &lt;td style="width:0.865%;"/&gt;
        &lt;td style="width:1.302%;"/&gt;
        &lt;td style="width:1.272%;"/&gt;
        &lt;td style="width:11.379%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Fair Market&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Hierarchy&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(Loss)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;48,160&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;48,160&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Short-term marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;51,116&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;44&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;51,072&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Long-term marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11,764&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;45&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11,719&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;    &lt;/span&gt;&#160;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;111,040&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;110,951&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:41.894%;"/&gt;
        &lt;td style="width:1.302%;"/&gt;
        &lt;td style="width:12.971%;"/&gt;
        &lt;td style="width:1.302%;"/&gt;
        &lt;td style="width:1.272%;"/&gt;
        &lt;td style="width:11.42%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
        &lt;td style="width:1.302%;"/&gt;
        &lt;td style="width:1.272%;"/&gt;
        &lt;td style="width:11.391%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
        &lt;td style="width:1.302%;"/&gt;
        &lt;td style="width:1.272%;"/&gt;
        &lt;td style="width:11.391%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Fair Market&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Hierarchy&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Gain&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;214,522&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;214,549&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;     &lt;/span&gt;&#160;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;214,522&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;214,549&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_daa370cd-ba07-4256-9731-796b173d6a0f">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s financial assets measures at fair value on a recurring basis by level within the fair value hierarchy at December 31, 2021 and 2020 are summarized as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:41.9%;"/&gt;
        &lt;td style="width:1.302%;"/&gt;
        &lt;td style="width:12.95%;"/&gt;
        &lt;td style="width:1.302%;"/&gt;
        &lt;td style="width:1.272%;"/&gt;
        &lt;td style="width:11.409%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
        &lt;td style="width:1.302%;"/&gt;
        &lt;td style="width:1.272%;"/&gt;
        &lt;td style="width:11.201%;"/&gt;
        &lt;td style="width:0.865%;"/&gt;
        &lt;td style="width:1.302%;"/&gt;
        &lt;td style="width:1.272%;"/&gt;
        &lt;td style="width:11.379%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Fair Market&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Hierarchy&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(Loss)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;48,160&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;48,160&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Short-term marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;51,116&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;44&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;51,072&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Long-term marketable securities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11,764&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;45&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11,719&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;    &lt;/span&gt;&#160;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;111,040&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;89&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;110,951&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:41.894%;"/&gt;
        &lt;td style="width:1.302%;"/&gt;
        &lt;td style="width:12.971%;"/&gt;
        &lt;td style="width:1.302%;"/&gt;
        &lt;td style="width:1.272%;"/&gt;
        &lt;td style="width:11.42%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
        &lt;td style="width:1.302%;"/&gt;
        &lt;td style="width:1.272%;"/&gt;
        &lt;td style="width:11.391%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
        &lt;td style="width:1.302%;"/&gt;
        &lt;td style="width:1.272%;"/&gt;
        &lt;td style="width:11.391%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="10" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Unrealized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Fair Market&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Hierarchy&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Gain&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;214,522&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;214,549&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;     &lt;/span&gt;&#160;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;214,522&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;27&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;214,549&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_be7fbd4c-1845-482f-953d-2642af2fb06e"
      decimals="-3"
      id="F_1d4b84c3-529f-4b7b-8179-ca151d5cf9c7"
      unitRef="U_USD">48160000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_be7fbd4c-1845-482f-953d-2642af2fb06e"
      decimals="-3"
      id="F_dcc3beb8-2546-45c0-8972-c57084eaf3a6"
      unitRef="U_USD">48160000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_e8bc2828-4017-4ef6-bfea-d1f31df30f70"
      decimals="-3"
      id="F_06bf02a1-dea0-44b0-bb97-4f5947ad54ce"
      unitRef="U_USD">51116000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_e8bc2828-4017-4ef6-bfea-d1f31df30f70"
      decimals="-3"
      id="F_e285aa02-8a27-4a41-bd0d-6baf17cfaef8"
      unitRef="U_USD">44000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_e8bc2828-4017-4ef6-bfea-d1f31df30f70"
      decimals="-3"
      id="F_4dfc28e4-b3c5-4b59-9d54-701f114002b1"
      unitRef="U_USD">51072000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_1d3c986e-4a0f-4b46-957f-19f2213ac557"
      decimals="-3"
      id="F_1b7f9880-9667-436e-aee3-71ea58005b13"
      unitRef="U_USD">11764000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_1d3c986e-4a0f-4b46-957f-19f2213ac557"
      decimals="-3"
      id="F_e179669c-26ac-489e-bce2-7ac5488588e7"
      unitRef="U_USD">45000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_1d3c986e-4a0f-4b46-957f-19f2213ac557"
      decimals="-3"
      id="F_7221de22-c102-4b35-8997-ed0985ddf552"
      unitRef="U_USD">11719000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_cc3ef655-c17e-488c-8981-986ec4c9084c"
      decimals="-3"
      id="F_6d38a4d9-6d80-42be-a414-9a7117e106b5"
      unitRef="U_USD">111040000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="C_cc3ef655-c17e-488c-8981-986ec4c9084c"
      decimals="-3"
      id="F_a19f7f80-4204-4509-b97b-0f8902fc8752"
      unitRef="U_USD">89000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_cc3ef655-c17e-488c-8981-986ec4c9084c"
      decimals="-3"
      id="F_eff28684-83f3-4270-a391-b7172c18f5ac"
      unitRef="U_USD">110951000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_961e7065-ef44-44fe-a970-97b4c237d73a"
      decimals="-3"
      id="F_06bf308a-6fe1-4d08-b5ec-df6b2d9d36dc"
      unitRef="U_USD">214522000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_961e7065-ef44-44fe-a970-97b4c237d73a"
      decimals="-3"
      id="F_88d61607-3d6a-43d7-b109-11ca017ac249"
      unitRef="U_USD">27000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_961e7065-ef44-44fe-a970-97b4c237d73a"
      decimals="-3"
      id="F_16e79f2d-7a23-455d-a73b-4166fe7556b2"
      unitRef="U_USD">214549000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_5d611fcf-f5e9-4ee1-96e1-00b7bbb48319"
      decimals="-3"
      id="F_93d197de-bcee-4302-8eba-b4016873c0aa"
      unitRef="U_USD">214522000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="C_5d611fcf-f5e9-4ee1-96e1-00b7bbb48319"
      decimals="-3"
      id="F_4a7f7e82-2a60-4618-ac2c-59afea4e4cf8"
      unitRef="U_USD">27000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_5d611fcf-f5e9-4ee1-96e1-00b7bbb48319"
      decimals="-3"
      id="F_0de9cbf3-4f70-43fa-81d6-2f2e21b078ec"
      unitRef="U_USD">214549000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <freq:PrepaidExpensesAndOtherCurrentAssetsTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_685730f8-0499-4312-90bf-a909fcca4808">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;4. Prepaid expenses and other current assets&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Prepaid expenses and other current assets consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.816%;"/&gt;
        &lt;td style="width:1.481%;"/&gt;
        &lt;td style="width:1.282%;"/&gt;
        &lt;td style="width:13.192%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
        &lt;td style="width:1.481%;"/&gt;
        &lt;td style="width:1.282%;"/&gt;
        &lt;td style="width:13.192%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Rent and deposits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;470&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_1798d1a5-8d3c-4e74-b507-c3d76c7abeb0;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;858&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,729&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accounts receivable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;144&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;340&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Insurance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,384&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,552&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;185&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;102&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,041&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,723&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</freq:PrepaidExpensesAndOtherCurrentAssetsTextBlock>
    <freq:SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_0307d8ce-18a4-466a-ad4c-355e9b1a3f9c">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Prepaid expenses and other current assets consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.816%;"/&gt;
        &lt;td style="width:1.481%;"/&gt;
        &lt;td style="width:1.282%;"/&gt;
        &lt;td style="width:13.192%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
        &lt;td style="width:1.481%;"/&gt;
        &lt;td style="width:1.282%;"/&gt;
        &lt;td style="width:13.192%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Rent and deposits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;470&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_1798d1a5-8d3c-4e74-b507-c3d76c7abeb0;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;858&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,729&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accounts receivable&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;144&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;340&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Insurance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,384&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,552&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;185&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;102&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,041&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,723&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</freq:SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock>
    <freq:PrepaidRentAndDepositsCurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_94e73d67-f7e2-4ede-b849-4a8f1eeedceb"
      unitRef="U_USD">470000</freq:PrepaidRentAndDepositsCurrent>
    <freq:PrepaidResearchAndDevelopmentExpenseCurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_df309547-352c-450c-97ff-144133a19791"
      unitRef="U_USD">858000</freq:PrepaidResearchAndDevelopmentExpenseCurrent>
    <freq:PrepaidResearchAndDevelopmentExpenseCurrent
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_74fdbd2f-c996-400c-b5fb-9396f042dd0e"
      unitRef="U_USD">1729000</freq:PrepaidResearchAndDevelopmentExpenseCurrent>
    <freq:PrepaidAccountsReceivableCurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_9f5621ff-29d8-4c76-8996-0b85ef285055"
      unitRef="U_USD">144000</freq:PrepaidAccountsReceivableCurrent>
    <freq:PrepaidAccountsReceivableCurrent
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_4b9dcef3-d7f0-43cd-89aa-daee83fde9ab"
      unitRef="U_USD">340000</freq:PrepaidAccountsReceivableCurrent>
    <us-gaap:PrepaidInsurance
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_0e5a7eec-feaa-4ea5-a933-86784415e2a6"
      unitRef="U_USD">2384000</us-gaap:PrepaidInsurance>
    <us-gaap:PrepaidInsurance
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_0eba5832-503c-4563-aa8e-98977c94c16c"
      unitRef="U_USD">2552000</us-gaap:PrepaidInsurance>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_359197e7-5e3a-425c-87f9-4f3437e41d33"
      unitRef="U_USD">185000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_cfeebf4a-f1fc-49eb-b956-874ef9f9b546"
      unitRef="U_USD">102000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_1930dfe1-84e9-47ea-ac05-b2e7b8cae1a1"
      unitRef="U_USD">4041000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_416da0d9-366c-4655-a1a4-730dd2724e99"
      unitRef="U_USD">4723000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_258e19f1-3a08-4f82-ba5c-5616ec750602">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;5. Property and equipment&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Property and equipment include the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.446%;"/&gt;
        &lt;td style="width:1.879%;"/&gt;
        &lt;td style="width:1.282%;"/&gt;
        &lt;td style="width:17.642%;"/&gt;
        &lt;td style="width:0.964%;"/&gt;
        &lt;td style="width:1.879%;"/&gt;
        &lt;td style="width:1.282%;"/&gt;
        &lt;td style="width:17.662%;"/&gt;
        &lt;td style="width:0.964%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,177&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,166&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Furniture and office equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,238&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;283&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;291&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;291&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,419&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Construction in progress&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,340&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accumulated depreciation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,212&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,522&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,287&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company recognized &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,775&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,146&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of depreciation expense for the years ended December 31, 2021 and 2020, respectively.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_5fb5310d-6508-461c-aa93-c921f40e2289">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Property and equipment include the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:56.446%;"/&gt;
        &lt;td style="width:1.879%;"/&gt;
        &lt;td style="width:1.282%;"/&gt;
        &lt;td style="width:17.642%;"/&gt;
        &lt;td style="width:0.964%;"/&gt;
        &lt;td style="width:1.879%;"/&gt;
        &lt;td style="width:1.282%;"/&gt;
        &lt;td style="width:17.662%;"/&gt;
        &lt;td style="width:0.964%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Lab equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,177&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,166&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Furniture and office equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,238&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;283&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Software&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;291&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;291&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,419&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Construction in progress&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,340&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9,706&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10,499&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accumulated depreciation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,184&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,212&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,522&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,287&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_49c37535-f895-4807-a0bd-aba968e19e1d"
      decimals="-3"
      id="F_8b1d148d-4710-4146-9efd-b0139b0ece09"
      unitRef="U_USD">6177000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_6b618c84-e67f-47f3-a70b-580a46e694b4"
      decimals="-3"
      id="F_adcf2610-9341-4df6-9798-0f56eece367f"
      unitRef="U_USD">4166000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_0a19bf2f-1258-4062-91ef-67f93a769e1f"
      decimals="-3"
      id="F_fd7c55a9-2ee4-4e80-96f8-0492510481cb"
      unitRef="U_USD">3238000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_f16d2dd7-db5e-4985-9658-6e9c9f5382ec"
      decimals="-3"
      id="F_bf25cce6-6dbe-490a-abd7-5d1a00342238"
      unitRef="U_USD">283000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_d31917a1-75da-46d6-8ef7-52754985fa8f"
      decimals="-3"
      id="F_2ad2c2dc-6251-47d0-8c07-0305fd6ac1d7"
      unitRef="U_USD">291000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_2ca9c59f-69d7-4fec-9a05-50e04ddc9998"
      decimals="-3"
      id="F_cf1992ab-ec19-43a9-9478-d286ecc22b5b"
      unitRef="U_USD">291000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_f970257d-5f8c-4f69-a8af-6c7b98ed7be9"
      decimals="-3"
      id="F_80f74aed-584f-4049-853a-ec1b844259a6"
      unitRef="U_USD">0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_14a91b0e-22cb-42cd-8677-a4630683bcaf"
      decimals="-3"
      id="F_2919d6ca-cc21-4753-b22a-ff3e1b3c59fa"
      unitRef="U_USD">1419000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_76fdd776-fb2d-4e7e-946f-9baef372cfc0"
      decimals="-3"
      id="F_17f7892e-0818-4675-9a41-d63845526b71"
      unitRef="U_USD">0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_b4192ab1-1392-4775-850f-0b32e8099e98"
      decimals="-3"
      id="F_68fb1196-8474-4074-9614-3a4db58d9733"
      unitRef="U_USD">4340000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_bfb3334e-9395-4d6c-8d9c-0e5574bc9111"
      unitRef="U_USD">9706000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_8757d297-d7b8-4aac-8598-08786227a1d1"
      unitRef="U_USD">10499000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_a2b1c67b-5179-4044-9ef6-7cf91ebe4023"
      unitRef="U_USD">4184000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_663e12e6-b2ea-4884-8c4a-26d15ca2118b"
      unitRef="U_USD">3212000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_14003389-128b-48ec-a25d-f2f3aeef23c1"
      unitRef="U_USD">5522000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_af0ce29e-3e3f-4782-a1c8-c05726c4b3ec"
      unitRef="U_USD">7287000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_dafb35c5-1fba-49fc-89ae-737273112b20"
      unitRef="U_USD">2775000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_6ffb14e6-1463-4822-986c-b2d15d680bc2"
      unitRef="U_USD">1146000</us-gaap:Depreciation>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_3c04b666-780d-4054-8bab-21c3bc4c6c72">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;6. Accrued expenses&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued expenses consist of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.2%;"/&gt;
        &lt;td style="width:1.392%;"/&gt;
        &lt;td style="width:1.282%;"/&gt;
        &lt;td style="width:12.742%;"/&gt;
        &lt;td style="width:0.964%;"/&gt;
        &lt;td style="width:1.411%;"/&gt;
        &lt;td style="width:1.282%;"/&gt;
        &lt;td style="width:12.762%;"/&gt;
        &lt;td style="width:0.964%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Payroll and employee related expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,375&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,062&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;767&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;647&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Third-party research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;840&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;874&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,101&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,663&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_69f34471-d29b-4d66-9e54-d141b757d1ef">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued expenses consist of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.2%;"/&gt;
        &lt;td style="width:1.392%;"/&gt;
        &lt;td style="width:1.282%;"/&gt;
        &lt;td style="width:12.742%;"/&gt;
        &lt;td style="width:0.964%;"/&gt;
        &lt;td style="width:1.411%;"/&gt;
        &lt;td style="width:1.282%;"/&gt;
        &lt;td style="width:12.762%;"/&gt;
        &lt;td style="width:0.964%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Payroll and employee related expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,375&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,062&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;767&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;647&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Third-party research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;840&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;874&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;80&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,101&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,663&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_194cbf5c-5f26-4d94-a83c-82255ce1254b"
      unitRef="U_USD">4375000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_7b06532f-0c33-45f2-9cb3-e52998b1a7e0"
      unitRef="U_USD">5062000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_1c7a9cf0-bab6-49e8-80a3-19e539c163f2"
      unitRef="U_USD">767000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_eb0f28f0-4c18-4314-a498-a0f0091554e9"
      unitRef="U_USD">647000</us-gaap:AccruedProfessionalFeesCurrent>
    <freq:AccruedThirdPartyResearchAndDevelopmentExpensesCurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_579b6617-d361-4b5d-888b-45c53b5bfe5e"
      unitRef="U_USD">840000</freq:AccruedThirdPartyResearchAndDevelopmentExpensesCurrent>
    <freq:AccruedThirdPartyResearchAndDevelopmentExpensesCurrent
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_3b8e7b6b-05c3-40db-b8dc-c413f3967ee3"
      unitRef="U_USD">874000</freq:AccruedThirdPartyResearchAndDevelopmentExpensesCurrent>
    <freq:AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_53de23a6-e374-4c04-b4c0-5632a57a6f1e"
      unitRef="U_USD">119000</freq:AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent>
    <freq:AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_84fba69b-7e4a-4a02-98d7-bc03f5097fa1"
      unitRef="U_USD">80000</freq:AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_5679035a-7b31-47dc-b186-d6925efd1cd4"
      unitRef="U_USD">6101000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_1c661f46-f336-41ab-a63b-4d726d043371"
      unitRef="U_USD">6663000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_9e4a1bb7-5f77-4bd7-a921-b361b3e52383">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.035;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;7.&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; Debt&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On December 11, 2020, the Company entered into a Loan and Security Agreement (the &#x201c;Loan Agreement&#x201d;) with a commercial bank for a Term Loan with a principal balance of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15,000&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company will make monthly interest only payments through &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;November 30, 2022&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. The principal balance and interest will be repaid in equal &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;monthly&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; installments after the interest only period and continue through &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;May 1, 2024&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (the &#x201c;Loan Maturity Date&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. Advances under the Loan Agreement will bear an interest rate equal to the greater of either (i) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.50&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% plus the Prime Rate (as reported in&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; The Wall Street Journal&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, subject to an interest rate floor of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;zero&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;) or (ii) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4.75&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%. The interest rate at December 31, 2021 was &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4.75&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%.&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; Interest related to the Loan Agreement was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;764&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; for the year ended December 31, 2021 and immaterial for the year ended December 31, 2020.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company may prepay the advance made under the Loan Agreement in whole, at any time subject to a prepayment premium equal to: (a) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.0&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of the then-outstanding principal amount of the advance, if such prepayment occurs on or prior to the first anniversary of the Closing Date; (b) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.0&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of the then-outstanding principal amount of the advance, if such prepayment occurs after the first anniversary of the Closing Date and on or prior to the second anniversary of the Closing Date; and (c) &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.0&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of the then-outstanding principal amount of the advance, if such prepayment occurs after the second anniversary of the Closing Date. The prepayment premium is waived if the Term Loan is refinanced by the bank (in its sole and absolute discretion) on or prior to the Loan Maturity Date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company will pay a final payment of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;150&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, which will occur on the earliest of: (i) the Loan Maturity Date; (ii) the date that the Company prepays all of the outstanding principal in full; (iii) the date the loan payments are accelerated due to an event of default; or (iv) the termination of the Loan Agreement. The Company is recording the final payment as interest expense over the term of the loan. The Term Loan is secured by substantially all of the Company&#x2019;s assets, excluding intellectual property.&lt;/span&gt;&lt;/p&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="C_45970929-9cc5-4976-bf18-cee30c4707f1"
      decimals="-3"
      id="F_15d9d055-7745-411a-b84a-83046d35271a"
      unitRef="U_USD">15000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentPaymentTerms
      contextRef="C_9b494e1f-e9d7-4e68-8c4e-6503e6471f18"
      id="F_e107107e-50c4-4885-aadb-6ed9dedb724c">The Company will make monthly interest only payments through November 30, 2022. The principal balance and interest will be repaid in equal monthly installments after the interest only period and continue through May 1, 2024 (the &#x201c;Loan Maturity Date&#x201d;)</us-gaap:DebtInstrumentPaymentTerms>
    <freq:DebtInstrumentInterestOnlyPaymentMaturityDate
      contextRef="C_389d9cd1-a5f9-4537-a214-aae7847e6a94"
      id="F_00b4091b-1582-440a-a094-ca15b3a1fd27">2022-11-30</freq:DebtInstrumentInterestOnlyPaymentMaturityDate>
    <us-gaap:DebtInstrumentFrequencyOfPeriodicPayment
      contextRef="C_9b494e1f-e9d7-4e68-8c4e-6503e6471f18"
      id="F_62641037-9e3b-4230-b39f-ce32fc7c7da6">monthly</us-gaap:DebtInstrumentFrequencyOfPeriodicPayment>
    <us-gaap:DebtInstrumentMaturityDate
      contextRef="C_389d9cd1-a5f9-4537-a214-aae7847e6a94"
      id="F_c80e5e65-22a2-4f1e-a640-ab8c6c908a6c">2024-05-01</us-gaap:DebtInstrumentMaturityDate>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="C_f955b24a-1210-4587-a090-44353cb3e0a3"
      decimals="4"
      id="F_b77b9d46-289e-4b60-ad9c-d1b4a14f9f13"
      unitRef="U_pure">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <freq:DebtInstrumentFloorInterestRatePercentage
      contextRef="C_45970929-9cc5-4976-bf18-cee30c4707f1"
      decimals="2"
      id="F_1ab2a623-151f-4461-b766-d3a1b826b2fa"
      unitRef="U_pure">0</freq:DebtInstrumentFloorInterestRatePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="C_9b494e1f-e9d7-4e68-8c4e-6503e6471f18"
      decimals="4"
      id="F_b27d447d-8c21-4711-90e1-1de9fc72f1a7"
      unitRef="U_pure">0.0475</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="4"
      id="F_56ffe904-606c-4331-bb8a-3fd71128beba"
      unitRef="U_pure">0.0475</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:InterestExpenseDebt
      contextRef="C_58f5a961-03f6-4320-a30e-9ed5284f4e0a"
      decimals="-3"
      id="F_7786c2b1-01bb-4cfa-b1d1-a9861899d47a"
      unitRef="U_USD">764000</us-gaap:InterestExpenseDebt>
    <freq:DebtInstrumentPrepaymentPremiumPercentage
      contextRef="C_fb927f4e-76df-424a-920e-b43ae68e4b30"
      decimals="3"
      id="F_2910024c-7886-48c5-a21e-cffc007b8962"
      unitRef="U_pure">0.020</freq:DebtInstrumentPrepaymentPremiumPercentage>
    <freq:DebtInstrumentPrepaymentPremiumPercentage
      contextRef="C_b7c53ec7-6b2a-4521-bec1-3cfbee53835a"
      decimals="3"
      id="F_1bc2e1a7-e1ad-4901-8adc-b080e81a9cc8"
      unitRef="U_pure">0.010</freq:DebtInstrumentPrepaymentPremiumPercentage>
    <freq:DebtInstrumentPrepaymentPremiumPercentage
      contextRef="C_0f0e0f6b-efeb-4ef1-b44a-ccadd9a887cd"
      decimals="3"
      id="F_85c274b7-6ff4-492a-aed3-a758d1457c75"
      unitRef="U_pure">0.000</freq:DebtInstrumentPrepaymentPremiumPercentage>
    <us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid
      contextRef="C_45970929-9cc5-4976-bf18-cee30c4707f1"
      decimals="-3"
      id="F_b5e03086-c81f-43e8-9168-939b3c88af10"
      unitRef="U_USD">150000</us-gaap:DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_9f41010c-2bdc-4dab-b042-2d628342cb1f">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;8. Stockholders&#x2019; equity&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Preferred stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;   &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;    &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has authorized &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.001&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; par value preferred stock of which &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares were issued or outstanding as of December 31, 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Common stock&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has authorized &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;200,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.001&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; par value common stock of which &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;34,611,213&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; were issued and outstanding as of December 31, 2021. Common shares are voting, and dividends may be paid when, as and if declared by the Board of Directors.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has reserved the following shares of common stock for future issuance as of December 31, 2021 and 2020:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.146%;"/&gt;
        &lt;td style="width:1.779%;"/&gt;
        &lt;td style="width:1.004%;"/&gt;
        &lt;td style="width:11.33%;"/&gt;
        &lt;td style="width:1.004%;"/&gt;
        &lt;td style="width:1.779%;"/&gt;
        &lt;td style="width:1.004%;"/&gt;
        &lt;td style="width:15.951%;"/&gt;
        &lt;td style="width:1.004%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Stock options outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,830,037&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,816,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Shares available for future grant under stock option plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,552,630&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,475,923&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8,382,667&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8,292,721&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Equity Offerings&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In July 2020, the Company completed a private placement of common stock to new and existing investors, or the Private Placement. In the Private Placement, the Company issued and sold &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,350,108&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of common stock at a purchase price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;18.00&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; per share. The Company received approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;40,100&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; in net proceeds, after deducting placement agent fees and other offering expenses. In connection with the Private Placement, the Company entered into a Registration Rights Agreement, or the Registration Rights Agreement, with the investors purchasing shares in the Private Placement. Pursuant to the Registration Rights Agreement, the Company filed a registration statement with the Securities and Exchange Commission, or the SEC, which was declared effective on September 3, 2020, registering the resale of the shares sold in the Private Placement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On December 10, 2021, the Company entered into an Equity Distribution Agreement (the "Sales Agreement") with Oppenheimer &amp;amp; Co. Inc. (the "Sales Agent") to sell shares of the Company&#x2019;s common stock, par value $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.001&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; per share, with aggregate gross sales proceeds of up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;125,000&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, from time to time, through an &#x201c;at the market&#x201d; equity offering program. Subject to the terms and conditions of the Sales Agreement, the Sales Agent may sell the shares by methods deemed to be an &#x201c;at the market offering&#x201d; as defined in Rule 415 promulgated under the Securities Act of 1933, as amended, including sales made through The Nasdaq Global Select Market, on any other existing trading market for the Common Stock, to or through a market maker, or, if expressly authorized by the Company, in privately negotiated transactions. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company or Sales Agent may terminate the Sales Agreement upon notice to the other party and subject to other conditions. &lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company will pay the Sales Agent a commission equal to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3.0&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of the gross proceeds of any Common Stock sold through the Sales Agent under the Sales Agreement and has provided the Sales Agent with customary indemnification rights.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Issuance costs incurred related to the Sales Agreement are classified as long-term assets on the balance sheet at December 31, 2021.&lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="INF"
      id="F_76668500-4d0f-4fa5-9508-a83501db6c7b"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="INF"
      id="F_3adf5ed7-883b-4409-b2f3-27347a1589ce"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="INF"
      id="F_faee29d2-6cf9-44fb-a0ce-9e87b76ccb4f"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="INF"
      id="F_9a55a0d8-9a10-47f5-800e-201e60233a22"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="INF"
      id="F_bb8e766a-957a-4d59-a54d-46cf89a774c0"
      unitRef="U_shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="INF"
      id="F_4fda8906-be7f-44fa-87ea-8a1a2cc3b141"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="INF"
      id="F_3858c27e-145c-4d98-af38-31bc679a2508"
      unitRef="U_shares">34611213</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="INF"
      id="F_272da50e-1487-4315-8c2c-3d5e477c645f"
      unitRef="U_shares">34611213</us-gaap:CommonStockSharesOutstanding>
    <freq:ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_e978e1e7-392b-4bb1-ab90-2dca8b9b7b7d">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has reserved the following shares of common stock for future issuance as of December 31, 2021 and 2020:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.146%;"/&gt;
        &lt;td style="width:1.779%;"/&gt;
        &lt;td style="width:1.004%;"/&gt;
        &lt;td style="width:11.33%;"/&gt;
        &lt;td style="width:1.004%;"/&gt;
        &lt;td style="width:1.779%;"/&gt;
        &lt;td style="width:1.004%;"/&gt;
        &lt;td style="width:15.951%;"/&gt;
        &lt;td style="width:1.004%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Stock options outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,830,037&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,816,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Shares available for future grant under stock option plan&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,552,630&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,475,923&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8,382,667&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8,292,721&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</freq:ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_fd9346ee-0123-48e4-a5e9-177e9e88d4c9"
      decimals="INF"
      id="F_fb908091-36e1-4b87-9a5e-e56ac12efd1c"
      unitRef="U_shares">6830037</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_afc37fa6-10a6-4cfc-b132-46416981a53b"
      decimals="INF"
      id="F_d3cacbe4-0f91-40e7-b95c-82e3a8409ebe"
      unitRef="U_shares">6816798</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_81e252a8-16c5-427e-a03f-1106ff94238b"
      decimals="INF"
      id="F_f650b28d-a836-4cde-afeb-9ad59c9c7686"
      unitRef="U_shares">1552630</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_5cd63438-4bcf-47ba-83d5-992899a88d69"
      decimals="INF"
      id="F_0fd28d4b-18bc-4911-bcbe-82c62103da76"
      unitRef="U_shares">1475923</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="INF"
      id="F_90d9ee00-68d9-4c1c-b32f-d5e83faf1715"
      unitRef="U_shares">8382667</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="INF"
      id="F_31f603c9-2317-4771-a21a-73b240b344a8"
      unitRef="U_shares">8292721</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_ecc116a0-70fc-4e40-92ed-6d00d8ab497a"
      decimals="INF"
      id="F_c3e48338-3574-4da8-b07f-32c9edb379aa"
      unitRef="U_shares">2350108</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_8464360a-28a5-4526-89c7-192cc0292849"
      decimals="INF"
      id="F_45bf129b-7dcb-469f-8ad8-c8c2da8688c8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">18.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_ecc116a0-70fc-4e40-92ed-6d00d8ab497a"
      decimals="-3"
      id="F_600347d2-92e3-4873-ab44-893aaa6794e9"
      unitRef="U_USD">40100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_9a6459ef-90a2-45d3-bb28-8c54d3edc4d6"
      decimals="INF"
      id="F_ea989a9e-37ad-4024-b47a-ea0ef6f40206"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.001</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="C_49bd1a34-70e0-4358-af75-4f83449a848f"
      decimals="-3"
      id="F_0a886165-3e9e-4d07-ac40-08ff33b60548"
      unitRef="U_USD">125000000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <freq:SalesAgentCommission
      contextRef="C_9a6459ef-90a2-45d3-bb28-8c54d3edc4d6"
      decimals="INF"
      id="F_abdf2643-a6b1-4ab2-ac03-7d3288532ad9"
      unitRef="U_pure">0.030</freq:SalesAgentCommission>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_85330db7-1fac-42ee-8e4e-84dc49258c61">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;9. Stock-based compensation&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On November 13, 2014, the Company adopted the 2014 Stock Incentive Plan (2014 Plan). All of the Company&#x2019;s employees, officers, directors, and consultants are eligible to be granted options to purchase common shares and restricted stock under the terms of the 2014 Plan. The Company reserved an aggregate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8,550,415&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of common stock for issuance under the 2014 Plan. As of December 31, 2021, there were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of common stock available for future grants under the 2014 Plan.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On September 17, 2019, the Company&#x2019;s board of directors and on September 19, 2019, its stockholders approved and adopted the 2019 Incentive Award Plan (&#x201c;the &#x201c;2019 Plan&#x201d;).  Under the 2019 Plan, the Company may grant stock options, stock appreciation rights, restricted stock, restricted stock units, and other stock and cash-based awards to individuals who are then employees, officers, directors or consultants of the Company, and employees and consultants of the Company&#x2019;s subsidiaries.  A total of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,100,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of common stock were approved to be initially reserved for issuance under the 2019 plan.  The number of shares under the 2014 Plan subject to outstanding awards as of the effective date of the 2019 Plan that are subsequently canceled, forfeited or repurchased by the Company will be added to the shares reserved under the 2019 Plan. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; In addition, the number of shares of common stock available for issuance under the 2019 Plan will be automatically increased on the first day of each calendar year during the &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;ten-year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; term of the 2019 Plan, beginning with January 1, 2020 and ending with January 1, 2029, by the amount equal to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of the outstanding number of shares of the Company&#x2019;s common stock on December 31, of the preceding calendar year or such lesser amount as determined by the Company&#x2019;s board of directors.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;All stock option grants are non-statutory stock options except option grants to employees (including officers and directors) intended to qualify as incentive stock options under the Internal Revenue Code of 1986, as amended. Incentive stock options may not be granted at less than the fair market value of the Company&#x2019;s common stock on the date of grant, as determined in good faith by the Board of Directors at its sole discretion. Nonqualified stock options may be granted at an exercise price established by the Board of Directors at its sole discretion (which has not been less than fair market value on the date of grant) and the vesting periods may vary. Vesting periods are generally&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; four years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and are determined by the Board of Directors. Stock options become exercisable as they vest. Options granted under the 2014 Plan and the 2019 Plan expire no more than &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; from the date of grant.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Stock options&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;A summary of the stock option activity under the 2014 Plan and the 2019 Plan are as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:42.779%;"/&gt;
        &lt;td style="width:0.736%;"/&gt;
        &lt;td style="width:0.507%;"/&gt;
        &lt;td style="width:12.355%;"/&gt;
        &lt;td style="width:0.686%;"/&gt;
        &lt;td style="width:0.736%;"/&gt;
        &lt;td style="width:1.044%;"/&gt;
        &lt;td style="width:12.056%;"/&gt;
        &lt;td style="width:0.507%;"/&gt;
        &lt;td style="width:0.736%;"/&gt;
        &lt;td style="width:0.517%;"/&gt;
        &lt;td style="width:12.494%;"/&gt;
        &lt;td style="width:0.507%;"/&gt;
        &lt;td style="width:0.736%;"/&gt;
        &lt;td style="width:1.044%;"/&gt;
        &lt;td style="width:12.056%;"/&gt;
        &lt;td style="width:0.507%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:7.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;Number of&lt;br/&gt;shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;remaining&lt;br/&gt;contractual&lt;br/&gt;term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;Aggregate&lt;br/&gt;intrinsic value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Outstanding as of December 31, 2019&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;5,968,672&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;5.21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;9.08&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;73,561&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;1,645,859&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;24.22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;9.30&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;769,385&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;1.99&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;16,667&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;28,348&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;16.38&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Outstanding as of December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;6,816,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;10.11&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;8.45&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;171,415&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;1,357,426&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;32.76&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;8.07&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;642,314&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;11,652&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;701,873&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;16.48&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Outstanding as of December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;6,830,037&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;14.72&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;7.76&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;6,987&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Options exercisable as of December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;3,993,231&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;9.77&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;7.34&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;6,275&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Options unvested as of December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2,836,806&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;21.70&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;8.36&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;712&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Stock option valuation&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The assumptions that the Company used to determine the grant-date fair value of stock options granted to&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;employees and directors were as follows, presented on a weighted average basis:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:53.724%;"/&gt;
        &lt;td style="width:1.364%;"/&gt;
        &lt;td style="width:0.981%;"/&gt;
        &lt;td style="width:17.268%;"/&gt;
        &lt;td style="width:3.525%;"/&gt;
        &lt;td style="width:1.364%;"/&gt;
        &lt;td style="width:0.981%;"/&gt;
        &lt;td style="width:17.268%;"/&gt;
        &lt;td style="width:3.525%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;79.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;79.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The weighted-average grant date fair value of options granted to employees during the years ended December 31, 2021 and 2020 was &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;22.39&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;16.41&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; respectively.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The total grant date fair value of options vested during the years ended December 31, 2021 and 2020 was &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;16,304&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,907&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Restricted common stock&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company issued common stock to founders, employees and advisors which was subject to vesting over four years. If any of these individuals ceased to be employed or to provide services to the Company prior to vesting, the Company had the right to repurchase any unvested Common Stock at the price paid by the holder.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;A summary of the status of restricted common stock as of December 31, 2021 and 2020 is presented below:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.673%;"/&gt;
        &lt;td style="width:1.491%;"/&gt;
        &lt;td style="width:0.646%;"/&gt;
        &lt;td style="width:13.627%;"/&gt;
        &lt;td style="width:0.865%;"/&gt;
        &lt;td style="width:1.491%;"/&gt;
        &lt;td style="width:1.282%;"/&gt;
        &lt;td style="width:13.289%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Number of&lt;br/&gt;shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Weighted&lt;br/&gt;average fair&lt;br/&gt;value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested, December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,093&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Awarded&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;928&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,165&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested, December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; The total value of restricted stock awards that vested during the years ended December 31, 2021 and 2020, based on estimated fair values of the stock underlying the restricted stock awards was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;20&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Restricted stock units&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In April 2021, the Company issued restricted stock units to employees which will &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;vest in equal installments in the first quarter of 2022 and the third quarter of 2022.&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"/&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;A summary of the status of restricted stock units as of December 31, 2021 and 2020 is presented below:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.547%;"/&gt;
        &lt;td style="width:1.481%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
        &lt;td style="width:13.799%;"/&gt;
        &lt;td style="width:0.865%;"/&gt;
        &lt;td style="width:1.481%;"/&gt;
        &lt;td style="width:1.282%;"/&gt;
        &lt;td style="width:13.272%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Number of&lt;br/&gt;shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Weighted&lt;br/&gt;average fair&lt;br/&gt;value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested, December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Awarded&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;800,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.54&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;173,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.54&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested, December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;626,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.54&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Stock-based compensation&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Stock-based compensation expense of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;21,750&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9,983&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; for the years ended December 31, 2021 and 2020 respectively, is included in research and development and general and administrative expenses in the Company&#x2019;s consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 2021 and 2020, total unrecognized stock-based compensation expense relating to unvested stock options, restricted stock awards, and restricted stock units was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;39,112&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;31,006&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively. This amount is expected to be recognized over a weighted-average period of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.49 &lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;years and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3.08&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; years, respectively.&lt;/span&gt;&lt;/p&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_314d3398-4d13-4f53-b054-20b54a955ba4"
      decimals="INF"
      id="F_d104d08b-b321-450e-8fc0-df7896003914"
      unitRef="U_shares">8550415</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_63fbb0a1-d118-421f-b0be-baa522b2c4c1"
      decimals="INF"
      id="F_43592d85-54f1-4438-af11-09794a83c695"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="C_90c637f8-8aac-4313-bec9-a8d318734b7f"
      decimals="INF"
      id="F_ce4baf70-b81e-4e88-a1f9-5b1f5d6599f9"
      unitRef="U_shares">3100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription
      contextRef="C_dcccf903-dd0c-4b08-adcc-14b5fde28ebb"
      id="F_405ebd4f-259f-461e-ab74-3fb293123717"> In addition, the number of shares of common stock available for issuance under the 2019 Plan will be automatically increased on the first day of each calendar year during the ten-year term of the 2019 Plan, beginning with January 1, 2020 and ending with January 1, 2029, by the amount equal to 4% of the outstanding number of shares of the Company&#x2019;s common stock on December 31, of the preceding calendar year or such lesser amount as determined by the Company&#x2019;s board of directors.</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription>
    <freq:PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance
      contextRef="C_dcccf903-dd0c-4b08-adcc-14b5fde28ebb"
      id="F_3621efec-9eb5-4972-8b23-0270acaceaf2">P10Y</freq:PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="C_dcccf903-dd0c-4b08-adcc-14b5fde28ebb"
      decimals="INF"
      id="F_587c887f-a4d7-4c32-a559-e0475b42be82"
      unitRef="U_pure">0.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_dccde3cf-4e02-4e64-9156-ac4d325e5c5c">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_7b7e8741-8d9b-4c87-a41b-14d39da56ae6"
      id="F_9656526c-fc42-4af0-8c09-69610e096ad5">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_f080ccb9-1f5c-4ce4-a7cc-21bc59f2f3af">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;A summary of the stock option activity under the 2014 Plan and the 2019 Plan are as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:42.779%;"/&gt;
        &lt;td style="width:0.736%;"/&gt;
        &lt;td style="width:0.507%;"/&gt;
        &lt;td style="width:12.355%;"/&gt;
        &lt;td style="width:0.686%;"/&gt;
        &lt;td style="width:0.736%;"/&gt;
        &lt;td style="width:1.044%;"/&gt;
        &lt;td style="width:12.056%;"/&gt;
        &lt;td style="width:0.507%;"/&gt;
        &lt;td style="width:0.736%;"/&gt;
        &lt;td style="width:0.517%;"/&gt;
        &lt;td style="width:12.494%;"/&gt;
        &lt;td style="width:0.507%;"/&gt;
        &lt;td style="width:0.736%;"/&gt;
        &lt;td style="width:1.044%;"/&gt;
        &lt;td style="width:12.056%;"/&gt;
        &lt;td style="width:0.507%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:7.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;Number of&lt;br/&gt;shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;exercise price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;Weighted&lt;br/&gt;average&lt;br/&gt;remaining&lt;br/&gt;contractual&lt;br/&gt;term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;Aggregate&lt;br/&gt;intrinsic value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Outstanding as of December 31, 2019&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;5,968,672&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;5.21&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;9.08&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;73,561&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;1,645,859&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;24.22&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;9.30&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;769,385&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;1.99&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;16,667&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;28,348&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;16.38&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Outstanding as of December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;6,816,798&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;10.11&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;8.45&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;171,415&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;1,357,426&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;32.76&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;8.07&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;642,314&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;11,652&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;701,873&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;16.48&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Outstanding as of December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;6,830,037&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;14.72&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;7.76&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;6,987&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Options exercisable as of December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;3,993,231&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;9.77&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;7.34&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;6,275&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;Options unvested as of December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;2,836,806&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;21.70&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;8.36&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"&gt;712&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_f6dcc9b6-8e32-4d98-bffb-d9bddefb3adf"
      decimals="0"
      id="F_e2c86059-7628-4735-a8a2-435ad0afa40f"
      unitRef="U_shares">5968672</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_f6dcc9b6-8e32-4d98-bffb-d9bddefb3adf"
      decimals="2"
      id="F_46279e32-f426-4c54-b0ea-6f561df1a660"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_514ddae0-918c-4159-afcf-c75cb08a52fd"
      id="F_27c0f8b4-76a5-4a08-b675-17e884dcddad">P9Y29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_f6dcc9b6-8e32-4d98-bffb-d9bddefb3adf"
      decimals="-3"
      id="F_43f102f0-31bc-47b9-811f-5d1b98ab1933"
      unitRef="U_USD">73561000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_c51b15b1-1d54-4248-ae05-78c643fea245"
      decimals="0"
      id="F_74533906-b4c8-43f2-bccc-c3608df51369"
      unitRef="U_shares">1645859</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_c51b15b1-1d54-4248-ae05-78c643fea245"
      decimals="2"
      id="F_b871d9ec-c75c-41fd-9605-a8ca910cf345"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">24.22</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <freq:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2
      contextRef="C_c51b15b1-1d54-4248-ae05-78c643fea245"
      id="F_5f41bb57-062e-4313-86d5-8353969df64a">P9Y3M18D</freq:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_c51b15b1-1d54-4248-ae05-78c643fea245"
      decimals="0"
      id="F_7b5efab6-bd06-4708-893c-3694ec82658b"
      unitRef="U_shares">769385</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_c51b15b1-1d54-4248-ae05-78c643fea245"
      decimals="2"
      id="F_b911d04c-6582-40a7-91cd-5d608f50be84"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.99</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_c51b15b1-1d54-4248-ae05-78c643fea245"
      decimals="-3"
      id="F_2d82ed4d-f4d6-4a91-a2e0-40ba289b39ad"
      unitRef="U_USD">16667000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_c51b15b1-1d54-4248-ae05-78c643fea245"
      decimals="0"
      id="F_0ea446bd-ab7d-4eba-9bd6-5a0138874fdf"
      unitRef="U_shares">28348</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_c51b15b1-1d54-4248-ae05-78c643fea245"
      decimals="2"
      id="F_186ebe2f-4e7a-4a60-96a6-79558ccf7d52"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">16.38</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_ac62a1b7-c43f-4181-a7f5-94b13f47cb97"
      decimals="0"
      id="F_a5c46280-2dd1-4298-aefe-c0c477c1ecb0"
      unitRef="U_shares">6816798</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_ac62a1b7-c43f-4181-a7f5-94b13f47cb97"
      decimals="2"
      id="F_04384858-fcd2-4013-a424-f1a9e30daecc"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">10.11</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_c51b15b1-1d54-4248-ae05-78c643fea245"
      id="F_d9804df3-c8d7-4ee1-8f70-0d16e7d41ad5">P8Y5M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_ac62a1b7-c43f-4181-a7f5-94b13f47cb97"
      decimals="-3"
      id="F_64321f4e-f350-4f64-8ee0-03bf3eaf3f47"
      unitRef="U_USD">171415000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc"
      decimals="0"
      id="F_1e9cd947-ac66-4a64-a6d9-e9cf208ed9ef"
      unitRef="U_shares">1357426</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc"
      decimals="2"
      id="F_b8aea6da-b621-4e49-899c-b94c1a3fbf27"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">32.76</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <freq:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2
      contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc"
      id="F_883895a9-ccfb-4534-9473-c391c63ea9ac">P8Y25D</freq:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc"
      decimals="0"
      id="F_4142b3f3-91ce-4c19-b718-2bf8e6d91dc5"
      unitRef="U_shares">642314</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc"
      decimals="2"
      id="F_71206924-7475-4f2e-a26a-72ccd9181726"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.02</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc"
      decimals="-3"
      id="F_436e736d-38cc-42fc-87bb-c5549b7fe5d0"
      unitRef="U_USD">11652000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc"
      decimals="0"
      id="F_9d92991d-99d3-4f72-b7b0-6fab86ac31fe"
      unitRef="U_shares">701873</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc"
      decimals="2"
      id="F_e07e81f5-1262-47a1-9b38-dfd79b4dbb3c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">16.48</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_7186f7f7-8d1b-4a52-9633-5bf6e27f4982"
      decimals="0"
      id="F_4087028c-6c22-4f3f-a51d-fc4e24a55fe3"
      unitRef="U_shares">6830037</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_7186f7f7-8d1b-4a52-9633-5bf6e27f4982"
      decimals="2"
      id="F_06e8e78e-b05b-4277-9141-8dccd53b2d83"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">14.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc"
      id="F_369f3565-ec49-47f0-a1ae-d4316eacfb3c">P7Y9M3D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_7186f7f7-8d1b-4a52-9633-5bf6e27f4982"
      decimals="-3"
      id="F_0611f6ff-b6de-443c-8346-fc1c97d940a9"
      unitRef="U_USD">6987000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_7186f7f7-8d1b-4a52-9633-5bf6e27f4982"
      decimals="0"
      id="F_8129b7cd-ab2d-4702-aa82-0629773914d6"
      unitRef="U_shares">3993231</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_7186f7f7-8d1b-4a52-9633-5bf6e27f4982"
      decimals="2"
      id="F_836c6027-4713-4650-90c2-1fefe63efd18"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">9.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc"
      id="F_970fb8a0-286d-4112-be0d-1d1ed39e76ea">P7Y4M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_7186f7f7-8d1b-4a52-9633-5bf6e27f4982"
      decimals="-3"
      id="F_8c0d196a-84f2-492c-83a3-2f05bd1f1b63"
      unitRef="U_USD">6275000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_7186f7f7-8d1b-4a52-9633-5bf6e27f4982"
      decimals="0"
      id="F_2e8157d4-7944-474c-97ef-834b6ac3d054"
      unitRef="U_shares">2836806</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="C_7186f7f7-8d1b-4a52-9633-5bf6e27f4982"
      decimals="2"
      id="F_2b6e0dc9-c3b5-48c7-bf18-994add77f32d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">21.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="C_3518f4db-a6ab-442b-9131-2ac71642f3dc"
      id="F_5894de8c-9906-49c1-9d3d-3c6095da9eeb">P8Y4M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="C_7186f7f7-8d1b-4a52-9633-5bf6e27f4982"
      decimals="-3"
      id="F_3827d1ed-d0e1-41c4-afe3-0380b99e6528"
      unitRef="U_USD">712000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_a2011dc4-36f5-426e-b3c7-e28881f0816a">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The assumptions that the Company used to determine the grant-date fair value of stock options granted to&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;employees and directors were as follows, presented on a weighted average basis:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:53.724%;"/&gt;
        &lt;td style="width:1.364%;"/&gt;
        &lt;td style="width:0.981%;"/&gt;
        &lt;td style="width:17.268%;"/&gt;
        &lt;td style="width:3.525%;"/&gt;
        &lt;td style="width:1.364%;"/&gt;
        &lt;td style="width:0.981%;"/&gt;
        &lt;td style="width:17.268%;"/&gt;
        &lt;td style="width:3.525%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;79.8&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;79.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expected dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="3"
      id="F_75edfd77-747d-4ac4-9547-b667e39577c2"
      unitRef="U_pure">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="3"
      id="F_2b101da4-2a01-483c-a5fa-d2494cea398b"
      unitRef="U_pure">0.011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_adec2ebd-5d63-4270-9f99-90d610437315">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      id="F_a4f81be7-a85b-45d7-a967-1826401d0340">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="3"
      id="F_ef79f5c2-ee05-4122-947c-52c8c4dbb107"
      unitRef="U_pure">0.798</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="3"
      id="F_dfc20fb2-84c6-41cb-b7e5-36d909a7f02e"
      unitRef="U_pure">0.791</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="3"
      id="F_3baaa1df-36e9-4332-850e-515053d81f74"
      unitRef="U_pure">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="3"
      id="F_8867c12a-cacf-4844-8397-762b60918cf3"
      unitRef="U_pure">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="2"
      id="F_18054162-8706-4c92-8cc1-4d590205b4ee"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">22.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="2"
      id="F_5a4ff6b9-4ee1-4c6f-9bbe-d4c42178164a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">16.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_70eceb40-fe86-419d-a86b-ed911fb329a4"
      unitRef="U_USD">16304000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_c44939bd-e566-4ee3-b786-11e3ca70d942"
      unitRef="U_USD">7907000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="C_0d93812e-8c05-49cd-9223-e00467bcba4d"
      id="F_60e8e26e-edc8-471a-b3ec-f56d6301d0c8">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;A summary of the status of restricted common stock as of December 31, 2021 and 2020 is presented below:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.673%;"/&gt;
        &lt;td style="width:1.491%;"/&gt;
        &lt;td style="width:0.646%;"/&gt;
        &lt;td style="width:13.627%;"/&gt;
        &lt;td style="width:0.865%;"/&gt;
        &lt;td style="width:1.491%;"/&gt;
        &lt;td style="width:1.282%;"/&gt;
        &lt;td style="width:13.289%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Number of&lt;br/&gt;shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Weighted&lt;br/&gt;average fair&lt;br/&gt;value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested, December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,093&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Awarded&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;928&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,165&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.75&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested, December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_8f05e1d9-5717-4801-93c4-ba371f31a50e"
      decimals="INF"
      id="F_cb2506a2-b1c4-4327-91b0-1e9f14aa7f57"
      unitRef="U_shares">3093</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_8f05e1d9-5717-4801-93c4-ba371f31a50e"
      decimals="2"
      id="F_0dc738a9-8660-42e9-8ccd-1328aa56f70b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="C_0d93812e-8c05-49cd-9223-e00467bcba4d"
      decimals="0"
      id="F_1ce77e84-342d-4299-9040-2ff2ac8f9854"
      unitRef="U_shares">928</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0d93812e-8c05-49cd-9223-e00467bcba4d"
      decimals="2"
      id="F_85124594-ba25-43fc-962f-097aed96a63b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_0d93812e-8c05-49cd-9223-e00467bcba4d"
      decimals="0"
      id="F_0d5632a5-c938-489d-a17f-0d568640eb8b"
      unitRef="U_shares">2165</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_0d93812e-8c05-49cd-9223-e00467bcba4d"
      decimals="2"
      id="F_5b162889-7a70-4d24-90f6-2c2a4df81c71"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.75</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_768ee818-71ae-4ce4-8037-4961cf5029cc"
      decimals="0"
      id="F_3700433c-f07f-4c67-9d5a-44c24552cab4"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_768ee818-71ae-4ce4-8037-4961cf5029cc"
      decimals="0"
      id="F_024dd129-07c9-4868-b7a0-059131d360c8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="C_0d93812e-8c05-49cd-9223-e00467bcba4d"
      decimals="-3"
      id="F_17f09a27-0ba5-475a-ab48-eb563166b4ca"
      unitRef="U_USD">2000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="C_54ac7307-3cc3-42f9-b337-69f60c51b471"
      decimals="-3"
      id="F_ccc3711b-bc3a-4e20-a3c5-daa575215656"
      unitRef="U_USD">20000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <freq:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription
      contextRef="C_fe2774ae-4979-4575-894a-1f57dedae7e9"
      id="F_ace26adf-e53f-4a1a-9b39-bc858f01c0f2">vest in equal installments in the first quarter of 2022 and the third quarter of 2022. </freq:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="C_fe2774ae-4979-4575-894a-1f57dedae7e9"
      id="F_ab685c8a-6e6a-4ac5-9707-7f02b3e0aca9">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;A summary of the status of restricted stock units as of December 31, 2021 and 2020 is presented below:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.547%;"/&gt;
        &lt;td style="width:1.481%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
        &lt;td style="width:13.799%;"/&gt;
        &lt;td style="width:0.865%;"/&gt;
        &lt;td style="width:1.481%;"/&gt;
        &lt;td style="width:1.282%;"/&gt;
        &lt;td style="width:13.272%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Number of&lt;br/&gt;shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Weighted&lt;br/&gt;average fair&lt;br/&gt;value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested, December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Awarded&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;800,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.54&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Vested&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;173,700&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.54&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Unvested, December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;626,300&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.54&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_746daa8a-e230-4375-9cc8-fcf4f87699a6"
      decimals="0"
      id="F_f7e7b588-3695-4afb-bd9a-1ad25691b16e"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_746daa8a-e230-4375-9cc8-fcf4f87699a6"
      decimals="0"
      id="F_801e9250-28bc-4761-91a2-e64ba139e832"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="C_fe2774ae-4979-4575-894a-1f57dedae7e9"
      decimals="INF"
      id="F_0d82136e-bbab-4ff7-9b66-82555fa10128"
      unitRef="U_shares">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_fe2774ae-4979-4575-894a-1f57dedae7e9"
      decimals="2"
      id="F_2bed57b9-6d9a-4720-b3ee-a77ad4d44100"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">9.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="C_fe2774ae-4979-4575-894a-1f57dedae7e9"
      decimals="INF"
      id="F_b1335636-a98b-4ae9-868f-a15f000649cb"
      unitRef="U_shares">173700</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="C_fe2774ae-4979-4575-894a-1f57dedae7e9"
      decimals="2"
      id="F_f1f46e82-8a42-4827-a0f5-09932bf25c36"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">9.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="C_0c30c3e8-0228-45a8-9bfc-3207d2e201fc"
      decimals="INF"
      id="F_1e028910-e709-40e4-a2fe-903b645c1789"
      unitRef="U_shares">626300</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="C_0c30c3e8-0228-45a8-9bfc-3207d2e201fc"
      decimals="2"
      id="F_b3f17e65-c739-44da-9a64-4bdc07f68e37"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">9.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_51d717fb-7e75-44ae-bee6-68ee19956485"
      decimals="-3"
      id="F_304c1225-a0d8-448e-b824-d4f1cc40b6ff"
      unitRef="U_USD">21750000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_e6d90f27-4552-437d-96bb-a911e3141b0e"
      decimals="-3"
      id="F_1bfa78ef-a224-408e-a9b9-fe409226c7c3"
      unitRef="U_USD">9983000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_e803b3e9-d0e5-47a8-a306-b15e687074ac"
      unitRef="U_USD">39112000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_48311898-f1a4-4663-a849-a68745f9547d"
      unitRef="U_USD">31006000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_a70e3e04-13d2-4552-8646-695d4356e231">P2Y5M26D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      id="F_fd8604c8-348f-4e26-911f-a6ec98db4b73">P3Y29D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <freq:EmployeeStockPurchasePlanDisclosureTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_a04af75b-8633-4afa-a6e1-097c82c9eedf">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;10. Employee stock purchase plan&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On September 20, 2019, the Company&#x2019;s board of directors and stockholders approved and adopted the 2019 Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;) which became effective on the date of the Company&#x2019;s initial public offering of shares of its common stock. The ESPP permits participants to purchase common stock through payroll deductions of up to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of their eligible compensation.&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The number of shares of common stock available for issuance under the ESPP will be automatically increased on the first day of each calendar year during the first &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;ten years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of the term of the ESPP, beginning with January 1, 2020 and ending with January 1, 2029, by an amount equal to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of the outstanding number of shares of the Company&#x2019;s common stock on December 31 of the preceding calendar year or such lesser amount as determined by the Company&#x2019;s board of directors. The Company&#x2019;s first offering period of 2021 concluded on June 30, 2021 with the purchase of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,064&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares in July 2021 related to this offering period. A&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;s of December 31, 2021, a&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; total of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;956,021&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares remain for future offering periods.&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company's second offering period of 2021 concluded on December 31, 2021 with the purchase of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;31,832&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares in January 2022 related to this offering.&lt;/span&gt;&lt;/p&gt;</freq:EmployeeStockPurchasePlanDisclosureTextBlock>
    <freq:PercentageOfEligibleEmployeeCompensation
      contextRef="C_ad952da4-5b38-4e64-a1f0-d990bf170c57"
      decimals="2"
      id="F_daddb8a7-10ab-41ce-a289-ab406d19d21f"
      unitRef="U_pure">0.15</freq:PercentageOfEligibleEmployeeCompensation>
    <freq:PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance
      contextRef="C_ad952da4-5b38-4e64-a1f0-d990bf170c57"
      id="F_b5241f0b-4529-4c4f-8e77-d330e220d0e9">P10Y</freq:PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="C_ad952da4-5b38-4e64-a1f0-d990bf170c57"
      decimals="2"
      id="F_75c40b25-49b4-43a8-a94e-1ce642a2449e"
      unitRef="U_pure">0.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="C_1136a968-0349-44e0-8596-79d8ce8e10d1"
      decimals="INF"
      id="F_3c4bc4e2-5647-42da-b40a-2cac5c928107"
      unitRef="U_shares">7064</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="C_f92ea8d8-789c-4c65-915c-479148f6a96f"
      decimals="INF"
      id="F_b779d928-f9c8-4458-8a9e-9c4bbe97c892"
      unitRef="U_shares">956021</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="C_419cd7aa-c2d9-47e1-b2f2-d57d5c727db3"
      decimals="INF"
      id="F_0c3f2ab4-e6bc-4eca-93f5-24bcc165abfa"
      unitRef="U_shares">31832</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_6e6b5cdf-7324-4fe3-bbf7-0eda9195dbf9">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;11.&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; Income taxes&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Since inception in 2014, the Company has generated cumulative federal and state net operating loss and research and development credit carryforwards for which we have &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;t recorded any net tax benefit due to uncertainty around utilizing these tax attributes within the respective carryforward periods.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 2021, the Company had federal net operating loss carryforwards of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;149,071&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and Massachusetts state operating loss carryforwards of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;83,467&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; which may be available to offset future taxable income. The U.S. federal net operating loss carryforwards include $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;22,399&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; available to reduce future taxable income through &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2037&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;126,672&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; which do not expire and are available to reduce future taxable income indefinitely. The state net operating loss carryforwards are available to offset future taxable income through &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2041&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. As of December 31, 2021, the Company also had federal and Massachusetts research and development tax credit carryforwards of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,241&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,071&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively, which are available to offset federal and state tax liabilities through &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2041&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2036&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Realization of future tax benefits is dependent on many factors, including the Company&#x2019;s ability to generate taxable income within the net operating loss carryforward period. Net operating loss and tax credit carryforwards may become subject to an annual limitation in the event of certain cumulative changes in the ownership interest of significant shareholders over a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;three-year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; period in excess of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;50&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%, as provided under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, respectively, as well as similar state provisions. These ownership changes may limit the number of carryforwards that can be utilized annually to offset future taxable income. In general, an ownership change, as defined by Section 382, results from transactions increasing the ownership of certain shareholders or public groups in the stock of a corporation by more than 50% over a three-year period. The Company has completed several financings and has conducted a study to assess whether a change of control has occurred or whether there have been multiple changes of control since inception and has determined that an ownership change did occur in March 2017. Accordingly, utilization of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;12,400&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;the U.S. net operating&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;loss &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;carryforwards which were incurred prior to March 2017 (pre-ownership change) is limited under Section 382. After the Section 382 limitations, the Company may utilize approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10,800&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of its pre-ownership change net operating loss carryforwards based upon an annual usage of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,600&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; for each of the next five years after the ownership change and approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;180&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; for each of the 15 years thereafter. The remaining pre-ownership change net operating losses of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,600&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; were written off due to expiration under limitation. The limitation has been determined by first multiplying the value of our stock at the time of the ownership change by the applicable long-term tax-exempt rate. These carryforwards may be subject to further annual limitations under Section 382 in the event of future changes in ownership.  Additionally, the Company has determined an ownership changed occurred in October of 2019 as a result of the IPO.  Accordingly, utilization of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;46,123&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of the U.S. net operating loss carryforwards incurred prior to October 2019 is also limited under Section 382. The Company has determined it will be able to utilize the entire $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;46,123&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of its pre-ownership change net operating loss carryforwards based upon the limitations calculated from the October 2019 ownership change. These carryforwards may be subject to further annual limitations under Section 382 in the event of future changes in ownership.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;ASC 740 requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of the evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. After consideration of all the evidence, both positive and negative, the Company has recorded a valuation allowance against its deferred tax assets at December 31, 2021 and 2020 because the Company&#x2019;s management has determined that it is more likely than not that the Company will &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;t recognize the benefits of its federal and state deferred tax assets primarily due to its cumulative loss position and, as a result, a valuation allowance of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;50,931&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;26,995&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; as of December 31, 2021 and 2020 has been established.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; unrecognized tax benefits. The Company has not, as yet, conducted a study of its research and development credit carryforwards. Such a study may result in an adjustment to the Company&#x2019;s research and development credit carryforwards; however, until a study is completed, and any adjustment is known, no amounts are being presented as an uncertain tax position. A full valuation allowance has been provided against the Company&#x2019;s research and development credits and, if an adjustment were required, this adjustment would be offset by an adjustment to the valuation allowance. Thus, there would be no impact to the consolidated balance sheet or consolidated statements of operations if an adjustment were required. The Company has elected to recognize interest and penalties related to income tax matters as a component of income tax expense, of which &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; interest or penalties were recorded for the years ended December 31, 2021 and 2020.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company files income tax returns in the U.S. and Massachusetts. The statute of limitations for assessment by the Internal Revenue Service and Massachusetts tax authorities remains open for all years since 2014. To the extent the Company has tax attribute carryforwards, the tax years in which the attribute was generated may still be adjusted upon examination by the Internal Revenue Service or state authorities to the extent utilized in a future period. No federal or state tax audits are currently in process.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;A reconciliation of the Company&#x2019;s pre-tax income for the years ended December 31, 2021 and 2020 is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.763%;"/&gt;
        &lt;td style="width:0.845%;"/&gt;
        &lt;td style="width:2.048%;"/&gt;
        &lt;td style="width:12.245%;"/&gt;
        &lt;td style="width:1.461%;"/&gt;
        &lt;td style="width:0.865%;"/&gt;
        &lt;td style="width:2.048%;"/&gt;
        &lt;td style="width:12.265%;"/&gt;
        &lt;td style="width:1.461%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.8pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.95pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Domestic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;84,624&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;25,744&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.95pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;732&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:13.7pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;84,671&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;26,476&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s provision at December 31, 2021 and 2020 consist of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.121%;"/&gt;
        &lt;td style="width:1.123%;"/&gt;
        &lt;td style="width:2.067%;"/&gt;
        &lt;td style="width:12.514%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
        &lt;td style="width:1.163%;"/&gt;
        &lt;td style="width:2.067%;"/&gt;
        &lt;td style="width:12.534%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.1pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.25pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Current:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.25pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&#160;&#160;&#160;&#160;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;35&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.95pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&#160;&#160;&#160;&#160;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.95pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&#160;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.25pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;35&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.25pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Deferred:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.95pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&#160;&#160;&#160;&#160;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.25pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&#160;&#160;&#160;&#160;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.95pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&#160;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.25pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total Deferred&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.25pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total provision (benefit)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;35&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;A reconciliation of the U.S. federal statutory income tax rate to the Company&#x2019;s effective income tax rate for the years ended December 31, 2021 and 2020 is as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:62.7%;"/&gt;
        &lt;td style="width:1.859%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
        &lt;td style="width:14.355%;"/&gt;
        &lt;td style="width:2.137%;"/&gt;
        &lt;td style="width:1.859%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
        &lt;td style="width:13.679%;"/&gt;
        &lt;td style="width:2.137%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;U.S federal statutory income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Permanent differences&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_ac776299-523f-419b-b2ba-1e3e866cfec3;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research and development tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Stock compensation deductions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Other items&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Change in deferred tax asset valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;28.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;40.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Effective income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_ded4314f-4db0-4f7e-8996-c64ecbefa332;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s deferred tax assets at December 31, 2021 and 2020 consist of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:62.662%;"/&gt;
        &lt;td style="width:1.038%;"/&gt;
        &lt;td style="width:2.119%;"/&gt;
        &lt;td style="width:14.105%;"/&gt;
        &lt;td style="width:1.408%;"/&gt;
        &lt;td style="width:1.038%;"/&gt;
        &lt;td style="width:2.119%;"/&gt;
        &lt;td style="width:14.105%;"/&gt;
        &lt;td style="width:1.408%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;36,590&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;17,885&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research and development tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,992&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Intangibles&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;360&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Stock compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,554&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;850&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;107&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Deferred revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,606&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;176&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;142&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Fixed assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;265&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;56&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Lease liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,269&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,285&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Right of use asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,448&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,181&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total deferred tax asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;50,931&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;26,995&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;50,931&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;26,995&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_7f631c9f-2ca8-42db-859b-91805fd36959"
      decimals="0"
      id="F_fb6860c6-26e5-4041-b257-1d100ccd406c"
      unitRef="U_USD">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_6ad987ee-9ba1-42bf-b041-260c412a34d4"
      decimals="-3"
      id="F_f2830edb-8010-46c6-808d-cdca502d9944"
      unitRef="U_USD">149071000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_cf3edb08-0022-48b3-8d33-0b7ecf23a4eb"
      decimals="-3"
      id="F_fd8bfb9c-176c-4b1b-b0d2-7de91e19c586"
      unitRef="U_USD">83467000</us-gaap:OperatingLossCarryforwards>
    <freq:NetOperatingLossCarryforwardsExpirationWithLimitation
      contextRef="C_5acfbb01-3b1d-498b-b247-28b787110380"
      decimals="-3"
      id="F_80c5406b-5db5-4788-9837-eef9bce87cbb"
      unitRef="U_USD">22399000</freq:NetOperatingLossCarryforwardsExpirationWithLimitation>
    <freq:OperatingLossCarryforwardsExpirationYear
      contextRef="C_17ed3f9d-c233-4f9d-80c1-fd64ea247cb7"
      id="F_37deb3ac-0585-461d-b5f0-eb8a9aba507b">2037</freq:OperatingLossCarryforwardsExpirationYear>
    <freq:NetOperatingLossCarryforwardsExpirationWithoutLimitation
      contextRef="C_5acfbb01-3b1d-498b-b247-28b787110380"
      decimals="-3"
      id="F_1c6a466a-38de-4640-9fdc-28b6d16c586b"
      unitRef="U_USD">126672000</freq:NetOperatingLossCarryforwardsExpirationWithoutLimitation>
    <freq:OperatingLossCarryforwardsExpirationYear
      contextRef="C_50db1a66-c934-4741-b3a2-b2969bdf7bf1"
      id="F_bf8bd597-711b-414d-ba26-53a02d983cde">2041</freq:OperatingLossCarryforwardsExpirationYear>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_e4d444fc-edc2-40cf-ab70-0c120e61141a"
      decimals="-3"
      id="F_5b3b8be2-50a3-46c3-80ce-a467af8ec261"
      unitRef="U_USD">5241000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount
      contextRef="C_7d7f8a9d-9d6d-47a1-b8ea-fd4b0fa83331"
      decimals="-3"
      id="F_c837ec00-7641-4881-8881-218b7fba343f"
      unitRef="U_USD">2071000</us-gaap:TaxCreditCarryforwardAmount>
    <freq:TaxCreditCarryforwardExpirationYear
      contextRef="C_17ed3f9d-c233-4f9d-80c1-fd64ea247cb7"
      id="F_ce368509-bd71-414f-a77b-1d28260ea6b1">2041</freq:TaxCreditCarryforwardExpirationYear>
    <freq:TaxCreditCarryforwardExpirationYear
      contextRef="C_cdbc9d91-abb1-471d-8577-f5ca0f7f45b1"
      id="F_7cd1fd74-1f0c-4ef9-86ff-5188b3a17d56">2036</freq:TaxCreditCarryforwardExpirationYear>
    <freq:PeriodOfCumulativeChangeInOwnership
      contextRef="C_50ecffe0-e791-47f3-a7b0-8430f4d7aedb"
      id="F_ea3b96b4-5fbc-4060-82d4-c67ae3222205">P3Y</freq:PeriodOfCumulativeChangeInOwnership>
    <freq:CumulativeChangeInOwnershipPercentage
      contextRef="C_ab8f2bc9-2386-4491-8d49-6ec657154d28"
      decimals="2"
      id="F_deea5bcd-c188-4a8b-960b-0a73d55b4865"
      unitRef="U_pure">0.50</freq:CumulativeChangeInOwnershipPercentage>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_31fe05e6-676e-4a62-ac60-318d537f9748"
      decimals="-3"
      id="F_7e4888e2-a41c-428a-a8ad-ffdeed55cd91"
      unitRef="U_USD">12400000</us-gaap:OperatingLossCarryforwards>
    <freq:OperatingLossCarryforwardsUsageAfterOwnershipChange
      contextRef="C_37c7af32-e4c8-439d-8648-1ffe795bcb36"
      decimals="-3"
      id="F_a25457c4-45cd-4120-a092-4fd3c9c82466"
      unitRef="U_USD">10800000</freq:OperatingLossCarryforwardsUsageAfterOwnershipChange>
    <freq:OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange
      contextRef="C_37c7af32-e4c8-439d-8648-1ffe795bcb36"
      decimals="-3"
      id="F_4c579672-c7ab-446f-9cbd-259bef2dcdb4"
      unitRef="U_USD">1600000</freq:OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange>
    <freq:OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange
      contextRef="C_37c7af32-e4c8-439d-8648-1ffe795bcb36"
      decimals="-3"
      id="F_84e6955c-683e-437b-aa98-e29d96e1a9eb"
      unitRef="U_USD">180000</freq:OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange>
    <freq:RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration
      contextRef="C_37c7af32-e4c8-439d-8648-1ffe795bcb36"
      decimals="-3"
      id="F_f820b6a4-e9f8-48bf-a1c9-469a60325800"
      unitRef="U_USD">1600000</freq:RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_86cb445a-0d20-403b-b211-6cec00f8b29a"
      decimals="-3"
      id="F_28b65280-c211-4db0-aaf3-c74e95b16f74"
      unitRef="U_USD">46123000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_86cb445a-0d20-403b-b211-6cec00f8b29a"
      decimals="-3"
      id="F_09e04eb7-ed0d-4fa2-aae1-04d2240f6096"
      unitRef="U_USD">46123000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="INF"
      id="F_d2f0a9e6-ffd3-4f03-a2d7-a00ae47f4b7b"
      unitRef="U_USD">0</us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="INF"
      id="F_4b294199-6dfc-49ba-91d3-74ee7a5a9479"
      unitRef="U_USD">0</us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_e43941c7-712d-4e22-b443-0fd809122279"
      unitRef="U_USD">50931000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_13e9dcd6-f6e0-41ac-bcef-35532011514e"
      unitRef="U_USD">26995000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="INF"
      id="F_a1aca3e4-51d3-421e-8e81-3a60db500128"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="INF"
      id="F_5656eeb1-efa9-4b82-a6e4-debcdbca9e50"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="INF"
      id="F_bf4a5c5c-4731-48b2-ab5a-65f4832c1f14"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="INF"
      id="F_77a187cc-7643-4cf2-9ed5-b20911f568d9"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_375181b1-1526-486e-94f6-1bc667e8e4c0">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;A reconciliation of the Company&#x2019;s pre-tax income for the years ended December 31, 2021 and 2020 is as follows:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.763%;"/&gt;
        &lt;td style="width:0.845%;"/&gt;
        &lt;td style="width:2.048%;"/&gt;
        &lt;td style="width:12.245%;"/&gt;
        &lt;td style="width:1.461%;"/&gt;
        &lt;td style="width:0.865%;"/&gt;
        &lt;td style="width:2.048%;"/&gt;
        &lt;td style="width:12.265%;"/&gt;
        &lt;td style="width:1.461%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.8pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.95pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Domestic&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;84,624&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;25,744&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.95pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;47&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;732&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:13.7pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;84,671&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;26,476&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_50cac8d8-d2d2-4add-a180-f8feca431565"
      unitRef="U_USD">-84624000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_99f5d9c4-2669-4216-921b-1f116b3f1893"
      unitRef="U_USD">-25744000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_4a14d562-0849-48b5-b53b-23d17275aaed"
      unitRef="U_USD">-47000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_fe32d24f-5e46-4a15-a188-a9e720da2040"
      unitRef="U_USD">-732000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_107179ad-c5f9-4e5b-b138-cd968c5e1d2c"
      unitRef="U_USD">-84671000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_34a1b62e-d0b9-49c9-a47d-0625457dc0d8"
      unitRef="U_USD">-26476000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_370a0a04-66cb-4b6c-b5d0-85d23241e0e1">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s provision at December 31, 2021 and 2020 consist of the following:&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:67.121%;"/&gt;
        &lt;td style="width:1.123%;"/&gt;
        &lt;td style="width:2.067%;"/&gt;
        &lt;td style="width:12.514%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
        &lt;td style="width:1.163%;"/&gt;
        &lt;td style="width:2.067%;"/&gt;
        &lt;td style="width:12.534%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.1pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.25pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Current:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.25pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&#160;&#160;&#160;&#160;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;35&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.95pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&#160;&#160;&#160;&#160;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.95pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&#160;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.25pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;35&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.25pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Deferred:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.95pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&#160;&#160;&#160;&#160;Federal&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.25pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&#160;&#160;&#160;&#160;State&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.95pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&#160;&#160;&#160;&#160;Foreign&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.25pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total Deferred&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:12.25pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total provision (benefit)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;35&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_4119a4f9-4841-472f-a849-eea3a48451cc"
      unitRef="U_USD">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_8bcc4802-24f3-44ef-93db-c54f3b823739"
      unitRef="U_USD">35000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_ae68fa38-e11c-4409-9088-6f8eded2f1f8"
      unitRef="U_USD">15000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_7c6bd208-e287-44a4-b3c2-366a8bb3dfd4"
      unitRef="U_USD">0</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_da111924-068d-491d-a50d-97b50ef8295d"
      unitRef="U_USD">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_9ece8b18-10bf-426e-970d-7427ad844140"
      unitRef="U_USD">0</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_37112a2f-e627-4da4-b0fc-10d8ff1fc950"
      unitRef="U_USD">15000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_71d7968a-6cec-48e9-a39b-61c8452693ac"
      unitRef="U_USD">35000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_7e2d329b-6592-4892-a3c0-b3542b492754"
      unitRef="U_USD">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_0b366ec2-5129-42c9-94e4-4f658a1bd6da"
      unitRef="U_USD">0</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_82a94f29-bd6f-4279-b6af-2cdc9487a9d2"
      unitRef="U_USD">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_36edb460-8a86-4c5e-bc70-fe4ee92188bb"
      unitRef="U_USD">0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_aa03377e-bdcf-4a8f-841e-552e03ee222c"
      unitRef="U_USD">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_cbc3008d-efa7-4416-a97e-755326fbbac3"
      unitRef="U_USD">0</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_1ff4afcb-67f9-4250-9f08-eff621586c75"
      unitRef="U_USD">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_cb8b5761-fe9b-4e08-9c33-da609cc74ebf"
      unitRef="U_USD">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_c9a359a2-51a0-480e-986b-89340cb61e3f"
      unitRef="U_USD">15000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_91aae879-e33c-49de-a6bc-95b86bcfdf61"
      unitRef="U_USD">35000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_526bfe60-50da-458b-8c6f-65638fc2c10e">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;A reconciliation of the U.S. federal statutory income tax rate to the Company&#x2019;s effective income tax rate for the years ended December 31, 2021 and 2020 is as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:62.7%;"/&gt;
        &lt;td style="width:1.859%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
        &lt;td style="width:14.355%;"/&gt;
        &lt;td style="width:2.137%;"/&gt;
        &lt;td style="width:1.859%;"/&gt;
        &lt;td style="width:0.636%;"/&gt;
        &lt;td style="width:13.679%;"/&gt;
        &lt;td style="width:2.137%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;U.S federal statutory income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;21.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Permanent differences&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_ac776299-523f-419b-b2ba-1e3e866cfec3;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3.0&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research and development tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Stock compensation deductions&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5.1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Other items&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.6&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Change in deferred tax asset valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;28.2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;40.7&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Effective income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_ded4314f-4db0-4f7e-8996-c64ecbefa332;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="3"
      id="F_e0ad9f91-486a-4cad-b1e0-5d684ba2bd16"
      unitRef="U_pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="3"
      id="F_8d6aac62-4e01-4db2-96fa-0f52c450973b"
      unitRef="U_pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="3"
      id="F_d1dc60ba-b771-4ba6-8c8c-34b53084b552"
      unitRef="U_pure">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="3"
      id="F_b908801f-71c9-48cf-921d-3dc28ea84316"
      unitRef="U_pure">0.027</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="3"
      id="F_97ec4e50-d6a3-4422-a89a-23c95097416e"
      unitRef="U_pure">0.030</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="3"
      id="F_07910f01-fd29-4752-aedf-03db657dc777"
      unitRef="U_pure">0.036</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="3"
      id="F_f0fc5011-8f51-408b-b7e2-21224505f6e4"
      unitRef="U_pure">0.112</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="3"
      id="F_b9289ea3-25e5-49bc-a494-93565e8e15d7"
      unitRef="U_pure">0.016</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="3"
      id="F_b7f19879-ec21-43ae-89e7-01b5f28d1e93"
      unitRef="U_pure">0.051</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="3"
      id="F_70f825bf-6a08-4da8-8926-ed63c0ebc5c1"
      unitRef="U_pure">-0.007</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="3"
      id="F_86978056-f6db-486d-8251-7f843621f79d"
      unitRef="U_pure">0.006</us-gaap:EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="3"
      id="F_e04e6202-926e-43bc-8def-6116038097a3"
      unitRef="U_pure">-0.282</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="3"
      id="F_aee4767f-ec46-4d76-9f6b-91e416ccacb3"
      unitRef="U_pure">-0.407</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_09defff9-d432-46af-8443-a9a7de484f45">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s deferred tax assets at December 31, 2021 and 2020 consist of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:70.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:62.662%;"/&gt;
        &lt;td style="width:1.038%;"/&gt;
        &lt;td style="width:2.119%;"/&gt;
        &lt;td style="width:14.105%;"/&gt;
        &lt;td style="width:1.408%;"/&gt;
        &lt;td style="width:1.038%;"/&gt;
        &lt;td style="width:2.119%;"/&gt;
        &lt;td style="width:14.105%;"/&gt;
        &lt;td style="width:1.408%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;36,590&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;17,885&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research and development tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,992&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Intangibles&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;392&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;360&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Stock compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,554&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;850&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;107&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Deferred revenue&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,606&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;176&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;142&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Fixed assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;265&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;56&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Lease liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,269&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,285&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Right of use asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,448&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,181&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total deferred tax asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;50,931&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;26,995&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;50,931&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;26,995&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_fb9db2cc-84b3-4fcc-a903-21a444fe132c"
      unitRef="U_USD">36590000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_bbfa134a-9dad-48ed-b3ba-3714d6bdbfa8"
      unitRef="U_USD">17885000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_295b8816-50e8-4a1a-885b-aa7dfbe61ad7"
      unitRef="U_USD">7026000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_03c4f229-ec2b-41d8-9237-fd8eedfcdfd3"
      unitRef="U_USD">3992000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_9d5eb8ca-3748-4c24-90b0-8421b437bef7"
      unitRef="U_USD">392000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_83430884-febe-4b1b-9197-d30e6a259f9d"
      unitRef="U_USD">360000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_69c9ea0d-e8a1-477e-b987-84a55e1612ac"
      unitRef="U_USD">6554000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_d8ced774-031e-4e64-8564-dccd711cae38"
      unitRef="U_USD">850000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_47a6265c-bab3-4450-be4d-467bb1b76db3"
      unitRef="U_USD">107000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsDeferredIncome
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_c2291dac-805f-4017-8cc2-061bd070ed9a"
      unitRef="U_USD">3606000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_bdd005dc-b8a4-4569-89fe-6be98a9d5dec"
      unitRef="U_USD">176000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_7e8a5577-eb67-4eca-898c-2d297bd45273"
      unitRef="U_USD">142000</us-gaap:DeferredTaxAssetsOther>
    <freq:DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_5d22bece-d58a-49ee-b026-eb0858a94957"
      unitRef="U_USD">265000</freq:DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment>
    <freq:DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_cc23a1f9-3fd2-4107-85bd-f527c9d7bf11"
      unitRef="U_USD">56000</freq:DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment>
    <freq:DeferredTaxAssetsLeasingArrangements
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_ed73ca8e-7c1b-4942-ae6c-3264ae0b0da2"
      unitRef="U_USD">7269000</freq:DeferredTaxAssetsLeasingArrangements>
    <freq:DeferredTaxAssetsLeasingArrangements
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_f2cda2dd-a43c-4b76-b150-a8c5aabd7aa5"
      unitRef="U_USD">7285000</freq:DeferredTaxAssetsLeasingArrangements>
    <freq:DeferredTaxAssetsRightOfUseAssets
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_64f36dbb-6825-434b-b13d-43ade6cf6736"
      unitRef="U_USD">7448000</freq:DeferredTaxAssetsRightOfUseAssets>
    <freq:DeferredTaxAssetsRightOfUseAssets
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_e657739f-3afc-4e61-ad04-0bf0954faa02"
      unitRef="U_USD">7181000</freq:DeferredTaxAssetsRightOfUseAssets>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_352f7def-3c8a-45f0-8f2e-67972c1c3e56"
      unitRef="U_USD">50931000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_6455aae3-21fb-4dd4-896d-1c62bbc83b06"
      unitRef="U_USD">26995000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_cd333216-8329-4a97-9ab8-62c40f07ef8a"
      unitRef="U_USD">50931000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_e361af5a-8f11-4290-a2c7-05fb7f6adae8"
      unitRef="U_USD">26995000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_f03ee966-0a7b-45bc-91e9-46f9c92f6144"
      unitRef="U_USD">0</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_d1f1074f-6f43-4d3d-a34e-c9e39be16c99"
      decimals="-3"
      id="F_e844dabb-c68a-4e67-9de7-92b44aa1bd14"
      unitRef="U_USD">0</us-gaap:DeferredTaxAssetsNet>
    <freq:ResearchAndLicenseAgreementsDisclosureTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_dd75d70e-bcd1-4f30-9fe6-0e64a96a5315">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;12. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Research and license agreements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Massachusetts Institute of Technology&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1020833333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;December 2016&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, the Company entered into an exclusive patent license agreement (MIT License Agreement), with the Massachusetts Institute of Technology, (MIT), under which the Company received an exclusive, worldwide, royalty-bearing license to certain patent rights to develop, make, have made, use, sell, offer to sell, lease and import products (Licensed Products) and to develop and perform processes (Licensed Processes) which incorporate the licensed technology for the treatment of disease, including but not limited to the prevention and remediation of hearing loss. The Company also has the right to grant sublicenses of its rights under the MIT License Agreement.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Company is required to use diligent efforts to develop and commercialize the Licensed Products or Processes, and to make such products or processes reasonably available to the public and to spend certain minimum amounts on research&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;development of Licensed Products and/or Processes each year until the first commercial sale of a Licensed Product and/or a first commercial performance of a Licensed Process. The Company is also subject to certain development obligations with regards to a first Licensed Product. The Company has satisfied certain obligations related to preclinical studies and the filing of an IND for a first Licensed Product with its development activities related to FX-322. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s future development obligations are: (i) to commence a Phase III clinical trial for such Product within five years of the IND filing for such product, (ii) to file a New Drug Application or equivalent with the FDA or comparable European regulatory agency for such Product within nine years of the IND filing for such Product, and (iii) to make a first commercial sale of such Product within 11 years of the IND filing for such Product.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; The Company also has certain development obligations for a second Licensed Product. In the event that the Company has failed to fulfill the development timeline obligation with respect to a second Licensed Product and fails to cure such breach within ninety (90) days of written notice by MIT, MIT may restrict the licensed field to the prevention and remediation of hearing loss in humans and animals. The Company does not have the right to control prosecution of the in-licensed patent applications, and its rights to enforce the in-licensed patents are subject to certain limitations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Upon entering into the MIT License Agreement, the Company paid a $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;50&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; license fee payment and issued to MIT shares of our common stock equal to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of total then-outstanding capital stock. The Company is required to pay certain annual license maintenance fees which may be credited to running royalties during the same calendar year, if any, and to make potential milestone payments up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,900&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; on each Licensed Product or Licensed Process. In addition, The Company is required to pay a low single-digit royalty on Licensed Products and Licensed Processes and a low-twenties royalty on sublicense revenues.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The MIT License Agreement will remain in effect until the expiration or abandonment of all issued patents and filed patent applications licensed thereunder remain in effect, unless terminated earlier. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has the right to terminate for any reason upon a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-month prior written notice. MIT shall have the right to terminate if the Company ceases to carry on any business related to the MIT License Agreement. MIT may terminate the MIT License Agreement for the Company&#x2019;s material breach uncured within ninety (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;90&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;) days (or thirty (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;) days in the case of nonpayment). MIT may also terminate the MIT License Agreement if the Company or our affiliates commence any action against MIT to declare or render any claim of the licensed patent rights invalid, unpatentable, unenforceable, or non-infringed (a patent challenge), or if our sublicensee commences such actions and the Company does not terminate such sublicense within thirty (30) days after MIT&#x2019;s demand. MIT has the right to increase all payments due, instead of terminating the MIT License Agreement in the case of a patent challenge. &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"/&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In May 2019, the Company entered into an amendment with MIT, updating the diligence milestones for a second Licensed Product.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In March 2022, the Company entered into an amendment with MIT, removing a patent and certain patent applications from the MIT License Agreement which were unrelated to the Company&#x2019;s hearing and MS programs and which were not being utilized by the Company.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The patents in-licensed by the Company from MIT pursuant to the MIT License claim inventions created by, among others, Dr. Langer, one of the Company&#x2019;s directors. Pursuant to MIT&#x2019;s policy on the ownership, distribution and commercial development of MIT technology, or the MIT Policy, inventors of intellectual property invented at MIT, including the inventors of patents licensed to the Company under the MIT License, are entitled to a portion of the net royalty income derived by MIT from such inventions, but not amounts received by MIT from the sale of common stock previously issued by the Company to MIT pursuant to the MIT License. Accordingly, pursuant to the MIT Policy, Dr. Langer is entitled to receive a portion of the amounts the Company pays to MIT under the MIT License, including the Astellas Royalty Payment and future milestone payments or royalties, if any, that the Company may receive pursuant to the Astellas Agreement. Accordingly, Dr. Langer has received $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,980&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; from MIT under the MIT Policy during the years ended December 31, 2021 and 2020, respectively. Refer to Note 17 for all related party disclosures.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;The Scripps Research Institute (California Institute for Biomedical Research)&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;September 2018&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, the Company entered into a license agreement, (CALIBR License Agreement), with the California Institute for Biomedical Research, (CALIBR), under which the Company received an exclusive, worldwide, royalty-bearing license to certain patent rights to make, have made, use, sell, offer to sell, and import products (CALIBR Licensed Products) which incorporate the licensed technology for the treatment of multiple sclerosis. The Company also have the right to grant sublicenses of our rights under the CALIBR License Agreement. CALIBR reserves the right to use for itself and the right to grant non-exclusive licenses to other nonprofit or academic institutions, for any internal research and educational purposes.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company is required to use commercially reasonable efforts to develop, manufacture, and sell at least one CALIBR Licensed Product. The Company is also subject to certain milestone timeline obligations, which may be extended in certain circumstances as set forth in the CALIBR License Agreement. In October 2021, the Company entered into an amendment with CALIBR which updated the milestone obligations to: (i) initiate a Phase II clinical trial (or equivalent) for a CALIBR Licensed Product by December 31, 2023 and (ii) initiate a Phase III clinical trial (or equivalent) for a CALIBR Licensed Product by December 31, 2025. EW do not have the right to control prosecution of the in-licensed patent applications , and our rights to enforce the in-licensed patents are subject to certain limitations.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Upon entering into the CALIBR License Agreement, the Company made a $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; license fee payment and are required to make milestone payments up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;26,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; for each Category of CALIBR Licensed Products (Category 1 is any CALIBR Licensed Products containing a compound that modulates any muscarinic receptor and Category 2 is any CALIBR Licensed Products not included in Category 1 that could differentiate oligodendrocyte precursor cells from &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;in vitro&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; studies and/or are active in animal models relevant to MS. The Company is also required to pay a middle single-digit royalty on CALIBR Licensed Products and a royalty on sublicense revenues ranging from low-teen percentage to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;50&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The CALIBR License Agreement shall continue in effect until expiration of all Company obligations to pay royalties. Royalties shall be payable on a country-by-country and CALIBR Licensed Product-by-CALIBR Licensed Product basis upon the later of (1) the expiration or abandonment of all valid claims of the licensed patent rights in such country and (2) ten years from the first commercial sale of each CALIBR Licensed Product. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company may terminate the CALIBR License Agreement at will upon a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-day prior written notice. The Company may also elect to terminate its license to one or more licensed patents in any or all jurisdictions by giving ninety (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;90&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;) days&#x2019; prior written notice to CALIBR. CALIBR may terminate the CALIBR License Agreement for material breach uncured within thirty (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;) days. CALIBR has the right to terminate or reduce the license to a non-exclusive license if the Company fails to use diligent efforts to develop and commercially exploit CALIBR Licensed Products. &lt;/span&gt;&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"/&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;The Scripps Research Institute&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.507%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In September 2018, the Company entered into a Research Funding and Option Agreement, or the Scripps option agreement, with Scripps (CALIBR is a division of Scripps), under which the Company provided funding to Scripps to pursue certain MS research activities on selected targets. In the same agreement, the Company was granted an exclusive option to acquire an exclusive, sublicensable, worldwide license under certain intellectual property arising from the MS research activities on the selected targets. The Scripps option agreement, including the MS research activities and the exclusive option, terminated on December 31, 2021. The CALIBR License remains active.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Massachusetts Eye and Ear (Formerly Massachusetts Eye and Ear Infirmary)&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;February 2019&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, the Company entered into an Non-Exclusive Patent License Agreement (MEE License Agreement) with the Massachusetts Eye and Ear (MEE) under which it received a non-exclusive, non-sublicensable, worldwide, royalty-bearing license to certain patent rights to develop, make, have made, use, sell, offer to sell, lease and import products and to develop and perform processes which incorporate the licensed technology for the treatment or prevention of hearing loss (MEE licensed products).&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company is obligated to use diligent efforts to develop and commercialize the MEE licensed products. The Company met one of its milestone timeline obligations by dosing a first subject in a Phase II trial by December 31, 2020. The Company is still subject to a milestone timeline obligation to dose a first subject in a Phase III trial by December 31, 2024. The Company does not control the filing, prosecution, enforcement, and defense of any licensed patent rights.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Upon entering the MEE License, the Company made a $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;20&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; license fee payment. The Company is obligated to pay certain annual license maintenance fees between $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; per each MEE patent family case number included in the licensed MEE patent rights prior to first commercial sale of an MEE licensed product. The Company is also obligated to pay a minimum annual royalty payment of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; per each MEE patent family case number included in the licensed MEE patent rights after first commercial sale of an MEE licensed product. The Company is also obligated to make milestone payments up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;350&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; on each product or process that incorporates the licensed patent rights. In addition, the Company has agreed to pay a low single-digit royalty on products and processes that incorporate the licensed patent rights.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The MEE License Agreement shall remain in effect until all issued patents and filed patent applications within the licensed patent rights have expired or been abandoned, unless terminated earlier. &lt;/span&gt;&lt;span style="font-size:12.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has the right to terminate the MEE License Agreement at will by giving thirty (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;) business days advance written notice to MEE. MEE has the right to terminate the MEE License Agreement if the Company fails to make any payment due within thirty (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;) &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;business days after &lt;/span&gt;&lt;/span&gt;&lt;span style=""/&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;MEE &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;notifies the Company of such failure. MEE shall have the right to terminate if the Company fails to maintain the required insurance. MEE shall also have the right to terminate the MEE License Agreement upon forty-five (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;45&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;) business days written notice if the Company becomes insolvent. MEE has the right to terminate for any other default not cured within sixty (&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;60&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;) business days written notice. MEE also has the right to terminate if the Company or its affiliates challenge the validity of the licensed patent rights.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Cambridge Enterprise Limited&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;December 2019&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, we entered into an Exclusive Patent License Agreement ( the &#x201c;Cambridge License&#x201d;) with Cambridge Enterprise Limited (the technology transfer arm of the University of Cambridge)&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&#x201c;Cambridge&#x201d;) under which we received an exclusive worldwide royalty-bearing license to certain patent rights to make, have made, sell, offer to sell and import products, or the (the &#x201c;Cambridge License Product&#x201d;) which incorporate licensed technology for the treatment of demyelinating diseases. We also have the right to grant sublicenses under the Cambridge License. Cambridge reserves the right to use for itself (as well as for the inventors and the funder) to grant nonexclusive licenses to other academic institutions for any academic publication, research and teaching and clinical patient care.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;  &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has agreed to use diligent and good faith efforts to develop and commercially exploit at least one Cambridge Licensed Product.  Upon entering into the Cambridge License, the Company made a $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;50&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; license fee payment.  The Company is obligated to pay an annual license fee of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;50&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. The Company is also obligated to make milestone payments up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10,500&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; on each Cambridge License Product.  In addition, the Company has agreed to pay a low single-digit royalty on products that incorporate the licensed patent rights, subject to offset in certain circumstances.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Cambridge License continues in effect on a country-by-country basis until the expiration or revocation, without right of further appeal, of all licensed issued patents and filed patent applications, unless terminated earlier.  &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;We have the right to terminate for any reason upon &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;90 &lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;days&#x2019; prior to written notice.  Each party has the right to terminate immediately if the other party ceases to carry on its business.  Either party may also terminate the Cambridge License for material breach if such breach remains uncured for &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;30&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; days.  Cambridge may also terminate the Cambridge License if we fail to diligently develop and commercially exploit at least one Cambridge Licensed Product or we or our affiliates or sub-licenses commence any action against Cambridge to declare or render any claim of the licensed patent rights invalid, unpatentable, unenforceable, or not infringed.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Department of Defense&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In June 2018, the Company received a grant (the Grant) from the Department of Defense (DoD) under which the Company is receiving funding to further the Company&#x2019;s research and development of a therapeutic drug to treat hearing loss. The Company received funding of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,596&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; over &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;two years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; from the date of the Grant. The Company has determined that the DoD is not considered a customer under ASC 606, therefore funding received from the DoD under the Grant is recorded as a reduction of research and development expenses. The Company has recorded $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;323&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; as a reduction in research and development expenses for the year ended December 31, 2020. No funding was received in 2021.&lt;/span&gt;&lt;/p&gt;</freq:ResearchAndLicenseAgreementsDisclosureTextBlock>
    <freq:LicenseAgreementEnteredDate
      contextRef="C_ff34e46d-05f9-400b-970a-b5976aa47ab4"
      id="F_15b9f7b7-e649-4996-a133-b39661f23b13">2016-12</freq:LicenseAgreementEnteredDate>
    <freq:DescriptionOfFutureDevelopmentObligations
      contextRef="C_becb1019-1881-4f79-9f76-55c0d3336ef7"
      id="F_71073a87-b1dd-44ed-afc5-745afb4f297e">The Company&#x2019;s future development obligations are: (i) to commence a Phase III clinical trial for such Product within five years of the IND filing for such product, (ii) to file a New Drug Application or equivalent with the FDA or comparable European regulatory agency for such Product within nine years of the IND filing for such Product, and (iii) to make a first commercial sale of such Product within 11 years of the IND filing for such Product.</freq:DescriptionOfFutureDevelopmentObligations>
    <freq:LicenseFeePayment
      contextRef="C_d5705e72-9931-4ce1-ae42-4f74ee48fe5f"
      decimals="-3"
      id="F_1bb447cf-5e05-4256-976a-fe2fcac9078b"
      unitRef="U_USD">50000</freq:LicenseFeePayment>
    <freq:PercentageOfSharesOfCommonStockIssued
      contextRef="C_3248f726-ed7b-4ffd-ae3b-b39e2f79d1c2"
      decimals="2"
      id="F_3c639aa7-3542-4481-b2df-760b9257d62c"
      unitRef="U_pure">0.05</freq:PercentageOfSharesOfCommonStockIssued>
    <freq:MilestonePayments
      contextRef="C_6cb0fef5-08a6-44b1-8683-04aaee45ba50"
      decimals="-3"
      id="F_7315a657-a702-40c3-a2d0-097bc00597ae"
      unitRef="U_USD">2900000</freq:MilestonePayments>
    <freq:DescriptionOfConditionsToTerminateLicenseAgreement
      contextRef="C_becb1019-1881-4f79-9f76-55c0d3336ef7"
      id="F_b8d78c6f-c4fc-4a88-91c6-0b3b08113c69">The Company has the right to terminate for any reason upon a 3-month prior written notice. MIT shall have the right to terminate if the Company ceases to carry on any business related to the MIT License Agreement. MIT may terminate the MIT License Agreement for the Company&#x2019;s material breach uncured within ninety (90) days (or thirty (30) days in the case of nonpayment). MIT may also terminate the MIT License Agreement if the Company or our affiliates commence any action against MIT to declare or render any claim of the licensed patent rights invalid, unpatentable, unenforceable, or non-infringed (a patent challenge), or if our sublicensee commences such actions and the Company does not terminate such sublicense within thirty (30) days after MIT&#x2019;s demand. MIT has the right to increase all payments due, instead of terminating the MIT License Agreement in the case of a patent challenge. </freq:DescriptionOfConditionsToTerminateLicenseAgreement>
    <freq:RightToTerminateAgreementUponPriorWrittenNotice
      contextRef="C_3248f726-ed7b-4ffd-ae3b-b39e2f79d1c2"
      id="F_84b5634e-70d9-4ee8-93fd-dcf3f4a83d0c">P3M</freq:RightToTerminateAgreementUponPriorWrittenNotice>
    <freq:RightToTerminateAgreementIfBreachRemainsUncured
      contextRef="C_3248f726-ed7b-4ffd-ae3b-b39e2f79d1c2"
      id="F_4ceb3e6a-dd25-4c16-a977-50ee3e041c1a">P90D</freq:RightToTerminateAgreementIfBreachRemainsUncured>
    <freq:RightToTerminateAgreementIncaseOfNonpayment
      contextRef="C_3248f726-ed7b-4ffd-ae3b-b39e2f79d1c2"
      id="F_eb4084c8-59a0-4842-badd-c05317ae6e62">P30D</freq:RightToTerminateAgreementIncaseOfNonpayment>
    <us-gaap:PaymentForManagementFee
      contextRef="C_8547fe2d-e68e-4291-9f90-da18d274d639"
      decimals="-3"
      id="F_f84e7f25-0f43-49ab-80d9-936de098e075"
      unitRef="U_USD">6000</us-gaap:PaymentForManagementFee>
    <us-gaap:PaymentForManagementFee
      contextRef="C_e07d7cda-060f-41bc-aed2-892bed256b7c"
      decimals="-3"
      id="F_a4e844f8-f598-41b4-bd15-586e536f979d"
      unitRef="U_USD">1980000</us-gaap:PaymentForManagementFee>
    <freq:LicenseAgreementEnteredDate
      contextRef="C_78fdf8df-07e6-446d-b5a9-2f520f345e58"
      id="F_954bf8c3-7fd9-4308-aea4-2dd1957bb283">2018-09</freq:LicenseAgreementEnteredDate>
    <freq:LicenseFeePayment
      contextRef="C_06abad24-e21e-42ba-b771-10d1643ab3f6"
      decimals="-3"
      id="F_74daccbe-e076-46e6-9c85-e0eda142644a"
      unitRef="U_USD">1000000</freq:LicenseFeePayment>
    <freq:MilestonePayments
      contextRef="C_b9d233e8-2d05-48fa-b3db-72146492d1a0"
      decimals="-3"
      id="F_52cfa723-ac96-46ab-873b-c46c196c2583"
      unitRef="U_USD">26000000</freq:MilestonePayments>
    <freq:PercentageOfRoyaltyOnSublicenseRevenue
      contextRef="C_5f444349-7223-41bf-bdbf-3c460376bd0e"
      decimals="2"
      id="F_605696d5-36d1-43b0-9962-f2321ec1d50a"
      unitRef="U_pure">0.50</freq:PercentageOfRoyaltyOnSublicenseRevenue>
    <freq:DescriptionOfConditionsToTerminateLicenseAgreement
      contextRef="C_774fe501-efdb-4b83-b9f8-19875ffb2b41"
      id="F_0ea1f81c-39de-4c09-87f2-160d4d316171">The Company may terminate the CALIBR License Agreement at will upon a 30-day prior written notice. The Company may also elect to terminate its license to one or more licensed patents in any or all jurisdictions by giving ninety (90) days&#x2019; prior written notice to CALIBR. CALIBR may terminate the CALIBR License Agreement for material breach uncured within thirty (30) days. CALIBR has the right to terminate or reduce the license to a non-exclusive license if the Company fails to use diligent efforts to develop and commercially exploit CALIBR Licensed Products. </freq:DescriptionOfConditionsToTerminateLicenseAgreement>
    <freq:RightToTerminateAgreementUponPriorWrittenNotice
      contextRef="C_5f444349-7223-41bf-bdbf-3c460376bd0e"
      id="F_0bc47b99-5359-4138-a548-190fc5ab9297">P30D</freq:RightToTerminateAgreementUponPriorWrittenNotice>
    <freq:RightToTerminateLicensedPatentsUponPriorWrittenNotice
      contextRef="C_5f444349-7223-41bf-bdbf-3c460376bd0e"
      id="F_46c12aef-3e2d-44eb-9402-f9ab3caa0e43">P90D</freq:RightToTerminateLicensedPatentsUponPriorWrittenNotice>
    <freq:RightToTerminateAgreementIfBreachRemainsUncured
      contextRef="C_5f444349-7223-41bf-bdbf-3c460376bd0e"
      id="F_8ee451cb-1e4c-4e82-90b7-3444e6b3f863">P30D</freq:RightToTerminateAgreementIfBreachRemainsUncured>
    <freq:LicenseAgreementEnteredDate
      contextRef="C_227c25ee-a3e6-4434-8f48-824b730e370e"
      id="F_865f20b2-54ef-4182-9702-58dc91c7440d">2019-02</freq:LicenseAgreementEnteredDate>
    <freq:LicenseFeePayment
      contextRef="C_a6c92f46-0d7d-45d4-8e0d-11c1797e8585"
      decimals="-3"
      id="F_55e50018-c773-4be3-890d-383cfbfe683d"
      unitRef="U_USD">20000</freq:LicenseFeePayment>
    <freq:AnnualLicenseFeePerShare
      contextRef="C_46cac2fb-9412-44da-9032-89c8b384ae1e"
      decimals="0"
      id="F_e04db82d-b579-4eba-9169-0d86530cc3e7"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">5</freq:AnnualLicenseFeePerShare>
    <freq:AnnualLicenseFeePerShare
      contextRef="C_7b227e56-bafa-4e07-a541-a4c468281188"
      decimals="1"
      id="F_87f75518-c76c-4c93-8825-d28b3f1b337a"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">7.5</freq:AnnualLicenseFeePerShare>
    <freq:RoyaltyExpensePerShare
      contextRef="C_46cac2fb-9412-44da-9032-89c8b384ae1e"
      decimals="0"
      id="F_0f98cb15-1310-4f63-99fb-cbc139bb5c12"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">15</freq:RoyaltyExpensePerShare>
    <freq:MilestonePayments
      contextRef="C_3b0f514e-4e02-4094-a8b5-6f2ea6aca5d4"
      decimals="-3"
      id="F_5e4681a9-b0e4-4e85-beb8-e0dfb9b0ddd8"
      unitRef="U_USD">350000</freq:MilestonePayments>
    <freq:DescriptionOfConditionsToTerminateLicenseAgreement
      contextRef="C_c58972d9-4eff-40b9-999f-af1bc8c7e65c"
      id="F_d4e45847-8cb6-4c29-b299-9e48306e23d2">The Company has the right to terminate the MEE License Agreement at will by giving thirty (30) business days advance written notice to MEE. MEE has the right to terminate the MEE License Agreement if the Company fails to make any payment due within thirty (30) business days after MEE notifies the Company of such failure. MEE shall have the right to terminate if the Company fails to maintain the required insurance. MEE shall also have the right to terminate the MEE License Agreement upon forty-five (45) business days written notice if the Company becomes insolvent. MEE has the right to terminate for any other default not cured within sixty (60) business days written notice. MEE also has the right to terminate if the Company or its affiliates challenge the validity of the licensed patent rights. </freq:DescriptionOfConditionsToTerminateLicenseAgreement>
    <freq:RightToTerminateAgreementUponPriorWrittenNotice
      contextRef="C_2f466342-40f3-44b7-934b-9ce9617ba401"
      id="F_25194614-695b-4733-8293-7978381fdda8">P30D</freq:RightToTerminateAgreementUponPriorWrittenNotice>
    <freq:RightToTerminateAgreementIncaseOfNonpayment
      contextRef="C_2f466342-40f3-44b7-934b-9ce9617ba401"
      id="F_d2ed6d57-a3b3-468b-bd43-81d311b95e15">P30D</freq:RightToTerminateAgreementIncaseOfNonpayment>
    <freq:RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent
      contextRef="C_2f466342-40f3-44b7-934b-9ce9617ba401"
      id="F_4f91d6a8-5351-4f47-baba-31c56f472bd2">P45D</freq:RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent>
    <freq:RightToTerminateAgreementIfBreachRemainsUncured
      contextRef="C_2f466342-40f3-44b7-934b-9ce9617ba401"
      id="F_0bddc65d-f08c-47dc-96a4-50a982998c63">P60D</freq:RightToTerminateAgreementIfBreachRemainsUncured>
    <freq:LicenseAgreementEnteredDate
      contextRef="C_5bbe5741-fe10-4417-b986-c463fe4c347d"
      id="F_d2b38462-b7e0-497f-ab0b-68ae01045d75">2019-12</freq:LicenseAgreementEnteredDate>
    <freq:LicenseFeePayment
      contextRef="C_659cc924-ac55-436f-91ee-94a2aaf8f068"
      decimals="-3"
      id="F_e6fc5587-de4e-4a07-9560-5cedb40d3bd3"
      unitRef="U_USD">50000</freq:LicenseFeePayment>
    <freq:AnnualLicenseFee
      contextRef="C_2ae98e31-ab5c-4c24-810c-110edeacf851"
      decimals="-3"
      id="F_548d458f-dfbf-4e5e-8f3a-72ed8afef12f"
      unitRef="U_USD">50000</freq:AnnualLicenseFee>
    <freq:MilestonePayments
      contextRef="C_9a711a28-f230-4980-b126-e2e78357768d"
      decimals="-3"
      id="F_6beb44b4-5d37-49ef-9602-3aada312f326"
      unitRef="U_USD">10500000</freq:MilestonePayments>
    <freq:DescriptionOfConditionsToTerminateLicenseAgreement
      contextRef="C_639ebc28-c88b-4d67-a3ae-091fbf1f8c30"
      id="F_33a96e7b-9b8e-4f9d-8dae-495c1c4ea5ac">We have the right to terminate for any reason upon 90 days&#x2019; prior to written notice.  Each party has the right to terminate immediately if the other party ceases to carry on its business.  Either party may also terminate the Cambridge License for material breach if such breach remains uncured for 30 days.  Cambridge may also terminate the Cambridge License if we fail to diligently develop and commercially exploit at least one Cambridge Licensed Product or we or our affiliates or sub-licenses commence any action against Cambridge to declare or render any claim of the licensed patent rights invalid, unpatentable, unenforceable, or not infringed.</freq:DescriptionOfConditionsToTerminateLicenseAgreement>
    <freq:RightToTerminateAgreementUponPriorWrittenNotice
      contextRef="C_2ae98e31-ab5c-4c24-810c-110edeacf851"
      id="F_404ee546-9cac-46a8-83c8-db1680be8c75">P90D</freq:RightToTerminateAgreementUponPriorWrittenNotice>
    <freq:RightToTerminateAgreementIfBreachRemainsUncured
      contextRef="C_2ae98e31-ab5c-4c24-810c-110edeacf851"
      id="F_b219720b-1866-418a-aae2-bc3b637bac9e">P30D</freq:RightToTerminateAgreementIfBreachRemainsUncured>
    <freq:AmountOfFundingReceivedAsGrant
      contextRef="C_962eb6f1-dfe5-4536-a514-2f4945f570af"
      decimals="-3"
      id="F_c3b05cd7-c117-4c35-b9a9-7a042044c07e"
      unitRef="U_USD">1596000</freq:AmountOfFundingReceivedAsGrant>
    <freq:GrantTermPeriod
      contextRef="C_962eb6f1-dfe5-4536-a514-2f4945f570af"
      id="F_cab74745-5e22-4ef9-9c85-011cbf49b9c5">P2Y</freq:GrantTermPeriod>
    <freq:IncreaseDecreaseInResearchAndDevelopmentExpense
      contextRef="C_aef0c60c-efa8-489b-aeea-79457818c6d2"
      decimals="-3"
      id="F_890c8b32-860c-482d-917a-f6f80044cd64"
      unitRef="U_USD">323000</freq:IncreaseDecreaseInResearchAndDevelopmentExpense>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_50e7bd4b-2c26-4079-a7aa-0f66ac2852d1">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;13.&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; Collaboration agreement&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In July 2019, the Company entered into a License and Collaboration Agreement with Astellas (the &#x201c;Astellas Agreement&#x201d;), under which the Company granted Astellas an exclusive, royalty-bearing, sub-licensable, nontransferable license to certain patent rights to research, develop, manufacture, have manufactured, use, seek and secure regulatory approval for, commercialize, offer for sale, sell, have sold and import, and otherwise exploit licensed products containing both a GSK-3 inhibitor and an HDAC inhibitor, (the &#x201c;Astellas Licensed Products&#x201d;), including the product candidate FX-322, outside of the United States. The Company also granted Astellas a right of first negotiation and a right of last refusal if it entered into any negotiation or agreement of any kind (other than an acquisition of all of the stock or assets of the Company) with any third party under which such third party would obtain the right to develop, manufacture, or commercialize Astellas Licensed Products in the United States.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;These parties have agreed to use commercially reasonable efforts to carry out development activities assigned to it under an agreed-upon development plan. Astellas has agreed to use commercially reasonable efforts to obtain regulatory approval for at least one Astellas Licensed Product in sensorineural hearing loss and in age-related hearing loss, in each case, in one major Asian country and one major European country. The Company has agreed to use commercially reasonable efforts to obtain regulatory approval for at least one Astellas Licensed Product in the United States. Astellas has the sole right to commercialize the Astellas Licensed Products outside of the United States, and the Company has the sole right to commercialize the Astellas Licensed Products in the United States. Astellas has agreed to use commercially reasonable&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;efforts to commercialize Astellas Licensed Products in a major Asian country and a major European country following receipt of regulatory approval in such countries.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The collaboration is governed by a joint steering committee (&#x201c;JSC&#x201d;) established under the Astellas Agreement and shall be comprised of three representatives each from the Company and Astellas. The JSC shall oversee and coordinate the overall conduct of the development, manufacture and commercialization of the Astellas Licensed Products. All decisions of JSC shall be taken through a unanimous vote with each party&#x2019;s representatives collectively having one vote. Both the parties shall be responsible for carrying out the development and manufacturing activities in their defined territory in accordance with the plan as reviewed and approved in the JSC.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;   &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As consideration for the licensed rights under the Astellas Agreement, Astellas paid the Company an upfront payment of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;80,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; in July 2019 and has agreed to pay potential development milestone payments up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;230,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and commercialization milestones of up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;315,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. Specifically, the Company would receive development milestone payments of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;65,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;25,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; upon the first dosing of a subject in a Phase 2b clinical trial for SNHL in Europe and Asia, respectively and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;100,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;40,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; upon the first dosing of a subject in a Phase 3 clinical trial for SNHL in Europe and Asia, respectively. If the Astellas Licensed Products are successfully commercialized, the Company would be eligible for up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;315,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; in potential commercial milestone payments and also tiered royalties at rates ranging from low- to mid-teen percentages. The parties shall share equally, on a 50/50 basis, all out-of-pocket costs and joint study costs for all the joint activities conducted pursuant to the development plans or the joint manufacturing plan.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Astellas Agreement remains in effect until the expiration of all royalty obligations. Royalties are paid on a licensed product-by-licensed product and country-by-country basis until the latest of (i) the expiration of the last valid claim in the licensed patent rights with respect to such Astellas Licensed Product in such country or (ii) a set number of years from the first commercial sale of such Astellas Licensed Product in such country. Astellas may terminate the Astellas Agreement at will upon &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;60&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; days&#x2019; written notice. Each party has the right to terminate the Astellas Agreement due to the other party&#x2019;s material breach if such breach remains uncured for &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;90&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; days (or &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;45&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; days in the case of nonpayment) or if the other party becomes bankrupt.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Astellas Agreement is a collaborative agreement that is within the scope of ASC 808. The Company analyzed the joint research and development activities to assess whether they fall within the scope of ASC 808, and will reassess this throughout the life of the arrangement based on changes in the roles and responsibilities of the parties. Based on the terms of the arrangement as outlined above, both parties are deemed to be active participants in the collaboration. Both parties are performing research and development activities in their defined territory and will be performing joint clinical studies in accordance with the development plan and the study protocol approved by the JSC. Additionally, Astellas and the Company are exposed to significant risks and rewards dependent on the commercial success of any product candidates that may result from the collaboration. As such, the collaboration arrangement is deemed to be within the scope of ASC 808.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The arrangement consists of two components; the license of IP and the research and development activities, including committee participation, to support the co-development and research plan. Under the provisions of ASC 808, the Company has determined that it will apply the guidance in ASC 606 to recognize the revenue related to the license since that component of the arrangement is more reflective of a vendor-customer relationship. The Company determined that the license and the related research and development services associated with the Phase 2a clinical study were not distinct from one another, as the license has limited value to Astellas without the performance of the research and development activities and the Phase 2a study is essential to the use of the license. As such, the Company determined that these activities should be accounted for as a single combined performance obligation.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Revenue associated with this single performance obligation was recognized as the research and development work was performed, using an input method on the basis of research and development costs incurred to date relative to total research and development costs expected to be incurred. The transfer of control occurred over this time period and, in management&#x2019;s judgment, is the best measure of progress towards satisfying the performance obligation. The Company determined that the period of performance of the research and development services began upon the signing of the Astellas Agreement and continued until the completion of the Phase 2a clinical trial of FX-322 (FX-322-202). The transaction price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;80,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; was allocated to the single combined performance obligation and recognized over such period. The completion date of the Phase 2a clinical trial (FX-322-202) and the total research and development costs incurred in performing the trial was June 30, 2021. As such, the Company recognized the $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;80,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; upfront fee as revenue over the period from July 2019 until June 30, 2021, the completion date of the Phase 2a clinical trial (FX-322-202), using the input method.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;80,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; upfront &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;payment received from Astellas in July 2019 was initially recorded as deferred revenue and was recognized as revenue according to the policy described above. As of June 30, 2021, the Company completed its performance&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;obligation &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;with respect to the upfront payment and, accordingly, recognized all remaining revenue related to the Astellas Agreement.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The potential development and regulatory milestone payments are fully constrained until the Company can conclude that achievement of the milestone is probable and that it is probable that recognition of revenue related to the milestone will not result in a significant reversal in the amount of cumulative revenue recognized when the uncertainty associated with the variable consideration is ultimately resolved and as such these have been excluded from the transaction price. As part of its evaluation of the constraint, the Company considers numerous factors, including the fact that achievement of the milestones is outside the control of the Company and contingent upon the future success of clinical trials, the licensee&#x2019;s efforts, and the receipt of regulatory approval. Any consideration related to sales-based milestones (including royalties) will be recognized when the related sales occur as these amounts have been determined to relate predominantly to the license granted to Astellas and therefore are recognized at the later of when the performance obligation is satisfied, or the related sales of licensed products occur. The Company re-evaluates the transaction price, including its estimated variable consideration included in the transaction price and all constrained amounts, at each reporting period and as uncertain events are resolved or other changes in circumstances occur, and, if necessary, adjusts its estimate of the overall transaction price. Any such adjustments are recorded on a cumulative catch-up basis, which would affect revenues and earnings in the period of adjustment.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Astellas Agreement contains joint research and development activities that are not within the scope of ASC 606. The Company will recognize research and development expense related to the joint study costs for all the joint activities in future periods and reimbursements received from Astellas will be recognized as an offset to research and development expense on the consolidated statements of operations during the development period. In the year ended December 31, 2021 and 2020, the Company invoiced Astellas $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;885&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,046&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; for joint costs.&lt;/span&gt;&lt;/p&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:ProceedsFromCollaborators
      contextRef="C_81406c60-6425-4fce-9724-dd646af7f352"
      decimals="-3"
      id="F_8c085539-d6a6-40c7-aa98-b7cce08f666d"
      unitRef="U_USD">80000000</us-gaap:ProceedsFromCollaborators>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_5d72a168-259a-44dd-9d7b-8058d6b3899a"
      decimals="-3"
      id="F_a33f62cd-921f-4ffa-824f-02002a2e2a46"
      unitRef="U_USD">230000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <freq:ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones
      contextRef="C_5d72a168-259a-44dd-9d7b-8058d6b3899a"
      decimals="-3"
      id="F_155359ea-0f82-400d-8461-22a7e77b99c0"
      unitRef="U_USD">315000000</freq:ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_d4edc7de-0885-4db2-96f1-84fc825e4ca5"
      decimals="-3"
      id="F_9d3b8ac6-f9d8-403b-b18f-4e6b25a11b27"
      unitRef="U_USD">65000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_e468091a-59de-4c2e-9cae-c71034b0d9a8"
      decimals="-3"
      id="F_1b9f7d54-8260-452f-9a9e-390e480fcfde"
      unitRef="U_USD">25000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_f644c8ed-481c-4510-a475-3d938a78a2e1"
      decimals="-3"
      id="F_90fa7659-83c3-4a52-97ee-1d235a257202"
      unitRef="U_USD">100000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="C_27210ea1-a4d8-4337-a254-d92c29bebf12"
      decimals="-3"
      id="F_25eadf7f-9b4c-427a-8865-5c1590a1a0cc"
      unitRef="U_USD">40000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <freq:RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization
      contextRef="C_5d72a168-259a-44dd-9d7b-8058d6b3899a"
      decimals="-3"
      id="F_124ee2f3-7489-41f8-9197-e6c1ff482274"
      unitRef="U_USD">315000000</freq:RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization>
    <freq:AgreementTerminationNoticePeriod
      contextRef="C_81406c60-6425-4fce-9724-dd646af7f352"
      id="F_65b0d9db-1534-4b1b-aa72-290bb59bfc3f">P60D</freq:AgreementTerminationNoticePeriod>
    <freq:RightToTerminateAgreementIfBreachRemainsUncured
      contextRef="C_81406c60-6425-4fce-9724-dd646af7f352"
      id="F_157ebaa6-aacc-4ba2-b552-409dedca78ba">P90D</freq:RightToTerminateAgreementIfBreachRemainsUncured>
    <freq:RightToTerminateAgreementIncaseOfNonpayment
      contextRef="C_81406c60-6425-4fce-9724-dd646af7f352"
      id="F_48ef3fbf-3639-4ab6-a145-94aed14104e0">P45D</freq:RightToTerminateAgreementIncaseOfNonpayment>
    <freq:RevenueRecognitionTransactionPrice
      contextRef="C_7a257f5b-ab22-4c07-8bef-38a92a6dc698"
      decimals="-3"
      id="F_aef02f0f-e64a-40f6-a92f-ab2e2f5ef218"
      unitRef="U_USD">80000000</freq:RevenueRecognitionTransactionPrice>
    <freq:UpfrontFeeRecognizedAsRevenue
      contextRef="C_602a4133-255d-4026-bf0c-6e87837e587b"
      decimals="-3"
      id="F_438ae4a3-be18-4765-930a-b19fe2b4b340"
      unitRef="U_USD">80000000</freq:UpfrontFeeRecognizedAsRevenue>
    <freq:UpfrontFeeRecognizedAsRevenue
      contextRef="C_7a257f5b-ab22-4c07-8bef-38a92a6dc698"
      decimals="-3"
      id="F_aa47cc81-d2f7-4172-bd7c-e2a22940ca88"
      unitRef="U_USD">80000000</freq:UpfrontFeeRecognizedAsRevenue>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_7a257f5b-ab22-4c07-8bef-38a92a6dc698"
      decimals="-3"
      id="F_ee3086ba-da65-420a-9926-4538b12387dd"
      unitRef="U_USD">885000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_36d6826a-c031-4794-9b6c-6a3f3d257de7"
      decimals="-3"
      id="F_65020f0a-de41-40ff-8ae4-065129c194d3"
      unitRef="U_USD">1046000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_6c2bfdd3-2b05-47a8-86e0-92e7b8f97588">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;14. Leases&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In 2016, the Company entered into a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;five-year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; operating lease for the Company&#x2019;s primary office and laboratory space in Woburn, Massachusetts. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;November 2019&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, this lease was amended to add additional laboratory and office space as well as extend the termination date for all spaces to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_ed329d69-2529-48fa-9178-d9e728957db7;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;February 2025&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; The lease and amendment do not contain any material residual value guarantees or material restrictive covenants.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"&gt;  &lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On December 11, 2020, the Company entered into an Agreement for Termination of Lease and Voluntary Surrender of Premises (the &#x201c;Lease Termination Agreement&#x201d;) with ARE-MA Region No. 20, LLC (the &#x201c;Landlord&#x201d;). The Lease Termination Agreement provides that the Lease Agreement, dated as of August 14, 2016, by and between the Company and Landlord (as the same may have been amended, the &#x201c;Lease&#x201d;) will terminate on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;March 31, 2021&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, unless the Company elects to extend the term of the Lease. The Company exercised the option to extend the lease until May 31, 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As consideration for the Landlord&#x2019;s agreement to enter into the Lease Termination Agreement and accelerate the expiration date of the term of the Lease, the Company has agreed to pay to Landlord a fee of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;200&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On January 7, 2020 the Company entered into an indenture of lease (the &#x201c;Lexington Lease&#x201d;) with HCP/KING 75 Hayden LLC, for the lease of approximately &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;61,307&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; square feet of rentable area in Lexington, Massachusetts or (the &#x201c;Lexington Premises&#x201d;).  The Lexington Lease commenced on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;December 11, 2020&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. In the second quarter of 2021, the Company began using the Lexington Premises as its principal executive offices and laboratory for research and development. The term of the Lexington Lease is expected to end on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;May 31, 2031&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. The Company also has the option to extend the Initial Term for &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;two&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; additional terms of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;five years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; each.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company continues to lease a small office space in Connecticut.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company's rent expense for the years ended December 31, 2021 and 2020 was $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,960&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;835&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:77.097%;"/&gt;
        &lt;td style="width:1.67%;"/&gt;
        &lt;td style="width:0.805%;"/&gt;
        &lt;td style="width:18.28%;"/&gt;
        &lt;td style="width:2.147%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Other information&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted-average remaining operating lease term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.4&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The table below reconciles the undiscounted cash flows to the operating lease liability recorded on the consolidated balance sheet as of December 31, 2021.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:77.452%;"/&gt;
        &lt;td style="width:1.833%;"/&gt;
        &lt;td style="width:1.278%;"/&gt;
        &lt;td style="width:18.457%;"/&gt;
        &lt;td style="width:0.981%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,159&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,284&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,412&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,545&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,681&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;22,389&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total minimum lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;44,470&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Less: amount of lease payments representing interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;13,872&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Present value of future lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;30,598&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Less: current lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,747&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Noncurrent lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;28,851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:11.0pt;font-family:Calibri;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Future aggregate minimum payments under the noncancelable operating leases and short term leases, including the Lexington, MA lease and Connecticut lease, which is not subject to ASC 842, as of December 31, 2021 are as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:76.935%;"/&gt;
        &lt;td style="width:1.653%;"/&gt;
        &lt;td style="width:2.133%;"/&gt;
        &lt;td style="width:17.956%;"/&gt;
        &lt;td style="width:0.248%;"/&gt;
        &lt;td style="width:1.075%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,161&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,284&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,412&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,545&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,681&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2027 and beyond&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;22,388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total minimum lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;44,471&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_c1ca8ce4-5cf1-421c-b2f3-843fbb4b6877"
      id="F_ee19634b-c63c-48dc-a928-09d1020663a7">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseOptionToExtend
      contextRef="C_815714a9-1c63-462b-be7a-be127a4674d0"
      id="F_17e9e704-8a77-4947-8982-8a0e7b4879f7">In November 2019, this lease was amended to add additional laboratory and office space as well as extend the termination date for all spaces to February 2025.</us-gaap:LesseeOperatingLeaseOptionToExtend>
    <freq:OperatingLeaseAgreementAmendedDate
      contextRef="C_815714a9-1c63-462b-be7a-be127a4674d0"
      id="F_58b58484-0cb6-401c-9b57-c4a37abaf9fe">2019-11</freq:OperatingLeaseAgreementAmendedDate>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_0342be7e-519c-43c8-ab77-ca720271c910"
      id="F_9d84a3c7-6f43-49ce-b024-4e4e4fe355d4">2021-03-31</us-gaap:LeaseExpirationDate1>
    <freq:OperatingLeaseTerminationFee
      contextRef="C_fcb1bda2-b216-4764-a4c2-09a3d13f32ac"
      decimals="-3"
      id="F_93149a81-7ee7-4150-807b-a195c994e351"
      unitRef="U_USD">200000</freq:OperatingLeaseTerminationFee>
    <us-gaap:NetRentableArea
      contextRef="C_1ffc57b1-4997-466a-89cb-19ba9650731e"
      decimals="INF"
      id="F_aad6aab7-d2ba-46c1-bb7f-d5e3200cbf28"
      unitRef="U_sqft">61307</us-gaap:NetRentableArea>
    <freq:OperatingLeaseCommencementDate
      contextRef="C_9ee00bb1-b451-49aa-8278-506702da2a88"
      id="F_1328e47b-3323-43d7-8174-15e0dc40283b">2020-12-11</freq:OperatingLeaseCommencementDate>
    <us-gaap:LeaseExpirationDate1
      contextRef="C_9ee00bb1-b451-49aa-8278-506702da2a88"
      id="F_bc2599dc-3d2a-40c2-9bc6-b62b3a784af9">2031-05-31</us-gaap:LeaseExpirationDate1>
    <freq:OperatingLeaseNumberOfAdditionalExtensionTerms
      contextRef="C_1ffc57b1-4997-466a-89cb-19ba9650731e"
      decimals="INF"
      id="F_727c4c5b-9d29-4fc9-92e5-d971ca412152"
      unitRef="U_Term">2</freq:OperatingLeaseNumberOfAdditionalExtensionTerms>
    <freq:OperatingLeasesAdditionalExtensionTerm
      contextRef="C_9ee00bb1-b451-49aa-8278-506702da2a88"
      id="F_38c69f58-422b-4ae2-92aa-70d7144cfd77">P5Y</freq:OperatingLeasesAdditionalExtensionTerm>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_972493fd-024c-4439-bb5b-ccc0404a111c"
      unitRef="U_USD">4960000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_33d1264b-942d-4f03-8eca-c78a9e6b6f1f"
      unitRef="U_USD">835000</us-gaap:OperatingLeaseExpense>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_dbcd4ac2-4582-47ac-98ff-957c6ab7532a">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:77.097%;"/&gt;
        &lt;td style="width:1.67%;"/&gt;
        &lt;td style="width:0.805%;"/&gt;
        &lt;td style="width:18.28%;"/&gt;
        &lt;td style="width:2.147%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Other information&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted-average remaining operating lease term&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.4&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8.5&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      id="F_07f7a25e-4ed7-4cf8-ad11-1e707e4debd1">P9Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="3"
      id="F_3d56b245-ff5d-4daa-99e8-89c9500d2ade"
      unitRef="U_pure">0.085</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_29e1cfd5-5e4a-4773-8a0f-b3de8119e54a">&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The table below reconciles the undiscounted cash flows to the operating lease liability recorded on the consolidated balance sheet as of December 31, 2021.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:77.452%;"/&gt;
        &lt;td style="width:1.833%;"/&gt;
        &lt;td style="width:1.278%;"/&gt;
        &lt;td style="width:18.457%;"/&gt;
        &lt;td style="width:0.981%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,159&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,284&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,412&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,545&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,681&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;22,389&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total minimum lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;44,470&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Less: amount of lease payments representing interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;13,872&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Present value of future lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;30,598&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Less: current lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,747&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Noncurrent lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;28,851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_aa55cd31-cd0b-41a5-91f2-fdfb5931e320"
      unitRef="U_USD">4159000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_34506e36-d1ef-4d5e-b230-ac8d70b587d5"
      unitRef="U_USD">4284000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_6fd3234a-e4ed-4f49-89bf-1a07eb39ec05"
      unitRef="U_USD">4412000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_cdd9d9f2-9db1-4318-8685-03af2f144225"
      unitRef="U_USD">4545000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_8b42b399-02a7-460d-bec4-e2bc3977a0ce"
      unitRef="U_USD">4681000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_d3c4e0e3-a35c-4f78-b072-89dd6a3dd747"
      unitRef="U_USD">22389000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_c30c208a-c367-46ba-9d08-23ed2c65c677"
      unitRef="U_USD">44470000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_c3da70f0-5e06-48df-905e-ca8f51393a6a"
      unitRef="U_USD">13872000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_901978b5-0dbd-44a6-9a55-7c00cd7ada18"
      unitRef="U_USD">30598000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_77980166-c385-4c32-878f-37715f399622"
      unitRef="U_USD">1747000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_11d43c29-a984-40b6-830e-377f4c8cae19"
      unitRef="U_USD">28851000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_7e55cd27-7764-4384-af11-23dce3259310">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Future aggregate minimum payments under the noncancelable operating leases and short term leases, including the Lexington, MA lease and Connecticut lease, which is not subject to ASC 842, as of December 31, 2021 are as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:60.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:76.935%;"/&gt;
        &lt;td style="width:1.653%;"/&gt;
        &lt;td style="width:2.133%;"/&gt;
        &lt;td style="width:17.956%;"/&gt;
        &lt;td style="width:0.248%;"/&gt;
        &lt;td style="width:1.075%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,161&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,284&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,412&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,545&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,681&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2027 and beyond&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;22,388&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total minimum lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;44,471&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_7521c5e1-bc37-4db8-93ae-97403eca8ba5"
      unitRef="U_USD">4161000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_fa349bf4-6cb3-46fa-aa9d-793fcf71f90f"
      unitRef="U_USD">4284000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_c64dc124-f048-465f-a3f0-3fd584910a9d"
      unitRef="U_USD">4412000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_bc78f261-6427-4ddc-9b1d-044386e45ab6"
      unitRef="U_USD">4545000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_975db203-3f43-426d-944f-523061ac63ae"
      unitRef="U_USD">4681000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_ee776326-d9a1-46b7-9714-9fada7ea4dcb"
      unitRef="U_USD">22388000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueThereafter>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_80b45493-3793-40b4-b2f9-cd89ab880607"
      unitRef="U_USD">44471000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_838118b8-1964-435a-b937-1e2a3485c802">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;15. Commitments and contingencies&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Contract commitments&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has contracted with a research institution to provide research for a therapeutic drug to treat multiple sclerosis. In September 2020, the Company extended the term of this contract through December 2021. As consideration for this extension, the Company committed to total payments of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;600&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; through December 2021.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;   &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company enters into contracts in the normal course of business with CROs, CMOs, universities, and other third parties for preclinical research studies, clinical trials and testing and manufacturing services. These contracts generally do not contain minimum purchase commitments and are cancelable by us upon prior written notice although, purchase orders for clinical materials are generally non-cancelable. Payments due upon cancellation consist only of payments for services provided or expenses incurred, including non-cancelable obligations of our service providers, up to the date of cancellation or upon the completion of a manufacturing run.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Guarantees&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has identified the guarantees described below as disclosable, in accordance with ASC 460, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Guarantees&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As permitted under Delaware law, the Company indemnifies its officers and directors for certain events or occurrences while the officer or director is, or was, serving at the Company&#x2019;s request in such capacity. The maximum potential amount of future payments the Company could be required to make is unlimited; however, the Company has directors&#x2019; and officers&#x2019; insurance coverage that should limit its exposure and enable it to recover a portion of any future amounts paid.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company is a party to a number of agreements entered into in the ordinary course of business that contain typical provisions that obligate the Company to indemnify the other parties to such agreements upon the occurrence of certain events. Such indemnification obligations are usually in effect from the date of execution of the applicable agreement for a period equal to the applicable statute of limitations. The aggregate maximum potential future liability of the Company under such indemnification provisions is uncertain.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company leases office space in Lexington, Massachusetts under a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;ten-year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; noncancelable lease. The $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,700&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; security deposit for this lease is classified as restricted cash as of December 31, 2021. The Company exited the Woburn, Massachusetts facility in the second quarter of 2021. The Company has standard indemnification arrangements under these leases that require it to indemnify the landlord against all costs, expenses, fines, suits, claims, demands, liabilities, and actions directly resulting from any breach, violation, or nonperformance of any covenant or condition of the lease.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 2021 and 2020, the Company had &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;t experienced any losses related to these indemnification obligations, and no material claims with respect thereto were outstanding. The Company does not expect significant claims related to these indemnification obligations and, consequently, concluded that the fair value of these obligations is negligible, and no related reserves have been established.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Legal Contingencies&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company accrues a liability for legal contingencies when it believes that it is both probable that a liability has been incurred and that the Company can reasonably estimate the amount of the loss. The Company reviews these accruals and adjusts them to reflect ongoing negotiations, settlements, rulings, advice of legal counsel and other relevant information. To the extent new information is obtained and the views on the probable outcomes of claims, suits, assessments, investigations or legal proceedings change, changes in the Company&#x2019;s accrued liabilities would be recorded in the period in which such determination is made.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In addition, in accordance with the relevant authoritative guidance, for any matters in which the likelihood of material loss is at least reasonably possible, the Company will provide disclosure of the possible loss or range of loss. If a reasonable estimate cannot be made, however, the Company will provide disclosure to that effect. The Company expenses legal costs as they are incurred.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On June 3, 2021 and June 22, 2021, purported stockholders of the Company filed putative class action lawsuits in the U.S. District Court for the District of Massachusetts against the Company entitled Evans v. Frequency Therapeutics, Inc. et al. and Hingston v. Frequency Therapeutics, Inc. et al., respectively. The lawsuits allege violations of Section 10(b), 20(a) and Rule 10b5 of the Securities Exchange Act of 1934, as amended, due to allegedly false and misleading statements and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;omissions about the Company&#x2019;s Phase 2a clinical trial (FX-322-202) for its product candidate FX-322 in the Company&#x2019;s public disclosures between November 16, 2020 and March 22, 2021. The lawsuits seek, among other things, damages in connection with the Company&#x2019;s allegedly artificially inflated stock price between November 16, 2020 and March 22, 2021 as a result of those allegedly false and misleading statements and omissions, as well as interest, attorneys&#x2019; fees and costs. These matters are at the very early stages of the legal process, and as a result, the Company is not able to estimate a range of possible loss. The Company is vigorously defending against all claims asserted in both lawsuits. The Company has not yet filed a responsive pleading. Since an estimate of the possible loss or range of loss cannot be made at this time, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; accruals have been recorded as of December 31, 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&#160;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On June 24, 2021, two purported stockholders of the Company filed a lawsuit in the Court of Chancery of the State of Delaware against (i) the Company, (ii) the Company&#x2019;s Chief Executive Officer, President, and Director, David Lucchino, (iii) Computershare Inc., and (iv) Computershare Trust Company, N.A., entitled The Gregory J. Parseghian Revocable Trust, et al. v. Frequency Therapeutics, Inc., et al. The lawsuit asserts causes of action against the Company of conversion and, in the alternative, unjust enrichment, and against Mr. Lucchino for breach of the fiduciary duty of loyalty, based on allegations that actions were taken to prevent the purported stockholders from selling their shares in the Company. The lawsuit seeks monetary damages, as well as interest, attorneys&#x2019; fees and costs, against all defendants. This matter is at the very early stages of the legal process, and as a result, the Company is not able to estimate a range of possible loss. We are vigorously defending against all claims asserted and have filed a motion to dismiss the complaint, which remains pending. Since an estimate of the possible loss or range of loss cannot be made at this time, &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; accruals have been recorded as of December 31, 2021.&lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LongTermPurchaseCommitmentAmount
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_edf089d5-fa8c-42a8-befb-3b031e952480"
      unitRef="U_USD">600000</us-gaap:LongTermPurchaseCommitmentAmount>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_a3c46bd6-df2a-4676-94dc-776e2b2317ad"
      id="F_badd76a0-b8ea-44dc-9b85-cfff1f573f06">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:RestrictedCash
      contextRef="C_a3c46bd6-df2a-4676-94dc-776e2b2317ad"
      decimals="-3"
      id="F_969d0d86-a089-48cb-98dd-b8110057412e"
      unitRef="U_USD">1700000</us-gaap:RestrictedCash>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_b87d49b6-4a53-4e7e-b5ec-fe9df38d94aa"
      unitRef="U_USD">0</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:LossContingencyLossInPeriod
      contextRef="C_4797ad8a-06dd-45c0-9f2c-4e424e5a0cc2"
      decimals="-3"
      id="F_6971040c-b6a8-42a5-94ee-269c3252ce03"
      unitRef="U_USD">0</us-gaap:LossContingencyLossInPeriod>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_5a779dfa-84ef-4d2e-a8ee-ccce03c749eb"
      unitRef="U_USD">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8"
      decimals="-3"
      id="F_2e3dd689-a8d8-442c-95ff-6c6d4c25e8a6"
      unitRef="U_USD">0</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_4354211f-12ed-464c-baa7-120f99c68ebc">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;16. Employee benefit plan&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Employees of the Company are eligible to participate in the Company&#x2019;s 401(k) retirement plan (the &#x201c;401(k) Plan&#x201d;). Participants may contribute up to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;90&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of their annual compensation to the 401(k) Plan, subject to statutory limitations. Under the 401(k) Plan Safe Harbor Match, the Company matches &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;100&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of the first &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of employee contributions and vests &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;100&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% at time of match. For the years ended December 31, 2021 and 2020, the Company made matching contributions of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;723&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;400&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="INF"
      id="F_847e574b-fded-4c2b-a8c2-45487791c009"
      unitRef="U_pure">0.90</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="INF"
      id="F_eacd65c2-e78c-44d6-8876-9bda84e85b72"
      unitRef="U_pure">1</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="2"
      id="F_a421a269-c5d2-44f5-9a15-640152de9d26"
      unitRef="U_pure">0.05</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="INF"
      id="F_4f5b1b4a-8b67-4ede-9077-32b4afc91619"
      unitRef="U_pure">1</us-gaap:DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      decimals="-3"
      id="F_ff06427d-7f5d-408a-96ef-77affaf44412"
      unitRef="U_USD">723000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_5b1c30df-3436-4ba5-a445-bc2cba68d121"
      decimals="-3"
      id="F_365ac2f5-d231-4d30-9b05-01434e2c83ca"
      unitRef="U_USD">400000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa"
      id="F_425149d0-b925-47e8-994a-312aca55af1a">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;17. Related party transactions&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As disclosed in Note 12, the Company entered into the MIT License Agreement in December 2016. The patents in-licensed by the Company from MIT pursuant to the MIT License Agreement claim inventions created by, among others, Dr. Langer, one of the Company&#x2019;s directors. Accordingly, Dr. Langer has received $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,980&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; from MIT under the MIT Policy during the years ended December 31, 2021 and 2020, respectively.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.1164583333333333;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company's lease for its Woburn, Massachusetts facility, terminated in May 2021 as disclosed in Note 14, was with an entity affiliated with one of the Company's directors and shareholders.&lt;/span&gt;&lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:PaymentForManagementFee
      contextRef="C_be99fc1c-8083-4f95-90f4-0e839dbb422d"
      decimals="-3"
      id="F_d778b1ca-28f2-4105-9806-adc9d508fe66"
      unitRef="U_USD">6000</us-gaap:PaymentForManagementFee>
    <us-gaap:PaymentForManagementFee
      contextRef="C_a8197e94-f689-4588-95d8-113863133fd1"
      decimals="-3"
      id="F_3753d73e-1ac8-4a1a-a461-b638d40c1da4"
      unitRef="U_USD">1980000</us-gaap:PaymentForManagementFee>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>106
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M#F\Z5-D N+Z1TKQ,[%G:OCLE_P!02P,$%     @ 3SUO5 Z#DD%:!   N X
M !@   !X;"]W;W)K<VAE971S+W-H965T-"YX;6R-E]UOVS@,P/\5(=C#!BRU
MY6\7:8 VO8\"VZUHM]O#X1Y46XF-VE).4I+>_?5'R8Z3VK+;AS:Q0U(_4B(I
M+@Y</,N"4H5>ZHK)JUFAU/;2<616T)K("[ZE#'Y9<U$3!8]BX\BMH"0W2G7E
M>*X;.34IV6RY,._NQ7+!=ZHJ&;T72.[JFHA_;VC%#U<S/#N^>"@WA=(OG.5B
M2S;TD:H?VWL!3TYG)2]KRF3)&1)T?36[QI<KG&H%(_%G20_R[#O2KCQQ_JP?
M[O*KF:N):$4SI4T0^-C3%:TJ;0DX_FF-SKHUM>+Y]Z/U7XWSX,P3D73%JY]E
MKHJK63)#.5V37:4>^.%WVCH4:GL9KZ3YCPZ-;.S.4+:3BM>M,A#4)6L^R4L;
MB#,%'(TH>*V"UU<(1A3\5L$WCC9DQJU;HLAR(?@!"2T-UO07$QNC#=Z43&_C
MHQ+P:PEZ:KGB3/*JS(FB.7I4\ %[I"3B:_1M2P71L99HCGX\WJ*/'SZA#ZAD
MZ'O!=Y*P7"X<!0S:DI.UZ]TTZWDCZV$/?>5,%1+]PG*:OS;@ 'SG@7?TX,:;
MM'A+LPODX\_(<SUL 5J]7]V=P/&[@/K&GC]BKXNA#N&*UY!<A3[U>XKN6,9K
MBOZZ?I)*P/G]>V*YH%LN,,L%(\L]T#UE.VK;B$8Q-(HZF_=+'+A1LG#VY]$9
M2OE1F@2=U"NJL*,*)X/0'AVV0?0%"HZD\G+"UZBS&KWAJZ1$9 6"HP>INH<:
MM-61MCG?6(K.W(K<U/-[S@^E_#C H=WYN,.,)S%_HPR\KPPER2%G2[W=NEK9
M0&,+ HZC'NA0RHLQ3NV@20>:3()^YPHP^6"O;)C) "!-W#3M80ZEHB#T1PY3
MVF&FDYA?N)1H+7A]1(6*9$-,!XO/D\#U<8_1(N;%8>C:(;%[*J3N).8=4U10
MJ:! ZC2WED9WN-EIW..S"*7I2 CQ69G'[Z-K-]F*AX>AB:.@SS>4&HN==Z+S
MWLAL4I7_00?Z6,%F?T(;N'\@:/(EVP.SZ4A68,^RE_T<MPB-E3=\*O+8GP2&
M*P1<$!A$,RL(V]"&N*&WDOH#"-S/<8O,? STU![P='_XI@HJCIO^&3%JK9:M
MD=>!C : 0ZFQG3\U"AR^G=Q/%.ZCM$T<I,B+O0:UIGH9'L7]#+?)>5%P5E1?
MPY[Z#YYN0'=O 0[[R?RLF[1T%B%_I.7@4\_!TTWG#[CQZ]-GQ8H'/5['+1GL
MKT7.BT*,1^!.?09/-YHC'(+ZC61!!)W#U;O,FD9>5CO5OPFVX(W9Y!7013"H
MF!8Q]R+Q1K!/?0=/-YZ?9@:@^9SLH>] DAMT<S>&<U!#?8+K>?:,8#J2"ER!
M'OI.OX8]R _\$'OQH-A:)#TOA+^XYYUS-@/45&S,:"0!=,=4<YGNWG;CU[49
M.GKO;_189F:+DYEFIOM*Q*:$::"B:S#I7L1P4D0S)C4/BF_-I/'$%<PMYFL!
MHR456@!^7W.NC@]Z@6Y87?X/4$L#!!0    ( $\];U1X%94?M@(  '4'   8
M    >&PO=V]R:W-H965T<R]S:&5E=#4N>&ULC571;MHP%/T5*^K#)JV$!$BR
M"B*5=-,JK5M5VNUAVH-)+L2J8S/;0+>OW[4#&; 0]26QG7O./??8N1YOI7K6
M)8 A+Q47>N*5QJRN?%_G)514]^0*!'Y92%51@U.U]/5* 2T<J.)^V.]'?D69
M\-*Q6[M7Z5BN#6<"[A71ZZJBZO<4N-Q.O,#;+SRP96GL@I^.5W0),S!/JWN%
M,[]A*5@%0C,IB(+%Q+L.KK+$QKN ;PRV^F!,;"5S*9_MY+:8>'TK"#CDQC)0
M?&T@ \XM$<KXM>/TFI06>#C>LW]TM6,M<ZHAD_P[*TPY\1*/%+"@:VX>Y/83
M[.H96;Y<<NV>9%O'QI@Q7VLCJQT8YQ43]9N^['PX  31&4"X X2G@.$9P& '
M&+A":V6NK!MJ:#I6<DN4C48V.W#>.#16PX3=Q9E1^)4ASJ29%%IR5E #!9D9
M?.$6&4WD@F2RPH-1VAW; /DLM2:7Y&EV0]Y<O"47A GR6,JUIJ+08]^@%LOH
MY[N\TSIO>"9O$)([*4RIR0=10'%,X&,1327AOI)IV,EX WF/#()W).R'08N@
M[/7P?H><06/LP/$-SO U7OYOY:W(907DQ_5<&X7G^&='NF&3;NC2#<^D^X(_
M/,<M:MN)&CER2/M7;]++9!@ET=C?'/K3$A9&HR!HPHZ$C1IAHTX?OIH2%,F/
M#+!"KSJ*CAKNJ+/H)X&-B[,_>'0M)<&V@*WH&0R=<R :\K5BAD&K*35S=&3*
M^Q-'6F+"N-V.N)$<=TI^E(;R%CO:),:OD-@2<TYBTDA,.B5FKQ*7M!VJ.!Z=
MZ&L)PT,U2$XD^@<=K *U=(U=HT]K8>H6T*PV=\>U:YDGZU.\4^HKX!]-?2'=
M4;5D0A,."Z3L]V(4I>HF7T^,7+D^.9<&NZX;EG@O@K(!^'TAI=E/;(+FIDW_
M E!+ P04    " !//6]4.O)< .T$   #%0  &    'AL+W=O<FMS:&5E=',O
M<VAE970V+GAM;*U8VW*C.!#]%95K'F:JQ@&)^Y3CJHGMU.9A=UV3N3PK( =5
M 'F0B)._7PD(-D+@3#9YB!&<;IUN-7TD%@=6/O"4$ &>\JS@E[-4B/T7R^)Q
M2G+,+]B>%/+)CI4Y%G)8WEM\7Q*<U$9Y9B';]JT<TV*V7-3WMN5RP2J1T8)L
M2\"K/,?E\Q7)V.%R!F<O-[[1^U2H&]9RL<?WY):('_MM*4=6YR6A.2DX904H
MR>YR]A5^N49(&=2(GY0<^,DU4*'<,?:@!C?)Y<Q6C$A&8J%<8/GS2%8DRY0G
MR>-WZW36S:D,3Z]?O%_7P<M@[C G*Y;]HHE(+V?A#"1DAZM,?&.'OT@;D*?\
MQ2SC]7]P:+"!G#&NN&!Y:RS'.2V:7_S4)N+$ #HC!J@U0*\U<%H#1S- P8B!
MVQJXFH$3C1AXK8&GSV"/&/BM@5_GODE6G>DU%GBY*-D!E HMO:F+>KEJ:YE@
M6JC*NA6E?$JEG5BN6,%91A,L2 )NA?R192, V\D!BQ]2EB6DY&#SNZ+B&<S!
MC]LU^/CA$_@ : &^IZSBN$CXPA*2B_)HQ>V\5\V\:&3>[TS@S&"VFC9;L3R7
M]5AS,UBOIZV_)@E5]8RS^1[31(6PPGMJ9K(YXRN.J[S*ZKS]*U)2 LE-OMRI
M>NL>";@I8I83@]_KU_M=DQV-J>@[L>0*=\N,NF5&M5=WQ.L5N:=%08M[<(4S
M7,0$8"'=QQ? @9\!LF%D6L+&IU?[5"WJ<0G]P/'"A?5XNF1#F /[D/40@AP?
M^AIL,X1Y;A]R/83,_5#^=;!>?IPN/\X?YN>C+ Z>XI+P3Z_)U:KQ[Y\FP0Y=
MU[,#,S.W8^9.,JM+?:Z:9P)D14E%X;CNR>1)79LJ[,H=<(FBT-&6Y RH1];K
MR'J39&\XK^KLR?X1-Z\J5_Q!M:\9DS*FO'[:W&9[%8JQ?7@#>M!S/:WRO&&!
M:E$:W;CF*/TN2O^=HFSC.RTF4^WX Y*!'SFA9Z89=#2#M]&49+8E?90M!FPS
M'-<=_S,HB#"M0S#@YMK0U8II%0S?;VTAS'Z@.<2P"S%\YQ#/+44XH(D<SX;V
M2'^).J+1)-%&(>*>0M!:(4#&N/$%B 9,YBC0^N4TIL<4VL<=@3W)]1^9I3%2
MK6E_1M^#VFMW?1[7)W>R78&3Y#9%,JYBR#9RAL,N$2$WTCBO##A'4Y]UB^G5
M1QB$*-(6QH0+]!P-,?/(<Z)H)$='K8?38J_E:%S)1O*%AE+F1+YKV[:>L5<@
M^S$<]1A."_);9*]UV>M",/!L?0V'4MV']2D?A1I.*_6V*N-4$@95(??,8)/O
M,_9,2+-9!=U3V8\*(_NA(/L#ZI.8/N^C9L-IT?X#WN>Z)QS*;6#[(W(+CWH+
MWTMPSVXKX%!K(8KT'6V+FMI8F!V--=^C9L,WBO9;]Q9P*+R^BQPXMBA'Z873
MVBL/]CM"1576;.3THJ2Q.K4T?,_1&@KM'$%_9,L#CSH+WUUHH4%%PT%#GP;U
M#V5'J45OEUIDD-#0]4-?/Q"=Q?7)':46_1^IA4;.!JF5QR"DR>C*@'.TO?W:
MA(%VY&CQ;PRXN8_T)!E ,+3ML3TV.CE8OY?8FC-FD%#7AQ!!?8O]&F03@W7R
M.4A]'OP;E_)TRT%&=M+4O@AD&LKFBULS$&Q??R&Z8T*PO+Y,"99BH #R^8XQ
M\3)0'YVZ[Y[+_P!02P,$%     @ 3SUO5 E8(#]K!@  0!H  !@   !X;"]W
M;W)K<VAE971S+W-H965T-RYX;6R=6=MNVS@0_17"V(<6B&N1U,4.$@.)TV(7
M: NC:7>?&8F.N95$E:2<YN^7I&S)EBC&WA?KXB'GS) S9X:Z>>'BI]Q2JL#O
M(B_E[62K5'4]F\ET2PLB/_"*EOJ?#1<%4?I1/,]D)2C)[* BGZ$@B&<%8>5D
M>6/?K<7RAM<J9R5="R#KHB#B]9[F_.5V B>'%]_8\U:9%[/E346>Z2-5/ZJU
MT$^S=I:,%;24C)= T,WMY Y>KW!H!EB)OQE]D4?WP)CRQ/E/\_!7=CL)#"*:
MTU29*8B^[.B*YKF92>/XM9]TTNHT X_O#[-_LL9K8YZ(I"N>_\,RM;V=S"<@
MHQM2Y^H;?_F3[@V*S'PISZ7]!2][V6 "TEHJ7NP':P0%*YLK^;UWQ-$ &(\,
M0/L!J#\@'!F ]P.P-;1!9LUZ((HL;P1_ <)(Z]G,C?6-':VM8:59QD<E]+],
MCU/+%2\ESUE&%,W H](7O49* KX!*R*WX)->9PFFX,?C WCWQWOP!V E^+[E
MM21E)F]F2F,P,\W2O;[[1A\:T0<1^,)+M97@8YG1['2"F0;?6H .%MPC[XP/
M-/T ,+P"*$#0 6AU_O#  P>W#L5V/CSF4..UC?7:1O "Z( 31+'RN=FQ3#$J
MKSUZPE9/:/6$(WJ^ZA#/N70N03,RLB--'.^6TWD8S^.;V>[8,0XQ%$<0MF(G
MP*(66.1UP%WVK]ZVS2Y27(=ZRLN4Y124>\3FK;E/C:=JJ?>=WE*7NBENT<1>
M-STJGOZ<FD#/0,H+G?TD,?G#Y;9FIOC('P@F4=#SVE!JL9ACM\^2%F7B1?E
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MVX+&+FKG0/<[I>S9< +=(%_^!%!+ P04    " !//6]4BE)L:?P"  !<!@
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M>I*T>>CT 2)7(FJ08 #0BOKU/0M0M!0[;OJ0AT0DB#U[]NQBL3Y=67?G2^9
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M_ ;\&1S9!_\PAAS_CL))J%R(.%//C<PDUU(88 [B5=R&9^R%0> %07 )81:
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MXT4,-6J3<\IP4NZ#HUM%>F%UV[3:[A#A/MCR =:=*VL*$M9:F&42R ++)>6
M=MVCY:^@93E\MB;4'FZ-1'D,D)!KHW_YWK_K_$W$#UC.8)Y-(4_S[ V\^1CO
M/.+-7\&[PZ <4E4%N$:#E0H>_KXJ?'!4'_^\86 Q&EA$ XO_B="WT;)T!B.B
MCXCM'K$E1/C-P#VV 9L"'7'$/&7OIA!JA!O;M,+L?OCN/,_.+CP45C@)M@))
M#)3!.@_"R!ZUMEHB'[2MLX\HXXV0EI!E!&-8>"LV^(G%V%B>7MS>K]=QF5W\
M#-M:E3446(H& :L*8R,"M21K2!&0G7K)8V544$)3R(56)4E5Z)39L+BOA4//
M*\Y@:9N&\&(H,_B=H-@#:-$U?-T*%U2I")LVP3Y1>*A''CC;;6J2WCFK-?6V
M[.+HB&:ZEC6S$_A^\%8Y0*TVJM 1AZ:D%RS=VS==S,B1IT?6Q*-06K R3590
MWG?"E @=]8V+9,0(MHH<*1!$1X. X$NA]8YX*6D >TK-0&*EG ]$Y8[-H""Z
M21"-% YV2#^RB[P]B08T\<;OJ0]$U7[-EJ=D=:.,8;6M"C5\$J:CJ0U]*Z:Q
M0,C"*_=4@L6.9$ TMJ->PR\=Y9$)'/D#>B)\$#W$2W2]5!%'%-*"QD-?^O-L
MKT)O4XD1])@#RT\1,:/1>U(8'!.>\LS!4^-)]OG;.J=/\G.YGMNQ3*G\E(UZ
M/+S(=U/J3O99^]09A'G:S[6>P>C\OC))Z6R:GB[V?"A6H=1'<8=:Q,:TI*3\
M<XLSN(+(X $[O:$I"%(*E JZ?7=R.F6TP0)-17K#8S567>@</H<]#OI'#QXI
M)/EM\?['E9=CIMOS>7X8]%!6I)*_&O?LI;F='#R*#;I-?/JY@BCM_?LXGHY?
M%U?]H_HDWG^:?!:.>L%3Z52DFL[.3B;@^N>^WP3;QB>VL('Z-"YK^D)"QP)T
M7UD;]ALV,'YSK?X%4$L#!!0    ( $\];U1-NA/,P@L  $,B   9    >&PO
M=V]R:W-H965T<R]S:&5E=#$X+GAM;,U:VW+;.!)]UU>@M,E64D7+$G5U)G%5
M+I/:5&UV4G%F]F%K'R 2DK#A10. EK5?OZ<;($5)M!U/S<,^V))(H-&7TZ>[
M*;W>E>:[W2CEQ%V>%?9-?^/<]M7EI4TV*I=V4&Y5@3NKTN32X:-97]JM43+E
M37EV&0^'L\M<ZJ)__9JO?3'7K\O*9;I07XRP59Y+LW^GLG+WIC_JUQ>^ZO7&
MT87+Z]=;N58WROVZ_6+PZ;*1DNI<%5:7A3!J]:;_=O3JW836\X+?M-K9UGM!
MEBS+\CM]^)2^Z0])(96IQ)$$B9=;]5YE&0F"&K\'F?WF2-K8?E]+_\BVPY:E
MM.I]F?U3IV[SIK_HBU2M9)6YK^7N;RK8,R5Y29E9_B]V?NUXW!=)95V9A\W0
M(->%?Y5WP0^M#8OA/1OBL"%FO?U!K.4'Z>3U:U/NA*'5D$9OV%3>#>5T04&Y
M<09W-?:YZT]%4N9*?)-WRKZ^=)!(UR^3L/N=WQW?LWL4B\]EX396_%RD*CT6
M< E5&GWB6I]W\8,2/ZAD(,:C2,3#>/2 O'%CWYCEC1^U3WS0-LE*6QDE_O5V
M:9T!(O[]P!&3YH@)'S'Y@RY\<#<EW2N[E8EZTT=6665N5?]Z-!J((-:16'&C
MBT0)^K=E,.L"#AI-(N$V2KPO\ZTL]F(CK5BK0AGI5 KPY%4F"?-BI5)<S(0L
M4F$=[HH"Z8[$QDI=K 6\8ODF*2!-LN$/J;I%SFZ1@4XD1J4:+]*8/9A@)TUJ
M!=Z(W49C^4[A<!Q4E,)!2%(:H$&03G003!!+Z+6"A+2"2:6H8(EQX RW%]*4
M%8ZKG,[T?TD=V&39<"&=,WI9.7A@I]T&5I.]T'*K.)N/%!*P1Y>I'8BW5I0K
M 2BI?*E, Z=3;Z6-8SK<<6PJQ,GMUI1W&D2@LKUX)D:3JV@X'[&K/DMK9;*I
MK'+.!A<_5=YB'$UF\^#07.[A,B%OI<[D,F.?E:L5Y(M5Y0C"< _?T R3@?@&
MTWX=W Q^W";LS*I4X>@XCL975\>G(> 5(-=Y&OR(F*TW\.IXS@XX<TX\BV;S
M.%B3ED"&$^INJR&+UQOUA.,TR&6E"TW"O:7WHOC8Q+-C'O)ARZK)2/P@BF1F
MRR,HG</AWJ0BA'<F%HY])J91//'H0H 8:5$+^=D^"LZ]U\:SI*?S,BV7R#.G
MD5)']M(RA'-V<LI ?%42>2F9=J#8P75U3@-)%G:A34C)*BS+R3,KT&MI;!1P
M%A*[=MQ?_[*(1_.?$")69T^*U]QU&I=6ZC\2\4 ! _&/;GZ[U^,^W_@T6RW_
M ^M)(8FNH2@J.#'3N7:RIE[2!'$D8U<B$%F;;Y.-+-;*UDO+'>RR&[W%!:?@
M7=YG];K0*YU(B+$;1'%39H@8HG\+M$F*CE(7>T G6$7BU%VB+ -D.A3/(P'&
M1^+=:J);D"@VWOAVQXKQ(F:;QXLQK2=%/M'Q!<SY2MI7% SD/VZ.KA8S%B9S
MBF)ZBC3<V:%QHE<+3V30R4.*#Z<&S7)>VK:QM1?(M^P_'\&*LXD<=Q0!MY$4
ME()HSY<"KB#D_6S_./U]*@)\LHC"=JH%F\ D JG+?>TE<A+;BAX.]<R4N4!;
M4%@9? CIZ'1MC=V#U%;<CV.'8%7+3"=BC=S:-A! 'Y=\9]87*([;TG@L09.\
M)&N@)"+Z_-[8>]9K%WJ8O<T4%7J+8%*BPSA9)-#58]TO*D"KM$A"A2IE1X*<
M"$.[C8)F=)IW$=N$9LZ@!Z6]99)4!KDBN,K[M?0OE/JE4DAT^$U#C2;6+1GV
MI&6I=4JAM,DY$!SSCFB)5*?^?/+?9R9/M#MS<')"O05L)%1ZF#3,1%4GF@R'
M-=JY&CY:(NH&QK"NWN(M7&[(58>CQ0MT9Q>GBKXDZF-LG^8?(0OJKISW6OMR
MBTSL<3&A3 G8/Z^HPVCA;2/&[5+F<5MI?(&>6XY&36V5E3[X9R=&,QQ(39Y"
M,:N]6J@[)"&Q',$34&M,/-.GLS%8G(L<38,LAA<+]'@WBL9*,N8'[57=G1H;
MPB'>&>V<(KBLZE:4NQ(/(A_!0WB\%BWN)_PR\%L@1@ZOM &GAV38UVQQ*[.*
M'5M6)A" ]!SH,-;6QI]9!7ET'4: 1ICCLK)87]!YQ'H7ZD[E6W39L*[FW*Y:
MUJYCJ\KX5#\M9O8<M&?U+1!NJZ8U*@/@*6HI=A))GP\C+2]U9'EZH!@(_07=
M0B@,R+<K+D:!F9OR]>67AQG@-/"3632*QT_C@W,2J#5CM9#OW/(]D/2G3-WR
M FK@3J..4FL?NK4ZW]GGA:,&N:WXGY+L[@C%M#!+J%?!?5_S</_(RM/3_@^
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M"XY\MT$3^>%T+/A>@$0B\IG,2VSWSP26*C05%LO(&]0R'QY*L4MK%" W04T
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M3%J ^ZNR=/4'.J#YW<CU_P!02P,$%     @ 3SUO5$4"$C1B$@  ?D$  !D
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M5?O3)?2DBW7D%:(DRE3(4D$*0_%JZ8?4^< ,<?4[2&PD1,TE40.[,X$4DLW
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M$TL<T>>91ZZD7;?!DMV5RP2/N1*"R08H8W_J_W3^,:X2>FPRFTA4=3<]8VA
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M>:M*FXMET 8)[:= %AC+L%[=V]_*>$U=?WD'./V"S6#4BHZ1 F\-LU'QH-G
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M<%:%SH;Y]Y3243*;9O3=V6W\W!Q!&*%UZ'5'<D;#9'(Q:[3EX5S@CX*G^&Q
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M0(X7X/W*VE"^\ '#C^DO?P=02P,$%     @ 3SUO5/D#'R#[ @  @@8  !D
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M+S=9>OV'IX#XFANR,]CFN:%"ZDKUY^E0"\LJDB.+0 &_PA4([=]I_/O-_&F
MCK]<FEK?&YZXAZ(CQ@N[/0JRS"=_WT]<G;[0 ,F+><R5;(M!<50_T#BV_,R"
M0I818$$%R;1^,(>.= P[8?E0Z\ZBX]U2Y%))QR/PR?&]#_3P^>Q$/Y;Z[KDO
M8SBRYRA=S<WX<V<,$&7)8 $B>+XE\MD9A6$*6PO"VBAFP\Z^=R.2,\UID*J@
MK'R2IM-ND)]I=Q+O[:!93^&#\N\$55)[7DI.G<^N7T1 @YH.AC-M4+"#<:R'
M85GS#PC)!["_-#S\:/@"TR]M\P502P,$%     @ 3SUO5(9WF+YP+@  =:(
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MA>N&5_DBN2$3)>(=\=N-]9W@ED0X-.RIP>Q\&^(\8U/XOE+@LZHM!'^NKA_
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M;L#.FR*=#[IY.&)L^F<8L>1S(E?GL\(_W%"SFK]7!F\G_QF]_0\P*[([1U7
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M[\!Q?X"KBDUBRAHX>/1Q!UQG&GP ?M_4=>O^P [NZ^8S#>^'_P=02P,$%
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M"B#'@M7"WJCU!VSS&3B^3 GCG[!N?(<4,:N-554+)KOBLGFS[VT==@"CZ!E
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M@D#G%39,7\L6!=V44C7,D*DV@6X5LL(%-3R(PS +&E8+?SYU9RLUG\JMX;7
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ME:71]F))NQ2U<Z#S0BE[4%R"?CNO_@%02P,$%     @ 3SUO5'S*7OLQ!0
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MR_W"<[>PJ_)3W<2=K="J"]6KYIGY@#UVCHT^-NW).]+M P]G@>F3/O0SN]<
M]6W3_>2ZVQG*J#U;C.W!J>.1.&HG3J]&>JW_8JABLRZ-V5,KUG6WCW6AU0 P
MP?NO3OQ]E"SI?0B3_[1HA^'_3=6Z<MV8S?]?BK971EW-IAB.?(SAE(["MF"_
MK>-^S1+X'$O _MQY#%5M3&,O --GUO1HX4YZ%YR*RZ6]QBF0\Z;6[J[3O>VN
MBC?N@K0W=_?,MTPN"SC;2KX 5PR2&B/IKFYNH,7:7I=F0L/ERSZNX+K+I3&
M^840NAV8!;H+]/1/4$L#!!0    ( $\];U2J\SBHSP0  *8,   9    >&PO
M=V]R:W-H965T<R]S:&5E=#,S+GAM;*U72V_;1A"^\U<,U+BP 5HB*9&4'%N
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MJBSJK;J9BIN-51LWB2Z4I;G6+=?T1P(U$]#]4BF[V[" [J_)_!]02P,$%
M  @ 3SUO5-5\$;OC P  :PD  !D   !X;"]W;W)K<VAE971S+W-H965T,S0N
M>&ULE5;?;]LV$'[W7W$0,J %5,N295L); -.NF #DC5(TO5AV ,EG2VN%.F1
M5)S\]SM2LIJDCI&]V$?R[N/]^(ZG^4[I[Z9"M/!8"VD6067M]BR*3%%AS<Q0
M;5'2R5KIFEE:ZDUDMAI9Z8UJ$26CT32J&9?!<N[W;O1RKAHKN,0;#::I:Z:?
MSE&HW2*(@_W&+=]4UFU$R_F6;? .[=?MC:95U*.4O$9IN)*@<;T(5O'9^=3I
M>X4_.>[,,QE<)+E2W]WB]W(1C)Q#*+"P#H'1WP->H! .B-SXM\,,^BN=X7-Y
MCW[I8Z=8<F;P0HEOO+35(L@"*''-&F%OU>XW[.*9.+Q"">-_8=?IC@(H&F-5
MW1F3!S67[3][[/+P'H.D,TB\W^U%WLO/S++E7*L=:*=-:$[PH7IK<HY+5Y0[
MJ^F4DYU=7B&%9.##/<L%FH_SR!*H.XJ*#N"\!4C> (@3N%;25@9^E266+P$B
M\J9W*=F[=)X<1?R,Q1#&<0C)*(F/X(W[$,<>;WP\Q+]6N;&:6/#W$<RTQTP]
M9OH&YATU1]D(!+6&%O]0YHYBN'8[,UM6X"*@?C*H'S!8?K$5:N"R;3?'6TH'
MUCEM[E,R^.:IAN4G]H":.H>:P[4?EQN@9M5D1I)P7H%%7</I,(4G9-K\;%ER
M4ZA&6B KA&PX@5_@2'HF?7HF[T[/+19*%IS8!10;?)7[.[&$"V8JN*2'@<Z4
M/_[2!^#3"E><Y5QP^W0HOT>=.)S?>[K#.JY#[AXD2MT+[YKGWA7.N_5S[UZG
M5^R]\SB:^ ]4,:=)J$8)7C('E#/!9('0/K/,N+3\5-;A@'X32,-X<NK$,8E)
MECHQ)3&-$R=.2)RD$R=.29QF\8!"HN=X3:6&) G'V>G@7EDFW&O!ZZ;N7-VR
M)WI+K8&4L&:CP14:<P:L]M4G?UYI:?0YDSY83NF@E84/$(_#;); Q\%->PP/
M3#2^SNO&-AI?XXQ'X>0TZVXK&JV=S<OD<??^0!S.TAGA_D'E>%/M!)(LS";Q
M,8Y.>XY.W\W1R];WU6:C<>,ZX;K+W4T7QR'V'8?O(%D/N2]'GQKB&I7,D452
MS(X@PA/S%<D,,%D2=92V;3NWNR%5I1!-Z?0<QA4^DFB5#.%ZU:7.&5XH*=T$
M+)HNH2'L*EY4P W=:VD:Y__0N6/XZNX"LC0)WV(H,!>0@;42KBG.6L*>.,I.
MX_]%61)GWKL<GQ3]>=YFQWE[TC+WX$2(G@W &O7&CWD#OI';6=CO]E\2JW:
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M7)'M_'Y8V+<6:F=@]W.E:#UQ =K7V^@/4$L#!!0    ( $\];U1=D'F%\0(
M $X'   9    >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;(U5;6_:,!#^*Z>H
M'UJI$!)>50$2+YLV::U0LZZ?37(0JX[-; >Z?[^S QE%P/H!XI=['M]S=SX/
M=TJ_F1S1PGLAI!D%N;6;AS T:8X%,TVU04D[*Z4+9FFJUZ'9:&29!Q4BC%NM
M7E@P+H/QT*\M]'BH2BNXQ(4&4Q8%TW^F*-1N%$3!8>&9KW/K%L+Q<,/6F*!]
MV2PTS<*:)>,%2L.5!(VK43")'F9]9^\-?G'<F:,Q."5+I=[<Y'LV"EK.(128
M6L? Z+/%&0KAB,B-WWO.H#[2 8_'!_:O7CMI63*#,R5>>6;S43 ((,,5*X5]
M5KMON-?3=7RI$L;_PVYOVPH@+8U5Q1Y,'A1<5E_VOH_#$2#J70#$>T!\"NA<
M +3W@+876GGF9<V99>.A5CO0SIK8W,#'QJ-)#9<NBXG5M,L)9\=)E3U0*TCX
M6O(53YFT,$E354K+Y1H62O"4HX$&)%1#62G064^9X2E,9 9S+DJ+&3Q1S?U0
MQL &-20YTP@3:S5?EI8M"605S%114.X2J]*W7(D,M8';.5K&A;FC UZ2.=S>
MW,$-A& <@P$NX45R:^YID<8_<U4:)C,S#"W)=R+"="]U6DF-+TB-8GA4TN8&
MOL@,LX\$(<6M#EY\"-XTOLHXQ[0)[>@>XE8<G7%H]GEXZXH[[3J7;<_7OL#W
M5!:HF57ZX0I9IR;K>++.)3+*IJ!LGHMSA>QZI&L3VW%CT.D->L-P>ZS^C%G<
MZT91;?;!L6[M6/>JRCE*11?A?SI[-5WOJLY7?]$Q:[ M!6^-A[JC$D^K:C6N
M6H$ZH+%4>'0E&JYQ4/'3#+*J^,]%J3JW=R2_W6EWH[C?.8G3&<,X[M*O?SY2
M_5I:_U,I]!?2RVI\RO&*=? A;\U._\3K,U:MYB ^<3D\:DU4G6O?L0WX[E)=
MM'JU?A0FOA>>K$_IL:AZ^S^:ZJ5Y9'K-I0&!*Z)L-?M4/[KJWM7$JHUO@$ME
MJ9WZ84X/'FIG0/LKI>QAX@ZHG]#Q7U!+ P04    " !//6]49-ZM1#,#  !!
M"P  &0   'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6S-5EUOVC 4_2M6GC9I
M:[YH@ F0*&VU2=N*BKH]3'LPR0VQZMB9?5.Z?S_;">&C%'5/[0NQG7N.S[W'
M.'>TENI>%P!('DLN]-@K$*M/OJ_3 DJJSV0%PKS)I2HIFJE:^;I20#,'*KD?
M!4'BEY0);S)R:W,U&<D:.1,P5T3794G5WPO@<CWV0F^S<,M6!=H%?S*JZ H6
M@'?57)F9W[%DK 2AF11$03[VIN&G61A;@(OXP6"M=\;$IK*4\MY.OF1C+["*
M@$.*EH*:QP/,@'/+9'3\:4F];D\+W!UOV*]=\B:9)=4PD_PGR[ 8>P./9)#3
MFN.M7'^&-J%SRY=*KMTO6;>Q@4?26J,L6[!14#+1/.EC6X@=0)@\ XA:0'0(
MZ#T#B%N JYS?*'-I75*DDY&2:Z)LM&&S U<;AS;9,&%M7* R;YG!X631V$=D
M3A9L)5C.4BJ03--4U@*96)&YY"QEH,E',I-E52-U]3> 2\9KA(Q\-Z?MJ]2:
M5*#(HJ *R!11L:6)77(@*"VR-* %RO2^D#P#I<F[2T#*N'YOF+5%Z9&/)B4K
MS$];^1>-_.@9^6%$ODF!A297(H-LG\ WM>@*$FT*<A&=9+R$](S$X0<2!5%X
M1-#LY?#@A)RX\R=V?/$S?%-C0F;K; X[64!:*X;6C*O'E-<F8W*M9+EGS$U.
MKJ@2QCI-YITAO[X:8O(%H=2_3\CJ=;)Z3E;O);+T5A9L9.565KI_7F CRYX3
MY_@QPYN-$[>QO80>)OW>>1+'_9'_L.O#T[AD$ X'P["+V\OLO,OL_&1F=^(!
MM#W5M^:A6&J'NZ?W1/&2;HOD+7G:[V3U7\O3_A.O@@,WGT;$P3 ^;N6@2VCP
MWU8Z#\F=8*A/E&S8[3!\2TZ&P?96#U[+RW;GO3]>E,3!H:-'XH+C?H8['ZOP
M9%HW-6JD(K/?I<;)F\JJ/^5E&&W9HS?EYO8;$,:OYF9\Y!HU9CZY;H\&ADE_
M.#@PU=]I1DI0*]>C:>+ZB>8SW*UV?>#4=3\'ZQ>V/W1-SI:F:2Z_4;5B0A,.
MN:$,SOKF2E=-O]9,4%:NY5E*- V4&Q:FQP5E \S[7$K<3.P&7=<\^0=02P,$
M%     @ 3SUO5,A>27V1 P  0 X  !D   !X;"]W;W)K<VAE971S+W-H965T
M-# N>&ULS5==;]HZ&/XK5K2+31I-;!(^)D!JJ;I-HN=49=TNCLZ%(0:L)C:S
MG;)-Y\>?UR8D&2$94GO1&[#C]^-Y7S]^$H]V4CWJ#6,&_4@3H<?>QICM!]_7
MRPU+J;Z06R9@92552@U,U=K76\5H[)S2Q"=!T/-3RH4W&;EG=VHRDIE)N&!W
M"NDL3:GZ><42N1M[V#L\N.?KC;$/_,EH2]=LSLS#]D[!S"^BQ#QE0G,ID&*K
ML7>)/TR)<W 67SG;Z<H8V5(64C[:R>=X[ 46$4O8TM@0%/Z>V)0EB8T$.+[G
M0;TBIW6LC@_1;USQ4,R":C:5R3<>F\W8&W@H9BN:)>9>[CZQO*#(QEO*1+M?
MM,MM P\M,VUDFCL#@I2+_3_]D3>BXH##!@>2.Y!S';JY0]<5ND?FRKJFADY&
M2NZ0LM80S0Y<;YPW5,.%W<:Y4;#*P<],;BA7Z"M-,H9N&=698K!'1J,.F@-C
MXBQA2*[0#1=4+#E-T*76#)9SVQC!3MRS9:84%VMT1377Z.TU,Y0G^AT$.5[K
MH(?Y-7K[YAUZ@[A 7S8RTU3$>N0;*,9"\I<Y\*L]<-( _)HM+U 7OT<D(/B$
M^_1\]^!W=Q]:6/21%'TD+E[WSWW,6W0I8C3C=,$3;CBKM.SO:LNLU5]2J*,^
M_3.#^.BS8:G^MP5=MT#7=>C"!G27J52&_Z+NY$RE-J?ZO0\1N1#V]#]-,,9!
M"-UYJO:U;D9P&!%2F/V&,"P0AJT('Z %-.&_H#\SJ4_R81^@5TG<&0Q/9XV*
MK-&Y63^"Y)VB453+2OJGD_:*I+W6I(XJMU0]@D@[QIPJME=+"WLQC/#19M3-
M[&:$#6WI%PC[K0AOI6 _#Q!O,CB?Z#\T8T\L0;B%C8,B_. 5GI5A@6[X_+,R
MK/4]'.#>\5&I6[4=%1R4FAT\E[9YA'-XBROO"OQ\YN8Q_M2;W.Q81YJHBTLA
MQJ05Y'P#^]<Q3*4Y5+J E]C<DF9/K@.520M9<*FLN/L*R8Q+7<7MPGH6G7%=
M6R,0_U[#7I3RBL_6UR95QW6![81A0^)28O$+:"RNJV>$@W[3\2S5$[?+YTR*
M];,)6(HI?HUJBDLYQ2^@I[@NE1CW>PT\(*52DK.5LHF I*Z4G3!J2%Q*)7D!
MJ21U#82J\;$$^I7/>WNW@K!K+C1*V K\@HL^!%#[Z\I^8N36??$OI('[@QMN
MX(K'E#6 ]964YC"QEXCBTCCY'U!+ P04    " !//6]4F#[Z+;T"  #J!P
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M9[J04&[[CS1E,;S+7NPUQ=$[NL%XHQ3CCUE<\3;M\XG?W_&X!47Z?KO'N"F
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MTD!9!SQ?2VD.&WM!_TAFOP%02P,$%     @ 3SUO5/S Z3N= @  "0<  !D
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MRDO'&IFEDL5BB?Z0=RR;,87ZD5,.TD,6+W]*#@)-:["<FQF#<953;N\C]JV
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M!S=W</LZ>+F#U]?!SQW\O@Z#W&%@8I\%RT1Z@26>33C; ZZM%9J^,.DRWBK
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MP/)LG8Y/HN5Z P@1=(_(-ABZXX'7&E7HE"W0.5.W+" D%&#%66P8XR0@@*U
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M_2$^'55.DG)A9.&:\4H:;.W.S'#X@K(7\'PMI3DMK(-ZG$]^ U!+ P04
M" !//6]4K](2MH(#  "'#P  &0   'AL+W=O<FMS:&5E=',O<VAE970U,2YX
M;6S-E]MNVS@0AE]E(.Q%%T@BD8I/@6T@3G:Q!=HBB)'VHM@+1AK;0B312])V
M _3ARX,BJ9 EQ]DVK2]D4N+,?#.D?F'&.RX>Y I1P9<LS>7$6RFUOO!]&:TP
M8_*,KS'73Q9<9$SIJ5CZ<BV0Q=8H2WT:!'T_8TGN3<?VWHV8COE&I4F.-P+D
M)LN8>)QARG<3CWA/-VZ3Y4J9&_YTO&9+G*.Z6]\(/?-++W&282X3GH/ Q<2[
M)!<S2HV!7?$QP9VLC<&D<L_Y@YF\C2=>8(@PQ4@9%TS_;?$*T]1XTAS_%4Z]
M,J8QK(^?O/]MD]?)W#.)5SS]E,1J-?&&'L2X8)M4W?+=/U@DU#/^(IY*>X5=
ML3;P(-I(Q;/"6!-D2>[^V9>B$#6#L,V %@:V$+X+9"FOF6+3L> [$&:U]F8&
M-E5KK>&2W.S*7 G]--%V:CI7/'HX-7G%<,4SO=F2V7*=PMQM%/ %S!53&VE&
MMRB52"+EEF=ZH?4 ;ZY1L225?XY]I;&,<S\J$&8.@;8@$ KO>:Y6$O[*8XR_
M=^#K?,JDZ%-2,]KI\1JC,PC)"=" DC_ ![EB J6[=O@/RZ*%UO]YB_^6(G1X
M/B\]GUO/8=MV&$28-;?C4@B6+U&_#PIFCU!?=\,>[>W+'1,Q?'ZG7<);A9G\
MMP.H5P+U.E/]L,GN49B==]4[@;M\J]/'^ 1TF=$^+4H=P%?85V.W92Y.W\8Q
M6K&=AL$H'/O;/73]DJY_)-U'R]8)TF^ G([H<#_(H 09' FB-6.!R2&609.%
MDGYO/\RPA!G^L#TCG7C#!EZP'VU4HHTZT3Y9E=1%85L46O5AP1(!6Y9N\-#)
MJM[C?:0N[+!&2LX&+74D026.P<MQRZ/635:$&#T/K:;;Y.5H]<-W@(X<0T<K
M.OHS]ID<YG5Q>X>/)*G4G#Q;SMW'["Y/5-=W@E1R3GX3/2>5H)/74G32E/2V
MO:@$G1RKZ+8,!V24-#5]&)A?"TXEZ^3GZ#K9(^QD$ Y:B2IM)Z\E[J2I[GW:
M#UL1*XTGOTCDB[C/>/EI)?'T?TA\=?:ZP6A3XT=GO7!4_[6 5H)/7T7P:5/P
MGXM:J3_]1>I?Q!T> >_7>J,,Q=)V@!(BOLF5:Y/*NV67>>EZJVJY:U'?,[%,
M<@DI+K1IH#^3'@C7];F)XFO;:=USI?LV.USI3AF%6:"?+SA73Q,3H.R]I]\
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MQ9$#>(M/# [F;$Q<*BNE'MWD/I\$D6,$'#+K7%!\[.$6.'>>D,>WRFE0QW3
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MM\#^/I/2/%VXUP+UJZS1?U!+ P04    " !//6]4O+ ,N( "  !2!@  &0
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M;)V6RV[B,!2&7\6*NFBEF>;&I:T J4"KZ:(2*NW,VB0GQ*IC,[8#S-N/[80
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M!22'@M;<S.7F,[2"3BQ?)KEVOV33[HT#DM7:R*H%HP<5$\T_?6D/8@>0C/8
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M!7!_+:5Y6]AIKIW>9_\#4$L#!!0    ( $\];U1/G3^FX0L  +$]   9
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M6LT6-VK;HM&Q#&NJU&WU)^ERAV$J(>;!.$2E1,/2SOPZ3G,0F\[)/$]"EBS
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M648AKM,,M!T22*-H^"@"QK P6SBS(A@W.@2($^3D Y_#&D(Y<'N6"YB-$*
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M?O#Y A-+1.<@:CS$8.+%]\'%19:NY->FLS3+TEC^7%(?]@0< ,_G:9IM+E!
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M^#N$G3RZ)KHK"\Z_ZYN;8-1P=480@:\T!</3(TP@BC03YO$C(VWD,37P^/K
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M7^9RC5MV$+H!OE]RK@XW>@>6_PDP_A]02P,$%     @ 3SUO5"6Z#9G^ 0
M@ 0  !D   !X;"]W;W)K<VAE971S+W-H965T-C$N>&ULE91O:]LP$,:_BC ,
M-EACQW&VKCB&IF%LL$%HV/IB[(5BGV-1_?&D<]-\^YUDQV20!/;&UDGW_/2<
M=5:^-_;9-0#(7I74;A$UB.U='+NR <7=Q+2@::4V5G&DT.YBUUK@51 I&:=)
M\B%67.BHR,/<VA:YZ5 *#6O+7*<4MX<E2+-?1-/H./$H=@WZB;C(6[Z##>"/
M=FTIBD=*)11H)XQF%NI%=#^]6V8^/R3\%+!W)V/F*]D:\^R#K]4B2KPAD%"B
M)W!ZO< #2.E!9.//P(S&+;WP='RD?PZU4RU;[N#!R"=18;.(;B-60<T[B8]F
M_P6&>N:>5QKIPI/M^]P9)9>=0Z,&,3E00O=O_CI\AQ-!.K\@2 =!&GSW&P67
M*XZ\R*W9,^NSB>8'H=2@)G-"^T/9H*5503HLO@&5Y-@-V]!Q5YT$9FHV3+Y=
M 7(AW;L\1MK*"^)RP"Y[;'H!NX)RPF;3]RQ-TNF_\I@<CC;3T68:>+/K-G_=
M;QU:.LG?5YBSD3D+S.P"\RF<&%0W_ 4L-2#UF.]BH7=,^NT8@E7G2K^._<0.
MP*UC&5-&8^-8FK&*']P5Q]GH./L_QY5PI>DT,LL1SEF]SKN=S),WYWS%)PWE
M_\WOW.Z$=O1=:@(EDX_4G+;O]SY TX8>VQJDC@W#AJX(L#Z!UFMC\!CXMATO
MG>(O4$L#!!0    ( $\];U1V!#>5(0,  )X)   9    >&PO=V]R:W-H965T
M<R]S:&5E=#8R+GAM;)566V_3,!3^*U;$ TAL29RD2:>V$G1"('&9-@8/B <W
M.6TLG+C8S@K_GF,GRPIUN_'2VK&_BT^<SY[MI/JA:P!#?C6BU?.@-F9[$8:Z
MK*%A^EQNH<61M50-,]A5FU!O%;#*@1H1TBB:A WC;;"8N6=7:C&3G1&\A2M%
M=-<T3/U^#4+NYD$<W#^XYIO:V ?A8K9E&[@!<[N]4M@+1Y:*-]!J+ENB8#T/
M7L47RSBQ #?C"X>=WFL3NY25E#]LYUTU#R+K" 24QE(P_+N#)0AAF=#'SX$T
M&#4M<+]]S_[&+1X7LV(:EE)\Y96IYT$1D K6K!/F6N[>PK"@S/*54FCW2W;#
MW"@@9:>-; 8P.FAXV_^S7T,A]@!Q>@1 !P!]*B 9 *YR8>_,+>N2&;:8*;DC
MRLY&-MMPM7%H7 UO[6N\,0I'.>+,XCU@#30Y(S>X0:I. )%K<@VE;$LN<,#4
M0&[;BNM2=JV!BBR9KLD;?/LX)MWPIRTH9GB[(8Z,/+\$P[C0+Y#U]N:2/'_V
M@CPCO"6?:]EIUE9Z%AJT;@V$Y6#S=6^3'K%Y">4Y2>*7A$8T]L"73X='?\-#
M+-A8-3I6C3J^Y'35OKU:::-P)WX_P9F,G(GC3(]PHC7J*TR/RAS*?I1WBS3.
MIK/PSJ.5CEKI8UJ)3ZM'3?:U:)'ZM;)1*WM,*_5I98=::4S]6I-1:_*85N;3
MFAQJ96GFU\I'K?PQK8E/*S_4FA2Q7ZL8M8J36I]KP(Q>&U ^Q>) D=*D.+)%
MIJ/D]+2D-$S8Q.%-UQ#AONPM^XT);KS?[]3S.M,\\IN(HX=XBD[:> ]:7Q#6
MV/2QT?2W$3Q(\/#2V+3QPS&@L&>\\1(=^#N+DR(_LN'BO?R,3QJ\ZO7)'1.=
M"\]U9SH%3ZC80+QO*8FR:7'$T4,VQ?0))2L[I:ROWH?@;,4%-QS\5JBG.GF:
MCU:&D*4'67263/,CAA^"+SZ=?!_QL/DOMX>12(LBB_]U>SC-UO=?N^'>X6EO
M+A^8VO!6HY4UXJ+S' E4?QGH.T9NW7FZD@9/9]>L\0(%RD[ \;64YKYCC^CQ
M2K;X U!+ P04    " !//6]4Y8UVZFX"  " !@  &0   'AL+W=O<FMS:&5E
M=',O<VAE970V,RYX;6R%E5%OFS 4A?^*A?K02EL)#A!2$:2D4;5)JQ0U[?8P
M[<$)-V#5V,PV3?OO:QN*LH4T+\$&W_.=$^-+NA?R694 &KU6C*N95VI=W_B^
MVI90$74M:N#FR4[(BF@SE86O:@DD=T45\_%H%/L5H=S+4G=O);-4-)I1#BN)
M5%-51+XM@(G]S N\CQL/M"BUO>%G:4T*6(-^JE?2S/Q>):<5<$4%1Q)V,V\>
MW"RF=KU;\)/"7AV,D4VR$>+93K[G,V]D#0&#K;8*Q%Q>X!88LT+&QM].T^N1
MMO!P_*%^Y[*;+!NBX%:P7S37Y<Q+/)3#CC1,/XC]-^CR1%9O*YAROVC?K1UY
M:-LH+:JNV#BH*&^OY+7['PX*<'"B '<%V/EN0<[EDFB2I5+LD;2KC9H=N*BN
MVIBCW&[*6DOSE)HZG?T $TFAKVAMMCMO&""Q0W>-;B2@>5%(*(@&=$\YK9H*
MK<B;V1"MT.42-*%,7:$+1#EZ+$6C",]5ZFMCRDK[V\[ HC6 3QA8PO8:C8,O
M"(]P\+1>HLN+JW]5?!.ISX7[7-C)CC_/]7N^45J:K?_SB>:XUQP[S?"$IG&(
MAP*V59&KLH?@)0N#.$C]EP%6V+/"<ZSQ$*NMB@]9. F'65'/BLZQPB%6=,P*
M SS,BGM6?(X5#;'B8U841L.L2<^:G&/%0ZS),2M.3NQ7TK.2<ZP),B< ;>!-
M\'P(FQQA,1XGR3!WVG.GGW(?A2;,-@9W/IE]ZU'=G=(A$]/C=S4,)_^']P\:
MBNW-]T06E"NCOS-UH^N)$9!MOVLG6M2NQVR$-AW+#4OSB0!I%YCG.R'TQ\2V
MK?ZCD[T#4$L#!!0    ( $\];U1-TN7$#P,  %8(   9    >&PO=V]R:W-H
M965T<R]S:&5E=#8T+GAM;+56WT_;,!#^5ZQH#R Q\J.T!=16HNVF(14-T;$]
M3'MPG6MCX=B9[5#ZW^_LI*% &WC92V,[ON^^[^YRU\%:Z0>3 5CRE MIAD%F
M;7$9AH9ED%-SJ@J0^&:I=$XM;O4J-(4&FGJC7(1)%/7"G'(9C ;^[%:/!JJT
M@DNXU<24>4[U9@Q"K8=!'&P/[O@JL^X@' T*NH(YV/OB5N,N;%!2GH,T7$FB
M83D,KN++21PY W_C)X>UV5D3)V6AU(/;7*?#('*,0 "S#H+BXQ$F((1#0AY_
M:]"@\>D,=]=;]*]>/(I94 ,3)7[QU&;#X#P@*2QI*>R=6G^#6E#7X3$EC/\E
MZ_IN%!!6&JORVA@9Y%Q63_I4!V+'(.X=,$AJ@^2UP=D!@TYMT/%"*V9>UI1:
M.AIHM2;:W48TM_"Q\=:HADN7QKG5^):CG1U-5)YSBWFQAE"9DHF2ELL52,;!
MD,_D*DVYBS<5Y%I65>.B?S0%2[DPQWCE?CXE1Y^.R2?")?F1J=(@D!F$%NDY
M)R&KJ8PK*LD!*G%";M![9L@7F4+Z$B!$78VX9"MNG+0B3H&=DDY\0I(HB?<0
MFGS</&JATVEBW?%XG0-X,S &@,P RXY,P3#-"Q_-WS.\2:XMY.9/BY^SQL^9
M]W/V;DY)03=5;C4(:B$E5N'2 -4LVY>A"KCK@5T'>!SU(I3^N(=-MV'3;64S
M4ZCZ!0&.Z<TE7W)6%9-:"+[RR[U54\'W=C@],ZK2V'W#^@#G7L.YU\X95ECP
M;/=;.,&.PW1)A9/"E'Y3H179WD>I]!LJ_7>H/"$'BV&ZH<90EI4&+"9T21D7
MW&Y:ZN6\<7'^7^ORHO%ST2KE>P&:NH@2X5U9T/F^&+:CQ!'98/V:%D)Q]-S]
MHE:P.;!28Q2Q\Q?*<$N8P"AC:6*E4I=I8S5GKFX9-7N_F-K!;L;C_IMO)MSI
MT#GHE1]<!BNLE+;J9\UI,QRO_$AX=3YV0]-W_F>8:N+>4+WBTF!LEP@9G?:1
MDJZ&6+6QJO!S8*$L3A6_S'#P@W87\/U2*;O=. ?-7XG1/U!+ P04    " !/
M/6]4E/I8W,\"  #Y!P  &0   'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6RE
ME<ENVS 0AE^%$%(@ 5IK\9K -N E17,(8"1->RAZH*6Q140D59*RD[?OD)(5
M)Y65%KW8)#7SSS?#9<9[J1YU"F#($\^$GGBI,?F5[^LX!4YU1^8@\,M&*DX-
M3M76U[D"FC@GGOE1$ Q\3IGPIF.WME+3L2Q,Q@2L%-$%YU0]SR&3^XD7>H>%
M.[9-C5WPI^.<;N$>S$.^4CCS:Y6$<1":24$4;";>++Q:C*R],_C&8*^/QL1F
MLI;RT4YNDHD76"#((#96@>+?#A:0958(,7Y5FEX=TCH>CP_JGUWNF,N::EC(
M[#M+3#KQ1AY)8$.+S-S)_1>H\NE;O5AFVOV2?64;>"0NM)&\<D8"SD3Y3Y^J
M.APYA(,3#E'E$+UUZ)UPZ%8.79=H2>;26E)#IV,E]T19:U2S U<;YXW9,&%W
M\=XH_,K0STRO>9[)9P R!P$;9L@JHX)\(K,D8;;.-",WHCPLMNKG2S"49?H"
M31[NE^3\[(*<$2;(UU06FHI$CWV#6%;<CRN$>8D0G4 ((W(KA4DUN18))*\%
M?,RG3BHZ)#6/6A67$'=(-_Q(HB *&X 6?^T>7K;@=.L:=YU>]X3>'1BF (^^
M.519DQ^SM38*#_'/E@"].D#/!>B="'!+GQ@O.,E!Q1@%;Q^1&P*'K8VQNHJM
M"[>#1N+EJWERW.VF'6N/=QET@N!#"WB_!N^W"JV:@!6>;Q.G3&Q?D3=AMJN'
MP7N<@YIS\.^<0*@0!5Z06')\5'5Y0QP[)&3]3$P*=4Y-].TQ^^^P#VOV8:M.
M=<.5;BXKV8$V=O'E\#2QML=XO]*CFG;T/[1-:*5@WPG:IK6;#J/NV-\=7_@_
M;7I!4-N4I/[1*\I!;5UST1B^$*9\>^K5NG_-W+/]9GV.?:UL0R\R95.\I6K+
MA"89;% RZ R12)6-IIP8F;NW>BT-OOQNF&)O!F4-\/M&2G.8V !UMY_^!E!+
M P04    " !//6]4(S5E<%$"  ![!0  &0   'AL+W=O<FMS:&5E=',O<VAE
M970V-BYX;6R55-MNVS ,_17"Z$,+;/$E2=<5CH%<-BQ "P1)NST,>U!L)A8J
M2YG$).W?3Y(=+^N:8'NQ*8KGZ) 2F>Z5?C(E(L%S):09!"71YC8,35YBQ4Q'
M;5#:G972%2.[U.O0;#2RPH,J$291=!U6C,L@2[UOIK-4;4EPB3,-9EM53+^,
M4*C]((B#@V/.UR4Y1YBE&[;&!=+C9J;M*FQ9"EZA-%Q)T+@:!,/X=MQW\3[@
M*\>].;+!9;)4ZLDMIL4@B)P@%)B38V#VM\,Q"N&(K(R?#6?0'NF Q_:!_;//
MW>:R9 ;'2GSC!96#X":  E=L*VBN]E^PR<<+S)4P_@O[)C8*(-\:4E4#M@HJ
M+NL_>V[J< 2(KT\ D@:0O ;T3@"Z#:#K$ZV5^;0FC%B6:K4'[:(MFS-\;3S:
M9L.EN\4%:;O++8ZR.0I&6,",:7J!!\VD8;[ !M[#L"BXLYF J:Q?C"O]Y02)
M<6&N;,CC8@*7%U=P 5S"0ZFVALG"I"%9;>Z$,&]TC&H=R0D=<0+W2E)IX),L
ML/B3(+1)M9DEA\Q&R5G&">8=Z,;O((F2^ U!XW^'1V?D=-M"=SU?[Q2?[L =
MDVO49\AZ+5G/DW7_]];@^YT-A2EA97Z<.:C?'M0_JWK&7FS+$I""@FO;>DJ_
M=;<U2=^3N+FQRZ[3<'=<[+\CXH\W41M4BPN/WG&%>NW;VT"NMI+JBV^][009
M^L9YY1_9R5(/@M\T]5BZ9WK-[>,6N+*44>>#E:3K5J\7I#:^6Y:*;.]YL[33
M$;4+L/LKI>BP< >T\S;[!5!+ P04    " !//6]4X_.,YA\#   N$@  #0
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M6_]Q_/@L.]OT;_EL_"/:X@502P$"% ,4    " !//6]4!T%-8H$   "Q
M$               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (
M $\];U0X01_.[@   "L"   1              "  :\   !D;V-0<F]P<R]C
M;W)E+GAM;%!+ 0(4 Q0    ( $\];U297)PC$ 8  )PG   3
M  "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ 3SUO5,/J
MKFJY!@  :QP  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE
M970Q+GAM;%!+ 0(4 Q0    ( $\];U3<CY%$K 4  )46   8
M  " @?P.  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " !/
M/6]4*X1(1;L"  !'"0  &               @('>%   >&PO=V]R:W-H965T
M<R]S:&5E=#,N>&UL4$L! A0#%     @ 3SUO5 Z#DD%:!   N X  !@
M         ("!SQ<  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0
M   ( $\];U1X%94?M@(  '4'   8              " @5\<  !X;"]W;W)K
M<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " !//6]4.O)< .T$   #%0
M&               @(%+'P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L!
M A0#%     @ 3SUO5 E8(#]K!@  0!H  !@              ("!;B0  'AL
M+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( $\];U2?E"?MT@0
M *L*   8              " @0\K  !X;"]W;W)K<VAE971S+W-H965T."YX
M;6Q02P$"% ,4    " !//6]4R8<$TXXG  !+A0  &               @($7
M,   >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ 3SUO5&TY
MCNT. P  _P8  !D              ("!VU<  'AL+W=O<FMS:&5E=',O<VAE
M970Q,"YX;6Q02P$"% ,4    " !//6]4X[/X7)H"  #4!0  &0
M    @($@6P  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    (
M $\];U2*4FQI_ (  %P&   9              " @?%=  !X;"]W;W)K<VAE
M971S+W-H965T,3(N>&UL4$L! A0#%     @ 3SUO5.R'($.% @  8P4  !D
M             ("!)&$  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"
M% ,4    " !//6]45$'LA@@%  "H#   &0              @('@8P  >&PO
M=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( $\];U3:=[U7?08
M -L/   9              " @1]I  !X;"]W;W)K<VAE971S+W-H965T,34N
M>&UL4$L! A0#%     @ 3SUO5/%8GS E"@  >1P  !D              ("!
MTV\  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " !//6]4
M#,1\!0D$  !_"0  &0              @($O>@  >&PO=V]R:W-H965T<R]S
M:&5E=#$W+GAM;%!+ 0(4 Q0    ( $\];U1-NA/,P@L  $,B   9
M      " @6]^  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%
M  @ 3SUO5$4"$C1B$@  ?D$  !D              ("!:(H  'AL+W=O<FMS
M:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4    " !//6]4+)GA;[X.   C+
M&0              @($!G0  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+
M 0(4 Q0    ( $\];U2/OPWUN 8  .X/   9              " @?:K  !X
M;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ 3SUO5![YYR4(
M#   6!\  !D              ("!Y;(  'AL+W=O<FMS:&5E=',O<VAE970R
M,BYX;6Q02P$"% ,4    " !//6]4^0,?(/L"  ""!@  &0
M@($DOP  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( $\]
M;U1AV.&M&P,  -X&   9              " @5;"  !X;"]W;W)K<VAE971S
M+W-H965T,C0N>&UL4$L! A0#%     @ 3SUO5(9WF+YP+@  =:(  !D
M         ("!J,4  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4
M    " !//6]4S ="5TX$   X"@  &0              @(%/]   >&PO=V]R
M:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( $\];U22W65G+P,  !\'
M   9              " @=3X  !X;"]W;W)K<VAE971S+W-H965T,C<N>&UL
M4$L! A0#%     @ 3SUO5*&*A$>E @  NP4  !D              ("!.OP
M 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " !//6]4"3A!
MBL4"  #6!0  &0              @($6_P  >&PO=V]R:W-H965T<R]S:&5E
M=#(Y+GAM;%!+ 0(4 Q0    ( $\];U3B\8<FDP(  &0%   9
M  " @1(" 0!X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%     @
M3SUO5*WK$A&P @  J04  !D              ("!W 0! 'AL+W=O<FMS:&5E
M=',O<VAE970S,2YX;6Q02P$"% ,4    " !//6]4?,I>^S$%  !,#P  &0
M            @('#!P$ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4
M Q0    ( $\];U2J\SBHSP0  *8,   9              " @2L- 0!X;"]W
M;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ 3SUO5-5\$;OC P
M:PD  !D              ("!,1(! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX
M;6Q02P$"% ,4    " !//6]4WO(=EG "  "F!0  &0              @(%+
M%@$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( $\];U23
M4J/]6P0  !<3   9              " @?(8 0!X;"]W;W)K<VAE971S+W-H
M965T,S8N>&UL4$L! A0#%     @ 3SUO5-1U[TC2 @  R0D  !D
M     ("!A!T! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4
M" !//6]479!YA?$"  !.!P  &0              @(&-( $ >&PO=V]R:W-H
M965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( $\];U1DWJU$,P,  $$+   9
M              " @;4C 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L!
M A0#%     @ 3SUO5,A>27V1 P  0 X  !D              ("!'R<! 'AL
M+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    " !//6]4F#[Z+;T"
M  #J!P  &0              @('G*@$ >&PO=V]R:W-H965T<R]S:&5E=#0Q
M+GAM;%!+ 0(4 Q0    ( $\];U0;[NH(3 ,  )4,   9              "
M@=LM 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ 3SUO
M5(3@GUY' @  , 4  !D              ("!7C$! 'AL+W=O<FMS:&5E=',O
M<VAE970T,RYX;6Q02P$"% ,4    " !//6]4_,#I.YT"   )!P  &0
M        @('<,P$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0
M   ( $\];U0J ,16>@0  )D2   9              " @; V 0!X;"]W;W)K
M<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ 3SUO5)PLU=&:!   .Q0
M !D              ("!83L! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q0
M2P$"% ,4    " !//6]435WR#*L"  #7!P  &0              @($R0 $
M>&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( $\];U08KD7Z
MF 8  %L:   9              " @11# 0!X;"]W;W)K<VAE971S+W-H965T
M-#@N>&UL4$L! A0#%     @ 3SUO5!'-Y8=+!0  \A8  !D
M ("!XTD! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    " !/
M/6]4P>SUHKT"  #:!P  &0              @(%E3P$ >&PO=V]R:W-H965T
M<R]S:&5E=#4P+GAM;%!+ 0(4 Q0    ( $\];U2OTA*V@@,  (</   9
M          " @5E2 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#
M%     @ 3SUO5.=&4Y@E P  _@D  !D              ("!$E8! 'AL+W=O
M<FMS:&5E=',O<VAE970U,BYX;6Q02P$"% ,4    " !//6]4,UN6>70%  #6
M&@  &0              @(%N60$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM
M;%!+ 0(4 Q0    ( $\];U2\L RX@ (  %(&   9              " @1E?
M 0!X;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ 3SUO5,<1
MN=OJ @  ]PD  !D              ("!T&$! 'AL+W=O<FMS:&5E=',O<VAE
M970U-2YX;6Q02P$"% ,4    " !//6]4W@>VPE0#  #Q"@  &0
M    @('Q9 $ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    (
M $\];U3;R4*!E ,  ,D+   9              " @7QH 0!X;"]W;W)K<VAE
M971S+W-H965T-3<N>&UL4$L! A0#%     @ 3SUO5$^=/Z;A"P  L3T  !D
M             ("!1VP! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"
M% ,4    " !//6]4RT<K!_H$  !]%P  &0              @(%?> $ >&PO
M=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( $\];U14LBZM5 0
M ! 0   9              " @9!] 0!X;"]W;W)K<VAE971S+W-H965T-C N
M>&UL4$L! A0#%     @ 3SUO5"6Z#9G^ 0  @ 0  !D              ("!
M&X(! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    " !//6]4
M=@0WE2$#  ">"0  &0              @(%0A $ >&PO=V]R:W-H965T<R]S
M:&5E=#8R+GAM;%!+ 0(4 Q0    ( $\];U3EC7;J;@(  ( &   9
M      " @:B' 0!X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%
M  @ 3SUO5$W2Y<0/ P  5@@  !D              ("!38H! 'AL+W=O<FMS
M:&5E=',O<VAE970V-"YX;6Q02P$"% ,4    " !//6]4E/I8W,\"  #Y!P
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M+G)E;'-02P$"% ,4    " !//6]4<F=VP1$%  #%*P  #P
M@ %4EP$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ 3SUO5![?F5X< @
M/2<  !H              ( !DIP! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ 3SUO5*5_#G'N 0  D"8  !,              ( !
MYIX! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     $H 2@ ]%   !:$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>157</ContextCount>
  <ElementCount>463</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>70</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100040 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100050 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100060 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100070 - Statement - Consolidated Statement of Stockholders Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity</Role>
      <ShortName>Consolidated Statement of Stockholders Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100080 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100090 - Disclosure - Organization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganization1</Role>
      <ShortName>Organization</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100100 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100110 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>100120 - Disclosure - Prepaid Expenses and Other Current Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssets</Role>
      <ShortName>Prepaid Expenses and Other Current Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>100130 - Disclosure - Property and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipment</Role>
      <ShortName>Property and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100140 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>100150 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>100180 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>100190 - Disclosure - Stock-based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensation</Role>
      <ShortName>Stock-based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>100200 - Disclosure - Employee Stock Purchase Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlan</Role>
      <ShortName>Employee Stock Purchase Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>100210 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>100220 - Disclosure - Research and License Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreements</Role>
      <ShortName>Research and License Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>100230 - Disclosure - Collaboration Agreement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreement</Role>
      <ShortName>Collaboration Agreement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>100240 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/DisclosureLeases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>100250 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>100260 - Disclosure - Employee Benefit Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeBenefitPlan</Role>
      <ShortName>Employee Benefit Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>100270 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureRelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>100280 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>100290 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>100300 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurements</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>100310 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables</Role>
      <ShortName>Prepaid Expenses and Other Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssets</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>100320 - Disclosure - Property and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentTables</Role>
      <ShortName>Property and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipment</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>100330 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpenses</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>100340 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquity</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>100350 - Disclosure - Stock-based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables</Role>
      <ShortName>Stock-based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensation</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>100360 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxes</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>100370 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://frequencytx.com/20211231/taxonomy/role/DisclosureLeases</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>100380 - Disclosure - Organization - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails</Role>
      <ShortName>Organization - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>100390 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>100400 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>100410 - Disclosure - Summary of Significant Accounting Policies - Schedule of Basic And Diluted Net Loss per Share Attributable to Common Stockholders (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Basic And Diluted Net Loss per Share Attributable to Common Stockholders (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>100420 - Disclosure - Summary of Significant Accounting Policies - Computation of Diluted Net Loss per Share Attributable to Common Stockholders (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Computation of Diluted Net Loss per Share Attributable to Common Stockholders (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>100430 - Disclosure - Fair Value Measurements - Schedule of Financial Assets Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Financial Assets Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>100440 - Disclosure - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails</Role>
      <ShortName>Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>100450 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails</Role>
      <ShortName>Property and Equipment - Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>100460 - Disclosure - Property and Equipment - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails</Role>
      <ShortName>Property and Equipment - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>100470 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails</Role>
      <ShortName>Accrued Expenses - Schedule of Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>100480 - Disclosure - Debt - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails</Role>
      <ShortName>Debt - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>100510 - Disclosure - Stockholders' Equity - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails</Role>
      <ShortName>Stockholders' Equity - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>100520 - Disclosure - Stockholders' Equity - Schedule of Common Stock Shares Reserved for Future Issuance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Common Stock Shares Reserved for Future Issuance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>100530 - Disclosure - Stock-based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Stock-based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>100540 - Disclosure - Stock-based Compensation - Summary of Stock Option Activity under 2014 Plan and 2019 Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails</Role>
      <ShortName>Stock-based Compensation - Summary of Stock Option Activity under 2014 Plan and 2019 Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>100550 - Disclosure - Stock-based Compensation - Summary of Grant-date Fair Value of Stock Options Granted on Weighted Average Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfGrantDateFairValueOfStockOptionsGrantedOnWeightedAverageBasisDetails</Role>
      <ShortName>Stock-based Compensation - Summary of Grant-date Fair Value of Stock Options Granted on Weighted Average Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>100560 - Disclosure - Stock-based Compensation - Summary of Status of Restricted Common Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails</Role>
      <ShortName>Stock-based Compensation - Summary of Status of Restricted Common Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>100570 - Disclosure - Employee Stock Purchase Plan - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlanAdditionalInformationDetails</Role>
      <ShortName>Employee Stock Purchase Plan - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>100580 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>100590 - Disclosure - Income Taxes - Schedule of Reconciliation Pre-tax Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationPreTaxIncomeDetails</Role>
      <ShortName>Income Taxes - Schedule of Reconciliation Pre-tax Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>100600 - Disclosure - Income Taxes - Schedule of Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionDetails</Role>
      <ShortName>Income Taxes - Schedule of Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>100610 - Disclosure - Income Taxes - Schedule of Reconciliation of U.S. Federal Statutory Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails</Role>
      <ShortName>Income Taxes - Schedule of Reconciliation of U.S. Federal Statutory Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>100620 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails</Role>
      <ShortName>Income Taxes - Schedule of Deferred Tax Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>100630 - Disclosure - Research and License Agreements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails</Role>
      <ShortName>Research and License Agreements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>100640 - Disclosure - Collaboration Agreement - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails</Role>
      <ShortName>Collaboration Agreement - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>100650 - Disclosure - Leases - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails</Role>
      <ShortName>Leases - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>100660 - Disclosure - Leases - Schedule of Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfLeasesDetails</Role>
      <ShortName>Leases - Schedule of Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>100670 - Disclosure - Leases - Schedule of Reconciles the Undiscounted Cash Flows to the Operating Lease (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails</Role>
      <ShortName>Leases - Schedule of Reconciles the Undiscounted Cash Flows to the Operating Lease (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>100680 - Disclosure - Leases - Schedule of Future Aggregate Minimum Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails</Role>
      <ShortName>Leases - Schedule of Future Aggregate Minimum Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>100690 - Disclosure - Commitments and Contingencies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails</Role>
      <ShortName>Commitments and Contingencies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>100700 - Disclosure - Employee Benefit Plan - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeBenefitPlanAdditionalInformationDetails</Role>
      <ShortName>Employee Benefit Plan - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="freq-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>100710 - Disclosure - Related Party Transactions - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails</Role>
      <ShortName>Related Party Transactions - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="freq-20211231.htm">freq-20211231.htm</File>
    <File>freq-20211231.xsd</File>
    <File>freq-20211231_cal.xml</File>
    <File>freq-20211231_def.xml</File>
    <File>freq-20211231_lab.xml</File>
    <File>freq-20211231_pre.xml</File>
    <File>freq-ex10_7.htm</File>
    <File>freq-ex21_1.htm</File>
    <File>freq-ex23_1.htm</File>
    <File>freq-ex31_1.htm</File>
    <File>freq-ex31_2.htm</File>
    <File>freq-ex32_1.htm</File>
    <File>freq-ex32_2.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img88009329_0.jpg</File>
    <File>img88009329_1.jpg</File>
    <File>img88009329_10.jpg</File>
    <File>img88009329_11.jpg</File>
    <File>img88009329_12.jpg</File>
    <File>img88009329_13.jpg</File>
    <File>img88009329_14.jpg</File>
    <File>img88009329_15.jpg</File>
    <File>img88009329_16.jpg</File>
    <File>img88009329_17.jpg</File>
    <File>img88009329_18.jpg</File>
    <File>img88009329_19.jpg</File>
    <File>img88009329_2.jpg</File>
    <File>img88009329_20.jpg</File>
    <File>img88009329_21.jpg</File>
    <File>img88009329_22.jpg</File>
    <File>img88009329_23.jpg</File>
    <File>img88009329_24.jpg</File>
    <File>img88009329_3.jpg</File>
    <File>img88009329_4.jpg</File>
    <File>img88009329_5.jpg</File>
    <File>img88009329_6.jpg</File>
    <File>img88009329_7.jpg</File>
    <File>img88009329_8.jpg</File>
    <File>img88009329_9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="561">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="40">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>112
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "freq-20211231.htm": {
   "axisCustom": 0,
   "axisStandard": 28,
   "contextCount": 157,
   "dts": {
    "calculationLink": {
     "local": [
      "freq-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "freq-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "freq-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "freq-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "freq-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "freq-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 622,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 10,
    "http://frequencytx.com/20211231": 2,
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 17
   },
   "keyCustom": 67,
   "keyStandard": 396,
   "memberCustom": 32,
   "memberStandard": 38,
   "nsprefix": "freq",
   "nsuri": "http://frequencytx.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100110 - Disclosure - Fair Value Measurements",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "freq:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100120 - Disclosure - Prepaid Expenses and Other Current Assets",
     "role": "http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssets",
     "shortName": "Prepaid Expenses and Other Current Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "freq:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100130 - Disclosure - Property and Equipment",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipment",
     "shortName": "Property and Equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100140 - Disclosure - Accrued Expenses",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpenses",
     "shortName": "Accrued Expenses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100150 - Disclosure - Debt",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100180 - Disclosure - Stockholders' Equity",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100190 - Disclosure - Stock-based Compensation",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensation",
     "shortName": "Stock-based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "freq:EmployeeStockPurchasePlanDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100200 - Disclosure - Employee Stock Purchase Plan",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlan",
     "shortName": "Employee Stock Purchase Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "freq:EmployeeStockPurchasePlanDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100210 - Disclosure - Income Taxes",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "freq:ResearchAndLicenseAgreementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100220 - Disclosure - Research and License Agreements",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreements",
     "shortName": "Research and License Agreements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "freq:ResearchAndLicenseAgreementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010 - Statement - Consolidated Balance Sheets",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100230 - Disclosure - Collaboration Agreement",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreement",
     "shortName": "Collaboration Agreement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100240 - Disclosure - Leases",
     "role": "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100250 - Disclosure - Commitments and Contingencies",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100260 - Disclosure - Employee Benefit Plan",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeBenefitPlan",
     "shortName": "Employee Benefit Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100270 - Disclosure - Related Party Transactions",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureRelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100280 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "freq:PropertyAndEquipmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100290 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "freq:PropertyAndEquipmentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100300 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "freq:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "freq:SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100310 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables",
     "shortName": "Prepaid Expenses and Other Current Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "freq:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "freq:SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100320 - Disclosure - Property and Equipment (Tables)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentTables",
     "shortName": "Property and Equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100330 - Disclosure - Accrued Expenses (Tables)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesTables",
     "shortName": "Accrued Expenses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "freq:ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100340 - Disclosure - Stockholders' Equity (Tables)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "freq:ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100350 - Disclosure - Stock-based Compensation (Tables)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables",
     "shortName": "Stock-based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100360 - Disclosure - Income Taxes (Tables)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100370 - Disclosure - Leases (Tables)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RetainedEarningsAccumulatedDeficit",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100380 - Disclosure - Organization - Additional Information (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
     "shortName": "Organization - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100390 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "span",
       "p",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": "INF",
      "lang": null,
      "name": "freq:FairValueOfTermLoan",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "freq:PropertyAndEquipmentTableTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_23b528ed-dd66-4d9c-8b20-60a086d86ba5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100400 - Disclosure - Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "freq:PropertyAndEquipmentTableTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_23b528ed-dd66-4d9c-8b20-60a086d86ba5",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100410 - Disclosure - Summary of Significant Accounting Policies - Schedule of Basic And Diluted Net Loss per Share Attributable to Common Stockholders (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Basic And Diluted Net Loss per Share Attributable to Common Stockholders (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100420 - Disclosure - Summary of Significant Accounting Policies - Computation of Diluted Net Loss per Share Attributable to Common Stockholders (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails",
     "shortName": "Summary of Significant Accounting Policies - Computation of Diluted Net Loss per Share Attributable to Common Stockholders (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "div",
       "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050 - Statement - Consolidated Statements of Operations",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations",
     "shortName": "Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:GeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_cc3ef655-c17e-488c-8981-986ec4c9084c",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100430 - Disclosure - Fair Value Measurements - Schedule of Financial Assets Measured on Recurring Basis (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Schedule of Financial Assets Measured on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "div",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_cc3ef655-c17e-488c-8981-986ec4c9084c",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "freq:SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
       "div",
       "freq:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "freq:PrepaidRentAndDepositsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100440 - Disclosure - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails",
     "shortName": "Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "freq:SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
       "div",
       "freq:PrepaidExpensesAndOtherCurrentAssetsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "freq:PrepaidRentAndDepositsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100450 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails",
     "shortName": "Property and Equipment - Schedule of Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100460 - Disclosure - Property and Equipment - Additional Information (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails",
     "shortName": "Property and Equipment - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100470 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails",
     "shortName": "Accrued Expenses - Schedule of Accrued Expenses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100480 - Disclosure - Debt - Additional Information (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails",
     "shortName": "Debt - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DebtDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "4",
      "first": true,
      "lang": null,
      "name": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100510 - Disclosure - Stockholders' Equity - Additional Information (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
     "shortName": "Stockholders' Equity - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_9a6459ef-90a2-45d3-bb28-8c54d3edc4d6",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:SaleOfStockPricePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "freq:ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100520 - Disclosure - Stockholders' Equity - Schedule of Common Stock Shares Reserved for Future Issuance (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails",
     "shortName": "Stockholders' Equity - Schedule of Common Stock Shares Reserved for Future Issuance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "freq:ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_fd9346ee-0123-48e4-a5e9-177e9e88d4c9",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "freq:ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100530 - Disclosure - Stock-based Compensation - Additional Information (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
     "shortName": "Stock-based Compensation - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_ac62a1b7-c43f-4181-a7f5-94b13f47cb97",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100540 - Disclosure - Stock-based Compensation - Summary of Stock Option Activity under 2014 Plan and 2019 Plan (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails",
     "shortName": "Stock-based Compensation - Summary of Stock Option Activity under 2014 Plan and 2019 Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_3518f4db-a6ab-442b-9131-2ac71642f3dc",
      "decimals": "0",
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060 - Statement - Consolidated Statements of Comprehensive Loss",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveLoss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100550 - Disclosure - Stock-based Compensation - Summary of Grant-date Fair Value of Stock Options Granted on Weighted Average Basis (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfGrantDateFairValueOfStockOptionsGrantedOnWeightedAverageBasisDetails",
     "shortName": "Stock-based Compensation - Summary of Grant-date Fair Value of Stock Options Granted on Weighted Average Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_8f05e1d9-5717-4801-93c4-ba371f31a50e",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100560 - Disclosure - Stock-based Compensation - Summary of Status of Restricted Common Stock (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails",
     "shortName": "Stock-based Compensation - Summary of Status of Restricted Common Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_8f05e1d9-5717-4801-93c4-ba371f31a50e",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "freq:ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock",
       "div",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100570 - Disclosure - Employee Stock Purchase Plan - Additional Information (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlanAdditionalInformationDetails",
     "shortName": "Employee Stock Purchase Plan - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "freq:EmployeeStockPurchasePlanDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_ad952da4-5b38-4e64-a1f0-d990bf170c57",
      "decimals": "2",
      "lang": null,
      "name": "freq:PercentageOfEligibleEmployeeCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100580 - Disclosure - Income Taxes - Additional Information (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
     "shortName": "Income Taxes - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100590 - Disclosure - Income Taxes - Schedule of Reconciliation Pre-tax Income (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationPreTaxIncomeDetails",
     "shortName": "Income Taxes - Schedule of Reconciliation Pre-tax Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100600 - Disclosure - Income Taxes - Schedule of Provision (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionDetails",
     "shortName": "Income Taxes - Schedule of Provision (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100610 - Disclosure - Income Taxes - Schedule of Reconciliation of U.S. Federal Statutory Income Tax Rate (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails",
     "shortName": "Income Taxes - Schedule of Reconciliation of U.S. Federal Statutory Income Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100620 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails",
     "shortName": "Income Taxes - Schedule of Deferred Tax Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100630 - Disclosure - Research and License Agreements - Additional Information (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails",
     "shortName": "Research and License Agreements - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "freq:ResearchAndLicenseAgreementsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_aef0c60c-efa8-489b-aeea-79457818c6d2",
      "decimals": "-3",
      "lang": null,
      "name": "freq:IncreaseDecreaseInResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100640 - Disclosure - Collaboration Agreement - Additional Information (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails",
     "shortName": "Collaboration Agreement - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_81406c60-6425-4fce-9724-dd646af7f352",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ProceedsFromCollaborators",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_fa37d2a6-9437-44d8-82ac-ad9b23ac3a6b",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070 - Statement - Consolidated Statement of Stockholders Equity",
     "role": "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity",
     "shortName": "Consolidated Statement of Stockholders Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_fa37d2a6-9437-44d8-82ac-ad9b23ac3a6b",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100650 - Disclosure - Leases - Additional Information (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
     "shortName": "Leases - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100660 - Disclosure - Leases - Schedule of Leases (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfLeasesDetails",
     "shortName": "Leases - Schedule of Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100670 - Disclosure - Leases - Schedule of Reconciles the Undiscounted Cash Flows to the Operating Lease (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails",
     "shortName": "Leases - Schedule of Reconciles the Undiscounted Cash Flows to the Operating Lease (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100680 - Disclosure - Leases - Schedule of Future Aggregate Minimum Payments (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails",
     "shortName": "Leases - Schedule of Future Aggregate Minimum Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_a26d2fd0-a4c8-42fb-ae77-1bba378b8de8",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsDueCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermPurchaseCommitmentAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100690 - Disclosure - Commitments and Contingencies - Additional Information (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
     "shortName": "Commitments and Contingencies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LongTermPurchaseCommitmentAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100700 - Disclosure - Employee Benefit Plan - Additional Information (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeBenefitPlanAdditionalInformationDetails",
     "shortName": "Employee Benefit Plan - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_be99fc1c-8083-4f95-90f4-0e839dbb422d",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PaymentForManagementFee",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100710 - Disclosure - Related Party Transactions - Additional Information (Details)",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
     "shortName": "Related Party Transactions - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100080 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100090 - Disclosure - Organization",
     "role": "http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganization1",
     "shortName": "Organization",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100100 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "freq-20211231.htm",
      "contextRef": "C_740cc1b5-7cfa-4fd1-9820-5f7454d03afa",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 70,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "verboseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r658",
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm Id"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r658",
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r658",
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r658",
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address Address Line"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address City Or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address State Or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "verboseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterestAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r665"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when an entity was incorporated",
        "label": "Entity Incorporation, Date of Incorporation",
        "terseLabel": "Date of incorporation"
       }
      }
     },
     "localname": "EntityIncorporationDateOfIncorporation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r664"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r658",
      "r659",
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterestAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r654"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "freq_AREMARegionNo20LLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ARE-MA Region No. 20, LLC.",
        "label": "A R E M A Region No20 L L C [Member]",
        "terseLabel": "ARE-MA Region No. 20, LLC"
       }
      }
     },
     "localname": "AREMARegionNo20LLCMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued income taxes and other accrued liabilities, current.",
        "label": "Accrued Income Taxes And Other Accrued Liabilities Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "AccruedIncomeTaxesAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_AccruedThirdPartyResearchAndDevelopmentExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued third-party research and development expenses current.",
        "label": "Accrued Third Party Research And Development Expenses Current",
        "terseLabel": "Third-party research and development expenses"
       }
      }
     },
     "localname": "AccruedThirdPartyResearchAndDevelopmentExpensesCurrent",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_AdditionalFundingPaymentsMadeAsConsiderationToSupportResearchActivities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional funding payments made as consideration to support research activities.",
        "label": "Additional Funding Payments Made As Consideration To Support Research Activities",
        "terseLabel": "Additional funding payments made as consideration to support research activities"
       }
      }
     },
     "localname": "AdditionalFundingPaymentsMadeAsConsiderationToSupportResearchActivities",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_AgreementTerminationNoticePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement termination notice period.",
        "label": "Agreement Termination Notice Period",
        "terseLabel": "Agreement termination notice period"
       }
      }
     },
     "localname": "AgreementTerminationNoticePeriod",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "freq_AmountOfFundingReceivedAsGrant": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of funding received as grant.",
        "label": "Amount Of Funding Received As Grant",
        "terseLabel": "Amount of funding received as grant"
       }
      }
     },
     "localname": "AmountOfFundingReceivedAsGrant",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_AnnualLicenseFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual license fee",
        "label": "Annual License Fee",
        "terseLabel": "Annual license fee"
       }
      }
     },
     "localname": "AnnualLicenseFee",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_AnnualLicenseFeePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual License Fee Per Share",
        "label": "Annual License Fee Per Share",
        "terseLabel": "Annual license fee per share"
       }
      }
     },
     "localname": "AnnualLicenseFeePerShare",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "freq_AstellasPharmaLimitedLiabilityCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Astellas pharma limited liability company.",
        "label": "Astellas Pharma Limited Liability Company [Member]",
        "terseLabel": "Astellas Pharma LLC"
       }
      }
     },
     "localname": "AstellasPharmaLimitedLiabilityCompanyMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_CaliforniaInstituteForBiomedicalResearchMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "California Institute for Biomedical Research.",
        "label": "California Institute For Biomedical Research [Member]",
        "terseLabel": "CALIBR"
       }
      }
     },
     "localname": "CaliforniaInstituteForBiomedicalResearchMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_CambridgeEnterpriseLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cambridge Enterprise Limited.",
        "label": "Cambridge Enterprise Limited [Member]",
        "terseLabel": "Cambridge"
       }
      }
     },
     "localname": "CambridgeEnterpriseLimitedMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer liability revenue recognized from commercialization milestones.",
        "label": "Contract With Customer Liability Revenue Recognized From Commercialization Milestones",
        "terseLabel": "Revenue recognized commercialization milestone payments to receive"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognizedFromCommercializationMilestones",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_ConversionOfFrequencyJapanPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion of Frequency Japan preferred stock member.",
        "label": "Conversion Of Frequency Japan Preferred Stock [Member]",
        "terseLabel": "Conversion of Frequency Japan Preferred Stock"
       }
      }
     },
     "localname": "ConversionOfFrequencyJapanPreferredStockMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_CumulativeChangeInOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cumulative change in ownership percentage.",
        "label": "Cumulative Change In Ownership Percentage",
        "terseLabel": "Cumulative change in ownership percentage"
       }
      }
     },
     "localname": "CumulativeChangeInOwnershipPercentage",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "freq_DebtInstrumentFloorInterestRatePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument floor interest rate percentage.",
        "label": "Debt Instrument Floor Interest Rate Percentage",
        "terseLabel": "Interest rate floor percentage"
       }
      }
     },
     "localname": "DebtInstrumentFloorInterestRatePercentage",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "freq_DebtInstrumentInterestOnlyPaymentMaturityDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument interest only payment maturity date.",
        "label": "Debt Instrument Interest Only Payment Maturity Date",
        "terseLabel": "Monthly interest only payments due"
       }
      }
     },
     "localname": "DebtInstrumentInterestOnlyPaymentMaturityDate",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "freq_DebtInstrumentPrepaymentPremiumPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument prepayment premium percentage.",
        "label": "Debt Instrument Prepayment Premium Percentage",
        "terseLabel": "Debt instrument prepayment premium percentage"
       }
      }
     },
     "localname": "DebtInstrumentPrepaymentPremiumPercentage",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "freq_DeferredTaxAssetsLeasingArrangements": {
     "auth_ref": [],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets leasing arrangements.",
        "label": "Deferred Tax Assets Leasing Arrangements",
        "terseLabel": "Lease liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeasingArrangements",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets liabilities property plant and equipment.",
        "label": "Deferred Tax Assets Liabilities Property Plant And Equipment",
        "terseLabel": "Fixed assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_DeferredTaxAssetsRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets right of use assets.",
        "label": "Deferred Tax Assets Right Of Use Assets",
        "negatedLabel": "Right of use asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsRightOfUseAssets",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_DelawareLimitedLiabilityCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Delaware Limited Liability Company.",
        "label": "Delaware Limited Liability Company [Member]",
        "terseLabel": "LLC(FT-FJ)"
       }
      }
     },
     "localname": "DelawareLimitedLiabilityCompanyMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterestAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_DescriptionOfConditionsToTerminateLicenseAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of conditions to terminate license agreement.",
        "label": "Description Of Conditions To Terminate License Agreement",
        "terseLabel": "Description of conditions to terminate license agreement"
       }
      }
     },
     "localname": "DescriptionOfConditionsToTerminateLicenseAgreement",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "freq_DescriptionOfFutureDevelopmentObligations": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of future development obligations.",
        "label": "Description Of Future Development Obligations",
        "terseLabel": "Description of future development obligations"
       }
      }
     },
     "localname": "DescriptionOfFutureDevelopmentObligations",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "freq_EmployeeStockPurchasePlanDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee stock purchase plan disclosure.",
        "label": "Employee Stock Purchase Plan Disclosure [Text Block]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlanDisclosureTextBlock",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "freq_FairValueOfTermLoan": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of term loan.",
        "label": "Fair Value Of Term Loan",
        "terseLabel": "Fair value of term loan"
       }
      }
     },
     "localname": "FairValueOfTermLoan",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_FairValueOfTermLoanIssuedTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of term loan issued term.",
        "label": "Fair Value Of Term Loan Issued Term",
        "terseLabel": "Fair value of term loan issued term"
       }
      }
     },
     "localname": "FairValueOfTermLoanIssuedTerm",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "freq_FundingPaymentsMadeAsConsiderationToSupportResearchActivities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Funding payments made as consideration to support research activities.",
        "label": "Funding Payments Made As Consideration To Support Research Activities",
        "terseLabel": "Funding payments as consideration to support research activities"
       }
      }
     },
     "localname": "FundingPaymentsMadeAsConsiderationToSupportResearchActivities",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_FurnitureAndOfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Furniture and office equipment.",
        "label": "Furniture And Office Equipment [Member]",
        "terseLabel": "Furniture and Office Equipment"
       }
      }
     },
     "localname": "FurnitureAndOfficeEquipmentMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_GrantTermPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant term period.",
        "label": "Grant Term Period",
        "terseLabel": "Grant term period"
       }
      }
     },
     "localname": "GrantTermPeriod",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "freq_HaydenLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hayden LLC.",
        "label": "Hayden L L C [Member]",
        "terseLabel": "Hayden LLC"
       }
      }
     },
     "localname": "HaydenLLCMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_IncomeTaxesDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income taxes disclosure.",
        "label": "Income Taxes Disclosure [Line Items]",
        "terseLabel": "Income Taxes Disclosure [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxesDisclosureLineItems",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "freq_IncomeTaxesDisclosureTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income taxes disclosure.",
        "label": "Income Taxes Disclosure [Table]",
        "terseLabel": "Income Taxes Disclosure [Table]"
       }
      }
     },
     "localname": "IncomeTaxesDisclosureTable",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "freq_IncreaseDecreaseInOperatingLeaseRightOfUseAssets": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in operating lease right of use assets.",
        "label": "Increase Decrease In Operating Lease Right Of Use Assets",
        "terseLabel": "Increase in right-of-use asset"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAssets",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_IncreaseDecreaseInResearchAndDevelopmentExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (decrease) in research and development expenses.",
        "label": "Increase Decrease In Research And Development Expense",
        "terseLabel": "Decrease in research and development expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInResearchAndDevelopmentExpense",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_LabEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lab equipment.",
        "label": "Lab Equipment [Member]",
        "terseLabel": "Lab Equipment"
       }
      }
     },
     "localname": "LabEquipmentMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_LeaseExpirationYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease expiration year.",
        "label": "Lease Expiration Year",
        "terseLabel": "Lease, expiration year"
       }
      }
     },
     "localname": "LeaseExpirationYear",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "freq_LeaseExpirationYear1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Expiration Year 1",
        "label": "Lease Expiration Year 1",
        "terseLabel": "Lease, expiration year"
       }
      }
     },
     "localname": "LeaseExpirationYear1",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearMonthItemType"
    },
    "freq_LeasesTerminationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease termination agreement.",
        "label": "Leases Termination Agreement [Member]",
        "terseLabel": "Lease Termination Agreement"
       }
      }
     },
     "localname": "LeasesTerminationAgreementMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_LexingtonLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lexington lease.",
        "label": "Lexington Lease [Member]",
        "terseLabel": "Lexington Lease"
       }
      }
     },
     "localname": "LexingtonLeaseMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_LexingtonMassachusettsFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lexington Massachusetts facility.",
        "label": "Lexington Massachusetts Facility [Member]",
        "terseLabel": "Lexington Massachusetts facility"
       }
      }
     },
     "localname": "LexingtonMassachusettsFacilityMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_LicenseAgreementEnteredDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License agreement entered date.",
        "label": "License Agreement Entered Date",
        "terseLabel": "License agreement entered date"
       }
      }
     },
     "localname": "LicenseAgreementEnteredDate",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "gYearMonthItemType"
    },
    "freq_LicenseAgreementExtendedDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License agreement extended date.",
        "label": "License Agreement Extended Date",
        "terseLabel": "License agreement extended date"
       }
      }
     },
     "localname": "LicenseAgreementExtendedDate",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "gYearMonthItemType"
    },
    "freq_LicenseAndCollaborationAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License and collaboration agreement.",
        "label": "License And Collaboration Agreement [Member]",
        "terseLabel": "License and Collaboration Agreement"
       }
      }
     },
     "localname": "LicenseAndCollaborationAgreementMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_LicenseFeePayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License fee payment.",
        "label": "License Fee Payment",
        "terseLabel": "License fee payment"
       }
      }
     },
     "localname": "LicenseFeePayment",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_LoanAndSecurityAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan and security agreement.",
        "label": "Loan And Security Agreement [Member]",
        "terseLabel": "Loan Agreement"
       }
      }
     },
     "localname": "LoanAndSecurityAgreementMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_LongTermAssets": {
     "auth_ref": [],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term assets.",
        "label": "Long Term Assets",
        "terseLabel": "Long-term assets"
       }
      }
     },
     "localname": "LongTermAssets",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_LongTermMarketableSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term marketable securities.",
        "label": "Long Term Marketable Securities [Member]",
        "terseLabel": "Long-term Marketable Securities"
       }
      }
     },
     "localname": "LongTermMarketableSecuritiesMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_MassachusettsEyeAndEarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Massachusetts eye and ear.",
        "label": "Massachusetts Eye And Ear [Member]",
        "terseLabel": "MEE"
       }
      }
     },
     "localname": "MassachusettsEyeAndEarMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_MassachusettsInstituteOfTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Massachusetts Institute of Technology.",
        "label": "Massachusetts Institute Of Technology [Member]",
        "terseLabel": "MIT"
       }
      }
     },
     "localname": "MassachusettsInstituteOfTechnologyMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_MilestonePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone payments.",
        "label": "Milestone Payments",
        "terseLabel": "Milestone payments"
       }
      }
     },
     "localname": "MilestonePayments",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_NetOperatingLossCarryforwardsExpirationWithLimitation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net operating loss carryforwards expiration with limitation.",
        "label": "Net Operating Loss Carryforwards Expiration With Limitation",
        "terseLabel": "Net operating loss carryforwards expire through 2037"
       }
      }
     },
     "localname": "NetOperatingLossCarryforwardsExpirationWithLimitation",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_NetOperatingLossCarryforwardsExpirationWithoutLimitation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net operating loss carryforwards expiration without limitation.",
        "label": "Net Operating Loss Carryforwards Expiration Without Limitation",
        "terseLabel": "Net operating loss carryforwards without expiration"
       }
      }
     },
     "localname": "NetOperatingLossCarryforwardsExpirationWithoutLimitation",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_NonCashLeaseExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non cash lease expenses.",
        "label": "Non Cash Lease Expenses",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "NonCashLeaseExpenses",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_NonExclusivePatentLicenseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-exclusive patent license agreement.",
        "label": "Non Exclusive Patent License Agreement [Member]",
        "terseLabel": "Non-Exclusive Patent License Agreement"
       }
      }
     },
     "localname": "NonExclusivePatentLicenseAgreementMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_OperatingLeaseAgreementAmendedDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease agreement amended date.",
        "label": "Operating Lease Agreement Amended Date",
        "terseLabel": "Lease agreement amended date"
       }
      }
     },
     "localname": "OperatingLeaseAgreementAmendedDate",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearMonthItemType"
    },
    "freq_OperatingLeaseCommencementDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease commencement date.",
        "label": "Operating Lease Commencement Date",
        "terseLabel": "Lease commencement date"
       }
      }
     },
     "localname": "OperatingLeaseCommencementDate",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "freq_OperatingLeaseNumberOfAdditionalExtensionTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease number of additional extension terms.",
        "label": "Operating Lease Number Of Additional Extension Terms",
        "terseLabel": "Number of additional lease extension terms"
       }
      }
     },
     "localname": "OperatingLeaseNumberOfAdditionalExtensionTerms",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "freq_OperatingLeaseTerminationFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease termination fee.",
        "label": "Operating Lease Termination Fee",
        "terseLabel": "Payment of fee to landlord"
       }
      }
     },
     "localname": "OperatingLeaseTerminationFee",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_OperatingLeasesAdditionalExtensionTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating leases additional extension term.",
        "label": "Operating Leases Additional Extension Term",
        "terseLabel": "Lease extension term"
       }
      }
     },
     "localname": "OperatingLeasesAdditionalExtensionTerm",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "freq_OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating loss carryforwards annual usage for next each after five years and thereafter after ownership change.",
        "label": "Operating Loss Carryforwards Annual Usage For Next Each After Five Years And Thereafter After Ownership Change",
        "terseLabel": "Operating loss carryforwards, utilization after 15 years thereafter after ownership change"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsAnnualUsageForNextEachAfterFiveYearsAndThereafterAfterOwnershipChange",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating loss carryforwards annual usage for next each five years after ownership change.",
        "label": "Operating Loss Carryforwards Annual Usage For Next Each Five Years After Ownership Change",
        "verboseLabel": "Operating loss carryforwards, utilization after five years after ownership change"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsAnnualUsageForNextEachFiveYearsAfterOwnershipChange",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_OperatingLossCarryforwardsExpirationYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating loss carryforwards expiration year.",
        "label": "Operating Loss Carryforwards Expiration Year",
        "terseLabel": "Operating loss carryforwards expiration year"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsExpirationYear",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "freq_OperatingLossCarryforwardsUsageAfterOwnershipChange": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards Usage After Ownership Change.",
        "label": "Operating Loss Carryforwards Usage After Ownership Change",
        "terseLabel": "Operating loss carryforwards, utilization after ownership change"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsUsageAfterOwnershipChange",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_OutstandingStockOptionsAsConvertedToCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding stock options as converted to common stock member.",
        "label": "Outstanding Stock Options As Converted To Common Stock [Member]",
        "terseLabel": "Outstanding Stock Options (as converted to common stock)"
       }
      }
     },
     "localname": "OutstandingStockOptionsAsConvertedToCommonStockMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_OutstandingStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding stock options.",
        "label": "Outstanding Stock Options [Member]",
        "terseLabel": "Outstanding Stock Options"
       }
      }
     },
     "localname": "OutstandingStockOptionsMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_PatentCostsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patent costs.",
        "label": "Patent Costs Policy [Text Block]",
        "terseLabel": "Patent Costs"
       }
      }
     },
     "localname": "PatentCostsPolicyTextBlock",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "freq_PatentLicenseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patent license agreement.",
        "label": "Patent License Agreement [Member]",
        "terseLabel": "Patent License Agreement"
       }
      }
     },
     "localname": "PatentLicenseAgreementMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_PercentageOfEligibleEmployeeCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of eligible employee compensation.",
        "label": "Percentage Of Eligible Employee Compensation",
        "terseLabel": "Percentage of eligible employee compensation"
       }
      }
     },
     "localname": "PercentageOfEligibleEmployeeCompensation",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "freq_PercentageOfRoyaltyOnSublicenseRevenue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of royalty on sublicense revenue.",
        "label": "Percentage of Royalty on Sublicense Revenue",
        "terseLabel": "Percentage of royalty on sublicense revenue"
       }
      }
     },
     "localname": "PercentageOfRoyaltyOnSublicenseRevenue",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "freq_PercentageOfSharesOfCommonStockIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of shares of common stock issued.",
        "label": "Percentage Of Shares Of Common Stock Issued",
        "terseLabel": "Percentage of shares of common stock issued"
       }
      }
     },
     "localname": "PercentageOfSharesOfCommonStockIssued",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "freq_PercentageOfVoteOfHoldersOfPreferredStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vote of the holders of preferred stock.",
        "label": "Percentage Of Vote Of Holders Of Preferred Stock",
        "terseLabel": "Voting percentage of preferred stock holder"
       }
      }
     },
     "localname": "PercentageOfVoteOfHoldersOfPreferredStock",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterestAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "freq_PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period for automatic increase in common stock available for future issuance.",
        "label": "Period For Automatic Increase In Common Stock Available For Future Issuance",
        "terseLabel": "Period for automatic increase in common stock available for future issuance",
        "verboseLabel": "Period for automatic increase in common available for future issuance"
       }
      }
     },
     "localname": "PeriodForAutomaticIncreaseInCommonStockAvailableForFutureIssuance",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlanAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "freq_PeriodOfCumulativeChangeInOwnership": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of cumulative change in ownership.",
        "label": "Period Of Cumulative Change In Ownership",
        "terseLabel": "Period of cumulative change in ownership"
       }
      }
     },
     "localname": "PeriodOfCumulativeChangeInOwnership",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "freq_Phase2bClinicalTrialMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Phase 2b clinical trial.",
        "label": "Phase2b Clinical Trial [Member]",
        "terseLabel": "Phase 2b Clinical Trial"
       }
      }
     },
     "localname": "Phase2bClinicalTrialMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_Phase3ClinicalTrailMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Phase 3 clinical trail.",
        "label": "Phase3 Clinical Trail [Member]",
        "terseLabel": "Phase 3 Clinical Trial"
       }
      }
     },
     "localname": "Phase3ClinicalTrailMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_PreferredStockSharesPurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred stock, shares purchased.",
        "label": "Preferred Stock Shares Purchased",
        "terseLabel": "Preferred stock, shares purchased"
       }
      }
     },
     "localname": "PreferredStockSharesPurchased",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterestAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "freq_PrepaidAccountsReceivableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid accounts receivable current.",
        "label": "Prepaid Accounts Receivable Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "PrepaidAccountsReceivableCurrent",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_PrepaidExpensesAndOtherCurrentAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid expenses and other current assets.",
        "label": "Prepaid Expenses And Other Current Assets [Text Block]",
        "terseLabel": "Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsTextBlock",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "freq_PrepaidRentAndDepositsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rent and deposits.",
        "label": "Prepaid Rent And Deposits Current",
        "terseLabel": "Rent and deposits"
       }
      }
     },
     "localname": "PrepaidRentAndDepositsCurrent",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_PrepaidResearchAndDevelopmentExpenseCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid research and development expense current.",
        "label": "Prepaid Research And Development Expense Current",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "PrepaidResearchAndDevelopmentExpenseCurrent",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_PrepaymentOccursAfterFirstAnniversaryOfClosingDateAndOnOrPriorToSecondAnniversaryOfClosingDateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepayment Occurs After First Anniversary of Closing Date and On or Prior to Second Anniversary of Closing Date.",
        "label": "Prepayment Occurs After First Anniversary Of Closing Date And On Or Prior To Second Anniversary Of Closing Date [Member]",
        "terseLabel": "Prepayment Occurs After First Anniversary of Closing Date and On or Prior to Second Anniversary of Closing Date"
       }
      }
     },
     "localname": "PrepaymentOccursAfterFirstAnniversaryOfClosingDateAndOnOrPriorToSecondAnniversaryOfClosingDateMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_PrepaymentOccursAfterSecondAnniversaryOfClosingDateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepayment Occurs After Second Anniversary of Closing Date.",
        "label": "Prepayment Occurs After Second Anniversary Of Closing Date [Member]",
        "terseLabel": "Prepayment Occurs After Second Anniversary of Closing Date"
       }
      }
     },
     "localname": "PrepaymentOccursAfterSecondAnniversaryOfClosingDateMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_PrepaymentOccursOnOrPriorToFirstAnniversaryOfClosingDateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepayment Occurs on or Prior to First Anniversary of Closing Date.",
        "label": "Prepayment Occurs On Or Prior To First Anniversary Of Closing Date [Member]",
        "terseLabel": "Prepayment Occurs on or Prior to First Anniversary of Closing Date"
       }
      }
     },
     "localname": "PrepaymentOccursOnOrPriorToFirstAnniversaryOfClosingDateMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_PropertyAndEquipmentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property and equipment.",
        "label": "Property And Equipment Table [Text Block]",
        "terseLabel": "Property And Equipment"
       }
      }
     },
     "localname": "PropertyAndEquipmentTableTextBlock",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "freq_RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Remaining pre ownership change in operating loss carryforwards written off due to expiration.",
        "label": "Remaining Pre Ownership Change In Operating Loss Carryforwards Written Off Due To Expiration",
        "terseLabel": "Remaining pre ownership change in operating loss carryforwards written off due to expiration"
       }
      }
     },
     "localname": "RemainingPreOwnershipChangeInOperatingLossCarryforwardsWrittenOffDueToExpiration",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_ResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development.",
        "label": "Research And Development [Member]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_ResearchAndLicenseAgreementsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and license agreements disclosure text block.",
        "label": "Research And License Agreements Disclosure [Text Block]",
        "terseLabel": "Research and License Agreements"
       }
      }
     },
     "localname": "ResearchAndLicenseAgreementsDisclosureTextBlock",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "freq_RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue recognition potential commercial milestone payments eligible upon successful commercialization.",
        "label": "Revenue Recognition Potential Commercial Milestone Payments Eligible Upon Successful Commercialization",
        "terseLabel": "Potential commercial milestone payments eligible to receive upon successful commercialization"
       }
      }
     },
     "localname": "RevenueRecognitionPotentialCommercialMilestonePaymentsEligibleUponSuccessfulCommercialization",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_RevenueRecognitionTransactionPrice": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue recognition transaction price.",
        "label": "Revenue Recognition Transaction Price",
        "terseLabel": "Transaction price allocated to single combined performance obligation"
       }
      }
     },
     "localname": "RevenueRecognitionTransactionPrice",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_RightToTerminateAgreementIfBreachRemainsUncured": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to terminate agreement if breach remains uncured.",
        "label": "Right To Terminate Agreement If Breach Remains Uncured",
        "terseLabel": "Right to terminate agreement if breach remains uncured"
       }
      }
     },
     "localname": "RightToTerminateAgreementIfBreachRemainsUncured",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "freq_RightToTerminateAgreementIncaseOfNonpayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to terminate agreement incase of nonpayment.",
        "label": "Right To Terminate Agreement Incase Of Nonpayment",
        "terseLabel": "Right to terminate agreement incase of nonpayment"
       }
      }
     },
     "localname": "RightToTerminateAgreementIncaseOfNonpayment",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "freq_RightToTerminateAgreementUponPriorWrittenNotice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to terminate agreement upon prior written notice.",
        "label": "Right To Terminate Agreement Upon Prior Written Notice",
        "terseLabel": "Right to terminate agreement upon prior written notice"
       }
      }
     },
     "localname": "RightToTerminateAgreementUponPriorWrittenNotice",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "freq_RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to terminate agreement upon prior written notice if insolvent.",
        "label": "Right To Terminate Agreement Upon Prior Written Notice If Insolvent",
        "terseLabel": "Right to terminate agreement upon prior written notice if insolvent"
       }
      }
     },
     "localname": "RightToTerminateAgreementUponPriorWrittenNoticeIfInsolvent",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "freq_RightToTerminateLicensedPatentsUponPriorWrittenNotice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to terminate licensed patents upon prior written notice.",
        "label": "Right To Terminate Licensed Patents Upon Prior Written Notice",
        "terseLabel": "Right to terminate licensed patents upon prior written notice"
       }
      }
     },
     "localname": "RightToTerminateLicensedPatentsUponPriorWrittenNotice",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "freq_RoyaltyExpensePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Royalty Expense Per Share",
        "label": "Royalty Expense Per Share",
        "terseLabel": "Royalty expense per share"
       }
      }
     },
     "localname": "RoyaltyExpensePerShare",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "freq_SalesAgentCommission": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales agent commission",
        "label": "Sales Agent Commission",
        "terseLabel": "Sales Agent commission"
       }
      }
     },
     "localname": "SalesAgentCommission",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "freq_ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of common stock shares reserved for future issuance.",
        "label": "Schedule Of Common Stock Shares Reserved For Future Issuance Table [Text Block]",
        "terseLabel": "Schedule of Common Stock Shares Reserved for Future Issuance"
       }
      }
     },
     "localname": "ScheduleOfCommonStockSharesReservedForFutureIssuanceTableTextBlock",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "freq_ScrippsOptionAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scripps option agreement.",
        "label": "Scripps Option Agreement [Member]",
        "terseLabel": "Scripps Option Agreement"
       }
      }
     },
     "localname": "ScrippsOptionAgreementMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_SeriesA1ConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A-1 convertible preferred stock.",
        "label": "Series A1 Convertible Preferred Stock [Member]",
        "terseLabel": "Series A-1 Convertible Preferred Stock",
        "verboseLabel": "Series A-1 Preferred Stock"
       }
      }
     },
     "localname": "SeriesA1ConvertiblePreferredStockMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterestAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_SeriesAConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A convertible preferred stock.",
        "label": "Series A Convertible Preferred Stock [Member]",
        "terseLabel": "Series A Convertible Preferred Stock",
        "verboseLabel": "Series A Preferred Stock"
       }
      }
     },
     "localname": "SeriesAConvertiblePreferredStockMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_SeriesAPreferredAsConvertedCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A Preferred as converted to common stock member.",
        "label": "Series A Preferred As Converted Common Stock [Member]",
        "terseLabel": "Series A Preferred (as converted to common stock)"
       }
      }
     },
     "localname": "SeriesAPreferredAsConvertedCommonStockMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_SeriesB1ConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B-1 convertible preferred stock.",
        "label": "Series B1 Convertible Preferred Stock [Member]",
        "terseLabel": "Series B-1 Convertible Preferred Stock",
        "verboseLabel": "Series B-1 Preferred Stock"
       }
      }
     },
     "localname": "SeriesB1ConvertiblePreferredStockMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterestAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_SeriesBConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B convertible preferred stock.",
        "label": "Series B Convertible Preferred Stock [Member]",
        "terseLabel": "Series B Convertible Preferred Stock",
        "verboseLabel": "Series B Preferred Stock"
       }
      }
     },
     "localname": "SeriesBConvertiblePreferredStockMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_SeriesBPreferredAsConvertedToCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B Preferred as converted to common stock member.",
        "label": "Series B Preferred As Converted To Common Stock [Member]",
        "terseLabel": "Series B Preferred (as converted to common stock)"
       }
      }
     },
     "localname": "SeriesBPreferredAsConvertedToCommonStockMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_SeriesCConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C convertible preferred stock.",
        "label": "Series C Convertible Preferred Stock [Member]",
        "terseLabel": "Series C Convertible Preferred Stock",
        "verboseLabel": "Series C Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesCConvertiblePreferredStockMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_SeriesCPreferredAsConvertedToCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C Preferred As Converted To Common Stock [Member].",
        "label": "Series C Preferred As Converted To Common Stock [Member]",
        "terseLabel": "Series C Preferred (as converted to common stock)"
       }
      }
     },
     "localname": "SeriesCPreferredAsConvertedToCommonStockMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation arrangement by share-based payment award, award vesting description.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Description",
        "terseLabel": "Vesting description"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDescription",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "freq_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award options granted weighted average remaining contractualterm2.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term2",
        "terseLabel": "Weighted average remaining contractual term (in years), Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "freq_ShortTermMarketableSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term marketable securities.",
        "label": "Short Term Marketable Securities [Member]",
        "terseLabel": "Short-term Marketable Securities"
       }
      }
     },
     "localname": "ShortTermMarketableSecuritiesMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_SignificantSuppliersPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant suppliers.",
        "label": "Significant Suppliers Policy [Text Block]",
        "terseLabel": "Significant Suppliers"
       }
      }
     },
     "localname": "SignificantSuppliersPolicyTextBlock",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "freq_SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary of prepaid expenses and other current assets.",
        "label": "Summary Of Prepaid Expenses And Other Current Assets Table [Text Block]",
        "terseLabel": "Summary of Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "SummaryOfPrepaidExpensesAndOtherCurrentAssetsTableTextBlock",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "freq_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Significant Accounting Policies [Line Items]",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "freq_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Significant Accounting Policies [Table]",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "freq_TaxCreditCarryforwardExpirationYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax credit carryforward expiration year.",
        "label": "Tax Credit Carryforward Expiration Year",
        "terseLabel": "Tax credit carryforwards expiration year"
       }
      }
     },
     "localname": "TaxCreditCarryforwardExpirationYear",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "freq_TemporaryEquityTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity.",
        "label": "Temporary Equity [Text Block]",
        "terseLabel": "Convertible Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityTextBlock",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "freq_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term loan.",
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_TermOfAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of agreement.",
        "label": "Term Of Agreement",
        "terseLabel": "Agreement term"
       }
      }
     },
     "localname": "TermOfAgreement",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "freq_TwoThousandAndFourteenStockIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and fourteen stock incentive plan.",
        "label": "Two Thousand And Fourteen Stock Incentive Plan [Member]",
        "terseLabel": "2014 Plan"
       }
      }
     },
     "localname": "TwoThousandAndFourteenStockIncentivePlanMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_TwoThousandAndNineteenIncentiveAwardPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand and nineteen incentive award plan.",
        "label": "Two Thousand And Nineteen Incentive Award Plan [Member]",
        "terseLabel": "2019 Plan"
       }
      }
     },
     "localname": "TwoThousandAndNineteenIncentiveAwardPlanMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two Thousand Fourteen And Two Thousand Nineteen Stock Incentive Plan [Member]",
        "label": "Two Thousand Fourteen And Two Thousand Nineteen Stock Incentive Plan [Member]",
        "terseLabel": "2014 and 2019 Plan"
       }
      }
     },
     "localname": "TwoThousandFourteenAndTwoThousandNineteenStockIncentivePlanMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_UnvestedRestrictedCommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unvested Restricted Common Stock [Member].",
        "label": "Unvested Restricted Common Stock [Member]",
        "terseLabel": "Unvested Restricted Common Stock"
       }
      }
     },
     "localname": "UnvestedRestrictedCommonStockMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_UnvestedRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unvested restricted stock units.",
        "label": "Unvested Restricted Stock Units [Member]",
        "terseLabel": "Unvested Restricted Stock Units"
       }
      }
     },
     "localname": "UnvestedRestrictedStockUnitsMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "freq_UpfrontFeeRecognizedAsRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Upfront fee recognized as revenue.",
        "label": "Upfront Fee Recognized As Revenue",
        "terseLabel": "Upfront fee recognized as revenue"
       }
      }
     },
     "localname": "UpfrontFeeRecognizedAsRevenue",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "freq_WoburnMassachusettsFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Woburn Massachusetts facility.",
        "label": "Woburn Massachusetts Facility [Member]",
        "terseLabel": "Woburn Massachusetts Facility"
       }
      }
     },
     "localname": "WoburnMassachusettsFacilityMember",
     "nsuri": "http://frequencytx.com/20211231",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia [Member]",
        "terseLabel": "Asia"
       }
      }
     },
     "localname": "AsiaMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r117",
      "r241",
      "r245",
      "r250",
      "r451",
      "r452",
      "r458",
      "r459",
      "r545",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterestAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r117",
      "r241",
      "r245",
      "r250",
      "r451",
      "r452",
      "r458",
      "r459",
      "r545",
      "r650"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterestAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r51",
      "r53",
      "r115",
      "r116",
      "r256",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Dr. Langer"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r255",
      "r292",
      "r346",
      "r348",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r604",
      "r607",
      "r651",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r255",
      "r292",
      "r346",
      "r348",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r604",
      "r607",
      "r651",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum [Member]",
        "verboseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r183",
      "r321",
      "r324",
      "r562",
      "r603",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r183",
      "r321",
      "r324",
      "r562",
      "r603",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r255",
      "r292",
      "r326",
      "r346",
      "r348",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r604",
      "r607",
      "r651",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r255",
      "r292",
      "r326",
      "r346",
      "r348",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558",
      "r559",
      "r604",
      "r607",
      "r651",
      "r652"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r52",
      "r53",
      "r115",
      "r116",
      "r256",
      "r293"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r130",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Scenario Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r130",
      "r135",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r184",
      "r185",
      "r321",
      "r325",
      "r606",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r184",
      "r185",
      "r321",
      "r325",
      "r606",
      "r635",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r130",
      "r135",
      "r237",
      "r347",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SubsidiariesMember": {
     "auth_ref": [
      "r336",
      "r538",
      "r539",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [Member]",
        "terseLabel": "Frequency Japan"
       }
      }
     },
     "localname": "SubsidiariesMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterestAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r187",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "stpr_MA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "MASSACHUSETTS",
        "terseLabel": "Massachusetts"
       }
      }
     },
     "localname": "MA",
     "nsuri": "http://xbrl.sec.gov/stpr/2021",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201601Member": {
     "auth_ref": [
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-01 Financial Instruments-Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities.",
        "label": "Accounting Standards Update 2016-01 [Member]",
        "terseLabel": "Accounting Standards Update 2016-01"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201601Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201613Member": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.",
        "label": "Accounting Standards Update 2016-13 [Member]",
        "terseLabel": "Accounting Standards Update 2016-13"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201613Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201811Member": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2018-11 Leases (Topic 842): Targeted Improvements.",
        "label": "Accounting Standards Update 2018-11 [Member]",
        "terseLabel": "Accounting Standards Update 2018-11"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201811Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201815Member": {
     "auth_ref": [
      "r219",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2018-15 Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (a consensus of the FASB Emerging Issues Task Force).",
        "label": "Accounting Standards Update 2018-15 [Member]",
        "terseLabel": "Accounting Standards Update 2018-15"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201815Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate201912Member": {
     "auth_ref": [
      "r425",
      "r426",
      "r427",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2019-12 Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.",
        "label": "Accounting Standards Update 2019-12 [Member]",
        "terseLabel": "Accounting Standards Update 2019-12"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201912Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "terseLabel": "Accrued Expenses"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpenses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r37",
      "r548"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "totalLabel": "Accounts Payable, Current, Total"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r40"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r36",
      "r226"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Accumulated depreciation",
        "periodEndLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance",
        "periodStartLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance",
        "totalLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r29",
      "r56",
      "r57",
      "r58",
      "r592",
      "r615",
      "r619"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive (loss) income",
        "totalLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax, Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r55",
      "r58",
      "r66",
      "r67",
      "r68",
      "r119",
      "r120",
      "r121",
      "r457",
      "r610",
      "r611",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r27",
      "r393",
      "r548"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "periodEndLabel": "Additional Paid in Capital, Ending Balance",
        "periodStartLabel": "Additional Paid in Capital, Beginning Balance",
        "terseLabel": "Additional paid-in capital",
        "totalLabel": "Additional Paid in Capital, Total"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r119",
      "r120",
      "r121",
      "r390",
      "r391",
      "r392",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional-paid in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r123",
      "r124",
      "r125",
      "r126",
      "r135",
      "r188",
      "r189",
      "r204",
      "r205",
      "r206",
      "r207",
      "r209",
      "r210",
      "r240",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r425",
      "r426",
      "r427",
      "r428",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r488",
      "r489",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r535",
      "r564",
      "r565",
      "r566",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Accounting Standards Update"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r350",
      "r352",
      "r396",
      "r397"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense",
        "totalLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r352",
      "r383",
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r109",
      "r166",
      "r175",
      "r181",
      "r199",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r451",
      "r458",
      "r486",
      "r546",
      "r548",
      "r570",
      "r589"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r9",
      "r11",
      "r50",
      "r109",
      "r199",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r451",
      "r458",
      "r486",
      "r546",
      "r548"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r196"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Unrealized Gain"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r197"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Unrealized Loss"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r194",
      "r211"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Amortization Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r191",
      "r195",
      "r211",
      "r574"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Fair Market Value",
        "totalLabel": "Debt Securities, Available-for-sale, Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r193",
      "r211"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Current",
        "terseLabel": "Short-term marketable securities",
        "totalLabel": "Debt Securities, Available-for-sale, Current, Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "auth_ref": [
      "r193",
      "r211"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-sale, Noncurrent",
        "terseLabel": "Long-term marketable securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r353",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r98",
      "r99",
      "r100"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Purchases of property and equipment included in accounts payable and accrued expenses"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r7",
      "r33",
      "r95"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and Cash Equivalents, at Carrying Value, Ending Balance",
        "periodStartLabel": "Cash and Cash Equivalents, at Carrying Value, Beginning Balance",
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r16",
      "r96"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r16",
      "r96",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r88",
      "r95",
      "r101"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period",
        "totalLabel": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations, Total"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r88",
      "r501"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted": {
     "auth_ref": [
      "r0",
      "r1",
      "r119",
      "r120",
      "r122",
      "r188",
      "r189",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r240",
      "r386",
      "r387",
      "r388",
      "r425",
      "r464",
      "r465",
      "r466",
      "r488",
      "r490",
      "r491",
      "r492",
      "r495",
      "r496",
      "r520",
      "r535",
      "r564",
      "r565",
      "r608",
      "r609",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether accounting standards update was adopted.",
        "label": "Change in Accounting Principle, Accounting Standards Update, Adopted [true false]",
        "terseLabel": "Change in accounting principle, accounting standards update, adopted"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate": {
     "auth_ref": [
      "r0",
      "r1",
      "r119",
      "r120",
      "r129",
      "r188",
      "r189",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r240",
      "r386",
      "r387",
      "r388",
      "r425",
      "r464",
      "r465",
      "r466",
      "r467",
      "r470",
      "r488",
      "r490",
      "r491",
      "r492",
      "r495",
      "r496",
      "r520",
      "r535",
      "r564",
      "r565",
      "r608",
      "r609",
      "r666"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date accounting standards update was adopted, in YYYY-MM-DD format.",
        "label": "Change in Accounting Principle, Accounting Standards Update, Adoption Date",
        "terseLabel": "Change in accounting principle, accounting standards update, adoption date"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect": {
     "auth_ref": [
      "r123",
      "r134",
      "r190",
      "r208",
      "r393",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.",
        "label": "Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]",
        "terseLabel": "Change in accounting principle, accounting standards update, immaterial effect"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r106",
      "r109",
      "r138",
      "r139",
      "r140",
      "r143",
      "r145",
      "r149",
      "r150",
      "r151",
      "r199",
      "r241",
      "r245",
      "r246",
      "r247",
      "r250",
      "r251",
      "r290",
      "r291",
      "r295",
      "r299",
      "r486",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterestAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class Of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterestAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollaborativeArrangementAccountingPolicy": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for collaborative arrangements.",
        "label": "Collaborative Arrangement, Accounting Policy [Policy Text Block]",
        "terseLabel": "Collaborative Arrangements"
       }
      }
     },
     "localname": "CollaborativeArrangementAccountingPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r442",
      "r443",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "Collaboration Agreement"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "terseLabel": "Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r233",
      "r234",
      "r235",
      "r238",
      "r637"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Shares of common stock reserved for future issuance",
        "verboseLabel": "Common stock, shares reserved for issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlanAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r119",
      "r120",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized shares"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued shares",
        "totalLabel": "Common Stock, Shares, Issued, Total"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r26",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending Balance (in shares)",
        "periodStartLabel": "Beginning Balance (in shares)",
        "terseLabel": "Common stock, outstanding shares"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical",
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r26",
      "r548"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "periodEndLabel": "Common Stock, Value, Issued, Ending Balance",
        "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance",
        "terseLabel": "Common stock, $0.001 par value; 200,000,000 shares authorized, 34,611,213 and 33,964,000 shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively",
        "totalLabel": "Common Stock, Value, Issued, Total"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r61",
      "r63",
      "r64",
      "r75",
      "r579",
      "r599"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive loss:"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r154",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk and Off-balance Sheet Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r102",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in Progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r318",
      "r319",
      "r322"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r318",
      "r319",
      "r322"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred revenue, net of current portion"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r323"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized potential development milestone payments to receive"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "auth_ref": [
      "r24",
      "r25",
      "r302",
      "r308",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "verboseLabel": "Convertible preferred Stock, shares issued upon conversion"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterestAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r110",
      "r422",
      "r432"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "auth_ref": [
      "r110",
      "r422"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Foreign Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "CurrentForeignTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r110",
      "r422",
      "r432",
      "r434"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r110",
      "r422",
      "r432"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r105",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r269",
      "r276",
      "r277",
      "r279",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r20",
      "r21",
      "r22",
      "r108",
      "r117",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r259",
      "r265",
      "r266",
      "r267",
      "r268",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r281",
      "r282",
      "r283",
      "r284",
      "r514",
      "r571",
      "r572",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Debt instrument, Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r252",
      "r281",
      "r282",
      "r512",
      "r514",
      "r515"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Principal balance"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFrequencyOfPeriodicPayment": {
     "auth_ref": [
      "r44",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the frequency of periodic payments (monthly, quarterly, annual).",
        "label": "Debt Instrument, Frequency of Periodic Payment",
        "terseLabel": "Frequency of interest-only payments"
       }
      }
     },
     "localname": "DebtInstrumentFrequencyOfPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentMaturityDate": {
     "auth_ref": [
      "r42",
      "r255",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.",
        "label": "Debt Instrument, Maturity Date",
        "terseLabel": "Loan maturity date"
       }
      }
     },
     "localname": "DebtInstrumentMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r44",
      "r108",
      "r117",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r259",
      "r265",
      "r266",
      "r267",
      "r268",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r281",
      "r282",
      "r283",
      "r284",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPaymentTerms": {
     "auth_ref": [
      "r43",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.",
        "label": "Debt Instrument, Payment Terms",
        "terseLabel": "Payment terms, description"
       }
      }
     },
     "localname": "DebtInstrumentPaymentTerms",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt.",
        "label": "Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid",
        "terseLabel": "Debt instrument final payment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentTermsBalloonPaymentToBePaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r44",
      "r108",
      "r117",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r259",
      "r265",
      "r266",
      "r267",
      "r268",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r278",
      "r281",
      "r282",
      "r283",
      "r284",
      "r308",
      "r312",
      "r313",
      "r314",
      "r511",
      "r512",
      "r514",
      "r515",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Debt Instrument [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r110",
      "r423",
      "r432"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state, local, and federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal, State and Local, Tax Expense (Benefit)",
        "terseLabel": "Federal and state deferred tax benefits",
        "totalLabel": "Deferred Federal, State and Local, Tax Expense (Benefit), Total"
       }
      }
     },
     "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r110",
      "r423",
      "r432"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r93",
      "r110",
      "r423",
      "r432",
      "r433",
      "r434"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total Deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r110",
      "r423",
      "r432"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r420",
      "r421"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred Tax Assets, Deferred Income",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Intangibles"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r413"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r415"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "terseLabel": "Net deferred tax assets",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r420",
      "r421"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards",
        "totalLabel": "Deferred Tax Assets, Operating Loss Carryforwards, Total"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r420",
      "r421"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r418",
      "r420",
      "r421"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Research and development tax credits"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r420",
      "r421"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r420",
      "r421"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r414"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance",
        "terseLabel": "Valuation allowance",
        "totalLabel": "Deferred Tax Assets, Valuation Allowance, Total"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Employers matching contribution"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeBenefitPlanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Percentage of employee annual compensation matched by the employer"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeBenefitPlanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Percentage of employer matching contribution"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeBenefitPlanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employer's matching contributions to a defined contribution plan that vests in a given year.",
        "label": "Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage",
        "terseLabel": "Employers matching contribution vesting percentage"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeBenefitPlanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "terseLabel": "Maximum percentage of employee contribution to retirement plan"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeBenefitPlanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r93",
      "r224"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense",
        "totalLabel": "Depreciation, Total",
        "verboseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DistributionTypeDomain": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Types of distribution made by the entity.",
        "label": "Distribution Type [Domain]"
       }
      }
     },
     "localname": "DistributionTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of distribution.",
        "label": "Distribution Type [Axis]"
       }
      }
     },
     "localname": "DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic and Diluted",
        "terseLabel": "Net loss per share attributable to common stockholders-basic and diluted",
        "totalLabel": "Earnings Per Share, Basic and Diluted, Total",
        "verboseLabel": "Net loss per share-basic and diluted"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r146",
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Effective income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r112",
      "r406",
      "r436"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "U.S federal statutory income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r406",
      "r436"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Change in deferred tax asset valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": {
     "auth_ref": [
      "r406",
      "r436"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent",
        "terseLabel": "Permanent differences"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r406",
      "r436"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent",
        "terseLabel": "Stock compensation deductions"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent": {
     "auth_ref": [],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent",
        "terseLabel": "Other items",
        "totalLabel": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Percent, Total"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r406",
      "r436"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes, net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r406",
      "r436"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "terseLabel": "Research and development tax credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationOfUSFederalStatutoryIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Payroll and employee related expenses",
        "totalLabel": "Employee-related Liabilities, Current, Total"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized unvested stock options, weighted-average period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Total unrecognized stock-based compensation expense relating to unvested stock options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "2019 Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlanAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options Outstanding"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Lab Equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r66",
      "r67",
      "r68",
      "r119",
      "r120",
      "r121",
      "r124",
      "r131",
      "r133",
      "r148",
      "r207",
      "r307",
      "r315",
      "r390",
      "r391",
      "r392",
      "r427",
      "r428",
      "r473",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r508",
      "r610",
      "r611",
      "r612",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r476",
      "r477",
      "r478",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r267",
      "r281",
      "r282",
      "r327",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r342",
      "r477",
      "r550",
      "r551",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r476",
      "r477",
      "r479",
      "r480",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r481"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r267",
      "r327",
      "r329",
      "r334",
      "r342",
      "r477",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r267",
      "r281",
      "r282",
      "r327",
      "r329",
      "r334",
      "r342",
      "r477",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r267",
      "r281",
      "r282",
      "r327",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r342",
      "r550",
      "r551",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r481",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring Basis"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r484",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r214",
      "r215",
      "r217",
      "r218",
      "r563",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r214",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r497",
      "r498",
      "r499",
      "r500"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "terseLabel": "Foreign exchange gain (loss)",
        "totalLabel": "Foreign Currency Transaction Gain (Loss), before Tax, Total",
        "verboseLabel": "Foreign currency exchange (losses) gains"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and Office Equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Assets",
        "negatedLabel": "Loss on disposal of assets",
        "totalLabel": "Gain (Loss) on Disposition of Assets, Total"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative",
        "totalLabel": "General and Administrative Expense, Total"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GrantMember": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award of money not required to be repaid.",
        "label": "Grant [Member]",
        "terseLabel": "Grant"
       }
      }
     },
     "localname": "GrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r93",
      "r223",
      "r228"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "terseLabel": "Impairment losses",
        "totalLabel": "Impairment, Long-Lived Asset, Held-for-Use, Total"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r221",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "auth_ref": [
      "r111",
      "r435"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationPretaxIncomeDetails2": {
       "order": 0.0,
       "parentTag": "us-gaap_IncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationPreTaxIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r71",
      "r166",
      "r174",
      "r177",
      "r180",
      "r182",
      "r568",
      "r576",
      "r581",
      "r600"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "auth_ref": [
      "r111",
      "r435"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationPretaxIncomeDetails2": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "terseLabel": "Foreign"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationPreTaxIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r72",
      "r93",
      "r164",
      "r198",
      "r575",
      "r596"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationPretaxIncomeDetails2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfReconciliationPreTaxIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r229",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r112",
      "r407",
      "r411",
      "r417",
      "r430",
      "r437",
      "r439",
      "r440",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r113",
      "r132",
      "r133",
      "r165",
      "r405",
      "r431",
      "r438",
      "r601"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Income taxes",
        "totalLabel": "Total provision (benefit)",
        "verboseLabel": "Net tax benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesScheduleOfProvisionDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r65",
      "r403",
      "r404",
      "r411",
      "r412",
      "r416",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable",
        "totalLabel": "Increase (Decrease) in Accounts Payable, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Increase (Decrease) in Accrued Liabilities, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r92",
      "r560"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r92",
      "r527"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Increase in lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets",
        "totalLabel": "Increase (Decrease) in Prepaid Expense and Other Assets, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r70",
      "r163",
      "r510",
      "r513",
      "r580"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense",
        "totalLabel": "Interest Expense, Total"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r80",
      "r273",
      "r280",
      "r283",
      "r284"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "totalLabel": "Interest Expense, Debt, Total"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r85",
      "r90",
      "r97"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Internal Revenue Service"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r79",
      "r162"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseContractualTermAxis": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Axis]",
        "terseLabel": "Lease Contractual Term"
       }
      }
     },
     "localname": "LeaseContractualTermAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseContractualTermDomain": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Domain]",
        "terseLabel": "Lease Contractual Term"
       }
      }
     },
     "localname": "LeaseContractualTermDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Schedule of Leases"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseExpirationDate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.",
        "label": "Lease Expiration Date",
        "terseLabel": "Lease expiration date"
       }
      }
     },
     "localname": "LeaseExpirationDate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee Lease Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee Lease Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Reconciles the Undiscounted Cash Flows to the Operating Lease Liability"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r532"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r532"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r532"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r532"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r532"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r532"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r532"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r532"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails2": {
       "order": 0.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: amount of lease payments representing interest",
        "terseLabel": "Less: amount of lease payments representing interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseOptionToExtend": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.",
        "label": "Lessee, Operating Lease, Option to Extend",
        "terseLabel": "Lease, description of option to extend"
       }
      }
     },
     "localname": "LesseeOperatingLeaseOptionToExtend",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r39",
      "r109",
      "r176",
      "r199",
      "r241",
      "r242",
      "r243",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r452",
      "r458",
      "r459",
      "r486",
      "r546",
      "r547"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r30",
      "r109",
      "r199",
      "r486",
      "r548",
      "r573",
      "r594"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r41",
      "r109",
      "r199",
      "r241",
      "r242",
      "r243",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r452",
      "r458",
      "r459",
      "r486",
      "r546",
      "r547",
      "r548"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Term loan, current portion",
        "totalLabel": "Long-term Debt, Current Maturities, Total"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermLoansFromBank": {
     "auth_ref": [
      "r22",
      "r572",
      "r590"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of loans from a bank with maturities initially due after one year or beyond the operating cycle if longer, excluding current portion.",
        "label": "Loans Payable to Bank, Noncurrent",
        "terseLabel": "Term Loan, net of current portion"
       }
      }
     },
     "localname": "LongTermLoansFromBank",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermPurchaseCommitmentAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum amount the entity agreed to spend under the long-term purchase commitment.",
        "label": "Long-term Purchase Commitment, Amount",
        "terseLabel": "Commitment payments related to research"
       }
      }
     },
     "localname": "LongTermPurchaseCommitmentAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r44",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r236"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "periodEndLabel": "Loss Contingency Accrual, Ending Balance",
        "periodStartLabel": "Loss Contingency Accrual, Beginning Balance",
        "terseLabel": "Legal contingencies, accruals recorded"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyLossInPeriod": {
     "auth_ref": [
      "r236"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of loss pertaining to the specified contingency that was charged against earnings in the period, including the effects of revisions in previously reported estimates.",
        "label": "Loss Contingency, Loss in Period",
        "terseLabel": "Losses related to indemnification obligations"
       }
      }
     },
     "localname": "LossContingencyLossInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment classified as marketable security.",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestDisclosureTextBlock": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.",
        "label": "Noncontrolling Interest Disclosure [Text Block]",
        "terseLabel": "Non-controlling Interest"
       }
      }
     },
     "localname": "MinorityInterestDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterest"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money Market Funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash (used in) provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r88",
      "r91",
      "r94"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r59",
      "r62",
      "r68",
      "r73",
      "r94",
      "r109",
      "r123",
      "r127",
      "r128",
      "r129",
      "r130",
      "r132",
      "r133",
      "r141",
      "r166",
      "r174",
      "r177",
      "r180",
      "r182",
      "r199",
      "r241",
      "r242",
      "r243",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r475",
      "r486",
      "r577",
      "r597"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveLoss",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations",
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r127",
      "r128",
      "r129",
      "r130",
      "r136",
      "r137",
      "r142",
      "r145",
      "r166",
      "r174",
      "r177",
      "r180",
      "r182"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net loss attributable to common stockholders",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetRentableArea": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net rentable area for properties owned.",
        "label": "Net Rentable Area",
        "terseLabel": "Rentable area of office space"
       }
      }
     },
     "localname": "NetRentableArea",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "NoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r119",
      "r120",
      "r121",
      "r315",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r166",
      "r174",
      "r177",
      "r180",
      "r182"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r523"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Lease expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r522"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails2": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Lease liability",
        "totalLabel": "Present value of future lease payments",
        "verboseLabel": "Present value of future lease payments"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r522"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails2": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "negatedLabel": "Less: current lease liabilities",
        "terseLabel": "Lease liabilities",
        "totalLabel": "Operating Lease, Liability, Current, Total",
        "verboseLabel": "Current lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r522"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails2": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Lease liabilities, net of current portion",
        "totalLabel": "Operating Lease Liability Noncurrent, Total",
        "verboseLabel": "Noncurrent lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfReconcilesTheUndiscountedCashFlowsToTheOperatingLeaseDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r521"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right of use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r530",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfLeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r529",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfLeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": {
     "auth_ref": [
      "r516",
      "r517"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.",
        "label": "Operating Leases, Future Minimum Payments Due",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": {
     "auth_ref": [
      "r516",
      "r517"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments Due, Next Twelve Months",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": {
     "auth_ref": [
      "r516",
      "r517"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Five Years",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": {
     "auth_ref": [
      "r516",
      "r517"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Four Years",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": {
     "auth_ref": [
      "r516",
      "r517"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Three Years",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": {
     "auth_ref": [
      "r516",
      "r517"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Two Years",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter": {
     "auth_ref": [
      "r516",
      "r517"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due after the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due Thereafter",
        "terseLabel": "2027 and beyond"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueThereafter",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesScheduleOfFutureAggregateMinimumPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r418"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards",
        "totalLabel": "Operating Loss Carryforwards, Total"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r6",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganization1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r49",
      "r548"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r60",
      "r63",
      "r66",
      "r67",
      "r69",
      "r74",
      "r307",
      "r502",
      "r507",
      "r508",
      "r578",
      "r598"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income loss",
        "totalLabel": "Other Comprehensive Income (Loss), Net of Tax, Total"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r60",
      "r63",
      "r449",
      "r450",
      "r456"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Total comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r54",
      "r56"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Unrealized loss on marketable securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Long-term liabilities",
        "totalLabel": "Other Liabilities, Noncurrent, Total"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingExpense": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Expense",
        "negatedLabel": "Other expense, net",
        "totalLabel": "Other Nonoperating Expense, Total"
       }
      }
     },
     "localname": "OtherNonoperatingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaidInKindInterest": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Paid-in-Kind Interest",
        "terseLabel": "Non-cash interest expense"
       }
      }
     },
     "localname": "PaidInKindInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentForManagementFee": {
     "auth_ref": [
      "r86",
      "r538"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount paid to managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).",
        "label": "Payment for Management Fee",
        "terseLabel": "Payment to director"
       }
      }
     },
     "localname": "PaymentForManagementFee",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r192"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchase of marketable securities",
        "totalLabel": "Payments to Acquire Marketable Securities, Total"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r82"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment",
        "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r326",
      "r328",
      "r334",
      "r335",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Employee Benefit Plan"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeBenefitPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r353",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value",
        "verboseLabel": "Preferred Stock, value per share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized shares",
        "verboseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r25",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued shares",
        "totalLabel": "Preferred Stock, Shares Issued, Total"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance",
        "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance",
        "terseLabel": "Preferred stock, outstanding shares",
        "verboseLabel": "Preferred stock, outstanding shares"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r25",
      "r548"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "periodEndLabel": "Preferred Stock, Value, Issued, Ending Balance",
        "periodStartLabel": "Preferred Stock, Value, Issued, Beginning Balance",
        "terseLabel": "Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued or outstanding at December 31, 2021 and December 31, 2020, respectively",
        "totalLabel": "Preferred Stock, Value, Issued, Total"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockVotingRights": {
     "auth_ref": [
      "r25",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.",
        "label": "Preferred Stock, Voting Rights",
        "terseLabel": "Preferred stock, voting rights"
       }
      }
     },
     "localname": "PreferredStockVotingRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterestAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r9",
      "r31",
      "r32"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepaid Expense and Other Assets, Current [Abstract]"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PrepaidInsurance": {
     "auth_ref": [
      "r8",
      "r10",
      "r212",
      "r213"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Insurance",
        "terseLabel": "Insurance"
       }
      }
     },
     "localname": "PrepaidInsurance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsSummaryOfPrepaidExpensesAndOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrimeRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate charged by financial institutions to their most creditworthy borrowers.",
        "label": "Prime Rate [Member]",
        "terseLabel": "Prime Rate"
       }
      }
     },
     "localname": "PrimeRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]",
        "terseLabel": "Private Placement"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromCollaborators": {
     "auth_ref": [
      "r89"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from collaborators during the current period.",
        "label": "Proceeds from Collaborators",
        "terseLabel": "Payments received under collaboration agreement"
       }
      }
     },
     "localname": "ProceedsFromCollaborators",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock",
        "verboseLabel": "Net proceeds from issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from Term Loan",
        "totalLabel": "Proceeds from Issuance of Long-term Debt, Total"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.",
        "label": "Proceeds from Issuance of Private Placement",
        "terseLabel": "Proceeds from Private Placement, net of issuance costs",
        "verboseLabel": "Net proceeds from private placements"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Redemption of marketable securities",
        "totalLabel": "Proceeds from Sale and Maturity of Marketable Securities, Total"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Proceeds from Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r5",
      "r59",
      "r62",
      "r68",
      "r87",
      "r109",
      "r123",
      "r132",
      "r133",
      "r166",
      "r174",
      "r177",
      "r180",
      "r182",
      "r199",
      "r241",
      "r242",
      "r243",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r449",
      "r454",
      "r455",
      "r461",
      "r462",
      "r475",
      "r486",
      "r581"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss",
        "totalLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r36",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r231",
      "r638",
      "r639",
      "r640"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).",
        "label": "Property, Plant and Equipment, Estimated Useful Lives",
        "terseLabel": "Leasehold improvements, estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r35",
      "r225"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "periodEndLabel": "Property, Plant and Equipment, Gross, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Gross, Beginning Balance",
        "terseLabel": "Total",
        "totalLabel": "Property, Plant and Equipment, Gross, Total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property Plant And Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r17",
      "r18",
      "r227",
      "r548",
      "r584",
      "r595"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "periodEndLabel": "Property, Plant and Equipment, Net, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Net, Beginning Balance",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r34",
      "r227",
      "r638",
      "r639"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r17",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r17",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property and equipment, estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "auth_ref": [
      "r602"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment.",
        "label": "Realized Investment Gains (Losses)",
        "terseLabel": "Realized (loss) gain on investments",
        "totalLabel": "Realized Investment Gains (Losses), Total"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r536",
      "r537",
      "r539",
      "r543",
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureRelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and Development [Abstract]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": {
     "auth_ref": [
      "r400",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by form of arrangement related to research and development.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Research and Development Arrangement, Contract to Perform for Others [Line Items]",
        "terseLabel": "Research And Development Arrangement Contract To Perform For Others [Line Items]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": {
     "auth_ref": [
      "r400",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r399",
      "r561",
      "r653"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development",
        "totalLabel": "Research and Development Expense, Total"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development Costs and Accruals"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research Tax Credit Carryforward [Member]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r101",
      "r569",
      "r591"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "negatedTerseLabel": "Security deposit classified as restricted cash",
        "terseLabel": "Security deposit classified as restricted cash",
        "totalLabel": "Restricted Cash, Total"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r12",
      "r19",
      "r101",
      "r636"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Common Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r28",
      "r315",
      "r393",
      "r548",
      "r593",
      "r614",
      "r619"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedLabel": "Accumulated deficit",
        "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance",
        "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance",
        "terseLabel": "Accumulated deficit",
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r119",
      "r120",
      "r121",
      "r124",
      "r131",
      "r133",
      "r207",
      "r390",
      "r391",
      "r392",
      "r427",
      "r428",
      "r473",
      "r610",
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r160",
      "r161",
      "r173",
      "r178",
      "r179",
      "r183",
      "r184",
      "r186",
      "r320",
      "r321",
      "r562"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue",
        "totalLabel": "Revenue from Contract with Customer, Excluding Assessed Tax, Total",
        "verboseLabel": "Total revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r103",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r528",
      "r533"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets in exchange for lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyExpense": {
     "auth_ref": [
      "r77"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.",
        "label": "Royalty Expense",
        "terseLabel": "Royalty payment"
       }
      }
     },
     "localname": "RoyaltyExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyMember": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Money for usage-based right to asset.",
        "label": "Royalty [Member]",
        "terseLabel": "Royalty"
       }
      }
     },
     "localname": "RoyaltyMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlanAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Common stock, sale of price per share"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesComputationOfDilutedNetLossPerShareAttributableToCommonStockholdersDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Computation of Diluted Net Loss per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Financial Assets Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "terseLabel": "Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Provision"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Basic and Diluted Net Loss per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of U.S. Federal Statutory Income Tax Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]",
        "terseLabel": "Schedule of Future Aggregate Minimum Payments"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation Pre-tax Income"
       }
      }
     },
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r36",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule Of Property Plant And Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r540",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureRelatedPartyTransactionsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable": {
     "auth_ref": [
      "r400",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A schedule reflecting the terms of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others (including royalty arrangements, purchase provisions, license agreements, and commitments to provide additional funding), aggregated by similar arrangements or individually if necessary to understand the effects on the financial statements.",
        "label": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]",
        "terseLabel": "Schedule Of Research And Development Arrangement Contract To Perform For Others [Table]"
       }
      }
     },
     "localname": "ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureResearchAndLicenseAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r353",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlanAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r361",
      "r371",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Option Activity under 2014 Plan and 2019 Plan"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Summary of Grant-date Fair Value of Stock Options Granted on Weighted Average Basis"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of Status of Restricted Common Stock"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r46",
      "r106",
      "r149",
      "r150",
      "r286",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r295",
      "r299",
      "r305",
      "r308",
      "r309",
      "r310",
      "r312",
      "r313",
      "r314",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule Of Stock By Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterestAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation",
        "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Options vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription": {
     "auth_ref": [
      "r351",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Description",
        "terseLabel": "Common stock future issuance, description"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Number of shares, Forfeited",
        "terseLabel": "Number of shares, Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value, Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Number of shares, Awarded"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value, Awarded"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Number of shares, Unvested, December 31, 2021",
        "periodStartLabel": "Number of shares, Unvested, December 31, 2020"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted average fair value, Unvested, December 31, 2021",
        "periodStartLabel": "Weighted average fair value, Unvested, December 31, 2020"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Number of shares, Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r373"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Total value of restricted stock awards, vested based on estimated fair value of stock"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value, Vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfGrantDateFairValueOfStockOptionsGrantedOnWeightedAverageBasisDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfGrantDateFairValueOfStockOptionsGrantedOnWeightedAverageBasisDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfGrantDateFairValueOfStockOptionsGrantedOnWeightedAverageBasisDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlanAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Number of authorized shares reserved for issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Common stock, shares available for future grants"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Number of shares, Options exercisable as of December 31, 2021"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Options exercisable as of December 31, 2021"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r373"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, Exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Number of shares, Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Number of shares, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant date fair value of stock options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r363",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Number of shares, Ending balance",
        "periodStartLabel": "Number of shares, Beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted average exercise price, Ending balance",
        "periodStartLabel": "Weighted average exercise price, Beginning balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r376"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, Options unvested as of December 31, 2021"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Number of shares, Options unvested as of December 31, 2021"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Options unvested as of December 31, 2021"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum",
        "terseLabel": "Percentage of shares issued from outstanding number of shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlanAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period",
        "terseLabel": "Shares issued"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlanAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r351",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStatusOfRestrictedCommonStockDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Exercised",
        "verboseLabel": "Aggregate intrinsic value of stock options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r353",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareDistributionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distribution of shares (or other type of equity or ownership interest) made by the entity based on a contractual agreement such as a partnership or employment agreement.",
        "label": "Share Distribution [Member]",
        "terseLabel": "Equity Distribution Agreement"
       }
      }
     },
     "localname": "ShareDistributionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Options expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r378",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfGrantDateFairValueOfStockOptionsGrantedOnWeightedAverageBasisDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, Options exercisable as of December 31, 2021"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term (in years), Options exercisable as of December 31, 2021"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term (in years), Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average remaining contractual term (in years), Options unvested as of December 31, 2021"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "auth_ref": [
      "r360"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value",
        "terseLabel": "Total grant date fair value of stock options vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software for sale, licensing or long-term internal use.",
        "label": "Software Development [Member]",
        "terseLabel": "Software"
       }
      }
     },
     "localname": "SoftwareDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesOfAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r24",
      "r25",
      "r26",
      "r106",
      "r109",
      "r138",
      "r139",
      "r140",
      "r143",
      "r145",
      "r149",
      "r150",
      "r151",
      "r199",
      "r241",
      "r245",
      "r246",
      "r247",
      "r250",
      "r251",
      "r290",
      "r291",
      "r295",
      "r299",
      "r307",
      "r486",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureNonControllingInterestAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r48",
      "r66",
      "r67",
      "r68",
      "r119",
      "r120",
      "r121",
      "r124",
      "r131",
      "r133",
      "r148",
      "r207",
      "r307",
      "r315",
      "r390",
      "r391",
      "r392",
      "r427",
      "r428",
      "r473",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r508",
      "r610",
      "r611",
      "r612",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r119",
      "r120",
      "r121",
      "r148",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "Shares Available for Future Grant Under Stock Option Plan"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityScheduleOfCommonStockSharesReservedForFutureIssuanceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r25",
      "r26",
      "r307",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Purchase under Employee Stock Purchase Plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r25",
      "r26",
      "r307",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock in Private Placement, net (in shares)",
        "verboseLabel": "Common stock shares issued and sold"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited": {
     "auth_ref": [
      "r25",
      "r26",
      "r307",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares related to Restricted Stock Award forfeited during the period.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Forfeited",
        "negatedLabel": "Forfeiture of restricted stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture",
        "terseLabel": "Stock-based compensation expense (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r25",
      "r26",
      "r307",
      "r315",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Number of shares, Exercised",
        "terseLabel": "Issuance of common stock upon exercise of options (in shares)",
        "verboseLabel": "Options exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityUnder2014PlanAnd2019PlanDetails",
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r25",
      "r26",
      "r307",
      "r315"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Purchase under Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r25",
      "r26",
      "r307",
      "r315"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock in Private Placement, net"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r48",
      "r307",
      "r315"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock upon exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r2",
      "r3",
      "r67",
      "r109",
      "r119",
      "r120",
      "r121",
      "r124",
      "r131",
      "r199",
      "r207",
      "r315",
      "r390",
      "r391",
      "r392",
      "r427",
      "r428",
      "r447",
      "r448",
      "r460",
      "r473",
      "r486",
      "r502",
      "r503",
      "r508",
      "r611",
      "r612",
      "r670"
     ],
     "calculation": {
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedBalanceSheets",
      "http://frequencytx.com/20211231/taxonomy/role/StatementConsolidatedStatementOfStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r107",
      "r291",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r303",
      "r304",
      "r306",
      "r315",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "terseLabel": "Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureEmployeeStockPurchasePlanAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "Subsidiary Sale Of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureOrganizationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "auth_ref": [
      "r418"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Tax Credit Carryforward, Amount",
        "terseLabel": "Tax credit carryforwards"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]",
        "terseLabel": "Tax Credit Carryforward"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "terseLabel": "Tax Credit Carryforward, Name"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "auth_ref": [
      "r15",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.",
        "label": "Temporary Equity, by Class of Stock [Table]",
        "terseLabel": "Temporary Equity By Class Of Stock [Table]"
       }
      }
     },
     "localname": "TemporaryEquityByClassOfStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r241",
      "r245",
      "r246",
      "r247",
      "r250",
      "r251"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "verboseLabel": "Preferred stock, net proceeds from shares issued"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Disclosure [Abstract]"
       }
      }
     },
     "localname": "TemporaryEquityDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Temporary Equity [Line Items]",
        "terseLabel": "Temporary Equity [Line Items]"
       }
      }
     },
     "localname": "TemporaryEquityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Authorized",
        "terseLabel": "Convertible preferred stock, authorized shares"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Convertible preferred stock, issued shares"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r123",
      "r124",
      "r125",
      "r126",
      "r135",
      "r188",
      "r189",
      "r204",
      "r205",
      "r206",
      "r207",
      "r209",
      "r210",
      "r240",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r425",
      "r426",
      "r427",
      "r428",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r488",
      "r489",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r535",
      "r564",
      "r565",
      "r566",
      "r608",
      "r609",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Accounting Standards Update"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureCollaborationAgreementAdditionalInformationDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r114",
      "r327",
      "r342",
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "U.S. Government Treasury Securities"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsMeasuredOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r402",
      "r410"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized Tax Benefits, Ending Balance",
        "periodStartLabel": "Unrecognized Tax Benefits, Beginning Balance",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r408"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Interest and penalties",
        "totalLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense, Total"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r152",
      "r153",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureDebtAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "terseLabel": "Weighted-average shares of common stock outstanding-basic and diluted",
        "verboseLabel": "Weighted-average shares of common stock outstanding- basic and diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://frequencytx.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfBasicAndDilutedNetLossPerShareAttributableToCommonStockholdersDetails",
      "http://frequencytx.com/20211231/taxonomy/role/Role_StatementConsolidatedStatementsOfOperations"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31010-122693"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL82887624-210437"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL120254519-210437"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120431994&loc=SL118172731-207502"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120431994&loc=SL118172731-207502"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123364984&loc=d3e1205-110223"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.F)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187171-122770"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "http://asc.fasb.org/topic&trid=5833765"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121483254&loc=SL120254523-199619"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL75039408-165497"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123403562&loc=d3e38371-112697"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123341672&loc=SL77916155-209984"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123341672&loc=SL120154346-209984"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62652-112803"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.3(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r654": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r655": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r656": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r657": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r658": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r659": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r660": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r661": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r662": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r663": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r664": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r665": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>113
<FILENAME>0000950170-22-003655-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-22-003655-xbrl.zip
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M(?XB1_V7+G+%R\&;W_[S3]^1@[Y?\02 2\:1SQ@)_<"@W .&X0M./!WH)(H
MA#)8[01.-.Q6IL/4;OXP+W1ZGBV,^)#"@TA:8,IOP]F ,NDE&I 0=&'094P$
M:XH-4*60,E1&&N6KZV?S9YYF'_.R/,X^@'6!_ 3F.S9[9:FK\@:[?DY<ETI%
M6L8@:GP.RH ;@3(@-&C*O@%KQHMTE+#KN[&^E6/SK=1V \>B@NUI(-V#[W+
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M4^BWUF_F>M-YIM]-@:%F0QO+>?&;Q^"#&W'!E4^)]CV-.B'@0QP#PKG*BVC
M16 ZQT=0-_VHS_FP-@KFX+?/ARG(Z"SE1T C:36N4)3\GH*RH%(0X^C-YX4<
M;)):/;!I& G60ZU@<3"PB CE+E"KH!$!"\X0=![X7L!E&,9=@TY+K8<\+?Z'
M#\= =],?_P(SXOE//NI+/5QDJ=-!1QG0<&E'^.MB_$>6L'$',UY>6[^-A_$3
M+_[0%1?#.<:PKI?/G<0G4&9 P[165>L+O^48YH:6)[BF IC9YL7,C*T\!7&-
M8'YLP(R-(P6(ZU-.F.]J(H"E@$:HJ0C<KB(N8@BHUD6!FB@^NX N/ .;OL&1
MR=YYH>V0M2DH6E3(NHKQM1=;G\($/SR6\&XP!(Z++P"/XFM^F!9EM9=E*=[1
M\F)R;/:'8"%DYR@4UK4PI).J\<1?(R$D'SR7C<M'5()6EX_>6N1C2!GU$Z.(
M#ESTF22:,!$)P.:01R&/->=^5Q'Y2Y'#5JL)7@BA)PK5[1'.\?ODID9KS:Q!
M/E1'%Z,BOZSYSH9!ZJVN\GCK4WF22 I*0[".%6 *=0/T37@>B:26KFL2X3/>
M59!.'1][XVJ0%U/M9\H_X%M0?.1^/LZJ8K(^\7G]M9_!H%]\M76\9:AC7>IL
M#&*TN$RE/CHYW:BRQ4!379/,XC[G<> 'Q \-RBST1KLF((PE6DL:Q*'PNHH7
M*YK4>TI9SQ$?U@[3YH[R59*Y\2+E*Q43)4)0H%D2$A:%"8DTD\R$0>+KSEJZ
M#^+<AV,P>/!^&08>IM_M3?-&]41W?7HB<V44Q"8A">>2T, +B-"2$9ZHP$OB
M@(K8=!9( )P9&ZQ5H:O\ZR ?ESQ3 (S/::8KK=%;C6^[U'M7O%#XV(99(MB?
M7KP.\!@6NWX8*Q*:1**K&B'##8C*6 !75+'0K+/@Z:#VLR%CR_5EXBN7<.F#
MX)(:W<!^0A27F@4Z\D&6=15*>^H?X]HP+P_SXK.^VI,2=1<P7P" &?Q8ASM<
M%V3342#Y,@5D57X;X?T_XK]WG]N@,Y!S ^H+'6L2>@S9GTP(%W%,)(_A1;$G
MF=<Y,[DLJG=6O=3%" 3YY!H+W#LY^+1WHL]A[.?<=S]^W%^7$GJG78[T6Z(E
MFF;6_;NJ9;Z=5BD%=%$QYT3ZBA$::P],&.,3!;PZE+$?*Q%T#6^FJNI8E*E*
M>3$YY4, J/6M+U+WP<5HF$^T?@ZW^\LHIRM%?6P8@"^G] G*J/8,T0S4<ZHC
ME%>P^2AT05K1&,XFZ2KVOJ1S\.5]<"]$+ '(])A[) X5)S12$4FTB4GHQR':
M=88GW342'J*%GN:F A,!#;GVQP]X#9+;)_;S<GMT4B6E-,P-B%(N:#;"!<T&
M/B,>%:%1VD\POJ^K,.N28=<!^HL"(X0+]*<\+R'4!\XM7*&)X#ST?>%+*COK
M&+L7EH?YN$!86EUC"M!-&^GK)#7*A/) >R"QJUTP(D(@-1.'8*XG :6,)[1[
M[!&-B!,4H35<\-=/_'MZ,;Y8E[#L@XP>P5T6PHSNY2ZSH4^ZCEDIMKQ[Z#M%
ML#_K_+S@HP$&F#3H7(V*=Y_V7ID8$,)()6*0 #'U,$/-D,2#V2D%^1#'L5"F
MLV)@ VZFR NV14(8 [8EZ,W$#0T#R+F"L-@%$@M9''%.8RYHUR!W>Y#7)UZ6
M7 [&I:ZJ<AKG=6R^:CG(\F%^OK9KS\,T W;]$?0!3"L <96*81VR7/X^^<3_
MD1?[0UC,?)@&QX31CRFH$:5^)A^4%R&FK,0.ZJ%KNE_C0:Q\'A%& [#BJ0(K
MWN<2U'PF_(#+@$<;U_ ??%>\-L>M8D'B^9HDT@5-BTE%F.\'1+LN2"PA!:>J
M:Q0U96IHK-S4-F8QKZ_8[6:DFX2)2W@D 6<3IH$1TI (IHR2(>.QVUFP=?J*
M_V6"ES55E%(CB582]!!7&KP^@;5(SW=UY'G4ZVPDSU?^?;_0 *M]7A03DQ=(
ME3<H<I5HY0YJJYM18X+()"X-)0D,6@J>%Q,>!AK3&1/#728X[VQ$Q]K-T<Y
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M9)AH2UP5*P"-HB31KB*>)[V8Q3H)NU<O\^63;!="$A?R9I\$"QGYW!,QD31
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MYUX$:E*('E.JL&5.+$CBAHF*1(#)35W%A)>6RYLI]-0')-^6Y)KPF#+J$Z%
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MQ\^[_GUEK^DNBZ,U3+2V%0$H7;IR3S9W-]EHP%5GP^LZS>P_+F>+SW'7O75
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M\;1+W4Y6SJ;E(X0K'\)'L%3-"\ 2G&-^9IF7^$B57K0%_H?I'WJ8#O)<X<8
MM20LN@;:;!FY^$?]6KO[61O0&GWJX[EV)LUIP4SPW5UX_74 BYT__#2[S(>P
MPS^R_*KN6C#.ZI^+M/P#9AQG32BO11Z[/HL/Z06"E..RN$WHKBO/7? )'/D8
M7H+ A&\0_-/EP:IM[5*8$RF3RT$*YS5/2!>PL@* .YPX*C4&B K?4.07\.K)
M->2X>SZ )HPK 1ESN]IA.J//.XZHY\2/= /!FO(+X(38 7S'F>1C)#W0&>#
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MVAB<]M(LTUI96IJ['VCNSK+SG@IZ*N@P%5R[%IB*!AO)/94:L* A%TUJZXT
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M)<^J:;XE\@$;G2_2?%8W:,<9V?(0TEX+MQ>[%^C@JJ-;T(BSCK1LOG5!P\]
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M3.1#]=!C_+)W\EP5%QZSO*_.45?KMM2(;2&,\O?,.VMMP8Z"NBX2L.O\WF6
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M%Y;A6RXSJQ(\G-0Q/7B!#N^RQ0G$9$YU@F_G5M[JJ?@\GXJ9IH/BHOQHN3D
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MKCD_^HJ,PU!5[9>@5N;X&JK:; (OI.N:?,$,P" N83H<QS_M\3CM3[+,4VG
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MJ==F#]\>7SIP7EX(V'O)K;YRTI*W,(]>%G1(0UK\#P80_XS6(\%A :UN"7U
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MCJI:.&ND. 'GDT0T4NO*T0W8_&6F-_1>/E+R;LUV6Y2T5DVILC)7Z+F\=+3
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MG\X'C9,N3UK%CQ8;L<V*;2GP<Y'MR$30 [E?_4TEC;V.BLSDR;9(F6QF%3"
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M;^Y3S>/J6[> 9=UZ*5!*-*7+'B<0V!/[_!<<PZXB&AP9/H8"P(49VK@9DZ[
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MGP<L&=W'<*JS;\4O!9H1@X<CGU J2SMNSHI)F\Z#O1^>HIX[DZKY<F;\2<X
M[(@\?-<H #LH^U@:^[Q90I?68J=]>DR:;7>_M*ZF]E7SQJ'/A2.OLW:^08,Y
M7Z4)=[IY!GRV'SWN52$8T"X')5\]CGXJ4'=Q9/D\4-MR2--B&$F:98TMUX1(
MDD<#6?53X2A2:Q1]B#FZH3SB^@_V6B%\HFV&HMB*G72X@X.%R&A;T+R$D< 1
MTKY9%R6=2'GT7_%F^VWT2[RBIQ/=.WW\\)$DUCA=GTI1YVE<YF:G'WV]7&=Q
M0V._-S\Y>7B?5Z\TVHO863PYPNXRJF)*4Q_LQ+_*C,24ZAI(=<VG5-=D1N[
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M^N+*]-J,ULNVU16.(YR>?4=2R58XI)RP;NBKX+ S+$EO*?]B=/Y[ )2I:\V
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MF%&\$=W(K2G))G'MY_42$80<FT_CS:),$SK ?L#]MB7%(VSP_.D#MC3Z&JU
MYZ&1_9+(8I4N6)#Q5]<M8<3J7<:7JHY(D8JDP=Q#I,F;N$0_4A%1X)$FTMN#
MVA4O1.:#*3I0_3C_DZ=X>&F]^^)6LJ6'>@@.W4$8RKOLQSXKKM'IR.$O.NWX
MQ=_$[U+PYTAIE^S,2A0EP"-WE28-ZP0@-?WB=0L>GS(!1Y:^!<^-!/R>_,2Z
MF](IAU1#\/(B>7 IS96:N<[).%957.Z.HS=%M.3*JW8OAI!^OG\H(\BI]<1L
M#3]R;[3<VVUMEN#=LZ+4:6K?(K/<9+M^8@'&*4$]N=BJE2-CM&'+@5.F9O-,
MAO/ETQ_$\K!MAF!$+6)\;>,HZY.4M!!5_TXS6\A>P*;#^K[-B^O,D+V9<4=B
M3LNY,-Q>TY15(P=3HS[C@*6V;B0/:I>:+)$1.1E'##M@A)0SA=Q*NG=\R<\'
M#TW; 8:.S#!A9",3M< J0&%_*W.#"@4FE7N_%<V=N[)((8-;;@J<EOUC<*=R
MO\&1"H.N\HAC=NR' I)((Y(QCYM&:2.2 "D!+6?Y]<P_61=F]M_[;BK.X<M3
M_WZUWX,QK\D-P>68ATV/D@-\!O8,!?D^AMPOK#I_H-J@_KFCCT9,AK N>2-/
M%E-(T"[9.*./6AR]!&YJW^OF;G2>NXARES'M'Y;LG@6-]^#V8M.;PO&E@<^B
MRL"CLTI(EW#9F&IJ*RK0*TZIP#JZDV!/:,W=WND?DII)*Y](X>RTB[MCI-03
M\1*YK?TK#)TGAW#$#N&?@OD\.%R8SX-],)\'0S"?A_, YG/QX'.+SAQZKFDL
MLQ['"S/D!;PB?_LJ155@-8 M^()P@D'W\Y">^4&<#0>RUS\^JUKM-EL:NKI4
M&O09CB1SX/"1.P11+B.HKTW\%K^=D;O_![E4^ #<*'I':@H'R&O;(HA;4EPY
M8S*D I6+8D'!'<B*S#M-%NHO%EF<($>!WN3BVH1_VL:HL'G';[D&O %)3_(/
M!6+G?B6A/*T+,PVAT)9*06Q&SF15M_(<YMW6E*F0?3+,? L:X"/R6U/I0 @^
M@&"YTN991E',E'R(/E DE>0GKS%Z=R&_G*LB(Y]: GG0'G'8CI$&W\9==<P_
MQ&6VLZ %O9T.8*9U'3\)>+CDX6O53TH_1>![2PK$XSIH%)Q(K9@A(;P#9T\,
M.BX$ZZ_-QXKY0'C>O;* 0MH!86*0T,%%P.2D?1SVTNRV@S:U+ TG5C'<W#2E
M2UE#296V#$:W!#^47@ C>&GQE"^LZ7WM8%VOBV5JL-%RPXN'3@?:Z!EO.E-L
M62F!K_(?VA"T!J]K%DW ZF6TEI;9F *)R:>_:W;[,'SZCS?;0!"CG,4UC*MV
M\N_+92SF'[+9Q[FX:AF/-D62KG8*Z*!+H]*.NB.=D9Q6+0WG3 5UO6D@C2O0
MLKBN:3+(/%B<B.0Y0/@0?,FG:N7PP$&6T+]VWG!*"8P&I&993KHLI:-*\.5J
MQ&TJ]SARZ?\<QE"LN%AY0/(J^@8=16RQ2^ZN6@^4W'APK;(;LW2SV<P+H7ZW
MFZZ=\N\ME"H:M>AVZ"LH+DH+&U+G=$ W^<;4T<8D?!PPI7>:#Y4GVNC!.-U4
M0?H:N#\A#?292,WE[$'T,%5YB&[,X"Z@8M)S]#\->=K7B-=[..'U[@I>[ZN<
M]#A2$W_[YT],87MIX1M @Y/]JL$(Q/9VU4 Q+NPW^I+9B<^,\7KPX/S1F?O/
M_+ W^D@783QG"$1IE#HU4AU#VZN&@YP\#74)JA9^H?>:K&/; V^19. ;2)*2
M\QB=-@I7_PG?*$;QBA?5PU'90M3,EZ1HC;)X44A7NV8JZ"D(B(JS#5*SLE!@
MDPL[FT *8@35W)@'R;P!)PFOO3B7F%4 =0C">\ N@$<K,B 3N+6O*(,>$7'Z
MWIJ==%"(<RN<8JQFPD V*/_ANK2:'9)ETUYA^:)EF5ZH.7)DSI(DL!TE#;RK
M67095W4))2!&UW'!C3S:601&:T7(D3?+]_5+%.+ %)2QTP5C7S%8,EZJ:_9A
M>SM"M L!XW!@,,YW!!TTO.+ ]\G<D.$0@4\/_MX7,S"DQ2ZI0%YHWV;U>D=+
ME"\MHV5:58WZI KWT_Q%9760D*_8(P\TMC3%QV67[Y0]'^42C,6->1'GS8K>
M[P;F>W)0#F)#CW01QN.@:%8"218/(ZFL-@'K[T%PP$,,/2Z'CA(Z]IC4T_ 1
M+ 0_?"8$!]&$G_I,M+&HB,0JN<%N&#IK2\/U!'93KNF9'+4AJ?3_5W&:<>%E
M$]HS14(UET?@'.*23VV6Z]RJ#"K@%,"D*Y;S6,8)^J]VXI9*2P-[#8R%2@#7
M$EF+BER7I3@PL2"Q>I^^+,E38= MH_!9(A/]P7Z$Y,J)=Q2SC_56]3A8YN+[
M)T?8E%D*8<-_O?BY/3%:)F1H0.=4E.BC=5XOZRB^TQ]8K*/>12K/:1LF>%UI
M3=DG5:AAS&*.6:4N>&J+>L.CY@#7<]]*(8UF(/$PY_A6[#LRYX9]%?&MIN(R
MD$=SR9!X45'K$TEL? K*?[1+8@HN=N@%P+*TING&1KN%'X>,B_72RR5-)OW#
M.=2%MPCP^UF^G3.==9KQ']$P(6$!E 09!UW1^ "*AD(FLS'3P'ZC+0#75OA%
MA- Y]\-J[[YE3&LRAL:%@_62)D=Q-([BT^YK-3F+![&I1[H(XW$Y6GD,5Y'C
MKKY:SQF_\^7(YZ1#S\&T6C^.$=&3_JN4PRQ*5[Y:-X2&F,'Y4+?$9K2 ^Z[H
M*)*4A P,?Z/;+(%&X>P4?O'#RS<J&:8Z8>AU/*8;<.,1W>I)A2;!N(J>0"P:
M(YOYW]EL'%-$2I_2GB5X_S1Y$/E.9=)<O1,G=DP'/XV5@>AQCS12OA@]^_[)
MT^"WP:I!F;BND!G4M%5K^8Y9$[EWYS ($#DT+I[6C-JQ%QI:G%8:T&O(^6?0
M71QQ. 35?VE+K^Q/,+?7$AX7/6'YW_B3%3+OOAD;Y1*,Y6Q^/M3\.YW/![&Q
M1[H(HSJ?P8$E[,-;=.8OY5 R^9KE+SE6ITU?IH;.PB#$W\TX3LO#:D_8O^^.
M F_! ?K<@(L@EGA/@)M\'-L3#D?R O47!M[ZKDPRZY4Q;SF^!J9&3SJ+AUW1
M*<(-I3$KB_(IBT+3VJB4J$U%V& 2*8_2-_@K&71:)H(U-=(&R[JJ+C]2Q@GS
M5I8&UZ;C=B7%&$Y((&#WX3J:0X_6X,<.%0]==D1R&'EQI=VGO5*9E[!2TA.=
M 3.6F?R29J5?LXMA@W#WH!SWM?YMA<;9@PB61_K23I9K5)8+:6B%@7@+@RY[
M+@)+%[U0X^&-GG%W)!**BOJNBW]$Q8+?G-9KI!8$OW->KG^GQ$ R\7LK&=:V
M;#>82&L8A/5=:L6AS?M6C9G:8(Y"7.6]3T%B#9W.,ETV2.FQ*0@MX;>@5*H8
MYZC\\\YT*0(>7VD9N&]E";;" H9$*H4&L'-(OHD93BN.&VAU8DE\TI)<46CD
M ))"11).A;/(,C0)IL+5E;%*Q-"RQ*]:SXVV8K%M?T3L]R:6\X'+]^C R*21
M@Z4$%6>/7_) Y7'QF6$#*%D2Y96QZ5%Y/A4C6F53V5PYJ]7R.2:PA&NE3=!I
M,$+A/2M0=!;= A*N)*3T<-?T0 KB([5:D^D>E>EF@BNQ3]9+X==^D1;>=HIY
M:-=]N-D_QPL/HA9Y,>%B2N$05K@AG[5T5GTI9.6  _%W,_,NRLQE3":@XJH#
MVGK$,'-A@273@4\1\H\XYS0&2DWD%5MGLO:C#]%23N*Z*8''IK$PNXETWF1Z
M83 3V)>?Q[@+[?9O39E6N!?75<K6'9<9(\"A4T]?XHLE[E)\ RNP&-14]IU=
M4C+;;$V-#%#@Z^J4R0L5B9"X;M]#)L%E-3I0;$%)IM%?$?X^+4LA1Y*XMX4:
MTU7J>Y;D' >2O^1G!EZ<8 B<<EK9=!T*BH'K'MA2=0=:(UYT I"F,JLF$Y9!
M61!-! YDL]@QH$>@'6SM^A.3V,<;PR@Y6]2;Z?FJE//\T"09&0^L$*_#PG0:
MS*1O HBT%;A'W!=9B :/7>,%FF&UI .:5XSA:ZFPCIE:"[?,7[%<T[PI9,#O
MN*R)BR"T&ZP&X^E?-G%)0S']U7='I5U:74-Y)-+M8'_'!QV%;0/GWG'T@F96
M</.&WSM^OZR+++%KXX=/L51:+IL-'"I.5<(ILF1GB=256V[#:YJ!@,J6W_Z2
M5F_Y':?M)[][P+^KNH[8H)\EWTB^9:\O%DX8O#^E62-@ _6TJ4 $9RNBY:TO
M?9>/]=.3^4EPHIU]E<?ZYUZ$\1SKL(.YHGS%UUXVY4W1BS_\K\,SG$^&H?-$
MZD?^A;) Z.,(I@P]W0Q$/IVQG B;-#XO9NZT8*LAZM%"EB,@:_US=/;0WI<G
MR5;DC725M7_M6L?GCZ/_'+\^MB9L%IV>G%)D<-3^Y?PBVFJ&BO] [@P',P.3
MQ!4>NT_;*]DOM#\)&W^J]\?A7PFLI'_5NVQD3LX?/0[\Y@./'::NNH&NND=3
M5]T7"TH_\]LUGEWV9FWV'E-EO2JRM&#W+X0H\.D3Q4-G#T+!JMG0DM ($DLZ
M]W-9X%24O#R\[XR3^3O;O#*+$HDN?*>+^/A6E%&BP-22?H 3'V0>VA]CWH&=
MV8F)< 4?I\///JGY!ODFE-BC5P@3S7 ,DL=E*80>$H38F($Q%AI\(C3(LA:V
MD"4HY7H\6A3BN\%B56R,BR?:99O685^:E2E+.>QE]0[A$/NX2OK7=83=%3OS
M:6BLG@5"=%\/P]:=VO%39/@A"=_N86I?@)]8B5'I+E(KU-)LM7 GF;]6I=QE
M_WQ<IH(Q$IRU"DTWQ9,^]N1NRTTK*VT97 =RT?9CLVZJ4#I(;8J0L0[ \;54
M)Z7"5@4"UJT =W@8]N1L@20%,GCC"+GMP6MQ?^!01=.ZO^[[EU;<G\5O>NC;
M #NVZ#_+<A)75;Q<-Y!$KZ+G>56G=5.S?_"F70EH?_*'G?!L_1"7]*U52M,N
M=YJ$6]#PT ";YL=[TP)AH:XN9DX,&YNLK-;IM@?)F$5G\^YN"P$J%.*W8_Y'
M%P-Y@/D'Y $XNC]YV,L%##M++M/(3P^?#Q_@+-CB0@?C/B^[@MRX-=(N+0:;
MN)9]H5M42(UQ'?JW>J(*.I4<-V=ZQ#D,Y^TJ$YWRN:3*W1X--KF5?9=MZG>I
M[N#!/8HO_6]T>]O.:]HPQ3+E:3HMVGA1,=L="@A,7+2*;+U(N]!46J]=7H9/
MFZ,[G*Z1 5[@LM)"Z^_<\J#TCO9Y*=:$'\%[$6:M.6V.2C%,71[FRE>*M46;
M-PH+UT:R[C17+JPW_*F;80%<PF\7S[?H<@?6"I6EJE4*LAQQ#;V<MB<>LHMD
ME!)ZE6@L_%0YSFAM;-DJ6"190[ZHW;:#%2'MF1+(=KZ;N</ /E$]!\(W;*_9
M8X; LOC-F4Y)\(%7GXP)>+4I/DFUL5 YKVEN]374<>8G9^>\3O.3!R<S^J2]
M'=8^Z-6B;2G4(_KZ\<]Q@I:EC:T_A7]B=$ E;[(@K+$*],@^(R;Y3CE5HUR"
M\881+_I2P%]>!?BC@XJ1>M136#&JL.)7 W*3O-_3.GPJ:N/(#K@*.@":-$OT
MJ+%>23=7Y1" 6F;ZE?ZNA[SGX;%UICUW#7WZ7D./YPV,DRNK%I;+*82Z,M/D
M!EZW"YZT7??#;\=G,[QY*USVB^7O\=[W/BVS/?YT7K10W%Y:PDG0D6,.O60N
MVR^:6CE^;Y=KI3'W](\\QD9#O2IZL*=$AR=\UJW1G?==\[,/\,P?W^2+J^-^
M>R: ^?GYS/[_Z5^KIW*+TN'8&0T^*FR9]>,67@KI[S^Z=?"B\)Z;XNY>M&T^
M*K:8@HG]P01L+U]GT&CV8PQONC\B= CBAKF-&^:?)6Z0I O_DJV])8AU"Z48
M=TF1,<4LH(WN&QZG6#F!>'IGZU*,HR\Q,9>8@N'Q<)[G0B4_\.EKP^B,60B"
MY/N1NSD_B79DIBO;3&,B4)6GX+SEE:,AT7=%?B@O\J,)LG W K61+L)X#JGG
M@ZWH=?!R.XPG(T?%BC!+C6MG9ZH7,HK<ZF%35JBOHJF=WC1:AM09^F&#HAT)
MN.^SN%ZNCWZ-W]$ HR?H^!.I,/I@W#KAA$)QU;I@XO&OX,<NS26(:F KZ32
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MPF6,3*(3"+BT8[BU]V[49JMV!Q[[=*S:KU/V8[+\>ZQ0.]2#3>NMC;NNS3^
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M(#CR%.3#7G% PL -.4/V>ZM:<2BC 1#LHG^HJ."EZ::XXW?+1:VU*S@[3?'
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ME'-;K('R$"H>@:Y0 &RT/12A\2SPDH#Y6,34>*,&N![+V N*3Q][>VC)0\R
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MZ((&N6Y5*Y;3\5 ?+"IE8\;.1/3'9EN\3B]A>'4%="2#P%3>M W12"C:Q"!
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MA^9]A^FO ;V(HB% EGE#H0V:S5S;[J2$B7K@TO^J[7>[+'@CONM^FS6H33<
MY*R%*?+E[L5C$W*6+^N73!);V_'7KU!X+%U&AJ^S>(]!\<J_Q-[9:-VVBT^Y
M(J@:!CHSZ2<>UW P*I=_%A7H@PS/\ZGWY+^S:#+R+-!\5W,^6IH$O,^8!2PH
M8*6\*NGQ7W'*,#Z,EUY%PT_K4B?'SP07C3$1RGHD-7]]_=.O;3GDVH'+ J9S
MQCE<-8PEGMB2*D^4/#1MOG-WOC2WX<@ZL0SHD?GZP_7EYSS01Y$'"G8Y6Z$;
M.1#O>WZIUE<6>%U;^O_'2^WAIJ6M4<8[^@B\,P7W0EOX;$61R(;.HU56FIQ
MO-DT8F3"-V;(#;Z\A^6O95OPR4W.PS][QH<NE>MEF9*]G%@*Z+17[KQAW_.&
MO3Q6PRT"?QU\)]4MF>BJ#YJPD;*(E2BK_*] @$$^+Q8;$8DK[HUCG!<G2:1)
M#N%OW79[SZF$[$ESD#ZWP!4@%3WFYS-.@)B9<< O->"**(3::% O-M\WU=V5
M&F;($BS3+L*#5;K%R'"UD=]'T!4;/3W,Q<6]-PB/G2\N$[67BFQ0O^L5-TI>
MYE#M=UH AHQ:>'\TEB!1.1J67NK3SA,G#AX$O[BX)_>=OIM<XK.HTIZ%*"@(
MA;&/W B.L1*,HB53(OJ"*$>BXF8> 9GF8GRYV-Z"U.CE"QY7'A&'_'K+XZ_<
M55%Y:HL\BLUTG81%)I,4K9;D0<.24? G>!$ZOS2USZ]QY2%J0CAV,=%H#+=6
M("/#+%F#H*M?%]$_$T)/?E1%.03MG_!N::EQ#23Z$8*$P1ZZ5=Q2[FC?"'3]
M0AD/<L[?]WP8<BR&%BZ=50A3RZRO*+(@(U247(6118INO6;Q*3]J5W<BK^:W
MFE1ZPO)^TYO[S=Y\T,O4N?A,:2R@(WC;G2_^^#N;6/;M,ZG;KSWZL:#6'>G=
M"<GH;3LKRI7P:A%C<&0O<5/S?V=[9DZ-#:VN'FF!U-3,&XRF5=TTJS!F43',
M$3MGFT/<A^A1.M'U @\)?VBDW:?;-3I<=,.VSKU*CH:V+J,%[OU(B4\A-:N"
M>G?",9RA(A-0D8L9*O+AN-X?Z6.?SG;Z^]95!O:;PGKZ,S! ,;-<Y+QK\\,B
M/HD)G,ACN^*O<L4G3%L&M_G3\-?[]^Y=_/7^O;\^??Q9X,.?$#KR]_AMF ..
M&T_H$SL^HMID?(H;/-+/8RQ8W(X_.)^9?77QE#Z[;J/ZM8TTI$;2K)[/$N,0
M,C)T3;<HZ-3C+9-YY[/ZDD92@H#D\Z4]\S[S?;C#:?TE:&I]&OW]X8,O_HI+
M?.9[R'">-DXQF%M6ZVDP]*/OB6:R3GCS.9G#K:!<!A^B@U%=\JG^0>U]"&[5
MY[KE8=#SIH^=">V^_Q4/AJ96B/!$J@ ^L4;'R,?2M1-Z07*N03(S&#(Y2&BG
MBNK/Z1(6(J>@ZKN*Q:!QI_4:U##P?KP.UO%EKV[R[>]0VJS:Z)%HZ'P;7C%U
M\NI ;Q&VAN7N;KDZ39H$S?8\W-,531\:FKB41$^'?L(/PUWZ$,^T$WGH4^GM
M>8)(A7F2U@?E):%= AN,XV3N\SG157PRCWTZGME/$(9$Z5/5B&*MR5C:,>Z3
M]7J2Y/5TRDLUK1<IW1[JO1B'%3?/ML[T:Y8+EJST) ^L5[F1LUTX.9(-AERQ
M:UKMM?9ZB/'XI&Q[9@+6T:?8XYE(?%<V"V.IS>D'"S?CI 7"P34$;KB(E/D9
M608\5U!N/&HW4MHSMQ""1Q [:=+C!5I[E3\*W\91#95+_=&EI-(OOO[Z"Q:E
MS';<ML]IC^^?O[A4R.+X&=_VA2X^=>=7Y\O%2_W,0_,&GOWZ&'?_3!W<(Z^=
MWW-H>?8-\EW@-AN\.L;^="I@/GKGQK0'I4JN2?1-I/IH%<7X)YK\SYJN8JJ!
M1-+#D):M+Y97=77&5#7R=N+^J<?(.-5-560HH,OLO= 7>ZD\R_RYQR_,40K?
ML _^@HW;II]_\<MEZ%4:>(A_8X!EN>#CYT68N.!S^>O\[<F+7Y+]-[GJ_JW-
MQ&+O.F?KHEGW.T%<8J;J782(\9H>Z-NKKA@5 C@JK\G $^X_#[TD5JM%787Q
M.+P$\&JB/"62+IZD&?EA7U5JP:LGI25,?=^JN.LZT\Y[K_3JP+;(O,U94?82
M;@ZD9ENG;_]&D%_>>UVJX)9IHW+J%MQZA2WF)*MJ>JBHC8TE41/B1=K,*G5Z
MOO!K9<):I-*\?JM$2JG":5>S%A9"%W==E]?<08=)@YTMBW6GJB%AIFT6& $\
M,5]!]"L\?E%=0Q;%2[1R[=_E$O8BU%U']9T2O./@ _F=,S2D6LC%#^->PYBL
M[0ZXLK/_[GV<^P\?+NW_%_]!+_YI=5TTM;)5T*E6"_$9%MK?V'#RFG^N;%VT
MO$_?L3^1]SPO[O>\N.7#&-<W!2WN8LT=.0TXG3J4<%N<VK$KZ>*]P/!J4+7)
M!][CLI]ZCCG"O0./_>=MAG>L0+C%U#(^G4"<28KAI^7>DVPZ R]Z)4&$+^E6
M%?'-\\7?I>."G*'>LL?DNN?_[+-&&(,9K?7#TZ=/V&D7ZN557Y3"BYLMKLIZ
MI:(CON6@/>QHS[(O.S 9ZVWAKH.N#1PZ&OZVV/-(8GYU&M&N'AL=115PS 88
M)1-E,]\C,T.!\LN=@99[7V; I/-M!JJ&\+8[HY8\K$L%7S.#V?GB9[JTY:ZW
MAU53Y(N;NGDEE,'(V]<4X3JZ8GUP FKC7S<.PRU-8P6O(6HKO''NU1*LG\I+
M)K ([5EL1^JMX?*HQ/1=E%:7IYY=UA-_Z%,_U9^ !QM"EXO_D>WVC\A=951+
M8)NZ$\?%?$J>RBF)0^2T3\JU5L:%Y1%=R8'2LHBZ@6'-I0"] 6:/TTG(/DIJ
M08QZLT#CD_9*#>%<_$S+1</T0:U[O0S2;W537(%VPG5H^V5L6</0-B3/LBO)
M<^I1Q]_MY4LXLR7#=N6X;4+Y^3WS(1#+>V43E;P),F.<E4%>LF\M82KM15$Q
MM<QNY,P3\0=^HLY!UP#NO3^'\'[CJJQ[O24WO[-<+!_5V[IR;<=/QZ5=3;W@
M2YN^]*Q-FO3R\RQE;TVRACL.X!P ;^=.YE>N(Y \UW$1HLJS)I>:/\/M]@V.
M4W)GMMDU0R:TR3.NE&>T&H0^4]Y]OP<HLE!63;HX!H0OH->:::3+O:']EEXB
M8:G-<IH8K_<\]^B[-T+*:.6P-J)?.N YOZIYV:U?5?5-Z7)] SH;:'HYBY8:
M$UXS8L,_1RW :5'AX#4HKY-<FZ8OE*Z='HK=M1RR(_5>.=SUN9<"$:G:,,0L
MOX8/*7Z:S(.)]-&]?2^< "@-@[TTJ *^2JOW55$J'QL6#A:Q0A" MP#]<,-O
M05:T[!?YM&T.>1!_4BT73^F9QR?6XM,G3Y]_%B%?(")7^95T5H+OETS0WGH)
MFE=",<Y]?MD-B%-10\+:H2MYGO5KS1YZ+0Q.'7M:MK&K6O@115[JVH?/Z[[L
MN"/ULL0<7&UQ+6X\7K0[4-0WNI+,2Z7I%C3L=S7FBM:$X#0 ,-TYUVGG4LR3
M)IHE/UV^?'+Y__W?K7XQG/6_] JA1=FL1(%#JR4E5+'/XI]NBI)E6CB??5/3
M0F9M$,6ST!!FU,6I^BDG\M"G[@(_#8<;[0#A='F<[?%[R./0QEN'W.V=\ MG
M=_@DW.%+=@-/VQL6ZOVOA'G_[8?Z_B:5(;[;+%]\^7EP$N.*\Y?W%^1EEF>,
M#/2?.%_\O::C$2<K5*:J3MS#U\4NXVS-PWM_&;F>2SGUT@_>__HOW###:297
M%77B,;.>VU]#.FO1U*6TCQ5-=SB3CA5R@M:1<Q=<72&PKQ8_GC\Y9^=]\6*+
MOSY#[,'/@^0/_<F3P$SWC>,".K8BJRQ4JK6<B7N (FF_9[>44V61EMN'<6Y_
MC,TE]^?FDMDW^I/P?,I%D]HE"9C5<&KF .0E9*+Z2O,.3*\DOS/0%O1I:$HL
MHW+5.!?I9]X@*B]1!M#X.A(<8;N;CJ$ ^7.=OU7"^V0\DMD1.XE5_7?!CEU;
ME ZI(,B.2,:C<5LPA+.:$K>LMK%6I$*...>#8)MC;="%8TU7SN7M:+](OD):
M>AMWPPDIXSD2/T4*.MPEJA*5CP9#B11I_:CL&MS[.G!2Y-FMCV3JV[9!Z6&^
M)MM'.UC!I6T&3%?+#2)]I7 N2_.P,Z%L^8]HMW.)C669P%DI/%X;97*BGY!G
M5.0X<<* <LX!DDMT[437$P1WW,/+];)VO75YSTY2 J>\X2NCQ9R%.L<NW5+T
MA]UK^D'G\9;R3X%,6@<R6M<E8U3?5.J7%88OE<<T!K&VJ]>OE"M2R&8BA1Z7
MZ^]!3&J8N>C%ZV]5&8=+CY545N&I,22"G;K/[UU\^NHS_K5ZF(N'?R$OLEMO
M9_-V!Q[[!,W;IE[W#&G,.O;]5<ZKL\PN R[[L@-"E(O(62E'>>&EM5I>JK26
MH>KTK[#/XF2QR4S)B;XZJ#&5S+6I+&:TJ,F^-I"I8]O(')220E7E1]H&R,8.
MKZS)5#$70IX4ZO%/TQJ$25;%&?Q Q+0,[7,\9..W%35JQ_0&IA%2*=M9JUEY
MQ&#^859-G7'U0M) PM\"LZ\@B;;GCY)YFDOQ)_[0IYZ'?,G48'?*$LX'P$D<
M +]RUX(0RZE3)Q%667)%:Q30H3*V0(E29=T/['PI;).]Y,<__\_G3\XNOM9T
MV[4+X"FFE93;<36YIB=M8U'1(Q[>,BU1&3'X#9EZQJ:!CZI]);D\E0Q<TSE@
MQX!2 6HU.<OA70:JWBV[[!E*=O]R3=17K\,32JA8WC&T:413IH\5"LE95&*%
M4)(T/RVC+I^RQID2B5R:?#$YH=DKH>X5/4G6+I;BZE5?Y,R%[3NB1=]>JX]"
M:8[6(-:@Q&U>2+W9*K/:UI2P?D>4AV-GFM^AQCZ"9#O+NK,MMU0W?%:'UQ(6
MRLVVEM(DYIB>(B<_MIY/NA-_Z%/I<T88'&#CST/OUYVR]O,A][[I7W!(L.R!
M!U'DBG#P%"QJ15MC1G_B2D9T(-#_B6PSIT7 ,2+)&3KWR$;OR7!'"O6,J)6C
M D:]DV3)EP\7WV<'>C>+2S+ /1UC+WMZS,6#>_>6BQ_HH*NN.MC8'[.VS=;;
MOG4=F=%[]S^_?^$S!)TKW1ZP*+0*KX14_-,OO[KX;/'@XN'9YU_<NZ=X8[]9
M;MRJQ5W(A@/.A2^<<B%QRI^]N;DYWS!LJEH?NM?G=.2>\B-\\JVP/*8=PI42
MXA0*I^-HCWT;31D),L=>5R&4^,E*71V"=K%QDM+G+@6J]4L C1WJ'D*":$K&
M1<QC2$945\G]) C-N"=9]L#PRAS5BP,GJ<<\N8!?7]74J)2H+F,@55%E)IGP
MFF4"_%/-#L&)/_2I. 0B?X%U#NS<I@#HMFZ2/7>GSLC9-7C_K@%+103)X&Y@
MPI.84[V$E]((C[;PIZ_76TY4>O:+!Y_'[!=R)KQ\^MBCP]46=A ]( O)5EAU
MG^37 MZ4'O;7!\U[A@&QBQ+508V=(!XR,+$<.4( I]$2%)"8"Y8&:6I.;9:'
M0"I10\JVO/;UH$Y'3=^+#]W?]1[_I'>V[;K]-W_]*]R#UJW/*7+VB_^DO8,9
MK_*.>)4',U[E[CH2BR+_?SZ!?MO_N<C^#]0Q_L]&L&4GZF(\IZ$N+B[/%[\4
M_RE[\B[#;%\MGF4I?OY.'/UO6/5?S [/?SK,1MY@TZ.CQ+BJR'$08IU6*:Z4
M$0D(5K!LFL2]=(W(!X/JSG0D2&[),QHPQ!S^WT7>>V9=6 3)R?>5LCFQ7Q6N
MMW)E?7.^^-\AN/6!+0 J ':(SM6F1D^U),R#,Y2MN$V(;\.7P@#==5;V\J0(
M9E=]BU1ZRY)>R@657E&'N4;<"N;U-3F R^2[2X0C604.%^XL*[27R28(-91
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M5S]+TC1"%#8%7W<%GY!9J1_TR/JZ9(T:4R5E#+0?A>";X]W$[3>-6SM6_)S
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M[0%.1-FEH-&^>HOF9]\IY!^5'M"X=A7HE&S7;%.NU*9\NU61?DAH. H2?("
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ME"9G.]9FVT".4(<6F]?K>JKFUI3=4CMCN'!&R<_G]Z8%%,/=EOY^U"F0:9*
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MPNA.J%#[LL? -?W=+,*S"#]E$>8N]J+R/6[6&IBUD3+ZXJ@%PLY]?)-_+N\
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M:>000F]$%G.B:=:8*]48:$.J_Q6Q'+X&[JN4OO=9H&>!?JI[!X'&2H=>>S-
M,D26NK]%.\*@O>KCJ .(+(9[P2'"4,NB7>^7/KKG,V 29S8UO5+*WS+LA#X0
MDP@NU$>I@[LI3JG5PM7>'=C>%^"5V:5#4],IOXV.EL2IMM/OM_3XJ[)OE;XB
M(4;IM8:VUT&@N+>-H$-C![>%:,=T=!UGMHM9\Y^^YI\=93RJP,\I8!5;[VM:
M%4\JTE3; I QF7)8UC>T.J]'#"4K' S\-/,[O.^[^E:&/F4O#)7<3I*9U1;Y
M4H$?C?QUMJ@ V\HDXQK8/%@Z1J9'%@>UX%/=-2-0T@7+;GU(CD% LU!^-.#:
M6NZLN]K#IS;*/6*=*C81^"1]>?RHF'%Y"/E3RM\C'1$>;D2N(ET^C(>ZQ?G&
M*.X53C@]P/S%SI C36MM[_FPQ B$SF>!C$#8.!G6ZW#L78=0TYXU&3!QDLPB
M3GC,M#7G[0QR7O.3Q+&(,EX]-F=LAU82?WGA$NV*T/>F'<\ER? "W+S/G5'W
MX\?=AA=]S*OK*^'7NBWA2+@>K)ACV1J<86K8XGF3D;$E2I/19#L86=]:0\ZY
M!^EI6+T/T[B"^7DRD"IH3@%;)QPEO4 ?A?K&D_T=R6JMRV-1Z9AP'%/\D:]^
M^*X34AOR"@N>875#E^*_";_F:=3+I$H7ZETA8,PU4H,R#H)S)_=K2O[] VLK
MJUX$;)* \^B(K*"5'J<F[WLT:-EA=L@DU1N& 8T3*\LGT<(W-S#]DE[$1Z _
M=QQ8(ME3RN4?AYL8I9,6*<OUVTIF]K;H]:5WJ#MA.DG'_=#OFQ:L 6=^Q4W9
M,!?<B &-KCM4-J3;,Z'%5?S_TM\\Q9:F4>PW7[]*)J$KZ846[25P7FK?TK6.
M;8;,@^?;*84=?UF]'[1.ZTCOOAUX7"%&)_3*9CK);!>+[NF&7XXRQ]$4?9G-
M,5S&(89+<G**01AV"C(U&7OJ/I"SL%_#XYK:IB^Q.>_[0*GD,R;MPX*?+]X<
MPYJ!#17*I,S=M_3U'^]AD&\(:@=](4J^XAZ"%(UB33#?M0FDS*WS)(X='*))
M:9"66_&GR1#<"-4&[=HR$^^WY?HMS RXJ3&-8D,WCDM4T<!*;]#)IX2!W-C7
M7;@OU-1X:[D,IAQ^"/W0B-A:OP&]U;45P[@HP#^X6=HR^?K0I$:@3JIO7<>_
M6=.V- >F!@!"39;8[-KBT$VRZ?I]?@[20]-(MZE"@Q?5AY_0]>YKFZ&1;\MI
M.\@W:%TD0(B(R)LWB^/%0V9!20.RC"''O!!V8\T7[7&DPB"ACU,OP2^-K (P
M,M &,(J0]1D3ZC3M^640%%55V#'?2,?S!6G7XY4W[; S>Y@?\I+O6N3S"=/
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M0@/\>4'24R#N]]#=L<]<H9JH]HT" =]F^$ GU$FQ,M;NN-SEX1[%L"EY3)C
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M:-^A':7:I>Q I'PT\4'((?6T" DGX[X-RL%![QQ"E'ABLQ*P>3=QGRB"7Y,
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M!8<R<0F71R<H&HHZ<A&,UZ2AH:42R'+M*EJBE(&D?E\B3O-;FIID>#?D#"X
ML>!^@%MPEZ'9W*A*K^B'8?22-2>?@UZ&'V?Q) [8%3<]@YO^_8J;_LG4K^]'
M?S5)<3\!+^YAR+!>L;> A(MK*:A#7:ZLE$-S(00J\CXW:,>,BUJ[L[1;^N,7
M9II/F"300"Q4Y&V1QJ F17O#X7LK#RDY,5,NT@<3 /A0EL[[V2?P65Q6S9:<
MR^3U^Q==%]TN/SD$MN!5!*S52=28*<\>CD+J4SK/^(@UP*NH+%,1+TM(030%
MINO)+)=QD, .1^CL;[SG*"MT -5)Y/'%=:B:J%RU8=4BZ4?GNSQH%E*C%I5#
M1[0$'W*;N=:J &CI6TK3*;\CLJ8</ ,$[#U#13KQU=-M8@458KQ/$398*L_L
M*Y,HSE K)$?56#!YG7,<M ?*>WHA0GMY=KWARI5("4UE2EQYPS;.@ND(M)"<
MZ4G>4N!?%!;8Z+!]=_ K!BN%ZO,\F_Z<ZUU\$LB3U",#<+-/6$9JYZ1"M&&A
M.7E=> HFY17HU$8IS;H#N:>Z"))*KW^[J,12I9FZ'G9X='*P_;-SJJKFE1S;
MWCM] HW0@@W#'V)')F>RB<XRAEZ4-<+,#>QD!BF)FX(@NR>D-"X+RL_WP5L!
M=KH[LX+&8C_\]B\VK^JS'@FSYP2  ,/DL)#]FTE1WN2X*;BGH$R'R YM2-<E
M.G6&TEG(AL,<FLTN5&WT:CC"FWM[$[V%FL)*!/J4=R=RHP2%IPQ\81[M5@S$
M$@(7V8X96(E/CN)P!;+$8'PVYN1&Q]C:*<>@4<\:!Z[QN/._I ?%<K!9SH<Z
M_9XN;>A[JM]TDWR7S1W[05Z;[-/X...ZCU,Y1%#EII(=TR-T)N7%**E=X#R'
M'-RN10OV63NPZT@=;^EO8P:9V!_TS,FX35S[P^>+>VH[H\VP:!B168*WEX5#
M4XRH\C303+5 59K$D5_K,7,%F5V6UBY-3MUN5B)FCBI.,Y]0X3"[Y9Y9#( H
M>Y=1?E32$H$R4JZ=GM+T;CZ)4&#S6F?=W.2HX\H%S?+%YBLG<L'*I[7/E8!Z
M5[:[X<@J/9S&G*N(I$D'249*9D%;F^5>K^-;2X4<5$A09,HQVXO>^A3'%^L^
MBLP#7JNA4@*R:92J._@-+,.(?)BS99'T\0+E&;]/OU&N\K;$V0E]A*10M50@
M008+GX?3P"*GL3%*6T',04EZL5QS'6*Z3AR=2(;*1R:<B4LPA_O%!0CPDTBM
MK*9\,F\A*RCF6O1-8$)G+#<M-P,E3$.*8/J,NR%^BIKR)>_C3\0?GV--<L?L
MZ]=O7LUJ9*:R@)^RVT>?9N>XLS4 W<PM9HB7]FO_5OQ_ZS*/?8$"7N=SI+//
M,@I_C-?JGR3DH$$"2-"IT(0P\XQFI)+)Y@&-.-'H=Z%6E*+M\P"0I0>B0M(N
ME)'IV.2C1;LU$$!02CST-K ;:SZZ 73B<CQ"+(7P:?8L@YU@IYM>; "=&@7'
MH$2@=0M:*7-*KGU"RE2Y*U?)F[ KS::N:66\^?:5*'.#BBSOI 4MOEAY#GPN
M%4P@N=0NKB]E%YF)+,8^2/+JZR#MJ#Y/BBY((A3I?Y4E*%L#G[<RH1!,P1T'
M^@M<HMQ?JD_/3Y)/\Y>AJW7O) (G0PVHSR ?T44X"+E6!SU7<N7Q!:JQTT/3
M5I>(,J=[FKTQ?GZI@BL^2=833HQ8QK]R$P]M'%5$9\UN,&L)PF8SX02_T&/^
M0],:B73:15T\/R^;FVW%9UK'-"\G'GZQ=25=V09-0&\NR$'(>2]OJ(@,+W&]
MQ\7YOR7."#^ON/AKF'?O>O!X9G;&: /PL&=V"V+9/65QB'RN;QW5N$"'._9#
M=+IMC]J<H 9/-36@"?8K8DML));Z$O6^*G=33"DG@NA+Q_R=2XR(X%E(LTF\
M<)2&^I ]&KF7HZA!*)UT*QO3$ N&A3^^O'N[2];:7'#! :=A?R)I$@GA9QH*
M4F6/!/UT0X[V9TR_W@F;_N'[,'@W_^5JVB!?X3V_B>_YVRA$DVM#8V/0F7ZE
M>/^?*_^*L?[Z57+\)I\/(1#2A/-?YO-%<AB<!B7J@\ZE652FK5:5G,8':I\$
MP"<13*<]->CA 856Z3_F0]321[7J@6V=WYPE@1\M%J+;5,TN[Y/!J3Z.*@.,
MXKQ0@#:/\^SZX *AMB1M,0-R"8AS*AR5\UZ49F5:USS>P._RHFF9M:NJ\BW
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MKPDGBOR*W+?1$.Z$ZZ.L>X'J9G/2C#SH 0>BAZR\1<(L._1J4O6TF7@6\'\
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M8@"P:Q+\K5=I>AO7$"^N<;.+4!0X4A)Z# 946)W,!5>X.2$83NPD"1P/[&T
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M)#D',B%#&JIDD@+CCK.8;B<J;9-:EA"SY?QNK)[,:T,UI7F@U,(6VK-^QX;
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MJ<(D90K\D,LQ."$!!>+JM8MR2U14L/K"*:QB0@PH/)T$C?Q1]'.=*B)<.<.
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M0^L"([R0+2+KZHI25"!HSB3+V^&1B"%-XFBSQB'LD,BN2P$^&097@##D'0N
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M>GS>63$)XXRNP-Y1](SNF8W*U%UQX2#@'/-,5:KQQNY2(>2A>0)M_,B8\]>
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M B=;WDG ;ZK"7 L]D2K>3@LP(0TP\T9OR/ TPJK3.6910?K^J J!6KWQ(RN
MIUNX%^6G-4^:MGZT<R4G/'K,VN*IE3PEP>3Y2Z>5*GYS"O3!3*FC,.,941V5
M7#FI&H/S)SR0'S/*WU259N2"7\E-:[6IRGJ/9&\R#WA(U[88.$:8#F@ZAE#J
MQTQ#R]&NF9)[?G+0%+:0),T#5F(ZDYJ+-V_D++EOQ^Z6K;9EP:L(6U]?Q*TK
M5!9@S+8#C14Q5<F:=$>E9*+7Z1?U4W _UEAI.G%_T^XICH58 [TF"T*E"%LZ
M\JO&6Z<C]]W(8E?X8CAS;EQG_HMZ'HP, VI9W+K!B5V.T32N48,V:NO1O\M^
MEU8:_:B<,X1)F:8>3&$(JJ$$PFI=V$(W[)FXST?#8;[ZUE6Y=M;Y<#%8MK/9
MI3:?<030J>Q'#$N,8>YZMF)JD\+81UL\8DDELG6I&?=S=%4V50CC[NU("@B@
M.H^.>WT#J;U.3_AL[A0GZ6>6MS6'BH14=>>/"!#PUWZE'IV?5V%C1LB)*5C-
MS1,U-V]BR8RH^DQP>Z_UN&1(9$]Q>H\[H2*J6[J$"&T=D&8*0*,R;M]+C89.
M-S8".6<# Z=92"SRK4Y#G^S&O&>I;B2+'!M$RH!HHU[ 2/@?.=D#)W#N6J/\
M:;PN]A82I<'CEV^WS57SSHU<1I3.J"5V(^W2L8>- .!Z].-P]\XO^W7GV ZJ
MJ%IE[8E)E2(_YI?6UT-.JZ#*T77>$LRMI.[<S/H7,:WF+>;1Y<BZ[(?J8O-J
MMVN(QQSS8=_,3UDG.:UZ$\X$#B)O\O\Y('2PY$$)4"(,U AT!_WZ^5'H9*D#
M&OW U6(]48LE#I)&5.0@X80=J@XUY8CHI1"42]S"2)"D60/5,D[G2JK$(UPM
MG9-F\XX.VV,ZE,B3N9Q5U<T> UC_*R>25*W]-1&<<J,=W9:1Z<:=LA7M\$ T
M'3005X3]/_9O."E*LCIS6$..R 4UP(!:> >12XCG!R%CSLR>.SM[N<[?9/HF
MZ6@B!Y*9\6Z:NQ+2H-2NJRPRXE3$05HV"+:#\(\*YW^@8E/0LQ\AF-T#YNO6
MS.ZOG]G=1IX/H-;X2*:"AEVXD<0BZ'(;$@<XR'Y!Y>+\FYW+^_$:605P;)Q9
MWHJ)(W95@Q_\I_=$R8Y%6L)P'$-8,&I! *V N\,E@;Q#]WT21TEW2YGV7_F[
M1<8((:E0OR0\L][T6'9$6.D/=?*>^'(++0UZ(0J"K&;7M;8%$>P&R19!6,Y?
M:4V//[;]]Q/.;3E %O8.N\YQ\Q [ OS@LADZY+CY:X@+_,&.D*$+S2#2C)44
M@/'[-.(/B16+W;3GBY"/1\IS\P?O$E>0X+H\8/GV[9D]X0ZET%O,0C9Y-@G)
M!T%Z65<Y,0+MYEW=7#\_-,2.1T^IB?42+"/M.TE/V!Z6J453#!ZE4ZG/:D"!
MW%B4J1E9V-A&M2&U+[$C;O99,N4&D@2]CB+2\BP;IHO-7R/7C#QD[4#'F_-K
MT *MN%?B+-&S?R#G]4>(A_MBQ</]9#S<&D+>@D=BZ#73$5&N!T(69^[M9/J*
M^YQ8AR9F-*@!-[#?)7V!^Z5\12/*/4GCKO?$D =1WIS%KZ:'P."'N8.)]&XB
MTY=+55K:=^IX"P[,B#Q+X,Z'AE)Z>6S [&Y)L4S<N8O--\O9(7HB"7_#<TK;
MK3O:_)2/O?;/X]B;$+@S_ZV&??&Y8SS*3%NC--O4IY:S(YR4CAG%A!K-,$Q-
ME''OX-?.^[2;MX$935.D#P"C[%8<Y8=MMR@7LY>LL,&9Q%4\9=XC5S?8.Q%G
MP<>.3<T^FN2-@^V ]Q>[V6^L'\)5)J&$VHVDG.^VG&U:1Y=VS.^DJY;WS(W#
M"2K2DO#F/A73QQ%L1?BD;?<.:6=-8#$@@^AJ3"\(O&J#11T!)LZF-3UDWO2"
M%E@2 */4^V&2\.C_:*0O#EW]F2W.$0A@=$4XPTW]/#!B7FR^CMPL.6-LS$&P
MO'#$UB6+)R%YO$LM!\_&1 N177M$(4 0H,!2^13,T4?I.SZ2AW[4.41LKTC6
M9 )OPR'CMY(W:[(;S'Z*I<(T9E>6SA!1F^_\3"#C7S W]DA6U:,+PY[N9GKO
M*(Q+6%V?W66WH,>AV4-CF%AFQQ2P$3.U;ZJJN69>8Y +P5N7;3.6D^,L6KRY
M-%E081]*""+72H>RE*<$#*226VE^<=J$,L%R_0AY*M!%I5@NTL:3@5T1,HA*
MAR7:4ZE1A52L1HS.?=#DFR&6PK-3*VER(_\H<7Z(A+BN&[2,6"33FP,Z4%_F
MFV=_^K_GG[U\^?SEIR\_8:1$>=08 V.)%R()YWBE#%[-7P8_\Y]E&__M%^QY
MT6]>OM1?G09PTZ*4D'!3QX<YP9=%HR]A,9C]/%T?"HM0K"9Z4+Y2,G3NYU&6
M\O!K?_V_^6OXZ-&_P;ZWL:$C1"SN&IJ''W,O_)P1_MHOTVYSY5]/2Z#FW1E@
M/G\W6I'>H_MSO;O8./B3L^?'8WDV?YQ8\=_'.,2YZ?]O8*EZOS0_A#>0:;6>
MF@P$%1J(Z:G,&(&,B7C@BT^?;3_!/G^6?T+O\=O!QS,O/MW^)L@O1)/_]8_2
MV!4Y_S^WG/^9DE5*91-&+*\ZUE\ZEEWE\H*) 'VX:5@ZA4<$A/^-0+F":<.Y
M0 :ZI_@TL73*5#EE]^)/*0/W:=CZEZXE$^(8V;K^&L?3WYLKTM[<O/B"K-VG
M-")A7Q #.)I/$'7ZISX"@JX"&,)5*LBN&7YTZE@+LY(S^3<?666]K_)@7.6@
M6!Q?-C- >@4:\-%K0VK@/5^"D+Q6%=,%,B=C!HQ?T];N')D;]\Z2'3P,7?<O
MXUS]"E&KNJ"K[WF?V7L5^($(W"BNRLO/U3'IKYM[.2>Y[N)E"8U%T1EU/IZ5
MGU"6^5GI_X%;O#Z4;N]M(^5JO./S#4M]9)LWK)<!+PO;Y"M1 \DV7^579;'Y
MZ[#;></1T*7\M>#1#% ')Q<39P]_[UEY-?[C=U R5A<HV_S]XM5%]G0](5C7
M_VK=)7"!?[G8O/$.M+L\E'[PW[JKA@4.Z(D?\X/A$'[,XYN;^*?@VL _>\PC
MG)O7F_S)3!S*1_U0O"?55C+"K&.9@<[J0D7)(^J?J0GJPQFS0,1E%+% 9?4#
M+)>KO9-S. ;3J!?Z&Q D8A9'XIG,ZI3*9^XW57/VU_<F<$L!=%.SUY.;MAAE
M/V -%] ZC'KREDZ0I,U3,A"POET\/,C^)NXA>8?=3-'FO9RJ+,P,^E.Y H""
M]IJ+7YV]#\[9^P<+2U!?7TW=-T,KC"RAH1UR%$* SF(,@FL@P5,G< ("<31]
M()3K3/#&.2:_E5&7K]#H[3U$ 1A0?XK?TFB]TPZ<P#5OKR!BN:$CZR=P)_%>
MAS+&OFJNT5I$.!<I"%Z5WBEB4.6T_$<MZQ8#C !\--C;2X$L4$9&F-N[E-$S
MK04:4;[0["7:5/PBQF7E]IC,R0S=@27 $0.OW#5VLB/&<U]6TJIIQ>W21T5T
MBV<B4E23H.4')&KPH&:E&CD<<G\8-O6C[Q?X\]X6*?X_>V_:W#9R-0K_%92O
MY[F>*H@A*5&+?9,J6;9G-+''BN7)W+Q?7$V@22(& 0:+9.;#_>WO6;H;#1+4
MO@!2IRJ)18*-[M-G7ZEP, 25(T,4$/&2QA]BLS1*K%+)#IBL5#E&L""ZZC=I
M91X;E[V_BCM<VY?Q[P'KRKE.75"!C4Y& %UV?*-:K.]9!:G,N!P[IA/EY-8K
M.8"D&F^9Z0G,.!=<I<D=+!2.IG:4J\)8<F""C&#_:#6_U.*N$UWYQ<$B]4-,
M$,01(A0+NS;>EZJJRZ3\S-,0$X@VEY/: ^DQY8BRRA,UG3U2+AGMT<V+,M0-
M4ZO10EI,4OX4<G(I5;7>#_1P5RYL?<AU:N3>.W'T79+@9 I$$(%63H=&X6 D
MNP%60 U="5Q8LPH/,*3U3O0MZ*L#6)6YZH>6J98T2@I1:E:41V,3'F3[1:L%
MC#M&:.+W9:8S=]3XW95#H8)2YS"4YWC'[,7ESC]L[OR>RYV___RG9Z\4G8I8
M.6YJ%H UZ8 =&PWI"<8R @8=R 5G"J+,LA?*:?TY[MA+ Y!??HV579S_0,/M
MXF8_I%.1.J<BW0>NL:#>B&6A7& OT\;4H35TJ[+YN"!]M9DHCZ&Z:/:=97VJ
M$6_US"1I';&.Z5QZ@)F^:6PJ3KA#2*RCU'KV9?/FL9 _DZC74*-_>)0;JT8%
M]1\T@^'46$C5L0V5%,KT)9!6\P2LV'X5TM^NA_33ID=]T,;PADC[I41V/K$(
M5)HVJ+P$UPD:[:JA8.[Q$!,Z.><9[.QLW U#,I,X_X7BU1O11OEY,Y[,4 CE
M)L&I*#QRITPT7+AVTOIK)7)N*=_H6%CW6F0J4_N""[9>;"6+VEM+%];LW5QF
M6'XTJ8:0H9Y.X]88-+49B@KAH@0U&^JR@),X.;9/*>;HSO(D\ D:R&BM2MAK
M;>A,YE7O2W,;YH^]_N""JSDVRG-%"QM@(A2Z:Q- 391'"H_.J#J="7QIYD'P
MTXHZ%%4P6;/C2*O!FVG\GFSOQZVC>1A!TC+5[>[U50Q 19-E=Y2WKR0C*$<4
ML7Z2!B79GC(YB[)4=U?-X5C *<U0%FSQF@;<K((Z4 &Q:2>I&5["A$,VM/'8
M@G5;%E7B>]58A5WC]$QER.HDT[8J;X^PG_:&QS:@OHN0/09SN+$#,I.48T_9
M]19?4(*2V<.8)@N#A$^Q60Q\ J?%F':=9_"<5B)_4IUE&(GUOLWX09(FM<_2
M;"H2-=^!F)'PS@0VDR 79.TMON9#57_0%5XUQY!25K75JW+O/=+KJ7%'RH%!
MGJX^UZVH3,?0YB4]>]Y>6>LFPK7>F''/_9CK0YY0%=0SE*G*8%X5.%3CBVW.
MNGDS]K1;+"JL.@5SP2<>D52[&T%-G4Z'*:QV7.A*+DRG672CLGM5%4BL+#=-
M1:Q<J2L28(W9\[CZ$NV4ICO3TD5/P<)06T:*9%4U7RY4S+1I%VJ_(N?A%3.<
M6:_+'CBU56UVO9"U\FUK:54/S:X<R$1GVYJ]ZCAVYSGVB@6)Y4KS!3#P:%V)
MNSK1HP!@:E3S3I$&JS _Q8!"-C.I\RGLIVF B\T0\1F.;#";J&;^:0:FXR"8
M4QNKH35Z9;\V%X8,VZ:E&AF,(<ZJ+GQ%Z;2Z^76#0)T5U38KZH-A^E96"+;R
ME"FVDN$B0,RK,=U U0P(%5*EBC6DLC6#2'_;K9MZ!G6UK1<-?\HFEJ<;F*(2
MK_K'6[UC-'N?QND8'=#P33I?JIDB]C=KP>:>]PM_$^!$KF)%%5(/K5>_KB11
MA5&>E8O:5K T&'3-,]HIU;_:<H6^D%876XFA>1 )9KB9W@]WVJ!7^=IYIXNI
M\A+[S.DFG)A08#_ 4 "-'.[UO)CYE8>#1I!Q#PM2(3,:LX)OM=//.*_"K&*8
M /=&JBF/=DA^8^]9O#K3WL4L&Z;G"8;Y?0U3JYF*I0=0]VO ;$"X 'VV]1%J
M6-9,7"HVL0Z[L5#=P%$UR: STPU&5N';EQ*L#K;V_OB>X5"8IKXPL6"W<Z5-
M8R2!W+UD)]I(&'6D1TAK4F];IB3<5Y#<B\*_OH"3SK\-QM\H%$,-U[X!$D\F
MWZBE#FB&K50D0'O'8=F#MSWO#[WQAZK;N,EN:?K19(*5":RYM]\-VIK 1WO4
M@M_31+8[[Z4BZ>$WE?L'W+_-)#SL>2=9VF;:54!T)'M;DAV.1K[^[^!!"?<S
M]2( %2Q:H(^<ZH QV!VG 17XB\+;&WF_BB6 T3L\DTD)>NQ'^0,TK *]0_5N
M)_WA#M8XFYEY,2FTU-G]1X0-^T#AW!WXV_T]+_]/29DAF"J+\7!^,VIHH%"G
MH/-B:2T=5T\,PZ6P:QVWM"-%'Y2[=Z O<K>!@=4- :R!B"+[">QPZ6W3=]N#
MNS%X'X!';7^C"6G?K)*=-K.J[1[@!$YT:S.WL@92=8!C/<NTV-;8.>W1K#[7
MFUUUH==5F5>-':[3,HK.=LTF1ZZ-D&LC]-AMA+QKE %WP=ODJEX:JE[V7=5+
M%X-^[1;N3[@GP,VZ :  @:N<F7VV-43IVG9TF.P^NZYL5^K*=N4N9Z9#U"5*
MNWG.]6IJ=:\F[E7-F5OH#>1R%^\,\5IBX3CJT%.I)S]ZY*QB69*KF3"68N[;
MJ:0\?"+UL)0'/8+X%%E6.,HV!44<OP=;Y18R!%]/P6!-J_-43XL 0PBU?=HT
MY81A,%UG97+A5JY;NG0B,MP&9^7.-QQ;]"T7$UDLOUFV9IM=ECL][Q-F$)R*
M29N=EIB>_JZ"Z)74H98'.QXG/EE@&"*.2&AURA79,A/M.?4EH-&RJIO8G0"O
MNV1W$^!5FBQ'][)<I>.Q^IH[7G;CAD[6H U2J'+,@P2-MIC59OS6^X')2^Z#
M!@NR0A<JHX62_P^3!#LF?:'T>%2"/\ +O$%_Z^_..K^&=:YNBG>C#H ;?2W*
M(GTSIH(CV@O<U^O^&WI\*Q;+M"Q>3Z(?,GQS'H7%#+9 $%4_@&/%8I'+U[E<
M"$P5U;"AP76\]@M\/VS N"RK/D^O]>_50_!4:"0/O6XXZ@UV#GY"</ZE"#<\
M-.@=[.Q?^LQH.+CDF5%O>'#Y.H/][4N>&?:V]W8O>69W"!L:U1Z"?V2KL-(H
MV>\-%D4#E-0],"+OC0 [L!L F.5U5+N$?YS#*NQ$?LVN9/S@S1DFV 0B5FC-
MZ*YOWB#_J&]>BH?91(0:;:]!A?U.L-&;R*;?Q=Q6 QO1Q-UL6_GK.H.M7R#L
M!;__ZXOABW9>9@,L6W.Y#Q>*NPGA'DX=W7:6;B\A6W=_+;\_[U+.ZZZPPTK1
MB1J/W<1@+U"-MWN[S9KQ'=SN/ K#6%[Y!G>[3(.[=\!"C>:S\\)=0PNN8>BN
MX7&NX4:F_!U<$8#9R9N;3YA=37[(+U7V[TZ%:/NUM<G"=M!O@9WD@.^ [X#O
M@/_PYKV#_\,BO[.^VVYO..N[A=?@K&]G?;=.HK0GDTB5#U1)\<[8=L;VLX/^
M@P/?!?]O?ENC;<>CG@>5.. [P[P;:I15GKFQA+.JV<24ZZ-TZT-*HZHN"[4_
M6RWY7LI>GCO-.* ZH'95!^TDF-L$UB>#NPZH#JAW#%3GK^R"HGTTRZ(<#HZ=
MY[[TO(]IFDO?.YGUWO4<I3C/Y;.#OO-<=LASN3-P/.IY4(D#OO-<=D6A0G?E
M:1!ARS<<'*O\E<Y)V0:CY)F2AP.J VI7U<U.@KE-8'TRN.N ZH#JG)3/4*<^
MD=@T]Z3GG4PR"?O)@UDY<S3BW)//#OK./=DA]Z1+K'PN5.* []R3W5"EV#WY
MP4RA4=Y)YXYT-IT#J@.J<T<Z=Z3#70=4!U3GCFP9Y%ND0XLL1F_D1_E6QBY9
MTGDCGROTG3>R0][(7>>-?"94XH#OO)$=T:3(&_E.GLDX7>!(..>/=$:= ZH#
MJO-'.G^DPUT'5 =4YX]L*>3;HT7_H\1:H\3[%!R5XW'4.&O(D8?C.<\:J-W3
M[-K#8$9#A_W=QGX'U&<(U/8P$/;S?1)).1%!4691,G6>/D<2#J@.J$X?=)X^
MA[L.J ZHSM/74LBW1X_^4R;ATCOM>8=9DL:AHPZ7=/CLH.^2#KOD.>P['O4\
MJ,0!WR4==D.)8F?DB4P7L71>2&?*.: ZH#HOI/-".MQU0'5 =5[(ED+^/A3H
M<1J'U[L]?AAW]#HJ8+,!;//W--EZ/U_$Z5)*,Y4Q=T3CG)//#OH.^ [X#O@.
M^,[A^*S@OQGX%VBTV[W=>U-HYU$8QO+*=[3;Y2O:O0/V!#O![__Z8N>%NX86
M7,/07</C7(.SP+L0POHDLL [['E'Z4RZ<C]G:#\_Z+LLH"YE >T['O4\J,0!
MWQGEW5"ACF8B@M\E-)=5!RU<&I"+I3J@.J"Z-""7!N1PUP'5 =6E ;4,\NW1
MH.&3M)@MO=]ZWEN1C646!6XHJ_-%/C_H.U]DAWR1>SN.1ST/*G' =[[(;FA2
M5W4_.EW8F78.J ZHSBOIO)(.=QU0'5"=5[(=D&^/+GVT3(I9)+R//>^#C$/X
MT"5(.K;C@-I]Y:X]/&;WP&%_M['? ?49 K4]#,3E&SK\=T!U0'7*G_/L.=QU
M0'5 =9Z]ED*^/4KSIRB8"1E[OY8BF3K:<(F&SP[Z+M&P0T["'5?T_$RHQ '?
M)1IV0X5R?D=GO#F@.J ZOZ/S.SK<=4!U0'5^QY9"OCU*\Y=T#.##J:L?13*5
MF>^=!KUW/4<ES@/Y[*#O/) =\D#N;3L>]3RHQ '?>2"[H4PY#Z0SXQQ0'5"=
M!])Y(!WN.J ZH#H/9$LAWQZE^;=4QNA__"2RH'2#59WC\?E!WSD>N^1X=#T6
MGPF5.. [QV,W=*BK.![A_\4XEO3/36#]Z=I0'73#)KCYH?<?Y-#W@4KC- ZO
M!SA^&'?T.BI@LP%L\_T/&91%=":]=#*) IGE5P'K3F^TO7TQ8'<["]B;T&@3
M:-^)LRC$7DX?RR"814FJ(=O& X ,F(G<RV5V)D,/_I66F7>2R3S""Z=!4T>S
M2$Z\"F$^,\+0=\*;R_D8_D@G],MQ*K(0_P@5ZX*EHR20WN_I&3\X[ ]VZ*?G
M\#+A!>G6!*%0+1&D<X#3TCN/BIGW+NMYJ[DL//T*OCB:95$..#>#S[[ MVF:
MRY[W(4OGWCL96*\KDR**O=_*1.+?N[[W*:MNQSI[,9-7/#OL]7U29'(JO+=1
MZGNBZ8X?08NZ'5,<#.^<>-NN]N\?K$!N9GQ*"S&5K--LB0D<XK6(S\4R?_/"
M^XN3MM<[]/,2"B_^=E)F\JL,9MZO4L3%3+&XT!M':0$?)["3Z=)PNDD:E#E\
MFR9>FHG8"[-RZH4R!H:3+;WJ!SU@3E&:>44*G$H4*VS,<-+0.Y7S15;FR)I.
M@T@"_\U]6%I_#NRJ>2<^\;R*'T9%?D5^.$&FJQAL?P]WJ+GML%??)LB!+!?G
MQ&M#>2;C=#''U8&CXD=J)__SOW[ ;P_>Y%XL10A")D0[PEMD:5@&<'*X-X N
MB!@9X5X_O#OT G@R$RAKHD2]6,.!1$WPGQ)D$MS!TOLJ 7UB^</WCI.@1Z"I
M/H)?6WLW$#>PJYT&S)SO"*N"-A\E9S(OZ#B3*)M[)VDL0$1Y)R(K$CCV"B@B
MECC1'(\G"NDM1%YX@1[RJ"#2(%+ACT\BSUGR>$F:; %@)A$ ,9N*)/JO*"+
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M9D DAWF>!J2RG(#B(>&O#(3/OT%VDB+W1Z98(:M%_Q*QS>%)),*1>]8;4(M
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M6520QD-A93@/J7!X+K^N,UXK=GSX'1[,5V6G=3!^ ,]U%F5%":>9@T(Y3E'
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M4$YBHASP*S]2H24,C^&/-NB .LV(@@]J=[O5ZQ Z^&MRQY]Q$DCM)'W]EE4
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ML4DV]JL22,QSCA98KX):8ITS*X.8!-.5NT?8<9#&9^$]">YE0W2XVD#E)%B
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M"Z<(1)8M.9H1E_)*(*'\/6#LZ30!*4$]/$\CP%E8\)\ );GTW@*6ZWR3_S6
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MO5,1,U_[(\GD%+@UL,Y031OV3IOF3VP$,,K%[>='3*TY=GN8]#O &A"U*/E
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M*0_@40*=U-@'Y?&?_O[K1QT*B/**[< 6V:?J%<N%7.4\Q!R0(U@,3Y$N%N2
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MJ8(? Q+D8J$[-=WT."N4[@D7MSW6F)F;9JO@(96YJO[@N+? 2DP+N)A22>T
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MEZ&0+/67,>$O:DFL&_Z0KJH<:WC:PEJ?1',0D^Q#9%4#)^!.8A'-=2.;9K&
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MS*J),7P7E#DGO>A>+1F%QI0G*K=F;-&[:<;\IEF<]-9$GC^V:]=5A-VP(NS
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MX) >$ ?6<'L3*;V%6-*SZ<1[N=^O]D6O%$$ (DHD 9P[*F;>X>F1M]O?I0W
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M.3[6'J Z/M8I;&\)'WOU3K+5_I"Y^(Z;.4O_R=R%DRQ=E"P.AYU[]FD N45
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MM<(.D<#I-/*+:Q<8S#$%+"#Z)4C:$ 1*@$64)BLW Z8@5]MZ:5?:J33V7HT
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M-P_!4T%)"7K=H-<]/$37T?][G0<W/.-U^P>#=<_TNL/#_IJ'>MU1_V#-,P#
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MR6OC2:+<?PG#7D>(MMU+VG>OZB3.8*AL0@(;8+OA1>3*H2 ]ZCE-. 1A#T&
MPV*@Z)!8TWKXMC#'4 ELXK%._UK:A-0X''48A@BR8HR*(0]U:".*3./PY8V<
M&"=76#4>I^$B?01=VL(K-C#^DN@\06/.T-=N$%"6N')9K@074$).663C-;L7
M4]XP)2R[X?4E3YM1E(35E*]#_,SVI ,Y]M)<C8G^H1F-UF$6M;PFH4(R(%Y*
MV&TTH=I\:$>,08+J5O!ZNC@).]]7IN$YA<] P?LY]9M^.<;!,O1YDLO0?KEB
MA,JX:6*L6]#/='9;%1$K/Y[+'.A.7H2;EO:H3CS6X+NDP7\OV19$%_%+G;^"
M:WQ38XA2ULR+=)[HU FK8DP2ZZ8"W)PJ]$PH53.,+Q/LBX[,\V_,N;]4I4"J
M-=$M8[-5X+N,T:[R^L.V""_# 'V'-QL9.H77D$,?.I"+R<&' MUZX,T)16;:
MJ*@$=]GSE\+).-EI..^*S\TW-H2%R5PFD:_CSYK&90X82A.M]1M"SH=--5:Q
MFH1Y-:]ET(PD3&+2=2:1*D\N] K)6-!+ 4KJ&$8EO,J QZ4,(YO.W)C"2R,I
M.RO?#;#Z<JX3TR8P5=P9=G6OM-X.P[IFKDY7*X7\BE<L3P@/6Z:/+DS<JI4*
M.KU6,_JUO;BTGDTG46>,FJ*DJSK?\N7-\:HK/L1FOR-%[&Z3&W$>:5N[6\I@
M6CVSW69D=I82]FSC:97B03?\RZ0C(D VW%7.M)YWC9F?L<:Z2M>V!"]3L:UW
M/E]HXZ!F&;^R^0MV(U'C8OLR($0"$\)3.$44<Z2XH:!)_("%I'^H?!Z! -2Y
M[ICV6A)!,W>N8N05RQ!+1*>SPRU)?H^-!!!/UHR.$<4*U.K8$&:-#'Y ;*Q-
M;YE?&Z;&OM\1:>BEB,@RK5E9URR@^B^6[9\NQEBT=JCA:H]@.DP9QM;NSFB/
MEB<.-&QOT 4V.0A#G";BTR'5HKY)S#T%NI171H 6'S[33L)@\]XTN>K<?'L!
M#Q2752;S:XH'KTP[?FZ/3*N"D^TPX%H1"[K;=D'%82[^D=LU7HAB#O((MKQ)
MFZ:S]O5#9"D>4 [6I2(Q'<J#\NBN_2O$PXVK2\;OHC--[GP^-7HT+:W$F^46
M+K!V3/U=+7DBJ@FM=COHQ'_[(NW_48%.^A ST !:F.*7%/NE&UD+.ZQ^@%YK
MJ*2',20);GJI37F_R:\!6XV,W!6. MF(M*,T33-)7@&_F!61]GFGS8#@7W2L
M!JJC/DE\OP!*G5B? UTM([&-YU#0*HK&Q< Y^:VI!30A#5NT3%O9<)E+*?[7
MUJL33A=E7B7^'IX*XURG!<$^C17>)9/I CX)\(:S]LB4V\XH\>22TC^OOP.6
M"B_0Q@_]OKHX@.1) YVP*NOT\V7N3_>*N4D5LC%\W0T;#9=R(-8-K!O:I!LF
MY!VOV6>E=&^81G1TOD!VP-OPUR_P:LEOA8$UE4E*5I=2E\ZLI1PKSWDIBAU,
M?6ZDS=3$MO8KKA<CE03_CI#^JC.$LDI(X62L%\!Z%.@M5H?4SP&;"6,M=8U0
MODJ***@+72#_789IB.[.\HFH0D=KK3!;3[&N^.7ZI>Q&(J,YHYI$)1UY2:VP
M-?:V*L^4U69I@SSD_/-5^>>'G'_.B6D/O:WD'#V4,L(S]M*-V/S[RL$47PB,
M:T+'7<OAK/V&,=K@0:Q9/8/2[;14^P%-RYIJ,UYG$]PS)BOJL8X;)JMUFF@-
M9*X;6=>+UK<R1?7&QFU+)8TSRW9'UKR_GCMF3^54 F5/WTY,DX6,=&&F*BEA
M18V:\BXC63QH'=/U<QSI5<-7HD_L-0>&,8_(5XY.9PKEFY@2>J\7Y6V]TG-)
M\720-C:6;G+&@P3C6>0*4+/*BT(N_'(9^O!LA%J9WT!?+TIKDJ))-2JL6+!)
M0\#!R-+#8!(E+.B(@3ZATQC6$L6(=UA_ZH:8?#GQ+)DI2O*I$AGL1*=@1E*D
MVZ9^!-5'-ADCH+!(W3J_(=L$LPU(C#7]1S>YIVRD4I&@+&,<(*ZM40V?S(!8
M"^LYJ^H1E.0SH;A&*J#U'5W+#"R#4285IWX J(4G3,YA?:$3#<[U&*'V?NDR
M&$LQVYHW;TJY$_775>_ O$18)&ZW2<T?9DKKY V7H)IK%X^)*Y5)+$:/C%5^
M11=Y36F=\:)Q<,A*!JBO:;VOKSF&]23B+L9>H%0R"=:MXS^:!&0+(!_F5:I9
MK512(SD+SSMIH/,I*C=B1<1U5%/?PLS<C*L845;O;3HD;_  FK!*Q05FV:FB
M.#+J^ANXK)'*I,/TJQ]$T"Q'=6STE\ZA\R2DH[#>^GC@NT1RP#^Z@N([-P7L
MR_&J7Q 7SI3,3"VJBY2R?Y(KS MNU@WY3HJ5.=M+]";."WN:;UXT![8%^T[O
M*7J*]HJ>TN*[@^L _*5VO":YN;'HZ]OC=B"=>H.#&:0(/*#7ZE'Y"ET+ENV.
MU7)B[OW;PXP.'5=!#5./B%)2KUWS:9X))!H1&#A!*T<_#$>)=>.7;I]RZVL3
MI!8\J,FP6NZ"UT>=F$^S6@IJ3O=K(V*);*I4KLL'D2LP I&LZ^>1#J(Z17%>
MWJ5=U +D5=9]8S"^GMJ&9;O#6WC%@])S5P3$= ')AB5C;5PC\T\R--UAKY[8
M^G_D:*#\&/B9=0VL?K01&PV^8QQWS)ZOZT/\Y#,5&>O+I5II9)B__]^]0;^_
MU^_U7W7,&7^L:CH8K*U_%F"Z#'H= 0]Y,&]MIS4/":64J)0VLN95?2A*V%FC
MZ%QV#SCBD6,WY+/=CUUU2^_$]]."]O\-R4&VKDZK!"_KF^>VY3+*A*R=9=$1
MK*\L8:*@+3B[244L6^VD2O.K_,=4 &3#'6QRI^U<RL1I$/VA(ILM@0=KCC,<
M:*G(98>47A'3M5V,B5).84''P0R+GM,UES*;KYDC6*OJI=5(=7 ;JZF,)IUZ
M -@:D97#S=:F+']<9HI6,5!=$,O6OBS].>5$Z&A\5:M1O5"YGA/2 QZA+!_*
MDKS"W%*L^JE/LR8!5?OOZ#5=\0L&F6\JG6E'Q')@(<7: 9_ERIUV+1WMQ\<M
M6+M.DV%4O(CH $XSK^>,+P78X3S\1DR3*PP6=[1_S>P9(8-+TMC60T6.B:7R
M9&85=C>5941E5@925ICSFQ8)JH[IDW)K-4KUV*) "5)+FFQ1[6YXI],[LWK%
MQ6#S;5^Z?B?H*9K+L#3KRL/*\<U=*XP40FEC&R;<U,ABM%K&<2.+QV]D<3#L
MC_JCT4'?\P:'O<&/I+Z^@<';+Q58"SM;8+WE&TLKT^UQW64"/7XHAXTPT0DU
M:W.=38I_C,7:=0G%JDZS*<^L'UFJT-R0V)5]T&P3P1S$'/3LM'OQT_^H.$C2
MU<Q2V^ZK&80N"_/^YOWM*NU 0_S2T!"7W]ONN@7(]5M>R^F>>(TG#<>%=4$U
M]$*AJ[AT;V +MX^'?"I^_CO$5:%0:Y[7?*VK3! ;V:L?5!HGNC*<06='$P"D
MT3$2 N?7K) Z@_C/(LDKNZ=1CPDM+3IR&(/(]IZ0%VICPP@_(X:D@2I&J_KO
M4)NQ(MW(.FN86;I8=76PP@.BI<3UQD:UG+187< !UKB7+V6ZT$&?,GY?JTG1
M,6M>F$MZ*$6*&-W"9>Q^ L>ES.9/XY.4DVU/<&%L<CO*1(B9#)2MXFAE$X7J
ML<:3\84O'^]KW2RJ N/Z(A*Y3A9U;[O91/J.+!X(J?B),I<*EWLI5;EMZ.0V
M>2BE8\"D$%SW+I0SU)O+!,7*'69+5.BQ*;6[YBBHTD.N.?YK2S9>BN4WX6T:
M^%9?(:TQP7):"RU=4EYVE55 U K+D[RIR0:3B19=<6*ZF.! )E-$!_V6F$VO
MU;;0B!:URK$Z>FABBGJUT:+6=00'HFJS5,^J1@3T"A39<C./:QZ19DB^HNBF
M/\?]23O>;FM?8MN&PA3UH7J@=OIEY#-/$C$%":?OO2<"-KPN)+30!R^_B&1:
M0OTU(2](I^%0HDV//[!4:Z1N&F[0H=R&4-O<C]<BQ[]CT8Z=3.<_XG1^CJ,]
M=ASM(]52;!$I^3#PS(+I:RTY5D5EOA'H/KRQ%R3SG&J&'>[WVU?[M<D-+L[Z
MQ4\=$]KY)QQ4T$SR*$.DIX]1%@^;F:ISS$S*96&*.?X&/_!&>[V^H)KK)K/7
M8JJ3T3"_*\59PA[?0_N+>B?HZ]ZF[7"5]I6L2_O2913!4#=]FW715#H,14E\
MH7/8XBH?39^;[(QT_\-JJU6E^H"V?^!1C\QF/(39EA5PV-/YP*9@#&W0K$Z4
M+A4W-H9UIT$!S+ N:P)B#-'L9QS%+( 2A<D3DR\#T9Q[K3YD>/WJ;M8QS1NH
M0F:G)*VL96AWQ:?EMM<R;=ZI7>J+;8!+)GMAEA6JJ@;\Y=-O925@TPRC8UQ0
MR[E\57O(I;'KC3/6XKZ9S3OL#GL'+@C9I]4MSBS;'=D&&]0V:4EM>_C5UR]H
MB^NP,Y[:M&R+J"R=EE23\FQ.? ],6-6.;FSB-2]J7H*AX/M2?WHX[%.&>UF=
MC;[OBMIBECO.V*1?FYV;UZ;:R$ZD8'WC'I.=;'FK96DV]N0?V)S !@VT<"IG
MID5K51\&!-;2</I4G*.8&JM)DJKOSE0W-#.CZ8=0CL7H#J@\?I3,N)+81KX9
MSX9Q*-'5 :RW[8>Y2.G<7I?6!>4*Z.21E.8".F"<I*G.9TZO4;#>1KHJ>K<&
M@_#ZK:4U2&A25Z3/Z@6P0*R:;G*)KA6CB]28ZH=U(M<*SI:-DQ9EL^_RUHZE
MAG'38?FWS-Q%25:KD=+!1".7>Y'26>@^+.H0%#VFALJ-NZFN-FM:FFXQE9JZ
MGO)NTEOT!C,E9E&]4H;--$G!YD!VU9O!7H2E^W43RJZAY',S"UA@9PUV'7-E
MJB8)X*55[KNY<Z3]-HG*ZLUMJ7G3W')_F52%;[LF<:YA<0-D28D/:\<6+-L=
M[8C7MV!#1>A_1"%A;,4JB$ N+3()T5V98OUJ<UT#O43:&1N8[5SCN\9%6S-H
M'%#+ZY*E] 6Y[+JA7+?+:UU&*GZ\>:BJW<-LIF_"8/MILMG)A 1>2R_(#M4W
M'L%2KS&Y'H99J 7+=H>%SNC.R$V, -(93W!57*#)4* *8QC+G+$HP(72'VMB
MDC4*(Y4GY>P&:],<CTCO_3#PNON8#AK9MKP_#'K=D?VD4[LQBD=48-*W8$'-
MQL#* \_<"^$;'(XRGR.+=M?S?)8G_A^FE@&*<[!%Y6,W/FOYGG)FV>X(]-^K
M&^H9;JCR8%5E5V6UC2:OJ(7912IC8[10W!Q.E\F"T@\".)A0M>T.N;5 Q$O=
MXC:X##/,@V@<)2<R3.WY3W\2U,H#T5LZYIT=T!VZ$)$.AX.1-%$AIIF@#\Z>
MK>AHE &EZK<F=,$C>PJJ*C#A#RY55JN+5);DJ$H-T-MU:>?O$P)MM!HAZBQY
MTU'1SMJ\/-#):4L)&MK7$>LJ46-3%:GQ,E,@RMR@5 '?$6[!LIT2 8V,H3I3
MVE)B-=&@]_PRO^H/JS*4/T>POKTS?YK0#1;ZY1X6^*!:0]@7R+)D86[;V'(3
MUV:@+]K0$4?/8[E'])6YU&//39<))M#8.F;+/^_4"KL@YQI_!EUEJDM TT0[
MS/[8F\ )D6(A(!>T"TT'9"SCZC0:K,SVK5;"<Y-7D)0U68'T+'7?0'?6(E31
M9ISLB*7$YN&S-L#UU5+?Z32)X>_:C[<R)/MDD^,J=BU8MCOZZ,2T22_="^F:
MS6T3CQ=BGN!=")VQ&<[FTN1U5@G$\T1'KSME1PZ4RW-3!LV$DV4VU2F_IKL'
M-DBEIBGPV?*52;<=1^PO>^YRX[&N0X()(]J@>']R]K.@O(* 4DE^3;HZG<0;
MM"_?YWW)6!^P!FRAV7%/G,)9)<S%QR1S/AU(O-2]M@?]T:MC\8L^"]M<^\8Z
MT.1=N6 =QB-@T:-?U=U%*:21KO>)3JH4(L1<6\'D+M5UUF:V#".U=+-AX5HZ
M$GY&[\PHJ=RT%;>7WO5U#CWQ2$^<:EEAXC<6$[;5Y$J3TSRDFW6"()S:="(=
M[#45!1I/T3NN)-Y94)=A4F01Q9&#LI"!'$=A-D7#WC1BP=N&9:OIQN47,U4T
MM#-]SBZ#RGM@9>]AO4W0".,<CL0P%^T&I@2H(L9H#AVE]>PZHM%(&D[)5U4#
M/*PG>*5]QU5YKU1G &6YDH%6-4%15IN4,RR:_)>IKF!] V&,/@-=#&D9@RB<
MA?E2E<,F%-<JBTTV6["]"Z"''2_,MO%EFBYT3UD\+>G[)5G] -5H JA]&U7'
ME!I\M2DU9QQ.ZL-1DH"LJFJ4M#;W2/RDL7TGS?*?R$+-=*]!,P9.(U((7E>F
MME!893Y90MAT[%M;A^$Q_?S]VYC SQ5G>-2FYKU!RRT7=];MCF+4M]UT-XRR
M^^4FAO@5%KN)L':\%@JDVF1U+<CR\H8E5![&![*+-V"\'M^ V19'T[I%[^*:
MMP1H$09_?X&E+LX/Y/F?>&D[S.D"*/XCLG\WUK.C_L</6)W_X*0K_KLV?[(]
M_]NNX:F.@7>9/LSU;>UT<D+ML'^A?KKB"QQ,'LY\9/^I$Y;;-ON<?E>VF#6Y
M+2GKGG8R';%MC6FZNH/G,+#ETJP,M(W1/T =!/395O]FGH8P1AA5^=?-:%BF
MR#>A2SAT!58=M@_LF3X[-JV+^D[HTS0Z6CO:W8H'5#CQZ?L =&\=9TR)Y=4A
MV/I*<'4 ?J)SO>D&SV_=LZX(L"-WJJO\3>$\?]OQ*:?,V^]7267D#SXX^-%2
M1U?(MS=_5B:4B0^6,D J.@S#^LN,ARJ]#;TG/_1J^6OVJ$Q]'/2MJQ6CUTEK
MWT!=N#4 5#1 -V(ID;;]P<LJ"PWL8!T5ND3&YM==<88)!]?@#&L./_)"@(D?
M*,REO?8*VD15B4:\QV7FB(X,K_<CSK3Y5CA$4%4"?7@(9S,5A+K).#5>235!
MK]''Y,2:P:ON@S0*;HD;CR'70P2"LH57! G*_07P'9;P4?]9?0>,?#>4CNCM
M=_OE$YBST7@$E$Q9(T+?2;PY/[$5,G#G#+;#\W+?G%<GUG,J%Z6OTJ0N&VR'
MW9I#^\S.WV5#34OOLQI]%^*MS"4;:*YRJ3/+=L= ^[19 >P\N=!]E_1M[ZD-
MXI0UBY'"5(R).CQ>@%6E.TD6XRCTZUZZ29C.T%Z9S]&VP+X]$NV#]WL>#)M2
M/:3W>X->Z5X_B6-,L?RBBP5AV O6"8IZ[U\;6BDG,4WNFQX1^U:N+(X<8E7H
M@GH6"1)(WA!_\1DKB'_XGPVF\T"^P<-'5Q1'Y\8H.P]C/,I7EX[.$=US ,ME
M17'4%:>548DB^&U]#7J'8CV PF7E$5,N,FZ@DXHW<#&5$JR\ &QYM6#9[LCT
M7Y-8.6VT[KBE?B3/31?W[)PZ003HZ7-:YIZ T#53?K+$H+O,%B7HYY*D+;#$
MF0>W2V(_S'VZ=R;C1/MR*D.@8L+F1F^5HF3[X/F=\G0U'RM8V')254*<\.M[
MK-)/'5MNRG2VI/(=,,*7 F_5> .YYPU?JE?T*V\8F'_I.F5X2CNK?-OO;'_N
M$YU'Y1T-]G5E@!D=XSJV&&_]P4Y5(390V/S7E *+:=*F[D%5#:;>JVFL:JG3
M8=PXO]HTD4FH6_QDQ1CSYJIY-R8+)\"7WJLR7:]C.SGA7[-BAJ[KO\JJR2;+
ML=:DLU8 .1-XK4^7=##?UBB$ Y0O/DUFLS#+8%6UFDE$=7P,EZS_]K+_"D_:
MQ:S0"8VZR+9M%55=D=0UM75?Q*KINBF)"V>/.15>@\F4@=/J\^KLG$PFH8\^
M=,0-[QO!0W1M*]'IC;18K%8,J\Q,?]\+247:*G"J;:?#"=74JB1 6QHX7MRX
M-3$M"'#'PAA3>/.5BJ)JDU25SQ E7\9E,2+3C=*4=:%P2)':PM#2GX;JTB3]
MA:E(J* W%3^R-Z5JLXT5;@,=N="EYG0AHW\7P86N#Q<OYQ%B(N>>;2^N"RT#
ME:;AG+(A$P <YW3#DC6YUG/M-7ZQ:]]TV6;<VO*?O4X!NSA;L&QWU-VG)9%7
MNC!U-7$0:];00IX^A>T_ =EKQ=\G+>9T9P'ZKO+0V.]>WB0[D]J/ORM#Z]5!
M7G6LI##5/\L4YMCT+TPV9/T;XGCBY_J]=]6P->\W=.?.)(07F1J8I@P8O8 B
MJ+KNUX83HUAME?-MJGBM%'84@^:,SCMG='J<T;DM)^&=7+2[Q_]?2FU5&?S7
M D^4VX-WF8Q/0'S"$AZ59-5/@B'7*K.!K26GK"5=)2:;8Z(<:L^)[IBBK]39
MD)5U)M"_ SC:Z2*K9GN6!PC<GI7ID]KM2;J>%#W5I@AO=BY,&LX%^)>Y!5<_
MH8-QHW23&<S\HDJR4V6J8<\H]Y>N5F\\.[K*K0O88ALF*IZ+Q6.QC1N<R:N;
M(>(DRA+R!_Q;]WS3#66PL'[#P&H:<W @FQ2Z/Y7Q"BPUC[)U/\K.6-KJT8V?
M=,9=7-)\7"V]EG>'[;3"ZDIY6=JTRI"C:CTA&46Z45V"!7H5E5.MV5;X4BJ<
M&R8I7?LL$P WHF284?\HW?FZ/))6CI:LF&.=H:QFB=[#IEY[UJV\$=I"K)7
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M[/0?G#WE$NOL(N7=88EZFN%7^2V)D]E"O/N6JSC#PH=G_E3-).<=[@SGL '
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M7Y8]V_N7F*?)K(@N)/X$UJFT9_1,^44:YB',XL3/86!?%IFBK\)8.T)Q )A
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M]DGW% EK^Q8S,9S L2SRQ/KE\+V@%8][;^CQO4@NDB(_GH3?5/#F*@SR*<R
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M!RD?X=+"[XI3_8@VBNF?Y7]=Y8^3?U?^3''Y.I-I_\WS3U6\WOFG.C=Y\Q)
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M!>MR7.LB75"&)X]""A1QHG2V+LXB'(/U/-F #=YCK?NS=NF'=#)ZIL50[=.
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M"J-@32ERM24FBEG^*R9Y=Z8YUT-OPP84N:&Z80$W'#W%.LG\=CVK_V$(\[)
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MGPM,-^V\SY_I/B?TUM=0?>MKZ'TMV"TOPO>-Y =\(//U#_29++_>8Y+_^N'
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M7^G(V2Z6\V:G9W'9V9YPXMOR]2';#%4^9'"$$B =93JS&J[9GGCDL !&O0
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MN;&$_VE_$?+CS:H4[O>F9MN)M__F\RUC/CFGTO"-/7F5-#.FQ?$+]8$X %@
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M9SAA=8%:C )24(M1@ ]J 6H!JPO48C2$!>"#6H!:@%J,9G6-;\V,$640D%&
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M.;U_V<,_["J<L_XWUU'FU2(%G <9B]A_#R,S%=D!8*O3<P@>P_'WB2T& !:
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M'^K!3[_*Y#R)AB&JB4 <<Y5WNS9O>9D*>=/,?8JD7DO_G__QEF+"/TR;C_^
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M4I_0('=)PCU!TDS06/)8>BX]AI/V1U87]2]YWQ_[?B$^ R *0!FV6+W7I0V
M6+^6<T2B^M@.V>GJ5@_Q@?H7SN?U]36:Z<!+ZP[031$)DO#2@'KDWMJ17.UI
M3(4C1UUX& =)YL<D%7X$:E/(2>I%@B1N(M+8#3.1AD<DZ VRO=/_WD>ZK;8@
MWJ\.W>S_>);B'VB&JSO2I64=V[6N@G'1_TY%9>20> "C,I3/>A;>P=0_3I,(
M5>1!0F$_<V2W\JI,A4R"!0'[6+*JJ^JLA#)2E'^C)Z#ANPO!*@$&@5PYV9W2
MB[O,B8[[8A*%>?+'$O[CO/[X_O./;[0BCS\ZJG>6MM PAJ7- -A 7QVH"EAW
M.8>#OOZ/]^]_?:,U_KXAEI?S>7FK+#^YP+#Y/B-GAO;!>KY2_*?3_F?&?UE?
M.;E:2 <@%L"HT&4/&P/ E!5L[,(!Z03*OK9S2@<W9!3]%A!X+I7U .S->'>,
M3?/MN\ 7FX?5.F.VOW<QSEUW/^8S *O_4 JEA"H>\/K]YP]O.I-M@T7L=(?8
M(,U$E=+,9VZ:8SNK%%.!0IJ2A+I8V1ER/XY2+L+T&$KI(/WG?E5TW+<Z7IWR
MUTY& &/G?8!;S7)<1#SN,X]'+GTY2%\P?3B4PM#VX0 2N"^'2"D[]R8.?5]6
MT-XDHB;+:"-M2*=PK*X S)=7G7/51,H$:%/E?*T#5._G<SW#I4G,6%5L4>O8
MA/9\9VRNG<Z=%BOGQ76!Z1=B5$D5WV%2C83?3T**>]SW193G)&:Y#_::FY+4
M#RF122!EY/F"TJ-(\=]K^4O^EWI57 -FU59N'T4: E"1[F4#5BNLQT6KXS[S
MN(2U=IYH,W(8*.XBN8<(='P((_48AU6>%^5C0.E95/!:>"&[5 ^CH^":_2$[
M\M$QW+I>7R^UA-21V#R77#M,&C=&FVH"&]4-S&?]7N7H)KF1B[6<M8VZU-*5
M-"D?;7V"4;?1X,<=F6;H^&QO.<>X:QHQ?Z K1+UP>[_MCL2Z,EF9YCGE+0+1
M4(H+YQ<,:#OEXK+$3S/T.<]VWTD/H/*&S=<*D*B)M&"=@:94\*M6V<K6*^6H
M690K!W4-W*"ZBV:A;O&_K\6E/@Y">J/Y60MF3-<I+Q?&196SHG)P)P:ZU]?E
MHDD<TALT**;J9@B<#0%TBZZ66>-4[[Z_U8A>JW\+6!?41O858_GO^6JM$_>4
M;TQG$(@"\*9J(N!EW<.S;\>T1RT/IZ'7B(CF7B*)G_L!H6X>D"R2@OC"RUCD
M>EX81L?Q3EP##*X (8L;^4FAQ4."9H=LUP;-'JR)#&Y)Y2]956E<Y#_N,X]'
M54),+A=*)(X[,*!E;X_JC,S$X2Y ?S.C#JBF'7*U]5=4$%KU18>#]FI\^#>M
MN.!O6MF S^[,(DHW^"<&GWY1E5_W;4LG)>:8.XK)@4K5TE-I<$(-Z)"@51K%
MB37OU")^T[-2JG>A@F*4,5Y4?'V-P3_TMZ@O@=0BZ#ZJ')-U=P$@;&'Q&C?T
MIK?8SHTW3_7AA0!%A6EQU^J<H*HXTFBR)3Q=X1*@6-ZSYH6SS38;):Y6[U"?
M,,S?FZM<2K--!3!U,TKMN@(.*:NZT>H:,"KE6NM,NT$X)N\3J!CRJSKYB$J'
M;3^9Q^TO&294JG\.;"HS:CWL=#DM+0U,SVHY3GK+P7KZ.#$>9.&BO 8C:=R$
M::2F%B<@)Q;&@E;^G+Y,,<*^J42XDPP^DZK<:*L21PE2^,%M4E-01*X70-]S
MU ZT,(.+!MSZ0^I<^KH-V%PXWY74\+W(-B))-V8:GH3G@4O)<B^-22B2G-!8
M)(3%KB1Y&GM^E-!4!EOM-1_B>?@LE6OLM\9W]Z!<W0/V:MT.CVA/>&G&/>C:
M,9M/,3KBGU*F[MZ<VT.I>)S2OIUW!/+VLLOC[)GAO'-Z*+/648;/LE(%@EFY
M7AD]H-8A)*DB+)5<R3[EJ3X6;8T9J@RR"P>8Y%-^5<B\5^F(!9XU_)U@H*A"
MBQ8_44Z+J_)66=)S8+.Z5T53.6>B2%CQ!PNI]X/)/RR_PV=VA[CNW<&>&(S^
MDOP*ZHJJ5BRQ9 ^?OBGD;;W[.[WB/=R,CK[4PX)%U5($?KZ<]\L_S2VU89W6
M!]-^#RX);Z"\D=I3LA#]/B UX,C<N2[GL%U86%3KRR;4UG0$65;EI5P4*[@D
M+N?S6FE^S5M*H2HLX8+QT2O0WU97\(E*([:YI^-DLT?6L60B/9I' 8D"[NJA
MJID'MI@;TX0%H#'E87(,'>MC60&D%Q^P*\ "U*J>A^K]0JA?YYJ(OD_O.F3_
M5N]ZL%9CKLWAYMZLTC4N;C EI6L'VSJDT?L>5>U@PA^GJH8)I3KJ43>I$JBA
M;<1J?O_L"&RY4M5-(PC=I M+B0Q%:OT+P*-2*D"#JPN3AOO[0B6$J&Z>*ARC
M/FQ6Q (BXZ]!K:+GOKEDA5%EFO84&%/(-SC!1I!!;3P'1:0791JDUO0"38.2
MIR[:8;)1=N;*CN?BG)^Z;)\#O63]"C$,HE7X_/-O4>.Q+(HB7Q#7#STPIM*(
ML"02A 6IFU$>)XG/3JM:_ =@\L^ PS]*Q-XO[.M1!J1XT8BZTQS"04?NHP9V
ML,5<I!GBVV-&SY]@6)@+GGJ,N!F+@&" #%+A1B1W@8K2W/>\?*NGTT/&"9V$
M8 YI[D1'1#@'\?I[45-+1U7)B_V>"C#+[ZS5/$X]^<A6LYN*E./@+R:D3VCF
M40*"*2,LY#%+ B9%DA\E)Y+55V >XW_^\H]U<0.D!PK4]UG(A^S56L@/3XC$
M8OVV:E]VMV1-Y7&Q@"F9RON,WH-I>9SRM.^W5ZD#*O, ?=A7L.K\SIFK/KY@
M/][(>F4ZVJF>'PNGK J 'AB^H%Q@*H%IW/6U:9"':8?*TX[.;UBEULT$=0>\
M3=HT#G>T6I5=*O!KJMQ!YRSHJH4+9R]QX_/?SHNHE6%>R;G:+&\6@QW+N^9-
MV >PMFK#.'G&D=6&-$N\./ ]$K((R#?W<I+()"9)''A<I*D;Y_'IU(;?@*9@
M+X#M]ZD5MJ#T*.*V [:B^V^247@1NO$80/J$10FC.?,X)23VT7[^3@^?^3(1
M3!*>^L 3A0_L,/,8B5/IAE&:,M_;;F0=<!IE(B(B]X$G1G%$4BHXB>-(^ID?
M>#$3VXVL^]SO;Z5N4+[XCO;5][D$9['K3M"Y40VYU+[6ZT9=JJ2)5*AD!IW1
M>8>=I\NZ4!V=>X[N_U/OG:8#BA97W9UU3./YHS@/W#R684QX) (0X3(@J4=S
M A^ZG*59Z.5\$\5]'OLT2N%$62()#9.$))Z?$#^3+(W].//2_(E1/'D>*+ZM
MN+L=9DN=3+0/N;^)TOT:'O824#N)19AZ">&>ZX)!Z@,G=CG8IZ',XR3T1>9M
M:;1YE M09C/"$P&HS9A+,K1DO8Q)GM+ <P/^M*@]/<3^-O>%M]T4Y;IV_F^9
MK:O]/'A,!N:I:V'<8"+J\I'M3IKE(#5$2@(O%T"E 0B3)&!(M'',/#!*^5'<
MU7]M"SZZ!ETGMRI/<*GC-2O_NJNDYE2>W<F0R\@//1ZYL1-].NW'P6(PG/*C
MDL.;#&\"HI.H&5*]@BXALU5_C1V-FG<F2W>N73U> 8R SU=EM2(X?F5WQ9CV
M^,HF<[E<Z,2;;B2*:;WGU%=2KG1S'X#?'".TB\L#%E8UJ>VZ.(VJ<S\7>\K8
MVHIXE<S3>(^5VWC6^*SO[LVJ:O.\S+GZHZSNJ5+7F>1->GZ;SZ^\X??4B&,O
M9&RL8W935N83!C>)$,(^A2:U_YJI!#)TI"_T3@A6#@(@K['38H5*!PZQE!UP
M3)<?]%B47$_^TL8=N\:2JG^J:4"Z3G +<> \XN_K6K5?PMDW^AMM;R& P'6Q
MOC;% !R+$<Q?5&*\:L:D>A[IJ #.]4#/?G^5X3>'J6H*G ,H#I/1 !EP/&RM
M-*S>MFL LVYQH*&';;>9F=2I+(@E:)>YDL 8 VC[.E_+U54I3$^IWB:*YC7Z
MFB^<]RI9;( \IK."K-N7-(/=.J+:.EV[AFEO@$NIZ4L=DC]I%Z7)")5C-WF.
M,^%G 26,@>E#8PI&4N:G)(S@_X07)$E\E,DC'\ V@LO1V96_%?4?'X 8P42"
MGZP2=JP>2#T0J\B> K%3 8QUDY$\)T.AA'^:D,9BU;3SMOMHV_, VP=:U4T6
M42*WHYOG:LP@EO+WLXOUQ,$..>M-[&P*]KN9H?W ]':46]6S[:SB[T<JKD&F
MK)2(TB-&ZZO9UEHS(_.VO'&UO,&A&UI"BV+8AA'/7ZS69C@&:DFF_Z(9MH>3
M3IU<"C.VHU!#-X1NA@B;W*WO]KH6U*A[JM%_1C7#S&[\K2\>89FV,^-PVM_&
M$$;LPZAO1?5A[(\5ZU^"6+>S-;J3*C=.KV6G<>R4U=T "%U?)@3U().@;;N-
M.D!S)1MS_T9.@I;OC"KZN!CB\+988U6%J;#:5*J5XEVW&;-MHBPJ->A7!0HN
M53_8P2>5T;B;KUU)<:EJ77MK6PWU*;)3 L\-71QVZ6*]AI2<)*Z?DSSPX1_F
M,>H^JH%Y7LE_O.W-M/R\7BZ!F5;?F<]ZR#:/G,\Z$:(_4JN-'L77S16]E&36
MR=#^Z;-9CPB*?>FL!Y/R^,7EY@CNU551";)DU0KUL\4Z!VD'JFFEG%6*K.ZP
M-X-8XZ!P]'NA!Y95_*K?XT%[=+"TQ%1WZLDDV-.A8M>#SI]P+/3) =G.M2K?
M_+*2:AXU.K(<W$[!UW,V;'^!K2V;?MQ[9I?K'-9%U\2B?Z;>OO \.(M;J*I/
M?;)UK3R%W8XJT'<W+(A;U>D;1W(+L 9J?)ON%J_'V;&!'J)\9=5:JQ*FUM2
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M/YSBU.ZL_7M97;*%F=;8?V#8.+_;O[*7%DU[#:R7Q)9!VM.(=HLV:M LY&C
MS;O6'\U.E^RN>[RKPMQ_QEZS$'7Q9L;E!\6.<8:6K'#<TI[._;.V(5QW)##W
M%"Z0PY"AV:BQK]H60VS1V+Z]X5&JSSWV;U)M_*^7\W9H9CN7<L7J/P!^OS:
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M$M'"J;OI\AO+V"S")_ F!QD/HR0/2,I3BIV&.$D#SHD0+'9%GGA2QL?P)G_
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MA=70$V"DMC+6,19GJLX:QZ&NZ3#>PW)NXE%[_9^%ZOIM(C>*W0P(=%BUT7I
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M;(&V&T"AZ/%0TZT'[[L-OR_1]:JPE-VIZI[N:=-E RF\7.A-6F-B=(K4B:.
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M L;#,!Y%=,WS9G%T3'_=*4EBNW?!F"CA.3$I*YQ'20!6.(_M(B8HG,<C;U]
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MYIV3!:R5W%9R6\G]Y)*;LCB/9>(3GT4NH9&7$,9]3L*4Y9)127F>/('DGFK
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MP?D@_U&5=7V49,YHYL7Q. ICQX3#EJE;\#XO\(Z'IUJ9^1)E)A,\]R,0EVE
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M'\\<(+[+P6W:MV=>V3FX(WL>.2GJIZB?HGZ*^GE^]5-@:C]45;$  [0 WUQ
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MKZ5\P<V!6MD,;XVV4-3V*ZUZ6@*X+A"^O%P&=+8Y7;I(-C]2B]F $^N+.BQ
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M7_5<M_NP0XMGY^/I9817[214H9X![IO.FNISG+7C5])T/)Y^;D85?&<3VQ,
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M9V[A.1_B+FCJ'LG2PU$Z:XU)VY=P7;]<TQ'VPM;C7('69JWJIEG8B8_ H*!
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M++<(I,B0<TDA'(,UQ(C@TE9@["%%16\GX C&C_9+2?+N*<E+[F&5G__VJN[
MJ[G]$IN>)YQ[DWXM*>>#MIC6.=&1?YQW2&.2T\+\6KJY IRU[++)=LLOSA;C
MKK\FQ;!NO6F[9ZI)G*\Z9P#;Y3:95:W_[@8>/XNAAO_8V>P28$!;L]:B\BZ_
M_#G"E\,7'7V%=7)22^PEHC+W V"><9I0B 2"P? $CN56/X!*DA%O4HY Y7Z
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M>_Q:7CCFM,MUB-BR'$]@&85$!*I?V:2CIW)K)$+D@7.>/(K!@Z>&?4+6*8P
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MAJNP<QAVZ;YS+IN?(=<,<^S:7G#8V2QT@VNAYXEW@\O/*;M/LS78&':?KG&
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MIHTF(I.<I+$48%:+0F^7PQ_0JG@>Y?#9J5H6=W%XR\"=P-[+Q1O'H!U: E8
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MN*F]JQ_R:.<@'GV>+.@''"<QM D#6K5BNXE,6T*]E1K<Q4#?M_>Z8WHE]>O
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MFG-P#/BN$YF_@<3\:&MDA+7(VO6RMD-HC;!Q;.T+H;7S_:&U(#DFIDG_<A]
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M<R*:%<GSZM';^J+U%A:O&RYBGY9$21HO8I-WR:]^1^?VC6#L3/Q7F4#,P&(
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M*E^2:65;ODN:NXF3D:WSU5/;\DARFW[*T"0D<4*1#D#:5GY]%R#%5X $14D
M+IG)Y"P)N]SG ;!8+/'RX\]O:Z_W@C!Q _^B/SPYZ_>0;P>.ZR\O^H^SP6AV
M=7/3__FGKW[\VV#0&U_?W/?NT6MO9(?N"QJ[Q/8"$F'4^V9V]VWOE\OI;>_6
M]7][L@CJC0,[6B,_[ UZJS!\_GAZ^OKZ>N(L7)\$7A3" \F)':Q/>X-!HOX*
M(XM^WQM;(>I]/#\[/Q^<O1L,W\^'/WQ\]_[C^^]/OOLP//_[V=G'L[.<6/"\
MP>YR%?:^L;_M42EXMN\CS]OTKEW?\FW7\GJS[4/_T;OQ[9/>R/-Z4RI%>E-$
M$'Y!SDFLTP,$'[TMC#?B?B3V"JVMV\!FYEWT<WC>GK!W$N#EZ?G9V;O35$I8
M@GX:;(L-Z%>#X?G@W?#DC3C]'M2&3]BS)1ZR+?Y6*?_ZCI4>?OCPX93]FA8E
M+J\@J!V>_G)W.V,X!U!#(;"&^C]]U>O%=.# 0U.TZ-%_'Z<WJ9(%1K]'T&(V
MX1NK3&!_.#Q_-SP-K;? #]:;4RIQ.H7__3H+H5IIB[@*:!-P'?CH7%H>?=1L
MA5!(P$SVM!5&BXL^U3W8*J3\?-U23;AY1A=]XJZ?/=0_W1N8K-E#0PK6:&Z]
M(4*I<R(/31939 ?0Y#R7-98'C$ Z+CB&/UV/G#?!W-L##D[ +8)VR#$-D?D*
M/?H.% PB'^KGRB*K:R]X)?, ?ID\(PS&^TLFWYZ6@SSV0&2)VVSZ)9DL$M/@
MU]W[0+T^I?"N@O4S1BOD$Q@V;@.R)Y1"M6K!;AO=GD"6U1T27-;'KBT7_\?R
M(G0'G04^,VNR+I<.K"-"P.4FA9R)#WTQPA@ZV:5%7))T,BDF#OSL@SM#\,3/
MENM\>GN&!HG(R'<FX0KA*S )[(]MG47KM84WDX5,84GRCF?!<5K> P[ >X4;
ML.C3[Y'[3&L_JWS>K[NULL[/.0X=(]O&$4KK*;.P],-N).RH_3C0N>$/5,R+
M2^<KNP%NI5,AS&*4-UD\SJZ1 X.Z1\>&* SP)A6;PF"Q1S*Z/5DA96.T0."\
M'/BZE0/=AVZC0FTUD;8RJJZCD'JZY1*C)338.]=WU]'ZP=JPN*(S)ZW4B\#;
MEF=''NMQ-(-2*(W>0N0[R-GJH' /-0.G%G%L&F&[8)*%[:TU\&?!H&K"(BEQ
M2FCH0;4-7#!C*[_ P?JB'Y'!TK*>?[UUK2=P/:&+2!*)I,P%62D8G&BS(T"R
M]>2AM&2 P5%=],_ZO5=$<SL7_6&_%Q$P+GBF#[:\F'.5"&/W40..=B6(.N@_
M-/)XL3S:CD;AE87Q!OH4BXS-P#H+ _NW5>"!I81B">G0X44TO?@08&9*&&+W
M*0II-<Z#>W N@1^"?E"VO ''@A'AD@31:^R0V2,,HB37P*&2JP3QP.9DC /9
M@,? KLMU2,5.;0*871KBOOISPL]09WYJ*OL%1G0*\#K ,_#.,YIV8$2.T5.8
M?:+H2RU":\2'\]97P7H=^!Q7K34?#5[LBF*W[/"_;KBZBD@(DP:\%=F85O?2
M<1=-"M3X;ZU!-H9>LCW;0-3\("K.<3W #"#,)[KN48;M7&=LAW-9(\=Q8Y0/
MENO<^%?6LQL"9"-H:?!<Q>EYG<\R!67==*K.39<[LM9X&]U7,:6_S>CS8U.M
MD3;-'P)_.4=X?1M8/KD&R4N+KG%(D+TS!%E-10HZ:+D.M49Z0-=LV]&:PD')
M*ZO\:^ X>TM?!L,@-EG,K3<SZ!*/TL7&P-8L31:/T+^IA!G@FL8C6HNY,IR!
MZ+W.\,1U-X4FC%T[29";ADO.66V],0V1RQY*:WB'\U!3FO3WD?/)PCX4)3F/
M-48+UW8-8:C:L.GKAK3&MS\G4+Z3A>(%1?L]NK(RP,57,!0  03,^H5%GAB$
MQ#+VFN,4>2'9?L/>U@S.ALE:RJ^;VS!,])!7V]B5&2UZO\$U7%!8G?&\,+5L
M<Z&,,E,E7[5P(<C)*H.V7^=6PKXGY<K(X;X]XB+EE=3!E]6F[,6>C2^F Z!F
MVU5[M%I7IM"X'=Y&\(&T5Z3.<5=>*/!]=+F80H,E7Q8(<,A)JPQ81"\&1#&+
MH+SV_:@!6$LM"H? NMR_8"RL$5%7;Z)$/;]^!*65F2^1B^<":9;3T]?5=Q\I
M495A8W-^711&-DJJB\+XZ71^/,8MJUOOJ:^,!B&5@VB[O+9H:&VE19.ZJ^2U
M):JN+*,.2DT"FX]#+* ,A#A7S84@+*[<CQ42T;5>+%]2(>_-R6)!#30*M@=5
M7?G.3?D6#.*5B->VGY93U[?P^7BKWKOOI%:=@<\<-AULXWS-'0I7 <2N+] #
MV1X#WBN(HB"-JUP_@E:2[0R^1(N@0,P8_B"A:YNQ?O68S,!D#GCPVZ_W.J8?
M:45(R97(R6H"K65CE@#<3J-)-*0M=U\L;!5JYM_W>R2$:M\FF*%T6"JDM2N_
M11 S( &2="-=EN4MK#ZHD\U7_*<W&XJ.UO23&;1T;P7&K4+OT!"$;.D\9C=4
ML5SB0COSS4R_M&U\Y3FEK+B> ,6NLCU:H2[=&NJ^LNRJXR"YDX1RAT*I=O0[
M!)Z?WD)L@2]W?0MO;D SD5^/EU9C]ES#0H#M.2R"1:8(E-+52&/T@KR O91+
M) S#F:^@FGK,Z*BB&^@'[QZ%]< .VA],: !'=@A95B-6:-;69,G>,@5GX$=H
M2VCYO2J,S/&2/9JQA?^<_%X),_#7><7/R*>'%H%3'#EKUW=)2&5>4-DO:HU4
MTG% S26P+@'UPN6V8PW]XM%[??Q;N0F<_T52WFM8GOL'RB5^/UNN3^CS<^.M
MUMN-CLQ8DA*-)[#V9HXMGX"OA>=0YJ@9\>/R_E7K;1_'CL[IRW H'I3<.F]C
M24/_U#P;WY:E[NEZZ2>JGYI7!SK19#Q74KW9Y1A$9'1:3N4"C[IYHFB51XV,
M,BC<N*AD>K&,0C<AFFH(^KB@N,)FL\,T0M"8VFM2!KMQ_L"%V"2E>+3B3!1J
M1IIJ:87FET)W@=G%4@K[3&T0+>@==3+*H+2*;KG VFA0NX23&X3RAW51<8/>
M!U2O3U ]\9!9L,S=8/I@"8]2$:A\]''2W_X5>'30V;;%B9_MTAEAE\!/XXA>
M*O" L!LXE5-%M$ZK<H"7EX_GR2J%55\@PLXM3.O5!/OI/CQ7UT&K=G1T[_JM
M>.K\.)6[;)OZ5G7#K5#"M,FB(8-X>CV0<D\,EI1.PRCN$8%)4?&+7,FXR4,5
MX'@A9OQO>JH$3 U7EK]$],*)3XL%LKEC/50B5<MN\P#R+S>/A(;3:0J&75MH
MT#': CSQ!*&$I\K&=LW1/!C90'1VX4UE_ZXY;]&EJY=#!PY@!FM.8"- FUQ^
M)8'61LAAB>(;0B)ZQ0.+^+?G(9A!@K8^A=L'#7FCO$^?<F?AWQ"+][)8QI"7
MS]W<R6P%T>TEM">'QCP0\+#'&=T&=G MS)70\>3/T?KSR,''@/.YLT+:ZC>3
M16U/T/JTW4.,- \8O'"(H&G8J!!B:,V$ML,-MRY,8+2;DQTCF$W:;M&U?H%X
MV0;J^\"GHFRE>65]J];K;0[A0/);](UF079ZPHXC^K?K.Y6UJ%JO%>J&.DN%
MC5WR'!!V-M-D$9\A,-QA 9!Y%%0'C.2PH.V5D]Q#@U)JOO]345,ZZS9EX9]?
M;A>IDE![2%9*R0]_)DJJYPFF/'S0\4V-FD"3<X+Q$8U0F?]OV=BJ+P=D%>@&
MLF9F*P>2IT#= 7PM4MI<D"T4J#R9,TU4\T%D!71K;C4AOUQSXRE061--2711
M!37(Z=.#^&DKN<[#E55WXKT@(\O%(BBL15/+)U4;VU>NL![&R^5%FW%)Z=$"
M<EW6LX5_J @K U=,NW$A%(KL[91!?@JL8("XG&9MH9C :M$."H(*!XIJ/DHP
M*E0*JENSWY!.X@)H$%*Y8G^GQ! 7Y([*- )?2?U(XBS+:02I(9$C";!>BT9P
M>4D:^4HLB^JS1B\[A?#:<C&[:.0.S(;/+%S.#B5,)C>6%_>NI) S\:<THJ$K
M/R$B=4ER#*'R!7WENRR*-UB,UG3-[Q\T@"8ALYN7JFO0D9U8_!F#"\Z6RE*G
M7-TUK??Z-)5\\7>9:[T6XQ!TB:Y;:?_R6.75,[),--P]TZA&5\"R7F$7%B1U
M&T>-S$:\_>C6AAIQ9Y="+Q37(K+(@HKBW3%D&Z$GYV7&H<2,^EN\H4F$YL*Z
MQ!<MKM-)%\DD,E/$LO5CQ.9KE<OMM5[3W EVS6D,91*T'OP[D+"=T$'0C-R7
MPOVX)JP0:XF\)';C@TN@>2(SUD3M")97JKK>19\ 3K>+P03IU0;G6<VSU@OL
MWRX9[U9CI83XOFVN<49"0\4RJAMPSKO4M=:LF-J]O3(=3-2?5,=WI<S1=AU"
M?@E"ECCB_:I/%-=\D6AIN2^_/)MTF!+"M<-<N)DK>W$&?WN(&>X[R?2<?=^\
M45-^9]617X1]&7?*-K71=E!B(1VNE>S8^/C3ZGVIU]$M)^\=MM/IS".7?M#%
M&3?>PYWW2I_6SUZP06B*6.WQA$QPQJTP)X7I$CI$"$-PC:J M9X[2P%F 6=2
M<KYRL?-@0:^KC9$K+&@]CV[-0NY4U'2>)=;1=G9]9(]>#[WJH@7EE4&0\#U<
M*,URJFM%Z%KJJD8DM+?IZJZ>H#J)W5'3OI&TZ\U"&*W4Z!BA<"^V9:NJ"8O"
M](A+&DX?S8_0"=E-%QMH'9(T81"BOD8./3YV#[#_.EM6?C.65&V5-T_5"ZD&
M(VY(=6B$4L9XON*5WI/%XRS!1,],BX#T32I&MZ;IXA_C+7+IF7F)=;P3_KD3
M.:YTD8I16$N$&7[U\#0E9Q47&XD+@K1[N,"!$3/$P_/$CB"$B.D67)F7ZXEF
MS!T/SP]\>861X[(MM2P\-N.%[>&9N0_H.!!!L2=ONWF#OQN++E0SXQ",P[/&
M9B;I5_Z27>7R@+"=3U9\]^?FZ(KM.+_QMUL:H%#\XH\NR8[!>E[P6E@]H>5R
M@O94E;,D\@HT ]DR:&F!OIUFK6EI#E)VYJ51M=;$B*.2G0D1JM2:"%[XL3,%
M'&5:@V\;8>Q,3,L':4U:?8"Q,T6U:K4FI%4TL3,_;9YB3!*F D:7-$O%L,)Z
MCN+)DZ62Z6$_=#/$E87Q9A'@5PL[ABQ9J@ 2+%424?1%8ZR9(.A]AG6'!IV.
MZH7&7,E6:)WGZ@#_<Q XKZY';^J[\4-PPG0,+YVMJ'4.JUO5E[;]YV,58"1)
M^Q.)O(S6V:R]<D2[!GYA[XG9*V++(S7'#FJ=K^K R_:+>. W(_749=BG\6O[
M;)&>*-G"ATJQ7.MM7GBL]4&K.S. +'KYU@AC&HRS0QO,.$9U5\!3"FBR>"3E
M$4_+PU+K458.IN(6UL?XNHF$'*(:#?K %"_YYQ;5QW#IZ;WTE%T+6$WAOAS$
M!BWZP*T-[R4=1XT*?8#N)9:7KOS.C]*9.,D ?U>RY-3K0U YTI?#79+2!TX2
MR4L.L:SPWM8L[QAS%VSMH.B .'B1LXS9'+G#65D-=R5,K AID7[/,N_L\%/.
MRD=$YBOTZ#M0D.XRCP_N9S?$S@/X)0L>XQ/V]$C,WR+@N&1;>H;A]MSI<83R
M4YNVLO? __P5>2_H+O##E2$Y[6,P\S^(WN:O@1DYWZ,1 CX&F9$*/A8EUT&$
MS4C\'HT1]P69D?(]!B.C18APA1;IU/ QP\.V=)0"1FEQ[0%61\5.@"OJM"<@
M'?PZX=YJ,0-N/+1U!\ST& $Y'KHZ(V9JS #,7'!WP%2-]H!+ T\GU$5=FD_Z
MKJ.0GE*R7&*TM$)TY_KN.EJG:#29W15))['195OYH8>DJ%$'EAR>CAL?QB+:
MA@VYEOTHC-#!JLB)UI.Z8W!"A[,B)5K/ZHY""7C](B5:3^L.3\E\A3"RZ*"H
M]XRN)1/E8R(EI76'UW 89CLENH/-#W-=\.;T&  Y-XYU!)UITA]V;JCJACI3
M9 #H;##J"#I5I#OH_'#3!7-.3^T<+OF>_N\)]/WT?U!+ P04    " !//6]4
M,%B!,I<S  #_SP, %0   &9R97$M,C R,3$R,S%?9&5F+GAM;.U]67/C.);N
M^_P*3\[+3,QU.IU5U=-5T=43\E:M"=MR>*F>?LJ@24C"-$6J0=)I]:^_ *B%
MI  0)$'B0%9$198L83GGPW8V'/SIO]\7X<D;(@F.HU\_G7_^\ND$17X<X&CV
MZZ>7I]/1T^5X_.F___PO?_K7T].3JYOQ_<D]^GXR\E/\AJYPXH=QDA%T\N]/
M=_]Q\K\7C[<GMSCZ^ZN7H).KV,\6*$I/3D_F:;K\Y>SL^_?OGX,ICI(XS%+:
M8?+9CQ=G)Z>GZ^8O"?+8]R=77HI.?OGZY>O7TR\_G)[_^'S^QU]^^/&7'__P
M^<>O/_WA/[]\^>7+ET*U>+DB>#9/3_[=_X\35HOV'44H#%<G-SCR(A][X<G3
MIM/_=S*._,\GHS \>62UDI-'E"#RAH+/>9LAY>"7<,/&>X)_2?PY6GBWL<_)
M^_53@9_W5Q)^CLGL[.N7+S^<;6M)2["_3C?%3ME7I^=?3W\X__R>!)].Z&A$
M">];HY--<?9KD&XK% O_=);_N"VZU_3W'WC9\Y]__OF,_[HMFF!10=KH^=G_
MWMT^<4A.Z6"F%&#TZ<__<G*2(^<1G\0A>D33D_7'E\?Q/G4X2L\"O#A;ESGS
MPI!VS5N8$S25\K]AB6'W$T/MWPHUT]42_?HIP8MEB#Z==::)?D816QJG 9IZ
M69BVI%#:3G_TQ@L/1]W)+35CFEK>^.D"+5X1:4NJJ W#=,YI<\3/7M'I%IB6
MU"I:DM&\(;A*[92@?V1TJUZE[WP7I=O>^?G7'\[/4N\]CN+%ZHS3_I32K93M
MPI<QVW9Q0/\,ME].ID]I[/]]'H<!/0*N_Y'A=%5FC75SNFF;\]"^Q9Y8?*3_
M?-L=1;S_"[H]!I?Q8DE!YGOVL_<:HJ2.MQ9-]<34CH@)F7D1_B?O>A0$F/W?
M"\?1-"8+_N452CT<UO+6OL6!QBU;+#RRHA,(SR(\Q;X7I2/?C[,HI<+( YUI
M/D9)%P1ZZQ 20.Q<#K(03:;728H7;'&^)&B:A;=48$LFTU&2H#3I$[%6%$""
MD"WV+.4#/9E>82HVHN >I;=QDCP@\C3W"!JE*<&OM!#="IYC6F$11\6-KT]\
MS9,W#/@W'B:_>V&&[I#'_F;'16&R;"7U?'ZL"P63Z!'Y&2$4 +H3XY;(]M+W
M,+ ]D)@*#>EJ% 7L.%TRTG>4BWYM!U'G?H:!XPJ]I@8/ =WFAF&.BE14%T\Q
M7;8/E'Y$"!.MZ+HUR'&G/H:!X3Z.*)4I_8DV/AM'*2(H,3GJ[3L84(8MR= F
MY9Y6C=MB?+<%%8XQ?L@E&[/-34QNLI36'B=)QHP1IG QT+=-G<?TG&G5@4T
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MK&!V  $Q?<K?9<>-4$P]7-QZ.2MT)&)WXT_L3,6JA'VX^!F;DEV$>'<#9(:
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M'O@ZV;"T #0$%O!@*&^FFD7C$"SRVC)J$9J"\.<NY]J'<1/Y$J8]%\X1*U^
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MW4[.M=BF!!X%582,*1@.(+1%WWY8A$9FF ,*@];::&:O$V[&>A8B\""IELY
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M >G)?-);K,WA MV/*%F-TH&9A@^&-:K7^[8#)E.!O:9[R]DV?%;$/B>C4FF
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M*Q>!EO^9\5[C]07*NWS<M;S8G/&-%QDHBUI[7*W/N3B]:]VAX)%0[78FH3B
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M+3N,=%#D^D2$]@_W#Q\O_[CQ OZIQ+U=/;8?[!QAX5YY\<+Q$:ZBVA%?.73
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M]G I!)AXI4.C,,R<2:TP+NXB7NB#H5U^.T51TDB>+9=@ ,W#+"6GU.8VS6/
MTQ2^MI?0=T$&<3C>A@EO;G:Q__.]@A D'#]%[Y6#7N^4:QF-PX?$D%]1LZHF
M\/C<J/X=E^>(61+-P[=J5(?=D8,'?07\4'WU7<.Y?Q I.P4*6&7L)1N$RYCS
MQ4L0^N%S.8CF?L\>'PS3E>-%Y)Z#6WFS4D',-4==%[6BJG:9%AGV\DF"88]J
M^\-V]13Z)1]B_O?F(D3.4PO,Y))1 R8/47(#&9.Z-Z3]9;</A;'Y#:X)<L!
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M\RU396VS'/5G3$9(^J/@F12/>N#ISF0'O..%(T#6>E9>[OE1HVDLDD4F\FU
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M=K8\AZL?6Y97]4HU07$X ]N)L,5PK'#OVD&"-SUUA%"OE6&L@PD.&CA.3\+
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M68#DUM=&5K*2DY::<J[5&MD!1K_<8(EE)X>.(&'1@=-UGKFR,Z)C<7.A+B4
M(O0R?U%??LO?Z%>=[CND@,[ZG;ID:KGEO6)XZ<YW%A(".8"-A.4(HIC98M&1
M'<G5F4,22AP003XUR 0'C&N\B1$V\7JL"%D$ ]%>ZBZP?ASZ%F^9MHEOUK,:
M1Y+,:"^+\?ADVTE7$TUT;'>&PTEG[=TH OZPCKCCSH*?G<A#01'J\%#W,;VJ
MC/Y$)M )%AB$5TPL8T':$E-_:R2KI\EZ;1?9,==ZY6'! Q D[ !NH$CTTRNF
MRX3S65N"CIWIGH<!7 D>.H)=@E# [[P31)I&D"F*%I'2S J1UZU+)+%8?1-N
M'3_9RBAOI_1/04GE=(YURGY^MI>V8M$"ZG*QB$ '2N&7>9P6MHO?:+G2!M+R
MB?+QBE($4!5TX>PG?.T$>>J-F>6O-5C["5L(SM;ZU-M?!+D_E? 9N#@7V?42
ML4#^6L^UMUY@0O?[;*D%&4-L:2C^V]5#(S08=,^DY(?IW6A'2OTS346]@ZFH
M_3Z0_:=ZU(M.\;)'WT$=XW.^1DF(;0(7=JMBHAK(J]\BGQ$8^N;68 _+OVY-
M+-[W17]@ 8V.3A=$4/)#K-N).T*N['I-2R *)_),T]CV@L#2TU+D;9D@)'=^
M&/UDZ8IZ#%[!-N):SRW3$%&*0U5O+>N84!9$E/NUM6C'(UD>BK9>O'$E*%VO
M$,4P\AS_<KGD!Y]!G=*XLCDP,8D1)W1U72]CF5U>MFB<9M)OS<R^F4:FZORZ
M)W+U6?W7\WI5502*4.I9PZ*=;7,#>UXT$[76-QV;FNEUY[+6VJFJM0[U6NN=
MTG19:WW31ZNN05?.9J5Z+ZMWRQ,LPZ!NB"YWS[:/,?H>KND6Q]42+50[1K8P
M:D_%&1\V,7E;OL7V[,01#RM/<6-.RNX81?8S::F0YDZ3\<.CDCQEQ*8]2(NA
MC<S"Z.I!H4!)1@[.Q3[<)89D*$9\+*I6SMI+,)D/[AI791:3W] ]VR2W8?)7
MGMPYWL%5 X(\T^DSQ8 ];1(X3Q*VA6V(3(Y/S#(W#SFSUA+WG&X<KD#/T7LK
MLJHR73+&&(' E(2ARH_+K=6TJ269.^_G(+X'1TP4;9=AA.I#A\@>%J@*@DRG
M:"W09UR.'(1@N3"])#G&%3FV9C-1X^H4ZGZ24DV)*;??3G.KRH3IHY)NI[RO
M\*Y&V-GRC@-1V';/8%=IG3Z$U\9YQ_9DPR'+9I/#4UJ;GG1IR0G^-I8U=WOE
M%B:?M$8IP%K3%*T.0PSL^72_=5:\4X)$Q?$^84BYAY9RAJ5J<7,)T2R&#V0
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MRW/7_!!%->V6P]Y!%'H#)51";5_DE#4_C&,+]506)<H\1;LZYP?$T/HV[7D
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M0.9$\0LALF)+:LN;S:0HPX;\&IT6<9778B9@LS]C.ZY8N2U^X8B$P=WI*X_
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M[@>AK *DE?IG%<R1U<0"$R]"<UPVBV(MZ"&BT(AN.P]1(B_ ?/[GB',!X+0
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MB9%O8)V%!!$%"O5_D&43YG@?HW<45RF%#+1(XF/RP[JK&[K/&7/$G>:.YF,
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M]Y>P1)],O)C:>9[ZT:I_MJ)_]/] AI],=3>R/"5]WTO%'!M/"-"")')#(_G
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M+T2/*WDK:ZVA+[A+OYY+?IFT:A@"1=6:+3:0E.<%:$HUC2 ,NC<5^,0N)^M
M4C[/] LO<:<XE8[ZS7OT.4/+P>T.0E+(:YQ>;[?(_(&GH.O[O!N,N:=J]#U,
M_".)?P=^L+NN"/I)!_"\6 ^H!*LM3=(@:N/EX:6 !YZ5<(:YL\P9B_C?O_<"
M%(#Z\NY\^"U-?5^*X3XIP6Q#CF,L#'$4NC:^K'@-UL<P,=M.>_;U#:YEK%1L
M0<ZQ-EZ.*:NP6-N.&+5LW7P_/4.S/(@\%4&L_!MY6)H%>.[#;Q!+/\AD/6*\
M)6[T&HZ]]W9O(+A[E,*Y>L # +HUR=Z=EAW*:&+I2!?O7A%+1+?%"]W5WO=K
MV!6#T['G^O3SSIK4QM3T%#,WQJ8+@.*"Y"A0G=$>%TEIM2=UMC[7]ZXO'@H(
MRFTL)0_#^UYH89<6*;=D*QC2D;I,-R>26(;5V!Z(HC7P>9JOJEV5TA=,V$[6
M7\D+5[PG^UK*:IWJ7KT6YO/2O56K'0!Z_PYGKV >GSZ^KV,T?.<4:EH&#7!8
M;XF^3HT8)OXZ.W@,[>1K?+C^%M']!6*P.G];&_\/>_-"$JF277=;CVX>G7A/
ML+AF![[RDV^#8)5GU.P!J W)-VH L=^^]M;^374UJJZ\?+1DMW><QN2FI:X+
MB[WN%!+>C78L+NL&Q:!6T5<>C*TX"E.R_;E6=4F4KFW2F3\WB)#OZQK$-D4I
M!F@6NV)C;^W[H;5Y5C[__.E?/WVV'\->'7UC"@$ +::31%ETH$YPHOXS(PWY
MHQ74JU='[Z=/M8-W'R]32X\2PA=>!X[I-]=$M6Q UU@;^58-M.S [B-O:^O5
M &XNL&YQ17>V]H]32YY)J5B**A@V=T1'<]_JM2S@NLZ9;> >E>\X9CXZA)2R
MKI>'=F/1S.XUGI"^]V\.<Z%@9V2<*_(MWZ!(2]@-!'N\E_\G^'A\U]'&OI2,
M<I__Q_U*4R[8G_RK<[KQM;L,4$=SWTE2!3F? M3%>+GI+;R+)8W<./$'=@5W
MB?^6+KX%?7-%D8XSVMW#Y_O_!151GNQ9Q@&#2_N"/E"*J=]H_9HF;_1>;.>K
M].[I-1>O@7-P34$*6]+EL;;>)8+]/J5S"E,0'6]2_/4VV^)\QV26+D-[OZZ^
M&11BF IH9Y/<K(U]O]KQ7RLF5A0;#'@"692D2#/@;+ I^$K>#G7P5=<G=3&.
M[Z7K,!W\R\^?AMD<9$??S(U+^[(CB4U">%&W,T1/Q7VO9Z6Q=PE'33BR*EZ&
M9LN*1:_AUWN'HC>[>%<(&0@Q-Q##BILUP%8S[UNH(?$"=+5>%D<+*\AB;OPN
MS'$'X,/L)5E/,([WI5./U7U84C]B\PXYWMIW])H$:_V2%#2NAM[:["L9\QR[
M>RSD)$*8LB5<K='$=T@D31>1+EMR+B!)E-G\*_)N<ND)FY.Q^O?VJ^VIFY_H
M CA78=L[0D1Z]UQ*W0O^/W=)ACXW'0G6AC[AKY@MX"8IHC %.!B+$\36SK=Q
MC>@;\/_!1OP1IH@6Z53='5J=ET9+YM!IEX<#0996$&8A(;#1.I+%9IV!5\%M
M3_Z#; &DH-:M"@YDUY;9NEI[S6^F^@?8CJA#B=5TA;FUZI?U:.Y=!FF(5=2]
MWTL HRU]!ZI %9FL),U36@F:7>QVM;NKO5>$ZG><TW*FIB)O-ECJXWV6($IE
M8<K/[#/*/Z"4\]-SEXNKL\LR4JZ:Q8!?"B(_K+9DYC+\E,6CMOW0I]/P?D%H
M\A-AHH(XDO66O3Q)Q"/"CZLL]KX^OZH5;^!(#N?)G;WBGU1PK/: E@KAJ2;,
M%E,;W_9'EO/<95'66GB_[;@"Q?VM;!WMB79=[7U'FQ&] B&+\T^I(/5 -O?F
M*TH_T#UY5=_-Y>X&TO*]^9B!OB SA)>U.X[!T')1UW;W1K2U]2H05;L=Q.YL
MGQ,B^6^3"!(#=8 <(N7<F; 3AO3WGB])]+D27H[( H??W7)1F^V&3*VKBHRY
MK6\S0!TT\QCFZYSZ:F,:'"O<3D=B;6S=O.9(*@GJUVGR!G7)A,RB&L-;QZ=O
M1]_N=XDC Y/"&4U"W,J'58^V/P7 _&1RB[0!"Q][0K^53.P'\Q(BQ(U50X91
M\KT/U#2+?R,J<$&4B^Y8RB-=?#\(81+?9G])LEC8*(R/0:N55Z<XSMY.-&$<
M[[((F1Z4=1:5T/:*-*KVHH(7Z[5+_$.H^7X=F4QKN0F-#V-G#_^Y#_36HD@
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MHX#?I%*P_6TZJ?<R08UXRO) P&A#;]^OK31BP^>XHF##;T3QU,IX=D+BG4+
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M+<2ZH[%O#%<3ULEJ!T?)]%TZFOOV [DJ?4"%-/X@&EU#<PR\%,>)XO\HGJ"
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MX^LW$+DPIEY/D!_'-)8+\7D^SZR!S&3Z5*<\:[;XX43>31BM *3?1SEC0--
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MR,[KG&;.+F\TTK9=[T < U"O4LSU7G$ZZ=Z4Y FH[BX>U[9MJ-81O-W"O)P
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MU']'Y:-P,,0>!#1XB!U0+MK"$4"$W 85OT-UTI@^"T6#CF])5!\8J"0IYN9
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M *)X W<GIS();+&.BA.ZEBO&9^DI6^QN XB,;S$"8[%*0'3\;$Z'G/2@#S,
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M).QWSKEG*4 \$Z,>);<4!$G9<TX@W]+7NCOXR1AZP^1 HB\S\3P+2^\O*?'
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M3K0O&YWFC>9C^,GKAKG;(\<?CO:.]H[VSYSV0&EX?O3O?]K[TX_8!QU TD0
MFNW %X@T#@-?5*-BW=RQ]D1)+^2E^ID<=^=.[[U\V3/_'Y_>U2UWQEO[]Z@]
M;+G;=VJP71SF:-\-SCD>GHS.1M/1^=G$;:-C(4=[1_LNB:\]MWGM8AQG63\S
M!G.6=<LXS-&^&YSS83PXFV)!W7CTX>/46=>.C1SM'>T[)<)>N\UK%^,XZ_IY
M,=B^LZY;QF&.]MW@G*/S3Q>#LS_$\>AT]&%X=C04Y^_A7P,7R79,Y6CO:-\Y
M@;;K0MDMXQQG;#\O#CMPQG;+.,S1OAN<,S[_8W Z'0TG8G!V+"X&?WP:GDW%
M=#C^Y$QMQU*.]H[VG1)GNR_=[K6+<YRI_;PX[*4SM5O&88[VW>"<\?#B?#QE
M0WL\/#H?'SL3V[&2H[VC?:?$V.Y;MWOMXAQG8C\O#GOE3.R6<9BC?3<XYV*
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M'F1=PX[ .J)__]/^G]Q^M9_;!A<7P[/CT3_$P'%=N[C.T=[1OIVT;X_TVG<
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MH=N4&4UM'B &FHV6%8S;JZZZM.:>Q67D8 <%X4!#S?.$ F;8&=VKO,Y'?RP
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M<,=,EP4?#+3?RG8:N]/T%.-PPV_7_0ICO:P/6L6H,B['-(IF&'ZF%]$*2<S
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M93W8#ZL,(NSA-H4,=JZ?FJ.H\E9%Y*ZX6*580A"D5S:;N,0IQ@F64P@?7T4
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MO/5NA-F=*>$A%&#&T+Q)'E%39Q*O).,<TFSQ?^6P28C>E2ML7SL;3@FQ?"+
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M<7:6TQ8/T!;[G=468WR&WWH%8<02C>8U8R%Y>@G]BKVJ>^2;BWO1!0L5CJ1
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M3*ZQU.*3\L%="]%3 Q63ZX;74>3U.=@!GE.PR,'C6, C..I1K,S:9CKC4VD
M+?)K>]78!]8,9$G.*3,/CE\&W\04P<=K8II&X4DIF%)/ZB$)ZQ6@%4Q13.ZM
M^WPT)8=<(%3!LA+N[\$JHQ>)BM0-5C(V!/^#J)SQ;*S;T8G51"U#.&RT Y7M
M!%_8., RH8VTE+1YB+H?R]OFG OGG?WTE)K)I.F@P9H0NV-VT<9Y15QL@&8N
M=U4(+&XSE45NX]S)__DG7Q]Y4Q!G^A<X0%BJK+B1 >&^\?6I<\6<0?D0@](9
M)[^@A'$BVADGO^;&N9/_4XT3<1)3XC>A8G\Z]^6<*?P%P]#4K,'!#7Q>3?.4
M4*MP0@<U9"!&[CO*B=ZS*@Z+D76< 355423A<ON/'TF%E3"8@^<>44?11U*T
M7@AWJ)/TP (1W(5U#O-J8W1CZ?5AJ7IZ'2^N4B<_2V+I,RH<-SEQFUK#U9C3
M7PNC?4N@K*5NB\.+;B53O.TN7O1X>#$>3H9G4X*+GA!>].^#\7AP-AT-)RT]
M#\Y[;R43=!<P>ESIK^:BUM\9=S3H!A*)]NZFRKN*X-V7*W%*_5FHC\\)4K?H
MPN;OT[BJ9&AFU)6LHQG#DY/AT73TVU <#Z;#7GG.@E&:>_V7/9.'^A+%-Z'R
M+PU*!]O@.&<WB# YM@)+6&[#I51/0I65.5R#-C<^@M"^=&J0AT28 DM2^=0#
M'$0E,+">0'P;_3BTEKFC!4WSHM&%\6B#Q#=SI=(4*S2!&&9&QD)W[ZY-OM!M
M75[U'04FV=JC"^0RDP2LS]+@6D4J< $#9AXBA*V=J+$9]:P1R<6)9">2[TL\
M%@K&$D[U9/?";B[.:](@ &^L &RH'BXA"7SUE.+LN_%A$^6IH-+.R?A@&\9?
M'H#FP!>^ZN]WQQ1W![Z%!W[XCZ/AQ50,)N)\^G$X_GTT&8KA/]#"G9S^(2;#
MJ3@Y'T\_BM&9F'X<@;7[83P<?@));<.C:/]BO_"GP7\-Q=FYJ-O'Y^.2>2S.
M3P2>Y_\:P5U'YV='P_$9SFJ&=]<T #X6%C1\_X<X'DV.3@>C3_#+T].UYU?M
M[YY9/;YW].GB=#0\[L'JCTX_'^.+?A]-/YY_GHK3T:<1/Z&VND_#\=%'^''P
M?G0ZFH+N/!E-S_!Y0 <Q@$6.IZ.CSZ>#L;CX/+XXGX"Z/SN';S@9P^.),OB4
MT=ET>'H*1L'GP2D6V5\,Q],_S*?A6TKX_O!<(.WXF)^-G_#;X'1T3"\?GL%K
MCX9Z,?2MDR-X&CZCIH-__SC$'12CR>3S\!B?>C$\PV_NT6U(X<%[H-L1W7S*
M-\-5M._B>(@F3.DQ\)>S\RG1_ORWX7CP_G3H!$O+/]I53KO*:<<3O]A'M[5R
M^E5+Z>4JISMHIH+Y":;E\#>T628?T0Q<LZ"&(_C?\>?)=(@FU/%H#/;,^1C^
M>7YR,@([$TU#L ?/_X"_DT54@D=_/P2#$$T<LO+ 6AP=HX%YBD\&*W4R_/\_
MP\\C^,7QX-/@0]6.+9N70[CZ_-/HJ+@.'_>?G\=_B.EY80CBZT_/)U/\#=B7
ML+3Q\,-@?'Q*ANN)-<*TB0T/P<_D#X>U#HY_ SL=7LR_^3CX;:C-N/%P\'_;
M^]+G1FXES\_>OP+AC3<AO673HHX^U/->!%NB;.ZH)4V3;<_;B?D 5H$BGHM5
M=!U2<S;V?]_,!.KB(5)MM1I%I2-L4V0=0"(S\<M$'@. M/"N?[NZ_JUE7B\N
MNF<YV?!K? ,![NO!H&^1I?T*IM_[^1IFXNJ^QN<Y3LHG7-185S::>S^3403"
M._QT?>DH#WQ_=,,;TQ+QAG4G'_PQ4W%"Y_8+W3C"J*C<&5=Z"V!OM3GEZE"C
M/:PF$@LT.)*QREO75>NB;RRN:?>,Q>*GM;8%97U3?+EY,QU-V!%2B9+*$%<6
M&X#Y436\L%[N ,\:T.E?]A-<U5,/AS-5\2V6D</!1X'V;>!JK*+X5H;ZOXNR
M#(D,3+5=DQV59".<%A;;#>;FRS&-'L\L#'WI_  ;U-F84_QUE"7 E@F%)9FJ
M#:M:<*N$:Y!_6Y'A&N3?F+S$_!A+M[D*R^KN"J:0)&D%$@R\5'/](0Y==2!T
M-5G#I#8AMCS0-M6\3,RVW5M5>;"'87'22ZNN0E,1=>6IG9Y.E8^UWV&_*<.^
M=5'XW-0>S]\BQE(')OJ5.IQ@E:#8Q-'6NH# IC]"PN:EZ"D*-F_+8<+_5ATD
MFCUQI' W-^'E1;RY;\OL+=&FC!RL0A+<%2M6L(P5^4IAO+XR-<(MK<VIOXXW
M@X*'V]86E</-8_/33PQ]6/DTVV_,UT5KI/+]^WET?0J<4DQZ83%,#F\7*S9E
ML6E86U5L!I@ VL*2O[6B3X </  =G8.RIF^(]8Z1;'>1]@U$&B.J,^1'Q%5]
M]+H#8&0ZJL$41G<%P 'DH:3I*/# ^M"),.8TP^RU/9#.2_#:<D\4&YTO6F6M
MI.=1&G61EK/ (6SN-V#:[JCB3J>YYO[/O:O>I^XE"1H(%IZ'XJ&PN.S^QM&;
M;/D_1@::&[YYME!0\5+>.Q^T67I!8!O%,]NBJGVMEC9LQ[#/)Z:K#,S2U@(Q
MI2'SJX)*5E(0>9@BFP!&42TQ5CXF';5L84NXQN0VX85 )/HZ+HZC\P9G95,9
M'RS$()H9V 5#S\:8?!'G11ZIWYEU9RS6=!S0KXNU&7L#5S=G5DL.R@FHI>9V
M1^E]08PNSB+J2M@4A;3*E(*O*G5?!T9I+>JCSYCO!1>F5 1WI7JQ#1J#W(6K
M#(5 >W@VK :56H36HC)WIQC03H6:P!J4U48K*PPR'(4E>M?' DX8ZT*_?*H,
MP@9]UX=[KC":.[=USHQJ56!L32/,:*/&4-1N*T&/E )]O7*"8+!-P)A)C1ED
MNH'(/+*],&^6IYW.9R;,]N'YDZTS4YX>:^530[0TABO+Q<-H>;"_,22^[/\
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M00#" &0OX]^Q-7DM+Q$NH +"^85T:+E\VJ7#O#'S-++^LP+R%(V##7S! BG
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MKOB$7%<!"["@&AI#WBLSG=*+LBKPQYYG$A! X( 1-TDV^B?^:2J=&1V2 4(
M,Q/Q RB36:S1P9<_.3&N*" ['@(8E;0IRFCY1:XJ&@^/?6)79<Y<C&,ZU2D,
MV(.!_M\!C%NFB 5OP-81%U$01/?)_W.4P-]?DSLR:?:;L=_L)<N$JWZS8T?I
MY;[?S!&BN+)9__CW_I7XK3^\Z@T&XK=?>I]ZUQ>M&D2B,')2:?[B,1IHM!&>
M22HO2XL@=1T+/T-#+TLG40S#\$'ET4%FB &.=UN>ENVT*3.* O^QZX2Q^[V+
MB][9L/]K3YQWA[T5A^'PQ[GRU'0$*+ESU!*'!YW73=I0N ;PBM*])^TW!Z\W
ME@#N'&TJ 7Q\T#YZD@<=M8]/WC[!<YYP8H=O3[BXL6- CG/<F?9,>Z8]TYYI
MS[1GVC/MF?9,^QVD_:-JO,&*P#C"O_UX]".OE_ONP8_=P:![]LOG06\X'(C^
MU6#8'WX>]L3UA1CVSGZYNKZ\_OD?+)!N"233GFG_8FG/&TRC-IB+3[U__]R[
M.ON'&/[2^]2]Z7T>]L\&+=AJSMJ;P 8+G%,"=\@"Q^O Z\#KP.O Z\#5WW<0
MK'V8G[+-XY:(O7#:VY";XKLW)_"M2"(L1U$7B<8(V4_)3^)2)8&:BX\Z"&3\
MZDI[$]C,RAK#S  L?$Q[ICW3WD7:N[.5,%YCT7&+]CN*U\[E'4S@,O.\B0XC
M-H5W7[5BIW>6;]:MS:&].[+#UBV+$].>:<^T;R#MW=E&&(*Q[#2+]N[(#ANL
M+VW%ASH-%+L#65\VB/;N2,^YCI671G&+%Y$%B&G/M&?:NTQ[=S8.AETL/4VC
MO3O2<]:[WCX)B#._W) K#KSG=>!UX'5P:!VX1,7N8@0N4=% @63:,^V9]DQ[
MICW3GFG_?."7%\,%06"+D->!UX'7@=>!UX'#[G;:.\4IN,Z)V NG_8ZFX'Z4
ML99BV!;_)QNIF->=98YIS[1GVC/MF?9,^Y=$>S8A=\N$Y#Q7]V2,:=\,V6&K
MD*6(:<^T9]HS[9GV3/N72WNV"G<+V7)BJ8M2QK1OAO3\JCTE;F*5:"20&$>Q
M^*02)6-OPLO*(L6T9]HS[9GV3'NF_4NB/1N)[J\1TYYI[R;MW3'O>NUN6_P<
MZ^0^"GRP\Z*Q2A*P\:*Q^%E%L\D\T5[""\S"Q;1GVC/MF?9,>Z;]2Z)];NC!
M_^4H4/1Q'3G^\FAJ=)Z<&L^('86E5TZ\F?/$62T\AR<GK?S?SK.B[__\ZU__
M^E_B#"11ZE#H<(Q/276$GT4ZT8GP(R^;XL'+1"9BI%0HU!<OR'SEBUD6)YF$
MG])(?%*W66#N'+SZMY;HIVHJ7A]T]D;[>YV#_;889-ZDO+7VID2$42K@+Q5K
M&0@9^N(^RL :"/3O*I@+3V:)$EXTG:E4I_I.P5CB*;XUG2@1JUN=I#&.0X]A
M3*- >W"3KQ,OB!+EMRM"Y3I[?!--XM*D2;%_'V.TLT2[,QC3*-8PG*,31^GU
M-4SRT$17,L>D<"#.Y*TR&_4K.09Q/)7!O9PGQI78:*(T7G)>Y*0]>*^*GT-?
MC*+ -V_VE1?%M#.=PAM4C/-Y+%&[-S>]J_/^?XCNBR>L5<1/1MI+V.S1.7@#
M< %&WIW-8+^G9R:$',SWB:-T=]L7^Y\YU9Y%VAXY.$"JSS6\KZ/>?S6(Y]A(
M:X9 LGGF$F.PU#P('W8>CKY(#.ZJR?[:47JQR<Z2LR/6ZX<73]AO9;V>P3#3
M6,.O>P9TZ?!6? YA-+X8I "UDGW*=( !UM(<>!6>8A5NNL/>U5!\ZO_\RW!0
M=R'\IH- ?%#B0@?*;V$\4J*\#)<%<>]'@.$(Q97OZ)HX;LZP?X']"R_+4G)<
M(-F_X!)CL-2P?^'%3=I5_\(;1^G%_@66G!WQ+YPY2MAG4TE/3-<P5%_$<;NS
M-]G?TW?[CE*WL6P;IOK5N0XR@JTW<90JCSYV42^*"W@P>G&&DU@E$WCSLQJ[
MZV>Y(LRZG/CK]IN-\^XXRD=.(FB*T2Y6V_1OP%<#9YP>O*=?7P5R'F7IZ5A_
M4?[[>^VG$W@C$=#> +,(Y"Q1IXF:25A097-Y*ZF^=SK1(QWH='Z:7[TBX=<\
M_*A]<'SR%R35JGA^<\V[U^UW)_6+.,-XMXS]3M44YM2.[[UZ3[<O^?_,DA2=
M- F=&>3N'+-5W2G13]!/XZG$;?_F2O;D[)?=V(!.7F_8@([;!V\[FS:IP_;;
MUT>\237#5.8MYGMO,8]<P3VYS\O7U.4S%^.83G4*P_5@H.=JK$--!]N.;_WB
M H#++(MG40(_16-S^#2P!G:G14<]8]AGHGNTL?UR8B*9R" 0<C8+5O=OW!I!
M'+=/CHY<P!#NK,N>WA?_\C^_'!YTO/?/S$%/"(]]XA09B,%$QH:]SJ+I%,\J
MT\C[W6W1,.3WWUL^GRH9"OR0K)R+T(#UE2_VHKA5.Z M1&EOM"]&"N2H!5*D
MIG M_#I2]D;X;4ZR=G;]\:9[]0]!/G_ZIO!KB7, A"T1P9?X"XQGK[._(*!K
M1H=GNWN'^^M^M@.R<Z@.O_[TZUF9[W,6A;27(.J%268Q+#:&57D!'ALG-#;[
MVA9V30Z0$'<JF+<:S]F]+VHZHXBQ8M[-X.7]TW4N1:LM42N>O@.+X"_O';3Q
MW"'H7G>M+*T1(I#FZ?(&&ZP]XN(%>=R"?%BW(*U":Z&+9K72LFL&*AB <@)W
MPC.D\/4=EK[V6S!=7-ED!E9WR_SO53;#YQE=[&,@C!Z9\XG(;!/P WS.TB25
MYGAB]>C>PU.8!9Z&!<[6RN3ZE9=>FL%RS7,6R&912/*JOJC8TXG"9U48:-W^
MNNXQ'KTV(<:(,0X+MNU;9>Y?-: 6!H IZ4V$)^'E3=TA9W&$LO-L1W%?Z<A+
M,#A.6R\M!L2MU=ITI>&#-=PTWRK@C6V=%;;.#A@[JZ79;?9?:>&$<Z%HV_.,
MFD.^'0'6#54"RBE7?_G.EY2:U-<Q@!I0@? CW)3_Y54(HT,0JXH:)(\YG9S4
M]FO82$69G&&5KU/AI-9;7WSWY@2^%4D4:%_4EXY/+?C8?-?=JCBX5\?MUV_?
M5?\Y@7<]GI4WQ\7,HH3<2J>QPL#W.[40*</N\^^]_S_9IGH>RW$JKJ)4N;V1
MGHHA8$7"O(DQ%*R9;P(#8<O$K0\L2>/TL^!8>!G8E;!T<S&*(PG,!HC?%V8D
MRG\E@=<DV H2P]_\//QM5H:_H7<-GVWNLP;'TM7YF& C-AET)L5$B6GDJT $
MZE8&1;9)8A(YDHFQAO&R*VF=N+_"[QF\[DS.\*!#=),D\K3))=F[^O6LN]^V
M=-"AIV=P!::.1"$FL>19+88@Z42F>?K)TK#P279LU9.(/7^_3M:6R=',J6E"
M,/ !!9Y'([[T07L&8QA3'E;A%B,TU'@,+\ _ZW23E=".O2S$A)AR<)A"D[\=
M;898336N .S_F#9#*U-Y@AEVS10DP<#OJ^@(GC-6<8P/PC'N<UC&4P <EXGC
MC@;C?#2G&&/G,RA<S3UZZRB]W,\]8L?6*L?6#GBVK/_%;02^RI5%.B9IB:CT
MWM_+&#>(!/>,)!LE7JQ'Y(&B,WMO@B[WW+=UC\Y_Z?V1:<2\6YTFL ?X:P7E
MKOER0C$NXB;6GN/6ZBI9J<>95*;20CGY9VXCE39-&1.R'*(B9));97Z!'PM#
MCH7D*X5D!V2DSB?-%!,?.=R:]$NIA\S<7\O<.X"45BK09C+Y6.H8+/'X=Y6*
M.QED2LR4#7[(>;\>_Y#D7R]&*\(OOL)C]-S'=QM%/CX_G>0>Q@^1C'V\_YP.
M#:.X>%@>#&DO-,$Y=&(ER]IA)EBG\AL.V/PR5>DDHK=*#];7)[?@/;XZ77+8
M#O$)63RONC#03'KS'O:LXX-WW5<!.C$ JNQ]V*]OBS-XTBS6M/656Z3U9ZH[
MZP/$HU7C?5P36.1%TY$.91YC8$]8-2R=C&%^GO&[ZO\V5] T@-8S.XJE-8D\
MP*4QJJ=UL:1M<4UO@C5*(G1;)B49YT >Z>%9ASFD7;_=MVI+91B)G*OW@(I3
M%:)7!P0!QTB!+20<>+>*EYFF(CG+K+-J$0&\J]L(1@;#B&X5T<R2IF"())O-
M(D#K%,">2ATD;?$YC]"I7!>K/S)EZ@3*ZC!7S5".X<V^B0NISJC&B1&]-PMU
M.L?I>\!J69":\8$ @I5==1#G+X"9PI6A!4S%3'-:%$S_ &B[GQA* %>B5YQ.
MW0T7T(#KCRH\>E/I*][!OGH'V[TMK'E6?VM)+R[J'"/,838=&?VS)J)OH@(Z
M EL6\+5;W4YL"0UR@'[WLR57@V>.-P3/G+0/7A]N"K#IM-^^.^8 FV:<[7#0
M2]/@PHA3?AN[?.;BQ91?2J'#DA]D(C<\^_'/!9^P?; RH[=?M_-D2@ PA6L1
MW(WC:&K^0.B&_U\'TBS>I5P3>L3F#*>]I8#J!RXVH4UH3L*[IXD*[N#+%4F/
M^S8C!L8"^(9,7S30C8LT#\=:,EL-CDYR_.L%,C$I%N4 @(=T&IAH.7BF0F\"
M8>4R"^.!\;=,\A7%N,DO>II--\/]/?2!*#S7B %#6YRNPR2-3=2+"38U_H]8
MI1$ZMI)LFGM$$O@Q&4NO\$>%%/GNVU1Y-$-,/I$T.*Y51G[1W_6H>/,5AL$C
MH@?XB,$MZ".C.+5YZ;BJ1,_1N&#<2'9)AYOHS("1UP/1B(*&&OLF4@YIMS+K
M:8'8K9PJE)BT-H&)PG;RNVA0=+SZ<"X4O6K=8AH&&ZEZVO1&_9JG8I7VFA&T
M<9GUH_)IT93HZSH/FU=/)+ ?.4@(Q;<JCZ30(OQCE"4:4R0P^H\>5'E,DVRJ
MG8\\XN;@'(W',M&,:+QWCM*+H_$:"<!+!%ZD]9;@>5U6;VLII\"@8T <69#:
M<ZE:N+_5@-63K+5IQ65Z@V>KPQ#LCM4=912 <I?V36:T0L(K_/PU!#3LLV*:
MBW$05P:S^.;ZF><66<W5A!7$EDK3*TQUESG,WL/S+C)@?&4_6Z"X$72OQY^M
M*EB$K>>G!<"X8 RL'3Q\CV5O-HT4#^9@@N;T1,SDG$:5>]"MN4:#3,R&N6*4
ME1$: Z1ELTMP:RSO73F,$8!%LB6*.UI+/(0[+?7#*H@5@=[6"(!U[G38AB1[
M\$/Y"#H04'FV3 W\UD\3C-FS7Z)Q&#FQF4'DY3%)>7AKX *AYVADS92)]'-\
M;%C<L"]!&*Q\8/)QEJ>81]U4!7&;G'S,'L.)%&4X%LZ,PZB8R IY 1!DRAD)
MTAX5<X"8U0R6DJ1I(?/G5^E )AN(+?:=LZH#V$0IGZPC 1)O1 0KRBS>6Q)$
M3\'RP=,D.I>W9[HU E7F@,>XBZIC48EM0;L62<^'Y6%1^E9E<0M52!X,DK6\
M\.U6GC!@R;*D5:44U2.>\.=GB^HWO5<J7$M68D&$P99_%W[B@_,_$R7_^(WY
M&[FTUNWWOO;)(+),]G2[_I[=46$/($VS8C\J0J_V*O$PJXO,J?W]7  V2TUQ
M8&V4N[@',5)_9'"#B1BY!29/<\%<U@)5E4W*(I_"-ML0OLMZ:,Q5(W04J17>
M3EB2&B9:YQ1M$%AZ8H#TY\'1LP"B[38="D8S2X>\D2\0^=U"_RLY>Z\>2&9<
MPV%($5)EH'HA1H(B_?;W5_D>2V^@9=\_@?)XS_@3"2.?2YF8Z;B(D5DX;4#N
MSL*<0?T*^V6A]<$;-L.+#+>NK&UI@#.%$9K7QBH:[R\:@[DR)T[0:5+'Z&9'
ML;]*H]'L,/%:4D[[3[>U+-L07P?>B=F7$?P6=L82N4)U1UM=(3TL 5^?#6(Q
MTS<VL[<P$K;:,<066\;"$%KHA?9DX&6!"?I.RW.<;5A0EQ C+G84/%:#'U:G
M-5$IC54G\]\AUFP7O)Z-=XWS<1$?%[%,-.*XZ/C 47JY?USD"%'<@5<6IQ1!
M-!2QG[0($&U YKD].:8ZF O)S]@$H #AQ@Q$ET8%UU3C4W)[H?1C%*6^*G$\
M5>07YYYF4UNJ@L@V1!*9\EDKPX82L4>5QLBKL/+W8D8I.8S\Q03PHB4 >OJH
M)P#Y_):ZC:#9#;M,LW#MU\!:3X:X6XY4CFXM%U!BV1. W&T8M>+%MTXSRAJJ
MFY/+W+L]K]H@Q1"L3# 9U_'[:D:V%%O'S#"HL8Z3M&H<[*&,(GJH(/O5_+I?
M"=X;+[2_R=>#*K930-AF(CY @S2*?A>S0'HKC)?B51C')T,[HY%J8!K>SD,>
MMW<K/$9P.9S<7%R/E^_6PE*K,D5^O7[E *;IH?2B7TW[6Y%*7(D#7WNZ8<[X
MMSA+U6%^*K;YXA6-B-8V+]IO%1BBKHPQ=)V"CM>=6@48%[OR#&G# 7<9J%L)
MZ5[CS_0S#_<]&(.):,#:XQ3!4(WVW8*76@2-< SP_+W*]FRU?ZCP+F!:4"YB
M NP%KX:W4/0$-EC?WRIG/<^F1P,:GN^JVGN^CO%?)UHWSRSY"YE4AFR506_3
MU?W0;6TE_B::2-6.VU3]ZUY7_"_Q85_\BTGT?B_HB[/])CFVW"'G<M/*2E!7
MKE2_HG?EVO9+%FGSHFS9L[*)*L1QQ;RN5--F/%4I_+(]#MJJ,1V+Q99QYTV6
M"\>WUJ^7BQ5V!HO&]RN0W%VWDAL=P=4VBT^QP&*/'-FY?Y"<H!9N4.YGY74;
M.@*7[NF5_00?,VX;-O38AH*UE^P5?L_J<"@6LG+58O;N_J;![6]EOSKCK71)
M "I%73]\-?\O!N17HQ.U]=%O9OH)>>G+.]$M9?T@I2^G" _FG>SI3>]JE.IH
M;FJ"Y3DE\O86C^[2Q1,I6Q[!7^P?KL,B=Z>>\@[7\=H]^=KMO\<SJP89\WQD
MPY%;'+GUPF3"U<BMCJ/T<C]RBT'U@XT2SK; U-NAXQQ.VS@?U'B)J??$&L[Q
M23O$FG[S C5JD1C8)/,\;Y)I)87B-=:&<[@\W:78#.L,6>[=N3[WJAH?5XE2
MJ$=X&,MK93'J-0$+#PZA!8;Y)J= 2Q"!J5[$8NS"/;Q\A5MAKT@<M5^LB A9
M" CT]UN-KWF^BJG=YMI\4_NJ6!.QIS'*$+\ADB5I%/DM$\)S%VD_EW4_RD9I
MR_B6PF@AR+$2>$,-TH#+0AOFL^J5)L TH3$*T\#[+F? _;4'L!S\\B 7#!KH
MQ3ER6[#$WT03J>JX;TS\5>P-!S=E[,O@)D?H1^^;27"G4=R/?W_52*HZ'H#1
M)#O/':IQJ):#BU(-U6JBIG <1FQV.H5P]4ICNA:*7RO-80Q&CCWY%F%9390!
MQT'?EEV&R\I:S.3?.L"JB5SN."9<Q^5EM$:I\U?I^Q8>FLIPWGI Y2_VP=P<
MX+9V=]ESOD7=^E REOW'RG[E' S,[T>U?=\ZFH7/'Q\\?UQ/]O6E-,6>"=B_
M!7DKB@7FLE)-1[>U#>UU,49S%E6+*[GE)JV_ZK-O5-81'UE^7VY6S3NR/%]L
M.756#9ET>39X(KGL,5DZ8]PR!C1OP54  ]S,MRB>FA_N%"7G96*=,\E6AS6\
M*:STN+C,>*O$Z$PF$PH'O &@"%A^[O($4'(HR+$N&L3+6_D-W[4/WC*D?)B)
MNUB=-HG&DHP2;2M!)*DMG9-,6G6UD2X80Y5Z/LA;:_162Y25W<T=B9A)306.
M\@),=%SM>;&)R0)UKY)T*].!EWGS,G]X:)EG5AF(2M.&M4L_ECH60(S?52KN
M9)"IO!3PVCI2JK5H[X;B-HI\?!28CI93/D18Q SN.]? 1&D4%V<+EH<X'+\!
MD^9P? ['?\DRX6HX_J&C]'(S')_1Q>/0Q=E^W<F\17>GN'(D>JL(=Y CV3J;
MB^*GE1;2A2M:)HE*%^$!X<>% JG4R<&+,+M: &D-H+%M8/)&!CE263 RBB[5
M5(&L-)JK15 1/%/M4T!7<A3=/1'0:5:A2(?84#^_1?YD(<MYAC[RT^JT?]=-
M]>$#7:X><F<]IJ;A4B[\NM*&K4I[]TAL)FZM)_FJC&UV.#R=PX&LQ"A%*$R^
M@/+(M."3*+:?R36PP#6@9.N,MN0576ATOW;19T%F MQAO?4TFZYT;,B20>NO
MW</&5F &P^O32;X#8G7D.#-5M$L>- <[K4TUN_$%MBD/W:)#6XAS9=GCU7O7
M_H,EK:LUM5=1RKJBUQ0DH:O7$3.OCHXEL.M54<8/+,&# UI_8]$Y["L'V]1]
M8C1G1?1D+C'3-.X+2?[&DBS.2+M-LGF@6/[+%6QVAC@^:8<4P+BYU@(Z-/58
M>[9)*BB6,EO7>4/A\^I6Y91(6U5W<;TC\^/S=DO F%(W1O5EIL+$ICJVK#4_
MG6&:KD3U+1, >2,*PL,Z !XJU\+Z7T[B71C?FFQ-TW@C/R(!W3;.XE GDU6Y
MPU1PO%Q9V&WRBG7P,#QOWC0&ZF4],1D7&CMOP_82V&,;#RA .X5QBVR<3F);
MT]CN+OL+\>XKHQ'+MB6;HMX7>_MN&(XQ+VLIV%LN8*7^_CWL$:D**<,5DZ:K
M5?IM*$4MD3M?*70LF4;.-"G[=65>6ZS>(NOFN]S*6+V%\#'>U!R?-)]Z\:G7
M2Y8)5T^]CAREEYNG7@TD2N,EY_DJ4HP 8SR= =+[CU_Z'_I#T7WQ='URT^[Z
MZN*R?P:D_?6Z?]Z].NN)P; [['WL70T=);;;=OY_/I<]3!+VR,$A4&O0JCYG
MB1%+EEQ]NT\<AUB>\;]+C,%2\Y(AGJO&T;&C]&+C:&L\N_.R\R(51M-MP@\O
MGJY/;1/VKWX%Z^_ZTT_=S\-?KC^)[MF_75W_=MD[_]EAJ["YY+Z^$%?7XJ)_
M!=9WOWLI^E?#WJ?>8 @?Q,?^T.3_OWL_$+U__]P?_H/I_T39J1?P'/&KC?EX
M\U/G^">@\X&CY'7< F2G!YMO+XSEV>GA$F.PU+QD&\95I\>)H_1BIP<[/5ZT
MPFBZT^/LQ=.5#\)=!\B.VX1NQZVSQ;HCV-L=EF*+U2G&8*EAW/WB)NVJH?[:
M47JQH<Z2LQL6Z_F+IRL?TS>:W'Q,S\?T3;< '7?)L-.C@>:;XRS/3@^7&(.E
MYB7;,*Y:_V\<I1=;_]_?$'ZD_'V422*]28;E6!+1#Q-0Z%C.)QJ+H?(F(8SC
M=FU-/2<IN_-:R6V&<K<+!;.+@^QR0=6F0F^.%:S@@2I+M8>*R',5)C(;N<A&
M_4^#H>A^[%V=.^Q,_/X@FNOB+Q%OB$;U O^T;&DY-&TEU;K]*.>B<] 2Z#/%
MWL5@'?M4>1N-XY%*[]$01^MW*T#5$A),[' 61V.-]6\3)6-L!V6O1B-\(JG)
MJ<26QZ&G9VB'^SY<FF!AOC=O%E[4O5,AMI(ZDU/ SOXM?/S8%0>'G:-W8B]O
MSEJX??WWIC7# ]H7AWBN GF/9?>\*)Y9A[0IVUL;URR0ID;E*$N ;<P(CPX.
M*A,6@S\R>%!+O(5[+X(HBC<,U=8R+(>[1]4@@8VQXGPF RQJ6'2=O9%Q.B\:
MS^+,@($"LX"!J8Y>O52KI$X'.56ACZ7.8>">];WTT#62( ?<R!3]+9?:H_J8
MU=6V3[,T@9L*MCF79M'/E:>H*&3GB+CG=4OL5<=SV3_K70UZHOOSIQX%[U6F
M#.LEKJ*V.'[7.3XY>KO?!IK9YM)87I%*9V98A-*61\X+*OMJK$-=M@,TC0&H
MG+.2(;+5+0PQ--49S6-L!>.ET;BZ"[,J=5"5_O9+[U.O.VBM[#MQU.Y@36%;
MIW:)T5I%^5)0KM$(9BM34T/4]I0!<?<5B',T(^\G*!W;7'V:I58?>)Z:I535
MU-?P "J="T-521J!6LJKARLO I&W S@7-Y^NSS^?#5W%7<SH+C-ZSK.3:N\C
MY._',R"R.BA\YD/FPZV)=W7]6TL,D1DOKC_U6C5((F]C1369"=RL5KJ/[7/]
M(OG.D4F[PW6=]K:;.N[EB$VQ4Y0*5&J:OE&Q^3#5L4J-_10K,B'\LBR\8<J'
M&DOQ"CW(W,:X@.4136[D,%B]5;J="M,DD^F[GV\;N)ZO810#H]"K4?0/WM.O
MKP(Y!ZOV=*R_*/_]O?;3";R1"&AO0&-?SA)UFJB9!)Y3Y@@0GEZ<%6)+H1%@
MLG1^FE]M+X*K_&)C,0\_;'<Z)W]!6OV4^FLN.FD?O#[><,W;P_;;PT[M(O@0
M+XXM7U]#Q>51;6#M&79@"V]SKND<Z/#]/1#&'(V>F@-2_.(]=03R9& 9 FXH
M;J:C[N)V&/ ZKLW7^1%L>] , +!R(9GV[NYR>YU]7K[F+M\U=2X;*;"*E7 ]
MU--MR/%?K7KS'R'].^JS),5Y[]?>Y?4-H?&S[M5Y_[P[[&WV1'3//_9,%Y[H
MB_:,#S]),Q\M2XV>XQEVB#9]@43_ZESL81>Z/S)])P-@]WUZPR2#X>6WM5?)
M:KX=PO]QJV>\Q'B)\1+CI5VBO3N[Q-XAXZ4&+Q_CI6^'E\8:6R$:)/,@-F(4
ML[,HYJC=.>YL0"C'[8.CMXQB&,6\--J[H[OWCAC%-'CY&,5\.Q3C1=,IQ9SX
M48)1?M&X$C!)?ALI;G[I#GKB4)Q=]J_Z9]U+,?R$U0&V!SU.\_FWW2*:AO/<
M855.:W:*,78^@,;5S-VWCM++J<Q=M@[9.G1$I[%YT3"@L7?,UF&#EX^M0Q>L
MPZ.OMPZ;:BJQ2YP/]ANHN1GT\*X)H.>$04^#EX]!S[<^V*=KSN/L5G1GLP#8
MEQR"BR&+1?;1Q7D75P0]@;"+XK[<R^)HIF2(7D#T/T;Q7,A;JIS V(BQ$6,C
M!Q4\8R/>7 $;O69LU.#E8VST[;#15/Z.V,C4OH*?/O8^4:> 0?>R1YD=.XUJ
MW%F8PS86FU*S%,LQ)#/EZ3%J$:QH@Z4;BOI.IKZ#J==D:ER%/E5Y2M8GX)N5
MCM74G+N+<8:@.(HQ-P@>8<J<\=&UXY-VAU?[5^*W_O"J-Q@(*H)S?6&X<F:K
MCE"E,0JD\$U<QT)E/8RF&"FAOB@OPW(0(ZK.IF/A9\CO63J)8JIN%JL9UL4+
M4XF1&(DMP^?R!F!+!&*%0+<W@B:).]N>*TS&UP C7V\P*P_:KT^.-L4K=-HG
MQYL"%@[:G=>; A^.VF^.-@]H\W.VF]CFYZR86-6F9@N C6>F/=.>:<^T9]HS
M[9GV3'NF/=.>:?]$M'_4 2:L"(PC_-N/1S_R>KGO ?S8'0RZ9[]\'O2&PX'H
M7PV&_>'G84]<7XAA[^R7J^O+ZY__P0+IED R[9GV+Y;VO,$T:H.QA]2;< 7+
MEE.R=<BRQ>O Z\#KP.O Z\!1S#N(RS[,3]F\<4O$7CCM;71-\=V;$_A6)%&@
M?5$7B<8(V4_)3^)29K$*Q5E;7$1)JF)>>98ZICW3GFGO,NW=V4,8J+'HN$7[
M'05J9Y-8)^(RBA+%!O#NZ]4K.56L65FS-HCV[@@/&[4L1TQ[ICW3ODFT=V?_
M8/#%PM,PVKLC/&RHOJCE'NHT8&7)RK))M'='>KI)$GE:IDJ<ZUAY:12WQ,?^
M4 POKWE96:28]DQ[IKW+M'=G*V$@QM+3--J[(SUG$ZW&8N!I( ^61!378_CO
MZJ.#IE6?Y#*&W(^2^U&^&&EPM1_E.T?IY50_2E>(XL%[5?P<7/1UY4^31'H3
M4%EIFHA^F(#.RE*%55N'RIN$,([;N:/LMIJR.Z^5W&8HV \;13=FE^_*+A>Q
M^B.CCCS#B8('J@SL,51$GJM(B-G(038:],ZNK\[+@N6.$O%%HFBW;<H?AF@W
M+O)/R_980//-U+"_4*,XD_%<=$Y:XO#@\+"%IN!4^@JKX:,5.%+I/5J<:.9M
M!:M:0H(M&<[B:*Q3@77S90QFI[97H[4YD7?8]%6*6:Q#3\_0X/1]N#01,A5O
MWBR\J'NGPDRUQ)F< H+V;^'CQZXX..P<O1-[__(_OQP>=+SW']O]]K!M_O+?
M[]/8UZMA'.2Y"N2]C-&JC6=1; SA#6,[.CBH3%4,_@#BP7#>IA-Q$41X.O?@
M(&TYF7*4>TH2;?+6M]AW0.17W\@XG>?7VBX;06#6+Z!>!;5+M4KJTZ>.'0E<
M!P/WC'NAW<+V'D&6( O<@+4/S'NI00N"<=^]C94B-T-US>V3A2^Q18+AFG/E
MJ>E(Q:)SA%S3>=W"'_(&(::-PF*SA5;M";8_ =X,Y*G.9*EM2(589HW%5=06
MQ^\ZQR=';_?;0/"93D$FL5&#Z4="#1],FQ+JHQ=EJ?#56(?4H,2V(:'F$/CB
MJ9(AKO@MD 1^1!>)>8P.5_<Q*;;PJNA_A]X K!$?I1%7=E182;OC]LG1$5.O
M2CWJK](=E%V;P@C=X"!G1B9;IF5W /H:U(*1=./7Q,[>H,-]E6A0M6E$3D%X
MEP:5#M(V \V;4H,GD,D9*2334,A\%K+LD8E]5VPTA&_Z8UI]<"9!>Z%2H#?N
M,V)@^?AN\D$PR;"EX?\;R]/W&AA\A*[R:70'##R.H^GJ_:5)_/N\,)\9;SD4
M_?JWEA@B]UU<?^JU:I!-(J!#E4O(;$U3-L!C8T"5T7URRGS'?+=U-,DZ/6?0
M]2I%5X'@L-_?=(?(?I_Z/_\R'-".WYW-@$WU%]%=WT)06CZF,ZQ$W.*1(^+^
MJ  F> 4"CN[%1?^R#R\9E$-"7*]#P@^E(=P%0R\0G;?&_G75/\="X* 0?)Y%
MH>%S&>0\NU(H"AE8X'H0%Y5B"\P4G0!B@"P)C^P(.0+9*=$VS#B,[@/EWRJ#
MCDFU6]->IZN8WH_H1)_,7!G.<XD!29G%$E[C*0$4!+"./VJ0(O(L9#"1&;:7
MC],Y8GH,%4#C&-9G(CZ#](+H#%*8E1D&WA>'A,[E1OC>V@Z_LP2R!&X?'[_%
MGJ$3<@:-YK #@8%*D2\D+1C*%:O4^#EC-0M@<)8S92BRF3%C*Z^0:2J]B74N
M(:Z"^TH!'BE 432&! @GTRQ613-<"\F8MYFWMR8>]V%F5FT(JSZZ$_/BR=37
MMF)VN0<S2Y#CDW9'?M;W,?KAAXM/O7__W+LZ^P>Y>;HWO<_#_AE>=-8D!G.'
MUF5CJ!_HGP81\45*Z8N<M#OB4BG@^4P#)-+XRK,A&:?DID""/_I(BPI8JR10
M<_%1!X&,7UUI;Q(%2126<N\FV7]H.MUO%)X$WXQC!<])O$DV:9:N=8<5J-K0
M#VOY^ ?Z7?RP3'"F]E>GR5;*+0POKPDGV!],(N"%#F7H8:;40AY@=5+/J2Z:
M%!3$.SKG&W*^X8N1!D?S#4\.'*47YQM^_T2-)\/"Y>E1@[AM>[(>';<.W[7@
MO]_0M]S^H7[P?%,Y9NY6SI<;1."=U_G;<]7AR4DK_[?S_#BH0?1[D4SS(B?-
MM@+;"B]3&ERU%3J.TLLA6^%??QI%_OSO_^-??YJDT^#O_Q]02P,$%     @
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M37$FB]G0[94W\=Q><?OO-U!+ P04    " !//6]4,0MGIZ0"   U$   #P
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M%4NV,A33//QW#_W1L'U=\!U02P,$%     @ 3SUO5-K;&AR""   5$@   \
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M@B)9L*L,<&ZHG$QLAUT62>\V3:$&ZJ^MY[Y\SQWNGN?^@B86Y)SY@ET7>JY
M3*$3'-@$SQ4:<T2A'2,E<%DP7BQ853A3 :Z"HZ>@9LBE.<OQBABSE"=XRS"=
M8[G@=*!;(R@@ 6NY61!)SJ\!YUWA:?&>0&%P2D4+HSF(()$FJ7(D*W X2B+
M,%1*DC%;T9?;\7,P4#.A!>32*JQ[93%E<^DR7* M(?$"$M\21=,"ESG#88+%
MBU4UM)C<34P>O2), DME@5Y/ +KU\@X"$LGQL5EY+HN4IG02^<@B495 GHBD
M%9?N( JE40N&$EO",&%;J5N0UOBP]Z9&Q0M)C#M$42DD0&1JA(^?SGIY$FXS
MEBH]MPUL#4RE=8;C1)QN!KE1RLX*^FPCS)JT+0!W$X#'NP? JSO>^G=;@ZMN
M*BA]Z#25>+EO#[P37S)NP,,%W5_&"LBM&:!.8B5M1B.(+,?L21F4KE$#B=*V
MPG&D1Z-5P$UI= (";UNVCS 1@+@+6+BX23)>3(&=8\KZ5"FD&!SQ[F"T#T&*
MP4B$JW IJ?4M EZ)/Z.\M@+C "N4I;'/M[3(HT$G_/LJ6[SKC1XP!=M>N#_/
M/[8V3'K',"D:AOSB?C!$"FH?HB\'N#KD4"0A@ U/WXR?%/,&HS;*/7.4.QD-
M!R>G;X_?#8].CD^&HS?>/PYV+N9] (OF0X?V-?27HU.'RON$5W;[(51GQX#(
MJ6<*E;NN##+ [#^3UM<42 6%YT.[-[?5R&I%8T!Q"EU-Z7X+ITY=[=!#B94)
MRF*UDH([+VALI9#<2%J # V&K[$*XE19*OI]L+>^0_ 5B+:  CFL>&A0B0X@
MDTIQ*IQP65Z(V^8!1X169+6#PI]B($*T$HX'L44MTT)]-Z >[SK4MRX3UA"_
M]<CM@8_!8B8%X9E;77"JI+C%6$"M/H&<&]$ #D. Y+%4TBVHP]@T+84?CTT/
MNQ Y[I"N;!7X@NVF7E!9F1)A;WU'E"3:""^ WS280H&-CD+TXQ,H*:P0256X
M@' ,/[+$&J#%^*O!>+)[&+^8<57YG$< @#3%/E[.T'7MAGX<.YPMLG>XW-R<
M>S#C0,R\-FP!Q+IR#\^]37W!E]1 ^QOIE_?H6-SLG/CX!$$'*,^8F+=X?"UX
M%+N'QP_!X=>!0YOI=?OHG]S#Y1-R+!7+.DDJ0\!8J4SO\,NU=7B'SL61BTV0
MQ><*E8Y,]]>(4T0U9KQ[=+68";JPW_6G P%_TA5D.0B29-PN2W?*E3X*@/!%
MA%]]G> 73,EK4/41P#WZSC<H9$O,MWN&+PGN]9[AZ*?8,_1GQJ()#)W;[$7)
M=!6HMXF, />$@GVM.T:Y./;&3AN[K([]#626Y](Y@(WE0:RQ\J8G0J),?O@^
M AFSL:5LC]^I-V\B#GRN)(KL8TQ5)/Y0X*#=WMI%0+Z6[:USA=T>&E B!FG3
ME;9O$PF(F+JR76XSS8%?4ZD:NC]?K/J^U1]G-V=<3\)AO2,4C@@VI#TN<*"%
M9=;;@-FZST5BA!^VHYU0*5LLDVV5HQ/C\OTRZJIBXSE@6P6_*A3NX,[3.1:[
MJ<&$TT%,@$^0B"K_:D8-OTZH'F4QTVH&5$(6?%J_86+JG IYJ?0"\.D\TR&+
M\CO@1C!^8S7=>P F+_.%X:]X9WKTH(TVOBCM_%;<A@#!*Z?',48D,'XRU%W4
M'WOR+OJAKM"GY0V(<7#E0=\KJQZ _J9X:2&R87]N&0C\&]"!]Q[-CP*89G;:
M+0SA,&K&UT1()9;+#\@Y[KWK'Q-:)H=./$!TVNOWAU^@&?6&H[=?H#D>]$Z/
M3N\0X0_FOOR-!P0KKDN^U<EKR05MA#;>->C+8CQ'I79CS##7D?_:I1OC&16@
MV+[5KA)<:#D^*+KA@)(_Y."-LSS%PY_]<P _.GQ]0!>-V+^XP6P^&'78L#\<
MK@!EHV^TYGS0G-_=7LW+ TU(^R$FP@$[:I\?#;=?%M&+0%>=K9:J&XY08N9/
ME=G=Y6^V\P8UOQB[/^4#,G^>Y0_MX?JG.C;Y0IM@VXC<FNCUF2B70BCXF4RT
M_2<'7X2!'L50F_">9M$VU>T(2'<NCK8F:DWTXDS4IKJ?-]7]8<!*TH@_K7J?
M24C9Q0TD%;TAQGX/1^2KZ:_5YF,?1/DCO&[*U;H2#QXK(O [;=&WO_EE!Q=]
M^K5KSI9U8\FG$.)>EZ?HU1%7<[ZPOH*<'(;?"30Y]+]-Z/]02P,$%     @
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MC5V>ZD->[-A3CR\ZZ62U:\[PC)2KOH5CT+2/V1PO5;%_[C?+!V+[S>)1VG\
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MY>>>_3O)?G\WV4]Y8CPLI<VT,<09PUG+YDH:F$K0!HRGC IJIADSAL"-F*Y
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MG0RP 13@^&UM:Z)V9$NB^P>(:FRF/,K23B>_)KGG^:JV!P(]C=H==_I@$]Z
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M-LAQ$L_TVKD["R;=E6V]QWGZH[-7GHU77E@YZUYL?J!A[]*M36XX]5*@$I-
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M2\R?)'T=1^KO$FVH#NGO'Z$  %F.QOF7=V\(]G#;F*NBH+RJX4T3:S"3>I8
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M:$4K]A32X:3D"E/%9"CR$:]JK8,UB!1 <<?)[@&6\2L<:0IBGZ.GUZ'O):A
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MVF17/Q+Q"K@N5:C@V+ @-.1$3M=RRI)_L*\\ 0_T]2S:<OHUAA65:OB)MKT
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M92J,F@C^,X*UKC%7V";W@"7@7^DM_S#Z\0X5<L2W*<*Q-OS/".Y5W0.DP/>
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MW&Y9^XCZWB87Z1EO3PEE@F/Z=3S&*>J$NT36!>P<?X. [K<^ Q/LWO*UM,E
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M%JZC:PY-YUY7GCX!X6Q% F+V*^LWD9-^IVN2)T+E#QOO 1&91WQZ]X"I[_>
MD86Z9^<.BS_#CBCN ><_KH)(U S23/^5I2_ 2^O6ZDXZYAY@B+X'C((U\15;
MR^X!/6KW@.TTORLND&08%<^7FU;U/SU]&/C7/D1_N1?UUX\0)>]:<OXZC*1>
MVB!T$^)R#[BZBK@'2)/D'U1OWE@7+'K<@M@-]NFAS*__S1?8M<NM-]&J?E.4
MDB=49S:'F<'W@"-AJ3^<6OQU_FJFM*?['D"^ZBNA=K=W:[)!HB;C2)?U+\WW
M_P :K?ZW,H+I-YA;; ]@_XY=<H/:/Y:]F,(Z=+Z3:92\NJ:_>J3C;G]7>EA.
M_,<$$6Y^IV>2)QC0@\6NL-X_"G3+S%Y%N7YM2+]Q<VA28/K1_N&:Y*-5@HY
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MX'K-)8)6'+MYEV_CCN(4T02!GJ34OW.\\4;$'7M]BLYTW\*LKLE!.[,-?\B
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M.FM8:;![,V7+-$EX62'GXVA/=F*(@R=&4X+:X?-#J] \I*NNJP&$Q+",=]9
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M$H*2K'93V'WY<G1F'IV^[<9!;237)73@D:DP62Y@-2XY4NC_)IS:0792^S%
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M_5:?A=UP&TVK8SRDP4*,--;=5N#'V:?E@:.(U?#V2',E5G66;*0FVV3L&Q=
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M#4EL:6 - 9.Y[ <,=LR9\5W-%5EL1M.?4!P*.Q%:H>JSNLZ%3]$VB=D@'$G
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M^R7-OR"@191Z<EUA+P!7\$S;96E-JA8EOR.6.I\- /]J?,*_,%QCFI]0/7M
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M<OBX7A:@^P=(X]P:A:C@^\_NXF'DKL8>$Z[D(D,&N1#NFG=A;X3U#+^ /6!
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M5];)1:7^Z1OEJE R-"RZ8ZRB:@8]"+\)6X^7*3EB*>PCO1U<%"?<2O]+0,4
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M/XQ6_J*(<TL$-(60X;**3=!S**Y<OKD*SZ*O93'-,-,0+R6ZN_!'O>FB62L
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MNTG1"6,Q*+^2VU.6?^EG)WWS13LHP.QD1O(P3_Z?<6B\:_FWD3R:8"*F_>]
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M_)9MABWBF1A6A4'G!P,\<FUEKV]HN#Q_R/>#7NQ%1<8' =CK9?V)!MX8%).
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MUT2=FY[.UQE%.I-+D<UN>3B$&!B+*R;X6N#7&!WU5D]\[4OQD.TKKZ>?44_
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M4RN>OM8P,17D>L)T7^FL^\&=OA4QSR;W3%E;+&Q:^773.,5ST,C<EI:;!*]
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MS5H09'X)N80';KBKG=ZKV#K%\IZ=&NVDX&Y.N.)@E#@<+V8H1_TE_,WS\T9
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M!2'*;4IG-7%97/12M8K*K3K'LF<) O4AXV#;D.N<5U'&[IDKB4]DRG9T2W+
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M=VI1H-;RWB$L/K/.N4JXJJAT9<D_'F]6U"P\=.5&K9#5<EJD#$+Z[4P;.?A
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M_'6U][W[?[5)%@G0[&6,0YBF>CH6N"\1[G7XOG>*B:,.E+5,-U%+16&2A'K
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M(LX-\\#H4(2ARZH\YL+GCF3F*XDL'OC7S@YDYD5/LN]>6./=M2M$ 5Z4FU*
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MY[%H];_@5I-_TS^%0)2!/P!02P,$%     @ 3SUO5%,(D#:T= $ P)H! !$
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M6@&I\:,QL3,0#B"3XOUHCQ8'1A?L3R">*"SJ3LF( VF.6<7NRU=G:#8J4.O
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ME0I5;/ 1%2-L2,<A7WB ^ GL&\[Y*D[G.M%&S_-8W;R30;H0+!U&U?U3?%-
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M@HKG9<S,@U@EBDR<N0?Q'J2B4,YXRE!T@#LE3P PW1J;S%YJ=I,=PH>C7&>
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M$5?W"MY_[J*U*R!4U*FKO:[!0_*]-3_@]*5Z2-?2N')UI Y1@MZB4N7O_:C
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M>1NX<%/7>=<:6HY^:/^[1@N)6U:QQT\2;NDT W9KQ7JZJRHS>5ZP%] QIO"
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M;;EV>92NK^XTJU[&REQH^POIB+-Z4A1 V:W07-9W0<&#,[X_F<NY>V%=;X.
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M7[6-;1!_L7^MGU\LYV8O=BG5M9N$_G"UEBX>6993[VE_<,3^4!7J&8KX7:;
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MY1T8TRZ$':\*5 +H5>3#4CAE*9Z3WK<D+DZSICH:H"T? W7E.1:Z.-\#NO&
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M:VYL4?-,FNDP^0C^Z@4FEA"_ C%E\&3R^5#6Z[Y='+."!AA&Q:E#71=D.P_
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M]"<?8-NKK:,_&U:X"9'E?TY@[$;0'*VF'- V'"!2/I:^TO6.XV7:Z!M'X*%
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M['K@&&R/[7O,-4(KZBOL)A2/Z+-WMHAU^RY=78:>1WS2LEX)ITG8%$C>-"/
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M>]P.?8'LTB]$TSKK'V_52/9EU6,8#2ML5LU#JT%7#8_/ -HH QE#ZNT$_6>
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M .<:W108'0_..1[F+D;S^*UL7:+'4\MJ4-7=Q:8SZX A5)/7523M5!$V:F:
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M:&V 0- GE6S2<TY[TB8AFV]F2%W$S;CL7$!"0%Y>%MAC\,GP3^X7#]-G@(3
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M<OQ;0]] ?4;V]+O@2&O#>G3F!?Q_?NV&QXY FF$2>O\MYN#4RU[9)Z[I@V=
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M""!N&HIL9US(MKF]6G9):"I*VKNBUZ?IG%_NQXWA):-!LBMM*QB*U'KU8<\
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MV.,T?@:H?:J?9*>0K1W;2+W,1%Z94<SG?+WYP:7L_<N>N:&).^MC@X5R]@R
M'ZSE]C'7.-\^10[@]:-XBH69!PGM @$VZ0+52!96CG#4/>^OV)TZL(T]\ >I
M$E.LUE3Y5.$RUO:S(A3@B'W*K=H_'38U>F>T9(8 C@O_/U-*89@]6LIZD<&'
M@G]"H*[I+)(% JVO"Q"\D0FE)G1U/Q>H#SC9]NB%&07A]MC]Z?M)J#<R1'QO
M#)G2JA.SC=7+B8M(TE:S!O(T8IVV!7Z*:WY!T]YXGS<.,5$>/*I1KI$$C1B[
M'_41'"-^AFRIKB-_\[SLBKR!*7@&=+:?7#\\"C[>L[G17-$M3CX9VE^*:$QY
M5;$%']=9??"6^E/8CQGY#'CIBL"V/[O/@./YT@QTYR'@E#NOBYF%]0A;T*MO
M?B91<FQYP^7!:<[4S9):!VQEX$FU*ND22=@<!\*I.[QFG?>9^]>N;TX:ZKYF
MK4L$K_6XB067J^_7T=E!'B[L!5U0LHK+@!W+7^6(/Q27\(_P4/=?YB[Q [_8
MAP+9^GU+4'XEFX0Y0.CILJ6@H9VLK&899O0"RMP%QHS.H=82T9^.P70<2@Z4
MS(D=(]*$W7M>+KA]A?D;6?"0@V:@,*,!OZU K2ZX15,;[VI+S9B+,' *-@3L
M5&EI1CE*IG43N4X].H*_E'&_YG77V9JE9 JP?]62L.9?G[%.%QJ/>Y;%)7#@
M==?;ZMAT&C&IH(VZ;<32RJWB-O C=X2!O23L4NYEJOQ:1V)]Y3[P2PU%*L<V
MU*"@SXCX)*RM,?N]P.*ZYOWLUA=\5?Y*A>%M,6-/NX$*<*J+?M:B;M)98E-Y
M[I; '9.HD9;\ID]DBZO*6XJM2(K)/WH4!\N!KW(L YK)2IVKX^;?7^<?=9ZW
M%SC=*:.?[1(Y&XQ._.A=!V.CT(YF\U0=X/>N9WWVR)=^K;A,D#6/?=V<W-!D
MU'#?WGA)F1^^#E2;\O'I^;H33^=.Y$2NGTK=I_$P6$Z'G0B^SGL2W[=G5M/Z
M&5[4.>!QO&TWFO\Y+%_ASE?YH:\^82 Q .ZHH7Q#87(]GDR#I#*+W!;YDY9.
MF97W'-=9!"OO+)CH)Q5C:=Z(PV)6 -T;_^$=*?2(5F+EOBZF.!*2T^2=S.]5
MOJGKC7[<86@\WN:9DRGN"!E2CT2R4K321;?\;&N<<&/C4_A#TVRA6WN:!L3G
M-[/.;?:JL$5V>OEWC[GZS5/WOKLZEG2F#Z-%@ZM]9U[>^5&!&#7H6B:ES@5A
M#"G T]*$#^Y9:2;RVUY:LY6[UPA.!1T\J8%"YB-/M(LH IT[R%G?GP$\>WSH
M3NRC_F52WHY(20+3B[JK.>\?(LG?/L;3EC&FI,EBZF)3-87P-8ZJLV@Y\NM8
MD?60?N&)4GA'S-<O2[X =_]K-0T:Z4YTS<*$[R/P+>6GNOP@1Z1&R,(*UZ81
M730/NJI9,YG*5B/\8MC6KPU%;\!OQ7$EVPGI+U2PE"VM#MKD&J?I64[%VIWQ
M\:>UK4W]GE?.# \OO^N"06=E;U^RL;XJRJ A#IZN'CCJVCOV@)FWNR##<1WO
M>,U)8BRI_JDAH\Q*"A1BJ7E@JZ^GF)N#PX!5?F]6]2@3&:A1X\94\T(\++1J
MFWV[2 4G[V8%#.0/$7I/-2'CH]L9C!+56\5/F'-:-WR+-_&C*N,R6*%XL<DD
M#8C\E2I_3IX!H4G&];*N[QER^P6^DOR &UNO4R$=WDS_0YZC\EDINHUN8J'$
ME:..];)P8_*B%;\;3_:@7D&]'TT=-YC1[_I)-]S4.>#Z"8W02GR\=).2ZM7>
M6NPS $Y/R2-%].1/ .7)XU,6T1__M/H33?[VNVG! ![>+B.!,H%MEV> TWO+
M;/9G@& >;PGWU>*O9\!T5[S67O1D$J/1PN+COG#>40ICQ2GK7M=A3,=7ANE<
M5 X$ !RFW+Y8TV2+"4K@0:UTPT'%!]ZM,R'<?KB3\IG5KFM4YX4_FJR]7^)1
M<3ZGM9\^82R.(B]IW2R,:JH;?/B,*B:2UGW^Q,Y2&A=W4;^N?%)6)+5P[HE'
ML'F%LD:,LXLZM[S$7[N/$<VMZ[1Q-\G.^[[6*WAB#F$@TWOQ;<S05[0< D_G
M\AR=D\?>DG(S['%IO(^Q_FF:W)9I-&0GC]V>7 E:K'V;_&VQZ&GS&P_4X2I&
ME)?5+^LP]UJ>T[L*IV2FK:GUXQK-,J9>C@7,B"(GPK0+O0RFZ+=R0H+^.LV3
MJYU$#.,]_EM=BRN26T,$Y6H$J2:7Y0F@DXMK3]8?,_&F,_BF=:S$+?+\@CR1
MW:YLR>65N<L];) ZI?>$<K8O(.E6*=R\(?\.(G/24FQ)ISS+M%:_;KMPE/=8
ML8%?@G![;#!Y"'A%IT+1[)JJ5,.=/MK-4*#1^I#,OP14TR)]2Q[1/7-4L98R
M%&Y^;R+:?$^XP3C/R:CRE%UFAD=45Z^X9(Y7V+#2+ K*GR:Z<).@=3Q;')8+
M5U5OYEW9O75</:GLOW'JPO.8#6,/-8GW8IP0TB=3?/^G\1CL+F+B4/0@&2I?
MWQ(_3U$/,X_":_.+#KS?T93WLUD@*P<":J_G.@<#1[=4V]9PF@580C4X46_-
MX>*'?!M2#=@>BVT5MW=OYJ21/L+)"J]</JD^HH:NAS(=&)V,A*$/[B1X6SIN
M5;6?*T*$][N?.!-$W08L2AG(D/?1O_0[O_#MN5/L@*/+T#(.M7)48.XZ&"5=
MB#SO<YDS^.X/.%)MH@*8=U<^H\]:SK^GI\BAZKI_7;4'2HZ--3BZ;W*2MM<<
M=Z>](RH\UX0XH1@.1%9+.;FO-!8]Z!6/Y#@;'YVM/EK#*#P#[&/"IAGP)6;+
M+CFGV"U Y5KY'8@&$$^5LJ(%\9+=ZKGE;O<B5;,^T [0@.JX@,HN/[F6AAK8
MYZ:U<?" 8^DNT)2:7/;GRN_'[<\O,5NOPS:(XI*RL"/7P%4BA.O_AZ^SC(HK
MRK9U)3@$" 0/+L'=@FNA00LM-+B[>_ 4#@$2' K7X$X([B[!W=T='J2[[^U[
M7[_W8_\YU*C!V6/7V7/ML^8W76Z^')U.9>L2GE#BA,A$::/DZ></^'[4^S09
MP=<V/G/-]@00L\P/G\;$4?_=BD#D2[?CJ.8:?Z%V-X0WYC5:16#.=]/H\<,C
MD)OEFEYXNB1U8$J$X!-)4\CT_56)$.:N[]R9V:Q >,@#2_$9M@ %R?JT6)ZY
M-'I0UNAA*F4',2AFY$1C$?W8*@GN_LK55=IN ]9./SW&EZ0-.BMZT!)1??98
M:KE/EX/7;4Z9LV%[!GX[FQ"UFM.!/+B1$QND?7(%=#2A:5ER6Z2S!M-'<>PG
M,-Q8-)=##M=&J/7>*Y2ZC]ZP"9,CW0LO.]ZJZ0P%K;95:I7^LJ6JJD<8#,0!
MW-J+TS%R;@<IAQ>?^[[S)IAQ:F#W4J!$6K%&OQ.\E T5G,CX-)A@6Z)S@C7M
M,1Q6W,1#-)%0DTO"91*^DCX;]@O!L'W6)]'<J7AJFM@K<OF^F^=CT2/9\7E#
M]6 I-&]H*BFBKDT* =:#P&M$SG+R"=!JX+1;=;Y#A!M_&"ZGIY#8>AN9[)ZG
M.R_0=(9H[*\^C^8),2DPY"H_X9(E<^=L0K4JH4[X0ZEO#U9R4]"<J):U7/!5
MDHVQ<@5B658[[H%I5QHSUZ0Y<].$J#(Q]K=<[."(1QD7%M)^1?.RQT\83&B!
M?4R%+C7Y*=92V::&3MT9CD0P)>D/N\%'3%01\ANVWSW4<,I6W"_0,<T]OCF2
M0D92=V=Z;]6E&%=)6ND)XI25;'WR5)&5 _.P2M[O7+UM]W[GA_3[**FB@B(J
M_DO^8#'C)!SW?DQ48XRFF3.3<[T!I&SC4_WLS>WHYJ>Z^1^WRC]O&K,ZL0$-
M"JNPWA:J,>^AR R<E-W_'ESR=P3"3"B/"F/G5$ 4?;1)E!2!KRGVO;:JS4"4
MX5)-%Q>%RI[X=8QC!(QK1 A[DC-K D!62K.A[GM4C>Q#CJQ;#!2W[F.(W4M_
MK2!$G:['II,HB/5@U2>?#DR#0OYKIN8)4&0@D+_$X>ONB@XN!_*%)98CSY,M
M'WOO*K:><TQ])73(RN):=P@7@0I?Q3S?0XO17;M='F/?NX!H[^V?CN06M##P
MVR(YV8H@RM"/YX)5<8-$59@*]-:1G S=(\B_GP"!6^U+YV_U[M8G)=@\R:EH
M2B@'XR@DPBL\["RW"GY-]SZ>/#H?L%U/MU=(]-E.K/LZ34-ZQ&36G1BD2@<X
MP,VC6X:4Z8RIP\;7KD\ <N]?=Z>^VQ(-A6=+<-=0R;%[;M22C3^1QJY44@)_
MDK:%5GB.KQY@<1]O.(>5,1T]B+Y9_ 9!K*V<5%2)V-4KIDC=BTTPNR*J0_%^
M=_F6Z!8G64K8)%ELTR('/,^QE)&<[7N7[K&,V%GC7@CHG-,!XFI4]\&TL_E[
M23OA9&<PY_HKF9/B %@533?>TV]'#LH;\^5^-+G0HO  ^0*._T&S>DF\S,[Z
MHLF&7M%]]!)N7>Y0^OO?$[5I8W.O>XYFTX& R1[K)2<W :"<ZJ]);=^*29/D
M#WP:_QEN_X^!T8LL/8&<AUWLXTA+= ;&UOF9:.';1!=GX@@93;,OHHGKZF(1
MU!/D[-[03>%%/N-[ B1V!Z;?W"ILTH]+ROS-TH()'JL[0:M,;PZ(&BJ09NN>
M+C$/O*..9#+D9QS0Q(YWMWET-,RGQ! F+)*A2A#EC37_.I5RS,'-%KP<S+$8
M<3T"JQR1'3=Q3,?&390&Q39?PWP5-_;=X&%S?P2&HPV36AI],"7E"4 W4ET9
MYSMK8!V>1X-GKT(5F'A&\='^AJ"<N,CQ[>R)S54GP)7 ^UX9SZC1"!6C1SM-
MP2)$9Y*Q5(P5N1N/25)DFS[2VL %3ZK\6E4Z;75YTYREY4<&7)IMM6X5])!:
M1LN9[5,H7S0=)QU+(0N]F*SPU7(IVGS,H1E,7D5XO-1)KY5:%<6!+G>$)+TE
M//I4QAATP2/<0P*%I*WD6D*H:M$"'.;;+\U%>TFRKHB@"<12A&/4A$V26R4^
M_G7*V>I&VW?]1;V20CW3@A*5=SMMY/GBEB[:$R &PGP%]A,0_%^=:6_0"9X
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M=%-6?:MEB,199.VXZI/L:/JNF!Y?A*)TB1UP]D _3OT$B'(76A#JJT=%:/>
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M2#&^7*?6Z-_QE?PWG%T=IV0;V,"2!#6WXG,<A73M3&6GR[&Y"\[  5P*1E4
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MK@P^.\NO',\A#U4!%B-&!!!I0?VP1/J(U5G.B?U:IV,>!W W\?O+MDB.OIQ
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M)IN>GR\4(*[Z<">>6Q"PXE@C%BA53GZN)/'EZ&UU>\RIA)P8]>P&Q<8KBT=
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M^2.O07]\3D:1;!OQ2&=#5S4D_B-/?T&:,R0(')-'4GD;),F^K^ X%K\A?C<
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MYVM8<$N<(062E*RMQ/_P1[\ 3"C+YRT%&#AB%18U&?8OY&&_%:D(Y:"/G=B
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M&^ #\6"MQZSU, CL9954N-.K;20)VI#P]?.K4"F\K!03(Y96G>()T;1\-15
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M K_KG5V.AM100J'F_A,-'M&DR12W;= ^&;'2D31PN&M<X$.KUZH[W8Y5X(R
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MYSH/EU(LYD5=S#*U+;E:D>QRSY[T4"K%R.Z2==%OMSR.K @'&K$$Q K11WK
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MFFR#W\EK)*1WW>DJ.7V^^=8&K%C_41,N](6MU8Q<1#?ZH)UJ40/)J<NA?P[
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M."+28EK^'(F^,>\G$@1G415^7(\-N85RE=1UAJYR;^VQC'FR5:>5;Y%;.,U
MTY&$L.RW,=][N/I%@9X9[;,U)B&4Y)-9QQ!3Y"&\X11KW@WL[72872Q!.&QA
M\2PB(.I+P?7R6U+U0YAR5RYN M<5 WMD2,,I]:DW29]#_?1>2CE=K_]U@-\-
ML6:JE<X7 T[Z'"6X+T,(I[QB<G%""TBNF!M'C=E:RLT7E60E:H=LPT;[+>0V
M?$@K@?9$A\LWO;8'6WL':C<3A\\!/56U"$?VQIMGZ.[M5843'#5?6?=9DZV!
MJ^LZY>+S62HSEB5M@=@JDFY9R::!X2/EMAU;X!/^/9&&;_<8/SL1$FMI7:$
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MG!8Y7,_T?6@2)$.&^\!W$NZ%FK9, O&BY]AOO2"7&\=M;Q'ZP48,BU%F;>>
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MEUBB6+J8+L7[F!<FL+D$>MHINZ5PA0D:(FNZ1#VI#"V@O=PCUH*O$[7/ALB
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MS41:&A7F4MX14;F2HW>VF[^><D2$H["9V?=%>:, 5 +7B#]TX40RO^^(4\C
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MS)I<_7#K)B1CHT/A=Z-HX'BH/) M[L5'P"++P%_S :\JL"RS!'(+J8'13_*
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M4'*92K9F  #V^P  $@   &EM9S@X,# Y,S(Y7S$P+FIP9^R]!T!3R]8HO$.
M2!<-2!-46@ !Z8)4%9 F30B$H@)B"(+2(;0H"A@I(E(,+720+KV)($54.H0J
M"BA5>I7Z!X^><[[;WKO_.^V[U\@B>]IVULR:U6;-L->W]P$XJ*ZBI@* 2
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M57!>V$:O2PKJQ,S-%APP#-6SHK2)(*) EQ3-?:Z]TY\<<U29QR9-^:@6$>=
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MEAH5&/C0F/:[8\<<<,5VU@?IHG =3<50 'L*2/]N!SPNTB'1Z_@;.^4'_&6
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M&]T8MP>P%^P(M#;,N;2+*PL>2\T]C/^WG.VGNVB(DE.0^W?P9_TE28S3C5)
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MXK#%2( =@D=TYWZ;/@L*]^!_OQ=,HCD,F/0><&]IW484YR664N#O?V-0/Y5
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MN2N$ 5V1/V!R/$GY?-)%']T%0V+F6[=:.RI1-+[-VQ5=+X/>E1^PHY*##N_
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MQ!G5R-(E/RA(T#,<RW&$O<276<?,DUY5YQD]+H:R;38;,?\P]%#2%:I-E0F
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M5(<&-OE&8560;=SX7X>[$9M+>[%':&"P=*4M<T_D:TBWXS_HW(;_[U^F?FC
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MT](V)3G4/F" \7R$N<5U>:;H;]CK&5%7I'K*9=.DDQ8$_.P<;LI)3P%V3-$
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M'-0R=^^A37A>C!714M7Z/+FF+!U^92'\,CQ[GL:]+1;Q+-1!B<G:0KU6B"#
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MV@@;$#F*O94P9![<X/'(;PW\BHQ26*]C?()=#"3/S%'OX)5>0 ,?*9T>YS3
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ME%@R&@BUN5R##QP9B1(B-H*4(V3[1<62'I/?&=QW[1J5]+B6:Z7A]])KRZL
MECJVF,<TY+/3.IWR@=_9$RJC24=&P0(\V[A'AP8\(-,?';M1"$YP1?"G0?!@
MTYDFD+46-!"G7SRP<W7^)<MWK\T)SKDGW;H9&8S^OA+/VPCH\I1R*\NZ+:?*
M<DJC^V9%E\,)"(6GGTQX,'Z0!E[698WM6]5O+0Z];"5OK9CZ7CWQ:2O$2E/L
M?%9#W15=1^U)>K>I"IHKQR%I+WN,/.4F\CPG=X58%LKHTG_2C<K3R%-_&PC\
MV< 4-!*><S/110!^&<ZUTC)XKRZNT/11PU7Z1&U!G.EML+*8:J#'[^'F_^)'
MO&\_:F$@T3-C'N$<P7\[F%N1SS*].42(]LBAD1))$/-X_\:+C7;/E83OA3D^
MJ!J+5Z(E5MS4"FD?&45DY%GFG5Z4[RGUV[E0E73MZ"Z!+H$M%Q%1K&5UW5%;
MI$F*35=FZ<E>S;Z)3?_\9RNCT6)M!WX\4DSWET$U PFR>*:THJ3H?6&]>[0L
M]_3XY>1LA8GA:A2+-.<H;6_OO::;]:I@C5)IEO0MR^R0+7@!FKGS/HS>L*#8
ML6A*L*WKCC>\+?]J@SBW+2N*K6_PT1.W% 4)AKU>X(G:GW_)\W]_:9\6MD&H
M4O@T1T164 T:V)A@.;:#-&H%5S+2H &L=!W]:VC [SP:6$I!R128<]0R;$PP
M'-LQ-/9+J[A']J#X;&S5I*VC)OX[&LWZ01OQ*!DZ?%25 .)([$V!3D6/50$;
M8R!J<W)ARON^CVC&C*JMJOSXQ6A6[(YM%? %< 4VH$5T')C^EJ=WHJRT=%TY
MFU=8O(3:';N(^/&.KW2[E#]^R?#"X]MFVIVF70L;HR/,P5GTBL]#/EK6Q')$
M7JF:C?'2N?;MYB<9WT<#MX5I;P<T7O/]]$[,8&+5#V8:BU3H'!J217@U+,]2
M]>3=^63]#I\E?!PR<6E#Y?@"M $%@(NAMD?5,;Y6H+^?\KMY::2V@^#6G.^J
M=.!CVY&JF9PU+<2$R(;'\26G.=1%L)2;3,'.6O_2.JX"+$6S1K?=[.'AQO,S
MQYW&#<.>C;P=^8Q88'SOL;.FWM7)UK:PC"'][$]O[P!>JOJ*2ER,P2PRA%7K
M"H$0FHG5'0L%%-FG+=72$D^ZZ?OA+^RT;<*>$(SG3$?/96K$7%ZK%\;1I]]/
M\Q]R/\+M_:D=^K)XR## [:(S=@@:>->Y$8%2Z*M (0T.F3G\X ][N'VRAWBR
MDHYN<-JCGOT<5?#U^@9AI7N7LF:5M<-1PKV6E5Q:$G1U-EIR=8"*VJAI'.L>
M?:Q#HIEP4171I;KD1WKZ<N$)RTU6%^3N'1Q<EY@L1\$('7W[1N57^2YI41FI
MKS&%OF9/\TT(O(5+0<^^01%B4AAN7Y&F,\S&;%A4'LB'L_DJ[5XJMZCQ9$29
MJ4766\4,)9PT=;G$RI"0GG4)W.^R!8 #-#HHU6SL')(VW!+NX+C@8*]G$6M*
MZ,=;(B)1]\+Q:E5XN>N-@C[^X:M1'-+=-W73R]('O!7.T57?>W*!]!ZM<>;K
M4'&.#?HPD]!P5T3:D.Y-^QJK-TPF)4*"JO=H \VX%&N%1W-H&M+,:=PWV9HS
M>UN:L7:P/&,(RK4SX23[>0_[;E5;KNK?O]2K 6&%2%=E?9D0];S[9;;SN:"'
M[O?B[J@\G\2.$(A>,T1XPDS1V7.%^VE)8;B<L:=; ^=+S0"/:Q^$<)PZ\$TW
MU/J&ZPH/.3D?.-&Y5T9GP\O5L'D/5U\@TXOV/?B(D6*E&V2/[NS79=#<_X7*
MD*:8:T!>DG$MF RCO/)KI,7&AB](A8,R4(<J3X1>GFE3?B<53"!+"ZY,EK+B
MT*%^A\&)-Q>81'QUGP:Y-TU/90).-SW1P,V]2:LCPFHTD*OE4 T_X( 2'6VB
M@?FP+"%^COG\!=O]-4O29FTBYMSF'W<-.T+:",9M'OS/MW"5##30Z*"*!K*_
M0;89]<;J_0ZH;!F.@"$TL+PS=WF-R8?)^^>R_ NC0/E5)17GE#$S=5GFXYFZ
M[@8J3YHW.LTQ\S%!5=2BJOA6ZWDH8X,C<A[$KL+688XY[(W1W+'OJC-,_.8'
MJYN2T<\L]@)R>I7Q),9[G8#M*"F4TI@<&OB^#3_D6FI-:S&[VYY\,[(_[-+3
MP#?I+Y\;T53R%G._NBS2PZO(=(6IH[&SY2J>K-0G=2$<DHX._(1%9A3U/J_M
MUXCF#>42TA;G&Z3T;?UIM40O+#,/G&A4KDA60M9?NM[)5[7+%-(:>^Q.]D(:
MF\#Z_2(>$5T%1?GJ[NZ:6EG@ZN&B>?JW6_JFT]PK[]^'BD8#R8.+#H>O(A^-
M/1[RG.)]<"TDZ*=4KRY^P+()-N@G=W\T\'P3,G%Y'38R. M[QHWZVF;3/YH&
M0B82&Y?Q"LC_(.ZM@^+<MNW11H*%0("&X"%X R&X0X $=VG<)5AP=R<)P0D.
MC3:--80$=W=W=W<G0 B/)'N?L_>]Y]Q[WGN_>N^/5<6J^NCJKWJM.>>8<XPY
MVX@ITI5=XR5?["]]=-2J>DDKNK9ONLFSJY.F,UIN+2.9.IAK^41-A67&I"(I
MVTB0+4<1U3M70]_\*5J=,N>-^[[!&&U%I'QY-0J7^_C)"$-T=/"._0!K<CET
M"\^-1+1TXHE(]82 C"]:59G^E[HHB^/TFCU J[2'_W?!V^^+2N/.9'KV0K \
M7;T^%.0$=HXPU%R-Y!$%4K<*G@F>[RKP GH$L#.Z\'V,P0F0*-+X%G^I9'5K
MU*OL6=L=<#7)PL/6Y4%/[;SJQX_%IYZI:^'QKM53?V\>2;RNX9@C^@Z0:X5N
M?A!?^^ZZT(<UE?3)/29ZD:;G5M*F%=I26?,CW^%S#^U[!7>J*P>LB&H!ENYF
MTE,UW_]J*]F5/H_M;9QRRLA4T23&SSN3,$IZIG[>+'FI!54_%W14GPB3 (_;
MEO1IGO2/M_9^Y1G@Q@M;\@&+_I_) 6]QO/QVXGN]Y1M5[%/SZ.&?&$]:'R?<
MUV\T*Y0Q8^7G<R#P/T"=?@%QY9^@KO'_+JC+!E9E(&<E %4^_Z1]:_R4!S#]
MY*$3_&22?_PI.1#[*4W(:J(!EBD9X(9JT?]__6#[_3[[-P/^/UI_C2?4N76?
MOKL#K-X;HI_U]7+H,>'DMT>6/<>HW]TD?A?1_QYJ5.8??4W^(XW.7O?_-P_E
M__1BS!QJ7&V_?]/,'Z+5.UM.+[X=_SII?U07Y.]?.O!GWU$#Y7\>J4953ML_
MBNM@'Q3PBW#",R4Q._+W_V.0)PZRF$+Z):WY5T<<),QDQS>6CQO'/_LHU:@L
M&"0WC? (>!%I2^-_ ;P#T%MW+T$"BGG<*R8-=<P23M8^DX^%9D"T@4OA 9X8
M46VU"&0*C=(3A*Z"RK.-BF\# :E(5Z/);#!DXWK):&;QU6\8[C;:#-).*V6P
M8'EN2.3UG#KC2NHP6['DTFAB?)?22:CB4BY7ZH0]5$9U,9L(BR>G79*;-(_\
M+-B^W6 9.M%*)"8)M0_@S4RA(FPGC2X_0';CZ0<IUXM)Q1AV$N824!NE+A.6
M1#VZOXN/__)>B;^E*_\O^#,QOR^ E/+_&K+JDOO_@R;B&#?BYOM#X.FO:%KK
MEYD8+RIY[-L9Y'L^YDNE%9>P@OTG?\0C_2%OOI?YQE96Z"K__\([ROV;+@==
M1HSF3X':;^'6GPUT?\F>/I55K<3\(9M*+:V]'3,^ ^;2Z=@HL^^J[\%L;-0-
MB*3D*4*E0XH0?@O.GO^2+/WSI6C^T-<H_=$?0$I&#/!/3=S_LOZBG?F??X&:
M^RA?0/^70844?Q2YO_?W+J(8=H4QDM!FK+_$L945IB[51O-3T$0_3J;]SZS9
MG[>AH!&)[&DXX=C/*Q#U[X[_O>%B^>- _!>^SS+)V\7(A(E@W3:$L?$;7EU&
M&R3S=LF=4-%,)L]DW421V]69L@O<6MU@^SR2F/K\XPX3ZC6$1=HX2H$0F+'E
MX^S875VG/*V1O+))$1W'XO4EBLY7HQS-K$H!H1)Y*Y!:0L/W7>1Q>&QKKIW2
M6W!N$M4@N.^N@614] M G+XPJ.2FG!##>]LU2@A,>J.XI4;6B8QWI9)>3R3-
MU_U<(X#2+_*0_&P% [%HX1S3P$'&&!C\T;78;<7=@GJB_J5V7&\^)=^^82JN
MQXT* H+&F^A86Z\1A-C0%K!9CM:X3[:D0^VSGLN<-\P6DD3-G*9&'ZI$73V2
M:S@LP7K],F(C=X"H18=<4 LMM5G8]=B")!I1%\7Q66;TNJ+(  ^^?7/5=^E#
M3XPUK%HL=-1MR0)-/R0X\^A8Q#E3P88BHE^;2[&S3/*)U,RN@M*'=6/&KQMD
M%@&"/9*HD=))Y+IUV#7NM%&%18F$U*?!Q?E*N2,Q'RMAY]ZOQ3]'.:QB8'-2
MOJK:)(GE 7[A^M9J38'7S](P5\ ZJQ 33.39L^O[LC/#LBW6* K?<3<Y7,3L
M2OT(GZ^$88L;LA2JB$_*0VW&'W"1[T2Z!GV.?^TR:G;ECQG4-?O^8DE%DFA+
MHER6.SKX)K@F6>W-Z6EK])7J0&C,AO7.1 7B\]J$X,YZ=C.XMI&H-8,#";4+
M-'9364C$/SIT0H.'8_Y<3[1:L6V6^PZ +2V<<RMHV:QH NYHCG"4-K["FMO\
MC 0W.5*OC53H8U;'^8KI'RV'(=6$SQ,@/-6E$G9BCC%'<*5@K'D+GM;EN ^,
MJYB%1<C$00RN<GM9;%J!&/L [L$Y\G%L=&[:["\_R@Z>4&1!CN,$1:Z5W]J^
MTN!SD.^W9"U3CI)0DE*Q^H=\\S]=/_6#/T]XU+]GM?D\O;]<J+\OUR9C]M#+
M/WUPV6\?K/57'PS7Y+L#?'>C^P7P7_\@<%3^-CR@)(;?X?KOZ7X_=90QH0 M
M:?H_I;SW&]!/:=U/Z=UO*5SV_7T,3>;T>RU3NCB%\-HVV/ D[++=J8COTCVG
M?+]D<>HU!9YR>5U!9A(:*E0Z?O9(J8EP0&,%*BL9)NT'-/8LO67\$J'K-"Y'
M,ENY=@<0X07VL=%WBR-MBW8,3"G%>&+4DAU+]K"PD4^?Y8I\KJUNB5M#&BG9
M(;3HP8B3670ZJQPTJ-T1-HA6C1<%[,HI)I%\C?@&5^! :<6..N?%EX,)IRCC
M[XZ=ZO+453X2R1?/34MVK3G;HJ&]1MNW7O^2M12Q&6.!',FDIR4,(VLYE:)*
MF@=2P@S]E3^Z/XM6[2[7#NBQ$.>T4G7(K1\,KLJIG/6NE_CR6(_#4['EB:TB
M3[\(T\%)PE/0&3Z[5D\E $1'%\(QC8CLY-S77&6XD(UW/HF*,6(OM>ULK3RS
M"Z_8PIC'@%&O#2O7F?H<,7BCY1WK<4H[!'ZEEZ;/^GH?64D#M/Z%,\<-=<AT
M 3AS?!$?KI@@Y/09\*J[&*UZE /-^G_L W^JE/^'DZ6%_=VM\5=PQZ]+\-,-
MOOC-EX"^>-_1V&1Y[S]U47_J*A'$\RP7_^ "WBJ.-ZX.^RX^[1H?_T:X[67>
M<>^\_<X"_M4WB(^)3_XIT?7[ITDGA!E@@*2C[,1!LX0 Z51BJ+Q"QB. &22.
MGGZ-&3%2BX!E[G987K()^3.U2_$,AZ6$R3T0*U'B"@$:C](X-N^K(" ;/)Y-
M&06.B3OSBP@%EC.T]$Q3T8W4F(]^\O[6<KES7ID1K+I6L>BAP)+1,5>Z8W%(
M.WSRF=0@4/DU4GN ^JYNV39(87HT+BW=R(95\N1Z"0(BDV9>02 #I:C&.';E
M5>(NCE3OK%0;9-,4]PR>@5XC)V)R17B.%'@%=UI:;=I#13V,J4;JM@87UR$5
M4X6 J#6S:,G^JG0%:>5J&[[1&,K! #Y5J!JLJIP\R$ ER(R."BJYE(&$!#BR
M:.*OD.@IXK^$&X9$<C/6&E5-/!/2(\2Y4LF1-8AK)37 T"OJ 2A%G#,_#G#?
M'K"J ;I_BKL5@/LFOG_S(4+?7,< 1P8Q.F&^7'B3@\(A\5&\XZ6<0'"X"ZWF
M^U8D,(;2!61AP5<HOK)G2R"$5(YVC/#I "3UP52VQR9ET",\_ ?RXA99HC?S
M?EV$A#R%@8I>H]_F#W,G)A44Q@A'R"HZA $GH-HH_-TJ<CFI4EFSF/VP,-]'
M+'6OUI5.(#F3@I(G9;/2%XOZ";;IKYLQ"B)TF((PCR%G^],]@:<13VP](@$=
MLU1T$.*4Q@T58FO*3+"B]+;5S/7.Q=D\9I*P6M/ .FG^@3E&"?&ZG:N#N;CK
M@Q0D5/[:,7&UJ>YFY$W.LD*5(!4K\;2RLSL H[ZA9JQ[:<A43@;9=IX2P*"-
M"UMI(DN1BB31A/P3JZM2>@T/?L+$F_.8\;?PBD47?\,[@,-C;5XZ"O*05)@;
MOP:*3389 RB2PF0)Z^PC(R5;F-=X>F4X7VJ)"7SS\YYL@5<%%<V'SG+^ $FC
M/ 5D8ZAH 1I TGTM-%JG#4N1+[";<U1<BL;9]/*'UOGC6K0TZ;39=VKY^$D2
M/8WT2P&>X[[\5##>U9D<3=6PRIZ%[)&RS/<Y.5<T-HWC]ZB9-KC+SHX%5DC>
MD9RK@\_3*9LN#48#KI4J^RB)'W)[O%A2L/2<KCP4^EB2 +-5)/=SMT2$8&'Q
M);_/LQ%WW:S*5UD/Y^8>PBIKI1*7[L*24# &@U_%"%PS>L_XD L'T6MBQ'6,
M=L,860S0]%*)WZRW?&5\[!B[^YJGYQ.J;Z.LFETR^ GSP:+K_ 8!.KZF:[J>
M<&Z9U&6UJB"#$M&CVI!''8*/V'O!RD7RCOY;# Q*MIIBOGH^W@&K0GTR2T\3
MBN6$6Y%#*WNJWM",V6_+)>(1I_EA'GE;)3<0I%-]PD^^NKC2L(@SAW8*TE-$
M9-75LGX0^\_AY+T7X8BC^'>1)_[PUM/CE3O ^=@=X)G.NI/'O4][^?=$MM9/
MSP;[Z=DFX*9N@3\$J.Z=8O85\8+O?2C^W7SSWI^N_8M0_'?O []?_:'^*5+_
MJ76G^161?_H=FBN):?II[PD9/UZ4G@E^HN65#]W90]2>S>EQI% C0X5K$$A3
M]*+@>H#%&$F;/YF*#&![?+ETD%]61"8KG&X:1"*64PO>_%(^?SBIB\.\NAQ!
M?_2%5@,B18I!W%0VA6J)DSKL-$I)N]$]"!7BCT]C_6XUA'6^XRE G##.^$IC
M&LZTD)P[:I*[D..H0=BQ9A_I$6(:)EX4<W ',+DH5.F\@&+6QKU[()G;:A)D
M$UV[A+!0VF: KS4"#<JI-JFLK2Q)R*X:'=F/TJS&"Q[@5BU!\LY,+>3#RAG+
MFJ!B-&#IM+.D88^/-HIUR#_44FZMX: 2_^)PF:)3LU<K%. Y_R@<;R/1N\E.
M+3,IJC>Q Y!#_8XJ#OF$H4O;38?'KD?U?!.E[OS'*+8IN4;.N6W]0B&\[EU%
MS@L'4\6BPG,DJ-!V-D,P-9-] +O2*R1Y^1$404M*KAA&B%N10JE#03$LR[;W
M\UY))I/LB&3H2!QYSEF6W4=6G%*JB:Q^LJ\Z)3C],M&%M0NWWA@5E<P](T54
M@\*K7\V@O$8!^"H4<_ N6^E<<BG$SJKHJ3>I!I_X<M'I,O"W6XG77UAAV+A(
MT3'R"PW*V8Y<1]N$AZ72I2YH7#FVBZF]1I9;[W'Q'%TO]<%TM[]23V="H:T4
MU&@U*] NB5_7I4P#GN(Q/FX*X"?V<ODB-63@D;P:0EZTV4U8<8,9$CIDQ<D2
M4QBBK]*=)]07PM8"'KQ4T-HO_+1B49:LK>_IX_*$C5%)I=UZ(_ TF*HT;T:
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MG;8R< %0\S+7FY^A (]5E]':3U^^>%G;6_40HT)<HF<LX_9(T0\%"X3RV.]
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MY;M2(U8P!:"KP8 &&R[C2*HMDQUV!W!2M6(U%TBKO]ZH\S)5+64-%P-FE<F
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M=F<%W"2[DVJC,C)"D6*C9F,)#JF*#-+#,6A4@4HD*B3L+)C D^R18L3E1+8
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M7/'%LR1GK8NX5([ KPYY"GI-KVJ-#'%0>,F:O]:>WV!J!3NV@NDGFANY=U5
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MDS4Z!B>K[4%'@L&?U^5C5CMW=0C%68QLB#TBTG/C5]#*.JY31J!HMUMA.7Q
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MM?9;C'AUP&*F_?7GC3#;J.07B6T%U4V&<RHZB.V22L01JZ%!1:5=LCIY,
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MUY>MJS'%QMB'?HS#ND^Y'S%TV;QP@[1:USC91X!B]U$'D0RB!5<KC_/:K7\
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MQKF/-;J[-0.,W>#F0+^Q1KTDT1B)G+9%XD /,'3_>LGL\FJJVS9*V;PVI,0
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MZHC67:%N1PZ)P^>*"KF_J<(:WCDL;T>HLM ;OW!VMCNW_AX]^V8=!653'%1
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MLX*8/PMZPJFQC>VQ:H4HGN*J2$4[^,3-H&;8TAS;^\1-P<SU6"M"JU_-/L1
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MC/?7YNS.P.++>7.+N"52/KP^F>8U+FF:8!_:-_4--2MX*:^1CX77!-P<OW4
M-]YV4?BC2(47\GE.EM60P,36VRNFW8_!%Y6*X[)*\VJE?P"B!@/BR:(&;9WH
MOBN' !(X?J"?,V\H4^3<9(*,9>#FBD-U*1[QJY@,%V?Z-REW6EX7%R4_HIIC
M\>-J6$\/6QI"(T<_KD^ 7<I^M?[NK#,[C.*B]^!'S,O5PE 5C)=SOVHTM[1T
M?C+!*]0IO+)SY:'UE8"O-S/:6=A!R]'K=&FA0B1,*B:77*;)FCQZ&6HN-]?$
MY "9WKRL0JB$!(.NG=W+D=FJ0 5@Q3  228]S[##.:[YL&;519/,=<@'^>ZJ
M%4C*D@"]B3TRE4IH-#@5U0$[ .A5&2$!I6::?"XR:1'71_%R5GKL+=D;V(_I
MZX:Q,;TOMH\+:[[\ :#.S;\<3I0R$VM,-VW?'MX'9'P06&],Z)@+D4G,8"1]
MF3GL>6\\H6%4VVAZ6!(!2H@_]@KK5Y(>).U]KFH-'I*D/I[N_?+V*L5Q9#@@
MF#[/SG&V4CL.=:V+N+85$.?@4F5Y.!>=#@42H8?!_<^ V+2PC;!#A8S7SY+3
M9&ZS]_P'=L"M^S4I:TXW#+X,Q4E/><)R*+5L =\'C!$X.B?ZUGCN(;G<*4\(
MKVL)2.2'!YO4[36I[J_]O#^:=VG/UI(/-;RNR.T-E9ZY-J!<TG0Y1N]@6K!,
M1]-@201#Z[_(+9+RV$]CPM?C?_J.7VJHE_\!:+33D*=\ ]]%RY:VN-B;S\@\
M*Q\.*8=QM'03]2B&%A4 ?$L4&2[I=AH9K]<^OBW+&.+_[BW+\.-)M(Q$4?%D
MP;L_@$?8W9T]>.RT-T;VX"U&/'^9N*)- 8;#/*[X_A!A]LH66TPL=H'<V&^.
M5CN_=(W!>/C-AK#4&>C5("FL"(U^Y^MV04PA:;9]2N/]_JRR(+>7,0@DX9.4
M),6DQ",)IT*&MSE:LP:(7IR<W\7I4)>1+$CB+!4)A_IS M'<<'EGG_=6>"HK
M WA.R!+'\[2YDYI-0ZXXL_>0!T_/49H/T;!:B9&B8SF85^^OYL'KNA3%,OU^
MB>G;Z=L#63@U,X^GIIR)3@])X/0<PV-\&>\J/E>9SU)1M"Q$;32(E(2IKW<+
M-S ;K^/N==VX5)I!:@<6@" #A<CSV%8\?-YEP^?N*7K+Q?<G/^5.>T;T?-PV
M:;98=+7K<.2\O:N0A"@#F2@SG9V[V@*</ WUVIHE\>(_@,E5S"Y#&Y5?TO>%
MW33?2L9U5( 94YK=!B]M*+/0$C<NBQKFI_QNJVR%\4?3D]M_6%RF<(XD<3(M
MS28*5G[W  BIIC6  T^-*77 @ TCWUBE[ J=,<2XJ?U65-7')6&2AA?561?\
MYGCO^>L9P_E4FJ<6_N%S(3ZHLH3!7>2F<?>RL&<0J'&"C<:,A"E5])W1D<QU
ML7DK4UD%FL=:7^E[D=W:Q<P[8?9?=Q=53/#:]5/)4M V2EJOXDT$T\,FJZCB
M&L>W*T$*-X2<(X/X&.SW6$D7AP.@UQ1JR?DP0N?'+P#5<8T!:R)MJY_47QF
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M7/]O\$(/#8!^55 HMTZ65S<$5$OM225?-X3S>!)<\XP_,M>IRF%MUK&C;Y@
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M8G'\+JK0LHYUVU_\9M_H<@O5K[\>Y&C3PO[ZBO+0B?/-,6IIA&#)_$/QS4[
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M=Y[A?AWWE#:38,O3A]:CU$K0T;7YVYNL1]QVSECY",_TFP%A#:7&JD?T98@
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M"5DQ.AVO-5XSLQ?UT.#4X81=<J*A!3^%B6L>.'X$SKF];&B(@AG?O*#DS;J
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ME73TL!%[(H -,9-\;$SX0@)CYDO];3H#8KOSY2XE*%"B_M>0DV)*/TJ/I,L
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M6& W6]@W4KUT\=B1VD$/2[GXWL;.2C]3"%/B[<(7H7]RYEO_J#!%G GLWU<
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M=0E155BM[F/*7L8>,O55(!9.E*.3[<HC"GM&*B+A3$5J2/_X6![:V&'J]@_
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M"O=7LEOKECW,'FPNN>"68RVBB(44@Q/I4@^7L<&"&QKKET#X!^QY,MQ3O?E
M%\\(A$3M2B&-_:W>5D@7ZMQB^9J#U8"./!'OUQ+N5_DL\E\"KFU!5P; 'GN6
M=[3#+(-WVF^%J!K,:>X>&R]$_9Z#O@U^LO]KOR7<]!KLF@DU?HGY6NW=,.NB
MDFQL,PY^NCM_!'EE%DP#DATIE)0;![NBH7A/=DE]H"T<U+U;2CSN!!8P@LW,
M:?&XOQZ'A:(2TM*>B[)VW[!0NHZI*6$-27-[JB>$*6)LQ]/&I:BYJ*Q.^3Y2
M#YIE:7-P=]=,\170: ^([5/6K:9_5,CM,H;IT#2POR7=40>O$QID"TJ5\L,K
M.PU5+NAZ656CH_IXO8I9V,A=A*BF3PF<*LEFK-,)"GZV,+5#I5\>G*>LZ6MG
M!IYM,[L\E\*(^9$A\5]2'$4?XR^JJ<H_J:9C<Q)YOP']R;\!<Y+_: 2\B+-,
M]XS*/[_%_.,#?>M9B[8_E\O]DX7:_OC"6&53YMU?S-/YO_>63Y#Y0GEQ &V?
M6$IBP?-F5G,#)3H@88*T#OB)S4,-N(= X+M/S!T'#0UP<7_(P^,W("@AJQ:G
M$NFUA3/*$Y-8E"3W)..SH!Y/@'/<=%09 HG@=AYUGBQ06:V1H9))TG'G/_UB
M-22ZO62[_[VR]<;Q \-*)EU[\K8&9=?-J1IE,#),XQO*33AC3Y\V$HF7,C#P
M$96$ =50,+I/WJNEU65BW]?M/O!)TI0:B)P:Y_.$[PZ\\0)OWV>KE&\GSMI
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M)<&DF2X,\B@YG(T<1M<P$O6N0"ADRS'>>!)1R$K<O('M0,PL1!*P=FGJYRR
MTNL^D_:L0]4K\]KTT)2'M7"_R/':W>]-R[R%-%+Z-8FK\Y736+'9NY5*(*W
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M[EY%N#Z,_MFBR+&.^OSL DNMK\W*_3(M_IQ+V:R_4_E\;NO2OKI=REP>B6N
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M&;7=C[:D'D(:Z@H])9!QR$ (FR[PE7D_4;MC'SV+)@H>]\OUL$#TU@;C;//
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M##IZ:X[8G>,MJ^AZ0L9[+06JTHMNVMW.Z7;[$:>VH&<Z# "YK:T7T5:N#'$
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MXYKOM]<ZRS.SPX)!S8SABCG;,(?+^H$,R8[2V9[A*L2#VL_='8Z#^F&9F-\
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M_/A)X^CYCVDEBG878BNNM *W3IWWX&'OGI$8U-Y6$8*67<WSTPI+[4J]H6J
MG(F/U4)VSJ')IY060.%.1#E>U_Z4+=M$5K&!+[=>4B.(#X4TS[_A5:D[88M9
M<Q>.MQ'FB&5R[$Q4XA9S^"Z9RVR(0^W>!S;IJAI,.3!LPGS/YQ'MB;/A)6"E
MWK/ATVU3%JQ1-[V<\0\^XQ>LHEESFXT87;7'LUCZ.AYOI8RX[JO>B%%-3G4R
MQ!$]$PQ3U:UUGKG6OS"<=%9+60WK;L:-L8"R4<BG"WW[<9',0)I6_[RT0Y?:
M->W'>$2^!'C8X6QJ<V)3T2K=9I:ZDR#*0<@=9U: C ]3UEEC4K+'>;@XRD^N
M:76M5U>G^4S<^;YZH\IO ,$QA3XGZ;QQ=!GY J-#T6.A6KMUY^"\ B(+\1X5
MW]Q[%S.<H5LFWC/=(SI>C=<RMXNFZC0MBY7LQ;]TW?<-5LUK!-MET(EM$;YC
M?IEM=F[T$4 W* N1.W(S::?* 4*JL$< =Z+2[Z@6KVKYKT$TFO=4:3*'8G8T
MC+/^]>R0*LS+2<K?(8U6?4D?)Q;Z*9])TR#4' +^J?R1?B  -5P$K4\J<^@=
ME./!P: $*K[RH&9J4T1%5+\<6[C-CGYX.?G2'2<_:XG[" ;U/5%]ERYK"Z61
MQFR( COI$$2>2[T6C\%6@I8CU)-;$&R)$@_II'"4-Y9JU2K^C5TA+98T^4^!
M-7EK' N&$&F!TJ?E :2"8)J-'2TSGY."*^[706S"KSM%/,ZP%AL<"2%;S=F>
M4Z2M[@%E"=7+Z:X"@DW4M HJ>/A%6>F)<<EW-BI7P.CXAT+*W$N>=*R:&MEJ
MKP4WDTEB5%T)J6DE%K5OQQW5--BM/[JNQ%NN#@6-1R&B34J<DJE6X*Z?8F?M
M[YWLJ-.+[6L-HW5-\EDHF6UH:)[$XW&3X"L';&'?[+8E9<A0/XJSVC-#23I-
M.;G(?.AFE;91;O%W($SG!#8;^$:,V24/WF$Z59OU02 D.//?+J\O:2A?W2RL
MJM/UI".8TJ@& F'HEST]"AN(GW>Y6-FU-*<*^1KLG5[1X'R6D<>B9F<"-I.?
M=D<)1IS2D/95$\A\RO]:E>^X<#D;9T3#3/K,K*SS)2MG"B>(JCC,D"'*5Y<+
M88S>DPXR/04V&&#IYW=&,KJ+G)_2V,:L$]!D?]9#B)N&2)QFF2@7ACPR*BK.
MPOM!-'@O!ZSSQ7XS9B$@\J55JCRO90)*YJZ19\4'OIQ?0$FBS*#K']3$'((G
MN3&<ER#/F9&)^)5<;C_;D7-D1>/WK:6O^Z;1"<Y&CN6\I,.373M&6FO^V6TY
M'(!WR9[4WRW9@O>>6Y/!]/<?*@?+P;-P5@MU'(%:F'C4S/SY^-[3I\:S"*DR
M>G7C:'/S3FG/'9IH(\%@FE6B?&%@22W)*L2(^>.;:AU\.9'[2&8?,N(.'E](
MU@J[AY=M14G%.8AG )*X434H4ALR@ENPE63S2-6ER(KYE,&V]$>8JRJ;78;J
MJII[SCV@E+Y43+ZRR:#>WODID:A,N$$_VUX^IGUFM>Q*\XKEDY=KP^V8P3,;
M#YL+=S)1CH,D>G .[$24'C#L+#<;91!_QJUS)H#@KH\?:8B[K4,XCIZ5,ZH;
MW52P5+L]Z:;C9"G1*LJ[',%8!YDH"PV>ETZ.V[P;\+(S%&=;R]\KF=#Z]22B
M68E*'_Z/<S@Z\/\Q ,J4*>@/A2/[9_]L0%\E^7UGR&_ OR>DT979PL%;H+M_
M:1[S#:<G_J9Y-/^;YC&1;)F5Z ^%E#A5^-\(DT3;&H*X@G#OG ?E9NZQ-?V@
M  IZTM,<5C+F$%*;F;1EZ%Z.[O;\!G 'T+H;P#_;.H4*] 0%RA6FMU6!1[=%
M>QMZSG=*AW<J@O7G2"N"']7 :=.GZ+NH%ZZ2,5IKI@01U]QDH=(*;S?7D:^O
MTU'6'@#TAC29JV.LZ.9O +6'J:R1/[%V15WP\K(IZ*$'_.6ZV-6DA>1C]&DA
M-S04Z\B6UVDUR+#T@7 +7/K@@B%242/25NV])G=?CF?1(E/#*+?N^[HO%P%W
M>4A?FKTH-%FOAW0^P/_EL:3.91,>^I(6JVOAVJZ[$K$"T__6H2/&C)FB%G:(
MZ24/%3"8.;"J-S4R*3([KYN?>V:G^7AR_A12CIG;PRXK6VELBE]C"[B0O*IB
M' J'[2H<<U5*TAXR83*&UQV$+*O6CXU.8[?$EKB<QQ?BZODCU 580N4$NFT[
MI. ?O.'BG#^S48C2P#9< @>X!W#5CK7"P3$+'!*OD3LEJ[D\OF+E7H^O4F^
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MEWV6W&KR&TJ[$DXZXSZ"%1BY)7D",NV#Y?@ZXZ?A3XE,?US/.9<]_LYI%&+
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MT883RI8QYGQ+,^:F@E#'R?)Y=<)=66M%R*%ZL#*R+(T=?RI1MG:G]^-'GCH
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M/IPJ*M4_0P:S8AX2X6HW"3(360#PD_K9/<C2V!SID$[O6?4NL!&T*=&M'3>
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M8I2;[-#T---&O?:)_-$S,YU1#D6I,_V%LP>7R\?9  ZJ\.- 0ARJ\G><*:T
MSY04=7^>]VP1X\[%[_OD?A@_Z] <59A=0#W*P@!+EE4PGJ0*\:> ]%H\<-B8
M2XN!K:K0,O1304XZ#F&!IHX)JS=3V3GM+5@%2O:R,Q_]Z5,C/\0">AB#]7Y,
MIK'E(LW5RL1F:+.FKD/F$EWEG]#R[DAR2'DR:*;#/G\S84P,/A9P8WI4(F:
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M9.O9UJEGK$NE<8@_I7_CJ4I;UYKI^TF>AF(34',E2EE&(;@X1[7C9*2&SPE
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M@I-\4.XUQEDU)VGL1IWJQ$'5W-ZOI;-DP]=^KK93 LD4-K" V8:/!K@2\16
M;2=:A]F"6M1ZBQ65VUCH '9>V5;85E.2I1UQ3P_Z;$VW=@7.L$X\4M+ 0F&N
M\&F.:/6*I"ZK<#["+HNXA<T=[P2[P7X$Z&]G\ZN]@58WS2U,EJPU>CS20V77
MO!BX-.V&ZWR4Y6)R)<V?C'32<QK)F]''9TU)D]P3);SZV.;5=5'VTMV [0A"
MK4#\$4]I8LJC"I):A(+70O9;KZ[.>)JW\&J?#S>CLY$='HV/47-W\G@IYS*_
MEZ5TKX1,Q^@-,N/T,%<C(&3Y?G;<)NTY%PV'ERF>2S&75OZ4ZPA)Q=Y]F-B4
M7G@EH=!SVO/RRT? "DS,,%I+[VI5G\)H^*'YIV#I[T:/S/"O2OQ-MEW78V,C
M9F-ONA$J>EG9RXO"O]&W[A_0QEY<]-\H[%]Z^29F_^U>V'!3I]-O7HKRC"1+
MU4)7<'#Y4S$P?E+7\(]PD$L@_G#T#^(_Y(-,2->__T%-14W]#RK[7^-(_]O
M'J/]\>J4K4!OX3PO3^)@\QB7/31XR,[5POP >8"157PL;O)JX Z7Z\VZ5-YI
MO6\1@]AVB0CZ;)'T/M9K1L^%S% L44;8C=YXSJ9[[MRY57[-)V@T&WWJSWEQ
M<CS)<I[<-HEP-'CDRVR(;R6'*H3-A>TR5<2V#..F96/Z\H0K:0!?HZJ4/[$M
ML[)5E3B99FJVI$')*,4ZRG7=2="T-K-V1K#:O.1C>OS#,ISZ#V[!,V&;1XMS
MV;,5;2BGBDC  V':$ZDTHRVARV1$[\.N3?Y.@2\?$/04*FV=P6XM@U4.F)HK
M$8O'R/%AG3A!5D1CR/8] .#RE+\U:C^=LKS8+$8^$AWIIDZ%?&L/(I@\G% M
MY HD&A9A\31O?>/)TV9>X=VAFXS$5C37M'>P++0\)[N0,P++#I85O0S_RFU
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MEO#7@^*.L[XUO[^]_8= .W #8?N+0&O]_ZM ^[>IT.>N&4L/RH."C+W=M7L
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M'GW>7#SX[=Z[%/DWS<I<7E^.Y<^Z#KD\<\V_ 3YOIAV$(2P@5TR=CW#97F9
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M<_P.]^=!Q'@:T72UX++NSN?-*5H3<P?\[_(?>_F^P6DU'GX=J?;9. G[DTM
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MJS4ZPW$*+UY(,T=NUU!3]@$]7\G$[^#2SULOG&GS+9\N_I67QI3!X1 GVSW
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M4"<_JV^_].PL;E2 3$8 E<<?B4W6_DCV_LC[BOS1_:Z8#W%EN=E35<\$0$8
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M+E] >#9EG9),G9>1#^&"TFS<TDJ21@W;S#5U _T35 &I*28?0 1Z*UXFR?S
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MN--QQ-JO6W_^# A=F851GY6\*WI(6OQYQ^[I3OXR;X5F_-U02TL@\A -GT[
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MEQ(M>]KWIE"B6$)H08A?6U!R7+1N$NS#(@L7VQ-&B[Y8)^AC=GL!>+EBZ@B
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MF(U3SC1VV105PFE)*E=A-'*A#.5_5,?4*72]@NV9_;-YD,6NK"0I3EZCORQ
M['Q@>%4/904AR8LI=7L_PH-:GWS!K-<K&(Y)I4\*-W'CENL@4MVEVWUQ?DKB
M##9JUH=-F?!!)F1><DNYU6@R&8;OIES,K8$,W&]5U75TH5PS$8-%*5O&CQ<V
MA_FD=@J?,E(7R=5I1CPJEKK5,2755<<2O1XS24<3T/M%*;W\36?-1(*Q:7M?
MSCH>(1L1#>SIBZ$B94&_FL&/QI..CD6UYH+W9<5L0=53O3F]I"/J*J^7,TE&
M05;4<XNU/7ZX4E'LZNGV"?>_4I>SK4@S),CGYFH'LB9ZP4K&I$OP\[1Q,P:M
MC@#/5=OUC:0O88#5RM 8Y;K-YZ&''5\Y:AZ3>6YM9XBXRTM=S U,+K*:LIL7
M34DG\8^A=G[_]<7]H<OG#&2^X<3AA^5FVM+V#PW(?O'1U-:F3LLNE5Q2BL)_
M3]%Z3_CEJ%WHZ."B&/4;PW"6[3<<C6K!-1U:=8EI6J&LSZ?,I[$',J#,AV)E
M%8I?(!Y%QAW%!P<D"ZG*\1YJW'?E/RV*\QOG)W7T+?.5<.-:,G49/\(46I4J
M[M-],SDY0&T33H]HQ<2$[RF?-R3,5WL9<]OC*PT;\7,_!]^IY!EE)J95D[SF
M]"(F+?II=Z,5!(3%6&G!=+%^M/JUQM<%N#9X@YV/+:TM=4A,7WF4"%%KYNPI
MDP)94]5 ?M0-LG?]*E9OQK\(]PR='!V4E/2Q]4O0M>44^;JLM!)?VL6QY#._
MK#8)\CP_O?A)*;5;4?=@F[(KD6%#N2N^?"+#[JUDW,>,)VX#^;C^LG.1O=&>
M@9\R?#>SGP7/D87/^0<X6:DWW /RS#Z[_=;Z/#4"E%4@(GFYB\B<B$B@,#X@
M]_U^8K\2\KWAAE!1'7,J4PMBUE@>\F(3=OM:/<9!;^+6KFUQL6&[)KM< \Z'
MUJBGZTIPD61K8^;( P/L#7,&G##B5B/U"- (2.[-!CW)Q)-S=%>Z;V""$RT/
M43;ER9([QF./EY/'#?:,4([I]A-%SAN"E &V*9F#U6L]OCOYFRT6)331CV:<
M038E\]H#Z=$V=&&#Y;)H2J'W3P:0\8RL>I,J'5+X&>/)BMX,DBQQ"Z$[C(5J
M&RVDM_%99RV"![,-WJF/U247FY24Y+LV?@,7%L[+P'M=;P$IC-1"HY+55=4?
M%>>-?,O_]G26?:,9!"ZDA:K-\[%D:6L/&Y&8I),90G46R1,.LS*#,C!-+EKD
M")OJ<WI9E]$]*9-BK2S%?:Q#]5@A)A+N\A"QY%A]O\T9#G'X'MHY5&73\>D:
MP_)+Q0L$#15X&/W'['-<88%X-R;C?607#) IK'QX'3P:C#I(^'X?ZB!SN'AR
M=](SG\-.Z)BB\QN657$TQ3VYI>A'?<#G.N0">#7M..3I\+KVV:8GEQ+5$.Y^
M.G:Z^U$7BZWW0Z>@MN#T[&H-QV?YAMO;W%E&Y>I A(USM IJ^<;/T%>1K(6K
M0)5\A4A"\K.!8NEA/]0*ZC\&IM1JEW;!0]V8T4)&(>;49VQV/AZV_YEQX8P+
MV&3I:)60T8-%2_?;9,Z0BA]#@IN"]HC^QBQ5,HYC>?IU45LQNSW 'Y48R9@'
MV?+3#KU./%9W^%;#4 >IX)QG*$3%;H\8(2N_0>-V&O3X\BX7;31HOO=#*UB0
MVP__4_&'BEL:&\JQ23+)U9^<CA<0I__9"9C9_P;(*W/DAM4;K(V92IL_S,C[
M8L:EG&ZJ=.JZRZ^<.)PMC1E3V0TD/IN\B50:\8XLTIT^N"D\[D-=J#6BJ94<
MU"Z2(^"4:X+-CUQL\?(TSJ2)%E_1+PU]ZM)*H1<5N+D1\*TOX A0K9 %;9>
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MX@X$?Q9:N#<\MA<(%OOW<O:.6=1&=FES:T(;AL=6PP]^9XUUX,).]HQ<OL6
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M=DB[@Z)RL7#4)PL:.6@&D:ZT>/J6O-7XR/>+CH[T3)G"N6(7'NH9RU&0=6&
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M->[5U./NO5P<)3).^" 1X:WG:P&M3KMAZ932FOFT,X!]A\JGJF#P.1-%B#V
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M 6(\$/.GA47H20W?)]0X(N6<7QTR';\6O;!@D_R3G=,S]+8=?U]T1O:5S$I
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M0% W?DI&\J3'G8"2+NP:0'^16>:V9@O'U#9P<&[>WV@OP+QB$@KW>E83[V^
MT"T- YJ5F<,8DP1V/;QK<%PM2F%G+BZC-+N=JJ?&HL^%&^!^P)N..)TE,DRS
M/Q(4HB:_6"Y3I=C>%&VL_.)(_*5HHVCW4PO[VH ?M1K-.?%"3NFN&630N /E
MY'?P;^2Z-3(F7*^?6+92\9'S<)'T Q76V6C:^Y<4$7:'!3RWF+E+?F?F]AHZ
M59^GMZ##EL*-)NRQNOIEE#43L=7,^0,]/8!7YK],Q9\\W?]D+N<7_A/="(BQ
M)Q$$7ST6YC/8(A$^.U7HS= ,-SDCR$QG^W^G_21OU!=*WS2'?7AKQ>9'/+9O
M>%YZ*$&-Y&Q# (K]'Z/"!F)_["*].%404#18OZMQ#Y7VV>EHPBCXDDIQ]#SX
MN3"E_:4YL\%N3+T>[ !GJ.$W/7!@@"T5MC'*&D@D/>M_1/%SU1]@XG@*B-D
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M,0M:\W'Y<1]3LTUQ7ZG[9'P8B.^0CS'=-_Q9\%VL=:!&M>!67V!&Y"N@%4W
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M&C;75H*G9TZRB\(TK@$%DN.61SI)#]?[-160L*&$J4%??$(+73TXEN0Q#3:
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M.0255/Q,PTW^?&=#FX\S>UV(JJ)2-JZK@!(?.7'RA2=64.82T89^(M;S1_2
MH_E0RF"!37'=HT:XW&K>RS3F9-I^+QW ::JG' PJS7$@EYQ8PHJ<&5M(3*VN
M0<>8WFA\.!YG[[=4IC?#BK&)V+>@IQ%.+KT_2@=IUX9D:W:Z9]:5$K"9=3]9
MEK@KN:*\8="E/((GL;61'HSX#4O/G&_2D1O2%GZO7/?$@Q>NT\QMVXND&4WU
M=2U/:Y0=(#QX5<FKUB9<%,:?8B6,F?>%IQT$>\SPU-<1VK/2^2J2GI()\*M6
MO:U:*3\6O]2:9Z N9WX H.)P1BF0:3-'4?@<A6!!*G=<1GVO=[O.W7RDG%4:
M^M0E7FDI8ZI&@_QKYM'GL21(_LK73I!IQN6+ZL3CJ<60S2QNYK?'Y*X(6H/C
MNCUS9-IS+#2RKCE#)H9CMA54='BKNZ<VTVP/)\V6)=XE/B$*\H0"^DY'VJ/B
M1+=()-\#U9A%5P,7/EC-OT.;WZ*Y!LR1#;XI+9W"JRWJ%'A2P PF6JA3K8@2
M!+416[3%O*-FUWGQ8I]#'.7196VP>7_ADT"@5&B:\YA_U2%AEAI4G=/IQ=1.
MRI(5V  3)PG#-^F"=QLVNFS![^"),=.M4I9C>KA#:* @V-I:5MM/[R.5=_FC
M$<!U-1@<N>ZJX;#YX'Q P)26.[5<4,(LBB:SZ.DWVHIU9YJV2&I]K*+[>$,!
MK*G4$\QN7N'AGCQW*V84Q/;0XS:3JO%U*=B64.[4-/D_1Q9!3&YE;9VJ,>G+
M9Q 0V^3\$.(QX[6PDS$C-WN1[G,_0AS"$9C".QZUB'$E;K(ZLJ"XQ\RM-*4_
M^?7Q^XZ1>1I$"KM+L/"5V>&L/P+"<Y0"7#]LB7LOU%#R[S)<O86.T*W+QLBL
M1&F/<5\RY6EP!:V4]@6V.9([G4!V]HRR3XV/EZ%B=[Z52V#A/[JL<RJ0VQ^T
MG *CE#,0TT\".M(P/(,CZ@MWB@Q4U*6?=1X=ZNB9*U<6N]:81S<[LUDMTWQ;
MR?P.U(^&NT>L 68GP'N9)M_L$!'D]$R,'![T0ZA2J-*%,M+UG=(M@NCGKN+C
M"RKA=LEOX-^I/?^%U!YRT-X[F/BJ\$86+'(A<A.$#UK4_P"K#EG3Y]7O13N5
M[%INV$%0T;H!+157]@K+C,2QOT-H/>7Q1#<A:G<V4SAV^7(# 2)M8;_7F":7
MPDVX%&B2XGO5-8 4U$$$FL';_SHSVWV%]F\(_6\(_6\(_;\40BL.E24(2XN[
M;D3X<K]<##]%;=!W+3CCTA>NJ!].9<LD<??MCHND2)R)-)5'E>]NJY.4YY84
MRS[-;QMM+EEW"&]G1WWAU,<RIN)& 9E>/S>LK:GRL6CWP@XM&=ME\I6UKQH4
M4'.T,-.0C[1]G\[.C=")6&%VB(DJ0BI$7'P?NTV;71.Y3:'.7!GK(\?D,EC9
MGI'VN,@K]W1>T[Y&%EWH[I.RIE;FWDI]J0Z*!!.GS_H-%<.YA^Z,/#U33=%L
M;%-J\"F$FK)0*3IM<H=G5V@R;<L V-DJ.<\@$;J0P*]>I8%O?#<H#55*I2]=
M.5 [0+8*)^'%<MQZ4!+JQL$&FJ.5*W:[L^GC8+DZDDD-25UA+ZJP!<41SN>!
M7W3[+E*;23QWSM73>S[[ZR]+?-"HD)+%]C=$\CI35_%>*7;@8U +RXB32WC,
M@S2*GG4Z;W JM7FX04C281JHW$,YB_VL":8V;*JX_A#Z?BA?>?Y]4@(N??M
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MW;/2'K[GRDOXX$/2UW<-'#]B?JQ!ZWP*L,*:MAF&Y4F,$$/R]/(Q7PZ]ER@
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MKJ/HE0,@-+8YS$)#??20:.NM/Y/?X?[ ]ZXOR8G-0J6:K"[HPT/XUD3Y;Z7
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MG"?$+B2F'L&>T_\!94ZDX>JW-4$7UY-L0'.[C@O)J[_8*K?K!R$75=A]0'S
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MEG?%0*T&Y<F]&6P#@B?W#"[C\#:O=>;MC @6@D1E"5R.S\&W,=Z&3]3;D:?
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M$57LZ^JE.Z'PX%2+4T<P#$0S3SB# &"IM,#2KDP][%@7 \&4#2E<^WV,HPA
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MI(%O<)GB<:+N*57[(65.)41!AMFA,T-X![)R5W\_@G#J6N;SZEF.A]_A\*$
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M=FCA158233OQ"OL5+FM[F(J^5!JM(5I*7E:>+TA!@I%VWG\F#CE7]'CW01!
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M<-EP?]\%19QT68QTC>)7#/2O)B&KD#W(DC!\Y(;17S_<KWOH;KYD$.R_GD
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M-F3XB'[YJAW2%3C!95[FI3$'TL-<LYYU+2 9E'SDR9O5/1,M;_X&O+7+Z0_
ME0'LFOFF0=4VO5G+)%97;[62RI<%G1UA8F=GSFXX:81I%J06.KS6>KLK6KW\
M).*UY/)082N>S8O0%P&AJ1^4Y;V2'0#RNRG"SNZF9PB KFOWYD%&?P 7?9:8
M5&;( ZNP@G$US!/TK-Y:X6,R!&!*M37*6)Q@[3HY?(=20?1SU92N-=_L\#[T
M6E&\>)0*;1>P1T3#AQ]0XT%T'\02G8%$=#C&@*!.7V?J4KY3@\Z\]>#SH/J(
MJ=5-]_F"4R1H:6BAY1^?>'Q *'MI!':C-C[8A_>A>? /K&O >R'=VL"=RP:;
M'K@*WV:;_? QE(&!KRZX6G R+L'\DD/  0&HW-VLOH(V1MF+DIE?<G47))U<
MSS]2 3-:D[GTN8U%XMF[HM/&<;Q&=D%S./Z]"P><I.[V2W7BXTU0\5A#)W J
M6I:0][K#/\D(/-71OXJT*;TKI(D6O:7\XY' :5597,OK_K ^L5W/$W&9!+IB
M_LE#<!FA+ 7K+KROS]/Z;4AD!HAT3B3%W*QG&@4:DW0)<M@GF(_>WEZM=-\E
MHV>2J;*2/?'>;,8B]4B(KW!W)(+RTZT=H-[15#'2('/>:=P,S+JCX_HAOK%2
M/N Q_]Z)W]ZXS"7!<A?'>1SRYOZ72*-M_=C.M?0IF?.E>.1P0TMCMO&A$URM
M]Y[C_ [%;$'""=ERE/$A]^E.T%C"SZ=EN5>+9 !'AL/!B>+L'.>?]P8,Q@);
M"NXT'N$/!U>2]O51S">WF@Z*\WSB=2UEO]KR7@ ;LR2^GN(X\;5!FE:O((,,
MYO.QKZ$( +)8T;H?6>SLKN?PW:H?D'S8R^.PEBDCH"AB2=2TWGM[8L,#+GTW
M7*C!TE=^X@XN+D@TGKY$ /B2K%PNJXC;=<I_D\^B.ZQGV@?J$8!=RI)HU;A:
M%)ID?(6. DS 1;Y(?E;Z[V_2^/3=Y%6=_7#0>I:N&]+A6S]:.32F7?1ZQ0.U
M>7#Y:K:#E6V$>[G,;6<ZR%W><!QGZZ+_A%-.0K#JE3]5!*2O<[8#?6TZ:']3
M8RKS728,-S NT'[]*O=-B%CPQWY1I2 (5*>DN'P8&C75=\L7?X4A!)XU<CE:
MW:XZT\:9\8:P9&O\8E<YP,/@DE^=IKC\4C]I]FLTNL$]_F(=@9/4N2UE<_J5
MJF&JD$7@:'/TX_=)WYC3\#- XNS;EAT( -(^K!A-Z< 4IF>$^L+TPKAZ; /?
M@SD/FZC>31=""30^'#?W6#GX[[PRC[S+9+E&\<QG? NI:8X3>.2)AU? CMZB
MD5U6<E"<9%W91*V/=)'O"8G:(<BWX'0<C6;H^(X6O>4IS@?%G4_M2" 46-"4
M]L3:I:=D+.ID;QL!F+P(0K^UESB1:KLW%.AA-[6& &R;6[\-,PP>TI#(:;]\
M85!N.@A:GGC)L7=&'+IU@FL&U$-;T+*F]ZWXQ")^J6E[MN:S1,9D!IQ<6PF$
MPG5:2*[W7BWC9X$((7IEEX6U<(PXUH^<G[FPBZ3 N-I6&*ML7SHW@!J.;;49
M&CH>8<OR%0'+D%E!+QXAWKR5FW8BO5PI_M/V7X/F,IYQNJ>8)8S/(@"WH+9Y
MIA7AYX3\'_(Y# 2H8Y2+CVC28^%]4R+ALU\>A'XJ?*0@7LA9JJXQ(WP.38FL
MUWG:?IRIM1E%6$ .ZYIR0KF1X:_V;K,C;99D?6R,QOTC%0.YR;A-QTR3H6)@
M,B!*Q\U^+%?'Y,(H66[.]&3X<]O((>7=,C>LHTP=$PWM*YMVY]>W<F[N^*OS
M/ML0XL<4&K!RFV3=6C&15Q_7N!?M:HY:=F(R,!WTPNO3?7>]2P79Y,UQ@ON3
M@BS,BWS!*L8*P/MV)F7N']8G/1" ;W<9&+F.!'B&#8IZNYZ16&E'LZ/U UOC
M$QO*P/I-G/U%S+TP,1+GSY6L:^!YUSZA[.\5I_>1T\I4V?SRTH.[2ZHV:Q+/
M(#PHS V ;B=+E-N9EFM::%AYX4M<Z=JV4)8W[-5>B1^9MZDXN2DG27I:XU5>
M%[(Y9'1O._#+'2^.H'7RD66B2O-0OCZV^AI<5O_T"F:ADU!74\-M[,153;TF
M8D=T!F"D@X@OP/NVH+? .*W'$C/+NDP4B>30R=(2=PBC28.Q$Q41XW0AWZ8V
M0:3YDZA08W-&JS B7&YK!3P4&=N26A5\^CEI>GO6K6*K +K\WG\@=K]^#+<+
MH;3!*[XP#%QA[3 1T6N)S9>;=VE.: LQ"ZTUNU6]^J*?EE'EO_LB?W94>+^0
M@LOTX,?YG=3C98V_T5M7] '4/Z:W'^%?XHV3RBHION$7Y-\7>];K(?S;(3FT
M/P[)*4\ VWL8\_>355673MWRI[@8Y0,^I?C*%L(_%OS:[.+5N',;N&1Z3DS_
M=G$OO2Q]B>=K+_OQK59SY7(*A^: P.CZRN,-^2&"@UT7EA3VXD/_Q)59JQ#0
M^NK!X9?--C3&O/PX;1S+N:D%F2VG@#Q!_Z&W6&0MU:=;&J.<>LLD[/L/@E9=
M=J[!NJE_17V[]LD+'(3NN:]^E*)<-'@^4$J*=6FO[J114&Y0.+GI-ED6H?NB
M%RL*IFJ0W:F8F$8&&^5>MB<>#S+NN&HD:SC,0>*DN]YA,8*=EM;4!Z349MJ0
M(F*N=X]&CP5H;-TJ] W/*25:\!6'F<>!+_OL5P<92S4<SLNMNOOA-V(*88I;
M-1\'CMJN)X"-$0Z\6V?8(V/7'X+X'>.=HKK?ZV35DJ^,"Z5KFR:2#4^R8*7N
MIQM^IF:FPLU*GL(F]3D;&[DH!:'65<1ZM"[&.*.J2)R Z^N"'/.+1MZPSLNZ
M>MZI/(\S8'L*N10"^@+=D;.@NV,\F$U11;IU+OW$ABO"B4UFF3VCY^O':]_Y
M^@N%7K+CWO=L"(!YB[G=O3=A<UQZ<TW"MMIOZR=;^B>!6R-CF5*<<F*&L2^"
MT56< )Y&I=3#T%V'C?S=8Q+_"NZU"-G5VN.%B';2HZS,N/0GWFJ?]:(F2=S:
M.5Q]G M[$UU3!W<)XR9QN_,W!R;BAIU)IM$F# -/?9RSNA/-.,<4EJ7=IZ6D
MNKV@92\HV6J/5M#;28_S;.*D7+[:G+,E;^1XH2_0P]\"#T>!>RE(N\C,,Y*&
M/Y=EG]7+L)EG[G"/,F!-[_D]OB<<(5?N\K?<OE8H9LRVIO,PPW-VTI@>P(@.
M+Y3WA'_[U-M 6O]OGWH[HEO;]@FO!8^GB,Y+56D*?&9UE(HKY=]A$FV3,TBH
M%6G55^_T2-9HSY3-U)ZE1NFN3!Q]CO'@S-F..][&OM51Y^=8Y+L%^2"G.:?M
M^]AN;Z^)6:+Z6'J1LX5#X%EQS?LY75W*5GOW1_:8%7OT>*^5$M=)DZ 6(YX_
MZXHG85\=RUYN*'7.SE2!0.JX\O+GWQ" ?B4$H.$#^<^;OJ_Q ?[]T&_^R3+
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M\%#[$SLVI\/0;>!P=AS4S#IF9+LM,AUS1GH"T"Y9X1-BIP<$$5.Y/NN9C%3
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M^:>57&6;2/T28:;R]V^P_F$0 9@2KR"'%2N,1#TP[:=1'4OIF5U*9U?R["X
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ME4,HE*O+847462][5PS7O-:NC%.9YERXAVUPG6K?.('#R5GTD2GU!4#<LFA
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M9P B\WY(/,W/1#5+W[@N !TKR^DA+1/_VS[E#_S #_PQ7(S_&U!+ P04
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MK]N<2K;=M[L@@_OE^QPHX-%/"]O$S\%<[7EH[UH3PD'&C5?9#?&"SC(0V?/
MJ]2]]]Z#-)]+T7EMHTYQ[RIO6]\A30A$49/69'0^B?-B+5C\P%,/6YY+,E:U
M-D'E]BXF'^\.GKX5^\L+%!#1(0*/M0CO2ILMK!A_O2K,10&-8EF^>-J^$P-
M6YUE>X(EX;GY3K7PYY8X$SKGA<DZ= \85G-&"@TZ)[S\Y)PKP=&!PJ6[56*O
M' (8KCY@#(L. #;,254Y#O987]I8\WS#->':Y0[COI9"@AV+PZ?4(:$<ML2&
MC.KL,;T3;:(^;I KNM4N!?H9,5JR9TZGS>ZL#V_8$AZI6?%=S_C/@=HKO)ZN
MT3)%526^+I?FXUZW-E2G!>_=1]B2XAU7R,MV2]JMN,9PA'=U_C1)@U'&_.3T
MXTQ17JZV^;+17HFV0#Z@VVP>!=QLNV5#E>9Y9MRD.='%+IM/*Y<TVQ(P1&T
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MQD@R<[\JEH3GS8&J1T"_5#_EEE<1IZ+S;VW%Z\#KA-F%%C=_EGH*<VY4*D)
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M?^(IK$9?K0'K^F<)9']5*<G^_,G!'T7:OR/LWY&6L(I< ]R[4J%Q\E@GJ_'
M!> @>[]&:!)FNFW&&'=JUE@!/8!T*V<9W;**W;1+=#NG39.7,6F!-WN>01-*
M6TJ\JB6&N>UG/+#[.4C,?GUCQO(%6T]XSA$9]AK/!%/KWK:?E@VJ&Z);SJMA
M3U@8 OS7?(_ZEEH3%-Y=.!;?QV\'/H/_6&Z@KT*!L=IBA_@X7(("'L-00$Y%
M */OQC_K34HWK9ZL]LF@@(1Z76+>[SSWZXK/UC:1F"2;5A_W;M&^7S&R3?_%
M'+4SBP+B&CK)M%,?NM[&#+";V,HAZ6MYB3P4U_D&>^XQ/7;@[\YS_Z%^!!9
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M!3PSFX"Z!*K!J$U@6(1?7"^+;YXH\J" ?F7$+ICHH-EHKY,I\G=Z>"%<?J=
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MSU0 _B>4FR!H*X( !2A+*QYVZZ, @L[/G<?D;Y$(<<!?@--O"2&( C#1#-I
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M9:TY#H> V8I(%L0%\>KVG.=)K/*(MYI? 1FP6@YUT5QXRE3AU*HG?M42^FG
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M;;V?L$U+_U;]KU=3[28R[T=^*$J[5Y_X[K<S[^7X\6CQ\.O'_P!02P,$%
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M]/-\9UP07]"(RSE  MF5'J^U6;+ZT1/_ \^!0"8P_Z1H7.K^_"D1\B#BI$I
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MRQ%Q9B\D[79]O+;>)%"&N&*,\J?P3X9>OWNL,:^&>/SJ((.6Z?A!A.G< "E
MM<'][UWRRSE!^!NX5 ;_T?5/G'^V_(V34V@E2C^;QAF<!V$:*_YKCBHP,#!:
M!9)MA=&77Q<=CU9Z4?;7.T(9H[S\4^MM/L!\K9%IZ.2^+6=5U$N29$&90^4
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MD&.I&5II)#_;+[KV^@._;VJ%E0SKL,M$HA&/9A5<X;B3#L]T0U(3/XY*2Y9
M0;&:O-SVN69U^LO$#[_\F3@*['>U8F2/$JD#+:XP.ECB6.9D7P@X?6Z<VUY#
M2I[_AXWY'_?C?\#YW^WK3\)H@\[AOIM*].'E]0!H-!'RO8WJE@?GPW?$G^C\
M#3U7_#DSLR+=<]ZI,[X?BOZPT?Q6VDG%WLW>-6E[)=(,Q)#ET 8. M04^*B
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MUVQU%D;4RMRS+1M?\SH&2W?EY5@VO:^<(X%HD-:ZV?O8\R=)[[U_N?=-G9E
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MV"=X>''$4"29K%\_3VW\XG-L1@&#UTO.^ "BDQTE@8,#>[NWY7#3!2TDG[8
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M[[6^-A $YSAFR+SCW/OT&X2U_@=,J :\#3X"O**M/@(\YL ]6/X+ZG<RH4X
MM=1_Y8$ZKIRH8N;YM%J Y6+50-)'!:;AR%$W3+7]O=V9/1V3 \YQ6KP)UU&/
MD\;1A&,,E 9$(, 1OFB*]-C/ K$*+OL/M*W;.A6]QRC3H#)IK@ZA3]: X_<H
MQVNC;#]%2CCKC^-NJ;39F\V;@+ ]HKVHGA*#P-CG\W"I+(_;(5LK,;MD&_9
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MAFZ'7U@*UK-5B41!$+QS96)SXBW/!OPDUD2O#_)5;G80ZWW^[$K2*_+%R%L
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M6RF4->UT@ 1-X)U$!9Y'A$9RTH*V,?58,U2DZO#7\=F>)U%?^3G.\3$]=O[
MXCG3,^$MB&Y)-3.S?&8M$-1,_I1 DI! 7%Q\+A&P%%'H=\85L"F^)!]_G6"\
M0IK2-J8&:XEZ?RC:JI'<H^UH2O^(T.T4\4EK UA0,GU-CUU)&Y1#M$PQXAKG
M(Z55=77/%,J2=CIZO@KI#>7W+&*.AEZSE=S1^*95W?;"[^S91>.CUBZ$#IXS
MR%=WLDI 908]Z5K9M"QY,V3PM5?IH]N7)TN=SG),)*T:5#:O-#YYN+6@'I75
MWUMOHV^_3G(*Y(#;FO'EZ2XQ8ED<Z(4/UPYD>'1[)CA-V_ IRT_(5.9'3W-
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M8B_NDU]_VAS2X;6<J)[$7=SVV&:UE3V1A@WRM29W\BN/[U5,X^7 !WVD9&D
M"H0<PO0G87X<4O*+0G/@\'&Z[BL8^2H5H[EX(1[,Q1L*2%A]QG/E""D-DL!-
MRRIO:?AWUA!(S<2D1.)NXB3P/+9G=:))/V+@Z:U($?@*>Q+FE<"(.$C>Z*W5
M>KXG=V9&]1$ 3M\Q<4L3'1SL<JC>Z:.F^6ID2*_\W3.9M:K:-Y3+&@#=3.Q9
M^$70.9$O4FIY<#8O8L@^E.^KPJO/&J?FLA!L.S*--?)3A@CICY4%@4BOZ@\J
M'3[9J#9HOI3(IPY+PL^.[$7"SU@;Y)15O^9:<PVW;VQ<X\Y6@,,99LNC7EB
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M0^R+_9!N);4O'J/*1FDI6UF;+65H_N#\&MLI2\N^5?_K34< [_AYDLJU^6O
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MV^81@-SJ]1@TI]G6[GVBI$?#]. S_1)D)/O-J+"O2J2/7]F*/W@S-KMZ+\R
MA0KJ4:S85^/Z&)KQH=[\)7]R5'C53:%.H8"1=9@1&A%J5Z-EQM[_QOFR,F?\
MK1R"3J%!B'[]8<+C(X",Z,3. K@Q,X@4VFLNP&;[ 45-H*\#/=/,SFCP[6US
MIEL;7JK,"M/^7#3\W=V#H/V. *&NQ\9XI6R&"PT"*XN33R#!):?_6'S*P%^.
M  JI>,T&C;SYRYG[W:/[.POE_R;#VG$3&!ALFS&DYOE<0MZ>;#56^0;9M:C
M*1_&IH$UF6@PS>BS,N2@I_:J!)(>DS&*-;E3+HM9>Y8STOI4DKKMALP080IZ
M^;SU$8"I=%^-+I9;M_>QYY6(QPJ$@,GGFJ>. #2;7USI-M=DX=!<MB<*%<)^
MBKWY"!.P*CKZC+6.[G!R7B1J8N42-:0Z1 I2:0A9_0!I[:F"A?ER8>)A4]P(
M,BEK6_NSPE]?E<&%%5+-DI4D==^-ZG=8/KWWV>%R/%>Q<-@,4>N-[?P<&TP]
M^\I2-M '88HI;VKOL+<_N#39[VH9>;DB65"%!.!IY5-%91R'GFB@32;M:J1Y
M*,+MQS#K).A\V.5SVLF$2.J2&3"8%<.84_L-]=+;\LF94X?JL@3&K0_O-G,K
MS^$4N;>.=4 1W<D>A=:_B"9IE'%5*IY\K?DOD?AR(N305]J%,\,L&,<@E(:^
M D&W[HT9GB!O+AE1.(]?W!^&'?K6X^52+]XCPTNN8_J4BOR7>9C_RI'[CPRC
M_Q$,]D<6X)SR/9]/V9:\&5LU[K3KY%).? \"'Z8)$[Q/P^))<9A=UF/WJ#@P
M:O;XX-#,@1K0-&VH#PHOIH#4RN1%UCO/<MIX'N$66IF2QPAH-G5LVWSY%\>Y
M"FJ+RKKM\E?SYOQK-H-XESX< 2Z2E%JK#%N/-[59>22MC"8+]$?6O;-">D'W
MK[5=;G[QS/_UKI/M$HC<&C0H0]?K4K0_/#!V^0GS%R9<Z7JYGX@CU8+35V')
ML^4J#M1W><ZMCBRK4\K$;2U:FL[E7\O52.Y<ZG8AS;7BQ4M:4\W_% E]:0&K
M*SMY!-@]K0Y>F%6=<*SRC?.?7'7QU#B4:M-KQQ;NXH+NX=A\P:E=>,FOTY)Z
MW$_/3T5PTN//3:D?89X_\S3]$=G_4T/\.GY%[6<&)PN/:'B9#%<W9T_I:;-3
M%9*O4#'^7QX]/V<KU&A,7(3^D. N,&XT86*T0F5D5#=G84QX>-I56),$ 682
M-M+AIQWV>#'>K3]FJA? X>MM_FH\&/*U G'>HTSVXI"^=:)LT&OUQ'.7XN_[
M-"=T81#2")$U,)64KAEJ19312$&QLI^U;C3C$<B9;FYPH]F#'XYW)!=P]!C*
MU*RQ^8O([^EC=EDU34Z>CZ-*^\EBM QRW185]"&*!^(]?"6R1-95KC/<Y 4M
M3FGY9SHUZJ60NIK#B.WWMRW)[JLQU/7VF5O2B#B+N3MUX4?\WJ^$%W_G_* X
MV;EIA#C?._8#\U]NYH,;(8NE1$< C5A=.2\=8=F@B/D#TKD#WB. @,;>(7B&
M.S7_>6.]NS:^/1(7]__?I#CIZ5A\?BRJ44P3K4^[F\E[V!_Z*F [7'?D\N1<
M@!S36A.$QJ:.J9OI.+&FF),"&\3J['ZUA:'%V[V-AK6'#/41KN\=@UD8DCOU
M.DNA=*P/DPC(.@4141!<%;)/BM\YXT"P?]/@>?NA_JR:IW=YI<]ZY>-&I"34
MPUU/EJ+FDC3T9>RB_I61417+[L%KJ#= _5,.'D"3@2=(D36*I1T!H_$%AXAR
M@=;B;Y$M2LJEUD;>2FAO?N$+V!=M%A%O+/B_7'G!?1%U&)3A.06[X)&KV9O9
MVWO/:KJ\O(+NM2F?H+)#O]L:BO\%'WORK!$E1[R2Y9,-4+S4ZP'_9$^T03..
MI6O3QY176Z>LU-,Q\?: SF>+5BUCO!=R5NPS>%-@\ @PX?H=1")U&@6[L"!1
M,UR7F" H[V4:45PPG.(RB4P_ C0FH3D/ :9'@/IHG##!<QRMXXLCP+P9WBJK
MFS\"!+Z?K-^C6P:O5:4= <C<&\";!.$XG"RV^Z0&^:O6=7H-^[#N[!$@-:H5
MMY_VLX\"?!^+T0=7)PC!7<3\^]@CP+3R'S6YB_6H)UA^7) D:'\U^K<N8)P8
M?K\:$3-,.-R+O2XQ9F'GF9 &J1L\IKK.>;B6RYL9S2$[0W3Q\ ",23D[@2[V
MOHC7ILS1ASO*!SP3IX\ 7:UF1P"??A!6NP[/I"GD)CN8(T!+-+YZZN^J'S^X
ML0-M<DCN)KLS!OJMD_M@E#H6B/,3 $^T'@$89/$UJE\U0.WO@^OR6Q=X-_<\
MCMY#X1::&)JUL'?KZ=CG<U8SE*W6HR3..MYGT=6?A\O]-VWWQQC$\RW+=&,5
MKE T[2S),8-_?^;N/TBGC*->\Y>=__&F:;]7_M-KG_KWK\TGUH0X'<?J$=6:
MN;/$V#AQKH;=,D/*G>'PC<,3M\^^+?E_,H7(;#(0#0HJY0]GX>E>W>R+;?P"
M+&XT*O@0[95P:B9C,)BQ[?86Y+^B?^%/^A/@'^TW!OBM>O_A?^(XR/^&XPK_
ME>.,;3&.#;X,Z'GTSK;.V_@C@$W]^;NE@ZO&-V:Z2/+^'0<H?YX@-,/)_2\Y
M0 O_^)*3LGL Q2, &'1@];/:_*-*N//?4QIO,_Y%W2Q^WW-8!F[&4*J;(8(M
M32 !+*N/%9'NOQVJ];4 "+!&8,J$N,TG=\':V8DOB:BX8%?I^@V1>3 ZTYOD
M.)][_=KT$2 28/S[C;)_S[^L$[*#?LD"\/].,OQ)IY]RHHMX(&$ZFGQ)M\TB
MTU8T08SOC%Z:W>NHTBXW&I2;+W-/C=#^+>LR"<6<$0-&6A__T-VP,@V1U8"4
M?\"2?QBW5_]8_L'_,NMM/7U7[+.^I+'Q=<\AC:&5A+4[#2XLXYFEUAXO;4D4
M/UAQC-KHL6A5["=Y(E"),R+/F?5-@JHZ$&&IO=_[4<65Y]L=WI$&2E)U83H
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M!]Q/_8%R-NU\#')!HD<7>G\ VFO#14^3/_JQMP2P .X6"##LU"W"OQX;W@\
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MG5?(1REW(J6M9WVIR7BMQCL.$CLOV"_$5/):\Q].&&Q&R;DE)T3^Z3'AS?U
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M2 T),;3ALA %ZNBI3.S7Y/'%85"JDR] PB4?LE9T,,IQ"DO=_*3IN_[1^J&
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MY$ 6,GG'B9_1[AZ/)LR!5-"J6"#!MQP7#BENOAE^0Q-A@2^84MR4X*X<P\*
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MKK&R76(O;O/,>O4PS@%AVW/7L@]$59[7P._T^LO0((3JTKV^%+0*+JRU#_#
M O$JW9AV.,[/6M^#B<#K.;A='$X,/64Z:I.!#N2]P9'O/9Q[+OZTYXO@*!%Q
MR^,>O3OY*+G_577+.X&?V@E?9+Z4D8,UKDI[)&)@/N 7=56>7BW5KOCXW?26
M*5E*O0$I.%.#1HFBW#K%1O06-8=Y46%KKSDCH,VC9/+2#*6EA/OCWTDB):/K
M;+E^H)3,I\2+:J8FG5<S!NAF5]Y1D1W_\L>;:<N9.4BX4)P2M&94+\^/J=Y^
M&7GBCP5BK@)^,GB8\YV;[I /A V\,N\/OC!*/%W;LX@J7R"E('>0=,NXI$]0
M6T3I0?ABM4KS_!Z'ZF]X*SRKF.Q0N*,@U=04:ZYX\+;ZV6^.1:/'<F3QL>$S
MC?P0V=+^AQ GL7V9,C4C3%*A?3$JO,M=\VX+O,FZ.LR>LC@F@^R DVHRT5RD
MV< TXW&5=\+8E9#*N-AH>!MCJJ!52Z.RE5@!QS^.RL(7]X0H^V@>_GM1 $F&
MX46RSA2+,/2$"KC:*IB0 YC"^;1SG=!,D6DY]=LWR:5"68)%JNH#>*FF<BQ^
M5K!67&QDJI$UE^V1\(NI$K#!2(CD1M_:5C%%DH$%+LKL=R0*&J=-%_,+6..$
M"W(C=Z1BVU>@Z*^!H)L=\*DI_"<:%QL3O'VQ@/E;+##6ZW/1=73)>P6^GH!N
MU\/>H%JQ .?A"::I%Q=+(C>+T<^\=#%D<82(=G1,D^0-%!=1\NC;\F?$HK3<
M=20D=S9-1?.:;)GK?KZFJ'L"2T8+X4"M<PS./,:@V[VP?+2[MV!<\%GZ9\9D
M1<>ALL+;[L?K( N[<B0_!>D[8K,*C# B,)IFEKNPD,]49;8^NF*>]SJ;G'B-
M@6X=2H%FR)2<.?(T5[E/G\K2F\G;]N2PWZNW7QDXB7LMWW+8%H=2IE9%' [&
M/['G2LJX^KX.9>?]&IAA:JY,?.U;P)4KZ)#)CT@)?N[G?J<\GS3>R9Y0(V1^
M+3BSY=A^^%YH&Z?=L5I\M\>')!&"63'!LS[58X4S)9.Q-N9%R#W]W0LF[_.0
M]J.>IG0.0GP&_DTRU]C'!AXTB.MN(5F[JQ^)CK8DG%@@XEO@G]\*)UGZQO:0
MTODE"XC&?&$(*J5;TH(5*38GNVE )A>.?^-0OP"V6'H!69237KXAZKBB;&F-
MG5]09KM.G_U*7=A@=LKZ@36H=A,+,%34+!B:31R*-?^%S#+AT]RDO4ID<"R2
M5=_:%"]?.0KUJ^W[RC%S5AJE:0\(OL&G[W\J:7U P/8';#+GC-1J9IE:&];3
MX-MRR4,K(?H_U])-'-BZBZ52Y8\E&0L3KRETG/6Z6MX+H"N<M8_?FWM7X_6[
M*K0Q]GZMD:1*_Q/W?E;W ],K'$*@6AEQ&*O(V]J-8A?FO("T>U<]$D6%&& >
M00?E6K! 125T^VUUE ;DZYS]4.)6[0C%;11,'4GXG>Y'EFC+C!>2.$3%T+Y/
M)K,EQ"! :<V<INM"^.]NXB!M(O<I*8V$BNM<R^2R(3I4'':U<>_$(6HM!1WN
MT7YU[G)#DE5M,?G58DXC#JR?BO)=[EZ]L9_QLIX\>.+_R:(\\[/\;PJ%#_":
MI3T%*I2_T]T<-2?21WK,/O5JW3_68J'4OKVO RAC5$-=\O&W(.=Z@:'V<9L0
MRQX3R>[K&QOCVNLHO*(/I0]&BQE250@)%]987I\>99YJFTU6_WGY9EA=0Z+Y
MT+BZ#9'28ZY@-\/K<LOU@2;;K-7 <LA4H"*,#-D?QHF(^VPQ(*L.>7!9=RR\
MGB/5>?!%A6+9'UYC]R5 !K&QMK CDYSD(MMG98.96DCB9'F3$9MMR(5\>ZT\
M4R&G,).6E+0X.">M1SR-B-9/K$&.83QVFC6&WT)Z-;YO.+MP9*.\$>?]:A-.
M9X(:T]S3/+H\1X;O/[ ] 4X=/>7=>^UVP91R],[Y$RXN;U+=-]28;B']7F=8
M@0J<?7[X.LEQE.DX]W+%#AFH6)0\9:$ZA7W=#@TLV+@_7;Q/'4IU]B/NQQ][
M$T>ON;=\QAOY,:^JLA\+=IX.KK8Y(X_0<6GPFX!:__"NZPAG!39[)]&4=]3L
M/-<E^P :P$? */Y'1(9OTBY#7_NKB?3<41 M*G>RNPF-<* 6,*@?*+)QOB4%
M?LCS<SWZ?+6!;VDLX![,)YFP86(_=(PSTW1@(C?,$7^ 1_[.-K]]_IJ-JYZ;
MOK9LEA(NBC9)1@F^U=*@$+5YKJ_RUUQT6U5WWXU_U 5#7"-"?&KNM)8,3A-O
M>$[9_<4;IG.]V3![)L00(--N+KPK1'P\HTN^(N"O[4=(0*Y(1#=E!V4ZG%F5
MJAV^8T'_FLG?L93]C,^]&='[.D\*YKG 6E' V/S2P)9N];M0KXP %K"%%S0G
M2((YXV356;*>ZM2]]ZV +[N@H7O@LR&AS>F=3,&)'+@<3Y'Q0.1&MNWGK)7W
M(OE!XIM0?"B.<!GC?$$7*E$X.J(5H7?NN581';X6_C^V'!>,!8Y9I\%[L]!3
M/@4IZ("W)A: V>!B;A$*A 7NC^AC6E.PP--"+/!('0M\@^U50M:RKFXH;F:Q
M0)HA#KEBU,^R;CQQ,DKB@V@<Q+7,P0+-X!.-/05J+#"H4(V[/0X+;=OD6G:I
M_,0"?BF%ES2[]1@*1!!,')/]5DO[K*4/*C#X2(KE-6MIQ^EOV9F8UM%/:.]\
M:>7Z*4&=H:&=3]$8*;Y B@V+>T@18TY46,EE=#\DMT@^Y>T:W1B:.O,54B7'
MF>%2R-H\93II"O]2-,AC >R>=A4I%35][C6V&>"]HK0"IJPM<QRU%;FL.USP
M.N4+[,1DUIYR9:$CWT/AD;CG:SJ!QMK?2\J5=M1L>GV/U7!]$$T.ECF- E_2
M+N-FA X+C'N*IHB]G7WY.L? 'B2*\E=J1-(W.A7\I82)NJU;/XC5!&7#H"%:
MB,+N<D9G+K77^'?@(H\N"URT4^5%@SM@,B@N,I=5\Z=6%VLU<^U/][+6^2?1
MAH4^^KK7?*A,TY>S#1V/A,@8?TN^)F0\."TIY1].R<ED^E[<6&KYJ[@ -=F5
M^?C;3N2@0 )^E'^#ZR8@W><#UFXQ3 W000BP,6<*ZCS7:PH<WK>KSN)[;@T$
MWB':"3DP7TB.0?1KMWT\G[C0C%PEHF".,4*H5B82;3N (_P.PXI0Y!A2<RN=
MAH8%&E5:0]Y]G6^-'43RHAJ/)LSJ*SVM1K6N-<V]I"W#,$#M3(Z3BV'42*WA
M7Q<\L$"HI\T9@(Q=9X'G.02)(NK#'AD^SUR5]:52>5,?&L]P\"4/?T??AX1W
M%<$=7<G[2F*HAT)_$)PJ?M(>49 ,I=V=>/YK@GG0S?3FI%>L-?_[X-<VF(9<
MJ4$@7IF/57>;]+C!JEAPFMV)BS_)2GCAE&U)UAC\-N*O^4]$V&)ASNZQG.&$
MA0!O*>/K7R*MKI/BF^,0O]K6M-G.XD5EQ\:>Q[^'0GAX/K@N?L\1!4=XS-AP
MQ:P_2YSZOEJN7V7?2F9Q7[I8V3A+S\$OJ2[^QVB1Q6-3GWON/\V^*'QL ?7+
M%(3'RKD7_$B4%7-7IOMQ$5T!%ZFWBCLB.5OZC&-V.)_KOHJ\K.LZUL(!QM9P
M-J>64C[;'QOL<1NZ*C+NS%9\8E-L_>/#;U9&PX-8$Y!.MY1O%26\BY:;2'@O
M$JBNT&%;:S#>XKOBPG!YKAU&DF,3_B(&\#CTBU_ZX6YP"F)"07N]^!D:@FWB
MO8;?O7_BN!8?<A'>\&,)+87(S&]T>L!@RB)?^=@*84&QRB^O,+.E4LZC,;/O
ML]7C!%*<%/]6,";D5/!Q^7'"(O&SCT0$MCE21'(45F86_-7(BV!0)_S%,,&1
M:^$\-8<W2$080]]/%*MX-,IBR&C^(FAG?49+:\&(5TSWI0T7;<U70%=9\#^I
MW!X<0 ,T>',_4$>:*#VYS27(A4_R7S4-PG_MMVEUU=[^2QM_U1M_0JS^+Z?;
MB^M/]O"QYG_E@GOR"_+S_SOS^Y]:;G"$LB#7OXPO3NK?*2 -DX=D&AHF&L##
MAW;9;_7>)O_7#6EH=97Q'^1&\@V3G($_9!W+XU#A'PF=&V8ZWW<.VVP<TRV/
M RZ:Y)=F*]@X:,#)<5\YJ84[8DO ?*G\I?>([+G])0_PL0"[TSU,&PX&C2G[
M"+KXA/1ELB.?"RN5[8(<8@D%&8ZMM/(10;N1G05W&OI^\:EK&"I:6O@P8YX)
MXF,Z$;C(<*M-J:*M?S4NNN8OJ3^SEM5P77W,VPB%$>*Y[-=D7P?79G[DLR2'
MZ:6%3&V)NUR2+4'A/5E75# K%/$J2T7.RFP&$I/D3"PO90BZ(NYOA-$D&V;:
M<\?7JW/06T5;)R8:G,;@(*[BU.I4S7"(BS>]EQJMA,@=.4K%Y<S<$MW-F#!B
MMZ&M&06^F0>(^M!:02TZVFYF,4@LDX%<D.,\1OR8IGF00R[ZU[ZFZ.-!S@ON
M)D'O_DQNI/C'/[M7J0UUQ@3!!(\+?^$!&R]IIN#2^MHLI;I3Q;]/%7Z@7%>;
M=>A1*HL/N0S;ZCXK>I-2-2Q;!<DSN)\-')@)8H$.1I"^U\^9O,C>;TG&;P20
ML$*BNW$6_'W[L(K3OS5-E8W)<RL*^S\;#4"?*RH5!'U6Q?Z(SW!,E^?PG#Q,
MR[+E/*(WK(E.^A%G-25W>QET%Z7I5?F&M!,"&G5;+YNH<Y]6XTP<"V+EW]PK
MOI]\["NX<LSNRY@7Y>H4J4.:.-BQ)NYMC*2O7&7LF:O+D_\+6Z"6'&H_+%H.
MNE7-MT)?;ZWM8'H?LDWQP?*8?S?K[!H+5 D&X-@"8?":"Y6/Q8RI$[/NM9A(
M^[>]=95+1ROI=_)A-%$)521NNDFS\  O''4\7L)T(G'+ZV)A9>)W]/G?@<?R
M<YCG>7I2]#/0\,M+14XR7OQB\51MOJ&N])9T.JI\SV=ZO_OQ7EHG^!M.99&A
M&=HH$7,18U#[A6"N26_+9U>/H"*037G9%XT3M7>$]A?T-@F7F&L<5DPKNV^!
M-78W495KOLL)]^#,UI&OZOX^+22P^DC#L<OGH#S\[)6TBDRU[=J]&.W6"JB5
ML?IWL(X;0VS"R%A6]C88I&L1AH#V+2&^V$'_7%2%%!NQDQBWV;_99MZ5(D+(
M[VV1M.=#9#Z%%*L6[:0(NGBR/1W(9KO324"I"-)5^I'A*#7E8/;K3"<FB)@^
MA:.7GNHMXQ^N71BB71F:LQV(W+,PM5^]Z]"WX+1_YG_M<T_6ZM/&N(JV-B"U
M9PIOIY6S*OHS^LZWM*QN,B=6;6Z"120S[]#POO;# IOGZ^DM6NZK,"JJ$-AN
M*.@J(!$-J46)KC9;4J ^;79AE#_]U7WY*NDW':>>U]88:X\MG&[3HV9>WX#6
M>K+QC"*NC7D6M?QW/K!L=NE),_T;AO<[&0=OOOALL5R(6W58 -4(\>\=L1L5
M1X]<M[2':U[;DI0F!@\>C01<YJ.?(FTB'.IFF*9V;D7SJ97RZFY+A@3O\TX'
MW?>I-JGUAQPXKRR[AJMU]3!X=/XA5*TL:\TX@&P['=P/@CAXM#/)Z3KA0-]B
MU^",D=B4M?W+=;%HE67Y3],@,WA9@##BJ\4]1#XY,KC((G?$;3V@FX,O2YGH
M9"2@T?PGJGXM#+CK I#AG:N!49'%BL=%N5:Z[M)J%UF,/MQ@QGQA\]WZY)E*
M]W7%&G[)BW3V]2L_P_M8@(1&"0MDU^5=\J ,TZ%=\\C1&R+PL1X%YD$<RC13
M&M>VA=' L=:>ET5:=JG:!1*'X_HK2V&3O9G"=3_3,?(/]%W=\#H?%[,$<1:A
M(;M)86_K*3M*J7,/GI1V?1 6EK\=$);M4VB,:#G1RK,(3%/_RAFSP;&.GQ'0
ML5J/!5:<?;8P(5F7#XFP -6SE8>/]8L9!'5TVU$\A0XI)Y:6D+G\"U&)2\[
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M7><QE!\8H 6JW: I[$KC.>ENCN,Z7',);L1#&T]+&+A%LF2>VR 66I/HOY6
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M2H=A'&?9&&U+_<G8F<"^M"":0^9YKKI@3?NXH<99SMEG7Z.74%"4.YT216D
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M<6J6=#U]2WNQ 0<8NRQ_:Y13?WQR0KO<H#5Q,6(P7RHC/Q9D!-=919CM#N(
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M%<S&'IR)%V]<7W R%51LM*!]1@'7/E]"G/\S'A EOV0/QP'>X@!K]TWE6'&
M)!>\S%AY[>[/YQBHAU4VTSYEQ+X96T+B )ZE.( 'MKC)"JOLVV9]_C PPK]Q
MHHHZ6MJ>4_B7 ".ROI7>O0>CVQB=Y$C $I_SIB#"6[O(Z\SP3A4.\*0<!S@_
MA>  BJ+5\UQYR59 B(1. ,-CN48F/&;!!/$'I#4\F.T$Z,-+AOKAP8=)F]WU
MZ(H[5=Z+9C__!D&G)^( CTVQC*/%2 _6H%W>64);SC4P)$?K2PC6KW?61-O:
M^_B$-#E)^W=8;TGYN>6[D^/:F2&!29B-;NCXRQVYR"3U5C9N@2D#\ZH+1&I^
M!_J=U[W)5Z&;%S,-;:.FDNXBV[H*-EML1D[HDFEM"=BM/_55/LW I"?3:GS"
M;W-\XM#8>ZH9ANF?[Z0\87\:YBT_LFC<<"*>)JXKNMBB3K5L=:K]A;[<TAE<
ML8ZJ ?+45\XMO<Y5IPH<*_<OP',PZC,SZ>-KS7;^%%(%(+>(Y5EBU22ZJ/GF
MG*X)T2^@ON!!;'/,6JMXT8AC_@;EX]+G,B^8GW[_=C=GO*GM?H1+/7Y;1NP9
MT[M]1D-'2'=]@BX3FC=3K,-F+?QQ@ 9$D?:"!QY;Y&>MKFX9%J5X'L_>0=O'
M?9KU,H^,<R>0ASD$YJJ?QNRR4',KAUSF59F ^B)+<(");UBO,7UU8U.NDP]K
M2NR+\5VB;67AQ:(6*A_=&;&D;13,:@^H;$<LR@!8OQ]&2@N,9S?6K(Z^(\!&
M6FP<EBD7B/[,SVJB'ZK<!W$ =66QSZICKGT2<L'X0R+0<+S-'1(XQ,RRG+YP
M__2W(3]4?@&(EUHL\(>!(GGM@DE\0RS%;^+/<1Z)1?>57*Z G+L#.( (\'G:
MAN:@>R#V)7J/)#J@=.,)<@,I8?NL!*RJP-!J4_/AW2YY)-_11Z8E4L'%P])0
M(QN4-@/,5680.!H@=1!Q%]3)F.)S7 ^9G6:E6+-4EKF!F;XPI)) G[>:.[."
M)S1;YO3R&;FMS, I[)C@D!'+\9]K,C8Q]M49H6X\+W05XS^I]IY"T[HA$BB1
MDAL=(B%]1TP ^?0*35O-1(VV"R'SZ%^<O(J+P,,-%ZONG+W-Z[C6FY>I*1+*
M0IW=TE7!P^/KO_R<M72ZU352+AJ,$/K9Q4\E*C-Z[OIUQV:;P'JT%\V'?-L%
M\,N )YR6"\V;H%;D]?:Q>L[C -.;.  &D4%/>?GQ,;Y?KVO'^F^UM8V(QH=F
M*NVZA/<^286YA$^GR]SV+2.<E!A9*3Z?D"2K4;Q82%H$[3YA0L\'P8S2PAW/
MF/=:&[ZL-C!CQJ!S?V)=Y ]6\2BM=^E<X(\RV7R(&<Y@4]/S7J+S?N"<>*%\
M@06YR^]N@N(ID#+-6:U@:>ET(]Y>UGT>X[+C\+%RLSS0RG"0C'!R6 PXP Q/
M)5@3&KIHVF"IQ4N#A6;F]=]"^P$CJ-QBI_/*=!!7#.T]%^F.!ZDOG17D=2)/
M#<7C0$M2H$TP_D#H3%")40*+<6\HZ$K3_,Y]4VQTCZ(RPV)NN7ICP4<=+8C2
M&N9JXZT_JML]$!%MB5>T4%2MN_LCB>XV'2?#G.DLLL(NX_LN/3Q)B>W'!Y^^
M7U1WJ89E[VX:'!U:&"G7C=OHM (@-S X !J416.* [@$FBYJQB7".S"C/B?O
M?;#,*28'\]8> :EJ<@.S%E4.4B)G@G6/W4-_NDMM[, GVBICYOY$X[FCD>T/
M5U?R\Z:IS7:IP7?R@3Y>;MS-E-&V$(G7PM,DOXWH]EJU=)4X-SP-WA.(EEY]
MW%N#E9@/+M$M2*1+@B9B9MLDZ\AU*[?-9C91I?WO89KJ6O&4OEE7.ZFU;:.Y
M7_ G7T,%#M"$EV:A75^;6NJ;[O1G.7C!7:DYINH/!<XHCG).Y(_U5"+100U(
M[O>-JB#?!Y8XP)7S!QV]XP/G<YB<ZKB(O=G&U[@F,VV#]NTU [P D1G;;A #
M"!ED8AP4K7:TI4_\4&<\OD\+MF5KS?]4?+?-.T!X>GIXR(L5K ')6EIB?.E_
M;J17M'Y@$JBG$X3.'Z)]^AQ-[)4S7DR];2!QH08S'160S^#A/Q8J%[#57*>V
M: A/S%-S.1 ,%<<!6&X77_3B  JB%"UX<CXX<K[AK$V2U<X$E]\F/:=Q:"UP
M:4BGNIH7G< !!!''NQN>\F<457C6;[MD;16YTOQG/,O%3>1A/E.JMFC,#JLC
M*EM[OZ+J5(D?L;K?B\7F_"DW>ICEV#$.-HL_F(Q/B*P43%RZ46G.0T%T@U?K
MZ5W)2E=6[L9^97]@2[E55>GD9ZV(9#9N+;4>L=!QPX9B9;_FJ RS4Y6MD\>=
MO%]5J8D]L@E[0:4EHF)BV:2H+Q^W3; !)[N7(^LF#>?"P"G?QR-BDRLX0"IM
MT$UTYI5T $PLOBZ'\!L3;25O LU3(=7C2\$SFB'EIZ]RQ$6",.[C1I@=A)X1
MUQ"ZN']0W@%LU%(#O+IL$_^YPE.DD9KSK9:%[K,]@?#Z)Y6#2E<62@*R5 [:
M9ZNB8R.OST$1]@DZ]49)%A.RA"R)?42;O>J41=F7 [UW3(A289Q;N3Q7O1Q*
M9&N9O=RJ &EC.H;3RN,@-9=2]TZ#5I1Q!E"]=.-#BGR4JT ,^/<MM,@:NQXZ
M\8\DUG<[1)OFW4-GJ*_U@MV-T;L\B=9GC(4^"B:?.6]5_[XQWKJFU[FPN,U&
MJU&EG).5:%KHZF E8$L]*RM5E&.WDQ!SH8':]>T7Y>-,)CU@U<1,K%^6LVC4
MBI\G4YQ*XX7)$Q6.0QB&)P I(PSB^R78AMQ2Q50QO>U= '''=GZLEPK;@3%=
MQ-;(G,AC6XEZ1)>UXI6H?4RF!(:P_HXO_WPM_YBW2DY;"2RL43_'%")Y R/5
MQT3I57PIFB)$"1EWR1PGXG" 3+U+Z<*-X+#-V QSLY=15JMZA[\92RY=/HM/
MN*J)"]OMA_LHSEF4WZ$4MJ-+S!S/T:O:DOT@XN;BB@/\Z'>@,H@YG^!MJ@H;
M:Y.CAQ4M0;/2OZ(=ZIGFS99/]/JN>$*4&S6L""TU60FE>"][KFBE;PMWJ3:<
M^V7#'C)*O8/0X_D)XR5]0] ^R]PUP;U$UI;J8>9+#W:'R*X\'%R4T\:\4L*R
MI\')833->#Z:\';:%0"/OVS7LDP=%N86Y&P=J]'08*-PP'*3Y; ":KJ=0!3'
M6@!I/@"M!$%^>(DRS[/CZ[<P[HN%RH>XN;O#W'\5&*E]19P$XP#QFAQ1_,8>
MM4T-C8G5]R.QC# =E&]DZ7?OT9>W?E;.4TRGG=.-D0/=ELY,%I,")5A)320D
M#3-RI34TBBKK40U:/7ME^1^*Z31Y>BT-L[+/*\O#UZI#[A]58D*JN:.623'<
M<EEEA7XT&8,<[V!3.( \4"@TZL,/%5G0@W7S=AY7-B/#^W"()DS,?R,AM/,!
MC:ANK)L(M'WCBDH7J6/!00#747MV[S\/Z;]7*27#/Q=^4?A?DJQ[JD"GOU<C
M 8;(;*Z]@V.X ,DZ,8+XPL_Y9/]S8/Y7B:][[3YM<^T9_*^_\/7;)]%J?Y-O
M_7N;DLW;ZTOW"*^]KJ_U_^I<0,&_7NG7.;<X;W#FD_V]Q(GXKY_P=0:N6W]]
MVR/_5O7ZSQ,^AK/@MC-G'IS*8(9'+T.UW:S%+[[@U;-'_ZC(*W*G\'%U:_$+
M34(5O=\E+VR-LG4-^?CP[@" ="TW4*PK^7DQ0!.3AQCWK::BC8!@@Y$<(']O
M#\$&53"I&=^BF^HR>'9 \L$E7%5K%STAJF&LWZE3R@_L%O/5[3'*9S#U =+T
M+_#@J;HE9J!?"G^,5  5>!_4/V"\<N[/BT&2S=_;+S<?+G1.X1O>M37"/KJ'
MR@79A>8X8H])+ATEAH/#R=/4-%YP=5 N&[8CGI8:^N'KV=NO6:%$,[:9%<<A
MY/=//L65ARDYY] ZFVFGW4[6 BWGO0@(+VIJYN'^;"K*-B11-%1JZT66WT\(
MCZYT=VS-*FY,*4AJKJ6IGQKJ7(LN2([=6KOH?+TSK+:9&7!8L<%CI'6?=1Q#
MU0-?P&B',7ZN@Q6>QN  :M&Y46!56@A9>9,+>PRW7I3J_I#%;>XQ+HWLC%KQ
MRE"+TI&;SQ]&C-'NAF6)04Z7QFAG;!:P'<AANUBW$@SMFP!;^@=RG?L5YSP2
MUB4=PX+J/76"*1L66FYSSPT%'LZ9K7O^4M05B=$69#7_<)?U:%API-#*BM;Y
M]3]_3/J9\*0XGG3FG&9EK33UT;NC9)U7O3;6!0X3VHU-)1MI4%AO5A"7/QWG
M&ED($41[G%]D4P/CI,NN =]?XB=D>IWP%#0EFJ/DM(9:.O9'5<=4Z>@?9XYD
M("HC4]*II 0-]3XI?+_33-#J6%J@0=?OXM.0K\F@O:;D@]8M5\PR\^E9UND:
MRP4YLE<Z.X<SH47M2*=5RPG6R6R=\=+Q)G\,=RDJ2F+_NPFI8<7&8'9^"U&M
M;<G,.N1L'"*B/4?_ !U0ADY>)F<#\N0J>D?JQM:J:,GXE-FN1 QE7*P(YZR:
MF&8WE3AWA95YV]YE%J75#Z>_MK[D?2U^EZME_C/BY7IY0M=8(NO*%%M#(Q0Y
MSQ'QG*[$NT(J!D^7WDWH2 AXV.V3@$54 @XJW6.:&X,-+%9IDU3(36.<,Z$O
MISYT2Q4$QUJV1@O74!VKRCTKB/QV*]A07QA.J3/-7.(T+54Z+$3BI:.+BJ?Q
M1'#7]6<S5VP/L6^7^NBCB\:JH#M^\7:O[[#<(I$K0,&'+$]4D]L*,,_#EEBX
MYW3TN9R.7RT=NX6T16UOA&@[%YRU9-$&3NA^%_SN^#CGS"F)?JZT@C8VO7(5
MN,,&9+,=%%Q"Z^LC.Y&%%<Q)?M4&Y3SZ$"<TTN]BAIXU8?K%GJKWZ$ 3]66W
M$;J.6E0# =<@TZG_V6)C3OR@IQ1]#%'Q""!#/>.(I^6CI;MS+!)"I:Q58;L;
M;KV]H4X45[B#55Z-6+2N4/,W+Z#X6:L^\U7E^24.0-2-%J!]A>9H":]I<@TF
MZ=R'F>T^XIT*^?4+N&?<^>1'!BT;@H[H>T6)'J24>XP\8U1 X)3]-.9K/-7\
MNOJZ14/E[D0-$6=>\_!CE0N'Q8O'%SQVELI7%U\#'"4W,\-3LI3(2=]9AQNT
M%PX7%+L[AO"$1I6?*U=YY5NT#=6\&.ZS97ZF^IWIF 59HO-BGKJ[1WT]2@I<
MS"8A+4+.*JSA)C1$'$_WT;NB^):^KX%(=ESR5("*<KLP.H(SE5;M%_%=,#](
MD4=<;WRWSI_1.8,3X2]*I7.*IP#6Q'Q4&E!!M2Q1P<:8I*5,C!),"FLAA.7I
M,Z!1/7CS.ZF/I?JD9,?1I;RID@ZPWR)]>XU0<B$WKVXI45RV[E?GE 8$?(YG
M'H45<0##'!UX;4,*LSY<FU_H380R8)7C*NE%<^N!TT^@:U+0PR:_UR0+X>[%
M$EB6J=JU4GU@ =A,NLIJ/76/W,S;P[#B2@3/]VL# V3C.T;<>%2X#ZVQ0;"Y
M4TW1QQ''Q^Z+6-._D.D= _T+F623^EX&:^5Z$%4\R*=!"[!NT]U]\RK/$ H&
M7)PP6ZKOWMTF5,/>F9E%.[_J"@M<TDQY!L8''P=]N8.GU?12I)LF<'UT,4V2
M%[29.\L$"<VDAY*G9PT*#@KVRQ7!"R8\V$;UU*T9/S6>?0UX2/*,0^)*VM">
M3#V3P]V^ON2)H2>"IVXLYXOA^_+R:>?]%R>$CSY#;,Y>)\CN:SJ.:G;PJVLZ
M1]& X\P?C^[NBXK @@]4U5C>O-CK\^[G7G(\(,/$6X9D&=(KY$6Q?2PU4'H2
MKI?4XR(5DVBMG3Z29@@\@D['Y(C%VIFB!9;1NTNMZ3IV$&H" CJ ]!57?8"V
M?1#Y#VN-+DSRTT51RU28(K=,-+ ZHU1<WFFVH>URD'+"VVIVT(^[)(A$5>>M
MP3J0JX>;BZV&7=<;DMQ@?R5LT(B$.KQEL>5V=?N=^<"5%(]^!;GD'*QU]NH%
MA>1W#LU"O]D]5-$QA29^%/ SXW2K?*%D\R2RY,GG1;J#1&3-6B&W)T07/.8J
M85!*,"#HKPT24N5(G;*'$M)(DBV;:#,W&/5()8RN/ ?RW#B9O0:\[+RB2H84
M"T>RP?P8F))I)E3 V;1[IVR^LG"Z_$1'F2R<7#G&%/DPCF60W,Y>MV!#;=A]
M.XI,=XP:2MG<W7T5#RLH?9@PJ9C[2H$)(+DZE8O:+41YY+=$Z10D2I 0TD5(
MASG#R*&%M^_>@H,J5RK;5'3T/68-)U V9NFS&QLN'P RE</?@__1"BSB$7IJ
MSV:BI7#W%HTZ-U+-A+H>TS(]&]L]!>XIY38S=UM#J4#.2?6/Z/UQ 'T%NOW;
M'WT3!.M YT<92M;$; 1_446XU\:11$VS;D/#S4>TL$/;XTF"_K*QX=PE.^4J
M\?BQ@P(.P$>,!]4*(NXRZW6#@$P]Y@3^-K(Q29'XP%"-DMX@ML'F'\@GBC4/
MDA^\)NBV9X%[\W[TK_DTH&*KF5=)!NRX+)M@]MM -\AD-&RXS006'>^/;J^\
MGVRH1+%WMC!FZ<8:9/,QNPGJ"A./M'V.;&20\DF<IR^+YWOAB<Z#4:V'7 YF
M"[7.B11@ZMI?<F^O%,L>P0I;2ZDT##BC%/KI_%:G2G5,!TC=U&"&/8*9^91D
MAR%8NT_JXR>D/]Y0Q$>^";:C0Y\GY(J5!D[HE?%\O8F'NS"ULF3=I=@TV;K;
MNNHD68?!4%/W)E!AJ2KK'99Q<6HK;)TYI!L:J]S_R,QLM5R)X<&&IK6.B3:A
MHO=*LL'0?$)7!UU2A@;:T,&?=\LDNI]U"=I2XHS:\,(4]--\?&RS=<O.:X)C
MJF343$*ICKW.C(J[-LY<;W1WA3Q$9XQCC(8BBT7OD:O%FVOLTBG,_8M=[\JT
M!#VU51!]HRC1P38N.]5;'G0?>,'\RL[W%;&:RJLCJ1))]5%=MC=CRI74\S4U
MT1JS.^;5Y/::NMXG1L^*NY^\MTMYQAM'Y5A,-F ZNE%ADZ&UUE#J+.R<!@)F
MZ5@YF3,Q>1VQE^DH<2HH<@N:/D%GEEV#)93"M+L[);X;6J"K(#]K<D-BD>YU
MXCYW85O7.*3BI^IH7QN5OJ]^V2LC5-CE@%^9*-E<9T-2JXP%Z&W[/16O2S?J
MD8,*S)76KFZRFA^7:]@8W>USHF(E1^U[RIE-N63I,'-W9G@0MR;<$C[F6%O3
M!(]G$9PFEGSM+=%+AZ9(\_DUS7N\3Y843'H9_US--(33I>CB+#W$.7NW[<_V
M,GI.[O_0]IX!3;1+_W 4%04%14! FA3I(-)K! 0$A-!+0E'I(""]$T4$"4U
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MCN_UA&[&&6L-M264YWXF<4V)G+X9GU_R@IJ[M4'^E:&U]3'6G#'=NZ"";PI
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MSB;<)(4ICB.4UQ(4K5[,XL21)UY3'MGP$P0_^$BW6?/)IJW-&586:AJ>J_F
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MGP&.#P#:K4YD%<40@$:3YV^_71E()G#YO+#?NPYPJ(L"]<)/ 0O+E=P'G_$
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M^7NR)7@!^)*6S%W%<UI:*89C?\_5 P1N@&PL3NT!V:@UX!]1L0$+*';"@XP
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M *HD3P1^SP=9G?R#_&< [V@ XGKA-LQ5L3X\-RI.R!ZU)L^A#/_CN;*ED-O
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MO [B=1P6@ BWZ9_&3!U@]AE7YV&(B_D-AQV%\,T-4US8!;4]M:)JFFJZZ&S
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M]5\/XNRO4]5W\;K'-P7>^/()*Z%E(*S,:LJPB:=H%'=+ZYHNO4!80$9J-19
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MX].E01TQ?(C=U"\0:\XD!^:Q_7>'/Y[XF='8>?^4Q(?/E(<N+\PF#2;'N*K
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M&6G01C-<_YG7@<7,-N88_Y.AK.^SIT'UH*79]!-KJ:V^/IW5+<))X 4.]-U
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M?^M_>U=UC,0VWXJZ,(3QYA6%5MAFEDE%,UZ4AGA(R@J.?D)'C_,J>SA<X^<
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M9$+4X.9O.@>-.I?(".]&4^/S7<Q6T+5$9_*]:FD3[J0J%-\AD/56*9#O*Y/
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M8F712!$8?XW [P6D #( ,&DP&($+F5U&/*3XI1D-",[X/""M9V&5 [!:$+R
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M27XRVJ)?6_CB<8EJ)?_BL%97[B*BQ2)KZ"L.?#U@M MRRT:^,5.WY5E4A\Z
MI.4;'4J72RH&DM3GK"]1(^QMI:4KO;HR3#7,6D17F%41C"MY+;Y6A)9%GX.F
MKKN^:KPR AFO!B_V"(P?Z)LA6,K80[?<]#9,[LWZS$&6<Q&$>8MW3(4OM%LY
M\!:5"XFJ?O:N+PGHK79Y4DH]DOCRJBR_6T_\1'AX=P252RD++"<H-S:#4&@/
M\3)J[2VKP=O+;P=X,:JNFK>[VR7I.N>/M7SGO_QTK]W-01PWM)3PQE>*(*%7
M? 5W<QQ=\U,R+A+P;*LFE3X^_S-F;Z2K@:6P>TIY*D+;J- XJ=J*[06"Q$S>
MK/PQK'.=E+O?ZQGN"UDA?W"TG0KM']5#1@M8EZP>V.D,R-@P_!AFBG[F(<,Y
M=S/]NWI<:=,[BV\X=W;U]Q:;.906AA;GW6+YYXT*BP(V9\M4.JLP=DRX>.^S
MIF7+IE,V7+UFWY+91W@(^C+_,[NI-LG-!8]=>TA;CA3]F22SSTM#+Y_S*[QD
M0HS35\U9?>VSW02*8**Y>@&)=)<OQ?8^%PR^9:=#Y_^D\-,JCY^@!1:P6^LL
MW CA)ZNXL5P(W1^KB,WC3G/?8C+H*;GR-(/)\HDA(5\+=KP#;5*;6H4]*Z^_
M1I; UJ:$^3C%17.>(9K/G?;E2AY/7!^TR6"?XT,OR.A)9V_27O4-9?59@8EW
M+)%I.B_5AYO^4'U,9;C2S/2BN+M(BU[PM8SL&B9D.E[I8\'$%3'6)#>;9\4=
MNMJ2YTI#'JQ]D*_C>W;CS9K+-B>]](.A5V2:GNO2JHZ)X$-0J/%7V!8.Q=YY
M!T[PV@/6HUJWVC0UFX,#\C5V#H)M7\HI):F9J71YY5VO8LA)74QR999Y51ZO
M23"@OXX3)9<_,,YY$#<I_0E#@T]*=5!K10#JI[?&M@-#5$"V)!FM=I.W(9L'
MAZ!/>3;\*HM=!7V4):6Q]%,R'U-M\:_CB*-G3FQN9J9ULCVXKOZZM";)MA98
M,Z-I)-0$[DD()VYNQ/42\:KUDE4)>%CP962ECYDNG.?@"8W5Z /O%H07C8WB
MW,U/?6*F7 -K6F(_K2M>)GO@Q6.Q+.<O4L8RF6>-!CGT,DK<5J!<KT;KM'7=
MZ]BRBJS;&]#M=1,3L"\9-2SJ $\$S.MM7=,[2%$M;&+[OF?L^XR+ LOLDTZ-
M=>GG$C'%VY![>:$]MT*].P)&"/86F1/K63.T)$G<OE#?)OH\47#?F2(D0V/.
MU3>A?(&GA[N\:CN4B=;S,V<"3T$F8UO[[$Q>TFSB';?7,+]0[9W8]J%AS?4O
MQ=C5'R>,J4J(?LQ^6:Y17M4-A>0X4WPK(2!HL<'/"R>*85^[XM^#V+5JJ%B;
MVUI"Z'&OS9G[LP>N/]0>GS-3YPJ4[>[LZY_CL=%Z?ZN&="'3KN>YC:2B63>C
MRCCM4J'9D"L9[ UL(GY'"56L.#EEQ] <+T6S+* ;.T&U;U"S@<_:]M>S$0KK
M%&'$YG<9B)N=!7[AMM/UKSBX8M0^D>#!\R.>^&25/[?"F;L[)"_G;.MR,U;/
MB*E]<@_BH>MG,\NPFNL6BJZ^[CP&R&'0M'9H'N>O];<:N.@?SC,^YQ,,<=G(
M;<'T7!YK_EBP%L6CCO$&L4,QV>3RO6PJ3[!-FCO+C3J4>V9PB31"^%WXUW1
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M$&0!V5#J$5F-0XAJ6AVXE2!\M-L1_!L"CQ&S;'IK@LT!]/GAKQ@1?H<@JHM
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M%".#3-5[55":_\/;=P8TV32+1D%!1"G21 25#B+2.Q&5+KUWZ0("TCNQ 8I
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MJQ>)?#&^;TY,%)\EC2)DL4.]XO=!G0-O]12\, D='SO_B;-#,+ T36/H'8F
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M/;"VNJ&7G:N4EDO5%'JQ->[<&Z3#=?P0K8;Y>&T'QRHRV'Y0JI1B;\F[9S<
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MTU915VPZ:<'&5"&PO.N(8_\7TZL;_)DKYG\8M.&O^5JP )?IQ,:\=_>O7HL
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M(_G$.8I'9 *@2AQVHX0K/<M=!2Q1BQ30NGB*E7-B'MY =]VGNF,U%*X)9RH
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M(0O@0^"=0$BA>>*!%$P^WY4:@I5,:N5&%WW'0(L*>9S O*BHR &FAST(BAX
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M83JA$?C8LP_Z< >\BUV!>J=9E_'^.Q5"<<!RKSZRGI1^R1*#;^Z'BO6QBNI
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MZ\OR,#GOP/)D+Y0*C6]VU5Y;%S"$Y5E7^$-S#^N(]\4<=/846 N%?=MW.<$
MEE0F/FCL^K[N5,N^&AU!>M^IF!O9!YD0O\B$U%<!?BB\&;9#D,Y"Z,(YETR3
M:\W2QQWTW+E^(T7M30%I3@O#$'5]<UV")&=94)$U\>6':<WAFA6()P>(M9 >
M()8#+*Z?&<TW^V(/>".H-P3PIL6GYY9";*9'-.LB,#XY-7LC70?+&RT3TU+?
M&&KI=\5W<P2,JOEQ@*$E<PU5!# ICCQU[Z!9FMQND[0Z+/BM^HWU<V_!Z90M
M_@;4)L8*:IYMI)L0)?$/Z+\ 8]R<@Z=3HQ^BP;%^H$(_R=%?&%.,S=@F %S,
M#4Z7PR\W;E9KPBABNWKH;D4ZY4/((9H%;Q7S!,& 6A,#%GJ7BG4M%>M;X$54
MGD'3'N7/!M+&@>MV\)=?J'YTV/<I5(MR-A=K%DR([XWT0-&U<H$%'0#@6S!1
MARZB0Q?M1>!9$\836S<<=/,(Z 88$:%2*?N\HZ*')T6Y*A4'3:)/:DEK%B!=
M9L ;,_N@/,KL.=F)[7:MVY%OQGI?_3""S9H7! 'D:4I%,*F_R5>.3]4]:+=J
MB%J:D^O+]BB5"CX"Z,*&IA@8=,0*4[MJZ<=]4,E.^R&.)E4#U:FB6@>-Q _
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M)<4=YG\.**^('I/<,[=.[HNGH+?K-<##>G/R/TZ]36<\&%VN1*0'/7Q':0F
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MJ<G7^5N[HY>MFA]]QQZ "[SY3IP(?EDJ2A(,[S#+"/W!G!O0<>,;YL0X'W7
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MJA>1@@[6#0515_$JUG/Y,0[_A[?W#FMJZ1Z%8T4%C0JH2(D*"HJ(TGN.(D1
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MEW-M'2(N6P!4CL=#@X5JB6*PWX*H_65W\1_?F/Z1&.W)I>B0/?4_2&;I;WX
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M>45*5'TQ^6T6(,:>NK@5*3+6AT'M2*$"":9ZBFUH&,[O+ #F5"6@US@17/'
M+RVQ&M:D]L+F< ]2)652)?T6BN^<?AF/B^^_^KE<<X=B,6%1J8282=R/# ;$
MGW*WE9M8\XO8/K-ZJ.DI5V=:$J#F%4U1-<R87_/,$%.?A'P&%GBB#F#$D+K=
MU3E8[!LQ&?9=O]WB!XTK#YD"_7:S3?8-C'8TRL2SIRY( 6*6T]HL<+-GW2IJ
MW)4)*O21W#ZM=O72=JH/0'%^.&?\U@X07U'A-[0Q4C5F)FTJVQJ8[2 D1M*F
MLMR#"6HDS'=6%J^1RBB GO9\<A]P.Y9T+I@?7L4=PXW-](P^<;%>9N[(2\3]
MF#5^I$XUXD> *Y&RA4 ZDOC[H5IZ#?P<0U>& F5F,H >@7U_2!(BT,/1HB3,
M)"&3&%LGP38#'B$!8O 3Y'YI_P:@ ^B1)_<E;%O\BF1AO"56D]H0[KO':EH.
M?\N^U^.8T"AO82S%3W9.5"*1*4P'3$)! *L +'6V>'*OH4F])I\A11X\*--3
MF\#@J?D/@V<'X;;TR=4\[)'WE2US2^;=>M3\'598 HI[E2W(!Q!Q,T.\>H"Z
M[HQ-PFAR%DGO2: >NV!82>/:P]Z%I#X]=<"P!H9;#/ B?ER=9*8]^HPAI#8
MVPR 1C6D*<I\+P=$ 34B*5\S20O08<EMBJ1Q83A5;?TIUVQ^OU8%W8^II'U)
MVQK:\9;D3JD_J@@,GA.%/20-50'  0HJ740R8;@QA4T:P%@ Q,GLZ??*(IN[
MU[8F4Y$U>6-;Q;R[8LFF(%T*J#I%($]/5^RC#HLSO4B\6'G7.W[S6>%4$6L)
M^N>1=NAT/+&:O1X>WA$D2M\7H3W#0?-6F25>@N.R'4.)=@>PK<&=W?1<5SN.
MV L_HTI]K>>2M):T5F:$]-XI<[*6NU]^\)+:ZXSK;TP/U1QX(H^(XWC*7G )
M0Z-X__>#^9M_=^?:=NDB+W@E=CP"0/\I;DEL7.P?"64._CK]3]R+8"+Q1W:E
M_XNP)>)[3G.0_^XT%_U_X32WDV5DKXKA+R>Y46"':/%;[I):8-/7]C^7\2@S
MOJO7PN5%D7^2=93C$<_>5;$VRZ/Z=]6BBXY-EQ93-IF<T>K#.JU.[0NT,EI7
M%BV>1HILJCF^$CF+,(BN2#,+W0(A6B*>U)6!F>0.(YF$]H,MZE5]^8*/QO8C
MN -(Z7E.[N9Y4B<E4FI/$@K< K5)+%L$D,A^>HA&77<81:FQ9KK)/:/4*[62
M((.-^/9(4N@!6$M.BJ?@[8=>G5#QP.@<MZNQ):EKX;6R^<ZGZ6H/F[VDNAF[
M\!J&D/8NU[(3@KU$9&TZ./CT*?D\O)#.M+8_P-A#8<2MD,#'S1;M$RVC!IW6
M)G1[(9;GB N)*<B.W,ULJO[ID=T$3=I"D3F>9WSC:^/U&OFBAPDWSBJ=X48-
MKL.0ME(%^]5EW[5M^T\#8Y@]81[K-;-<!"[GS^62>S.9TV=WB0]TJWM\K%H0
M<F$R8)GKC4_!M9.V#C!.)2GB)\Z/1'O&G=FJ_?2?5U'MF*CGLXJO%$30/\_.
MS);G&AO,ZQ+$39?@_1&?7LW/FE>D>%QL.V,B?#?U PR=6E(UO-;Q."$H/<7L
MF_0&I]HCTBU[\&;\NAK61X3;?M!=?<;QQ&68[L+]F'V=&Q!%=1'8X-/!D-88
MN"=/)U_]]>=4U]"W^Q>(JCH+#KE*[F^#9W,$?=BB$\CW(0\ZF=269TX==;Z^
MX M'\HJ$'& 5_0FFW>$E])J@%E#S=;0/-GJ2__Q8NE6\-KCO_MJ/[^J)1DMT
M/.\S"L[+%EQZ09LXQ"XK5*:3E]DR$J[M1%_+=?]KJ$'9J2<"C0<F=6$OQ!AE
MD[OD$Z:*W3$?7F8=^Z+^>KGQPB R4B;Q7%58Z'FNMWF7'OTD5&-_$#_%)%[>
M#"1E-K?WH)SGZ'R5>G"5_?IYPW&[,B_;B3 *J-[;T<NT#FQWE$.OR]WQR4O2
MX@C)=#4^L7+/FHGE1^W)<T\C'(<*Z HO#O:#M;11-!:A<.2CJ <YF:IU<&+'
M[;DHISF_H:!PM44&<VGUGP+7V),78"^L>(IN-&JU<(8O2A=8^33<G.@288KR
M[S*B/9PYV.,D(AP/[]:NOQS\]>>XYCT3+X.VA_M*2JH8BR:4Y;Y.2NDZ".:S
M1:?4D4ZU\\CGY.!I5?HY-&8[_Y;W<I+_:F/'ZXVC$C3*)_]PM ]"DD['84JR
MVQG-_\T%S'O;!<Q[SP7L'TY.9,<O&V0P &8UE%!!]L0G63&E[</V!Z0?#F)4
MV^?B@%T%K/TMO>"!QO6#%MCE5F"*I1W+)J7>JEU36*("R#J2+$&C-GXSN&@O
MTK6!&FXW]9;-+4P&2UQL7+)@^:[S\O:Y[8Y?N_\??NTJM8/&K6N=B;X2-*HG
MR42I.\]WEH(Q%J^2=*NV0*>G8=6 8>-XR/!TB5%^0#B\Z8_ 72E%22L1+R=4
M(!DK*8M"VW'",5N@(TZ&PQ5"+5H?C'-08!LVB(V[6/R'+="T2DU"<GKE#5D)
MZP>*>O4+UGWL\A23.?.2Z66T+=&7_ [MYP.I^[4IHT6<_=E;5I1'BTI]V)N+
MF?!07^WG%AN?C8R^O#2@8#)G.'UOA$W$-7"RO<'BV(Q*HG1LGJ%S/>TL/_:4
M"/M@7@ ZOIONKCZ[>\!EC;95NNK&P?6V<*2/"/-P/+&Q(%/QT?IWVMX'W#9X
M*K!^^?G:'NE.FZ:)C13Z465UD6L^,X6N R'SV=TZ6IE2GWKYNFK=)WI26Z=[
M/6?<!8?A9C52N@R9SS_>T+2FW?8?3TC21JRMHZ95I/[C76!2WK_?W.Q^"^4E
MH?3KN\L?%X'_+Y( >O^?)@&4^#]- K@[%:I@?^[&9B9S<M5LWU7S[:O(^RO^
M-@G^YAH'3$.B"2>>\_PM$CSM;AXOB=W47@H'5<C^=F^S?BG@/Z,SQWRTP$3#
M<US>?$!F5I]+)%YL0E6'-V#0Q^H_B0_)\'5<D+*4L7HM]BCO')7[TTKW1!D3
M%;'+ID;9;7;H(TX-*[+2M>7L\7HZ-[ENVX'HTYOVPZ!W)!Y.]]$O0%]D'<5T
MX*QY!/7=_*T]=") &J<"(TZ$T6R!3N(%VEM5P]W/MW/R3';5'!"_A$]RIGSF
MZN+G9YASW3)-A'Y^3LM7+]((/E&GEN-:QI6N='1@..*93:N5K2U+*#LVL&M@
MI)_'<KG=BL#-?[?5#GG"B4-$-D4#0ZCOC=*-RXH9.<#ZYE:_N:!H>D"VZ3TK
M\-!!=2W-9@X>C-0EKIY&DX\JPYD@BH3I*.Z6;#?AE*E.+)C#8+[M-:-228Z\
M]<#IFJ!GW,N00%J^R(2UJ7LWK)??%[@S?3M2&Q:?HW;=??\(Y*=06\ZRNSM2
M_%XEGX^V=FY_8JUXO!8<2G4C7%C@4GN6<R9WK$6&% 3J]#3HB;S^K(K'T<\9
MV4WVV%-3:B&K-[LK1DH8)ABUE#V;/!ND 5.598X%+W^.X@RG[#B.2/;V>O"(
M)O-A@&@-,P2GN@5B3'*"EPFIO[@09&N<:JW!I!V4"WT%7:W&,,[5]&^8W!H=
M575E=]M ZMUUN?$^ULFQQ'?(W;""<]9ZY%9WC[38[9H1/Z,UJ1J<GWVRD+@9
M\N2E_):&5^9Q%E*G0OI<>8_%,[X#B<)T%J*",8,_3-6*UISA8*_8I]DRA[^+
M%CR1N2)WI+'-0S*N-1O"*(6P=4SYT3.QHB"I4R^:D6XT<?8"8/XZ/N:F(?6;
MNF_Y1X=TX%:GC)WH95OH2[2*.K+C*VYF!8?Y2E+YT.Q7H:YNN-5FGQ+[Y?/"
M6':\V<KYXY\"(>\:>3JF"K[MBWC(AHO*&_%I:HIW1;_H8_OR>G0T+#+@UAN'
MH I;O?WMF"7$V>^]/[[<H[>3FW&2+0.A+8=2&_M"58F2<E)L$C.KFPV>J@O\
M7DNR:K(WJDKSW=NSD\_%AML=AC%[/KLM:MLHF()FF#ASWJDUV_^B+@].CO/6
M)<3ZPRX*2)J\D6Y.&G+A?(]Z.#VE4ZH574UNB,#K9]Z?I$087#IO+9R?4]7(
M(D!5VZU29_]:C'MV;K_S<;\'GUE%Y>/OKR9^(HPB&H93BFIT7<SA#,==U?W=
MH)^F%<TYD$.45E>CGSS7? OA%G:F,VB%8)PP+O(5:>M/MD"=F<B9[+B[O<.F
MO=\\I2-ZU+NP@] C$_F(5S.I.#==8W<1XYR>2A^ZG[$VWF)YD]V90_-M3,QK
MD1A"=I@E!XNY:4GEG$2CY>+:L7$B([)Z,PY8@0-S$$=R5E.VTW4QUC6?;YIJ
M9XL,7W\C'/3\@'^,O.Z8,EY/)VJ-VWBO/!+!;&]<OW'.J-*#+DAA\WK4Z=9.
M&9/O8R^K(LY^FGD:,1QQ .T2G^($A\T#AL(@H\TZ2O2\Q%GZSW4])QYAV5CG
MJ$Q;^_+3W1>@F[ 9DPXJ1,_XNOGH,-15+)+@GG2DT%][*#@[(#.A>PK]\.DS
MVB>27GH%1VJH_AI/TQ-6B+,J</PBL,@2M:J=[!'GSEU^7G4EPW)I[K"F;/Q1
MMW0A[=G7J39?(O,8;#U5/\V/!KQ?<&F5UV!^4_GX\DGI@K;]F->W&R1O8R;B
M%T;'7VH=-3KO$,K@;7OIT@<_?H4JE@@7C^ 364?6>F)=2[$U4\J9#C,;O;GT
ML?V+-T*X"Y53G6S+-N)6@DP'X?2OG@B/!],<=*#;)]GZM7H"MIS2?\9\Q:%O
M_WQ]W9G7$B(U8<;W2C/Q,7,GN9#G2Q>P^(!\+,&-UZZ8>POTQF802K+P&3[-
MDKTYTT1)KE#^+*S\(E^A-M1;A.-,)-?:X\JIE2&J:SP6Z4E^QCY/%T_?PZ.8
MBV_D(F*<O+^"AX09N1CY9EL&Q*\_8COR_8+1$PI)Y0@7'S%VP.B/^6Z!],37
MVX1,\8&Z<&(I)6 B+ PQYVHQM8GL;1$<<=@[3@/->+I!#GZ%PA;<LJBRBC[O
MF1'K (%Y\)U;36EY+(M/M8CTZ+)BUA9[5]0:+,4*@<$UC&H$O_:[I:8 ^_88
M+&_MSKULQ84\MW;VK_SF)U_>RWK/=)Z9DIR_D]!(%(YPI&*'?>T[W\8C"M;)
M:XO>% D]4Y=>6F[=G?3=4-B>)K:3W6H:V99PU?7NFU6KGEILXHC]! 0,+(R4
M%M((3BC"65YG@@MG&=P<(2(XM*EMU\_3X<L C[ V?/-$<)6W".$YBV^XS[^@
MWOC3-%+=?" -W&5Q\L?4QA>3UJPN/]1)8"'I7U/5>B#>S2=^"W1LN@*Y= 2Y
M28!L@6AU.3UQ492BMB4;3[5E)6?!/]@_"UK%^P6 #\DS9DXJ*YE7_,Q(:+&
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M4;TPG#,5Y?B29H-+LAUF\.IX%?^AQ^>4(PV,_:N<=5PC>G*7"UQA]ZE#57'
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M/PN UZ)9OE$)_2@FB5UE4_S<(ESGS;+?@.AUO)B7D0KM9IOZ"K%%\G'F(?L
M6BO@>>"X0?D^(,LQ9H=$"5>_:\;)K-NPY3FU'%O2H&[+=TRIEQ&+@E= =2U.
M^P#M&> Z]]R;+_ZUMP+9X?B"H,\+@K@KCT@:9WFM/R:)/$WH5647NCSQ(7CK
M \(>@">6>HN72%QZ5K,J?XN\K,HBQR^>Z;3(C$9M!0@*ZX+,->YTWQKN,Y&
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MO>0.QMJY4XA3H/FO*A!V(*)_5!%C!DL)%&TQQT 33G(",<-M!Q-X.'[P">+
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MW\T#Y,DA(,K*1*!==A# V.]A1["+B3W&U/<R9;F!!OH>F;+W@##BO$.,4/]
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M*5+?RNI:8O/S@!>&9^_>C$IM8?LJXL;[("N+E:_E^]F3:S=S-T9\G)ICDB1
MK/FJEV6^@UY\B+%TN@P 9O#R)3B_58RTDYP*JUA=T-ED8S"5'-!KIKW)8\['
MUDHE,<5<ZA10X^,*7_9T&@K=9:ZS"&H+*F!)N?WT]<8H6J7*5)BDM,UF"/@H
M0OUF'DQV5?!T(!_NQ7>W'%$7'YHP$2OZQUC(Y# =/7?YFH@P7U=KA?(P/G=G
M,3W-P?)0W7S9JYQ?T-F6R$LUPHF4+S?$58IM<>IK%$V!MU2BM5<@#^MWUU?S
M(N[ZA7<6"=]6+MP.%? P)*G5FO97LX;S^?BX7$]!9'6ZIL#:6'GM]"KY-C&
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MISO93KC>5Z:ZW*XDBO@J'$GA+3DJ=>+V?&XRK3""1V.@NNQB*VGFQL43LYN
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MVM%34VTCUB!"<]*6,HW8$'6$*3>8+N+FES5^UN_MP>K1\1#>C"?58^=E"6N
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MQO.QHY\NN1D@+RJ$JW<1CW:5SLVIN2\,+:Y7+4[I65M]Y:\F!JZ L1;@A<V
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M7A><XCPHLG'6DFM'=*UWK1=UCM?F.-;II]AML@25%P&*4G3!4D)2*6S8F6(
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MQIYQ#BTG&?0).(!@@@QZ"0@N!"@(F%LGH"\T%B0;2,&B=<"YYY !0@3:1IS
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M;UR_B8^/3T!P\]9MLCNW"0EO4Y/>(R:CIV%DH*>AHV-BY>-@8N9AH:/C%'W
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M>(VH$?Y0Y[5_@G[[W.6Y@-:F1/C5[E[FG;FP&LC\BR_B^*>%$8VCI<9PK&4
M&@ID_R9HTAC*RY)(/T[;CM_6^J=&EO*?S.CO!UR)5\O'A;%J <B+H>M!F^ID
MG5@ *C44 +(_ 7F[C=F!GEO)!1*\;C+@-!V/BIWC1C>:G8^&=#2#8\B:*:_<
ME5R-*2HSE<_2,N9E1<!6BD//\9'F7]0\JUIM=H0C(1(*6?A>H^;6N2P9,2TW
MDF78KMP(_'C&QO>EY/U+P&\V6O1;Z5ZMC;%_\&+% +?P6H63O'V7U D6]%7S
MMLJV$OW'MO&":_13'\W=Y(87S=L:KE4LJ391/HZ;_\G]4&;84RC W$$ZUB?
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M#_!&V?)-6]:.%$FQ=Y^6;4'I/F& 9T-[J#*3P8@BM>Z/#C3D5ZOI!LO=KT-
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MI-;T?U<-<B FY]XI7O8W>WVYF2H6,3D7>7=&V>7&LO6),$G:B:<[RJ:#0=#
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M:](_>LY\C']%W]S@XDF':YJQKL)\RC+_'4-E3\L2]GQ[W#U;WQ[9UYE793]
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M\@O9DXZ8H[SX5K!F?*>C?/*PG_9Z"WAF.I-; I^WS+D!'\#1L;N/S*FQJD^
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MNUG[:%5?.U7F4WHGP5T3TY17-^)S6RWL&EX%X7*>% IAO\00W3:C59;X<T^
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M" AR\(]=M,%MLW#8>K<Z!F@VPP 0J$RV45GD23%MPV6D>4:C*YIBK0H#R$B
MKPXP $J'$5$C7'*.',4 ^_$88"GO(M:A]:HP> ^]/+E10H>-=G50\&!$&@;P
M@V$ <B44[X MVL\- URN8H"S NR]2\$VBPVPVA,)[F[0HH.MV>%R+@98X,<
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MF8VN%2^$,]#!XHW4S(R;(&M>F0+R9 ([3_#S5Y(3,_X?]MXZ+ XDVQMN0M!
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MEMP 0LFF-).O[U6!SDZ%#L!?J>$Q+BV4;@"ICGM0: >4'00T!QTS?O<-C]\
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MAT=(& 9 ZX_QED%?ZJV"/+L0_GX%@:A[25TW !0K']A_I&ZB_/XVB5;*#6!
MFJD3-B/G&6PW*CR!R:\78XI51SM/-%YW$<5!5()6KN!@-/@"HYL)- :BBJGJ
MB _C;[_I5_G3;_*/^4U^C^)^\LO=RZK;?'-L8.@<+_5 Y<>  1@-55__U,;C
MWNV[$9__9FX/6-UGQ=]IK:PT)?HFU3A4FZ83J4)&F4-6XI*7>JY[KJ'R),NK
M'@" &W@YK%B55I6#^$N,&0;!@=I5**'_M0/4NV3+H$WOD-V<[&3L K6CL'H[
M$,87/OPL:,'S&-]P\:!U0L>%:34@ *BSN.EDX@:0Z8#3+13X'C8*R3_E\W]
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M-)1[CQQ0WZ0XI&]GD9D5;1DJU8S@\C#<?60DXS]531KSAB_ R$ER6=5PP4N
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M\VZ&L@^IN&.8R,.6S9UL S''Z9WWXX-6^P.MW,,KP%Z7^-6'3A\%C;]5+F.
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MX3M[">:V,@R24HX-K'J"(:KZUT:DK@-<'XR \D$C_GY,%%S93C@>I:03L!B
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MDW1P2V9 .5B@_/RI6@1_M-P1&UQXO?.5'QW-E9";K0=:')M6:8M0?%G>0SK
M&^RDI)$JVYR)2=J$X _I&%]WK=(2!+,-+ ..=)X'DW_%A,T48,#E7R3VON1Q
M#_T- 'BI;?1^_FJBQ3,Y!NO<<?=<K]O%@:"Z1G)4(,"QHWR-=(FC#-8>6-97
M&\@54JB5<W*A:)L[/FG07QO$[]5BYX#4 #"J:)CF*C&O;8#<(3+]^-SV4;-Q
M<_^WD[Q&LF'CBI(ZB&-5(M/'4V6C5>YN7'C2Y;5#\#*$GO$I;I<=6M3#:G+]
M-[Q#A9FOQ_2,M')")MJ;I]>&O$A,&8GD W2*+Z5"7'R=6PP^J5*NUV:.U'.J
MQ95(66"_/=L1-/S  ]<D/1:M4ARD1RO3J2H[Y1A+T)\IAE@&M"N0SVIO[D)%
M-$A:X_=\;]5B:*2^'M\+/IJ1<3-A+Q74%0\,1H"NK[W5<GV/A\?)A%/PA28,
MM0PMK 'Y6(#&RH&.[D=FY^589A=D/W8:NT\_K"T>R37S>IIK>#3L+61-Z\L9
MUC//WL?U6-IY<,34SPTL3*B<>M431"'61C75-75OC:,&P4L/4Z=(E[K.=K30
M<S4>UVIS0$3P+@O5]2$6N<^/K*12.-/(F+N:(J,[2!-=TCO1B+;X\F4%IS?5
M6#C  8C8@?<W$B6ZDJ$5#$W^C)C#+ZH#M"I:5=MY#&IDO\J0M%[;Z:#AC:IU
M]J(=2.=VZ_M4YLH73:* 7Y7'\@4^J58/4+U,68[^!B^,(_?6#IO3[AF_$+#J
M8V97./+46P0;/OWA0GN@].%=LZ)TKGMOHGUIW2ON#0IO[6D=*R!Q@!8N9T2<
MI+*K3#45*7J+OY5X/9O$6(#!!L6AYM\O$)WG!D!H7FHF2% ="Q\<*.E'"1TF
M5B%J$!&ZXRS2%CO=[R\Y#=_-YB"D/2Q()=[1<EIV T!HV'XI=)F:)Q1@6>IL
M)V?[M>+XKJ=]W&;<"M1@LP&_]+Q%;7@7^'B$7:5JN#!#?4@ESB[5*L'7W(+P
M-#=[%MGRBL\IY[DR&2\-CL1P?,]Y\ V 8B?\&O3L:DM"9<"!07KE:<4!PLH[
M-\!A*CS!R6KR-ZCW#>!1O'5 1?#4.7C7G<'-!"LYWN6Q2/[)G1HBHFL,$4A%
M)[\LII0;52^YDSR;NTD*:<RH&91HI* (TZ5>UL,^.'GZ*YZ%[6S-'*HY+^='
MZURMK3TTWN1)*K/>KX=;2<C]BD$ZGL^&5TW/^:0L^N&G-768+CBF)/5%)L;?
M756DS^N(:\T IJ9++()I-&=%7!.S?;ZI"/F;+\E!C)\[;U/5F92KX;=ZSDYD
MG+MGR>]TP_1B%8'+]V?P085-3(<W !:!1M"JX_N_E9-)PI9U:JJ;[7H<4G(!
M%Q^5:_&0_8)A6^HL"0E^RT=:KJN<(Y\'A/QU)VU3]TFUSM%,V5>V28Z^$=)I
MY0?.<UI-@^U%!BE(I6(,CUQL.D@<PTZ$?)?5SC6Q/=;!AJ'^Z0 [N?WB&T"P
M!MZU2],A^TKFSB 31'%T;+.7@%_6EM'?('?#5: ]I4KT"7>B<O88ARR_6F%Y
M$'B^]]DS<ERVIZ0G,BV:.JNY\R0D]"=:H0*14L9>:%4EO=KR*!8R%"4'GAG-
M#R0?N5S35)BQ, 0G/1T^\5 =(2^KQU4-)>"B1S3D]QC<4/8DI [^;,LHA<*>
M_G0B/^\33LE[3*F'$5)[;6_F[G=C(!KAV:%D-0OT+4F9V9YR]]*>2;HX6,R(
MMI1MRHV%];.V5(NG+!6Y[F$.2XS5XU#Q2E-H2A&8>C-R<J]E&\3G9SLO21("
M^T_#H[-G1'I*)R.]Y8OWXDU:IEPLKUCL[/B!:$K]5 ?I:$#1SL6X"8M.D#G4
MN,B'0X/#&FU*EJ7G8)5 _E+:QL*S>L]OL'C_^"CR7=*N!M9&;1UAKA4,9_ZT
M;*KUC7YM.%E4B-SX!/D<O]RP&:J#MU5G]2-![F5@_3EW^X]7)1X]>O8T934V
M/5'F,\7]@@R,K]'C#SN=Y43S-C4[ HR^-;F.GL[#A.)3;0_99V9+.A9J9?%K
MT@.QZCLSL>*Q.BD[ G@02!-&6#_JK!87YF<[UNJ]3T-7_&0'DMJ@L9X;0%_"
M583#M[B=>A6.&X!?VDCY]1.W&HU3@5)FM'<V+H(Q:E#,7C?HNP91Z W@L?$Y
MGWP-I!Z/"K<V9!33HU)IM25DR4G.0@+ZD,0:ZD\B?ZBWGY[#$.Q:&0S,T]:P
M(,SGU=(4-W3C(E#HJ#FAJ+F^[X:NMDA0/Z#RNLQO/+,+7C\R_ 53%=C:W/.1
M(!FD@+Z":B:[EW2LP;-/J&$J_G/L9L?+\^ L^51LPZK0T.V!D">SS4FKODVQ
M*:=CG3.E^Y6)F5GI'OGL:F_D=JBBY=)7Y'>/-C0$D8IU1%OBZQ$Y"75Z6X*?
M6W7M[,2W0O@U,IV3M>.GE$>BNL4JHJTCHVM7_.W"%XJ>#U0 R91**<6K@[1,
MF3^$Z#-54!4VBEKK?8R;E_EF9:]A68A?T9[,IL4B($EF#U6!C.'-,QO5'Z O
MW@!RX\_?"5;C<TRJZ)Y:E^+V%BFD!='\9@;R]O4PAWXB\_@0?WM>3P9@A[X\
M/2A3 B.D OAR]6)*<E#5C'[5=-G%:/(#"<NNV>P=4K&Y "#5HOK>1(!@:&?Z
MPOGU:M,-X!52JKVNVE53#YF>WA&,Z>U^7*RI$+BS>(%.:V8-S&"1,0Z!MR*Q
MD56#:7EENC> 5#J%&T!3E\8L=EG2Q51K[.E9U,3729_7IB4U%J*W5ZV_R_/9
MRJ8VI-QVT4*6=^NE!O#1V_J-@D_>1"0))!8?@]9D1JY F<D8M&*G*@;VFXWJ
MAM!=OC&QW"TN4AS_%T%''C,)57%V;D]GY46$"] =C^1&KI12LOTG>:PIDMV'
MIL)PZ>VJ@RP657>?[M>=\O*![FF*%ICS5F8,SM0O6[(Q/4@A0;0@^OQ U"[G
MW'_;+!17PU&DZ8L<\Y1'/EVK($/):/TSSF"[_">)&5/$VEQ\:U:;+ -J%@M@
MK9:SV*;7 U:OHNB, !GZH6GO'=0.B:M*$N># QGFE >,7G?()5L^OP'T<RYC
M?*G=7+QB18/R'W ,@?*4B#6VU5%WJ&>>+I-H_J9H^X<BC#AE9Y5V+L>Y+[[K
MP5RR48/EXP7&)2XG*(^?.!B2YUOU+;;:;ZATQ$Z2C":-%CTIXB_$Q^][H^4W
MLXY(5]/<9\,FCF@79@H?'#78EPR>D;$:ZIL"IM%_I$* ISQX$J?\UKZ&DKFE
MQ-+^C._+]9HE-<&NZYB92M'V:PBPL9_3O?1S !+!YUX,!4UB[V"7\FO:8?E*
MAZ2)6(WDK^0=Y4:EMEU/\L#E^YP?&2!%0"PQJJD04OTCC3)OEC'$AKL 7@ U
M.6DZNT,U,=<$JJ:F%*TLE9K:%GU":CN F"0]A1M'7>OKEXM)LTP\+CPT/X0*
M-,<U@!_EVZ!CWA=H:_""Y2"]N&]P'>*G%PY]67'[7?P+N-QP 37V*&'<'=JK
M5?;WE%XM=$O6E^*+56>[)]E>C!9^GVK*?93M824_ <%VK3:IK*/'E0Y?FKE@
M(^TOSB^>3A22AQSO/5'R8&A->GE7B-FZUFX8O[ >P'N_O)J@CR>]DW=Z966X
M(I\$5?)U?>A2T-3KYY&O2O%(/"M$C$MK")]SXLJMCG_K<T^KILW8H0K+&+,6
M!MCCI_?PA]V9ZFFL&QH11CVC,#,(&\\)":F\]_#3:I$HD&&U 92!0-%K)=:S
M,_%6\=V59&'-L+UE4-L]-"O=]-E\LPM[37NYDK*ZSJGER#Z-_EQVIJV+;_!L
M]7+9VXX)D?&#5@K3M&C0;;?[,W1L+]V TC2X7]H@+PZTKE,>*6QJT;.$>=VO
M&'=( 2 B89-SYS)0-51'DN)-..72%M/:KCSGN\1$)P2G]^;J=2#444@#=Q A
MS>25JT(QCN4*7DO@U8H*H!S1%@TCDU&U$8R8,AU>V/ A<$']D*Q828>[01@4
MBM"PXL<U3D;P@%C*M_WFQV@_K,UW<J6@H5-,C&G7.JJB *UQRHW\=5DEK^FP
M-.OBM4(5"CRUU_DSQ"H9#PMYET/@^LUW<YG9/MF)0G#]$5SPRQ^_.A(<PRFP
M\4A2YV^M!H!0.D@D<QU>4M1]G ]-KU7')"N50OH0S<CFR[U42%?]EXW\-A[.
MU,:.OO(B\TA;\G2O!!,9=UR:@#,\1HK8+M[R=$GNN>2L49TW1+Q$'NE#F;<,
M$)_X@1Q=8_-3;@)L?:Q/: -(*)[/7]:UW!-UK!QL.^7RZ0E3#%F0MY+"L4WI
M'"U*ZE[UFV&8#S>V?==U[_R3)\[8O DW06;JYCW1D.JAE0H=UM&O=\JT-&0>
MV33H&0^PG3S),XOUMLV:RNP9PM<PCKBG[\>I*[?:+B=/>C+W$H DS)-V,:TZ
MU(%KB=:(/PT,GZP@:NZ1=O]**#^,2J?5LNZO.++B+"UG97OT1% 8@"]PY*-U
MK%AUL@$5=?UDZ1H:,.J0'YS@&*OS!1EDK^6LV$GL&M\?U+<E7UVF=>E?I5YP
M W"X#.<0Q:4J$O5&1'#"Y7PP+C+X' 6=4E+FC0Q+5SX5/ 1>!#YDZ+B,,36[
MC?\E/]V:;G$L,\#XD;*^#=\G9:?*[<GW9]'"B\UZ$MA!.:"1M$_$3CKM=4&\
M@]<@O0ABSIPB-X:3G7>8#!%^W(;4OB_2>Q "2.3P* _ ^ BQJ8O!*/3@H!8S
M^*IX"MJ,3]3PE$DG$'VX$%MA !I<$*[7R>]_50R'0U:01.U%=<DG8YZ(U-.S
M/$&RLCI_,;]^E3">QU5\.&'XW&0.C=7@>&JX*#'B/%S)D68>.#^7[$&8;J*Z
M]**D+M*PNMQ;33=D'25?60'1J@)G8=#$YT4H0DM1'!F?B$D(]$Z<Z%#:(+N;
M&W+-X=BJ]1Z7W;?1T+__&$C?>KQ >VC>)C-MOID3PYI$_[3!61QI3&.)>.0W
M"\("Y_8!9I;C[$%A=,DA*A1"6NKU/&8$WB!J "4E8@*Q;6N=@9C8EB\^]B;U
MG8Q)'=_619>"^2C%P4EF6:4#DHJ3V>#'L9]P#),?QCV%>W B%&,Q*%:+<!'#
MWBM(PO2BJL3K-;<"^5F^O:*H$P2S^.?$X PR<CKBW(,9-"55-K0[S^Q<$.+S
MY2Y%B3' ?_4@U2]9AI$$C-*G-SQIZVJJ5(""UTY?:RZC[I^?@9>#N*,M;?.8
MM*F;LP<E9)"T0L*H%W5*TM+6N!7?RJ<% <+<G*U>L_1C2OOGU2XK.XYR5MJ^
MKZP,PA$0H2;(QU9 4,H:CXXVLI2_?J.WGS>96#^P?L:RP7G T!-<<<<K!:M=
M3H!.+HBPT2LQI!=>,EQT$+RML&M($'D#J.^( O$.IP4!IW^8V6\&@*XE2]:4
M'7B;5TIGW<NYRB_O8Y:8>:75A6UK=;BD//W&,<3P_^WRB\5+&Y)<9:+W[+AJ
M+C-WL:3)+XT%;-XBQ6[)4T4O? V39%NX]?*;-YN_14<DGH_M8,LZ*\(8N>6U
M>M+9]+R(3YZ=1?5>?=6%F:G6F=\V<C>U)ZUJO5.=<O66!K/XH5_:&;L\NM+X
MRXUGKI,I+WMR[:I(P($1M+R4JAAEQVZ3Y@&A13O8E95FE27HP&^Q9&!@D&7%
MG@Y&V$+@R[3=9CO@>'">^<'<;A^U.^2IM)I=^RR&F;X>O Z]06T+.(U=C4UV
M+F /]#TK.4I21J;-\E7+7+J"<5V6R+/27Y?GKM@6>VG:&PVFNP.=(-UUDER/
M%UY:LJA!H^9$P6&V)?QAL:+')-(6FBW^$=&_ED'ME_G%;VG__NK?[/_^@M'\
MXK[I;X[__E([XS]#78-PK?3+NC/U^]U'Y4;EAJT<]V7)E_\9TO+?7UJ[ZC^#
ML+"# ,.E;6+KCC69<&F&AK*))%!V6NDH'AJ8_?]- %!+ P04    " !//6]4
MB=[;RIBK 0#W&@( $@   &EM9S@X,# Y,S(Y7S$X+FIP9^R[95!<7=0NV 3W
MX$Z'H(%  @2';@@>@@>WD""!#A"\T4YPUR!!@X=@P=TMN+N[0^,---V7]YV9
M^\TW]\[4W/ES9ZIFGUK5U75V[3I/+7O666>A9]&K@,=O%)05 !B/  ",APN
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MQ'A0'B89  RXON4J7GF\I/IQ+5WW>.Y*'3MMO >!"^$F)R'%C96F?Z<WA ;
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MF,T-V;C2QN''Y(9X/E8@]C![\#.$"FR-HQZUC%JX>S&[8+V 7$J]SN=OC=@
M(88\IRRF?M@LWL"Z;HEW_+W5KOK/7GQ?AQCT8B>)Z3)OT-Z&39^V1EN=FJ;G
M&W+QYVKB\WW_PNPK@P1LPIJ/3& ] _>OYF=MME_>QGSDKI/L!KXFO>L%7@]Y
M</Q@SS7,*TXZ?54#X?X12T+(X0%,^%RM9^6@^'$.18:0O9-0%[_?A-8W&!L5
MD6B]./$QNO&!3.PS*!\=?U[+&!L[VI0>$_ 9SW6,[O@-$=].73L@\_IM?)^Q
M6!<!ZH$E;WX+Q+H2"K>KE"N.I(<$6;POJ0YY(BSH?V <C>1]@0,;?2#B[%9H
MP#H/3&'FU<KCV=0EOITCZK5!RRL![TZLB)>X==E#V&-MADBZRIKIDC*+*>;]
M93&YN(41O/O5 [^VV\N-E%U?%M-/TRV$D[P.&2O.TEK+CQ1.!($L.@?M[;=Z
M>N#4*P_O"(\%DL&+I2BPX<V,'L)\W>YIA]'>SR!H#G;N&=MB/ZYV! DH0679
ML\(TE<*;O;HNLW<Z7J[X0VV4XH]@Z3R""!2;7J&W MRW8/W.B/;57=$G+1SW
M6.OGF.0 X_?,F2([QL$=T73Z1D/ X*V)U>K$5=3Q]O-MO0OO^)$"^UFJPZKM
M^82.9_JK*$8HM1F!K(=P;LV961_'9!QK'5[;H1*61?S"GU+%#9_J7,.H>$FE
M<-?G3J%A$=0:>C;@5+U?T,RN*V:J\92KR[/>I[3OD..U/U$%U=[7'N[%2.E3
MK?0,NZ5V?$9;D'Z,VY5F'^?^I\B%;7,>]H^3*/P?T8$.LA1;A)V5H$8:T7N>
M]&:$S#IAL_D)9W-YBM@Q43Q5;.=:ZG,/LP/3DK5('%)BJ.^,2L#Q69( ^'KQ
MK/?\GM_PHK[:CC1)]8U=_BS?=Y?MF@!]/&0EOL9CSCSOQMS$Z*Y$CJE4SZ7>
M+2K)'6@/ST0+.U)1JW*7GNWG)NUQZ;O3J, 'AQ1$Z,(Z''!4O'[UKC/,]L\;
M"=LE!$G.@9NDDF[NB=_Y3+FI3,TQK\E3ZBH$^R,A#_[6/X)JWT,#<MC*I!$J
M:  ;:@+5,( &9-&?HP&1L#.QA]P\*P6^L$C8!>+#-C/G83,&L M6PX%5N1<A
M*S/>+W*A0</Z+XK7K;^X#3[&?WP;=& FM'W2R<PNP6"WG.FBH$AG\=E7$1A;
M5@39!C)OH"B:K8'G9Y/:/H]\1O*RFH/LA"7.]F,DG]H-0G58Q3CW3%V+D#;C
MGX]-F<0[()?:T:]:OT=>K*;Y/JH%_SF65(0WJHROMPC;2076W!!Y]6%0)O0H
M:F$[BY-VJM)TNL<;0W,T_M2IYOQ5MC@;)7$:I#U?6"AYH[DOXOO-\K2CWR#!
MP<5@-2*-)LR1 [>4H,2]UI>]2AU??9V!J3:Q#^,'P*[Q=$%45*I!+]Q;.;B#
MD#<M@SYQ97B M\MM[EG42Q_!F3PW,.Z&JDI[2D8FU ^B[?2N9PG/PCCZG^ <
M*N+%;++^0#]@'3IE+857ZA7'D=H#YR(;F'3#N&=E*@C74XHCYUT4-6I@KH85
M..\[EED7,;=0V[+H>F(,[FKF&U \_5Z3XE-AM!#RT9S>I8]QI@2*VRG^' 0<
MJX9>(/0TA-LC-B0JWOG!'JN^*^EG]TH%<9S:)ZRIR*5J)D3$6??[\2?%,_M/
M+,YD]IT.LW"PPN\J/*MGM6\^@X>KFAS@XW==MY,-N9Z#7,)82NPA@9'2>W44
MDYL7)UI\_O 5N7'R$8W4MXDZJA5OSH,24ADS2!37-.H_:]=GK9F%SH-#RZB[
MLQ/[+]& J=YGV&:S+T\.I4N76S17B)-"W?<JD_P8!A=4_0BY8 G-BK1"EZX4
M8498)AU-#!O2F2@*AH\<WF7E!4E[UZG@*%B>UY#S,A_<-W/]7LKN.%Q>4B[9
M_K%E3$:3.^[X=Y/DS=*H%VO6(4V\UC^[+=EJI@U_6IUG>+,DL:T&2S*_Y,]8
MDG)'.JQZF='NC:D6I.J7)73RSEBKK28<'""\9I)L5_"1ZOF-#%[0DS4FYJ4>
M1]1>.[+2>-.=_CKPY&6T3_XB9GJ!B\6]S#Z/FE%COOQ%I6(=%+,M:9FDOC'.
MYPU/2*D&)N4G:2)27,[9S.$ZX']R@CFD",)?)#1#5? =GA!>O.<;_T\_%(VC
MOD9$I<,(-D /V>?OUD.@?7^!!HS%:47>5#/4\@65!;6PV9A2PDD2+,;ZW+VQ
MBD=[I/&(2A6VI03$>HC-)EI$]-6=RO?IWT['\K<GB@4T^OR=;_(1U/!^"6>.
MA:UM3KNJO&N,6UN4BW,*^?WFXMB)U' 3]0SAI0Y' T*S5(7)L&BHU[4?[Y;4
M^4?;XU(:\L[JV1C?DN"O-]1&K>-3*UEH[.X[T3++4(U "WKI10)&V0^C>2<B
M\JI8^10+#W%GX$.6WL*31&"B)PUU['%35J [G>3U)K6E%]Z6Z[OC-LZNOXR]
MAST(\'>BI24\"9)[]9S2JJ38D,[A0VWPN^3SZ\A9W+.Y>T@%O+:+B:9;RR=C
M:7G^FNY.$H'=NB3%<'/WC@S)"T^QZ1BKVG;K(3KB\0BXW1%%\D?;PH]@;^OA
M[N$%57YK735.1>TO5S<POM]_D7^5PQNP8)2QLA'-K+(Z$/Y*7'%^O5[AJ7J5
M!]22E95!_5>)&2XB7=+H9VE^(AI@Y<"? VT:NE.Z;CN4V5NN!P.[)#7A%1.&
M<LR?E:F6<=]WDH")T("-ZFBXK#:A<%%>_7Z14]I%;__*D(V!TZ+[Y,JI0[<<
MO#6$?3Q>^<Y(+LQ4O>H&^EPPXK-4R,ER0RLAU ],@?!<T(D"<@XMTO/>U3Q6
MZODB."$E,3-LV#0!C>^:+[DP>^F>N &*+56Z!U#M9>)4_UH;=?527L'_M&)[
MRV*6>C9W._%=Z[56XRM)E5,G*<PN&D]C0_!\=R.VH$^1E1$@-C(X2_1@OE'Y
M\LY.I#/V@+YE@8V?I\FK-L&*;E:4(=H^X7PFV,[BU*&+T#)=Q:?T<$14$ODS
MR?SF$<\X2*3[RSQ'TE,<X;XO'6]=B/2V1E!2LF$-TKF'<U0KO0QRR>%2)#;9
M(\2\;1&9;3PP\;%1%/^G^?1QHY7Y@0+!&*R(=:7SXR]XM^M-=VTM3^'YL0Z2
MS$_&R(\-V!:3> F&JK^ 3$HFZO]>EL:M/+ G4DF#$CJ7>RL5,Q':\F@RII7#
M$\:=*!PO%'$/S\]XZXI'>'\W-74.GT^H31P=YG@PB[+J3^6*?0"T]1W;=EM\
M\N#L?8&X&(,=Y*[T<3M\0P/.\*9:#QI@NQQ9B"TT@#GEQ;U+Z@V[1VGP^I%S
MYY<AZGB?*Y<?_J)GL6>*P*[\ZC?P\E2WV.-6<I=T\?/VE(2I23(/N/RV/+\&
MDS[9MTS?Y.LR!H3U\W)OF?&F;*?!_39WK<B4PE^(I&YF'DV(J[N[9X#_9C<M
M@;I# @"G&;CF_M6AJNB\U!:>S(ZGM8QSURE);;X0$>&5 B/ZW.F>M0 MZ$E1
M#\B2]3Z^)B?J=7@\\.?R G,15=TATBO:E6Q&6AX-ABZ_W]BKO)T:H4'RMISB
M-#H71=H_9F>]=I9[)_?U/4!&"G#!M+_4$PD?4!GO3EB<MV$1KLJ >H2BKON=
M,\?SN&;MM\L"4&PVS-SUU)_B#,T>O^GDP_LB?F0^L]=>ZKZ>%(EJJ\V@0PV?
M@R8^%QR!W(0WT0!W!RDI2+\+OFI!^,4>KR4;^Z$7D'91Y-O$HEZ]M^+HJZ)H
M(MN4JFE-*:3N*MN.1!)N]+9-U?=OPF/KRR2G8.13PY.KI%G4U%U^],"Y=TO=
MCB@H(^$PJ97<MV^55Z(+#9B30,U]>7\G,N]8B2.3ON"!!NCMK<PWM:[Y)I@7
M(^KF]X7['''GTFO ;_U>0I8LX36APK$D\1RIA/K2VTJK8O,E(ZR95ZGGV6XM
MV9&'WKU\6=N0Z$(/_24GZ[-KEP'['L?;]68TH&T9C 8$#*^?O3@<*;__056Y
M<Y-:H83:[7T#3PW_I-<]/E]L^X1F^V5ZS4UR[Y:9LLTM2>A:W;&]RQUM"<;;
M_K&=!..,G0.YH_>1_2U<IZ71:Z))1^.5BZ*#;F-$C:1FTE(C!\8LB!V:U&]K
MU_QH '0I F4$+O$H6<Z65%[/;YXZGL>S+\"Q^6+6'RT%H./$_,HS$7>^1J ?
M_K9CH-8FMJ1  .BSX)PBIK6$*VC]<<V,^1/J^:!N,=R4:W%ZXKVPU+N+I\6(
MSJY6>-@GWL+[^"/]V(]GR*%TKQW<&[WA,@^2P/5XCRR3JE$C8X>:Y$*M@0P,
M+,P)_U[)F4JD;KI]"R-[QY>* <+HK.WX,%5BE=>EJ:=):G439:4G%U?5GX@@
M1/PCVTU;M2XW>@"[S;M[@272#2S/X5J[?#3 7)6N+D8A*@GC;]^^C&;;P733
M1)LOE1DU(L1@B+470FEE,P>Z&I5NNV:+GFZN5$0XK]T3&OB_^Q/FFD%EJ7%F
M;QP;<;Z"A7)1EG_D9*4>CN*"=?"4M23=1U^5E!?=9-K,I45L,)">_Q("1C2H
MIN>5UU;$[1_K:RE_4 8H_?A.'GC:1]>+B>0)0#2B :P/Z>ZRX\6624%G-&"W
M$FJZ\F[R,*>IOG'@VPON\#@ 9L'GG>7T[+C/? M_&M1[2H3/3EDF7>8^?W3K
M3:NX^=UR=.:'.R&T]_?@*4\.C@*@Z-E?ULE_V@?D+A(O2!$M1B8@,-_2NK*<
MQ]_7SC%2=?>0.4DR]JF93E[)GITCCJEQCI'7A-QH (LV5Y$)EE'SC]1U<+BX
M<+ '>T(Q^3X-F?"<9 TA?>RD_0[G+@_YRD9"XQOL8?_GCM>?COTS__Y"N6YY
MJG;7I)<NC/S63VV$6MQ?5J91'\K<,CL>F2;!?B'Y3^53%@+HV6ZP+57XZ9A_
M'F*K,U<;%[K0"%K_V@4]F6A2+B \$H8)/#]ZKT#',!;\T="U#\'9(0X.YMUJ
M&+ND.WG:J+.XK0-=8,*;EQHI,SS@$8'L&A*L(55/%>7@EQ-S/15FIBR=N6S8
MLKOZU[>8#P% J-#E!8[9TD*Y4= CVF08(7^/[T\+%-4Z,P#^&UK;9;6\MV3'
M$C$DICU ])42Z 1[8IM#!2E7OE!T)>WEHG_/.<JFU%AA@@..U40>C#9)K*=S
M=E-;;;RM6]2[M^ 3[@-.PC2[G6][.\J(5VP<L"-C*AH([PIC9U>OEN*<I+QF
M(A$2NO7PE8CB+:*_DFO8'9A3^)V8!U&M&L_.>E1D3 H*Y[TU3_L:Q(,#@S+_
MR M8[0P/'YJW'"^+W\ZPKD;3DN+LTXC YM;A(X\C2$4&%H8]CT )>T#J"V)N
M4N*1(GE+\I4^1UJ/'G?&TWML)S"^BY2@\50U7K6$Z'&<*%6LF233DFU"O=S)
MH)=>\*7#T=*CD7=GDM%5O:T#*XT.H@^I]T8W7<;2TJ[ H-O&AKS3X?%\;)D\
ME=2'3]Y[IQ]1;ZBN[YW#T0!IPRN'X)6S)[LKEYVW*:>9X< SC;+6@S2SVT=3
M#+(;(:]""BKB355%.3Y^8ONN0+. "] =,N4:DA#V7.DNXN5MHG-V=Z94\8SR
M6S;)\?C01I:Q80^]NBH31\ALHP$='L"D:]\1SA^H8]S+;B>.[6OCUB")(^6E
MI9K0,@ZK=R-.:E]X=H&/H-0S'<)Q;ZR,4@\"'RE/FK^^)&A9.E^.O_[XWO2\
M?A1"/YWYT^;$I]#X^<L7@ P5H+1$RCFD-4HXE)_:DW%"/H/>Z!L=^*LNRK7?
MVV"&8Q)ISAMU?@4!/)4;80C!CIZ1]*6J72MLH=EK>(7_:U'>W7N7WCUEVJJ3
MK/_7PE=<-?%Q3663R+[:K"FH\_IP>,E27OJDELTU^>/"[3^?9F_M-W#W>5K9
M,.+;RGY(0H!!"L7Q4-/-/AMN*Z4:\9!,J=JO7Q1GFCVG W^;(?Q7CP9R*E?R
M<J?O&BH3L$B[2L'T[,R_*!L>0V!TKWS$]XXN[I1=J67]GS@R6MPQDOO6]4Y7
M'O[W7HLUM7;21_W(@_PQV;_]TEKY]CA@]7QV%3Y[(:F794N.%#C]T,ZHS1<L
M7KNL8O[8/"H8T[J (S7,!'MP[D!<K<2R9&_,;.^\>/J,A-85MXZUG#EAIP$-
MZ$8##J4\K]^B.LY10RS1@W>F2\N(6<>;&:-5-(#PG]=EN:I\9U[)?$KQWG$\
MA:(]>I\P,W=YVB6]'L+7=B4:8,9[_TR>HY=C7,K,#-&>:R,29SAKV/>KR:*H
MH2Y*\A;33WV&]G;"!1AAJ%8(39P/3$MQ5OI208<5NU.CA@%,?.9-!Q^1#>Z\
MJC4LR5XV->ZJJ$U68R42H"2UWYEN0@/6W0/LO'F+C90+"E5XNJR4!BC*OT>V
M40R+:2-&OYM^74PL&%WU$Q"CZD<4]=Z*!#+*.(TX0A7DFT2?XW[H@K>.S)<W
MX:][@-=TU7\9B_S@2(SK31P9*I?E OMSE0%'+P[*:!$MA 8[SD*'W=O)9]);
MR2CI#7AN5E&=F)L4K?<#56^'W]UXW*U Z) U,,,CY(N-$H;N][W6//)N.;QV
M+S%.%Z.^=.[=ZH@@C-:$)R*S]P8C(_"[2K8Q#](VX#U211W'ZTT/3#TOBJ[<
MN6#1.^X%P]==WP!7YHOQB!K"ZOJ+AX)9'@W JPW>FO(=N"KCG?(N$[1R9W1M
M1^GTVL#HJA:*(/67##B5CP//QL6:9GY$03%M-VCWU<2*6BGX$N_6O$R?=*AO
MOLD9Y<>]G4GR%H$/U88BU:^\5@W'EUDE?S$PP*4)8T>T;PA8J0;<B!MWW0HV
MOH-\<;YQ)F0V7V4U E4SIYL).T'/)KSU"AB:I68I)2R#9((C[J(W(2&(A-42
MG-[V6OK(P #=).I(.N+'/?!A2O^#Z\I,VQT0_N#!>N,NIN_1H<J?2Y91TGN\
MT7''!L*JPQ&#TQ=A%ZT$!KP].3SV,;&4_!%- :YMJ(*P\SF06!?[TQ>DC8IS
M*8?/D#7 '?U6^IQZ,VI#90[51D,,LD,\JT504_2@=A/G>O0CHT\:LQ!#+)BM
MAEP2[^>*FXR[%O@M27KAKR)C!O?R769J1&H.-&7O>9BRI2<:X/1,B7MG3-\5
MU$LU+\C-*O%'1S-.N>U14WSG,C9<H:PP=8BSBX;BE9/'F Q%R+PD8Q2=^WO/
MZ8(>57L[B<[$6Q<2S6I\.HLGJ\DS6-%="4AN0]4Y8A%(N5!K1(-PIM.HS73<
M/CL)T;<NQ_A#);9[QYLI5?"&6^:K_:1;N:OR>'^V?UH2"M1U,(PR?Q;!)43^
M+AV57_OG,:6!"*=>V[3;CU+13#S:/>/>DBUC\PZD(XSTW^4HHW@\-"WIVG%Y
MOCH.0_=T^LL@%.[UQ]0B5PWIW_42M7.OSB)R0Z!"'YJL5Q/+7S9/OK)V,N?W
MR1?B//[#8@0TZ3PKLRK>+#XT=)>1I]2BU92G!/R_173!X>!-U1GP(= 1#<B>
MK^$1Z1*N-(-:ZU35J)Z/6+_2S)=>' QXB*&;$T;^( ^$*QK CJF(!I06H $R
MMK<?FD3:8:1-FKF(3M76EG%DT2<+7M;[;(ZV>47IKNLRI]^_CON"VDWE3SLZ
M=,.5)BDIR.E8G*,"5LMV@I!%,[919;D&!RG&MZY(4\NF3BR7)U</UV3WW**=
M";,#W,RX"M7?,&812[YG+:B0N_HW%^"X+V,VJ:=\*FA4.8YD\'%X5705_G?P
M97?FC\K)C5&B<U.'(B3S*7;"A/!W^(I,6H^<GQCNI#".;U#1O#?GJ5N6$VB!
M4O=G9HK!,=4P>)4]M(27^L2)[PB"#P_J4"ECDG<JNFL4M8A-G7#ZCOE0K=T3
M6R-5RA-[>QN2DD$&LVK!4_JD![$(O7J$8H>N*=GX4$DEG=7WH PW6H&7*&GG
M;R<Z39#55#"M?G;C#<V?G;XZPC1KA+X[<."\?\=X!L@7F(D-24PY"2RVKHDE
MBNV(':*5[%E][P<FD9+WZ.U)MQ_>AA!S+.O$>;EY<,X[_XD!:)_,1!>4O!^!
M%_7H"OZIKHER_'O.>ZPC X0_S:]R>>'OV;TTKERBPI3^1\Q%D?S-<B>=YN7(
MJDT>Y8FC\'QU5.IJ?B8;,U-+BVO'DC&V^A?_LFTE)+$'$#G4>H4&H '5//L,
MA QV AV$/$H!;O G<C*S>@&PCII3!R2;F2VJ[[YW'CFT8A-^?#+LV"C%%9&P
M@%.EZ'R:/:R,9+5S^II0VZB%ZN]7@$F2]C2=K*T$7JA3+2_-V2:Y:QC_+EHH
M)G]ZXY^^XJ&FM%'0[(,+^^A0.*MNZ4X;M^S"M>_E;\I9XLT\??B"J(%QSQU/
M+((.RZE@1A08 OZ:1V=CW@=QAA@C/JZ.D.Q%_[(5SRABY'[]E3VBDF*6."W%
M_:N+ R8X9+5IM%I5S>[UDDD7#0& X%TA)]DWI&FSH_'OASS;4_3%7R/Z/2.^
M?1FU= [\.63:F^I!-[BS#3DWUY4?1^IX(C:R?QV",[>^-?*V\[I):J_K?$\T
M!4UV^8>F6\GNT\F@/("!7JW^U>$FD(X&GZ&JL&YSI2UI#T4-#-Q38"*/2*\O
MMG\/=6R34TE+%N#I,Z7^/Z@#]]ZS,BX@D:2#M01[=5D_5*#3+2S7]SGIGKKR
MDRE!HPVU,HA7T=ZM"_GS. .VH \%$@;]R()%[)$-$\7_U$1:=P ]1H2MO WZ
MI"71.,<&LN#O_UU>*I[X04#YHDP)8?;3UI<)/C247V1WY;%\FO?NG.HL[[$U
MM](^,7DM;PS/N?%14>;I"#)D?N;>$WQ6ZE>.U/OH6 C5?E=1%3U8E[$4]VH1
M9UWQ;0:/4/UG."RP]4SS(O/.[B$$F+;$E%' 2;]ZJV8C9M0GA8@%^ZJ#!U<X
M,QD^\E=$85),AEWU_XXZ3/Y,E5H&T6UA'BL5DNBY7^2)J6]W.\Q93!DOXT8D
M9"%:N^F_NS7X)@[E+3A%V#\U$_J[]<=(TH7N^K(PK''2;HY9[]5\9H2WFOXV
MY.[FJV8&#A1S3AKYM;1U'=BY!5_^80Y[3]@66TSS\$BJX-8+^XQ%SYF/\-XV
M/1"3X+YGUR,IF7-&S6.]LXGZOVP6#\71B>FW?^QK[WQVJ8>M-IU _-;?4&QN
M]TU42H8*/+A' H@B:]P#Z;(7ST7+3A9L3/J"LAM;F1%6!]V^S*KBXY_,8]0J
MCI-$V[#<<*>;H@[6',*+A3Q(4JVLPNC<C19+NCXIX7+//L<#3S>/R&9JU8V5
M9.I5W?&B%E5I7<WKW+&5::4<Y[^7>/V,FK:.>N#/<3/@7?8"7P<TH&LF&R'1
M>;U,!(^<*LYG:/SNP2D?$L-X1&L<FU&TM]RPSVV<NIA'&<TR#A)4]2B=-UK1
M-S+4'^#HLUSNCF<%['S%<<P0URNPO:V.2L@>^66J IS3$EB,#15=4RSUTDN%
MCJPQ)EV?VQIBQ;*^[=ZLBCEBB-8*KO%<1?D419H%9@C&=JD7<&=GT)7F<(,!
M7:@$W7".,P7<P*P4&+4-67OFJV6Y=U&S7YP1KF5YE_=.$YT-0CT%4/6DQVN*
M>O;]4D-.S(\0GS)HZU#CDU91&YKSND(1WC'^DWX>G#70$PWO=W T( 2I-.]3
M&FNY,_^:7IDT+?0\ Y>H\^?(CES*]V\<L9NW&86_$3M=O\__9K@,5;!9+S#R
M[,6/DN3.U$)%Y. G 2[WL;;"6LM_<T;J!?GT;TF@9@[#3>$H*H=_/J8C1@/B
M-=" 4Q=81\EIYCU&ZYDM$,57.+?GI#,CNUOD5>25Q^L@J<TERB%"A('D&6AY
MAKA2(4<!QRWG)%[<OMOUD%9<Q"UG+2S)# (!IY""/_<?[[N9OCL1^<'H:RM\
M6D7R6XDQZG+;'4:,=/3QD%KJB3.UR;5ABIR4+!<#]VI3EA6J-I)[@^"N4=6.
M]SDE)NTDZ13FYAY^58<2KG_-M%=^EKGY:XZSA(D^::Y0&L52&G\'(/F*D7*#
M!OP? +A^Z%Q+BF"9M+.,5YH/Y18$5G5\P<!" YC$V&Y#A1N <IKR5+%9#VR>
M'@W8='I@['\\8;M]/*,@<C2@#USUD' K'DY3J%\)8R8ZQ0UI4K5SS]/WR<:J
MU/^!W)T@8AI^.4CZ^M\/S(PVP+>8L,U),-($DA-9:OW;76K'\%0X]J=!GR/,
MBX 2EPP7>_$6>U_5>UI^):Q)8UG+ZD"SX3FE"_8".&9DDR>[!J&Z?K-)R!XA
MO 'V- IX EMA2[E\@>4M7@5/9>C;HO&,YUL1L:=^Z1D(G+G1*'D\+0<C$QK(
MQ(/R3:^\=68<IZJ.,G:FQQ9C70$\I(6!=F;\I%[GY2536P=RZ7ZFD'.VV%10
M052ZJI=ZA/<+TG 7FHG-^/X$?66BNN%>.L:[QTI(2.\JPGGCB/HR*KDT )GO
MI3(5\?)Z #.ZX[MA;?)F-<,I17L*V/_H%>*PU)ZC,3VY;T<\\SO&7P 14<JA
M+QX:\+>Y$#8SBP:,8COK9>(W:3KG#_U:6N)=_C78:#>X\"/(@Y<U1D!*P+=Z
M!LD#1S6OU5TRF)BI"9^^U5+:/(\]4Y"AU06M)(@)#=3%3:Z"^!X.O ???PF_
MT:N 4OE#:>2?^('Z_<,V0>Q(J4EOV<+N(IM'8AQG =JOCRG3K(GP-UK$I +?
M0P7;0'SCWMH%9B8&(;PE6XLW];)G,3)MNE*A67.]COL_8D]?=!LF%JY#C@2/
MR!4+YM^8ZY/]*=;S&]IWSFCF*1GW)9CU27Q6;:+K[I2U9'?U.THPLE>,^0)Z
MO69W7%*L6K0;32'5OB14%5EUC#J+[Y5J[T6\-T3@KK-O5=C4TE 8SGZK'4A!
M US,?82+F*7*Y:>J/M0TY(0TA4T#R4:HXJFK5&KT:=/BOJ&T,Y ?6LK*,EW-
M EK8*R<->847CJ;[?^NNJC!ZB#*TZ'Z.8)QIGE.6K!$^,WEM7O=I<H#LR>%G
M)P%\W,PWVC;SG6'E4M""+C,::.7K4]7N /KX=HO^BH7#4 QNQ>N:S=5-UR/3
M&>.="$DF\_5[4=DOWJG)%>_K=?ID=Q6_^'!_&/=,8'?-4F_SY:\\I?:WC3=5
MO"\@Q]L)G<6U8K3';/$\79PR"[U-#,MXW%S5G+)TO.3H0"(3HQSKAZL9M3/Q
MX+Q)#Y59DPY$D+>*^KHP@_G9E!,H2IX:C->DY\IE%,)[.-&H(EX#QAHRR?%:
M3&TT[(+A?TA4#Z&.II5@#=.-QT2XD2'_EI#^IT;8/H@8KAKM?YAN[BRUV>8Q
M0\2?YJ8Y"\M\ZYA)*4FW3DH&39D_>?/G3@[?JESP9BR?5B+-/)DY0",WK91'
MB.(WP@@-8-M01@-J5F[%#D9 P@\6-/) F&>2'VQROAG<)JYS'+Y: E:?9#FS
MSSH7Z:T3%F1]N4DN3F;LT/T"%[+,.O/YV"65M$J6J39Q:$<AV6[0,<A\-DP3
MDFSGE9_9F:K;@M"X"ODR4=(EG:G['%P"/0F\Q!Z5-"]8-BGB-C+^\%Z16TQW
M8X'SK,P+X9ZSLFM*6OMG\N<9GY8R7;QG#<8'16ZE4J]>,"&-27/2N['M*,(^
MDKVL>!8V\#*6"^>>_]'KN,:W]&Z*V;WN=KP_&Z.@*7-)T.^B\WHS4OQF0M [
MO=H9;YM?IG,U=TX#C/;@".[ OU=L]&-@(LG/];4FX)?QPWP;LSZGC;=ZD-61
M@&#5EG"MF;PP@P\LZS7AVQJ=61\412^ Z4*?#APE!F1K1B]D:+X]OS"J[CE@
M(>I7?#UP3N+35Y9Q,7"7B0^Y_MT6FA.V/M:V0:3S'=C^!T9P&]5DU(L&D+@N
MJ73/B-P*9W#6U.O$AJ0(=6X0/03!SZA7/R_=&9,^M+8?$4B]4;5?7Y,)+/'M
MC7\@$H*-0+_HX;HB7H6=SK@#7;! GU13H@"I;!/.R"JMK] Q&D",%'-=*R/@
MK;YXRM.7[V$IW5YSA?DD!JH!HS\_8? 6.7V(Y^$G)R[IHNHV7]8U4"Z0\\<B
M1(*8UY7O<NN34]SDH_T,%7\\\-7&LL<_:R,R=;=:G^#>7YJ&KB_!.CTM,V>]
MY5:[78(?)QM<?_7HP:7=J,N'8G:>0QTZA*?U-&_</P\]/Z@3ILWXP>A" ":
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MK$5^[*JY-;2AAME\8I9]<JXIO,D'.F4.RD7HK34;=7JZY5"7V%RYI^A8,'\
M2=.BR&V/ZY_+-V^,<F6'#5;ND#(B,K5/@:''Q?-K<?T\07YX(G8R00OUS<H'
M\1-"2_I(JO&2-?+]ANJN5#V7# W]4<\SY]Y6*I6>%0(APJ$/&]JC$5IY S_8
M:MSP^G?BJS+P.#-FBP=@ ._74RPJQ*_/(%Y4&Y;=U\E?2>5U/]_ISNB._5@P
MT>S:>\VRWLB"P4'FP]P!:VSZ>%&6U?+ W/_Z%S^X.>D^3Q]?"S6B0'5ZP*8&
M_+G63P=:(*B08?72=^]S%&3A4E7,=81T<=:81_:JCN"E*(> 8BV6/[)0M2A?
MM*!P#0W U2=E BAAS?_%;7USB]/B7H?0WB TBOMCH"A>>&,5MD4)A"7[W^J5
M(4'C0E*D';'ZMK^IU\5,OI([=)0O37K%OW'SS"=KZ?UF\L>,06U0&E/S@_+1
M7?^MYRU.P\2QW>1:7F@,Q;X,U08S/T*O5&6=86")&:^TI-32Q@]?AXZ0,3;H
MR4>V#=P\!^1+>&9(D]3O9?6B-A8_B,]7NJF%+^\5"=1IE]1T;:_QE@1[JQ8@
MVJ5&\_M#;-3+T*BUF*]C$:L9,HQZE='^S+3\H3A9A<E_%VE5J?D/TM.YP8Q(
M'M1"2Y+.6'X40[W:WL^D@-C6)KQ==9B9[3II9QGPN<*@T1L[3SN:OJV-^R4T
M8#S]I)*J9+2F0:3CJCENJGK(DH[QIS</:XQCN_ZP8K-;*V5)3@7"ACA7?O"+
M,M8GLY/'.9@@I XIMC>'N G2,*.935N%C)BJRIJ[9+;\)%JFVV6%_)6)K!D\
M?G8O$>73E\[(<6F*XSSPF-M(SS"2EP1S-1@9=*E^>V5V3]!<TU2[9AT@M$*\
M7WMN.PVVCM)_Q'*N>>;^4-+/%+X;<>S]N%,6WGH&5D<#C)^B= Z!I*V;,F.M
M!\&70FW>"G"1D,L3&A6??)MEGTJY,.!(I =F!MVW,B6X6Z9K'E11M;PYO+\^
MB+>"8W563*K]Z6]5IRSV(DF'#2 RFA75S(JR,\U<)?SUV9=V;\:=M +O?9PR
M ]:1QJ%RVW8]::@IWBE-B*3>U=(+]?,CU'!HZW"D!];F0Q*Z7$:(*-5--)%]
MS-MW6^-06N((^6/N-]0C\P3^*=[X%_E4FG"6W0-K[T6QG#VW+^6]%&M_"LWA
MBHL=X>Z,C[AH%_)?CPZ8 0''^5Q%A?1+W]>:#$?319:G.?;AEE4;SZ!(;6L:
M_(VAOI^V:WD;1)=5XQ2/XMM[2V5^DR-(U_F*"^U^"0VTD3XZT"!_BL)(O='A
MG N]R5YIMU/;!Y,MV63]*.&HM7EC'>C*C>FK"$S*\TIP7,:$LX%(:Q*5K6CH
M U;QV34#=8 =+<OW!^7%VQ.>5%06#TGWT+(%3G7R76!40$WQM__()CXXT".I
M0\II0NGT[1]3I5A%#]+$.+$V$KPG% N2*-$R7Q<#LMA)@9<L"4$RS$%-D"XT
M .>X>S$)Q)S(6>N<63%X9R"5$(WEXXB8DB\R"%->WKULUM.I''/9*SO9UO\9
MZJ0LF6F^KVYNQK]'/0Y9YJWR>W53>MS.>O>S1GT5!\:]2['F'FEO\C3E+QND
MHZI624=QE!^<YPG[YLMDA%"-/)H<<"UL2%C.V0QASG+N Z$!>4*?2CH-!, 1
MP#.6UGOOWGM(-(+EH6YMUD8U/Q"8UZ5HP+I"^"\(BMR+26#EH13*"5@N:AOV
M^(#M#".49"E%..BTINJ6WTDZM9&1ID3'-X([>N(@,?37T5K983P"(^F@Y["^
MURT/<=41MDMH.@2_0\DQ,:#J8-JF'J>$;1GL,Y*6[K "FQ:?XE!:O?,-XS6
MI"#FI%X^5$*]8;R)-7]VN7O+N)-ZCN++9\:,U5A#Y=)WKPTK>U&\4(-7)DY2
M:L-/$MWGGO]^2:XY<WYP,V,'#^_JU1D%OJF/=YT*>F1Q-@9LO&$&)9?F]("
M9N2(#R=J;>=A-S$4\_);,%#F:T@_DF'UA!YAW775$'PE=B:XM<A5'YP\8K9Q
MU'[[37XB,MEP< ?$9C!@O7&DH22:*,,-U+'$12JNF<P$MU!#]<Q&/U]RN1(K
M-^VV?XE7/ .!+._2HR EIR/?>+W-[1C]S"IM'S]ZFDJ'Y3K?.7&CEY 9U"(^
MP08]_&BEL'\U\_M;J[#VK;96PW)'=49/5/6:6; X2<E]JD\QY-&7K+0>S0[K
M\BYO9L0UU:XO+3,CO-9O_JH#M:[*6)^\J!90R_9"^NO&$[<RJ5$0B>V,7JAP
M\W.WZ;6*T]QO6[#/43@^3KX)AUHVU.2?2G(9+*@Y@*Q]3(\^T@(WWJC:.78S
M&W$$KX*!$.?N')-%@Y6*'_JY7A_C,Y04>B5W(MQ+G7N 1/9-/'DUN0W?173[
M]P-H!QU&,"-B8.*MOY%/3TE2?]%=/!O?9K<;>YG4GP"J;QNI R?HP8);'[O6
MLX;KQ'VDSV"^0KXI.ODZ"'N3B^R:B:V'*VHWN$]>]+I!]*>LI-7QNF(<+U$)
M[=!KE.*0-:K%Z%:O$<'3/KU,.IZQ+"9Y5_@7$EH>V>4"\"3*')P)^(]MFC0>
M$IBZH1>X_I=>)I".>9_NXK %<Z5-#0]%P"/2C5N]1*3M5$F9D(^$FI^\Q^=Q
MA52;X?$[7^V3P)$-'3X4#31L7K2T"C^RN[E+Z4[7G#(\-HTQAD1P!AQ(S]E^
M[WMU2E*V-;M@/Q@\9,!FOBL<)WBLOJ/,5>#E;U>DOP+'"95:Z3"Q9=,]=QA<
M5NI=[L &(N!/F^[:/)OH22-?W2U4D"\**K("5XGRG!'DQ#[/S#\ZY.O+6-K0
M1BUCX85)8)A:;Y@%]+YK2=(>M0BCRV//JXE9,VA,D*K<A=YJ::DV1G;O?9S(
M.)Z7D'6[)N/]8[*MM6&_8GS1[=VYWOQ:RJN'/G KI;+7$?24=BN8@$3J]';Z
MH5PD96 T2@=?BYVX,X^4BL#>G'B3P7]]<A^S31D<&W$G(R;B=XJM+61S4MPD
M+?F7X/XM/R48JCH)B-6O$3%BK^)D+JJ"O=GTQ8?]'?D%F_GQ4!!,-W.N<T3#
M2A&@]4Y5_Y%Z#U9+U?UZC&^2Y8_JP8$M)#--8J7+QOO30.L@%0=>H^'(LX7O
M&P2]?U[%7^O/7T>EKB<AXR.-4 _U[NYFF0CB&1K FK!S[[^"!B@HFA9N''%?
M&\)ULPKVX#<SVAY>K(LTHK'Z9TI,&*6<:S!_R7^FL8R7]FN UM\.Y]EAXB(#
M-+(1/!2C]!3&Q?374?Z]XFB WYS%6)/<R/.QM::Z=9_3. &"&O[1VWM((ACW
MLY 1;34QA7&,T;"?4B+4'^Y%K05.<&4&(]PRGC_SL18PVM?,'ZR[83=M+__+
M*N5Q<>NQ"<)"1.;E&.DS_%KEC+7[]9L%*1*])><VYK_RSLE]NG:9XO1YXL&7
M(J^/7%U_RGL4Q8#IGGH]2CO-H]Y2A55>[QS(,<8,Y74QT0!&(9I U.,5X>RD
M9;9$?G+0N7UT<Y[8R. 2X+*=[4ZO"&(HE=&<.Y*_PK'+84PN7GC8.>JOIJ7W
M6M--4F)MQK^*E,9HJ1OFX4%U04+0BQ62E?/$V2\WC7%GGR?KE+0S$PMJVLUW
MR:NN)^<^&Q*G8!#]9VZA^<.^&1Y2)=_TQRL/K>.7SHRQ_4]C?)RD<7=M\4#4
MB!'=1NU"[.#RE/U=)6DTX&OBJY.28^HS"?5@3Q%_;;TX-*"S(2/+V9F1W2)J
M[0N5?E3KDYUHPXO^-GA2P&$3:^Y]W.0/CIA_&PHB%YA_2F[[U0ZKBOW"N')?
M9H=Q ?Y_^9\O9<E-_[NN.L_>/'<.GZ:R<5[. _LG[T0U/_R.RIO\,S/[/WL2
M[7]8M$VF1><5176PXKPPI$FRZ_'XA*(I5-D2:SDZVAEL*^ZWT8 #U--BY9\0
MW;YM0\C$ /<9^><8F(#BGG$XQ3.^3S+5*[+UJQNX UK96D>E&:6]ZO(?$%X&
M\>_\]$LU%#WL%RPU^#.]?7'R,_KOD;)V'DS#"[0;/&R@C\1#Y\ZU6?M@[FFA
M[S\+L%W0@+*VCG>,G%SOW""W2-4W7-DU+_]CN)NG*ZX/-_AX*T@Q2EXS2.%)
M=+([%5\PZU#67!]/9:,<H2!CG,^0Y9%>U96OGO#5B]D[H\O:->?785PE;U__
MUR%1GO0Q>^NDKH8F+7767@;BD&$E4R^2J;1]KC?\QQ"U^#1+-A05K*=77IY2
M-TCFOYFVE/%P98I,FQ'(C&-_[G-?E%P5;7Q*GEK3 B%4X!Q0JHP#$_EZ%-OJ
M;L;YZ3EDC2F2[,L/JRKP%-V3-(1MV;^*=%<+632 4)@($"7G8QW?6J1-MP06
M\947\/:,QCV;>QKUK;FY\'7S5A_77((V\0"I#?XSQ8&"WU;I5)&NOX=HPIZ[
M5.F0J3 H'2W"9YD72SY/Q_S*GS=ABK#5^DYIW%#T8'BZ5O\.!FL:HP$!?-;U
M$WS,ZS;LYD[]1!'ZWZJAVY4)<OE9RVC MV(;,>T$M6FDFE]8_T2Q*Z&/UJU7
M:IGPLNX@_TW$ H[ZQS8DCVX:VV;I5&@A-IV!Q#]'2_]'__A]KRM?R3I'&'[Z
M\V+8-.4'R3DI$O%O]SQBDQH5^T,VX\Z-<^SN]QZID[JZS45H@(5^<"16$GG-
MWYAK4/5K7E+=A@A5GY+%;AZBFR],OUL677^E0U3B" [':5W6CCCYWEV=WT7%
MA6T9GFO!MR[(5A93AT!N\QSFYRS7I2D><?/+RENB44+/>V>U"PS4KL=*^HJ"
M$R0,EJ12]I7EG1)MBJ 10ALK*A^M]$-R@H/>2\0K>]P7K>4PK2Q8ME0\IWZ7
MFFA\-VUF>.UQ8_8"-KTPN[)O>EVY8WQ?O5)]53^M^3;H70;M=L06FT:_CPP=
M%=7194VF_<32F_*?E_L^7X\AA7WL@\O!]!%I]5J3Y?*.MZ!*]T)$27A5^4*R
M<A2Y$NT&5K3VC-"L[CN(0I5Q3O6A74AG?\!WR^;2!\U\=@ZDU"*G)%<"."G_
MQ,ZNRZ2 )FRJ5^[%_655?&04T@?(^/(S.@M95%/\3"]2N9]_UV6Z8SB"5>R^
M:&_/X9R J]2YRY=%192]JN+#=:#:>MJ-;#WHTM6VY[M'KO7K@ /5UWB[N\5E
MQ -L*&!5H@VS,IV:P6R<[\?%Z1)QYYVP)"?;SKFA]@LW AX1O>F2BV2!'9].
M(D6"LT$O7ZJD-<*%QJW6N&,]=_(H6G@S%/-/\?)3@M^YM;!O55\J74RLL\U"
M)S3EJ>H'_S6Q=\Z+LA!"5<EP1EL!@RALQX.R15M3[@I]>OWB\,?A<=F:P\I,
M-\ \<R,R E7.1O%/YM8&;U0L4NOG->596&38ON*RI2QN4X>M>ZNNZ\6"1O)5
MGD0RXMNSLCWRZ/ #!9^5SO_),Q7BY.K-FC B%'\9L7-55I#7.LA5/.2N2P_*
ML")@MK:+93E>63/XL]O0O/G!Z\AJF\[8NO_K$?Y1-T6)C9.,2:"DU#_6I#,Q
MN/>I5->H1+U33^.^8JO,9<_()K9W./@ Y<F<T%IHI.Q1,,#4=$*4:R5&%M)^
M-%']N&0P(Z74KS!XT]%>)=$$5MK=P"/X>G*XL" XQJXNY,;Y10[I:8GX-(5V
MV'<W*YUG_6F+[ T/RI'5I4G*>!&M'JQ17QVYMG17^^01AA0&<T*Z;4L?)V1I
M=H)4=D$Y_S#.X5C\EB?EP4.M-=" K+"[<P<4=T$5_/ZH>E%;N=3T;<@<?_UG
MD?*;WSJ&)?^%O>^,:K);MXT510%!.@(JG5"4WE&1+D%:0D<Z)$*D=V)!D"Y=
MNM30DD@)'6*A]]Z+] [26TANOKW'V?N<>^ZY/^X]XXYQQ]@_YK^\6>^[UO,\
M<\YDK>?=T-Y5B8JD11=A:HB F 9E6LC3MK^G^/\"$$4/-YF3^8YIN\]/1II3
M'K4Z*BIRNF\"OY:L#>GAXDI1QJ"4\ "#GV' )+\M)8NA?.R@LT*GK;-G^YL<
M@=9)/!'PD1]K( LT:_B\VN?AO&-3!<\:TC$=.A/"V%)GM!K59.@S[2%E/YS?
M'LD(_:MNA1YM)H#:]<Y1!+I'*!]7=:,D/2H'/S7-Y$"5!+K>DPS8^S.G!&S3
M9_FN$V&6.T_NL66:$FAG3U0PBJNOAA1WR@EB><:FVX\BMY;#HMCNA;FE8Q;'
M^W6,C.UB%#)=!SJ+S,SXGM5Q6SV1)I/WW3T;#G E[&Q5IAA\./5BD+9+8AK[
M4(V/7M)?K_Z5 IUYKO(^':3A6KM355BG[#HZ(I,1"B45-O#R2L?]=KH?4R4-
MNVMF=.D#YN-*;NS3"5<NK6TIR]0/O(DM)Z^0?HAD\&Y0L#D WYW2*CR)=$(M
MQP@*!#I.2'#X982Y#%%IHYR'GV6G;Y4]S.,!C4X7GR%,2"71F.D:W0<T;,=6
MQO&(VN=XS]T\2W1CQR"GSZ,N;U]8?#PKIF;\^AO%A\ 4PVB?GVFF*;-5,QZM
MM[;YAF/#_.!>>ZK:RJZ0QQL$=CW7I)"7%>8V1F1=9!BW4_:?M?(R!%90BVP!
M5<="S+3V&VCAJ%X2!S@@6?Q-#[7!PZ'L,\QH*93$;#VO_J%12 %R=W9Z,I4%
M*"U7".<:7_8R)TG1\4+<G^CUQ\H/HDUK8U4B$YY'_?"B_M$# F88S,I&6/LY
M>ZA2L-LAI?,"JF3X^3.2X&ZP_%\44S/NZY3'4R9R&2LI-2;-E7'05KF!B!30
MG#)=SXG&LM\73,1^.Y_)>P:_Q.\'3 4)RDPMK#LG#.0@_25=(H "=S<[.PRH
M=/^_U%,U&#(S4S/C&9;0I?B2L>NJ@N^B?==@,N)TAGSH_+$PH4A5K;HQWNRP
MOB;>$@MJZ+ZCBXD >=U*G-W1BL,"UDE?)=>6YUKMA1:7ADZ0W9%751OIL^7_
M"ZF\7,_JX>(!\W;F2=0M?\5TK_*Z_(:TODZ:Y5\D6,%;HY>@B9? @Q)),WG[
MV?^VN<3_(;+J@J:,M"]_OAU3=MG/QBH_ORX7:C1NH.HI19NB910EF)\BM4,!
M Y_IBSCZ1CGE12D%6[;*1WKT3?UPK?N:(:U:) 5?,M@^Z*30HD,[+7RQ7@H\
M.>)(::[^8X \ZV1)WLIG=]]N(P+81ZKGF ^L.VESD]I)=6)5/X.%FD=:\J;\
M02T1(.HZ^Z("6Y^QS=N6X9;,XB*-EP';CN1XL$>4O*8Q->Z\Y*65$Q>R$W%$
M9_%T:"=[V*[?0W*?.\(YRD)G%!-(Z2B,6\QRQ!UN(N(31(K2I6I]_=H5<;HY
M*CK%4L/'#2V#L_F1=T^2()GJF2#O1>"M#O\E\INV5VW<ME+")':%"C(=@QT$
M[@=:1\:+4D]*7_^ZFR*0Q*SQJ*.BB7HK 5V>)\ZDCQ%;W$25[]$BR0U]775
MH#-L(%+<L@0JD?+3T?A[9(JY5?KU*[X(_K%A#RGW5++:5$Y*.E6P\\_2>I4<
M @W%I=+V+^\1M 5XG=##!OK^%BM'UU^CGQ5[1_*&TWE!DG5:7 C90(B@#M+8
M?7$X/LY)&+BU8?F'BA;Z^%:,!]PFNN.Y]=6%V?O#K!"+D8IJYH%53B\C"M8F
M*'E;PPD'>YXGMNMDGC: 7EKM=.'+J_,[KHI)2RH/X]?Z72.F1S,/X9\M@3]1
MWC_=%^S.$9#31/SS9CS7FR[7;F8:!#58[/JMN4EN*\"=]^I;!AY$P"DM#Q&
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MR4L!'^67[X@\TZOZ<[3E[%.ORCX%5IYU@22 AP^ZQ$O+C$<9D7U3+'60U9I
M]@^ /'<7<@_0.C>OB%ZJ) 5(>@4IB*VC5KDR9!G3Q)%;+-WFBQB?WH(8VZY9
MZ]&#2DL^/F;LEV/NOM!("K.A:A>\97'Y%]CKQUIJUAA[S):I5ZC.&L=J+.PW
M0K0CI21%@$1Q],89N<V>P/$-#>RX)S,^.!.]E/4!]V)^;B>3(;#&Q25 U:
M@"U4L5" &:VBVK.C$62INTV0-62&.NF-[(P,R_\7GTO34%[5$MS;6.V_P7&@
M0&)_11;9_VZ\:N37KU]3TZY&M(3O[U^7CDI@GIC^[KA7=6]SP>"/^$O8A?#
MTA]T11W' L2PYAIE\]3@;:Y94C;J"%6&@#*SQU_CZ*.G\BP&8G-ZLWIO; #Z
MD.5P6G^/(\&BBWJJN,+W+UK&]B"Y&C-4GDXN3WN[9+=[;W?N")"B$,#C]* '
M;&$TUG+T1/RH.$%(,R47 RLHW>H#?7?2N9NFZ,P0CR]/>/H0Y$&#7 )QCXG#
M;+T4EU+(S?D];#T$AP\9J#K6D+<-(OX=N:2_+?7ZLP9*4 ;^,Q+\?V_(B'#-
MP7M1>JA>JF<7;O5)/RYDRL V^D5TD<Q4=W0VH<9+]$FW;RMSEI[5@0"JT.=&
M-TXX\3<&\7P(^S%Z#8B\78CWFB^PM2'I16-#7>S.\BJ)PF$D =5GX%%-P?^)
M5,J=2HD\%5RU)B$;D7)E!G@,$;*XOWSWT47UXI)A_TJ87F<M8><K(Y,O78#W
M8N6EEMKD=S,3LG??F=>*(MUD7"#S38[^\Z5E[O8]ZE(&4G>_>1_$O)&=WUX(
MNTMS<59HJ_B"W#U5UV36KJGK$\\WH:IHP+\D_.B5L:CH3C;(;\S*Z 3] ;N6
MN3VP %S-G;P'>Z?QY+B^>% \24+;N+D'B>3\Z?SO/\Q9:IG\G7^HZ5)<JK-U
M'%3G8-"\9]7/]WZ3A-U*F'9948,^&]7%<E3?X?*:0P#+>$7D;IF&\:3[#)*H
M.+'O+ \6FE)H_=SGQNS]N*30M&#2Y0MD<->X>$1_DLY</RN4Q?';_ZW&%_^%
MDJ _C9(?=AW\'L2S8TZU:1OKH6TV-E17]'1Q?MW($\E3)4TZ51&\$:ZJ)UF@
MM\Q0G$F->K_=]'>6CYW ^+H@8L?9IYX-PEL$(@E0^T_>^=F8>(\OT"K!RR)!
M\F'?]WFQ7([9-MW(0" +M]EO2TN':VHB G;>)6ZAJYVNT7PYW+"[V#Z8Y%>1
M4GA82R;]9U$6*KCD\<>@6SY'5YNRV0!;BP;^PD]4K]Q9'9\C5<AD4#97[7UM
M$)J7[ZBY=H1)GK/ 4_H+!@JM[$BX P'SG_1(X:MENDJ7[YPVCFZ%.@R=?@ZL
M,&6JW^WVZ-FVYD2EO"(9-M-1R<LO!9M=EDG?,.O+FYHFP/:_/]=BGN/V=R#U
M?D45/ZC=^R*^0*>U]RZ?H70N&MX5L=XM>IKD;D1/06_MLHFRELSJOUD4*?->
M1?L:N][9SQWS/&_LO,_NQ0H.CQLZX$^"%"UY2EBNJJRB,J>8,#4V)_<CYKE+
MMSY2G(IWD=W5T8,#:WY@M"L%)Y0_(#I9Q7_^\49]\?>R/0+PED$ G2HF1)9%
MB]8I]U[LXH<%"."R2&Q2X/92'[SX$/Z.U;6?\FK852L@ #%BZHL)\*T&]1^G
MLJ(F,T-A>0@@_6G4S8[X/7/4'Z<2/1HDU-M7 P\'=M^=42, 0ID_3@U#^A!:
M>E[8LOEK]?[ZP>Q"L_\X5<JW4DKSSW_TCW.S6O^-51FSCFHT_W$A?Y[\\W\6
M_3^+_I]%_\^B_]]%_]V,1!GG,6.7K-,PWO#R'7+[] +-A,U7_-QRFI?4;EA%
M':N9J\ (>OZHOI*O#\-VLY" 9B^(+ZC0:N!<+?4G:1O-<30.NJ_D?@_$T^@2
M3AC9X)EG*4;>/.W3*MN8AL8<L[\<\JM&8LU\R?YR!+UX5/\BP,LL[W)10D%/
M8:&XMIN5V\Q+D?-=JK<D>BW?R B*%C$GK,,B32.")V+ 7EN,9O(3NY-\B$E]
MQ)I-K;*[."=?@R,(=4Y,HP-$^U%8J=1X]UHZ'92EKX!:1!\&Q>3I'D!5M_G,
M[U1VA3P+GFX$7S\N=E9[X#_1HHEWGMT((",4*G?P '=4_U39^X\00/'/?R7M
MM5G=0@C?5DUQ,_M]@+Y ^JMLXOI&DT),I!$O0#0'BSK+0FE##B+T?8=@O6\A
MWYNU$E^3XC@RV--0JFA1++MPV&%/]L-SF:QSPAVR#X4VQ;H8^]]7LU_NY(],
M(X&S^7)/?\8O<<&\9:S7!\I44_4I1^?C3L:*^51TC281P)LG-5X<7N>Z:TAR
MLSSNBLUUV]<K63?HU59;9&\4BELO?W4LF%&_=[H##62^RRHFICSP)"F:^$'Z
MTN:#!R&!BI&JE_(_DU/_M^^"_Y6]0$-%7GJN4"K^.L"RL*&K[*?'T\48Z;T[
M>0K(4G)CLQ1F);L@H[\?<YYAU]YIIHE2J39G-B;"()([K.6Z6*F0\2M;&4^7
MAAXS=.C2Q8H-L$WTE,?%^NMO4JSFNGQ3<6$AZ R>=;+/WQZJ:=:G>H^MYA:%
M#*S2"5Y/\2X\"[&\MLB-A^L96%5@9-2_;.$86NF3'=J+=:?6W;;,6BV/RMB2
MD2&.4W*R/;3[\!O">'+^Z#. )"D(X*CI$:C(/M'MOO7C0 "[,*4[E$E8[I_R
M2 8%1N2G1H79]V1GX P5*<(/_VZ)_/]UZ$=TI2\A@& 5:Q\FD-L>F?U]'*?+
MAZ2O;%4O&5GE1,6C5R%E<;?.JPTX)%Y2\#(Y[P<6W)7.TTW8%*)Z@$[>;(JF
M'=D4_,A7F.-+F.<*!Y5;<;?_'%RGEZ+P<3?J; #28;7ZQ[G0IAL!VMY,T._:
M>5:H+"4\MO6ER/7=ZM6TPM'-BLP7+_G/S<1'YW'>%@3\ [L4/[MBOJ \$M-B
M9'3]O=&X^VN!KO:2KG"WGJHNQW#NC3V3)VFF2HTI-U(O71"YA[D_#@$2]$:\
MO&;ZUB*ON[-*+5/J_H!,ZE["YW53Q?DYEMC,G#[7X\<4F">@?A\4MX\J8U4&
M:GJ3&6[L9^Z3D_2JY/T&'5SH,;'[EP!HBI)(BGF'5$FYG=:7JV69=:QE,R?]
M8F_*![I"*78CFP9#=Z3;;V62D4:_UI(_%[:[N@B^OR2,7Y&WI!MAUWD>H?VI
M[0G2S:]2W15>WG_@SU0O2!ZLS?>/E&;U]D&PW"UWX43I-WPNA'\JB_LS:2G@
M^,@_)8#O%T?PZ?(:<^*T-TMG*9;X!I*K-#(6O[>G_BFGK'S50;B?3G:MLHZU
MX^)%2L"VWK30&]B<"#?'0#[I&54U\8QH\3HE1G[A!6['N/6NZ70 >TZ @3::
MBV*@MJ=?-/C-U;2[NPGJCA_S;7LV=E9=^E,K5#N%578BSM?IJN#KQ2&(6W G
M2ZZLC4V,15V7-G1>J:RPS.S)J@R6!US_ZM8Z@8[TD]CY1)6(,/:!A; W_V]=
MEYKHV>X*@B?":1N-^UXF)24- UO]Z;5F) B >JH> >!<AK)9D0E($O9A5B"W
M4665886V*WK]U/3YX#9 Q9[ZJDBXC,XAE*GL[<GKO[NQP1)OA =R=85]$;(+
MSJP+&EHO3=::0+'X#O@<M,\&>P [!25W+W;5ZB/?%&['S-1'XZJN*=1Z;%IV
M6OZQH#!E!4OOYJE$XZ1(E/C>Z.')Q?[\$%<JA8\Z4NY_R<S^2>D<@NH_-),J
MKI;7?E T!@1PYRGWH&G)#<K- ELM:C*W?#L(0"(KE'G@O[7=^?_'XTERQ-;X
M/N8&*4,;LC6V.P2D?0PTC^5!;P@[/,]O#P1)C,&Y+H1Q*W97Q)"6)>IKDJ((
M"&H3R[W$N='9(?6]/_.\^EC+&HX% C \1@!;M*5CGK[_>;O\:U8Q19"]%5^:
M)#*XMJ@P2Z?8/,C.U*V4C)E24&X^6W8R52..K* \0UVY"!UP*J.NCY5/J<N/
MICQY97:9?,Z\S!>!"5N4[4NOBPE[3OEJW]#%0EHM7-]%ICAN.O!5K[R+@Y[>
M6%45ACETNN0'-\:WY]=4.+^+P;/WDY7+^P35)P:RWT/9I3VKW;]QCCO3V6Y6
M?NT<5[<8G-DKR J]=ES]NX93*TKJ)0U+#XF,X?^6@ !@8[;$]K+##?U1@LRM
M9B1WH$:(]*+"L6(\N*@F-9FW9CHQPBEOQ4JC2T,+A1GWEA>IZ!.?S9O7M543
M9:;^)^^O7,E<+FN<F-WI-T7=VR@TL<.*=L1>3*KVK9A9.WWHRJ!)I+9,Q2/
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MGE3XHZ-FK'VXNNP?']Y_XFA\47)0-BA/C_0@9Z8)V-&^1GJGJJ+E24C2IY3
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M+#;S#9/VHI2IQ4P56*6L'9U'9.VP/_=_3'2HS%,S2O$\*I[\8]YGGK2>]B;
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MXM:\B-_WPU_3 B4ORIGB^8SGYYKJYII>XZ9_-[M2^*AGJB_)A !$>^_!41"
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MBI];)=<$..7L,&MK0A^($&3(7.%JUYQ5-,5?2LKJ;KK_EB1N_@_SR_]B<O]
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M5ZZ/S_$+KR([_>B"9DJK;PO=.[^8.<TK7?0<PB9WB9.S3:RG=6U(PIVL&*'
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M*[N*CG="$^!(?BG9.O9M6S!"19OP*ME@%$K/\+UBK#2[;C)GF#(>HT]]!P%
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MQ+7\+AO6=]]\7Y8T^"WKOV;#+%,MS&ML,FW34+/VF=]@$ZEQ[BWM$WV;" 3
MLB)!=9Z<(0HM,@/C>G+^UU6055KG?EV7N;\:UB5UN), 9TUG;2+/O.R<>7@
M:[D@6:\->7'WS:_S78NC*=>%W*66PNEPPO7:I:>G,.&[/0^%4=VVL)/E 7D
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M\#/W&N)5D ITN8$%Y^MO3Q.U?2#4F:N!5'2]P=M:+!*LH_P#55WX!QH[YQ*
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MCM)AS-_Z!IZ![@%35PYK+R;]K 3Y[A?SL^\B59%O;4\]\&\:_+_1A!& $ 3
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M+.<F!@?ET\0P0K;$:(O"/6Y#6]&-SMHLV.YS0>"/.7H=S3 <\T?=86?"J\7
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MBJYJL9I6$$_-[6-YCEKMY^BFT%(NJR>><:G]>FG\UG.FZEM&Q3@*3TT[):T
MH2ZKW&-_[RF#F/<6J $#P$^2&SEKC.*;I)O='-=A(N-\_(/QZD[-S.2>G/[Z
MW39E'^H6EI:U--K,>]6B'-E+IN/%%!1G._[?%<5*(JG[0&KTY>*AQF@;6Q<J
M#LLQMN1/B\:KJ8$X%G1Q/2^?=<<5S=A/A6ODRCTS\H#-^@(-[BJ2C4J6Z21
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MGL/!R_.+,DBV_1O@'YW66-4)#J85AG>/MZV8CP!WV]"!K)QH,L]W;1MO:C"
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M'R@NVOJ.W2@*OQ-D4_4,S!=%^9HXO?XB6A!Z+9/LHSEC<N$L?Z5#[*S^!_/
M93=\[<C=8[<%ZA?;DUE!KVN3.L^$/VXI][B2O+T_N.P7M'H1*M0SZ N^7;9/
MC?)]K,2SU0IUWT:Q]^VY)6<?Y&<4&=<0*W))Q1B"!-/:[MZ>BHX_H5CP'7^(
ML">+*3!$94PR[[UZ^_KUZOP;?(40>MS,O>7B,I(?-25>)Q\;^%+U@ALR2.OK
M[I)T10XX/*D";"CA+:I\M\U[Y$A072-N=MPXO^80M@80<#V*;%B/UI4/\(0A
M^]UJ;/JL&LNW#<3D*6O?)P+?'--!0.*C0K ^2Y$@RQL0-P<AW&CY;=X/[G63
M=J^(K1E-<[M'PC00WB(A=TS3+[;AU4BI0BNGV3FLP+[@O*[K(W]7+?E:KZ6&
MZ,IQS<E9&7"G#:N=._008.ZQ*X$=D6-$)V3HF.L,XCX]S1>_EG_#?;X0^: @
MX=G+DFJ]\KK]U16=(U$)#.!V!I15ZLH2$>"Q&]=_A(1"/<!W-:-#C-/.X[KN
M%'VW<M#:F7Z/[U=Y]-A^%OK:<BX7W75 A#S%\D+[6ZP%M06ZU?[&?HD@@)VM
MVPZV@]:)4MP^(T_C5_*&^JRDQ;TO;?2 :*SYD.0R3P3#/1UWC7;:&,[2M:;L
M,8#U]T9GWW)WZC" XP[.JP7U&BWB;6+_Q'FTEQ0&X(<O/N"( 8@^Q0!:;RA(
M :00>N"+Q8>H ^8K]C;DP4?T.2D["<[#?SB.\G63.>)1\IX1*>I71L=]P/T8
M5947Q!?$8"@]=K3_MW\D(,XBOY7ES_PS<]:H/UT*(& "=@>S\#.=:1T58FO_
M\G-D&&H"63RNC.OQZ^?<O[1P)P',_OJYZ)]U+/L)8*2]2] VKF%3^P;=TC:+
MS@GD_4\>R/^Q/)#_Z)+AO3<CLPJ]+YL\#%.6V=;.>#*VD_6CW"QD]-;,7S,F
M%A=MW=M,;+-*-XASTJ>]?GQ:[JA]R)Z8G:]H2^(:ZE_/D45(3F-D4U3HQ/&G
MK%DEOV70NA:>6[*%$"9+.[N,*".M,;OI'IE'&_>VXYW/E:9_>7Z.U_JKII!)
M[\(J%^/4,Y<7LSAT:_@^U#F?'EA3,X[QS<JH58^M\O"G;3X>+<<G,U8B"1I^
M+G%6.BO9T^@>/+LB9UH\)VD\[>A0QG[VW<$YEGSE_HN573RJK=!W._:\T$?G
MP_W=<UA$:5:EO13I]$5\6$0-34VOZB5\#HT8 /LXW-Z22W@+;>5Z\4@W.KS4
M+C@0$K*NDJHLR5[#+U\.)0<D#=R[MA EMTY'D>55H>A_$ZH5.ISXJ"_QUE/U
MKHHG]JG\L<\E"-).\/U9PP\LHDM BT:W;2]-=6MW:R/J*@B6N>EC>%9ES:^_
MXX_JH45\@8LHYMKPDWV=CE3RU4O>M2<!QI' HAOUDCWO.<54] HRB70SXTX6
ME682V8*G$UV;$\MLW6V=$)#G#^=7>^N''^$ZT1;CX0;I_A[";J]U@V9/D&7^
MY7/;R/I10[AG&"Q!S%^FS$,]JG(PVR)"D(KHI7A( Y>VN0[3!-5/-M/.ND:>
M\"N\6L<-8?#4D\3%;DIE4N L'CW:"UDB9\^NO/)2&P.HFZ(9+6#37ID4],,O
M%/=V$^;RCBM1'(M6H].I(^Y-*3:8-W\;>-T,;_;(\M /3=I9S=-@83+80Q\7
MJ^C#F&._4NTK5*#NFUW%P+3_7(@F1$9W>3A-([SJDT3[=;?RQ]U)^V+SFQF)
M:KKC_JA+'W#G3!QH\JFV)AQ%-7*3+D'(C/H]=>Z%9@VWM6NE]OZG3Q$KW@Z$
M)/=]3;/$MA_L4$]X='?VA:^MAEYC#/.?Z@;&,%;ELX2/6//X'.3M,]=E)KD0
M2&I_Z$!,WMJ*XJ(??CXH!J#"JRAS\-+=W:LI#.ZSJ#/&P0",3VC>WFR8_^JK
M69Y!F"J>>8NFN;%!\\TF-?Y=E*? JE9(L2I?_&K=/&P02B$??["7)O!KWS50
M1&_T,. ,OZTI;0^:ZTF3>5R*'4++L5TU*OO'J>:F,BIJS,.OX-)Q^4++7K\M
MQ4%ER[N&1XN<&9K]-L<:O+GI-'!53[B# =3^# #W-\H;7GLO=2LHIT)>?J?S
MA_J;_JB[ABS:8<?/L= T:_4?A@P^4B1<-VR9*"?;Z[_Q43GE7EE^YS-!H3X3
M;I#8-I'BV%*2]L1BX\3) "/D\RM*7V;\@9JJ58VO#[.&Q;S+ESN,CA]C %];
M>M #^K%POKUFA%.J=E[CA&-"0>*H4.^MHF]^G85,]=N&\8S[S">&"K#*Q8E\
M4G)%UKIYK0HIF.+@@&#.1^DQ<\J"S]1+*Y+TW%/?]J\EVC7QF'\@QTMSDN%+
M+"I>3(HWT+V(=E]--<6G\-@E:!:Z>+=BBAO56I#^.'$)IA Q-QTQJ.MDIUY;
M3]!NT6U^_;['R3)U@J5*?:UP0MZ]+?XX^+Z,;_SH*"?;2E#"G22 :U1(XRC6
MF/V&??W>D84T"9"]I$PD(8*?;WUDZ< CFN'#6%16 5F\=&5-FK1KL^>CRD^^
MI^4NBV3S\J/EIHVUB9K<7($O4W,Z[SJ*Z5-G/=_LD8^ZO"BW7U"=+-5V="9-
M<XJW^SK=H'Z?*V@36FO@M1XG=2-C7)HMN)MLF"^ Z:BRF6!J60@J1E1&'/U4
MRU]&-:>$<73S0L]@@'*VV2-)P+F]5$<_5^>91=T[YDG0/.?>0>BC$%S+<KQ\
M(_00%I>^C^O]E=9.]@C=U[8+-(4<5;<]XE]WV+O8CK89Q=:X[*.)VW;!=3_!
M/87PYHJ=#\"&)@?G<TO2.%2",R*SQC]G#(S@1(0 JW.F(]8M9NRA5UY#)@4I
M54F+& !@,^&9M):3S]3^F-$^)=QDD[^5WE;A"G7_<A!.\6K>'!+V*O7;=,P\
MA2 T(*%Z,;H2W*&X1(,EP&I4$NJ1Y=1A]1Z_<Y3P^F'I+@WH:^,A0V!*QTBB
M ;[0K/CPV]?!W7I6Y$,>'HW^"5$80.74]/1^]S[C\]3*,<''IWQ]NM8&[K:G
M8FSLS_CS\^/\]VO;5(=(5/0M"_Y;"MBF$^4+;D)):?QUG8L9]^7_YNGM^+_;
M!W]G/13]X3"?I2)%:O'?.M+O-X\&G^#?<MVLKLVW&[;EBJ5%HY8,,[]P%>6$
M7QQOO?MG#P\1I?NU^E4Q@@&<X&J[_WDQ:YX :>53,;C6#6X:/P'';-:H2/E;
M'V3_3QQ:H4/-B(LFWBX'-F  V>$-13/ZNG *]K+(KF1<8\'ER88R4[7Q/=[B
MG/I1^*U4A\W;HGX=7UB5.;7_H5V0O-1T]9'J@7TJ27-S!JL@/:ZXGORB ):_
M)=C/57W?0J2\SSZ0>37+/ 4Y+H75E(@)WZLHF.DCYVQ\N=<E?/&>62G9P8=R
M:UY-UH_179']D7*4"*?XK*XJI?OM!NFEVWU44-<A6HH"*^#4W%,8GV/-128\
M^HZW'M>JM_/[[0S7B!/R4MN*ZT9L\#1=T ?SL9I=)<W$M9]Z;!&ERX0F+M)#
ML^>B:1'J0\L#)!.&,QT!W8TJXP&31JN".,W-IN4=CX0*"\-.%1JD:D-"'\,^
MP3N=?4F2WG'=D;U-7/S3LQ5GB\1M/04 #U74([C-.\2>./$&<L0^F^05?2>8
MWLRAQ[!Y4A1-I#Y:X^O/?U'&R9MTS+YG".05X4[XU+CB,-\0MO(X;2T[J%N+
M,OTTN#4ZM[9_=HIA,]8WFOY5<'C"FQKDMZB@"C&NE&%8LUJQX8: EH]]4$]!
MV9(>PXFGGCF#I;K%+;R97O/AG>4Z9MS" T0H*M126,X%IJ6E1>3N*J288189
M\:E!Y 4 P.U%6J'_Y;_E=?N[T^Q?KJ*F=*WQI=@@SD^QKQ\Z1U)T7"X\"%><
MTK<VF*+V_C)7B\[GW9E2_2FQD9N%+)&'&46.J*D$KQASK7=+'P'A>$&GRX<%
M!ILFK$FWCU_-\]H!PT"T: V\GV(EJQB +P5D8L\_<X])B6NCCK>[.N\F>=1F
ME<S=+[G'?6B-7&=W.W-;[\5$+EQNSH00PQ8GYZ#SE,[*48*A'97EU=E$\7#A
ME&W=[HEU;R/?1)-IYQI7@W,OS9*'.:(S^@<G9@GSIR@>((I,!%0C<S?J>UW6
M9P!1\3<F6N>YY +M ;Z+<8<PD\(GJ>>I64B\$]*J@0?/&6_U*0.V \6XTE03
MV6$'B/*?BV(KJU6BF\LMW5FU_G[OL4J\YOB?<3LAC=0A1TRN_K;FV5G Z[(O
M2HM^$+OR%U# )67[5YC;3U'%&RM)(L8&T@B7*_)%>JE;SA%'$LM%^X9E^H5A
M^[LUT =>/D='((Y;Z+$&1%Q$%NY;J"IK58)LOR)S4\WEA0^U@<^#]T]G$G)@
M(+[6 J*P9H4\&\JYM\ZVGFM2UJZM%D<S=@:]KKWK>QD)1KH3I>Z9-!L0L@<7
M(ZS?@NNX%YM'G7NI<VK=.<FLDJ@9?^P_;9F]49&Y#HQ?=EC!\>I6 N73'"1:
M91ZD@JW\(:B'5R*]QZ*%5VB+'5.*S?E\>Y*EA*P3T/&)T!=YGOB&+S(ZG.WL
MGA?DC4Q(+P4,P&07AH[VZ;[RAR! ,6L!Q]C>TS4HK%WD_1D+3KVAH.XZ/Z;R
MS4:+;$OV56ABS"84ERK":<W#29!FEG8]7VWTU/:1K=Q]'43EB&4MKBG-7$UY
M?XO8+:%-O:EB,6$,(+G'JU[*E3T%V3R<BKX_] !]+Q.K]+" .Q]LZ4UM%(\!
M@ >F(Y:I?$]*C79G!= !X#6#*Z(9Q]/YV<W+D[.RBG,%7M#Y2W U>AJ=@$I?
M\0Y0PSX=IP-/A/O^:/0_J_P:H>\1-'^YX3%LH]DBN]&6?X@7S+E;T2QGCK 6
MN*"\+\'4+PW3TH_R.=T>;>H?/L  D!]]C% ^4K]2@(^4LXRJ9H06!Q<L*AK,
M7?[K8XGT,R!E6QG4L/MKJ]?A]-^8]F!K84VQ_N"78MNE7^"!-<)^2QC P!5C
MY]I%IJ>]@1 #N\9(I)>\\IFY12T&$'J$4Z1+!=Q=6@)6V<VOK:].;^NO16('
MI(7IKHU<%V:C+=Q_F!Q==(;6:'\0$>B( 2R27QE=8 # R1:PTA4-PHW&&&O6
M?/4V-'JM)27OG$M]A@0NI+FQ0DD9*EBBT. #(/<$UB((S?OW:GK6I*0EIN#L
M#&TC53 W$U>]GMSGFWC7S1B?P1==BW*J:CF)-X5?OH!!I.YN&?)IIT_%WXVK
ME1"DKB\VFSSY65-T*ND1:<XQSZ%^XRR1EAEP38Y^F3S?F/<_"PW_]HOT3P>[
ME_B$M9"%[MQY!(KI/.GQ6:L-@44E/&^)FM%#-O6; KU,V\I9<FJOG?YMETDG
M@_5K?>N(@$ZQ[X#04O.[Y\YKO$HTELA;U]HBK7];9R#T.9.?X+O-T#A6VV!7
MMF^L$3NW--YKNKPO?8<S\5R0-H2"BD<7[I!NGV^MV6C_)<;>'K^3LK(/GHLK
M7NL0_L+)]J!_RNVS';#&B'CKVF9F_^K"U"HJ[?C,[VM)IMT2A-/MSOZN;[J"
M[,3]#KW>49&$V/'7CRQ>-B(':@/MS%:<!)<:\?_D3/@LW^GI")+S9IBW(WM+
M9XVR]:99,>T 5:F>M]V1DC\K]W:[9Y4.M$#7UM8Q3\$=D>U@C]O(E31D3E3O
M%USE#*$3<_[NP:N*FS A2B->4A3&X<[KR^5)-4H'#W(F?DE.[^IPH1PS9BU(
M;YG2D*,[Q @ILSGN.KR33 <)II*/(WD2:$+TNJE7IH[ \1_$"K*D/1?LW2/R
MD6?&9=_5[>'B-?2/H>]V#7F-@)[P&2+\N3L$YTS%-X6TWW'L^)QN9K"ZZR1E
M=_M<P>A*\^2^Z,_.%[N8/7.T*W1858,XBR5%!<7M&FIR4'<+1"__0!SPB5>*
M@ H=VF":DDQAY71^VM*)A^![QE296[)H[3)_NB[KHM=U,-D8I1FZ"OSU,:KH
M3?VI"3-HGZW91]2(7>@I;>9D?H3>EMU]YMC)J]( G2<,P-GVJ[+-8?&$=@52
M59YF<S!')N<F=;X?*47'6'#S9)D/!O!Z;Z.@>Y>-6';9MMEFD"OB/@[OUB7O
M7KE?1!*K-5:"OOZ7Q]SIT[Q',N78!%!4-S=7'3/%!:P?ZUL2?G,B%,91;^;+
M/Y=>[T14;<7JWNF>7[O-B2\P3VON>=<Y:D)+::R9B^F=X=KJKO07VN1 VYR*
M9K*I(X?MCL,HVT;>"Y)<LC,#,3_H4_>6TERA;G87B 5*%"*L:-J>05,[PKGW
MY.LTF^:HL$#ZD\X;]-2ZE6\.)C_! D@DK1/:ZCP;J$V1.T\U\2H>QWI]-[=-
MU+U.?7_,@8UZ9@NTZKW(<>?KH%F=%A,-OXBSYM)8\W,'/_YR1*O^@8C1VL8!
M6IO.<^@H?6HY6A[.(B_<=XIL"5A.<;B?'O^TE;H%?G0!I*O\?5]&0^'UJ)V;
M(TUMRWOJUXKY2:PMJ>QK;S/D3DAO!MOFZ7IM+H_HDM4)O['@4EPC0%M!A427
M'VL6(L>CK]Z#=VW6'&PV^VH="MU,%8OZG\L5ZX&.JX19F',:B&3_Y2G(<9,G
M]EI=PDMP_:]!K][CH:9=N4[$,8#^1J]RXQ0YTW"KV241,PUC>1K)3=6)#@?"
M;5>6FEQ=T;+-BPM2<'4I%LFBVQ%>Z+YJRX0H+OV]L!P;K#JDAD]U8=5AV_XC
MK#H$B/U2AWE7[H73 =\1GULG()YQS0X]Y2S?^82D>"\Q "U&]3="S]B7IX_P
M69XY&+^3S4TTDTFNZR[]R>&<1J2;6,W?B,^<\_;?Z(Z/<_N)'" 63V*N&2:/
M_1!C'>(/KE[!/1(G$04*'S_?+;4T9]/Y_%SD)@[6[H&%GX3E/I"DETJ7+#;H
MG=:VK!>+=%;U\OT^NE&Q>#;A=C8V^YK=;Q&^TN%%6WPAUT,QI/J 39\/"1_.
M7"IC4D3_@#2,B58P#6GG*7;)EB4*MF_XHFS31O=N)C$FF1;),'18NPKGU^;L
M\1C)ZO27.]T*HRE_<?U**^>14"DOL6G>AZZO>A_LFQ$B$AH=>[0T$O"O# <)
M0^D988P)HNQ%UBZBP>4N9(MYJ@QL+^CORPFU9W/Q.FS )^H@MO23F[R@NV5W
M?PPWF87U:+R)VV*5_MK,ES.S*0=V]J?G] 6[P;@_\*P6O,#1$DW#&9_<9?R[
MH'?_ L>+PTST)1;_AA>=1E]<,\( 8#69E[=+:E/^\$'!G[=.1?M98NW&7 Q@
MJ>CJ]?SQ,A!UBM6$I)I6)3RL?QXE=Y<'#(W  ,[&P4B-7\&V_ZG\_WME!?^A
MR,-#JFEN[OM:JW9F?KD_8@SS?P\D2?X'@21>_R*0)!._FNE#6;*I]2VBHV(*
MX+-36LU_'C8/M\  ,BDP@/TB#.#\B_B8 /(<B@'XRV  WS52?GD2_7_^IOY3
M^6^M_'_DX?7G /46:;AODQIIRX!>7SW5EHB/%E^IM6YD70+OV%85Z/[NH-EC
MFL]$ND5E+UK>8 "TVXZ7*YF]&N%#E3]JK>W9"Q1]S5Z'=W!69L/S<"%"ZU$\
M!@3?P_OL65[.O2Y]3_]Y]NMR4!",.CYC03D'2_4=(F58A-*' <0^0_,U)JI\
MT-!;^\1QYZ2O1U\5ER^>.\$8/^8=D<\1RD@QI5/;EW=NRJYSJ]\''+IH^!$#
MN+4'P0 DF="RA><3JP>GS;$_9PP%X!QE$JB]V>R^O1>;43GE]U>-E4?M;J86
M=-H1ZD@;M&B?EM1J&A%M$_'4!#PY^E')DFDB6>-! >4K?E/0TI+3X^V,:'@K
ME&29%//3^+&Z@!/+B/+LAFX>S$7.OMP_@PS(9F2F!1?C5E(T&'-KV'WCWMIR
M91=<5;%Z"Q'A]HT7YP;)D.2K<0Z.B$2?GJDGWZYQ5K-]%F]@+!CC_=BDQCE]
M2@.YV=V^<JO.'2HY[(4LPHE7W=(5VQTOFJ0L_/F)@T)\F'[&WP5$,BL@W5;7
M8-DZT3I-_/(ZV$+[P$6H%V@HMH%C5>PNQKBV:4KV$ -XPZ)TO!+FZ>,NJF%+
M1:3Z[I"^:;)U C"\$=!?W!0E;NPBM!9(GU-J(VP&X6]G<T#W<"R\SM".HQN[
MC@&D:?K7!95(N3Z 5GB/L%X[1$4^]-KC)B+!,0EO\"VDV%F)&G6L&OXYS3][
MY;V^RH07!:3L-2*RE6AW)-Y3]J9Y(Y$Y&<@.PZL88.AN\8)F)KX,VF@F6C5,
M<+>DJ/DLO83'[-'O_=/Y[*L2(6M8_3LJ!??=F@RG7IVHV4*PXK3OS6X9&.G:
MFLKZNW#+RK@AM>)G?/EEKLGPN?@LX4_2$H_?L;I> >&E/S<<?9V*OKRT7 =+
MH/F690CX=Z(#M'NE#';<1N3'ICMY(GACZ#*+E:TG<JGBY=]JW^S!I2"G"C7L
MO%9I<8#^>BP[<AXZ$/DY 53Y!,[S;=B[XDNX-3TT/$Y),6<(B]L5?7VEHHZ6
M=UVON7) .>F^?A,LO6JYHYZR)\=>"ZWNZ%G]N!-^)5,@UU<@QT?*GYH/M;U3
MAMJ?UJ_30&93CVP&>G^!AX05Z1M0L)U&5TD&7C>RT'GN[Z(($ \/2,XS@-<4
M8&VJ*R=C?B):J6I8]CH&4*8X?N([4*Q2R@>LI-7G1J7)U5^N9##C,.>-N=E>
MV2;Z[NKM5I+0RB#,H_'HTH).E^<*QD]24_,BM(U0P?'IZWWW]Y!0$AQ24JJH
MT&()KUB#;2.;0$LWH+GZ; _-<Z''QUI\5-QZJ<:) F#3)"=&$)M<S.8[\##S
MM192P_D7$[D-86LPY$;"6R]T]\=F3PJ\\/&6L0B$BXRUP)2EG7VJ ZKY^"@N
MJ(<F$J"6\X4SM#;K6R;Q"F[O%;[KY>0,XAE#<_$=;]6J>[&F'IU1A$3Z/LHW
M_4E!:.)91W0("!D#.BS[N9.KK6&T_HGYQJ79<CDSKG!XX6]L.CF4'Q@R*;A'
M?_6J__G1[E3]Y0(U,^Z0.+6UC__>6]$D#_[J7HYD207\!EP3YUAA%YO8S920
MU$7KW?)F!ILCF>M-^RE6"N6>5#_;A93]?=4-*:L/(\OR9^OB+!L%'3*$0I-O
M33,#GE\T(E:<9>>)\S(E&L?V3O;%O9=B@347BQY[UW%K. 2ARX:I&E0Z+B4E
MY6T'H!OR[ZUDTNO[A^S;YI+UU&L:ZP_F8NX&/(;46F>01!TR1+MWDM!> UQW
MV.[;';(N"/O"!E?(Q(-734GW<2<O8@!R#-="')VDO:&Z:WNB&OYB=9D.A+VE
MN@_# M1"(IV(E) 9KI.-%03G9ZHM#0:BFT"X5AP7%SB/31#'16:VYP6(3TTC
MWBU\&X:^G?[LC;F8Q7XA" UKFU]C*(4G)$4HZ'KIDC,)!Q#D:7%EL:Z!2V=N
M\GRZ*3PYETQ8X;XT.<%YTO:UBTVQGL9*SF7.V&$^VF%"\Q9?F=82;BD6&[V9
M(>!Q*5AIZ+\-V/ZV$K??T^*18A'C:3.:BI+9;0_\*?J6#&H8FHFN==$LMF>K
M0S=F)%)&<SLF3XF5)FU\[G_F+D9]M*5N2P#:D7UXM\WROH-X U.X0WK._+1^
MTE]DD^I?9)/7.BT*++PJ]E?A1/<7X63.Y'WTJJF-Y[MFY8]39DZZV'W=*_4[
MZ3]0"6J>>+^H=0%-@L- :JDRQM!01SQEX!]E\.VB53LN^O4#G<G+FV54@R#^
MMO57I7=Z$+P&R_6]HLHWPEE6]S(L:V)%=%J'1$SMICUWUW^D40N6!A\@:L@?
M+(D&8@63$E@7 )&R IG$ZO5_@B2P/KG-*& GN+!PVI/_YG>%PXOC$CX2WL\7
M3 ;*>)'%<S+CW-?SE\.[/'^=W1&' ="K(:VNK9)ZC(&.[$VCUD UKW.).&93
MH\MQOI4FUQ"\68]9.L1+>L3U%QUB^3;M.!Q0+:4[=@*#U!+/Z:/*C>6X=XZ.
MQ)X3LHH?OYQ@;(I5L'?=.:B\,+EZVCK?E98"2 E/51PMK V;1)_MENNQH)6C
MK4Z^B4[X_U(A#LT#[*8[3KNX_5?<?=!RN2Q"'H.1"C=%.:1D]C4YAO+=QE J
MN9[CDZUGL%:Q=_;<-T;IK&M9*Q*>L,81GYTB2G3GRCP7)X5=L&##=NOL!=N]
MLGH0$[#+(\/U)\WKDU*%Z.O;K925T895#??G<ZH-7A41_O!).#U;GM%RY\TG
MV=H?@\)ZCUCEU=>9%Q%7FIN;ZRL*6%:F6D=X3J-GF1!8F"@R.-\-;LHT F]J
ML37[7J<T6]:*S![?#9 )<KA;MKNYOZFV.<=44_=C&.)?AJK%__P]^E-E+\/"
M,NW)-O0U34=54GO*>GAV:I? _1YK3T;JR9^%&E0X3(5UKON*AIZ(2\YMD(3\
M>,IE1EF9YJ5G #C947+$D6](RD^B_-TM6OBTVRWAH.CC+=NZ<K5VG_2]XN*6
M@I)B7L_$[^_K[NNQ4-R\U?LFJ'TEPN.D?.P?D)C^Q$Q#&3N;YQM2H.40GN_>
MY?Q@F906Y >?U9Z)=RT&(,S@9 BLS-FG6#&CYMG636KTSAB5W;6XXMV-K+:?
MAV2^=/):JA0.=]/@6MRU>L[4Y4VQXA\LA+)U\26)G7OU_N)O8E)D>3209^,+
M^"!J&WS"#5X)!T<Z?#>G[/C(!*55IKAT$%Q9K@58JJAC (M4DUB3W0P#Z"/!
M "BG:L:0J=K+#7&[#Y@[!R 6R]N!3LS7$DAU[7&UO5>\FB56NP?EL4;#+L6"
MI>A230V*7\%7A6H7"E_K$W=,6CW<#+2Z5OL'ME?GY&57M6V@KX6)#]WYO]A[
MZZBXNFU/M @$ @1+<$^PX,%=$SQ @ #!28 @%=P*+21 < @!$@@0W#6XNP37
MPJ5P+]R*JJ[<^\:YR7M]OW/ZG.YW^XW7?ZPQ:N]:,M?>TWYKS[4F70)W!?O^
MZL2WI(:L;8@.3]]Y/Q)0K=BS#F94J/0TI;5"5_XO^U:-%4ZCVTTK=:2]D)J8
MIYHU(U.7".1_+>V S=[/LQH5;]:^R'A$%@+W03%C29TG9.N 8?' ,)^][C7/
M)@91C ]P1-P(>D-W;SL8NA;*9=X;,$_-'W*--@]!AR$!,A.-2M"OXK9%)=/]
MB?Z*/5^F9^_1+6BT7A,\TS?>-?I8G5L*28";0 1PL?F]\+C.-V8]OBX,-A93
MO#D.HL!*52K5+!4]:NE84.EJ9JQNCGY94U,9QO0Q@+S>3XD#2];CC(;-#+CS
MJGJD$Z5$T*$*MWA+5YJU*#0/M(2"/U:)L0\R/!\KF1U2N;A=V^X O'X".%_[
MY#A,T@TJ['!?PN-VN=52FMQPYBM[VV$]_]2AE?HI_47)36<S16*/)U=HT;0A
M4VHZM9+C0V$FAQ4#K)*GCE%XNJ]F).45@L_P@!U+#X:#7/'T?32G0.$*G&U,
MG_>X4Y48TLD';93RC2\SH<K;US[[G:(Z$4)&E0\JL->'YX6[Y>6?^E#6+2@H
M3S8R""R%G]W*XPXZ6=P(1+CU]WSIKQ2B=S&$89UDC;NJ&K3SZH.TGHV_:824
M).[K5AC64,VXV^Z(/ME1-RDFW?$[9V./@K%$,A\I+^DOZ6>79)JO6"CVL<DP
MFEOFW*,_]M(U>SD9KK8B1ZSY-_!:RGUD H^ I*%8?X2T2;:QI0M\S&?LHX4$
M2.L?G]@OEYJ,I@XI((ZXU2?))S3DO*_._G(-](^O!46BOR?8L0]&\$OH;CB;
M22WL>$KUGLZBD'7EY<L_T/17_GP,7E7VNU$"' ->:'T"JR.@\1Y:ODFNQ/9M
MDN+L%O&"!\2;=AL.'L+B!(@F_A+F/2\FDHW4.T<;A7F[XY?.G3Q/6J)!>MJR
M*7T7\7ZKY2*T\=LN J:H*3NGLAQ51ZY8T>V[XS(MSF=G67+U5(/K)89W#=,Z
MZ,AW?5FFJIZ<B:4S$G4RACUZ\.1%S0L_[-4HJW6W6B/CGMQ18_=5*9)=:^@N
M 2[(\S5G2>[+,4/E].JX;_@R  #?2*J<RK(Z"9!L]CQ_9= C(^FZAX,E4O80
M+>";'^ @RT%T'-6/B0'-+4GGMB@B%\I-9]SUQOF'S#C9S\1[N</)L1V$:GRI
M(9<*Q6X3267CM1IRQ'[_:L)S=I;.I6-N(W"KU"F/SAD5QH2M:D,?HYG#^_0V
M:%VQ64?,:VLMP^S!C@K;]CIR$5,)B9U,H/_8MLDQ5@424 I" DZ)='9RXE'P
MTHO[^@*%:F5(['[%83[)^GM!'ICJH2GC'37!4HVON)<5L4Z9&Z>F@(6L'Z;&
M^.TCS-UI/[B33 $7G^#F)Q-+GULI&YHZP4W]MZ,WV *WPZO,0Q->TWV.]WR*
M")EMY##3+EA,OG213.96)WB64'"),@I^HN,&G^?ZG3VL;=Y^O'NE'9_E/(+O
M(/H M,6.?_*JL=GIW==JMTB0W#5:E_5.PE"27'W>E?<%Y]EL+:(J?$TJVQ&2
MHDH_LQ2<JZ(?"F[E>&T#F7V?OE]"([WS85U]0C?':C;+L_E;XA/!:K=Z2['7
M;J7LQW1C#29W&$/QMM[O<=2>#HL@XB<3IO(IFP?WACB@0:P:KKJ=4<UA3TJ]
MKQS^;I;JZ/:DA92%TR3[4$0?WL)$HBK9](,7?&DZ(EL .'LJ;"BH="?U3B@'
M7+9,7YUXM#AY)IV<8SF091'P[20BXD8W%\()VT0\EQ!"S*+L%*0D7M\P<KM^
MJW$(^TW^S>L> P&NTD;O(1!(I0>34Q3;594+Z"/Z.KLFZ!C  ZM[_%2QA\;Z
MN@;.M 1+N/3:IYM.>X]RGF^X$S>NP#O=MU>;N2_<=XVC#:L;D "&S0](P/X)
M$B"'XU"TSJDY<WIL/MG>_4UB1F(5,H@9FP5<@L57_RAJ3D8":)E'=0;Z;F&M
M,1V[2V/U24]*/ ;[%E(JMPML>E&\&"?]]Q[+0U5824H.4"BIR.;8R+#.]KAZ
ME=8S2$I_+B,L7ZEO(>Z>/,ZHCHC9,AXNX@'!OB.NW=")?4]\R\UTS_:OX3*T
M/C<SOV"53;DB*7F[0TLV[LKY;E@GGE:L7_<^+?-<"PVZIS\2,+5M\$I#J:\R
M;NO5&_+JL7D497+_,_)X$5?]L9ZL\AH)B&%" FZ]E)" [TD-+YN%MEJT%. "
M.RBEFA'&-M#^G]GPV.2W?(1JF Z8JIS$:">I/[#"!4H?-O_P6$F17_;X&K4(
M9'WQ!NWJI7]@=$\JL!%V$>'MZ%X\/;T$,M5_+?;ADUQ9*@^EUX-IDAUB[3J3
M=#86HKS+N"[!18D0Y:I1[P6*K%#CP[V*:A*_>?? FHC4>1V%Z$IUXKG+L*5.
M2;J$C0W^)\:C1E_8N6\HUA5WL$2&BSU=B3\7B=$R%.B#QJ'RF1;V/IG-7RW1
MKI(4DP0,5YV]Y\M;EPF.!/;.=6)?OS:8:><A:51Y0'#^RA3,EAJF.O^@?'-I
M!K+(=AEWWG##_M'%E@PA\>&(%V7U%BFH(R+6P*X^0+[.V7<_OGN_B.Y*H'Q^
MG5U9[G<T%_!:*'$]U@^;&N <H5N@H?Z%PZ.E@X# QLV]OKFF0%_B6^+P32TC
MN2DN*6-4YB<LR>"FQV&L0NX.RFTHRT;^O^-Q01$%6[T[%*]- WCOE0!-IDZY
M[VQ7&"6_?O3)[$/ HH!"2LB("\6.I^5BS6$)M*RLKNE++$FC*OOJ30&VU,]F
MRY8CF2FX[NV/XMFJ/;0*CBE[3MGH>K_E9<^C8<DJQ\B^N/(E^-/1TK/HAPN7
M/Q%2;"*4SPB[,:+6UJ+/I1E]?(.; AJ7VEH>9AYAU@#3.](Y/[^(($K8=) N
M4$1S(WCA6DQE\M'$^C)@D031/Q?*&+TO936\(#LS5]/,,Q7*/,W\28 %)AGJ
M =5SW9VFW-D^MU52,U/]#I"]$'<?]"AM([C"VTD[VVNY)O&R!27^=HE]4T2[
MM2-NL:)JVVCR!AI-\.SNX  .J8J'(9=B+]8GS'O"N[-U7VW/AK%+"DMW@-2>
MB%K]L:$ITOE7#7<&VQ@BGE"G.AI/*+Y4HD?K8VY<DAZ.A(.=H:QHMNS*S(NM
M8-P6]UOGR])L["T\BEG+L#<P@5K84'R&H0UD*N_=!&-0M=_EW6&<&=SVS:@
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M.RR!W\>B^P\:("IRU /XP-^&DOJ-A)*$,)$OU)#?AOJ!U[1&J/!@OE6;^,D
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MV*\LYSUCOX$E)H9#^L]OW;OT#WAKR#86F:46HJ5&$X\+?904')TW;Q-,*J[
M5M/>I4)B0F:1TYL4NV'K4M U\$0^$A!',CG?<1ZN9WK"&#X@FVJN6@5AH-":
MCNJN4_\5<6IW9(*XWW)#^5GP_98)+/9]&N(!P5[3#*WZ.?AKA'/*'!)PWVRQ
M:I=!=@1<-N:*F)H4(. /3)%='62-N%W$Y$OU#:C:,E.( MUTS!;WG+O43Y6>
M)_?/K5575]88E;473T0<J\NDBD**%JQA1MM.V\-UG.L?VY_;5@8QD&-M&]HU
M@RL1["![M2&SB@ 5"/K$&O=.YDGQ(3$HLI$'" 2=<SN^.RERY\U<W=L!1T10
M1_?7%&LU5#"Y/A48)@2YM]53@=X"3HQ\OG21?)=5.<2X,^@GPI**F&Q:3GF\
M*0MS2\DU-MLG8B #;%I;ONOV^1'=7M="<QG7D503E%U655L]<5CBIZ)HVQO;
M$=>V>K *.RT9?UZ=.BP]7FP79?>H*DQ$S3D1!VVSA7[,Z\Y\BQSQJ\__]7[0
M;XDYHJ'%TMO&Q)/<VF'B.L/E_FWX\B@M5<T><EG(5Q/T:/SM>Y6\1;GW6*5B
M+4EA0$>)"!\I!<AA(T9222'41VTTXP?PH^:B9J[5W4#E'HZU*,=8_[ ]<8)\
MHQW$_7'NTC[@5P:QZ;/W/"_!A&APH!24LWU;"K\T(YS!V]J6_)R12^KP&T3F
M^_:J\@C_S7W3N;DLVS,<7K#XN-V6BI.$4X]V2TTD?XKE#9>V=V.:A=Y%A$N'
MR_44'9RAF0\)2#]! E@)D8!(.V JS5BC@CU-<S'P_&.&SU:S&3,^3]KGL Z4
MI!@L#U^C@]<FEN!&V)&9>>7!T,7N>R4'S9,.'S'BKMZ(=^Q6.DC&ORV<GI[;
MKGZJIZ^P/M?JSZ#:N8]>K2X0LKI@5&ER=T=(HWHF28KYL>B!<PW#%K94$.?T
M@!$QN-UZE3W2S3Y-:<S\J76O[^Y/R=.6?KJ0;!<$_6@NY/VG(0E-:/N#I1;!
M9:Q8QPMW-^)4DE&(#*PY+??N[)'L_=0##_N)I)'F>@,:R8U]Q!H1?_'I2_73
M]":7!_JT7C"(8L6/(^[0C?*(XJK&70ML%I&YE$V)8]FDTP(H@G2VD?9>\(;)
M6<UXOQ/<E:D\K4_.[?-ZK8)I1AB;_-]>[P;= _ *59SQ.$0G6:NQ7J[=.N$+
M6VMJ;CK&#?4WG-/K96^]95LMC2.YFH^G>+*+LP@F')TUFCH*0 3Z]"J&MH*C
MBIE?&7N.M]8H;8]<P\AJ2B;FE ?Y#W8>30</P#4MM++Q6=:S4F\G(][U;P9#
M^1L8PAR%^%"^PQJ2"E_:RPPPR78J?<MDD;V=:3RMJ^VH7\$,SA=CT+"ASD#J
M_0D#:*4QZT/]VR R3(G!#90E8AVW$TTSCO?N3:9V*\W4 YFLXOO;9W9/C0P\
M<I->#QG8BQ#I:[N3-5E,UBU%L:0TL8#HL&G087IOSH;)(%&AIE[EVOP8]BZS
M$"X[>G;C4:PSUO?V 6-$V] ,111 4_3I 1LW&0CS1NOHON0C&"(C033#C[HO
MIMC?SPEMOXV</LRPE\,A50+6G+*21FK5EQT<-KL2#P^.J97'1Z/_I,Y %^\U
MZ,&<#H-T)55GF^7O>*ZG+,P[$? +KK^2H_?[\H(..HQ>8P@I'HL;Q7\"&R:;
MVQ$RH12/9%[A+)V7?Q1_S7H<8DSP_KQX^%+'F 'BRN[1J%<JYVR/#156X6&H
MI=#&_>;:5IS<@F&C2T?\YDA4W8HC)I\GT9[OX_GI7%3SV=++]2I_A;HU209M
M]2C/QWEHLK( =#])&_=?89!DB3V,"SV%P*2/TBTS4_,]M%CH[($'TL-::<I;
M5>"[.Z(AG2E2G8ZJ-M5N;>B9#=CX\YOH=F+7DQ(&K9ZGM+QIG9(4DYRVZW58
M P;9+':.W[R+[@D/V[C+_A QN<-GC0209E76C&^.+2<QXUGP!WW%2J V3VV,
MB#@=5%KQ88;T+(I#N*IN+XA:U7J?1WS'ZWS22[^,-C=5STG02GG^=;56_)E7
MOKZ)G8X0EPI#@@7[<9ZAJ>.\+W%];L>@S7 GA'+I0Q7HO44=4W:8J5N FIJD
M#L;#H7O0E!&])%&L#[:-%,Z%2]NS67$&5VK=G:LV1"=<:LZQ 7Q;P)\N-%H=
M%^[ZP>G0.3SU5PVUX,^MDMK#6A<3FV4T )*=9CP8\2QSIGL14+<07&#$*F^*
M+8=UZ+JCAO7&O\M"89G@X:7;^=ZE@E%U346=;3=5]M#P"^\B;-I&355WS C[
M8-U#VEPH'N^,7:*RE[4=Y]CRF[C[@.'W,?.K8WG>'##?.*B5*_:9N<<8YJLH
M(@;ZN_[]-%G4,/8Q<9X5577%BF9;+8/:"6ZNR>"IV B>N'GT^=1+.N754_7@
M5![8J=-P-G!*I^8334F!7J9+#\5\BLRPW:WU@@WI=/Z* AC;6Q'BXL5*LZ=)
M8?A\4X2M 7)$'3$N20MZV]&#5PBD?61MS\*'@;M1L1S[:9[Z&B!Z7]=ZN11M
M\+N)L<UL%]3$)M&TL") 6T;$3ITQ+JJ]?&YE^&,EC=H.&&LW9M; ,"V)*@*>
M^8V@OG65!0L0,5:/2RR.:0$[[-S7[= 9;TQR7-0FW[0FI[]U</ !0G;#8>K^
M5!VZNOJIZ5[G^SJ[C]8W<;#[VL0_J6L99;](F='01X$0S:?_\$K$/Q'<AZM"
MI7+OA:!;V=SSU^6*9O>R4G/1FTC/!1/L^>;TV]#5-I1>: 3Q\NP,1N7.3YS^
MS;_"^(\J0QM*^D_:OY*?O>O1.K#Q?/+]WMW(C"6!X]E6KAGQZF_RXNU-;@F[
M45@D$G^QJJ-A.#NW.-?4-$&DC@X[^ND?WW!,@)F=X?<8:$4[,5M)5%6GSM'^
MDI@UPK;GA5F$YMQ<A_4=&=O[#AWD[0J40=JT?OAWE?Y;>^<9U637]?E0I(N*
M@'2ITD&E-VDW7;K44)0B)8860A41D-X$;D$I07KO@01"D19 JDDHAMY$"+UW
MQN>==];,FO7.\VWFG9GU?/A]NM8Y'_9:Y[__UW7ML_>_)^ /9":51*0O(^;2
MXP %H'PW:1FR)>SS>D3V42JKKZ9R#',%SECE+E]BH7^J'5\E-50H,A6:0.XE
M3SRKO53R3SZ$"5;'<S^5C](D?5K;SS.&+?U* 0:#-ZM2YS!SP@'W%1QBB856
MUM[+LF7J_4<A-?SO]D!%!,QX5I,^0>0WL I?>O*+@0!'V'C)EN4P_N4$I4EX
M_+V;,UE=3P-@#/\AF?,,HI3^Q1DL2."5_IT0>E?HZ/_ 1-+_[9B,0T'L]PW2
MC' N=ZW1*BYX(#,G+8!W'R04RG[J,&D,I&R,85R-L44ZT,.&OKTRK..AW^Q:
MT]!@T+P 8N #YL)7!M\QFK;?TV9$G)*-*->UJ7'F*GOVT4SOI:X$TKX1[ROO
M_:/\MUJ\5[ZX)'@)>(?*]<3>,76)QQOJ5R#.II(2><@;<6[V\/1+@'AOBU06
MP:(%EE7>H#(0PO^%UP3PN+.-DB>Y9B(G$C)66@TQW\TX;BK@6[ODE;^"[9*G
MN02NHI%,BWXG!)N,2%_"K&EOJIUE0+1-KDIMVNL+%-K;7V #P,1*W@XYW;44
M"XJD-];^9YV%_\5_+N2W]C2LK_LTQPK -67NE,R>&NR&"Y8/N[Z>IC@Z%[Z5
MMQ7JPO!:;7.%,U"/;&Z/A+:JP4*&/3?:V5MPE^#\C6%>Y9?8@H]GSDD'/#3$
M9$^2Z(^VM&(O%: U[GC2TEUJ!>H:N WOA^VWCJY&1.3M/AK6P703:ZH@2@0\
MBFYUR+N<4<F 3,)F-,[CL"+XU/P&T"73@HL2J1QSJ_"YZW19E*P^SW$T_L/D
MBU9V7UF 5__7MQ+C+U9>)44P]758'[H+Y*%B>>+VQ&(KIT_+1WM9;K7*^-_K
M E>+\GK!')P^JG,0K1VR!U:_7CQJ"UYJCR0K(Y5&_]"?_,F=,;1/[[0ZY67Y
MR2[;$0RU+HDZFO:DMP'-L:+J=#RY+:N_MIM/Z28($[>N ;PM%$47+7ZXH'!'
MK!T(D$R?S .F;R3U IOR[]0QY<=J=19+'!40MWSUHO4UEJBJQ_!H=A7EP Z>
MY#>3Z@5NTN<<R:!B?#4W(H%3%KT\F]PLIYSH.'?JMWT#Z,/[-4I\\[V@=K',
M%]$[J_H(9$(_UGHWCGW15ODL[W]L7ODO_O_"XKYT1>7,>E!U,[BTJ-5<0K?,
M:;?,PG*$PD_YL6/$V+D%V(:C9I%P06A3X_V!]BCB\Z#;K6J_0ZP5[Z<7MA6N
M =9*/\]&5@>+ 8_P-P#1CL7HC6N^E*-@UZ4)9ZRHO:%>P2H^=JKA_GM-C"9@
M=-6B!.=AY0NTE!IS0"6YV1O?TZ3>!)1VLFK-K25<EA19"U?\/N%64'HB1?W$
MD\V8:46[4*V R:'O8X"B[V'IX3!@ZM1P,Z.)<?)$R"D;^+2",R66R\*?A!D-
MTEQTO@&0G%\,_>TN)^5_>@C2WZI),=3=,[4/=9&:/6HL=*,(1OB]H.O_21&/
MPKU=XZ@@V(9!7X@-$1.E]NR25WD_/?4Y_M8GXG=OXZF^LXC$^PW4:Q_*5\@P
M1&*K#X#-0A]4(A_@<_MIH 0W7A2%7,O)TBDMSRN(+>8P@R9,%%&'/K":&2 "
M*APV(C]JW)[N(C7H67BY)ONLT"$^^8$5<,!'H^AP8J+:$;8MH*[!>J>5<L1
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M U]3=&G?HO@=R\9V,; X9[KO7 =WY8>Z$:^ P^)E?;?U\SB)ZBU1WP[]XQM
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M]E 4/M_$;G[6[BX^H^BZ <QSYGXO:A15$"=<)G(7/0RTMVCP!+><N?OZ&FM
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M_IMM'.($$;E>5 E5?36V0CO$K)BKHR6]QD@$U,I]:5WA?KAACT??E<[5L:S
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MW4(/,^YR8S<J'--IBB6_;IC2W0$:C</J)+%W-Z-E'Z_?UU8%9IFN&WDHQLK
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M*S%2,D=RQ9"L^[.,C>8=QM03*-P5EKJO"@QACKQCAYR:2VLXL^+?Q ,2]C
MXKV\JD.Z:-(^+53DI41$9^B6M)N+-,UHE4MV/7>K-B7N8:%ZI87^UN%5@* =
ML9E9M%)EU%JIV&XYX#H8-)X"/;Q0.I)H*F6908I&4+GT;A@.O'#7\^Y5&WH(
M@JP;#XGQ+)_%#5"1_V3>J=67S1PF*R@J"/N6A05+' "^2$*59-]U6G2'R</>
M%1BQMT?MC3O4N^RN$WT$V?"GZ''\(Y5'EQ"#0\X<9QJU^Z\\ANU<OA)&I3E)
MDIU.:#2-N?UU,\2>0QFWV*76(8CDG86%Y2.A"7J1R]0NJN$HSKVE%#*\R)M4
M@X^LKWPOF*<J_/@/<YLI#G?\RST6C<IB+88\ !):UU$JXU,J5CG;*<Z#4>DV
MMOX? C6N\!O>Y;E_Q!>=SQ1&J2,V*X[V4+$Y>/L>_4]C/K=;XQXS1+<UF(2V
MD)S16NF7C3CL[9$_OR,=@X-K%AZS2'MGF PIE.*?F/,X['QL88-GU#)"&/6M
MX-6I$JMRW$ Y5F*:W(P89-,/X-/$:9OVEPQG-O_3ONP%[=TA6JGE\R0+IX:L
M3,40(;HB,\#$+(S8.FF*R]4S9_OB:;.0HD#%:\$'#^0IQ0#L*.YN1T*G=BI9
M4EL2$M+[6C@ @.@=^;YM!H6!*XC!B$#+':_ %W1FWNH.\$;I*Q-:\<JH7_^U
MF]N[ DP7*<D)&7J8[)'Z;;2&V.DA ]5%LFF45PI;CCR3 R6M)"Z2R!(2XH:W
M?J(AA=!^O^E5%4%SZZPUE+%E",M:7B3V(_%=X3 CDME_IL1)>2]6G@$#,)0<
M&MV)&\< ]$\S(^B/G[?<^G7?VC4"7@( @*4[JL:Z,[;<WL^JRPS;?_C5K3ZJ
MHSWTREWW="[XHWL$"Z(_IIX [?P!G[+O!7" >T$-&$!I.7CK;3V4EEH10;NH
M@OBT1]M%6;*DVT\L]9G=MP%H]'9N=F%6RO4.P\^-"-%842>L-6_#)V/=WU%/
ML)$Z4Q4; /DP@*P2WW2U\E'^$E[MQ/;W%54Q279BY#N43",_1+60S/O[_,4A
M?SF]_+T^.C;2G,)]O%:R$\]PU+/"2Y"F#8F%+^W-WOX(#9?87=EYT^MS6!X;
MI=8X% L^07@]C-_Z?D\,9Y8$<'OESXR\V;-R^@UXD?BTY92!OD.;L,(KO+M^
MRZS2Q)@;_VXIN<#IJ18L>[&=CCY6A>=4G"=39&XR)NYJI8ICSWZ/D<1 DI0G
MZCO5??H?19N*'U6 R $P[J6[']<RU%[(RUO&V(J62FJ*KOW7M4X@ZFU91GNW
M?M%0L-]VQ&BLL(6#)'W_(2S?MF0?"VD,BCM NSSC<#&%I0"S?-[*VCF'8N_-
M=@S@.U5TF  BWY;\O#SPTU#%NV+*-+*=N*BO*4L!K-;/?&3#2_?7OC?W^C]/
MH71N94TT*1!919 =3.I+).67V]$*#DU$WVN]FW5[7[>V)@CYE*B#9_"INSPI
M;^9OA+K\/"[')"3D#\IL<FGL>9DBM8U#S#UY)\\G7K]9?#-/PI;@!KXW]LH6
MXV/OFEQ8XA6X_SC1L\Z%X![!"CGX::G:'$6'Y<MJDFX.9QF%-NX+[K3/L)SU
MS\UO7?MW'$2.#7Z*&@P,C)51 >#;VGSZNO)'P9^1 _R[-V]@5GNE3X H8L_^
M5R$*[T%S@%2I%TY'ZX#EPOG=-PMU\CH0U$.5JU88)(:<7U,:/PR@I?89]U>!
MP^ZK,[Q&Z*P<ISEZ[6^J.8]2UT%(#*AUF;="_T0WG7&L[R7=EK?]N=,@TY<)
MV7R[I,-&1^+(4^M<:B.!EV2A64\X[;;#.>@5$;KPJ%0KV^["H/M2U_B!8D)9
MLBXU;-G;_:*U,18&FH34(G./^-).4K"]#NX;5#CD"K^F/W<,2U+[[OSH5VHO
M3B#CX6(^XC+EW(3D,E7Y$!ZADQ(GQYBH]N3*KG;SWNGIZI7.-S^YHT8ZCD9X
M2"NS ;6J'"_A,]?QU3+ AP!^#>7EU[IQRQ(1[M&4X7]:O8HUAP;F-J3:T")8
MZO=Y:L2]PX_C\,3:^(F\ ],?3[\%WR_CG!)OP(_ 2S(-/LD-Y9UZ_QOQ-78T
M?C@CX-^J*DA/ND-"3PT(@FLKQUYQ0 R#8ZD_RE N+06FC$+8C.;4M"6-58[
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M>;K%OFJ;XM/<U0PG1M@DNZ*0(\_C>7](4M[S+'G^T.0RZ::E9RA/SF7V#TM
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M5:6=PY0QGMSC)P?6;P/G5@/5TZ6-=>!7/J03K"'!L/[A*80Z/=YT885H[NI
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M(69O%?KJ=H5!XU/2AE/8_Z_=Q0#.YEM^E&S$=DA>@48V\F?;-%5RHI':AW/
M8MND^L&^[WAQ'Y^'O+W :KNBVIH0Y(,0KTFYZ0]0_ T_<@S 2G%/4"71VO*5
MYAE3X"U('UGX8<Q-P[=A<;RX35TW)+%O\K0Z4?B 0#^5ZXFM1V<X7I)MW!0E
MQ2V/4:1+"E&?T66#=C+>2QU U->[#\ *R*U6YD+]UT9HTY]UHE.)YR8QQA@
M6G(*=-:+ <04F]P']S2#=J!@A87:\*'J1 ;G)OQ-)##E\!V2_R:<53B%4I[=
M9VGU^HNT$@]WB]4U?F*MPG<WNS/1E#64[]]=!9-K)#C!/:'G<G02:4 DRE?O
M&<<BJTJ,<Y79%^%YTYAT5FO1<J#FW]*S+0"ZNK< GL+% $:47)L?(K+(']R.
M\ ^LJT6_UO3Q<4W9@O_3#RR\A-#2TRV+X$T%9Q4RZE.54UJVVJ5-AY* ]_"5
MU\*EI\ 6'DGK'!N2;^MRE*O'.>WJ8G^GVFRP+"+SC1S]+RC5/[WZ.*%" .Z!
M6Z!WP%LR1;UFCK>+XZDU7RJWN4:3F^FPHY!C@ &4AOZCE&97RS%7YC6R9?+7
MX2%3I^@"N 4#J*3*_.]?UR7=I&$ >P>#Z8ZWZ,S;ABO&@]"JK6+^GX(%)WF2
MS-%1NC$9S1-)*S?IQ]/;(::$.L3U5N:?21^+HJT.R4:FP3VBL^@ZUF.R :_J
MEW$Z8_L.F@*%CIQO? DWKYY>:=<&]X:L1\U0FK+L\:0A)I!H#P\,X+.#@<E6
MM<?._::]>.>"WVJ\V.CYP2MQHXUMS]U( OFG="4>ET0NM_[F,YBXJP8WY-3L
M#CG/8Y_'*I<3!O-\[3Z>">=0W9P3 UM"GEX4FW:PGL:Z7Z'?*:&X @ETD,[R
M1L]NL1"LC0B!0SAJ:ZW-76@2#/?I,C?'\G7*$1QCQ(($7B,?'GR 1Z^$]^[:
MO]HM3NT5(EX_H-62>8"[P6[@B+>M6L G<X'MU=._F$R6$^>N#R$;*/'XD_)5
M"Z^^PI:C@;F%+D0YR]\"%,'?N_M"UJ65Q?J:)LW]H%6@;B7SBAP&GC>YQ=/F
MA-'FM815^=KI9D>;%UI$ONG2-1<^Z+2__/5TN6$.[ ;>>EL6>05DW:S)0DB8
MV(0Z-U4M@K\EM6, QUS3V/7^W/!XV*K@LAYII.#UA  TWTDS1$J.2WM]_! %
MS3K$ %#AYZ"S'AT1R+2>XLJ@]K!JC3R=+&]GB_A#UNC?T7WI!K7JBOW^U2,I
M-$5YWJ_G3>POQK>'2O)X$T2#8]2Y)9.=9#<-SV,XFI+"-ZO*$T5>[><L9 L1
M%OVVJEF]"IOYE]A*EE :_*!T1%^*:O'-P^=2?K\BW+<7JM+8^U1=*BI/;B(*
MAR),A=N3YSVTCWU/+<V[Z@\BUD+ *9.=PA&GYMUGH#QW"]+\MAQ+GAH:\[$Z
MN[NO_-S]";OI;91&XQ:SND]04&A1&_-XZL(^]K:S*#807[7[V!=A*\[?(2]2
M5V_DEJE-8XS?&1[6R?30?RL=JC. QJ>N$'V5<UWKZ%M4+W:^(C'2HI F&\JI
MX4/].!J+;TK-0$%/3 TYTNJ+C5DFAI+N\8G$'SQ)^^ @W,W84+3N)XX!,,G4
M8*D.,?JKC5G.H*CM^=0I';YA/+)O:M01^3U@:N7@&E<7 U@TN4VWM>%%CA6W
MS"0>OI6D,XEWS:@;9IVILBXQE>[2V7"<0E.TY3]7%FN,,4[" /BXU$:9QL\(
M#+ZOFY.U2,C,0>DUK@.T;.UEVD;($O<7.!KM.>_039>"=6-7-8^8]=F'#@WN
M+;))]1]E'I8 P036YZW.EA7<:#;Y3[>2JZ?%.6PB_7^D':&.A57+%(C0FKB9
M;9;1JRO40#3QX"<T][AT.(X=LT'7:&!:J==U8KY7V]R\G:A1?1JE2_)I_QUU
MZP.<RQVU&VZU)ZU5]P"/\'$B?+^H>X6B92*?HNN);_%TF'3:Y4$;&,!LU-J5
M<TPL6KD!):X<.SE)_=HM:($[YM=O@ Y/J3QM9O@G1ZX?\!_1UO9U^',8P#<0
MNFC'-F)*WW_PS]@F&W.G)X71PWOFXEW YB:!ER\A]EHM/2?<$X:V(OSSB!9?
M\>ER$YN9"&-#3_(3: 3IW*. [#C%L5]C#%X<"QK4@KNOK7!GPX;K#T-BG(B3
M"-[<I@B!>HZT4$!W%]86!"<+'X'L3"S]^YCHL4J-6"B9-ON!9:21L"BOV\?=
M$K>AE +;:YL)M_.JDQDRR_O),BZXCNM76M>;*+V"N3]ZDD30G^NU<58_B=G%
M6Q1F25YVQ:>=BQR6I>U(:WA8YH)-Q^QS:DZ>!_$;XY09WJ2LG]GM4*+4<I5,
M>>6%TIB2XQ ,CWP/]>'V?DSY;S_/,<V_#SCI^8L*R:6=5O8K1(\F)RFR/Z;K
M30K@!/5'K&[919/LB<=NR -A1L-2> 4W5GUSZ1D-')E0?C$[#(#QZN]C'[>V
M_PEB%?\[)%<7@]9H[3$ P[@K_!F>_V+-:2>INB\[/ZUA %(91_Y#5Y_<VKE#
M@*'S?.6_\?%HP7R7^)/5+:.?]B8)?&=?KJI]SK;  *C:CSZIO8#ES<T5V*DO
M&'X^IQP^9CTNB5ENHO@L'?&.[NM3M$":?PY,B-I$Z49W,J#3M)"MQLHSKZ8N
M=,4@%0\"GW"[@5HVA*G22#/&[NS?08&H=M6^9->?FL;H/JNW"CD] .YIE\MN
M5(]3F,==:A\S=H5]XRX"X(QHCS]_.9X:IS\K?>O.W3'T).\^Z6DS#*LC/HO6
M<>$MP_UM%I/%1GMW+E)!8_4SJ_,8P#+MD5^<4F<Z6AGE5*RLL@:64GRZ/Y0N
M6P%.*=<5&%8N86G0]TL?:@M[(_72@B&(%^] DN&N_&]:^=+*SVN-IL=('S[(
M$V](1FC(>TWT:RSA90:=';=<$VB9LJ*8);C#=+TKRUL71)\\ FM<XU>N_E(.
M):$M)<V\68?V%1YHE*A]PH[K;-Z^5ON8;PG:85/%$!8)VJ#\1U*LK3[!PDU'
M(\'TAZRS85+D"Y4JFQ]6FR<$,5N\N%?7.MH",%.NI UGB]Y;2Q"H-_T%!$LB
M4H>OES" ZX?%L =_TQ3/;@Y0.SH:][9U/KL?T_\]B#=A:?'JF1D&X(\!I(N
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MP+YL'BGM*H$X,2CS1/H-P64$(DIWK-^,P5ETI]*3."83[IX[CVDW<@CZ[-V
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MP5-F%N5&=>XY838:>N>>OD/3LU+B<+V9^IKQE-F/5WG:W J%,W34V(A\M_L
M-C6YD:61?:C0#P_*#06*8O*1K##U2/.!8E_;92TB8'?<A\;X2+ -D[NWEEL1
M+^(3E#8\([5UV?,X9EELUR*<=5E%ZF+G\#)IK)@U"NBLX(/@#XD3*POC/)Q?
MY38"O'HK$JK:Z*4],QB!6T9@/D,1%OTER;/L 6!0M55X\6K-'BQK,F'M5/1C
MNIBS03KY451HGX3D6ZKC> 3[>OLMBED?1&7*Y5;%]?(:&2O=5UK<2\&W"J.I
M\2$)L-*#=34230T'785'!]3?]/5#X,=@-^[P%7'3QP=<A0\9TA#1>4AK59E3
MHIO_(W2V6;+<W16-9O+7]EYUJ>*O/:J3\3TSRQL"*XB"$]^ DQ?G8E++3Y@G
M"^PM,DKHI,O27+=DIP]JN\=&TC$CAHB[&!);L1-6V5V'V -W?[)9AS.J\D#B
MYGTSR2LC&9__@=_+LD-E.MQ+.=1%C:7DRDM5]Y9BE-W.844L682KV+/%M=K%
MK D;6R6F[^*$CI5VDE=/< P%U@X&T:LE#!)-1E7_Y-VE,N#WE#+(BO'P %$#
MUAI:>V_Z6,Z\$L^AX0Y03T2O=R2,Z:4%&:FUF\"IW!_L]6BG'7<B/8VCLYA'
MQYD[=P?9NSO@*3M_Y(#'4%V+7QPR:003"0T,"NAMVXBO0N.4CQGW++!AJC-"
MAJ%<;^?DUB12;:SJG<E!D%G# $)'A9WNL?%ZEF",ME-;U'Q['I,+?6\6"%(1
ME;W-NWT37>C ANAU>W?53B!/9CI$LX\UG15>[SPN=-(Y"-/7212M>0!PO.@C
M'WC=N<JRHQ-:P#_D[M4!V2:)4W-@=TQM>#.C,%/7.RA'5>_U3S[::G?2\LK*
M-+8/*NS:YNATUL>/;67M>$:]4O?;F<-4T>.U?$OH7NELD!L U9)Y'X\<D5'D
M+D!ZE;8IX0LKY!;YD-<#"T6!7@6A/L8HU652&4)3:WK\MDM4L99492VRZC?L
MG8& >R\ H?#L==J2YT04$5='.\&F8:(6D68.D+$&;+ 0PAG*%Q%%AQU4Z_Z[
MC^EX'>+>74L$ER'*%7;()\+8BRP:C]>OZW,EU)#1__U?K)WR+_P+_\*_\"_\
M"__?0IM$3V.ZU3S.@0R+2%;_AQ  SVCL7$NCRJO!&9^GI$*^$F%XL*YJ[U-D
M,1.Q/E=O_4Y!Z;--&61]/;*;@5<FZK@WTM^3&O.9R^%,#KQ.J9;8O0-C*C4W
M1!#G_(8:_L/S3\0/Z'HL0QIM:7F%'>NS7M,47 4A2K>+X@EH4(BAI465H7,:
MSZ=9IH- (7HT=!H#!)'/KM+-_O8#X-E6H?3\1LQY7G/+$;;;9.R4OI(+BT4T
M-^25V;A&T5]YFFEA_P> ?_X#@$CYF!,54=-RX*>AV>U4Q%? @,S\P([&5=^+
M5H=8L$Q9K%IOJ@)QSJGGTY@/F9U[-=C8\<\-9Y7#P0U13+L#X:!M5U&X DU8
MSEZ'1,?NE=:FPK*/B!*)D^^5B)+X86JUOSQZM0+JN2"(:;SZSO6VLWP_EVWK
M 2!3-G^5K*VKU2801S0PYJ8Y8$>)N_%VKF[NA22.1[<Q&V__S^WV#1&8RN%?
MC\#+UQ[?YEWW9VNH6F $97W9!M&DMCY?SL[\8DP+LNJV[50V\MD%\;QPN+K)
M3F#9/R']/&X\.)'.W53;(1<G+ SP:"5_B%$W#LGKSK_+)F4+: R?3@_>BBK+
MED.0(&>4]T!?<<\>*H:+^S3W8Z+EEIKRK=9*\H"57"*=A]V?=[7SK4#J[/3A
M">KL?/Z2&:?<^?X?%ST=#*,DO7NRGG[GV^\VZ^X'QY7="!@BO']0V$K0,HFC
MUS#'.&GN*G*<<K3\76<7-<O^>_D $*$B(OHARF/EYDH@Y^;$ G7 B> +[GB:
MLXF>V;.O8/ZL'MZ86&ELU&D6VZE$&*S+K\LJ1/D:X3%@4NVV7IUG&Z"QN7'I
MM_P Z)G+^B,JP8"T'!$](6-<I/W*#.PHAPE/$&R&)SJ1_UQ+#OWZ*2N<->S_
M9-V1;6%QQJJZS,7+B:@1\S(G/N#[]:1 .@&*^M1#VB#&U2$.Y[L?3VV)&C&L
M.OM8^OWHN2NZTBVO8JR\/419"8!7)K.Z2+5;'R>'9*H6.+&Z@&&_S./%VN]&
M$CZQ6%BA:'"NK8EG"I&L8X@*9,-3E]$IGV#G%XGH8=\\9?R3V)OJRC5UGQ+M
MAS-!$H@">BT7#QA/>E+1*015<U\'0[F<:C^=48E<7!;?$.?FFEB3=PK[)$YO
MPNNYYUM^%6[T#@W\=%S4&@#8:ABY7\5GPNO,HB^48L26E80R\7CC=Z0*13T)
M9#Z.>KOE[D"+MAT-%[<G!WE^FK2M\]X!^9Z,:6CS^UAT2"'3;C5J/]*J\GBP
M>P%$H)LD*ZH)#0SU2/YD-CE:CO6!V(^J7@?/CJ_4T3_3EVA41=L78;_>>JXS
M>J[$ 5:)4$=NG,(L!GL%X@<QM=H YR_^E*"DS<NF=E;Z^MDLAM!$3,&I=7]_
MJLJ)N9<,!;><J/*EW]H\ ++3_$6PV.)JKP)S86L3]3[1A<6-'-6Z2!OEHE D
M$.T$1H7696#RXUFQ.<,/![R;62ND6<6=]@- $3";%<X"*")OAN=OZ?YP*33R
M>-48P&@3.6V:@L/"7%'BH]5MH)M:V)R$0S(3?V;*(YG?ME'IX_&T]I#&O5CU
M&#V$+F#.2-+M)8K)4*D@TC&CPU%R_RP#[V-6D;5!:D*L*>-!IGW"Q<C=IM_Z
MCEIYJ>$]L7'RND_^+0WH%L^DVB?L6NA\T-.7\,F,A@[?O&J?7D7TI5JM4H25
M^&[F'5[F!?_@G+<4DO@ [(7]TE"'JWK:#+F/4Q!:RTSG+SS#1O/^6"!I1=[<
M"Y-2 =L&BJEE%IM^D9 Q@?J<NZ7G,*WX[EW9&@5D=)">/<=SM6;%$LTW?/WL
MD-K*;2;%TV:@.C//6*E3PUI@@_[-&64L2 9 -+CC*W*$B'&<F*QO?,N3PB,+
M>Z.UY8H6>%Z(^NSB8KYT9[#17SDG]ZV+S+.,,O:,3"+8S%MLU%GFR"=X((7X
M5(E/LI2)E:P_O1-3],B1^ST%5/#'F=HK6W+C[)<=++V2\?9BKBF4OD2%##\(
M;1BB"_[M:"L\3?#/8\' A4UUI(O/4S8O%<V9=0,YF@8"&91D.7!//"B\]ZJA
MF+01*)# ;C<[@-]C.TK9VB(Q_W7H9;>R&^&3K3/=Y^GAJW6C+E2R-O1Z%>'M
M]&RP]?(?.>JYT:UJ8F+UX<A1.(M+%.ND1HT^,<7OSK!* "G:;H#ETW6B>*>R
MF9FKZ#YI]PU!/0?1BOJ"J:>;0."@^UG!^0. <-N7(IK>CXTL3R@$(\X;0F-.
M^ 3&UVOW+$YQUC1*J0)A#^@MV?*6R35R]]ZM -DBI7B34-64;VE3:^?'J,<'
MYZY.51K^U%4V5(Z=U1UPK'U\D6W]A0"2_T15?D#G2&<\-::M#PR36MPG=I 1
M42%NO1U3O"85I4'XBQ0K%=B5+#54^QRID?=1+$7][:!=.A'BY]= VNYM#)<<
MVHS8E!A/,T:1/L.7U7Z%08F#U_JE#G$5DR<_RA^2"+/6/8:0;PSV-$I3>3"H
MHYO*F&\9OT%ZRYG95DVCNG1GZ;AFCFNRT4;_\'-2;E>3_X*Z-.5E%R[(W%=S
MB$_]-;T0_?Z>2HPH,-.]0?GX>6=U.7:$UY2L655#1%^\7"F;YW_YVPRLH8B/
M 5;T3]\FO#7*T:J,BO9!!^XCW@]8ZHE?N!$+$!\/#B<K,1/0OQ%9:[LF(6T%
MTKKP1^DK"H#M=N\Q1Z1>I8[5/ !"[[[9</P56YUE^;+U_??J][3 W86\$@JO
MZ;V,^I^SF$$JS0<FO.BN3SYE4P:34LDISNOB9OY:P_]IA2P<;.R%*;1=DT7
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MO:.)^<*+S=INXI6I0V8D4B(*H'^4&,Y/<:=Y^7X29AJH5ZF^]T6"H<#A%&_
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MXO/G\R5Z"1MDD@C)YZI8L3VT%_RO8_@,WJ74621%%6)OOSL;JO))XWHW7.(
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MY1R9N3)(S[Y /-U0\+1C+,M,\?V2 \R7+7MKTG5-W#3P:^I2.Y%<!2"YEL<
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ML-EODVADP-$![V4E:,>[AL-M$!;Y_N9@-8U".[&!5U,QP%ZZ<"\O:D\;.JJ
MW3 J1S[47T7_0XJFZ0<E*NHR>LU2:;M![YL^^NMV[$1]%2E"]3>!"6FH^?^
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M[R]Q15_>Q@!T_SA_7(410Z?$>\##V)Y*\-B1.:[6C.Y?LN[8?88!NORTU3'
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MQ+HS.'MR_:B #^U@_PJPZF^,[^'/^JI6B1+" $'DCS& K=SAU=XQE9,;S=(
M WA4R.DQH 6V#A5Z3F *U?3L)"Q8R.A CF$ Y-D<2N@YX>B8^@JQ$Q:\C&1H
M(T,'NI@1[<;<RPP]30BCVCX2R*[_9,C;Z1]BC--^C$&^A3K7V5VT?G/AV^_U
MP0ON-NAM4'NB*["2_K[I#$O*#SMM7QMR4'LH5]B" 8:?SF$'^]7GN)_%E"R?
MV$E-W)!](G5H?RT4>3%'*\?QUM[-!:=V1]3#HTVJFSO^I]W9\N==6H0?=$)
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M7R)]*@D ^+&D=S_2FV%7XDT*3>F1"Y0-+RZ2'0C:,>B?I9(\X+%RWD4=#&*
MT1T,,,$L=)Q-BK._<:!41=-7:&@=?XEIU!D#"&-_[1["]GR^BFM$_/3?@.J)
M![RCT(X*V-'U.>@;1Q;3HF-YO]W1S=6C \+8NKR.3H&:'W^0<**E1Z;W7V3_
M ++XG^W@S38?RZ?$(5]S".H\>'E3R=KZ?Z_@BI08SQQ8!HH0=%6,P.=O%4K'
M6\_28GU2&V3Z?]K@SYJJEFDG_O_5U/SO)IO)-I'P\E1N(_XURK]S*4?,NLV[
M!#LK39B9<>2R=8M7GWYL7DY8 ["S8!;5[^%R1@N5666R(^ZVC3C_ !V1O:J0
M%Z#4P[;$8*2>_=1..^Z46UZ@930*?F=N)\B8P[C=PXQO.6P@LSQ<I,R^_E[5
MLD]B;5<;2AK"5=U\XTG;S>%BK[2#VN+Z"S(Y=N;?MQWG"FI2-$:KSL1F 2',
M[_/S<NF>?J\>@^_H$GPI*/T:IG4HNR' 0&P&L;&LY'LX)P)<]O_.2):;82)O
M=E?/H-1>O"1(]\%]_(^DLP:6N[+WZH7S=:L-W#M3>D-4U;D''=4AD-NJ<U1C
MK=?RQ:9K+A**-E7K.\L]6A;DRHRY:&?;HV3\5N[.DSDB$4/]K( 7:<FFE=1%
M\-4;%=)E+53%$W>\EZ8(VBCN,;\BJ+>?#S3="4]&S"&?43I'DA:]L8UE9(0'
M.TO1H[FQ$D KG;]R7+],A'7'Z\[9*L:V1Q4G3(P:1Q IZP@BD4 J,4",(_0
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M]I6[W[T0P.$,:;1K!'XH?)T6B]#([DTKC:VRJTW!N(S9OB-']8^XB$^04 %
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M!!Q^@$T6TI,\!\ "A=,F+=CZ!BPN:'L)D-09],9SVM)JN7>-XLK*\5.U1Q7
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M8\^<(SFD*4T(*+#C"/2T+>LS"=?U!\XG&U\R4R4*IO]8>0(%7;)!9>7#O]H
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MU3\V;%[HYU@L&3>UZ1T0=D9(D$>2"YV?5\2CU@F&(05Y!6:_/C%/#F8+ @$
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M5<6*3FMG38UNW2-Y@QR!0^BGF<8.X1,9"$E=5<OJWM=P;/LA+F8#Q9D1O,W
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M/X._.NY2-[6!GP:OP(*Z&-[A?](F^M_YYV'(CUQO?@4J"LKG%,C;75X!0T5
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MR5%L3$V#"-$:>:TI_?V@2OPQRO<8%"!!T$[D@1CBG=,Y9'C+B/]<Y8(H!FI
ME-=4T]XR..XHJO]TJLVI,:F/%[V-UP52%:-0V.. .QJS-L34"IO#?AGH.2X
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M>HY'OZ2I)A"QWO7<UQ#J5)$XU;GGK#!3.R;I6>5^P6F-"C3(6.^X3A0\B_L
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M(8">A!@A32VK6URC8<-D^^HH1S'!O=.Q?A:N_+'7>6Y\(X($HMSDF20Q*]/
M[^J7B7+@0ZJ&3#ISN5ST:LU]4%SXY\.-+<V/&5X6](ZE'#):TND+I)X4VD4#
M0BGJ&-$.)!,D'YJ6J)HC42;/S6#2=N9S O'"QOC3LZ\4OF:H)Q.*#<=?PV2P
MBT'KU7T[O!*NBQ$A""-$)]ZC(@%D9.6330/Y]5Z.Z<K-?'L?(W1#')M%;CCE
M"*//NO>M/-O?DJ5S"-YQ(6[%G!-G%6AY(B?_N =(KA\FH?7NIWOV5KKMLG7"
MK*F#.. 18()F35/BB8 C)ZS[&?D.U619<A;O!]3]DOK9!>P5D#5A<BZ%6?1E
M=+Q]64<A),;*Q/T[30)H[@ #\;OCFX ,N;.;+/CZ46UW&I0^77.L$@728N:J
M RK1^8+DW>2#>I^B+&N9MU:I=TFDRMQZRUO[YA%[6PTM)GMGVQ_'*",$;N"S
MJK^MZ/=62S2XEQ(.I9TGDZ1AJ(X!UD@*/8P<SQD:#N_>)<N.S2 <@HXT]ZH@
M#_O[@E]3--E+N)20>^4.*-,IN5A91KS.E_84M[6Z(V\3A9S.UC-=1&C2]:XI
M"WKV>INCG7UN-I_IH#_&OLO3WXO QN>P-0C/<B4\ F%+&5)1K.6$<4Q0_G(9
M^*!GRU,C7CS&9)-IF>[1BB?8& 85,(F*'*-@M3Y5?KYWI:9%M=]]0/O620Q+
M1FBP+34P9A#'H7M+>4O]%U_)!7=7:PS/=[B6DGM[XAB?W4^:K FHZ_;[XVM-
M$^3Q .AO&5'QG*!_3[K@/R$D(;LE08XY0R[;.EU&RD:,^7X2"H7Z^!VB.*&*
MH:/W*W!3!-FFGTOA1<6%9)H(S'[KS3+AB>$0/]-DU2)."DZ;;(M:#2Q3SR*8
MH*T'I' _R"5)6Q01B)Z_$X3:/:!VG3!XG,E]K[?<0[:(J8(GUKI@15+A3U8/
M3Z*_-F#-I5WRC5)?K<ON[<=B>W\]'1,()G--;>][AO?.@1<R3?T(X@^3L%KA
MM])X4V),N=BB"<0'NC)(@U3G$2YR),3='NUY&ZVL+"ZH;>3Q+J_ /#<#5CB[
M,_-9_#P;S8_P6()[KQW^9SHO=PK,$JK- 0>P()P,G2=CI*T*G,]\ OA;]#E1
M]S8ES_M<5^<$!,:@A4+O !J+N7QLF1:W0R@U9X]WW3"3EC"BY=H-\6/U:V6.
M\F94!]6=MO0(_(AKEXJZ*9S<82 [^\3J9(QT.]<E\P,$:V&>*S$L+ZO&7Z.&
M7"?WSM,2B.9IZ #MS4Z*+UQ>"P839?<5=0LT\NIG-A%;UX,3S7<=2# ,4F[$
M=%WAV4N/OY.<TLARUQ- HE/4WU6Y%?F $%SR]F^!\!A"+^ET4%-%O#'ML>_:
M+]ZOZG(\Q6*N6I+?39:XFQ$G?QII5&JEOE^V_<T^ZB=^=X/K%/*HV1#PLF:?
MV1)C%N67@YW!'JDD_+MD0<X>4$C*G;/--GU)Q.R=)'^/GN<- >QJ)87C&JK$
M/CKN%50E1?6^ C-4T0'1?=*"AF()=\6HTQR@ WDE++E^/ED5$>.?:A-8BB1J
MN\<-4=64YK'/E*LOI/[IS*,Q1CK2;[U8SZ9"_0HP:[;7VMWOLM#">?7QY;^[
M8(8X%RGQ&S2*892#0V#-B/8:*Z-8;.V7]_W9N$+@D$];'87Z7IB\G10*QY@P
M4-WMJ4/D9M^D(2Y6#UU.C$6JIP#'+JKMO>R6HRE< W=)R-V-<_;<C$=<DQWZ
M4GD3#/ $!P#@)\L_!BH^2BBVI([ C^)E#QUUMP=$#F!PH!IBJ$.;276\@U+<
MO-H2T0K!:@9',[V$^M#S=$MJY@<B2Z1\/U/.7,\LB-MI&(]N]>UA6P2?NS&H
M:'&@"D'1NFK@2:X08BZ?8G=\M:!=/L+'9T:N=0.;(^+06N00->/0O1XWPMBF
MB:R?8L3:+1 ]>N1(IE8%)NL-4J]#AA00]]FLA4F'#FI,=R%]($?>KN\ Z==R
MJ=N:$6QQ!NF]P=%SIV]S+;C&4098H F<.YWW5E5#A,BP"5<"0;#O1<3P$58O
M,JZA].:VL-:,:EMZ@WF&&#)9&=C>6\]Z6Z[7F4A"K;LC1MD_:HRB<,2 2*LC
M&/BB$QR-OXSQ'(DWQ7V44>8CO8T=((NGUTZ3=$0>E4_:E?9?#5JK\MX,^\0%
MA6.A8-TQ L8&!1P0)Z\P2/*^Y:T017;%FY3V)QDWVM\W^\C"?OEEW&F ]!60
M]Y:;'K$29R'"&_JR#^UY\BQ*5$[:G#@$+IXV(1!B6PFOSJ4[BEZXR$)A]D;O
MRAO6<F#0: 2")^YJ9T@TD-#Z2I[CJ0.',5D^8OJ.45[*O;WCIK*!^H@]VKVT
M369VNXG@2X:@E#8K8+  ;?%9A[L]R](\QMI#,,:EZTD1 )GO_K23MI4N3G5J
MLFYR1I",E#?#'FJY%73@N938NEWUC3ZS'W8*! HE2<(TM\(+DBE%-.>&NOCM
M-0(F'.0-):CCE&H_*#]6U=SS#*!G^?&__2,':*6N_K'?=ED4:A.>]-C>J6=>
MT_,F9GQ]5:(JH JW.^VJ#]$B/GW[NPD&5EQROTZ&)^. <J6WKMUI1"Y:;X#(
M?-$((6UZ^R\ZJ.^" F-"SL^YPQ+AL&(N;W<W,YY+1C&_-9191?<U?IMS%'_B
M*RK_*3V78Z#7.UKVNR?\"^IFAHUR==_MSX:/]^L?$M/2[,:]56"6/]:6Z=B-
M(B&0./U4FS;EJOL/VP+49NB@F=NSD[?B4K!FLF6A#MXXVY7?$HC*,!)%VPAW
MTQS2\13B:LFUX>7]I+EV6HOB69%L8F9KZASF=DX/]D^\1U#.O$^T\U6&;4QT
MX!P@RR2MK[N0US@7<3^UO#1:.U$[T:BI:7ICH%0];.S5'>4_5\#+N]7TR2V@
M^+?-_KFBF?X]>WY?>XT^M.<:-N?'@$EG..WVZ9LU2QW>1#RMVVJ61#>K(A;>
MZAC%)-K/[)<SL6<']U9O/HS:KOR&#*CA<5HW3H+LG-C#!&5>@?9[%&,,F(M=
M1UD]6Q'V7T]W*+#><;9CK+&M8%LL2V*4'2O;5P")OPA;JCEBHH>MI%^T5OZ^
MBPR>@GZ@DJ9YC;)'>TZ(F"6L@:<8[,:UN7;?1%=@07W:K_#@$K8YQU5I1K=6
M6EO9?"$2;ND[[[*1\SX,3SD>TJ_$1OIY^<NN8Z\;SH@RUI(16'M93]H]9FG'
M-T9?KCHM[/F2_3[#QZ(&/;QT6<?&6[B]O.YV87KTQ(-ZD8YZ]Z>!^;<A&(0H
M!'F?W][W]O4*4E!E-\1RF[PB%F24U7%[/@=!\X59#RFW1C13-X3+Q/IS'HAF
MA#(JQP(U6( C![]!A VS:-\#>BD3YI(-"GN3X615>/=0OYP6%>Q.%3^!D)9(
MYM;*?,+B!SUYM!3>1$8;!P:'176&+XYLRD;QS(E?6>W:WFV%<Y5)["CZ6&2"
M'7E8B!':U10N,2MS/"$S1KR4R\2#8VWEV%ZWTS)(ZA$H@"AZ;A-NI8XW;OIM
MND>1_H1]ID7"OL*W UT.I:OT?*=^_O+AZ/]^8$M3(9RE^_P#S_8PDAD5<0;;
M7W9>:E^!JKK,!_CE5V C6_86+_85$%OY\'A-!R,!F7CIGO8_) :_ I^"R1?U
ME)]A[/Q_3F:A(3.*/J* 7H$LN\KG!QQ_8VO1:[3Z5Z!3XC,77=DK<,I,^Q+0
MT'EWJ/H<G/<*3/(LO#PC Y/_ST?1)'2Z=\.1GQ:(Q@-61"61=N9,6B4\7*.C
M$*C=&Z%9&-D9Q.%E"=FJDCLBZ=0FR/KXNRA<DY^$C(U"80\[7%#69WMMCQKX
MD)"E0<PO)@1A+IG]N1QMC>HH@O'^M?VF8'<2A\UBVB,5Y3QKO!R%(;M92AH"
MU"B$"@1O6V_[C(2950/K:"F<V/C[4+I#S]LS,8RK<B;C#R*\-7+IH*5>\]2C
M6<OY7'2[D?6U(O<WC0]F5&]ISN'774X418AKP''F&E9*>G*&,/8(A4TPN,DL
MD6:42V 'W/"NE6#C#IBK-_@B>2_"=-"[VDJN=RV\0()RJLH7>P-&1T(_K_U<
M%+C0^MFI^KCP*,NP\X"A0_G;FZ)S5P6Y,\GG$$;&,'@O'(<O48O+GYJO2_")
MA,/TM7P\KT^6#"+9T.:OR"5C^_UAQ/"6CWWTK;97[ CBG@8/V)0*'[_^!HT[
MVIS^JMNB"!'._SIFZOI)+0B($ZZ.'C,Q.,)+N!"'7;:K8^7$89,#!4JF[>GX
MS1RIAXO\J#"K?P3BSE1L=^\-\4GB?)]6=]H!P^2@45OF>!;C ![A\('A3708
M*K*ZI?P-UP:5^)0U5=-$I41HJ9T27F=&D0W%Z;T,$%I2I]S>H$0K3?WM@!;Y
MECI/?(%2X+$@W4_;0,R#(D8AVL[F5^!$!>Y@R==,(\Q($GWN$2?7MNJ-0*"7
MZ$&*V=20&W:/[:>U-\AZ_:=VKB27!%>S6G85X0Y<(5MV%)VU"+M-H?2.2<*(
M+TR:WUQ7P*$>7K8Y'0T(E#H: VP4+;@[A5Q00B-1S%+*;L#'<E-7QV.G*%/3
M!9*[O!295#PVA?UB@H3NQ[UWLG?Z':)$9D1N^;O3HDMOV^NPWE!<WBHB[1 .
MD?*7J%OA\=K_.JI96>5ZW[5L1$N%D"7L3P1,S5;;.5BPP$BE7DZMT4>K8"\M
M9%^7:M'#W7VK=# 3TO4M@DV=Q4+?O^6#@90QY\R<=BG76;^74POV/5S\K.1S
M\;-/<X:U:ZY 73BW?AE!-HB!.AI#B&SWSR+M1C\Q@$HU&B?U2T0A' #[9YW1
M>Y)XL30&&ZW,%#WH1'F?/.HCKGIOMI_NX>\[7S/B._16[822OK__X/ZS#!A/
M1Z:Z4AJ'M4,T_GU1$W*VM[>CJ) *@NJ6G_S):8Q.!:6&RJ]3PQ7-'W>GJ\]P
M2JP-:V*)^*5"%_*ER=3+%16%4:7]?IP&PG-7B\>Q:#Q2R! J[7#OSVQ.F49@
MH3&JP0*0 D8<EK)Q&#)PO1(7P2S"59OJ*O?)<]'^<E (*.WB%SY*?'D[$[UK
M)?<GFH4>8L"*/@CD.^JJ0)"9VFR+G^V.EOE13?>%EPHATVC]9EKOMX)BZNA:
M@5TZA2YE@AE:6U @<D3.9P%%CG/]X#4/UI_&818GCLN2&3P!/Q 0*KD_[6UJ
MX:OI#=$U1B>UO@(C[(TQN4T/6EPI\+$%TC6,Q#CA0M74-6_=&5PF32OD^G3\
MB!6JORB*9-KXYA2_ZYUB'<^[%".]O\Y"PTF62GBQF&^,/8!8ZS B"..P"-,9
MKON2-\=8O[4(+_2/HJ.*C=C)*BM74)PNIXJ3S=<SEV]1Y#*.UOT&?'31@O]:
M +4ODOS?F'OKH#BC;<&W<0D>(+@VUDBP$-SIQB5(T 3W!AIW#1 (UDUP=R>X
M)[B[!K?&"1 <@F3.G9I[SIE7-56OIMZ=-_^OO?;:W_YJ__:JO02-7MQ2L3RZ
MPS3IFFX@F,>(<GV%9*A9 -WF(SLTJGN3QU<;BD!'7:!4ED6.$G7Q,\%&K2+E
MKLL]VR23=L5D+# 6?B::ZNN2FB)M-!:JOD4V?,7AF*UBI'@-\E$)53R%+0<S
M1<QP"QF<QNC=P"(]DRY;=U1=W%;26VHK5<0,9:U:+U(<$=G XP;R<BUOO]YM
MZ=K#A5E%9IZB!"'=^#)D%:^=H>5E+^%B55YK%'J]425(#I4O!KD0++@3LG/Y
M/.OB7\9$WZ:.:U&&[J:+V!:J;^F8/7'CBY4=%EX$#JHF3I+)JDFI1FM)#,1:
M..)9."B6ZV\BCD-^":BU3;MS9EBWQZM%V+(T YTTX0 1RJMQ@#M?5.'%.N3%
MA1GR Q@9=[73',L4+31Z[U\6J!X0V!B=SII]R?Z 4;*T^PG]8A/+P2*Q_:)?
M"!]+Y<?L-+*N46G6E2N#[+=,-UO,RWZ DT]ECPE<Q'(3E:_]P-YL-GW<Y*4B
M.N/LKU&D\$6*E&&H&KU:2W.+"E1H022%O8JE9>#L(TR:VF"<+(4\I)A+&3A[
M0MF%DBI;P+90^&_( MAJ&?P%_)-;!?_&+)0\!9N_@'^!*_Z?S-+$#"?+^3=N
M2?T+6=)4I'I!_T;(_[VIOMJFFVX:R&+E&N,".F7*Z1?3G1_O^^\UW=7>/OMO
M/Y:B/I')/;Q4^PO($>X$2=4*;MQ??KG(?7&E2_CK?T@\]\T&[4^\'@E^/:WS
MGP(%_QP"Z/S/1R?Z&]:,OP!)6*#NNU'PK(JQ]00/BT0IFGUTWE-4\5_ 9.;'
MI'_.CO$'%/F?XCI!YG:=E_NO=J5?'?S3/JU_C@%\S"_]3PG(/\>@!/[?JK;P
M39)'T:(,"D*"S]H4,I2E(7G-,7W5';,L*S#(%,P6?T)OFV3MK:KV7*5#M'Z_
MG].#&-\4&A#3!<'YI+&9T0/L<V[(TR/'_(0MOSHM>VXBJT7G" L/FU&%J18H
M/NBP;$OYXUF$$FK:HNXT$:DX(4SZHH!.K!8$D#&Q\^'R;Q+=C1=YMF]X=>YK
MZ]$#JF;CLB1\9[)>J8= \^,X77(W[UNYCK LLAO1_^@ENS^D.;D?5-US(K:\
M\+;43Y=R,<Q9E?+JTT4H%R/J.C:A:.BO700VT+7)^5BAF3&=1F+5(P64,4^P
M<;V6J:O]]RI5DF*%4:H9T[AM01XZ?P'$QQ-V%W=^2BW\O4"B-53Q6?1@'*9W
MPB_B?/],87BD[38A^J>K^45FSR:67*1:-OJ??4H+C5.CJ3,2<08L*-H:T-VE
MUNDC]W40 ]TG!6$/XO9"?6;Y'BL>6([(EMNR%;F:G!$C]U=3U2_]+5GZ6Z\E
M"^:(I:FMK>QR6ZW>.A!?(-O"DN7"VL?0@K&*WH%^UOM<BI:'K[8EA?V6?GY%
M,\\R ]WGI4 (F2RJ9 A.?KP_IG?^=E$8(+J\?,1!M[XPU20[CKT!Y?L+L/70
M/DL'M(I.)#XU[7["PT:]&=K]F!C"](=@K]!F? PJ(E3O)/::ZSY4XW;0\>'9
MPQ#Z4O52<I9*QH+/)9</\T5BG-_MI&%ENF0B^E_ &X3=>\=%XA\?U@.EN +!
MP4)G4(;TH^4]?8WTF6W.=KXN6ID@\\!&]9MU)=R/7/%NNQ&L?[J#_0FBM1-Z
M\E(@,] B17F[$O7%(#[-QHY(FCCO1WY\_()%0Q,%KAL.ZSS5^#<U:TYWART>
M]/OI -9T3B3-#-?[F7+\9O)WV*>:%FTV(L?/9+8=_!]7:MJ:$(JXX2H[?*H=
MKG*P[!])VK\6!!BXS9Q=" B7KP;OI^)D!K7^S%]ETK(SMD5X]_E%'VDE.;X,
MQMDD0!8!I'HOQ8D_5 Y9I)RHM?N']\3P\&N4'BJ5'FEE%+4VLL\ 52/=3H[
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M^-]L2Y,+,9\DH+HJ;^X0:#XIV!RM>XS@_&)+?A7-D##(0'R&'I\J!<&BE3@
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MBV?UJ?$B$3V?7 BFQJA$%SR:V!FQDN,)! \(8U&0,=</<*=_Y-M9:[C']41
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MQ.F:ZT>LI*45R;F>O>-QW@Z]F1<AN^+LP%7%8R9DF#21,[EO?X-2B40'WU]
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MAI]D<*^[ZT@L_8R](.AXI%=])<AP=;?R:ARB<:[XG3S4P2]+='T&;$!*027
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M]2[;$J^.6N%]L+1*].\?1DX]N&D;'?Q^D]4P75466Y4IUDLT2B+,D!U&/]%
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M19_S+6/]72 IBK4(TP.T3PD-![5"[%>7_]5^IS*)2E1!>)\L5^(><V82A?"
M\'&T;6MKHJ1N&87U.ROH=U%Z%[M.F_9,11XV[$]Y"I&AA:Y@OYTI=/C@CASU
MV@25X@5>Y"[-0Z#.PO=8'LOF:#:?!,ZZ<B1#IHT$R(Z[:H< &$LA^19S7_A0
M3:44F*E C6F>T:W533EH"'"<FA2!BV^ !!H*(+<ADR)/(&<>09M$FAKJ^&I0
M^XN*SX9"6IAWDQ-5R>";DH X)N[';4L$RD4[#0EL6!"%<,7P9H'#$?-NCT6U
MM3O^J9*N8_:DZLP<\5KH0(6DOS%$54 R\":H2#:]0UMQ:K'KDI@8KL^S."D\
M<&;8CO*50Z#.*@.$91:7O5\%$,8(?<4W.,O=B*7]\[)D8$\Q:>0KET!C6[2\
MO$)/,*;2H]W5?VE&A@Z^![/QP% M^S:ES%IF7*$?5?UWKZ^K;PD4Q^7/%7\2
M#[%:*: +>E,X7DEV:&)P5&U&DURT1UE*UZWU"&6R3RB=S&0XPUR+3N7S+T;>
M_9"."K2BV$E<1VQK,(T9]9",[^18!MJ?OA\>'I  VW__"7=BTF*<=2H<TVQ>
MCP?LEZSM;V3;HGI/TSC7I6K84;5)?,-OO3SRI=D/4\)?<*+CM%D?OEQ=470]
MWW&I6$Y]5BL\<^/B@'HP4^2EUG)R,(N8"M.*S1'RKY;6=WC5S5'*O.+#+V,F
M/&T.RLO%3"/Y!Q?2G2@9)$T&<D A@W79L8<ZMUPWK_@.QV$P8I=X>^D-Z'&O
M!]V\]35C7?+::9&#PS89.+=42'%CS='W8<ZU8U:%MG'"_41AA6^U!T6IZR]
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MB_WB_2&REP4M+HA9GQ][]@R(:DI*[IRE@RE+/F"P_CCS'+!-HFS@_<I4/7L
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MQ;2$[_1NB8D5U(*4/M_>>+DF5,V6OC221 V?(#8<@^A. >K/)A4WD43/BB?
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M?EC003B4];61B?PN$_D$-R">/WE37A,44.7AP1HW+#%M>Q4]T"%&'%NI??Z
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MFMYA:.ZCYGBAJ2%*=)O>5J-8ZU3!V(Q]M%+Q')=>^*F/XC<(?RG+<G7U@;/
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M;/>7@?5-F5O2AME5=;S+S&UQOM*H^A0<EK$O%"8,E>KA81HQOJ'\PZ4)[<W
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MB!OP?*6ET]M"RC7BB+#:UNA.6SF>96XT";E+A58"7#A5V0N]T_AUC]VVV=X
MHF>ISV\ 824YSW.SCJE)?6N4OK5<#E2&I@KL\N_?UI;'MXT:$F:?YR'Q'SO,
MZ[T$)^">F4\GPL!B<@)!NFW@F"T$<JW=RF&+K\5\W D1K<3*K=2[IV>ACDS>
MY0:G_,\469(%." ,=-WI:7Y'IWB5 ,P1Y]*/SEF@=_.RU6$NYVSP.;2ZV[%5
M9GI&+YU+Y8]%Y9NZUYULYYMM+WON8K\'MU?0N[8/95'ZRY1MAWJ9U"//8GZA
MIF4-B5Q'?"*(^X,XR>WOQF=NC"5=@Q+FG$NO1\B3X"E8+81S_^Y2;#Z'-F;\
MDXOG[ZA7/E'A"*O\\9EGT\(U6LNPXB:9W)]# _M&*DG"2N>"-)&5;:6KGB*O
M)-E32:(ED"EYE"9$_$^[T%=XD6_)DV':W/S@C[T&<IM1I5$ 9\/@U-YLNC-M
MD@>VDP)WDMTK.*IM,N>!^0:V-I/-]3K[2-WZ&%Y"/=HF[>0_GH3C*O*JE>:"
M'S$URI(]M'3"JYUZNRX(>T+\\>LT&BXQ[^JO*8*9!=)=0Q[6!.2PY1QW89L>
M8OR -ZF8$=<HIU'E94L&*.*NVMD?"NL3.%6)!HY50WO7R'.@(ZD:,WD19C2#
M3](A2%D[06JV5D.XO/ZC6WK;X>$-T34Q*!MQUK/1<+VW_NA[K \?'=RN-VXK
M^"\(@AWB6%O.<@%$F.]6J=:::(@FME4:+\3]XUC5K%M\4'$?C!4="NHPMG.N
M8>II%>T+P-]/@>'8,/5-Q62^8TK&7"9(YQGVJ[%KG-U^PAD]L7VO9.]'(\OT
MF(>:P-%.^:Q-I+"^8LQ+%Y:AFOZN8X*XD[Z%$G^#TO>*V'\+2O_N6YU#RIR&
MV(*3$@133I/#WT4(8!GX(]5(%)ICXASPE[-(5>HJ3(^TE:^6P DBD;XF76VM
MH@,=EM=2J%BZ!92:(#-BC+#_A;>OBHH#6*(<)!#<"0[!/;B[6W#7X#IH<'<?
M+&AP=Y?!W=UM< L>W&'S]NS/[CG[]W8_^K>[ND]UU;W=77TG'S/XZ0Y?7$1;
M9Y-CC#OJ>BA(/@!+"9;6D"'['Y9?"(FA[_0M'02O@M4/KKZ%66:9I>K/RX36
MI[6KA!U/\U3^_OT!0)8OG:9=JOPEI^6"(BJJ.>4.\"*AA7&8 !V[\ V9?4&Q
MU[.E=I15_BS(!L^1$LF=<9.^J9F>AFV!1MSPCU^V7DG%84U:<=I:_X#,RQS3
M6X@H03XINB,O.'M42'TG0'EH%I+E>2%+UY75(AW,1.\+X*3TJ ;N@U F_C9P
M3-M2]Q_FW.N5\KPQ$'AK5W>L)"SM'J!J2W4I]+P$7S>QG0YZH9QWN FO:>+:
M@+J_951RX4Q/MA/S.7HMF4^UY(E$W3]75?2SU[$V1')!S1]0LKS20EU9RW>^
M3W+GT&<VHG+)A+_->;ZB< AMC_Z$8A1V)V]>5N5G?1-RF*H0WQ4DYU4Q4FWP
M(.71*<*D/5H_E*-:O"4,)(^5@V"]8NE7?'N%$_%X)@"DR3-UE'?\^@"D)'#H
MH_*=OS[ISC2S-CI_';@0\O#WCA3Y%W$_ -%_/*N=!;7D@SZ1KL7S; 15T8Z]
M@#Q)3I_4:ZJ.G:6FUHK*(?W7^VWO5THU)M+;OJ4P%?/[41?<T:/<7V2$7/!?
M.'J\0;&:^:U14\K,9LLM#' 8]1?PZV3.#-GU5]213(W'@N=)Y_C:U<SJ+#S_
M;''V%]>ZS<%9J934&E06$?T :)0">9ZYI*Q@RN9+Q@>Q^0Q6,"H^9>]OQ]PL
MW$P:R5R@;G'N!+%55A'Y;]($$<8=:#>_T\[M8WJ^T\_AX8V0*)1RY>A?<-*\
M4I$01.&:+U;:FT%IYP@B.// 5[.+X)[[A%DM+>$SZY(OS7VG.V"=YCV=5)R=
M)'A:"X4866K+C1-48V?>3:L,XU7N[&XPJ]!75Q6+:(I@9!P0>CWPP$=Y/Q;T
M.W',45>84H+4^=Z*/,\ANP&<:)G$.RVA*@(Y&U,R%()A?%?*@03CR%K(S*YX
M7]GHUEMX]RAJIUC5F04D<_5%!=0\@GK)[8!6%QHZTLL<PM&-F@D%X9KS :SF
M]@0'B&%GK)DYNH"YZ^)L&;,,46PF#%FFS_!.0K?-H\1+:>0R5$T1!QJ E1Z8
M]7G.Q$WZOZ<&>IX9V3F,9?$66*48F:ZG6T6\ BKY@SY'+\YCVL5/]?;*GVL!
M/4>9UU8P?F*G&->_V&^A0)]D&+);KJ3#\X$)MKAP<)!WXW:U&ZSYFDZ@KL&P
M6^7?@_SMPN +,!FZ^@/1S*>H_Y(N+H,-[M##][8F9/1)+"F\F#VRF&6>+N(E
M9HYQ [;K4T7<VHA #S*GKY]%\:AJ$89U3VGSK$BDOU1X^"N']-E9H#"N[6Y>
M7D=_3C4F99E6Y+M:JOJ^HS=^.KSXS<'X?=Z(X>P<64(:+S8]@"PS,X7W:!YG
M445L_OD):GSC4?=4.UH%J'M/(;@8O3)\;S56*0.IVT^4Y7DMY_\ (.J?")NT
MM[U/9K\O<85CZ:6$QL=[8<5[G&:<TN:BN@WW0T]=RH-%+1$:V3GJUGH/"AH#
MD .S>U"5=,,>^AH@\J5**!!KCN>0+S.78AJZG))KD&O4^?FEMBC:F_?VH'DQ
M'HG\SP,'R.U2U\&(2CZ63;+_9\6!E#5>J*J2J @.<S9DQ+0U(FU/A35A>5^?
MU$@E9IZ9V:=([[*IKUE,(.M1>>"6/W*O23O*JOI\2?TIWVGH8$AZ9CG3QZXV
M78C@U%W6D[Q/<T-W'9 W<+4=I]07P.>T*PBOVMP<K=K>U)*UY=6WS! _YK5/
MH%>#V?_CG+:KOB/P $J5;D; %J1DZ#GH\UT2X-M-7;&SH33:^EVS9QR*FDYH
MIOLK!3'[]%P#S1*'KQ3.W-VD5(\!"Q/VWXEVV2DV5 \'F\>I*, +@NL&9TS&
MEPA.0CIC5^C-,X5NX87@_I_%HC4KUL"WR(HM78/CN=<Z \^3?OC\%@%?VWU$
M6IC3\4Y3Q9:$VRP]Y4;P7#4ABP'E:9I>*3Q\ +\ZYJFN3\BCO_X"$\',!V"X
MZEJQ\&J>1BC3/W-Y5%T9?H6KBVS>OB"G?^WN+07Z/&A; 9SL370$51[?7=<1
M^2I<8:,9\>.P[Y\=7#SXO+>#/JG_YN:)6U5B>X]2;-,6F]558>&"W>?Z!.+Y
MX?*TR+$$O+"/?3'2[:_1 1!\$W33SWV88A,5?&/8?_YGIWR6M'PGZ=_X8^ZE
MH#U"^TJS=!&GV3#V:1P-A\:Z$EFFT(.JJ1QN;CZ7J;P=!_7I(I^*?Z,9/A]F
M.9FCQ'#S^979%1R /)?H=H;M$J&&FX26OM,CZ*3,$E(<Z&6I4A DW=H\<?U;
M1$5!KUX[3<K%LZ_*Y3A  _W2WI%1GM/-(E]+A2CN>!LN&[<+EZ.",:6-L0!'
M5(9=+UJ8\^!=)L8!_UU;:X=.L92;^(DC!_C@ *^[T@] 2^.2%)M-<W,M/YT&
MR)R]G<@5AF>*-= (9RY(=(225$6$U#$YXVRJ7:C7FH'N1GU71_9=Y_A4$9VJ
M,T.R7MXJ^5<EB]DH&.LA8NI?9+Y;CGJ%NM(L\"TUL.+6HM:((N7#IZ)*5V;Y
M!$53PDN2N=S>(W5>6Y$3SP+V$T>^G=8%1"X:\A!<=4U5D7,XT?6BO<U)&_HG
MNPAC-B$ NXA/KL?"X.E-)%%1_PY;"7@3G'8TWA1?/T0:B#O8U0?/F KX07?,
M[TDD9-'(S0?"G3Q?\\2UP21] .(P1(C]@\^GLK;?<.>H3&8E"12@0:B0S"/(
M?569*<BZCG D46Q7ZC-7.,\?15Z\HC Z3$H= W$*S HT0.F?SY>#"JF?KX8F
MD"V4VJI95F\' 5Q6 S6?V=K8NK:QW\[<A!9-&O)DY2!KDMC-LR7/9>/P$"7*
M )>9[#O[U249[,HN*WS5]T)'?Q41+*Q #>8C)R#W:E3'G]]!KD(0RTZ^ZS7Y
M^*B&M'GW2VQ:_F6\]6FEOFA^/#L3[1VU .B@8:; &<NR08"F4:,-NB@M^RJ+
M\HO'?KQS)5J13 H;GJ6L?1$3PP6DQ'XJ#>EXKL:M7 M#%D;)$WJ48U-S,7BB
M+Y&75/Q2!+LZ0Z:FVLRL0T(CIF)H._*SL*O6PD-I-;.)$IM\.,,OJB5;U1=Q
M1_1DXC@5K>J!^@[Q,_(?T8=E;%#-HC/^=R?1>A QB2MMME&:9XEQXB$D.1Z$
M:5B_3&589SU17T];!_:!.DF\E$U:[;)XTWCUJY:UNIISI.A8@\.,.5DG;!:<
M]3"U'DJS'X'+47_V]7ZGZ^1Y_DCK0TR))*;@/?"5K?8=K96R$EBI7!*937:.
MY1B&^A5^OC #1]6GKSMXR%D_#<3CM77_A-VB01$OPW,<-7P#H0T5JP\7;A/V
M16OV) VLCK.[;_D3I8(D3\$2Z9.4"3/6@BR4G.Q,T99PR( %D>%F-4IH/?TE
MJ-26 ;#C5F)J5)4)W2 EL?*1"7Y[W7M_QLGKVI1-T6"@21/V))G.?*DG3>XJ
MM\T*94E$R;;H8Y-RBJM1>5P*:-5/FXV9M4?]:@G(&[;SYWPMA98/DS'S9P1H
MU Y36!LI^M_B'FU6]KO?6\H"]6'BP]2'B!6%-.'G9]YA9VU=""&-U7.!'.8*
MY;^GB=-(B+Q!-DT+UIABJ>CM(L,V\OACV1Z]%\*K G&Z@*WFJ(%ICIOTVWO-
M#X#1#[TQTW\!T/J>O*7*H1*936SS*S><<9/B'7*W FK3X*K1Y@H_]B__:0SR
MF_9L*%B7P)6;2P/JY/)QQI#J6%LG\FSS)G.UQXH?40!(;&YS3%,CEGYC0B3,
M':KZ#V</V,6>:SOF'6-ET:?6/:*CF:,G#9YJ3J00_JK$4<1X FGDL0TP$<;C
M?-J:X;HLD.&MSL"=+; ?:@B.YT30"EJ);7/K',&^V'KX,D9NU42IV(8AF#+%
M^:U-,X@.,01]G^^HCD+P<3<ZG;(9ZO4/$(A+FI[F\\?;VR0?U9#[]W?"_<QS
M[TCV)CD0(7SILS+LX:[5D6NR:7.@@0:5&^QXPGP-7+1$2W,$DFD]M1OR7 I$
M.WN][4:E]B:/+;8E1L. >UNBDF>$9Z^U@L8L<$JB2"0!.7C?D*=W$, FMBQ+
MKN 306W$).4VVI[] 5!,YF"\'L87N2I/Q#<W2@L<KI*D1U!('.CR&1&53 I!
MAE<9[E91,J)BI@2SM_";T!L=J)T)>N8BL0XE%"\H5V1N(ZN=%.@+MG^GFI=(
MV?DE)<I[!/(G:/FOE1)2B_*,C.0"%MF=.$B4,X@'5X,%_%VQS8)<U/0%1F8]
M61%@A(A2AA;O'HIN<E-DF1X*^.*RV$?@%Y0_40:_81-3[W)HIDY8"'=HCNZ[
M[N8F7A".,M^^B2WFQB1@C@Q#*WO]>%[86ODK;D\^#UF-XY%3,$"X8/'6<%^B
M;.[$?4Y.B.)R)@>KM;*NTSQ^!TBSMO]]A9/8<B\9BLI'9Z=_.0*7E83-#WC]
M5%V'=$CP)%#&A4D11[PG&^H4_WUKDT?WWA#,;(QM=QE.&A*4E'9Q.*P_S4"B
MF(X91^?129T!3=!"I:J*ED\RAY</[T/B,C:=>OREU$Y/Z*MO6MXQJEQE-?7%
MO;-)X2FRAQH-&C\ N,=Q4*;8?SS5!N+!E0/@%QTA_.4]<@43PEQ'RF$QM"H
MH#/0".V48G*^V*#6P))4TO1460GF^ \'D\[#<1+:K6T?;VP[C&JB7<#?^W8\
M;_BQ]4VL#X!/\!_K6;^#K7Z^D2UK\MVE/U<)*Y;_UH\HA*+?:W4"_C<_Y.9\
MTK EYUR>)LRU]!XLQG2A]-HX+"9X$K6&&_]HJ6WR%;8I>77[!=''9BW> <6F
M9*RM^7#IM/CUYQLMM%*=K.\' /NP_-U@$+QE[28<@_KKEF%7SWWNVVC3(J.B
M:>K+RI[C\SS&ORS[Y05-=0-8KG.#,N3W1'R<JC*^BWV]![UE./\[V^DP$$(
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M/*%,93C)\]C.P9 'MU&BAQ8V/+,$/4N_7&$_^",=)7,7Z&GJW[P66P>"37T
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M*Z& U9*W_:+A;?O"LS&ANW%0P6Y_?8E%YNVR?I4+UV.@+V_M4&@CS8L,COP
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M2P6QF.L>$Y#5/LR!Y?KA,\;;JG2)GT?I1?2ZC%BH>=+1CQ*,"?:'O5NA_@]
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MJ%[>KE#'*G*@XBD3S/&A![J6.-UAV61/3)XD\9+O7@BR1[41KR>]UXY-5IH
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M=69B8[ Y^XB*+%[)]X) !S0:#N[3+KX&G>4!OP_%[Y;V3OZK-_4BM2S&#'^
M>U5DXKN-]!_1D\;"W_%]8?G:MZ9<H??I0T=.*_Z$S.9%<E&\_*=2P0I+93XX
MVAK]UR1 G83@(@8U)&F*,J)Y25$4HOD\H=V2!/V8..9U);.R@Q@2]]HE;>-T
MU1?LM4 8W)%!O!45Y5[I(H$D:\4A+,LBBC^R$W3(2@=,45DOR7*DB16?P<:3
M[%$_%9K0RW,K=3C/KV_VC5REDD$VM7XG[1Z#OQ9<'@WV >I[U.QX::HX%O8Y
M5*/:Z\@\X,3AD31%E'I%!7RR^VCSIS/E\7M<;2FO%?'(&P"EYM?R4(ATLKQW
M7!FKX!_QH+@34?3TIFQ=K[#7O">"&]U&:X]2(2B1&@NG@#6G+(VR>=JQL'C;
ML;ISW&0CB&JM9$D@T")5AQGJ+V4KKG.SQL_:W?&Z:!\"VZ<)9/W"N;1D.%Y:
MVO<"*I#<I#MXAN=_4HH=O5?ACJ/ZXLCI+-D$A6_("4#I?/##L8"RG_"I+0H2
M@$8C+>8L$E,3M606_S"_T+V;RV@N*C986SJV;B]*DJ1,SOK0PT.9TU@\(R3.
MPP^_!<9\;?C6;H\=VR\"K>F2+=<OO">HR,.S._$2>P-X\E5[N"&<G(UP2%,V
M7C$E9!&/NK")XJ*!Z*S)I9!BTCF7M2_45H>4W@ U)]]:VA*'-5LSD7(I]&G9
M>P+:UT9SLM\ 17KR@QW:.PL2@YY-),12;-<TW@9_3VY/%'*F]+^!C$R/=_#B
MB08]NGPO<P]N\Y LXB9"1<LMZ 1'R-2N$MX 0A0BXQJ$4M:TDEZ:V^NNKY59
MB/>(#2B=X71)G6!!>L(S\8*#QL2I>P;OTHNJ A=S&6T%O#> ;*0TR0SYC:#R
M^ZF'])6?GRK(F.M:KY,\2<!?-I6ZK*5=6'X%KJV%=EK ['R$=T,Z7>(N<5)-
M.%4O=+8_D/2=#[-NWB7[09SU/)HGW&)08#WW#/G5S%[+;MF%$LNEP&%H\:]!
MCG4;'C2Q->O?H,Z<31?@HY:*,4UD(84O+-T+03X.S):0%=2S<UWM,JF#$VR=
ML2V>E_R$F\<7_8A^6U",?)[A=8O:-$]M+#>(_-)WUHO/.^0J2KC<Q1TD.*#W
M8_G["+&P%!'NBG"6AF]A/;MH_= ],Z7@5*J+\D>.N2S@D2[W%?+VJD<X*>.O
M9O&<'2ZT!>>T0":TJ,JZ=,11CE>HA"@12YU0ITN:@]L9+KX>F*?.GN0IR?EA
MD8L(R8)##*4![C=O/]//H$4GP<6\C7^:#0W?L5 M4'-]7FJJP :.,K]:2V4&
M]-70W*9,K[WZD[[>NY)CK0P ;,J],$-&]^XE0^?S:&P?'4HQAK@4V]^;ZFR<
M.80NNE]B>U7E6XE\.XAPB0]:.3I&ZT?-*@HEHS/UN>OQ?3)]+TBKC-5339:=
M3:W:-<*PTH_F_054,KY?%$6R ;8"."E\CL33U!;:9\W!.->+C-";HG:J2CNJ
MCZM&+$?D$O%MQ.B^3I*X_S8V_"!#]<F*_%4F[8LDXJ,J5?6,'WAALZ%G$THU
M+,O@W2/$,1-(S6*:8($ISS2#(XO%QU[WM)D%?)PF,D$?B["QT*_-GOK0)@0L
MW7D29..:+Q](F<$%>Z)(\+26O5=9'?IM(]W@)D'D@.ZZ2)7350J,1X:-RE@E
M2<,E)TVFV_A'/"Y$M;>.UIH<?[ :GF!_F.5,J?TZT:;G0&68+N3$,%_X$29:
MIS=0-]#MKNXLBCUEG?<_SQK78/*_A;ZX<SG\UZ,_ZW=K_YN;YT_G9T6M.2(;
MIAMFE75F%[O&KOJ#I]QWCX;)S&ENX4//Y-<^0:TA?[7DRR3<69NYZT'T_!S1
M.RYPPY6YV)(47E9J-A8ZW.TC>'"$"'N\(E4 8UN5<AVO#&#'O1J$'^-;?$"5
MU8D:V^]N=\K[YGBEK(-DF"[/>,,QP>@; &<RG2A*R E1KM_*+A$C@.<;'=MJ
MS1N@0?3S[8@TC$L2EM39&+6EU H1F:S;[O@XU,R#<D_@2S$\]JRRZZ)^M]_T
M1;:U>9I& WZ_#DSDDXR'@YYNZ<!2J9'XLX*>$K&.TNE?Y@1\5_BD$L-][)$J
MV0J:6MU)RVR9S?GU*X?F27W:VU1O"1ME:71-<E9X%ST P]8BR\[& NUS],;R
M_0/ZTAM @P+,+B*71AC2HJ@JTLBY;;@@^09(*5LD>7:A>^='XV42Y#:VL%%H
M%)<PLH\O)%1K4P]38HK[)3?^A4E"*'1S<[AM<F,LX::\1\*MH\@B=N$V+CTV
MY3IZYQ#CBLM^@J6H!-4%Y417AT2-?E^=% J7 9A;7Z?[\^H=IS<[Z;5U)0)Y
M6,C)= 7M8&!T95]\IN,>+0C7),9#.8"'P9"^JYB%IV6G_D$?]\DU=M9-G?JI
MJ81C+3JV?^V,H:Q^*SR@_)Y;)7(@!V<1:)"U LW"A2MFT+XE/=U<$?EQ)CC&
M*6#29GV%AYY>I=<A)#+$K\XQR#VB[B MSB/E]X%[]/AX4<DNX"/5^_"K;5,>
M9 "QPK<#/!8; ?(A%L7A 7#_UW"C1NO1&05*^^C=)/U;QE>OZA"E0-&3=P)4
M2D#)5'\.&N^^G)+UTF4=YF>PXJ%I\+?!=Q2;9KF*(1LG>KC3:8MGC'1IY .E
M[$\HU:PY68LD^+XZG1(GOVXNKOD91:QP9-TV%E^!7&UVC2T)NV!\"E,2UIX4
M")Z]O[O?7/W'JL:$WIMR/::S35XUQ!58UCN\!HRI^59*;>-83JI?=,JR([SW
MU3MI$LA?/H5KD6CS 3:Y_>QP&95G%*N(5U4-Y<9G"MO(M4J$@FZJ/LB/I:S)
M"*QRF\58P/99SRYN*KT6+DSD?5$EK\PP?_V,5>?90"1F$T6]^\?#"P^+*HRI
MH!;<WD"->Z*H(E]WIH10.X$/7V60D_2:ESE@L4W6$WM2YUJJ#3(]82AQ;-H8
MVQ"1;-.-7/[=IHE&GE*MS [R9FN(:5\@R](:!.XT0K6MOLU?H3K_FEXX,*/*
M98&'([%:6[YD+:2)Y>SJXR-15/!MM>':>RDAVU[I=<:GPRX?5X6Z[A2\:&[:
MLSLT$5\KUS@N(8_8&T#+W;W32LP1;DOQ[36$?4ADG6C.PV/T\O.?\W+EK/.Z
M-@?91S<NGYF9Q0D>8<)N[D4APR'7P/4E+M5M9O;7>\N&]^U212O:?V.Z#M]5
MC2_^K#IR]"Z1)A[P-^&^S%.A023RO:ENF>S,[+\V.*9CDF-L5)9R[E$+W-C2
M;TQ9=/9JD&V.4]%K"_UFTBH8=%^76\PH/YBX9L.OBT^MUU:-LYFB-C0EY047
M=>+DXK;=X5^22#!=1"0IZQ;PB_DO!?D; &E<:FN'>Z:C)ND8?9\YMGNFG?V?
M6H%12,/HKF:H)Q%.Z2$MNON"0'>F1PZ)O3,9E[H4!_QZV9YGNT)ZZM\.H>)V
M$"0P S< _QAX%)VH8XJM8>%_H&DXVS=K5\\D<_:N8RQ=O16I-*O:2>3QH>@*
M_ST8BR:>S?H^Z.IRBJ"* V^O-7C&\68Y=5R%1D<+CS3PKFS+C$G!D2FS6!*5
MDB'Y?<)*G0"BCM#8\M"B=20?*7_^,.)*KAVP)<),[BI[L(7O(#&CQI*92;"*
MFV\D0<U)VF]22TC!,.]=A>$&S.8/?G6Q3 'QTNVCAI"C8<.T_;I.H1H=*97H
M\[@=E#SG9&"=O FDS+-<J.6U0\0RCUBR30>G>#^D&U[AT9RA^H,B10QKU/_A
M_JYRN#'!U=61:W56$5J::6EEZDE7P2]9B-*.&JJ1<) ]ME.JO_.@4<'-6' H
M'Y=A()OKP;^9(/I1WR9E1S22>4?9<EZ.'"(@9BPB%Z%2&^L^5XTT#CZ6=Z@*
M"OP]7_1N^,Z'CRI@6&.$]*?;BVVKD4#_'][W7$-U'4?7R@C"-5;O#(][/\(1
M70YE>L'Q0:\J&#W+O%Q5V\-GK'RM/1@E><;1-P7\;'V7DH<*R/'9CT?P::<"
M'H\R*K@&STOHGFK\/@%\SJ!O -U ZE@%1LT<*2M^J>+0Z/ 7&*F28Y$J>$7&
MH9 'I5E+X9Z0M+7U->OVILC.5X?"9C^Z7O!>\)Z*1?I$KL;9RKPYM;;I/'L7
M(G 0'N&U69:'XMR84BO[OLY!=1F\_!@G'3T?3D]/2 .?[4Q4^+WA#5!']GK?
MI23H$4T9;I.AASE8=/5R&+G+^(028E_GET_=8L0U:=5"3&4X(WVQ6 2PE-S7
M,92FP(HML:L,.<\)9;W9;\P;Y6?]\E%_*S,!4Z0OX"@S0$VQ7<S#*9%I-@SU
M???UG^SY[A4</:56,)_3\FB!%)9B--\XZ.)(E,"C&G=(P.;,/&,.?)Y[-;-T
M<)'_>N'3QER9RI8ODZH3\=?!Q"^QI('D#1##H9BRO!>,T&&=PS68/?**H5WX
M;!M ,XJZP:$2=2+;M1;'O2BLGK,=R,/YQ-OX\!W:4-2!)X%<3;U!$Q 9P+ 8
MM:)4WTEJDU2!5OGTVU]1P;5=HZG^^-W5C/S/OH&*M36_I2$!JVH?+15[(X=E
MO>]E_;4&>?\T>_+\C.2=#66SYO4Y+@][-"L$'^(Z:'K<LOBG&FT1N_)G5J\U
M=RGT^Z(*E3)%(Q@>P'TU\4R+!VUR):A,H,T$( M&!]/R\/"B%>PCQN[FS@3R
M9A9%V25R.E"Z>!3_C=:FS-[X@C]A=Y@1FJ@O=8^Y?ORYMME8A94M9)9V]K)<
MK:@S]'-C'2 'OFL:#6.GMQ2:Z(B).^/].>\"P3&YRU\3$?$R[Y]^H$TG'AS:
M;XMVU#9S$"5[QY;CWPCK^_AP3N#[(X338[J9AWXG&<H5ME56;!>6X8LZPG)@
M4&\PW)N@[M9[4U7ZD0OVP)MRI,YHR(Z&V9&$=T[W;MGCZ[!40J$[B1'BV$YW
M;:DY.^AJ.B]3-<:E\B@0*+Q&C\J4V-55Z<*@U%;8'AV7'(%WT*5K,(,0C4]Q
MM<1RA:"/1OK:!) @X,1*GXL47'@#R)B1D[-V]PDW82P/CLG%AX>O&#<0_MCM
MYS@HJ>W!X9@@&&CQ1)"WWO88Y0&V]5#Y_CL$%@,!UBRIC@1+;6*X>!4<5H*Y
M1Z*??V7PX4\3.D>?.9JISKNE<S.%/CB3IJ)S9QW 52EE '3I.>3__[P])"_*
MN\E#2\=ZO3ORMN,]J^;H7;L+A1R-5,LK-Z,B_B1CO*>*W7*&\7&M?%M8G!TS
M8>!C"XW_(RJX:WR_JXGP*U]0LAQ62NC06#^1<\H#%,7SZ4B_N&5O?>?'PA>P
M/H0>(.?>@5]=L^GXX%A0X;P:BJ-#.B&/D:!3/&/QDVKG_!QR5<:I0F%'P"A[
M[\!$]5.X=>.%3?03*%_$BBRA^4#6#,I+M_$28P,K:\V8]F'>CS4=(5Y\ \RK
M'-4X?IS^=DW%EN:0;T-%!K_7/50T:X"K]('7:9OOH&65GW4$<F@-AS6TI&"!
MF^M.A[GV>K6@.#V*C,=WZON*PRXT=TG85>YP,[UG(+VNW6[^N!,?@!)[-7]0
MV]"B"E=T.D4OU/;>]7;B6XMJ+J-.U#OSEC> =/>WW=HA'M+28>'M0'JH78.Y
MBOX_^;K"E$:Z==YZZG6VZKLPG:&7*>"(HQO&PUTH[8?KO \<"O@8,,G([4MW
MMKHDR2$'IEUQ>^CMA=[[E^ ]1OG'5##G%.&,E3-G+YX[4M &^N!"3"8#^ '3
M>MVG0N*D'VTN$PO6C>51<F]!JV9SF D/FK2#.O8W&VB_JXH-!!TK3>$(B!!(
MO3.O5)%N;8\4VKU<7D[/17/[%P_(XQ@QA42@.RMM-1^]T(]/5,.WJBRZID_U
M<)M'ESEP'])AQ)]_;;H/>9T#8_[D:BTP4\Y]:6+T79-0;-.0R9"R6J.XO J)
ME^*E;0;4Z#=FG%M=LVS%3M*&I:!RXQ,9IWQ'\W%6;ZS2T^V,9*[BE&D\- 7"
M*>(Q1)L!G408YEN:P"M?6\ Z<(U@00N=+!%B(R%$0;2I]^7F[>DL5;O1)F),
M>:2-+.P D3YV!3Y#2@NO>Q.%5F@Z<AQ#($::VT,W@U5*SE?Q2SXG,MX(-(B0
MOUK?DT93R)=/+2C@\= P=WUXQ$M.P),14]\_S.@%CB(-30<%(II Y$9M*JNK
M+ZIP]\^]44O2B1RDDX>),*=\Y@T"AG#YY3K9<%H[C!XL2\*$#QZUN)S+O4)4
M.HP7[2R[S7FL:]T8$+_=3@#<L?5A>K;.A@HT9?A.ZA+A;)=75X@DMSCU4.J]
M58^,5:U>S_W)+2!YPRS?)*+<_LV1^Q'*IP5J^,J)I74>=$(\3NXFOP^-GWD>
MW;"J3D'UVTOV21C;N^C_Q-7\V426%AO5&'>8#X\E;[A)XNJF<;!?.3ZN'_<^
M8(NS8T26;IH;5,WVL@6KDLN(SETN+2VKMME)_UIP/Q7G#%72S1#P(F^TJ_KP
M!FCD?/6?->-P8!!9)A;+0ZDAKEHOKN,GQM;!HYO.79,]]#K*O<Z(4([U%9A[
MG=&<O6BXLN7NWPVX#X0(OP&*L&$0SQ)9E@S_>=/.$3/RE]ON,HE%'.',*J&B
MP%B+U]EI*+HY8 QX8W(H9/W.;DV,8)Y94*5XT-N*X51O*=#"Z3]NO4IH7CXG
MHM-H/EJ1DA-@N6N0^RIE7*DHNS/D1'6D4.%#AZTP8:M\!1^"[JA2MG!@@&)3
M^,P1&&;PX,&^9-M'NXRK7=", 7!'G'V<@G<,NTMA^VMK8*=L>L;U7/-)Z#MD
MA\A3D,C/;@[M"U7PG9NE=5(C:UDOOJ$8?B]?C=!?/^+PY*TJ"OPJDAT=@YX>
MA&\Z";%*)KW5CZ=<A7'_Z;RY/I6ZP%%D(<">#X&TG5&C5^LZ,0M/,[65E,G1
MCPFP&IHBUA\.6'IA=F6Z9KO=*2(N2$<Y_;&_;Y:8<Q8D&$?O/=$UN<G.5MHV
MSR9YH8:WQKFG)^\,#EKI-PBSZ_U^-P)%DO&2QBF->!S6_N)3SG+V.H"5<,8C
M(Q-0XC)YH49[\B2[IM1);![4"&Q!1Q?J-1?YTP6MOSL['.GKZBECD8@_MTT
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M6E'XHJTZ=OFG@2R1ZL\4IB.AOOH09%)WY[.,!]C6[Q+A[)U,3+0AJG8:9&V
MO^;C92_@%>=&:.(EBQNLK\0@8>XQG BA0:N:^R,<<B**_;I'$1_^4:^ 9T5P
MJ?DAR\7%^6&1SWV;KXA5SUJY=#9%/:A:*QK+A^S1LQ+VHJ1\211=SZAG<XSY
M7!TVUPI'NY&AY[7U4[NAL8':_G6#*826EPY &J$+F)]F1M7MPZ(QYI*E\CCO
M< T.D#NZ.8&VK" _%\<QC36U_Y&!'FD;$J< BW1E.003Y:D:'"1Y)Q5/M]ME
MS&5-=2A'I/#QW_N'!U+]3],H4D1\#E[;,UK^JVW*"73X[Z:,_SWRP#/(M+(K
M7.Q#2-+GP!.U.>P1)DL1!E)6CL"_9""21N"0H39W:M&RJ7JB944G.ZFJU^.\
MWMG"A+]&U$NJNFQ=[,2_LJ#B,XIT:),+X(.C_V3V7?S.LX+:_,\1X4[7JQ&;
M]QNJ;!, V8H.5"5L*;8F!XIXC&J^%X:NYVVCLPX/07D[G %OXC\<*OIK7/W'
M##V)GB72+&QKHO]6G?/(OW ,)N[^/1,5N#[V2A%(*3Y#DQ>!")TMB,>X=W[]
M!+M%%QQ_ T"&TF+]RZ7? -A:;O,?6-(&G+ES.;_N!$L=1ZWAJL\ OUW4M<;1
MMA'^H7N'2I=/SFFS3P]_RC:!3;J9%'<R7)1!G\,3;!TT[[;1E9#+3P[9"93>
M4AFQNAN^L9?16)D8W6D@-Q5)UE$0/4ZI,X35O<(:C-:C ZJCG?Q+/@$U0-3M
MK;BXB-RIQDKH2H_AB(FW1%&GN6(M'<U1S%*RCOB(ZPE0??>>:B/IC+D-J+>M
M_P0^J%=)P M?Y0QL)W>@VY'V20OE=SFK3$WN@"6K!E6YD;1Y%X9N"I8BV^Y)
MA85\QX2$$I;>T>(,A C4I)X5[>,ZTV[ KMG6H"&38:=30)9./0[N)FQ[)3)>
M).4P-Q.\KWH#('*-)VS >NFBJ1*&4=&"LLY)8QF9"@A5-0SH!4I\O0GV\;2E
MP&7$B]ONI54HDI^^XJF;I+?M9 $O=#[_#]K>,JBN+HH2O+@& L%='BX)[CP(
M[D[0""[!+4#@ 0D:G.!.<'BXN[N[N[O[@^;KFJJ9J9H?75W3/\Z_NZ^<N_;:
M:YTK>[9,;Y&U-NS&4 #[9)/2PU9T'Z6VFJ3[.C>>S(VP%80VI-WV<YB*86?M
MZF&6%/$V::7VFUM^7=R$=5P8-8-_VPC'7<B#1A>HU4O"T!.C**M\GVLI*#-8
MGXBX%^R3G80?T9Y-U1M3D&*<?\#(>7+6G(TN7T52,GX\-;%L_HAA6,M _T9,
M "$#,<T";F'JL\9=% Z:^EG]J)%<?^%"!*W!0C&_;]W5;9&'KYDH/0AVY=\[
M^93D$"3_<)'?)OA3F>L(;AC0F?JEY%F J+4IK[C;*I'4,T]+>BR]U-P\7&7?
M<"PB#N!Z5Y=<V*W27)B,>_\,5V8BX8YU01WS@C$S  \^C/ 5@LN&M/JM-[8-
MJ<9DH-W22?IT1D/Y:^,8$K<@FN],:M5FX+&IV;A(Q87?0R&W:'F=W.H( Y$"
M5,_XVG)&C19'+HD_FR6,FJLO/'!BWSQSPWW0KF]\:U!?=HYGCD'_(>;!O)9'
MW7+7[YE%P32ZLPNIHX^6LL'D^9Y<Y <462M):J))TO5+BE<<3*#ON*_$V]C=
M=,-=7ZV%PJL$?D#:C9$,NV_FSL,JNWB$K//MGOI.A';4G&@X>Q:":E-#?3Q9
M_=_\T3(R],WXKH:T,.]S_54%D6Q'&\9=H7CAM;2 9*\-J/0);["A<>B9*SL&
M^FZ.[?+A1$[ ^*/$3KE V"ZA>-7LY]VJ/;=(JP9%E=RFK/D*$G.[%1:$OBVG
M);-J4#V]"OT<FJ$!:]U7X3(9#0.&SM[F9)GZV@"M$,1ZNJ5K555SNQ9[ZYHP
M,4[Q[^A].9@Q@@Y4F\*W_*7,Q0+TFW,/36SF>J%6HOEAJFVC-G;4GAN^2>X:
M0O%NCOS7&Y4NHSB+>_;)C"#+:^3'D%5>M/T8&'-+^0:1\[:@=#B)P@VUYJ\Z
M)N.TO((2CYZV06%"P;C/9P=^3&0I,;Z3E_B)8^)TH?&"R$4%!]3IJ@K^H7$'
M=3TRAY]XN*6:9PW.1#N)U*X7F)<O?ZTOR]4-6B4X'?"A%T$SK2/>R:(LZ[PK
M%8]ZQH/3T^10HBGH<?[62-Z@Y24O%3[0+_&S4QXN<#KP;K(:3E"NL&S3- 4G
MA:+7E$M/*L225O*QX2=&NK)&$C!M./89?XD#.8 C;1[AR4K([M[^HS+M!,@>
M6_'5AX81%AI-5=ML13#(2U(&B:L&ZLRW"7=G,8IV';\::. GG[?\_NGDT8-B
MJ&@>3545;+PV\*]3Q8 EQS6^K\/%1PQXCFSZU:[2NZ09SK*T&>X7((Z$]L,-
MG07<#>Z]_=X<\8^C$_JG]D*K;E:HPL],YV #X^F$UZ.JD,@66'QCB1U/"4VQ
M&7&TPGB2R<O='N$V04A+=!##.6#%73G&BX140O_9=?U2F5JF?E[Y;*\]3P@[
MPC[+/;!/A%0M\E]\K?XRIN%BE[:K9;#UFD5?PW_]$B,H&>BW*3'9'&KQM?><
M(@DK5BHVT)-!)1@M^!A:Z!5QV9\=]33I1H'AOC# ^/W!+"=._9F1(Y8:-%UK
M#FL#]_AP5IWO9M2D5"G5!Z0+D2'9>Y]X84EQ,BE2?-?H4%]>-)T2<R(-#Q<1
M>,XJ4;"X3:.8H/9Y?M#OU^94*<#;VXF^JVX3FW4=T+Z@[[&E(5>I)P+G !HM
MUM4-M?ZI%#?VM S$<AM@EV"8B'5&S1FL6+6-P9T^#K^CSZ#@R[>0+?8M61<3
MB_?$T W5F2-W1L'C)RS+V\]T4R=O>W?])7K4Q$"JB)6'3I;>U)Y!N];YF5[_
MAH7"5];>C3W.YEMZ5%BYVA7H$23-_QOH??K6XUCW5-1Q0AG6W-]?*G_WC38,
MZ\[?G(EO(..ZC[C7"CA=B\KQ!5DL\)HB_G/1V+-./<>JS[6<J-(8%5(>/[Z@
M^FXNTG]D98=[V#H_LS$Q79F_]*:<ZIGL!< IP9 -SIEFM3W)N=23CG;GPXQ\
M2^%TC1)A!7B7E^A]F2M7D,N*ZD!=4/QPK\(OXJ3[UOOYR\H07;*_E/%M8*4K
M6&_%C]&D<F)A'4["SHT#)>_<J'Q5R6*")6C<T+A&(3@VG"N.]HD1CBWG;;"J
M7T6EL35LGO"Q&!Q5_/@"$"[?GQK_&]R:ZQ"CFQ(J"B^$[F%[M!9VUTK73_TS
M,\5)#7^*_2JZB;UE/<1VLE43=&_7_XS+GX&5] (83&=)./,HM NF%!$'[S2
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M[@)=>-,CB&H59(Q;BP#6:W4L'/\L_V['RU)F^Y5>\ET,!W.LQFOXR'4<P22
MDO1$S\JI(;4!JZL:S?/U0XKGXZ3))+1EL(@\VNZ7BI_P/73*-V8F3+SR!4#C
M(MN]Y0A-\X@X*]+SLZD^QUH1M3;=3%MFA&\I_Z<;7!J%WU<S:6QP'S95=ILS
MQ=WXI=:JT"CF5D]][1XZB[!2Y>)0=1<<,?!HLZD18EN\2-IEN^IY-";5VPQ\
M7;9T+1?_L6*0:,A)WMIDR_<6VZ,T?[]F'[\-?8AV<@WA%MJSH^[Y.--2TJ)N
MY1!URPJ-0:AET;SF_<*E_O'#SZ(?%R)^Z7L6" J/[*./TE<L2W#(D:T7EPR(
M/I#FR<4<];2>E96E*AO'85@4$>4^I_W0 +CY=*+4L#7688-WVU6WFZBW3J_
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MWM:<;>93:T:+QGYVPW9R0N?#/5#M\I)5&SU4\EN3*RB^HS!("IVPAS2TPCR
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M?FN'M[TEI$^6,_PQCV^P$9S[H\&C4(.R8*46'^D9E:IA IF?8T@V/#1)^EK
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M C3;RZ$4R\*CU:+"?#A9MYANB9[77H?I:)HHC7BVB,SU]X0MK"1"0$((=(M
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M"JGOG<I>%-6+O)Y8<";/I"+$-6%(]$49F:;K6X\A)',B]DW+F<\!I8.AHED
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MW<:,XSPU"E\\LNOQM>C. 5_$$"5*S9OK?9$N5 BQG#T5<)1"2,S N=E]SUQ
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MA%$$N><MT1>)?Q*E9F_?-CACU!E[I>L!64=66^CNU*0(E#B$-W)0'L@]W>^
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MD=M[04&7 0,2SR[(NH)+9C/C](V89";R;UFE]+8BMO+9<[/2D'HT3@8)V2I
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MT6RQ)\Z]YB0#R\^5"Q:Z3#,JP$H83/>26L:=6G#2QZVDC7CSH40!/?"AZN3
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M[#G,'!^ !]FF[9P<&XV275A24\O[- +B(]R!VJ7#[SAW$, "726P4%IHM$R
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M;'TT#0A! =X):5F^G,A;.RI% 5B4*11)BN44AP;.93)\D-Q3:0TF73)7BRC
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M1P0(;G.?VYO\?K"AW/*X7":9>6_V?EX'RK=AW)0:V+.!92,<["+GV]WE?'"
MO8%O-:>KK].UJ?<GEM4ANVQZJB&-,GX,S#RU^-6-XP*\I.ID-\@YA^9(;V2+
M%@<_Y_>YXM%ZQFR9#?&W[/TD3V8ILTOBA\4W8#C]):F$OD^>+?F-$,A>^&@6
MUR5,J])M_O"(%*8S87=:9?@[^.686O41U/56;Z?[E&:RY<)MCB5ILX\I+J"=
MVE9:,M5]>-703"WT\\>DHZS@EU=%4WI:T6G02GVF#R<Z3L US^*?!6,_S;8E
MEFWCWI?I\4>"QUL2KA=K926JR3G(UG VU48^?@O95P[H'YN(M[?!8[KDZR:_
MU;P (8JN:_.EQ&$#OH\STOO'=@(=;? ZW>-XEX?RL[['CX8I="WRLW%GU*K7
MGL@3IV<)/I-23 QG4^!^_F:^B9,ES91ZR4EWOB1CVR/LO>5^>)4L"5MNY5.%
M ;=7C[YA/B;$I(S&M>(V/3M<C68:<NO.E/,+R,V*X%QX?6B2%<X>&NYM]5J3
MNY.H/SLC%H-P*@4K#5;J-VR+)[J_F6&\J3&JE&!T-5'JJ9]X1R1O8T]2QN7P
M(4[A>E'U\;+&4J*-AYV&V4D/!\1U@O?!6I%M$U03^'OI>B(<U\9;D]T>4[50
ME.&?Y=IV)>2./EF;>AFZ8Q;Y1DHL/5Q4"V:+D:Z]U9IM&L40*4_)P7"A18%Q
M4F!94=5H.TWV0W&I4HX"6?,EG%H#9$62DS8^$4WE83MN]KR'^(XAF"Z7:Z3+
MD2C<:NSC?)%8 .$*^$+-W ;WGZFM&;K#0S/5I)\5\0(N2&8/5QMB!M(I-C]M
M?PVGL-Q!K[&RYMN;M$XM3=4B@"HO@/J1VK MUH2?82=?_^^A61+>X9&):M4Q
MZ[\OP(M8H!1@9;WO^>Q\__*21T+,'L<@B4A^-DY?U^);O'"*#.4?W;'YUVK2
M=+F2X>RY)K8M.EH*@C Q74H%+F[#F<W?F>H*UR+%+NJ.ZHL$_#_]R+\D74DF
MH0#2\U+W)_!54-9WMA=F?#G@APE5[%U@5EP0J->I4!3,ZE# 6EG=2+^@U\%'
M@Q?['>DJ03('E%.,CVAD")C#->>TQW1DWV.4SKXHM,H*BAO%L&VJK+MR#4U5
MOGH+$:1I![*[6TZ+% NJO0O7QXA// A_J^]A[ODE@"D.V+KG3W:7?K'+$&TU
M)ZIF)K=2C!=XH[&3U3]%8+%XQ,^6'< <33$F,IV5Y8^]PGZAILSYM&FOOW*W
M5J#7++%_3EX\T>,G=)CTB\@8TU-*#OJ=(EXLL7!%]K<Y&JG)59^U<L=++'W/
M=?5[MV_2F5DO22W0P5M\QN\X^18OFFU5.E:N(#"KX$\>VM]CF/4!HC^H@V,Q
M +Z>Z&W\LX"TXP)-#7T9)Q(@IE.PJ.$.%?:$1>X_YS_ ]FW&/R<5)@DU=V;]
M+9'67!9I%\=L&E-(2O>O#M6V*G!9N;2J 8%U%7Y.*XRK!;Z&6E%0![PR"+S5
MRI>-?2;V79WW/5Z@2E9R)*A7Q2D1EK!245WC='55_J[3I-HQF,F/Y.;0=C5A
M,QPG3D'471-0-W%=:)4IQVE&X.1=@8/Y7$YF#U\+V3\>>'R/58I&!4].Z"9H
M)V\M?8=15-[2!/#(GQ?KPU7MF4I\,Y%@7WMO+R[/R!5ZA)QK8MNOI'J&8MWN
MRT()S=&0L#5UB!K(*K-+8D1.12S_<VP7-1LQV^1S%RT*4@WMUA25\:4C3HC4
M 'VC7<_ PN2>V-A/_0@U-PYB145U;;[5QI%+'?4M&;.C/V:*_Q2U=!NZ3F%>
M:UMP%OB[,#>;)9^I]:.+]0:I8%OEU2A*3]R6\"<2;@)LB&^D=@.?*L>_D27V
M$4E\I(9VGAO$98.R-A+BO&N:WF:&9BH:G&S9?DTK@=.FAZ:E<UII>Y=8U:L:
MEDOI;;FRFTXWOS?/_S/ W=)PGF\N:IP' 78W4LWCVLHM]S9%_(UX57O$"&U/
M,<W3W2WHLWS<275L$H>NBC#K\32Y['P>(^1W$H[QG-3+[:G%FCW]HA-=_7F@
M^$A/K<*,8%1]6L]I,0GHD.5HR)PE7N&().B)>LDC3#1+3 S_PI[&JL)=OWN5
MV^*3,'Q6;%T43DK"$>V/]TA)5A$=R4(5]<4%CN8K,G>>5N^/S/:ZC'AHY[+E
MC7GQR:F\WHWMP'RS6TD1)X3<8\.X*&3+2@;-4-F#_HG3WW@%3""';X\95M*.
MMV:UFF(?ANW1*T  3J^$3!%\5L_!%P4PJ5E^.&9V_@<N1?(;J2W9#@X  -XG
M@((H6$,#^1.<R!43I7([C/VI?\[J@D)-N::Q>=T]<,XGM!EA.C@C;/J?W[RP
M^5P:P4#BBI=C\OWED\R [K')@?FY-ERB@-%NDM@;K7 V1^7%#'6PK@ /: KF
MLO]T@YSH]T_2#WA/E\<I[B:,*,;G@:/9Q'C*?.=FPP;I@6==BN)O<R*J7*^$
M!,B6='_'2#@'..HE!($')[8+;=]4C(M5KRO-CK4VUJ( F"1JLB[4V8;$']@9
MBMGW2OCQM2.4*P)DF$"@T?H-_@\92(]B377T_%D_-Q+B&;SU/5D5EG"2->\K
M^1\/7$@4),X]71).Q-GP&#*UE%:D4]L=03NKOPE;L"E8EKF:N#^N#].>">(X
M^XCS0J)(CPTLT9FB_R_%$P7X?ZJG8'HD(RNYRX'TE5NE-+VWE=YS)T8S+/E5
M#0 )  !P .2B"]H,=<HB>EA8<Q73F,R+?BAZ6/,[VDEN],,KZ&%IK+)^A=H>
M<L-(8#7-JM_1^((+[4<#T>O_ **[CYDA^^IHT-*;&BD%&R??_9 Q!5O/PPY-
M0M-/_P-MT?S(*FACXV@6\\JM[@-5A)5%#\9?Z>6A-"Q82P'#$DX6=D'48Q2
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M+1SY?7U4373M/,SB_W8X+'FJ99TP,%D[]-".&U;].YMN#O1K0('M)\,!LP*
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M<B<;]&97L-UJ>F"6*U)NK"T:@\!_&H8>2WX=&M+*&-&C>K/=QO_'E3L#:".
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M?P(D\-.&J<3]O2W)HXV[ND#7^[(8="'(+%_,;B,N29)T,043U=_GUKDRUKC
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M;6<N+H>QQM*YPR_7_^7!"O.RW>3@WKJ:AG-F^A^M^@10-2//U4,Q&@V0DG[
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MATJW&'=%2.<R^=QQ:4X"E<X!&!KV<KX]44#Z(8Y+/SV\QU5#$@B%9(!VPNX
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M;!WO\<F0]<IP>;8^>_JZ2?BL\^O2JBLMFJC]CVAT<_0J2$F>^;9PW)PZ;)J
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MI(/W%>#RZI,\(V23AQ;J=?+NWKXBC (K%FND(FF;J,\7(UXM__/Y:/\]TSC
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M<=,1F]BGUA_G%V6I79SS?04"4/^>*DM:ISZVK>=E<I=]'V>J]9D@A6%]H:[
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M"[:E^G+>2EAMTWI(QH%R0^(BV/;!%CG]^9I'^W:+>L,8<<PS'K>!+/31$]%
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MJ:H6FI<=9/=K6O*+,4[Q*MCM7ZLXVS?D4H:A.U)U93TO:VMOG*Y;IOJ^/-(
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M<5GN5^G2WY$'!H:TS8PZK>P,BN*X$_;I^ $&K&Z!>B22V%R73Y!]CEXWQ.G
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MYH<7HRMI<+IG7DE+ AMXZ@,N;#]H;WX_\VLCX]WJ!Z#9$P:(;TX?-24JXT,
MYG+263,\/[/6T5X6@NJ;L"P H .@C[QS:0D,:7'>\ REB*=(9NA18GU7 2$A
M+<SND["'-FF]['6F=I^] F^T//T]1 9E'HL^9"-$FH$ITSD@(^M'%$\IK]%H
MT>%GCNA@O*XN:I.4C>OQH?C46S6.M2AWJK"#O2P,WM/C*O>\@Q5JTRFFX\M]
M#O/*:_L_%21^3*(4NPBXG81;1//0[);9!RTO$4=#@?AT2%5=;=BVR]!VE.;0
M,^#-&H!WMB_T!<(9UA6LFEVT+7M3[RXMUM@IUA>/<5YM5GR=R4*W[."LQ_-!
MJ0XX>*N?K.LP.12H86)*27$Q\(+Y0PNU"@/1QE*+;EV\O\S+G<-T8 OA 8I1
M+@WP% 'R$(_7.' CYH6J">/*+3639;5SQGV9J!-'L:>\P[6G;_=XHZY"RW3Z
M*\RFM'3<6!\AH0:T*)I^L<,1B-A. #+'C/@]%04DM*(]]5GL/:WFA4A=&;[W
MQKX N P1_XLLF[S/-*1R%CU<HDKMD."OIU5U$5)$.[N*E>>JE*1?T%%XCN;5
M#<4!CEH<Y3VZO&<"/3%?8[XE&- 1OE&'1:%/36Q2<N_+-D,:;$.UG*&+0]9Q
M<O%$^L$&5?9^\M_NU>5?+-0=O+:Y#^,< YC]_JA^+M,L:%N?$7V5P=F^@X?@
M;EK9 BJ-D^!#<YH_N@UEH_"4(1<D5!:B4Y)>[..F^7'G4JN Q+>6SGHA?3JM
M-A=B8$@Y2/+ZAH#2A%I9L"OGK+5UI,DFW=':DF.P>KK\."\,8>EWR-(1Z3C'
MU*0PB4^9Z0S$]^WJXOP*E;0S_0"U?WP.\9OAZ/7!JU)! 4A#RRFLU]*6X=P;
MC+B A<>-]4H.29^^,,>/NQ4H%_?US JV "56J6SU_] 01?L3U+5_HT%W\(9[
M,Z6FX!LLJ@9>X];>BN&#FCF8V>JA6+,]T%#WS2Y("@S^YU<>Z?W]A2H%V779
MVQGK0ZT,S98RT'H;8,J'VVE/B,T'^47[>+SU"SZ+@%^PL?K/GPW*2<(G_1'(
M%:-^8J&+ Y3/3.($6]=)@=(0-ZCGL.;[R'PJ6A,"0@KLZ*X:O<ZJ R%4QI;W
M)5*-.KS$TL8_00BQ)>N)W .H61&;W']M[,)S%=7M&: ]F=J=4E>3^S'Q0PB8
MN3PG[LBQAR6V]B%,PTZ*9E\WT-P2-SX-+^&PCH!28U-[%SD7X/.EX.5<G@%8
MMT#5U)X$']K3F>7RM@H$1*A9!6X$_F>\94C8>1X719AI< M]J6^7M.N&'HZ.
MIGRQK 5#=GVUVCGC^M@&G(U&U18(Z5 G_25 2A#$/!L/=DKVXLDZN).\%MP%
M6I;6QBQK]?6D 035*&D08A_I:T[K@ZWY:=9+&;$&:D0MDE:Z$PVD3824I,O#
M7JQ+&TMO?2?+ 1XT"0(DWOLX%?:XD]:@D#OW/C7:UJ)%D%QS^+0- W'X?0AU
M$SR_87P:Z8[(E)"@?*O5\JW,E_8STKIV5_T:"Y<A/,(,R?<LH#??C@:H+B)F
M9P!V&#D/$M/E&U,<:*[2-35J>IS/ #EI\:6A0F[ 0Q&0)$9^BD3IX.G=W/NS
MD;:/$V.Q3A<PZAK1DE V]*7U7&>$BR7[#/>=Y@-:^%$&+Z0-,3*>.*5II\/2
M"BP-!CJJ[YL:VYB\ '6D-UQ^Z-)=E^#FKQ/'C/QO#;.&G2:610OZ3>8XRT0D
M-;ILOPCS8\;& E]4(/% %^6L/:1%B#SP:EE>/%4:D84I*Y2N)5[1'PGM/)B[
MTRJC$&PIVE<9:=LG^.YTA**ROHFH=8YG 8?BY_+3!:<0\B5ROFW>/.P@T2--
MP>#Z2-$D/CVI.JO+/RX0GL;?'R2O!6C^+^2)4JV-23/J/>VO T=O)32D.Y=^
M6&(>]L&@9>4&79:IZ9SGTQB"T"V6P4-LKVJ,@=W3<JU&B[A&>IFL?][]7Y 7
M._0V<J:#"JN0F[(HBT%QYM)2QV!QJ &!]W$0OR3S]#H?RE[D%(Y;'YYP<!*E
MV6KQB)M9'2Q46U?0ME)8<ZU^X_F"_+0("7FO'JX5%GHM.FV8CG/]W^HLBO 8
M1M^(E%N,U4TK76BVU&B(X(FPL0CU=8"0)@R%M"9+$T+I?;_%ES;**P?QA>,%
MJ"Z31(5T3^,#IBYOE1;EZ^NB;+F!?>]9C;"^1A9RG_2SU__=+;XI*^.JENFV
MW04P#78/' ]"$?J;9X ;]C/@%7O"B+PTC:%$&&TQPW_E7C0]EV0=:-+6,$&$
M,K61:@F1VX$ H^,S>: 0,.K &^\8A7IT9#(IYGBQWG4(*-@1=ZN2P,* N$$U
M-NVL&)>!8/:I;9#<TO;P3KR)-B?OKXH\'*'J1"Y ->B-0*\[>JD!S*;0WFSA
M<=&K<,;CQQ^#5I]&9F)SQ(T%9P)UUB^<PU'[A[>^>A9[W>,):MYR#-9,'E[#
M3G;LBN(>2!'_,,4/%^<_&[;W\#Z/^%%*>ZBQOOY]E&]H,\:A,@]M:?5^YS0H
M[,#E#B_S,3D7N/BYQ]]5^NELZQD0O*[%KJBK[.IJ.M'WB4[<Z44&8D7^GLQ'
MX^^OK/\;"3;<V&VA,%%Z/<QZ[I&)>D]H.^?.VYL^\S2C]3'3_IJXL+<V\OPE
M7&!8?,#X<Z(;J*T>VL+"/C?H7"C:/&XE]2.R_/$D^^3DJH(-_XM=2H_B:LFQ
M)P')MT_*;MJB-QZ"_9;B*M"UQKHI_:#C[PP##:;DA7.':H?0\";94K)OH(@4
MN75=ZS/L3@P//2WHQC(W88._)"O<@\S) =^CQYTL;OFGZD(FL[3YL'<52&\S
MF11U%S<R@SEY-P==#89-O9;2,)8'?&'PV3?DL16,,RV48#/PJF7EKSZA[5I1
M#_(>IP=[W5$&6=YP21.O/DIXK1\S.JX2U']UEHF(ZT[5ZLBKV27@L2T9;3J\
MAPD69CU83GIQG598YH^U4E@Y,!KP^W:DWF&,51?KXLRUC*40?(6L-M2>3.QZ
M8:PUMHBZU+N:#1:(K;+PN^?YOKF^XCA^$T[TZ4.@.($J/ #CJ]3W,!A.T!LH
M=XRUBHA?[@2RM]O5X5 9^%HP\^W/*"(\8.O\OP3C_P/,X#CJI*461 \K K(8
M,LUA*PN7,PT@Z0_JY]%)0YJ2+MR* ?;3&WD!)UJ3_*H%^QY1>1Q\.K+4F ,3
M#$IB9^#-&V$$S"=O85X8??KI2J%[D84/1="!+2N?S 4JO!DQMAGWFN/@B?1C
ML?LSX*U:E?&N;^[B_IDLEC4Y/>@/3Y^\R*P?+R_]^ /["LL939#UU0OB_YT7
MBP$*-R=V3Z*RB8GMDS=^0?'%7D*.&Q5X9I\/X=7#9;#H,$5P2P9(*EZGM<DS
M8, 3X,!!;X.!3YW5]0WW0IF[.N*V]3Y+ME:FV?O[6C,[*4^-CJ4/[%!GTWJU
M)JXSFU!T^*:OP_T%7Y\@K:ZF&_<RA!PX<Q0I.U2L=9G7XN_:>&C)3^[A,X?\
M7EXJMOE,IR_[>W9_=IFY9SF=DWG?=KTXH0N%,V46Z:ADL7S%K1K!E4RYOD6*
MAU2I*T[=(+9$1*=K]C<G*CO'7H"+BCIFL=YMU$7_U)Z6;E9"0LX@C7O*ZYC>
MBW<N 3PT484 ^%YGF!<^YRR+J+N;+1,.Z452C^>?I[TU#X77*?2)TQ!&9:4S
M^CTB@2%-%#,US^&^"*GA9CY%G+.X.1J(&+-S!?JAAS>XU*<I([-H<(NZT]\
M1%CYM7CQ/,;.T_3.#]A\AOMGSH:]G$;RWE$KAV.D6CM$E6NKB!#)OF/<8J]T
M_(&CX*!XL_W=GY1+J#O6(G'$HI@@%%43L.;50.+5 %Y42CZZ+!W,L:Z6A&]*
M,T6@^^#'J*A-$S0>[B6]OBC[U=O9Z8+*<%BCG#)F,(JK;3U*GEN!NU<SN(\+
M3Y=D9F>&(A(B\-&V9B#FM*;9<-CX$JW!FR<+?2AL:RQUD[G*N^+>!Z/>>O6:
MN9HFMAD\NNI+6I-201,.OI)E^Q(N&<4-(=47&J5=JALFO^NC;$,7)AT%N/Q2
MQR\9W1!"UHK4VE0G@OS\UFX9)*,2.O,64(W33RF [I:K-N.\W^*)'IJG(TI:
M!K-8XJ]X9X]_0H!/EN>7]<I^S%Z8--_8_&YN$7)D^.U></SW3J#7Z)\+_I[5
M*1+#0F6-&IW##*(9I_6B YD2\_JI\E*^CEAIA,@;C&$_E0P>$A6\E A>R= 6
MYR+Y.-S*NEB_ WLDD:M]85(([L "S*U>96IS6D\GK,M\:C1JD!%S4UA"53-U
MAX94Z@.DA:ULL'R?S+N''FV+]04\RTQ2BP;!+[9O"N-SD"K-R<BX-)F0FS5$
MP2A*T\=V ;YZ76!UC#-TZ+4Y.QW%]%9])$3&;)8CD( A,(IJD'#@<E^+J"VW
MQ'PX;\_%E<ZQ=)6-&;8;\5I,)#&F9,T4 <"-,(&D*&[?].ON&1#X/5JE:1:Q
MN# OK-Y>QBJ6W6P$WP.G_XLD$K_RB3.IC-*9\TJD=;EX'G698C4<LC1CIYTT
MI2^Q!$O'H3"IMS(4(J-C*B]S^-&TWL59S;C/I4K)?C^>(]W4<@._LK6Z;?J#
M]$P'9)HBU)7UU&$R1H4L%]J8^6J4,_3T$1*^+"%=9A#E"M2C WRI;K/K,$J@
M;"\'>)#^OYU7MB_A<GW@6@J]5% ]Q_Z4>*-A%1/\.^F36D.AF"ST"L7F>\1D
M5_>:D7M^9J:139<9&L(C:"3OR=&=<?[..//1N[QFMO3F7R2F[5I;'/?,V/LK
M1--,F5JRLCXC&YZF$*D@:!Z+A*X(X1BZ8]A^"]\SX,/8B^/2M7L&[+WR8R\"
M<_5H@5O)(]F7R253J&1*U<U1JX(T3I<&#Z1(X&)8)<QMP9!5Y'%S=^^22.5O
M*4X!ZT;U4AEHN\@'RH2 38IGP)T?'Q']KU2%F:O5=ZOF*;('YM<I/C,9AX-8
M@U1E;!!1.P"I-%)*G'S[C-,XEGCVP8VT-^D2,T?^?(C$5@%7+NVFGPB"@1^O
MQXMQ9+'?:,=:E'']V)#@<JHCC158&PFS*W,$"2,#NB(<.S^VOO)#IH^< CN?
MX);!XA/*'Q,+W,M)<ZBKOUY\ J%466U2D;TF0JP #Y?<@OK5$B@_IN,(*@8"
MU); KOYS,?@4<0'HM/#5.0UZB,,;Y;XR4U?A1]84]89Q5@DAWP[0WYKT#TDC
M'?O[AV7*-<X] $E>'@%F+_\\= :C<AFD'RIQ.3'X T]% O=G LE4W%ZTAPA2
MD+RAP_NDT0ZI;:9I"#B@@C/Y$J%XG>8G0D"9[W3'V%/O@9?IR&>;8FFVY=)!
M:) 5YW\BC%]4P=]R)@A!ZH[D4@^RY5)(.#*TC95,XI_5:>A#%(:G4"N?R8Q@
M=+J95M:N3SFFNM#J_AWVWLI!@6OU&HD=;DY1Q<E:B=%2HF8Z6ZEJJ8<*6>YK
MW+0/TH>*_Y'[V/\$GP-^(BIAB/8:N3G;,I;E5[:NC)NRB9.,/P,8#==R3??L
M;]5ZC0[/5V! <5\3S=F9FW&;+').ILAH.Q[RKPV6QZX?M3S[(#C3SB .)XI2
M@ AI+V]6UC^F&9,P%F/J>:T(DO\N3+#R<>894%W;16FE+?LK>G'Z"7?\EFQV
M_SB_Z2)/QG@]D5^J?VY_MIH#)?E!<@-0911LRX0KU-76/I)R&2DXQ,C;1Z\A
M.4RT*5C8^' XE+="CWTD..(B,'3 S4!3=>^X.NBK5VP21ENA<MI5\A<W5%SA
ML*>#AC@!(3*K- T [D 66):3XM)J3Q(@D61^0[--.&\,WTZR*= \(T*__)M.
M@'VIV=S4U@3DG<',/!9;$ >2X7/^6*8H_O&DE*S7<_4*Y1F@8_B"-&=+#DI=
M$HF\9XIC$^C]XGI^KF_Z_@+Q'5$#]]"T_IZH]>W"4K)DL@9MV2C1\8YQ$Z25
M8AGVS= $ />!/)D$[B#/AV(V'4USGI*:VND%Y'SXOV'%>!7V"9SOBYY8*.\I
MZ-6@4 5?2M;A&><G6 MMKL8VIZ^N;&I,[0F"?5"#KJPZ]9O]V7(\C[A_;=A_
M$PC\^SEU=;(.UY\%-JA<&8F2%7GI#6/H&/^>? L+!R_Q6",GC.Y_,Z!$E.PI
M_F*M[$2P$V=\"<S)J"> DBVK[SY"E>_KGO:?]LMXKX'-4LSE&2L;G\^X.Q%;
MIG1/C_HBZ>R3K0D>0/Y3"ZT8%^ [W,9$AGI^+S7<SHM^VX'>G##ZO/7_&-V5
M>KBD.I;HH'AJW+ <].=$*YES@IJ)9)O?LQ\)>LM=\P&=AUFVKA674JZLN>2#
MOU6&03'/L[:;JXYEU2>=@-Y$4\/1._&-H"\\AD^XA;K>%DO'PX:PKO564$O]
M=W$<-22-_\+D&V5JWT_X<8:",XP0">G^[R?:?;$;F\667V!2"01&!.%IZ2N[
M*U4O,'HKEZ9T?B6!*%]CR$Y+TK'D;\S3K^+'H@MT62S+>:$N-%3#KZJ$DHHV
M3Y_"46S"I2HE2&<7X)Y4<\75V>L:R<;05KH .( L "^<C#@N]3^B(/YOJGB0
ME#P#!C7BGCK,GP&YL.AWO@,W:R]>8/]%+'+0G%44D-Y^+UUP4^YI>B":+IBT
MM0F<J1T+-BI1>04'7T1)4'09*7,/[%VA:I8RCEJNW?N)J/))!_$9D(H4\W:,
M;1&Q^8X6/N76^\5+X44_ [2%BHO:B'T'!:!"AZDOAVVMHXH#M^7 7^5%,9D7
M(,1I/,-%Y=ZW@\^J[_.Q:;$BA%=Q:MGJV_G!6*#!U$,"]EL,.$W[/@QE:-/+
MJL-7&&\+XO+<=*WEY7D#,]*Q>XM$B1)IR=/7T*74QNQA&;,K\"TI*-8H(O4S
M-MLQ=%&?]ZJ8W$T-/F>A+\M_O831PH-JG@&@XI<X<9Z)_!&MM/PEA-YD.@X.
M;+'T+M$K!<>7B&!!AK*-@S0Z 8(\@!]SL[DMTT</AN"]61B/93@?<96WHUN1
MF(6JQJ=7'B#@*?BO@H67T#. <C5"Z#"_\"D$M[G,=P#K&?#4FO=B(F1U2FY.
M.6;3G6U^(B70B#-.8+W9\>/60W(;_SK%_[X =H@%^7DFG(T06X7]45#M"]QR
M[+P#NKAZPP3S@_1Z.Y;%EQGHIG)CE*>,>]"L6W:'<'>5/@;91K,MNGF-V1/)
MU.5A4&1!G;^A2P0HSW^10BT?X.Y1W^UHGC"I:GM]49A$=7'S#'"T!;\\;K*Q
MQAOE";/5A9&TW-H*JG'"4#[X:S&OY9C$:+V1F_2P/<>/FQGK-JJ[EY<]!=V?
MKKVYG1Z3I6^1XEODV):_'Y)-8X$%+\B,'#L;)&4,&G12"3-71$E2'[/B@4\S
M MCQS66IT4X>(T6N:JWB+T2EU*4ZN)Y@X8^Q1.C?/>' C1^D0#(C3B[+V<0=
M76W1MEQ=$]_D21))#NCTWR9MYHMR)MS-EIXAR87Z)3C5J= 4G%!@9EKYZ_J+
M ]QUPKP$P^7#!/2DPL95(E_)FU.QN@<)\\"05A N^\M=!7'J@A9%(CIS(ZFI
M3>)^-]_@C@/J2;  W$= )P4DFLV;=^9-JEO)[[0L9N>P&Q!^1P(3N"]'C6_K
M5N5FC2?YI:_UCJR)R#GYXB-EWD5VQ, -(@^/_TL>?4?6>HUO,*MNHI;86^U8
M\U72)GHXUFZ""R4RX&CZLCSSW0$96:):2G=OB@J+*%&IENY(8(*JD!LBROD[
MWV#^*S T#+#Q\"[+0JMJBJK1%L/GM^:?[8'5'^W#RV,KF=%?!T_/%P^%,)A;
MJ$D.4EJD':J%.P*"1PT:QPWC'PZA15D8]%7RP9/F9Y*E^YB:![%9TD=40?*?
M!Y#XA.\[,I*NRODB/TJU,.=;I)CXS3(;^C!'I1/;Q&YN ^O1U9%(JZ(@>^P*
M2&@;Y"3[7&U$TXR7R52MK2DPL7=4WX@^JVQG4E@CL\IYTQ>>GCR$\\H_NG>_
M6'MDZ(L("&%92$K?QN4M0UIJA)N\<ARQ$LPF&OZ<\E"0F)+6R%0<JNFR!JP*
M3Q1P!7F&K!RKB%:_4?R!-2*II +@G7WLB[1GCK2ZBG=K&T5+2_B=E[Z=[(^
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M&U>4WI '!'<;+LF)YJ(8;V==\/=YQ>1 [L'*]ZOMA\+B25U+LIIB\1O;PF>
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M+4H3WZ&G""HE">Y]7742EOEUUNG(9KEP"@QRDH#=(K"22R@'8$RK8V?I6LJ
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M2U4C (I0LJ_[=J(JY)N??).T4S1'K).?;V%H\B9Q+[&L<\$*<V5UXVE (?$
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M*4,P7FBRM01(\V@_^S@VU_R+Z*-_\9Q>XTY'A<%>E""16@!852\P?G9LG[G
M195$='H;$&&5>/D1SALV;\VDE&^F_[3Z*FQYJ &ARGZ7R9!E$$Q9,8IG-QV)
MB;0SF6W/,5-S;1T(!F_XOALG$RP P2C)(\A^3Z<*K67A'ZIUJK6DJ&_X 4R@
MOT= !&#:8(OV%U1RJG/D<E=Z=%\%H**^Y!="+$=$*!D7)$INP9EE.D)-<]FH
MSRXSFB?+SJ 829GJ3WT<8;$05SC=XG1<8*]N\IUYS71,'SA&M380// FKU>W
MZ?)Y50!%23IO#E>H6V<\QQN/K+MQ8RH).4R2=Y)W)JKS?J'PFW2V+G#.W,?&
M'B9ZYEKFL-6)HN*C41++H; .BYBL-^9,@Z\8+53!8F[:CRDX,"@*T>^U3*D9
MPUGDL,>?]T'[:4NZ@8L3T_<2PI=,V:R25I0%0\$[)UA;V*.Y9.40C0SQ#'>V
M6:71Z.WMW]_^!PN*7"*+"%@#<-E.5]C#Q<U'C8O+0EBG(#2B/'RMUK>GIG )
M C@S9-4\'FE!.WXR/=VAB_1#08_3/U([O24H5!Y*7^W%W%J^QF1W?ENS,',N
M-N><XH**=E,A>=-?/$ #%U-WFE-<(,QP%8$IZ9"[A?\V>/R+F>#ALPLR"QA7
M4X_%66&:+51\(M>BH?@F2+[N9]#BW,.C7T/S"Z782A0Z!_[0,K[U&'#/.UK?
MZ#G6::40>GPP*ANKI'BZ-+%_5&C&D[17.R%&EGPGK+ZM<./TCCQJSI?^U_,:
M=&-^N22R(0UVO5&/NS[GV@J[^8B!5$8HG,<E*&"PE+)L=G&K>[RJU- R5ATP
M&;;H$H_>7)=*[7D,\S:?_]3E3Z'$MO+3OAH_1;>0/:8K8F%6HEG;MWAX;U\H
MM"FDIA7KCK.E9YERN&I)4>.<!H;\6&R%*V&QT6231Z2V6I?1DOXVOPNE<-,!
MV>&MQ0U3F?IP=]23A\:$^@4OC]N'@-&DOLM5KQA$4#0F5Y935+[9EV3W_,=X
MEO\.^4O&O<I?LQJ\D?HJIE%+\W3:7S=(YGS,H4X)_UAA$JNP+#@B5RQPHA+%
M7BC#-('!,,*WZ-N+C*7#>D7M32^C(/]%F::?"XXHM=KQMV9Q__(N&9E8<%1!
M 4U'02C _X+GWRK4=<&,"\LGXW#\Y@D0Q-ZKWFYAP3LCRIU&A\9N&[>VZ;9N
MN^&3/P%FGA$7XEGI+[#"ORE.J0ZW3. 0(]$^TFE>QC3P!10=8BF(?OB;(3"L
M^<E0_7V:\9@OT%#1ZATY/14B*C_AU UVL?9.B!4DA*)*K'/(=O4XX@S4-_/C
M>#E>B:="(8)UU[8A+L-!>H^I\H<EN@F7[K1B8;O5M5J\!?1W^&\1"'4+?T&W
M*X[T1^=P6=D3FS./"^B!%_FGW.Z;T8=B2!A+;MYJ1VM)NRB6"N8_Q,??/#PK
M]<9'&9;49Q@)NO'*SW?+R*S$EPH?;VC +,I]&]X3'6R8&IMECIQO-C[: P%'
MH@[Q/ $1FVJ% :<EZ=<ZXH<C-D00-.,C*&FL$WN[*E%%^=&7?3<)ZJEG4&2%
MZSQY&$:5DEW'&EI4&;%VK>?EN=JOE$L7/DYL/I9)8D:P0G;FGQI \+*MKKGW
M_I>SW$V$5;9+0&'QZ@'K77Q,I;>G>B]2JY R?L)<):9Z<K0<572SE#*YW-0=
M1(PIVZ0DY \$+!_X%UTYV(N7NV,[1BU8.^DN[;\2! 1SPB\XB6?=NO6>+6%5
M3U]WOUO31L5H72%N:1:(78+%@WWY]OQE:5IAX6EMJ/$$,2.S1G89-5RCZ#%_
M<RNS)]V<7C5:W559O9_N;[U6R*A:1@+*^"B2#')ASQI+1;(OO]G53FK?/Y;Q
MCAVTL8$88/EX[;5KH>7@M_DF O43OP;B@;I^JP](S'YM^@SK46W;\!8@,D>L
M?8:KU^9'].&G2$] YBIGX:]'M-M9 PVC)^!X_ [Z=97=J7OT]]W;9Y15=M'Q
M[R0I_/^UO_8_($C_[,?M-<1">'13^(_:!;3IZWRF4KW1;*U!!+9_#T45W'#P
M!.0RQ5-0F51CC/S^@24VHFSRL&2RIX+M5-)A)3P<95:\T9 X#3XV"OL4-!W?
M,F$SPN*E62F*E=1(\-?,GK^+S0KM&/,5OR;WX3IJJH2J_MIG7P^Y'/KRC/)2
M8?;U?L;P4 XJ9]?4"<+8R]LL/]GJX*\N^9B%:SN1 +M^,+UR4=$7ZJ'%+Z)8
M2NA_:_J>9,'9:C5M_)/H%Z_2X_@DQ(O@F'VPM=ST!M/O.WVY9V[P1?!^9Z\+
MB2>/FV"XL^(&8E#O0">IU%L-57B-GVS>7WXZW>33595+,'])%1!#DJB'DOR"
M(M[-:LZ*C%PPB?Y/E9*&NPHZKCUG&PC/;O7WTO']CVC[?TMH3VZ>U:;3?:+1
M/WE=BC>BXL8L?_['EE=L?U?"Z*TO+\'ELL"AGKJ(+=<%+H4KR1-0[.(/5G>.
M9=.!/>1&,+*Z=."?>P*$0F?8\^NSP2-%C$8R+> 078XSR<E-,$O/)QVNQX/\
M;7;^[_6/]$/FDCG1&TZ))LP4H1H_KRBF'&:EHG,)R8>[U&)=+O@;GE^%YK_K
M!!!;^?$I+L@,S"W7<[#4PJ==?7)[Y/<":=_GO0WUB](3F,UU1NQ"N![;<V).
M6-/NZKV-F=P'Q4_4V2A[+GF:E,;K5U\KW7E%+3PKI#8WF/^\X-^_$&] $D"Y
MROY/9O2_)3CR_V7).^]],3TU42:QZ8,_=PG@4DRR+4I+J%HTBC$QIQV])B<Z
M[L/KK>%!*BW8.RKH]M"O_,FW2Z:X9O)[:9XTL ]BH8!A(/I1OB 30/56T:'9
M[9YRP%)0?/]OI3KE- 5AXD9-HSL8<\&FJ#@06M68U7+,]4=S*%SUDA;3<L28
MYE%LQ<QI@<5&KL6E+7YN&[9_#DM62;R(>+%T1W :E 1K.O]>SC/SCG2DF:2^
M[&>$E5S*L</F:>%KM2C>0NWGP>QS_4DS0U7J<>+3TO0[($<;\]+<*C3HNKB[
MWVJS#X4GC9/;ES&839?4?'EF@[E=,*?XGB$+5H@<GSC?M!A%HFHG]FAV!%ZJ
M8&">6 +>Y"S?G"OW2SY[(TQ5AX[<-MIE/BTHT,OH;]LVY^T_D. %_$]FQ.S'
M/T$#Z65LXI\#-!EYD24&"LT/8KG5<L>; VAV2U"'QGSMQ[@.#9A. _-'&9NV
M-;\EU:G,J=]=LC-!F:+ %IRH1N1_>$8L1>!>AU/>]QPNB,RZ<W7*X^5&H8*(
MFJJ!3*Z]VW+LDMJU_'*;'5$?L1?)JF9JG==W@H3$CDU9QWZ?IKZ+QYE]$!SD
MH*Z4H(B;:L-#%*EE)C'-^M_E%S22_A7!0.]])EON@A9(PBN=KX]!EJZL#\/O
MZG2@<_9.B&(-5;*4.OI^1<;EY(3B%7@G02?B!F8$Q$0_,F1$+YS,&</_M0!=
M,44S#47MZHXD_VL%8Q8]*\X/LN\&2YN)G=,0JU^FW=$;=X8_K?7]=K[>$UF#
MWNCJ;*0%\H0WG%B9CIKDIG+0WFV1'I'N<MW/$NN)BL-D7(?>'JK:G+"+NC\!
M_235-F>>_>HA8"H7W/)H^;0^@G!0Z'N<Q^,0L@B5NM=/0$7P>2)]X;Z]&XG7
M=0[=$X"[%F$_Z4GI["3O($D=/;P8JIV#X+6"#W?6[1 U2#1>%,733XA22-M'
M/C<[>%7]RSE7Y71KO:@$+5I6=_DN[ E [5VR4U=NH]=%.4Q/EN15U702'V=3
M)0UP5S+8<'O#7GN\(W<U<VC;YY5W U6IU_V:L7'$.&K[)DPB7W3Y>0?12?\5
M4M//>^59W1]00P.F]0O_\OT_C4:_=U= TA;*Z:0[#I>^C0JPB12!4_3JH$Q_
M D8CH*)>9YE=>A>OGH"R'Z"9FL)8Q5R>"KM@-\OP6<UBGO?R,5J'1U/=3\ W
M:9$G((T4$OP$;(I#R#1)(;=/P);:$T"PD%%U7TVZI6?+<K]-#O64/C'$B8M4
M7\BNKOCJSUIM*\MBZR*PG9L1/$T1&^5G*7MBG1%,&_C_M-+[JVQXTMQNR\$X
M*YOCS.SQ_^[J>(GSZ5#U;?1PN 1 (A"[XY38VE-,*O0\!SG[)[*)[0:XF!J!
MF93D?%O^\M:(VMSLNT_ &S[^=.>T3M+Y^Y5"A)\?4\'50Q,%\%%"Q'AAG?!;
M:C^&UY^ D-77AYI@3A4=<<E*Q1ZV2*E\/'P0A9\UWF$S#=P"WYL-FXTG $G3
M F&^.#L2.Q%GM&]M;9._,<) Y[4S<Q#$UMWM06!?,W3FP,KEQ13'S<MO1PS$
MJ+]'N=Y])ZX_F*GUVIX#'6,\FL+-6O!VX2JIWUHI-]9ZQ+2;,)37P"P,?//S
M:]]2"]C3I6H^K3T<M'+*Y15UXA^*&Q_*_7DCM55VT\9U24%@%-&AH;9>E,KT
MO8LG^F"6QZ99GY)$.:K"ZD,M8;A::%R/G!1PTH+DG*MQYN1GQ7PU.%J]+)['
M1P=5%/^&T2/8 ?"40PXFZ'>\ E;>UIVV'CYL>.B.>65UYO%T>36,1+ZU:JOQ
M0HIO6T4Z=I=<EV@R8 YBEV@2MR?1DHS^\NU=H,Z6[W TB[4X@C=/J<\*ZRSD
MBT%1?ZG>8_%15I"^P">;(W@.SXW02V*+&8OM)\"W8?+6Z7EBPZX"-S$E3:/Z
M"5+]?5N6'DRP1W8KG#F[:C@):L/=P?G=&Z^R#-##:?$$6=LW.(C=: %4KD.8
MJUCLBQU?B%:>L]]::YC]LMC>\>^)PSE1ZZTXTV5"4XIS:X6&"U]ZYK;6UU_.
MO#H>4I14ID^FP=\V.A9P86D<?X=@DT>KI\GR7K8A3ERJQ7B.-G1#"]<L\DI+
MLNIPX@-H-,48!I*PCOH/7SUKHZ)_=5P!@7(X=%;@?44]/KKF8B,GOTY%P8=+
M)B^DQ:)!^H TK6ERZM^U'\00^)6<H$,6L@4RNVERMS;TYF-_/<+^-Z$GUST3
M"UH/<4C3F/I5*?[@,Z(!#6:16Z,+\#]#[O"D;,!ID*V&GT4\[MH?Y_5J((+U
M0@+V\O(LCX\.&2D;&U.Y&-<5SZ7)P2IP^53U8<P;3GX.*9)L!\2.^$PI-1EL
M5GAVN\@T\(^O 8<J>5D$.:GN,3Z-#.?TDIXPM^MRTPWN%'T'^:53?._7D^7\
MS:* #4\1.-,Y0SS08/#GI]2?( Y0MJN](L4X17F9H0-*EA-"?1JVL^>.:D--
MXKARG1*1?Q* ^@N:4W.9)%G$5L=H$FL83;E8+XXW"G=*I);R+9M'I4!LY6":
MI(:GFN?65:FUJ<KB'EK--"Z*O9LJH2#*8G*^]FQ2&[*@PMY\ _=Z(/FZ>.Y5
M<M*9PG%15S/U4\+&NF>KV(6D8O*I1,./AFOO/.:1)IM0B&$+*.BUX>H=<,G*
MGBJM?'1YAJN?(O_99K\"#$^?/^L?T@AO+2<,4!J*1-O;SZ>3/<U?%EN\EAI4
MKKTXM-2OBT@W_+IV3RK7DRW)_X:V0U(G8QK;SVL3A+877S&_HG?GA$'$X\)"
M9).:;K-2^ 1T=)S6/KX G>OJ0:GB^=Q^Y,OL9T W<S(JJU*<9&;?1>OP[(Q(
M)%FDA-;Q>P4B94 Y3A=T'A.JU=W;;"*+U$ G!E8'<HF\2ZF2NC.<NUFJ*.D_
M?%_VD3?+AVA/FLQ03NC7K[IA'D>SB_&*$VOA'?-.-F#*')K^&?]_A9_XPW-\
MO@VWNGH/M[]SAW:@SIY9W-^J'.EE_>*1]=&"I^%7,9;+M,[VX!E15^Y"FH(6
M40=_F+0(P9^<,1$DFBP*&HI(8"M&$%G41-VBP3+7=N;:B4Q#11H=XSO@DQP5
MOE$JS6#]<6)@/RKO3Z"/EI:J)$'Q6\81I;% <*\>MFD$YP]V^.5DPT*8NZC@
MV;\-+LL08VPL&_]K+YW=]ZXB1NQ8NPT9LHFMQ5'7$!JNM_0<:/5PL%49<=P;
M&OH.SDM&&K)"6+2BC52TP@IJYIV[!;;F-0KF'_9...^5_>CQ%)WO?7PFF[5S
M$MU>=1<_;R2LEW_4_RX?KMLU,]:"X3H5%<[-$M>CC6ZW[@LPJY:.",_C[A+7
MO5_B3??GW:+<=P%"I2!"4A?6Q8$=9RE^_W\7%FF+Y_VOIQ3@./42U=GH:WR(
MMVB4X?')^=[<HB2>/@'H<C4+7,J/%W6/+US3NL*,JDJ1);%D:BQZSK'"TVWB
M0/&D8<[&D@"F-8_JG'OCPFP E9S$Y:/G10AQLAL*^R<L\J(;I\6!E;2?/Q1$
MW7K[_BENAUOEH7LB,K7>6NE1T>-"G.*6?\U^R1%6J'7@*M.2;BX7S[)CMI^;
MCKA$<%?23+_.5*;?TCA!85!A=)%!$LIE-60 O2MA &/3V!6/'QBIQ\N65KA)
M7_#_*:GY]E[^O^< !!SN7V''O_B!YX7I19Z1>_KE M(13%,<_B?0!9<PZ^Z2
M:<IYD/N^H64J<'2NZ!VK%&(=$6IF_HF*_4D0 ?MV+DZ2&SC?]":&2 0GW_PS
M"ZF@K;B7II</A-IN?:Z:L%E5G<DA3'AO.W6#3().;N!7)"HBG]N4%U;1UU)/
M$O-1YT"9)EU[IF5%04]MDJY4$ %P*-G6OZ<MT]OU2*0S;)5C=M]3O?5!PVB2
M86@\G=AV'G@4$S5R3NKBG-&#36]-6-);GA/"\/S. N WAR^E%3NN$(XS0GC7
M#QB9%MA%?=_B^=RDD;*2*LK* $+KK3A[)'2^&FSS<_W(X,17\EGEI&)*D'N5
M91/-R:K7+#(BR@W2;NKWC4[\WG#1'O[6+11![J SNTZ>ZH+ GA**\B;DWI]B
M'#'[MFIIUZ*<&]QA[E9K,?F;#Z1'BBZI)O>MG,B53I8M+=!+F&>8AZPD+='=
M=4\=^&MR%&05(TN&XGJ,R 6AKRAKK9IF^-)<7A>^L6"T3%2>'(#-<(393BXK
M+XR5@/)S 9=HA\\ >R<-L1<B5=U;C<+F.&W,XPRZ&.5O;O#D_H4F7O)&^38_
M9T\S>_I;(DXKZV+?>%7D CTYNDTL;X^HD[T\8B)USS"JY K\&$1XHO=F4^LC
M0ZO"MHT6%._L*C[8@98!7)6B.[[Y;<BPN59]S%OY,WIO6M(E^\BM"%1:+@QT
MD*S7;U%VAAABOXJR8A9W[_W3RU1J/"L8U]"Y1Z.?'"XUDPVF6;V!.>BP>EE.
MK:PZ>)UR8N><FJ7 WW@GMIV;B*2NB)]^(R"D^$!^;P:'IZJ0S9^\$:?.^^%X
M1/ ^>&G<7<ZH9-^UV;]([153/"B*.U:9GI.OY%7?VE4W %;0[@U\7G+.ME=L
M=RV3+GD-)SB.[Q.,>O.)$3?,4U/.6,6:IK],,C-<R9 =.RZBN*;D?Q^R>EYR
M.\' _!DHZ+").D?4RPN[*TJ21Q >*;N6P]J%/)S>O&GG&3\'U7A=O_&[8W=8
MH3ZC3/-GHW5PN]V)7J%2,?(1<B\'/F,B>FD"<SG2;X.I(WV%:?41E8+]/DV1
M35<E\4N]< @XAD]ECP3:=40 :XD1M&+-7VC<3X!_;[;76..&'@16#\J4X;=I
M_-W>_^@2A#Y0X!A#G/$><3*(9S9[-L$=[0F(DE-]WFM-J_?P]C"SSEK=<2OT
M-76I"YWRE>A<PK5E@8.&)N3P6ZJ/7YQCNN]!_@;?'\2<+G:X?!>PF!ER'V-)
MA\[4Z<^TQ()-8Y0GKH;):"5>":3K&X3NY+Y-Y=^%:\RHK"XVGQ49*ZD.\:&H
MF3F[*WH'DQ"_2 $W.U-/GQ;20O)ML;BY)M>#HDR<M]?,DN+]=_DVT+"WM9@@
M]9].Z.J)I2%L86C"W]6F=BS4J55,)SX*&.#@(Z';-4XY%KV$TIL.,G@M$!C7
M9B]*M2L>WW=E,<;X7, Z0VC@&C+*W4$;;FB8'%D,JI\9F%8FQ*SK'/4V%%\-
MI/9&9,O/>KXU;2#)?$RJN9"?$AS4V#O%SU(XYH(K_32&J*3B0"PU*%$6]R!?
M'[ZP\"X^6L0;U/6@QID)$1UW *NPY:>W3ER] DTOFJM"I4%E6Z$/QO7,80NK
M$*48T]5YU[3[N:P'J_DG8+P1TF+L>5-# S>S6Z2'YAP"Q<0[)GT@5)MTC\XD
MB"V-UN-^:$K>)'H4!<LC8F\P!S7(!5Q=C^=.5FL55H<9@0Q\M,$@-<3+HI-;
M[08Z]\G=U'>U@1Y[1I7R!?RR)(7M3P UAMT3\-D',M/,YBT$#XLF;PK'*S)[
MV8II-NB5M9P]7,\KJ8N4)H88Z1%FIA9W*_OR,B)LA7JBZ@K#['P^>[ CS8'R
M<=72[Z2^M]E^8;5+!E=L6O9'U,J^9O3C@PS/TM#!U1;*@PD;S(R"=GC(&:'(
M#+OHQ);T,JN"5;U%OM!6XR,WN<#\L-EM1#>' !Z!2TNX$^ZLM 6^O_*1\:X6
MQ6=/>YA:4>L;4JPJE53URR.0^@SYMPW)RT56!G-QO9]1:7D;M4V<&\WDW8YR
M=MG:N!]JYO6C'/LQ+HWX0;'/^TZ]1I>ZHN5,-7=]+J,.U]7>II^^HC2N?>K]
M@EU,)^HOU=BK+5?/-#LW&N/P%:K8#I1H+$R;DVY M,@\TC21?SO?MH(/IYRM
MI-Q;W9O%)AK!BX#-0_&UE7CE-&/<1]]]RE@<03A 3,Q:8G13NS:0O=$* _)N
MVL&-+9;Q^"N5H88WZH>H/OCPE>K,-4S<]6W?(4'8'A;)H_,Q1&E1ZPN(TKC,
MT-A>HF=E41%%$.7DUZ'R?&)/?3'/S."YT]G02R]L_,VR:,/ZVB= Q\(&/UP=
M^NL)D )FZJ>*BH[!X!(F@W"W7%IX0\@$.HLUO_>!LKO<AC0(R51Q_^9LE++I
M4\$@K.^=/M!&@0JM_KW"=*;[! 23$-1#VV;5'OB/WPQ8\/&/X@V1@[A.4KE*
M15K/JE/CU]8WM!XYE6MJE["+C;TI.Z(?$.3+X&9+A6G@,H.%V&CI?+&GWH]J
M$W@(6ZY+,]=(DW4#$4,FD=[8-LDQB\$;6AL]8?02]D?,.E-'FUQN2?289Z@V
M4Y%>SWX>39$<JG.EV)E*X7"VSBL"UJ O-C42$0]2+J2ZL6EY$)$QMC K^8DK
M?*.:Z![L1$D=L=[E4+K/<<8[.;P$P/YN"2(49_L[4?[U,J=V>;4C$M-QD53W
MJ$BDY"-]0VTJ8:'S,>.6QI=8D<ST/B/RMWZ"F/]9!EDG1/[6O05T>NDX-A1W
M[U^8P&AD<[X5RE+##:S9\J#3CVZ5W:[;9( "?M>6/]!_!"\\Y@0VBHFARAY>
M;O(Z>;*?8,DCQ@B=>DHS^\U"WP1<4T\=;^'*<9*QTM )AS]8>YL07X1/#^4&
MM# NN0O$MU>8)3HT?_O P@!UQ<\5=&(P%XED<>Y'[E6:%7@"1 $7JJ#3B2=
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M1GM?BG>K0 #:Z.#D2R^I;7M3^X15(M4/S68D\4_ *P&?9XW9S/L$P,9 3)^
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MQ3D\<05821F<OJ'V'9ZTF,EH5%^?F&8H*]J73K(JXG8,>5(>5KG5\%>%K!0
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M=6A49N!K5;]T!P#9.@KP4%_Q*#<K]Y)VM+FG,/Y(T74]B[!"?X]Y(9EB70?
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MKHL$<DSMV4*]YMRS:337-1D/GP8S5=LPDK-8%<7EYZ?7^^\ 7RQ:;;QT;!#
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ML%!INWEF3\R^"!2)SU0>[?UF'P2KS9G[U2&I,4ZAFC" 1:'LY,$5)?9I:;5
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M2L&>'?4I2R/?" 2'<Y?US1LEL)"HO%$UX[J1\[[>UOVR .'8JI.7"S'S1^F
MJW^ %CZ>RRQ.OO-I];\5VG:LG+LPUYA9; SMZC_)C$/UDBZ;.CJF,5H'K<(7
M@\JUOU<<43[H[K-,73]]ZC&P62 *#G: MBK!0:B@F^ C""EB"-_#Q04WI;Q*
M],$WM2=9:S$#5+([STK$/VM-RG \XR@..MXVH2/2L'\60&%,$OP2/^T<?&U7
M"@<KP?D:<K9UZ'4^32:$F$JJ!3MDAGL:V4>[D+U1.5!,RV#R6?F=SAR_[:?-
M2N2CC+MY-PGQ9?$\*;&FMQ*98<OSW+RB+ZKT>#.V\#FBW3EK9"K2C:*"BSP'
MSG6BB"U:U6TGG@CZ!#=%:7PCP1MR=O8L2.S?##.#,\?CQ63/S-G>%KCR/?Y.
M2C8_,%SO?O80:UC;Y_ "?PX-3-Y%*11JB=J,3 _2$Y4I].+GL;Z5FESJ3+)P
M.SJ[QW>_*"MN_T'DR)-"[Z@UW71B!B5\-N4R'.CH[W>&CJ/QV^"<+9<W;$50
MI)75D9:V4CW\*_@;E](81:)5'OX8%00!(VD5T4#'$'Y&+)62(( 5JVIWL=LW
M:@&?1++?LI;T9+3K2EFLII%TVMCKFIM'04,:^#M$4'QPFM"3>=:%9KW&-&"\
MF-J5=1S\@6;C)\4@&QO(1((?(5\.0\B#E^FO!%!]QU+1_%*KD^"%0?'3C;<B
M5/%C#[Y;F7^4ZV:MWVQ9/-:5<D$##FC@DACB>:.K78(I92"XZ)%5^0^_!)I6
M>1E7XT^YD@&,;DQB^P,< _$KA\0(-& P42Y-36PPJ*WW@W[;W.:K+.,!V.3K
M#A>VI$'9.#]*H@<OI0AJ:93"3FL-T:J>JZM1*VI&L<$L=HWYD:PH2320$8D&
M/CT%=V;!/P?QN_6<[+LHU"B!R&R1K8>]$JFE556<,)?=#J$B7Z5$;+M4BM&B
M@Z>S9Y--.D$@=5K)IA3 QE.R9;*1?ES8[]&Y$7WR3!);KWQ&,W;QP9M"1<DZ
M++U%[&'-Y9$'$31U\4ES1^"/5".>0JTYK3.6VT[NDXF1:_TN7LX*4CVD:2=H
M8'<"VMJ/KW&T&9@Y>@IQ+)LG6',!?2EID7+^%@;T(X;1 *L][#IH":7\ CZQ
MB-!'85\IR/1O*E=YJ K=JH(/S(PC4M)V3.X<C5=DQ]N??1BYO/=5--\<;R^Y
M%+NZB)3>4P5,O;7M4$4,\;-G21U8]^Y@V49 +Z_4\)^9.+X'+Z<-QI\/?+A:
M/*]" W!)NW:)KO:?GCH#CK=L)W6QUZ^\%_.?+.[3HC#:D!^/9.L"$?SN9[B$
ML8]N#-_$3D_CL!L#E_R7[^UV-?/EW&]))-7P5(-=!\GL3(3@WT=\U:^CN>VB
M-SI=$0=$'VK.&$MI:?O=^I>A3%1W&EDCJS<EV$&KZI[O6KWG0\,&PY!LO$VS
M=^683B-;9IFZL0-)7RUYNPYXO\,][6IW))]N_%++! M=_>I;<VAR:FV6<_A:
M:\MI]R(J#3L)GA-L>>312GORE;]_[U;>M]BG=X[?1G[H;N9L:O(^\T0VW9,J
M:C09KG)\X=Y5X9*WE,+K>PO#MK^23)@H?C):]7J]"9WT$!ZP+8)3M%;:?B.F
M'VVG'N+_;.]>%8X=!'(5<ZAFAGW=E<5O-\='WDV]P0FR08U(0N=[K4\[O*6]
MF#:#I*SS$9-M"^SC.@N*(?LO$BI'N*(&J%BB] +WGHEW>OL)[G["ZO+51@.Q
M5D684\V.!H;#C9I"4*2>JII'C3%0%^+IU)U>NF\\;V3GN@F:+Q/WI:!9)KO^
M>.,/YR5 $@>>8XK,2W7OW:3UWHKA-]AXOASPDVSU%HX?\S?N:(@@Z_V*#\D'
M%!3Q/WJKX7F$HD (ZS8:L.WHPW:E5-E$!5LF_^ /7<M&9P71"-,9FI1SZ _+
M8Z'1OKZDTL/*!N8:,#U"P92<(Q[UU?U^18-P7X('CN\W^"?',Q7P@#+@%K]Q
M:;*(,+W<C,<TI!CH.O]%+71869CBN*(7NK=X]-ZV<S-G%EQ.TW-YX34?W5E>
M3[%,AY3X/'F9-;.PZ_TIT+ NF%8]ZGUC&^?H=G,:$6G02U"%9WWQHMCN;?S3
MV;BJTWF3=_E>T&G11H=%GFZ_JUH+VP%(IR]Y]B[<KI%CTE?T_FVC["+AAH[(
MX5FF=J^YF^;G1K??>+L@F#.UHU?P(^[/*B8]K3@ZC5BU&O]IPML> 6LGXWQQ
MA7+%ZFZ^"RK#G?R:DJV^OGG59&>ZFWB60H.2-8!>^V#X7EI87\.17_!@@.71
M-_F,<I'6FXMY&N)$?BI+!*?%ADK5B/@TVR.;S;9*^L19EA">]4:]%O76!,U?
MC$3NE,"U>0#B?'F\>^YASS/F18R(Q%9$SH&N6\!GW@7?$*+M1\@7H_7*A<^8
M1G\2-4$\]6X6_<C2>*CA03YHY(%463S#^[NJY[.W^#=5#PS;X+_LG^Z<.]A>
MI$TC$%ZDGV]9$5IN(K4ESK?K(4OP.WZ?4:4906TQ=BRVFGNIP_DA#?'.8YGW
ME?'S\\>EY89T,WKVK%[&0W<X/,2;N[N[MW6%_6ZU)X*BBI&:RS^5_%2D'U&&
M'?3J!ZD0 E@*4J[JDXO13X7#29D0LRHPE?JR\J,#&*OHE_ W?)Q?SI1_!A.J
MFCKVOA6N)T #[)E*:* $^]HNN@5Z<=<=?#KA>$TTT13PL.%16S,UO4Z1P\2D
MTY.C[J3Q(U&1F]Q/M^1=%DG+T0 M0IT7*>Z3;MB3U?4P:$=]OF1>G&UM8'7P
M^ZXLZ9$',GZ0$0W,-J'>/3MZYSB%5-Z =BV>S:$<_,\$J@=7:\OKA=/LO*$8
MU6^G2F?!.!X-Q)W9^G9(GA63 FO^+-K&2JV7J("5\"9RS\=[HT4H8M17YUEJ
M15!GY-2Q]SEG\1M L@[&N5?FE\FLTK;AL%W%N'E40C8BB@;:A.T,?U7Y[ WF
M)#> &2=U\TK:P33ZC7%W8VR79WD"UN?FA&?FGJI=+Z5+>S&B+(H@GI];'6"W
M^'R%TF;IC.U'N-CX\HU"-9ZQ!\3UR)Q@U2SK3?#C;\6DM18% :17KRJZ/:-1
M2J'OH+LSNVA OL%]AJI\PI]YU-Z!PG)HIH,Q_..;%H"-+2JCI@$B-U:,XO:$
M& 3.^L.L<+:=1+]DFEN^:;HG+A4S1 _L_Q5W\P0B.E94$0HHQL5ZQ\J=\VL2
M(D;&:LGHI?0F1ET?4U'DFXGU29D[M@N@\C*8>JB2.OM9Y5)"_"S1SV:QBQL1
M2ZMWWY(&BI[[WX;/I=*-=7U*;$C6)>=Q^O6E/?PB4T!FB?"21F-LS]6'P+&"
MH=K>_B6=URNS?&GQDH1ZOY5Y"VTX<\Q*S#+#/IZ?Z,L/5@OJ9Y5K=(*YH';)
M-9#=+DIJMZ#($])2-OO\9]:._(%11#)3Z?Y@-0G2SP9[)!W1L,3SGN]N=+N:
M_5N'-T/=A0I.QWE&54@<^NWR?1^E\7*NTSK)=GN1)[;4RRV1[H%RG&]PL-Y-
MU,-6#@.D.#.1]Q,.54;V>?E>][$N>*KA?^;+?RRP?OPMU654N!>1@3H8/;,Y
MJJ<^Z"&>[XH7![6G9YGEP-6@A, I0H;7\_:J^A61/UOEKW-[W)B)!]#==..F
M(G>S$+5>.?R/BMX7L9<,28>A\*V)IIO658YWB SR*RT7NPYO><FFS'?NF5WS
M#)<;*W8N,",X<X0KPSD&FEZC9,MK J;KT]9N:)%Y&GFDD6IYZ*W:,BYKW59-
MH^K  *R%(]I1A33?QV15MB_8!)3JOP.P.(<]\U"Q+FD(J$7F'GRA028'/PPI
M2?T5PI0DI<%1'G/@&Q!1]M'S;OWY$G_@0Q#Y-(0^I,R<ZI<\JQRE<Z V%DYI
M5U[W9B47]MPIB [A\6R8MR+IVN#F?;Z/4K<;7;AC/FH[51_)+6G),,$W@Y'Z
M/&T9$++Y%^^<PB$*B-.9I=O2<!.:U9X-:!1\2C1T;?+^23=KU.!3!>[B0+)K
M@6FL#YQ1CY9&%@T]0]# "DE T18:("E&B@L7=EOKT?!P.]"QXZC):#0G.Y-6
M (X8<-HS,XV1911HX%NT2<X*/\C3L-7E&_U"*7'AGNC-P/+HJ/;\&[+GK/4_
M-E$J$X.H:M@UN[>P\>,G8S)<.Y4HFB-ZSU#C]S\6YDR-4.MT3W7N6/9&,/)Y
M;LE28NW46D<A!0NW)FLK805M3M86%,K.O46U[$ IQ\WY(>:YU;!?I 1(JW =
M1$IN6[Y=.'7D'9':%^K-5U867#?;S3[V-<P"UA7FOMP5"?R1,JPCI\0RG?.<
M9:F2!;><:N=N]'PB=+ZY%N&Z%I6L#0N>X8L'=S;1SO9GZ_?@)I\30QB:L\QX
M7(*Y;K8NN78*RC(/KH QN]VJ1#<IK&=/+_<I(L3#?(=<[K7/"FSYD,:&F2=X
M?>CTJ2..YT)!O.O@BP) <85G,W2LA \EZAEUO-GJC,B'Z&>',; NWG\:1<Z8
MI],-D$S]?%59SV]5@B&4S>\3>[X4'LNS!(KQ7@YI7P+C64I;<]541B/<Z-)(
M+>"D[:2$")UM>[>B5PR0$.!"SD 1..%0NXT_41]UJ%4ZT63K=P,-*->%[8SH
M47XK%9&['H.55,@?M2F.^NK#53O._=DK0E '!$9=N"/XZE_IGDUY2LIJTVTG
M!KL:\\M=Y^S=+_\RPN"\8!XH&/PA$8]#=D]RM=(&>ZOWOQ;[5+9?/EBV*SH3
MKMQ0G/!0:S::5XM9:)$]SH J;KE.,HF73N-4Q/C9_1^]HGCK*='J>_(&([R+
MEZ@8?E>(^A^SFU%MHB01%9F>K+M74BT<J*QR(</VEB=F$9%[+H'>2]A=RWK,
M#!CLGVEW^4G'NSB)+W[C^Q/8X.U.@NWJ?8W,1?R%M]+^81UPQ0\GAS>W*.PN
MXZIBOV@]6<]R&=;%T.J'$I'11K"!$M2NMBK4H7SV5N;[$J*Z%KK.O==TV(T$
M'8 /$Q7N^'I#2D15%06KH3Q=_!KGVS1+6&]--("8@#)NGWN_'YYI[12/T#F6
MNIKQ=1.;$8R23'665,,W_E>S;,2;"+]<['M1FYQC&[D0'N<9^<FIZ8EU35\?
MB5CQKM4(?V'OL!F^@4TAW<<6T ?L?H5U;R7US*(M5/(-Y-<^7UKJWLXO#/KQ
MW>1M 16XMWB8X]40IYOS_SRB2=[UWUR+4>&N=TW?=^!S/SRVL!79I&L>$#(1
M1 /$&!&NT832 E\9$T_9BI;NC^F^Q\C 1] Q#/7%DZ(FC0\RX:2J(U*DYBN2
M"";Z2W8;>_(J(2&B53%&K+'52T)=V97AJ6$3XW2D=473A+WKM>&3ZI&$0\<8
MH9X&0X]Y3NYJ_#%+W0P(?5%Q:.;\CD=TY<*,$-MELBOV7#+6@>T<O4V=O$OC
M+3C'8+B43&)%Y^?KU-@:LO2D/K[,R$6W-T(Q"%UYV<"_YFK-"+^V1 .'T=>X
M=@9A_*=Q:* 1?$*59EG^VS$CDP^V"1$Y/V3AP7GQ@7DAHMVJ[(2V8#PI:]9(
MWBUOT#G)P">YJUM<-C_?\Y*^>BNI^NN(8?)L^EF'DIH!8[/TA[Q=_)JA2LP.
M?OQ[H/@2T@NNJW#T<->*_8&IW?TZ5#\%[LV<='=IH>U R->C\WW<S!WO(/?:
MRL]\";$"VLDJ=R-=YANU67R6AO!+U?69V>!W4Y;];OA9JW\,MWG;K&*@ ';3
M'8.AFI[_8N"?N3%^L!^5M5SWDTED^7W4>?_"37R<_:D'^+X4LLP_Y1^=N\/U
MA5?[PE^7?C70\%=[:^WN)]COW'@#WMXH'H(ZEKY3>+)U][AHTZN*(:I&TCVR
MFL$G505#>/_#24D_L3B)=W\BR<5A*\[ Z,,M4<_N.V-^<M<\*KF[:C^=TDW;
M\ [%]]?(]Z029IRB._-)1I[TV)AD%&P?*_,E03A:?_0-93XM%'A,]N#FY7B8
MLO[4MS_D3],.*W%"-8ZB:F'76'E8+__ZF?X+A?#,=(<!5=N#!M(K]/+_6/E/
MFQ*9DD/[.%&_':D-9@K_5#%'/D-&A<%:0@=_$?XC)\X_.[/_:B'A7%X(R-LR
M/?J(!FP-O4"0<8[J=^=ALZO2I+TJ,J&)^[G_9#CI+XSVZ?M A@&>7; 2/F]Q
M]?P,*8,_79].?38W=3$K#3 )X'KC4F*%KI(2RZV@ <)%&X_;7DK.;^_7B=+.
MD?5.=0_<9+2T=#(Q7XDFV$(1(Y0<TSVS_1[K? _;2X+LWI)_=O^G942(2WR/
M/QIHQY.@/ZNU+%5\J$Q96OC[S;J(0.F;::2QO@I2(E*,O$OPC;P5AJRI1/MW
MLS\IW9L$YO0$V>XX9]+N"';X=(5*$3OF^S*,U NMW&1TJ"39D=&_XZP4*$WG
M 150M-LI\KVW/,M0ZF&;9JMSSK(Y$#+PT!<-U.-!3-Y*O4'>JD^<?EA7PFPW
M:J,>\Z/-', :LJPQD?2M]];-WYJ1C@K(G-DV>,W*H&0Y36\MQO2,LX8]5C6O
M8$P-QZ5CT["'VJF!<)/I 4\$ G+T"T6UD>1G?9UWG7Z6%U2'&ERW;^X4K"DS
M;OC]M,CJ<G!HA.-^A8W;K2)._4KCTH69T^8>.CI\-DX<,J]+"_Y'"$FFD@\L
MD\AG*SR'9(N& C8R0UGJM(QY+:\X\3\^P//1S?G]D%83,7(P7 UQ>&7(;&!_
M13-]B5KK.C_WV3RX\IE0*3IR6X?;;[Z7DEY)VB>$;/"Z?E2L\[)(:"&J[ME,
M_F62*0]XE00UDN<$23EROK=WFSZ(U:._9UX;ZAK5A_7JP<&.GL-5 _Q0VU&&
M&(SD%&7F&)%2]\AF*(B6\?',X.SC>/<C@:3IGGDR&62<*XU4 F[:"O%S:;=N
M-Q"I\DK;)0)B?<SC?8DLWVIM M@#).*4A_A(SO*CC<8%EG%AGP87@Q8"-Y?F
M%Q&WL=@W<:*>K320A '':(#2ESY4%_XP]<Z0V]4@Z8Y0K+6/%;LD<Z% KU8J
M<NE2BYZF1:P<Q&"[P![=+BJJ8>C@-;+!=.C$AH<;?K!Z2"+@[29>HOLO9-L,
M%PTO].4],ZUL<^&<\=@[UE81617O 2U0->G)L!\EP%9@/ZYK#3]=B5RG*G$-
M[%F+XU]E%,,X'VQ.=3:5GSE.^RJ",5JOXR,T )-61%UC5& :121OPRV4[RGH
MZ@R&-)9$4?$%H &P0?3UM2J*-1JA58N/O+8#GY^"$6$8;<KREQ0:0*@?,V"Z
M>:R@>C)J"UW_>97%0,&2PPD654WV+X>VS@XU;0YBD$J3+1KH&&U:UK.)\F]W
MX$=6-WGG]+U81XA?>/N^.\W\\TBQER6&4:8S-"-M#"L3[]6"RL:PR5L$<TRO
M#NJ(;Z] &@A;-Y:KE(5KG^Z_??#\W9 N"QH@*+_#0%DS=@MX0_1A$H4HKI(-
MTY.2SNZ0H(SGS=31H64)QL;1<6N(YCP82.:?<+ANJ"^T&9:GZG/_A\0&\7G>
MX/*U@E<<"E,I?4GU.NB5H3.DFY*^26?:6PN;89/_416J,,Z[OQJVO/"4G2O-
MT>A&39>1R\6DX)&S\$BCP"VZV==A5=1+HAJ]I"#$=O'H652J8.:6SGIHXN1M
M,5.S-(K+,& 3Q6(Z#P%A2S'X[@T$JE,63?*%;1&<7]"GP#751XH;J3RY&<33
MO8+4X[7,GG.]Y[DAZ3L%4C>).<)@!!V)G!8_-L7QHJ"S*K*'$1%O_+WHQ@+%
M\3_*%?I$!_GC'%DU#+X_C#SM;PC[6I^4]ZDKYESA1J#S&X!]D_7M@WI(_HY!
M: B2X^A0U=G-_OG([/X>>#T1AVY^Z\$MD-5YB?(POY3@\JX2F&AZY])9R2Z0
MJO)*PRNK+K9F8,59M::$JD+BDS\N7+=]=L)RW$WS#$*-\X[HQ3)MWGY7;T[N
M]*'>:K.$-9(K<_7V"!JP\YIM<[QP]T*IS/G7[")SL7<,>,(1J@7S$%/B\J2"
M'GJE(-W@E"@E'.<TF"^6<=;?K9@]T''P53;LQ>=K3310:X-GA?E >0.Z99[L
M;Y,\6Q5^/$UZM'_Q[F,72$T9([K>=.#@FL?U/6:/KF,Y'M"+DB9@+=1,6#$D
M_U=<]@<KY@C/;WOOS3_J[PK:KEP[='IF@0]N%AK.,[09^$6<?S90^,I43_Z5
MW<7NBS8V^TE1[?%BE/<O6Q1EU4BZ\P^[!\M'7L>C.-'M\=<V%@9UC*I!KGHH
M#N2CFG'.TI#9)^5W^NO5@S1J+MA8/,0XHB?'=+KVL2@_8 3,A7;'C\+>&Q&X
MCG'1W?[Q<[X<0Y,*".C+=2 5X5?\.*JN\1 E675:'-W.S#0JI9Y5"<N?O?A.
M4?-4S-*A+Z=T(WN&JC]O%<3@>%^8(9KX;CR[RU-SYT8EO O:G 0QF7YC_.B#
MXGKSE2+^9A%-*ZVBSIS[?C388DA\L(Y!PGFS"1G"/F=PQ=JPH&<?;]?F8%VC
MT?$(H%*$&JV6V*T6[SN>@()U4]GKXM% !5+)-??XQ"J@2D:ZRI[]BHR+7KI+
M>;Q>FCQ4<;1"6JS^)FO4!,^G^^D*P P)Q*01,HFD,,]$\@PAE2#L/_-4V>UY
M#L7NM DT[RG@JWJ?1^/M:.Z@B$?X#PQ=?QFDQS353[6 /]!E?^5E^*0N_^#1
M?QEE#@X[9-6/]OT2V1!ZGK9$^DD2:W1*)UASE,^BMO)CQ\U@B\2GE20P'G)8
M5\FJ3B,U7_;\Y\LXU.G?,([JU?C+[SXIY+_#WA__9IXR1D?EZIX_5V=_YN8;
MR9Z7#:BCK*QD.VB& BH4AW1-KQ[;) AL&R@4X):K&Q',S"<^O-7P_("NRXA*
M[#)QK9&.==N423YY+9.C8[YZ_GJI6/!2U^-*OI\>8:'X]OLOYI/:DEPM%AC2
MT]\5ZR>B3:UV FP-(YP7$GI?'"3$N,F 4YH'?@OZDN,K/_:P(#J0^59592)-
MC3II;Q2!\?<?/3&PPQB3T*.NMDKOSRV1DB]^G_C)<)X>"GA+?-A'1;8(,HB,
MX[M4[*-R#_KK*U-5VU?9[B$K5H+P;EI"@LV(VRZRM*G<$VYTOKA+: #8WC/4
M&]\K2E@B*6TK-Q-U2G;V(R^;:!"5A;4Q4XT6U@LZ%MJ6#MH%@N\46^@;HX'W
M\0/.*JJK)N(Y2KE*RZ;42*UZ8JK]WB1C4?SK1T*%\I^N;E""S@PG2E\C<;/G
M?<D:X*^C[XWKO-RZ&I@/E U^>KZVN2T+TE WXFS9-]G5Q]"=DA>;TD.B,Y0%
M8X+V:S[_=]A'Q0=_%V&/DQG=]I64W6]&;&8$*@->^R4=D0\D]6+/)DZ+XV7C
M,R)%$@XCJIXGH:@7@M& C'?T]94JBB^S' %9WL=HKO)68R\-LRAP?I'9$P_(
M;#8H8\#99UF,."M21/UVWB$W/KXLFA^5@B'4MB'$:""X*ATZF)J)!GX[GX5G
MHJA#(EVNQLJ;;D&N)G$IV$%QT4G%1O[EAW^2<Z1MQ+=GR3DZ+@QA\S*6+][*
M^,N8U,A=CC7EGU2O7J?[O1;]\^RB$8;>-,B+'?#Y/AA1ZX'D-L9&^5> KBYA
M2'G049XKZ<7E&/1P!PJG1 /34AV8*<L\AB[;;YG^VLQ% XOE:&!EZZ]3S8&V
M9@V!-W=_R]$\#(A4_^M"%:\XOT!;HS\N_FEP\)^[W5[\T_!_[1/5LP$ZRES[
M;R\'^L,K%,EU\3_;YS]VF/)OYO[G/O=2S?_OGOS?/?DG]L3&9L*T-G8$6>9_
M0O6D$[0)ZI@DXOHW6T,:0L]Q>&A5W4345,M@^<)<1@XI_2;CSYA6::=R8O7S
M6?!\D7G34>4)_\4OS)QGH'#7?XMC-;9 OTY_[]@89L=^CZ:4!AV<P(P&Q6"7
M]SF83>+_%V3\WP78X&FI-A2E;P@:^//@PW_M4^6OH_\%34>?J0I@_@*Z\_]N
M39G7<7W@9<5NQS\MP6.\!3/!/U&(KI>>SIF!#UO)K=,4/PS.QF [,[=_/&A$
MV\B*!KZH7@>EHRHJ]/Y4:4/$73!1@=^1PC;^D/>[QRKJ9JJ^$;O-@SYO+"-4
MW$K'N)MI:=97^3OO/_8D!^Q'[^JKE-_AH),VZ1P[.N56T P<D4QAHM2E1<G<
M8N/>GGW+CKUYB@:Z;'7:-3,=;?:=<\TA+_GWXO>W+U-2J+JG$:O['A-GB].S
M4MO4T@O^3G$1J_9N8^HE*C\<DJH+EO.79[2U2[8O,7,WI,6EU%%I*$(#+PT[
M^*>1AX)GJ_YS3K#'ZAK?;#MZ#=F>:V7IV)'IOI[(J$D!=>SFVZE/5\#BZAE%
MD^H^"D68Z3YC#Z=494OFOM%^B:7YO$*B=.-=+7<E<Q&!LY:.16XQ/XH"Y3D*
M_G_:NPZ@J)IL/8B"$D00D"0@.8A(SHR*9,DP9!#)C$/.:10$%&?(&21G&#(,
M&92<<Y"<<\YQ>/C>[O[^F_]]M?OVO7I3]55-U]S;U?=,WSZGNT]_W][UK,Q0
M^_BL9]2>_Y"]>'LJ<TKOPM"I%IAFBF-,FC[/AIP82T?'EVOF"BCJLZCK'$HN
MLG]H=6XYI>G9LW!JA20_-H6=826EGQ2?BVG* 3?T])8,EEPJ5NZL!EKDY_:7
MZ*+8D+1K#OD\'3O;V;VK9GENNKN21_1[VAZ!W9,DH4ZQ2%(Z0Q+1<"?E86#Q
M@=J@>R"7M=CB=LO4<1,P5Z4Z'/6PZ5!FV!O95#86$P:2][ZV!V2\X]H>"6S7
M]MC837BN-62_3!:L'-#9C6!6COTP%(/U0P7ZGTWVP.JS>["=O1;SP/N1H^K0
MHCE[]-W;)1\M'7H@R]@)"">U>@M@Q<EZ<K7W'='/PDKW)X>?->*=X *,G.>5
M^JW<P91^^=.7@0UDQEX3D\]".#VR3=\4-KYP[[SAY1A0&YZQLS;R3%=6J7+'
MMY*Q5X\'U/_1%F)Z<]%WOP*-]%1JX7B>*"%'/-U,_^&F \*NW;__7';O[=9R
M?8!0N*6ZS:RVZ0N%7?RIU($\A ,0KA61,3OP<+*F]O.BOO1-[_:(F5HE)QRO
M<4F]T992@,LP+/[&8*X#+K31DWCXD+=BT-*T?!"2'+MQM-)/@,XI&! 7@M;L
MDI]X</N@O%HD(]U?=15LZ368$D&I)ZJGP!BH!PX<0-$Y@Z!H/5#GMP<#A+9I
MW4%[3"%\-WT#3=#H$BSM#G.O !@7@OV'^3YZ9 ,7VNG<^UHMC_N:]Z5)85(;
M]0]S[SJ&SQPDWJWZ.D47VSBL%;:OG8HQH!S?]H+ Z78K6H!;W(@8+2$\BE9
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M]C-E.1.N-@L/VWP/*V;([K;D@R'U=Q1XZX8/@00LFDV0O:WNUK"X!+M57;F
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MY@*CB7C^,=YOW")N&\Z"KYQ"GK<^425E_5;*D?_'_^._ >#5]_\ 4$L#!!0
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MZ>!U++%X3"]0TF(KT&ATMV2TVOPSQ@RI6K5:'B9Z\F[DI\P1Y_L+W:OOC.!
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MV]$JC,26</-FR!T3-'3J,LCWA/4]YNAH.>I6!8TW6Q,W6[RM$_S.\ +%)B[
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M4&1+X1O7M'_^_EO,,\X<,I7VS9;\O2Z+Q;9?(P>]]4ZGGF7W*R@BR3^)+_*
M?=>+%'I-M"TXHK2"C#J6F?:6>*8]1&M<<$"U!GO=Q_*-GH]N ])I)C-9!\T>
MI=;;6*H)CWT^E'N>EF3KGYG!K]MJ[.2E7C^K]!:MM@7A8+3+.I0F\$TW]/FD
M+$AU>?_P2OGC]'OM6X_5CJR/$IIM75:I>*WOY_C]+JQH!M:#V/547J]#3/8T
MWCUHSWJUI?,OB: Y#[DB$\"^2ZD74A5"#U_N9^/YH@ WD^CC:,C*O=RI<G1V
M[S26#S$1_*#<]5T \=C@%N=\/;$?5T;518Q^$<GG?F]#=H_VM@L8#IAOPT[
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MT;QQWVVWY!DU-VHM9U9>X03O\#<500+QK9(+HAOIK>Q)7!3L;2YI 8RJ92W
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M4,NO@P4J5\V'E_+;W!D)D#HZ,%SWTNW]WH[JG2=5-OXYAV?$OT@G+L4C8#Z
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MB"2W]ZEP]+^7 A;,[O-P(A\@(<E*PA,?=+&_=45!T?>JNE*D#C^5Y>\$_2X
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MI)<O.\%SYV"[&^ELJN2;:=6FO'>WXX(7"F;*)L)$C?2\I4B&./^M;A/0.N>
MR^LY'XI-\92*TC>'8(6VX//U9<G*/V9B=7TJ#-0U"<1J\"F%%2FR3E]Y"%NB
M];EGVA3BS9^F=3S1FZ[K:48O#(#5J[/M[,09 \A)L_\Y_!U%7[H I/YS9%K>
M6,:+'%.M7C2;&,3! P/'#_5J/E9<RJA-[@??YNJ8/]7\I%QEO+;L!*99ALJL
M.*,28]C1\^"MS8)&1NW*W$A.^?_0P,4C#*#S<G+J;\7HI[!(CM+'_]G'[/P#
MZ7Z;=R76[-8K^2$9KQ0D3*ZI:/[_U>6B6R&T2R_/3W^6V3).%"6I_#L05S>-
M QN2\KUHNU2OHV=N2ET35_D36C;;R\8!C!5\/$<;H<XF]E4\^^?DJ08>[NAI
M!+)UB"'9HO:F\TK%*<B+*/Q)CP+$(&$ X?!MW[HV=/.+<B^7/ &3U*N[WXXO
M!X[TLNP8DC=P E1@T/EQ>BAVD:*-3]"XM?D">!$E9$0+XM*(E1+' )!DBT-$
M?<K%:$HT]_1'.:%N"XDH;]X<6Z>GL;;I!ZR1U.J3-!#+?+LT<TOS(B"0<B6F
MF8 AL)[",_(-2]I]J+FMS9=G7WJHZ=\\9_@]Y<##J#)!G=:I6@/_L/,^2".[
M3W>. YN@B<OH\A%5RNA"A]H[-WEZI6N&YV3JU;%=!@4%C7-8L%<LV'SB:T[\
M>AP_'HH >9,+^ZRJ)KB1)O4\N \_HYET=SA^W.NG<Y,?&X@\JNSD>A0LU:U1
M=XB.LG'AY8%%W6?#E[;2ZX-D%U-#:#@ Y9MW-BIOS,0V):&+FO^?6MFKLV%!
MH) &[DN]E&G$",C+F:*+.&;L7=!4I:L ,?Y70E4Y<BSE"_GQLY?Z;1..^]_E
ML;+P7&7X]<R#N6SUGC KYKX.?:M1BE])\8P<2^U&:<)#JLUY LE[?KLL39'(
M^"XR:PZQ-(P7C+C_(S1P[R.3+N.G$ML?]T%('HCD<HU1-W'FTQ1U'NP#MZE8
M\<1=1%A-K1^LR<$;^$>8(Y$<;TI=@[:80I@<"WBA5CV92V)F.+\H3R2K3EJ/
MOR7'DQF:E4F<:&V'!S,<[F.Y+WB*7:[YBN* &R1\WS]]WH#78MA3]8G'R.@D
MO^V<\>/>1T!0QD<%IF02)HW2M3RLV/M[OE,['(#2BQ21M&@&.60Y%=^FM/%1
MN/'U[ZE(#NPG>\@<&&6\44=*N^=]7<"KUG1?BS*@K:]:MEC6H$IU[;>S!%IW
M>=3/LM,[]CUPY#[CP*5"?#61I?5*E32?EJYG@1CD?N+' %;(#I=O":[UT5@*
M: I[0BKE6EC:.*' ,)==&Z*3[F'Q;:LU#OY1V:2F"RV=W2,E<L42&@Y=N2</
M\5_AFVNVVX#L3Z1:8'RPD3_*EJ\*Y=$GEB47PG=?1%4H4T3B)# M('<IX\^*
MN>;3$;-TZOR6,5B+ZM3!Z;Q$H>8GFR#CN%]_<9CH^\@YBK#["1Q?S37).8/V
M\$3FAN<&6"@*FOGD#1H,OG)P^V80_2G,_?0P+R#/SC<];X<&E#G_HP/>1?!4
M<TN T/1?=J2(!T9FE.YC'JMX?\[2&D_QM%<Y)9(7CXN'5F6"/NMO'/Z$[3[%
M U2HBH^E7?&;]:6Y=C=*MVK;3FA@V-TPD>O+C2?T[R6^JS92XC/%<LJAQ6?A
MBF:P7^NFJQ+28FYV%$DR_ZI0^/S.'@AH#<F;\\G^,.YH?J)3GF72R'OH&Q+4
M)^SYQ+(N3-0\AB52^'Y$)'9IT"< /:!H[!6ANR%)_*0 W]/DL-<,867T+]0=
M1/?F.B;GNE['XCS<DQ7#Y>7CU]OZ@9T#A]56U:HXJ'A#?K]#1I+?+TM,_"1*
MEV!O_Q\?0RBV03/V%/[M^AE72%-.(_@_>P' /U!!R$%V@9Q6^\7(^%>R,3GR
M_X5O^.]4:S_]%:OK)CU>/)PU4?AC-%)\Y<JFN% $B(Z5\SJ[^^_&[#PU-+!]
M/:#B1N%".M"_9<'24ZQWO%3BRYZI<V@KZ9Q_C+21'3C,%EJP%#YI'7'+2?S@
M\@L,B6^@ZGN5'R?7XJ?7_-XD$PM+"4"JIL9I$[+*,_ DZZ S)7+Y&+'(YF7V
MPXE+HBN+(:33[,&9GVB!S[J_JN2^M)V5'14W6'T@ZYK?ER&$MKRJ/,*U' =G
MA_"#PJH4FPGOB99*\YRA1.]']A0,@(5]Z4F/FE1062WC,5$M!@!50H7Z%(2C
M$AF?8 #3&YNG)<IKCGOZO:8T ?++ZJJ:##MK-JDT\IO//G$^P $<BXH*6^H?
M.87F+! $O-%4+&*1ULI3_.V;K*&(LG^!9Y=R;19R6O\C1J??,:'OI^O^P)/$
MW7XH^\_6IY2-.HU)6?33+RK.'N2G^ WZZ7J OWTJ[0[ZV:O6*[07ZC;FGNGV
M;AHT%R!P+/%M% EJP%//P8^_1(3ZG(5V78!)RL^X>'#T)WXW!"LZ+^W,R$>_
M6HAVZ;)AH9:>VA)*JYR0/!_L]73S/CYBN%[?[D$(U<7M57]B94_0=U*8G#8O
MNPQ1'K50$I;80G9F,&?4O!R35T+AN5T[HY(SG='MAV#QJ$X7MH*U9=(=K_<J
M'VTX@49.U"1,QIFMG[-W=U7S>521+-V^#$V";XKL208%HK]]![[LA2( JYD!
MJP%4JLU9B N-V"7;IV1]K+B S[_IUG 39]R0QAA 5P0+;,(1/D/.EF/N0Q)I
M_<2B?,::O5YL6W?^7>VDM) 2SR\5#O@$J<%4V*N 2WR&G]D]43R]GN[B9M$H
MJ?*E* EZ)8;UZ')GVIZATX5[X(?CDW C0H8AZ!EM,>2'Z<N^F?Y3AJ(9?9XC
M!@[$])LF'>P_/, %!0Y&@6"U5]+A.)%#1T0_V@YKD.,'*FV3R#UN_QD0A)D4
MF9S.8/F<R47T>C7*6%\\YF5/*_W4 >7XB)9\/;B!+K[9NC7]Y\B*T=D?-,]4
M=A>0+F7T4KM+<UG^;6TB/"V.\]5K_*=?Z/D<1KF?I06(SQE%_'*35!Q_^H2S
M"UM>&I9&8RE,K]:K6./0(KLCX> A^N+ISY$?9])3B>9K%80[^E6S\_;V3L\D
M+)68O2^R7QF^8M_6N*P%82,">'>!)Q_2'AB6(RVUGR;WX>P3-RO@VA2X+C\6
M;D*J=U!I58150,SK$IZ3'A\EB'RI*\9E4R%UB^M)TR>SR2DLLV:KX$VJ 1?)
M/?Z>R]&YSHX5Q()K$TLHH3VY=QH@;70K^Q$/9K"T3A:=071/:3TV><B[&6SE
M 'SQ92("N7'S; 4#*!3XF+@'";D<6PU%SQ_)1ZV,G;R*N<WSEO"Q=8D,B )S
M<DNDIU5$P#))E\3@7).UAM*K]1+S6Y^<9)(5\KV+WDX7>,/F3]-TJ&V_&](1
MFY1C=7\42?L9M4H5\6+?W41;.VM)#E[K(.&1#!HE4N#F4]H\*?% JJWI39Y&
MW<IT7)^UYMAX1MND_>*P52>*?D,6K3G E1F6M]I"K-28-8<!:"BR!3\5BMQ9
M>"KZ1+1=;$_LO,C .T]N\O0+W,CHU.&^DB&[A^V48H];/;'FU33OM75KSE'!
M1D.,%66CQ4!D)TL@\@<:D+9\%'[.>"X$6GU [3CN'F^I!?9=8V4;NZC9EONZ
MWV=^&;IB""6EF!HS')ZR8XY_G'TQ*XN&CZE+ZHU*3O3%=X6X-67@,>1/XZV"
M/-?T#U.*G)U75-_L60S+"YKB!EEB*1&1)ZCQW7]2>ETC7;"2C;WM1<I?-ZE:
M-U?I$Z_'-Z]>)3,0JVF\#4(%K/B5P6JC].)^><Z$YGG(2P=%ALID.M@U=H=5
M%-VV]OQ6<DC1?JKUB4)4QIOH6Y'IMIYX6"I;^D<0+5#<\;CC$[EG;Z&$KWY\
MKU M^!X$R6)GZ.0AZ/ B\6+Q4<S7UDTG&1K2=[QC6^I'!!U?Q#[ODB04V7G$
M_/+! /QYEQ&-B@6QMBD&F58Q/1L>8H^D7D-%7I#.ORGBS60,]I>MM<\R"-E[
M4.-<^'*RC6BMJ7:L@H>]N@56%W:L7M7KG6[\RD6'05U6,2>GT+TQ:K&[<*'E
M,[-#%:T/?PW>H\LUUO,AUVMPYZW(:H<8ZC5=6AA$(+R^/N7#@-AZ*4A4@QB'
M(7E6C[=EI0S\N+1@:#\'FS-YUL'54CMKW9U]5XG/=N#PV5 G;]7[:8'%V1E3
M&&4J:>TY!_[B(LK(-U X]<>E_INC=]>(JE(#GHFADE]?FR2(%PO)W5E&$=F?
M;;)5)^$O'ORR,"]B5G(0>$OFKR;S11_'14IQ5W/;C%#(S^@I4?&)_3 !A6 3
M)YL2NSU.4#_KV9_2<Y*&/&_]MX>H<=4"@V>P!.@TYYZK^ 5;+=>7\7@4_UKR
M*,^?%%7.ZRDH4Y@^+RA3[6&)))*E#J** 3S  &Z5I;DP@/8[P]5:J;#7G4$@
M005BTWG-LCCH8%X\R-'@_2U/NAO/<D'<B37.7\\Y$B56X*TOFVH\>F&7%IJC
M3:O 0L+/?:]7*]!Q_6:J@@+_2!INN?)6-TR,IPW&^R&!SRJ2;_[5NUO$"/4.
M9VW;[_C"&6B->?&2B8F=XMT$5S:#O5V15^P,F AJ?])>V/@@+5 \S2@.%U(C
MK[6FE;(T;^-AX]&'JGZ. 1Q"_)]B *\,V@[VLE&ZO#F%17%"A#0[$MM[[Y?I
MMX\51C*+/BUWR*^-" W&A?N2U%I:DB.\=@0I3MW:TBIFOXQ(G@UQS1 ES,U-
M*$^LU07I$:AX'_ZHNY^W<%XNV@Q>L8.&5CN04/' ^!5($M%7M&#@^L%961NI
MO]2H19-K@KUXN;C'&COMM-L]%H:FUZC=L?EW50%\VQ"[!]7\5X'R8W<,QP&O
MH[^A8P\#K[\Y<KX-6,8 MH3Q0UH9+HUT#V/3 _P*KNH$Y1H5;M[> ;\9/@KV
M4!!EY\I!9/G8!:1EZ/1U34;H.QN9T!<A[F8DQMXR[](FNA. 1C Q1;S/+RJM
MCNJ/[;.UE"#<"I\#GVZGJ27S])Z;%C@_]U-Z9F-@B/4T58Q%% <5>4ISXLU3
MT<RRIB(!<5H1#BFMKXG2L'[.^LB7[5?R0_6BMO$6YD(YIO]HO\+_7WP,.I4!
M)Z?%I0;25]=:V+X<N5\[_ET6MYI1VEY<9U6ME.S]/F&N;B,S%CFC)8OUD413
M0TLC[6:PJU$*^83@SNDYP\3!ER1(?9;].@TP'Y=6Y*N/*5Y+(G%J46K2C'"5
MI&BY\XL6;6(ZYYE[!_YZGHDKH \C*STM>2,/$M!_['Z)N=]NO0<X;N*(2I)U
M^SZC,.ZH4I"K2YF0G4 6F22^ =$Y-> _(L<6D-I-J9Y O?E]!07=F74\9HHI
M>BGWNSLZ>1HL$XJ\\ (DIIWEN$)CG16BNKS2.G> /8,$NG&#X:J1FNQ22_(X
MN->6=XAS7%..33"FJ1IQVL9@[" BKC$)>L&3%WJ^P*I*HMW_M#':5_O /=/F
M[1'/4MV/>;D O.L?394^;]^9R./D,8A[X&, 4]-C:JM570O;2TQ'H+,$!QIW
MH%ZB@\""$OX<I9T3?>#6,V^"7?3''.?\I:*NJ!;#']W1::ZOJ@],C:7O%.5$
M*[^),+DQMYNTR+BS1X",6F0/L?#*Y/NLURWZ]_/7CQ4V$-]7"<FT35SGNX#$
M"=.'': _==]K(5UO-ZGW7J\S'D(+(WDI17>_HZRAI8:]A;Q!!**"IL)SJDP:
M/B2A^P&JG@]%BJG9<:BE5'G(1023CG@32XD?;P<^'0?EMJ3ULT:J*+&2I.K1
MZ\8!XGR[CSYDKQY0;0G.0I,ITQ^N=!&[)JBX_#QL8.2,167]^"O%Q]=RFQU?
M7P=?BJ'0R4"#QD]YS]LY%,_7F#  SDT48:X]0L6G^#)(Q]XMXO<3EYE(X8=%
M3-G-KCU-#SE:4PCH0O<3R[>R6)L0,%I;Y_=M#\X'J9\=SS0>TC\Y%-TAQ@!*
M%=4CSS+UAE7*=$=/=^TD^RV-0M.,$L1Y]3^UMF  1?IR5 1T0ZV)OMFDO&<?
M0B@%[/JQ!UM\7*Y8J$?4+KL9^,:<X<\F7L"F(HV&1+:,6<GHRSCV!6>N:;:+
M<U<LPQ$*4<VJ>0O;47ER^7)";U6XI^VXZGL7-)H?90FHR]JKQ#U:VI&^-\8C
MP"V<*2)JNI@9@I<BW// >/TQL?JV2<&'W30>:%N!DKF[E:X%/6OTRIJ+*[6Z
M!:%$:#2U,#'UTCRM8([1]GC]W'6(*5?OD_V=D#\C/V1BS"]5.LLJ_)]%_ARP
M\$I3@A3M0ZOI(7'%,D&067^>5=I!KYJ6H^AQ0\4F5H-RRU@]T[5?_;N[D=OE
MW*#3(6D"6L4NST,FQ>G1AR] H9;?X_2.FOD([/P%01_=[RW#"XZYN<'-.JB?
M?GI_@JR+#>P<&,K\G9T-YY2LZ#A8;Z<P "N]3'*H!+E')B^]LWS3A-,#$N,>
MC<J=UL\!1,0KQALQF]%"4>03FZ,LDTMX)+T^A*ORU5@_N2%]HKO1TY9_?>_>
M\&8)#]RYPB((3&M'O!"W_X$$<_0C[O=GDAXRZ,:"0O9(R1>@VV2&A,:AI+>W
M*1N\">SWU63K ]<*%>R1''??_=N8NXDR*-"9Q"'WR?X<8\T\L&,>L22YOM%4
M)=6+ 905Y4;2U@^;=='P%@KORI#8!KY+'95%3!B]V]!;)77[M!@A&7UTY::M
MG=C=RE29JA(G%Z<8N?'(;7'$,R'Y32>NSGJ":'^O64^3.$=]N>MU7>@?$Q8E
M52+KL L%3I#_N*=BCF>UM$RSQ/6DX(ZTP"0/<'RY\W"[ID\$OCY=PJRP,U!V
M0K:=H6_R5U\SIX-YYMOY;"E3"<EK"SX$K\>^_9FR%)B?/?Q-6)T67C=+',Y#
M>>"T7$<[Q;=Y<\/?1']D$G W?5W0=(=_2@HNN4S&]Y/ZO22G356HS);O&7-Y
M_%SPH[-LT3F\W8P^Y<$>4<$ /G.-W CY28X@#?2]Q(;%>C=-P^6DWU=UQKSH
MDN:8=I]?=.T@Y.Q4_6:L8%_S)3]!<S2%[KTEZGR?(S?1BP#OW^(P_K>2Q@A*
M)D;U;]?[]VUS(W/^73( _WN0"OZRC'+DW[PN3.Q_I4/]SUZR]5^=.*DQ@/"C
MDM*_%3E8A.2:.DS_>M=;V+[8AYHL+A_4ERP1@[_R+UN(.C+42ZY^XD.IK^[*
M$ :DL&M*+?XJ_0((R'\NRNTMBG,&C6SN[6&@AHT)J:AD"QBUR 8H$XL?K]0I
MWGJ?,W2TB*?#/\=:G'2/BT"D4W/M!.WK]'JI'E5S:[X-(,BZNR5WI'L<6G;O
M.]2.S$[_)3ZH22C8H$!FD4CB=&T)!N.Y-]]Y7M/N>-R_J3;1SYI/]<&I@>GA
M9B!+M8F1G;C.$Y#\*EHD2&%)HV'P!BL+9E=I[WDV=-G9(])*4AEKR'RC^@L2
M@>Q$LGI9N+C@3Y1 ("H:M>/NVP<'K+/.V$Z>Z)"%TPK>(^O0H=Y@."/)3GQ2
M6ZOW9XWL*\\0;\YL[<F;,8H%6BFG2(Y\P93)Y@\64_GC,!#GFGY+^*W+EV %
MDE,;21S=N%@G]_EBBR/&\'WWX@*7*%<VPU7<TX4!T7)G(@>]5@*$< R+V:+]
MQ<LX-\+YG.<"=?77-COJRGO0:?FCP*B/[U,K%^;5?@@:#90/#K\^""8N+ATC
M=<2^C_OX]98<CQL#ZQ3[87;XZ8I%"2][V,1+0-7S8,%VNB,,  '-RL\56S\&
MK:=2SQ149=53I*]D.J-)98B!.\LV-S+9;1=&%\BY#=_?-H6^>DXQT$4'C<L$
MKF\K<E5-:8@7W(^5H2Y&K">GW:Y+. CALK@'LW99C%6U-K4GTF,>OK^8Y>VH
M@S\U5[7CSS-GPBA&-,OKIGA3N\:V+56_0X#SPR\[)2CJ2#9.>UP$I]N4NZN/
M1"#FT/DM-%MU;>C^,8\3DCI:BP]-2OO5?J\1.>Z-IL=5()XU4W\IUR=QX<P5
MO?GDYVENNUM.;H.J=M?<Y\:3+5/ZZK"=<PIB-ZG.^$> 4WRZQ#V9WL<JJZI^
MG1=Z=P96PNP,[8-UDH#J]FS'=[[.>IL,IP:\GCIZ5%_\Y1L?B8R]<9Q.BUF[
M\JPM=C&^8#W'B;YUX/7# .AGYFEG84B:/ZRT67.SZV18R[B'ZN-1>,.U/GFU
M=0D^WU@UGWM9SF EV!,*:M9-G<XX(U6>L-%^K6QG$1V6>;@I##+=-#WD3DOY
M?)[U#C'^O7O48B!(T9I6_1'QG3W9V5G.'E9N>G1Z5$"@97$\U?5S'\VLMF#I
MI6[/\\-,&YY;7T8([C9E_5)Q*B'%22C4Q/TB<)SJ&T[P*[40IC,(F&C7:RXI
MU1-8F('0/X_&00[*,4F&R:.S5J/PAG;^'H#_[^"8-NZ-Q0#6'Q#?^E>@@Z>2
M[;,&TC,K+!VE&$%Z0@<.F5(4JY/ZR;<5MR.]:"PD!O > Y@8Z40_0 KI1VDJ
MG+==R#!>8MV&8 #J,L27[+ Q4QXYQCD,8 $%_HU_3GPKB9+YG34AYPTG!SM@
M &YW#/R)<4;F].00 PCV4[VK6_._50T _]^*_V_%_WX5*U%TC?+96B>(T 5'
MO[Y]7K[H$;Z& 0 89*]U_KIE4,YECCB:S3!A7MOEJ(Z ?Z?HMD+SP&0$>%IY
M&:$?)T3,2/&Y)"R;^VXB0H;?_Y</?A&]6+5!?7+' &X>O,8 :O3MC"^BA;@J
M'MNEU"(29.,HUMVJDKX^A+K>P]I,6TX$IRR9+EY*>+F/.$YL\1:)02^S5!Q6
M\FQK.VX,/492LQ=_MBU]/6=8OK4'AZ/X;],]>$M*C--O/WS\PFO@$G)3+!/J
MD#TF*;,6\,!)M<G;U6Z_0%#]HUAF?GQ<"<!%XB'"[-) 8AJ,8J%U&Y8>R] ^
MQ1'L]KH0]"Z=0QR\1?">^C&Q=2>7Q#NQ]>A__ TR4_,IKV"\++O1[]"GS)X1
MW\C:?GPUG1)H;/E(/"/M3'FSV2''Q#NN4]"NUE4V42+OWK>OS719G[+'/[?G
MGD>5@QWG^U^>.^595IWOM88,?%@3PV%GAIG4RH_ TVW9[<^D.S+E%'^9O- <
M][?,A8S/<Y^7[X5Q%2<EO_\X<"R%_JPOLVJ&;7M^;8(H*Y"?,[G-5Y=T,Q)[
MG4S=3L_?ZZASP4 Z)031V]0XA.;A%3>"3F9-GMH:MLB+F75B !#-Q4NO[BQF
ML^K=1G@,-*O+I]*N>/:K+V6@PNYIJ>F[1/8NFJ3KWDXPL=E"W/*@'Y9;M%5P
MITRLX.5T(8(!OA(E9=2)_T;]U%N3_%6?X ;%3=%R@35;]MKT)T/5,CN2SIC"
M8]&,!<MI?((THSB+[! #@<NAI. BG0:FV' (\-+@*0-V#3])<__S5,:E)?"Y
M"=RR8XDLN[.6IN7[=];8G0_>M!]Y8-![:'SI^B$K;[_V5K9#:/:3"6$)JK1W
MZ>E&7Y%8CAD"?%A!\S &\=C3Q<\FE\FP[3D!J/2XAX'_5^ESG^WKP*0ZQF-#
M'O#>(_"I@PY"^LF4,_PFP*:KKG9"R2Z[>@[(==_2$F7HI(0!8&UK+(#[K> 8
M0"4_!C &>?4DB\*,E-ZL:ZA0.J&:7OFU:+,2P2:[DTAVTS1%%<1V26 :%A4C
M<&Q&',$.X'_[C:\=ER3!IZ\L+3M,^(E'OT<;D=D;!R_QT(:Z>EGS;/H'O4PW
M<4=#?ME$WE%=ZN32S&U546H*1.>-KFT'$6)8WZ]ZKRYR;V6[]<)4P%^6&(*/
M.IM]WS#S;8W'M/>-P+W@(:OJA&Q->+"OQK12LOVH0:,DXSWISU[:0;WP#ZI%
MESOHA5EC>Z 4C$BD90CF2AUY*HJ_@;^M\G'/WLQX^\+T\13KA%5=PH*16L.G
MF)Q@NEB)209<C26<<=U/G._;\7/6IW89B6>WEVC0G;5X(%1*1-7.?-!"[\)Z
M6O]A:U3%MHA#OKWK=BK-VX]"MF,/<'\]0'.CZMN%W+$+ZD)1KW.X%%8RG6:V
M-Z(4[/PH-Z(3$W J1(=LO?VZ4B_2NA'A$(-GA47.C]/Y6K<VHK^^)%I+D+*/
M20E:K2!ZBQ"G/__N5G2/[<D9WE?)5QF_R7<$_!"IX2@)+^M2DUU@RZK)3BH'
M,QOK/)UFW(KF=#%=FB-1;"1'R;\Z8^F_W?W8$$>/ ?21,EY?F=WBE15!+7O!
MQ[CAZ%;]OY(J;?1@ $TCHWN#&,!2SHX/DES3C#.@_E\T!+C$.-96"\<A$%.,
M]VHBJC^E&%.Q^[WKEV?WO&M@WB U$7 3W^VAU3&0[[.?<.(I6F9IKAPXDMQ_
MD-L2RQ"Y):FZLC&V'NO@^:$VZ>M+!HWK.XQX5C)Q&<BE_A #L%-ZZK-QOP\?
M"XOE1"B+,C<I=[JS[+FE[0!)&IBL^DQLCB.W(;;R;Z*ZD0>G\\A>/&#JMBO<
MZFFRI:E NUM"@!C4$Y[Y7)93O22:2]8MB:79ZR%';K7(0P[H#HBL\UHD$S<M
MR57Y()27NL'1ZO#^:B/'RH8>4BAAWW657^/':AJH)4$4R*D20M*0]+/ G-<3
M9]:M=QN8)A/N[&%'\AE$7R(C](N/'[EKV)%1Q&O 50-,SE&C._&4EZ*8N&Q3
MK!IO[3X7]6\3#,0 ,M-%YV.+%J;YU>#/-=,_U[U=V>UI$=:2X,N%N7/9.@N7
M&?E]7B:K>M3 (LFHO"N\3+!=:3LM.&ODX_:VJ?WDR:'X&7NM ]! ::IP1QXA
M+WPTN345\WSI8'_/14=O,Q16[&&B4S! %2PZR-=/+07HVVP%/YPZ^A!>N-VH
MHST[?^4JU*[B_*%OKK=!.CC"G)V3MWH6]VARQ<1\<1^]%IL;R96$_-O&+$Y$
MIM5<; YA;OT;+LN/U-VF1VRI]^*+Y4!8%I+)'SY(5O5OGD)TGXL[%;VUV'VM
MJ],(=V.(W!->)%.K.5QXZ7E^P^[\@J<E3G,$=[7^VF-+.;K!2HV6C.XMW<K2
M7"BYOLE*)I7ZI)!*5%096$ G.=G([Q'@Q[GTGTAR:Z!Q_",U9E%OMQ%GEOB[
M!I']^.^&=.,(B2V"4IH1UE@;8C4N?@^TY_J0U)N=7@ZD%EU$K120^+ ^8CSC
M_45*+[L<1<T/L(53/7IV._2X%0-H#3Q8011FB*WGN;=X\D+4;? E7CI%Z5EJ
M:IOXR#AF[V$ .Y(]Q]>W"T?36<F$;_0\>23*0O]GWA_3S!4)1,LH\Y+K82*)
M=/WV-8FII6GH;_4K;%4,P(P' _@!\34T3JMPVCH6+"X*:]H:FQB3HSA5Z/_'
M_6.ZS9-[0LALI]9:^(E@S4BRMJ?X&GM6WDF9;M]EVMS224\K1?#._:)0]'2C
MF(9 AOS]/DD/"O?5 BX9F;X!V,)3[P/WUO/X.T'^0.0.:+UN>8D!8-^!)QJ9
M%;91\-;+0@S@MS%X30'%(DY\BR6TC,*-0W%@ )]M[J#'#[;T.RP7CP&$ZN^C
M^F\Q@-15QL-$6YE3V@GP(:_,41Z:%(2/#O%U1N/UHH7 '8(_,(!1LKN._53$
M #KB+N7=&:^Q[=HN'S!>:MZT\?W+"B#*@__B5?8Z*JE[J<1VY\CC.][*'_VO
MX53YWQ*VV-A&78IH/K]BGZX5CH02'9U7M]L<8RA4Z-8>9*DSE3\E_.#I8^Z8
MAUW%WX>Q@^^$E1EPVS;W][\IQ,7-Z'_+R9E"W!J8]"DKDB.?[^]M^#\5W-N[
MWXZ644%/,8"*Y+M1!#9\;-L_.940P  NBGVS_.3(]0>RG?YY(QR\P8;H[LE'
MOT)7/69VQ-<F]76.+HU,O_;_D4\E\I&(=E0?/53?-& @G81P.UM%'LJS?".L
M%KV)EODJ!DFOP#-:,I7Z1=7.%%^7?)^6>OWWGQ9'SN*M O+"BIHM;X-I9=&P
M/POTL(0=#<1I>B;1GVD-H^].R+7O!MSE2EI$K]A'UR#N=6GS<Y>N/!JORH>+
METSW[^UYH1S(NGTS\X'O@*JP#AN3G C0O&Z >H7R:/"4\#*^$?"-2_%;V_*9
MX?'Z/I9#Z#=I8/)3N=.V7QO%#5OC)1% -R &L'CU1)IALGRMOBGS]&K?.=_3
MN^OCP<.[[KGZKC:6435.03:C],;'GPR+A(DM9ISOW%]+&S[LZ"3*]#-WEK0+
M3.@+[<--$-7K_:A_:N0W:/A'545;);V$G(2TUI-#ZM7:I&=I1X\RO^JBQ+*#
M_W6MO+A+TI_5\BF(W_*4NV+OH2/SLM[4>^HN*Z:1&A*E<N]<@C<^!7.SGP"V
MJ)\_S4>TH]V&[<&/N-@CX'!KIJOP$/2)/F,YN,\) T"W6MT-78SK9)FXJ&VQ
M79E9E(2=1A@+-;NV$4=;9OSR%DW3LBVI\3==PEI+ -W^W(_-,RB!_N2\WB0-
M,I<D(<<S)"MYZI(G+_MM<\T)N?(X?Z_+PZ",P'L-)C8J( 8,8 _".>!Y;^&>
M^.3JII:WO6MK9H#*SXD"=2H]$5BCKX<0ZFE^>XF9"L] >.0"3N7I![&>@'KA
M&O9HT,H4L&NV&&8H6</V,;9KC9Z+JH.FF<8:565<J0@%T([(F6?8S"<:J?_>
M]8'+M[Z,1,2QIVD#-ME%AS_&;>N'G6=UR.C##Z#+4]%'68.[ M=35Z#]@Y/Y
M$B(XN2DU G2F(N'QG+,:]@J)U:*P>:TW'2%<-+9G\=W<\!T$%CS32PTUZ@$V
M4UWPS1LILL8^2O$0PXLKFF"$V%]NHE]3@L^F,0!KX;*ROC(_]EQXB^\W3KH#
M8B0">G%J1$?O;.@=?!L:EA%;]2J!F3XDE;8I^["<IJ8(W*<V@6YB1W_FZBT0
MDS7=A8\$MHBJ,1RWQ-;T8@ G1!A ;?8-CUL*D*BH>/[JO';)RI#%ZUM>_)GP
MV.7=2)DOGT_<O;6<4*8+&/O=X=S/YC7#ZHP5?J))?9O-68.?T;QJ"\GF^X"Z
M2?,]4(#7F36$4:UQ0E+7G'#=U#C:*ZB>@4_!<L^A]D:V'VJ\/?X^;ZXL](SZ
M_?(O?:H">R_QBBAN]D9KWC:FN?JU1^ 22*;6P5Z@9)6KHOX72^<\2L81_$-H
M-(^B=N%"((-32YH8/ZQ(KSH:S:NRO2BQQ1MD[R[%KMN4Y+^UGR?31<84:)6F
M3D7JS_5>J5] X4Y6"QL<P4?KQO0670B[0EAF_+O0WJB=NBCPNDXE!@"]$^);
MA$!=9?)->0EYF72!'QM:<,FW=4EMN.5JE!,=XH_T&6T,G=9_<OO6D&38T&&-
M;*A5-U0?A65+ZE,.TAT=Q?<;GS*AZ9\'(25-?G0[G\=3+'A;%!6_Y\_PPA>Z
MX7)X@;]]0;I@7)[8/XR/5S6*=7E6%G.5#-F#;-P:?S%*/C&;7U:]N46P'.JP
M21!LL>)PB<DS?KJ7F7,9RZ.B"1*7X%BMG?-O]B76G"A@#V:U*Z^P!C=?X,5-
M!AEC "$RZQ9QZ(:VX_(</8V8^[TVX%]S!4\FLYBUET3J(#%^#R84CPJ6,IVQ
M(Z#T$FLV@TU!E^.7$_JVG7:FBER<W%D?]A6&)AA#M5NS))PCLAS+*7 C"!A"
M^(-N[0^B86[B(J4UT)D\G>.CZ3^[V;VG)4E%>YP=]*SHU3P:!S+Y G4X!;2-
MZHV^9FN<VN%&R^17[@U*J8C%EY8ANA8-45UHJL84/W<E%J*\5@0.4]POG4!V
M#"!>FOC&&E7*^ #<5P+& $Q8[R0 95VRDCBZ'\7++O1<SKRE^C*I3A1XT'RG
M^9@7EV\]P;=8#D%0#*"=H*WSXGF&4V88^#>!J:<1"IPHY;]\._\G%KN)\9[=
M8]5'C=%'/N4QU:SF/:^&?:Y7,S& ^SAW]<N!#T;NF%>O64:2QOBBD;![E*CB
MVSJ[TUYQ'T,XRN$=+Z5.&;NAH?N\&]T'$8HM95$?D[-EI\),V%SR.M*YQ':L
MU_9WS)*]M'2>))IB0,7&//>R:JVA+L'/T2F,5:,K<?2Q;]#(.I<G(=$.0B%=
M<WI?M3HD6JW_,D'5YC+PO.LR:QW^JP8[G:>PT;_JC%JZI:6LL-35)?K4:W$6
M;4*D3/A:)UG*<K T9OQF\>R6L(E'&7U\^=;=,TI=#%LI4 O?$G9][8?@Z0ER
M>!&C-VM)X&AQLB3\V_>][Z/56KS:'*)Z7F</V^[L[Q'O\9U0ZW@L<6;^J\4[
MT[L%WN.(U?=O28TB9JM&27U01%S*):+L^ODIY_,;HP,A"<531%5^9N!L30\P
MV?RV5Z^J"F["_9^DCSZ)T0-ZQ&DD;36;Q>PMGD3_"E6H[>FFJ0O]/561KAEY
MRQ+VBB##B>Z1%=VUEO?(7XC(?J3__9A/?U50'U=5I;W]C;.-_AQH A29MR<%
M(;8^"H!<B.4?0N&L#LR&U@;8Q&D9(9>(BZ </[\6-6I]Q_@D>>KA^]R$EKVK
MMZ8<"<()/,4Y\I;T>(Z7S#8-S5/L7X./*3Q_[JN0&7^3>S/?.6MZ?;#E99G%
MO@.7@D,*((%;9@1W!MY(.?@."%]3ES$>QG<[K+[8JR^/M[#[[+06;!AG]FL*
M_#_>4^Z7?<5(A6Y+Q !D*:K+.-W?KR'43_C<S?5)A(7]7LNTDWJ/#]": ,6>
MRKT6\ONN\]ZI?_-*_Z6)<QQX_:D=!F <=P)5;D;9JY"PQFGS)J90$I[?8;\&
MM='_$:]4R!ZRHX+8_B%?7?-Y"\'/[&/<='2KT1V  9ZZCER$;HUPB6$ 'H'%
MVUNYD=>"Z[+_:+2"O- *(P\P@/E-="3%Y#3/'?_W7:W(W/AC &.R\((C_^SU
M7_PRV&=QZ*38PDB.\IA_EV4Y_YQRLB_!-&E_NSY^? ?T9?_#S]#X7]%?0#*9
MXF^AVE?J<N1:_VJ'PC^F*N=?:[O"?G.';;G^2IOA?O;+^P#]ZBL&,#UPIQ!X
MC.N7+WRNZ;^#;R:EU*7N++4-];K_U Z?OL &]Y$Z7U\YW^(YC#B,-M\Q!Y-2
MV^Y&VRE%A0(W!N!M&GU<DWVAOQ-[!Z\K\J3?_H,EP94R#5[W/\R^;05OY9BH
MNLX=H.*RR#" NI%;<BZ@&54_^ETGV>%?6SVW%7=L<R/[%O[K!8G_SU+)^YO-
M;<V_N9KR<4__.MSF[UTSX,8@@0%\994Y.VZ[)M!7_Z=AK<$8#, K.V<V%0-H
M>3-Y,L>1VZISX_+W-! "HI)7U9-H>-9$.3;/\<&289\HH+? :EIII>T*QV'Y
M;$\F45^>AC_Y;3X4COH^&)V1(S= -*+>G:]P&YZ7A1^1,]*,CP%$EOH6AG\L
M[$K%5MSGH5MACUAGK"BPGE99T7L9%9 _^(NLPQ@'Q<W?A[J33_KJLXA4=I[T
MN2%TG6 9TE9A3NSD6:,=:,,JUCYR<ERH8!+W9$%]W7">P\ZJ1WW4;VK0B)%X
MAPI[?&D539T=L?0^5 DYD39,_HPU*PT)_5/3U4$(,:FKGMG<@I2IDK#'Z=1Y
M?@1_(& NH37&&7ERIY[+]=YJ-H_G:T8W5>HRY$\J9^0YG F%VJK"LI8/US@@
M/*X]\VJ3,07-L6@@1WQ&7-OD&DZ1\E"!:+U2]REGQI1B">2;7DIZOA1*:V%0
MW @HUSG$SB+]R4LX79]6HSY=-5RMXXJ_P>.AV ?IUA:[B76UD\FT4A"0:"D@
M_D<:'GQ'=/Q,<;_H=5._;;1CY[R4 P/'LRSW8%8>KMHIS<FT+2$>WEWUMCCM
MMN@Y8'O*A]0-]F ^?.,3E97>V,VN:?TF%Y)GF:^1=_ID&IIM4=3O,3 _/]A:
MQ(AXIJI:XL91=H?P['),51]V(#2=?2!R%"-8\>8VNM*A-8;76=^E4UV9OY5Q
M\5ZNOTGV.*/07,R/SYRIX6=-7$#<7MTH!)_.9NQ[V]B^8?BYOG9*05FD); 1
M ZDPZQIKA!40V9F\M,E%CB]#AGTC.:#:L+]G2G+]4R$B]<\T5@M=S>V*K^#
M,'C1K%3<]XYKHZ\>_Z,U;F1R!^9..L#G5QA ;JB'\*!#V[&TMSIZ6>94 V+G
M;\9^)?A(_6>+)090P%)R)S]9_BZ&_]?2_TO@BBMN"KYHJ7'$FL5PN!G_J+:/
MM:DYTXO;<)TS=C,>+?? F*@C<O4%R-\M=Z[E%+@(A59"KW@*:@Q4L":?FUY"
MTV6G5J9A*B9JB\J]+M_G%G6"7S,&X6I70FW_%NW6YU^A!][H-!_A>B5>E=F5
M#.+B6$"[\(-^4E]G.13E?-(T]$VB:6Z,3;OVF.2;4WCZLJJ^/U[TIUG2R70]
M1/F_#T6Y#,'NR"HM5U-AD+D!=#V(G"Z#5XQ].M$HZ7_06-8+K\OJ(AS_!.^0
MCVN]I'K,=[5X-?=Z?O3C@L:] HI?0/OI<93\I%!JM@B_07X)9?=*/[58C]_U
MV H$>*-Q1/6%QZGHA*FFX6V0)\=,/EUT4.)$J]V,_MVP0BT[Y^!G%U'^JI9N
MTC<.SYDHMZOD?PYT'=]3?STM%.9^^C_SZ.@1QPC3MK!WT(2>1;?J_N(H8+1U
MM/ZT]9J>D&=\UVM.))$WU><166J845&R/&N4\W#>ABAK_/89N0&OT]C_5C&[
M,4A.5<#,B""(;)E$L8:8EXYZ5TKK[X,Y@$$3__S)_Q.Q@3?B=-+3!'\A M<U
M\.+FEJ<U!G"@<29Y?J=3DZ7_+LW(E7^XC J"'UR?,_:7I4-:\'6K)WZW!I^+
M+4GD/[CY(1CK-AD'W.KHER]U]5P^MN$5$$BFS(6>HL:^F+!_QH]W\PM$O7%V
MFD]?.):)+T8=/"0*'"QAM-!'V=,K&,<ZO-B[E9X!SMIP"Z9\O4D;S["4-QWK
MEW!,=>,<SV)F&."SOZF;+V%(+N"9*K](U3?[4!41ZHGS+(X.ZTKW5D#UGI36
M& _(V>;;<)"IS4/R=;?0W=CF*1XNW=JZJOJ)BA4?'K:G)R2=941K,J_U>(15
M:96_LU7"&M+>+^_R*J.BEFU-!2,;U3)T@ [#US7B8V7L0A,!D-SYLN7)!!4,
M8.^ ;DA,-&[D.7OA1#L&P-A15#,^H7HDO'=<<<T3*;3;B\^RP;A97TYOND^+
M!*[N %;%C%R( %)B6^J^RP@X/@-E9:P<@9L7S55XD_SW.?5I)K2'1H91.MCZ
MY,4NHDNG2*BD.R _%P.0:3?>V/R^[\2:]28U/JKJ@EU8.JN6QR-&[H^B2)9Y
MS][YKBX'%(]+Y?N.K]/+.,[1^?JH3MDY;>>/Q=2UV=RBQI3(+'$]JQ0OD?-1
M$TEKBW1IHV"Q7M-,SA9'N^N61CMDX8X>4JH0N:6QLN9L/ZM,P=AB>UX'%L2G
M'HM9\W& 7-2E=,)B/MQZB#(GK!JN?$>(,2='E6%_'$74?G<@S(X6YGH22_+;
M_?5V)B3H%)V<Z5R\E6:4'D7KT+ ??EWCKL/):/P".!"ET1"N11/<ZH1S%1KG
MZHLX*BTI/I'^D'E+,B1.6KK9SZ SU61R>A.9_]A%_CXT[(#$FZ%#9*6@P0X@
M];-O9.=YS9)WX/D:4GMN64XP<USA@5:TW['/G^*=ZY+)S3@K65I;?2M^XA6S
MH_*$&([!I9:I^!HW" <[9?G^P7;=]TPY<OWG<W^7)W?+%/<OK+-\=KQ\_7 Z
M:SK'FPS]*A$\/0C>XC*--40?ME!OV,CL5TS12Y%KFLG[1_PCY/ZG5DQCV@9\
M^8I1DAT#<,Z^YM"#M;Y(1'T/8_]M6H4!C,=/WMD;\?\R%/?OL:5!$ ,@7M/^
M;X4L-@U';O'K?Y(LDJVL<#>+_LAZ.@)F]&P2Y*RIMS\J,JU53VUFUBFE3K_;
M!+5Y>R0T'?ALREU*Z6GPSMR[N=+@5G>I] 37CR&]%7 A-LV05;V$9T8!P&$,
M0"DY]G[3I]"12;"FOJ3R^5][J61!%'FU7]XO$\Q^_605JU-Q"EE4DZ 6FNTI
MK(1G=5B?5,%>E SY9,60(P]M@ "QNF5!X/[N>C 1F.]TZK.O?#C+T,JMB*%)
ME@+\R_=OZU4< DK[#CCOFAL35YT:;"\$A6&>E3"7FH0(1>JGOCA&TC1I8BB>
M B6R\#=VCW']./#/H#:=%RZF_CI'M/-]K&_K(@4&O!=^X%S1Q76D?CSG;WX)
M*K-O?7HDG6WCQY9MT9@_;FS\)DZXWP+[J8Q7#NLME[XA? I%\M!!Q+<GI\3@
M[<X+'N>"$R-S46Y(++'Z23<#5EL= ^O1ARP3N9'SC!K.Q$'>8R+ISX&Y,#3+
M\AN[WTU]='\<6BK?/+D9[HH-V1[2-R+(H?KB\;PWPI\9Q%NHXM<4QEN\H:<[
ME^^$4[S90G->5+*3Q1'522,\5C-/G!W@69;R=J]L2YWNYH8F#VHDE07Y36LH
MC1+P 9W=_X0!<)9Y%2C(=/M=.IW1RW8B$57]CN>I]Q@%;1_JLU3(?D0J8164
M>OL9C+I?>4@Q=HD7#'574S,LH9W%Q9)<Y?GX/F9E%QA.-5MO> L,ZDVL$GL5
M)X4AV,2P]=;PMT.NB(&@BU#N<L</#2U',A$LM3$$BB,E(@!4P[4>6XN-9=ZE
M6<=<V+<)]?SMBZ-AH(:7CU-WW>-7^]YK]7DN,_-Q[6E)E0^<_8W*;UO"#"&;
MLP^S7S/PQYUTJ^>U0^S%Y<[C*Y3<< \52:5DQU"%F5A]UBPY:_@SMPY%L6]3
M6!-$B&)QN)[W,9TR5\/B'L_MZE\GP_-=DZJ2WDYD.'KV/E7SZ;W4:J*/E5B!
M1E0X2%V<Q^8_HCIA_\JK^.4HUM OR_?F81WQO+_1:J8% F1_H0:?*"!1<+!F
M3]J7:'IIS+BK%_C7F4#X&AA 908&<,.CZI;G;=8C'K->RDH3FM3Z]N0GD)KB
MT\'N!#73Z5HD:(<W-(9=:=H=Y"AW6R12D*=$TM_L,O%VK9"6D4]F<[D0BJ6O
M=9@:Y1X@PF.QJ3EQ1NDN<@%J5:R-:Z:%BEV[@(G0B31B$@1E9<01C;'?W=R$
M4NH0_1ZVU8H&\CI(#^/3_8][7.P]C<C;U$ANU8SC@JQO7]P"JQJPIC9TYGYZ
MK+%G R>/JC$ FX6M5F;CH*+%SQE!X]32>NS;O9LZIRU2_DJ@U=W:3D)Y&]@=
M5U21(O48#[FS.]+V7[ 8]8IGS'F%\A)FQ-:E<J<@_@B&+6W2D8RNL1^6SUJU
M5!X=A,$Z ]Q89=Y_?4>CQZRG*R.([2-&W5\^Q'#5K%E\J3;;LU(T!]\8Q0 *
M(]ZI9 <,J-KO+!_K2<I@ *9N& !;'@C +;->8=]V3AB' <@")>]P!HMSM,SN
ML<SZI &XWW0*O$?+B/X,\Y9 RR\_ 4^O@_N+<6 5?%4ANFV77U9C9-2;1?@&
MCI3<7$,$.$N_4@B.9B[Z6;1(U[<]!/==K<E<[X+N0$K+LTG'D6FDAPQ.^SVX
M786]/J)$X-D4'-5ATM=+K1T4.S7AG0.?KJV%CR:QII+AINW]OLV21L+.9#;'
MJP,Y[\8ZW ,#,+&X0_NAZJM#1EJJ-@JC0H-)-:E:+UJ12?PQ.E:A^-%98&6_
M",A=I]&=*EGG@]W V99@MJ\^%[2KKO=<M)\ UNZL'EUA>@>MID/>F-7Z9\G/
MX/'/FL+8.6O8D-"'(2%](U)B)6=M#[810 KD?E6Y?5TNAV';N-/\A[V/H<9$
M]:M0;TH$UW)8+64-=.M#L.)B@$X-CH)*T"3/)/$'7H3NC5C<$*GG?/3F,91
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M!5AP1@& ,^TZ7@('OE0J.B@ I^C[2.9J OA_6L#3/UP.Z7PT;&Q% >BV/Z,
MA^<H@,Q3>&K?&3CI;2\"!RY^JR&4P9Q?+\"%T/LK*WK+7UG1X^Z)ITU^+)_1
MV79>[N3^K 1]1THONB.[_E#?LE?$G93TJC[=[2"$'51?FG"LX7@J$!R<91<^
M2\>)+,Q\WU%BL(YGK8I_K:HVM0H8P3652X@G36-FVM$E6S^X<'XT;$61 6\W
M Y=#CS*.E-6<GLD)NUP#J)+KRDWL<E_XOZ[8G2/:R9&(&HH9Q\1KE_N%J=%<
M.2_^$L3!*AVG#V/W.%1^,EME-=GAN%Z]\/HQU12\V^H88\];0#MC*>I)&=%%
M!O#@>P<' QYY&5<*#:+WN>2M^?>BOYXG>^RKB:B7&RS9#Z1O9YRVC6Q73^/%
MH^WVV;Z'AJ( (7PM%^W/V&G]/IO94+A^*4X K-0"3+.R H#B/1TT)]9Q!?-R
M0&LP))'OI0%[)M^D4E \:-1]^5W!.#:"88T)<D+5!)H<\GN6Y.Y*U)"X[9'P
M#3?S^]BI14YPT7C;"[/*7>*YFB]MBW(?VZ)58&VCCR7#WG][# #T:9X$?)V;
M"1,Q*#9A;NQHG>+ K4O*92F4H2M1ST)JN4N?=N3F[UP]0)!?4*\B&[(?$VT<
MTGFRZ*\!P5B/PC=P?E6M^I%Z.'^9VVR?7A_#Y7^15IS=848,PET\'1R#>!;T
M!5*8 V8N\E4!.(,H0'^+*NZR0I6_-+RZFFTC>,D/JY?+D)$T?T&"K:3X2$44
MJ[H2]+$G4I+LR5>LC1<VU-<:?GLX@_TH0,80"N"& B 7=,17P;@]-7M()D<-
MA:+)?+C3>WVV4#H['/]?\_),,=\"Q2#CX!%+%* %C (X,9]@(D:HK]X:H0 '
M#<??/%GLKEY<&ZRQ-R87M=7M-EVILLXUA"90JBX9YHB/K2[-D/^M&DKUSZ(8
M*K,26^4:?ZE3:0$= HY4P@F1<>E-D3\L9V%TV=\LUW=U^!:I9GXX6U3;&EM5
MU2\4"C0&R]INQL1B=S'A"FL9"1@CNQY<@<BBUF#M2?H<AI0UYN&;9P2;;)C"
M\DRY:J+V\)9*_>LS)4K\]^=.53$_E?V\Z*QBF<>WG>1)+?K%1SD-;@B^@<+5
MZJ<13K>,-15R)3M7_/OT$Z*#(8<: J\5!ADD#L3O]>9ZKBVZQV4JKU5UZB/]
M[%Z-U0<CY)O4B='"1@82LC9\M7/:[1SSKN>,W#4G,:X2 IP2ACEG>Y>M$MX]
MCB9HB%U+5+;IT<\:UP>92-9.<Q0F2,==4=9)I&]F1\;]_$1[ZABR;_*B@?Q=
MM648]L'&>6%H;3_;QB<_&T @;P[O"3QIM?/1HDR1?J9GQMYBX:_8NR^N]VM@
MQ>DI@$GD+5DI $_(%' X0DTHOJ&8A.PP10'&^^@OY0-Z3U]#9_S-K%8M6U+F
M!@YB GS- FK>./TNQ3?+Z>BOV,_!KGU 1=DZ/>;* NK?8TJT8VU8F=43J[%I
M@M&(;'K-MZ5.0^,B7\X99%+7\\7LA'J+*+3Z=DP,D>X?O.EH60?B >5;8&W\
M5E,0\L$Y#-U5E[HG) _#!@ RB"YJ[:;BM.#5;4KX8;P5@AOU9%.R:WNZL7#Y
M:33+CT=N/(<?]Y;0)MEX@:TQ& QU4W2ALY8*V6U+S[2ZZ-^*Q/7G3?,JU>#U
MK,9HC&*V(_N^S"_*/&<;(Z?1]J3J)8CSS=4\1::"BPSG=I3YD$6\'Q)Z*)Z)
MU,L*"-)@H)?=JM=(7/)V4(,'0PK ,_A[]C5Q!4 E48'>%]66,,Z7.@,@W</X
M0.E +>#J'\07(8%[%V1QXR4KR:4H]UZW\Z4W%Z]ROPN)!6^-M5@XY2F9("33
M45BJ/NE/D[$C?$/PQCRZ'HD1J9E#,V.B?FWG+%HVLE1'H5V'A@*(,OPPN\9#
M 9+5KOT8EDHJQMS]0ZUA;$F*791&>E&Y-3^3#7JNOBNM6Y[<Y1'[8HSTS3W9
MD4Y[&U?Z;."DY!9K"LC<L/P%25X7?J_5D4RO-&"U?JOME;DJBHDDMBZQN4_'
MG#T\6$UAOND6%)7C@_QM&Y5_W&OTQ>QCO;E44&X02%$K:HN.UI;%"T9#KR(+
MTM]6< 2N=938,?1.Z 6$,3;K&A8H8DHO"*(S,5$E<]1]FP4)Z([SX0$4K#D@
MS)5.IGJD!<GTHPJ/<V0?G)]][=A,%(#!Q@ %J/6G'LU>1P%NDA\VNFD#"C!;
MVM&(0QE*J*ZF]N\-(/A;'<N-3GP15NHO(KR)^P1C_+D4L2E7"G3T 6ZC\RX*
M0S^V(;R?9_<U=7(9<W)P3^%Q=L5*W+N^Y</D<R*ATY2 UZFB0G'PXG8]A,6Z
M\"+IT7:X'&Q";#R>2TJDDAM-+"1W>)FFUO!HG], =@21=WPYHY'1E=>BD)T_
M:J6>U>\BATDW4Z*XQ9?[6'\'ZC"7&SKG*(2<P,W3L+;\RCRDC:OB]B8WDD^]
M&B35#8V7"%O7;+16'^>G>"[^W%:IUO#"E_7SZ4AW1V>^'31Y(<6782#-B4&.
MF?+'C7IF[>[-5.?)9[N$2H&.%VW(,6C,U$V""JR/]H\V1BPHO\N],;\%GW1/
M9\2S".3W(;OJZ%*!1$$H8"=?/85NF73[]T6A<Q@4T'3_HS7L C=JLP4LX/TG
M[MT]<Y-+RV]UP[%@3^"(G&(+9"HS,*_$L+WP.*ZSJ2"0[L8::J\JF1Y(#3MJ
M"* 5%AY1=)2ULF9<<SARR H:8HJKLM?) 'U$RA?GH0#&3;E#94O/3ZRJ6U;]
MR#N?*XCNV'YJ:CS/I@OCZEYAH<BRS/4M;HW<+IPP9 S!N08.3%Y[X4043G*P
MA2Z\4-S\Q49N!\A9H(;E-7P7$YOQ5("P; DQA'9!@F$L3]FJ.WTR*7(*SA'3
MP5LSO<(549R/]G2(4U_.C^9HS]*Z1;<DHW517-#K2%GW55;-1K!9:"CL@6JX
M'_1XJ,6X"*NW6 3]N.[@8).7(YT(:*E(3Y+);@%S!6C19_+PDY7<6V3<#;NP
M+>N>MX>ZL?=*E;*'<]C,;5+UJC/OT:N[ 1'\WK7DR):=KSJ8^=?<,R:3KZ?;
M5";M!9J^,,Y-<A>^Z7FMI1GM E25'O>DQ@?").U<SG<(9)KE1%ISECY<&)YI
MH@ Y62GO6Z8FC/U*9L'=/Z8]R1<U[$9C[%S@\$:[US+Q-4O>74-[XN+V?".,
MXF@X 7Y2=GGUL59*^YQ<.0(QL0( ]V!LZMPM@V^&%V]8(TXI^Y9:UX;%<?2-
MAAWMKMR] ]CPPBU''Z'/BP1Z,@Q\JO28MVX]V<ZU*.MN+4BP]GI9NPT,EJ>Y
M0-C6&B:M5FU./^":JI*VEHPU"_I/0SRI%F'O-LZ-/%W!3U& #2D("E!=CP+L
MR$+GAPOKZYI;4^\-7S3$Q,F0BO\,;V:/V*D1?0!&X72G,<'[2$8?I[F=E.!Q
MQ6%"+&P H-#R5,G5%OGH]$DJP^=S2GRU+/T1(&NJKE''/HM(+ J0@,#QP,D)
MD?&);2E>L$<!B#NZB*8:QY5+F*$@%8I><@;)PT3" -:&<1'V(I"M"N_O0E5Q
M\C^#)L6^-B7Z9#B9FEK*VL"H *I;/^EE=\JVN*?KPEDL;\1%='*N#21/:B)X
MOSPX007@BE\\PDJ@;DTW7XS'%I3->30MNPTZHD5V E".*+"=9RG? ;I/HQVW
M$0'FIL4RD>IJ*B)IA!,Y]S#IF8>M5)7?W&Z 5!P(?]!6H^"-:>,;IM.X&$X/
MG98,2O(/,0_J0%!*)/:?U,'/*(S1@M[$(<Q0B$]>PGJ*,$LZY3-2^?>2CSWX
M\#\S96QWDVF>_SS[>34X1A^ME[9>QE3EAF1ZV"-1J^VRYSW%0"8#&[V5E]\'
M>&7D_<.8XKDE+PGCJ@QW.I\V6%@$!7A3\#<>@$/3/!%!]RSSRH]N<\(-8]-]
M/)EZ%]TFCJR!MH=FMJLV#,_CN=]?/$EW/EF6X5\]GCLZUC!+[0"FOG2Z-'81
MO!*/L;H6FKL:6^-H=P2[S/ \N%QLQW\*5?B3CJ-M%M2_447)^&PEF8K1&"_;
M0]N^BR41'F)D)\JK8QE7_Q:D/[V]*@&260:B-7^'\]IDL/.5Z#H[9&B#K@3(
M?PAV8=[<V_TEE&2LHR)Z-CZE_BHPMH.CC0:[2CW+'/&VNB/SWZ(1Z*1_*O27
M>^[I5"><+O&8%_7MM<<;ACR:./3290,=LMQCNQ^X>!4Y=-)?P%&S&B.$]/>9
ME"@:/%K$1O0!_W7WZS\>AUI_N6AQ][*/PS].V"-8M/5JG29K&Q,&8?W'-\ZU
M?2IJ!2QR'AXKN_U%H&[[W?I4Q(-_=(F+ CP X_L8ZI-<%&#JP2C1H0!7?'WJ
M)N+W!1%(YRYPPJ7XK*[X!L+D)KOFW_R'W%4LTTTG!E+R/CD$J=J' J0_B&'W
M PQ6&T/$H0"_)_[/!-E2XF?B*("%H18AV'8-G'EBLD']W_3_F_[_%_0-#CI/
MM1[<-&<4(/48<O. Z9P#%Y>+7:]U O[%MX@*SPT-#T=$VU)O2#4&3PAKAE1F
MSE/_9U_40P'^>8C _VUX]M_T_U>FK_ J+H]-9!_[A=_7>*Y[B6JR2"!7+PH@
ML/+Y+(ON3CP*!>"9X3W4'];ZTE[8-7@W"+*ZC6PU%K7R$\OU2N4_TI86#Z(*
MGVLW46F/4Y]<;8T+37"3RSL21S?NP"&]_#S5D"A",<!Y6Z$1U:9G'\E<??[K
M/W(B]Y2Y\B[&6ZZAY8YOM,(";T#UC=)G;43$",!67;ZR.N]K<*'E<Q!MR@/]
MTNT<<ETJOPB+,)+^[439I^6B"J+,CQ19Z@:3I!-[]TZA83H?XW]<T/PAW ,P
MERIOUB^QI[=\-N+VB<)V;:M1[O)=7RK^6THZFYXYY<.X2!%E'_<GPWZS:W[>
M2R4@+9J39W)BS=49>7[#MD?YD,0MHN:O!!1L*\)!4T%3:\7%/YCS(R7^(=Y=
M4^?56WV#]KY?$SU/<=L2WVJI'ZD^RHFMIX6^M31]6I\5+"H#$/K/>46[AB0"
M#X8#40 CJ[^R8G@E*RG"'#R4'M=-?CMSC$\L:\]\G)6CFZ1RB_DQ[=0$$9?S
M(!#53>*W3S7)K'X%4ETG5.DMR]?V5& =L5L&$J4](G7?3P1S^NY77V22[]^Q
M[J<)+,P2\Q^WAW7_0/_Q3A33<*)LYS80XG@5( MC30L:?":V>XE9BF!NKK0!
M=>HW3+0)@LX'.QSJ>%WZ<C/DS#X!]GQG2"MV)W>-T4Y"DW\F9XAJ+$!SR@U^
M.5 7NQK%9J_$X>T**+G;%/5_9UKTH2QDO5A08575@#EX@E9B;_'Y3--MHIVM
MYO:SJ+#&/G:M9<-P2*%;-85RY?JVONWE;0*#OQ(-:=.4\%?I48!7UY&;;5:K
M500]^M+0CB2Z7?VOECY4TK]$X(,W7DECQLLQWADIR6:5^IE&[^&L:0JCLT]<
M B3W\&'U#XX[.@CXH56IPN@-%S=%@?PQX^3O3[UKB5Y/8@WZO=3:C\/XL@-G
M?M7/;M@_E7S$Z$G"1/&))'=XJ3&W2PPS=G )$OH-@M,Z>B?E,%#M;0X=6@G;
MPPQ>HT\A?3(CIZ85GO>DI>_:9U4F=X1,Q.][=K$<:^X?;XN+$I=:% "C.&Q.
MLTD?XW-C2I*BK.5CGU;0 K<J=2H,JNC@.H"K1"%?1H;[IO0'^OA33R72K1Q"
M%""1I10\4[5]9K_O3X0"T&H_* 3C,D3Y8DGX12OE2V6RN1FKSU]V3GVBW:B%
MPQ3&!$7W-I.3.[*M\+(+ XW:F%_R+J@ #I-&^(_H8Q77D4H,-?=!<<@8^_ N
M[Q<[&7#(:NN ;LF=A9&!\[MS"W\+Y[*50!L8% YS,-!3-OHV<BNUP=8Z_WGH
M7;_K5(YK1KC.R552C6Q9V>\^UZ90ZT&KV[==U-FO<"B:^I3MYR:[O^\&RP"'
MZ[])E["5DG"9"S_CNI[TM]ZW>_490MIA8 #\'3UV_T-BX\X%Z$N-?NV$(YPI
M?]'<JT/W,O'(*,P]9N.((F@<WM<76K08I6=H,,#WG:.'(L2%[K3$@_CU%%^V
M^(=)$S4H-(8]V1L3]QD*8'4IKGA^C&MW#A3'NA1^%Q^QE6C^Q??H\5OJM#[/
M%.-')QVYH":O6^GW5L)?6UL_!4B82R J3)1A!Q=1UDUUX3\C"NV>'K&G6"3Z
M,";#?K-9@7@,&N'^ M86"8&3CY6(>J57"SQ)!"F_1T_@1\#.^Y9_-SXO^L7U
MWA+:HB"F:U!_T<4T*3XX"1%_?.VN P56+'((9'=<?#DD=:Z&\5S#4](+=F_9
MFV8O]N6K\IGH:>X&IG)*3@LDIL[!.-? GKCRO0S&%@L"^W@CGO>6"5]'L#<5
MSQZ,PDR5HT7/$OJ$-:0I5X[ R$B1-G()TSHAXCBF!WT)VF[1DR'64<JGA%7]
M%)>5H@)MA^2YZ_64OFHH+_LS=['L$CG" 9J?2L+G,UOFRF)FNMN>F%$])B^K
M^'"":2<AY)QU-U7= [3Q$DQ-@+\6NLI&__L$;[KSD;5$Y.?^EBW9@XH]52+K
MV^Y)#8B?P3SHB":PC'9#FR\NJ(VO>+%HNC'Y>?HS]>PYB9+?7#2!A-7A9=DG
MS=]!5(NYQZ1%3/MM,\H5>ME2LAWU&FC-38DTJG>*<I<%'QX8[L=E9X:?!+ V
MS8QR4U&E3X)7JRTU8=0-^HM,FS6?3'>DTWVYQ!,A86H*I/1*1!LHYAKY>)K\
MRQ?>F0?R'8(;?#E..=LV&TN,R&W?45&E5E4W>E*Q2HEIT/R*+"R3XCL*,*9E
M+2NN44B@[1&'ORN$ZTB5;D%4Z]RFPY"Y-T"/]#!R(O:C..Q$I"C5W*'CWY-!
MYK088 XZ>@%&IGUW/1N\K?-?!_^2\6>N&:T*,43'1WUAN:Y>9BEFN-92%!+$
MID]<T(X->X4X/XO8E#!6W.<Z]'LNTN7]WEGL(:)+.#8*</<.1#MI/QQ>4"Z4
MV1(<]G$3,6L9>RU/.$G U49B?>?\Y<+/8)?3(].\;DZ9YVCN5XG;DR.T]9,_
M%>*XG#3.&/._CW$\K<\&1#ZX#/KW.\D58]T#*VHG#RY:I1OJ&F.7'N\D5&/.
M[!_KD:4&BPA4+/$M'B43C ZP[1V$QI7-R8+)O#^PN3>15147G8(58F%:Z8Y5
MQ;$*SS>]D\TUJ39P;?:U>?>_((1/Z70;VCTC*8TLFB')HT3IDK@MET,B?OCZ
MNXYM? 6SAGIC0#,*;KV*RB?<FLQ.Y-$K27MN]OTE#V(\W31[22Y?;8Y)\^ZN
M9(JJX"1_A\WB>E^_$2;"[E\OWVG7$KH:3.,V^@MKD"J$'DGT<X]_DCH423YU
MN,XMEC)N5!^K(+,_L!'X:<;$:@6,MXNT:X2M:Z?PD/,(MSK2/7[4FS! 8=[(
M=N!8R49;U_B%H4&>3GZ(/?1B.^EZPB.XUTN_*C:OA#'/T9-@KO[H7 "7<V8\
M<@W!6B%5Y:\P4WT8N^_\78Y"-9:"I8MNG@:^L(R/8!<=:@Z@HCGP?AZ[]P!
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MLFN;T<E+'&GNTE@;JW^.R>71$M$KYX"LBC_=4VP-G"@W$%1'L$/.Q-$SFJI
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MY$S'2-2KS%.[7SQ8V(CVZ"/&R6S4?QBWB%;93J[U[!7)6M+H.4\G:)1_/3I
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M$MF4NT?X2RJ!UL)UN5]=H^$==2@ S8/IN[U*>M!OO+I8_N(58*<=8M^2A(V
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MPE[LDU^;(LNB<$I(D0#NI\6W%+KKVH&B8&-S=_1/VQ,//P?ORA*!X8%</PY
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M8&A]_BN -EX+5>O-8"(\NR^9IGRB;^Y(!S_)E+7E?)K/-4#T:EF?R?'C%H/
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M;/_S/X7M1P(_$QE0_,Q4H(H$2%HO'I>!441H_V6%#T+=@V+%Q1M_'0GL^II
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M23/+G5-FT*$$DJ^F.^U5%7:GY\53P_<8G.&MTDZ?#\G$*7Q('!/N6KN!WXS
MJ,0Z^5Y:30A>N&$4Y=0[+<11=2H/9&_G@,EXMN1OU<#%"<(I7"2%KZ%]A$DY
M/&3/!;-^4B51-%V@UPLV&@H3%GBSYL9F^:WWW4H16%M\4_F4/E HX(1=*Y7<
M_#HF+.26E<NZWV9,2[17Y HC!-T<,D'S5C\2*]_G)(IO<D=92%<_1QLNX#>S
MS>F22?S6-'* 2MS)TP;M#5]OJ<DS'DOX_?FUXKQ\F71-^0I;IH&6NX7L&\WG
M2_&NHP^,LW4GX ]]WY3;VM*VY_L9\9OTM:F"/)=P$"6N-2ZU@?-NW?+S#M%:
M!9W&[U@,HG'X,?!M'QG2D+>>#\B73VR!>6HQ=I=+HTM!XP1AK67F0@6WG83;
M]7O<-QF00'TA]+TUE^0.3648@6DV<10.P6#%/=+8Q9O&?8?0YD5F:4R%6SO>
MW)%#0Y:&GL!NE:OOM1]HAR<YUIB:F_?6K5DJ1"XFOT7KW^/7! M3*ZZ!<DB2
MUHQD%F^!L'P^Z]=7A$TQ)&X>?]RWO#%^X8HQNEL;Q$6!-;;>>EMML2OG<AV'
MR7XVS/Q3<?\V:/XMR.<]Q3A!F;$Z!@Z0?TUQC8*.?'@#3_@:J5-P6OR\@SOV
MDVBB$LWA3PLO^*R9[#IP:DSEYQ*P>M,?WDB9H!'D^11$2>;>".ZM$5LD(SA1
M+"JL&C@FDY&KT(QQL/=&#2PZ+!2>F1K/.413QJYQ*J.)Z*?&).VS].*MKFB9
M=>4N]=S,Z.;:-Z.XP^TPQ#,UM1[,G*PEL/Q9A8A?>._#J6J2"4^?YEJD^!WJ
MSS75AJ64VJTF2XLY=JHB)#4#"+P-#5O5JJ%MA96OS]+\.[;0,=#HR$ 8,*Y4
MDT,W/###IC61X5M/[/[Z)$_F?C%\VK]ZXOX<M(O@YKYZY:)\E.S'X/6'-A"5
M3<$/B5BIBJ+W9P0SQ/6]EU]M"W^)C??9S^+Z*YLT8EC#-8T=(;UX@9@6H0KU
M]#,^9#@E@(P8?GSE<= )R$A;HQG:(Y1DXUUTV&-RX]F?]SF?H .XD@#X\7L"
MOUX?[?YM%K%B@9R J)MS+Z+NJ"4D\N=@ /39%4(RB8V,S2QEZ:F?F]5)MMF4
M@A(#=LW,F<VEAXS8QC8<55]G;C^YN;&%]G*./#:XQ_^:ZW_J1BN>@H*\_:U,
MM/)XOE>QMT,;/-WY4R<T"E(G"VF3,R 6II!#W"(D4+>) C>_$-PB V3]'BW0
M_;KR*K'7B+$!)+!&:XP$(*,H7/@;=1RR_7%L"*%Z0FB2J3M)HGMY,QL)[)Q?
M(;;?*/(!LCXWDH0.Q (,7^9"7P:%CR(2+E%("06D?J,FGE?BZ"N>Z4YI_YWV
M<;E).HENF4$8+_R+E5EA@:P(3Q7(R26D)?C7]Z;8:\*!\LL06T>_M,N"-"30
M)]V+0 )Y*"3\&P5[-(U6D '/VV;I5ZHKY:H[1U=' K-'5QCU-THX53#QF!L4
M<=D\P1!UW!*%!$0901>(.A1V_)4H]G$@_X?H_H;H6GTAW2@-73Z+&,USS4/?
MIT$"WN''W75KLQ,(Z[B$*..XN/'U /OHXX1?FE/%'I%1JREE.;6_WR5L<B%3
MOS,>]?=E9GLAZ221\8\9\C]PAOQ'BTX*.\G0IOYM=5EHL$&$U"461BIYE]R7
MD5RF(C$\Y9#?3I#^L-'UNY:B!YLS!JILOO1S'XW,S.-R([*\RU&]B+;+91J=
M$UE@,4KPP*6?*?"^94"Y(1]U"/UU&)X2K].KL7%Y)[L+2D^>2(EZ065QJ1]+
MN_37S1@>RGRWSDZL*G7?E2?I?#@7V-%(.;?/Q\W]3[S<-C?=>5K<)BN$JISO
M50<7QR4Z_5A)L+3%G\Y69>,Y-1*EXKG3$1IBX_[]NL;55N>3L$[2^T)%DJ$M
M'YFV?]PB3XW_<OZGH"CQZ>#[;Y# ^+.A&0,+0C$OYU[^"<Z!7$7::#XJ4Z-0
MZD!Q]>GW@%OX4R*/AWW;Q:VU=4/;U.7#W.@W>O:NW[\>P,#B\H.\MJ1.J416
MHU.LD#?:"R%;;OCL@KB"[L9[]$U5TWP,^N20OWL?[_\!'6B-!H/SMD!W=*:H
M+>,5EIXC#FP3?A@@\)B?+H QS1/N->8Y-PPE\#2L@+860*NQH'?!^F$>B:/0
M=8$ C=IPT^]/(4ZVN&UHZ1+4NT(>^$UKY%R[*H'SG;*,%\KJ>CX6"6N%\U_W
M6[>=: 8]B,P)@B;2O<WM5R<UN@;5*UYC/FM-Q\9!HS@95M3 #1I4&76HP9B2
MS9AIM@ALV%XJZ\.6GV,4P"$]-5N967 N4>N83#^[%CCL>0ZCMH7?TC^UNW/4
M^W#SO'G!5Z=A<4OE0\7]6ST+:!G"E]TR>[QBQ76[$=.;XEE.)LF2RS=66FQ4
M1;P>-!.HYF^?"(QMPY8+99HCQ(I::'%Y.WA"0^1<;3>USDY]YD51OZ@"<OLR
MF\ .XTM8%41C&:X)P776;Q!0'MK!"MQ_,6KAU_2U_UZH]^JISQ*CRSO#N=3\
MB^M=R8-6O=1;N%NMZ3QZ_K=Z*I_HQ]-$$N-*3EFIBM]D.[H)SG7=;$40%%6X
MN90XPYOX+$.KWKO:==RY-(_;U8^9IFLF>1QE^Z@XH'QP&6PX5ICU!NL'^9V4
MQAFZP6KF9-&4S6CMF6],U :%W 4F:<*3=JO\5]E$=K+S<L /E2J+RH.<*;;;
M'QJ0%*CI$)7V+1275_0]EF*V2N/(#]SWN_RA.P]K'2@S4^MQTJX;-:A"=/9M
M8;2MD<B*>SSRHM@.7K2V3M.#<Y::LR\PJGY;-0%+47/4S=A56XFL$N?NE]<!
M2* 5"?@A@2U.T &T3UL"_J+BF\,T3[V1,_,1YFE.KI&B9T&90OPXXE-QVJ[N
MIZ5!+-\!9@*RJN?9;_A.9D=%SC)U!"H_:3):WE1K=7/+J)"D"O7+M%QJDURR
MW&RM,>J=F\47^7A,<?J2)F2KWC<18&N=YKA11[&*=XZF*#'?#>M>]7XVU37H
M'K\@2141)),<C^UVU#JO;6E/CC;TIJ)?4UX&/[]\T(!G<"*+X$YCN7#]$L+=
M->YB<HQKDY]E6SV2Z >3,G';*AD>KNLQ7OQ<*9."UBJ<3H<""23$),"O)2"!
MSRF(!WDX2*"WNQ<!]"*!)@4C0@D)+6._"5GKI@E=[Q?!9*D%)=/'+935TC89
MH6,A]J>J!@%D^*,1;T-;&+O!,6Z3L_[B'3WKL%L]L1E">[N;]RR[\(YIWG-.
M<KT@'M8]I7M:/1#?S%6E)O*:.I+>LY+7Z"Y_[T%6Y0NG2EV?M[(Z\W05I9_/
MBA[1L&G-'039!ER,T+8VYN!I1@XV-T<FIK#/M-JL/)V!TL5#SL=2=R]A)W[P
M&_;60EGDB2J:3PRIJ9V)IC]L22P^Q:_&FH>Q7#1$CIX'1>C;@QWWY?9EK7)G
M.6/MQ%WU*JN8":4'TSG5UB-5"@MAK#<Q B2T#+!C<3HJ<@3G:T/)$^X*%,0H
M?J-&KU375@"(&N@IKYTCP-BQX<Z*+<>5>*J*\FEFKZHC]UXN3TSWX3ZEBRNG
MR%N922P6C*9/3OT7L1C^XXZ>5H2<D "E)&1S&7)(D!O_NZ-@U$/$#NAY$2L2
M</7)6"U6$'N7<3S_7WC4AB:1>)JYT&#@N2\>W;<7N9QR@C8X48.OKHW?]TF%
M^*8#5;5.#6O]B25X_G2XYR6+7F]^/452GC534X?L0'B=_JI]+"DUO@[&-!+H
MNLI(/2[B_']_F33/W<T:JM;K!J8,NG.O;<L-8(SR;XZGK"[5W*1 DV?VSSV=
MD1D*4M6IN#]W1';;):?W_D9I)87/#O?#L>I-9\658&"'YCV:2*I?2YD\R0:;
M.(PE(KFAXX[O(]/E %?2D(ISY4<<<WN6V0B,J*;2D.(""4RI)4&+-YTA2O$V
M=HSZ<E6(OD%F5D<7B(DW[7@L;"IQ4?A\])M)!>AVR<&*"]1]M#? :C4/?\V#
ME'^W-DQ"ON Y"H]AD.0_5NF'BT>G3G2T Z7!+RO='$-3V]ZDT ;?L!Z,[BS;
M"\K*3-%>JR6,/Y!K1[=G'GAJV/KZ<R.-+4RKS3&J 0G<CY_V-SJW4BW_,7VJ
MS[T63[X/FG\X@.@N:K]@TN1Q:.E_+H5N9B>",TPU(D)YZG=,M/R9NZ:RV"YW
M-/#+O8[&H7MBEL[VNH-IN],KT&-ZKBH9EQ7<;.?)_7C=]_R@EY=F09\H*?#>
MR2]9]H[#JKOK9EM!Z8S!44[P)Y>*#ZOK8"H'MI>]_/8)5E]@-C5! Q2$YE''
M2,!R\!VUK4A\HX-=IV.H%-7YYS:Z^*F#U[KFQQY4IRZYVA/6KTM5V3OOII@W
M+?!TY&^99_IW[H=W3"[#'O(XM%JXJ<;P]!;#Y??9CR&%N>R#71>"9PE!K@,J
M;WK\Y4:RX:#=58DAUF]>4F\MDEX9Q@687?^^+2M*YR\D:FUA;?7NH5TD V\1
M[0171VTZDS$?++JQ!L/!^M.,#87Q 7.9U445/*E,Y*R'<9#>]3H'1=/Y2P\2
M<DI>Z@N^UA5T]G98&<5,+]%1]MN%:;"E>!+=Q^THN<GJ\LKG;/*ZC,1PSNB%
M-_M(8!YG\$3_@A>!V]Q[(A2(4B)DW6[<6#28BD%E>X&Y)7.!NAJ6'/PYEM%J
MB%[J;?7AI_S\.APXS[!,M4XC&R5V2X*@7%@D\GC/9@9N375U)6:;\/6N#Y0'
M,K:CS"#EA=DB_;8+Y=FHH!CGUG4-SBW$\*GE*DI7U84^=G(X$/(:/UU-$Z2L
MR +YEW2+3,UL>.#&S\KK&$0R-D4LZN[@ 0X[W6#',K:9B6:P)57GS39R7IV
M5 ,2S8\8D])6/"[7T,.=.V"M_,?-HFG=;VW315F^+;O[1IWH2,->NF&$QCHU
MN_DO[6H?LJO31%H5?,M]>?'2N%L+^'I6U&H[4OD@MQ-JHBH _6Q)/:ARW>-%
M^4$9*U$]8"?5PLBX$ 4/#]1$C*$ ^-)W$;HSJ/C 31U5@9IR:Z$'Y&QCLT&.
MJ\3-W)F2\G:04QEN)% 8LS<WF9=O.5L^#8TK&NUHL0\:[S;K7*AA &$@@887
MA<61M#=8^@]PY7@6+\87\1/*%M#@1[N]EQ<HU>:7?<G;L =I(,XPU1A),J"J
MJG$)T^1G"V%GJ%<J>T9$?G59F5E^ 6;7,)QW1'%G2A1*.4U3,$,3)IXPP_YA
M#+SJUWT:!W$">2V:RW!%R<<E1L$>NZ?BSF5NM?(OQIYDH:R@!OM$#2G^RD%P
MEAI>$3HUFUS';:F;[RJ:E?9J,[#+=ENPI&\9!JUHNEPO4SYK$3TG,7= F56Z
M(RL%N[%1$SL^L%A_+_F"DH8.+P* 9^%K&UVZH-(,S=X7'=(1K@MT"Z/R"SW^
MY^B=4408?N5+84\WV)40])"V"+K+=_5((,G/JHI$:D^^87*(+%\KOS=W0HI2
M?_N=::8IE6"<?>,#M?6>>8UEEC!K1CJ@\L./U:&1D;H%1NWK \0&03+?MK7$
M+*V!SJ[5_..3[%Y?W7UY,.1\)>&<9 0\,GNJYO'@8&\9"1AW+FVOKU@2M];2
M%[I^,#IIB:X--#F)'O5.+R[!<.PDF^BZH;^,C6<HRD>,0DS!SX>00&DQ([-,
M^[['(&[[\O9TF7#1AX2.Q#WY4"1P)S[O.*Y6?FQYNNIR\'P56J.RRPO_/,%Z
MZ4JWG];G+N?I1Y_ZYSN-OY;_^_N-Y9:O4(,DNL<J-XC6;9[28DUW>"#'@].X
M#/+-7?%[D,^6^Z#E6Y^0;/)IFHB:,J+55<)Y,@DD'[.//]W_S/&VS>-E^(.%
M'+G]#72#OB.5!Y>9>"R4X;&?;A3TZD)K7N_E^2>.OF-U,TW,+F/;P@([ZAOX
M<=TD-7S?^>##ATWMQSD9FY4LY:/7&]SEQ2/9;CI^OMO'MV%;_P;2([AD'N6:
M%\@,*K#@TG[6,&"L6Z(]V[P$>_IC7BDV_ <2$!IF63K#&2[.V@S&/#57'GQT
MD%?\??[;FQT&/.T.X5-\6Q%:9^?&BW&6Y*I6'DL+A-7.2WV*''!(4X@H*7L
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MA\=+Q.P3=J--9P]:-A&GN@B&X%-9KIVS13 2>,>*!/#5+IUPX&MKB)YF"+6
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M@@X%#Q/=\R[/='=3?B6ROBAL)8VCE6; >W>>( &#]=E#G!(D4,>(0/V<_YG
MM_,3_B)(>3P,^G:Y#-J*$T1\.*X[688T!/_R/E=!HM#'@'P">@"JAEZ&0R%]
M(J,(>-ZIPB_OE3OHCU]M??SO+S+%"T:4E!(P?W*1N?P&10*]@667YRB1*2D>
MVVQ]G!A"=2$"4F0!6>V81%RRGKY& L;CD-ZXNI^5N!2VYL=T1MS'=;<(( ?K
M:)<7>'5Z*&$FF$!VQC+6H.WD]3"Z*9^MR-F#'<++W2<>G=8H;$V%0ONW9,1(
M"[987)RH+X0H#EI %TL*2V*HS\(19_BT>&>O[$46A5!&QFHT0JGJ'@0#H;1!
M7X@_%B.1F);LI_>';[9'XM1Z1.#_O OU5/YOQ97Z#R[7YO)0J\$K)#"&&BYS
MU1I5S\Y_HHW_1#OR;KF2RZDB 5;A9U?!DT?^<#?_*\K_X@/A7XN.==*:DPAM
MS=ZM[E[?=Z*6Q^YZ*Q-\.=9^5,DA3X&/P37!+Z_IA&I!WH-64#J]P!.%R@PS
M-=%]X)041[S.J)&_K7N)4K+O(4/3"W5P8L@Q]YB"S#?O4)1Z;KB&!!2=_)#
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M+3J84:*!-'8$:S$[WV07;C:<=Q^26+M3XR-!<'?(E/]4L>U88MK.>CSU>@]
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MD;SW\[Y=$LU>\\LZTKRE&*:A3D_8+ZJFZ?7-3J#<D5]9L&F!*HBO%KZ4>UK
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MC@DF>(/O'F G<9YK'IJ2J?!;)-63_'WQUPBFLM1[ !/-43YX1^P>$ N^3?V
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M[Z[8?]X=* T^J.S)B,6_!OO-3_BR^17-<<SCPTKLY%'F I=7*_CLD"2:J'3
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MCK:C=*9,0?#LM'2.;PEWUQUQ#["5'9-/_6H>M(3NXP=4Y+,Y'DY_[>$S4)A
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MB+>#E;_7Y#57!2GQ\DU^%WOBPJU(''FJI0/U-$_57<930?!(-HV)X+)::E(
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MS&=Z=,*\&B'184!\LA9%X;.0;A-M\>,9&^=Z/U06DVR5$&4+BE'#=_O*!$=
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MCS*/)8JBZVL1,_SEY&3WDSSYMBF):G!M9N#1H*85H;(?MF1<V L3.6H!YU[
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M/-KTY6;Y:M$9^HS<3%6-&27^])GO37R(XSB:B$_XLHO(00QWT'A4(V@-"6"
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MM%>]E@3SL)DEHD1273+P"< 9F^KA\+O5!C(@@76[6!!C:W[JY1[)IXST*_7
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MNTU>]>!-!_Z$T="CI&[.\3AIT]PT)Y$<!1:%25W9C&7XXZDM+Y"8POHB2==
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MD9$&V9C#)%J"%@3+]X]$?R((E341D#DDL.*$!'I^M_Q[6HP$Q Z0P''=G3X
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MI-(E(-W=#3-G0-_W_9WK.G^<[QNNA^N)O==:.^9>]_WL/>A?Z!G +9 "4 &
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M3W/:2VMUE&7Q914:,(:(S&M^N=KCPBGB]O-X=<50DDJ+<E7]7:(^_&@ E6M
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M(HOSI_R:.2WQDW)Q[X3[+U?S1I^8[Y[YBL2;SEUJ3<W"/%#]-\3<%R =V]W
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MRX(":SJ;GEAKY[W)L<#[-V4]'Z]N]Z[#]P<(V<@#)-[J_Z*5V'.Q\E96=C5
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M/)&(^Z&RRL>KY82K77K<%EF?\3[W7VVD9__SJR/LZ[6')YC;K30946_N4,9
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M1JIV(Y>7:E3AB,T4<QMGZ^PZO9+^B)NKZ57,MV >XKVXMNV#PMW66N6HW@_
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MXZ3/]N<+C?PR()22Y:I*)6(,^E1A$QF3<"W5IA^#UX,9QFIH7NQJ5L7-B#*
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M1/N/_0M)\>[D+<+_?N6NPA71,&V&U_^)@1%X[[G D%\H41,FZX-X $F*%/(
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M,2:%.KIQD#HD\-_E8-O[Y1H2;&HV,$D!33-N%_,6X"+ (D;NMZ<W6R@"NAF
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M-AT9^T%P$'I6XNGP, $$PCRA?[X%6>,!H^5(6:-S(B.$8"1/J-7O<#T-0($
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M96?D^ :AB+2%N8T+=XOY@_(?"XZ<X>4D:=BN!VVN>WZU-?5##H3.8I02Q5I
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M$H,0O,*%ZU9PD:2(Q0@2J71O&STI9/4& (@0Z>TI# T&HFN3(7-XCKB\" 6
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M\\U1;I':&O30G.1/NG6<7Z;7&^7^/:4'*I?^+\WJ3_ES4D6PU_IM$^N3!\R
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MU'T-<N#PB8)K8!_!]DW2VBV6Q:5C_(^R; M.#JC9^=15<%V\ E_')L,O8L.
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MI%0QA%)\-TOU"\N.(5(.;SG^P=#-,,;_$C8O-?9[[P@#%"P^>E1QU?KT9#:
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M$JB(XC)Y8X"<OP6-\+8B#ZU'_@&:4/]_(7.(S(Y@V)7LY99 8LGER.0=8/U
M8(%L<,K#5@F6>*!W!_!_3IN;E3-C19LO+XA#FY5030[?.M"0T/A?NZ.\Y'\
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MKXN1OI9W&LM^4SVQFXI-X>&NF4+\=FYT&PQ?JF+*W2)WYQQZ,571JR)VCKO
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MI4A\_1R:5']1,)^T;3;WJMM]T./)^G38M&:Q^OT][+%\)GT3D5V\U-5Y(LJ
M$5B*28+L\I/U: C3(B^CL+F>](.D3O::-> G3Z _69<.6EV,I)@0)]YW9FK
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MA8EI\=A0L[_AAA7-&PAC;K&G!^I'8M@XIQ]&Q%?@/'_?8" LQ_>8/Z2KKVE
MG,(T)W>((E12.C?C<;ZBF1E@5UXZ%P>!/#?/5U(L<Z*/<2U.;X0(E)O)D>;#
M7/J;8&- N*V$-Y7'S<Z9HJ>4H08YZ9@J-%!.=*Q^QX &XQ0[Q 0QS#'G5;W;
MP5-=)BR4L6\T53&+_?71.A!4:&$%15Y(CM)G>GVZ,(;R%^^%"?*?BZL\TD]X
MV'P Y 'H)AZZL/QI?H).>W^N  BR81GQ4B'J""^]N*@433,PPB5UW))M#0R>
M?1^/VQ BW!PN3E]CFU?O'$5/3[&Q>)WKHXB>V>"<CR9J\&/PFP6VR(!C>;DP
M^:?69R"V.DADD%F^,8Z"<<C#!@DU16Z6CU_&B!F\:V.2Q)^.?!@/#&=XGTV%
MY\*,Y"^%[M4>',TC]TA>*,L[>"DA:FS,X#V1A.)8C+=WSI_&G%$C[QZZ_\FY
MCOY)[\#;OOV3[R$D^D<29H<T%6']CK\#V(!9E<K_U8>6!+E=N,AK<+^#\:@P
M;GF42IYO<7-H0:A7\KK1["L3PGM]^$527B'%7*C=?"=)H9B'59E\?W1ZKYDY
M4&X\;>P'H>+0ZI(4.I:0CT545L@ 1D!^8" U>V8U$Z$FOH"9\N(^CKRD9DI^
MH[O!,5YYAB8,?,4@ES;^0[QQF*Z\P322\-+PUG$S'?KM6O<.\.'QT<VY3O&:
M[ OW=\<.' S%>ZRQIB64)QFIM@U6]B?VY\+V=X#9.P"RP$]FMSN N^P=H'LO
M#8-VM@?*4T1#IRUYS'6$,,PXW0EYM>9L]CKA-V^#HS$W57IWM2=;[_ QIK)!
M5,(H_14Z]G5?T8[S*B/6FG&L6Y9._]P;]!A)MJ"-8OL&G\Q(JTG5-:NZ?%!@
M=ZPYD7;/'*,&P81X>6P4]ZH7>]:4V05A$UV59[X!5&!K'*@&Z;]X!W7UF+5(
MA'FLW'SH=)H^9RP1SS6-\JFQ*_%[RG7QA1#QI2S5\? 'U69<4+$P=/)+$.7D
MD>?@M&WG-RRZ99='4C<CMN>!NAJ1J]/A#N%D8A/7O&M/<HBL,FL3LY#B%QK4
MGG&W 3Y%!.06TKQN# T-E9<=K/U\^WR'MV/)O+ZSR+:<$R!;CH! %FYZ[7$'
MB(H(O@-HY=Y:*#&2K<H&E"+G6KH56CB_BQJ9[R-41L="VGQ&[+;]T[RE*Q+G
MI^>;0)'ZL3+WOE51]15FGKC%R@@QP(H/%UN,^\XNQS2EAGMX6?@=P/2V!_J#
MTR/9,+E\W'.BV^.X@2S<Y8O?]1%,RD&7DM]Z/G,^\KS+];9E_0X V*NW3 @M
M!$X[69/JK!&D:DP) Q![D;89>X=KVTHL:93NU4!BNO+8X=%IN#!.T NUWAE9
MXA<A*'4;E_+($XR?4I3RAQPL87'=8%,FS/WN5?.&VY:FVZ\EQ:F!9U^U83U?
M4ST\^YDOUVIOL+O6]M;BRX*K^CJ9$T-[^TO:V6>4!0'8WJT%C=9K7$R>5(M[
MER2S#B\^4#>NHE[W$:&O>O$IG>+0\L[WRF29WYJ UYLT5V]JPICTIZ\Y"[7-
M&2H&4U\;J;Y$7LP>)#9 S)<SQT('C;?6<V2R]P2ZTT$@?7XE:?)F8.?H&*&H
M,!/B]8O)^YL0!X;8,V4CNP:N,N.I%'N>5R/RJ:,4 756:[N@=UCG=]=QOF\C
M6M;"'(S9RKKJ9>[<= VJJK46=A2/B1<.EJ+B0&[)P-9Y72D$EDB*<]RUY5VV
M5U-]R=>U%.[&VV>+V?%5U?Z9^,8CQ$^^TU,U!ULP\;6&.-]]UAW.+RCZ-J.
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M70Q4&>[#/4?89VJ*W!SVQT_%X3>?N/ [?#;CY"16P4"%K61),0/O?$2I?%2
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M[K5>SH_R_,A:;LD@]-@G\OB>6,O+7NC#4]=JY="(T5H?&9NL3!<R=+#/,W^
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M]4('PRC3^N?8&4"L%*U$=B'_V(@JL$6N4AS=O61V="M$2?@X:SC)EH=00FD
MU8_TY](3#<=S/^;K@SG1ED+7_37BO;3S2B>HR3(5/M3$Y,HUYV5==2(AT+;[
MZF.4UO)K=[&?>WJ+)&.V=FU66*;--E_&@!5JCKW7 9E#_9=3U@4W2A0B<]G#
M,]<$$*.-%$/Y*4+IWA<Z/)Q^;X+5$<Z'7.\ F-ZLI>Z*[B7#6G4/AI'9R#^X
MT04]7B^^39==,S:"$)FT3GM;%F,4)W?9.-(W/[+<B- "'XLI<RMYNL&,Y+'Q
M[B+!U-NYG?7T,E5>=;F>R#[M7TX^Z)G#%,4JJ8G[14X_?U RYEE=7![F4F86
MZ+<,?4M_Y(6]#F^A.#)8=@._$VD=S__(O]6/]^4.<(-$56[K3?\PUQVCAY(.
MS.<U0S I@ V0NP@XI6^X1#_QJ/616=.T55:8"_(=;IY_^,!A,2LR,]AH?4XA
MFQ ,;"VLW",DTC?9/R"(.,5!^2: \BJB%SVSIN[7L.?RZ7!(XWGU2I.M7=?^
MN+0S1P(Y^L'FEH>ZW%P-0J!S1L)V*],T X2H_8$+:UQJ*"EO_-H1MT)-9I^=
M'ZEK0(4AU.W<ZW:L6K!!A>N)_6'U=QTW\8_#*ZIY8^->*8(%9_L>=X#05D*;
M5H)1,JVVAO$4E-?JT0,])WU(@5E4[>=%HCS'@]T9S-5$B=%=]E:^ZQ?*:B8W
M(W _3Q#SVJW(/4QO_/1 5J.Y/F3SD->>W]6;T+2I@3$-;\BKKEOE@7M0M^J/
M'4^&[$)=J^-G!.7K']?8%P TFH%9" %[F=9.<9$1<<3%UC$;^EN=$OA6GEY+
M^+6M@9QZ0VG! T6[#I)T/CR&&3&YNZ2'^829!09B/=\R78C&&^B.T1HJ':%N
MRWYX4 &]!>?2G=@=]=*'!ZOUKEM4K$Q,J,Z1:^%3LB&5;R50O2VGRP[I0F:G
M5N2E>' ?/YE[]2,CP*/O&EE=P_.,K*#&B]CD.%=48V/KP%/E8_@O8R\8RA[A
MNIQ&*X7AEO?%K>E%L_THL^87EFE;V<@.4F<$NTEW@ ?>2H35-[79T!",!L40
MW4/ZA%AU+R<$M$CA@ /#I=#:&P]?:JL+7\[QU2^I*BF,S)BZ2[C17!W]\\(7
M9Q>%) )3J_'J!KIQRE"VU=(]P</7-AA4/'DZ&O#%K1%5J+_5K+'LX]QQ(GM3
M;->J6/AH_ME<KODTR2Y.%5)VI1ZD," /&N-"V)3E'C+E[IWP(E";'G<K%GT+
M)-9!\O6Z_@Y  D-Q;MGN,A1(QH$/3_--'Y\YT]"1^QNF14E%"Z[&OYJ;=PI4
M,/^VNYF4;V*C_TZ;U*5ZWDC>H:KP)_S,EB3\N!:$B%V\YS.(*;!ZK]G2%"Y+
M6BPR@A07CM2Q)B$_^B4QQ!'8HI0 )5L-#!)(D?\JXUTM<GB#1U7N2$ESO%FX
MXJ-4QF?@QV(JP(S&LG>S(=;CJKV$*4Z]ZYD]44%[Q;<F&'>@0V33YE8Y "3N
MRW]+13F:R(%9\X[$U1#MY7P4Z[621=ZO<MCRK- ^,']W7->5B0MMG%_0?8[/
M[Y] 1,2N1AR9[?!00I7+R.W]+1$TK$N<<Y2/+,#&Q:+.9E,!1.-(]29:4G#8
M4=^$A*/P^#P@Q]U2T=G>[/A3/$V'BV06LWA:K(][!<>*22C[J0HIZ#S,877@
M\B7RR'J"A5^"LIAS7:8\![/,6HTY*Z$OKU^_#.R,5KJWG9+:Q1V[]>@79"1%
M/MVG=6S0/I&1[=B60W<\%>2;MDG$M?:K,4ZW=0I8G8DE$'LH][%O-Z>!(YST
MX#QW+6Q(6"]UWY5>G5CJE]3L0S.16.#6V+O%4.38R>H6J-YRBV7'+=-$[B2-
M4IQ^%(N[P5O[$!+ L?/P,Q2/NA!>(R]C2$6IS<J"RI7P ?)GT5:OKOC' !VF
MA[N::X4$"][H$/J%;W6S*)/=L3WX3[Q>.ZDD9@6;XKS\R4&E/P05N@/0RQK
MOH+>'>#TK8L J.H''QE!*XF[B$8#)'N*OKGV]3A''G@=R$I"YXVKYVOL(08D
M,%\]"G0AF.*S)_0I&=Q_^I)2)7G1;4'N]G#>9:M2OOLXZ3H1VK9/[W@'J)XT
M"<L\T>2+NC*'Q6+SDNDT?:='T*2N1?IQ;YI<:^&"JO-R[AU:_L0E4,QUM/E\
MK@U6:? :>/BX+=!EF.CKFL(75.+O/]CI;:N*]\(OQ-LI<UK05E6N8W%0_:;)
M_&X82S/XFS,[EA[68+$"8\J'5CG2>5^44B5Y+4?*;$HDX3.+((%;"SD\CA5Z
M7*>&>;E!T^'I9G7I=53V'S4M(16$<PJ-]5,OQ^0]!-3GV5I_!!A%&M@/]<H\
MW (WK?@]-G$W,:B;8&.(T7JEP2L_+_]Q0V[;?7BL16'5. &EL"<*8_<12^GB
M_/--?ZY$H*:=.)3:KQVT4&C!RE 1J>M- C&P'C;+Z8_!Y3'R*'N"? ? EC]D
MW&:I^^"+!TWM2GF5\F[0QLT>=X%57^Z;FE<59M;:3IJ."F3<N-7(>O@%V(.V
MFC ']$@W@):'\U>+)#K7&9_-LM'!T$%K7=Z\XMB/IU;JC"() G98 =L^+![Y
M@]]TGGHTJ-",G98>V*B"NY2_>(45*Q/RWK[* %SP;6,<"_2@2,',L8'DY-M1
MTZFB;VW4\5;W]"+YI)W,QQP_:^.%7MH(S?1MA/Y>A.4TRQU]UR5,W]]&B;<_
M_695I6;>J.)FL8V9SGQ'66G)"P\_97:+;!4'>]>7>&*V2ZONI #)*=JIHFU1
M8UZGT!L&H6*EEH<O-^SO 'FG=X HN4&BD!1%WB9&[*X&2ITSAH\0QEL@6I#$
M7D+;;=Q8R_Y ;4/,6GR-FC[)[[HW+#_^GU('O**,S/;_4^KX4/I;^G%8\*^\
M/@H;=7X62A:\&S0Q-EX#%[X[8T88KPXO$M]OJL#U,AZ&R<,[CZ64\6<=LIX%
MA6AL2U4D8Q:)3WZC#&FTL5BR);,L 9\X2Q]7S_9O0%ZX,LVI]!!7DE^@FD74
M7*N! 1:S_.,0&2:$ %"[1I4\H3\*_GG4VU>JA 5:P_@AZJ$.-NJ/KK*U,+U>
ME48[).=UX/0P,)\FYZG.JX%=F7IHL&!WH;GX@'GU  6P*W.XYIX&]Z'B!0%N
ML>IJ?G@8OEFLV4L1_P'*W+&<*Y]Z\E;QG/1@ISYT;G?$3_;LXI-.\C<]RYIU
MLTDIK9I"&/.7DYQ[F%YSQQ>EX6\4+"+RA%[VF$2X%QT<CU1T4\?T/REGL05H
M?E&71!%$-U1?S8)O@N@#F!WA%:68!-K9>#7)[]@[UZEU%$&DT^/LW+)\[TNH
M3AO:%OG,93.?HKRM/4PN+)Z7<<K)5)TC[V7QUN'A?YP(+PF.RJ,  %IB>@([
M;ABW':6UQM<6G3##5QP^*0FZB,[H"U-T9,7QM++S'*]P3[^M!5A??FC!?K9N
MJT,C1)!*I@7%(2BCS'^R.EY<Y%Z(OBV-RFQUO[4 N_JC_ZGVZC0N,Y>T3Y9^
M\L[NV--"%-H.]PVL2IWX-3\@T49)FD8:8YIV&O+\]+DZAD&9Y?ZXJ=\XC_Q6
MVG([J3L?@(^:3X?'ZJ.3'%*LM4ZD7![7U_!(X5+,1U =X++<F^[+C'S7",89
M-N^OH[A"\\H" ,\8K6;@JZG&A=J.QI1EXSZ*@>:UQX"%9$^(QH'8H?H"VO[$
MMVP;Y\WDUB&!Y%Q'E:?K.(:>JJ,*Q,\@PN\WW)C)6C-J=S*X*&4RBY3R -,J
M5?;S?F41_.$(M_U'>DG15I]W?*ELY4]V'S;'?)(F-ET2\%0K?YL>EH$]5+KO
M6#6S"*25I4CO:KS9T$V..2->37W*8P#\[)X7"DG_S*SQB_3H!_L=8,74A*]E
MXOB'9!A;EXS<?(D@N><T484USV[C4,]&Y^>:B 1MXMF68$,6(1[2"5IE@=:Z
M*KG?.U<VYC'9IS6C\+TL%_QXBP ,:9(\^ 8G*4 >"S\DP#]K#/Q<+IN)5UT5
M02HG-B#K7@4$ON,#W^#]VPV ".8!I@"^_RV\Z]?ZW;;X+=P6E/S;N24$R[-@
M!>?$@E^:4X+AO5J_7WETOY]J6>T-PY51?IAW@ ;'ZYQ*DM*ZR]["D@\AN44+
MBP^J-\)"9Y4^]CK6IUDBG1 H5[_S,#?;5<A0EBD,.0L9$046[F8KA($2?LAJ
M&X>C-2!/E[C? =JG*?D:PWJ,\=WM<YI"7U25!>@F ! %3-^V4R]'U*Y.NG;I
M3)SF]"E/V.U?^!Q5?Q_=VJL!TQ-YE?>1Y#6\KMH71SCVS@ 0^3)###_]>+#,
MU?,PF@?S1(6<4+ =$.MDDP:U+XM06<.S%D ;]#JO?ZWN'-C^R? *(:JS'N-&
M1VV2Q$"UK;'I]57!JD5T5 &PI.HK1.ZSS'YD'O?G-%S99UCL,D=NI:RS]#9L
MC[;O +BB8I7N?KUNQJQ>7.=4!_B)#[U[3(<N0B2%D#;ZJ'54UN!GIO/;IT\0
MB> -L$<WI>;4,+7V<BQ1!A)B-ZYCAM 9Y&H)UT8XH;ZN;?+H,!OY$?D%^UZF
M(1XXI$^C;9R.&W0QS1\K@%*^8=5_+94;LU-1Y V9-)#Q- ENQ0-:CUO[\C^:
MV7&@Q<,S!'SS>JQYC#9-MP:Q[]2N\@.[113TT;E*6*9^U2-CJW9:8YQJWKT#
MZ$^Z2&M-N(@,]F@D$.'5)(O/A1:5N9 M<*\=$!(E$<;9LFY*L<K,'')C.SY_
ME^)FI@&V'C27[94X$=F[ YP_AD&DT0CCCRM+OP32S6]^^9W25Y*G@.PL8SW6
M/2QBPIHC>SXFI\4"=X&E:GND:<+..Z/6 B"S7TMOJC]%5$^SII$Z18P]"]^?
M._2<[E!EO^9;M15G-*GYFFN-%]4<GG7K,N3^O$NX+?B6V=UW3K?FBG<L,8;(
MLYZUMD^+SC+RXVD%X<#M3^7Z*^F(^?-JA"CNA^C\8MS8UMV-YU5BISKCUM-C
M1IU<^$=.FR_N "ZA7Z]9/"B6/LI;#]S@J$R\_OS^/!:GB#BX/E'\=>_('<!"
M-=UO=B[*<PRR& 2AU8(8KBED[%W1@S^(AM6&XIM:.F ^%!I6]2GMX>!@K\4H
M;&QI2-E<@;3JI37QHZ("UX\!URS7ODP03/[5![4+RH*:IC)U3BA(XR0][+*Y
MS\]#%\3++DBN1?B#CLWUQ_*;(P\O!?-2=F+"4)Q#:*>#D2JG&MK>+YU(BQK=
M >RI+FEL!LK/6K3''BY_F3AZ&;(<Q^LXSUV6%T[13NDD!OIRV9H/>LV7\"77
M#2OOQT_32 O=]:\=\UG+ZXY#E$-SCE=:;P]&"G5.A7+K(*BIO!6/F0YSW,Q'
M)1V 99>L&G1>]KTF#VST6ZLHF\S??-XY;W0[6G]<Q%R5WM\A),JYD_+4M Z:
M>5S1)U/3 *:PD7N00_0&]4$^@J@E2&/B[9/FI-O'8L[[#'U7EFI7)"I/YVZ*
MKS_7]RXT]'+-%LW-#X.$56QYH[^EE<54:9MD4[#2H]F8F%NJ&379>3*^O\6"
M@K=T/]AH%[\N[%TI=/U(W!B9_2QN>F*-Y)J%(^R6N0:"$VI:.[X.?',*_6;#
M0E[:A&N 5D^L!B5=JV@&5BQ)3EUX3N4Z8F 2;S:ZJ8N_6ZUFB3<Z['?2WOB@
M,\+=5;Y+]8"7^!J+$YC(-+5M(%?5(,)%C>D8LM2_3OKKLF+&AC0CH7YG-F(C
MXP[0<NXQ*[9DE*<FN-CYKL'.RZVK#<T]2A&"J3\-KOSQ:N9XSF#8>?/KMP6O
MF!$\?^"E64/E ?2:%K*FWMCRR];B8TYZU85:YR?[]@/&.;XM[KW&[NDJX\&2
M): ;MG?#[,I@X6AUC%8E1\4966)#:V/&[HH_UM,3(O-(5.!F_G.#SPO2KV)V
MQ?FA.F5+[H%KVL?K:M:$I$&IP2>;DJIUC(G4N$ Z7$_2@UM*=[YKBI4A9=:=
M;%OM0PY^J]PWO^20D-&F8^=/#[[S&".]7L6R47S?_VGRZ.#)=U<I)TCE.A:=
M\&VU/5_WB/4T1,$)D#ZV,9G?A^2(MKFW&/<NI;:W$/]7F2=')YN]<N*@SG%(
M,5,(A9I*[/K:T\&J)/$\V[Z1*VVMOHY,HIZ25#E;TY0E5\)]Y9)4'SE&ATO3
M6[ZMR3)1M56"NBO!:1<N;*Z-L ;^-=@ZUV%M&8F/TXXY$!<<8ZO!":3ZP5^=
MMV=#Y]@<.IKWTVEK;I,Q<H$5[]8V\W;V#G PZ2$T64M;$,&[2V313AYF(M2<
MY9RV_UWXYUC4@8_*%0]\6O31E830%4?&HK9S9D.:RU:A?H+2W)9C8VA+HVZ4
M2K./B'IMZP<D^II^[J"1!.JH#>/)M2A,O\[OX_NB:BL@LPR7H(&4'^OH\X^?
M_6PWU0W$YND3;R71+G,1>ZX0DS]^5&%+)TI8EY#+"$'6DA=P>Q9>5C:L=%S7
MJ<>F;ZO1NRJ"Q8YL9F;C3Q)E)I\!N%Q/\Q42?S!V#8/&)+ND+B<J!'G=,*_Q
M/JW"066@K]B,4_+\2?W@C;W6I):.VL21/6):47UZ'N#*CJ%H;,-SX3VW]F<Q
M?JH0"=P:L5<]>:*AN''K38$'YC(D5SUNEN.T:)"*L-7>_.RA"JBE_!3]U7,#
M+N'P:/ZI"&*F?1QU ?,*M!:/9]#J;A!1?"OUY OWW@X/!J[3H5=--9'?]_62
MUZN$Z"Y3#,N;JG[2E47I0 0ZT[7G-,/4CX53(_C=)W,X%P"08V$>SGD<5:FC
M R/L*H;LE>' "U=*SF8BX?1%\R_!ZX_E&EAK"/OG-0.[SY<]=<)TH4'ZXS0G
M;_B\KN2JTZ,-FVU^(<'6\Q$?R?757L.A1:]H_SK[S&G_9A*K5U0Z6XQQ2]RR
M86*K<@LF%KH-#FDR9KK\2J,7:J]O3K-=7N"JC=Z8E\>KD%=">K1F984SD0GJ
MA@/=/2=-&?EW@ >,W4-^JK$4UI>;&#J,WU-63WFEG+\_TCT?)D;:T6^CH-;C
M]<-<F!,>M K4U--<YWP=7HSL((6NY"&]%,HW=^5L[U%N+< I@"I4D3YQB[R:
M53]Y)M)$_,;.A:RAG*8OP9YN?[0 %762$0D0TZ/"VOA:B)772_;#:0?$N6/6
MHC)'Z=%D67S9>10U>;0 AQBV#HLR MK)(-3ON$][S!L(*H.&TGSZ4AOOH=;/
MPJ/ +***^1CMFVR#(/$6W_J4VT6*2WM&[Z&77M6? ,0R.?R!K_1'=LJ>3EN&
M+CD0;]!I?_33]@!P.4I-EE6^?UO\[<+LQ.D2V5[H2EMD8F,-6)_I,0<G=A,)
M>A4EU%S#6PKJ4N2>I"O.<-P0IE;;IN7VXJ,4)H"$A!I7DN($V^;KD?T1'VN<
MLY^;V,0ZX'7&LWW);6Z/XC*^%@-Y&241S99J;:&7]@Z00!_E,:8-ZRGLMT?.
MB[?X4-*M3@YG\4JZAR7&TE=-6@Y#Y/(RJW)[@^R.[6L9-K'W%8/G_ZD8;,;
MKC_XYBAW\F@,,CYH$]S@2,ON7//%.3R@K_;YZY)=89>))&V!"^VZQXB53_&X
M11"=I*C73Q"NF9W$[">$QFH;*:)"&,%+:Z_4E9[ \E#%IN3E5TD 7[H _3L
MD3=5.0Z>]2+]%4LZW0>5##IC[(DH%.>F(R^SYI:-6+T4$)UE0G*U"'D58RSP
MK/3"^,G4T9NA],7J(D/]- L2N_21Y77OO+5P+:>F!8R/^M_.J$(E3N1$2>X
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MGGU76(SA9WS<'2G,.00$_Y(IV_=)<=-Y[J@ -E1?]2<#PR(1.S-@A%D2'HH
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MTM(]EV^/K_:Q+VF78'X8FBW>4DO</J;WOV]4<H53I)%T>.RGW[P<S?UQ\OB
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MAQO3X4DG3^OLV%S1(4]7NNK:FT@@+^/R^QX._G@EV<^U_5C?Q0&WDRX"/)Y
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MP>YA-?U/CML?SI(,Z'$^#])#]>ZI!.S9CR_S.&+D/QPHS)?\ T( R8 0<)2
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M *>DD;ML)@B+"LR_@M%';/[NIR\*7P^":_ >]QW\<IJO@WK&!/.A52F-%8<
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M)Z?+UZP4&*WDZY((;AE9#KN%\8X" UBXO."##EA*6[$7Y7*D5XG#1:E\D@$
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MVI<J5@+3E6X%45Q1DSR;$_'FO,4AI]N>LQ*C#C!^VSZ#%GQ;8<+K.3^+\5V
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MNQT7-I0[3J4?#*PQ%A=<3%_;$S"';R0(Q?S84:.>:=BV"_3R]^0)?T$_E,V
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M89\#1G>^T/@5<*MJBHJ>&7-K%'*<1,DXM+]#J>M _ !>03V^Q?#:['H/#_W
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MP(FLH4^OD/VPL)?X8HND>$Y$QKJTWW+T=]9!.A7E':6[:M'K2.E[S6_GS7"
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M9#.T%6W H-%<25.R*FH*8+35#_Y@%%)65AXV+S M)8( ^B(&(7\9P96RJG3
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MP/ZBDP^4YPJ#VPKYN>!D8/=0>#)I4R<#M0@$=I,@G36@&-Q%_GY!5@_:VM2
M_0=H%OCP>LD0; +<=W*O8C86?(FSGX^-:JGR=X#M!*.[WN'XI@6\:WR@K09
MI1Z6EHRPP 'CQ<,Z%/CE_A<_-C>B8],-C@*8:[V"XVQJTGUZI%\75HL51KKF
MG6BQ Z 6:P9HL:4I@E&Z[\[%<; GG9WC@',E31+=VD2"]T EVOF(H3#LUH*+
M=X)4'S!YPS&)(@ )#<P<)"L+7F>..KYE"8E"PK3XX'!\GBNO,78F020&>_V)
MC#"26<@F\;'9"2/2A1W'F3\90RJ(O6!&B_^T21W_"*!1__4*.Q;OP>ZRO%PL
M%N93]51C>@[*W_1OM@EI>X5KF_'0(+45'M'?T?[/B/O_XV<1]'=^.DS2(U"
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MMI*7/)&JD;PRYKHX)EO&\:W@%QC&!\KA -O$Q\<P)&"K#7C."IJ\P:OG1D8
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MXY]$Y,;1'U.+&P_*7!8EH-K,+Q<+M4"< 1.-  HTQM6=]"1'X>*)FS:E-B#
MXKBH8+9M'@AE:BM["RL>]'WG,<;CZU>6D/=F_]H-/;>5=?XGXO8K(C&6/A%?
M-X>9'^,4S\GB59Q34DC4$HP6$=U1VB;IGZ#:*NH6'2H*C-R@,?_A:R4O@*:
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M 5C+L@N,*5@+<F0%N))AM8+ FF,=SD"K,A%[6M(',(OD%>#3.ZRX""-Y3"U
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MYIPJ.2(@$.P<_]B: ?D[6R_L/N:%*(!:HJ": <.V=>+':YJ:EEQV@050?T9
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MC.'@<X;H+#S&^TB8HGLX:X_NPT/K3"BSN1#;0_\>O707<(:00(<,?I:"QYR
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MFL+)'0*O&-#"+\2=S8MK%;CKLB<&\GN=YJYJ64)[\V"J&4$K)UIX@W]X(OT
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M^U&[=2P[@8BA$L9FA1()FP2QS]8HOCU5I;$L5(G+L&9-98R2DTL"[SYXM'2
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M77WY=0GW4H7WWKUSK&$A*C]$/BSG^\]T3J#X"!HSDV?7;]N)EW;SQ,GO29"
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M(DYPI&O@V#QMWAY4\RM36R+?_:W]B'B?SK9$H7OC^X]?%H7 D%-B>S\_.)3
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M^QX/S/^7OD:D?_KU3*]0C/L(LS22L]?4XKC0XWUQ[_M8".49A'BBN&U81T%
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M,B5(B?6WN#/(L*PV9U7J<3:@9GK_G;Y(FL]B-<>4<\3VOW3N%?MI3]RHMO_
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M"?E)AH; ([[Q5\ ST>6*A5=J_-TA;RD@1Y?+\P$$41K4^9,3G@PJW"7%[_=
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M[,XGYQ690:6.KC2PJI,@H-2>=UZ/B14LA,?5H7J%D?>$^"[2;/=T1-=!/$G
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M1 \CEB1$%3BAQC<H?N38%RS@/Y2A8<--CUB"5=_FP;Y+N.U>5_L:6BL.\,'
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M.(T%9+&])U\M"I5)@0%M%D\TRQ21W@-2<7&9%)4F81:\YJSL[3P<%H".ZE@
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M8E-6>++:S_PXS[*?\(TZ7]:2F7P9TX,IF %( D]E9!48@$(1]2&.7>SY+&E
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M7/-/&N(J;&8,RPMK[U+R^X*/"J1"-^@KBQ3XA(LU'8)3OT^9>!ZG:\V=LU)
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M%]5$\7H 72XXPMKL =#D'+PTC)/-$O'??SUT?PJ+9'@M(2H(IC?\E..%XU9
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M)]B1]5^\M1,4CEG'\J<-^MXV)38)=@],38A:=^*>C\G\[GWACSF!=)11WO
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M.2$!CV$H$<P;@3G]Y/EI?12RW><6"WI(%"QIKLTJJUTWO?:;S0+(:@E*-CM
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MZX4FT/9^6%3SX[#1IF=E5WQ(^_0,'^^UEBE:'MAF<B^NF&K8\7F?6O8HYP.
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MIS#/3ROTT-'?3?V:!*A72M8*<QK,[&T&5Q8S^421LF2&Y <^BTD;IY"Z\64
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M;BH!!,V2&#!B#+4?CR?YN/-6A:A>[\&=+OTVTJ:;YFWG=2RR^> Q"*UI)7X
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MX45+%$*(J)[MVB#7?LJH4'L :AZ1%@.XE2WWMJ*&/<_!BM#;(XTOY@<QWF/
M>Z-(%L3T<P;F-QBB?T'^B7_(&VL6N*:32V'SQS8 OY>>^L&%:#(B0+^O*0VW
MLJW@WKDKEB0*:!/4O.1$[,,^:J0.$CEY ,I"'<ZE=(JS47&."#?<L'.(2@)1
M<I#33F2IKJ=49[4HS="_:@AY6_XI,G W[I_343_L+C <^AV&(./[B#X_P$&8
M"N:_F GABCR+6S[L+L46L4IOA!<V:W]9W;8ILLQN_AC?$-<S=W<*CK^4SZ0T
M6@8+6V;,$4-)/5(YQDAO*3#=$0+#&02W@@O80M-4LVV2'P"ON<]>)<@E(K@#
M#L=#G=J\^WB#(8+(Y/@=>3QZ WKX%_J;W_.HV\64J7M>M5L3WITRY6<23V\^
M "D.8J%X9>;'V@1??[<PMR1T+SI3)@YE'=-H%QP;P<DK-KXJSNT3X35WG-45
M]V%TDF>DLAH\@5-^A:XR%NCZ5"PJ[H[1*6RJK(6(1^<!@%+S[QP-/Z'H>P""
M91\ U,R2/<J[<UE&D21OHD2='U!JKZ)+LP>@(XKR.-PF:R7F_H;'*93.9( .
MOT/D>7'<Y3ITXDIS,,C^T[:5!-2_)UK]EJD]VBU\3[?;_:7/ F?08=9QV77=
MD\SS=^\J- PC[\^[1OI$[_9.H]3*;@A=/*,2)=%Y]5V%XV9HGE:6ZDIAMJ>$
MU.VGWPZ?=A&SL='2)MPC+);J7_&KU"8+?[3NGXXUT4Y*^2KVDT*V7N*$P-9#
M!*E4=!9;Q$0'C5U#G@@4V)UG[C6[-HK_C ?[$PG[)U?L:L.Z:I71#KI4M.M2
M2$=N"_BX$E/>V7K#_@FY 83\Y=CKAHF#*\JWI,XA@R;(@I6N8*+'0!&"IZY=
M68\NRO6]@MV.Y@,^Y,B! =Z35B[/FM;U)2S+@>1T3WDREA+FNG\(4FU,/3Q\
M1#6*@T<KS4,HQV7LN+W%4 EO7Y#DW&ME9*6[BG5DX8E;WJ\>NKKM5]KKV%?2
MKEN4WRZQTQ5_-A&+^ R>YM@7@VCJKQ+6;,?L51IFZT*^E^Y5[AC&#4!-D^Z8
MTV[=PDYT>W?DYAY)>\BL ^TU.2TY6I;20H4LM2+),"FR##$&-J(N_SHEG)48
M;9)E:_WI44I24V"D$_;5T^YL= K"J4J>%?CQ&;WF\'O(\FM+YDQAT[@]PSFD
M)/"W[U(VT4?5#&K3G&]!&C9>_V_Y=OUO%@5_I41%[XEEKSM)P6D=KE'-TI+T
MI9F:;L*1\XUNC2YGI8?:OAC]%*]_W;69<ES6Z-*7ZT&_%>:BO\Y"):^L2?SR
MFUKKPC6_ITK0[-H<XL&-9V&,62V=?='87B*GB4U]>H]XHGP_?8*5^:U]1N/H
M^;RASJC9W310$96J!;/>2H/#X$*EF55#)F^,<$DOX@B#EL;-/Y$A\O76R5 /
M&TJ6U3W3%E37INQ-4RKG5K4DF^ <K<MS!(6!7QV'1ZBX?)'<'B7[]+L#=+M#
MI88B+>TL>=FWZ/T&,D"Z*[$M1XH=<^D8,U]N<%6IE*G*I.NMW^+ICEX',S5:
MRDV+SR]MX=>AR-[^\J]YV)GHO@6;:IV'6)AB^O//HRN\&" V/('YKVFAF</?
MU) <$4^#MD9&"4VA"1KY-5VM)C_0A ?'C'(#GD=#B(4$)G+6"_?5AQ$U?<]T
M+JES;YGI;U*_^,; 1BMK^RP53_RBQA)5^WVM.7U$(,!:WTX:)(X[)8<JBF5%
MRS L@ ?4F\BG_A@-33Y:">9I7<Z04>A?:<TJT(OFC8(O[LI&EH4?* )Q@CPR
MSP9J@Z.U\,2*'748LM$ZM+_Z0[:P1,G\#9!FBFYV815\L-@Z#<OZ!&EH<1E*
ML;,$B;5#0'_2W-^\^?^6LQG)_A$#L:Q)[ME;0KDHX-. 3/WDYQ,L7G"KJ60L
MA]MCHVXFHXH85)2<WT1"2\Y*_BI[99\VL')"FXHQ$\T^?\\#'62"F&JE >TE
M5\(5BT3O8ZM;4]7SJ1;O#5@BF_-%M$22@U6R5LB+>!FT<"Z]"WP3B+# &^N=
M)9SB8;^DK\8&MA34,;YE/:2([P;Q>L7\0.V/C _H\/F%J^ P@9486KQ6!((J
MV\M4+0Z2,=;P(MBPJXZDOJDM2%1TB,L'-UE$;LE.M_GW37O$^3%<N9X+?XP>
M5RPR]/;0NYLL_\W?B0=W4,GB:/8U3E.4GTRS&]&<+/R4$E\?%.%'^V/WTCV%
MX_O>HO\BM9PY<RI'$3VEIC%[CZ_!+^UC)59O9F4>G#8*,[)DM#[L+7'R/].[
M\70Y-_P)Z3^Z?&S2P^R?/47-_DAF9P;Q1@/VC E>,O0RR:!6XCP"(G+<WBE5
M[Q*/D'M,9/E&WDC/1;U[7KK.B#;CGS$XK!.16GP1):"1DV;'=[Z""-&V"YFL
MPL8SB<-D_&X);#^)D'7PX-8(TMX&5WKL2$9T-:CB$6#0M;2CUW$%36;NA-]@
M. #@-+^DU_G=FWL7L4LR*@I]@;)[NO][A_9_UB]I\MW_\ 7['U9V:[.BL*"=
M$:?>;#4:E[*J!#'9)$JJ!_]@6F58F[>_F:/-A=NS+MH08BT4JC.S\TKE2K$9
MGBA)]DBOBB*ZL@@+NEQJ);\]FGHO3'13" P@OOUA16*2JVBDWV<..IUDP !1
MU'^Y"RS^9E%7;F#:GM-\MWYO6>#BHH;"QUMNIOJ^)3/>/-)_U%9F52R?[$WE
M=X\8A<[W<<8,"2UBCU2OWE988^H=+T/61&V(OH-;;?&0:',V>B6/5?KHX^:?
M,?N<MGE;*=\WI?EF0=!BS5A5-<BUH9$_XPFUH&PJR2V@BO_:U=A;94-C!JG/
MK*PAJFECM@2!\@O@$OZO,0;U,9;KODSG?;9.-"GWGB-\5>6N%J^33&6+>?Z6
M([L^QN/ P^?.L:V&<QX\O?A]4I?.R(]4D/>-/ '=\@Y\Z6'\[M9IG)O)X7DV
M*LG%6R2?FFPRGH@A2H7J=_,_*5F[Z4M$E?6T47.T3+'F\)(G1T>I)BJ]@+3P
M\@M/6'$+MW_+\O23G9B[=X(4Q<[B!,7%&A!B+(2?-R3I@O^Z/IE:"&\GC[Q8
M:1-J^5-01]WM1E7#\2/HA3/.S68GD<QG$L3,<&I<K[& $CYCZ4MC\U<R/^?
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MGLX5E:'S"VHQ\J^NH)GSU&/LOD'?CD$D9R 4([V)M735@WW!<E9UMT&\X?H
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M (+ZM6-0\6"=IU(4N>*V%X(&LG+1&2'PRLB*G)(R;VAW3?IQ%13@%:)1MVT
M*33J-K>1]?F7#(:3(EUI\R\I___>CPF]/1'*@U7(Q"LC38EI(V,Q/4+Y<$.D
M?0;)TR^,I/O-^/J2$]TUC=&G%GV!*TR?CB'&2>]<N=& BR<\:T;VW_W_6 ]N
M.9'>H3!BK]3?N(D3K+;=TY_FN?SAZP?#$K20.BBX.?)$IM2*',:.2*1M>[DR
M:^EZ1"ERZUZC0PO-E9W.H.^(][C)RZU"!=N0D9X1T0D>S4F6NO?X'M+A?2!3
MFPXT(/Y/IM?7^FJN??:,%,F]A([WE;Q)?E0KA5TVEC9%G.KX>I'0P9@3E)M.
M(7EZDI_ 1]]8.X;RI2@X,P(OHU0SI)"319XE@S!S_3&*EXLMSH_K**;I66&:
M'8-#(T!_#Y_A G9H_!5AV\/7VO-9N_A<FDOX-_)OY$] 9L]^06!TPRNX(?SF
M!QHKUPI6</]&_CQ$TR.@\*AIWZ-I'\^A+WL/7_O_+>_9Q7J*?M(VA _?#T)7
M)ZOP#>%'[7=X^O4J6[/A;1U Y3*7#PM'%*3(>@YDY59RXQ1SF/:D;IK%%6=7
MQD38N+P?(OC8KWFU"&PN@+F304P&YDG56WRLM (&6'D@/5#I*V">!*M+YX!4
MN50ML5:YW\$**S2 H;W\O2))CYP]8H#Q!5@8DF#U%_!B-*M/ "]S56-5F_3!
M\,5WF_\E<,0CV$] #"V&SERA$6N5NG7R*ZCV8(@@Y((>O3.3G-]F[A-H,LD@
M/'-E<%7?(V;XWP]:;@O\_7__;_!_"SCX"S>)244B1?(]@J,]?@,C'PSAGP/^
MY^#HBT7X:B![KS R 9EV\3QUV)@DSQ8D$C_HLKK4JZ*NP"4U0A,T/03,CBJ4
M/QEF2BK^[BS%>#[Q'U!+ P04    " !//6]4=!;!(2]C @"$?P( $@   &EM
M9S@X,# Y,S(Y7S(T+FIP9\R[!5"<S;HN.DB"!W<($-R#NR7!@P<G$"1H<-<)
M(008+'@"P=V#NUMPEPSN+A-L@ '.0/*O?^U[UEIG[W/K5MVANFKJ[7Z>U[K?
M[O[FXW;F=@F HR C+P- 0 0 $.!_@-M9P', ZL.'* \?H**@H*"AH:)C$F!A
M8F!@DN+A8Q-0DE$]IB2CH*"FXV"D?L)&2T'!),#,]I2+EY>7BE%(3)!;E(.'
ME_N.! $-#0T3 Y,$"XN$FX:"AOM__+EM!>"B(AZAN",A/ $@XB(@X2+<=@*H
MX'8^0+C_ /Y\$!"1D!\\1$%%0\> #ZC" 2 B("$A(B,]>(",#._UA?<#D'$?
MX-%P23W$5S-&>>)(P.T?E8Y*^ZRLC5!]](B.Q\3I QHZ$3$)*1D] R,3,PLO
M'[^ H)#P\Q?2,K)R\@H:KS2UM'5T]4S-WII;6%I9.[NXNKE[>'H%? S\%!0<
M HJ.B8V+3_CR-3$C,RL[)S<OOZ"\HK*JNJ:VKKZ]H[.KN^=';]_8^,3DU/3,
M3_#RRNK:^L;FUO8.Y-?QR>G9.?3B\LXO!  2PE^??^D7+MPO1&1D)&24.[\0
M$-WO!N B/Z#A>H@GI89B[(C_A-L?E>!95'I9&QHMC_H1H8G3*#H1'>\R/>3.
MM7O/_GN.??B_\NP?COWM%QB B80 3QX2+D "\(N%*:.)MA]=CRD-$<24AMS%
MP92FB@!BMF+"49-F!Q"H25.C,V5\>4"@)OGO&F!7.2>B<B=>'3[0/Q N0 /!
MV9"S>"L_^0=R,#_@L *81"<KP?GUGDL^8&"V' 30$ZB/()J$J8]*HDD3J#[-
M #$!,@G4-SX_$'3)&0]2(!E1DT;,,ADCTU-X\Y<%'^*C R0Q$IF9"%#UF#+>
MH]\U'FGZIT0@!;4N $'EUVRX AX92P"<#,&2TG(0J1B1+@/$3$#P)3OC/5Y\
M- C@2O AWO\!._V]6T^-%:4)\$BS"6(KWS-EA$W>*_F2$9^(Q91%S:L^IHH
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M:_\COL^4S@E<S&F*9'-E)W&QLIA,->L(SS41;)<())85M)=A"[3M@0= 'QZ
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MPK5OQ#6NAW=L6!81JAX<QEIW90>N7Y7K@E4<^KC;2?H_BT$T=YN@(BNXR[>
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M]MVF(1?$&X4W,_!LCU&04JB'3T7N&*\J+C+1SL57>0B?;RK9'5ERJ?$[=^0
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M'UI(O]Z$C[Q]+A3$JIC,_TL*GZ6=N'^^6S;O<IH5$M/.WXP/R=='[733CKJ
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MY1$P+)MY8Z;SD '8J&U%%8!H,]"(NZ(/Q+T9)=9+[O@0PS:J>[!'8.QX"T!
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M10+(/AU8XMD=J4+9"74ME?R$%,2A'!]?==I)0]TH,&,ZS!),[-H.-7KOZ%F
MAB7^OYOD.A3#"B30<6*#@G3W\A:>/.*&^E\@#PA*2 CR!N#Y^@BL[^5RP<5E
ME@D\$5NIO:CYQ+>T'T]5D"![]C06&"Q[]5260IDZ[M?>>7ME>XJ7SH]T-;>@
M$MQ+)IJMW79?N^%R("]I\GC(=*SDS=VH5I$EX8SK4[,A0^ST$4$#\Z"YG64Z
M;?OW[ZN7J,SUA+Q]OK9HD#U>R<+JI+T:MF@7/RC;8AERIT5D(<^)[ZKCK),
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MOC$#^Y:(<WEIP]+Z4,O"7BGJ7'Z9M;%-BQ)T<$(?;/Z6_^3<@_8*ANP V9=
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MR*N*UV9;5)\J;!9[]\7 )VJ3_0\'#!',.N</_6Q_I/*[-EIK+;+":!W:G(S
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M"IX7;;2*G?_%VR($/=:DLOS0YC#@U5"'><E$PO3\?:7<<I8$XEMFKT3RUI-
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M7BW(T*?AED&YQYR )]:QK9AC_'03)><2,+'4'K-!@/>1)E0S%K:K;JE[L9-
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MQY2C9"EX6@@F4V"UPCX(P$S]V, H 64V,_SO7PIH69A%$2*^5W!@F.N-3DU
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M,SG1^UH[4C9<>.*<:1R8.<YU_>?D"Y3%9-DDS6Y["R*?%SQH$ER@#UV3M,B
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M(%$-<4R_($ZCRJ=3,@U#KX:'-HJ.S:5*^9L*GI71XO..4=$M!+4?) \Q@N?
M#6HR>?-;B8Y$_(['/0M"<W7)1S]W(XM'^,/;R18?FA]+[E;C8Z9;2/IZ[GA\
M9.Y\X::9PM>1<[B^9Q -92)\/DKE7-(0-^]AL'0-,/>]H[EIAMR*H_1[@Q)[
M(#YU<.SK^S+QHU#O.$-OV>%%U<^$H]H05F76@Z HM84\2;.BSJD?=@ZS=5,-
MLXV,&)/*-DZ!F%MW\_0U4*,1( ."G=L7Z.XA<JD/9'5Z/VXZC:&(E!.BT4D
MLYODOA;CW>FZ]G.)1RG\YS)6\.ZC6]7#*\FM[A$_9NYHC6$,IM75&W[]?'6/
M,,=C#^6K&+.D$4[:J39R2]P IO:5L7W!ARC:37RM;*EN%)VI'<_K5 R\):AN
MHA](7RY\,T$P57NH'[WCEWQ>4>VZI8@U^%*87,=3XCT=L=.HCUD8H=OB0\%%
M>%8YS7'SF>0%.RNB?-^^&(XK[/W:;.MCY]M8Z2U7_NDNZ-?5/7M350?*^"V$
M^Q<S[=NO-275#RK9N]%.H;0](3M*>,=5?(MR>L1SX-'UQS3D":$K ZCC3OZ/
M61NY=#07-0\GYD,CTH_O#?5JD\!'1M=$9P<[RM.ZU-N9"C/[]L3SV:WT#%Q]
MX G?QGV1#(:V*]W0N[#:TL$_F01G*CJ-%H6_9@N/[/=?R!A8W:RQY+_+H'?Z
M /)@JVZ+XHV_;M#G;^,BP54#*VZSJ:MV&US'8<L&>R]/@61<C.X9K+(.W,W
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MJ%5%[!2+'MO5L]WU5+?\4A&ZTM2^BF%M-Z#S_*4/4MZ<>LZV:Y71TA*^D3,
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M2>MO3HHLFOLX809>!FDF_G8)<-?M=^#ZH!,]CQ[8U]D]0$6EHQQL63!+^>6
MQ%G2.BZ"45;+5=UP90P<L0E0_ %CF%7]N4:CAH6YFHKTV*='1H;1]E9D%<@X
M10B'>GEC=^'-G4U'FWYG9;C-GY,:M?GX>R^\91A"^L0ZV<TI^,H83;\)@RAU
M%FS_V0MQ/KFG+^ZCT[J\%G@BV<4FF%-CM<V^R2!\M4"//48D!J,T<DWA#)1*
M3'_Y.+6,Y%]Z59NR%'??B[U\-M;#+*2?X99(JO%M_4)\O*/9]$<$5(AS!N3S
M#*Z42 5^NA([['3_T#BPIY?KU\R;_#G1I7NWR:7SFHF4#0I][!3X4R05]3%W
M]QY#'C<.5BK9OG:O26PVFIU?"6D 8WT**/"T1,H]M)&>)I0N-CL)]0]]0Z;]
MM@]!-^_\"S#_8NGND21N55\<GS+WV-FD<:!B0(?\LUV-2#,-NS4+R=:7E3K(
MICQ'W[IBJ&_ECNE?B25QC*_T3K!5O,&G%;@@[MSV0X?AD3-%)>Y665GP)HX
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MU!M '2;EK$+N6'2CB(KPM+*K$:X]_JW\/QMO *A>E5\HL E92>EP?!<K8&5
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MYY.(1O30JQ\2@G[8'+=PS1=X>N.9%?:=4T;!#QU5/1$&^G2_M5&9YZ].(ZB
M]*'-[UAH[C_$P.M_#!+<2AVP0_MZ5B[6;>WQ2U\%3A 1^$,/]5^S\FUV>\AE
M#9P7T"[OF7,;\B 0J1P9@PTW(I6B(33>A6>LM-JYHTO(RH,N 1 FAGT<'"R"
M#?'E:LNJ;/^]K4"Q;Z+N$4D0.'DPC+_O4I8KA8QO(>;IWI7@"+3AZXW'._A4
M#4KU4.!FLAK&K2#[>LN#2X%E&9FE!O#A7;IK"CT#<U06!K<=Q>72R=[M0+WM
M\2[' [:>$<X%Y844&F*\&:04RLF2,7K'J(\H+\;DCAU@MI'U^&=-/H*17]K
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M<;]F7#7LQ3Q=$U8FZA21+(:6)@J#/=L%'(\?:.SI,+XCV]=+Z M?8J>LGC.
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MVR.2-ON^F>4VK^=6C7T@1.PW.,O[MNTFZG!=W" X:#K5JK&RM7OP3*1M_%\
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MAJGR+0IR/+,H0M&?/%5\YR4RJ1#%X@Y:,S5+S)PG]*LHI9'Z+9,;&48*PV=
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M<E%S&$#235][U$.O4E'Q=52_WL (KVN6>'1O/O#[S+&AK\"CR( ;%I :F'&
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M]OG!-UD: +/-(79?[JRQK?&$O\\ 4A7:;*]M;N,_3JI,7,.\0Y&+)K%=-@Y
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M._,B7F *E)3-7@*RI?FPE3"'EE>X7U[-*0>8$H7;T.Q%6B,P.1'>G1'^W29
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M$U]"P1/9C&-=Q+CF\!$[56/XE^9;(?_;1OR/E2A&F8F%,C<7@*0_./VFK:I
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MP#.7N&V_MY:>K!, 0FA->I%11XRA&JOB9J.?VV&2FYX_*8<T9V I<5?5CJ.
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M5C,7MO3@8/5@]DF^Q*+4H[,CPP03^].+Y+ M>,'WKH7'6>:N1?03%,8N0P.
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MF\!4B5K+5E6K$PS<J2M_*]IY4W=IWRP1X+MBW&\T>C"?I:86_Z*K%6U&?U#
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MJ7B[Y4M&M^ Q/(^3!'@JRL1+X7H@^6B$",YH<>P-XK-T/XBQ1FYVTIM]N7I
MC(.'H--=+NC65XFK8 Z;0N;U4^F*PM>^@K)D3A\I9 OY"WF[NOK=W,6ZTKS;
M5*9W\(.6N2W(@!<2]OR50KMLG8BE\!P,%>%EF/$76\M>#]K"3]RB<*=ZTF,F
M*] 89FN*K)9&;-7Z2E1XAQDDP*B&;)[P#?6<JI>S9.1B 5LD7%]M/=3TNI 4
M=?^BPSQQ'7= Q_1HR]C%U2)8P]\,RLWF:$+(^17>3(QVL9>=RER&3JFV>$6M
M"##A:V[?VGA'91/]$N+%HG%1J7N*9!^Z->BX9WI<@Z;?%"V)O7EUR5):J:F3
MVST-WKM,!>,&!>C 2WKT!Z8.,ZY)IIMX]E0I\!W-\2R;DS9>6A]O0_S^K2-\
M:DYZX5GIEI"@JL<,WL=&\E"974#7,3Z:=+/ RYH3E6M23,B_<D_+U4M8N$=P
ME(Z>;67=SV!E[%0SY*[&.FRMRFJ17M$44=+,9D(B Q08(N)'TE]4&(JTA(T^
M$KH,F[.@DTNKI DE"VNP]+5%RDVKT8+8_M7@PS\!(#OWQC.N)37S6-1D+P!<
MM3L2N_)0(D26L5/E=J?DK?M<Y$C!+G\=NW8$3#?. <&2:=^ ]']Y7HU\Z%HL
M5SG[?<0PK+C0X=86ZFD#QBU$LJOK@KU<IENQ<\_17WJXNRH# AL'(<ODBE=.
MZ>G?VNGK*2\5"DLZE 3UL1[+*%2^I_2#&F@L56^'7;+<;N7$D06P2!$D!I7=
M$;M7'T=(Z7X:/[(AFFC@Q]NAB,/:C#)GPZ)IXWP]7@ZGR#T_K[#.C^&1WH1I
MD#B^YY!'&-!D=9L:YEE/%EZ[4_8R)#;Z1<N&_?0(! =>-T&*Z:^[1 Z,!^[K
M3*<A%3Q<X>"1X]3Z<P_#)RC.;/ARO8_[S;%Q]H&J#C10B,']1>&'QX7E^J)T
MDZ$?L\'PB1ZY[39 @1)Q?4:&8$V(BC *-X==J0I'C99IO!';X>!NK*$69^47
M*:W6B@3.;$+H4[33$29FSIQ?S73 C\("R$Y1CV(<=2>6+.;LKD%#>M*3M/>+
ML^I [/%I6R??[QE3;V^.5"$>:L:I"R_*5!I_ BY/)6Q67 N;HR/1L0-Z-[+E
MF5Q9,M8R2NXJ-M=W^XWM.]QN)+^S-JZNE3A;]9!@Q3XR7^@E#[=%79:<^K7V
M5'7AG2RI71UC^!/!Q!UZQW2H19G[6QX 012)O8%^ML&(S?UN-1HCUO^-R^'W
MA.!:_^3GQM^A<8E3<V>.B0B;Z;K4SEZ^^-,?7RPN;1TF1MFX!IFP2]828HFB
M@/.*$_V1ZV^<7V%K]6:)U1<*I,V6*1(17!@=)O*XX8?S<8"6,"/?)XY,6.)^
M#]]/2!;=.S>JET"7U+%,Z2:MXC"$2U,@QI1>.W'# F3LB%8]2WX-HN<S 7?>
M;(-*V"#9/I8#M0 W LXJ:GTX(:MO_%?]C'OM<%\UJ8)G9ZA,Y2\TGLGL:2'.
MF>8[*Q=1C<./'J5DAMT[L7"]H=-+-ZE9/G)I*E*A#N,)'Q4@-<^ 1:TU3>7V
M[*1_-_ZBRY,%S']O\'+0WO175^N#S;7Q=RN(BD$#"QG_3MT%K%'2QJZ+]1*P
M@S^-KFZH'U1_5]$>.ML^4]*8JWH4,V@[9_N,#4?V&D"IAY:>Q5M2R8O%YH5"
M:!V<H$H315&'85@O02V"04MU@*2<\; ?6ZS*K64S?')@YI5Y]TP,.)K <9QJ
MP[D7RA,T09W<PG^0=6C!#=&_T7=$-UA8N9TD?9<$4UHG34)'"S;O"?"?BP^=
MR4!\T6* )%<AJ/W@N^>=CT!8+%;:9PD"%YKQD@%\-YXH3LP(R]3-*$6D-R=R
MIFE$<21^U<N2 <TC7F)"*$.A-:=9 ,H8E A&0=<C(S2FRMD>;Y1(F='3=\Z=
MIV8"2T__:X!&^7]T()I\O(44"AQFV9KM9OHL[!'/EU-[.AGPRI"-^7<S] V#
MY,CC2JJ)B$S<^L>GZ\]HU8IM.UN*Z/+TWKXVI5\(5X-\.Y1+NZ@S2]M;.??_
M$88,-?SV=-U(TE]";(19/3,F.O3K4EG+ X:\Y8TU]U_KRC\$EC_7I/?)&@NG
M/[4<F/0ZO<,Y$&'-,C>LHS"?6<Y"3FY&]U1S(NFI-^-@P&S53;6*0(F:H%=U
MTZXS!43BKS?Z)2DTM>*%M(?TJ2EW?UV0,)D"E]7\*[:1SSAV.'> /@*8^[?8
MS;N>3R@/<M<N]*M[:[R"M-<^#5ZZT_(A[/9O0--$+3^NAO3(S ?H5K-.)K3X
M5*ZQ8"USPGH%S(EB_/A8<R9Y;=,DF>?*0K\!MR4P7QF(+"G 3?>-8XQBIB*J
M[-U:YK\N:76B]"WNF"AFFF1)>SFJQ5_ATCL4.D6UN'KZ!<5ZBAC$)R!$W[%/
M1.-<,)1,B/7@26PEOZ9D:,YHYGASD0_IJ^T,TTLJ!VE2N8R "=FY<(<>FNR?
M &T[CJ2?X!-+R?<&]3]7WJT/BQ6(J2OQ S'@9X:J.4\H;PM_22VC13C-GMPK
M#;27!6N%7.8$3S+<8X)MJHB0'KI?ANAPX@J7;I$M[/H9;=(O;G5#1E]4\V8M
M$34GQ9U(^5'>48;NXLTZU LJ)F']"L2+2^,B?(Q!](X+!D*H=V9BZGY\@M4B
MCCC:$TN8;7CFK(JJBNK"K[BX9O#RV"OY@47,T.X=8':SAUD8<\IM4I7A5225
M4/:1$^AVX3#1%YAE5M95<V9)\TK'@![*,BGU"6F64*735<FNQEFYMX^M#(^5
M^L"/5^3NFL@T9GEYOL<&V>//O,6&RP3XBV1<=L.E#SUN.D:6JS,,S8A'Z1Z7
M?#="-6?-N[.VQ0[)=W81SB@<B*WZ9-D+WEJT5:;U@_I-_YCP:.8B17DS+D_-
MY7FC9K]4N] 3/!8((L3F<LV]DQ(0-!B:%O,.<DSVFSPP>3#9"4/)N!#FS_:P
MX)^\6H@76P;YG1@7UI;K-L$OS0J_+?#3WXX"[X;.C99/4_.QC2: I.H&]$)+
M+_UT[:EC,-(N"A^;N1;ITX<RW\5/#A<TK?A,DU7JA^L475=)P"T<!7P^\+>^
MN+C1X/K1R52OGF>Q)?'^DZ]2[SWY\&EZ[W _==3AY?I:F[,][^UEKIO.GL9?
M!L/>B'(6E,SP%K?*[Y3_K2!W$?GE)\E?.[;U_S*O_V;J^/!Y330D8@ULRA#T
M?U$+6=[B=DK]:@7/7XHS?\U'^M>=UWZ[_NM=L6K1AP1SKWZQY?VA- 1[_[(,
M_(^0DS=R*[Q]$1JC\EX;XZ;W3!-N%00CK[\[:J&"7EQKKLXE8]8S\1C1/[C7
MGLP'/-P_NB+[XHV#U@0?RX6&S:-ZWL2;FG=U,W>86E6 .&B,,B_)381!\ 4X
MC^B+U>Y-5%I(?G ! %^9G,OS&;7:W2_9C*$JGX6$DJW\=#,="'CB2T!37Q0
M#2<UPT_I]+)",[F??ZV'_N3G,;IOBB0/4$N_*?4 ;S'\E3!K)=PM?\WBQ2!G
M^@KV$1T)6G,8[R_[W;B3_IU1ACI7;_R[0MVU$I>\H!"N;E5?6F,[!SC :$;B
M1,#_F&>;R7@W?_QA4P;$Q^B7()E_<B$\2R,2DO-QFR=Q-G51CN4Y\_">I8P
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M5-PG)?[^3 2!K59G?1$1GR[NSH'1>V3IWJ2$Z?SQM!X=_LF(U(;Q28RZ(_G
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MQG>JV!J5LT'U9O4&S_UV\/HZ;?  UQ;.=]*^IF'20$=>;[Q-!W+3!*T\XDC
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MXZM\Y%->C(.N.+<XXB&O"1D:-60],LQ#[Y];8&Q_"4@W+KX*J8L.CMH*YTG
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MX*=Z7X^S8G84=-P:3 U]$:6WX6F($["U#%+&M?&&W-BF&1(^T<$/C^JN<W\
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MP.B-D<]0#_X$*9W4LEV#5!&GPTY9G?<E3.$^5,\[O5]KEZ+6%*LGO1E1^BJ
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M*^C);_N6(4R.);1A(!@BN6PVWH)8N02DL>PR8ZKHQXJCWH4_^= DL/IYHTN
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M">%)P]HAO1D$:*JSZ#1KRL440'U=QN*33Z[+J]L74RJB'Y@"=-WV)4UL8&]
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MOI_J0)DA-Y"J0P/7H]N&[!1OV>* 2[(CD!Y&^JD3F/125ZKE1+*!M^\;)\A
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MG[>8>8XPHNY+N7V'2JQ,'_^.*C?:(=AUCE (S9'PP0'(^N@!PF*637.<I9Z
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M'_!['F)8&;7566O[W(O3OY5VVUU<3^\4^'8FMV&6D"?ZQUE6_RR(OXO"H5A
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MOU-,YB70R??^#2!N2?ZVUW.QKN%5O[Y7\_*&?EF/%6B_"#>3D%\9#?\N1E2
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M85\@'#)OAA16U*9<$;S=K?AUJ1<'+R1E"DB?X@_9L]X :(]'.I(_Y"_3[YW
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M"C$5LA*E:Q)X:4L8X5%*^\*:X&5<S#L>$](EC-/Y2L(6;5EA4K+60G)D(N>
MU)=+W11[BK0@3KK#=8Q$3,:<GZZ.E*P2MA/C9>[GW3C96E \_VIDKO<]R4/&
M4G!QHTA)+CRS/6(%87;M<MD$C:RM$R3*&M:P&[J=$ 4#/MV#L!BUFC0YC%_6
MCHGUY/+$:<16Y'U@^PQ91F["VY.!:];N#():U%E186^!R6\Q.^@Z;D[1WC]7
MYR3=6@P=$KOWGCU)6&I4>5#-M<2E$V&+TL'2G54M\AF9 SNJ%;D=4K*^G'EN
M+U6UQP%RUS)E^"Q-(%)XDSQJ,?[( "I8VSA:;;:_WL\EU7$Q:F?48D\_76E
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MB1373+Q>ZR?1ZZ6FC\2V$#W$VA5/EW!<26LLLI<*9NH\UZPIBY .?VBO\&X
MQK4W@%]O2HZY6F-.> ;B^EQ-BL6(U3L;#RI6+Q$<NA"$9N[U7D[09<Z&]$>"
M41"117W])4<ZDECD[(\:6VU4J.5INY3COE%Z"(BL^0/S#2!FW&I17GS3]J2<
M'Z4[>P-8>3'6.MBVSV2KLEIN[*R4YJ0)L?FRPT[%V8H@D*0I!B.WFT7MBX3G
M@36_Z9]0X\9[D=@Y8RDCABSKQIME\Q=W'@48C(DPU^_<V;*K"N1%+H66PVX
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M1PU=!*28T%0(O8L!$D":@H8B@F "AMZDHX!2 DB5(#TT:1:J=*0(BD!H2I4
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MP".\[?QO[Z.V1R?X[I^QH>%^H\,^&B",UVX>_2+$OY6,O*7Z6;$$B.'#2X/
MZV;Y7CZ2#=%'SX^>+2>?U'IX?\__DAQI//#H[CLH5+B^9N=X4\[::+M?8%*-
M-J]_6)C#I>J'NB]56TIQO&T[3<TN;FKICC<LO.'QT#D.!?:%$^SU:\%WJ[96
MEQOTBB=J3NJR-)W/CM7<*%:1*1))C6@2G")+#'1R\7K@\B^F=O6'8!0KTS__
MT-242TUK]4ULXZD(#WHC*QMNT"*B4G? L].#//)8#.'L4-N*QP@+%6R>XL^
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M)XX9G/I*1R,(H&6EH6.E^=4!X*?X24]S] +\^:*AI3M&?YSA!"/32<H)^#,
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M;>6N!O0N!E:^ENVVW$_V93;1 CUU#1-:!@0@G=19SOO3K9B480>\!_<MZYX
M1[TK4$%6KR*2V+4X%EY]J]VTS C)]Z#+&>4J7Y8^28,:_=JZ*BN];@!8UB9(
MT2(!8NC_LO]]+2G'C'8^58@(U:F(V+GEYZG XAX L'N@@I%H*T;;7'/+5_WB
M,'BLB:_.6CVB_,?U3YC#[$ ?H?=X ,Q<3\7B-V;UC*5DC2([ :[+W*4?[,]7
M$\Z.E^8FHIK6V;A^CE0SSA<-CW\.7;LJ'CDEY*,%(['@PJ/>VZ&2Z('F6O^=
MB>B681IJ?XCGS+QP)S/Q<3]0H4)?MPRGY6D21JSV%&Z0 C]87JRL4-=1/M&'
M'+&VWB^5!RS_C_A!#@P$F/^7_;^:6:BYWD_Q N8V-^]ZXP3\0K6#P:X_\R\
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M:WV<N^WF+ZNI8(4TA@C!'.<[> *T>"RY+T!VX8N#UPI_@ ,?#M&4']-B-F,
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M,7,_.R4N;^E"H N$W1M$H$J:BR&=IN)PKV>X]R:PA_YPA1OBT:<\7@3(=N>
M+^>;X6ECZ3\HYAK+)1NM&IR3MSGO_)((%NRW76[- 1G%?IO/$O5??_88.*0
MS^Y'( 53R9EB/V(/[]%?W]PGLER$WC7QT./INZRA2A29*7 3R6+$5.=^\#(E
MV".=/)49!*LF< @#\)N:;P9@R]8F99"3-A[L;A+"G96I6,@_?@K>$<!N^?#G
M6YPN/VWYLZZY1#FDL_ZZ>6\3V%H:)JSPP?W]F_*9M.I.<Q-CQX8;,)G.^C[F
M5FC$FW%2Z877&#DQN%X3&CUY!@$]]H'#?/1TI[JQ8YQ/WW&#)I\/'-DH_+$L
MP4+TQVUY_C6W<M5;J$$'>2OHG0V",,$6Z(N"9GM#I6H*[P98HMWFG$8<]H>
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MU:!O6[ >S#:@JPO#F<%EMX4?@=A[8<P"T7G+2?^46_FU'+H60A./"F"ZWGG
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M7BK)*T87TNO=(_8@.D?1!'VC@,;ED14S63L%+:\0L_FFC!0:=C <9TQM*<E
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MJ)5,B5P0BYY MW4:XAES;BK9@M^R)WY6066 _A4,(T2%>VQ ?!UP!MC=!@U
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M#5IUO.?O;5U[[DG04XBRO'-LY%[DH^?7K5:IOC=-^9T4^X/5M=)=<SY6:UC
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MP,V@\QWLUS!)FG2##0,M$-Y?&L@[3*W"OJ8YA#^4'M[79$WJT\M[+5/J9-W
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M9+4/'SQ5]+EF>52.[.6UCJ#R=)$YCHZ&/+4A9/G=H:D-4Z[RHYIC/ODI4)I
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M9X0*U3#9Q]O80-)YRR3!L,:=G;]'OK9^#*&[)NQL'(L*? Q]N8)%+F(I""-
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MPX-!$<Q(TY%:MF1WGK<NI7U,LI!+E/[*R'OPM;E05-FY0DE5?*957_Z(M)+
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MWD+R!S=)@R'7!SR6 !%7W\"4S1()D<G2:9L#C\!TSQMH!O0SM*":2"'E#)B
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MDT?%.&NA2S3.@6T5=W8H]+-W&X(D<Z^;-A[H7"B\"CGSC)FO10RF9SM.<)&
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M3?!P<Y-VHGT%CWEI1_\0:;:/'$MK"JB1ZE(0?8&3>C58[V58QG!'QW@8)%I
M8@Q 6TZAK@^ZP<[?&RCF=+O!7KN)LT48U>WR3Y HE+%PUX'*HM?+96;G:W<S
M(96E?"&=7#F(I?#@&0DQ*6N7#NB^MUML4J2[I"_OT>UB6I\1->=+[9J:?]_
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M5V19.[572)5QM+$7@-&B#8(1C,%8B#K[8S-^]-8N\\/7QQGNK6>?T5B8U[>
M$I_C_[[WN#/F.=G];QZRLF5E$P,(%GU7,UA%MKE6-I5^EV[\AB0%3YBH\I]-
MSNV 29?;D\XKO*TCQ;AMN(GTF?X[$L+5C<379_U-7R]^P7(XT^0"-VY4$RM6
M2?\W#B'S5ML&\$\+ E@:*FC'<2]+PK76DV&V1D8->JE=?;:ZJ9FQ;PBM)P40
MQGW*EW"]%M-G7X0%,U^EGEPBI<]O9[5#]#"["]RYE9[\!B^AW><7T:PB6(S!
MKP<ER;S5=P;_$0!J.,[)9$0X4W4:HH!L[8['R[1W[B)_T15D:YE249%L2Z4C
M<F,/$(M_4#^>'U'$:3;_MFNS33A,,VJ4Y;]_&]QV(2KQG&RCUD'!@]X(0"RZ
ML"M29@2=YKNMIV]=RB9\TJJ3Q]G/Q&_09&)PVV=[P^;FB_KQGU]>7*9(+K?&
M7E2!O^X7.F4C6J6YV%YZ0[D.&2$:AC=]G<#=">_\74M&[B&&M">=#%0+CF:[
MG1"DQ,T]RE!G-47=!?&[?&Q^IA20.,?:X]Q)\,'QPCB^8IB#0VF,+*RP((E#
M6I@*;Y?LBS)1C>$X#:^[^YL_^$I37/1L;4-)A8Q@*YNN['B3%O:!3.IY <6B
M]73%VMK?ON/8)S&TH[\GB,=#:\;E(#<G78+1#RA^WF$>MWO=+G5TZ7:WK09K
MMV'>DGJG3RZM$-8"RRN[S#8M?FR.B9!&CGF]\E0 THWM/L<_^DY0.@[QV3?Z
MTZ3K;84H8JBO@W*Y\,K9-@A+7NXGMGI=N%65-RC";_Q]?SQYM(S4^4IA'S+8
M&T,U??"&E O?^F/36L2_ D'(Q-Z9+K'KUX]=L"2^9\Z#C*@D4]2$P6OPU?IF
M.)^ +7'D7@C%M&F%#/LW#AU?'8-<"CNCD%TG,-!>'#"XX:Y];IZ4+2P$W0Y>
M"39?B^-0/.QH;K&\4-M=@CS(ZHF<7%O989)TA"[Y%4U[6FW'[F\0?99RJ^CN
M6@A@TCG.SIA^+A/,H[VBS_8Y12:1A_/7#5[7*M?[.2JW&\V,NN5.?7,@^,LQ
MD&F[4P!4YP'.FVSQNNPUV0S7J'GZ7)\V:*:6:IG ?=J$O]@J0)Y1O1PI9+$8
M@_&(07N?X19$F>?>F4JMV7(Q!K"Y0Q-5FEQ)-A87(Z6/0N<9-2L79Y8#V)VD
M)[GHN_J.$%3Y(_>@6&?<I]].XFVC"KQ(AXD>X(KM%(P6=FO,F.U[)PP^JH!!
MV'!7MR,:TTI5N1'Q*I_P.:-H.[9KX<=L4R[UT<42PV6>AR(K$)]T-KE+5S__
M^\<XI1W;5@N/S'B]]SLKL,?72[QY1@W^;]2?-*FZ:L)?Q_+U$:<&"K GK0!Q
MR('#3_!WE\T5K]3^E-8J'K%7IO5;>SH47UMNBMA^?%NXR.<%4^$>.CP^[^8.
MPI:JD$;B9TPIUE=T6"FVQ0(8K:V9GXP4>*Q7P(&Y:\M7CC41YGX9N+&#--NN
M(^GE-YA6VP!%W'*07U_P5?@;(RJ<7UA<<.;O&;LQB1#<KWNRQ^.FZ0M#*LTB
M%,M#NNUA-=8>'XMM5A-*.-DBZO6:$KZ>5S,$U5D!/39GPF35\SM1F/-)5Z:N
MGG.V8=O9X"/QC:.SQ'N>A7/;1$JD73DU]8Z7$0.A6Q09U.>OSV%2RJ[RDLX)
MLAR5 15WH9-830&9AB%\8R4]5>@(+TD;=::+UJ-%)M!\TX:6*[6J@:;:LO2W
MV:3$0&I]7(>4[SIA+.7$(TK\KF5)_=__,KDV9',N=8$O46*""I[XY>XXG;/A
M]DAW T67_"(NU#*T@?G8++N!W<37L>!/!9(1UX6I,PPA4CTX@26!P9BB:HR,
MJ;&&KAB06@MM"U-B--C_$=74A#'-W4-5]P:7Y4X.SW05)D"WM23ONWF48E02
M#W=82A]^^%)A%]0WH^%DMS8WN++-2VSS^Z/><Z&YWYURY0=HPWU+_*K"JG7=
M[81&VT"[#1_I&22'[ 43I"A.%-\W_BOB*)$2@9U?44 M3UJ& /&:S6Z@1Q;%
M]_M. MY%,W.Y;].%FYN:8J(%S#YCZCEXS2E="!-3,FGM%/F[#JB?2]!V(MK"
M;BJ^CO&,TF?$PR8_F#^K$!TJ&7J@A&D.45W>J7'2)C6J3>[3=[&#O?1S@-HG
MEI>3U:8[QY/-=36 KK;G:+5W+58(6 F#$8&2+6?)YBWWB*UL0>4G6O1?*&-Y
M&VGC Q7?9,3 Z=.<]J#6H0T'">IQ/=!>Z(6@!-??)N![[8_V+@3XG/;2*#&B
M([TN^#F0UKH3;(R+\ML8AJ:DZZ-!+D +BZ5O*)9>;#/S-..Z<HEO70TP3X$#
M6N4RXUV0MIJ]M=K9/Q0EL)FW=99(?7LMR=P?[Y3LAVJJ<_<-L8N>2<HM434H
M4TGL61S&[9YG1]IJI!G.:CHAM/[<PH)HZYFZ"R9.7JWIIPQ%W^=S]$\N%S7X
M(2FC_O-1SOTE22>2IU,"K]YMU5XV7:;@O>N&0]HZ(]OV>W[2D?=/N)W09^%+
M[E_6[VHK5?I9TR3"#!0$3V'MP4GPZQ+2G8HL09>J?:MRB4N @D<D<J.+2="G
M[%L\4'I!!6HZ6E$/8A_Q#K=<ZSBMP]>1/6JFB=#'NALT'$GS?&Z5]@ PI>R&
M*[Q>]Q!LQUR-Y 5B+UUTBRWRM$P2KM)0)I,6'X8 'ZL4JY.XY8:G-OX]#-./
M^:R2J;-8%^->?)?=C\S2Q^-8\4<,J#[17<MM@8-_@P@OT@<MR95N(8[T2WAE
M3D6OHNK?%G!:NUIR=%>K;#]+G!=]^YWI\C3N)VX#U\JZY)>B$6=<^3 >YKE=
M[M4;[A!I4 51Y,]V5(C&<,L;3ME%S2BRHJ]M?PZ3J"UP,M07;4(-HN5@E-[U
M>^@/KI$5TTE[]@WG$8JUC\%674/$WI6. .=,3YD'19PWX1Z[$,ST:$R!?5L.
M(=PK-#?[+GB0(_F/O]"UC@[T&? N_9!'5V4TN8JOR7&["5)\=67+RQ'PG;ZK
M]*K&*6_*CK\=L+M'&"Y9XSX\U$38/O7VFZ?>;.$ @7-^A29]4WR<9?\)9_VF
MJK^QEY@ /&_@F$SHJ5.3!5@.LG\ZA<Z\#+QE[97CLM&'FYM--P,'J6#C'_GW
M^0L @^+W_<; JS'YX.C#A%>#VWFJP09E!/T^ YD$V-64K+T.Z(>B74U^P)K[
MN7)!0>]_:J1D'D)JH\,,EB76*2A'^IM' <0DLN?1N5##6,U/8;$^IHHQGC\-
MSHL<;G=2T&M0'?;_>R# ,>S@1 !"C?@+^<_K=19Z@JE\M&GUPL0T^53/RCWT
MQZ>^!\KM6EIW^JT=R3GI/OL@NZ;;Z;P8O$\_IML2?Y\%]FSZLER#,HR/#!AH
M^'H<I,[2-,)NU'4\$/"OZV)9& %-URY*V<KJZREF,N1+S^1%?,"F+HB.&SBZ
MP.>T%%IRB2!YVHD 6])Z,^/;C$$2\/*,[MRC0FG5\I)FDX)=T@2KS21-F:45
M[JY F,AGVYI[#@=/D(=_3$0($MYU7"V6,\_G!</Z C3B6BK"3]]1NDV)U7?V
M[PWP<9I:%OGE?OJFQB\'?SJIJT0=P\I_[/1<[Z&^E]&B]ZW[%W:2]INZ I&<
M>G(X.]2%=#%KI._*Y!ZRC7!Q2LICMAG1Y%T(>6:\A:[BGL;.HZ;DM$.[M"N'
MHU^U$9X7Y-46N&H9#=,O3B8@"!8'>!."6ULB$!'V\*(<_5WJ]=I1!0ZTH1BA
MG"CZ\AG7@'C/L;O7GRSH87AJ\$M8Z!4^TZMY8N-7=FH@;S8J_SBD=&K.N@^7
MM'2B;%)3%"B?3\GH"B:U:UTS:HHUGF*/A5U]OZLF2"H]M3'NXU3[NEQ%X#YI
MC(C*N$VHCL">[O]<+!S^^6W0XM0Y(W: M\^0MKEPVVJ)<3?:/<W6B $?@,Z7
M],=Z';NU[[1J*[</(!H]H+B2/CZ-#O,92PPEMGV4%YBJY<I>E.O'E;&,C.G1
M^NCPL><C:%5QTM1OWQM#B][GD7:]$M?R=Z^4J;=$7_3+FO@0]C+7&;=!/['C
MKF\V'['IR=]UO0'EZ3J<#GCRV -2 0M<V!2?E86EOT-T(-V@^2XP/,D&V6>L
M_.7=Z.I^_:OH6'")/6UI"QTF ^J 5&96?&2.N> 9*4\/FP/A[S\-2,INH;6U
MR[/YK0Y(.EI:4^N5K1%3+(5C[7=006)%J2%M7,N3^19+T^<W]XC8U4A+E/H#
MHK/V*S?O<56"*_<G_ &.L; ^4VYC[73R#0K$H>3NV9<4U(GW771'URW\RZU7
M_?G=3!E?+3^WT(2/:SMGBFFC_ZM$GD&*[HQF+<%2% 0*_?^R*,!_QPX;W]J\
M"6&;VMWF/)CN!5_K_@#?<SEU>V#HUSOK$UD?^_^(&'E=<-<2@=G^@Y7K$-MJ
MZE(9N->J/:(^1U,MKW<Q<,'>T56G*%,@S0/&#0-$N$"?W1W1&E7OCJO@J79E
MY;KV_O<W0<2A7,(X[?E@G>8(*:.$'% "G6)C=9.+516X*?B1)S!9;*MZEBRH
M]CR/XD@B#@NRI(][%:7?X%,\'6^"_8O>I6^-:79JLIY^VBG[QG;Y<9=7<9+&
MB+YKK?YP1:-58=2>%D'>767;N/+O)A"\2BHKQQJ<N1</SS!GFE:B5H#\_PB$
MW?AG@]'>W7A/%C^,>D+CN9R.D/UD@;K\%A08TW'/F]7>J&,("^VCV:S(,S2$
M\ZG3CH6?9./Z;(%9UU?1@U4@,.< #XKS2"5@R\;KFY)1IV:$SD!B[?VNLIP]
M:V])D8CJJ.6@OM 3>%ILIL$2YHON7;Q\CMZ?99H=>VK*\K&>H2-2GL\$-7H+
MIJ&7VAYV'4'OJ1QW3P%XBOZ@YHXV %FPG$.<ELASX+_Z4-C ,6T51'  H>*P
M+3RBMT<_'X(.?Q2Z7$124)ZU=@<LU]:72#GSQ(3[CFKYE;]JB*)&S].M$:&=
M#[]RORZ@SA^MWU'..;YVESLF8<UW?4(Z+ZUH(V'FQ1(3ZQPDY\N:+AVM$283
M,GZCYU.NG[E!J^T0O5/@YCVLO.&6\BAV'F,;G=5 I0<)?WYB-J+_%?>M2YD)
MD;5?)!;+4 ?-,N#&-$GW7DBQ?_GB)UQJ_YF\JR#%*73@G%SE$/Y-0'D:$Q)&
M3".-(KH:#GI< "2%D("(.L\ #64JV4M#O42^IN,(9R1&QOL>&PZ+=4',VXGF
MXW,W.[EBUXG3C?WB=02YIUU=68+%RQ6JB_VXW7DCQ!5ZUME199(&RL?N'B:C
ME_!T'7AU6MV(&2I:S:]U?"_I@K%4)U5Y;GC\Q-[BV &Y(HA.^L^3=4\.U^L%
M<<FDB37_>U%XUMJ)\[Q9+;M/8#)]\"CS0MQC8K'LZ;NJ1E0QR;DG\.H.F)B-
M1*B?JOMQW&M+9QWB!#KK"SEH3+,WO7;6:]2(?$JN6:V"<!&-%+OG!%4GJ;FS
M-8WQ_E;[>C;F1SA!D%(M__?6]K<C6$9G:-..-0=,2)&G:P"G-7+TDYNSFH^V
M^, XQ2'1_[EG)'BQR$2:<NG+K8]T8Q;,U;OA'%BHB  T;_ 67&?9' -V&U7E
MEH8"5L_";!K4&P,D^7<;SS_(4.#=/*"N$@M!)_G%V;$:PF1SHJLP;6LFJ6)B
MV/KQ^31.S<,M)@Q]788N/5FD7O,O0\DK\!@A!/\A-7TQ;X!,E^CR-1I$YEV3
M[I(":U]6YGP^ 'R;IED=*#^I/K!V@.9TG0\!%([<<PS(+\9@_''*%8U>XD?'
M<.1[[QFT<%<'_S3O@N9-UPZLWN)G PTHYUR+ZPQ-RA+-U84%RXPEU0^<&CU2
MQ5+XY'R#H7NGC2]J"Y/F3L_)Q$9*<$@RTQ7-YS;0BN?CZ5TYV<=#*;MS15;<
M/E\W(G) ,I([4V?,9S768%24BRISTK5##L+),=B$YDA!Z.\R-Z^&9-*LL4SC
M3LTSOV#ONP*=L&LH6>1WILS+H^!\LE[#AF<#;1*VK7#0(8Z_GFUU@^S77A8T
M .RPS!^2[&TIQ*N$"WGEK..K'!*^U_XXE3'Z*C)%-+K]4G&K$!4RV "C?M%<
MUW+3[7NZ@[3&-W0RD'W->/I0VU27*<W,23/<M?Y&W9=7V$;/P?K+KRD@(FFH
M(^Y?<I?AQW8LF3T#OG'R-/NJI*8P97 :NIV?$/IC6 A+4+M^N'!;>"]62(MN
M="L9&9XA;R*F15BN\5(Z 9\-E+>Y"=8[B:*U+$(1H1;SI/4H5!2,XS/,$'.'
MQ&EO>&">&F_.3>LO%*O7[<F(MFQTU^E^#8O+KD>E#%B^+[AN+,(\;<M&S;/1
M!3E%!0V*#*5]!HAN]YY%! 3R!I>5*62<K-V+'R7$)AS:)LZM=@G9X4]^=W.D
MP&4M /@O2@0HO#,=PSU/>6*)6(E=<7N[Y?\<(<)&YKS]YVO3N0OJ9S9V4G3.
MX,_H!V5?A&PYC%R&!#/4&^TWO1=*$<8'>5#GE5YL0TU%\_'U$*E:>09*+I_2
M? FSY=VR.-S U.-_6XC%H\ULOETHZ1MB&:;NT[UR6XZ#NX>J6+$+-3&D=R6#
M?'Y<,JD[J"Q).(R>.0P5+/!(3NDO@]%@OY3WM[QW>T)JK&UTQ6CI DOO3!(9
MW<:"T"U+UP5G"5]OATXBUD(8QDBX<";2\2>5PB,3IULZ@NAV$ZRPP8*AK<!?
MI>G/_0OQ#.^3?U'.%4FBR[UNA3ZM* _\=^T/A!EQA$(]:ZE3VN>3:M[AN4]S
MF>>;*]N:PB+$-^2AO SO.$(\P1S*]0<W^4]W%_Q=:74/6"/ZIQIM/B+:>W0,
M9&"D95T@ )3+E2-=5T)?9ZN&_H1J!;Y)\\+'G6Q*7FQ68@Z2A74@QG7)+A8F
MZ6/X1YK 6PC(I>!7Y/OG !_IRT^5XCP_]G";1]@&V8YMZT"+D'.?/X;SY-/V
MW #&7YP 5?M^69#I%EX6S$_-[#/IG)UGOH2R(L@[DZR $/ML.E4;44^R!61/
MW\WU!Y%19.11IK/;G3CG/HWDA-"3HD4G2NJ 2K_; %DNV##D()_T.LTCEX/,
M(O?IF0L[>67'H%=D8#AGD%ZM.%[*#]',QL2PA0Q@,W+Y%=9* -D'V$0\T*@A
M "">E8O$8V3K(^J5#:C?V,Z(.@@!EUT#"&YCVDA_I1]SKPX7102]L=%;JL*G
MC:VXUQO3TU.YRB&,DZ+>R+L<1<V3%R2P!H6I"]/1C)/M;TA.P#,2I0\#"/V]
M_EY,K[T6<,9($!VA'?F)'D<R;O"_RZ+=E2?:>?SB& (6., !<JZ\,:P!ES!L
MXS'MJL#]]LV>47H,.M8^]C-Z=:KAH8[ZTZWZ&?"4SZTO>QZ=^.OT;KRU"36@
M#YF4MN'F$M.5Q<9\P)+CG,-J(D*"3&$XK$_E2ZE&034GB;$!$>B:?#K88T<K
M6+SV27[QX P^-8VTZ/4GC1T[+$*!TYM3FW &)^#LFRY^F\X^#BI,;<PU4T^R
ML&:(F.<#6L09O" M:L>EJ-1->;]OCFX(7P_N9;_BUW=U+9R 96Z5[V$M1+2P
MC9_C-WX^Y;<_@(W@+MP'3AZ\.8-7;8QW(\5PDZ[A?2KBJ4XO19B:G3]IW'<D
ME3\O\*8U&X[Z*[V'U\TV\%I"NH@C?(K[@N;.%<^CTH A;[ AIV*GHS=DT=O/
MCHW(ZP.IYM]&=%VZI>^VL>WX-U[LX_,(;DG4VI"/6 ";G[H>$FEX"',WS9-T
M<^Q/G'M@YUSR.Q/G]3I9B)11G\X=O-JCQ.0R<6YI9YH(Q23T>T, \*KG#P57
MC1J#5QM.(9*[>,'$ 6Q-RLV,32=((;_PO,]5*MO/X5SAFIW99PK[1QS;6F@Z
M^!HSLB8P9HPU.S-+V\4T=L#K @P^H=#_U#XM60^4"TVKDY@C17 ?]& L"+>,
M:K\T  +9H>2;<^1I3S-(TA3LY'T-"J*@B+;0[W46SP*6B6Q/U[YRV<7M'8<6
M@@>."E(\4(K%2@\ 2YV-\[!<Q+G0_HOHZ&I[SN.XF+5[[,!+M/;P8)KZZ)IF
M?53' A#]$G;U_7\$QE=@X4R-.A!TLCPFZAGOV'E[XZ8[ R2;^VL;&$J AI-^
M:<G0?7B#%B.?W]W>,8YG:N5O\_ UZ=2*Y;FN,TYF6JH2%:0/7@H)M(P'9S2O
M'Z&V:D^_M["Q9TJ&?0:/NH:;@><&2/?U;R#UE]O/O0(R3WT4J,]J9E\HD^ZU
M3#0@N$D%#=+U^A[>8 S_$P1;H= 52@T:3&#9(8. [ :%[\P=")\F=0'_/.YL
M &U\R/<FF.'Q,-D=\76==66Z:PM5KV&UGM' <HG"96Y@_R,0^(.FTO%JP]8(
MK*KSJD,!_?8!(=D6&8 G>G;$W>CO\SPGE(RV##UV6<NC</-$!_2O:TGUV3@#
M/3'?%V\PJ<7S/ZV-'P4IE<*T2@KM:E(BQ4,.=SUZA!G:]"EB].IZMLQ&:1 Z
MQ_IAH#V%AEF/7]QL_]6?3>FXF2T$I<H$DU\S1I4IP&WM8#$E*;H%6/NH?)Y.
M#E [T2 /(I&I8X)F6<]/H."=@"'M5!:LBK_A>3K<^^])U]$[\4",R=^[DJ3N
MRTG6C=*(B?KA$WBF&C4R!IMY B]NBG1^.UR>IO68=>6\84)3VD>VY/P*"U%>
MVJQSN=4Y&<4(2.-TB-_8<MP]J*LPRRX'UD]QGKPY>88>E#-7;T=7R%-Q?E,J
M)@M#+9[08?K$O]7R,)18@V/3FU ?0*V2B\X%$$/GWCTOV9U_B5OM-%C"7K;%
MFLAAL#J_,X-SU.MTUED*;^%'!PU6.!2"T!GZ0?N/:DM"ZNL? ?[9-\'#5B)X
MNRF@;S0X$B<SD_NG&+[I9E=TC]!AO-Q5Z13K9,0@8E*I>2RSGS<DO!*(!W?<
M10=&.MF1&\GW1X7#/*<F5BF>'31N=W"-[@-XR;'42>2!)RSO2Z*GWCVONQ?1
M."WS?^1F=;^Y/HOG9L6/1C4_^8G;#'VQR#RK7=6,Y*O,EO]'(,C[YERL9=MW
MYED-0D ?P=DZ14\56Z8TSRE  H9"=KD<$.3$50FSE\JM'Y_MJ4-('+$"IT^2
M/W-[RM(BB^7F:/_(392<9]DK0 ^R?R0728W>3JB8OL=A6=T R.PA1]U;]5?2
M+^!;%6[Q+A#9IIINUL.N3].,-LQ?3W .O:=[>V_M6)?-VT6LZ[S@=(9-6$^Y
MN\51;VUEAI4\N[E+]$)BC&+TG$(]ID)V/WQK(KW_*X#H'='PGHEZY+N)-MJ3
MG:!RN(LE.TI+O)24NR&;'IQK*[E3$3L_1BJX5$^YWQ'.R]*#0%V_#6_NQ><"
M!_2HK?R8[I;HQ(L!GAZ+!<\M/8G#YJ83%SI>.X>!/__&F4[EVE=:^_TT5-,G
MHO*^FFU>VOU]*ZEQ+V8<NWAEN3+"J?WAT/N"B!S2*.$W;A-;DM@S+UO#$-5#
M!'Y[LY;0^+NG,B]W^AFSP+N_?J;T&^6,+<;[T6FQ404^17HT&>:_PZ]Z0IA\
MN8[VK#%;N%]':M0HZCQ@6P6RS82=H&W2IH\,XW_?]3@<A_UY_$C AC>/<1 I
M$2;_ ':ED<RZN#%BD?%E@50]7H#$RR+"+B<Q P*J8A,5DJ<FN":T;Z1P=N35
MK$ 4Q<E2S!<U_UFVY5S9&9:KEG=Q"[@3,%F1-4@=XC<HUX+8"/4W5QB2"B@_
ML#7643E'H/*9W!,EU7W:NS3'Y"+\#_!#:VQ[JG]UC(-L'U(_/W<V+PW.-#"N
ME;WDC5PT%+T7M@B0$>>& $UI[8P.6.C0)]F&FE?U0@UI]MEZ7R[X1.;&2G7.
MY$.>3.2C,&@#$YT/DG/_ @N-]EGLVC[:+,9L/-+D?W=>^_^I'8G]>_J7.^D&
M\9]++M.]VM<Z_V<ZXL1WXC[S4ZKM<<,EX\S?W[\ZV7S8E'#,(6V96EFKR*&@
M/PFDTX#C;S\^!7W>%[Y1#5-'!)/U_/"RC]3K,IYCPQ\@2NHKYB1+^%7/N+(C
M*&H,RL*_9<JTM[_*BT12&W&=V8J%WGD"7<=VKN!%J0,PE3 +I<<Z#&'=M>_U
MU"&&R+9;3-^_R#)^N+XCAY!RG5:S7/FVM@E6MT)!EL=@M6\A/?<,U0L7- ()
MIU:1;@^8E]Q(V3>46<:5VYZ>WK<E&26EIZ)^\\LCPO@KA'?MD]T&$&-HWD:_
M"PJWT2HU &OTV#*=CF!US'YS,-M^:1,FW#1N<:+D8O&32$_[ WI&[\%IA?8D
MRK/;N@[!3_\L%I(FK:%QSG6.VUO:O&^<MI6YE>JFX^/(W69VQ'Q8ZLW/P]$A
MUN<MPI#5A4)^/ZVM)6KO:X32F_$]_Q$@,"E+^]36BX#J@?'PQN-23YO:ZI/,
M!?:;TB(M$P%?+<6_640<J9&52>B.R<NTQMG1Y,2I&TB[95W2T/,72[E3O(=<
M7T('I]Y9@"[4#^Y=G';!UK[K7($]\_\2XUS;E53OFBP:GRA6Q2N:BN07J+UJ
M& X:IW44:, S:HSI$^\C=C#3*['\'&@HN5PV?3DCBVF_'N?P HH7BPMS2H>F
MYO-"<0?$!/ 9;4=-?D?M*^QK1.A. V"R$M:N(B"ZOB_C'4+T(0YT8JZ_KUP/
M(;@55]4QX)N6Z43P K?960AW#9=RS*@1IZ+[7-='$E<57[O,5NU$NNQE!)]3
MKE^TSB1?W8O5=6V1,J9:E<%T'A/.7PK+W9U1;!LXDDC+[:)Z;T./W2^SV*<^
MXP?WK[B7C*>J-:.76A=C;32[KZR<\TM;^.H4?S&B+D*67_+.:>Y07R1V_LL9
M")CX_+Z/G%8DNF0F2830YQ7N;0CDP<LM(&"[A"Z8J U/R4! I=_:,B8>^!6D
M\3@HB*U1]I*G%@>"#P_.9:Y$;[J?W&[TPJR*SF7<<D-,4HP-[->$MSP[$JQ;
MT[QT<]V4@YR<OH0ND8QESWO=3LYT0,H,,4?J=X=@#ZZG]*C VKQ"5)<?#@:(
MVP)[0R+K+W=#SKHH1D)J.^15J(^")K,QR[R$FY,>4_-W7( 30^H[)72'L!<L
MS:$:;L/-W-!:F0W+:D$*[F^B[P:J23HXS!I2;N0)F"A*Y;/"^1*Y>QZ9WEW
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MYN2W ]TO(AB?[&5<]'B2^),!,:3$N7J?3)YF/EO*=[),>P;VGLE?%SG"Y2R
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MPM^ 7T2:UC6&H*<'/TSM.#QEAT,8B4V(.4M%"-QDZ>@019.$9-37SPB0'EX
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MH@- SZYP$Z>NP-2E_:9"^27;T9FF!$VXPG)M5_>-!\+WY9^F+T@U>&L__(_
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M]0M4;$5JG\FYAQRU'*>SU,F,ZUSDN43@CLOK&, 71RP/_YG3N2++QMLE=6I
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MA]L27A.RGU55K)<VH.)Y&$&3VN#ZF+WL\L--2JJF.H4"/SF293]'16EN ''
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MF<BP6IMC<?_1CK]!'P-(^_%UU67A+<6]ZTU$1:\IW"UN4+28<X(@J]>+5@P
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MT;SS,.&'7?/X6V]_,==]*FU#>U"6O<Y&#]3ALZ^W=/SNMRI[SL7$>(G2NOT
M(TV>M N/R5Z?Y'1)90;V\8K*%??S#6N:4XJ-%TF/94&T8)*@=I2/J#[06JN5
M +EQ)+7.#MP9$G[6TOM.AMI<9M"60_6Q$;MJMZFX(GK8D+_Y3.RF[P[I^-HK
MH/(*Z1T5B^2W#QN,#"LJ+C>&8U4$+J)]@Y;-$^17^J)+5L2:D06>T.L@^052
MZ*5EF-E<U%D4K4A!ZL%5IQ6V?3:0J0'RL5L(<N$3V(<%? #L\QNG0>$T!^BW
M&!5C6$ $.O)(*;D1-"QRH03\:,Z%ZZ?Y#MXVE0\KD\>'S'RCXL*=?S3J-I@Y
M47:LEH7@4YID6/L/2N_$.3.-Z#*P&<S.+93"SEQI1SD9B B40Y P9#$NUCA+
M-0;6G>SNXNYCX&'I8M!@U?40FC0(U77W,U5M\A,X\2./8,-=PDIN.H'U]LG%
MF'G1P^7"VX,_4"!:HK=0(W6.FU7[2-,.LB!Z1V7-%0,T%*8ENH_OF%9SU\2@
M0;AN.7,"O? *.'".1P')-"]Z/@7[Z_II*^/*/U%V[(:M.LY8]_<F*@3F?R2$
MV7/]"J&!=P*^AM,S7L'#057N2,P^&L;4/<#$SRJJTD9O"]$D*W3;<'>C>3^V
MAP5MC33)*N!=_IMVU( @BE"BST6EZ'D?]P=LLSUZ&BT3]S]SF<[-+RP\4?M@
M!!4;,II5-)CL.TQ%7YZ;<9 [#2 9YV"+5T!O,<\L2AA$(79G%DYO<E)T=20?
MUTZ8V@A)@,:2E.8R_?(J*41UL!)J>PEO+*QL@K+O#AZK+ W+&1_33:OEZP[O
M31W90AREX'N&4DT-CF*4'\%UC\.=HT:X2B4I#%+Y6.&C.&)4DZ5=<R%9YP]*
M1]6;NFM^]'YH)+33:-4'W8T&!:0)!#!)/+1CU-*Y3(-XR.+/27EHU*KYA?0P
MI@ RU<]ZTG!,,\?Q.-AS' Y%60I5I74^T7Q? <6,G7CY!7$ IA32)$7(PM,_
M!YBCU>CJWUG[U9I/HEQCBP9L$YWO7AJLR>VUHP33V?=D:E[13?>;OF,N0.M[
M2&>>>[SK"@A^W9>*C:K?+^=N?)8<6,:HU $UTJ/MZZJQZE9 [3%*43KE,39S
MMN9RI;467G$[LR2RF12*U$X &0OMBJ!21Z93[L^TR[G]:*K_P>FA8CW^@LMW
MC5G=O,X1YZG%<5J6L C]$9"HZC+T5H6Q-766\WA1-6LOJ3QX^VQGVJ]DYD_$
M$,GTV+F Z\ZU?,5?0)/!8!!/UL*(=PQG"T]XM^%+V:X-UXX5S3%&DD-\#1XT
M%R)8&30GF\"M/!:L>@:OXN?5H[&MS>!;4YXG[[3Z;M:/?S[_<'\2[C]^L&OZ
MGR_51D8#Z X5]\M-"5,EC2F0ZF*,]F1FFQG@."X7/X.)M&-Y-W2)E6Z^:"RR
MX+2,0TMT<5'5V%=:XM7$9[-MX66%7\BG'5*GJ5J&ITZKOT$[BMVKS$;8C[)P
M83]:CY3"NA[-9N@OTOVT#VSTVT@[;84!+I+V^E?4V8IIC3KSHQL^=DH^92<G
MJT<Q,'OP[C3@+"P@^/&R*]U5!_9 Z*@#:\&&.QO>D&$BUC</2+7[Y3C]X,;>
MF=$PI:OH^EG/:40+@TJ@^9[$RJJ"W XJUF4N5<,:0]">-&B$;5^ +.'W'2*U
M Y?C:X9"PJKHP9/&:M-=T^4V$+MZBW9LP'<A-G%UMJ7G6>"T(H849>VF1^_=
M0R50B;IV GF_R3Y-.B$<<[(,KQE<;4.Q<9S>06XA*[1[43&+?ITXJ1FCBG8
M(U:C>O6$794>BF<OA0(LH4_.<,/]6M;U[6"5[8AK CTXDO=98[ ^W"?<[R@L
MMU2#5-$1NLX#"FA]G,&TY\ .')V.5+!0EK9\7DY/T$O6GX9(@"% M7GD.FB&
M X,;2#_^SP?Q:1S0MI>B[@&1$K54@N?/GWG'H\['='Y8KN$&BK][YYN7.LP?
M_@*/XC[[=QN;"WXU\*3N?S(+QO^WG>;_IU'X/Q:'P\IH[)MKI,\CZ2L73<8=
MO8]/^\S>KO^H9?<^XU7M[RUZSBTU<4KZC^9/,0/ZYZVJ^X'K?U]M-%9_<R(=
MN$?.DKP/WNGYZE3S+==)ZE=J(''JQ($*V_&W@QL:*%.'^Y*V4'[<:OA \@T_
M6;,,081SF%1UX9?\T_5/B9?.N!;>S2SO([AOLU$X][S+./MC\,"#>2/PU"[:
M$]Y!(NE'4B&9 7F/S^:]P>IG?VL*/Q934O&@<4R J*8G+0#FQX**<K@6^5A&
M(%O>G1)DYG8I:I#2H37FW2.OX*KJ5@E'3/C@HG:J@6XX1I6\<,Y$)FX=A"3:
MWLV![ 4CKPG]#]5S"KYQBH5F0QZ/-:I2FE5K%11V1#S@$. [@&*,B89A ,YW
M= [VX3Y>N8=1-+_7&O2EA*,JJ3X$QNQCD*(X[Q+(/#/8,8RL[.CJE7<BPR:U
M>;^V.E?GNE(ZOOX*Z#[G-[E<KY#<P[$*L6,:EH)P:H=)9=W2KBB,CN'Q1/L4
MN"+%S7$J=*%F4)ESG6ME\0P_MX541&-I:%A4T8QU2!-0E00UT)K)A0UV&_I+
M6DQO'B8UR,HPY:G(AK*\Q74]^V8O7'D[2A#<#@2+''ZPMR\7(PLGH+(DAF%]
M>K1+;#Z07TMQG:Z+YQ.M(NC?F\X8ULG4&BM'9&P1E=%RS=; ></+=/3=DM,#
M#N,"/Z(N4YX22QX/4M&@5BQS9)@+Y "F(6)+P]G 10)H7%5>'0O:PLUO$^*E
MM,3S-C]ZZ]\&1R91(+NA!8_6.&3&$*I>;U7$($/.*=7>/&-/;)8UK"SY$UDB
M>G'YXC(GN'<1W5FZ)KD>3U%NOP6?"AIW8)/0>,PCC7"-R9%^E;P"=*=\8LOO
MP8S-VJX 5.RD<L2T0R8!7&!B#[<QJ>CH$-T].S_+WD$EO(C:I<YJ//NJO<%
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MW(+44&8XY@^7S3KB/6H' 9EH _H?M"&<[6$730[F41&0H7<SUHCZ'ZSVY2K
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M[/GHUQG&&8PKN<$,A';_3:"8FH>]3C=6OB#:WE/7#0G@7L^>8YP6XJSPS<]
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ME;V5V@+0?] -HWT(D*+YJ39!1NH0E;VD5G?T7TGU0LMA2RRD>?UAIJX3F=Q
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MS?) #"RKL+RA.\[(&?'5NY'I4'<V<O?(7G]?"3<W-[7C*EW-+>(*<#49;MK
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M<:+KT16I0]KU@$^)_WAD994N#E?S"GHY,^XI^--;F<CIV/@[NXF]A6NKOX;
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MBBZPQ8F,*E29OW%:'Z6P_5ZH-&*V>4B\?21<+?/'-JK>,O#Q/8'0S<1;;KR
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MA"+GT*\H:=6= 5[E,Y_B$EDX:I@ZP-;G%S)J! 6S--V:SG#F8^'F*XUF_:2
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M%I>%/4>\J)8/+S^_N(RON''^WKO7+5.TUS_$R^J./BDF4X$;GCS\YP0F2V$
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MK0KN':M/Y)C@)+LVU"A\;(#2O_7<^$0 *ON@_8&WI([X??B3]YPW&K>7-*4
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MH6QW&$"]?P9?XU0VOK$L*S"#GT4N(%3P/_WI%9=TMO"]\=J=.%[ZH&>/TBC
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M*EO'<[XR,[.Y&/&%'CSU*I#C3%YA!()LAW5ZU:ZM.&LCZIC.I=2-?95P&P.
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MR'BL,6@"U1,HJV&!+JN>+N[':WZ13FGJI#8<#2#VO].OPQ6GW8W0([I)YWF
M#6[X;]A_N[B"!!QIK]>K/3S1BAA.S ?J%\$U<:CI<RW-G)I*C.<,\=4;:2DF
M62%H*$_NK4#7MT _2<"3@-DR$_K@X*Q_BN425G6PSU,RLJ+BV\XY)\=+@,FM
M^/"LDWRR"%D=+7W):B@X(A#2BU#X,N!5Y&4]$T/'RTF["&_?+[+Y]JK&)<\\
MH/SD&!KUVAE!>VOBA:%F/$([]2NV+KPR%!N0B!/O]S7\!>^8=0]?HIJ$%(\
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M8<=/<&EP3'+Q:G!-;KB?3]L6C^K5'U0Y;V/@>?@)K&%IB.D-36! + X1'S)
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MU0TIPI\P7HBQ-^*F%QZ?*%AE1(]N0'@%)D:0\#-1Y")44O GWTV"R+_'PK1
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M&L$C,\5AEH7H=3Q>48*775@R=7=2=4*3!5<J2A".""KE43UDH2LK!WZ,&I'
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MZ&(J<ET"-987&.%Z:MQ]QH8HVCCAI9/+I"55;% 7/9)TU8^C=<"/P6I!N!X
MOFMLR$+AOO<[!,EG:"X"\NDK9>8%L-()WT&VPSC/GGBFA.F98#G"U\A._23[
M6#7S']4T>P/JA,>O38Q,F?MK2*)M2!^/I'E$@=[^G(P(35W"A^ID,WW/"9N,
M63R^0NHQ)8^UV>82*G%O<3X#)['N5PC(5] U,T9Q <?1\LT7:L<MX":;Z<?
MN^Y<5(K>:RX,9F^VEIA+2S9+[S<&J)[%-!JP?$S8%^EHHC5.^*J+H7Q_8[/L
ME\:G"E\HVAV$;^N Y?!3FX!AVZY]WXR']Q%4X%["^[B"I>4_R23RF?]!TF-T
M5O+Z;<2@XA ;L6/_1X-/^F7,BQ+>5669;>5=OQKE_RU[;LSRT%?>]9[Y.T\Z
ML2_6&.?HZA*)7NI<')U 6D]D@(]%2A[$N%R5#E,Q/6_=_DFR\NY ^_H\G!X+
MFI3OT>(0.%ZVVA$2_WV7#' #Z>U*!.YR$]6)=1M[*,1;AH:)CY%G1_TJPPG
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MS*#'%H6*HR<B&B^EQ2 TU)R]UCHO.LM*D#MK-*FPL$@212+&+IUH__<:+7T
M7ZLOC,RYFEFZF.C@S2VM^#2$+?U<DKS3[G5W@ D&^Q9T7)U"&M' )RZQ\@T
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MXE6E)ZL[<]J %..6J_TE0\XJSYXX9<G9O@ 4FNB.;I]QLH96I8!='KR!V3N
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MN-1U1D)"\128O7R#7/?1D)[<DFAZ%FPS$6J1]*V@BN+#^3PY?8C[^+[T3,$
M;H 3.:^0WGAZV1:P[>NKDQ,^E=2TI.,1!FP#$/WU,=M,7NP.5- -PXQ^)(\K
MN#:-Z1%^(1 #78S)J!OM>B Y7NI+X#+F3CX"3/N8.0R)6" 6/+H",>$A8P!S
M?N136!>B/4A"C]7D^DX':H^KQV6<$X,7=MB$?C="#B6:?'*!8AV'"Y)TQ]1?
M.9!&AZRBF6"3B7:X)"W3MP41VN4/##-!2/3+T>0-.S*'YBZ9<.Z0G"2CA5K
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M8Q.!FOB6#TD1T$2-,(C[:!AL5-5_XSO#HJO05A9E#)@,)*3HG+#>D#=* >R
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MQ?A 55"-3:)&1[.;SB:Q[WGBOZ4,@\B)G?; I)+\*7VGS5&_)K-(-NY"+*D
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MP:6>$K6$Z5-SK@K"W&X+?CYZ #O*C_89%P9SM(H!IXBI&)0&7* R'#1C04#
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M97VE*-?+\U9G<0E&KYMA^@0O77+B3$ZSZ:6L2AM!^0?'@FCQ5;@"WY:B) O
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M0%S&8F^^CX_A"_KGX+B2AXI_M?P6P"SJGN GND#-A31W#YO36)T.:^E*>1]
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MFG/P4^R]0N3\9")$9J72P8',&9ASY!,W8*W&7-2>"7K;2NM!_<O]S&LFA[X
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M919]Q$?+:.^>=#SSX.ME'#4H;'ZA^3S;:G'\@YAH*.\P[0R:IYQCIT%^T%T
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M[6"D-2A0%Q@S C$)[?[->OU1 T?!XEP!TYN!/%0^T,8+N.L8%)\:Z)I44K-
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MX%\9S?#VZU#+.JW \H)*7<\V773(LCJ_B:ZSBC1-7_$+]-_\/I MK(5J0.&
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M8^!!(K-,UH)TZ= Y$6,74*NB@U5G78J(V5F>U4Z5AM?MXGIK]%)"C7)^(C-
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MO$A)0 K(U-.KPI8.#?$-7'(88+ Z[3Y>-7.(<@E# BKTR>D3N'^]B^-/E(M
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M[A_WN6?/S)Z9_9\[]_YGSSZ_R^?E>7I5]Q>J:E6]7ZVO2M0X:@YP1U%601:
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M%32.);(6M!YPN^W#% ':J5=)[+&J1!T*(.49E[+J<%6WU6=];' U^U;T^#(
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ML;%\L#@BP&.'AL[#GDMS$*?FFNHS?(PDKXC0SZI)7$?J/W](5AO%0YB:_Q!
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MZ+CK@P^1)5!UL$YK%N0%6L-V)&(1]R(H[-/ -R2D.T2P9@I2Z<:4.XY=-U
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M/AV!#6$*NWXF(0I@RW,@WI$H;M6U2%4QF^4C\0<^ O]:(XT4THK#]E0RBE"
MKQ*9//7P0 R"XP*\5'W7Y#/#U8 <V]%_:_O_SI3.W4-:\6\/'#A#0J#O+C<Z
MM^$TV@FT=D''*$"^!%_86/J_<Q?+!8<O]H*;S^/?^XED/N:VMX#QXFDG61YR
M)'L;+DIP-*2_% [%*:$=7QN%F36+RKR])P\/ #^<AJ(E>QN/F/W[C,9_7V&K
MM/=@>ROU^&D4U^,SUO@1CN^<;&YO8Y?39, (KA5YO^WXGZR;)1+0*B]T*WO^
MF#VI?$7L_=*V=,[@Y8*;9T8PMW:?0X,_<#;Y5R:V@R+VZPG4!U;I)RZ1*>\N
M]B8YY[B @-L.3,NW['K"-UD$_L-,^Y=JR>S48+(]E7RW+2V]) 0:^LJ*+)Y)
M-(,+J= GGA'14/G]WYO--!+)+?83>CFJ#TPVUSQ!W[_YIDM Q_XCC?,R+M+]
MNYL:%@UMUN+XPA,4X(V)O)@6+@H _O&[G#]7&RG-^7/H#IF-KHS:;VVM#KL+
MU>MMK?#F%\A1+CICU-".C/SK+TZH/5NYSUA.THZ.K%" +'5=,\/?WOCCW^W\
MC\:;(,P8 '6,KQ8I_-BS*3QKB@P-G[R5WH_.3XWLP8_5IG8_#10@)L ;!3#1
M"3C7)O$0^+L[_/]LJ>HG_L^!UG\ZUG,]?ABO.FPEQ?9.CG5/";V(DZ4K"_CJ
M_/PJ<LG;Q-01ZI]&Y>%<(;RX9F2#]@H3G0"3]NA&45#*V^<V-C>J7.,)9>^R
MS))D6EDXFK3J=;F=906H-DV5 8EU+',2_&2'+Y6Y0[@YB^N$'!VS_6'C_I7N
M]%M0P_;*NOK7Q5A45?U^NKEC-+^-D?]^8>LG_F\#Z[>U_K,9_GMA*K<0>E\
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M^?6>?.E0GQ>O@,0ZLO/ZB,.3> 3)5(U/QYAM6@UA>SW<%Y=Z-%RG$9ZZWKL
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MZG.XHVESHH;':+.@_* ?LZAVZS5/5?^,IF$*<7UB)40OQ'>R<<&]U);U'.G
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MAYIY&T=0.Z%C.>F6O6&J:,!H*/X.A'3&S-Y@-5$&+86_:-CN&-\S(=SB? _
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MO1WD;\F\_"(\BG;NAM'@2!YL*G"5XTO)PB/@.BC+57#B55LGA9QE,3'LP.Q
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M_7,21?CXRP0O\GR4BKWN5JD[7?>G\L.MU&B94(&@)OZ/MX "54R0CO!WXQO
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M\8 1GA^8VYI(,M*[$CB=?7M:&YEZ;XW13'K-P;0C/^\R!#,]RK7EL]8A7;.
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M&AV.OL="1&75L->0]-9-RN]H*N7? +FX9?[LYE.=DF^-@:?T$8(.*Z[JHKQ
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M6A.#OK'C3(C&(G,*GLF[:?K:VK17+5;!+$RG$\Z]UJB:&WH^I-51N0;T71!
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MQUP&H(OU0OUQ@,@L!8_]I:<,/IGRH1K=0D6H.H-D,9*0#^?W+!5X4=OK6EB
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MF;[;%R<SX\<#WA<;<]GA8U/1* TU\8NI8H5&%>F(U7BCN@\W.L'B+L,/HA7
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M&L(9$31R4]_RE6,7]!WX$C#5T,6&)8@C.?Y-G):!^VJ'5&*49\"%J7_Z/IF
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MDITA&7^>IE#06@+5<U]M] 25)118O)00IJ4Y.&[W7M:DKU/(CR'!HT2E\N
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M:")_!* E\0Z*XN>4'3"$#IFW66.PM/%[<M09) :V\"O:H% .+N7#K0%;AC<
M>B56!"-S'F%?[_'8+ ?4R6:-<VOL\#_T^,M4L&NW2J118)A-3I\TH(67;4RR
MBV$:2B/^Y>*56&JN6F3=35.86,\J1VC_]H&.XN7H]Q]X$7/"6^2$:J'Q?9N5
MO%V>\K.<-<$F7_H*'WQI _9X42T[,]5A]]2>,WKT1!OGGTKT;H(V"N_AG.CI
MR"E>W53W7?^T^4Q3I!:T$/(,]N2S6MLN9>NWB>=1=1L5FS)#?Z&!]FH4D#?&
MO:BOU4W5]A 6E#]2)\AN<'G?EL$#UKD<!9DD:5%V!3$Y1!LB!UPDNFOVVHQ-
M$!GCZ)?Y 1L)$OJ45$2'(CFFNW&I \I71DB1>_7,;A_K)4(5)Q5E.*"(1;L;
MCZH95,F-V 6E3EB=7;CR\+&OH/N*&A>F E6N:D9Q%)X#?NBO[DT//VO](D&M
M82<J>$A=5!Y_F#MB-^#,1>W!R_<WPF5QGW^+4' 0;GG,9O#KYW#I'/-TE*6B
MH>6K^+DBSY%J48I'/)%PP22^3;UBJ;OW'5X@G$'L46ULL#1AV6Z33Y8X8E,L
M>P+OL3R7<AI&G"2_:GU(2\D[W@UB0.))$4NS=/<3U"\.838#:-K/:XD)"9"5
M-'WF$9H!3"'*KC,X2LB>VV]C$%EAD/K;@#F:!TE>I&0C920,LB19%0?3AW[%
MIYF@S&4(%#K=A4%F9G_P@#ZWK%'>\6D@S:89,KO<!8L<CG%&F 'XTP@^VDQ!
M3S]8-PW=?\S*-#$WV0R+=F=9^CZYR, HQ\WY.:=:!#)7_7M))IZ0K*,"5$'4
MA)<FR 9MUL_)73PH*ZND+!I+K"7Z>U_L&<B#X:%>+$L!B/%1,Y6RH!&E]N (
M-\ZF%DW.T<C 0?/MI7Y29SW-<;LMR]Q112-#L4&IM;%2!V:7FC!QV5JJZG]U
M4+*I8S73OMK1<&\SU*(C*JF6^\-H9Z%OSXAR28P_B,QMYJ.V:\RV84D@8%W[
MS8M3B_)SZV*P!UNW8,6."G9K$<"C#*K:M\L6)]1 F5)(6H2<_!.41!Z*D@S-
M9(ZN]RTLT!&[9H>[*;,OE0_,#7,1$]DUX[+8GL1J4!Y*&V-.^N.HG161-<M$
M DT=07>C5/X56#270\=&NJ6!,L\I$ZN>XV*@4GUG27T GOK]N),0C#F.?S=N
M@SA'?/R)FKDCDF!"X5[F#IR+.SV>1'@Y3P0FT!RE02<E"&TL=L6O5J5ZMNNN
M#N,9Z^A*WV,GV[GG-%DB/:HH0D,&E.\T C15L]-BK+4'W2JX0U-%2"P:EVA0
MBM4Z&ZXI^*5&><M%3+\[;G#JQIRF!E74?,I$GG0YU,)]A^;P.3AO[LO2L#?R
M,V,OO!Y3[S]J#-'!L-/5O$?G.Z4#ZA(FT\:)-U^&K*BS+YL]_(YW+@2VA&Q<
MK7767RAZ2#JN0L"?(ZB:L0 N8:2?H. !<:ZY[H#)66N[OD7/L$64-7%E"5[Q
M.OU3E!HG$6*%3SW7<(DKZE.*)+[-O"<2DDW,..*^W3="#1@1XEZ)CC[QNB(V
M2TL0JA\X1$(=F-92Q'J)+74^IL7&BZN5C5CB<?ES.WABZO:_O,*;.;*(S0Z?
ME:AN! _7O'$!U$];^9E_GZ^P.CX^VR P7Y-04'BCA<+GC&DP=@)SQ3G7T["^
M,GW>6SI4\_YC>2R/R:Z'PZ54<"Y%,=/?TDD-S ,B05=HH0&>PKK[Q2Q[.,UY
M-JNY#2M58'R[H&>I(.D"SE7^4\T!:<BY6N*YOGR%>X*GPZYAFL?+HB1YAS/Q
M*_#.-KY>4MB-\J$C5CY=K?#7Z=F?-"&K\>V)!G8'*L00742F>_P)!NXS'D@#
M4W9S0D%V32:D6#K=)I,>XN&HP)RV#0B:*+%IG."\ \F/\SQ($'^=Q>V82J;F
M6?-1G\*]O!"J;WPEZ\HYD[-4.=HG:'#8S'S^39W[_AXA*U.6J5PY!BC^01*-
M*UB&4X +*O<KDFAY04O&8?.)7MIRE<GG@DD!ER?=3*7B2V&,IF+%@4VY4"E%
M%M+K";B3?2:-H-1\<^I3)"MHX@E]XEBO[:&?DI,5E&F3HF(LC?LY+L\028#M
M6FG#!N#OB5WVN?@-D ;4>&W85W*)4YDQ;^EV.C@1!BN4 NQ-,!,J]GG*/A/F
M.;U."F=4MIJB@MH0W5#(TP**Y=BSZG6$(UB#&N\M((?Z6<"U%QGR8NNC)I,-
MVK5,S(>HX7&2IQ]S,[.%WZG,#.L=$L!*6:7H/]-1N@A<<0R^>I/%?O2DBKW4
M%EY*#)C'>0,4<!IKWD<+[S#\;P).X$?[$<8F)/[U#> -+$M1W8HZX.GKIV$A
M44:68,%/K4V<@U$-0#T5;2M]HB4ZH37J-+.5>:@[9I8Q&PE2W@?9"C"-FD'B
M:8VNR?UT$#N#U<Q3$BKY_0*!^/>+M-RM@+!Y#V*--NZ(FX<F^: AZ\*=P,H<
M5P&G)#72XV!7J]7$?WRVEX&0XE'37=5^B=W0$C]92TIO:R*\Z96H+EHM[ A3
M23HC,#UM)2@O.YQGPN0=V6U+)3E,MA/+>BGCH<;UG?\0=TV2(_[3/[XGY)=5
M;36E;P5$Y)R;H_+<[$K5''CGR:PH9([2*'E>F*Q#CO:EP,_FJ3>]] 5;K\''
MG2P.CM&OF5D(I+[:X-\/2FYR%;^H40ASP).K6@MDYK BOM+D&=C FKH=UPYH
M,Q#^ZZ=\],IPJ5A:%OAW;[$X4V;;^F?J(QP$6N>FI^.+<]%0WP))K[#5JJ9%
M"*:,K(UYQ$69X2V&B;X!V*5>@M<?H6GE@X[WYH09K>']V/BKZQQSK=$+>B$1
M=G;=[W#CHJ>!D#< 6"]/*,<S>O,\S%?#!9>VE%_&CC\?811-V^R57I'?GG./
M\^#Q#?"<4(,6,+_S!G@D:5"-4M".&!J2/2_H\#*O@='U/&KF;AK07MY^@DD,
M% 0XV$#KDF,D"1D02.)_6G;:Q(=R.D1P+?5]:)U+!=L0*\P$,Y75_-QQ0X4@
MU0T[Q>R3\FO41!!7-SAMUF##@*(SMZ@<#W8?/J76M[A)@\C7T+QWZO9?$@29
MHB8;C(AAT=I-TQPO =I>>S_-UN4:/K:Q30#4:3Q7LV0UDV3W[399T(2Q?#U:
MIRDP6+;CI,*%5\PP4#K98YXT/T;YTWH&?WEOJ&,U#UQ\M /%.B!^+7R9Y5F1
M(1H:L)7:W+)Y[VOF8Z>D^CK5UA2E#6J^SE+NUR+$6,EQ?68:<S-ZP#!\ \SW
M 1]Q*F+4TEH/&/[1O9*J&P-:IPWA,#;/J#EJOKL_3.*(5_2TJ$&\C-A/+?<K
M+8.$59A46Y:1KB_2"EYE8V6ZTNN''YJDO*7#@_/)VR"EY(82]D=.,EM?@ODD
M^K,>Z@ZFVSU42FG>[^]1'2B_TD';CQ6GSQH,)-'1Z75M,U>HK8K*WP!8.W?X
M6\D=_;33LG2EODJS89&7GWI;JW/82!N!B(GT/$@"0T)&!8;"Q+VPVF)QVRW0
M;-7%''$?DP=>]5?MH+9'[F>T:E^KQB?R*(YL@^7VW,^$U\?A"0&RM:6Z0]M=
MH9J/KL)"E85K()7])./4QOANRZNX$C[ZP7);AN^5I4"8Q"NVD9'?\OK[B3OM
MCN_H"1"R-P#/&R"(Q6O,(P#_?)/OI3K$+&"R7LZ\/L:2RA]Y&_BT0^[&^5<S
M8>EE=+^CC:SFPEF.IQ[X4:XLWX?^E,IK,N9,A)J9;?USBYWXEE&4_2UVO=Z1
M\Z)8[%.VK0DNSWR^0;YQ(%E+=?8F5LYC9^0V*1\7.LULEEB,-_Q?$7;8?,:J
M[H2Y&PMX1@GCDDTJ=@ M<2'J5W)VBT(#ZL(-$$^./+:3J'=KR"26TX]O0]=0
MNK)I7"V&C/]YV*]N%OQ_@[#=_X2P+:VMC@#O!:.<SX5IRYQ#FC:E<1@J5T[B
MC?P;H#O4VE=DUJTR'M,SH.\1J[1,M'3$ZO=*<?%(A03%ZX7:/$VZ\$G0H<HN
M="]W>:W?",UF_;U=0P2+&YA)=X8CNQQ12\5P<? ()P[=/&6;:)S/-&I<3Z\+
MQ=<T6F+:@?7TI'CF] ^)<QUS+3L#VH+P5[CAZW/MU@^5VT8XMA\>+8 UQ]@"
M8S'9A^Z%]Q:\&VA^2?] K 4];1"4>Y(\6U=OBI*+YRW&T)3X7S!F!%?291UZ
MIW?2V#ZV&PK/@)/5VY\$&T:=Q>$R8ZR&*T11%7D$;LJ%F,4)UDI!L*1%D1"=
M6AFEFHQ\9)0#-.R_=9UT;X AZ;FNXXHWP &Z 79XU:>!=4S*J91DMV*;1$3&
M;W_?95L_PUD(7Q!SR835.4="K>^4N7NM?#_^<7LYBZ6M0A'O\O2$S#<](S<#
M?]TYD1.,5!F8Z5I_J#,87*W["" ?!<(P;=9AN92P4\R9GT(0:^=6[[@@4X01
MAV[<@2K/$-DWP"^\'J'/3:A40.U9S(;.@?V3,@^$QP3_PM+BMM0BCQ.I#3D=
MA\^7Y'&[TT#5F<^IG1!;$@562Y>D99&A@=U'C"=-UZRN?H\9S//D+9ID@<^+
M@U3D%YAM 6RZ1EB6K3/^9)[IXE#6O<8YE;FKE1Y*&1+,%C11%!@7\+[?L<ZS
MK=])>FIHB]2<])VF9D?*>REER2-K@UINJZ(F6&B1OJTN>?BS'&O&DG]M 'U=
M>Y.GO,3N#M./*_;ZVQ.I8AM8A3 N3'5MOE<('=I ?TH9:GCT")U:K*:A N9\
MF2Z=CC%I?K$1QC]0MB).C[CUR2[;R[3?^MW<FKBC$,YK;H^_\;B?)&A;! .7
MP4*4YDYO<^ET9Z8E9O)C-WU\FK1#[)[R&;H'X3JN_ [US#3NS>.1]&&]RIW_
M0A;0WRH)]BDTHI*B3I^KL\ +%G<PGU!&H8L)YM-P""5VG'JE]0Q1R$F3T^./
MT/X]L*M31/0L,N9B^+'Y<C[:3=RTU#-:0[7,4*:X*T/J/4+E>\5OGH<OM@Z;
M',DCVWY^9_9C*Q#Y',$>YU=K7$EN>X&<QRSJJ@R)U2(4=5C!EE[;G0_Z_G15
MPFE3?2.<*C6YJ^M^_!6?YGZ<?=<F-<QX<P)OK9_\KE+QKFXT.IY-\E51> 5E
MF8[4=I0)REGS0.%/\@;XG0(<MRF7H*V2-UOR$%CJB-[D7"T.#WQ6\_*#G["S
M'V'ZODI2D82R)5)#6J,/,R\> _MR7;KGVK,+/'TWY5GID4&XI,)7AXFE]SE_
M-,(3,'(I>_EMJ]8M2F,<CHX;KY"+^KC72OZ)6HCQ BM]V[Q1VNT+_TE6>-I7
M:BH*WN?PE]NXV;VD?FK<=M6!J<$8C:E_*:8'D2RL@U]?IIWW0EP.ZH#?[U-N
MD!U/TVP>XY(D?![_=!1)G?5;HC%WM%R(X@U@!I.2G_*E_W,(K3B?L9>E]RJF
M\)L;XAGWPX*/8S-0^KNJU4=&T]HV=;O7/L,AERV%20/]$[B($(GMK^2_-HL=
M<<O32:AKS><?!%K,KLSFS+-3W")G ]%1A-*5RF_G(SKI!J )R&R=X\/2?'(5
MKVQCOZTA8[@S2E)3VQ$J?W,"ENZJ? FMCZ6ZI%[\^\PT<W[Z[%:LW>OG0@J:
M9DM#3/WE3!I^3L\CB&(D.W&Y5EN^YEFC6]<ZXT!7'Z(*' [664P2X(=KD.GN
MWHZ;%>[EL.JDM;IL377+G0TZ0I6LZB+"\-SO(T)Y%=,B?V2K>)T"+@B:;@5$
MVPMPM)KQ":<[E*\NE += =^J&!5GB0[0/_+>50'##%EFGQ6J5SP]C%KXTH ^
M=K0WS8!4"G=AI<NJFECA*_9#\CO4\#> >%(^[,L;@.;#^FO'[AM@TI8CG6:,
M!%A?Z[ Y:NM%%R7PD3DHZ75)Z4\ZB==4<DB\8?@K@O8; /WFIOERM_U>]@/F
M-]XOEKC8K50DY&4FI1=58]S:#MBP%TX-:G3;.TN(:G:$,:S\<P=YG[<L3%CA
M<JTL&_[HCY2MV;^?N!2O)+C3,*I7./6;Z1:V>4,(RZ6<?;%'(2R/!\HYQW&3
M)*&6(YO#,^$+7W11WOYOU@5A]&?VS0WIYH[Q8F>48<?%!=1'+J'R![V+M11?
MNXL]B(P\T4V',4$C,--N3YCM;B?Y#0!7[;"E6=T*B;O]^.L-4*3[N_X77+?V
MJUJ\W7+\MMC::M#)[LI4&RS\)7LSEOO[14+SM";/O9&BAJ;,+E42*O7VE2"*
MJ(%PKX)<'QF]@I+4)?;2^8W.B7YDM4JV;3"@+[SSG:!+-U6QU!981^AC8R[(
MTT.F3@=4KU,R8T]Y39T:217LGPE1](2O[R2 A?2O,<PY5-_J#9VY+M@9P-&7
MA:EJ 9  >('^P(CR $PH@Z_FSUU_@A6)"@DPC.],A&(6K)._^LQ.OQ%T'!>P
M =^L9T=[MJ\?+:4]O";CR-)(ONFW[.AT8.VJH&J'IU\WLS&1:?MM$,"S K?C
M3T5U66/C1PR1O=PKWIXLN,FXF2H7D8+;2Y0-Y,=UA!QME7=JRNH/_KW$'$]V
MNE3K[23.J;ECC=U=,IX8G@A45"J@Q-^?G/'GF^FD.GRE:W.UDUU7BM+D*AG#
M3M[%^L@O^6[@VZ<.K[O,TG7/MKXAJV3QN^,'@]%DKEE69P@UPGS>;*N ]78
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M)YU+V<D._;!+<&242BO[HXJ+357G3RE&GR@3UF7Y= 1;$FY3Q51JR<&GWC<
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MV\!XM6;B/F_0KGVUIA._U[9C8HC]0X?HN=X:%2RH$I:LH,"E_;.J2N-Y('B
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MIY*B_DE$BH66.$@1%]8&A.D1STR)<9)^$9_9B_Y$UU&W3D'5*0X'_-LL,*4
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M[=$!=5?T;.EOX]^O^\6>U7S2]:19-&F23[1#A ?%%D0*<S<RZ&-S)<!_JA6
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M0H40NKB!)#'"$V4Y[T>-Q@C".*%]ISR;HB^I.(PZZ64LVKE<OZ/MU7=!A)6
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MU6>AF9-V ]/-EG..V_:."#G\/-,'W[-N.GMG]\3IYJ),>Y(:#=.D0O!1EMM
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M?>]6@XIQE/5WC@6(T/?FDF[%1 QO.ZUK[HA[>N.O-AV:]2W8V*S&1CY4NU*
M2Q@$$O2MS'NLJ6,B]/;K]W;;RM7GM7ZY:QF<\$67;K<[VC^^:,EZ7A#4&^Y>
M/<GAI!.F]F+)1_MJ*><Z,A/  ,_[I310QP-KZCEH)[V[XM3^;[4Y5U:9V)^.
M]@XB%0UB/^!EE[L@G5:LEOYB63+"X/Z"\ Y_=]L\$ 1D!(;.=*Q*NJ-(3[*5
MXU)@/"\1Z^&=ZUG@':SS<31.E5/DF*:X(O$08/3"P!X1N ]90QJ6AY4N\MMO
M!@P[N%>MOB>,V;54NY&%#28,AB2?8S]P#KX)0IB:G A.U-9XH?V^MZ:Q!Q^?
M8X;].3J%\W4:,H9?]TZ_G;^27'&K7%TM6E^)A!9'HRBN$/391-TQ* CI@JK2
M/_-\.8IB+)F_S^,=FDPQ3&1H$$]B\3E%X#EYJ"G:&S.WI?63SU,.;UKF*%B%
MT6MJ56GX1"2I.NN$U@ZSQF@DN2MH%A TR+V:>]L4X9.5ZO):69 F_1,&NIM_
MY[))0/*F3F-1U7/$!;:,10JE5U5;Z!FZR[,*R="/5/&DW-,W**K6>, 8H8NW
M=+E38G4FR\V+#!D7T+>J_(:(,&<_=5X'=#];=G(X]&8R-;D9C823J5-H;"%&
M$\)=/N%2D_ 7+61W:$T*9Q<+ZE!NF7LP<DFRSYL/Q'ZN4P.G0PR9_&C"=O5C
MTU:C^)/_7@UP2);D]<NVU'CY7B::[@I';2*"#T(T.7,TVMMB;09^*+Z][)LJ
MU]<)/,>#UL\"><";7DY,JUXMH6RN:%_3]L[BWCG!W@4CW[X1HS71<A11S=_#
MREO:7$O$QM<UW0LSP[1(EVK=;(5P(DV9!7U]=EUY4"17<VHJ7H4AIV>=@"[.
M;Q?D.1FF,R_6IM,K-_L ] 4 3X"<\6AYV7/G)6V2U-\]>GF(=MI?/AN'>Q))
M?Q=0!.EOKJS\RZP\3%<4MWMA/&.,87'I!GXA^L3( OAN.Q"PDT=>RTO:4%SH
MYM0_=B$2?]GK?F1"'._Z&_F!'FF#7^\:6.Z<)%T]+#1!GYAF1<A^E5<2U)E0
MHM'MY$0*8@QB"WL3\*&PI;AI_6ZX?)#5;)"BK*:TNG$SOR9_O28=<36()U4)
MLEV"9Z<LW1V?@@&.%/+THT@#FR<V_-ENPFM+'YG/Y:/U*1@: ',L,X9_ 4+/
M'!\ W&=C^>O2_#PSYOPC8TOF  )@&8ZTY4G>^LOC-+RDUH6=TMBQQV_L!_N*
M>V9D6];)$T?*E!D.\Q!2*+&C)1P!OR7!:\]3;R&*D^LA>@8O1 XWFN/3?RSM
MG0YU1T\81_A0^P-0KQ<D-_K\#VE1BO_K6K9>J.3DM_'?2>?>&*-)GP>JAM"_
MQW\[T906@0V#;E>.(+Y5XU!^.=UZ@=$VO)YXE^=J^  X&;^P:!->SVM$[G)%
MS?-HLE^,"8XG(>S*8+Z^(#BI$7_50_H 1'>49CD6[>FD,V[FE)$+@]R%<9K_
M3?B]5$ 0J$?(+1=*L]MJ])559&7DM09AY\^1]Y[$$@<JSBD?&,(V 'PI25DS
M8!EG99IN$Q8MZ.]0QG_V#"+*<<+QUB/USF"I,M*7DLY!KF(=O1I&V$8EF?-P
M[Y^>(F@=$'0]DKJ!9#?(O$N>C]D+B%SO3,\EG\L(AWOUP"^ [I43B$@:6U5:
M;O0G1W^:T*7'MX0<LR?VUPL@;MO_I=>.'.RA"GMEEEOX/8_8B:^['C"+>8OB
M[$,83) ]^^Q4P_7[QMQP4>X'-I=;1^5I=3=TV"4 BPWR2,#1/,,"\;#/<]/I
M!%]N9-MG(>6V>!X5)9KP$/57S*OJ92']KTS\GZ]X_[^O\/^JP_\:(P!33>V_
M'(CA/P"1AA"D+49YUI7>#T"(>MVF=%+EIMC-4HQ3Q)&->==:\">#U&5_<&K\
M-C 0D1J+^3_EX"+TTG6A<$YY:M,ET=9D9/%;((P9*[NAL@2$O=M:4>VO"J+)
MF*&L=YYD)8U:3\/S^OI1OQL=*;K]V*T9QQC;RC:*X[8)S/.?:SKK,&+_,O$
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M+Y;M?:WIW&+OC=4B9Q5MD;SIL@#%\KE+0VWSJK?FV%U")F7T9RU:LBC.OXU
M%;Y?3YCRU0..U"M+7_[N79V(G?DXHRLSG^B9-G Z/VCJ@%3*/TVY-D[,;_2
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M-A)NC!R+)0]9BZ.3>8<QX_ *OQ_$<>IW*CNU@;M0,V"\GCR4AF*AK:6/ B6
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M C<R4LH<@[3[9CEYQ;CE)O/G""" E*NM9ZJ:,Y\:A@@ X#4%.^\:^ /VB*R
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MRJ>3M5;W4ONM-AXCR+F+1MIQB]'7Z\B8PFQ4)+N7.+X2EZ98^\HB,Q5^>!7
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M\<I:?_F8G1'>M:<)(B2"VQY;((7/4=Q)[46O3%/WA>XR)@OKSRV%>J;"N-1
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M#?BN)/8E]&]JAOP?&F9^T#\[Z,K*@/]S=OYX0OV)*8E_.8_Q\&+D='^9D):
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ME8";@/VL[-X#EL%6@A)N6>>Q> -%:LG"@L.)F=D40UL7NQ8!;3^<\Y@^PU\
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MNV\6W-QLT 5K@.6[$< _(*+TK[F1B(=_TS+YK]>ASH/ZLV@7551P4TMQI(%
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MODK@KHD_#@5R.M%&[)6/'#PDK8(4ED5MV\??^OL-+X%YI;AU*Y>  GU>.3O
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MI#S0W.,3F,FGM)\&Q3@[(FV=V&B-42E>$?L6G)AN3LZN*I$>_[$%Y"UA'.S
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MC\:FZQO:AM#J@DW7^T2:J0%+K1]1Z#%R-N84!>EQ ^!@4!EWGV)]GZ99F&-
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M.HPDFBT4.($?:]\3!5391,.13MSA >.B/6SI0[14'[RNLK%VY?L4S9.]G):
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MBI[CRM2YA:H<=3*>X1K4-#C[%BYPF2_A=T U#"E#?[M?5N^(I[2:"61/S))
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MWU2%->8*C3%7=FM!L(PO+R(3;,S%MUR !SQ8QX'R:11''#[4*F"RS$;51M.
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MHV<889.F%[>0CEVVF(OID_^R,DT&O*@F"#8*I\MP2D3IZQ@D2-L\" )[:9I
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MXQ]BS6E27PS_/&0SM!6NRG469+"2?]T^IO6(#I5],\)S+QC1['M-IXI?Z&8
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MRNUTZR](JRM23L\5L, @^"HCD%>1O*HDJK]13W+=;YE-]Q_RS57DW%5^RR5
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M6HK/S^:A/7<)Y)X0X/144HB_M[1;]J40Z2NIZGLW*8[QU-HLP"LJI5Q:;\?
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MAMIJUJ,V7^Z6VYK?F&DO9W!(?U"K:90X8[5 B7@TR/:% N.N:)UW'L]I><_
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M0+1/:E.4 #IW!EI!1WN4*BG]]5Q%NY0F3EXGP4!) _>N_3A0*CH1ZE^KDU3
M+DHC1R>M3\3^)]$&M@!SR6]8ZK^J//1?GU4UQ1L(U&4 :N?F@:*SV@LZ_\VZ
MJN*,$B:N\:Y15=!)ZM%:NHI3<3[V&"U*@_^]VPO\_C/KC\/&TI?]H,MII0VW
MR^87HY1/*^EKQ2<^$8]\BR]B/[AL?NER,S9\6%$OG6V^ *V@DV$E97$LC'K*
MP-J27RQ4*07L!R+B[@QXET"[Y8A,8^>E.0.$)!(-2 *31[\UI6O$#1)K622R
M8<:)4->)"\RMLD.EV8"46*ZE& 07J_BNQ*69@V2+!XJ1,JJ:^J?X#EFQ6!4S
MQ?8&!KBTNQ#:#>I;K'?'PN)^3HJ4K,PT)9O6#Q7'\-N3X\L_K1IQ3)*8X=0)
MA&DEMH][JHAPD_FK'V<FJ8 ^%7\U/L8BHM/A"2GCQ_AL(C1L/>)!E!2VI^EI
ML5'/_GT,PT?'8/[5Y"]KK?I:>K^*!^ZI2&#M?"4]\R?S,W!C/>T@.!# @_UN
M_96BF3;N2TGN"A6?"^=(^M J]]P3MW6V$DR*AK+17B \C9Q<6T=?TT&F/]"W
MW, : 7"F64L\Z5.@+97&J ?A?> L=/<OCQF[KUH",/8:N[N':%C/"XR-IH"6
M>&+HZEC,N:>YVP^'2%></5!/QVH1M'W=FB9_-%C\<,]JRLM^Q5P&5%%[;/?*
MI=<G?(9R#\&PJ%:XJ.79;^R46O-YN((Y:@P2BR&]0'/YV-3-#_MN2%BYQ\.
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M$Q8[D/@6Y'QP,KB_\,$,-B,TO#%$QO69_,GWD5F[:N^#-3>(?_[QJ7F&T_-
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ML8?!%#%73RNQK,FU#%/IX0%BT,K;)<9>1A:.^8E@H+S.:TU9:X,9.]8">I+
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MJH:&8FBTQG6$\-W\9;7-OB:;9W<I%FZ8)_V>]F<XBH51@RY)?]X1/0*+DP_
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M#H:DL%N.;E\$=>M_!%?)BCK7'O2< T@Z.D&9J'3V[ATN4%_MM)SEU,Z!Y3G
MDVDS!0O\4'T.D/P;)Y'JX?<ER;C=/$_I'.![)\^[:R+O;->[+N10E?;@]&ST
M'# E>\JQ'[;.V.H9PH^J?O#G=,D_5(_*EGEP[C]LC+Z !?\)6_E/6*16VCF@
M+FRH=F%]"'LL.2U[RLG@@?5:\][ .>DA=T!F^JCI$Q+4%_+M7V+OW_%%(:_V
MU5;=@BB6IC93G3:.3HK/ 34AAU"<15F#<T!2I>')(HX58Z]$_8ARP;Q069XB
MKLO\.TGQ_R IT$#]/X)M*.5!_H#%8('1OW%62O4(4L5%=C'O&0[&^KLVV+^T
M+> HV*^Z)5 L)6VF%O]! ?(;!?JM=<9._1!!5+7@GU8DI^7_+0%BS@\[$;M=
M?UCYPX&8HO^9S5]AZRJ8=]1*\ZX+QT5]^Q]9XOEG.LY2/4)&VG[#K/\GYB*3
M9KQ-L3T&L?]F@>D/\VO,XQ+QE8QF8'>SWZ?_H?>AAU]AS'^+Z46&+H*5^BN/
M_R7R411+M?\E"@VK"\,[=Y0HEKQ_!ZJ&O(-MG@-B_L;QNA[0IO,V(:&_6"KK
M_\%R;^J?LQ9"[$YP*>I%[-8>JB(W?D\19^XYX&]7@UU_Q0R) /763BO\<?6F
M_9;]UW\M"V%4->C/ <D_)B7B*,P-[\#^WY6)_?P5?TNPN]8II^)O\8_\]_AW
MF.<I7/C[>V21_Q%9#,62X29:^(_(JOT664DXX_0OMZ &41=#?X0,[?1[R'[3
M]R_YA3XM_7_+U#]IKM3^1C.W\L\=[X+#8IX\;A+/KYB7_DUB%)>/,>]_KB'/
M$!%4-3L66/)K^M3?D858XE1;_W;![3_\X8BJOOV::LCN',#T-\[P4/7XG]K^
M3OIH=#4S%ECSA[9GOVE+Q%UPN(MI-ZV:"0ML+/\3EO1OL(5+T?\-UK"*'MY!
M@'!#OP^@<;0%<[W_9HU;:52X Z"37]X@#*?"3.\BH+9_9R'-J>OHI.2O:'?A
MLI4^O/,68A#XZ-I*TLZ>]3^BV_F;"Q1_;=OQO5JIWG7((<F%Y;&+A2/_#]79
M?ZG6^GOK'J!8G-I,*^XZ.B[Y9TXM?\/QP1EG+G =_P7W]Q:_(*25\KM9W#Z$
M<<!Z86K_WJLNCKK.ZSSNHK_+DWY7K/KW]BZ.JB;'DJYDI6(Z"ID4FTY!R,'7
M5'GF7"957XROG .BP[:+^F?VC1QG2V6NI'YVZ W>DS'J 0,!4##P*[0W.M01
M#8AX._B6D$<NGW_9#K+OO =<;9F75E>OD=I+:7Y4I!,02PY5/2(:#+E]C."N
M_]6YOLQQ@PD*_N1PEPL6T_P(%7*G&DQI-"_M&,47Z@EFE-H#ZO@),#>P*LXR
M0>5G13-0[6)A#!1\H9._D/0Y%SWVT,FBFJ?N"#'M\C"*O\8*2S-2HOP$[J S
MO3K_T0U LJ@7\XW$]:N>Q5Y,U=M:?ZK 95@HFH$^ 7F[0EOK$R6:S3-K6J<F
M@;6FWALD8MH.3>6$%)(CNOW0?4WL)D[C0X]0J-I95#68;X3NI"Y8$[<#@GK4
MSL)JJSB]&L\!DT#[ MS6#R*!%>R+XB:LVIY-RX+(X(QS[EQ=PTDG=2$%D@>^
M]#FXZS$J(]O0"&=$^4+R2-[Y F3!-31LB /EU^) X61PTCD8K'"?1A*GO.Z7
M<CF#7HG6M'#,F>\YH(KC!/\<X*HZ&_,<ES]U%.;L+4[(Z5TXA7,,I\^2=$Z<
M:VK_==(4L':DU_LUM(7WV]J+\71Y+<G"5.QARHFX\@9"C'58(N=!Y&)VT@5$
M]1SP4LX[R!RW\S".,K0*:9P#5LLE:SBP;1$G*[*%.$/=ZRJHO'. :<O97LH)
MU]-3RS^D\F=;LOO/:J=@N#V5J"1]O$M(T^]77_*+Z3D@,4!YI"V_NOC1O!-%
MRED8W^DN3LYZ(8?@Y&?5./D=#-^JO_<"JN>OX0LUI>GC':@B[X*Y"Z#L_L/:
MG9X+_R1ME<L3Y&&&P]NXO0R<<L)H>+18A*L#R'#R.'F8]U_R5&QC#-:=!W=>
M^(SUK;_LU4S:%\(I@$L6H'^INW!^]R2V2#/FE]P<V_0G/.8O>S@QCC]+)=F%
MM <F>:'<\V_I?ZCX99'/#!?LI0-!#HSD*AQ'J-?;&%<X25"&F/'6_X)'I9\%
M\1T,AJS":VO^X7<L&.YMK/@+AIOT2\QT03\5%Q4W7/_?=$3^%S9PTI +"W][
MHL@*/P<8MUWDC=9P _,/CE!<"'M_"Z$]Y%<F;#A!D%^"8GJD^J) JC"OO#,M
MAJ@_!0P",5L_EV((8I7_K*K:(V<$A8 !&B@$Z#& ^#9 7@*P8;"W.33=41-G
M1HG)>O)ELE54)O!^H'>0FUG]&J=P"*WV6'-Y$%W'BY72RS6IB'OW/K^Z3-2;
MCQ$IDM6XPIY-P?R3(4N*0B% E3#7.,.G-:4UF\Y\[#'%:=;#K(*2H"(\P_\K
M^C]/I-*@HGBI.3#\MB,SH;8);0](I>*:"M&'U_*;].[/K<T@(=:X7<;7^\TQ
M8H?KN%+U2_!QXTROQK6(.T_(RO*BG:X:FV6,CS$=F8+XIA-!69&Y.9U<FU 7
ML#L'JEBL#L'Q&>#T-3M,-M]CP%7&E,+.8B8P2V&4A)"7$VX'TUXHFRBR3C>*
M :Y2T>!\.84B+OT4Z4$X ;5Y18%&"0A^\+N?=A"$"J?=8ST;CH8'0+S'>HJX
M&=#'N;CQ) 0_3CRJ7U2DPM8X$T\(G%;Z/OZX2G4MO0<W;DT'WS5*\+6KA(_!
M[2"/<P6M>4>=.<TI&B_,01&$N 'GO@+(L[C ,4A) N27 ?$8(&'C3(RU>*"&
MMF(03A[/:0?VM?N$'E.Z%(-S2O!"*1[8]]?<3/-\G!5JG#-Z-IP7JA#.%(W6
MZ80S"0@H^*.5N0'.\&-T^O.RNJ)DUPN2VEIT)1'6DD"C )*?SKUKZ5"ENE_\
M>Q#<_Z#_7W\<<^3K!6+HW-*1SU3S]5X8F(\IWXWXY1D>_! 5<)V_$D[2MXBJ
M+VN'EB0@.+5Y[V%P+G_Z[$*M&4%Q!XC[<:%E1QZ,P)F.PT4H@+!YOY=B/A6%
M^[$EPZ7P#/IB_"6G2/^G5/3SLHZBNF)^>C4Y5/VSKNI"W8]=U';=@WB$VIG+
M]W,QO@ZCD48/&IN\+)$Y[@F'L*"3G$PP4)/('%=RX&E&XW8="?P?/[J"8[!E
MDMMY*3\I=D*^U1XQ_M5-O9L+FR(?>SK-#E5N$(;O^9=!_RI6_FS:XOOI;F9.
MUK;F-ZHZ0I*6H.M;3.C26>_&?*>9U)]FR3WT0O'J<0I8,S#8=/@<8/')],0L
MDNE0!%]E<;0H1E41[IK,B[*Z(4Z^S!6EX9BDJD^C4XP)RN**3L^031NIZFK#
MV\X["$&S1;'V#UKR#&N$'8T^(!W06XF+R63LV';8Y8."39='"PKXZPF\K-O3
MK_@<]<7W4PP_(;6-9D-3=%4W5MO2),R\ ^.S"1-)=A8+K3WA>=)BH^;+'.JA
M+I-CLE;@D,*1:ST49H]8Z,1X>CMQBUO)SS4Z%^7>[RJ^,U!\7=RU3]7_F@ #
M2KL)<#*?OG+CB&(/?F18JI:,RK00#X1YAI5YN5OCETN ^'F=5CY]7P*29\XR
MXR<M:' 5!)3,U@6FEI<8F$F!399@E0:*K)AV \5^0S<)SP9+C3H+BT7_.I77
M7TA C]SX8E1][WZD,R+=7R>SZ$Y6.+@5%/X"#-2X"82" ;^:.I5]D<@7N6H-
M>0HMZ>H8E3[C1!7\4CWUG5P;U2,F/M&G,@B.K-L<.+?L#61)Z#CJRU]1,]9%
MHEMSU8W;5_5180Y%9KEBZ#0YJ)Q#T<]<KN@XUM5WMB4R-_SN\$]8Z.7T<LHL
MU30L<Z R0E$9WO#D@9JOP WBJL0!+[2\!")2S]HK^0]_H.K" >7<CBTV=P$5
M/VF.^UL5.%NBKI2W@)WX>E1TG@U1WGMV.+Y(/9.>EC#P?2#A$Q1,A.8GI'C2
M"%DH*Z."<LG0'9BX4'A%FCK9HQFUGJ,0G.'_THUK&OI/MKBY)^>^<97]4"_I
M\T2-BKUIW+N.2#3U,D#;UQC8O"^"@J%WP$ 5O%_-U++B_:@3$G)%M:%N!V;N
M(I-Z0).AIJ0D$> X^BYN)!B%X&HFX4"](>'(<>Q/L[U1[7]U[DJ]68V]!:LP
MG5Z95.?^HA443&%""(0^_KU= 4O_1$3VT:$!ZG8[(9C7Q3.XNQX*)5S1H!_D
M^>P<\-K3<BX/&'*85<QWO&KI3A<_'!2(X+23&5V\_QT5 T^!?R;ZABW2&*!0
MPO,'Z\,&Z:@UQIUX;J>3='_G0$4(O>=A_0<#7(/(/_Y,V,##2O.9$!78\YB$
M(@3,XD&B'W+6>)KM -GR0J=H!^BJOVDD9G:?'3+-.<S%MM55@$_OC1&OE[J]
M3]>[*8DVXY27"#*^(F^P\"GJN9LJ62]B10ACL_"=\5X?[=&=(^TW%*_(+F<M
M(R^G>\\P*.;DZ,]0D>)10_MW.QY96S4[KN<Q*+D ?W!! G16Y^^-?^^1$\\F
M*7Z1LBP>RM;9,P<=J"!K'YB S>OE[A<H(0H]T@W@O5<V>"8I)40=)8,T&X36
MV9#CW24]Z^M%<4$*PH:%NJ&Y\@L/O8.@#""#IF?]O \?>'H2=K;=UR8VPFXU
MGP/(5>&)%/W"UJ"U_3B:AUW<F3^"W9,L]%H,YNQ%+9EOHDO?KN<:EP;0S3[/
M3H(M1WS]H&)4.IB#KL0_>]PIO]NEL( JJ S0AMSZ9//][65OWXP%Y1<>(LBR
M#IDZ3]YCR(-0@IZS54:N8G-+$9?HBO'!&'NZ@/QA;O$"3$;5+997LFSI6;#A
MASX@8"Q/R&MH>WB_04?)JGU1,0;CZKPAO3T;UNL!?S2[19^9VO-:P@U3^4FA
MP9;IN&5V6C-)H+AE-NK(RE3UC<Z[C+9;;XC<E^.^K@DIGR5DPPS:?=B S<:[
M'9J;T:%#B;<#(0\UUVQO\]!_G@MV)S'H@?U4-VV/6'ZN"(S>IIY_$BR>N<RU
MCTZ96)*W&E+XK)<>RTAF,;4U'\CCY(&[^2^1NNW&/YOKPB>QPJ[79[N[F ,[
M7NC404W=P"X?JZ1[W$MXI)MF/!-=P2!8IR5:\F1_?9GNJN9)B*CF,1XDX_#)
M?&_SE,[$4V^K6L_DY5H5^$[C/ON(TE!!E^I@=$CRA*6W.679Q"5;+O>D] 7=
M&X<<H9E.V:.Z>J5RNBP^BW(SF1T\A+2JX15B,%AE]I*H.\]6<:4*'8TF [4[
M(HTK0E&?IN5^Y3T@;6]/$:C#YJ7NJ\R;#BQ==1D8GQ\1 E^&+?9CU#+. >KE
M!&>"JO,1!1:1J;G!6O0J7)JE";R*A=)UK\:<C>.'%!))7%%/,Y:C2U3+FOVW
MM3WMGB*E&^/1!6TJ(%V=S;UY!'2.DZ<JR=ZU4R/+6K*NX@,ZK<'3.K^))4[L
M_MA0Q%H#_59Q_8C2?H&_K/MRT[MKK2OP[%$]O8P67X>(5= G5S;$-&92Y!;(
MBG/J4>1/H09Q^^"?<+!C@:N ]%N6?B>0)56HJ7$$:\$&(CG'U7U#AACT1=F:
M?3R15[T["UR)GR*4VQ-)2)&=XNJUH3.Y%8F8E*Q]&,^!X7Q(N_UD(WU9<^C+
M[19_ >HSP:>9P%6%%#%0JH-ZL<.S/O8!8=;\ &)!LPWGKQU6X!]'*K<R#,=&
M&+YSM;38>G&6IW+TQ$?UBE6$W8F:@6N*\*=//K]/@<:X>JV S=MSPK_Q'9>G
MG*15G$D^5OL!R?8N'</G3JZ:?%5]7U@@*UR12IF,4[YAR<1M@B+;[+.>X;(6
MI69O$_-7="EI4(A"K:C/;$F!V[KP5?,%\/AS]OD&K8=J!<@4D3SC.#3&D[T^
M1AQ=J2]4,#K*^0UIX+>D9;;Y_D,O)$A2I;2:_'IGV.P]IB#25+7\ >)B#_J9
M[ >$8.XFW$+7(9\)2PE3J(BGD  [>A'W^4Y6VS[0 S.%L?/7:OXL9@_833;+
MTILX^T+S>D1YO6^#CV') ]S5*BIUPF?NX%A<GNYJ,+_=;C ^#C:U\%II.S64
M@F2X&GA !-TL'2C6*L[V [+.I-+7F#W(5]DMA^M0>4NT$H.%KWK&UC2D8EF\
M*U(FB\>^S:N_,,Z"32BEL+$VLR\AZ6<2?&D%<:L4J:&ZGB%> /!4Y/ZX)=?3
MC-97NB(1)#Z%??3C') ;<-J@YJ[GR^3>OCCT%=:B8;SO-"Z YX %CCR\FMU$
M]T"X!&ARNG#*9<O8NI1;1RD#W7?\0>^<J]W%R;1BB#T6CA2;S7/(0B43VV_7
M5E7#49.&.GKZNEGBC[V<B.89#W/6!S(_6PJ8CR(['YD;SL:2R:C!1M-]$W_J
M^9S<MRFH.9N1$[^][+#;H9;$C;E+07'?@&[OWIIC0';UHYDC"LU1LJI5NZ07
MZJ#4+9%TDAP8;Z*=F64][L3A82K'.G7T^5CKAVGR!\P]N=5@K>VJI='/X]LJ
M'?9XRFGN/M&2CF87T,7NX:(!ZRM]6;LE& Q;SE;@.7_'%1/VI.&&I"/>FG1Y
MGGDP\IU6+&EZL@7M?<U*/_+2B3 WM<,!D <\=_WF5==1>;UI#5FVB@[BN8AO
MQU^F*$401)$FV'U9A=;-_0+;E)')9I6X)>:1J^< !Y^(TRSU.;,)6H5(L1CI
MEG/ ])5!A;-AZ4]=D8;SIP7:6IJ%(WK"U>V*P.P!;57ACF\QG8+R\V;.:Q,K
M65M2)X:^19"3M]C8VZ-K$]$Q0JA>SZ?A\3/C%#DOX.ZD*3DVEG*"M&=+=+Y,
M03K5F]$84YNARRQ(UCGDK81:6(3F$'.<?$&?XUJ/U,V7S^]/GCK(3U\=RW@H
M#P<JK=%W?)%FOQ,=X5#*#PT"97BQ$5*@9ZCO%&]1G(H<;D>K DD'/EE*K^>^
MX-BN)*1&(8QN]*KVJMQ#(3@ 0I%%*I>@4BG :T_!O)P<U!]">Y%D"H]EZLK7
MM+W3L!0]P@['^>< Q5,0[1C#)^7 K@;@JJI1>8B< J?Y9Q)<26).]/F4[AP0
MMN2]XG,.X#I^PANUX_U[7;VD%U7#7.)7IPWSY/]_J*OQVES#I?VT^TS"WJ'*
M6R3*,':Y2Y^]FV8E#X9S0F[*A*_06MESF)J)$2W!?C[M^W@."#$YS0YF[!M5
MCAY+V-DW:*4_&-OC_69'T?Y$6U^?[ DI^,7*H#)!S_)@V<WZ@Z:#F&H;*0+-
MGBLS*AGB>-JTU>W(A.,E$<SV+,VP]Y5=#.@<0*9_#E#CEMRR9:@XOC$LZ!I^
MQD=/;D9T7"0Q-E@1"J!F $6^U:T71SVVY[:YK^K]MO9XKSK3LW@-KR_V8:][
M^4\*(&L;5<>6$]\M1GB#K%QUP(#.JO7DEDTL7JP,OCM)H^]KR ([<A!KX&7%
M.!5E'9#Q^AQ0&$O5V>B\$*_9@T0.Z/;7.4Z(KK=B/[Q,F0&!5+:(IO@FKDC
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M]X!,N1W8[A/$QMBE?Y%=4.5&(DK1?+YW#> SIJB^\%&XVK8@0.IX;CE"7"*
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MR/51%-'7U-4H),KG,6FKO0N/5:)*:,B,#5_G4.F$_E,S0#! #EN-6+\X.R1
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M< B?@H'8A$]5%,$XY+'Q0QKBF-UBHUNBAX9H_D1B#E)ED"0'$;[R4Y7):!C
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MK3J%7$1N\F?ACHUN7U&*N/EMO?6JEX^!J'IQJB4ZL0RTA6;SU9S7UFLLK[#
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M>*  ?2[$_KB9N0S%K=M^OZZO-,:=B'KCI396U"),F5C L(@2L>GFUO1X3+"
M!3TB<#XQU+) P=QC@3:D7:43&U.+07KE&R0O5H^L:H,?[8M'9_G:22OO25[%
M857)TAZWK78G/\4Z[%,M\"J_.AM%640^4'RP^X@ 6+T 0&K8&'2Y%-V6LIK+
M+OV9](9U/$-ACJE*/'/D0/-$^ J\>]=OG'1M=,#&NWTLF@>W9.[PP_Z<TP"P
MSJ/,/<_ V-!P>W\GR3*9KO8:0..0Z@GD:G>90_1M_X.7+PB/O:-OI:N9$_R0
M[-7)3D6[N%?B/0ZMJQS:<3N!G=YGY[=TU:T4<;>SLSDRYI%Y&U>E%\(2Y?P]
MTMJIJLF,,'12:,UJ?>P^3<2%T/>VY>3W$KZ#&W8%>Y56#/?6]^B1Y(^78:6.
M"]QV>C61W6.35 90PETB64.Z4QQ85$<U[(I9]D&(G?7H'??3]T"?H90: S+X
MJ4_26X5K "OY^$9F/_)D5S5EN,W5B)\OV#'9E/9537%JH]7.;QU59?-FZ^<O
M_#LILAG"T8(INNE,M4H/G".U;^%LQ[03WHM( 19I9?+[ZGM^^?Y ?^<H= 2!
M;F#!D\#V6E<(F>O]-89A=;.8:+_84HXV)9^S_7['4^]G->VI1H'&NYK"Q!14
M7T)"7R[KVR+_D*[\K:6C=W(ZV0_ K^,N5+<?7REU9%\#C$,.!$*O 2P#5[,*
M^X(A)$6NCKDJ>6QS%=U3J9&NBH*&,3G7@)<7S59SS52KTDO#QPZ_#^Y71W$W
M%#NN?ZEN]7T.8@GM<#XR6*D\[QP^NN-3.0]WFGLOZ(EQJ#NP<D1-Q$+2;N?#
M -)5[5T>EA&'65?RD+@39B/2+BU-F_JM;PF*WYXFN7D356FL3R+F0EM*)_H^
MQSY6Y_6_!HR7"L?*)^HF].OW*Y4TMWEJZ7EIJ0RRO.V6393-D/GVY=(N$@&V
M\8!RVJ I-@_,5, 495V8""4 H%$&";P'Y0(K 1!(BO)?P0F1*T $$H#0 )Z"
M\6!XP/C*^)NRUGC1\?%YL?Y!K-RL.)1_)D3%(30F(\$WG'T$<U7_D'9[A2NI
MYC^<G701-*C6SL/UZ;!#4PT>?2-$=[#RQO\Z=TJO^]=JB>;KIB(7=)BHM_RW
M=5[$>!+:31?$?UT#L/Y/G@N\:1HF 6-: 'YEF@R8JK&>LX<GGX2P8P0UN?5G
MSVHBZ4G!S]&=5*=DNFL</RT0%+P!X9 M8^5(%Y<=)AUS?JS.YT.#8/U/XQ$L
M5&[0,YCM4Z"?BZ!I%A*$L!1O#$0]LY^WFC:7\_48J=08\@FP?\V()0\ ^$ D
M;!A;X=4C6@7P+EVJZ$Z&:;!I5OXB<PP8J/?8Y7%%:[UG?/+1% 17PP6 OZX"
MIGQ:;T$/6OIS"DJJ48]B6_P\CD--R_OF%!!>;;)UF $HCZD8MDB4%>6LJO@P
M?-E"QC=("<S%-!.D/3)2E2ZBH03RHG" L904DV'ZUR!M?PT@%W?+8*IYS!2B
M/*:8$VYVT\&3=DS_8(K($=<XWS9&LH GFI<I=Z<:<@=*)A-A16S*]J_9\/@B
M083 %P!\-#>PC4EC1D;:P "419 R>U_4.CK3&<)9& ["]&]0N<OSM6HAB=.3
M31C!K1?A0X//Y0" +U1 >PU7_TPCR* ,@3;O5T"4-R]?).;2W)*?))\*5U0O
MX93!#@< CA'PA%BZ*:H]ED 2V)RF7"L-T2-;_"S@&:C\SF< UGM>CIMCP@PX
M/EH\O1<N8*N0#62QH6IY6/I=:^WFNH?[&NH92HZM/VC8:@;I'"$%N"C+/]-;
M7QY^J+]4%\S55+'T3W&W0C:]L[+>X%%3+-7(00&A><_>/3<]Z)/>39'XV+R:
MXC?W,!>>$'WZ*4@[G.*6MWE2ULT"105F 5CTAYB> $AM#4!8A,%4C PH$!6M
M)AC S/FY%:#0R&<__S0A%.N8@A58'.)Q\^C$?U;Y^M]4_7+\9]6OJ+]F8M3_
M6?7+^YQ:0!/L1OL58[@/;\0A58V<N=*;8$,Z+KW7KM!IIWQ"ZWQH,!88._$]
M^<TC&2 $W/^VRM\6. <!*_^8_$T],"PP#HJ5&\ MX9ZGU6EPF_ /?J,(T0!E
M:=VMK(S7NIN#$DOA&+F9L[G%;3Q\I-+(O>RC]+8J04CTB$(^,4[WUN2/&Z5(
M[(VTA._.C;0$%Y&7XK2NMO3^1@M"H"E[LR<V#!<;"!G2X'@_#\:&F9L/><+C
M-9C F.VWN(V&C\3[>/S$^BT>T->LO4.K)8:QY] X\*RML>UEE#U2I?E&*QY\
M1S[KGAY1^X\*\EXU)<EU4"X\Y[-:;OX>+SS>+1>#CA$WCYP8$ -8K=<-1L?"
MAP0+HAZ/U/1SB<%4V8H[J47JX3X]/6'G^;6UT=^XW-FR,+@4BC?E::ZIHB03
M$ AFVL3< QIE&>Q$V(WG"I3!Q?QB #?FMMP&8YS4W4%9N'^HD@J8D1S&08R+
MM7DSE17L#^;&N1%X6 .V%6U\(#0R\J,1!=> SO%Y0U6]R:@+WW<4$?:1TPP=
M6NU4"'BM^O.;5:F(,-BX^HGX-2"P>5^B]']4<7A3^;W_7'EF/KQYS^EOI=O^
M_]JPB/GJM/KXZC1P=<\7-TVYO?*OY%$J5_4T9PE_41;0/RA+54[M@*FEY>#?
M*^.1RUY5ZGS5GO_#4U O7,8PUJUE,YK]_E]T5@1_8T(O0'#_/_6IL&_RL)0W
M@BA",0A,V> 6-VA322;K*1+,"LH+Q?S#P!QCCH28[4"(!O:@$A@@EIBJ(H/A
M+/  !4TEE>=R0S#9L7293UI(8E A"^:P,D' RH!$?UQN5N![ Q"\X+FF,@<'
M^%:8,N@FX U!AN]B7KZS 4DJ(;!;F$!W4ZD+#&"]&6I*:KE9/*R,^9";;4HR
MW]/7X# 98+RFS!TE,%.6^7<.$!"P@7DA^!,N.4B5.4!4 7^EMS5EY6XLM UQ
MLT=P8NQ[DI'@R!&/+#Q!"UOIO:,3: ]4"(,F&*1OGIZOQM]+X+"&UT8]QW T
MX/M^.(S+]4GS?QK6*L._65Y-T85"]O^-W/;_Q]O=X0<(B9OU877^$-\!F/J%
MSE_SUT_^S%^__;?Y:\)S:GUX;&(=B0;&1K'_J.PXTQ@VP484Q20&YY'Y?THG
M_MU5_IL]@X&$'#<62&  PF '&8PWPQX$<]\*XF:\F:_&V)<U=J+_4+P6"X<-
MAP_D;B.R-D< \[U-L-@GW,<&'-9L/W%Y;I;H)G@.\>\# >'IH37F\83$0&&*
M>G)(8I<!( O;1RL@TZ!#KU!S)IWW*S1C\!ZP!C&E1LB%_PEB2$?67=38@27/
MJ9$SE$;AR^E7B3P6T)<T6?L \4])>WBFU9![F%=!XQOZ1O)EF2GP4Y'T*ZWO
M*<1E6W9ZBP5-^1+[O<^\*;X@VI5?1'OTR3\ER:$8I/F<V+N83A-]$DT(RJ$=
M"V8NR-U5RV,#:JK(?&CGO@%)ID,"2'>?KX1T!5+GQYK0RDM<-#%DHYUV)S!;
M<H-VZ/L@)"W6#AD%=B E?;.G?LQND^O?PMOY[HCWUU&:Y_V[1@,/!?A"'N'C
M^._NJDRVE1;UKEIG+;([,E=9HXAN:E(2<&#\(UY&?/SB6&Q ''F*C2HP8 %C
M_K)R5C#,$-'$C"?&FY@"T%3*L,["S<, QZ<W)24 '!PVQ+BXK#<(4Q/,B-D$
MPL( 2N>\%( %5.JOX?%:T&(#1_@?PP2$^)J#=S-0.)PP+KD;A$"%EWC.X?O]
MHZY$9!CB[?(OSW\6GOA1ITOA]_&0]Q^(DEWFOXD^_T\:?3RA'<-84E86+MQ_
MZ.^9G.COV(.*8I#O6(HD-C:%;QZ^I_O?@=;_!]M_*#_T_X$W_MO($47D?>?*
M7?Y<6:FI>/OO::0;!0CTLZC=CHA6D(!6D/6+OSOC?VT8KXYY<^-F;])*<I[Y
M&+C!\Y<V%0RL9,+E!F+\*X<UT"V7,3>WCQN B9Z)_H!UM78<! CXK8;0 P0/
M &.GJPXX5/X,]TZ#ZG"UI/Q.;J055!Z8D=.JBMM6(\17=G^#=J669/0!\G]2
M, B4(SG< %&TB@UG;!UFRZ7=KPN"PPQZ?RA[Y0T'$>%#8++*'$1>^; 7^3 9
M":UV :UVQ4["=^UF7<!!"*&M2V1+@L@W?3A[1<39V[RBQOBP[HM1.,="W;K%
MIM:&$[1[37O=RISBI<@+,".J(XB5RAT/V9?/N\+<F5T*B7RIYJTB[^65EH&2
M-"O$,!E+ZWYJ18&$M0ZEC:B'FLX>9DI@*9%9?4J1D8JR+]CIWPSJ*2LO(;O/
MH]$5V[>60U JE-6>Q$?M"R]4I&>9T1JQ0C!Y!:J7/X>T]\$;!DC0NF\$QU%/
M:+8;85DR@=7+119/Y#5@GC4Y.U'4WCQ:&6#NFH'']0 (.=;DFAJH"8G+B*\T
M#_]3$!:"@86Y6=BQB8%#_J$P.1 BZQ[SPW"MM5R=#G,,:+P3*ILU*&.DS*&*
M 4"0(?I*#>PA&E N'S&P,AX0?S/5JF%^DQ6,380])<3$0@!>BDU'BC56A+[P
M-6!O[P1: 57]??'V[R!(!YX86QNE@;%TF9>#*DJ&G]*O ?].X43?_BN%$_I#
MX22)A+_\;6W.[_]C/<K_39-7WY7)%_U2$+^R'I*5W_U&=L,:6W;H[XG-F#K(
ML.E."D!G&<S-S_RI7>H]82CI[B=M-';F815]RWOV__>@TJ.3?T"EY#]028KC
M7Z%2D&\XC,.&*VN%,C$6AFNN)_T?(0PXKPJ<_]=4+L?-^DY9-]$*B#F;L@$
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MA[4NO.0ZX*GG9<S\3:#:I->#Q]^DAC6+9P]G^S 9P"*87YFB_?7 6J"Y+[Y
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MV$MGE^8Z7Q4<^^!)Q "JL.P@;S!RJO8O'-*Y?QJ3FPK A"GQCY^[>/#D*Y,
M )AZP?0-ZP2&UH[6(>4';E"[N+!R:NR>K;S6L8HO%_Q(Q%@B]!!/J&"YDFA7
MX-5S!'JV?C]]JS;Y)8N^G!11DU?[E;G@2JJSJ@)#Z&+-EF[FHF31/2E0PE5=
MV[.G'(O])8SX!&:C]CX]&! O#> NKQ_1\-]1>VE[O(_WTJQ=TQR1C)-^:7F+
MUU6#_H-W11!+R.&W INR@^V@W \/FKH7WVG&N\JJISRXUT9@'6[4Z>'7Y5=M
MTA&03<5N,J0S76KV =8A^CYN2%;WSV7DX4VK('+EV7%F2H4H4,Q_D%_7+$X
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MNTS\[<R/[WZBUT+;\RD+46?:\^GA75*Z6S-(]PO+YHUT"5_>0&R<TB6A9FH
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M$BIP Z.:5F(@N9'*I"!"7QPC1,35?-M? I$26&N;"5A\D[:NL;BV#TI8& S
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M?VM#B9[H<>N(<H@C2?O>_"UA.#]2S_?TF6J9NO6;;Q)D)U5F9X ^\JN&O:H
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MM;>V2$=A$#.[C;\9;W?5^#TIHZT$;>IXVAF0DG?0_RM7?#G?TU'ZE.P;Z:;
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M!C>.@0^"$>HD8P%#H&?SJ7%]EV/_Z6M+_<O9Y/]R-8#%'VO3(5^=NJ&7]<Z
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ML=VEYYN=]*#_\60>"@H_[N(XF#D#DCGBSU<4H?N9;</UM;T 96 +?SGQ^W_
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MXLGFU]XFRYX!#G%O2T4A=P>R$]0KD65O;-M59N&IS%D# E\JQJI+YCW%M+&
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MCNEXD>PZ;-&0@3&KJ]CIA^^2P\F['[U_(3Z!NTDX6XWF;^-P3;?_X+/S'(N
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M1+&$T,6;H!RFP.A:TQ!A(P'\-O$08&+9<! L+]H.?130NH%<Q'N;^K.BVLA
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ML\?^&J\W.7IA*;^FBN5)),&'"+V713<J*E*)]KGT>K[=V8J)? 4=DR9WFHH
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MK:A'B )P;C=!=O=ISK<ESA[H?[_L(.2PF48QDP:Q)]3KF%QS_^<SCS3JZ%!
M8B8*V(2*I"B 2I==$C;$G.5_/O7/B!51P#21A_A'"/C+KC "NI7X\[F@F1='
M,*1G"@JH8SP)?(P<25IT*R6> ?U\+J2A>9OF[/SBN[OB/OF;\_RG78<6+ V0
MGT[]6<%5;O13/;\/WP;5WZ* GT[]6<-+;BZYN>3FDIM+;BZYN>3FDIM>QW3R
MK=Z?E9+_\Y?4G[5R&]+$<![Y[I4E'KO)G\[&7M2*WO2LD1<\<AKN(?WQP93W
M@/+DP'=_+]O<3K@ERO*!']NVEWRM=IYX[KIKB)/4QV0HTPW&9"C TE/'!FFC
M[416HX#U]%J2FK79I3.O!_5K]<@.L#OOMF(K# 4XA<S;*XJY^;7Z$"D^QOA9
MB,M35EV%XXOO):5Z%#T9PUNT_+2W#$[_</8(SW=C'W8D\9E0VG#GK"=Z,TZ-
M,WMVPS [@4J.=U'H!#H\[(#+MO^"W/'# 6W&XO&AU3F&T9L$;^YD)W43@L#X
ML(J+F)'PB\D''FS&;K"^.9-IDOD(TL"T>L)Q[ML;V';J?(CBV]18W1LQC,F9
MKW^.#O[!0JJHRQWEQ\KZDF[0X32]S%?OA<\UHV#74Y5.RZ_C<_.B-FZF+*]"
M97?9/$Y>%#FH&R89I%EJ2=P7,UL3X![V=SMPB[O5:&_+/NFP3QRO=2^FZF&X
MCFZTHIB9.>*7DXC2A::7.52IGH9+]:6X:3G7F]O'R/84Q= *+KSX3]^;Y\_R
M^"*"YL#X6_+_F<)\/K-/%)YSZ#>HY$9,U;<7%( "[FB#3N9+/3/-ZG<PBE%
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MUIIR"[S7_MQ72C(V^)TV#=,>?.M$18):F/>)%#5(3 O9-0A::EA#GI4?*:$
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M(/''X4Y]D?XN]?3!*O)IFV/YH?8.E^7WD\"C(I_-48#(-@J8YO+P&D!ZS*&
M.C-D.Z2+9CSG&(_F1Z5]I?55TR'YST\Q,LY.6U& >]\!COSQ(0QYG'+*@ (>
M0JSRYX4@8(A#/9WX,'+-4[S6>YTD<7>3YGQ78I05M#0%.EV$K4==N!)5]<';
MY_#SX;- "NU3^#'Y 5Z!%J2W!G+83?.\Y%>LH NHF-^1MAY<(KU$>HGT$NDE
MTDNDET@OD5XBO43ZKT'*-8I  7_"/,9^['WJ +D[+_BCS!.\"[CY6F!! Q3
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M1J1)<UE=O_)V3TEEGUV-001!(R=J1=,6Y;:P.?#S=/4?MQD&7&W)=;Y>MMP
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M75UP*,B8:Y$^@UT<@RO&ZJ=P/\AMAW860T'U9=TI@>GU2PC^L]);J)[-6#<
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MGAUJV@2A8.3[_\[WL='1;B4%B(=SRY->']"YR8VD);L5D?2U\+_G25%_= -
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MU\\2)<,)%_S4M1DVR8$O[UD Z=8R?U2)#?5A*N"W30=GL0M/C^ '?URQI!$
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M6/BD^(7$3DI*2K+QGI:7%I<3D9 4QSL!D9&145)0,E!1,8B?8#DA_K<?[!N
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M?4\=?W <=AN1 ?*RP[I[85.8JK[7*06/7A/BF(U!S WDSC)9_ITO(Q)R4"S
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M%]+X-;VO?DKO>T4?WMV&;32!7(<R[CU^?KO#4H>+2BR_E@Z#&S+2]);L0KU
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M-(QWBHMI^^X\7<E!CX6;V]I9T[!Q@E<W>-;XEJ0,:@^+$P?:J=Y^NB5!.FB
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MY:;5RI8P[;*8ZQXLW[9J5SGS).Z#J"N<:$BG\*B;FI7?!:'0EJ1NFZT2NKN
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MJ9_,&L52JJ1>>ZOD0OO@.3C<HE\8/3S<\J5 LUX!6#=T;^U?,JWW]GBQZ>3
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MD%Y-3:@F[#<S'?-U#P2Y=JN^6TFXH::QH\[5L>"#$)=%0Q^_N5I XA^$'H&
MB_="C]/2FHYDB&O7F8+5+]M1M,#Z*P<W$T^5[F3:MVDOI@S(4=Z4W9?FZ7A?
M.H*B.KGM?#J(DI\C"&=*D#4=BW[&D(7[\9H79PVL7EG,NUHL*+GV!X]3[K/A
M)?2XZ8V]H7A[B V_]"Y3;C3SFZ^-@&)TQ)C+P=PLOQ76&K#NA /VT4[>:^2\
MCA+8;IXAFHW,UKOG<:*!+'/DZ>C\>Y/6_TF> 5L.L%GU:UHE)B+&'Z?[1^[
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M,W\!?M3MA6;2VS60Z2U;>L:G:/&O[&?9K[!2?8&F++Y[@B R&\/Z)44.)]%
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ME!X!S[[Z^:@= >=B#S<=H]06S)CTLP:7CH Q?J:1E-.ZQMA2>FLD"G6*AXZ
M*BO)C^R28WQ,(U154S#QX+OS;H\2W4:"SH3G#HI0-1X!#\D7KW)+:\15$L*;
M";<WH\8HW=1RU.4'-[XX7'XY*CTH3&5^4NFJD=]%GZ?()NOW4BEQXW/I/]5=
M+KO/8K[75:6FTEMC_%,_^)B&3_LQ]P_]*)<_[?1W]*7@MI]Z77':L>N/><@>
M'SB*9%T:LM[BI:WM7/)^&Y?IBR%S@7<3PK[M\V[KS!KJHN53X^9:(Z,NFK6W
MJW?2_6_QA_\5^&T+."=',^.K=U9T=O4C,XZ ]^D,GY.J6B1.)F+)K%O+.-JZ
MYQUI&&YAW0VN&U0R=]KDI8\=EZ@?'$\<Y>R9^>5,_+H^-2&63J=56SEZJ#G#
MS$ K6RM0UUS /A*O'=8&HE]_PU>$45>['WYZP$@$S* 55RO>N%PKLREG.+6N
M\/8(B6_7KHXV*'JE?L@8Z6969+LO6_K\D/9"HKRB7N*?<N?WD#N*Q[)"0\<V
M)N4P+<'CFA^QV!%@<,@QI>3:/[VJ<PO:^KP^0'_\>-ID-!R_(<')(UQ7DV%G
M3HESDN]V0NF;/[0SY,P-/>Q>%R1[P'?N/M3EXX]1<VOT-%_*:2\I&<M:95RB
M^VY]K*7R17_M%?Y_R0/Y[:!!4]"*EY$]'W+OGA-<#GME@4 :L&F[+SN(Z)CY
MSRP7J'?Z_8UE&XY95O*$92,-N8OWM9K@&U?S1KN_/SN61\%/C\EL^L]<XF=9
M@B/>65KQ#N7R(?8>P]1[61MH=+'**5/J& @\9AZJ]B,]-@RT'X#_EZS8_D;
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M4H>S*0V20_R^ZCDFNTVWRJG,3TI>A'MI89E:"TQZ:3K)V:>E*T> :]NF0GG
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M_-V-]_^XQ*O!",8 <Y" %JIK!6-@\N2(D]6ZU&/3D4/$BH($#D3 GH.>\"C
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MP"BX ]OM88"F#M9[DJE,0B";F/%/>!&/(4!-AT"BS.I*IHH$=E:4V(#?O,G
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MHW@4#T[,__\F %!+ 0(4 Q0    ( $\];U1PZ22+$HL$ ()@.0 1
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M &9R97$M,C R,3$R,S%?;&%B+GAM;%!+ 0(4 Q0    ( $\];U2YX9>#ZE4
M '&[!@ 5              "  42V!0!F<F5Q+3(P,C$Q,C,Q7W!R92YX;6Q0
M2P$"% ,4    " !//6]4X$QHC5.V   %T H #P              @ %A# 8
M9G)E<2UE>#$P7S<N:'1M4$L! A0#%     @ 3SUO5*;5>Z-$ P  !1P   \
M             ( !X<(& &9R97$M97@R,5\Q+FAT;5!+ 0(4 Q0    ( $\]
M;U0Q"V>GI (  #40   /              "  5+&!@!F<F5Q+65X,C-?,2YH
M=&U02P$"% ,4    " !//6]4VML:'(((  !42   #P              @ $C
MR08 9G)E<2UE>#,Q7S$N:'1M4$L! A0#%     @ 3SUO5%%)DO-W"   24@
M  \              ( !TM$& &9R97$M97@S,5\R+FAT;5!+ 0(4 Q0    (
M $\];U2-:-0B=@4  %$K   /              "  7;:!@!F<F5Q+65X,S)?
M,2YH=&U02P$"% ,4    " !//6]49(X4DG<%  !G*P  #P
M@ $9X 8 9G)E<2UE>#,R7S(N:'1M4$L! A0#%     @ 3SUO5"F9BEZ4&P$
M0Y@! !$              ( !O>4& &EM9S@X,# Y,S(Y7S N:G!G4$L! A0#
M%     @ 3SUO5%,(D#:T= $ P)H! !$              ( !@ $( &EM9S@X
M,# Y,S(Y7S$N:G!G4$L! A0#%     @ 3SUO5%!RF4JV9@  ]OL  !(
M         ( !8W8) &EM9S@X,# Y,S(Y7S$P+FIP9U!+ 0(4 Q0    ( $\]
M;U1#LI;NPR," !99 @ 2              "  4G="0!I;6<X.# P.3,R.5\Q
M,2YJ<&=02P$"% ,4    " !//6]4J2#D$U3Q  "=8P$ $@
M@ $\ 0P :6UG.#@P,#DS,CE?,3(N:G!G4$L! A0#%     @ 3SUO5#4YL4\@
MJP  M 0! !(              ( !P/(, &EM9S@X,# Y,S(Y7S$S+FIP9U!+
M 0(4 Q0    ( $\];U1CN(:C4U   !%9   2              "  1">#0!I
M;6<X.# P.3,R.5\Q-"YJ<&=02P$"% ,4    " !//6]4!=-X+D:B   GN
M$@              @ &3[@T :6UG.#@P,#DS,CE?,34N:G!G4$L! A0#%
M  @ 3SUO5 @DRP#.=P( E_0" !(              ( !"9$. &EM9S@X,# Y
M,S(Y7S$V+FIP9U!+ 0(4 Q0    ( $\];U0TY6>)-X<  #KR   2
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M.# P.3,R.5\R,"YJ<&=02P$"% ,4    " !//6]4EO=F&/2P 0"I)@( $@
M            @ %?1A@ :6UG.#@P,#DS,CE?,C$N:G!G4$L! A0#%     @
M3SUO5+8^3..CT0$ :O@! !(              ( !@_<9 &EM9S@X,# Y,S(Y
M7S(R+FIP9U!+ 0(4 Q0    ( $\];U0V6\9@].@  (H6 0 2
M  "  5;)&P!I;6<X.# P.3,R.5\R,RYJ<&=02P$"% ,4    " !//6]4=!;!
M(2]C @"$?P( $@              @ %ZLAP :6UG.#@P,#DS,CE?,C0N:G!G
M4$L! A0#%     @ 3SUO5$0CJ4.&/P, I9,# !$              ( !V14?
M &EM9S@X,# Y,S(Y7S,N:G!G4$L! A0#%     @ 3SUO5)@-J*/#6   L\H
M !$              ( !CE4B &EM9S@X,# Y,S(Y7S0N:G!G4$L! A0#%
M  @ 3SUO5&DIT)VY  ( Z1 " !$              ( !@*XB &EM9S@X,# Y
M,S(Y7S4N:G!G4$L! A0#%     @ 3SUO5#P55QD?*@$ ]54! !$
M     ( !:*\D &EM9S@X,# Y,S(Y7S8N:G!G4$L! A0#%     @ 3SUO5,>=
MD[Z<B0  :O,  !$              ( !MMDE &EM9S@X,# Y,S(Y7S<N:G!G
M4$L! A0#%     @ 3SUO5!=*R0[.%P  UR$  !$              ( !@6,F
M &EM9S@X,# Y,S(Y7S@N:G!G4$L! A0#%     @ 3SUO5(2*."/UB    M\
M !$              ( !?GLF &EM9S@X,# Y,S(Y7SDN:G!G4$L%!@     F
- "8 :PD  *($)P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
